# Copyright (c) 1966-2018 Johns Hopkins University. Use of this file adheres to the terms specified at https://omim.org/help/agreement.
# Generated: 2018-10-22
# See end of file for additional documentation on specific fields
# Sort	Month	Day	Year	Cyto Location	Gene Symbols	Confidence (deprecated)	Gene Name	MIM Number	Mapping Method	Comments	Phenotypes	Mouse Gene Symbol
1.1	5	13	13	1pter-p36.13	CTRCT8, CCV		Cataract, congenital, Volkmann type	115665	Fd	linked to Rh in Scottish family	Cataract 8, multiple types (2)	
1.2	9	25	01	1p36.23	ENO1, PPH, MPB1		Enolase-1, alpha	172430	S, F, R, REa		Enolase deficiency (1)	4(Eno1)
1.3	12	22	87	1pter-p36	ERPL1, HLM2		Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2)	131190	REa, F			
1.4	4	14	11	1p36.11	HMGCL		3-hydroxy-3-methylglutaryl-Coenzyme A lyase	613898	REa, A		HMG-CoA lyase deficiency, 246450 (3)	4(Hmgcl)
1.5	4	30	15	1p36.33	AGRN, CMS8		Agrin	103320	REa		Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	4(Agrn)
1.6	6	24	16	1p36.33	GNB1, MRD42		Guanine nucleotide-binding protein, beta polypeptide-1	139380	REa, A		Mental retardation, autosomal dominant 42, 616973 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3)	4(Gnb1)
1.7	10	2	07	1p35.2	SDC3, SYND3, SDCN		Syndecan 3	186357	REc, R, H		{Obesity, association with}, 601665 (3)	4(Synd3)
1.8	8	28	98	1pter-p22.1	SAI1, MTS1, TFS1		Suppression of anchorage independence-1 (malignant transformation suppression-1)	154280	S, H			4(Tfs1)
1.9	12	6	16	1p36.33	ATAD3A, HAYOS		ATPase family, AAA domain-containing, member 3A	612316	REc	one family with AR inheritance reported	Harel-Yoon syndrome, 617183 (3)	4(Atad3)
1.10	10	6	08	1p36.33	ATAD3B, TOB3, KIAA1273		ATPase family, AAA domain-containing, member 3B	612317	R, REc			
1.11	11	29	16	1p36.33	ATAD3C		ATPase family, AAA domain-containing, member 3C	617227	REc			
1.12	5	6	13	1p36.33	C1orf86, FAAP20		Chromosome 1 open reading frame 86	615183	REc			
1.13	7	3	06	1p36.33	CALML6, CAGLP		Calmodulin-like 6	610171	REc			
1.14	9	30	10	1p36.33	CCNL2		Cyclin L2	613482	REc			4(Ccnl2)
1.15	3	23	14	1p36.33	CPSF3L, INTS11, RC68		Cleavage and polyadenylation-specific factor 3-like	611354	REc			
1.16	10	13	15	1p36.33	FAM132A, C1QDC2, C1QTNF12		Family with sequence similarity 132, member A	616593	REc			
1.17	11	1	13	1p36.33	GLTPD1, CPTP		Glycolipid transfer protein domain-containing protein 1	615467	REc			
1.18	12	19	14	1p36.33	ISG15, G1P2, IFI15, IMD38		ISG15 ubiquitin-like modifier	147571	REa, REc		Immunodeficiency 38, 616126 (3)	
1.19	3	23	09	1p36.33	MIR200A, MIRN200A		Micro RNA 200A	612090	REc			
1.20	3	23	09	1p36.33	MIR200B, MIRN200B		Micro RNA 200B	612091	REc			
1.21	3	23	09	1p36.33	MIR429, MIRN429		Micro RNA 429	612094	REc			
1.22	1	9	17	1p36.33	MXRA8, ASP3		Matrix remodeling-associated protein 8	617293	REc			4(Mxra8)
1.23	2	20	07	1p36.33	NOC2L, NIR		Nucleolar complex-associated protein 2, S. cerevisiae, homolog of	610770	REc			
1.24	8	18	14	1p36.33	PERM1, C1orf170		PPARGC1-and ESRR-induced regulator, muscle, 1	615921	REc			
1.25	1	21	16	1p36.33	SAMD11, MRS		Sterile alpha motif domain-containing protein 11	616765	REc			
1.26	10	10	11	1p36.33	SDF4, CAB45		Stromal cell-derived factor 4	614282	REc			
1.27	9	21	17	1p36.33	SSU72		Ssu72, S. cerevisiae, homolof of	617680	REc, H			4(Ssu72)
1.28	4	24	01	1p36.33	TAS1R3, T1R3		Taste receptor type 1, member 3	605865	REn, REc			4(Tas1r3)
1.29	12	2	14	1p36.33	TMEM240, C1orf70, SCA21		Transmembrane protein 240	616101	REc, Fd		Spinocerebellar ataxia 21, 607454 (3)	
1.30	10	27	89	1p36.23	CA6		Carbonic anhydrase VI	114780	REa, A, REc, R			
1.31	2	18	08	1p36.33	NADK		NAD kinase	611616	REc			
1.32	4	4	16	1p36.23	PER3, FASPS3		Period, Drosophila, homolog of, 3	603427	REc	mutation identified in 1 FASPS3 family	?Advanced sleep phase syndrome, familial, 3, 616882 (3)	
1.33	7	18	06	1p36.32	ACTRT2, ARPT2, ARPM2		Actin-related protein T2	608535	REc			
1.34	5	21	07	1p36.32	AJAP1, SHREW1		Adherens junction-associated protein 1	610972	R, REc			
1.35	2	2	16	1p36.32	CEP104, GLYBP, KIAA0562, JBTS25		Centrosomal protein, 104kD	616690	R, REc		Joubert syndrome 25, 616781 (3)	
1.36	8	29	13	1p36.33	MIB2		Mindbomb, Drosophila, homolog of, 2	611141	A, REc			
1.37	4	8	13	1p36.32	MIR551A		Micro RNA 551A	615148	REc			
1.38	09	06	18	1p36.32	MMEL1, NEPII, NEP2, NL1, SEP		Membrane metalloendopeptidase-like 1	618104	REc			
1.39	10	25	12	1p36.32	PEX10, NALD, PBD6A, PBD6B		Peroxisome biogenesis factor 10	602859	REc		Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3); Peroxisome biogenesis disorder 6B, 614871 (3)	
1.40	7	9	09	1p36.32	PLCH2, PLCL4		Phospholipase C, eta-2	612836	REc			
1.41	8	27	15	1p36.32	TPRG1L, FAM79A		Tumor protein p63 regulated 1-like	611460	R, REc			
1.42	4	8	03	1p36.32-p36.13	DYT13		Dystonia 13, torsion	607671	Fd		Dystonia 13, torsion (2)	
1.43	4	16	11	1p36.32-p35.3	KONDS		Kondoh syndrome (mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism)	606242	Fd	linked to rs966321 and rs1441834	Kondoh syndrome (2)	
1.44	10	5	11	1p36.31	GPR153		G protein-coupled receptor 153	614269	REc			4(Gpr153)
1.45	3	24	06	1p36.31	HES2		Hairy/enhancer of split, Drosophila, homolog of, 2	609970	REc			
1.46	3	24	06	1p36.31	HES3		Hairy/enhancer of split, Drosophila, homolog of, 3	609971	REc			
1.47	3	24	06	1p36.33	HES4		Hairy/enhancer of split, Drosophila, homolog of, 4	608060	REc			
1.48	3	24	06	1p36.32	HES5		Hairy/enhancer of split, Drosophila, homolog of, 5	607348	REc			
1.49	3	12	15	1p36.31	KLHL21, KIAA0469		Kelch-like 21	616262	R, REc			
1.50	4	27	16	1p36.31	RNF207, C1orf188		RING finger protein 207	616923	REc			
1.51	1	20	09	1p36.31	THAP3		THAP domain-containing protein 3	612532	REc			
1.52	11	4	93	1p36.31	RPL22, EAP		Ribosomal protein L22	180474	Ch, REc	fused with AML1 in t(3;21)		
1.53	9	18	12	1p36.31	DNAJC11		DNAJ/HSP40 homolog, subfamily C, member 11	614827	REc			
1.54	1	5	12	1p36.31-p36.13	DFNB96		Deafness, autosomal recessive 96	614414	Fd	between rs3817914 and rs477558	Deafness, autosomal recessive 96 (2)	
1.55	8	18	12	1p36.33	AURKAIP1, AKIP, AIP		Aurora kinase A-interacting protein 1	609183	R, REc			
1.56	12	22	17	1p36.33	B3GALT6, SEMDJL1, EDSSPD2		UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291	REc		Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3); Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3)	4(B3galt6)
1.57	1	27	11	1p36.33	CDK11B, CDC2L1, P58, CDK11		Cyclin-dependent kinase 11B	176873	REa, A, Pcm, A			
1.58	1	27	11	1p36.33	CDK11A, CDC2L2		Cyclin-dependent kinase 11A	116951	A			
1.59	8	4	99	1p36.32	DFFB, CAD, DFF2		DNA fragmentation factor, 40kD, beta subunit	601883	A			
1.60	9	11	12	1p36.33	GABRD, GEFSP5, EIG10, EJM7		Gamma-aminobutyric acid (GABA) A receptor, delta	137163	REa, R, REc		{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	
1.61	12	24	08	1p36.32	MEGF6, EGFL3		Multiple epidermal growth factor-like domains 6	604266	R			
1.62	6	15	99	1p36.33	TNFRSF18, AITR, GITR		Tumor necrosis factor receptor superfamily, member 18	603905	R			
1.63	3	30	99	1p36.31	KCNAB2, KCNA2B		Potassium voltage-gated channel, shaker-related subfamily, beta member 2	601142	A			
1.64	11	1	99	1p36.33	MMP23A, MMP21, MIFR		Matrix metalloproteinase 23A	603320	REc			
1.65	11	1	99	1p36.33	MMP23B, MMP22		Matrix metalloproteinase 23B	603321	REc			
1.66	1	12	11	1p36.22	MTHFR		Methylenetetrahydrofolate reductase	607093	A		Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia, susceptibility to}, 181500 (3); {Vascular disease, susceptibility to} (3); {Neural tube defects, susceptibility to}, 601634 (3); {Thromboembolism, susceptibility to}, 188050 (3)	4(Mthfr)
1.67	9	9	13	1p36.32	PRDM16, MEL1, LVNC8, CMD1LL		PR domain-containing protein 16	605557	REc, Ch		Left ventricular noncompaction 8, 615373 (3); Cardiomyopathy, dilated, 1LL, 615373 (3)	
1.68	8	9	99	1p36.3	PTPRZ2		Protein-tyrosine phosphatase, receptor-type, zeta-2	604008	A			
1.69	1	20	98	1p36.13	RNU1A, RNU1		RNA, U1A small nuclear	180680	REa, A	?same as A12M2		3(Rnu1b1)
1.70	10	5	12	1p36.33-p36.32	SKI, SGS		Avian sarcoma viral (v-ski) oncogene homolog	164780	REa, A, Ch	formerly mapped to 1q22-q24	Shprintzen-Goldberg syndrome, 182212 (3)	
1.71	12	23	02	1p36.31	TNFRSF25, TNFRSF12, DR3, LARD		Tumor necrosis factor receptor superfamily, member 25	603366	A, Ch			
1.72	9	28	10	1p36.22	UBE4B, UFD2A, KIAA0684		Ubiquitination factor E4B	613565	REc			
1.73	4	6	13	1p36.22	UBIAD1, TERE1, SCCD		UbiA prenyltransferase domain-containing protein 1	611632	A, Fd		Corneal dystrophy, Schnyder type, 121800 (3)	
1.74	3	20	08	1p36.33	VWA1, WARP		von Willebrand factor A domain-containing protein 1	611901	REc			
1.75	6	20	01	1p36.32	WDR8		WD repeat-containing protein 8	606040	A			
1.76	11	22	13	1p36.31	ZBTB48, HKR3		Zinc finger- and BTB domain-containing protein 48	165270	REa, A			
1.77	2	6	94	1p36.12	HTR1D		5-hydroxytryptamine (serotonin) receptor-1D	182133	REa, A			4(Htr1d)
1.78	6	10	98	1p36.22	DFFA, DFF1		DNA fragmentation factor, 45kD, alpha subunit	601882	A			
1.79	3	10	11	1p36.22	MASP2		Mannan-binding lectin serine protease 2	605102	A, R		MASP2 deficiency, 613791 (3)	
1.80	12	22	17	1p36.22	PLOD1, LH1, LLH, EDSKCL1		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)	153454	REa, A		Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3)	4(Plod)
1.81	9	15	96	1p36.33	SCNN1D		Sodium channel, voltage-gated, type I, delta polypeptide	601328	A			
1.82	12	18	98	1p36.22	TNFRSF1B, TNFR2, TNFBR		Tumor necrosis factor receptor superfamily, member 1B	191191	REa, A, Fd			4(Tnfr1)
1.83	12	14	98	1p36.32	TNFRSF14, HVEM, TR2		Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)	602746	A			
1.84	1	11	07	1p36.21	CASP9, APAF3		Caspase 9, apoptosis-related cysteine protease	602234	A			
1.85	3	16	06	1p36.31	ESPN		Espin, mouse, homolog of	606351	R, H		Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)	4(espn)
1.86	2	28	08	1p36.33	MRPL20		Mitochondrial ribosomal protein L20	611833	R			
1.87	2	17	11	1p36.12	C1QA		Complement component 1, q subcomponent, A chain	120550	REa, REb		C1q deficiency, 613652 (3)	
1.88	2	17	11	1p36.12	C1QB		Complement component 1, q subcomponent, B chain	120570	REa, REb		C1q deficiency, 613652 (3)	(C1qb)
1.89	2	17	11	1p36.12	C1QC, C1QG		Complement component 1, q subcomponent, C chain	120575	REn, REb		C1q deficiency, 613652 (3)	
1.90	9	9	08	1p36.13	FBXO42, FBX42, KIAA1332		F-box only protein 42	609109	REc			4(Fbox42)
1.91	9	9	08	1p36.22	FBXO6, FBX6, FBG2		F-box only protein 6	605647	REc			4(Fbxo6)
1.92	1	8	07	1p36.13	HSPB7, CVHSP		Heat-shock 27kD protein 7	610692	REc			
1.93	7	18	14	1p36.23	UTS2		Urotensin II	604097	REc			
1.94	12	30	04	1p36.22	APITD1		Apoptosis-inducing, TAF9-like domain 1	609130	REa, REc			
1.95	7	17	09	1p36.22	CTNNBIP1, ICAT		Catenin, beta-interacting protein 1	607758	R, REc			
1.96	3	20	09	1p36.22	DRAXIN, C1orf187		Dorsal repulsive axon guidance protein	612682	REc			
1.97	7	27	09	1p36.22	EXOSC10, PMSCL2		Exosome component 10	605960	R, REc			
1.98	5	24	13	1p36.22	LZIC		Leucine zipper and CTNNBIP1 domains-containing protein	610458	REc			
1.99	9	25	12	1p36.22	NMNAT1, NMNAT, PNAT1, LCA9		Nicotinamide nucleotide adenylyltransferase 1	608700	REc		Leber congenital amaurosis 9, 608553 (3)	
1.100	9	9	08	1p36.22	PTCHD2, DISP3, KIAA1337		Patched domain-containing protein 2	611251	REc			
1.101	2	28	07	1p36.22	SLC25A33		Solute carrier family 25 (mitochondrial carrier), member 33	610816	REc			4(Slc25A33)
1.102	12	18	07	1p36.22	SPSB, SSB1		SPRY domain- and SOCS box-containing 1	611657	R, REc			
1.103	9	22	08	1p36.22	CASZ1, SRG		Castor zinc finger protein 1	609895	A, REc			4(Srg)
1.104	10	10	18	1p36.22-p36.21	VPS13D, SCAR4		Vacuolar protein sorting 13, yeast, homolog of, D	608877	REc		Spinocerebellar ataxia, autosomal recessive 4, 607317 (3)	4(Vps13d)
1.105	3	5	18	1p36.21	AGMAT, AUH		Agmatinase	617887	REc			
1.106	2	11	08	1p36.21	CTRC, CLCR		Chymotrypsin	601405	REc		{Pancreatitis, chronic, susceptibility to}, 167800 (3)	
1.107	7	20	15	1p36.21	EFHD2, SWS1		EF-hand domain family, member D2	616450	REc			
1.108	9	9	08	1p36.22	FBXO44, FBX44, FBX6A, FBG3		F-box only protein 44	609111	REc			4(Fbxo44)
1.109	2	28	06	1p36.21	GBD2		Gallbladder disease 2	609918	Fd	between D1S1597 and D1S47	Gallbladder disease 2 (2)	
1.110	5	6	13	1p36.21	LRRC38		Leucine-rich repeat-containing protein 38	615212	REc			
1.111	12	10	13	1p36.21	PDPN, TI1A, T1A2, GP36, OTS8, AGGRUS		Podoplanin	608863	REc, R			
1.112	7	8	16	1p36.21	PLEKHM2, SKIP, KIAA0842		Pleckstrin homology domain-containing protein, family M, member 2	609613	REc			
1.113	3	12	07	1p36.21	SLC25A34		Solute carrier family 25, member 34	610817	REc			4(Slc25A34)
1.114	9	2	12	1p36.21	CELA2A, ELA2A		Chymotrypsin-like elastase family, member 2A	609443	REc, R			
1.115	9	2	12	1p36.21	CELA2B, ELA2B		Chymotrypsin-like elastase family, member 2B	609444	REc			
1.116	3	31	15	1p36.22	KIF1B, CMT2A, CMT2A1, NBLST1		Kinesin family member 1B	605995	Fd, REc, D	mutation identified in 1 CMT2A1 family	?Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma, 171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)	4(Kif1b)
1.117	8	30	16	1p36.22	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B		Mitofusin 2	608507	R, REa, REc		Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3); Hereditary motor and sensory neuropathy VIA, 601152 (3); Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3)	
1.118	4	20	17	1p36.22	MTOR, FRAP1, SKS		Mechanistic target of rapamycin	601231	R, A		Smith-Kingsmore syndrome, 616638 (3); Focal cortical dysplasia, type II, somatic, 607341 (3)	
1.119	7	8	09	1p36.13	NBPF1, KIAA1693		Neuroblastoma breakpoint family, member 1	610501	R, REc	pseudogenes on 3 and 5		
1.120	9	15	11	1p36.12	NBPF3		Neuroblastoma breakpoint family, member 3	612992	REc, A			
1.121	4	29	14	1p36.22	NPPA, PND, ANP, ATFB6, ATRST2		Natriuretic peptide precursor A	108780	REa, A, H		Atrial fibrillation, familial, 6, 612201 (3); Atrial standstill 2, 615745 (3)	4(Pnd)
1.122	5	9	95	1p36.22	NPPB, BNP		Natriuretic peptide precursor B	600295	H, REa, A, REn			4(Nppb)
1.123	10	25	12	1p36.22	PEX14, PBD13A		Peroxisome biogenesis factor 14	601791	R, REc		Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	
1.124	5	23	14	1p36.22	PIK3CD, APDS, IMD14		Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839	A, R		Immunodeficiency 14, 615513 (3)	
1.125	3	12	08	1p36.2	SCZD12		Schizophrenia 12	608543	Fd	max lod at D1S1612	{Schizophrenia 12}, 181500 (2)	
1.126	8	4	99	1p36.23	SLC2A5, GLUT5		Solute carrier family 2 (facilitated glucose transporter), member 5	138230	REa, A, REc, R			
1.127	10	11	06	1p36.23	SLC2A7, GLUT7		Solute carrier family 2 (facilitated glucose transporter), member 7	610371	REc			
1.128	10	5	10	1p36.22	TARDBP, TDP43, ALS10		TAR DNA-binding protein	605078	R, REc	pseudogenes on 2, 6, 8, 13, 20	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3); Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	4(Tardbp)
1.129	4	10	90	1p36.22	PGD		6-phosphogluconate dehydrogenase	172200	F, S			4(Pgd)
1.130	3	16	10	1p36.13	PAX7, RMS2		Paired box homeotic gene-7	167410	Psh, H, REa, A	fused with FKHR in rhabdomyosarcoma	Rhabdomyosarcoma 2, alveolar, 268220 (3)	4(Pax7)
1.131	3	24	88	1p35.3	FGR, SRC2		Oncogene FGR	164940	A, REb, REa, Fd	same as SRC2		4(Fgr)
1.132	9	22	97	1p36.2-p36.1	GLC3B		Glaucoma 3, primary infantile, B	600975	Fd		Glaucoma 3, primary infantile, B (2)	
1.133	6	17	16	1p36.23	RERE, NEDBEH		RE repeats-encoding gene	605226	REc, Ch		Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	
1.134	6	28	17	1p36.23	SLC45A1, DNB5, IDDNPF		Solute carrier family 45, member 1	605763	REc		Intellectual developmental disorder with neuropsychiatric features, 617532 (3)	
1.135	10	3	11	1p36.13	ZBTB17, ZNF151, MIZ1		Zinc finger- and BTB domain-containing protein 17	604084	A			
1.136	1	1	95	1p36.12	CDA		Cytidine deaminase	123920	A, Psh			
1.137	2	19	08	1p35.3	EPB41, EL1		Erythrocyte surface protein band 4.1	130500	F, REb		Elliptocytosis-1, 611804 (3)	4(Elp1)
1.138	5	14	18	1p36.11	RHCE, RHNA		Rhesus system C and E polypeptides	111700	F, D, Fd	?order: C-E-D	[Blood group, Rhesus] (3); Rh-null disease, amorph type, 617970 (3)	
1.139	5	25	05	1p36.11	RHD		Rhesus system D polypeptide	111680	F, D, Fd		[Rh-negative blood type] (3)	
1.140	5	23	12	1p36.13	AKR7A2, AKR7, AFAR		Aldo-keto reductase family 7, member A2	603418	REn	pseudogenes on Xq25 and 1p12		
1.141	8	8	13	1p36.13	AKR7A3, AFAR2		Aldo-keto reductase family 7, member A3	608477	REc, A			
1.142	8	8	13	1p36.13	AKR7A4, AFAR3		Aldo-keto reductase family 7, member A4	608478	REc, A			
1.143	12	22	08	1p36.13	ARHGEF10L, GRINCHGEF, KIAA1626		RHO guanine nucleotide exchange factor 10-like protein	612494	REc			
1.144	12	22	08	1p36.13	ARHGEF19, WGEF		RHO guanine nucleotide exchange factor 19	612496	REc			4(Arhgef19)
1.145	10	13	15	1p36.12	ASAP3, UPLC1, CENTB6, DDEFL1, ACAP4		ARF GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 3	616594	REc			
1.146	3	30	16	1p36.13	EMC1, KIAA0090, CAVIPMR		Endoplasmic reticulum membrane protein complex, subunit 1	616846	Psh		Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	
1.147	7	17	09	1p36.21	FBLP1, MIGFILIN		Filamin-binding LIM protein 1	607747	REc			
1.148	9	28	15	1p36.13	MINOS1, MIO10, MIC10		Mitochondrial inner membrane organizing system protein 1	616574	REc			
1.149	2	18	08	1p36.13	NECAP2		NECAP endocytosis-associated protein 2	611624	R, REc			
1.150	1	28	08	1p36.13	OTUD3, KIAA0459		OTU domain-containing protein 3	611758	R, REc			
1.151	1	16	07	1p36.13	PADI1		Peptidylarginine deiminase, type I	607934	REc, REn			
1.152	1	16	07	1p36.13	PADI2		Peptidylarginine deiminase, type II	607935	REc, REn			
1.153	12	22	16	1p36.13	PADI3, UHS1		Peptidylarginine deiminase, type III	606755	REc, REn		Uncombable hair syndrome, 191480 (3)	
1.154	1	16	07	1p36.13	PADI4, PADI5, PAD		Peptidylarginine deiminase, type IV	605347	REc, REn		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.155	12	6	16	1p36.13	PADI6, PREMBL2		Peptidylarginine deiminase, type VI	610363	REn		Preimplantation embryonic lethality 2, 617234 (3)	
1.156	8	21	12	1p36.13	PQLC2		PQ loop repeat-containing protein 2	614760	REc			
1.157	10	25	16	1p36.13	RNF186		Ring finger protein 186	617163	REc			
1.158	1	25	18	1p13.3	SLC25A24, SCAMC1		Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24	608744	REc, H		Fontaine progeroid syndrome, 612289 (3)	2(Slc25a24)
1.159	9	30	10	1p36.21-p36.13	SPEN, MINT, SHARP, HIAA0929		SPEN, Drosophila, homolog of	613484	REc			
1.160	7	22	14	1p36.13	UBR4, ZUBR1, RBAF600, KIAA1307		Ubiquitin protein ligase E3 component n-recognin 4	609890	R, REc			
1.161	9	22	08	1q21.2	APH1A		Anterior pharynx defective 1, C. elegans, homolog of, A	607629	R, REc			
1.162	1	11	95	1p36.12	ID3		Inhibitor of DNA binding 3, dominant negative, helix-loop-helix protein	600277	RE, A			
1.163	10	24	97	1p36.13	D1S1733E, DAN		Differential-screening-selected gene aberrant in neuroblastoma	600613	A	aberrant in some neuroblastomas		4(D4H1S1733E)
1.164	1	29	16	1p36.11	MAN1C1		Mannosidase, alpha, class 1C, member 1	616772	REc			
1.165	1	3	05	1p36.13-p34.3	ANIB3		Aneurysm, intracranial berry, 3	609122	Fd		Aneurysm, intracranial berry, 3 (2)	
1.166	10	24	14	1p36.13-p34.3	EA8		Episodic ataxia, type 8	616055	Fd	between rs2743201 and rs215791	Episodic ataxia, type 8 (2)	
1.167	8	23	09	1p36.12	B6QTL1		Vitamin B6 plasma level QTL 1	612957	Fd	associated with rs4654748	{Vitamin B6 plasma level QTL 1} (2)	
1.168	1	9	13	1p36.12	CAMK2N1		Calcium/calmodulin-dependent protein kinase II inhibitor 1	614986	REc			
1.169	8	18	14	1p36.12	EIF4G3, EIF4GII		Eukaryotic translation initiation factor 4-gamma, 3	603929	REc			
1.170	7	17	09	1p36.12	EPHA8, EEK, HEK3		Ephrin receptor EphA8 (eph- and elk-related kinase)	176945	REa, REc			
1.171	11	3	14	1p36.12	HP1BP3, HP1BP74		Heterochromatin protein 1-binding protein 3	616072	REc			
1.172	3	3	16	1p36.12	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF		Lysine-specific demethylase 1A	609132	R, REc		Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	
1.173	7	20	12	1p36.12	KIF17, KIAA1405		Kinesin family member 17	605037	REc			
1.174	4	27	09	1p36.12	MUL1, MULAN, C1orf166		Mitochondrial ubiquitin ligase activator of NFKB1	612037	REc			
1.175	3	1	01	1p36.12	PLA2G2D, SPLASH		Phospholipase A2, group IID	605630	R			4(Pla2g2d)
1.176	5	25	13	1p36.12	TCEA3		Transcription elongation factor A, 3	604128	REc			
1.177	2	2	16	1p36.12	UBXN10		UBX domain protein 10	616783	REc			
1.178	4	5	11	1p36.12-p35.1	BFIS4, BFIC4		Seizures, benign familial infantile, 4	612627	Fd	between D1S2864 and D1S2830	Seizures, benign familial infantile, 4 (2)	
1.179	7	7	14	1p36.1-p35.3	AHDC1, MRD25		AT-hook DNA-binding motif-containing protein 1	615790	REc		Xia-Gibbs syndrome, 615829 (3)	
1.180	7	20	12	1p36.11	CD52, CDW52		CD52 molecule	114280	REc			
1.181	7	2	18	1p36.11	CLIC4, MTCLIC		Chloride intracellular channel 4	606536	REc			
1.182	2	25	15	1p36.11	CNKSR1, CNK1		Connector enhancer of KSR 1	603272	R, REc			
1.183	6	22	14	1p36.13	CROCC, ROOTLETIN, KIAA0445		Ciliary rootlet coiled-coil protein	615776	REc			
1.184	1	23	18	1p36.11	DHDDS, HDS, RP59, DEDSM		Dehydrodolichyl diphosphate synthase	608172	REc	mutation identified in 1 CDG1BB patient	Retinitis pigmentosa 59, 613861 (3); Developmental delay and seizures with or without movement abnormalities, 617836 (3); ?Congenital disorder of glycosylation, type 1bb, 613861 (3)	
1.185	4	6	11	1p36.11	FCN3, HAKA1		Ficolin 3	604973	R, REc		Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	
1.186	5	19	17	1p36.11	GPATCH3		G-patch domain-containing protein 3	617486	REc			
1.187	3	11	14	1p36.11	GRHL3, SOM, TFCP2L4, VWS2		Grainyhead-like 3	608317	REc, Fd		Van der Woude syndrome 2, 606713 (3)	
1.188	10	7	02	1p36.12	HNRPR, HNRNPR		Heterogeneous nuclear ribonucleoprotein R	607201	R			
1.189	2	11	13	1p36.11	IFNLR1, IL28RA		Interferon, lambda receptor 1	607404	REc			
1.190	4	27	09	1p36.11	LIN28, LIN28A		Lin28, C. elegans, homolog of	611043	REc, H			4(Lin28)
1.191	12	30	14	1p36.11	LYPLA2, APT2		Lysophospholipase II	616143	REc			
1.192	2	8	12	1p36.11	MAP3K6, MAPKKK6, ASK2		Mitogen-activated protein kinase kinase kinase 6	604468	REc			
1.193	2	23	16	1p36.11	MYOM3		Myomesin 3	616832	REc			4(Myom3)
1.194	8	19	13	1p36.11	NUDC		Nuclear distribution gene C, A. nigulans, homolog of	610325	REc, A			
1.195	4	29	14	1p36.11	PAFAH2		Platelet-activating factor acetylhydrolase 2	602344	REc			
1.196	7	17	09	1p36.11	PAQR7, MPRA, PGLP		Progestin and ADIPOQ receptor family, member 7	607779	REc			
1.197	8	20	12	1p36.11	PIGV, HPMRS1		Phosphatidylinositol glycan, class V	610274	REc		Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	
1.198	3	11	08	1p36.11	PNRC2		Proline-rich nuclear receptor coactivator 2	611882	REc			
1.199	7	19	12	1p36.11	SFN		Stratifin	601290	REc			
1.200	3	7	14	1p36.11	SH3BGRL3		SH3 domain-binding glutamic acid-rich protein-like protein 3	615679	REc, A			
1.201	1	17	13	1p36.11	SLC30A2, ZNT2, TNZD		Solute carrier family 30 (zinc transporter), member 2	609617	REc		Zinc deficiency, transient neonatal, 608118 (3)	4(Slc30a2)
1.202	7	27	09	1p36.11	SRRM1, SRM160		Serine/arginine repetitive matrix 1 (ser/arg-related nuclear matrix protein, 160kD)	605975	R, REc			
1.203	7	18	14	1p36.11	STPG1, MAPO2, C1orf201		Sperm-tail PG-rich repeat-containing protein 1	615826	REc			4(Stpg1)
1.204	7	17	09	1p36.11	SYF2, P29		SYF2 RNA splicing factor, S. cerevisiae, homolog of	607090	R, REc			
1.205	2	14	08	1p36.11	SYTL1, SLP1, JFC1		Synaptotagmin-like protein 1	608042	R, REc			
1.206	6	22	14	1p36.11	TMEM50A, SMP1		Transmembrane protein 50A	605348	REc	between RHD and RHCE		
1.207	5	24	13	1p36.11	TMEM57, FLJ10747		Transmembrane protein 57	610301	REc, H			4(Tmem57)
1.208	2	10	14	1p36.11	TRIM63, RNF28, SMRZ, MURF1		Tripartite motif containing 63	606131	A			
1.209	2	19	16	1p36.11	TRNP1		TMF1-regulated nuclear protein 1	616824	REc			
1.210	5	29	15	1p36.11	UBXN11, SOC		UBX domain protein 11	609151	REc			
1.211	12	22	15	1p36.11	ZNF593, ZT86		Zinc finger protein 593	616698	REc			
1.212	1	29	16	1p36.11	ZNF683, HOBIT		Zinc finger protein 683	616775	REc			
1.213	11	13	17	1p36.11	WASF2, WAVE2, SCAR2		WAS protein family member 2	605875	REc	?pseudogene on Xp11.21		
1.214	8	28	97	1p36.13	CAPZB, CAPPB		Capping protein (actin filament) muscle Z-line, beta	601572	A			
1.215	1	8	16	1p36.12	CDC42, TKS		Cell division cycle 42 (GTP-binding protein, 25kD)	116952	H, R, REc		Takenouchi-Kosaki syndrome, 616737 (3)	4(cdc42)
1.216	1	1	95	1p35.3	CHC1, RCC1		Regulator of chromosome condensation	179710	REb, A			4(Chc1)
1.217	5	25	14	1p36.12	DDOST, OST, OST48, CDG1R		Dolichyl-diphosphooligosaccharide-protein glycosyltransferase	602202	A	mutation (cmpd het) identified in 1 CDG1R patient	?Congenital disorder of glycosylation, type Ir, 614507 (3)	
1.218	7	16	09	1p36.21	DHRS3, RETSDR1		Short-chain dehydrogenase/reductase family, member 3	612830	A, R			
1.219	11	17	16	1p36.12	ECE1		Endothelin converting enzyme 1	600423	A, R, Psh	mutation identified in 1 HCAD patient	?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3); {Hypertension, essential, susceptibility to}, 145500 (3)	
1.220	5	6	13	1p36.13	EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6		Ephrin receptor EphA2	176946	A, REa, Fd		Cataract 6, multiple types, 116600 (3)	
1.221	4	11	97	1p36.11	EXTL1		Exostosin-like 1	601738	R, A			
1.222	8	28	02	1p36.11	HMGN2, HMG17		High-mobility group nucleosomal binding protein 2	163910	REa, A			
1.223	4	1	01	1p36.12	HSPG2, PLC, SJS, SJA, SJS1		Heparan sulfate proteoglycan of basement membrane (perlecan)	142461	A, REa, LD		Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	4(Plc)
1.224	2	28	03	1p36.11	MDS2		Myelodysplasia syndrome gene 2	607305	A	fused with ETV6 in myelodysplastic syndrome		
1.225	3	6	01	1p36.11	NR0B2, SHP		Nuclear receptor subfamily 0, group B, member 2	604630	REa, A		Obesity, mild, early-onset, 601665 (3)	
1.226	11	3	98	1p35.3	RNU17A, RNE1		RNA, U17a small nucleolar	180645	REn	in IVS1 of CHC1		
1.227	11	3	98	1p35.3	RNU17B		RNA, U17b small nucleolar	603239	REn			
1.228	12	15	99	1p35.3	RNU17D, U17HG		RNA, U17d small nucleolar	603238	REn			
1.229	8	30	09	1p36.11	RPS6KA1, RSK1		Ribosomal protein S6 kinase, 90kD, 1	601684	REa, REc			
1.230	2	20	98	1p36.21	RSC1A1, RS1		Regulatory solute carrier protein, family 1, member 1	601966	A			
1.231	12	19	11	1p36.11	SRSF10, FUSIP1, TASR, TASR1, TASR2		Splicine factor, serine/arginine-rich, 10	605221	REc	pseudogenes on chr. 9, 12, 20		
1.232	2	15	96	1p36.11	TCEB3		Transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A)	600786	A			
1.233	9	2	09	1q21.1	TRNAN1, TRN1, TRN		tRNA asparagine	189880	REa, RE			
1.234	8	1	14	1p36.12	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB		eph tyrosine kinase 3 (ephrin receptor EphB2)	600997	Psh, A, Fd		{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	4(Ephb2)
1.235	4	23	96	1p36.1-p35	MEMO1		Methylation modifier for class I HLA	601201	D			
1.236	10	22	95	1p36.13	MFAP2, MAGP, MAGP1		Microfibrillar-associated protein-2	156790	REa, A			4(Mfap2)
1.237	2	26	95	1p36.12	RAP1GA1		RAP1, GTPase activating protein 1	600278	A, REa			
1.238	2	4	09	1p36.11	RPL11, DBA7		Ribosomal protein L11	604175	REa, R, A		Diamond-Blackfan anemia 7, 612562 (3)	
1.239	07	16	18	1p36.13	SDHB, SDH2, SDHIP, PGL4		Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	185470	S, REa, A	1 of 2 polypeptides	Paragangliolas 4, 115310 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606444 (3)	
1.240	4	2	15	1p36.11	SLC9A1, NHE1, APNH, LIKNS		Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)	107310	A, F, Fd	mutation identified in 1 LIKNS family	?Lichtenstein-Knorr syndrome, 616291 (3)	4(Apnh, Nhe1)
1.241	7	17	01	1p36.11	STMN1, LAP18, SMN		Stathmin	151442	REa, A			4(Lap18)
1.242	1	1	95	1p36.11	GPR3		G protein-coupled receptor-3	600241	A			
1.243	3	17	94	1p35.3	OPRD1		Opioid receptor, delta-1	165195	H, A			4(Nbor, Oprd1)
1.244	8	12	09	1p36.12	ALPL, HOPS, TNSALP		Alkaline phosphatase, liver/bone/kidney	171760	S, H, Fd, F, A		Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood, 241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)	4(Akp2)
1.245	3	17	06	1p36.31	ACOT7, BACH, LACH		Acyl-CoA thioesterase 7	602587	REc			
1.246	2	15	06	1p36	AD7CNTP		Alzheimer disease neuronal thread protein	607413	R, REc			
1.247	1	25	99	1p36.13	ALDH4A1, ALDH4, P5CDH		Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)	606811	A		Hyperprolinemia, type II, 239510 (3)	
1.248	11	7	08	1p36	ALPQTL2		Alkaline phosphatase, plasma level of, QTL 2	612367	Fd	linkage with rs1780324	{Alkaline phosphatase, plasma level of, QTL 2} (2)	
1.249	1	11	17	1p36.13	ATP13A2, PARK9, KRPPD, SPG78		ATPase, type 13A2	610513	REc, Fd	mutation identified in 1 family with CLN12	Kufor-Rakeb syndrome, 606693 (3); Spastic paraplegia 78, autosomal recessive, 617225 (3)	4(Atp13a2)
1.250	10	6	09	1p36	BCC1		Basal cell carcinoma, susceptibility to, 1	605462	Fd	associated with rs7538876	{Basal cell carcinoma, susceptibility to, 1} (2)	
1.251	5	14	02	1p36	BMND3		Bone mineral density QTL 3	606928	Fd	?another locus at 3p21	[Bone mineral density QTL 3] (2)	
1.252	8	31	12	1p36.31-p36.23	CAMTA1, KIAA0833, CANPMR		Calmodulin-binding transcription activator 1	611501	REc		Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	
1.253	2	20	07	1p36.31	CHD5		Chromodomain helicase DNA-binding protein 5	610771	REc, H			4(Chd5)
1.254	6	19	98	1p36.22	CLCN6		Chloride channel 6	602726	REa, A			
1.255	11	3	09	1p36.13	CLCNKA		Chloride channel, kidney, A	602024	Fd, REc	11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB	Bartter syndrome, type 4b, digenic, 613090 (3)	
1.256	8	24	04	1p36.13	CLCNKB		Chloride channel, kidney, B	602023	Fd, REc	unequal crossingover with CLCNKA	Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4b, digenic, 613090 (3)	
1.257	3	3	15	1p36.22	CLSTN1, KIAA0911		Calsyntenin 1	611321	REc			4(Clstn1)
1.258	1	4	93	1p36	CMM, MLM, DNS		Cutaneous malignant melanoma/dysplastic nevus	155600	F, Fd, D	some linkage studies negative; see 9p	{Melanoma, cutaneous malignant, 1} (2)	
1.259	12	30	09	1p36.11	CNR2, CB2, CX5		Cannabinoid receptor 2	605051	R, REc			
1.260	4	22	15	1p36.33	DVL1, DRS2		Dishevelled 1 (homologous to Drosophila dsh)	601365	Psh, A		Robinow syndrome, autosomal dominant 2, 616331 (3)	
1.261	2	01	01	1p36.22	CORT		Cortistatin	602784	H, R, REc			4(Cort)
1.262	1	20	09	1p36	DEL1p36, C1DELp36		Chromosome 1p36 deletion syndrome	607872	Ch	contiguous gene deletion syndrome	Chromosome 1p36 deletion syndrome (4)	
1.263	3	13	06	1p36.23	DJ1, PARK7		Oncogene DJ-1	602533	Fd, R		Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	
1.264	2	23	95	1p36.12	E2F2		E2F transcription factor 2	600426	A			
1.265	4	18	97	1p35.3	EYA3		Eyes absent, Drosophila, homolog of, 3	601655	A, H			4(Eya3)
1.266	9	9	08	1p36.22	FBXO2, FBX2, FBG1, NFB42		F-box only protein 2	607112	REc			4(Fbxo2)
1.267	5	29	12	1p36.22	H6PD, GDH, G6PDH, CORTRD1		Hexose-6-phosphate dehydrogenase	138090	S, F	digenic triallelic mutations with HSD11B1	Cortisone reductase deficiency 1, 604931 (3)	
1.268	6	9	09	1p36	IBD7		Inflammatory bowel disease 7	605225	Fd	associated with rs6426833	{Inflammatory bowel disease 7} (2)	
1.269	4	17	01	1p36.31	ICMT		Isoprenylcysteine carboxylmethyltransferase	605851	R			
1.270	2	7	17	1p36.11	KDF1, C1orf172, ECTD12		Keratinocyte differentiation factor 1	616758	REc, H	mutation identified in 1 ECTD12 family	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3)	4(Kdf1)
1.271	4	2	01	1p36.12	LUZP1		Leucine zipper protein 1	601422	H, R			4(Luzp)
1.272	12	16	16	1p36.22	MAD2L2, MAD2B, FANCV		Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2	604094	R	mutation identified in 1 FANCV patient; pseudogene on 14q21-q23	?Fanconi anemia, complementation group V, 617243 (3)	
1.273	9	16	03	1p36.23	MIG6, RALT		Mitogen-inducible gene 6	608069	R, REc			
1.274	3	23	09	1p36.22	MIR34A, MIRN34A		Micro RNA 34A	611172	REc			
1.275	2	23	09	1p36	MS4		Multiple sclerosis, susceptibility to, 4	612596	Fd	associated with rs10492972	{Multiple sclerosis, susceptibility to, 4} (2)	
1.276	7	22	11	1p36	MYP14		Myopia 14	610320	Fd	between D1S552 and D1S1622	Myopia 14 (2)	
1.277	12	30	02	1p36.31	NPHP4, SLSN4		Nephrocystin 4	607215	Fd, REc		Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)	
1.278	7	9	06	1p36.32	PANK4		Pantothenate kinase 4	606162	REn			
1.279	6	1	04	1p36.12	PINK1, PARK6		PTEN-induced putative kinase 1	608309	R, REc, Fd		Parkinson disease 6, early onset, 605909 (3)	
1.280	4	24	18	1p36.31	PLEKHG5, KIAA0720, DSMA4, CMTRIC		Pleckstrin homology domain- and RhoGEF domain-containing protein G5	611101	REc, Fd, R, Fd		Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3); Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	
1.281	9	28	96	1p36.21	PRDM2, RIZ		PR domain-containing protein 2 (retinoblastoma protein-binding zinc-finger protein RIZ)	601196	REc, A			4(Riz)
1.282	7	09	06	1p36.33	PRKCZ, PKC2		Protein kinase C, zeta form	176982	REc			
1.283	11	29	99	1p36.11	RUNX3, CBFA3, PEBP2A3, AML2		Runt-related transcription factor 3	600210	A, REa			4(Aml2, Cbfa3)
1.284	6	4	13	1p36.32	SMIM1, VEL		Small integral membrane protein 1	615242	REc		[Blood group, Vel system], 615264 (3)	
1.285	2	12	03	1p36.31	TAS1R1, T1R1		Taste receptor type 1, member 1	606225	R, REc			4(T1r1)
1.286	2	12	03	1p36.13	TAS1R2, T1R2		Taste receptor type 1, member 2	606226	R, REc			4(T1r2)
1.287	1	15	14	1p36.33	TNFRSF4, TXGP1L, OX40, ACT35, IMD16		Tumor necrosis factor receptor superfamily, member 4	600315	A	mutation identified in 1 IMD16 family	?Immunodeficiency 16, 615593 (3)	4(Ox40)
1.288	12	18	98	1p36.22	TNFRSF8, CD30, D1S166E		Tumor necrosis factor receptor superfamily, member 8 (CD30 antigen; Ki-1 antigen)	153243	A			4(Cd30)
1.289	12	18	98	1p36.23	TNFRSF9, ILA, CD137		Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of)	602250	REa			(Cd157)
1.290	10	15	97	1p36.32	TP73		p53-related protein	601990	D	imprinted	?Neuroblastoma (1)	
1.291	9	2	09	1p36.13	TRNAE1, TRNE, TRE		tRNA glutamic acid	180640	A			
1.292	4	21	17	1p36.12	USP48, USP31		Ubiquitin-specific peptidase 48	617445	REc			
1.293	7	9	06	1p36.23	VAMP3		Vesicle-associated membrane protein 3	603657	REc			
1.294	6	27	08	1p36.12	ZBTB40, KIAA0478		Zinc finger- and BTB domain-containing protein 40	612106	REc			
1.295	1	2	08	1p36.12	ZNF436, KIAA1710		Zinc finger protein 436	611703	REc			
1.296	5	29	02	1p36.11	GALE		UDP galactose-4-epimerase	606953	S, LD		Galactose epimerase deficiency, 230350 (3)	
1.297	3	12	96	1p36.13	HTR6		5-hydroxytryptamine (serotonin) receptor-6	601109	REa			
1.298	11	1	06	1p36.11	LDLRAP1, ARH, FHCB2, FHCB1		Low density lipoprotein receptor adaptor protein 1	605747	Fd		Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	
1.299	11	18	16	1p36.11	SELENON, SEPN1, SELN, RSMD1, CFTD		Selenoprotein N	606210	REc, Fd		Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	
1.300	11	1	04	1p36-p34	DYX8		Dyslexia, susceptibility to, 8	608995	Fd	between D1S552 and D1S1622	{Dyslexia, susceptibility to, 8} (2)	
1.301	12	23	14	1p36.13	PLA2G5, FRFB		Phospholipase A2, group V	601192	A		[Fleck retina, familial benign], 228980 (3)	4(Pla2g5)
1.302	5	4	00	1p34.3	PABPC4, PABP4, IPABP, APP1		Polyadenylate-binding protein, cytoplasmic, 4	603407	Psh, R			
1.303	12	3	91	1p36.22	SRM, SPS1		Spermidine synthase-1	182891	REa, A, Psh	?pseudogene on 3p14-q21		
1.304	4	29	16	1p36.11	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2		AT rich interactive domain 1A, SWI-like	603024	A		Coffin-Siris syndrome 2, 614607 (3)	
1.305	1	15	13	1p35.3	ATP1F1, IF1		ATPase inhibitory factor 1	614981	REc			
1.306	3	28	11	1p36.11	CATSPER4		Cation channel, sperm-associated, 4	609121	REc			4(Catsper4)
1.307	1	27	04	1p35.1	CSMD2, KIAA1884		Cub and Sushi multiple domains 2	608398	REc			
1.308	7	17	09	1p35.3	GMEB1		Glucocorticoid modulatory element-binding protein 1	604409	R, REc			
1.309	1	9	17	1p35.3	MECR, NRBF1, DYTOABG		Mitochondrial trans-2-enoyl-CoA reductase	608205	REc		Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3)	
1.310	11	7	08	1p35.3	MED18		Mediator complex subunit 18	612384	REc			
1.311	2	21	07	1p36.11	PDIK1L		PDLIM1-interacting kinase 1-like	610785	REc			
1.312	7	16	12	1p35.3	PHACTR4		Phosphatase and actin regulator 4	608726	R, REc			
1.313	2	1	11	1p35.3	PTPRU, GLEPP1, PTPU2		Protein tyrosine phosphatase, receptor type, U	602454	REc			
1.314	5	13	03	1p35.3	SEST2, HI95		Sestrin 2	607767	A			9(Sest2)
1.315	10	25	17	1p35.3	SMPDL3B, ASML3B		Sphingolyelin phosphodiesterase, acid-like, 3B	617737	REc			
1.316	12	19	11	1p35.3	SRSF4, SFRS4, SRp75		Splicing factor, serine/arginine-rich, 4	601940	R, REc			
1.317	7	2	18	1p35.3	STX12, STX13		Syntaxin 12	606892	REc			
1.318	9	22	08	1p35.3	TAF12		TAF12 RNA polymerase II, TATA box-binding protein-associated factor, 20kD	600773	R, REc			
1.319	1	30	18	1p35.3	THEMIS2, C1orf38, ICB1		Thymocyte selection-associated protein family, member 2	617856	REc			
1.320	12	18	14	1p34.3	MEAF6, C1orf149, EAF6		MYST/ESA1-associated factor 6	611001	R, REc			
1.321	11	30	06	1p34.3	ADPRHL2, ARH3		ADP-ribosylhydrolase-like 2	610624	REc			
1.322	1	9	13	1p34.3	ZC3H12A, MCPIP, MCPIP1		Zinc finger CCCH domain-containing protein 12A	610562	REc			
1.323	8	8	13	1p35.2	HCRTR1, OX1R		Hypocretin receptor 1	602392	REc, R			
1.324	7	16	09	1p35.2	NKAIN1		Na+/K+ transporting ATPase-interacting 1	612871	REc			4(Nkain1)
1.325	5	3	18	1p35.2	PUM1, KIAA0099, SCA47		Pumilio, Drosophila, homolog of, 1	607204	REa, REc		Spinocerebellar ataxia 47, 617931 (3)	
1.326	4	2	12	1p35.2	SERINC2		Serine incorporator 2	614549	REc			
1.327	7	27	09	1p35.2	SNRNP40, SPF38, PRPF8BP		Small nuclear ribonucleoprotein 40kDa (U5)	607797	R, REc			
1.328	11	3	14	1p35.2	TINAGL1, TINAGRP		Tubulointerstitial nephritis antigen-like protein 1	616064	REc			
1.329	9	24	08	1p36.11	RCAN3, DSCR1L2, MCIP3		Regulator of calcineurin 3	605860	REc			4(Dscr1l2)
1.330	6	12	17	1p35.1	BSDC1		BSD domain-containing protein 1	617518	REc			
1.331	11	23	11	1p35.2	CCDC28B, MGC1203		Coiled-coil domain-containing protein 28B	610162	REc		{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	
1.332	8	29	02	1p34.3	DNALI1, P28		Dynein, axonemal, light intermediate polypeptide 1	602135	REa, R			
1.333	3	20	08	1p35.1	FNDC5, FRCP2		Fibronectin type III domain-containing protein 5	611906	R, REc, H			4(Fndc5)
1.334	2	18	96	1p34.3	GJA4, CX37		Gap junction protein, alpha-4, 37kD (connexin 37)	121012	REa, A, REc			(Gja4)
1.335	6	13	17	1p34.3	GJB3, CX31, DFNA2B, EKVP1		Gap junction protein, beta-3	603324	REn, REc, Psh, A	same YAC as GJA4	Erythrokeratodermia variabilis et progressiva 1, 133200 (3); Deafness, autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic, GJB2/GJB3, 220290 (3)	
1.336	6	13	17	1p34.3	GJB4, CX30.3, EKVP2		Gap junction protein, beta-4	605425	REn, Fd		Erythrokeratodermia variabilis et progressiva 2, 617524 (3)	
1.337	11	29	00	1p34.3	GJB5, CX31.1		Gap junction protein, beta-5	604493	R, REc			
1.338	1	3	17	1p35.1	HMGB4		High mobility group box 4	617285	REc, H			4(Hmgb4)
1.339	3	26	07	1p35.1	IBRDC3, NKLAM		IBR domain-containing protein 3	610872	R, REc			
1.340	5	26	13	1p35.2	KPNA6		Karyopherin alpha-6	610563	R, REc			
1.341	1	14	16	1p35.1	TRIM62, DEAR1		Tripartite motif-containing protein 62	616755	A			
1.342	7	17	14	1p35.1	ZBTB8OS, ARCH		Zinc finger- and BTB domain-containing protein 8, opposite strand	615891	REc			
1.343	4	2	16	1p35.1	ZSCAN20, ZNF31, KOX29		Zinc finger- and SCAN domain-containing protein 20	611315	REc			
1.344	9	1	16	1p35.2	ADGRB2, BAI2		Adhesion G protein-coupled receptor B2	602683	A			
1.345	5	3	18	1p35	C1DELp35, DEL1p35		Chromosome 1p35 deletion syndrome	617930	Ch	SRO 1.03 Mb containing 23 genes	Chromosome 1p35 deletion syndrome (4)	
1.346	8	21	91	1p35	EBVS1		Epstein-Barr virus integration site	132850	A			
1.347	3	21	93	1p35.3	G1P3, IFI616		Interferon, alpha-inducible protein (clone IFI-6-16)	147572	A, T			
1.348	5	26	98	1p35.2	MATN1, CRTM, CMP		Matrilin 1, cartilage matrix protein	115437	REa, A, Fd			
1.349	3	19	10	1p36.13	PLA2G2A, PLA2B, PLA2L, MOM1		Phospholipase A2, group IIA, platelets, synovial fluid	172411	REa, Fd		{Colorectal cancer}, 114500 (3)	4(Pla2g2a)
1.350	7	27	09	1p35.3	PPP1R8, NIPP1, ARD1		Protein phosphatase-1, regulatory subunit-8	602636	REa, REc			
1.351	3	1	01	1p35.2	PTP4A2, PTP4A, PRL2, HH13		Protein tyrosine phosphatase, type 4A, 2	601584	REc			
1.352	4	7	94	1p35.3	RPA2		Replication protein A2, 32kD	179836	Psh, A			
1.353	11	22	16	1p36.12	WNT4, SERKAL		Wingless-type MMTV integration site family, member 4	603490	A, R	mutation identified in 1 SERKAL family	?SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism, 158330 (3)	4(Wnt4)
1.354	2	10	06	1p35.1	YARS, CMTDIC, TYRRS, YTS, YRS		Tyrosyl-tRNA synthetase	603623	Fd, REc		Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	
1.355	8	26	15	1p35.3	YTHDF2		YTH N6-methyladenosine RNA-binding protein 2	610640	Ch, REc	fused with AML1 in t(1;21)		
1.356	7	11	16	1p34.3	CSF3R, GCSFR, SCN7		Colony-stimulating factor-3 receptor (granulocyte)	138971	A, REb, Psh, REa		Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	
1.357	5	22	14	1p35.2	LCK, IMD22		Lymphocyte-specific protein tyrosine kinase	153390	A, H, Ch	LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient	?Immunodeficiency 22, 615758 (3)	4(Lck)
1.358	9	29	96	1p35.3	PTAFR		Platelet-activating factor receptor	173393	REa, A			
1.359	6	8	15	1p35.1	HPCA, DYT2		Hippocalcin, 23kD, Ca2+-binding protein	142622	REa, REc		Dystonia 2, torsion, autosomal recessive, 224500 (3)	
1.360	4	23	08	1p34.3	MRPS15		Mitochondrial ribosomal protein S15	611979	R, REc			
1.361	5	11	16	1p34.3	AGO1, EIF2C1, GERP95, EIF2C		Argonaute 1, RISC catalytic component	606228	A			
1.362	7	1	02	1p34.2	CITED4		CBP/P300-interacting transactivator, with glu/asp-rich carboxy terminal domain, 4	606815	A			
1.363	6	27	08	1p34.3	EIF2C3, AGO3		Eukaryotic translation initiation factor 2C, subunit 3 (argonaute 3)	607355	R, REc, H			4(Ago3)
1.364	7	23	03	1p34.3	EIF2C4, AGO4, KIAA1567		Eukaryotic translation initiation factor 2C, 4 (argonaute 4)	607356	R, REc, H			4(Eif2c4)
1.365	8	18	98	1p34.2	GUCA2A, GUCA2		Guanylate cyclase activator 2A (guanylin 2, intestinal, heat-stable)	139392	A			4(Guca2)
1.366	1	22	07	1p35.1	TSSK3, STK22C, STK22D		Testis-specific serine/threonine kinase 3	607660	A			4(Stk22d)
1.367	1	30	12	1p34.2	EBNA1BP2, EBP2		EBNA1-binding protein 2	614443	REc			
1.368	4	17	13	1p34.3	AKIRIN1		Akirin 1	615164	REc			
1.369	9	10	12	1p34.3	C1orf109		Chromosome 1 open reading frame 109	614799	REc			
1.370	3	24	06	1p34.3	CDCA8		Cell division cycle-associated protein 8	609977	REc	possible pseudogene on chr.7		
1.371	9	10	07	1p34.3	EPHA10		Ephrin receptor EphA10	611123	REc			
1.372	2	28	06	1p34.3	GBD3		Gallbladder disease 3	609919	Fd	new D2S255	Gallbladder disease 3 (2)	
1.373	4	1	08	1p34.3	GJA9, CX59		Gap junction protein, alpha-9	611923	REc			
1.374	5	16	05	1p34.3	GNL2, NGP1		Guanine nucleotide-binding protein-like 2	609365	R, REc			
1.375	6	13	12	1p34.2	HEYL		Hariy/enhancer of split-related with YRPW motif-like protein	609034	R, A			
1.376	7	7	13	1p34.3	KIAA0319L, KIAA1837		KIAA0319-like	613535	R, REc			
1.377	4	6	18	1p34.3	LSM10		Lsm10, U7 small nuclear RNA-associated protein	617909	REc			
1.378	2	2	14	1p34.2	MYCL, LMYC		Oncogene MYC, lung carcinoma-derived	164850	REa, A, F, REn			4(Lmyc1)
1.379	2	16	04	1p34.3	NCDN, KIAA0607		Neurochondrin	608458	R, REc			
1.380	1	15	09	1p34.3	RSPO1, FLJ40906		Roof plate-specific spondin, mouse, homolog of, 1	609595	REc		Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	
1.381	3	11	08	1p35.1	S100PBP, S100PBPR		S100P-binding protein	611889	REc			
1.382	4	10	14	1p34.3	SF3A3, SF3A60, SAP61, PRP9		Splicing factor 3A, subunit 3	605596	REc			
1.383	6	12	17	1p34.3	SNIP1, PMRED		SMAD nuclear interacting protein 1	608241	REc		Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	
1.384	6	30	05	1p34.3	STK40, SHIK		Serine/threonine protein kinase 40	609437	R, REc			
1.385	7	2	18	1p34.3	TEKT2, TEKTB1		Tektin 2	608953	R, REc			
1.386	1	18	12	1p34.3	TFAP2E		Transcription factor AP2-epsilon	614428	REc			
1.387	7	13	15	1p34.3	THRAP3, TRAP150		Thyroid hormone receptor-associated protein 3	603809	REc			
1.388	5	21	07	1p34.3	TRAPPC3, BET3		Trafficking protein particle complex, subunit 3	610955	R, REc			
1.389	6	30	05	1p34.3	UTP11L, CGI94		UTP11-like protein	609440	R, REc			
1.390	8	27	15	1p34.3	ZMYM4, ZNF262, KIAA0425		Zinc finger, MYM-type 4	613568	REc			
1.391	1	29	01	1p34.3	CLASPIN		Claspin, Xenopus, homolog of	605434	REc			
1.392	1	23	08	1p35.1	SYNC1		Syncoilin 1	611750	REc			
1.393	5	25	13	1p35.1	AZIN2, ODC1L, KIAA1945		Antizyme inhibitor 2	608353	REc			
1.394	5	26	13	1p34.2	NT5C1A, CN1A, CNI, CN1		5'-nucleotidase, cytosolic, IA	610525	REc			
1.395	2	25	10	1p34.3	COL8A2, FECD1, PPCD2		Collagen VIII, alpha-2 polypeptide	120252	A		Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal dystrophy, posterior polymorphous 2, 609140 (3)	
1.396	7	6	05	1p34.1	MUTYH, MYH		MutY, E. coli, homolog of	604933	A		Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic, 613659 (3); Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	
1.397	11	12	12	1p34.2	BMP8B, OP2		Bone morphogenetic protein-8b (osteogenic protein 2)	602284	H, REc			4(Bmp8)
1.398	12	22	17	1p34.2	CAP1		Cyclase-associated actin cytoskeleton regulatory protein 1	617801	REc			
1.399	11	30	06	1p34.2	CLDN19, HOMG5		Claudin 19	610036	REc, Fd		Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	4(Cldn19)
1.400	7	13	17	1p34.2	COL9A2, EDM2, STL5		Collagen IX, alpha-2 polypeptide	120260	REa, A, REn, Fd	mutation identified in1 STL5 family	Epiphyseal dysplasia, multiple, 2, 600204 (3); ?Stickler syndrome, type V, 614284 (3)	4(Col9a2)
1.401	2	20	08	1p34.2	ELOVL1, SSC1		Elongation of very long chain fatty acids-like 1	611813	REc			
1.402	10	12	14	1p34.2	FOXJ3, KIAA1041		Forkhead box J3	616035	REc			
1.403	2	25	15	1p34.2	MED8		Mediator complex subunit 8	607956	R, REc			
1.404	7	30	15	1p34.2	MFSD2A, MCPH15		Major facilitator superfamily domain-containing protein 2A	614397	REc		Microcephaly 15, primary, autosomal recessive, 616486 (3)	
1.405	4	8	13	1p34.2	MIR30C1		Micro RNA 30C-1	615151	REc			
1.406	8	19	04	1p34.3	NOR1		Oxidored-nitro domain-containing protein 1	608854	REc			
1.407	5	24	13	1p34.2	OXCT2, FLJ0030		3-oxoacid CoA transferase 2	610289	REc			
1.408	7	27	09	1p34.1	PIK3R3		Phosphatidylinositol 3-kinase, regulatory, 3	606076	R, REc			
1.409	8	8	13	1p34.2	PPIE, CYP33		Peptidyl-prolyl isomerase E	602435	REc, Psh, REa			
1.410	2	20	98	1p34.3	PSMB2		Proteasome subunit, beta type, 2	602175	A			
1.411	12	17	15	1p34.2	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN		Solute carrier family 2 (facilitated glucose transporter), member 1	138140	REa, A, Fd	probably in 1p33	GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3); GLUT1 deficiency syndrome 2, childhood onset, 612126 (3); {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3); Dystonia 9, 601042 (3); Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	
1.412	4	22	16	1p34.2	SMAP2, SMAP1L		Small ADP-ribosylation factor GTPase-activating protein 2	616916	REc			
1.413	1	25	18	1p34.2	SVBP, CCDC23		Small vasohibin-binding protein	617853	REc			
1.414	11	1	13	1p34.2	SZT2, KIAA0467, EIEE18		Seizure threshold 2, mouse, homolog of	615463	REc		Epileptic encephalopathy, early infantile, 18, 615476 (3)	
1.415	2	16	18	1p34.2	TRIT1, IPT, COXPD35		tRNA isopentenyltransferase 1	617840	REc		Combined oxidative phosphorylation deficiency 35, 617873 (3)	
1.416	12	11	12	1p34.2	WDR65		WD repeat-containing protein 65	614259	REc, H, Fd			1(Wdr65)
1.417	9	24	08	1p34.3	YRDC, IRIP		YRDC domain-containing protein	612276	REc			4(Yrdc)
1.418	4	24	18	1p34.2	ZFP69, ZNF642		Zinc finger protein 69	617939	REc			4(Zfp69)
1.419	5	21	02	1p34.2	CDC20		Cell division cycle 20, S. cerevisiae, homolog of	603618	R	pseudogene on 9q13-q21		
1.420	6	15	99	1p34.3	NDUFS5		NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kD	603847	REa, R			
1.421	5	7	03	1p32.3	OSBPL9, ORP9		Oxysterol-binding protein-like protein 9	606737	REc			
1.422	7	17	14	1p34.2	CTPS1, CTPS, IMD24		Cytidine 5'-triphosphate synthetase 1	123860	REa, A		Immunodeficiency 24, 615897 (3)	
1.423	2	25	15	1p34.1	DNMAP1, DMAP1		DNMT1-associated protein 1	605077	REc			
1.424	5	31	05	1p34.1	EIF2B3		Eukaryotic translation initiation factor 2B, subunit 3	606273	R, REc		Leukoencephalopathy with vanishing white matter, 603896 (3)	
1.425	10	3	07	1p35.2	EIF3I, EIF3S2, TRIP1		Eukaryotic translation initiation factor 3, subunit I	603911	A	pseudogene on 7q32		
1.426	9	9	08	1p34.2	FOXO6		Forkhead box O6	611457	REc			4(Foxo6)
1.427	2	24	97	1p35.2-p35.1	HDAC1, RPD3L1		Histone deacetylase-1	601241	A			
1.428	9	7	12	1p34.1	IPO13, IMP13, KIAA0724, RANBP13		Importin 13	610411	R, REc			
1.429	5	29	12	1p34.2-p34.1	KDM4A, JMJD2A, JHDM3A, KIAA0677		Lysine-specific demethylase 4A	609764	R, REc			
1.430	8	24	04	1p34.1	KIF2C, KNSL6, MCAK		Kinesin family, member 2C	604538	R, REc			
1.431	12	30	14	1p34.1	LURAP1, LRAP35A		Leucine-rich adaptor protein 1	616129	REc			
1.432	9	24	08	1p34.1	MAST2, MAST205, KIAA0807		Microtubule-associated serine/threonine kinase 2	612257	R, REc			
1.433	1	20	06	1p34.1	MMACHC		MMACHC gene	609831	REn, Fd		Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	
1.434	9	16	12	1p34.1	NASP		Nuclear autoantigenic sperm protein	603185	REc			
1.435	3	6	18	1p34.1	PRDX1, PRXI, PAGA, NKEFA		Peroxiredoxin 1	176763	A	pseudogene PAGB on 9p22	Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3)	
1.436	2	1	11	1p34.1	PLK3, CNK, PRK		Polo-like kinase 3	602913	REc	previously assigned to 8p21 by FISH		
1.437	4	13	98	1p34.3	POU3F1		POU domain, class 3, transcription factor-1	602479	A			4(Pou3f1)
1.438	5	17	04	1p34.2	PPIH		Peptidyl-prolyl isomerase H	606095	R			
1.439	2	23	08	1p34.2	RIMS3, NIM3, KIAA0137		Protein regulating synaptic membrane exocytosis 3	611600	R, REc			
1.440	12	30	14	1p34.1	RNF220		RING finger protein 220	616136	REc			
1.441	5	30	17	1p34.1	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15		ST3 beta-galactoside alpha-2,3-sialyltransferase 3	606494	R, REc	mutation identified in 1 EIEE15 family	Mental retardation, autosomal recessive 12, 611090 (3); ?Epileptic encephalopathy, early infantile, 15, 615006 (3)	
1.442	1	4	08	1p34.1	TCTEX1D4		TCTEX1 domain-containing 4	611713	REc			
1.443	4	20	17	1p34.1	TOE1, PCH7		Target of EGR1	613931	REc		Pontocerebellar hypoplasia, type 7, 614969 (3)	
1.444	12	21	09	1p34.1	TSPAN1, NET1		Tetraspanin 1	613170	REn			
1.445	3	31	11	1p33	UQCRH		Ubiquinol-cytochrome c reductase hinge protein	613844	REc	pseudogene on 1p36		
1.446	10	4	05	1p34.1	ZNF393		Zinc finger protein-393	609602	REc, H			4(Znf393)
1.447	8	4	97	1p34.1-p32	PTOS1		Ptosis, congenital 1, autosomal dominant	178300	A		Ptosis, hereditary congenital, 1 (2)	
1.448	2	1	95	1p34.1	RPS8		Ribosomal protein S8	600357	REa, Psh, A			
1.449	8	24	09	1p35.1	AK2		Adenylate kinase-2, mitochondrial	103020	S, F, R		Reticular dysgenesis, 267500 (3)	4(Ak2)
1.450	3	21	93	1p35.2	COL16A1		Collagen XVI, alpha-1 polypeptide	120326	A, REa			
1.451	8	21	07	1p34.1	DPH2, DPH2L2		DPH2, S. cerevisiae, homolog of	603456	A			
1.452	6	6	91	1p34.2	EDN2		Endothelin-2	131241	REa, A	vasoactive intestinal contractor (VIC) = mouse and rat equivalent		
1.453	5	29	98	1p33-p32	ELAVL4, HUD, PNEM		Embryonic lethal, abnormal vision, Drosophila, homolog of, like-4 (Hu antigen D)	168360	A, H		Neuropathy, paraneoplastic sensory (1)	4(Hud)
1.454	12	28	05	1p34.2	ERMAP, SC, RD		Erythroblast membrane-associated protein	609017	REc, H, F		[Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)	4(Ermap)
1.455	6	22	99	1p34.3	FHL3, SLIM2		Four-and-a-half LIM domains-3	602790	R			
1.456	9	18	08	1p36.11	FUCA1		Fucosidase, alpha-L- 1, tissue	612280	S, F, R, A, REa	8cM distal to RH; pseudogene on 2q31-q32	Fucosidosis, 230000 (3)	4(Fuca)
1.457	2	4	02	1p34.2	HIVEP3, KRC		Human immunodeficiency virus type 1 enhancer-binding protein 3	606649	REc			
1.458	10	9	94	1p34.3	INPP5B		Inositol polyphosphate-5-phosphatase, 75kD	147264	REa, A			4(Inpp5b)
1.459	3	6	09	1p34.2	KCNQ4, DFNA2A		Potassium voltage-gated channel, KQT-like subfamily, member 4	603537	A		Deafness, autosomal dominant 2A, 600101 (3)	
1.460	11	13	96	1p35.2	LAPTM5		Lysosomal-associated multispanning membrane protein-5	601476	A			
1.461	10	09	07	1p32.3	LRP8, APOER2, MCI1		Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2)	602600	REa, A, Fd		{Myocardial infarction, susceptibility to}, 608446 (3)	
1.462	6	7	10	1p35.1	MARCKSL1, MLP, MRP		MARCKS-like protein 1	602940	H, Psh, A			4(Mlp)
1.463	3	9	12	1p34.2	MPL, TPOR, MPLV, THCYT2		Myeloproliferative leukemia virus, homolog of	159530	A		Thrombocytopenia, congenital amegakaryocytic, 604498 (3); Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	
1.464	2	3	15	1p34.2	P3H1, LEPRE1, GROS1, OI8		Prolyl 3-hydroxylase 1	610339	Psh, R, REc		Osteogenesis imperfecta, type VIII, 610915 (3)	
1.465	5	19	06	1p35.2	PEF1		Peflin	610033	REc			
1.466	3	6	08	1p34.3	RRAGC, RAGC		RAS-related GTP-binding protein C	608267	R, REc			
1.467	6	23	15	1p34.2	SCMH1		Sex comb on midleg, Drosophila, homolog of, 1	616396	A			4(Scmh1)
1.468	8	31	01	1p34.3	SFPQ, PSF		Splicing factor, proline- and glutamine-rich	605199	Ch	fusion gene with TFE3 in RCC		
1.469	11	19	10	1p34.1	UROD		Uroporphyrinogen decarboxylase	613521	S, A, REa		Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic, 176100 (3)	4(Urod)
1.470	2	23	12	1p34.2	YBX1, NSEP1, YB1, DBPB		Y box binding protein 1 (major histocompatibility complex, class II, Y box-binding protein I)	154030	A			
1.471	6	23	05	1p34.2	ZMPSTE24, FACE1, STE24, MADB		Zinc metalloproteinase STE24	606480	A, R		Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3); Restrictive dermopathy, lethal, 275210 (3)	
1.472	10	9	94	1p34.3	GRIK3, GLUR7		Glutamate receptor, ionotropic, kainate 3	138243	REa, A			
1.473	5	29	98	1p34.2	GUCA2B, UGN		Guanylate cyclase activator 2B (uroguanylin)	601271	A			4(Guca1b)
1.474	7	2	98	1p32.3	MAGOH		Mago nashi, Drosophila, homolog of, proliferation-associated	602603	R			4(Magoh)
1.475	09	27	18	1p34.1	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15		Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	Fd, LD		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3); Retinitis pigmentosa 76, 617123 (3)	
1.476	1	1	95	1p34.2	TIE, JTK14, TIE1		Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains	600222	A			
1.477	5	28	98	1p33	FOXD2, FKHL17, FREAC9		Forkhead box D2	602211	A			
1.478	8	31	10	1p34-p32	MACST		Macrostomia	613545	Ch	max lod at D1S2797	Macrostomia (2)	
1.479	9	11	91	1p33	CYP4B1		Cytochrome P450, subfamily IVB, polypeptide 1	124075	REa			4(Cyp4a)
1.480	11	4	91	1p31.3	DDIT1, GADD45		DNA damage-inducible transcript-1	126335	REa			
1.481	7	28	15	1p33	AGBL4, CCP6		ATP/GTP-binding protein-like 4	616476	REc			
1.482	1	11	07	1p33	CYP4A11		Cytochrome P450, subfamily IVA, polypeptide 11	601310	Psh, REc			
1.483	8	2	13	1p33	CYP4A22		Cytochrome P450, family 4, subfamily A, polypeptide 22	615341	REc			
1.484	1	9	13	1p33	CYP4X1, CYPIVX1		Cytochrome P450, family 4, subfamily X, polypeptide 1	614999	REc			
1.485	5	28	15	1p33	DMBX1, OTX3		Diencephalon/mesencephalon homeobox 1	607410	REc			
1.486	11	19	13	1p33	FAAH		Fatty acid amide hydrolase	602935	R, REc		{Drug addiction, susceptibility to}, 606581 (3)	4(Faah)
1.487	3	18	11	1p32.3	FAF1, HFAF1		Fas-associated factor 1	604460	REc			
1.488	10	13	09	1p33	KNCN, KINO, L5		Kinocilin	611455	REc			4(Kncn)
1.489	7	17	09	1p33	MKNK1, MNK1		Mitogen-activated protein kinase-interacting serine/threonine kinase 1	606724	R, REc			
1.490	11	3	94	1p34.3	MTF1		Metal-regulatory transcription factor 1	600172	A			
1.491	5	30	17	1p33	NSUN4		NOP2/SUN RNA methyltransferase family, member 4	615394	REc			
1.492	4	6	11	1p33	OFC13		Orofacial cleft 13	613857	Fd	associated with rs3827730	Orofacial cleft 13 (2)	
1.493	12	14	16	1p33	PDZK1IP1, MAP17		PDZK1-interacting protein 1	607178	REc, H	near SLC in human, mouse, chicken, zebrafish		
1.494	6	23	15	1p33	SKINTL, SKINTP		SKINT1-like pseudogene	616392	REc			
1.495	1	20	17	1p34.1	SLC6A9, GLYT1, GCENSG		Solute carrier family 6 (neurotransmitter transporter, glycine), member 9	601019	A		Glycine encephalopathy with normal serum glycine, 617301 (3)	4(Slc6a9)
1.496	5	3	11	1p33	SPATA6, SRF1, HASH		Spermatogenesis-associated protein 6	613947	REc			
1.497	12	27	13	1p33	STIL, SIL, MCPH7		SCL/TAL1-interrupting locus	181590	REn, REc	within about 250kb of SCL	Microcephaly 7, primary, autosomal recessive, 612703 (3)	
1.498	12	10	12	1p33	TRABD2B, TIKI2		TRAB domain-containing protein 2B	614913	REc			
1.499	9	8	06	1p34.1	BEST4, VMD2L2		Bestrophin 4	607336	A			
1.500	9	10	12	1p32.3	DMRTA2		Doublesex- and MAB3-related transcription factor A2	614804	REc			
1.501	5	4	09	1p33-p32	BMND14		Bone mineral density quantitative trait locus 14	612728	Fd	associated with rs17131547	[Bone mineral density QTL 14] (2)	
1.502	12	6	01	1p34.3	MYCBP		MYC-binding protein	606535	A			
1.503	5	2	01	1p34.1	AKR1A1, ALR		Aldo-keto reductase family 1, member A1 (aldehyde reductase)	103830	A			
1.504	8	9	99	1p34.1	B4GALT2		Beta-1,4-galactosyltransferase 2	604013	A, REc			
1.505	6	15	99	1p32.3	DIO1, TXDI1		Deiodinase, iodothyronine, type I	147892	A			4(Dio1)
1.506	9	22	95	1p22.1	TGFBR3		Transforming growth factor, beta receptor III (betaglycan, 300kD)	600742	Psh, A			
1.507	10	31	01	1p32.3	DHCR24, KIAA0018		24-dehydrocholesterol reductase	606418	REa, REc		Desmosterolosis, 602398 (3)	
1.508	1	27	11	1p33-p31.1	FWS		Forsythe-Wakeling syndrome	613606	Fd	between rs2354462 and rs718883	Forsythe-Wakeling syndrome (2)	
1.509	3	17	94	1p35.2	FABP3		Fatty acid-binding protein 3, muscle	134651	REa, A			4(Fabph1)
1.510	3	24	06	1p32.3	ACOT11, THEA, BFIT, BFIT1, BFIT2, KIAA0707		Acyl-CoA thioesterase 11	606803	REa, R, H			4(Thea)
1.511	11	19	13	1p34.1	ATP6V0B, ATP6F		ATPase, H+ transporting, V0 subunit b	603717	A, R			4(Atp6v0b)
1.512	12	24	08	1q32.3	BATF3		Basic leucine zipper transcription factor, ATF-like, 3	612470	REc			
1.513	4	6	18	1p32.3	LEXM, C1orf177, LEM		Lymphocyte expansion molecule	616446	REc			
1.514	9	14	17	1p32.3	COA7, RESA1, SELRC1, C1orf163		Cytochrome C oxidase assembly factor	615623	REc	mutation identified in 1 COX4D patient	?Mitochondrial complex IV deficiency, 220110 (3)	
1.515	8	19	13	1p32.3	GLIS1		Glis family zinc finger protein 1	610378	REc, R			4(Glis1)
1.516	11	3	14	1p32.3	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1		Proprotein convertase, subtilisin/kexin-type, 9	607786	REc, Fd		Hypercholesterolemia, familial, 3, 603776 (3); {Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	
1.517	5	17	04	1p32.3	PODN		Podocan	608661	REc			
1.518	7	14	16	1p32.3	PRPF38A, PRP38A		Precursor mRNA-processing factor 38, S. cerevisiae, homolog of, A	617031	REc			
1.519	7	3	06	1p32.3	TMEM48, NDC1		Transmembrane protein 48	610115	R, REc			
1.520	8	18	16	1p32.3	TMEM59, DCF1		Transmembrane protein 59	617084	REc			
1.521	6	30	05	1p32.3	TXNDC12, TLP19, ERP18		Thioredoxin domain-containing protein 12	609448	REc			
1.522	5	13	09	1p32.3	USP24, KIAA1057		Ubiquitin-specific protease 24	610569	R, REc			
1.523	6	12	17	1p32.3	YIPF1		YIP1 domain family, member 1	617521	REc			
1.524	11	11	14	1p32.3	ZFYVE9, MADHIP, SARA		Zinc finger, FYVE domain containing 9	603755	REc			
1.525	9	10	12	1p32.3	DMRTB1		Doublesex- and MAB3-related transcription factor B1	614805	REc			
1.526	7	2	98	1p32.3	NRD1		Nardilysin (N-arginine dibasic convertase)	602651	A			
1.527	6	9	08	1p32.3	PARS2		Prolyl-tRNA synthetase 2	612036	REc			
1.528	10	26	17	1p32.2	PLPP3, PPAP2B		Phospholipid phosphatase 3	607125	REc			
1.529	8	18	16	1p32.2-p32.1	OMA1, MPRP1		OMA1 zinc metallopeptidase	617081	R, REc			
1.530	7	7	15	1p32.1	FGGY, FLJ10986		FGGY carbohydrate kinase domain-containing protein	611370	REc			
1.531	4	17	08	1p32.1	HOOK1, HK1		Hook, Drosophila, homolog of, 1	607820	REc, A			4(Hook1)
1.532	3	5	08	1p32.3	MRPL37		Mitochondrial ribosomal protein L37	611843	REc			
1.533	09	26	18	1p32.1	MYSM1, 2ADUB, KIAA1915, BMFS4		MYB-like, SWIRM, and MPN domains-containing protein 1	612176	REc		Bone marrow failure syndrome 4, 618116 (3)	
1.534	8	10	16	1p31.3	DNAJC6, DJC6, KIAA0473, PARK19		DNAJ, E. coli, homolog of, subfamily C, member 6	608375	R, REc		Parkinson disease 19a, juvenile-onset, 615528 (3); Parkinson disease 19b, early-onset, 615528 (3)	
1.535	6	18	99	1p31.3	USP1		Ubiquitin-specific protease 1	603478	A, R			
1.536	4	14	11	1p32.2	C8A		Complement component-8, alpha polypeptide	120950	F, A, Ch, Fd		C8 deficiency, type I, 613790 (3)	
1.537	3	10	11	1p32.2	C8B		Complement component-8, beta polypeptide	120960	F, A, Ch, H, Fd		C8 deficiency, type II, 613789 (3)	4(C8b)
1.538	10	6	08	1p32.3	CDCP2		Cub domain-containing protein 2	612320	REc	?associated with PARK10		
1.539	6	18	99	1p32.3	CDKN2C, INK4C		Cyclin-dependent kinase inhibitor 2C	603369	A			
1.540	12	31	16	1p32.3	CPT2, IIAE4		Carnitine palmitoyltransferase II	600650	REa, A	formerly at 1p13	CPT II deficiency, myopathic, stress-induced, 255110 (3); CPT II deficiency, infantile, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	
1.541	11	13	94	1p32.3	EPS15		Epidermal growth factor receptor pathway substrate-15	600051	REc			
1.542	2	15	17	1p33	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11		Forkhead box E3	601094	A		Anterior segment dysgenesis 2, multiple subtypes, 610256 (3); Cataract 34, multiple types, 612968 (3); {Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3)	
1.543	6	22	14	1p32.3	GPX7, NPGPX		Glutathione peroxidase 7	615784	REc			
1.544	5	24	13	1p35.2	KHDRBS1, SAM68		KH domain-containing, RNA-binding, signal transduction-associated protein 1	602489	REc			
1.545	1	30	01	1p34.2	NFYC, CBFC		Nuclear transcription factor Y, gamma	605344	REc, H			4(Nfyc)
1.546	5	15	11	1p32.3	ORC1, ORC1L		Origin recognition complex, subunit 1, S. cerevisiae, homolog	601902	Psh, A		Meier-Gorlin syndrome 1, 224690 (3)	
1.547	4	10	15	1p32	PARK10, AAOPD		Parkinson disease 10	606852	Fd	max lod at D1S2652; ?associated with CDCP2	{Parkinson disease 10} (2)	
1.548	1	5	12	1p34.2	PPT1, CLN1		Palmitoyl-protein thioesterase 1	600722	Fd, LD, REn, A, REc		Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	
1.549	3	1	06	1p34.1	PRNPIP, PINT1		Prion protein-interacting protein	609917	REc, R			
1.550	1	20	17	1p34.1	PTCH2		Patched, Drosophila, homolog of, 2	603673	R, Psh		Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3)	4(Ptch2)
1.551	9	10	14	1p34.2	PTPRF, LAR, BNAH2		Protein tyrosine phosphatase, receptor type, f polypeptide	179590	A	mutation identified in 1 BNAH2 family	?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	4(Ptprf)
1.552	1	25	12	1p34.1	RAD54L, HR54, HRAD54		RAD54, S. cerevisiae, homolog-like	603615	A		{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)	
1.553	1	26	93	1p34.2	RLF		Rearranged L-myc fusion sequence	180610	REa, REn	<800kb from MYCL1		
1.554	5	1	17	1p32.3	SCP2		Sterol carrier protein-2	184755	Psh, REa	mutation identified in 1 LKDMN patient	?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	4(Scp2)
1.555	9	3	10	1p32	STQTL23		Stature quantitative trait locus 23	613548	Fd	linked to rs628667	{Stature QTL 23} (2)	
1.556	6	10	02	1p32.1	TACSTD2, TROP2, M1S1		Tumor-associated calcium signal transducer 2	137290	REa, A		Corneal dystrophy, gelatinous drop-like, 204870 (3)	
1.557	8	27	15	1p33	TAL1, TCL5, SCL		T-cell acute lymphocytic leukemia-1	187040	Ch, RE	proximal to MYCL1	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Scl)
1.558	5	25	13	1p34.1	TESK2		Testis-specific protein kinase 2	604746	A			
1.559	2	12	08	1p33	CMPK1, CMPK, UMPK, UMK, CMK		Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic	191710	S, R, F			
1.560	7	28	17	1p32.2	DAB1, SCA37		Disabled, Drosophila, homolog 1	603448	R, H, Fd		Spinocerebellar ataxia 37, 615945 (3)	4(Dab1)
1.561	8	21	91	1p32.1	JUN		Avian sarcoma virus 17 (v-jun) oncogene homolog	165160	REa, A, H			4(Jun)
1.562	2	16	04	1p34.3	MACF1, ACF7, KIAA1251		Microtubule-actin cross-linking factor 1	608271	R, REc, A			4(Macf1)
1.563	4	11	11	1p31.1	NEXN, NELIN, CMD1CC, CMH20		Nexilin, rat, homolog of	613121	REc		Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, hypertrophic, 20, 613876 (3)	
1.564	9	13	89	1p32.3	RAB3B		Brain antigen RAB3B	179510	REb, A			
1.565	2	17	09	1p32.3	RNF11		Ring finger protein 11	612598	Psh, R			
1.566	1	22	09	1p31.3	SLC35D1, UGTREL7, KIAA0260, SHNKND		Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1	610804	R, A		Schneckenbecken dysplasia, 269250 (3)	
1.567	8	8	91	1p21.2	VCAM1		Vascular cell adhesion molecule-1	192225	REa, A			3(Vcam1)
1.568	3	21	93	1p34.1	IPP		Intracisternal A particle-promoted polypeptide	147485	REa			4(Ipp)
1.569	3	1	05	1p31.3	AK3		Adenylate kinase-3, mitochondrial	103030	REc, H			4(Ak3)
1.570	4	2	16	1p31.3	ATG4C, APG4C		Autophagy 4, S. cerevisiae, homolog of, C	611339	REc			
1.571	8	3	12	1p31.3	DIRAS3, ARHI		DIRAS family, GTP-binding RAS-like protein 3	605193	Psh, A			
1.572	6	26	14	1p31.3	DOCK7, KIAA1771, EIEE23		Dedicator of cytokinesis 7	615730	REc		Epileptic encephalopathy, early infantile, 23, 615859 (3)	4(Dock7)
1.573	8	28	17	1p31.3	EFCAB7, KIAA1799		EF-hand calcium-binding domain-containing protein 7	617632	REc			
1.574	9	23	13	1p31.3	GNG12		Guanine nucleotide-binding protein, gamma 12	615405	REc, R			6(Gng12)
1.575	9	23	13	1p31.3	GNG12AS1		GNG12 antisense RNA 1	615406	REc			
1.576	1	12	11	1p31.3	IL23R, IBD17		Interleukin 23 receptor	607562	REc		{Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)	
1.577	07	28	18	1p31.3	PATJ, INADL		PALS1-associated tight junction protein	603199	REc, R			
1.578	7	17	09	1p31.3	ITGB3BP, NRIF3		Integrin, beta-3, binding protein of	605494	R, REc			
1.579	7	10	93	1p31.3	JAK1		Janus kinase 1 (a protein-tyrosine kinase)	147795	REa, A, Fd	related gene on 9p24		4(Jak1)
1.580	5	4	12	1p31.3	KANK4		KN motif- and ankyrin repeat domain-containing protein 4	614612	REc			
1.581	3	8	16	1p31.3	MEIR1, KIAA1610		Mesoderm induction-early response protein 1	616848	REc			
1.582	3	23	09	1p31.3	MIR101-1, MIRN101-1		Micro RNA 101-1	612511	REc	another locus, MIRN101-2, on 9p24		
1.583	3	14	13	1p31.3	OPHLC, C1DUPp31.3, DUP1p31.3		Omphalocele due to duplication of 1p31.3	164750	Ch	duplication of 710kb at 1p31.3	Omphalocele due to duplication of 1p31.3 (4)	
1.584	3	14	06	1p31.3	RAVER2, KIAA1579		Raver2, mouse, homolog of	609953	R, REc			
1.585	8	31	17	1p31.3	ROR1, NTRKR1		Receptor tyrosine kinase-like orphan receptor 1	602336	A	mutation identified in 1 DFNB108 family	?Deafness, autosomal recessive 108, 617654 (3)	
1.586	7	14	14	1p31.3	SERBP1, PAIRBP1		Serpine1 mRNA-binding protein 1	607378	REc			
1.587	8	20	08	1p31.3	SGIP1		SH3-domain GRB2-like (endophilin)-interacting protein 1	611540	REc			
1.588	12	5	02	1p32.3	SSBP3		Single-stranded DNA-binding protein 3	607390	REc			
1.589	8	19	13	1p31.3	TM2D1, BBP		TM2 domain-containing protein 1	610080	R, REc			
1.590	5	6	03	1p32.3	TTC4		Tetratricopeptide repeat domain 4	606753	A	pseudogene on 7p14-p13		
1.591	5	26	13	1p31.1	TYW3		tRNA-wybutosine-synthesizing protein 3, S. cerevisiae, homolog of	611245	REc			
1.592	9	23	13	1p31.3	WLS, GPR177, EVI		WNTless, Drosophila, homolog of	611514	REc, R			
1.593	7	2	98	1p32.1	CYP2J2		Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2	601258	REa, A			4(Cyp2j2)
1.594	10	30	17	1p31.3	NFIA, BRMUTD		Nuclear factor I/A	600727	A		Brain malformations with or without urinary tract defects, 613735 (3)	4(Nfia)
1.595	11	13	12	1p31.3-p31.1	POROK5, DSAP3		Porokeratosis 5, disseminated superficial actinic	612293	Fd	between D1S438 and D1S464	Porokeratosis 5, disseminated superficial actinic (2)	
1.596	4	24	08	1p31.3	DEPDC1		DEP domain-containing 1	612002	REc			
1.597	6	9	98	1p31.3	IL12RB2		Interleukin 12 receptor, beta-2	601642	A, Psh, R			
1.598	9	10	09	1p31.2	PBC3		Biliary cirrhosis, primary, 3	613008	Fd	associated with rs3790567	{Biliary cirrhosis, primary, 3} (2)	
1.599	6	15	95	1p31.1	PTGER3, EP3		Prostaglandin E receptor 3, EP3 subtype	176806	A			3(Ptger3)
1.600	6	30	15	1p31.1	ADGRL2, LPHN2, LPHH1, CIRL2, CL2, KIAA0786		Adhesion G protein-coupled receptor L2	607018	Ch, REc			
1.601	6	30	15	1p31.1	ADGRL4, ETL, ELTD1		Adhesion G protein-coupled receptor L4	616419	R, H, REc			3(Adgrl4)
1.602	4	5	13	1p31.1	ANKRD13C		Ankyrin repeat domain-containing protein 13C	615125	RE			
1.603	5	31	05	1p31.1	CTH		Cystathionine gamma-lyase	607657	R, REc	previously assigned to chr.16	Cystathioninuria, 219500 (3); Homocysteine, total plasma, elevated (3)	
1.604	4	2	16	1p31.1	DNAJB4, HLJ1		DNAJ/HSP40 homolog, subfamily B, member 4	611327	REc			
1.605	1	29	16	1p31.1	FAM73A, MIGA1		Miga, Drosophila, homolog of, 1	616773	REc			
1.606	5	25	13	1p31.1	FPGT, GFPP		Fucose-1-phosphate guanylyltransferase	603609	REc			
1.607	6	1	09	1p31.1	FUBP1, FUBP, FBP		Far upstream element-binding protein 1	603444	REc			
1.608	5	25	13	1p31.1	HHLA3		Human endogenous retrovirus-H long terminal repeat-associating 3	604372	REc			
1.609	6	11	11	1p31.1	IFI44L		Interferon-induced protein 44-like	613975	REc			
1.610	3	14	07	1p31.1	IFI44, P44		Interferon-induced protein 44	610468	R, REc			
1.611	12	3	07	1p31.1	LHX8		LIM homeobox 8	604425	REc			
1.612	1	30	12	1p31.1	LRRC7, DENSIN, KIAA1365		Leucine-rich repeat-containing protein 7	614453	Psh, REc			
1.613	5	9	18	1p31.1	LRRIQ3, LRRC44		Leucine rich repeats- and IQ motif-containing protein 3	617957	REc			
1.614	12	21	09	1p31.1	NEGR1, KILON		Neuronal growth regulator 1	613173	REc			
1.615	7	27	09	1p31.1	PIGK, GPI8		Phosphatidylinositol glycan, class K	605087	REa, REc			
1.616	4	18	11	1p31.1	PRKACB		Protein kinase, cAMP-dependent, catalytic, beta	176892	REa, A, REc			
1.617	6	16	95	1p31.1	PTGFR		Prostaglandin F receptor (FP)	600563	A			3(Ptgfr)
1.618	12	19	11	1p31.1	SRSF11, SFRS11		Splicing factor, serine/arginine-rich, 11	602010	REc			
1.619	8	19	13	1p31.1	ST6GALNAC3, SIAT7C		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	610133	R, REc			
1.620	7	8	09	1p31.1	ST6GALNAC5, SIAT7E		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6 sialyltransferase 5	610134	REc			
1.621	12	4	14	1p31.1	TNNI3K, CCDD		TNNI3-interacting kinase	613932	REc	mutation identified in 1 CCDD family	?Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	
1.622	4	8	13	1p31.1	USP33, VDU1		Ubiquitin-specific protease 33	615146	R, REc			
1.623	11	1	01	1p31.3	INSL5		Insulin-like 5	606413	R			
1.624	6	27	08	1p22.3	LPAR3, EDG7, LPA3		Lysophosphatidic acid receptor 3	605106	R, H			3(Edg7)
1.625	4	27	12	1p31.1-p21.1	SPG29		Spastic paraplegia 29, autosomal dominant	609727	Fd	max lod at D1S2865	Spastic paraplegia 29, autosomal dominant (2)	
1.626	6	26	02	1p31.1	ACADM, MCAD		Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain	607008	REa,A		Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	3(Acadm)
1.627	1	12	07	1p31.1	AK5		Adenylate kinase 5	608009	R			
1.628	5	8	97	1p31	AIR		Acute insulin response	601676	Fd		Acute insulin response (2)	
1.629	11	19	11	1p31.3	FOXD3, AIS1, VAMAS2		Forkhead box D3	611539	Fd, Psh, H		{Autoimmune disease, susceptibility to, 1}, 607836 (3)	4(Foxd3)
1.630	1	7	11	1p31.3	ANGPTL3, ANGPT5, FHBL2		Angiopoietin-like 3	604774	R, H		Hypobetalipoproteinemia, familial, 2, 605019 (3)	4(Angptl3, hypl)
1.631	4	17	07	1p31	ASRT4		Asthma-related traits, susceptibility to, 4	610906	Fd	max lod at D1S2890	{Asthma-related traits, susceptibility to, 4} (2)	
1.632	11	3	09	1p32.3	BSND		Barttin	606412	Fd, REc		Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with mild renal dysfunction, 602522 (3)	
1.633	11	6	98	1q22	CLK2		CDC-like kinase 2	602989	Psh, REn	near GDLD and PRKAA2; conflicting assignment 1q21		
1.634	6	20	91	1p21.2	DBT, BCATE2		Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex)	248610	REa, A	pseudogene on 3q24	Maple syrup urine disease, type II, 248600 (3)	
1.635	12	11	12	1p31.3	LEPR, OBR, LEPRD		Leptin receptor	601007	H, REc, R, Fd		Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	4(Lepr)
1.636	9	7	10	1p31.3	LEPROT, OBRGRP		Leptin receptor overlapping transcript	613461	REc	transcribed in same direction as LEPR		
1.637	6	2	98	1p31.1	MSH4		mutS, E. coli, homolog of, 4	602105	A			
1.638	7	17	14	1p31	OFC14		Orofacial cleft 14	615892	Fd		Orofacial cleft 14 (2)	
1.639	3	26	02	1p31	PAOD1		Peripheral arterial occlusive disease 1	606787	Fd		Peripheral arterial occlusive disease 1 (2)	
1.640	10	9	94	1p31.3	PDE4B, DPDE4		Phosphodiesterase-4B, cAMP-specific (dunce-like phosphodiesterase E4)	600127	RE, A			4(Pde4b)
1.641	6	3	14	1p31.3	PGM1, GSD14, CDG1T		Phosphoglucomutase-1	171900	F, S, R	distal to ACADM; formerly 1p22.1	Congenital disorder of glycosylation, type It, 614921 (3)	4(Pgm2)
1.642	3	9	98	1p31.1	PIN1L		Peptidyl-prolyl cis/trans isomerase, NIMA-interacting-like	602051	A	?transcribed pseudogene		
1.643	8	17	98	1p32.2	PRKAA2, AMPK		Protein kinase, AMP-activated, alpha-2 catalytic subunit	600497	Psh, A			
1.644	2	12	01	1p31.1	RABGGTB		Rab geranylgeranyltransferase, beta subunit	179080	REa, A			3(Rabggtb)
1.645	5	21	18	1p31.3	RPE65, RP20, LCA2		RPE65 retinoid isomerohydrolase	180069	REa, A, Fd		Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20, 613794 (3)	3(Rpe65)
1.646	11	18	16	1p22.3	SELENOF, SEP15		Selenoprotein F	606254	REc			
1.647	1	11	95	1p31.1	CRYZ		Crystallin, zeta (quinone reductase)	123691	REa, A			
1.648	8	12	01	1p31-p21	AVSD1, AVCD		Atrioventricular septal defect, susceptibility to, 1	606215	Fd		{Atrioventricular septal defect, susceptibility to, 1} (2)	
1.649	1	30	01	1p31.3	ALG6, CDG1C		Alg6, S. cerevisiae, homolog of	604566	REc		Congenital disorder of glycosylation, type Ic, 603147 (3)	
1.650	3	11	16	1p22.3	CLCA1, CACC1		Chloride channel accessory 1	603906	A			
1.651	3	11	16	1p22.3	CLCA2		Chloride channel accessory 2	604003	R			
1.652	3	11	16	1p22.3	CLCA3		Chloride channel accessory 3	604337	R, REc			
1.653	3	11	16	1p22.3	CLCA4, CACC2		Chloride channel accessory 4	616857	REc			3(Clca4)
1.654	5	19	06	1p22.3	COL24A1		Collagen, type XXIV, alpha-1	610025	REc, R			
1.655	01	26	00	1p22.3	CYR61, IGFBP10		Cysteine-rich angiogenic inducer, 61 (insulin-like growth factor-binding protein-10)	602369	A			3(Igfbp10)
1.656	3	11	09	1p31.1-p22.3	DNASE2B, DLAD		Deoxyribonuclease II beta	608057	A			
1.657	1	30	01	1p22.3	LMO4		LIM domain only 4	603129	A			3(Lmo4)
1.658	11	11	14	1p22.2	BARHL2		BARH-like 2	605212	R			
1.659	8	28	09	1p22.3	MCOLN3		Mucolipin 3	607400	R, H, REc			3(Mcoln3)
1.660	5	9	18	1p22.3	WDR63		WD repeat-containing protein 63	617968	REc			
1.661	1	28	08	1p22.2	CCBL2, KAT3		Cysteine conjugate beta-lyase 2	610656	REc			3(Kat3)
1.662	4	3	14	1p22.2	HFM1, MER3, POF9		Hfm1, ATP-dependent DNA helicase, S. cerevisiae, homolog of	615684	REc		Premature ovarian failure 9, 615724 (3)	
1.663	12	23	08	1p22.2	GBP1		Guanylate binding protein 1, interferon-inducible, 67kD	600411	REa, REc			3(Gbp1)
1.664	12	24	08	1p22.2	GBP2		Guanylate-binding protein 2, interferon-inducible	600412	REc			
1.665	12	24	08	1p22.2	GBP3		Guanylate-binding protein 3	600413	REc			
1.666	12	24	08	1p22.2	GBP4		Guanylate-binding protein 4	612466	REc			
1.667	12	24	08	1p22.2	GBP5		Guanylate-binding protein 5	611467	REc			
1.668	12	24	08	1p22.2	GBP6		Guanylate-binding protein 6	612467	REc			
1.669	12	24	08	1p22.2	GBP7		Guanylate-binding protein 7	612468	REc			
1.670	7	22	09	1p22.2	LRRC8B, TALRRP, KIAA0231		Leucine-rich repeat-containing protein 8B	612888	REc			5(Lrrc8b)
1.671	7	22	09	1p22.2	LRRC8C, FAD158, AD158		Leucine-rich repeat-containing protein 8C	612889	REc			5(Lrrc8c)
1.672	7	22	09	1p22.2	LRRC8D, LRRC5		Leucine-rich repeat-containing protein 8D	612890	REc			5(Lrrc8d)
1.673	11	30	06	1p22.2	PKN2, PRKCL2, PRK2, PAK2		Protein kinase N2	602549	REc, R			
1.674	7	18	14	1p22.2	GTF2B, TFIIB, TF2B		General transcription factor IIb	189963	REc			
1.675	4	27	12	1p22.2	ZNF326, ZIRD		Zinc finger protein 326	614601	REc			
1.676	8	25	11	1p22.2	ZNF644, MYP21		Zinc finger protein 644	614159	REc		Myopia 21, autosomal dominant, 614167 (3)	
1.677	7	21	14	1p22.1	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2		ATP-binding transporter, retina-specific	601691	R, REc, Fd		Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3); Cone-rod dystrophy 3, 604116 (3); {Macular degeneration, age-related, 2}, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe, 248200 (3)	
1.678	1	14	07	1p22.1	ARHGAP29, PARG1		RHO GTPase-activating protein 29	610496	R, REc			
1.679	7	18	14	1p22.1	BCAR3, SH2D3B, NSP2		Breast cancer antiestrogen resistance 3	604704	REc			
1.680	8	30	17	1p22.1	BRDT, SPGF21		Bromodomain, testis-specific	602144	R, REc	mutation identified in 1 SPGF21 patient	?Spermatogenic failure 21, 617644 (3)	
1.681	5	23	13	1p22.1	DNTTIP2, ERBP, FCF2		DNTT-interacting protein 2	611199	REc			
1.682	11	13	96	1p22.1	DR1		Down-regulator of transcription 1, TBP-binding (negative cofactor 2)	601482	A			
1.683	3	27	17	1p22.1	EPHX4, ABHD7		Epoxide hydrolase 4	617401	REc			
1.684	4	2	12	1p22.1	FAM69A		Family with sequence similarity 69, member A	614542	REc			
1.685	9	16	12	1p22.1	FNBP1L, TOCA1, C1orf39		Formin binding protein 1-like	608848	REc			
1.686	11	2	11	1p22.1	GCLM, GLCLR		Glutamate-cysteine ligase, modifier subunit	601176	REa, A, REc		{Myocardial infarction, susceptibility to}, 608446 (3)	3(Glclr)
1.687	4	24	18	1p22.1	KIAA1107, APACHE		KIAA1107 gene	617945	R, REc			5(Kiaa1107)
1.688	3	22	06	1p22.1	MTF2, PCL2, M96		Metal-regulatory transcription factor 2	609882	R, REc			
1.689	10	13	09	1p22.1	RPAP2, C1orf82		RNA polymerase II-associated protein 2	611476	R, REc			
1.690	2	3	09	1p22.1	RPL5, DBA6		Ribosomal protein L5	603634	R, RE, REc		Diamond-Blackfan anemia 6, 612561 (3)	
1.691	3	25	16	1p22.1	TMED5		Transmembrane p24 trafficking protein 5	616876	REc			
1.692	6	7	16	1p31.1	ZRANB2, ZNF265, ZIS		Zinc finger RANBP2-type domain-containing protein 2	604347	A, R			
1.693	10	20	15	1p22.3	BCL10, IMD37		B-cell leukemia/lymphoma 10	603517	Ch	mutation identified in 1 IMD37 patient	Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic}, 605027 (3); {Male germ cell tumor, somatic}, 273300, (3); {Sezary syndrome, somatic}, (3); {Mesothelioma, somatic}, 156240 (3); ?Immunodeficiency 37, 616098 (3)	
1.694	11	24	98	1p22.2-p22.1	CDC7L1, CDC7		Cell division cycle 7, S. Cerevisiae, homolog-like 1	603311	R			5(Cdc7l1)
1.695	11	2	04	1p22	CMM4		Melanoma, cutaneous malignant, 4	608035	Fd	between D1S430 and D1S2664	{Melanoma, cutaneous malignant, 4} (2)	
1.696	12	5	95	1p22.3	CTBS, CTB		Chitobiase, di-N-acetyl-	600873	Psh, A			
1.697	9	9	08	1p13.2	CSDE1, D1S155E, UNR		Cold-shock domain-containing E1, RNA-binding	191510	REn	130bp 5' to NRAS		
1.698	11	6	00	1p22.3	DDAH1		Dimethylarginine dimethylaminohydrolase-1	604743	R, A			
1.699	5	19	09	1p21.3	DPYD, DPD		Dihydropyrimidine dehydrogenase	612779	REa, A		Dihydropyrimidine dehydrogenase deficiency, 274270 (3); 5-fluorouracil toxicity, 274270 (3)	
1.700	12	24	08	1p22.1	EVI5, NB4S		Ecotropic viral integration site 5	602942	Ch			
1.701	11	22	16	1p22.1	GFI1, ZNF163, SCN2		Growth factor independent 1	600871	REa, A	mutation identified in 1 SCN2 patient and 1 NICINA patient	?Neutropenia, severe congenital 2, autosomal dominant, 613107 (3); ?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	5(Gfi1)
1.702	12	5	95	1p22.3	GNG5		Guanine nucleotide-binding protein (G protein), gamma 5	600874	Psh, A			
1.703	7	17	09	1p22.3	HS2ST1		Heparan sulfate 2-O-sulfotransferase 1	604844	R, REc			
1.704	2	14	13	1p22	KAZA2		Kala-azar, susceptibility to, 2	611381	Fd		{Kala-azar, susceptibility to, 2} (2)	
1.705	8	28	09	1p22.3	MCOLN2		Mucolipin 2	607399	R, H, REc	incorrectly assigned to chr.3		3(Mcoln2)
1.706	10	25	11	1p21.3	MIR137, MIRN137		Micro RNA 137	614304	REc			
1.707	7	1	05	1p13.1	TRIM45		Tripartite motif-containing protein 45	609318	REc			
1.708	1	4	93	1p22	UOX		Urate oxidase, pseudogene	191540	REa, A	nonsense mutations responsible for absence of enzyme in man and hominoid primates	[Urate oxidase deficiency] (1)	
1.709	3	27	15	1p21.3	ABCD3, PXMP1, PMP70, CBAS5		ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)	170995	REa, A	mutation identified in 1 CBAS5 family	?Bile acid synthesis defect, congenital, 5, 616278 (3)	3(Pmp70)
1.710	2	20	98	1p21.3	CNN3		Calponin 3, acidic	602374	A			
1.711	10	7	88	1p21.3	F3, TFA		Coagulation factor III	134390	S, REb, Fd, A			
1.712	4	22	02	1p22.1	GLML, GVM, VMGLOM		Glomulin	601749	Fd, REc		Glomuvenous malformations, 138000 (3)	
1.713	4	30	15	1p21.3	ALG14, CMS15		Alg14, S. cerevisiae, homolog of	612866	REc	mutation identified in 1 CMSWTA family	?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3)	
1.714	7	17	14	1p21.3	RWDD3, RSUME		RWD domain-containing protein 3	615875	REc			
1.715	1	9	17	1p21.3-p21.2	PLPPR4, LPPR4, PRG1, KIAA0455		Phospholipid phosphatase-related protein 4	607813	REc			
1.716	1	9	17	1p21.3	PLPPR5, LPPR5, PAP2D, PAP2		Phospholipid phosphatase-related protein 5	617287	REc			3(Plppr5)
1.717	4	21	17	1q21.3	S100A16, AAG13		S100 calcium-binding protein A16	617437	REc			3(S100a16)
1.718	12	10	12	1p21.3	SNX7		Sorting nexin 7	614904	REc			
1.719	5	11	07	1p13.2	CHIA, TSA1902, CHIT2		Chitinase, acidic	606080	R			
1.720	3	1	06	1p21.3-p13.3	RP32		Retinitis pigmentosa-32	609913	Fd	max lod at D1S485	Retinitis pigmentosa 32 (2)	
1.721	8	21	07	1p21.2	DPH5, HSPC143		DPH5, S. crevisiae, homolog of	611075	R, REc			
1.722	12	7	07	1p21.2	FRRS1, SDR2		Ferric chelate reductase 1	611578	R, REc			
1.723	5	11	16	1p21.2	GPR88, STRG, COCPMR		G protein-coupled receptor 88	607468	A, REc	mutation identified in 1 COCPMR family	?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	
1.724	3	20	14	1p21.2	PALMD, PALML		Palmdelphin	610182	REc, R, H			3(Palmd)
1.725	5	26	13	1p21.2	RTCD1, RPC		RNA terminal phosphate cyclase domain-containing protein 1	611286	REc, R			
1.726	10	13	17	1p21.2	SASS6, SAS6, MCPH14		SAS-6 centriolar assembly protein	609321	REc	mutation identified in 1 MCPH14 family	?Microcephaly 14, primary, autosomal recessive, 616402 (3)	
1.727	2	25	08	1p21.2	SLC30A7, ZNT7		Solute carrier family 30 (zinc transporter), member 7	611149	REc, H			3(Slc30a7)
1.728	6	22	18	1p21.1	RNPC3, SNRNP65, KIAA1839		RNA-binding region-containing protein 3	618016	REc			
1.729	6	13	07	1p21.1-p13.3	MRT4		Mental retardation, autosomal recessive, 4	611107	Fd	between D2S429 and D1S187	Mental retardation, autosomal recessive, 4 (2)	
1.730	1	11	07	1p13.2	DDX20		DEAD/H box 20	606168	R, REc			
1.731	7	16	14	1p21.1-q21.3	HYPT5, MUHH2		Hypotrichosis 5	612841	Fd	max lod at D1S2881	Hypotrichosis 5 (2)	
1.732	3	26	07	1p21.2	AGL, GDE		Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)	610860	REc, A		Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease IIIb, 232400 (3)	
1.733	10	23	87	1p21.1	AMY1A		Amylase, salivary, alpha-1A	104700	F, A, REa	multiple amylase genes		3(Amy1)
1.734	10	31	91	1p21.1	AMY1B		Amylase, salivary, alpha-1B	104701	REn			
1.735	11	4	91	1p21.1	AMY1C		Amylase, salivary, alpha-1C	104702	REn			
1.736	9	14	88	1p21.1	AMY2A		Amylase, pancreatic, alpha-2A	104650	F, A, REa			3(Amy2)
1.737	6	4	90	1p21.1	AMY2B		Amylase, pancreatic, alpha-2B	104660	F, A, REa, Fd	distal to NGFB		
1.738	2	25	11	1p21.1	COL11A1, STL2		Collagen XI, alpha-1 polypeptide	120280	REb, A		Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780 (3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis 1, 228520 (3)	3(Col11a1)
1.739	12	22	00	1p13.3	CELSR2, EGFL2, MEGF3		Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 2)	604265	Psh, R			
1.740	8	3	18	1p21.2	CDC14A, DFNB32		Cell division cycle 14, S. cerevisiae, homolog A	603504	R		Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3)	
1.741	7	18	12	1q21.1	FAM72D		Family with sequence similarity 72, member D	614712	REc			
1.742	4	6	15	1p13.2	MAGI3, KIAA1634		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 3	615943	R, H			3(Magi3)
1.743	11	11	14	1p21.1	OLFM3, NOE3		Olfactomedin 3	607567	REc			3(Olfm3)
1.744	7	27	09	1p13.3	PROK1, PK1, PRK1, EGVEGF		Prokineticin 1	606233	R, REc			
1.745	2	16	04	1p21.3	PTBP2, NPTB		Polypyrimidine tract-binding protein 2	608449	REc			
1.746	9	18	08	1p21.2	S1PR1, EDG1, S1P1		Sphingosine-1-phosphate receptor 1	601974	REc			
1.747	12	3	01	1p21.2	SLC35A3, AMRS		Solute carrier family 35 (UDP-GlcNAc transporter), member 3	605632	A	mutation identified in 1 family	?Arthrogryposis, mental retardation, and seizures, 615553 (3)	
1.748	5	23	06	1p21	STQTL7		Stature quantitative trait locus 7	609822	Fd	max lod at D1S1631	{Stature QTL 7} (2)	
1.749	8	9	01	1p13.2	BCAS2, DAM1		Breast carcinoma amplified sequence 2	605783	A			
1.750	11	4	93	1p13.3	CD53, MOX44		CD53 antigen	151525	REa, A			3(Cd53)
1.751	1	9	95	1p13.3	KCNA3		Potassium voltage-gated channel, shaker-related subfamily, member 3	176263	REa, A	mapped probably in error to chr.13		
1.752	3	30	00	1p21-p13.3	WS2B		Waardenburg syndrome, type 2B	600193	Fd		Waardenburg syndrome, type 2B (2)	
1.753	5	9	95	1p13.2	ADORA3		Adenosine A3 receptor	600445	Fd, REn, H			3(Adora3)
1.754	11	3	09	1p13.3	ALX3, FND1		Aristaless-like homeobox 3	606014	R		Frontonasal dysplasia 1, 136760 (3)	
1.755	11	9	13	1p13.2	AMPD1, MMDD		Adenosine monophosphate deaminase-1, muscle	102770	REa, A		Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	3(Ampd1)
1.756	10	27	97	1p13.3	CSF1, MCSF		Colony-stimulating factor-1 (macrophage)	120420	A, REa, H	incorrectly assigned to chr.5		3(Csfm)
1.757	8	26	15	1p13.3	AHCYL1, DCAL, IRBIT		Adenosylhomocysteine-like 1	607826	Psh, REc			
1.758	3	12	14	1p13.3	AMIGO1, ALI2, KIAA1163		Adhesion molecule with Ig-like domain 1	615689	REc			
1.759	6	3	14	1p13.3	AMPD2, SPG63, PCH9		Adenosine monophosphate deaminase-2, isoform L	102771	H, REa, A	mutation identified in 1 SPG63 family	?Spastic paraplegia 63, 615686 (3); Pontocerebellar hypoplasia, type 9, 615809 (3)	3(Ampd2)
1.760	1	13	16	1p13.3	CEPT1		Choline/ethanolamine phosphotransferase 1	616751	REn, REc			
1.761	5	25	13	1p13.2	CHI3L2, YKL39		Chitinase 3-like 2	601526	REc			
1.762	6	20	17	1p13.3	CLCC1, MCLC		Chloride channel CLIC-like 1	617539	REc			
1.763	7	17	09	1p13.3	CYMP		Chymosin pseudogene	118943	Psh, REc			
1.764	3	14	13	1p13.3-p13.2	DENND2D		DENN/MADD domain-containing protein 2D	615111	REc			
1.765	1	9	13	1p13.3	EPS8L3, EPS8R3		EPS8-like protein 3	614989	REc			3(Eps8l3)
1.766	7	17	09	1p13.3	GPR61		G protein-coupled receptor 61	606916	Psh, REc			
1.767	9	12	93	1p13.3	GSTM1		Glutathione S-transferase M1	138350	A, REa, Fd, Psh, REn			
1.768	9	12	93	1p13.3	GSTM2, GST4		Glutathione S-transferase M2, muscle	138380	Psh, A, REn			
1.769	9	12	93	1p13.3	GSTM3, GST5		Glutathione S-transferase M3, brain	138390	Psh, A, REn			
1.770	11	4	93	1p13.3	GSTM4		Glutathione S-transferase M4	138333	A, REn, Psh			
1.771	7	14	14	1p13.3	HENMT1, C1orf59, HEN1		Hen1 methyltransferase, arabidopsis, homolog of	612178	REc			
1.772	5	19	15	1p13.3	KCNA2, EIEE32		Potassium channel, voltage-gated, Shaker-related subfamily, member 2	176262	REc		Epileptic encephalopathy, early infantile, 32, 616366 (3)	12(Kcna2)
1.773	2	7	17	1p13.3	KCNC4		Potassium voltage-gated channel, Shaw-related subfamily, member 4	176265	REa, A			
1.774	5	24	13	1p13.3	KIAA1324, EIG121		KIAA1324 gene	611298	R, REc			
1.775	8	28	09	1p13.3	GSTM5		Glutathione S-transferase M5	138385	Psh, A, REn	pseudogene on chr.3		
1.776	7	31	15	1p13.3	DRAM2, TMEM77, CORD21		Damage-regulated autophagy modulator 2	613360	REc		Cone-rod dystrophy 21, 616502 (3)	
1.777	8	19	13	1p13.3	MIR197		Micro rNA 197	611189	REc			
1.778	9	12	08	1p13.3	NTNG1, LMNT1, KIAA0976		Netrin G1	608818	R, REc			
1.779	3	6	08	1p13.3	PRMT6		Protein arginine N-methyltransferase 6	608274	REc			
1.780	7	10	93	1p13.2	RAP1A, KREV1		RAS-related protein RAP1A	179520	A	pseudogene on 14q24.3		
1.781	3	23	15	1p13.3	SLC6A17, NTT4, MRT48		Solute carrier family 6 (neurotransmitter transporter), member 17	610299	REc		Mental retardation, autosomal recessive 48, 616269 (3)	
1.782	1	31	11	1p13.3	SORT1, NT3, LDLCQ6		Sortilin	602458	A, REc		[Low density lipoprotein cholesterol level QTL6], 613589 (3)	
1.783	3	23	18	1p13.3	STRIP1, FAR11A, FAM40A		Striatin-interacting protein 1	617918	REc			
1.784	4	20	17	1p13.3	TAF13, TAF2K, MRT60		TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD	600774	REc		Mental retardation, autosomal recessive 60, 617432 (3)	
1.785	9	10	07	1p13.3	UBL4B		Ubiquitin-like 4B	611127	REc, H			3(Ubl4b)
1.786	12	4	09	1p13.3	VAV3		Vav3 oncogene	605541	REc			
1.787	4	10	14	1p13.3	WDR47, NEMITIN, KIAA0893		WD repeat-containing protein 47	615734	REc			
1.788	6	3	15	1p13.2	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9		Potassium voltage-gated channel, Shal-related subfamily, member 3	605411	A, R, Fd		Spinocerebellar ataxia 19, 607346 (3); Brugada syndrome 9, 616399 (3)	
1.789	12	28	08	1p13.2	DCLRE1B, SNM1B, APOLLO		DNA cross-link repair protein 1B	609683	REc			
1.790	10	11	17	1p12	WARS2, NEMMLAS		Tryptophanyl-tRNA synthetase 2	604733	R		Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3)	
1.791	4	15	08	1p13.1	CASQ2		Calsequestrin, fast-twitch, skeletal muscle-2	114251	A		Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	
1.792	4	27	12	1p13.2	AP4B1, SPG47, CPSQ5		Adaptor-related protein complex 4, beta-1 subunit	607245	R, REc		Spastic paraplegia 47, autosomal recessive, 614066 (3)	
1.793	2	25	15	1p13.2	ATP5F1		ATP synthase, H+ transporting, mitochondrial FO complex, subunit B, isoform 1	603270	REc			
1.794	9	21	11	1p13.2	C1orf88, PIFO		Chromosome 1 open reading frame 88 (pitchfork, mouse, homolog of)	614234	REc			
1.795	7	17	09	1p13.2	CAPZA1, CAPPA1		Capping protein, muscle Z-line, alpha-1	601580	REc			3(Capza1)
1.796	3	14	13	1p13.2	CTTNBP2NL		CTTNBP2 N terminus-like protein	615100	REc			
1.797	5	30	17	1p13.2	FAM19A3, TAFA3		Family with sequence similarity 19, member A3, CC motif chemokine-like	617497	REc			
1.798	10	23	15	1p13.3	LAMTOR5, HBXIP, XIP		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 5	608521	R, REc			
1.799	1	31	07	1p13.2	MOV10, KIAA1631		Moloney leukemia virus 10, mouse, homolog of	610742	R, REc			
1.800	3	9	17	1p13.2	NR1H5P, FXRB		Nuclear receptor subfamily 1, group H, member 5, pseudogene	617386	REc			
1.801	1	4	16	1p13.2	NRAS, ALPS4, NS6, CMNS, NCMS		Neuroblastoma RAS viral (v-ras) oncogene homolog	164790	REa, A	cen-CD2-NGFB-NRAS	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Noonan syndrome 6, 613224 (3); Epidermal nevus, somatic, 162900 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Colorectal cancer, somatic, 114500 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Neurocutaneous melanosis, somatic, 249400 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	3(Nras)
1.802	5	25	13	1p13.2	OVGP1		Oviductal glycoprotein 1	603578	REc			
1.803	3	22	06	1p13.2	PPM1J, PP2CZ, PPP2CZ		Protein phosphatase, magnesium-dependent, 1J	609957	REc			
1.804	8	3	12	1p13.2	RHOC, ARHC, ARH9, RHOH9		RAS homolog gene family, member C (oncogene RHO H9)	165380	REa, A	incorrectly assigned to chr.5		
1.805	7	18	14	1p13.2	RSBN1, ROSBIN		Round spermatid basic protein 1	615858	REc			
1.806	12	18	07	1p13.2	SIKE		Suppressor of IKK-epsilon	611656	REc			
1.807	7	27	09	1p13.2	SYT6		Synaptotagmin 6	607718	R, REc			
1.808	12	2	09	1p13.2	TSPAN2, NET3		Tetraspanin 2	613133	REc			
1.809	1	17	08	1p13.2	WDR77, MEP50		WD repeat-containing protein 77	611734	R, REc			
1.810	11	24	14	1p13.2	SLC16A1, MCT1, HHF7, MCT1D		Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	Psh, A		Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3); Monocarboxylate transporter 1 deficiency, 616095 (3)	
1.811	11	20	95	1p13.1	CD2		CD2 antigen (p50), sheep red blood cell receptor	186990	REa, A, RE			3(Ly37)
1.812	7	13	12	1p13.3	GPSM2, LGN, PINS, DFNB82, CMCS		G protein signaling modulator 2	609245	REc		Chudley-McCullough syndrome, 604213 (3)	
1.813	4	30	93	1p12	HSD3B1		Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 1 (placental, peripheral)	109715	Fd, A			3(Hsd3b1)
1.814	4	6	16	1p12	HSD3B2		Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)	613890	A		Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	3(Hsd3b2)
1.815	4	15	98	1p13.3	KCNA10		Potassium voltage-gated channel, shaker-related subfamily, member 10	602420	A			
1.816	8	19	13	1p13.2	OLFML3, OLF44		Olfactomedin-like 3	610088	REc			
1.817	11	24	14	1p13.2	NGF, NGFB, HSAN5		Nerve growth factor, beta	162030	REa, H, A, Fd, RE	same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	3(Ngfb)
1.818	12	2	09	1p13.3	PSRC1, DDA3		Proline/serine-rich coiled-coil protein 1	613126	REc, H			3(Psrc1)
1.819	3	6	08	1p13.1	SLC22A15, FLIPT1		Solute carrier family 22 (organic cation transporter), member 15	608275	REc			
1.820	10	2	12	1p13.1	TTF2		Transcription termination factor, RNA polymerase II	604718	REc			
1.821	3	29	06	1p13-p12	VCTN1, B7H4, B7X, B7S1		V-set domain containing T cell activation inhibitor 1	608162	REc, H			3(B7h4)
1.822	3	20	06	1p34.2	PPCS		Phosphopantothenoylcysteine synthetase	609853	REc			
1.823	3	20	06	1p12	REG4		Regenerating islet-derived family, member 4	609846	REc			
1.824	6	30	98	1p13.1	PTGFRN, FPRP		Prostaglandin F2 receptor negative regulator	601204	Psh, REc			
1.825	10	12	90	1p13.1	CD58, LFA3		CD58 antigen (lymphocyte function-associated antigen 3)	153420	S, REa, A, RE	?same as MSK1; gene cloned		
1.826	6	4	12	1p13.3	GNAI3, ARCND1		Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3	139370	REa, A, Fd		Auriculocondylar syndrome 1, 602483 (3)	3(Gnai3)
1.827	4	6	11	1p13.3	GNAT2, ACHM4		Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2	139340	REa, A		Achromatopsia 4, 613856 (3)	3(Gnat2)
1.828	7	17	09	1p12	HAO2, HAOX2		Hydroxyacid oxidase 2	605176	REc			
1.829	2	5	15	1p13.1	IGSF3, LCDD		Immunoglobulin superfamily, member 3	603491	A, RE	mutation identified in 1 LCDD family	?Lacrimal duct defect, 149700 (3)	
1.830	3	15	13	1p13.2	LRIG2, LIG2, KIAA0806, UFS2		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2	608869	A, H		Urofacial syndrome 2, 615112 (3)	3(Lrig2)
1.831	2	2	01	1p12	MAN1A2		Mannosidase, alpha, class 1A, member 2	604345	A			3(Man1a2)
1.832	9	10	98	1p13.3	PSMA5, PSC5		Proteasome component 5	176844	REc			
1.833	5	25	00	1p13.2	PHTF1		Putative homeodomain transcription factor 1	604950	A			
1.834	3	27	09	1p13.2	PTPN22, PEP, PTPN8, LYP		Protein tyrosine phosphatase, nonreceptor-type 22	600716	A		{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)	
1.835	6	28	01	1p13.3	RBM15, SPEN, OTT		One-twenty two protein (RNA binding motif protein 15; Spen, Drosophila, homolog of)	606077	Ch		Megakaryoblastic leukemia, acute (2)	
1.836	10	11	17	1p13.3	SARS, SERS, NEDMAS		Seryl-tRNA synthetase	607529	R, REc	mutation identified in 1 NEDMAS family	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3)	
1.837	8	28	17	1p13.2	ST7L, ST7R		Suppressor of tumorigenicity 7-like protein	617640	REc			
1.838	6	9	98	1p13.2	SYCP1, SCP1		Synaptonemal complex protein-1	602162	A			
1.839	12	24	08	1p12	TBX15		T-box 15	604127	A		Cousin syndrome, 260660 (3)	3(Tbx15)
1.840	8	14	15	1p13.2	TRIM33, TIF1G, RFG7, PTC7		Tripartite motif-containing protein 33	605769	A	fused with RET to form PTC7		
1.841	9	4	08	1p13.2	TSHB, CHNG4		Thyroid-stimulating hormone, beta polypeptide	188540	REa, RE, Fd	centromeric to NGFB	Hypothyroidism, congenital, nongoitrous 4, 275100 (3)	3(Tshb)
1.842	7	24	15	1p13.1	VANGL1, STBM2		Vang-like 1	610132	REc		Caudal regression syndrome, 600145 (3); {Neural tube defects, susceptibility to}, 182940 (3)	
1.843	5	23	00	1p13	VUR		Vesicoureteral reflux	193000	Fd		Vesicoureteral reflux (2)	
1.844	3	2	98	1p13.2	WNT13, XWNT2		Wingless-type MMTV integration site family, member 13	601968	A			
1.845	5	9	01	1p12	HMGCS2		3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial	600234	A		HMG-CoA synthase-2 deficiency, 605911 (3)	
1.846	5	4	00	1p12	WDR3		WD repeat-containing protein 3	604737	A			
1.847	1	29	01	1p12	ADAM30		A disintegrin and metalloproteinase domain 30	604779	R			
1.848	6	29	18	1p13.1	ATP1A1, CMT2DD		ATPase, Na+K+ transporting, alpha-1 polypeptide	182310	REa, REb, A, Fd		Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3)	3(Atp1a1)
1.849	1	6	97	1p11.2	FCGR1B		Fc fragment of IgG, high affinity Ib, receptor for (CD64)	601502	REa, A			
1.850	10	10	18	1p12	GDAP2		Ganglioside-induced differentiation-associated protein 2	618128	REc			
1.851	8	2	13	1p13.3	LRIF1, RIF1		Ligand-dependent nuclear receptor-interacting factor 1	615354	REc			
1.852	9	21	11	1p13.3	NBPF4		Neuroblastoma breakpoint family, member 4	613994	REc, A			
1.853	9	21	11	1p13.3	NBPF5		Neuroblastoma breakpoint family, member 5	613995	REc, A			
1.854	9	21	11	1p13.3	NBPF6		Neuroblastoma breakpoint family, member 6	613996	REc, A			
1.855	9	21	11	1p12	NBPF7		Neuroblastoma breakpoint family, member 7	613997	REc, A			
1.856	07	19	18	1p12	NOTCH2, AGS2, HJCYS		Notch, Drosophila, homolog of, 2	600275	REa, A		Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)	3(Notch2)
1.857	07	19	18	1p12	NOTCH2NLR		NOTCH2 N-terminal-like-related, pseudogene	618026	REc			
1.858	10	12	14	1p12	PHGDH, NLS1, PHGDHD		Phosphoglycerate dehydrogenase	606879	A, R		Phosphoglycerate dehydrogenase deficiency, 601815 (3); Neu-Laxova syndrome 1, 256520 (3)	
1.859	9	24	15	1p12	SPAG17, PF6		Sperm-associated antigen 17	616554	REc			
1.860	7	18	12	1p11.2	SRGAP2C		SLIT-ROBO Rho GTPase-activating protein 2C	614704	REc			
1.861	5	9	18	1p12	TENT5C, FAM46C		Terminal nucleotidyltransferase 5C	613952	REc			
1.862	3	6	98	1p21.2	EXTL2		Exostosin-like 2	602411	A			3(Extl2)
1.863	1	9	95	1p13.1	NHLH2, HEN2		Nescient helix loop helix 2	162361	REa, A			3(Nscl2)
1.864	7	18	12	1p11.2	FAM72B		Family with sequence similarity 72, member B	614711	REc			
1.865	10	15	02	1p11	MNRI		Meningioma, radiation-induced	606190	Ch		Meningioma, radiation-induced (2)	
1.866	5	4	12	1p	ANON1		Anorexia nervosa, susceptibility to, 1	606788	Fd		{Anorexia nervosa, susceptibility to, 1} (2)	
1.867	2	5	01	1p	PSORS7		Psoriasis susceptibility 7	605606	Fd		{Psoriasis susceptibility 7} (2)	
1.868	1	2	91	1q44	ADSS		Adenylosuccinate synthetase (Ade(-)H-complementing)	103060	S			13(Nid)
1.869	11	14	91	1q23.3	HSPA6		Heat-shock 70kD protein-6 (HSP70B')	140555	REa			
1.870	11	14	91	1q23.3	HSPA7		Heat-shock 70kD protein-7 (HSP70B)	140556	REa			
1.871	8	28	97	1q	LRE2		LINE retrotransposable element-2	151628	REa	inserted in DMD gene		
1.872	2	2	16	1q22	PMF1		Polyamine-modulated factor 1	609176	R, A, REc			
1.873	4	19	12	1q21.1	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1		RNA-binding motif protein 8A	605313	Psh, R	pseudogene on chr.14	Thrombocytopenia-absent radius syndrome, 274000 (3)	
1.874	4	17	01	1q21.3	TMOD4		Tropomodulin 4, muscle	605834	R			3(Tmod4)
1.875	10	09	18	1q22	DPM3, CDG1O		Dolichyl-phosphate mannosyltransferase 3	605951	REc		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937, (3)	
1.876	7	20	09	1q12-q21.3	GNRHR2		Gonadotropin-releasing hormone receptor 2	612875	REc	?processed pseudogene		
1.877	6	3	94	1q21.3	S100A9, CAGB, CFAG		S100 calcium-binding protein A9 (calgranulin B)	123886	REa			3(Cagb)
1.878	9	13	89	1q12-q22	TRNL		tRNA asparagine-like	189890	REa, RE			
1.879	9	12	93	1q24.2	DPT		Dermatopontin	125597	REa			
1.880	11	9	95	1q22	MEF2D		MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D)	600663	REc			3(Mef2d)
1.881	1	16	01	1q12-q24	CORD8		Cone-rod dystrophy 8	605549	Fd		Cone-rod dystrophy 8 (2)	
1.882	7	16	09	1q23.3	DDR2, NTRKR3, TKT		Discoidin domain receptor family, member 2	191311	Psh		Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	
1.883	4	6	15	1q21.2	ACP6, LPAP, ACPL1		Acid phosphatase 6, lysophosphatide	611471	A			
1.884	8	30	07	1q21	AD13		Alzheimer disease-13	611152	Fd	max lod D1S498	{Alzheimer disease-13} (2)	
1.885	9	12	13	1q21.2	ADAMTSL4, TSRC1, ECTOL2		ADAMTS-like 4	610113	REc, H		Ectopia lentis, isolated, autosomal recessive, 225100 (3); Ectopia lentis et pupillae, 225200 (3)	3(Adamtsl4)
1.886	6	18	99	1q21.3	ANXA9, ANX31		Annexin A9 (annexin XXXI)	603319	A			
1.887	8	27	15	1q21.3	ARNT		Aryl hydrocarbon receptor nuclear translocator	126110	REa, Fd, A			3(Arnt)
1.888	5	26	98	1q21.2	BCL9		B-cell CLL/lymphoma-9	602597	A, Ch			
1.889	5	11	00	1q21.2	CA14		Carbonic anhydrase XIV	604832	A			
1.890	2	24	15	1q23.2	CASQ1, VMCQA		Calsequestrin, fast-twitch, skeletal muscle-1	114250	REa, A		Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	
1.891	8	2	13	1q21.3	CELF3, TNRC4, BRUNOL1		CUGbp- and ELAV-like family, member 3	612678	REc			
1.892	9	28	09	1q21.1	CHD1L, ALC1		Chromodomain helicase DNA-binding protein 1-like	613039	A			
1.893	9	9	02	1q21.3	CHRNB2, EFNL3		Cholinergic receptor, nicotinic, beta polypeptide-2	118507	REa, H, A	linked to AMY in mouse	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	3(Acrb2)
1.894	11	28	01	1q21.3	CTMP		C-terminal modulator protein	606388	REc			
1.895	9	2	96	1q21.3	CTSK		Cathepsin K	601105	REn, Fd		Pycnodysostosis, 265800 (3)	
1.896	6	3	94	1q21.3	CTSS		Cathepsin S	116845	A			3(Ctss)
1.897	6	9	98	1q22	DAP3		Death associated protein 3	602074	A			
1.898	3	25	13	1q21.2	ECM1, URBWD		Extracellular matrix protein-1	602201	REc, A		Urbach-Wiethe disease, 247100 (3)	
1.899	1	6	97	1q21.1	FCGR1C		Fc fragment of IgG, high affinity Ic, receptor for (CD64)	601503	REa, A			
1.900	4	18	08	1q21.3	FLG, ATOD2		Filaggrin	135940	REa, A, REn, Fd		Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	3(flg)
1.901	2	17	12	1q22	GBA		Glucosidase, acid beta	606463	S, A, D, Fd	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type I, 230800 (3); Gaucher disease, type II, 230900 (3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3); {Lewy body dementia, susceptibility to}, 127750 (3)	3(Gba)
1.902	8	28	97	1q22	GENEY		Gene Y	600986	REn			3(GeneY)
1.903	12	11	07	1q23.1	HDGF		Hepatoma-derived growth factor	600339	Psh, A, REc	previously assigned to Chr.X		
1.904	3	11	03	1q21.2	HIST2H2AA, H2AFO, H2A		Histone 2, H2aa	142720	A			
1.905	1	14	13	1q21.2	HIST2H2AB, H2AB		Histone gene cluster 2, H2A histone family, member B	615014	REc			
1.906	3	12	03	1q21.2	HIST2H3C, H3F2		Histone 2, H3c	142780	REa, A			
1.907	9	13	89	1q21.2	H4FN, H4F2		H4 histone, family 2	142750	REa, A	100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7		
1.908	1	15	04	1q21.1	HJV, HFE2A		Hemojuvelin	608374	Fd, REc	between D1S442 and D1S2347	Hemochromatosis, type 2A, 602390 (3)	
1.909	4	30	01	1q23.1	IRTA1		Immunoglobulin superfamily receptor translocation-associated gene 1	605876	REc	fused with IGHA1 in multiple myeloma		
1.910	4	30	01	1q23.1	IRTA2		Immunoglobulin superfamily receptor translocation-associated gene 2	605877	REc			
1.911	11	4	93	1q21.3	IVL		Involucrin	147360	REa, A, REn			
1.912	3	10	00	1q21.3	JTB, PAR		Jumping translocation breakpoint	604671	Ch			
1.913	3	4	10	1q21.3	KPRP		Keratinocyte proline-rich protein	613260	REc			
1.914	2	17	09	1q21.3	LCE1A, LEP1		Late cornified envelope protein 1A	612603	REc, H			3(Lce1a)
1.915	2	17	09	1q21.3	LCE1B, LEP2		Late cornified envelope protein 1B	612604	REc, H			3(Lce1b)
1.916	2	17	09	1q21.3	LCE1C, LEP3		Late cornified envelope 1C	612605	REc, H			3(Lce1c)
1.917	2	17	09	1q21.3	LCE1D, LEP4		Late cornified envelope protein 1D	612606	REc, H			3(Lce1d)
1.918	2	17	09	1q21.3	LCE1E		Late cornified envelope protein 1E	612607	REc, H			3(Lce1e)
1.919	2	17	09	1q21.3	LCE1F, LEP6		Late cornified envelope protein 1F	612608	REc, H			3(Lce1f)
1.920	2	18	09	1q21.3	LCE2A, LEP9		Late cornified envelope protein 2A	612609	REc, H			3(Lce2a)
1.921	2	18	09	1q21.3	LCE2B, LEP10, XP5		Late cornified envelope protein 2B	612610	REc, H			3(Lce2b)
1.922	2	18	09	1q21.3	LCE2C, LEP11		Late cornified envelope protein 2C	612611	REc, H			3(Lce2c)
1.923	2	18	09	1q21.3	LCE2D, LEP12		Late cornified envelope protein 2D	612612	REc, H			3(Lce2d)
1.924	2	23	09	1q21.3	LCE3A, LEP13		Late cornified envelope protein 3A	612613	REc, H			3(Lce3a)
1.925	2	23	09	1q21.3	LCE3B, LEP14		Late cornified envelope protein 3B	612614	REc, H			3(Lce3b)
1.926	2	23	09	1q21.3	LCE3C, LEP15		Late cornified envelope protein 3C	612615	REc, H			3(Lce3c)
1.927	2	23	09	1q21.3	LCE3D, LEP16		Late cornified envelope protein 3D	612616	REc, H	within intron 2 of LCE3C		3(Lce3d)
1.928	2	23	09	1q21.3	LCE3E, LEP17		Late cornified envelope protein 3E	612617	REc, H			3(Lce3e)
1.929	2	23	09	1q21.3	LCE4A, LEP8		Late cornified envelope protein 4A	612618	REc, H			3(Lce4a)
1.930	2	23	09	1q21.3	LCE5A, LEP18		Late cornified envelope protein 5A	612619	REc, H			3(Lce5a)
1.931	8	20	07	1q21.3	LELP1		Late cornified envelope-like proline-rich 1	611042	REc			
1.932	10	7	10	1q21.3	LOR		Loricrin	152445	REa, A, REn		Vohwinkel syndrome with ichthyosis, 604117 (3)	3(lor)
1.933	7	4	95	1q21.2	MCL1		Myeloid cell leukemia sequence 1 (BCL2-related)	159552	REa, A			3(Mcl1)
1.934	5	23	16	1q21.3	MLLT11, AF1Q		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 11	604684	Ch			
1.935	2	26	08	1q21.3	MRPL9		Mitochondrial ribosomal protein L9	611824	R			
1.936	4	24	08	1q21.2	MRPS21		Mitochondrial ribosomal protein S21	611984	R, REc	9 pseudogenes		
1.937	8	3	99	1q22	MTX1, MTXN		Metaxin 1	600605	H, REn	between GBA and TSP3		3(Mtxn)
1.938	7	12	13	1q22	MUC1, PUM, MCKD1		Mucin 1, transmembrane	158340	REa, A, Fd	5cM proximal to SPTA1	Medullary cystic kidney disease 1, 174000 (3)	3(Muc1)
1.939	11	24	16	1q22	NAXE, APOA1BP, AIBP, PEBEL		NAD(P)HX epimerase	608862	REc		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3)	
1.940	12	13	00	1q21.1	PDZK1		PDZ domain-containing 1	603831	Psh, R			
1.941	10	29	03	1q21.3	PGRPIA		Peptidoglycan recognition protein, intermediate, alpha	608197	REc			
1.942	10	29	03	1q21.3	PGRPIB		Peptidoglycan recognition protein, intermediate, beta	608198	REc			
1.943	7	2	01	1q21.1	PIAS3		Protein inhibitor of activated STAT3	605987	Psh, R			
1.944	1	14	09	1q22	PKLR, PK1		Pyruvate kinase, liver and RBC type	609712	REa, A, REn		Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	3(Pk1)
1.945	10	21	96	1q23.1	PRCC, RCCP1		Papillary renal cell carcinoma, translocation-associated	179755	Ch	t(X;1)(p11;q21); fuses with TFE3 in RCCP	Renal cell carcinoma, papillary, 605074 (3)	
1.946	7	19	18	1q21.3	PSMB4, PRAAS3		Proteasome subunit, beta type, 4	602177	A	mutation identified in 1 PRAAS3 patient and 1 digenic family	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3)	
1.947	4	16	03	1q21	PSORS4		Psoriasis susceptibility 4	603935	Fd		{Psoriasis susceptibility 4} (2)	
1.948	2	14	01	1q21	PTCPRN, PRN1		Papillary thyroid carcinoma with papillary renal neoplasia	605642	Fd		Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	
1.949	10	17	00	1q21	RFH1, AORF		Renal failure, progressive, with hypertension	161900	Fd		Nephropathy-hypertension (2)	
1.950	10	28	15	1q21.3	RORC, RORG, RZRG, IMD42		RAR-related orphan receptor C	602943	Psh, A		Immunodeficiency 42, 616622 (3)	3(Rorc)
1.951	3	28	17	1q21.3	RPS27, MPS1, DBA17		Ribosomal protein S27	603702	R, RE, REc	mutation identified in 1 DBA17 patient	?Diamond-Blackfan anemia 17, 617409 (3)	
1.952	11	17	94	1q21.3	S100A1		S100 protein, alpha polypeptide	176940	REb, A, REn			
1.953	3	4	10	1q21.3	RPTN		Repetin	613259	REc, A, H			3(Rptn)
1.954	11	17	94	1q21.3	S100A2, S100L		S100 calcium-binding protein A2	176993	REn			
1.955	11	17	94	1q21.3	S100A3, S100E		S100 calcium-binding protein A3	176992	REn			
1.956	11	17	94	1q21.3	S100A4, CAPL		S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)	114210	REa, H, REn			3(Capl)
1.957	11	17	94	1q21.3	S100A5, S100D		S100 calcium-binding protein A5	176991	REn, A			
1.958	11	17	94	1q21.3	S100A6, CACY		S100 calcium-binding protein A6 (calcyclin)	114110	A, REn			3(Cacy)
1.959	2	9	95	1q21.3	S100A7		S100 calcium-binding protein A7	600353	REc, A, Fd			
1.960	11	26	02	1q21.3	S100A8, CAGA, CFAG		S100 calcium-binding protein A8 (calgranulin A)	123885	S, REa	over-expressed in 1q21-linked psoriasis		3(Caga)
1.961	7	11	94	1q21.3	S100A10, CAL1L		S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11))	114085	H, REn	on chr.3 in mouse		
1.962	10	14	98	1q21.3	S100A11		S100 calcium-binding protein A11	603114	A			
1.963	10	14	98	1q21.3	S100A12, CAAF1, CGRP		S100 calcium-binding protein A12	603112	REc	between S100A8 and S100A9		
1.964	3	9	98	1q21.3	S100A13		S100 calcium-binding protein A13	601989	REc			
1.965	1	11	07	1q21.3	S100A14, BCMP84		S100 Calcium-binding protein A14	607986	A, REn			
1.966	5	13	02	1q22	SCAMP3, PROPIN1		Secretory carrier membrane protein 3	606913	REc			
1.967	9	9	11	1q23.3	SDHC, PGL3		Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD	602413	A, S, M		Paragangliomas 3, 605373 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)	
1.968	1	4	00	1q21.3	SETDB1		SET domain protein, bifurcated, 1	604396	REa, A, R			
1.969	3	10	00	1q23.1	SH2D2A, TSAD		SH2 domain protein 2A	604514	Psh, A			
1.970	6	16	95	1q21.3	SHC1		SHC (Src homology 2 domain-containing) transforming protein-1	600560	REa, A			
1.971	10	4	02	1q23.2	SLAMF8, BLAME		SLAM family, member 8	606620	R			
1.972	2	15	02	1q21.3	SLC39A1, ZIRTL		Solute carrier family 39 (zinc transporter), member 3 (zinc/iron-regulated transporter-like)	604740		REc		3(Zirtl)
1.973	3	23	06	1q21.3	SMCP, MCSP, MCS		Sperm mitochondria-associated cysteine-rich protein	601148	A			
1.974	5	19	15	1q21.3	SPRR4		Small proline-rich protein 4	616363	REc			
1.975	3	11	09	1q23.1	SPTA1, EL2, SPH3, HS3, HPP		Spectrin, alpha, erythrocytic-1	182860	REa, A, Fd	17cM proximal to FY	Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3); Spherocytosis, type 3, 270970 (3)	1(Spna1)
1.976	7	4	95	1q22	THBS3, TSP3		Thrombospondin 3	188062	H			3(Thbs3)
1.977	6	16	99	1q21.3	TUFT1		Tuftelin 1	600087	A	?mutant in amelogenesis imperfecta		
1.978	1	7	02	1q21.1	TXNIP, VDUP1		Thioredoxin-interacting protein	606599	R, H			3(Txnip)
1.979	6	5	08	1q22	UBQLN4, A1U, C1orf6		Ubiquitin 4	605440	REc			
1.980	2	25	08	1q21.3	VPS72, CFL1, YL1		Vacuolar protein sorting 72, yeast, homolog of	600607	RE			
1.981	6	17	17	1q22	ARHGEF2, GEFH1, KIAA0651, NEDMHM		RHO guanine nucleotide exchange factor 2	607560	R, REc	mutation identified in 1 NEDMHM family	?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3)	
1.982	8	25	04	1q21-q22	ASPG3		Asperger syndrome, susceptibility to, 3	608781	Fd	max lod at D1S484	{Asperger syndrome susceptibility 3} (2)	
1.983	5	11	00	1q23.3	DUSP1, YVH1		Dual-specificity phosphatase 12	604835	R			
1.984	11	5	97	1q22	EFNA1, EPLG1, TNFAIP4		eph-related receptor tyrosine kinase ligand 1 (tumor necrosis factor, alpha-induced protein 4)	191164	A			3(Epl1)
1.985	11	5	97	1q21.3	EFNA3, EPLG3		eph-related receptor tyrosine kinase ligand 3 (ephrin A3)	601381	A			3(Epl3)
1.986	11	5	97	1q21.3	EFNA4, EPLG4		eph-related receptor tyrosine kinase ligand 4 (ephrin-A4)	601380	A			3(Epl4)
1.987	2	28	08	1q23.1	MRPL24		Mitochondrial ribosomal protein L24	611836	R			
1.988	1	11	07	1q23.3	NIT1		Nitrilase 1	604618	REc, R			1(Nit1)
1.989	4	18	94	1q21.3	NPR1, ANPRA		Natriuretic peptide receptor A/guanylate cyclase A	108960	REa, A			
1.990	6	6	00	1q23.1	NTRK1, TRKA, MTC		Neurotrophic tyrosine kinase, receptor, type 1	191315	REa, A	TRK = chimera of TPM3 and NTRK1	Insensitivity to pain, congenital, with anhidrosis, 256800 (3); Medullary thyroid carcinoma, familial, 155240 (3)	
1.991	10	14	18	1q21.3	SELENBP1, SP56, EHMTO		Selenium-binding protein 1	604188	A		Extraoral halitosis due to MTO deficiency, 618148 (3)	
1.992	7	10	93	1q21.3	SPRR1A		Small proline-rich protein 1A	182265	REa, A, REn			
1.993	7	10	93	1q21.3	SPRR1B		Small proline-rich protein 1B	182266	REa, A			
1.994	7	10	93	1q21.3	SPRR2A		Small proline-rich protein 2A	182267	REa, A, REn	about 7 SPRR2 genes		
1.995	7	10	93	1q21.3	SPRR2B		Small proline-rich protein 2B	182268	REa, A			
1.996	7	10	93	1q21-q22	SPRR2C		Small proline-rich protein 2C	182269	REa, A	prob. pseudogene		
1.997	7	10	93	1q21.3	SPRR3		Small proline-rich protein 3	182271	REa, A, REn			
1.998	7	18	13	1q21.2	VPS45A, VPS45, SCN5		Vacuolar protein sorting 45, yeast, homolog of, A	610035	A		Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	
1.999	1	11	07	1q23.3	ADAMTS4		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 4 (aggrecanase 1)	603876	R, REc			
1.1000	4	30	91	1q23.2	APCS, SAP		Amyloid P component, serum	104770	REa, A, Fd	probably close to CRP	{?Amyloidosis, secondary, susceptibility to} (1)	1(Sap)
1.1001	2	20	03	1q23.3	APOA2		Apolipoprotein A-II	107670	REa, A, Fd, RE		Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3)	1(Apoa2)
1.1002	1	23	18	1q23.2	ATP1A2, FHM2, MHP2		ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	REa, A, Fd, RE		Migraine, familial hemiplegic, 2, 602481 (3); Alternating hemiplegia of childhood 1, 104290 (3); Migraine, familial basilar, 602481 (3)	1(Atpa3)
1.1003	1	17	03	1q21-q23	BMND2		Bone mineral density QTL 2	605833	Fd		[Bone mineral density QTL 2] (2)	
1.1004	3	21	93	1q23.1	CD1A		Thymocyte antigen CD1A	188370	A, REa, REn	genes A, B, C, D in cluster		3(Ly38)
1.1005	3	21	93	1q23.1	CD1B		Thymocyte antigen CD1B	188360	A, REa, REn			
1.1006	3	21	93	1q23.1	CD1C		Thymocyte antigen CD1C	188340	A, REa, REn			
1.1007	3	21	93	1q23.1	CD1D		Thymocyte antigen CD1D	188410	A, REa, H, REn			3(Cd1d)
1.1008	10	9	94	1q23.1	CD1E		Thymocyte antigen CD1E	188411	A, REa, REn			
1.1009	7	2	98	1q23.1	CD5L		CD5 antigen-like (scavenger receptor cysteine rich family)	602592	R, A			
1.1010	5	1	91	1q23.2	CRP		C-reactive protein	123260	REa, A			1(Crp)
1.1011	9	22	96	1q21-q23	DFNA7		Deafness, autosomal dominant 7	601412	Fd		Deafness, autosomal dominant 7 (2)	
1.1012	1	27	04	1q21-q23	DFNA49		Deafness, autosomal dominant 49	608372	Fd	max lod at D1S3784 and D1S3786	Deafness, autosomal dominant 49 (2)	
1.1013	9	8	11	1q21-q23	ERVK-7, HERV-KIII, HERV-K102		Endogenous retrovirus group K, member 7	614013	R, REc			
1.1014	12	5	95	1q23.1	ETV3, PE1		ets variant gene 3	164873	REa, A			
1.1015	8	6	15	1q23.3	FCGR2A, IGFR2, CD32		Fc fragment of IgG, low affinity IIa, receptor for (CD32)	146790	REb, REn, Fd, RE	FCG2 and FCG3 within 250kb	{Lupus nephritis, susceptibility to}, 152700 (3); {Malaria, severe, susceptibility to}, 611162 (3); {Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	1(Ly17, Cd32)
1.1016	3	11	03	1q21.2	HIST2H2BE, H2B		Histone 2, H2be	601831	REa, A			
1.1017	3	11	03	1q21.2	HIST2H2AC, H2AFQ		Histone 2, H2ac	602797	REc			
1.1018	10	24	00	1q23.1	INSRR, IRR		Insulin receptor-related receptor	147671	REa, R			
1.1019	3	23	09	1q23.1	PYHIN1, IFIX		Pyrin and Hin domain family, member 1	612677	REc			
1.1020	12	21	09	1q21-q23	SLEB14		Systemic lupus erythematosus, susceptibility to, 14	613145	Fd	associated with rs3093061	{Systemic lupus erythematosus, susceptibility to, 14} (2)	
1.1021	12	5	95	1q22	SSR2		Signal sequence receptor, beta	600867	A			
1.1022	2	21	14	1q23.2	VANGL2, LTAP		Vang-like 2 (loop-tail, mouse, homolog of)	600533	REc, H		Neural tube defects, 182940 (3)	1(Lp)
1.1023	5	4	00	1q23.2	TAGLN2		Transgelin 2	604634	REc, H			1(Tagln2)
1.1024	2	28	03	1q23.2	ATP1A4, ATP1AL2		ATPase, Na+/K+ transporting, alpha-4 polypeptide	607321	REc			1(Atp1a4)
1.1025	3	15	11	1p11.2	C1orf152, COAS3		Chromosome 1 open reading frame 152	608609	REc			
1.1026	11	11	14	1q21.1	CD160, BY55		CD160 antigen	604463	REc			
1.1027	12	17	08	1q21.1	DEL1q21, C1DELq21		Chromosome 1q21.1 deletion syndrome	612474	Ch	contiguous gene deletion syndrome	Chromosome 1q21.1 deletion syndrome (4)	
1.1028	12	17	08	1q21.1	DUP1q21, C1DUPq21		Chromosome 1q21.1 duplication syndrome	612475	Ch	contiguous gene duplication syndrome	Chromosome 1q21.1 duplication syndrome (4)	
1.1029	3	9	00	1q21.1	FMO5		Flavin-containing monooxygenase 5	603957	Psh, REc, A			
1.1030	5	3	13	1q21.2	GJA8, CX50, CTRCT1, CZP1, CAE1		Gap junction membrane channel protein alpha-8 (connexin 50)	600897	A, F		Cataract 1, multiple types, 116200 (3)	3(Gja8)
1.1031	7	16	09	1q21.1	GPR89A		G protein-coupled receptor 89A	612821	REc			
1.1032	7	16	09	1q21.2	GPR89B, GPHR		G protein-coupled receptor 89B	612806	REc			
1.1033	3	12	07	1q21.1	HYDIN2, KIAA1864		Hydin, mouse, homolog of, 2	610813	R, REc	duplicated copy 16q22.2		
1.1034	5	25	13	1q21.1	ITGA10		Integrin, alpha-10	604042	REc			
1.1035	9	22	09	1q21.1	NBLST6		Neuroblastoma, susceptibility to, 6	613017	Ch	?contiguous gene deletion or duplication disease	{Neuroblastoma, susceptibility to, 6} (2)	
1.1036	9	21	11	1q21.1	NBPF10		Neuroblastoma breakpoint family, member 10	614000	REc			
1.1037	9	21	11	1q21.2	NBPF11		Neuroblastoma breakpoint family, member 11	614001	REc, A			
1.1038	9	21	11	1q21.1	NBPF12, COAS1, KIAA1245		Neuroblastoma breakpoint family, member 12	608607	REc, A			
1.1039	9	21	11	1p11.2	NBPF8		Neuroblastoma breakpoint family, member 8	613998	REc, A			
1.1040	9	21	11	1q21.2	NBPF9		Neuroblastoma breakpoint family, member 9	613999	REc, A			
1.1041	9	21	11	1q21.2	NBPF14		Neuroblastoma breakpoint, member 14	614003	REc, A			
1.1042	2	5	07	1q21.1	NBPF15, MGC8902		Neuroblastoma breakpoint family, member 15	610414	REc, A	contains 6 copies of DUF1220 domain		
1.1043	9	21	11	1q21.1	NBPF16		Neuroblastoma breakpoint family, member 16	614005	REc, A			
1.1044	9	21	11	1q21.2	NBPF19		Neuroblastoma breakpoint family, member 19	614006	REc			
1.1045	9	21	11	1q21.1	NBPF20		Neuroblastoma breakpoint family, member 20	614007	REc			
1.1046	6	24	15	1q21.1	NBPF17P, NBPF23		Neuroblastoma breakpoint family, member 17, pseudogene	612970	REc			
1.1047	6	22	18	1q21.1	NOTCH2NLA		NOTCH2 N-terminal-like protein A	618023	REc			
1.1048	7	18	18	1q21.2	NOTCH2NLB		NOTCH2 N-terminal-like protein B	618024	REc			
1.1049	6	22	18	1q21.2	NOTCH2NLC		NOTCH2 N-terminal-like protein C	618025	REc			
1.1050	1	20	99	1q23.2	PEA15, HMAT1, PED		Phosphoprotein enriched in astrocytes, 15kD	603434	R, A			
1.1051	1	20	17	1q21.1	PEX11B, PEX14B		Peroxisome biogenesis 11B	603867	REc	mutation identified in 1 PEX14B patient	?Peroxisome biogenesis disorder 14B, 614920 (3)	
1.1052	3	15	11	1q21.2	PDE4DIP, MMGL, KIAA0454, KIAA0477		Phosphodiesterase 4D-interacting protein	608117	R, REc, A			
1.1053	4	26	17	1q21.1	POLR3C, RPC62, RPC3		Polymerase III, RNA, subunit C	617454	REc			
1.1054	4	27	17	1q21.1	POLR3GL		Polymerase III, RNA, subunit G-like	617457	REc			
1.1055	3	15	11	1q21.1	PPIAL4A, COAS2		Peptidylprolyl isomerase A (cyclophilin A)-like 4A	608608	REc			
1.1056	11	11	14	1q21.1	PRKAB2		Protein kinase, AMP-activated, noncatalytic, beta-2	602741	REc			
1.1057	7	18	12	1q21.1	SRGAP2B		SLIT-ROBO Rho GTPase-activating protein 2B	614703	REc			
1.1058	7	18	12	1q21.1	SRGAP2D		SLIT-ROBO Rho GTPase-activating protein 2D	614705	A			
1.1059	8	1	12	1q21.1	UAQTL6		Uric acid concentration, serum, quantitative trait locus 6	614747	Fd	associated with C/T variant at chr1_142697422	[Uric acid concentration, serum, QTL6] (2)	
1.1060	7	13	98	1q21.3	PIK4CB		Phosphatidylinositol 4-kinase, catalytic, beta polypeptide	602758	REa, A, R			
1.1061	10	23	02	1q21.3	RFX5		Regulatory factor X, 5 (influences HLA class II expression)	601863	A		Bare lymphocyte syndrome, type II, complementation group C, 209920 (3); Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	
1.1062	12	21	09	1q21.2	BOLA1		BolA, E. coli, homolog of, 1	613181	REc			
1.1063	6	22	14	1q21.2	CIART, CHRONO, GM129		Circadian-associated repressor of transcription	615782	REc			
1.1064	7	17	09	1q21.3	ENSA		Endosulfine, alpha	603061	REc			
1.1065	11	24	14	1q21.2	FALEC, FAL1		Focally amplified long noncoding RNA in epithelial cancer	616092	REc			
1.1066	3	9	16	1q21.1	FAM72C		Family with sequence similarity 72, member C	616853	REc			
1.1067	4	16	14	1q21.2	GJA5, CX40, ATFB11		Gap junction protein, alpha-5, 40kD (connexin 40)	121013	REa, A, REc		Atrial fibrillation, familial, 11, 614049 (3); Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	3(Gja5)
1.1068	9	2	08	1q21.3	GOLPH3L, GPP34R		Golgi phosphoprotein 3-like	612208	R, REc			
1.1069	5	15	15	1q21.2	PRPF3, HPRP3, RP18		Precursor mRNA-processing factor 3, S. cerevisiae, homolog of	607301	Fd, A		Retinitis pigmentosa 18, 601414 (3)	
1.1070	9	25	18	1q22	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS		Lamin A/C	150330	A, Fd, R		Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, type 2, 151660 (3); Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); Restrictive dermopathy, lethal, 275210 (3); Heart-hand syndrome, Slovenian type, 610140 (3); Malouf syndrome, 212112 (3)	3(Lmna)
1.1071	1	23	08	1q21.2	OTUD7B, CEZANNE		OTU domain-containing protein 7B	611748	R, REc			
1.1072	6	2	15	1q21.2	PLEKHO1, CKIP1		Pleckstrin homology domain-containing protein, family O, member 1	608335	R, REc			
1.1073	6	5	12	1q21.2	SF3B4, SF3B49, SAP49, AFD1		Splicing factor 3B, subunit 4	605593	R, REc		Acrofacial dysostosis 1, Nager type, 154400 (3)	
1.1074	5	21	07	1q22	SMG5, EST1B, KIAA1089		SMG5, C. elegans, homolog of	610962	R, REc			
1.1075	6	22	12	1q21.2	SV2A, SV2		Synaptic vesicle glycoprotein 2A	185860	REc, R			
1.1076	8	5	14	1q21.2	TARS2, COXPD21		Threonyl-tRNA synthetase 2	612805	REc	mutation identified in one COXPD21 family	?Combined oxidative phosphorylation deficiency 21, 615918 (3)	
1.1077	2	26	16	1q21.3	ZNF687, KIAA1441, PDB6		Zinc finger protein 687	610568	REc, Ch	fused with AML1 in t(1;21)	Paget disease of bone 6, 616833 (3)	
1.1078	11	4	04	1q23.3	F11R, JAM1		F11 receptor (junctional adhesion molecule 1)	605721	REc			
1.1079	5	27	05	1q21.2	FCGR1A, IGFR1, CD64		Fc fragment of IgG, high affinity Ia, receptor for (CD64)	146760	REa, H, A		[IgG receptor I, phagocytic, familial deficiency of] (3)	3(Fcgr1)
1.1080	8	9	99	1p12	SEC22L1, SEC22B		Secretion deficient 22, S. Cerevisiae, homolog-like 1	604029	R			
1.1081	6	30	08	1q21.3	TNFAIP8L2, TIPE2		Tumor necrosis factor-alpha-induced protein 8-like 2	612112	REc, H			3(Tnfaip8l2)
1.1082	6	28	17	1q23.2	CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3		Cell adhesion molecule 3	609743	A, H			1(Igsf4b)
1.1083	12	21	09	1q23.1	FCRL1, FCRH1		Fc receptor-like protein 1	606508	REc			
1.1084	11	27	01	1q23.1	FCRH3		Fc receptor-like protein 3	606510	REc			
1.1085	11	27	01	1q23.1	SPAP1, SPAP1A, SPAP1B, SPAP1C		SH2 domain-containing phosphatase anchor protein 1	606509	REc			
1.1086	1	30	01	1q21.3	ADAM15, MDC15		A disintegrin and metalloproteinase domain 15	605548	A			
1.1087	1	14	13	1q21.3	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6		Adenosine deaminase, RNA-specific	146920	A, REc, REa		Dyschromatosis symmetrica hereditaria, 127400 (3); Aicardi-Goutieres syndrome 6, 615010 (3)	3(Adar)
1.1088	9	27	17	1q21.3	AQP10		Aquaporin 10	606578	REc			
1.1089	9	22	08	1q21.3	ATP8B2, ATPID		ATPase, class I, type 8B, member 2	605867	REc			
1.1090	7	20	12	1q21.3	BNIPL, BNIPS, BNIPL1, BNIPL2		BCL2/adenovirus E1B 19kD protein-interacting protein 2-like	611275	R, REc			
1.1091	4	20	17	1q21.3	C1orf43, NS5ATP4, NICE3		Chromosome 1 open reading frame 43	617428	REc			
1.1092	4	19	12	1q21.3	CERS2, LASS2		Ceramide synthase 2	606920	R			
1.1093	9	2	11	1q21.3	CHTOP, C10orf77, SRAG, FOP		Chromatin target of PRMT1	614206	REc			
1.1094	1	13	11	1q21.3	CKS1B, CKS1		CDC28 protein kinase 1B	116900	REc	previously to 8q21 by FISH		
1.1095	8	4	97	1q23.1	CRABP2, RBP6		Cellular retinoic acid-binding protein-2	180231	A, REc			
1.1096	6	20	07	1q21.3	CREB3L4, CREB4, AIBZIP		cAMP responsive element binding protein 3-like 4	607138	REc, A			
1.1097	4	20	17	1q21.3	CRCT1, NICE1, C1orf42		Cysteine-rich c-terminal 1	617426	REc			
1.1098	10	27	08	1q21.3	CRTC2, TORC2		CREB-regulated transcription coactivator 2	608972	R, REc			
1.1099	7	1	16	1q21.3	FLAD1, FADS, LSMFLAD		Flavin adenine dinucleotide synthetase, S. cerevisiae, homolog of	610595	REc		Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	
1.1100	08	10	18	1q21.3	FLG2, IFPS, PSS6		Filaggrin family, member 2	616284	REc		Peeling skin syndrome 6, 618084 (3)	
1.1101	6	7	11	1q21.3	HAX1, SCN3		HCLS1-associated protein X1	605998	R, REc		Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	
1.1102	1	18	06	1q21.3	HORMAD1, NOHMA		HORMA domain-containing 1	609824	REc, H			3(Nohma)
1.1103	2	16	10	1q21.3	HRM2		Hair morphology 2 (curly hair)	139450	Fd	associated with rs11803731	Hair, curly (2)	
1.1104	4	10	15	1q21.3	HRNR		Hornerin	616293	REc, H			3(Hrnr)
1.1105	8	1	12	1q21.3	IL6R, IL6RQ, IL6Q		Interleukin-6 receptor	147880	REa, A	IL6R-like gene on chr.9	[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3); [Interleukin 6, serum level of, QTL], 614752 (3)	
1.1106	3	23	14	1q21.3	INTS3, INT3, SOSSA		Integrator complex subunit 3	611347	REc			
1.1107	9	10	03	1q21.3	KCNN3, SK3, SKCA3		Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3	602983	A, Psh, R			
1.1108	9	16	12	1q21.3	LINGO4, LRRN6D		Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 4	609794	REc			
1.1109	5	25	13	1q21.3	OAZ3, AZ3		Ornithine decarboxylase antizyme 3	605138	REc			
1.1110	11	13	15	1q21.3	PMVK, PMK, POROK1		Phosphomevalonate kinase	607622	Psh, REc		Porokeratosis 1, multiple types, 175800 (3)	
1.1111	1	13	16	1q21.3	POGZ, KIAA0461, MRD37, WHSUS		POGO transposable element with ZNF domain	614787	REc		White-Sutton syndrome, 616364 (3)	
1.1112	5	25	17	1q21.3	PRUNE1, DRES17, NMIHBA		Prune exopolyphosphatase 1	617413	A		Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3)	
1.1113	7	27	09	1q21.3	PYGO2		Pygopus, Drosophila, homolog of, 2	606903	R, REc			
1.1114	2	1	11	1q21.3	RAB13		RAB13, member RAS oncogene family	602672	REc	previously assigned to 12q13 by in situ hybridization		
1.1115	7	2	02	1q22	RHBG		Rhesus blood group, B glycoprotein	607079	A, H			3(Rhbg)
1.1116	7	18	12	1q21.2	RPRD2		Regulation of nuclear pre-mRNA domain-containing 2	614695	REc			
1.1117	10	2	12	1q21.3	PSMD4, S5A, RPN10		Proteasome 26S subunit, non-ATPase, 4	601648	REc			3(Psmd4)
1.1118	4	20	17	1q21.3	S100A7A, S100A15, NICE2		S100 calcium-binding protein A7A	617427	REc			
1.1119	8	19	09	1q21.3	SCNM1, MGC3180		Sodium channel modifier 1	608095	REc			
1.1120	4	21	15	1q21.3	SEMA6C, KIAA1869		Semaphorin 6C	609294	REc			16(Sema6c)
1.1121	2	25	15	1q21.3	SHE		SH2 domain-containing protein E	610482	R, REc			
1.1122	7	27	09	1q21.3	SLC27A3, FATP3		Solute carrier family 27 (fatty acid transporter), member 3	604193	R, REc			
1.1123	8	21	08	1q21.3	SNX27, MRT1		Sorting nexin 27	611541	R, REc			
1.1124	8	2	17	1q21.3	SPRR2D		Small proline-rich protein 2D	617587	REc, REn			
1.1125	8	2	17	1q21.3	SPRR2E		Small proline-rich protein 2E	617588	REc, REn			
1.1126	7	27	17	1q21.3	SPRR2F		Small proline-rich protein 2F	617589	REc			
1.1127	7	27	17	1q21.3	SPRR2G		Small proline-rich protein 2G	617590	REc			
1.1128	12	23	16	1q21.3	TCHH, THH, THL, TRHY, UHS3		Trichohyalin	190370	A, RE	mutation identified in 1 UHS3 patient	?Uncombable hair syndrome 3, 617252 (3)	
1.1129	3	7	14	1q21.3	THEM5, ACOT15		Thioesterase superfamily member 5	615653	REc, H, REn			3(Them5)
1.1130	7	20	15	1q21.3	UBAP2L, NICE4		Ubiquitin-associated protein 2-like	616472	REc			
1.1131	4	20	17	1q21.3	UBE2Q1, GTAP, NICE5		Ubiquitin-conjugating enzyme E2Q family member 1	617429	REc			
1.1132	9	20	14	1q21.3	ZBTB7B, ZFP67, CKROX, THPOK		Zinc finger- and BTB domain-containing protein 7B	607646	REc			
1.1133	3	21	93	1q23.3	CD48, BCM1, BLAST1		CD48 antigen (B-cell membrane protein)	109530	REa, A, REn			1(Bcm1)
1.1134	4	27	09	1q23.3	ITLN1, INTL, LFR, HL1		Intelectin 1	609873	Psh, A, REc			
1.1135	4	27	09	1q23.3	ITLN2, HL2		Intelectin 2	609874	Psh, A			
1.1136	9	11	95	1q23.3	LY9		T-lymphocyte surface antigen Ly-9	600684	REn	within 410kb of CD48		1(Ly9)
1.1137	10	4	05	1q21.2	ANP32E, LANPL		Acidic leucine-rich nuclear phosphoprotein 32 family, member E	609611	REc			
1.1138	12	6	17	1q22	ASH1L, KIAA1420, ASH1, MRD52		ash1 (absent, small, or homeotic), Drosophila, homolog of	607999	REc		Mental retardation, autosomal dominant 52, 617796 (3)	
1.1139	3	3	95	1q23.1	IFI16		Interferon, gamma-inducible protein 16	147586	REa, A			
1.1140	3	8	00	1q23.1-q23.2	AIM2		Absent in melanoma 2	604578	A			
1.1141	2	12	09	1q23.3	CD244, NAIL, NKR2B4, SLAMF4		CD244 antigen	605554	REc		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.1142	7	6	07	1q23.3	FCGR2B, CD32		Fc fragment of IgG, low affinity IIb, receptor for	604590	REc		{Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Malaria, resistance to}, 611162 (3)	
1.1143	11	13	15	1q22	FDPS, FPS, POROK9		Farnesyl diphosphate synthase	134629	R, REc		Porokeratosis 9, multiple types, 616631 (3)	
1.1144	8	19	13	1q22	GON4L, KIAA1606		GON4-like protein	610393	REc			
1.1145	3	24	06	1q22	HCN3, KIAA1535		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 3	609973	R, REc			
1.1146	12	4	02	1q21.3	LENEP, LEP503		Lens epithelial protein	607377	A			
1.1147	7	15	13	1q22	LAMTOR2, MAPBPIP, p14		Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	610389	R, REc		Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	
1.1148	8	20	07	1q22	MEX3A		Mex-3, C. elegans, homolog of, A	611007	REc			
1.1149	3	23	09	1q22	MIR9-1, MIRN9-1		Micro RNA 9-1	611186	REc			
1.1150	3	3	95	1q23.1	MNDA		Myeloid cell nuclear differentiation antigen	159553	REa, REn			
1.1151	7	25	12	1q23.3	MPZ, CMT1B, CMTDID, CHM, DSS		Myelin protein zero	159440	REb, A, F, Fd, D		Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome, 180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	1(Mpp)
1.1152	9	22	17	1q22	MSTO1, MMYAT		Misato 1, mitochondrial distribution and morphology regulator	617619	REc		Myopathy, mitochondrial, and ataxia, 617675 (3)	
1.1153	7	12	94	1q23.2	NHLH1, HEN1		Nescient helix loop helix 1	162360	H, REa, A	closely linked to Sap in mouse		1(Nscl)
1.1154	4	19	12	1q22	PAQR6		Progestin and ADIPOQ receptor family, member 6	614579	REc			
1.1155	9	12	96	1q23.3	PPOX		Protoporphyrinogen oxidase	600923	A		Porphyria variegata, 176200 (3)	
1.1156	10	25	12	1q23.2	PEX19, PXF, HK33, D1S2223E, PBD12A		Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein)	600279	REa, A		Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	
1.1157	7	29	09	1q22	RAB25, RAB11C		Ras-associated protein RAB25	612942	R, REc			
1.1158	8	7	13	1q22	RIT1, RIT, ROC1, NS8		Ric-like protein without CAAX motif 1	609591	REc		Noonan syndrome 8, 615355 (3)	3(Rit)
1.1159	1	26	17	1q22	RUSC1, NESCA		RUN domain- and SH3 domain-containing protein 1	617318	R, REC			
1.1160	5	30	17	1q22	RXFP4, RLN3R2, GPR100, GPCR142		Relaxin/insulin-like family peptide receptor 4	609043	REc			3(Gpr100)
1.1161	11	30	06	1q22	SEMA4A, SEMB, RP35, CORD10		Semaphorin 4A	607292	REc		Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283 (3)	
1.1162	9	2	08	1q23.3	SH2D1B, EAT2		SH2 domain-containing 1B	608510	A			
1.1163	3	12	07	1q22	SLC25A44		Solute carrier family 25, member 44	610824	REc			3(Slc25a44)
1.1164	1	21	11	1q22	SLC50A1, RAG1AP1		Solute carrier family 50 (sugar transporter), member 1	613683	REc			
1.1165	4	17	13	1q21.3	SNAPIN, SNAPAP, BLOC1S7, BLOS7		SNAP-associated protein	607007	R, REc			
1.1166	7	16	02	1q23.3	USP21, USP23		Ubiquitin-specific protease 21	604729	R			
1.1167	2	15	17	1q22	YY1AP1, YAP, HCCA2, GRNG		YY1 associated protein 1	607860	REc		Grange syndrome, 602531 (3)	
1.1168	6	23	98	1q24.1	ALDH9A1, ALDH9, E3		Aldehyde dehydrogenase 9 family, member A1	602733	A, REa			
1.1169	8	13	15	1q23.3	ATF6, ACHM7		Activating transcription factor-6	605537	REc		Achromatopsia 7, 616517 (3)	
1.1170	8	5	14	1q24.2	CD247, CD3Z, TCRZ, IMD25		CD247 antigen	186780	REa, A, REn	mutation identified in one IMD25 patient	?Immunodeficiency 25, 610163 (3)	1(T3z, Cd3z)
1.1171	3	17	06	1q23.2	IGSF9, KIAA1355		Immunoglobulin superfamily, member 9	609738	REc, REn, H			1(Igsf9)
1.1172	8	17	98	1q23.3	LMX1A, LMX1		LIM homeo box transcription factor-1, alpha	600298	A			
1.1173	2	8	11	1q23.2	NCSTN		Nicastrin	605254	REn		Acne inversa, familial, 1, 142690 (3)	
1.1174	5	9	95	1q24.2	OTF1, OCT1		Octamer-binding transcription factor-1	164175	REa, REn, A			1(Otf1)
1.1175	5	2	94	1q23.3	RXRG		Retinoid X receptor, gamma	180247	H, A			1(Rxrg)
1.1176	8	24	04	1q23.3	SLAMF1, SLAM, CDW150, CD150		SLAM family, member 1	603492	REc			
1.1177	8	2	13	1q21.3	TPM3, NEM1, CFTD, CAPM1		Tropomyosin 3	191030	REa, A	TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3); CAP myopathy 1, 609284 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	1(Tpm3)
1.1178	7	11	17	1q23.3	USF1, HYPLIP1		Upstream transcription factor 1	191523	REa, A, Fd		{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	1(Usf1)
1.1179	7	1	05	1q24.1	UCK2, TSA903		Uridine/cytidine kinase 2	609329	REc			
1.1180	3	22	06	1q23.2	CCDC19, NESG1		Coiled-coil domain-containing 19	605152	REc			
1.1181	4	19	01	1q21.3	PIP5K1A		Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha	603275	A			
1.1182	2	2	07	1q24.2	ATP1B1		ATPase, Na+K+ transporting, beta-1 polypeptide	182330	REa, A, REn		[Blood pressure regulation QTL], 145500 (2)	1(Atp1b1)
1.1183	8	9	99	1q23.3	B4GALT3		Beta-1,4-galactosyltransferase 3	604014	A			
1.1184	6	8	01	1q23	BDET		Bleeding disorder, east Texas type	605913	Fd		Bleeding disorder, east Texas type (2)	
1.1185	1	23	90	1q23	D1S61, D1S111, MS336		Minisatellite 33.6	157560	REa, A			
1.1186	7	13	99	1q22	CCT3, TRIC5		Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5)	600114	A			3(Tric5)
1.1187	5	4	12	1q24.2	F5, THPH2, RPRGL1		Coagulation factor V (proaccelerin, labile factor)	612309	REa, A, Fd, REn	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	1(Cf5)
1.1188	11	11	14	1q24.3	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B		Fas ligand (TNF superfamily, member 6)	134638	A		Autoimmune lymphoproliferative syndrome, type IB, 601859 (3); {Lung cancer, susceptibility to}, 211980 (3)	1(Fas1)
1.1189	7	10	91	1q23.2	FCER1A		Fc IgE receptor, alpha polypeptide	147140	REa, A			1(Fcer1a)
1.1190	8	11	91	1q23.3	FCER1G		Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide	147139	H, A	probably on 1q close to CD32		1(Fcer1a)
1.1191	7	31	08	1q23.3	FCGR2C, CD32C		Fc fragment of IgG, low affinity IIc, receptor for	612169	REc		Thrombocytopenic purpura, autoimmune, 188030 (1)	
1.1192	3	25	14	1q23.3	FCGR3A, CD16, IGFR3, IMD20		Fc fragment of IgG, low affinity III, receptor for (CD16)	146740	REb, REn	FCGR2A and FCGR3A within 250kb antigen	Immunodeficiency 20, 615707 (3)	
1.1193	8	3	12	1q23.3	FCGR3B		Fc fragment of IgG, low affinity IIIb, receptor for	610665	REc		Neutropenia, alloimmune neonatal (3)	
1.1194	7	12	02	1q23.3	FREB		Fc receptor homolog expressed in B cells	606891	REc			
1.1195	3	8	00	1q24.1	MGST3		Glutatione S-transferase, microsomal, 3	604564	A			
1.1196	2	2	07	1q23.3	RGS5		Regulator of G protein signaling-5	603276	Psh, R		[Blood pressure regulation QTL], 145500 (2)	
1.1197	8	25	04	1q23.3	NDUFS2		NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kD	602985	REc, A		Mitochondrial complex I deficiency, 252010 (3)	
1.1198	2	6	08	1q23.3	NUF2, NUF2R, CDCA1		NUF2, S. cerevisiae, homolog of	611772	R			
1.1199	8	28	17	1q23.3	PBX1, CAKUHED		Pre-B cell leukemia transcription factor-1	176310	Ch, A	pseudogene PBXP1 on chr.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3)	1(Pbx)
1.1200	6	15	99	1q25.1	TNFSF18, AITRL, GITRL		Tumor necrosis factor ligand superfamily, member 18	603898	R			
1.1201	8	30	02	1q24.2	XCL1, SCYC1, SCM1, LTN, LPTN		Chemokine, C motif, ligand 1 (lymphotactin)	600250	H, REa, A			1(Lptn)
1.1202	8	30	02	1q24.2	XCL2, SCYC2, SCM1B		Chemokine, C motif, ligand 2	604828	A			
1.1203	2	4	02	1q23.3	SLAMF7, CRACC, CS1		SLAM family, member 7	606625	REc			
1.1204	4	17	01	1q24.2	TBX19		T-box 19	604614	R		Adrenocorticotropic hormone deficiency, 201400 (3)	
1.1205	7	1	15	1q23.2	COPA, AILJK		Coatomer protein complex, subunit alpha	601924	A		{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	
1.1206	4	30	93	1q24.3	FMO1		Flavin-containing monooxygenase 1, fetal liver	136130	Psh, A			
1.1207	6	4	08	1q24.3	FMO2		Flavin-containing monooxygenase 2, pulmonary	603955	Psh, REc	probably cluster of FMO genes at 1q23-q25		
1.1208	10	26	97	1q24.3	FMO3, TMAU		Flavin-containing monooxygenase 3	136132	Psh		Trimethylaminuria, 602079 (3)	
1.1209	6	4	08	1q24.3	FMO4		Flavin-containing monooxygenase 2, adult liver	136131	REc			
1.1210	4	23	08	1q25.1	MRPS14		Mitochondrial ribosomal protein S14	611978	R, REc			
1.1211	12	22	17	1q24.3	PIGC, GPI2, GPIBD16, MRT62		Phosphatidylinositol glycan, class C	601730	REc, A		Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3)	
1.1212	3	20	18	1q24.2	SELE, ELAM1		Selectin E (endothelial leukocyte adhesion molecule-1)	131210	REn			1(Elam)
1.1213	7	14	11	1q24.2	SELL, LYAM1, LAM1, LNHR		Selectin L (lymphocyte adhesion molecule 1)	153240	A, REn			1(Lnhr)
1.1214	7	31	17	1q24.2	SELP, GRMP		Selectin P (granulocyte membrane protein, 140kD; antigen CD62)	173610	REn, A	in same 300kb segment as LYAM1, ELAM1		1(Grmp)
1.1215	3	1	12	1q25.1	SERPINC1, AT3, AT3D, THPH7		Antithrombin III	107300	F, D, A, REa, Fd	~17cM distal to FY	Thrombophilia due to antithrombin III deficiency, 613118 (3)	1(At3)
1.1216	12	22	16	1q23.1	BCAN		Brevican	600347	REc			
1.1217	2	22	13	1q21.3	GATAD2B, KIAA1150, p68, MRD18		GATA zinc finger domain-containing protein 2B	614998	REc		Mental retardation, autosomal dominant 18, 615074 (3)	
1.1218	1	30	02	1q23.2	IGSF8, PGRL, CD81P3		Immunoglobulin superfamily, member 8	606644	REc, R			
1.1219	4	15	08	1q23.1	ISG20L2		Interferon-stimulated exonuclease gene 20-kD-like 2	611930	REc			
1.1220	6	13	12	1q23.1	KIRREL, NEPH1		Kin of IRRE-like	607428	REc			
1.1221	8	18	04	1q23.3	KIS		Kinase-interacting stathmin	608849	R			
1.1222	11	11	14	1q23.1	NES		Nestin	600915	REc			
1.1223	12	10	13	1q23.3	NR1I3, CAR, MB67		Nuclear receptor subfamily 1, group I, member 3	603881	REc			
1.1224	8	3	12	1q23.1	PEAR1		Platelet endothelial aggregation receptor 1	610278	REc, R			
1.1225	8	24	04	1q23.2-q23.3	SLAMF6, NTBA		SLAM family, member 6	606446	R, REc			
1.1226	11	19	13	1q22	TMEM79, MATT		Transmembrane protein 79	615531	REc, H			3(Tmem79)
1.1227	3	27	17	1q23.2	ACKR1, DARC, FY, GPD, WBCQ1		Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines)	613665	F, Fc, Fd, A	by A, 1q22-q23	[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection against}, 611162 (3); [White blood cell count QTL], 611862 (3)	1(Fy, Darc)
1.1228	7	18	14	1q23.2	DCAF8, WDR42A, GAN2		DDB1- and CUL4-associated factor 8	615820	REc	mutation identified in 1 GAN2 family	?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	
1.1229	7	7	14	1q23.2	KCNJ9, GIRK3		Potassium inwardly-rectifying channel, subfamily J, member 9	600932	A			
1.1230	9	1	11	1q23.2	KCNJ10, SESAME		Potassium inwardly-rectifying channel, subfamily J, member 10	602208	H, REc		SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic, 600791 (3)	1(Kcnj10)
1.1231	8	23	06	1q23.2	PIGM		Phosphatidylinositol glycan, class M	610273	R, REc		Glycosylphosphatidylinositol deficiency, 610293 (3)	
1.1232	2	23	08	1q24.2	TIPRL, TIP41, TIP		TIP41-like protein	611807	REc			
1.1233	10	3	11	1q23.3	ARHGAP30		RHO GTPase-activating protein 30	614264	REc			
1.1234	9	26	17	1q23.3	CD84, SLAMF5		CD84 antigen	604513	REc			
1.1235	12	3	14	1q23.3	CFAP126, FLTP		Cilia- and flagella-associated protein 126	616119	REc			
1.1236	1	11	07	1q23.3	DEDD, DEFT		Death effector domain-containing protein	606841	R, REc			
1.1237	12	6	16	1q23.3	FCRLB, FCRL2, FREB2, FCRY		Fc receptor-like protein B	609251	REc			
1.1238	12	5	03	1q25.1	GAS5		Growth arrest-specific 5	608280	REc			
1.1239	2	10	11	1q23.3	HSD17B7		17-beta-hydroxysteroid dehydrogenase VII	606756	REc			
1.1240	3	18	17	1q23.3	KLHDC9, KARCA1		Kelch domain-containing protein 9	617375	REc			
1.1241	6	28	17	1q23.3	NECTIN 4, PVRL4, PRR4, EDSS1		Nectin 4	609607	REc		Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	
1.1242	1	1	10	1q23.3	NOS1AP, CAPON, KIAA0464		Nitric oxide synthase 1 (neuronal) adaptor protein	605551	R, REc			
1.1243	9	9	10	1q23.3	PFDN2		Prefoldin 2	613466	REc			
1.1244	2	21	10	1q23.3	QTV		QT interval, variation in	610141	Fd	associated with rs12143842	[QT interval, variation in] (2)	
1.1245	5	5	09	1q23.3	RGS4		Regulator of G protein signaling 4	602516	REc			
1.1246	2	13	12	1q24.2	SLC19A2, THTR1, TRMA, THMD1		Solute carrier family 19 (thiamine transporter), member 2	603941	Fd, REc		Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	
1.1247	12	15	16	1q23.3	SPATA46		Spermatogenesis-associated protein 46	617257	REc			
1.1248	10	12	14	1q23.3	TSTD1, KAT		Thiosulfate sulfurtransferase (rhodanese)-like domain-containing protein 1	616041	REc			
1.1249	5	25	13	1q23.3	UAP1, SPAG2		ADP-N-acetylglucosamine pyrophosphorylase 1	602862	REc			
1.1250	08	07	18	1q23.3	UFC1, NEDSG		Ubiquitin-fold modifier-conjugating enzyme 1	610554	REc		Neurodevelopmental disorder with spasticity and poor growth, 618076 (3)	
1.1251	1	20	11	1p32.3	ZCCHC11, KIAA0191		Zinc finger CCHC domain-containing protein 11	613692	R, REc			
1.1252	4	9	15	1q24.2	ADCY10, SAC, HCA2		Adenylyl cyclase 10, soluble	605205	REc		{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	
1.1253	11	30	00	1q24	DFNM1		Deafness, nonsyndromic, modifier 1	605429	Fd		{Deafness, nonsyndromic, modifier 1} (2)	
1.1254	3	9	00	1q25.1	GPR52		G protein-coupled receptor 52	604106	REc			
1.1255	8	31	17	1q24.2	MPZL1, PZR		Myelin protein zero-like 1	604376	REc			
1.1256	9	9	10	1q24.2	NME7, MN23H7		Nonmetastatic cells 7, protein expressed in	613465	REc			
1.1257	7	28	11	1q24.2	PRRX1, PMX1, PHOX1, AGOTC		Paired-related homeobox gene 1	167420	H, Fd, A		Agnathia-otocephaly complex, 202650 (3)	1(Pmx)
1.1258	5	26	13	1q24.2	RCSD1, CAPZIP		RCSD domain-containing protein 1	610579	REc			
1.1259	3	2	98	1q25.1	TNR		Tenascin R (restrictin, janusin)	601995	A, R			4(Tnr)
1.1260	09	27	18	1q25.2	TOR1AIP1, LAP1, LAP1B, LGMD2Y		Torsin A-interacting protein 1	614512	REc	mutation identified in 1 MRRSDC family	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3)	
1.1261	3	29	12	1q25.2	TOR1AIP2, LULL1		Torsin A-interacting protein 2	614513	REc			
1.1262	9	19	13	1q25.2	QSOX1		Quiescin Q6 sulfhydryl oxidase 1	603120	A			
1.1263	2	4	92	1q25.2	ABL2, ABLL, ARG		Abelson murine leukemia viral (v-abl) oncogene homolog 2 (arg, Abelson-related gene)	164690	REa, A, Ch	fused with ETV6 in AML	Leukemia, acute myeloid, with eosinophilia (1)	1(Abll)
1.1264	8	10	05	1q25.3-q31.1	HMCN1, FBLN6, FIBL6, ARMD1		Hemicentin (fibulin 6)	608548	REc		{Macular degeneration, age-related, 1}, 603075 (3)	
1.1265	1	23	01	1q31.1	PRG4, CACP, MSF, SZP, HAPO		Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin)	604283	Fd, A		Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	1(Prg4)
1.1266	8	28	01	1q25.1	SIP		SIAH1-interacting protein	606186	REc			
1.1267	5	12	09	1q24.1	TADA1L, STAF42		Transcriptional adaptor 1-like	612763	REc			
1.1268	5	13	02	1q24.3	VAMP24		Vesicle-associated membrane protein 4	606909	R, REc			
1.1269	9	27	17	1q24.1	GPA33		Glycoprotein A33	602171	REc			
1.1270	8	10	18	1q24.1	ILDR2		Immunoglobulin-like domain-containing receptor 2	618081	REc			1(Ldlr2)
1.1271	5	6	13	1q24.1	LRRC52		Leucine-rich repeat-containing protein 52	615218	REc			
1.1272	9	10	09	1q24.1	MAEL		Maelstrom, Drosophila, homolog of	611368	REc			
1.1273	1	29	08	1q25.1-q25.2	RFWD2, COP1		Ring finger- and WD repeat domain-containing protein 2	608067	REc	pseudogenes on chr. 3, 9, 18		
1.1274	6	3	14	1q24.1	TMCO1, CFSMR		Transmembrane and coiled-coil domains protein 1	614123	REc		Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	
1.1275	7	24	12	1q24.2	BRP44, MPC2		Brain protein 44	614737	REc			
1.1276	7	19	18	1q24.2	CREG1		Cellular repressor of E1A-stimulated genes 1	618055	REc			
1.1277	3	27	12	1q24.2	DCAF6, IQWD1, NRIP		DDB1 and CUL4 associated factor 6	610494	R, REc			
1.1278	4	15	11	1q24.2	GORAB, SCYL1BP1, NTKLBP1, GO		Golgin, RAB6-interacting	607983	R, REc		Geroderma osteodysplasticum, 231070 (3)	
1.1279	9	24	08	1q24.2	GPR161		G protein-coupled receptor 161	612250	R, REc			
1.1280	7	17	09	1q24.2	KIFAP3, SMAP		Kinesin-associated protein 3	601836	R, REc			
1.1281	6	4	13	1q24.2	METTL18, C1orf156		Methyltransferase-like 18	615255	REc			
1.1282	4	6	15	1q24.2	SCYL3, PACE1		SCY1-like 3, S. cerevisiae, homolog of	608192	REc			
1.1283	1	17	08	1q25.2	C1orf76, NDSP		Neuroblastoma-derived secretory protein	611727	REc			
1.1284	7	18	12	1q24.3	DNM3, KIAA0820		Dynamin 3	611445	REc			
1.1285	10	10	18	1q24.3	EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M		EEF1A lysine and N-terminal methyltransferase	617987	REc	mutation identified in 1 family	?{Deafness, autosomal recessive 26, modifier of}, 605429 (3)	
1.1286	3	23	09	1q24.3	MIR199A2, MIRN199A2		Micro RNA 199A2	610720	REc			
1.1287	3	23	09	1q24.3	MIR214, MIRN214		Micro RNA 214	610721	REc			
1.1288	7	18	11	1q24.3	MIR3120		Micro RNA 3120	614722	REc	in intron 13 of DNM3 in sense orientation		
1.1289	3	18	17	1q24.3	PRRC2C, KIAA1096		Proline-rich coiled-coil protein 3C	617373	REc			
1.1290	10	24	12	1q24.3	MYOC, TIGR, GLC1A, JOAG, GPOA		Myocilin (trabecular meshwork-induced glucocorticoid response protein)	601652	REc, R, Fd, A		Glaucoma 1A, primary open angle, 137750 (3)	1(Tigr)
1.1291	8	30	07	1q25	AD14		Alzheimer disease 14	611154	Fd	max lod at D1S218	{Alzheimer disease-14} (2)	
1.1292	7	13	09	1q25.2	ASTN1, ASTN		Astrotactin 1	600904	A			1(Astn)
1.1293	4	6	18	1q25.3	TRMT1L, C1orf25, TRM1L		tRNA methyltransferase 1-like	611673	REc			
1.1294	4	30	09	1q25.3	DHX9, DDX9, NDHII		DEAH (Asp-Glu-Ala-His) box polypeptide 9	603115	H			1(Ddx9)
1.1295	8	21	07	1q25.2	FAM20B		Family with sequence similarity 20, member B	611063	R, REc			
1.1296	10	2	09	1q25.2	LHX4, CPHD4		LIM homeo box gene 4	602146	A, Ch	fused to IGH in ALL	Pituitary hormone deficiency, combined, 4, 262700 (3)	
1.1297	5	31	05	1q25.3	NCF2		Neutrophil cytosolic factor-2, 65kD	608515	REa, A		Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	1(Ncf2)
1.1298	9	7	07	1q25.3	NPL, C1orf13, C112		N-acetylneuraminate pyruvate lyase	611412	REc			
1.1299	09	06	18	1q31.1	ODR4, C1orf27		Odorant response abnormal 4, C. elegans, homolog of	609335	REc			
1.1300	5	3	07	1q25	PDON2		Periodontitis, aggressive, 2	608526	Fd	between D1S196 and D1S533	Periodontitis, aggressive, 2 (2)	
1.1301	12	24	08	1q31.1	PLA2G4A, PLA2G4		Phospholipase A2, group IVA, cytosolic	600522	A		Phospholipase A2, group IV A, deficiency of (3)	
1.1302	8	20	07	1q25.3	RGSL1		Regulator of G protein signaling-like 1	611012	REc			
1.1303	8	2	07	1q25	RGSL2		Regulator of G protein signaling-like 2	611013	REc	related to AD linked to 1q25		
1.1304	1	24	02	1q25.3	RNASEL, RNS4, PRCA1, HPC1		Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)	180435	A, Fd		Prostate cancer 1, 601518 (3)	
1.1305	5	21	07	1q25.3	SMG7, EST1C, KIAA0250		SMG7, C. elegans, homolog of	610964	R, REc			
1.1306	3	12	96	1q25.2	SOAT1, STAT, ACAT		Sterol O-acyltransferase 1 (acyl-Coenzyme A: cholesterol acyltransferase 1)	102642	A, REa			
1.1307	4	18	05	1q25.1	TNFSF4, GP34, OX4OL		Tumor necrosis factor ligand superfamily, member 4	603594	A, H		{Myocardial infarction, susceptibility to}, 608446 (3)	1(Tnfsf4)
1.1308	1	1	95	1q31.1	TPR		Tumor potentiating region (translocated promoter region)	189940	REa, A	fused with MET in chemically induced tumor		
1.1309	7	12	16	1q25.3	TSEN15, SEN15, C1orf19, PCH2F		tRNA splicing endonuclease 15, S. cerevisiae, homolog of	608756	REc		Pontocerebellar hypoplasia, type 2F, 617026 (3)	
1.1310	3	8	91	1q22	BGLAP		Bone gamma-carboxyglutamic acid protein	112260	REa, REb			3(Bglap)
1.1311	4	29	97	1q25.3	CACNA1E, CACNL1A6		Calcium channel, voltage-dependent, alpha 1E subunit	601013	A			
1.1312	2	8	17	1q31.2	CDC73, HRPT2, C1orf28		Cell division cycle protein 73, S. cerevisiae, homolog of	607393	Fd, REc		Hyperparathyroidism-jaw tumor syndrome, 145001 (3); Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)	
1.1313	2	21	02	1q25.3	LAMC2, LAMNB2, LAMB2T		Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)	150292	A, Fd		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
1.1314	10	25	10	1q25.2	PDCN, NPHS2, SRN1		Podocin	604766	REc, Fd	modifies phenotype of NPHS1 mutations to FSGS	Nephrotic syndrome, type 2, 600995 (3)	
1.1315	6	19	98	1q25.3	RGS16		Regulator of G protein signaling-16	602514	A			
1.1316	3	31	03	1q25.2	TOR3A, ADIR		Torsin family 3, member A (ATP-dependent interferon-responsive protein)	607555	REc			
1.1317	12	16	93	1q31.1	PDC		Phosducin, pineal gland	171490	H, REa, A			1(Pdc)
1.1318	7	10	92	1q32.1	ATP2B4, ATP2B2, PMCA4		ATPase, Ca++ transporting, plasma membrane, 4	108732	REa, A, Fd			
1.1319	10	8	07	1q25.1	CENPL		Centromeric protein L	611503	REc			
1.1320	6	14	07	1q25.1	DARS2, ASPRS. LBSL		Aspartyl-tRNA synthetase 2	610956	R, REc		Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	
1.1321	12	17	15	1q25.1	KIAA0040		KIAA0040 gene	616696	Psh, REc			
1.1322	9	21	17	1q25.1	KLHL20, KLEIP, KLHLX		Kelch-like 20	617679	REc			
1.1323	7	17	09	1q25.1	PRDX6		Peroxiredoxin 6	602316	REc			
1.1324	10	30	06	1q25.1	RC3H1, KIAA2025		Roquin	609424	REc			
1.1325	5	3	17	1q25.1	TNN		Tenascin N	617472	REc			
1.1326	6	9	15	1q25.3	XPR1, SYG1, IBGC6		Xenotropic and polytropic retrovirus receptor	605237	R		Basal ganglia calcification, idiopathic, 6, 616413 (3)	1(Xpr1)
1.1327	2	20	98	1q32.1	LAD1		Ladinin	602314	H			1(Lad1)
1.1328	2	15	18	1q25.2	CEP350, CAP350, KIAA0480		Centrosomal protein 350	617870	R, REc			
1.1329	12	22	17	1q25.2	RALGPS2, FLJ10244		RAL guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 2	617819	REc			
1.1330	8	3	12	1q25.2	RASAL2, NGAP		Ras protein activator-like 2	606136	REc			
1.1331	7	13	09	1q25.2	SEC16B, LZTR2, RGPR, SEC16S		Sec16, S. cerevisiae, homolog of, B	612855	REc			
1.1332	10	31	17	1q25.2	TDRD5, TUDOR3		Tudor domain-containing protein 5	617748	REc			
1.1333	5	13	15	1q25.2-q25.3	ACBD6		Acyl-CoA-binding domain-containing protein 6	616352	REc			
1.1334	12	27	13	1q25.2-q25.3	LINC-COX2		Long intergenic noncoding RNA COX2	615492	REn			
1.1335	1	1	95	1q31.1	PTGS2		Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	600262	REa, A			
1.1336	1	16	07	1q25.3	APOBEC4		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 4	609908	REc			
1.1337	11	11	14	1q25.3	ARPC5, ARC16		Actin-related protein 2/3 complex, subunit 5	604227	REc			
1.1338	7	17	09	1q25.3	IER5		Immediate-early response gene 5	607177	R, REc			
1.1339	5	26	13	1q25.3	IVNS1ABP, NS1BP, ND1		Influenza virus NS1A protein-binding protein	609209	REc, R			
1.1340	8	17	98	1q25.3	MR1, HLALS		Major histocompatibility complex, class I-related	600764	A			
1.1341	9	11	12	1q25.3	NMNAT2, PNAT2, KIAA0479		Nicotinamide nucleotide adenylyltransferase 2	608701	REc			
1.1342	7	27	09	1q25.3	RGL1, RGL		Ral guanine nucleotide dissociation stimulator-like 1	605667	R, REc			
1.1343	11	2	04	1q25.3	RNF2, RING2, RING1B, HIPI3, DING, BAP1		RING finger protein 2	608985	R, REc			
1.1344	8	1	16	1q25.3	STX6		Syntaxin 6	603944	REc			
1.1345	4	19	06	1q25.3	VDAC4		Voltage-dependent anion channel 4	610030	Psh, REc			
1.1346	7	31	08	1q31.3	ASPM, MCPH5		Abnormal spindle-like, microcephaly-associated	605481	Fd, REc		Microcephaly 5, primary, autosomal recessive, 608716 (3)	
1.1347	5	23	00	1q31.2	B3GALT2, GLCT2		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 2	603018	REc			
1.1348	12	13	00	1q31	BOS2		Branchiootic syndrome 2	120502	Fd		Branchiootic syndrome 2 (2)	
1.1349	5	12	09	1q31	CELIAC7		Celiac disease, susceptibility to, 7	612005	Fd	associated with rs2816316	{Celiac disease, susceptibility to, 7} (2)	
1.1350	1	24	93	1q32.1	CTSE		Cathepsin E	116890	REa, A, Fd	closely linked to REN		
1.1351	3	29	06	1q25.3	GLUL, GLNS		Glutamate-ammonia ligase (glutamine synthase)	138290	Psh, A, REc	pseudogene on chr.9	Glutamine deficiency, congenital, 610015 (3)	
1.1352	3	30	18	1q32.1	KIF14, KIAA0042, MKS12, MCPH20		Kinesin family member 14	611279	Psh, REc, H	mutation identified in 1 MKS12 family	?Meckel syndrome 12, 616258 (3); Microcephaly 20, primary, autosomal recessive, 617914 (3)	1(Kif14)
1.1353	10	29	96	1q31.2	RGS2, G0S8		G0 to G1 switch regulatory 8, 24kD	600861	A			
1.1354	10	15	09	1q25.3	LAMC1, LAMB2		Laminin, gamma-1 (formerly LAMB2)	150290	REa, Fd	at least 3 genes, ?linked		1(Lamb2)
1.1355	3	21	07	1q32.3	LQK1		LQK1 protein	610864	REc			
1.1356	1	24	03	1q31	MGR6, FHM3		Migraine, several forms	607516	Fd		{Migraine with or without aura, susceptibility to, 6} (2); {Migraine, familial hemiplegic, 4} (2)	
1.1357	2	6	08	1q32.1	NAV1, POMFIL3, KIAA1151		Neuron navigator 1	611628	R			
1.1358	8	17	98	1q32.1	PFKFB2		Fructose-2,6-bisphosphatase, cardiac isozyme	171835	REa, A			
1.1359	6	27	02	1q32.1	PHLDA3, TIH1		Pleckstrin homology-like domain, family A, member 3	607054	REc			1(Phlda3)
1.1360	10	15	09	1q31	PVOP1		Pelvic organ prolapse, susceptibility to, 1	176780	Fd	associated with rs10911193	{Pelvic organ prolapse, susceptibility to, 1} (2)	
1.1361	6	11	97	1q31.2	RGS1, IER1, IR20		Regulator of G-protein signaling 1	600323	A			
1.1362	6	23	15	1q32.1	UBE2T, HSPC150, FANCT		Ubiquitin-conjugating enzyme E2T	610538	R, REc		Fanconi anemia, complementation group T, 616435 (3)	
1.1363	3	8	07	1q31.2	TROVE2, RO60, SSA2		TROVE domain family, member 2	600063	A			
1.1364	4	17	13	1q32.1	CDK18, PCTK3		Cyclin-dependent kinase 18	169190	A			
1.1365	7	27	11	1q32.1	CHIT, CHITD		Chitotriosidase	600031	Fd, A		[Chitotriosidase deficiency], 614122 (3)	
1.1366	1	1	12	1q32.1	IL10, CSIF, GVHDS		Interleukin-10	124092	Psh, R		{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease, protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)	
1.1367	7	17	09	1q32.1	KIF21B, KIAA0449		Kinesin family member 21B	608322	R, REc			1(Kif21b)
1.1368	6	26	01	1q31.3	LHX9		LIM homeo box gene 9	606066	REc			1(Lhx9)
1.1369	7	22	09	1q31.3-q32.1	PTPRC, CD45, LCA		Protein tyrosine phosphatase, receptor type, c polypeptide	151460	A, S		{Hepatitis C virus, susceptibility to}, 609532 (3); Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	1(Ly5)
1.1370	3	8	07	1q32.1	SLC41A1		Solute carrier family 41, member 1	610801	REc			1(Slc41a1)
1.1371	7	22	09	1q31.3	CFHR1, FHR1, HFL1, CFHL1		Complement factor H-related 1	134371	R		{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1372	7	22	09	1q31.3	CFHR2, FHR2, HFL3, CFHL2		Complement factor H-related 2	600889	REc, R	in same 165kb YAC as F13B		
1.1373	7	22	09	1q31.3	CFHR3, FHR3, HLF4, CFHL3		Complement factor H-related 3	605336	R		{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1374	7	22	09	1q31.3	CFHR4, FHR4, CFHL4		Complement factor H-related 4	605337	R			
1.1375	3	28	11	1q31.3	CRB1, RP12, LCA8		Crumbs, Drosophila, homolog of, 1	604210	Fd, REc		Retinitis pigmentosa-12, autosomal recessive, 600105 (3); Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)	
1.1376	3	21	93	1q31.3	F13B		Coagulation factor XIII, B polypeptide	134580	Fd, A, RE		Factor XIIIB deficiency, 613235 (3)	1(F13b)
1.1377	12	3	90	1q32.1	MYOG, MYF4		Myogenic factor-4; myogenin	159980	REa, A			1(Myog)
1.1378	6	4	97	1q31-q42	PHA2A, PHA2		Pseudohypoaldosteronism type IIA	145260	Fd		Pseudohypoaldosteronism, type IIA (2)	
1.1379	7	14	11	1q32.1	PIGR		Polymeric immunoglobulin receptor	173880	REa, A, Fd			
1.1380	1	20	11	1q42.13	PSEN2, AD4, STM2, CMD1V		Presenilin 2	600759	Psh, REc, REn		Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697 (3)	
1.1381	8	31	17	1q31.1	PACERR, PTGS2AS1		PTGS2 antisense NFKB1 complex-mediated expression regulator RNA, noncoding	617650	REc			
1.1382	12	30	05	1q31.1	PSNP2		Supranuclear palsy, progressive, 2	609454	Fd	between D1S238 and D1S2823	Supranuclear palsy, progressive, 2 (2)	
1.1383	12	18	08	1q31.2	RGS21		Regulator of G protein signaling 21	612407	REc			1(Rgs1)
1.1384	7	25	18	1q31.3	ATP6V1G3		ATPase, H+ transporting, V1 subunit G3	618071	REc			
1.1385	4	4	02	1q31.2	GLRX2, GRX2		Glutaredoxin 2	606820	REc			
1.1386	3	15	10	1q31.3	DENND1B, FAM31B, C1orf18		DENN/MADD domain-containing 1B	613292	REc			
1.1387	12	21	10	1q32.3	FLVCR1, AXPC1, PCARP		Feline leukemia virus subgroup C receptor 1	609144	R		Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	
1.1388	4	25	06	1q31.3	KCNT2, SLICK, EIEE57		Potassium channel, subfamily T, member 2	610044	REc	mutation identified in 1 EIEE57 patient	?Epileptic encephalopathy, early infantile, 57, 617771 (3)	
1.1389	5	11	09	1q32.1	MIR181A1, MIR213, MIRN181A1		Micro RNA 181A1	612742	REc			
1.1390	5	11	09	1q32.1	MIR181B1, MIRN181B1		Micro RNA 181B1	612744	REc			
1.1391	4	15	02	1q31.3	NEK7		Never-in-mitosis gene A-related kinase 7	606848	Psh, R			
1.1392	7	5	90	1q32.1	TNNI1		Troponin-I, skeletal, slow	191042	REa, Psh			1(Tnni1)
1.1393	4	16	14	1q31.3-q32.1	NYS7		Nystagmus 7, congenital, autosomal dominant	614826	Fd	between D1S218 and D1S2655	Nystagmus 7, congenital, autosomal dominant (2)	
1.1394	8	17	98	1q32.1	AVPR1B, AVPR3		Arginine vasopressin receptor-1B	600264	A			
1.1395	5	9	97	1q32.1	BTG2, PC3		B-cell translocation gene 2 (pheochromocytoma cell-3)	601597	REa, A			
1.1396	7	9	90	1q32.2	C4BPA		Complement component 4-binding protein, alpha polypeptide	120830	F, REa, A, RE	same RE fragment as C4BPB		1(C4bp)
1.1397	7	9	90	1q32.1	C4BPB		Complement component 4-binding protein, beta polypeptide	120831	RE, A			
1.1398	4	22	10	1q32.1	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1		Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	H, REa, A, Fd	in mouse, mutation causes muscular dysgenesis	Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	1(Cchl1a3, mdg)
1.1399	3	11	92	1q32.2	CD34		CD34 antigen	142230	REa, A			1(Cd34)
1.1400	8	11	17	1q32.2	CD55, DAF, CROM, CHAPLE		CD55 antigen (blood group Cromer)	125240	REa, A		[Blood group Cromer], 613793 (3); Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3)	
1.1401	6	6	16	1q31.3	CFH, HF1, HUS, ARMD4, AHUS1		Complement factor H	134370	F, REa, RE, H, Fd		{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)	1(Cfh)
1.1402	12	21	12	1q31.3	CFHR5, CFHL5, FHR5, CFHR5D		Complement factor H-related 5	608593	A, R, REc		Nephropathy due to CFHR5 deficiency, 614809 (3)	
1.1403	7	6	07	1q32.2	CR1, C3BR		Complement component (3b/4b) receptor-1	120620	F, REa, A, RE		CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)	
1.1404	4	30	01	1q32.2	CR1L		Complement component receptor 1-like	605886	REc			
1.1405	7	6	12	1q32.2	CR2, C3DR, SLEB9, CVID7		Complement component (3d/Epstein-Barr virus) receptor-2	120650	F, REa, A, RE		{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3); Immunodeficiency, common variable, 7, 614699 (3)	1(Cr2)
1.1406	5	12	99	1q32.1	CSRP1, CSRP		Cysteine and glycine-rich protein-1	123876	REa, A			3(Csrp)
1.1407	3	20	09	1q32.1	CYB5BR1, NQO3A2, B5R.1		Cytochrome b5 reductase 1	608341	REc			
1.1408	11	13	98	1q32.1	ELF3, ESX		E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific)	602191	A			
1.1409	1	1	95	1q32.1	ELK4, SAP1		ELK4, ETS-domain protein (SRF accessory protein 1)	600246	A			1(Elk4)
1.1410	7	18	12	1q32.1	FAM72A, LMPIP, UGENE		Family with sequence similarity 72, member A	614710	REc			
1.1411	9	8	11	1q32	GFND1		Glomerulopathy with fibronectin deposits 1	137950	Fd	max lod at D1S2782	Glomerulopathy with fibronectin deposits 1 (2)	
1.1412	3	10	05	1q32.2	HHAT, MART2, SKI1		Hedgehog acyltransferase	605743	REc			
1.1413	2	28	01	1q32.1	IL19		Interleukin 19	605687	R			
1.1414	2	7	01	1q32.1	IL20		Interleukin 20	605619	R			1(Il20)
1.1415	6	27	01	1q32.1	IL24, ST16, MDA7		Interleukin 24 (suppression of tumorigenicity 16)	604136	R			
1.1416	09	11	18	1q32.1	KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65		Lysine-specific demethylase 5B	605393	A		Mental retardation, autosomal recessive 65, 618109 (3)	
1.1417	10	23	14	1q32.1	KISS1, HH13		KISS1 metastasis suppressor	603286	A, R	mutation identified in 1 HH13 family	?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	
1.1418	2	12	15	1q32.2	LAMB3, AI1A		Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310	Fd		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Amelogenesis imperfecta, type IA, 104530 (3)	
1.1419	2	4	02	1q32.1	LGR6		Leucine-rich repeat-containing G protein-coupled receptor-6	606653	A			
1.1420	11	11	14	1q32.1	LMOD1, SMLMOD, 1D		Leiomodin 1	602715	REc			
1.1421	8	17	09	1q32.2	MCP, CD46, AHUS2		Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)	120920	REa, A, REn		{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	
1.1422	6	19	98	1q32.1	MDM4		Mouse double minute 4, homolog of	602704	A			1(Mdm4)
1.1423	5	29	12	1q32.1	NUAK2, SNARK		NUAK family, SNF1-like kinase, 2	608131	A			
1.1424	2	2	10	1q32	PARK16		Parkinson disease 16	613164	Fd	associated with rs823128	{Parkinson disease 16} (2)	
1.1425	3	25	15	1q32	PFHB2		Progressive familial heart block, type II	140400	Fd	between D1S70 and D1S505	Progressive familial heart block, type II (2)	
1.1426	7	14	98	1q32.1	PIK3C2B		Phosphatidylinositol 3-kinase, class 2, beta polypeptide	602838	A			
1.1427	3	6	01	1q32.1	PKP1		Plakophilin-1	601975	Psh, A		Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	
1.1428	10	15	97	1q32.1	PRELP		Proline arginine-rich end leucine-rich repeat protein	601914	A			
1.1429	12	17	17	1q32-q41	PTPN14, PEZ, CATLPH		Protein tyrosine phosphatase, nonreceptor-type, 14	603155	A, REn, Fd	mutation identified in 1 CATLPH family	?Choanal atresia and lymphedema, 613611 (3)	
1.1430	3	9	00	1q32.1	RAB7L1		RAB7-like 1	603949	A			
1.1431	12	18	95	1q32.1	RBBP5, RBQ3		Retinoblastoma-binding protein-5	600697	Psh, A			
1.1432	11	3	09	1q32.1	REN, HNFJ2		Renin	179820	REa, A, D, Fd, Ch	~24cM distal to AT3	[Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3); Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	1(Ren1)
1.1433	2	14	13	1q32.1	SNRPE, HYPT11		Small nuclear ribonucleoprotein polypeptide E	128260	REa, A, F		Hypotrichosis 11, 615059 (3)	
1.1434	5	4	00	1q32.1	SOX13, ICA12		SRY-box 13	604748	A			
1.1435	7	6	00	1q32.1	TIMM17A, TIM17A		Translocase of inner mitochondrial membrane 17, yeast, homolog of, A	605057	A			
1.1436	7	26	10	1q32.1	TNNT2, CMH2, CMD1D, RCM3, LVNC6		Troponin-T2, cardiac	191045	REa, Fd, A		Cardiomyopathy, hypertrophic, 2, 115195 (3); Cardiomyopathy, dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)	
1.1437	2	18	98	1q32.3	TRAF5		TNF receptor-associated factor 5	602356	A			1(Traf5)
1.1438	12	21	06	1q31.2	UCHL5, UCH37		Ubiquitin carboxyl-terminal hydrolase L5	610667	REc			
1.1439	1	9	13	1q32.2	CAMK1G, CLICK3		Calcium/calmodulin-dependent protein kinase IG	614994	REc			
1.1440	3	15	16	1q41	CENPF, CILD31, STROMS		Centromere autoantigen F, 400kD	600236	A		Stromme syndrome, 243605 (3)	1(Cenpf)
1.1441	1	30	12	1q32.2	G0S2		G0/G1 switch gene 2	614447	REc			
1.1442	5	29	12	1q32.2	HSD11B1, HSD11, HSD11L, CORTRD2		Hydroxysteroid, 11-beta, dehydrogenase 1	600713	REa, REc	digenic triallelic mutations with H6PD	Cortisone reductase deficiency 2, 614662 (3)	
1.1443	12	21	12	1q32.2	IRF6, VWS, LPS, PIT, PPS1, OFC6		Interferon regulatory factor 6	607199	REc, Fd	OFC6 in enhancer 5' of IRF6	van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome 1, 119500 (3); {Orofacial cleft 6}, 608864 (3)	
1.1444	7	9	15	1q32.2	KCNH1, EAG, TMBTS, ZLS1		Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)	603305	Psh		Temple-Baraitser syndrome, 611816 (3); Zimmermann-Laband syndrome 1, 135500 (3)	
1.1445	1	20	99	1q32.1	RABIF, RASGFR3, MSS4		Rab-interacting factor (Ras-specific guanine-releasing factor-3; mammalian suppressor of SEC4)	603417	A			
1.1446	4	25	12	1q32.1	ADIPOR1, CGI45		Adiponectin receptor 1	607945	REc			1(Adipor1)
1.1447	5	18	95	1q32.1	ADORA1, RDC7		Adenosine A1 receptor	102775	A			
1.1448	10	23	15	1q32.1	ARL8A, GIE2		ADP-ribosylation factor-like 8A	616597	REc			
1.1449	11	1	13	1q32.1	BLACAT1, LINC00912		Bladder cancer-associated transcript 1, noncoding	615480	REc			
1.1450	12	30	14	1q32.1	C1orf186, RHEX		Chromosome 1 open reading frame 186	616088	REc			
1.1451	3	24	11	1q32.1	CAMSAP1L, CAMSAP2, KIAA1078		Calmodulin-regulated spectrin-associated protein 1-like 1	613775	REc			
1.1452	4	23	08	1q32.1	CHI3L1, GP39, YKL40, ASRT7		Chitinase 3-like 1 (cartilage glycoprotein-39)	601525	REa, REc		{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related traits, susceptibility to, 7}, 611960 (3)	
1.1453	9	9	13	1q32.1	CNTN2, TAX, TAX1, FAME5		Contactin 2 (transiently-expressed axonal glycoprotein)	190197	A	1 family identified with mutation	?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	
1.1454	11	11	13	1q32.1	DDX59, OFD5		DEAD box polypeptide 59	615464	REc		Orofaciodigital syndrome V, 174300 (3)	
1.1455	1	27	18	1q32.1	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23		Dual serine/threonine and tyrosine protein kinase	612666	R, REc, Fd		Congenital anomalies of kidney and urinary tract 1, 610805 (3); Spastic paraplegia 23, 270750 (3)	
1.1456	1	24	10	1q32.1	EIF2D, HCA56		Eukaryotic translation initiation factor 2D	613709	REc, H			1(Eif2d)
1.1457	3	20	06	1q32.1	ETNK2, EKI2		Ethanolamine kinase 2	609859	REc			1(Etnk2)
1.1458	1	1	95	1q32.1	FMOD		Fibromodulin	600245	Psh, A			
1.1459	2	20	98	1q32.1	GPR25		G protein-coupled receptor-25	602174	A			
1.1460	8	15	17	1q32.1	GPR37L1, ETBRLP2		G protein-coupled receptor 37-like 1	617630	REc			
1.1461	2	12	09	1q32.1	IBD23		Inflammatory bowel disease 23	612381	Fd	associated with rs3024505	{Inflammatory bowel disease 23} (2)	
1.1462	1	26	17	1q32.1	IGFN1, EEF1A2BP1		Immunoglobulin-like and fibronectin type III domains-containing protein 1	617309	REc			
1.1463	7	17	09	1q32.1	IKBKE		I-kappa-B kinase-epsilon	605048	R, REc			
1.1464	08	07	18	1q32.1	INAVA, C1orf106, IBD29		Innate immunity activator	618051	REc		{Inflammatory bowel disease 29}, 618077 (3)	
1.1465	3	29	12	1q32.1	KLHDC8A		Kelch domain-containing protein 8A	614503	REc			
1.1466	3	30	12	1q32.1	KLHL12, DKIR		Kelch-like 12	614522	REc			
1.1467	2	25	15	1q32.1	LEMD1		LEM domain-containing protein 1	610480	R, REc			
1.1468	09	06	18	1q32.1	LRRN2, GAC1, LRANK1		Leucine-rich repeat protein, neuronal, 2	605492	A			
1.1469	12	10	13	1q32.1	MAPKAPK2, MK2		Mitogen-activated protein kinase-activated protein kinase 2	602006	REc			
1.1470	7	22	16	1q32.1	MIR1231		Micro RNA 1231	617040	REc			
1.1471	11	4	93	1q32.1	MYBPH		Myosin-binding protein H	160795	A			
1.1472	4	10	14	1q32.1	NFASC, KIAA0756		Neurofascin	609145	REc, R			
1.1473	1	28	00	1q32.1	NR5A2, FTF, HB1F		Nuclear receptor subfamily 5, group A, member 2 (fetoprotein transcription factor)	604453	A			
1.1474	3	20	08	1q32.1	NUCKS1, NUCKS		Nuclear casein kinase and cyclin-dependent kinase substrate 1	611912	REc, H			1(Nucks1)
1.1475	7	27	09	1q32.1	PEPP3, KIAA0969		Phosphatidylinositol 3-phosphate-binding PH domain protein 3	607771	R, REc			
1.1476	9	22	16	1q32.1	PM20D1		Peptidase M20 domain-containing protein 1	617124	REc			
1.1477	8	20	01	1q32.1	PPP1R12B, MYPT2		Protein phosphatase 1, regulatory subunit 12B (myosin phosphatase target subunit 2)	603768	A			
1.1478	2	16	16	1q32.1	PPP1R15B, CREP, MSSGM2		Protein phosphatase 1, regulatory subunit 15B	613257	REc		Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	
1.1479	8	16	12	1q32.1	PPFIA4		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 4	603145	REc			
1.1480	11	27	94	1q32.1	PTPN7		Protein tyrosine phosphatase, nonreceptor-type, 7	176889	A, Ch			
1.1481	1	17	06	1q32.1	SLC45A3, PRST, PCANAP6, IPCA6		Solute carrier family 45, member 3 (prostein)	605097	R			
1.1482	4	30	15	1q32.1	SYT2, CMS7, MYSPC		Synaptotagmin-2	600104	H, REc		Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	1(Syt2)
1.1483	4	2	03	1q32.1	RASSF5, NORE1		Ras association (RalGDS/AF-6) domain family 5 (Nore1, mouse, homolog of)	607020	REc			1(Nore1)
1.1484	2	2	17	1q32.1	SHISA4, C1orf40, TMEM58		Shisa family, member 4	617326	REc			
1.1485	8	8	13	1q32.1	SLC26A9		Solute carrier family 26 (sulfate transporter), member 9	608481	REc			
1.1486	3	14	07	1q32.1	SRGAP2, KIAA0456		Slit-robo GTPase-activating protein, rho, 2	606524	R, REc			
1.1487	6	5	08	1q32.1	YOD1, OTUD2, DUBA8		YOD1 OTU deubiquitinating enzyme 1, S. cerevisiae, homolog of	612023	REc			
1.1488	12	15	10	1q32.1	ZBED6		Zinc finger BED domain-containing protein 6	613512	REc	in intron 1 of ZC3H11A		
1.1489	12	15	10	1q32.1	ZC3H11A, KIAA0663		Zinc finger CCCH domain-containing protein 11A	613513	REc			
1.1490	11	30	06	1q32.3	DTL, RAMP, DCAF2, CDT2		Denticleless, Drosophila, homolog of	610617	A			
1.1491	6	10	98	1q32.1	RNPEP		Arginyl aminopeptidase (aminopeptidase B)	602675	A			
1.1492	10	23	87	1q42.13	GUK1		Guanylate kinase-1	139270	S, D			
1.1493	10	23	87	1q32.1-q42	GUK2		Guanylate kinase-2	139280	S, D	genetic independence of GUK1 and GUK2 unproved		
1.1494	2	3	05	1q32.1	DYRK3		Dual-specificity tyrosine phosphorylation-regulated kinase 3	603497	TM, REc			1(Dyrk3)
1.1495	9	7	10	1q32.1	FAIM3, TOSO, FCMR		Fas apoptotic inhibitory molecule 3	606015	R, REn			
1.1496	3	23	09	1q32.2	MIR29C, MIRN29C		Micro RNA 29C	610784	REc			
1.1497	12	21	09	1q32.2	MIR205, MIRN205		Micro RNA 205	613147	REc			
1.1498	7	27	09	1q32.2	PLXNA2, OCT, PLXN2		Plexin A2 (OCT transmembrane protein)	601054	REa, REc			
1.1499	12	17	07	1q32.1	SARG, C1orf116		Specifically androgen-regulated gene	611680	REc			
1.1500	7	25	18	1q32.2	SYT14, SCAR11		Synaptotagmin 14	610949	REc	mutation identified in 1 SCAR11 family	?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	
1.1501	12	20	96	1q32.3	PROX1		Prospero-related homeo box 1	601546	REc			(Prox1)
1.1502	12	27	13	1q32.3	NEK2, RP67		Never in mitosis gene a-related kinase 2	604043	A, REc	pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family	?Retinitis pigmentosa 67, 615565 (3)	
1.1503	5	25	10	1q32.3	ATF3		Activating transcription factor 3	603148	REc			
1.1504	1	30	01	1q32.1	FCAMR		Fc fragment of IgA and IgM, receptor for	605484	A			1(Fcamr)
1.1505	3	24	14	1q32.3	INTS7, INT7		Integrator complex subunit 7	611350	R, REc			
1.1506	3	4	08	1q32.3	NENF, CIR2		Neuron-derived neurotrophic factor	611874	REc			
1.1507	4	3	09	1q32.3	RD3, LCA12, C1orf36		Retinal degeneration 3, mouse, homolog of	180040	REc, H		Leber congenital amaurosis 12, 610612 (3)	1(rd3)
1.1508	6	12	17	1q32.3	RPS6KC1, RPK118		Ribosomal protein S6 kinase C1	617517	REc			
1.1509	2	25	08	1q32.3	SLC30A1, ZNT1		Solute carrier family 30 (zinc transporter), member 1	609521	REc			
1.1510	2	25	15	1q32.3	VASH2		Vasohibin 2	610471	REc			
1.1511	7	22	11	1q32.2	TRAF3IP3, T3JAM		TRAF3-interacting protein 3	608255	REc			1(T3jam)
1.1512	10	30	08	1q41	AIDA		Axin interactor, dorsalization-associated	612375	REc			
1.1513	7	18	14	1q41	BPNT1		3'(2'),5'-bisphosphate nucleotidase 1	604053	REc			
1.1514	9	16	12	1q41	DUSP10, MKP5		Dual-specificity phosphatase 10	608867	REc			
1.1515	8	24	98	1q41	ESRRG		Estrogen-related receptor, gamma	602969	Psh			
1.1516	3	26	16	1q41	GPATCH2, GPATC2		G-patch domain-containing protein 2	616836	REc			
1.1517	5	30	03	1q42.12	H3F3A, H3F3		H3 histone, family 3A	601128	REc			
1.1518	12	26	14	1q41	IARS2, CAGSSS		Isoleucyl-tRNA synthetase 2	612801	REc	mutation identified in 1 CAGSSS family	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	
1.1519	12	29	06	1q32.3	SMYD2		SET and MYND domain-containing protein 2	610663	R, REc			
1.1520	11	16	98	1q41	KCNK2, TREK		Potassium channel, subfamily K, member 2	603219	R			
1.1521	3	4	10	1q41	KCTD3		Potassium channel tetramerization domain-containing protein 3	613272	REc			
1.1522	6	1	12	1q32.3	LINC00538, YIYA		Long intergenic noncoding RNA 538	614635	REc			
1.1523	9	21	15	1q41	LYPLAL1		Lysophospholipase-like 1	616548	REc			
1.1524	7	17	09	1q41	MARK1, KIAA1477		MAP/microtubule affinity-regulating kinase 1	606511	R, REc			
1.1525	3	23	09	1q41	MIR194-1, MIRN194-1		Micro RNA 194-1	610940	REc			
1.1526	3	23	09	1q41	MIR215, MIRN215		Micro RNA 215	610943	REc			
1.1527	7	27	11	1q41	MOSC1, MARC1		Molybdenum cofactor sulfurase C-terminal domain-containing protein 1	614126	REc			
1.1528	7	27	11	1q41	MOSC2, MARC2		Molybdenum cofactor sulfurase C-terminal domain-containing protein 2	614127	REc			
1.1529	2	2	16	1q32.3	NSL1, DC8, C1orf48		NSL1, MIS12 kinetochore complex component	609174	REc			
1.1530	6	4	97	1q32.3	PPP2R5A		Protein phosphatase-2, regulatory subunit B (B56), alpha isoform	601643	A			
1.1531	9	17	11	1q41	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2		RAB3 GTPase-activating protein (noncatalytic) subunit 2	609275	R, REc, Fd		Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)	
1.1532	4	26	12	1q41	RMD1		Rippling muscle disease 1	600332	Fd, REc		Rippling muscle disease-1 (2)	
1.1533	8	19	13	1q41	RRP15		Ribosomal RNA-processing 15, S. cerevisiae, homolog of	611193	REc			
1.1534	7	11	16	1q41	SLC30A10, ZNT10, HMNDYT1		Solute carrier family 30 (zinc transporter), member 10	611146	REc		Hypermanganesemia with dystonia 1, 613280 (3)	
1.1535	5	23	07	1q41	SPATA17, MSRG11		Spermatogenesis-associated protein 17	611032	REc, H			1(Spata17)
1.1536	7	18	14	1q41	SUSD4		Sushi domain-containing protein 4	615827	REc			
1.1537	9	14	12	1q41	TGFB2, LDS4		Transforming growth factor, beta-2	190220	REa, A, Fd		Loeys-Dietz syndrome 4, 614816 (3)	1(Tgfb2)
1.1538	12	5	13	1q41	TLR5, TIL3, SLEB1, MELIOS		Toll-like receptor-5	603031	A		{Legionnaire disease, susceptibility to}, 608556 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3); {Melioidosis, susceptibility to}, 615557 (3)	
1.1539	3	25	16	1q32.1	TMEM9, TMEM9A, DERM4		Transmembrane protein 9	616877	REc			
1.1540	12	8	00	1q42.2	TSNAX, TRAX		Translin-associated factor X	602964	A, RE, H			8(Tsnax)
1.1541	1	27	04	1q41	USH2A, RP39		Usherin	608400	Fd		Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809 (3)	1(Ush2a)
1.1542	12	21	09	1q41-q42	AUTS11		Autism, susceptibility to, 11	610836	Fd	associated with rs12740310, rs3737296, and rs12310279	{Autism susceptibility 11} (2)	
1.1543	9	22	08	1q41	CAPN2		Calpain, large polypeptide L2	114230	REa, REb			
1.1544	5	22	07	1q42.13	CDC42BPA, PK428, MRCKA		CDC42-binding protein kinase alpha	603412	A			
1.1545	1	31	11	1q41-q42	DEL1q41q42, C1DELq41q42		Chromosome 1q41-q42 deletion syndrome	612530	Ch	contiguous gene deletion of 1.7Mb	Chromosome 1q41-q42 deletion syndrome (4)	
1.1546	5	3	18	1q41	EPRS, PARS, HLD15		Glutamyl-prolyl-tRNA synthetase	138295	REa, A		Leukodystrophy, hypomyelinating, 15, 617951 (3)	1(Eprs)
1.1547	5	12	99	1q42.13	GALNT2		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2	602274	A			
1.1548	3	21	93	1q41	HLX1		H.20-like homeobox 1	142995	A, Fd			1(Hlx1)
1.1549	4	16	98	1q42.11	NVL		Nuclear valosin-containing protein-like	602426	A, REa			
1.1550	10	16	92	1q42.12	ITPKB		Inositol 1,4,5-trisphosphate 3-kinase B	147522	A			
1.1551	7	30	15	1q43	CHRM3, PBS, EGBRS		Cholinergic receptor, muscarinic, 3	118494	A, REa	mutation identified in 1 PBS family	?Prune belly syndrome, 100100 (3)	
1.1552	1	7	14	1q41-q44	OTSC10		Otosclerosis 10	615589	Fd		Otosclerosis 10 (2)	
1.1553	1	29	01	1q42.13	ABCB10, MTABC2		ATP-binding cassette, subfamily B, member 10	605454	REc	pseudogene on 15q13-q14		
1.1554	9	12	96	1q42.13	ARF1		ADP-ribosylation factor-1	103180	A			
1.1555	10	6	09	1q42	BCC2		Basal cell carcinoma, susceptibility to, 2	613058	Fd	associated with rs801114	{Basal cell carcinoma, susceptibility to, 2} (2)	
1.1556	7	17	09	1q42.2	CAPN9		Calpain 9	606401	R, REc			
1.1557	3	3	03	1q41	DISPA		Dispatched, Drosophila, homolog of, A	607502	R			
1.1558	2	21	06	1q42.12	DNAH14, HL18		Dynein, axonemal, heavy chain 14	603341	REc			
1.1559	12	16	05	1q42	EA3		Episodic ataxia, type 3	606554	Fd	max lod at D1S235	Episodic ataxia, type 3 (2)	
1.1560	1	11	16	1q42.2	GNPAT, DHAPAT, RCDP2		Glyceronephosphate O-acyltransferase	602744	TM		Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	
1.1561	1	14	13	1q42.13	HIST3H2A		Histone gene cluster 3, H2A histone	615015	REc			
1.1562	1	31	13	1q42.13	HIST3H2BB, H2Bb		Histone gene cluster 3, H2B histone family, member B	615046	REc			
1.1563	3	11	03	1q42.13	HIST3H3, H3FT, H3T		Histone 3, H3	602820	REa, A			
1.1564	8	8	91	1q42	HRES1		HTLV-1 related endogenous sequence	143025	REa, A			
1.1565	4	10	00	1q42	MDC1B		Muscular dystrophy, congenital, 1B	604801	Fd		Muscular dystrophy, congenital, 1B (2)	
1.1566	9	7	10	1q41	MIA3, TANGO1, TANGO, KIAA0268		Melanoma inhibitory activity family, member 3	613455	REc, R			
1.1567	9	2	12	1q42.2	MLK4, KIAA1804		Mixed-lineage kinase 4	614793	REc			
1.1568	11	19	13	1q42.12	PARP1, ADPRT, PPOL, PARP		Poly(ADP-ribose) polymerase 1	173870	REa, A	?processed pseudogenes on chr.13 and 14		
1.1569	6	8	89	1q42	PEPC		Peptidase C	170000	S, R, Fd	1q25, 1q32 = conflicting localizations		1(Pep3)
1.1570	4	4	07	1q42.13	RHOU, WRCH1		Ras homolog gene family, member U	606366	R			
1.1571	7	20	01	1q42.13	RNF16		RING finger protein-16	606123	REa, R			11(Rnf16)
1.1572	2	1	01	1q41	TAF1A, RAFI48, SL1		TATA box-binding protein-associated factor 1A	604903	R, A			
1.1573	5	26	13	1q42.2	TRIM67		Tripartite motif-containing protein 67	610584	REc			
1.1574	2	17	15	1q42.13	WNT3A		Wingless-type MMTV integration site family, member 3A	606359	A			
1.1575	10	10	01	1q42.13	WNT14		Wingless-type MMTV integration site family, member 14	602863	REc, A			
1.1576	4	20	15	1q43	ACTN2, CMD1AA, CMH23		Actinin, alpha-2	102573	REa, A, Fd		Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3); Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	13(Actn2)
1.1577	10	4	05	1q42.2	AGT, SERPINA8		Angiotensinogen	106150	A, REa		{Hypertension, essential, susceptibility to}, 145500 (3); {Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3)	8(Agt)
1.1578	12	26	14	1q42.2	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH		Egl9, C. elegans, homolog of, 1	606425	R, REc, A		Erythrocytosis, familial, 3, 609820 (3); [Hemoglobin, high altitude adaptation], 609070 (3)	
1.1579	7	17	01	1q43	EXO1, HEX1		Exonuclease 1, S. cerevisiae, homolog of	606063	A			
1.1580	7	1	97	1q42.2	KCNK1, TWIK1		Potassium channel, subfamily K, member 1	601745	A			
1.1581	4	18	05	1q43	LGALS8, PCTA1		Lectin, galactoside-binding, soluble, 8	606099	R			
1.1582	10	12	90	1q42.13	RAB4A, RAB4		Ras-associated protein RAB4A	179511	A			1(Rab4a)
1.1583	12	5	16	1q42.3	TBCE, KCS, KCS1, HRD, PEAMO		Tubulin-specific chaperone E	604934	Fd		Kenny-Caffey syndrome, type 1, 244460 (3); Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3); Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3)	
1.1584	5	4	00	1q42.3	TM7SF1		Transmembrane 7 superfamily, member 1	604658	REa, A			
1.1585	7	17	09	1q42.12	ACBD3, GOCAP1, GOLPH1, GCP60		Acyl-Coenzyme A binding domain containing 3	606809	R, REc			
1.1586	3	11	16	1q42.13	ACTA1, ASMA, NEM3, CFTD1, SHPM		Actin, alpha-1, skeletal muscle	102610	REa, H, A	mutation identified in 1 SHPM family	Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3); Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores, 161800 (3); Myopathy, congenital, with fiber-type disproportion 1, 255310 (3); ?Myopathy, scapulohumeroperoneal, 616852 (3)	8(Actsk1)
1.1587	8	18	17	1q42.2	DISC1, SCZD9		Disrupted in schizophrenia 1	605210	Ch, H, RE		{Schizophrenia 9, susceptibility to}, 604906 (3)	8(Disc1)
1.1588	9	20	01	1q42.2	DISC2		Disrupted in schizophrenia 2	606271	Ch	noncoding antisense RAN	Schizophrenia, 181500 (2)	
1.1589	5	18	18	1q42.12	LEFTY2, EBAF, TGFB4, LEFTA, LEFTYA		Left-right determination factor 2	601877	A			1(lefty2)
1.1590	9	20	17	1q42.12	EPHX1		Epoxide hydroxylase 1, microsomal xenobiotic	132810	REa, A	mutation identified in 1 FHCA patient	?Hypercholanemia, familial, 607748 (3)	1(Eph1)
1.1591	8	16	11	1q43	FH, HLRCC, MCUL1, FMRD		Fumarate hydratase	136850	S, R, D, Psh		Fumarase deficiency, 606812 (3); Leiomyomatosis and renal cell cancer, 150800 (3)	
1.1592	6	22	18	1q42.12	LBR, PHA, PHASK		Lamin B receptor	600024	A, Fd		Pelger-Huet anomaly, 169400 (3); Greenberg skeletal dysplasia, 215140 (3); ?Reynolds syndrome, 613471 (3); Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3)	
1.1593	4	21	99	1q42.12	LEFTB, LEFTY1		Left-right determination, factor B	603037	REn			1(lefty1)
1.1594	3	20	06	1q42.12	MIXL1, MIXL, MIX		MIX1 homeobox-like protein 1	609852	R, A, H			1(Mixl1)
1.1595	6	4	98	1q41	TP53BP2, ASPP2		Tumor protein p53-binding protein-2	602143	A			
1.1596	12	28	08	1q42.3	ARID4B, SAP180, RBP1L1, RBBP1L1, BRCAA1		AT-rich interactive domain-containing protein 4B	609696	REc, A			
1.1597	7	20	06	1q43	RYR2, VTSIP, ARVD2, ARVC2		Ryanodine receptor-2 (cardiac)	180902	REa, A, Fd		Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	13(Ryr2)
1.1598	5	16	17	1q42.11	CNIH4, CNIH2		Cornichon family AMPA receptor auxiliary protein 4	617483	REc			
1.1599	7	18	14	1q42.11	DEGS1, DES1, MLD		Delta(4)-desaturase, sphingolipid, 1	615843	REc			
1.1600	10	15	91	1q42.11-q42.13	RN5S1@		RNA, 5S cluster 1	180420	A	25-30% at 1q31 (RN5S3@)		
1.1601	9	9	08	1q42.11	FBXO28, FBX28, KIAA0483		F-box only protein 28	609100	REc			1(Fbxo28)
1.1602	12	6	16	1q42.12	LIN9		Lin9, C. elegans, homolog of	609375	REc			
1.1603	8	18	14	1q42.12	SRP9, ALURBP		Signal recognition particle, 9-kD	600707	REc			
1.1604	1	20	16	1q42.13	CCSAP, CSAP, C1orf96		Centriole-, cilia-, and spindle-associated protein	616762	REc			
1.1605	6	13	12	1q42.12	ENAH, ENA, MENA, NDPP1		Enabled, Drosophila, homolog of	609061	REc			1(Enah)
1.1606	3	7	14	1q42.13	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C		Gap junction protein, gamma-2 (47kD)	608803	REc		Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic paraplegia 44, autosomal recessive, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)	
1.1607	6	25	18	1q42.13	IBA57, C1orf69, MMDS3, SPG74		IBA57, S. cerevisiae, homolog of	615316	REc		Multiple mitochondrial dysfunctions syndrome 3, 615330 (3); ?Spastic paraplegia 74, autosomal recessive, 616451 (3)	
1.1608	3	11	08	1q42.13	MRPL55		Mitochondrial ribosomal protein L55	611859	REc			
1.1609	7	17	09	1q42.13	NUP133		Nucleoporin, 133kD	607613	R, REc			
1.1610	2	4	16	1q42.13	PGBD5		Piggybac transposable element-derived 5	616791	REc			
1.1611	6	19	15	1q42.12	PYCR2, HLD10		Pyrroline-5-carboxylate reductase 2	616406	REc		Leukodystrophy, hypomyelinating, 10, 616420 (3)	
1.1612	2	22	11	1q42.13	RNF186, RACO1		Ring finger protein 187	613754	REc			
1.1613	1	31	15	1q42.13	TRIM11		Tripartite motif-containing protein 11	607868	R, REc			
1.1614	8	15	17	1q42.11-q42.12	WDR26, SKDEAS		WD repeat-containing protein 26	617424	REc		Skraban-Deardorff syndrome, 617616 (3)	
1.1615	12	30	14	1q42.13	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4		AARF domain-containing kinase 3	606980	R, REc, Fd		Coenzyme Q10 deficiency, primary, 4, 612016 (3)	
1.1616	7	15	16	1q42.2	ARV1, EIEE38		ARV1, S. cerevisiae, homolog of	611647	R, REc		Epileptic encephalopathy, early infantile, 38, 617020 (3)	
1.1617	7	31	15	1q42.2	COA6, C1orf31, CEMCOX4		Cytochrome c oxidase assembly factor 6	614772	REc		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	
1.1618	3	27	17	1q42.2	COG2, LDLC, CDG2Q		Component of oligomeric golgi complex 2	606974	R, REc	mutation identified in 1 CDG2Q patient	?Congenital disorder of glycosylation, type IIq, 617395 (3)	
1.1619	7	1	13	1q42.2	EXOC8, EXO84, SEC84		Exocyst complex component 8	615283	REc			
1.1620	8	31	17	1q42.2	PCNX2, KIAA0435		Pecanex, Drosophila, homolog of, 2	617656	R, REc			8(Pcnx2)
1.1621	2	19	08	1q42.2	SIPA1L2, KIAA1389		SIPA1-like protein 2	611609	R, REc			
1.1622	2	4	15	1q42.2	SPRTN, DVC1, C1orf124, RJALS		SprT-like N-terminal domain protein	616086	REc		Ruijs-Aalfs syndrome, 616200 (3)	
1.1623	10	10	14	1q42-q43	EDARADD, ED3, EDA3, ECTD11B, ECTD11A		EDAR-associated death domain	606603	REc		Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3); Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	13(Edaradd)
1.1624	10	8	98	1q42.2-q43	PCAP		Predisposing for prostate cancer	602759	Fd		{Prostate cancer, susceptibility to}, 176807 (2)	
1.1625	1	5	07	1q42.2-q43	SHFL1, SHFLD		Split-hand/foot malformation with long bone deficiency 1	119100	Fd	between rs1124110 and rs535043	Split-hand/foot malformation with long bone deficiency 1 (2)	
1.1626	10	7	13	1q42.3	ERO1LB		Endoplasmic reticulum oxidoreduction 1-like beta	615437	REc			13(Ero1l)
1.1627	4	23	13	1q42.3	B3GALNT2, MGC39558, MDDGA11		Beta-1,3-N-acetylgalactosaminyltransferase 2	610194	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	
1.1628	5	25	13	1q42.3	GNG4		Guanine nucleotide-binding protein, gamma 4	604388	REc			
1.1629	11	13	17	1q42.3	IRF2BP2, CVID14		Interferon regulatory factor 2-binding protein 2	615332	REc	mutation identified in 1 CVID14 family	?Immunodeficiency, common variable, 14, 617765 (3)	
1.1630	1	30	15	1q42.3	LYST, CHS1		Lysosomal trafficking regulator	606897	Fd		Chediak-Higashi syndrome, 214500 (3)	13(Lyst, bg)
1.1631	9	18	08	1q42.2	TARBP1, TRP185		TAR RNA-binding protein 1	605052	R, REc			
1.1632	9	27	17	1q42.3	TOMM20, MAS20, KIAA0016		Translocase of outer mitochondrial membrane 20, S. cerevisiae, homolog of	601848	REc			
1.1633	3	23	14	1q43	BECN2, BECN1L1		Beclin 2	615687	REc, H			1(Becn2)
1.1634	2	21	02	1q43	CHML, REP2		Choroideremia-like	118825	REa, REc			
1.1635	2	4	15	1q43	FMN2, MRT47		Formin 2	606373	H, REc		Mental retardation, autosomal recessive 47, 616193 (3)	1(Fmn2)
1.1636	5	28	02	1q42.3	GGPS1, GGPPS1		Geranylgeranyl diphosphate synthase 1	606982	A			
1.1637	12	27	16	1q43	GREM2, PRDC, STHAG9		Gremlin 2 homolog, cystine knot superfamily	608832	REc		Tooth agenesis, selective, 9, 617275 (3)	
1.1638	2	21	02	1q43	KMO		Kynurenine 3-monooxygenase	603538	REc			
1.1639	7	12	13	1q43	MTR, HMAG		5-methyltetrahydrofolate-homocysteine methyltransferase 1	156570	S, A		Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	13(Mtr)
1.1640	6	8	89	1q42.3	NID		Nidogen	131390	A			
1.1641	2	18	02	1q43	OPN3, ECPN		Opsin 3	606695	Psh, A			
1.1642	4	20	11	1q43	RGS7		Regulator of G protein signaling 7	602517	REc			1(Rgs7)
1.1643	12	15	10	1q43	ZP4, ZPB		Zona pellucida glycoprotein 4	613514	REc			
1.1644	12	4	08	1q43-q44	DFNB45		Deafness, autosomal recessive 45	612433	Fd	between D1S547 and D1S2836	Deafness, autosomal recessive 45 (2)	
1.1645	10	16	14	1q43-q44	SDCCAG8, CCCAP, SLSN7, BBS16		Serologically defined colon cancer antigen 8	613524	REc		Senior-Loken syndrome 7, 613615 (3); Bardet-Biedl syndrome 16, 615993 (3)	
1.1646	3	15	07	1q44	AHCTF1, ELYS		AT hook containing transcription factor 1	610853	REc			
1.1647	8	22	14	1q43-q44	AKT3, PKBG, MPPH2		v-Akt murine thymoma viral oncogene homolog 3	611223	A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	1(Akt3)
1.1648	6	12	17	1q44	CATSPERE, C10orf101		Cation channel, sprem-associated, auxiliary subunit epsilon	617510	REc			
1.1649	9	21	09	1q43	CEP170, KIAA0470		Centrosomal protein, 170kD	613023	R, REc			
1.1650	9	7	10	1q44	CNST		Consortin	613439	REc			
1.1651	2	21	14	1q44	COX20, FAM36A		Cytochrome c oxidase 20, S. cerevisiae, homolog of	614698	REc		Mitochondrial complex IV deficiency, 220110 (3)	
1.1652	7	20	12	1q44	DESI2, PPPDE1		Desumoylating isopeptidase 2	614638	REc			
1.1653	3	10	17	1q44	HNRNPU, HNRPU, SAFA, EIEE54		Heterogeneous nuclear ribonucleoprotein U	602869	REc		Epileptic encephalopathy, early infantile, 54, 617391 (3)	
1.1654	9	8	11	1q44	KIF26B		Kinesin family member 26B	614026	REc			
1.1655	8	10	16	1q44	LYPD8		LY6/PLAUR domain-containing protein 8	617067	REc			
1.1656	6	14	18	1q44	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH		NLR family, pyrin domain containing 3	606416	REn, Fd		Familial cold inflammatory syndrome 1, 120100 (3); Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3); Deafness, autosomal dominant 34, with or without inflammation, 617772 (3); Keratoendothelitis fugax hereditaria, 148200 (3)	
1.1657	1	5	16	1q44	OR2W3		Olfactory receptor family 2 subfamily W member 3	616729	REc			
1.1658	12	17	07	1q44	OR13G1		Olfactory receptor, family 13, subfamily G, member 1	611677	REc			
1.1659	6	27	14	1q44	SMYD3		SET and MYND domain-containing protein 3	608783	REc			
1.1660	11	11	14	1q44	TFB2M		Transcription factor B2, mitochondrial	607055	R, REc			
1.1661	3	23	93	1q44	ZNF124		Zinc finger protein-124 (HZF-16)	194631	A			
1.1662	5	12	15	1q44	ZNF695, SBZF3		Zinc finger protein 695	616348	REc			
1.1663	4	20	17	1q44	ZBTB18, ZNF238, RP58, MRD22		Zinc finger and BTB domain containing 18	608433	A, REc, Psh		Mental retardation, autosomal dominant 22, 612337 (3)	
1.1664	11	10	17	1q44	ZNF692, AREBP		Zinc finger protein 692	617758	REc			
1.1665	4	19	11	1q44	ZNF496, NIZP1, ZFP496		Zinc finger protein 496	613911	REc			11(Znf496)
1.1666	11	3	11	Chr.1	SPGF2, ASG		Spermatogenic failure 2	108420	Ch	inversion of chromosome 1	Spermatogenic failure 2 (2)	
2.1	7	22	13	2pter-p24	CTRCT29		Cataract 29, coralliform	115800	Fd	between D2S297 and D2S2269	Cataract 29, coralliform (2)	
2.2	6	14	10	2p25.3	ADI1, SIPL		Acireductone dioxygenase 1	613400	REc			
2.3	5	4	12	2p25.3	COLEC11, CLK1, 3MC2		Collectin 11	612502	REc		3MC syndrome 2, 265050 (3)	
2.4	4	2	16	2p25.3	FAM110C		Family with sequence similarity 110, member C	611395	REc			
2.5	1	26	17	2p25.3	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7		Peroxidasin, Drosophila, homolog of	605158	REa, R, A		Anterior segment dysgenesis 7, with sclerocornea, 269400 (3)	
2.6	1	26	17	2p25.3	SH3YL1		SH3 domain- and SYLF domain-containing protein 1	617314	REc			
2.7	2	19	10	2p25.3	TMEM18		Transmembrane protein 18	613220	REc			
2.8	9	21	17	2p25.3	TRAPPC12, TTC15, PEBAS		Trafficking protein particle complex, subunit 12	614139	REc		Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3)	
2.9	2	12	08	2p25.2	CMPK2		Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial	611787	REc			
2.10	7	11	17	2p25.3	EIPR1, TSSC1		EARP complex and GARP complex interacting protein 1	608998	REc, H			12(Tssc1)
2.11	8	27	09	2p25.1	ITGB1BP1, ICAP1, ICAP1A, ICAP1B		Integrin cytoplasmic domain-associated protein 1 beta	607153	R, REc			
2.12	12	28	08	2p25.2	RSAD2, VIPERIN		Radical S-adenosyl methionine domain containing 2	607810	R, REc			
2.13	7	25	18	2p25.1	ATP6V1C2		ATPase, H+ transporting, V1 subunit C2	618070	REc			
2.14	12	23	05	2p25.1	GRHL1, LBP32, MGR		Grainyhead-like 1	609786	R, REc			
2.15	1	22	08	2p25.1	GREB1		GREB1 protein	611736	R, REc			
2.16	7	17	09	2p25.1	HPCAL1		Hippocalcin-like 1	600207	REa, REc			
2.17	1	11	17	2p25.1	KIDINS220, ARMS, SINO		Kinase D-interacting substrate, 220kD	615759	REc		Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3)	
2.18	10	13	09	2p25.1	MBOAT2, LPCAT4		Membrane-bound O-acyltransferase domain-containing 2	611949	R, REc			
2.19	2	4	15	2p25.1	NOL10, PQBP5		Nucleolar protein 10	616197	REc			
2.20	8	6	13	2p25.1	NTSR2		Neurotensin receptor 2	605538	REc			
2.21	6	12	12	2p25.1	TYHAQ		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta isoform	609009	REa, REc	pseudogene on chr.22		
2.22	3	14	06	2p25.1-p24.3	DFNB47		Deafness, neurosensory, autosomal recessive 47	609946	Fd	max lod at D2S1400 and D2S262	Deafness, neurosensory, autosomal recessive 47 (2)	
2.23	8	23	16	2p21	DYNC2LI1, D2LIC, LIC3, SRTD15		Dynein, cytoplasmic 2, light intermediate chain 1	617083	REc		Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3)	
2.24	7	7	89	2p25.3	ACP1		Acid phosphatase 1, soluble	171500	D, S, A			12(Acp1)
2.25	11	3	14	2p25.1	ADAM17, TACE, NISBD1		A disintegrin and metalloproteinase domain 17	603639	R	mutation identified in 1 NISBD1 family	?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	12(Tace)
2.26	12	18	08	2p25	ALLC		Allantoicase	612396	Psh, REc	nonfunctional in humans		
2.27	1	15	96	2p25.1	ID2		Inhibitor of DNA binding 2, dominant negative	600386	REa, A			
2.28	8	27	09	2p23.3	ITSN2, SH3D1B, SWAP, KIAA1256		Intersectin 2	604464	REc			
2.29	5	21	99	2p25.1	KCNF1, KH1		Potassium voltage-gated channel, subfamily F, member 1	603787	A			
2.30	2	13	14	2p25.1	KLF11, TIEG2, FKLF1, FKLF, MODY7		Kruppel-like factor 11	603301	Psh		Maturity-onset diabetes of the young, type VII, 610508 (3)	12(Klf11)
2.31	5	27	05	2p25.1	ODC1		Ornithine decarboxylase-1	165640	REa, A	pseudogene ODCP on 7q31-qter	{Colonic adenoma recurrence, reduced risk of}, 114500 (3)	12(Odc)
2.32	10	11	05	2p25	PEE2		Preeclampsia/eclampsia 2	609402	Fd		Preeclampsia/eclampsia 2 (2)	
2.33	7	29	15	2p25.3	RNASEH1, PEOB2		Ribonuclease H1	604123	Psh	pseudogenes on chr. 17 and chr.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	12(Rnaseh1)
2.34	2	4	09	2p25.3	RPS7, DBA8		Ribosomal protein S7	603658	A		Diamond-Blackfan anemia 8, 612563 (3)	
2.35	7	17	14	2p25.2	SOX11, MRD27		SRY (sex-determining region Y)-box 11	600898	A		Mental retardation, autosomal dominant 27, 615866 (3)	
2.36	2	1	01	2p25.1	RAF1B, RAFI63, SL1		TATA box-binding protein-associated factor 1B	604904	R, A			
2.37	7	11	11	2p23.3	SAP14, SF3B14, P14		Spliceosome-associated protein, 14kD	607835	REc			
2.38	5	12	09	2p23.3	SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G		Suppressor of TY 7-like	612762	R, REc			
2.39	9	29	09	2p25.3	TPO, TPX, TDH2A		Thyroid peroxidase	606765	REa, A, Fd		Thyroid dyshormonogenesis 2A, 274500 (3)	12(Tpo)
2.40	11	22	17	2p25-p22	ETM2, ETM		Tremor, hereditary essential, 2	602134	Fd	max lod at D2S272	Essential tremor, hereditary, 2 (2)	
2.41	6	10	03	2p25-p24	HYT3		Hypertension, essential, susceptibility to, 3	607329	Fd		{Hypertension, essential, susceptibility to, 3}, 145500 (2)	
2.42	8	22	07	2p25.1	PDIA6, ERP5		Protein disulfide isomerase, family A, member 6	611099	A			
2.43	4	10	90	2p25.1	RRM2		Ribonucleotide reductase, M2 polypeptide	180390	REa, A	pseudogenes on 1p, 1q, Xp		12(Rrm2)
2.44	7	27	09	2p25-p12	PPKP3		Keratoderma, palmoplantar, punctate type III	101850	Fd	max lod at ACP1 and IGKC	?Keratoderma, palmoplantar, punctate type 3 (2)	
2.45	4	6	15	2p24.3	FAM84A, NSE1		Family with sequence similarity 84, member A	611234	R, REc			
2.46	12	30	14	2p24.3	GACAT3, LINC01458		Gastric cancer-associated transcript 3, noncoding	616132	REc			
2.47	9	20	14	2p24.3	MYCNUT		MYCN upstream transcript, noncoding	615968	REc			
2.48	12	24	08	2p24.2	GEN1		GEN1, Drosophila, homolog of	612449	REc			
2.49	8	29	08	2p24.2	MSGN1		Mesogenin 1	612209	REc			
2.50	5	24	13	2p24.2	NT5C1B, CN1B, AIRP		5'-nucleotidase, cytosolic, Ib	610526	REc, R			
2.51	2	9	16	2p24.2	RDH14, SDR7C4, PAN2		Retinol dehydrogenase 14	616796	REc			
2.52	10	4	05	2p24.2	SMC6L1, SMC6		Structural maintenance of chromosomes 6-like 1	609387	R, REc			
2.53	5	19	06	2p24.1	HS1BP3, FLJ14249, ETM2		HS1-binding protein 3	609359	REc			
2.54	1	17	18	2p24.1	LDAH, C2orf43		Lipid droplet associated hydrolase	613570	REc			
2.55	7	21	11	2p24.3	MYCN, NMYC, ODED, MODED		Oncogene NMYC	164840	REa, A, Fd	proximal to APOB	Feingold syndrome 1, 164280 (3)	12(Nmyc1)
2.56	8	27	09	2p24.3	MYCNOS, NCYM		Oncogene NCYM, opposite strand	605374	R, REc			
2.57	8	3	12	2p24.1	RHOB, ARHB, ARH6, RHOH6		RAS homolog gene family, member B (oncogene RHO H6)	165370	REa, A			
2.58	6	29	94	2p24.1	SDC1		Syndecan 1	186355	REa, H	close to NMYC in mouse		12(Synd1)
2.59	2	11	14	2p24.1	WDR35, NAOFEN, KIAA1336, CED2, SRTD7		WD repeat-containing protein 35	613602	REc		Cranioectodermal dysplasia 2, 613610 (3); Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	
2.60	10	12	16	2p23.3	ZNF513, RP58		Zinc finger protein 513	613598	REc	mutation identified in 1 RP58 family	?Retinitis pigmentosa 58, 613617 (3)	
2.61	8	2	13	2p24.1-p23.3	ATAD2B, KIAA1240		ATPase family, AAA domain-containing, member 2B	615347	R, REc			
2.62	7	8	10	2p23.2	C2orf71		Chromosome 2 open reading frame 71	613425	REc		Retinitis pigmentosa 54, 613428 (3)	
2.63	12	9	13	2p24.1	APOB, FLDB, LDLCQ4		Apolipoprotein B (including Ag(x) antigen)	107730	REa, A	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypobetalipoproteinemia, 615558 (3); Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	12(Apob)
2.64	3	8	07	2p24-p22	CLQTL2		Cholesterol level quantitative trait locus 2	610760	Fd	max lod at D2S1360	[Cholesterol level QTL 2] (2)	
2.65	5	24	01	2p25.1	DDEF2, PAP		Development- and differentiation-enhancing factor 2	603817	R			
2.66	5	13	96	2p24.3	DDX1		DEAD/H box-1	601257				
2.67	1	3	06	2p24	GEFSP4		Generalized epilepsy with febrile seizures plus, type 4	609800	Fd	max lod at D2S305	Epilepsy, generalized, with febrile seizures plus, type 4 (2)	
2.68	6	15	99	2p24.2	KCNS3, KV9.3		Potassium voltate-gated channel, delayed-rectifier, subfamily S, member 3	603888	REc			
2.69	2	23	05	2p24	KTCN4		Keratoconus 4	609271	Fd	between D2S305 and D2S2373	Keratoconus 4 (2)	
2.70	9	1	15	2p25.3	MYT1L, KIAA1106, MRD39		Myelin transcription factor 1-like	613084	Psh, H		Mental retardation, autosomal dominant 39, 616521 (3)	12(Myt1l)
2.71	9	7	04	2p24.1	ODD, OSR1		ODD-skipped, Drosophila, homolog of	608891	REc			
2.72	3	9	00	2p25.1	ROCK2		RHO-associated coiled-coil-containing protein kinase 2	604002	R, A			
2.73	6	9	06	2p11.2	VPS24, CHMP3, NEDF		Vacuolar protein sorting 24, yeast, homolog of	610052	R, REc			
2.74	7	17	01	2p24.1	GDF7		Growth/differentiation factor 7	604651	A			
2.75	1	10	18	2p24.1	MATN3, EDM5, HOA, OS2		Matrilin 3	602109	A, Fd	mutation identified in 1 SEMDM family	Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis susceptibility 2}, 140600 (3); ?Spondyloepimetaphyseal dysplasia, 608728 (3)	12(Matn3)
2.76	7	29	15	2p24.3	NBAS, NAG, SOPH, ILFS2		Neuroblastoma-amplified sequence	608025	A		Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3); Infantile liver failure syndrome 2, 616483 (3)	
2.77	10	13	05	2p23.3	TCF23		Transcription factor 23	609635	REc			5(Tcf23)
2.78	2	27	18	2p23.3	ADCY3, BMIQ19		Adenylate cyclase-3	600291	REa, A		{Obesity, susceptibility to, BMIQ19}, 617885 (3)	
2.79	6	3	98	2p23.3	CENPA		Centromere protein A, 17kD	117139	R, Psh			5(Cenpa)
2.80	8	29	08	2p23.3	ABHD1, LABH1		Abhydrolase domain-containing 1	612195	REc			5(Abhd1)
2.81	7	11	16	2p23.3	AGBL5, CCP5, RP75		AATP/GTP-binding protein-like 5	615900	REc		Retinitis pigmentosa 75, 617023 (3)	
2.82	11	22	16	2p23.3	ASXL2, KIAA1685, SHAPNS		Additional sex combs-like 2	612991	REc		Shashi-Pena syndrome, 617190 (3)	
2.83	2	25	15	2p23.3	C2orf44, WDCP		WD repeat- and coiled-coil-containing protein	616234	REc			
2.84	10	08	07	2p23.3	CENPO		Centromeric protein O	611504	R, REc			
2.85	7	14	14	2p23.3	CGREF1, CGR11		Cell growth regulator with EF-hand domain 1	606137	REc			
2.86	4	24	18	2p23.3	CIB4, KIP4		Calcium- and integrin-binding protein 4	610646	REc			
2.87	5	23	11	2p23.3	DNAJC5G		DNAJ/HSP40 homolog, subfamily C, member 5, gamma	613946	REc			
2.88	8	17	10	2p23.3	DNAJC27, RBJ		DNAJ/HSP40 homolog, subfamily, C, member 27	613527	REc			
2.89	1	27	04	2p23.3	DPYSL5, CRMP5, CRAM		Dihydropyrimidinase-like 5	608383	R, REc			5(Dpysl5)
2.90	7	12	13	2p23.3	DRC1, CCDC164, C2orf39, CILD21		Dynein regulatory complex, subunit 1, Chlamydomonas, homolog of	615288	REc		Ciliary dyskinesia, primary, 21, 615294 (3)	
2.91	2	9	16	2p23.3	EFR3B, KIAA0953		Efr3, S. cerevisiae, homolog of, B	616797	R, REc			
2.92	10	29	03	2p23.3	EIF2B4		Eukaryotic translation initiation factor 2B, subunit 4	606687	R		Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
2.93	8	27	09	2p23.3	FKBP1B, PKBP1L		FK506-binding protein 1B	600620	R, REc			
2.94	3	20	08	2p23.3	FNDC4, FRCP1		Fibronectin type III domain-containing protein 4	611905	R, REc, H			5(Fndc4)
2.95	5	29	15	2p23.3	IFT172, SLB, KIAA1179, SRTD10, RP71		Intraflagellar transport 172, Chlamydomonas, homolog of	607386	R, REc		Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3); Retinitis pigmentosa 71, 616394 (3)	
2.96	1	7	09	2p23.3	POMC, OBAIRH		Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)	176830	REa, A		Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3); {Obesity, early-onset, susceptibility to}, 601665 (3)	12(Pomc1)
2.97	10	12	14	2p23.3	PPM1G, PP2CG		Protein phosphatase, magnesium/manganese-dependent, 1G	605119	REc			
2.98	2	9	17	2p23.3	PRTHD1, C2orf79		Peptidyl-tRNA hydrolase domain-containing 1	617342	REc			
2.99	3	31	09	2p23.3	RAB10		Ras-associated protein	612672	REc			
2.100	11	18	16	2p23.3	SELENOI, SELI		Selenoprotein I	607915	REc			
2.101	7	18	14	2p23.3	SLC5A6, SMVT		Solute carrier family 5 (sodium dependent vitamin transporter), member 6	604024	REc			
2.102	2	25	08	2p23.3	SLC30A3, ZNT3		Solute carrier family 30 (zinc transporter), member 3	602878	REc			5(Slc30a3)
2.103	4	6	15	2p23.3	TMEM214		Transmembrane protein 214	615301	REc			
2.104	8	3	12	2p23.3	TP53I3, PIG3		Tumor protein p53-inducible protein 3	605171	REc			
2.105	8	13	15	2p23.3	TRIM54, RNF30, MURF3		Tripartite motif containing 54	606474	R, REc			
2.106	10	13	09	2p23.3	XAB1, MBDIN		XPA-binding protein	611479	REc			
2.107	8	27	09	2p23.3	EMILIN1, EMILIN		Elastin microfibril interfacer 1	130660	REc			
2.108	11	1	10	2p23.3	GCKR, GKRP, FGQTL5		Glucokinase (hexokinase 4) regulatory protein	600842	A, Fd, REc		[Fasting plasma glucose level QTL 5], 613463 (3)	
2.109	6	23	11	2p23.3	KHK		Ketohexokinase (fructokinase)	614058	A, Fd, REc, Psh		[Fructosuria], 229800 (3)	
2.110	8	27	09	2p23.3	SLC4A1AP		Solute carrier family 4 (anion exchanger), member 1, adaptor protein	602655	REc			
2.111	8	27	01	2p23.3	MAPRE3, EB3, RP3, EBF3		Microtubule-associated protein, RP/EB family, member 3	605788	A, R			
2.112	3	14	06	2p23.3-p22.3	GINGF3, HGF3, GGF3		Fibromatosis, gingival, 3	609955	Fd	between D2S2221 and D2S1788	Fibromatosis, gingival, 3 (2)	
2.113	10	13	13	2p23.2	BRE, BRCC4, BRCC45		Brain and reproductive organ-expressed protein	610497	REc, R			
2.114	8	31	11	2p23.2	FOSL2		FOS-like antigen-2	601575	A			
2.115	1	27	04	2p23.1	GALNT14		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14	608225	REc			
2.116	6	16	06	2p23.2	PLB1, PLB, FLJ30866		Phospholipase B1	610179	R, REc			
2.117	9	10	07	2p23.2	RBKS		Ribokinase	611132	REc			
2.118	9	8	11	2p23.2	SPDYA, SPY1, RINGOA		Speedy, xenopus, homolog of, A	614029	REc			
2.119	2	4	15	2p23.2	WDR43, UTP5, KIAA0007		WD repeat-containing protein 43	616195	REc, Psh			
2.120	1	31	08	2p23.1	LBH		Limb bud and heart development, mouse, homolog of	611763	R, REc			
2.121	9	28	11	2p23.1	LCLAT1, ALCAT1, AGPAT8		Lysocardiolipin acyltransferase 1	614241	REc			17(Lclat1)
2.122	6	1	18	2p23.3	GAREM2		GRB2-associated regulator of MAPK1, subtype 2	617999	REc			
2.123	12	28	08	2p23.1	YPEL5		Yippee-like 5	609726	REc			17(Ypel5)
2.124	9	24	08	2q32.1	DNAJC10, ERDJ5, JPDI		DNAJ/HSP40 homolog, subfamily C, member 10	607987	REc			
2.125	9	22	09	2p23.2-p23.1	ALK, NBLST3		Anaplastic lymphoma kinase (Ki-1)	105590	Ch, H		{Neuroblastoma, susceptibility to, 3}, 613014 (3)	17(Alk)
2.126	3	22	18	2p23.3	DNMT3A, TBRS		DNA methyltransferase 3A	602769	A		Tatton-Brown-Rahman syndrome, 615879 (3); Acute myeloid leukemia, somatic, 601626 (3)	
2.127	3	19	08	2p23.3	HADHA, MTPA		Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	A		LCHAD deficiency, 609016 (3); Trifunctional protein deficiency, 609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)	
2.128	3	19	08	2p23.3	HADHB		Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit	143450	A		Trifunctional protein deficiency, 609015 (3)	
2.129	8	2	13	2p23.3	KCNK3, TASK, PPH4		Potassium channel, subfamily K, member 3	603220	R		Pulmonary hypertension, primary, 4, 615344 (3)	5(Kcnk3)
2.130	11	20	98	2p23.3	KIF3C		Kinesin family member 3C	602845	A			12(Kif3c)
2.131	1	30	18	2p23.3	MFSD2B		Major facilitator superfamily domain-containing protein 2B	617845	REc			
2.132	12	29	99	2p23.3	NCOA1, SRC1		Nuclear receptor coactivator 1	602691	A			
2.133	6	18	01	2p23.3	NRBP		Nuclear receptor-binding protein	606010	A			
2.134	5	31	17	2p23.2	PPP1CB, NSLH2		Protein phosphatase-1, catalytic subunit, beta isoform	600590	REa, A		Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3)	12(Ppp1cb)
2.135	11	28	01	2p23.3	PREB		Prolactin regulatory element-binding protein	606395	A			5(Preb)
2.136	10	21	02	2p23.1	SRD5A2		Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)	607306	REa, A		Pseudovaginal perineoscrotal hypospadias, 264600 (3)	
2.137	8	17	99	2p23.3	DTNB		Dystrobrevin, beta	602415	A			12(Dtnb)
2.138	8	4	09	2p23.3	OTOF, DFNB9, NSRD9, AUNB1		Otoferlin	603681	Fd, REc	symbolized DFNB6 by authors	Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy, autosomal recessive, 1, 601071 (3)	
2.139	8	17	98	2p22.1	SLC8A1, NCX1		Solute carrier family 8, member 1 (sodium-calcium exchanger-1)	182305	REa, A			
2.140	4	18	05	2p23.3	SNX17		Sorting nexin 17	605963	R, REc			
2.141	7	27	16	2p23.1	XDH, XAN1		Xanthine dehydrogenase (xanthine oxidase)	607633	REb, A		Xanthinuria, type I, 278300 (3)	17(Xd)
2.142	12	27	10	2p23.3	MPV17, MTDPS6		Mpv17 transgene, mouse, glomerulosclerosis, homolog of	137960	REa, A		Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	5(Mpv17)
2.143	3	18	08	2p23.3	UCN, UROC		Urocortin	600945	REa, REc			
2.144	5	16	05	2p22.2-p22.1	ARL3IP2, ATL2		ADP-ribosylation-like factor 6-interacting protein 2 (atlastin 2)	609368	REc			
2.145	6	9	08	2p22.3	DPY30		DPY30, C. elegans, homolog of	612032	REc			
2.146	7	23	15	2p22.3	MIR558		Micro RNA 558	616473	REc	BIRC6 is host gene		
2.147	12	4	14	2p22.3	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4		NLR family, caspase recruitment domain-containing 4	606831	REc	mutation identified in 1 FCAS4 family	Autoinflammation with infantile enterocolitis, 616050 (3); ?Familial cold autoinflammatory syndrome 4, 616115 (3)	
2.148	10	11	16	2p22.2	SULT6B1		Sulfotransferase family 6B, member 1	617152	REc			
2.149	6	17	17	2p22.3	YIPF4		Yip1 domain family, member 4	617534	REc			
2.150	4	26	10	2p22.3-p21	CANDF1, CMCT		Candidiasis, familial, 1	114580	Fd	between D2S367 and D2S2240	Candidiasis, familial, 1, autosomal dominant (2)	
2.151	7	16	09	2p22.2	CEBPZ, CBF, NOC1		CCAAT/enhancer-binding protein, zeta	612828	REc			
2.152	9	23	08	2p22.2	FAM82A1, FAM82A, RMD2		Family with sequence similarity 82, member A1	611872	REc			
2.153	7	18	14	2p22.2	FEZ2		Fasciculation and elongation protein zeta 2	604826	REc			
2.154	1	30	18	2p22.2	MACOM		Macrophthalmia, colobomatous, with microcornea	602499	Ch		Macrophthalmia, colobomatous, with microcornea (4)	
2.155	8	1	14	2p22.2	NDUFAF7, MIDA		NADH dehydrogenase (ubiquinone) complex I, assembly factor 7	615898	REc			
2.156	8	27	09	2p22.2	QPCT, QC		Glutaminyl-peptide cyclotransferase	607065	R, REc			
2.157	9	18	17	2p22.2	VIT, VIT1		Vitrin	617693	REc			
2.158	9	20	14	2p22.1	GEMIN6		GEM-associated protein 6	607006	REc			
2.159	3	31	15	2p22.1	MAP4K3, GLK		Mitogen-activated protein kinase kinase kinase kinase 3	604921	REc			
2.160	9	17	11	2p22.1-p21	HNFJ3		Hyperuricemic nephropathy, familial juvenile, 3	614227	Fd	between rs372139 and rs896986	Hyperuricemic nephropathy, familial juvenile, 3 (2)	
2.161	5	26	13	2p22.1	HNRNPLL, HNRPLL, SRRF		Heterogeneous nuclear ribonucleoprotein L-like	611208	REc			
2.162	3	24	14	2p23.2	MRPL33		Mitochondrial ribosomal protein L33	610059	R			
2.163	8	21	12	2p22.2	STRN		Striatin, calmodulin-binding protein	614765	REc, A			
2.164	1	7	09	2p22.3	BIRC6, KIAA1289		Baculoviral IAP repeat-containing protein-6	605638	R, REc			
2.165	8	28	01	2p22.2	CRIM1		Cysteine-rich motor neuron protein 1	606189	R, A			
2.166	1	26	17	2p22.2	CYP1B1, GLC3A, ASGD6		Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1	601771	REa, REn, A, Fd		Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3); Anterior segment dysgenesis 6, multiple subtypes, 617315 (3)	
2.167	1	2	03	2p21	EML4, ROPP120		Echinoderm microtubule associated protein like-4	607442	R, A			
2.168	2	12	08	2p22.3	MEMO1, MEMO, C2orf4		Mediator of cell motility 1	611786	REc			
2.169	1	16	08	2p21-p16	MSH2, COCA1, FCC1, HNPCC1		mutS, E. coli, homolog of, 2	609309	Fd, REa, Ch		Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3); Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)	
2.170	8	27	09	2p24.1	PUM2, KIAA0235		Pumilio, Drosophila, homolog of, 2	607205	REa, REc			
2.171	12	19	11	2p22.1	SRSF7, SFRS7		Splicing factor, arginine/serine-rich 7, 35kD	600572	A			
2.172	2	25	08	2p22.3	SLC30A6, ZNT6		Solute carrier family 30 (zinc transporter), member 6	611148	REc, H			17(Slc30a6)
2.173	9	28	15	2p22.1	SOS1, GINGF, GF1, HGF, NS4		Son of sevenless, Drosophila, homolog of, 1	182530	A, Fd, REc	mutation identified in 1 GINGF1 family	?Fibromatosis, gingival, 1, 135300 (3); Noonan syndrome 4, 610733 (3)	17(Sos1)
2.174	4	27	12	2p22.3	SPAST, SPG4		Spastin	604277	Fd		Spastic paraplegia 4, autosomal dominant, 182601 (3)	
2.175	1	28	08	2p22.1	THUMPD2, C2orf8		THUMP domain-containing 2	611751	A			
2.176	7	12	92	2p16.3	HTLF		Human T-cell leukemia virus enhancer factor	143089	REa, A			
2.177	10	24	14	2p22.1	GALM, GLAT		Galactose mutarotase	137030	S			
2.178	12	8	00	2p21	ABCG5		ATP-binding cassette, subfamily G, member 5	605459	REc		Sitosterolemia, 210250 (3)	
2.179	6	21	16	2p21	ABCG8, GBD4		ATP-binding cassette, subfamily G, member 8	605460	REc		Sitosterolemia, 210250 (3); {Gallbladder disease 4}, 611465 (3)	
2.180	3	2	17	2p21	ATP6V1E2, ATP6E1		ATPase, H+ transporting, V1 subunit E1	617385	REc			
2.181	1	13	17	2p23.3	CAD, CDG1Z, EIEE50		CAD trifunctional protein of pyrimidine biosynthesis	114010	REa, A, S, D		Epileptic encephalopathy, early infantile, 50, 616457 (3)	
2.182	3	13	15	2p21	CALM2, LQT15		Calmodulin-2	114182	Psh, A		Long QT syndrome 15, 616249 (3)	
2.183	6	4	13	2p21	CAMKMT, C2orf34		Calmodulin lysine N-methyltransferase	609559	REc			
2.184	8	27	09	2p22.2	CDC42EP3, CEP3, BORG2		CDC42 effector protein 3	606133	R, REc			
2.185	8	27	09	2p21	COX7A2L, COX7RP, EB1		Cytochrome c oxidase subunit VIIA, polypeptide 2-like	605771	R, REc			
2.186	5	22	14	2p21	CRIPT, SSMDF		Cystine-rich PDZ binding protein	604594	REc		Short stature with microcephaly and distinctive facies, 615789 (3)	
2.187	4	21	10	2p21	DEL2p21, C2DELp21		Homozygous 2p21 deletion syndrome	606407	Ch	contiguous gene syndrome disrupting SLC3A1 and PREPL genes	Hypotonia-cystinuria syndrome (4)	
2.188	5	2	01	2p23.1	EHD3		EH domain-containing 3	605891	R			
2.189	12	19	11	2p21	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8		Epithelial cellular adhesion molecule	185535	A, REa	previously assigned to 4q	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3); Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	
2.190	08	17	18	2p16.3	FBXO11, FBX11, VIT1, PRMT9, IDDFBA		F-box only protein 11	607871	REc	?2p16	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3)	17(Fbxo11)
2.191	9	21	17	2p21	HAAO, VCRL1		3-hydroxyanthranilate 3,4-dioxygenase	604521	REc		Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3)	
2.192	8	27	09	2p21	KCNG3, KV6.3		Potassium voltage-gated channel, subfamily G, member 3	606767	REc			
2.193	10	7	08	2p21	LEPQTL1, LSL		Leptin serum levels quantitative trait locus 1	601694	Fd		[Leptin serum levels QTL1] (2)	
2.194	4	9	09	2p16.3	LHCGR, LHR, LCGR		Luteinizing hormone/choriogonadotropin receptor	152790	A		Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance, female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	
2.195	1	22	09	2p25.1	LPIN1		Lipin 1	605518	REc	related to LSL	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	12(Lpin1)
2.196	9	20	14	2p21	LRPPRC, LRP130, LSFC		Leucine-rich PPR motif-containing protein	607544	R, Fd, Ld		Leigh syndrome, French-Canadian type, 220111 (3)	
2.197	8	5	11	2p21	PKDCC, VLK, SGK493		Protein kinase domain-containing protein, cytoplasmic, mouse, homolog of	614150	REc			
2.198	4	30	09	2p21	PLEKHH2		Pleckstrin homology domain-containing protein, family H, member 2	612723	REc			
2.199	10	19	01	2p21	PPM1B		Protein phosphatase, magnesium-dependent, 1, beta isoform	603770	R	formerly PP2CB		
2.200	07	28	18	2p21	PREPL, KIAA0436, CMS22		Prolyl endopeptidase-like	609557	R, REc, D		Myasthenic syndrome, congenital, 22, 616224 (3)	
2.201	8	4	99	2p21	PRKCE, PKCE		Protein kinase C, epsilon	176975	REc			
2.202	7	1	02	2p22.2	PRKCN		Protein kinase C, nu	607077	R			
2.203	7	11	93	2p22.2	PRKR		Protein kinase, interferon-inducible double stranded RNA dependent	176871	A			17(Prkr)
2.204	8	3	12	2p21	RHOQ, ARHQ, TC10		Ras-homolog gene family, member Q	605857	R			
2.205	4	15	11	2p21	SIX3, HPE2		Sine oculis homeo box, Drosophila, homolog of, 3	603714	Ch, REc, A, R, Fd		Holoprosencephaly 2, 157170 (3); Schizencephaly, 269160 (3)	17(Six3)
2.206	7	12	02	2p21	SOCS5, CIS6, KIAA0671		Suppressor of cytokine signaling 5	607094	A	also signals at 3p22		
2.207	5	1	91	2p16.2	SPTBN1		Spectrin, beta, nonerythrocytic-1 (beta-fodrin)	182790	REa, A			
2.208	2	18	08	2p21	THADA, KIAA1767		Thyroid adenoma-associated gene	611800	REc			
2.209	5	19	15	2p21	TTC7A, TTC7, KIAA1140, MINAT, GIDID		Tetratricopeptide repeat domain 7A	609332	R, REc		Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	17(Ttc7a)
2.210	6	10	08	2p21	ZFP36L2, ERF2, TIS11D		Zinc finger protein 36-like 2	612053	REc	incorrectly mapped to 6p21.3		
2.211	1	27	11	2p21	MCFD2, F5F8D2		Multiple coagulation factor deficiency protein 2	607788	REc		Factor V and factor VIII, combined deficiency of, 613625 (3)	
2.212	2	11	08	2p21	EPAS1, MOP2, HIF2A, ECYT4		Endothelial PAS domain protein 1	603349	A, R		Erythrocytosis, familial, 4, 611783 (3)	
2.213	1	4	11	2p16.3	FSHR, ODG1		Follicle stimulating hormone receptor	136435	A, Fd		Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)	
2.214	2	4	96	2p21	PIGF		Phosphatidylinositol glycan, class F	600153	A	pseudogene on 5		17(Pigf)
2.215	8	25	04	2p21-p13	SCA25		Spinocerebellar ataxia 25	608703	Fd		Spinocerebellar ataxia 25 (2)	
2.216	3	7	14	2p21-p12	DFNA58		Deafness, autosomal dominant 58	615654	Fd	between D2S2259 and D2S2114	Deafness, autosomal dominant 58 (2)	
2.217	9	9	10	2p16.3	GTF2A1L, ALF		General transcription factor IIA, 1-like	605358	Psh, REc			
2.218	11	19	11	2p16.3	NRXN1, PTHSL2, SCZD17		Neurexin 1	600565	R, REc		Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia, susceptibility to, 17}, 614332 (3)	
2.219	4	21	10	2p21	SLC3A1, ATR1, D2H, NBAT		Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1	104614	REa, Fd, A		Cystinuria, 220100 (3)	
2.220	10	4	12	2p16.3	STON1, STN1, SBLF, SALF		Stonin 1	605357	REc, Psh			
2.221	2	16	18	2p16.2	ASB3		Ankyrin repeat-containing SOCS box protein 3	605760	REc			11(Asb3)
2.222	4	21	17	2p16.2	CHAC2		ChaC, E. coli, homolog of, 2	617446	REc			
2.223	1	26	12	2p16.2	ERLEC1, C2orf30		Erlectin (endoplasmic reticulum lectin 1)	611229	REc			
2.224	4	28	10	2p16.2	ACYP2, ACYP		Acylphosphatase 2, muscle type	102595	REc			
2.225	8	27	09	2p16.2	PSME4, PA200, KIAA0077		Proteasome activator subunit 4	607705	REa, REc			
2.226	8	31	16	2p16.1	BCL11A, CTIP1, EVI9, KIAA1809, DILOS		B-cell CLL/lymphoma 11A	606557	A		Dias-Logan syndrome, 617101 (3)	
2.227	6	1	17	2p16.1	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL		Coiled-coil domain-containing protein 88A	609736	R, REc	mutation identified in 1 PEHOL family	?PEHO syndrome-like, 617507 (3)	11(Ape)
2.228	9	8	14	2p16.1	HBFQTL5		Fetal hemoglobin quantitative trait locus 5	142335	Fd	associated with rs11886868	[Fetal hemoglobin QTL5] (2)	
2.229	3	23	09	2p16.1	MIR216, MIRN216		Micro RNA 216	610944	REc			
2.230	3	14	13	2p16.1	MIR217		Micro RNA 217	615096	REc			
2.231	3	17	16	2p16.1	PAPOLG		Poly(A) polymerase, gamma	616865	REc			
2.232	9	30	03	2p16.1	PHF9, FANCL		PHD finger protein 9	608111	R		Fanconi anemia, complementation group L, 614083 (3)	
2.233	11	29	12	2p16.1	PNPT1, OLD35, COXPD13, DFNB70		Polyribonucleotide nucleotidyltransferase 1	610316	R, REc		Combined oxidative phosphorylation deficiency 13, 614932 (3); Deafness, autosomal recessive 70, 614934 (3)	
2.234	2	5	16	2p16.1	PPP4R3B, PP4R3B, SMEK2, KIAA1387		Protein phosphatase 4, regulatory subunit 3, beta	610352	REc, R			
2.235	3	17	16	2p16-p15	PUS10, DOBI		Pseudouridylate synthase 10	612787	REc			
2.236	3	31	16	2p16.1	RPS27A, UBA80, HUBCEP80, CEP80, UBCEP1		Ribosomal protein S27a	191343	R, REc			
2.237	1	20	09	2p16.1-p15	DEL2p16.1-p15, C2DELp161-p15		Chromosome 2p16.1-p15 deletion syndrome	612513	Ch	contiguous gene deletion syndrome	Chromosome 2p16.1-p15 deletion syndrome (4)	
2.238	4	19	06	2p16	ASRT3		Asthma-related traits, susceptibility to, 3	609958	Fd	max lod at rs2063871	{Asthma-related traits, susceptibility to, 3} (2)	
2.239	9	7	00	2p16	CNC2		Carney complex, type II	605244	Fd		Carney complex, type II (2)	
2.240	6	2	99	2p16.1	EFEMP1, FBNL, DHRD		EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548	A, Fd, REc, R		Doyne honeycomb degeneration of retina, 126600 (3)	
2.241	2	21	02	2p16.2	GPR75		G protein-coupled receptor 75	606704	REc			
2.242	12	1	11	2p16.3	MSH6, GTBP, HNPCC5		MutS, E. coli, homolog of, 6	600678	REc, H	0.5 Mb from MSH2	Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3); Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)	
2.243	3	15	96	2p15	MDH1		Malate dehydrogenase, soluble	154200	S, D, A	proximal to APOB		11(Mor2)
2.244	9	3	10	2p16	STQTL24		Stature quantitative trait locus 24	613549	Fd	linked to rs1520446	{Stature QTL 24} (2)	
2.245	5	11	98	2p15	XPO1, CRM1		Exportin-1 (required for chromosome region maintenance)	602559	A			
2.246	11	29	99	2p16-p15	DYX3		Dyslexia, susceptibility to, 3	604254	Fd		{Dyslexia, susceptibility to, 3} (2)	
2.247	7	1	11	2p16-p15	GLC1H		Glaucoma 1, open angle, H	611276	Fd	between D2S123 AND D2S2165	Glaucoma 1, open angle, H (2)	
2.248	4	28	97	2p14	PPP3R1, CALNB1		Protein phosphatase-3 (formerly 2B), regulatory subunit B (19kD), alpha isoform (calcineurin B, type I)	601302	REa, A			
2.249	1	29	01	2p21	SIX2		Sine oculis homeo box, Drosophila, homolog of, 2	604994	R			17(Six2)
2.250	5	29	98	2p16.1	VRK2		Vaccinia-related kinase-2	602169	R			
2.251	6	16	99	2p16.1	MTIF2		Mitochondrial translational initiation factor 2	603766	A, Psh			
2.252	11	3	05	2p15	COMMD1, MURR1		Copper metabolism Murr1 domain-containing 1	607238	R			
2.253	6	26	13	2p15	B3GNT2, B3GNT1, B3GNT		Beta-1,3-N-acetylglucosyaminyltransferase 2	605581	REc			
2.254	5	26	05	2p15	CCT4, CCTD, SRB		Chaperonin containing T-complex polypeptide 1, subunit 4	605142	H, REc			11(mf)
2.255	4	23	08	2p15	EHBP1, KIAA0903, HPC12		EH domain-binding protein 1	609922	R, REc		{Prostate cancer, hereditary, 12}, 611868 (3)	
2.256	10	27	10	2p15	FAM161A, RP28		Family with sequence similarity 161, member A	613596	REc, Fd		Retinitis pigmentosa 28, 606068 (3)	
2.257	10	25	12	2p15	PEX13, ZWS, NALD, PBD11A, PBD11B		Peroxisome biogenesis factor 13 (peroxin 13)	601789	A		Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3); Peroxisome biogenesis disorder 11B, 614885 (3)	
2.258	12	17	12	2p15	TMEM17		Transmembrane protein 17	614950	REc			
2.259	7	1	13	2p15	USP34, KIAA0570		Ubiquitin-specific protease 34	615295	R, REc			
2.260	1	29	15	2p15	WDPCP, C2orf86, BBS15, CHDTHP		WD repeat-containing planar cell polarity effector	613580	REc	mutation identified in 1 BBS15 family and 1 CHDTHP patient	?Bardet-Biedl syndrome 15, 615992 (3); ?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	
2.261	12	29	09	2p14	ETAA1, ETAA16		Ewing tumor-associated antigen 1	613196	REc, A			
2.262	10	24	11	2p13.3	NFU1, HIRIP, MMDS1		NFU1 iron-sulfur cluster scaffold, S. cerevisiae, homolog of	608100	R, M		Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	
2.263	11	11	14	2p14	ACTR2, ARP2		Actin-related protein 2	604221	REc			
2.264	5	23	07	2p13.3	AFPL, C2orf13		Aprataxin- and PNK-like factor	611035	REc			
2.265	4	8	16	2p14	CEP68, KIAA0582		Centrosomal protein, 68kD	616889	R, REc			
2.266	4	6	18	2p14	LGALSL		Galectin-like protein	617902	REc			
2.267	4	1	96	2p14	RAB1, RAB1A		RAB1, member RAS oncogene family	179508	REa, R			11(Rab1)
2.268	1	25	18	2p14	SERTAD2, TRIPBR2, KIAA0127		SERTA domain-containing protein 2	617851	REc			
2.269	11	25	15	2p14	SLC1A4, SATT, ASCT1, SPATCCM		Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4	600229	A, REc		Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	
2.270	10	11	07	2p14	SPRED2		Sprouty-related EVH1 domain-containing protein 2	609292	REc			11(Spred2)
2.271	6	1	12	2p15-p14	VPS54, VPS54L, WR		Vacuolar protein sorting 54, S. Cerevisiae, homolog of	614633	H, REc			14(Vps54)
2.272	7	3	06	2p14-p13.3	HRPT3		Hyperparathyroidism 3	610071	Fd	between D2S2368 and D2S358	Hyperparathyroidism 3 (2)	
2.273	12	17	95	2p13.3	ADD2		Adducin-2, beta	102681	REa, A			6(Add2)
2.274	11	6	94	2p13.2	EMX1		Empty spiracles, Drosophila, homolog of, 1	600034	REa, A	close to VAX2		6(Dmx1)
2.275	4	18	97	2p14	MEIS1		Meis1, mouse, homolog of	601739	A			11(Meis1)
2.276	7	20	09	2p14-p13	RLS7		Restless legs syndrome, susceptibility to, 7	612853	Fd	associated with rs2300478	{Restless legs syndrome 7} (2)	
2.277	11	29	00	2p16.1	RTN4, NOGO		Neurite outgrowth inhibitor (reticulon 4)	604475	R			
2.278	10	23	87	2p15	UGP2, UGPP2		Uridyl diphosphate glucose pyrophosphorylase-2	191760	REa, A			
2.279	4	15	09	2p13.2	SPR		Sepiapterin reductase	182125	A		Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	1(Spr)
2.280	11	29	01	2q21.3	CCNT2		Cyclin T2	603862	R			
2.281	6	23	15	2p13.3	AAK1, KIAA1048		Adaptor protein 2-associated kinase 1	616405	R, REc			
2.282	6	27	16	2p13.3	ANKRD53		Ankyrin repeat domain-containing protein 53	617009	REc			
2.283	3	3	16	2p13.3	BMP10		Bone morphogenetic protein 10	608748	REc			
2.284	3	20	15	2p13.3	FAM136A		Family with sequence similarity 136, member A	616275	REc			
2.285	6	27	05	2p13.3	GKN1, CA11		Gastrokine 1	606402	REc			
2.286	8	27	02	2p13.1	LOXL3		Lysyl oxidase-like 3	607163	REc			
2.287	1	6	09	2p13.3	MCEE		Methylmalonyl-CoA epimerase	608419	REc		Methylmalonyl-CoA epimerase deficiency, 251120 (3)	
2.288	8	27	09	2p13.3	NAGK, GNK		N-acetylglucosamine kinase	606828	R, REc			
2.289	8	20	07	2p13.3	PAIP2B		Polyadenylate-binding protein-interacting protein 2B	611018	R, REc			
2.290	9	2	12	2p14	PELI1		Pellino, Drosophila, homolog of, 1	614797	REc			
2.291	5	22	07	2p13.3	PCYOX1, PCL1, KIAA0908		Prenylcysteine oxidase 1	610995	R, REc			
2.292	9	7	12	2p13.3	PROKR1, PKR1, GPR73		Prokineticin receptor 1	607122	REc, R			
2.293	5	25	13	2p13.3	SNRPG		Small nuclear ribonucleoprotein polypeptide G	603542	REc			
2.294	09	27	18	2p13.2	DYSF, LGMDR2, MMD1		Dysferlin	603009	Fd, A		Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3); Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)	6(Dysf)
2.295	4	18	12	2p13.2	CYP26B1, CYP26A2, P450RAI2, RHFCA		Cytochrome P450, subfamily XXVIB, polypeptide 1	605207	REc		Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	
2.296	9	9	08	2p13.2	FBXO41, FBX41, KIAA1940		F-box only protein 41	609108	REc			6(Fbxo41)
2.297	8	27	09	2p13.2	EXOC6B, SEC15B, KIAA0919		Exocyst complex component 6B	607880	R, REc			
2.298	11	19	11	2p13.3-p13.2	ZNF638, NP220		Zinc finger protein 638	614349	REc			
2.299	6	3	14	2p13.1	ACTG2, ACTA3, VSCM		Actin, gamma-2, smooth muscle, enteric	102545	REa, A		Visceral myopathy, 155310 (3)	
2.300	9	15	17	2p13.3	ANTXR1, TEM8, ATR, GAPO		Anthrax toxin receptor 1	606410	REc	mutation identified in 1 HCI patient	GAPO syndrome, 230740 (3); {?Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
2.301	1	18	12	2p13.3	ASPRV1, SASP, TAPS, MUNO		Aspartic peptidase, retroviral-like 1	611765	REc			
2.302	3	20	16	2p13.1	BOLA3, MMDS2		BolA, E. coli, homolog of, 3	613183	REc, M		Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	
2.303	8	27	09	2p13.1	DUSP11, PIR1		Dual specificity phosphatase-11, RNA/RNP complex-interacting	603092	TM, REc			
2.304	4	23	13	2p13.1	MOGS, GCS1, CDG2B		Mannosyl-oligosaccharide glucosidase	601336	A, Psh		Congenital disorder of glycosylation, type IIb, 606056 (3)	
2.305	9	12	13	2p13.1	STAMBP, AMSH, MICCAP		STAM binding protein	606247	A, REc		Microcephaly-capillary malformation syndrome, 614261 (3)	
2.306	6	13	12	2p13.1	TET3, KIAA0401		TET oncogene family, member 3	613555	R, REc			
2.307	10	31	17	2p13.1	TPRKB, GAMOS5		TP53RK-binding protein	608680	A, REc		Galloway-Mowat syndrome 5, 617731 (3)	
2.308	2	26	02	2p13.1	NAT8, TSC510		N-acetyltransferase 8	606716	R			
2.309	5	25	13	2p13.1	NAT8B, CML2		N-acetyltransferase 8B	608190	REc			
2.310	7	17	02	2p13.1	TLX2, HOX11L1		T-cell leukemia, homeobox 2	604240	REc			
2.311	4	10	02	2p13.1	ALMS1, ALSS, KIAA0328		Alstrom syndrome gene	606844	LD, Fd, REc		Alstrom syndrome, 203800 (3)	
2.312	2	9	92	2p13.3	ANXA4, ANX4		Annexin A4 (placental anticoagulant protein II)	106491	Psh, A			6(Anx4)
2.313	11	30	06	2p13.3	ARHGAP25, KAIA0053		RHO GTPase-activating protein 25	610587	Psh, REc			
2.314	6	16	99	2p13.1	AUP1		Ancient ubiquitous protein 1	602434	REc			6(Aup1)
2.315	12	26	13	2p13.2	CCT7		Chaperonin containing T-complex polypeptide 1, subunit 7	605140	REc			
2.316	3	7	14	2p13.3	CD207, LANGERIN, CLEC4K		CD207 antigen	604862	R	mutation identified in 1 patient	[?Birbeck granule deficiency], 613393 (3)	6(Langerin)
2.317	3	3	09	2p13.1	DCTN1, HMN7B		Dynactin 1 (p150, glued, Drosophila, homolog of)	601143	A, R		Neuropathy, distal hereditary motor, type VIIB, 607641 (3); {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)	
2.318	8	17	16	2p13.1	DGUOK, DGK, MTDPS3, PEOB4, NCPH		Deoxyguanosine kinase, mitochondrial	601465	Fd, REc		Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3); Portal hypertension, noncirrhotic, 617068 (3)	
2.319	12	15	98	2p13.1	DOK1		Downstream of tyrosine kinase 1	602919	R			6(Dok1)
2.320	8	24	92	2p13.2	EGR4, NGFIC		Early growth response-4	128992	A			6(Egr4)
2.321	4	30	15	2p13.3	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1		Glutamine-fructose-6-phosphate transaminase	138292	A		Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	
2.322	7	9	15	2p13.1	INO80B, PAPA1, HMGA1L4		INO80 complex, subunit B	616456	A			
2.323	8	27	02	2p13.1	LBX2		Lady bird-like homeo box 2	607164	Psh, R			6(Lbx2)
2.324	11	27	94	2p13.3	MAD		MAD protein (MAX-binding protein)	600021	A			
2.325	8	20	98	2p13	OFC2		Orofacial cleft-2	602966	Fd	?relation to TGFA	Orofacial cleft-2 (2)	
2.326	11	6	94	2p15	OTX1		Orthodenticle, Drosophila, homolog of, 1	600036	REa, A			
2.327	10	28	99	2p13	PEE1, PREG1		Preeclampsia/eclampsia 1	189800	Fd	?distinct loci at 2p25 and 9p13	Preeclampsia/eclampsia 1 (2)	
2.328	4	23	98	2p13.1	RTKN		Rhotekin	602288	Psh			6(Rtkn)
2.329	4	10	15	2p13	PARK3		Parkinson disease 3	602404	Fd		{Parkinson disease 3} (2)	
2.330	6	28	99	2p13.1	SEMAW		Semaphorin W	603706	R			6(Semawa)
2.331	12	27	13	2p13.2	SFXN5		Sideroflexin 5	615572	REc			
2.332	5	6	03	2p13.1	SLC4A5, NBC4		Solute carrier family 4, sodium bicarbonate cotransporter, member 5	606757	REc			
2.333	7	10	93	2p13.3	TGFA		Transforming growth factor, alpha	190170	REa, A			6(Tgfa)
2.334	4	17	13	2p13.3	TIA1, WDM		TIA1 cytotoxic granule-associated RNA-binding protein	603518	A, Fd		Welander distal myopathy, 604454 (3)	
2.335	12	31	99	2p13.3	VAX2		Ventral anterior homeo box 2	604295	R			6(Vax2)
2.336	6	3	02	2p14	C1D, SUNCOR		Nuclear DNA-binding protein C1D	606997	REc	pseudogene on chr.10		
2.337	3	9	98	2p13.3	PCBP1		Poly(rC)-binding protein-1	601209	A			
2.338	8	27	09	2p13.2	RAB11RIP5, RIP11, KIAA0857		Rab11 family-interacting protein 5	605536	R, REc			
2.339	5	1	91	2p16.1	REL		Oncogene REL, avian reticuloendotheliosis	164910	REa			11(Rel)
2.340	7	22	13	2p12	CTRCT27, CCNP		Cataract 27, nuclear progressive	607304	Fd	near D2S2333	Cataract 27, nuclear progressive (2)	
2.341	5	27	05	2p11.2	CD8A		CD8 antigen, alpha polypeptide (p32)	186910	REa, A	distal to IGK	CD8 deficiency, familial, 608957 (3)	6(Ly2)
2.342	9	12	93	2p11.2	CD8B1, CD8B		CD8 antigen, beta polypeptide 1 (p37)	186730	REa, H	pseudogene, CD8B2, on 2q12		6(Ly3)
2.343	1	6	11	2p12	DFNA43		Deafness, autosomal dominant 43	608394	Fd	max lod at D2S139	Deafness, autosomal dominant 43 (2)	
2.344	8	14	00	2p11.2	EIF2AK3, PEK, PERK, WRS		Eukaryotic translation initiation factor 2-alpha kinase 3	604032	A, R, Fd		Wolcott-Rallison syndrome, 226980 (3)	
2.345	9	23	08	2p13.3	FIGLA, POF6		Factor in germline alpha, mouse, homolog of	608697	REc		Premature ovarian failure 6, 612310 (3)	
2.346	3	13	07	2p11.2	GGCX, VKCFD1		Gamma-glutamyl carboxylase	137167	REa, A		Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	
2.347	4	11	97	2p12	HK2		Hexokinase-2, muscle	601125	Fd	no recombination with TGFA		
2.348	7	24	15	2p11.2	IGKC, IGKCD		Immunoglobulin kappa constant region	147200	REa, A		Kappa light chain deficiency, 614102 (3)	6(Igkc)
2.349	4	15	08	2p12	IGKJ@		Immunoglobulin kappa light chain joining gene cluster	146970	REa, A	5 genes		
2.350	4	15	08	2p12	IGKV@		Immunoglobulin kappa light chain variable gene cluster	146980	REa, A	25+ genes in 4 classes; orphon gene 1.5Mb telomeric of IGKC		6(Igkv)
2.351	6	18	91	2p11.2	IGKDEL		Immunoglobulin kappa polypeptide deleting element	146780	RE			6(Igkrs)
2.352	2	5	16	1p36.12	PLA2G2F		Phospholipase A2, group IIf	616793	REc			4(Pla2g2f)
2.353	3	26	07	2p12	LRRTM1		Leucine-rich repeat transmembrane protein 1	610867	REn, H			6(Lrrtm1)
2.354	3	26	07	2p12	LRRTM4		Leucine-rich repeat transmembrane protein 4	610870	REn, H			6(Lrrtm4)
2.355	3	5	08	2p13.1	MRPL53		Mitochondrial ribosomal protein L53	611857	R, REc	pseudogene on 1		
2.356	3	17	94	2p12	PAP		Pancreatitis-associated protein	167805	REa, A, REc			
2.357	10	7	02	2p12	POLE4		Polymerase, DNA, epsilon-4	607269	REc			
2.358	12	19	16	2p13.1	HTRA2, OMI, PARK13, PRSS25, MGCA8		HTRA serine peptidase 2	606441	REc, A		{Parkinson disease 13}, 610297 (3); 3-methylglutaconic aciduria, type VIII, 617248 (3)	
2.359	3	14	96	2p12	REG1A, PSPS1, REG		Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)	167770	A, Psh, REc			12(Reg1)
2.360	2	28	06	2p12	REG3G, PAP1B		Regenerating islet-derived 3-gamma	609933	REc			
2.361	10	4	93	2p12	REGL, PSPS2		Regenerating islet-derived, rat, homolog-like (pancreatic stone protein-like; pancreatic thread protein-like)	167771	A			?3(Reg2)
2.362	5	28	02	2p13.1	WBP1		WW domain-binding protein 1	606961	A			
2.363	2	1	11	2p12-p11.2	DEL2p12p11.2, C2DELp12p11.2		Chromosome 2p12-p11.2 deletion syndrome	613564	Ch	contiguous gene deletion syndrome	Chromosome 2p12-p11.2 deletion syndrome (4)	
2.364	5	21	07	2p11.2	SFTPB, SFTB3, SMDP1		Pulmonary surfactant-associated protein B, 18kD	178640	REa, A		Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	6(Sftp3)
2.365	5	13	02	2p11.2	VAMP8		Vesicle-associated membrane protein 8	603177	R			6(Vamp8)
2.366	8	11	98	2p12	CTNNA2, CAPR, CTNR		Catenin, alpha-2 (cadherin-associated protein, related)	114025	A			6(Capr)
2.367	1	31	00	2p11.2	GNLY, D2S69E, TLA519		Granulysin (T-lymphocyte activation gene 519)	188855	A			
2.368	3	5	03	2p12-q22	HSR		Hand skill, relative	139900	Fd		[Handedness] (2)	
2.369	5	2	94	2p22.3	LTBP1		Latent transforming growth factor beta binding protein 1	150390	REa			
2.370	9	29	13	2p11.2	ELMOD3, RBED1, DFNB88		ELMO/CED12 domain-containing protein 3	615427	REc	one family identified with mutation	?Deafness, autosomal recessive 88, 615429 (3)	
2.371	2	21	06	2p11.2	DNAH6, HL2		Dynein, axonemal, heavy chain 6	603336	A, R, REc			
2.372	10	21	08	2p11.2	FOXI3		Forkhead box I3	612351	REc			
2.373	2	20	09	2p11.2	IMMT, HMP		Inner membrane protein, mitochondrial (mitofilin)	600378	REc, R	pseudogene on chr.21		
2.374	7	18	12	2p11.2	KCMF1, DEBT91, FIGC		Potassium channel modulatory factor 1	614719	REc, H			
2.375	10	24	11	2p11.2	KDM3A, JMJD1A, JHDM2A, TSGA, KIAA0742		Lysine-specific demethylase 3A	611512	R, REc			
2.376	8	4	97	2p11.2	MAT2A, MATA2, SAMS2		Methionine adenosyltransferase II, alpha	601468	A			
2.377	3	5	08	2p11.2	MRPL35		Mitochondrial ribosomal protein L35	611841	REc	pseudogenes on 6, 10, and X		
2.378	5	19	15	2p11.2	PARTICL		Promoter of MAT2A antisense radiation-induced circulating long noncoding RNA	616350	REc	overlaps promoter of MAT2A on opposite strand		
2.379	7	9	15	2p11.2	POLR1A, RPA194, AFDCIN		Polymerase I, RNA, subunit A	616404	REc		Acrofacial dysostosis, Cincinnati type, 616462 (3)	
2.380	12	10	12	2p11.2	PTCD3		Pentatricopeptide repeat domain-containing protein 3	614918	REc			
2.381	1	21	15	2p11.2	REEP1, C2orf23, SPG31, HMN5B		Receptor expression-enhancing protein 1	609139	Fc, R, REc	mutation identified in 1 HMN5B family	Spastic paraplegia 31, autosomal dominant, 610250 (3); ?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	
2.382	7	27	17	2p11.2	RETSAT		Retinol saturase	617597	REc			
2.383	4	23	09	2p11.2	RGPD1, RGP1		RANBP2-like and GRIP domain-containing protein 1	612704	REn			
2.384	4	23	09	2p11.2	RGPD2, RGP2		RANBP2-like and GRIP domain-containing protein 2	612705	REn			
2.385	12	22	08	2p11.2	RNF181		Ring finger protein 181	612490	R, REc			
2.386	2	17	15	2p11.2	RPIA, RPI, RPIAD		Ribose 5-phosphate isomerase A	180430	R, REc	mutation identified in 1 RPAID patient	?Ribose 5-phosphate isomerase deficiency, 608611 (3)	
2.387	9	16	16	2p11.2	SIAT9, ST3GALV, SPDRS		Sialyltransferase 9	604402	REc, Fd		Salt and pepper developmental regression syndrome, 609056 (3)	
2.388	12	13	17	2p11.2	SMYD1, BOP, ZMYND18		SET and MYND domain-containing protein 1	606846	REc			
2.389	12	27	10	2p11.2	SUCLG1, SUCLA1, MTDPS9		Succinate-CoA ligase, alpha subunit	611224	R, REc		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	
2.390	6	13	12	2p11.2	TCF7L1		Transcription factor 7-like 1	604652	REc			
2.391	3	4	10	2p11.2	TGOLN2, TGN46, TGN38		Trans-golgi network protein 2, 46kD	603062	A			
2.392	8	19	13	2p11.2	THNSL2, THS2		Threonine synthase-like 2	611261	REc			
2.393	1	14	16	2p11.2	TMEM150A, TMEM150		Transmembrane protein 150A	616757	REc			
2.394	3	7	14	2p11.2	TMSB10		Thymosin, beta-10	188399	REc			
2.395	12	10	12	2p11.2	TRABD2A, TIKI1		TRAB domain-containing protein 2A	614912	REc			
2.396	2	23	08	2p11.2	USP39, SAD1		Ubiquitin-specific protease 39	611594	REc			
2.397	8	27	09	2p11.2	VAMP5		Vesicle-associated membrane protein 5 (myobrevin)	607029	R, REc			
2.398	6	24	99	2p11.2	ZFP103, KF1		Zinc finger protein 103, mouse, homolog of	602507	A			
2.399	9	19	00	2p12	C2orf3, TCF9, GCF		GC factor	189901	A			
2.400	1	30	07	2q11.2	ANKRD23, DARP		Ankyrin repeat domain-containing protein 23	610736	REc			
2.401	2	28	08	2p12	MRPL19, MRPL15, KIAA0104		Mitochondrial ribosomal protein L19	611832	Psh, R			
2.402	4	23	08	2q11.1	MRPS5		Mitochondrial ribosomal protein S5	611972	R, REc			
2.403	1	25	88	2p11.2	FABP1		Fatty acid-binding protein, liver	134650	REa, A			6(Fabpl)
2.404	11	23	16	2q11.2	NEURL3, LINCR		Neuralized E3 ubiquitin protein ligase 3	617206	REc			
2.405	7	15	04	2p12	TACR1, TAC1R, NK1R		Tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor)	162323	REa, Psh, Fd			
2.406	9	2	08	2p11.2	PLGLB1, PLGL, PRGB		Plasminogen-like B1	173340	REa, A			
2.407	9	20	00	2p14	PLEK		Pleckstrin	173570	H			11(Plek)
2.408	12	4	95	2p24.2	VSNL1		Visinin-like 1	600817	Fd			
2.409	1	5	99	2p13.3	ATP6B1, VPP3		ATPase, H+ transporting, lysosomal, beta polypeptide, 58kD (vacuolar proton pump, subunit 3)	192132	REa, R, Fd		Renal tubular acidosis with deafness, 267300 (3)	8(Atp6b1)
2.410	3	8	91	2q11.2	COX5B		Cytochrome c oxidase, subunit Vb	123866	REa	7 pseudogenes on 4, 6, 7, 11, 12, 13, and 22		
2.411	2	14	02	2cen-q13	GLC1B		Glaucoma 1, open angle, B (adult-onset)	606689	Fd		Glaucoma 1B, primary open angle, adult onset, (2)	
2.412	10	23	87	2q14.2	INHBB		Inhibin, beta-2	147390	REa			1(Inhbb)
2.413	10	23	87	2q11.1	MAL		T-lymphocyte maturation-associated protein	188860	REa			
2.414	12	19	90	2q14.2	RALB		RAS-like protein B	179551	REa			
2.415	1	1	95	2p11.2	CAPG		Capping protein (actin filament), gelsolin-like	153615	Psh, A			
2.416	3	24	05	2q	AUTS5		Autism, susceptibility to, 5	606053	Fd	max lod at D2S188	{Autism susceptibility 5} (2)	
2.417	2	28	06	2q	COPD		Pulmonary disease, chronic obstructive, severe early-onset	606963	Fd	?SERPINE2	Pulmonary disease, chronic obstructive, severe early-onset (2)	
2.418	10	7	98	2q11.2	CNGA3, CNG3, ACHM2		Cyclic nucleotide-gated channel, alpha-3	600053	Fd, R		Achromatopsia 2, 216900 (3)	
2.419	10	15	98	2q11.2	DUSP2, PAC1		Dual-specificity phosphatase-2	603068	REa, A			
2.420	7	26	10	2q11.2	TMEM127		Transmembrane protein 127	613403	REc		{Pheochromocytoma, susceptibility to}, 171300 (3)	
2.421	4	25	08	2q11-q12	CELIAC8		Celiac disease, susceptibility to, 8	612006	Fd	associated with rs917997 and rs13015714	{Celiac disease, susceptibility to, 8} (2)	
2.422	12	17	12	2q13	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B		Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095	Fd, R		Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3); Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)	
2.423	10	3	11	2q13	RANBP2, NUP358, ANE1, IIAE3		RAN-binding protein 2	601181	A		{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	10(Ranbp2)
2.424	3	20	08	2q11-q14	NNO3		Nanophthalmos 3	611897	Fd	max lod at D2S2265	Nanophthalmos 3 (2)	
2.425	8	17	98	2q14.1	SLC20A1, GLVR1		Solute carrier family 20, phosphate transporter, member 1 (Gibbon ape leukemia virus receptor-1)	137570	REa, A			2(Slc20a1)
2.426	9	9	10	2q11.1	KCNIP3, KCHIP3, CSEN, DREAM		Potassium channel-interacting protein 3	604662	REc			
2.427	10	25	16	2q11.1	PROM2, PROML2		Prominin 2	617160	REc, H			2(Prom2)
2.428	1	30	01	2q11.2	ACTR1B, ARP1B, CTRN2		Actin-related protein 1B	605144	REa, A			
2.429	4	23	98	2q12.3	SULT1C1		Sulfotransferase 1C1	602385	Psh			
2.430	6	18	15	2q11.2	ADRA2B, ADRA2L1, FAME2		Adrenergic, alpha-2B-, receptor	104260	REa, REc, Fd		Epilepsy, myoclonic, familial adult, 2, 607876 (3)	
2.431	12	7	07	2q11.2	ARID5A, MRF1		AT-rich interactive domain-containing protein 5A	611583	R, REc			
2.432	5	17	18	2q11.2	NCAPH, CAPH, BRRN1, MCPH23		Non-SMC condensin I complex subunit H	602332	REa, REc, R	mutation identified in 1 MCPH23 patient	?Microcephaly 23, primary, autosomal recessive, 617985 (3)	
2.433	7	31	15	2q11.2	COA5, C2orf64, PET191, CEMCOX3		Cytochrome c oxidase assembly factor 5	613920	REc	mutation identified in 1 CEMCOX3 family	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	
2.434	8	27	09	2q11.2	CHST10, HNK1ST		Carbohydrate sulfotransferase 10	606376	R, REc			
2.435	8	31	12	2q11.2	CIAO1, WDR39		WD repeat-containing protein CIAO1	604333	A, R			
2.436	8	31	09	2q11.2	CNNM3, ACDP3		Cyclin M3	607804	R, REc	previously assigned to 2p12-p11.2		
2.437	8	31	09	2q11.2	CNNM4, ACDP4		Cyclin M4	607805	R, Fd, REc		Jalili syndrome, 217080 (3)	1(Cnnm4)
2.438	9	30	09	2q24.1	CYTIP, PSCDBP, HE		Cytohesin 1 interacting protein	604448	Re, R			
2.439	6	23	15	2q11.2	GPAT2		Glycerol-3-phosphate acyltransferase 2, mitochondrial	616431	REc			
2.440	2	9	00	2q12.1	IL1RL1		Interleukin 1 receptor-like 1	601203	REa, A, R			
2.441	10	24	00	2q11.2	INPP4A, INPP4		Inositol polyphosphate-4-phosphatase, type I, 107kD	600916	A			
2.442	10	25	17	2q11.2	KANSL3, NSL3, KIAA1310		Kat8 regulatory NSL complex, subunit 3	617742	REc			
2.443	4	4	16	2q11.2	LMAN2L, VIPL, MRT52		LMAN2-like protein	609552	REc	mutation identified in 1 MRT52 family	?Mental retardation, autosomal recessive, 52, 616887 (3)	
2.444	4	30	15	2q11.2	LIPT1, LIPT1D		Lipoyltransferase 1	610284	A		Lipoyltransferase 1 deficiency, 616299 (3)	
2.445	9	21	15	2q11.2	LYG2, LYSG2		Lysozyme G-like 2	616547	REc			
2.446	2	25	15	2q11.2	MAP4K4, HGK, NIK, KIAA0687		Mitogen-activated protein kinase kinase kinase kinase 4	604666	REc			
2.447	2	28	08	2q11.2	MRPL30, MRPL28		Mitochondrial ribosomal protein L30	611838	R			
2.448	12	17	07	2q11.2	PDCL3, PHLP3, VIAF		Phosducin-like 3	611678	R, REc			
2.449	8	3	12	2q11.2	REV1L, REV1		Rev1, S. cerevisiae, homolog of	606134	REc			
2.450	4	21	17	2q11.2	RPL31		Ribosomal protein L31	617415	Psh			
2.451	1	1	96	2q12.1	SLC9A2		Solute carrier family 9 (sodium/hydrogen exchanger), member 2	600530	REa, A			1(Slc9a2)
2.452	2	19	10	2q11.2	SNRNP200, ASCC3L1, KIAA0788, RP33		Small nuclear ribonucleoprotein 200kD (U5)	601664	R, REc, Fd		Retinitis pigmentosa 33, 610359 (3)	
2.453	12	22	15	2q11.2	STARD7, GTT1		START domain-containing protein 4	616712	REc			
2.454	1	27	04	2q12.3	SULT1C2		Sulfotransferase family 1C, member 2	608357	REc			
2.455	3	7	14	2q11.2	TMEM131, KIAA0257, CC28		Transmembrane protein 131	615659	REc, R			
2.456	5	9	18	2q11.2	TSGA10, SPGF26		Testis-specific protein 10	607166	Psh, A	mutation identified in 1 SPGF26	?Spermatogenic failure 26, 617961 (3)	
2.457	2	4	09	2q11.2	TXNDC9, PHLP3		Thioredoxin domain-containing protein 9	612564	REc			
2.458	12	22	17	2q11.2	UNC50, UNCL, GMH1		Unc50, inner nuclear membrane RNA-binding protein	617826	REc			
2.459	5	23	16	2q11.2	VWA3B, SCAR22		von Willebrand factor A domain-containing protein 3B	614884	REc	mutation identified in 1 SCAR22 family	?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	
2.460	3	1	01	2q11.1	ZNF2		Zinc finger protein-2	194500	REa, A			
2.461	5	5	00	2q12.1	GPR45		G protein-coupled receptor 45	604838	A			
2.462	10	17	96	2q11.2	LAF4		Lymphoid nuclear protein related to AF4	601464	A, Ch			1(Laf4)
2.463	2	19	04	2q12.3	ST6GALII, KIAA1877		Beta-galactoside alpha-2,6-sialyltransferase II	608472	R, REc			
2.464	3	1	00	2q12.1	IL18R1, IL1RRP		Interleukin 18 receptor 1	604494	R			
2.465	3	10	00	2q12.1	IL18RAP, ACPL		Interleukin 18 receptor accessory protein	604509	R			
2.466	8	17	98	2q11.2-q12.1	IL1R1, IL1RA		Interleukin-1 receptor, type I	147810	REa, A			1(Il1r)
2.467	2	9	00	2q12.1	IL1RL2, IL1RRP2		Interleukin 1 receptor-like 2	604512	R			
2.468	3	8	00	2q11.2	MGAT4A		Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A	604623	A			
2.469	5	12	00	2q12.2	NCK2		NCK adaptor protein 2	604930	A			
2.470	12	23	05	2q12.2	UXS1, UGD		UDP-glucuronate decarboxylase 1	609749	R, REc			
2.471	6	30	16	2q11.2	ZAP70, SRK, ADMIO2, IMD48		Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)	176947	A		Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3); Immunodeficiency 48, 269840 (3)	1(Zap70)
2.472	7	9	06	2q14.2	MARCO		Macrophage receptor with collagenous structure	604870	A			1(Marco)
2.473	6	23	98	2q12.2	FHL2, DRAL		Four and a half LIM domains-2 (Down-regulated in rhabdomyosarcoma LIM protein)	602633	A			
2.474	9	28	00	2q12-q14	IGKV1OR2-108, IGO1		Immunoglobulin orphon (transposed element) 1	147185	A			
2.475	8	27	01	2q14.1	PAX8		Paired box homeotic gene-8	167415	REa, A		Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	2(Pax8)
2.476	1	5	93	2q14.2	DBI		Diazepam-binding inhibitor	125950	A, REa	?on 6q21-qter		
2.477	12	21	98	2q11.2	IL1R2, IL1RB		Interleukin-1 receptor, type II	147811	REa, A			1(Il1rb)
2.478	9	10	07	2q37.1	SNORD82, RNU82		Small nucleolar RNA, C/D box, 82	611133	REc			
2.479	2	26	95	2q37.1	NCL		Nucleolin	164035	REa			
2.480	9	1	11	2q14.1	IL37, IL1F7, FIL1Z, IL1H4, IL1RP1		Interleukin 37	605510	R			
2.481	8	17	16	2q12.1	LNC13		Long noncoding RNA 13	617071	REc			
2.482	4	23	08	2q12.1	MRPS9		Mitochondrial ribosomal protein S9	611975	R, REc			
2.483	4	13	98	2q12.1	POU3F3		POU domain, class 3, transcription factor-3	602480	A	previously mapped to 3p14.2		1(Pou3f3)
2.484	4	30	09	2q12.1	SLC9A4, NHE4		Solute carrier family 9 (sodium/hydrogen exchanger), member 4	600531	REa			1(Slc9a4)
2.485	8	27	09	2q12.1-q12.2	TGFBRAP1, TRAP1		Transforming growth factor-beta receptor-associated protein 1	606237	REc			
2.486	9	2	08	2q12.2	PLGLA, PRGA		Plasminogen-like A	612212	R, REc			
2.487	10	11	16	2q12.3	SULT1C3		Sulfotransferase family 1C, member 3	617151	REn			
2.488	4	23	09	2q12.3	GCC2, GCC185, KIAA0336		GRIP and coiled-coil domains-containing protein 2	612711	R, REc			
2.489	10	11	16	2q12.3	SLC5A7, CHT1, HMN7A, CMS20		Solute carrier family 5 (choline transporter), member 7	608761	REc, R		Neuronopathy, distal hereditary motor, type VIIA, 158580 (3); Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3)	
2.490	4	23	09	2q12.2	RGPD3, RGP3		RANBP2-like and GRIP domain-containing protein 3	612706	REn			
2.491	4	23	09	2q12.3	RGPD4, RGP4		RANBP2-like and GRIP domain-containing protein 4	612707	REn			
2.492	4	23	09	2q13	RGPD5, RGP5, BS63		RANBP2-like and GRIP domain-containing protein 5	612708	REn			
2.493	4	23	09	2q13	RGPD6, RGP6		RANBP2-like and GRIP domain-containing protein 6	612709	REn			
2.494	4	23	09	2q12.3-q13	RGPD7, RGP7		RANBP2-like and GRIP domain-containing protein 7	612710	REn			
2.495	4	23	09	2q14.1	RGPD8, RGP8, RANBP2L1		RANBP2-like and GRIP domain-containing protein 8	602752	A, REc			
2.496	3	6	08	2q14.1	DPP10, DPRP3, KIAA1492		Dipeptidyl peptidase X	608209	REc			
2.497	8	8	13	2q13	ANAP1, APC1		Anaphase-promoting complex, subunit 1	608473	Psh, A, R			
2.498	10	11	16	2q13	BCL2L11, BIM		BCL2-like 11	603827	A, REc			
2.499	1	12	15	2q14.1	CKAP2L, RADMIS		Cytoskeleton-associated protein 2-like	616174	REc		Filippi syndrome, 272440 (3)	
2.500	3	31	03	2q13	COMA		Cogan-type congenital oculomotor apraxia	257550	D	independent gene or feature of nephronophthisis	Oculomotor apraxia, congenital, Cogan-type (2)	
2.501	3	17	08	2q13-q14	FBLN7, TM14		Fibulin 7	611551	REc			
2.502	10	15	97	2q13	MALL, BENE		mal, T-cell differentiation protein-like	602022	REn, REc			
2.503	9	1	11	2q14.1	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14		Interleukin 36 receptor antagonist	605507	R, REc		Psoriasis 14, pustular, 614204 (3)	
2.504	9	1	11	2q14.1	IL36A, IL1F6, FIL1E		Interleukin 36, alpha	605509	REc, R			
2.505	9	1	11	2q14.1	IL36B, IL1F8, IL1H2, FIL1H		Interleukin 36, beta	605508	R, REc			
2.506	9	1	11	2q14.1	IL36G, IL1F9, IL1H1, IL1RP2		Interleukin 36, gamma	605542	REc, R			
2.507	7	12	17	2q13	MIR4435-2HG, MORRBID		MIR4435-2 host gene (long noncoding RNA MORRBID)	617144	REc			
2.508	6	16	99	2q11.2	NPAS2, MOP4		Neuronal PAS domain protein 2	603347	R, Psh			1(Npas2)
2.509	6	16	04	2q13	NPHP1, NPH1, SLSN1, JBTS4		Nephrocystin	607100	Fd		Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1, 266900 (3); Joubert syndrome 4, 609583 (3)	
2.510	1	30	12	2q14.1	PSD4, EFA6B, TIC		Pleckstrin and Sec7 domains-containing protein 4	614442	REc			
2.511	11	27	00	2q14.1	RABL2A		RAB-like 2A	605412	A			
2.512	1	22	08	2q13	SEPT10		Septin 10	611737	REc	pseudogene on 8q22.1-q12		
2.513	11	23	16	2q13	TMEM87B		Transmembrane protein 87B	617203	REc			
2.514	12	4	03	2q14.1	TTL		Tubulin-tyrosine ligase	608291	REc			2(Ttl)
2.515	3	1	12	2q14.3	PROC, PC, THPH3, THPH4		Protein C (inactivator of coagulation factors Va and VIIIa)	612283	REa, A		Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	
2.516	8	21	07	2q14.1	CBWD2		Cobalamin synthetase W domain-containing protein 2	611079	REc			
2.517	8	21	07	2q14.1	FOXD4L1		Forkhead box D4-like 1	611084	REc			
2.518	3	22	93	2q14.2	EN1		Engrailed-1	131290	REa			1(En1)
2.519	11	7	17	2q14.3	BIN1, AMPHL, CNM2		Box-dependent MYC-interacting protein-1 (amphiphysin-like)	601248	Psh, A		Centronuclear myopathy 2, 255200 (3)	18(Bin1)
2.520	6	22	14	2q13	BUB1		Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of (mitotic checkpoint gene BUB1)	602452	A, R		Colorectal cancer with chromosomal instability, somatic (3)	2(Bub1)
2.521	8	27	09	2q14.2-q14.3	CLASP1, KIAA0622		CLIP-associated protein 1	605852	R, REc			
2.522	5	26	13	2q14.3	CNTNAP5, CASPR5		Contactin-associated protein-like 5	610519	REc			
2.523	1	17	08	2q14.2	EPB41L5, KIAA1548		Erythrocyte membrane protein band 4.1-like 5	611730	R, REn			
2.524	12	10	14	2q14.2	GLI2, HPE9, CJS		GLI-Kruppel family member GLI2 (oncogene GLI2)	165230	REa, A		Holoprosencephaly 9, 610829 (3); Culler-Jones syndrome, 615849 (3)	
2.525	6	11	98	2q14.1	IL1A		Interleukin-1, alpha	147760	H, REa, A	within 430kb of IL1B, IL1RN		2(Il1a)
2.526	5	27	05	2q14.1	IL1B		Interleukin-1, beta	147720	REa, A, H	within 430kb of IL1RN, IL1A	{Gastric cancer risk after H. pylori infection}, 137215 (3)	2(Il1b)
2.527	7	1	13	2q14.1	IL1F10, IL1HY2		Interleukin 1 family, member 10	615296	REc			
2.528	12	23	05	2q14.2	TFCP2L1, CRTR1, LBP9		Transcription factor CP2-like 1	609785	R, REc			
2.529	6	9	08	2p14	WDR92, LOC116143, MONAD		WD repeat-containing protein 92	610729	R, REc			
2.530	11	14	14	2q14.3	GYPC, GE, GPC		Glycophorin C	110750	A		{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich], 616089 (3)	
2.531	9	14	89	2q14-q21	LCO		Liver cancer oncogene	165320	REa, REb, A		?Hepatocellular carcinoma (1)	
2.532	2	10	95	2q14-q21	VIS1, HIS1		Viral integration site 1	164755	A			2(His1)
2.533	11	9	99	2q14-q22	CMD1H		Cardiomyopathy, dilated, 1H	604288	Fd		Cardiomyopathy, dilated, 1H (2)	
2.534	4	22	10	2q14.1	ACTR3, ARP3		Actin-related protein 3	604222	REc			
2.535	12	24	08	2q14.1	BMIQ13		Body mass index quantitative trait locus 13	612459	Fd	associated with rs7566605	[Body mass index QTL13] (2)	
2.536	6	17	16	2q14.1	CHCHD5, MIC14		Coiled coil-helix-coiled coil-helix domain-containing protein 5	616978	REc			
2.537	12	4	08	2q14.1-q14.2	INSIG2		Insulin-induced gene 2	608660	REc			
2.538	11	8	95	2q14.2	SCTR		Secretin receptor	182098	A			
2.539	4	6	11	2q13	MERTK, RP38		Mer tyrosine kinase protooncogene	604705	A, Fd		Retinitis pigmentosa 38, 613862 (3)	
2.540	7	9	06	2q14.1	DDX18		DEAD/H box 18	606355	R, REc			
2.541	9	27	17	2q14.1	POLR1B		Polymerase I, RNA, subunit B	602000	REc			
2.542	1	28	08	2q12.2	C2orf40, ECRG4		Esophageal cancer-related gene 4	611752	REc			
2.543	11	19	11	2q14.2	C1QL2, CTRP10, C1QTNF10		Complement component 1, q subcomponent-like 2	614330	REc			
2.544	10	1	17	2q14.2	PTPN4, PTPMEG1		Protein-tyrosine phosphatase, nonreceptor-type, 4	176878	REc			
2.545	7	9	09	2q14.1	IL1RN, MVCD4, DIRA		Interleukin-1 receptor antagonist	147679	REa, Fd, A		{Gastric cancer risk after H. pylori infection}, 137215 (3); {Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)	
2.546	11	20	15	2q14.2	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN		RNA, U4, small nuclear, AT-AC form	601428	REc, Fd		Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3); Roifman syndrome, 616651 (3)	
2.547	5	24	13	2q14.2	STEAP3, TSAP6, AHMIO2		Six-transmembrane epithelial antigen of prostate 3	609671	A	mutation identified in 1 AHMIO2 family	?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	1(Steap3)
2.548	09	27	18	2q14.3	LIMS2, PINCH2, MDRCMTT		LIM and senescent cell antigen-like domains 2	607908	REc	mutation identified in 1 LGMD2W family	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3)	
2.549	6	27	14	2q14.3	MAP3K2, MEKK2		Mitogen-activated protein kinase kinase kinase 2	609487	REc, R			
2.550	3	6	18	2q14.3	NIFK, MKI67IP, NOPP34		Nucleolar protein interacting with the FHA domain of MKI67	611970	REc			
2.551	9	27	17	2q14.3	POLR2D		Polymerase II, RNA, subunit D	606017	REc, A			
2.552	12	28	08	2q14.3	SAP130		Sin3A-associated protein, 130kD	609697	R, REc			
2.553	8	27	09	2q14.3	UGGT1, HUGT1		UDP-glucose glycoprotein glucosyltransferase 1	605897	REc			
2.554	8	10	18	2q14.3	WDR33, WDC146		WD repeat-containing protein 33	618082	REc, A			
2.555	4	27	12	2q14.3-q21.3	DYT21		Dystonia 21	614588	Fd		Dystonia 21 (2)	
2.556	4	16	03	2q22.1	CXCR4, D2S201E, NPY3R, WHIMS		Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3)	162643	Psh, A		WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)	
2.557	6	2	15	2q14.3	ERCC3, XPB, TTD2		Excision-repair cross-complementing rodent repair deficiency, complementation group 3	133510	S, A		Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy 2, photosensitive, 616390 (3)	
2.558	10	15	98	2q14.3	GPR17		G protein-coupled receptor-17	603071	REa, A			
2.559	10	17	12	2q14.3	HS6ST1, HS6ST, HH15		Heparan sulfate 6-O-sulfotransferase 1	604846	R, REc		{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	
2.560	1	23	09	2q21.3	LCT, LAC, LPH		Lactase (lactase-phlorizin hydrolase)	603202	REa, Fd, A, Psh		Lactase deficiency, congenital, 223000 (3)	
2.561	2	5	09	2q21.3	MCM6		Minichromosome maintenance deficient (mis5, S. pombe) 6	601806	A	mutations in introns 9 and 13	Lactase persistence/nonpersistence, 223100 (3)	
2.562	7	1	97	2q21.2-q21.3	MGAT5		Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl- glucosaminyltransferase	601774	A			
2.563	3	23	09	2q21.3	MIR128-1, MIRN128-1, MIR128A		Micro RNA 128-1	611774	REc			
2.564	9	1	15	2q21	NMTC3		Nonmedullary thyroid carcinoma 3	606240	Fd		{Thyroid carcinoma, nonmedullary, 3} (2)	
2.565	11	20	98	2q21.2	GPR39		G protein-coupled receptor-39	602886	A			
2.566	3	17	94	2q24.3	SCN7A, SCN6A		Sodium channel, voltage-gated, type VII, alpha polypeptide	182392	Pcm			
2.567	9	23	08	2q21.1	ADHD5		Attention deficit-hyperactivity disorder, susceptibility to, 5	612311	Fd	max lod at rs985162	{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)	
2.568	11	16	15	2q21.1	CFC1, CRYPTIC, HTX2		Cryptic protein	605194	R		Heterotaxy, visceral, 2, autosomal, 605376 (3)	
2.569	9	7	10	2q21.1	FAM128A, MOZART2A		Family with sequence similarity 128, member A	613449	REc			
2.570	9	7	10	2q21.1	FAM128B, MOZART2B		Family with sequence similarity 128, member B	613450	REc			
2.571	9	2	09	2q21.1	IMP4, BXDC4		Imp4, S. cerevisiae, homolog of	612981	REc			
2.572	12	27	01	2q14.3	MYO7B		Myosin VIIb	606541	R, A			18(Myo7b)
2.573	6	7	10	2q21.1	POTEE, POTE2		POTE ankyrin domain family, member E	608914	REc, A	5 POTE2 genes within 2Mb segment		
2.574	8	18	12	2q21.1	POTEKP, ACT, ACTBL3, POTEK, FKSG30		POTE ankyrin domain family, member K, pseudogene	611266	REc			
2.575	8	27	09	2q21.1	PTPN18, BDP1		Protein-tyrosine phosphatase, nonreceptor-type, 18	606587	R, REc			
2.576	3	2	01	2q14.3	TSN		Translin	600575	REa, A			
2.577	7	22	09	2q21.1	RAB6C, WTH3		Ras-associated protein RAB6C	612909	REc			
2.578	5	24	13	2q21.1	SMPD4, NSMASE3, KIAA1418		Sphingomyelin phosphodiesterase 4, neutral membrane	610457	REc			
2.579	4	6	18	2q21.1	TUBA3D, KTCN9		Tubulin, alpha-3D	617878	REc		Keratoconus 9, 617928 (3)	
2.580	12	4	03	2q21.1-q22	CHDS2		Coronary heart disease, susceptibility to, 2	608316	Fd		{Coronary heart disease, susceptibility to, 2} (2)	
2.581	2	26	16	2q21.1	CCDC115, CCP1, CDG2O		Coiled-coil domain-containing protein 115	613734	REc		Congenital disorder of glycosylation, type IIo, 616828 (3)	1(Ccdc115)
2.582	5	24	13	2q21.2	LYPD1, PHTS		LY6/PLAUR domain-containing protein 1	610450	REc			
2.583	3	14	13	2q21.2	NCKAP5, NAP5		NCK-associated protein 5	608789	REc			
2.584	12	22	17	2q21.3	DARS, HBSL, HBSL		Aspartyl tRNA synthetase	603084	REc		Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	
2.585	3	22	06	2q21.3	RAB3GAP1, WARBM1, P130		RAB3 GTPase-activating protein, catalytic subunit	602536	REc		Warburg micro syndrome 1, 600118 (3)	
2.586	5	19	16	2q21.3	ZRANB3		Zinc finger RANBP2-type domain-containing protein 3	615655	REc			
2.587	5	29	15	2q21.3	UBXN4, UBXD2, KIAA2042, ERASIN		UBX domain protein 4	611216	REc, R			
2.588	6	30	08	2q21.1	ARHGEF4, ASEF		RHO guanine nucleotide exchange factor 4	605216	A			
2.589	7	3	06	2q22.3	GTDC1		Glycosyltransferase-like domain containing 1	610165	REc			
2.590	1	13	16	2q22.1	HNMT, MRT51		Histamine N-methyltransferase	605238	A, REc		{Asthma, susceptibility to}, 600807 (3); Mental retardation, autosomal recessive 51, 616739 (3)	
2.591	6	4	98	2q23.3	NEB, NEM2		Nebulin	161650	REa, Ch, A, R, Fd		Nemaline myopathy 2, autosomal recessive, 256030 (3)	2(Neb)
2.592	4	19	07	2q22.3	ZEB2, ZFHX1B, SMADIP1, SIP1		Zinc finger E box-binding homeobox 2	605802	Ch		Mowat-Wilson syndrome, 235730 (3)	
2.593	11	21	02	2p16.3	KCNK12, THIK2		Potassium channel, subfamily K, member 12	607366	REc			
2.594	4	6	11	2q23.3	CACNB4, EJM6, EA5, EIG9		Calcium channel, voltage-dependent, beta 4 subunit	601949	A, Psh, R		{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3); {Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)	2(Cacnb4)
2.595	11	16	10	2q24.1	NR4A2, NURR1, NOT, TINUR		Nuclear receptor subfamily 4, group A, member 2	601828	A, REa			2(Nurr1)
2.596	3	15	11	2q23.1	ORC4, ORC4L		Origin recognition complex, subunit 4, S. cerevisiae, homolog of	603056	A, REa		Meier-Gorlin syndrome 2, 613800 (3)	
2.597	8	27	09	2q24.3	GRB14		Growth factor receptor-bound protein 14	601524	REc			
2.598	5	2	08	2q22-q24	MAFD5		Major affective disorder 5	611535	Fd		{Major affective disorder 5} (2)	
2.599	7	18	14	2q22.1	NXPH2, NPH2		Neuroxophilin 2	604635	REc			
2.600	9	21	17	2q22.2	KYNU, KYNUU, VCRL2		Kynureninase	605197	REc	mutation identified in 1 KYNUU family	?Hydroxykynureninuria, 236800 (3); Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)	
2.601	1	24	09	2q22.3-q23.1	ACVR2A, ACVR2		Activin A receptor, type IIA	102581	A			
2.602	5	26	13	2q22.2-q22.3	ARHGAP15, BM046		Rho GTPase-activating protein 15	610578	R, REc			
2.603	3	27	12	2q31.1	DCAF17, C20orf37		DDB1- and CUL4-associated factor 17	612515	REc		Woodhouse-Sakati syndrome, 241080 (3)	
2.604	1	1	95	2q24.2	DPP4, CD26, ADCP2		Dipeptidylpeptidase IV (CD26; adenosine deaminase complexing protein-2)	102720	S, REa, A			
2.605	8	18	98	2q24.2	FAP, FAPA		Fibroblast activation protein, alpha subunit	600403	REa, A			
2.606	8	1	08	2q23.3	RPRM		Reprimo	612171	A			
2.607	5	2	06	2q24.1	ACVR1, ACVRLK2, ALK2, FOP		Activin A receptor, type I	102576	REa, A		Fibrodysplasia ossificans progressiva, 135100 (3)	
2.608	2	28	01	2q24.2	BAZ2B		Bromodomain adjacent to zinc finger domain, 2B	605683	REa, R			
2.609	5	25	00	2q24.2	PLA2R1, PLA2R		Phospholipase A2 receptor 1	604939	A			
2.610	10	31	08	2q23.3	ARL5		ADP-ribosylation factor-like 5	608960	R			
2.611	2	11	11	2q24.3	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS		Sodium channel, voltage-gated, type II, alpha subunit	182390	REa, Pcm, A	4 related genes on chr.2	Seizures, benign familial infantile, 3, 607745 (3); Epileptic encephalopathy, early infantile, 11, 613721 (3)	2(Scn2a)
2.612	1	17	01	2q24.2	SLC4A10		Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10	605556	A, REa, R			
2.613	8	9	99	2q23-q24.3	DFNA16		Deafness, autosomal dominant 16	603964	Fd		Deafness, autosomal dominant 16 (2)	
2.614	3	8	00	2q24.2	TBR1		T-box, brain, 1	604616	H			2(Tbr1)
2.615	4	6	01	2q23-q31	DFNB27		Deafness, autosomal recessive 27	605818	Fd		Deafness, autosomal recessive 27 (2)	
2.616	11	29	99	2q24.1	PKP4		Plakophilin-4	604276	A, REa			
2.617	8	20	07	2q23.1	EPC2		Enhancer of polycomb, Drosophila, homolog of, 2	611000	R, REc			
2.618	8	1	14	2q23.1-q23.2	KIF5C, NKHC2, CDCBM2		Kinesin family member 5C	604593	R, REc		Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	
2.619	10	15	07	2q23.1	MBD5, KIAA1461, MRD1		Methyl-CpG-binding domain protein 5	611472	R, REc		Mental retardation, autosomal dominant 1, 156200 (3)	
2.620	4	20	10	2q23.2	LYPD6		LY6/PLAUR domain-containing protein 6	613359	REc			
2.621	4	8	08	2q23.2	C2orf25, MMADHC		Chromosome 2 open reading frame 25	611935	REc		Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	
2.622	7	29	15	2q23.3	ARL6IP6, AIP6		ADP-ribosylation factor-like 6-interacting protein 6	616495	REc			
2.623	3	31	15	2q23.3	FMNL2, KIAA1902		Formin-like 2	616285	REc			
2.624	6	29	99	2q23.3	NMI		NMYC interactor	603525	A	previously assigned to 22q13.3		
2.625	8	17	09	2q23.3	PRPF40A, HYPA, FNBP3, FBP11		Precursor mRNA-processing factor 40, S. cerevisiae, homolog of, A	612941	REc			
2.626	8	3	12	2q23.3	RND3, RHOE, ARHE		RHO family GTPase 3	602924	REc, R			
2.627	7	9	06	2q23.3	STAM2		Signal-transducing adaptor molecule 2	606244	R, REc			
2.628	8	27	09	2q23.3	TNFAIP6		Tumor necrosis factor, alpha-induced protein-6	600410	Psh, REc			
2.629	1	20	09	2q31.1	ABCB11, BSEP, SPGP, PFIC2, BRIC2		ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	Fd, LD, REc		Cholestasis, progressive familial intrahepatic 2, 601847 (3); Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	
2.630	9	22	08	2q24.2	CD302, DCL1, KIAA0022		CD302 antigen	612246	R, REc			
2.631	8	19	13	2q24.3	COBLL1, COBLR1, KIAA0977		COBL-like protein 1	610318	REc			2(Cobll1)
2.632	4	7	15	2q24.2	IFIH1, MDA5, AGS7, SGMRT1		Interferon induced with helicase C domain 1	606951	REc		Aicardi-Goutieres syndrome 7, 615846 (3); Singleton-Merten syndrome 1, 182250 (3)	
2.633	2	27	17	2q24.3	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3		Sodium channel, voltage-gated, type I, alpha polypeptide	182389	REA, A, FD		Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3); Epileptic encephalopathy, early infantile, 6 (Dravet syndrome), 607208 (3)	2(Scn1a)
2.634	4	24	18	2q24.3	SCN3A, FFEVF4, EIEE62		Sodium channel, voltage-gated, type III, alpha polypeptide	182391	H, Psh, A		Epilepsy, familial focal, with variable foci 4, 617935 (3); Epileptic encephalopathy, early infantile, 62, 617938 (3)	2(Scn3a)
2.635	12	30	14	2q24.3	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D		Sodium channel, voltage-gated, type IX, alpha subunit	603415	REc, Fd		Erythermalgia, primary, 133020 (3); Paroxysmal extreme pain disorder, 167400, (3); Insensitivity to pain, congenital, 243000 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); {Dravet syndrome, modifier of}, 607208 (3); HSAN2D, autosomal recessive, 243000 (3)	
2.636	8	2	16	2q31.1	SLC25A12, ARALAR, EIEE39		Solute carrier family 25 (mitochondrial carrier, Aralar), member 12	603667	A, REa, R, REc		Epileptic encephalopathy, early infantile, 39, 612949 (3)	
2.637	11	17	10	2q24.3	GALNT3, HHS, HFTC1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3	601756	A		Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3)	
2.638	8	21	07	2q31.1	LRP2, DBS		Low density lipoprotein-related protein 2	600073	A		Donnai-Barrow syndrome, 222448 (3)	
2.639	4	30	15	2q31.1	CHRNA1, ACHRD, CMS1B, CMS1A		Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690	REa, A		Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3); Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	2(Acra)
2.640	7	8	10	2q24-q32	FGQTL1		Fasting plasma glucose level QTL 1	612108	Fd	associated with rs560887	[Fasting plasma glucose level QTL 1] (2)	
2.641	7	8	10	2q31.1	G6PC2, IGRP		Glucose-6-phosphatase, catalytic, 2	608058	REc, R, H			2(Igrp)
2.642	6	15	99	2q24-q32	MMDK, MDK		Mesomelic dysplasia, Kantaputra type	156232	Fd		Mesomelic dysplasia, Kantaputra type (2)	
2.643	1	11	95	2q37.1	NPPC		Natriuretic peptide precursor C	600296	H			1(Nppc)
2.644	4	22	10	2q24.1	ACVR1C, ALK7		Activin A receptor, type IC	608981	A			
2.645	8	19	13	2q24.1	ERMN, JN, KIAA1189		Ermin	610072	R, REc			
2.646	1	27	04	2q23.3-q24.1	GALNT13, KIAA1918		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13	608369	R, REc			
2.647	3	27	09	2q24.1	GPD2		Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)	138430	A, Psh, REc	pseudogene on 19	{Diabetes, type 2, susceptibility to}, 125853 (3)	
2.648	12	2	96	2q24.1	KCNJ3, GIRK1		Potassium inwardly-rectifying channel, subfamily J, member 3	601534	REa, A, Fd			
2.649	5	8	09	2q24.1	SYNSTH		Synesthesia	612759	Fd	max lod at D2S142	Synesthesia (2)	
2.650	2	9	17	2q24.1	UPP2		Uridine phosphorylase 2	617340	REc			
2.651	4	22	10	2q24.1-q31.1	INTLQ2		Intelligence quantitative trait locus 3	610295	Fd		{Intelligence QTL3} (2)	
2.652	4	6	13	2q24.1	GALNT5, GALNACT5		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5	615129	REc			
2.653	8	27	09	2q24.2	GCA		Grancalcin	607030	R, REc			
2.654	2	12	15	2q24.2	ITGB6, AI1H		Integrin, beta-6	147558	REa, REc		Amelogenesis imperfecta, type IH, 616221 (3)	
2.655	3	6	08	2q24.2	KCNH7, ERG3, HERG3, Kv11.3		Potassium channel, voltage-gated, subfamily H, member 7	608169	R, REc			
2.656	6	7	10	2q24.2	MARCH7		Membrane-associated RING-CH finger protein 7	613334	REc			
2.657	8	27	09	2q24.2	PSMD14, POH1, PAD1		Proteasome 26S subunit, non-ATPase, 14	607173	R, REc			
2.658	3	29	16	2q24.2	RBMS1, MSSP, SCR2		RNA-binding motif protein, single strand-interacting, 1	602310	REc			
2.659	4	2	16	2q24.2	TANC1, KIAA1728		Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 1	611397	REc			
2.660	3	18	13	2q24.2	TANK, ITRAF		TRAF family member-associated NF-Kappa-B activator	603893	REc			
2.661	11	11	14	2q24.3	B3GALT1		UDP-GAL:beta-GlcNAc beta-1,3-galactosyltransferase, polypeptide 1	603093	REc			
2.662	8	2	13	2q24.3	CERS6, LASS6		Ceramide synthase 6	615336	REc			
2.663	12	23	05	2q24.3	CMYA3, XIRP2		Cardiomyopathy-associated protein 3	609778	R, REc			
2.664	2	18	09	2q24.3	IDDM19		Diabetes mellitus, insulin-dependent, 19	610155	Fd	associated with rs1990760	{Diabetes mellitus, insulin-dependent, 19} (2)	
2.665	8	26	15	2q24.3	SLC38A11		Solute carrier family 38 (amino acid transporter), member 11	616526	REc			
2.666	8	27	09	2q24.3	STK39, SPAK		Serine/threonine protein kinase 39	607648	R, REc			
2.667	2	11	14	2q24.3	TTC21B, THM1, NPHP12, SRTD4, ATD4		Tetratricopeptide repeat domain 21B	612014	REc		Nephronophthisis 12, 613820 (3); Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	
2.668	1	11	16	2q31.2	AGPS, ADHAPS, RCDP3		Alkylglycerone-phosphate synthase	603051	A		Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	2(Agps)
2.669	10	16	14	2q31.1	BBS5		BBS gene 5	603650	REc, Fd		Bardet-Biedl syndrome 5, 615983 (3)	
2.670	10	12	14	2q31.2	CCDC141, CAMDI		Coiled-coil domain-containing protein 141	616031	REc			
2.671	4	21	16	2q31.1	CDCA7, JPO1, ICF3		Cell division cycle-associated 7	609937	A		Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	
2.672	8	17	15	2q31.1	GAD1, SCP, CPSQ1		Glutamate decarboxylase-1, brain, 67kD	605363	REa, H, A, Psh, Fd, LD	mutation identified in 1 CPSQ1 family	?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	2(Gad1)
2.673	12	9	98	2q31	IDDM7		Insulin-dependent diabetes mellitus-7	600321	H, Fd		{Diabetes mellitus, insulin-dependent, 7} (2)	
2.674	1	24	01	2q32.1	ITGAV, VNRA		Integrin, alpha-V (vitronectin receptor, alpha polypeptide)	193210	REa, A, REc			
2.675	08	17	18	2q31.1	LNPK, KIAA1715, NEDEHCC		Lunapark	610236	REc, H		Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3)	2(Lnp)
2.676	3	23	09	2q31.1	MIR10B, MIRN10B		Micro RNA 10B	611576	REc			
2.677	1	7	02	2q33.1	MPP4, DLG6		Membrane protein, palmitoylated 4	606575	REc			
2.678	10	30	17	2q31.2	NFE2L2, NRF2, IMDDHH		Nuclear factor, erythroid-derived 2-like 2	600492	A		Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3)	
2.679	10	28	08	2q31	PNKD2		Paroxysmal nonkinesigenic dyskinesia 2	611147	Fd	between D2S2188 and D2S364	Paroxysmal nonkinesigenic dyskinesia 2 (2)	
2.680	12	9	09	2q31	SHFM5		Split-hand/foot malformation 5	606708	Fd	between EVX2 and D2S294	Split-hand/foot malformation 5 (2)	
2.681	7	1	97	2q31.1	SP3		Sp3 transcription factor	601804	Psh, A			
2.682	09	27	18	2q31.2	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY		Titin	188840	REa, R		Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy, dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3); Myopathy, proximal, with early respiratory muscle involvement, 603689 (3); Salih myopathy, 611705 (3)	2(Ttn)
2.683	4	17	01	2q32.1	CALCRL, CGRPR, CRLR		Calcitonin receptor-like	114190	R			
2.684	1	4	93	2q31.1	EVX2		Even-skipped homeo box-2	142991	REn	13kb 5' to HOX4I		2(Evx2)
2.685	2	26	93	2q31.1	HOXD3, HOX4A		Homeo box-D3	142980	RE			2(Hox4.1)
2.686	4	1	14	2q31.1	HOXD4, HOX4B		Homeo box-D4	142981	A, RE			2(Hox4.2)
2.687	2	26	93	2q31.1	HOXD9, HOX4C		Homeo box-D9	142982	RE			2(Hox4.3)
2.688	7	19	04	2q31.1	HOXD10, HOX4D		Homeo box-D10	142984	REa, RE		Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	2(Hox4.4)
2.689	2	26	93	2q31.1	HOXD8, HOX4E		Homeo box-D8	142985	RE			2(Hox4.5)
2.690	2	26	93	2q31.1	HOXD11, HOX4F		Homeo box-D11	142986	RE			2(Hox4.6)
2.691	2	26	93	2q31.1	HOXD1, HOX4G		Homeo box-D1	142987	RE			2(Hox4.7)
2.692	2	26	93	2q31.1	HOXD12, HOX4H		Homeo box-D12	142988	REc	upstream from HOX4A-G		2(Hox4.8)
2.693	5	9	16	2q31.1	HOXD13, HOX4I, SPD1, BDSD		Homeo box-D13	142989	REc, Fd	mutation identified in 1 BDSD family	Synpolydactyly 1, 186000 (3); Brachydactyly, type E, 113300 (3); Brachydactyly, type D, 113200 (3); Syndactyly, type V, 186300 (3); ?Brachydactyly-syndactyly syndrome, 610713 (3)	2(Hox4.9)
2.694	7	16	92	2q31.3	ITGA4, CD49D		Integrin, alpha-4 (antigen CD49D, alpha-4 subunit of VLA-4 receptor)	192975	Psh, A			
2.695	9	23	08	2q31.1	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2		Chimerin 1 (GTPase-activating protein, rho, 2)	118423	REa, A, Fd		Duane retraction syndrome 2, 604356 (3)	
2.696	12	30	92	2q32.1	TFPI, LACI		Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)	152310	REa, A			
2.697	4	15	09	2q32.1	FRZB, FRZB1, SRFP3, OS1		Frizzled-related protein	605083	REc		{Osteoarthritis susceptibility 1}, 165720 (3)	
2.698	11	19	11	2q32.2	PMS1, PMSL1, HNPCC3		Postmeiotic segregation increased, S. cerevisiae, like 1	600258	REa, A			
2.699	9	22	08	2q31.1	ATP5G3		ATP synthase, mitochondrial, C subunit-3	602736	REa, REc			
2.700	9	10	12	2q31.1	CIR1		CBF1-interacting corepressor	605228	REc			
2.701	8	18	08	2q31.1	DHRS9, RDHTBE		Short-chain dehydrogenase/reductase family, member 9	612131	REc			
2.702	1	5	11	2q31.1	DUP2q31.1, C2DUPq31.1		Chromosome 2q31.1 duplication syndrome	613681	Ch	duplication of 9 HOXD genes and MTX2	Chromosome 2q31.1 duplication syndrome (4)	
2.703	2	21	06	2q31.1	DYNC1I2, DNCI2, IC2		Dynein, cytoplasmic-1, intermediate chain-2	603331	REc, H			2(Dnci2)
2.704	1	10	09	2q31.1	ITGA6		Integrin, alpha-6	147556	REa, REc		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	
2.705	4	10	14	2q31.1	KLHL41, KBTBD10, SARCOSIN, NEM9		Kelch-like family member 41	607701	R, REc		Nemaline myopathy 9, 615731 (3)	
2.706	8	3	12	2q31.1	METAP1D, MAP1D		Methionyl aminopeptidase type 1D (mitochondrial)	610267	REc			
2.707	4	17	12	2q31.1	MTX2		Metaxin 2	608555	REc			
2.708	3	3	03	2q24.3	NOSTRIN		Nitric oxide synthase trafficker	607496	REc			
2.709	8	30	11	2q31.1	OLA1, GTBP9		OBG-like ATPase 1	611175	REc			
2.710	9	9	13	2q31.1	PDK1		Pyruvate dehydrogenase kinase, isoenzyme 1	602524	REc			
2.711	8	27	09	2q31.1	PPIG		Peptidyl-prolyl isomerase G (cyclophilin G)	606093	R, REc			
2.712	12	17	12	2q31.1	SCRN3, SES3		Secernin 3	614967	REc			
2.713	12	6	16	2q31.1	SP5		Transcription factor Sp5	609391	REc			2(Sp5)
2.714	7	14	14	2q24.3	SPC25, SPBC25		SPC25, NDC80 kinetochore complex component	609395	REc			
2.715	4	28	10	2q31.1	SSB, LARP3		Sjogren syndrome antigen B	109090	A, Psh, REc			
2.716	3	31	11	2q31.1	UBR3		Ubiquitin protein ligase E3 component N-recognin 3	613831	REc			3(Ubr3)
2.717	2	9	15	2q31.1	WIPF1, WASPIP, WIP, WAS2		WAS/WASL-interacting protein family, member 1	602357	REc	mutation identified in 1 WAS2 patient	?Wiskott-Aldrich syndrome 2, 614493 (3)	
2.718	11	7	17	2q31.1	ZAK, MLTK, MRK, SFMMP, CNM6		Leucine zipper- and sterile alpha motif-containing kinase	609479	R, REc		Split-foot malformation with mesoaxial polydactyly, 616890 (3); Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3)	
2.719	4	24	06	2q31.1	MYO3B		Myosin IIIB	610040	REc			
2.720	6	30	06	2q31.2	PJVK, DFNB59		Pejvakin	610219	Fd		Deafness, autosomal recessive 59, 610220 (3)	
2.721	11	11	14	2q31.2	FKBP7, FKBP23		FK506-binding protein 7	607062	REc			
2.722	2	1	11	2q31.2	HNRPA3, D10S102, FBRNP		Heterogeneous nuclear ribonucleoprotein A3	605372	REc, REn			
2.723	3	8	07	2q31.2	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2		Phosphodiesterase 11A	604961	REc, Fd		Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	
2.724	3	18	08	2q31.2	PLEKHA3, FAPP1		Pleckstrin homology domain-containing protein, family A, member 3	607774	REc			
2.725	10	4	16	2q31.2	RBM45		RNA binding motif protein 45	608888	REc			
2.726	10	27	08	2q31.2-q31.3	ZNF385B, ZFN533		Zinc finger protein 385B	612344	REc			
2.727	10	27	08	2q31.2	DEL2q31		Chromosome 2q31.2 deletion syndrome	612345	Ch	contiguous gene deletion syndrome	Chromosome 2q31.2 deletion syndrome (4)	
2.728	11	4	98	2q31.1	HAT1		Histone acetyltransferase-1	603053	TM			
2.729	2	27	13	2q31.3	CERKL, RP26		Ceramide kinase-like	608381	REc		Retinitis pigmentosa 26, 608380 (3)	
2.730	5	6	13	2q31.3	CWC2, KIAA1604, NCM		CWC22 spliceosome-associated protein, X. cerevisiae, homolog of	615186	REc			
2.731	6	17	17	2q31.1	FASTKD1, KIAA1800		Fast kinase domains 1	617529	REc			
2.732	2	21	12	2q31.3	MIR1258		Micro RNA 1258	614488	REc	on opposite strand from ZNF385B		
2.733	2	24	12	2q33.1	NDUFB3		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 3	603839	R	pseudogenes on chr. 1, 9, and 14	Mitochondrial complex I deficiency, 252010 (3)	
2.734	6	24	08	2q31.2	PRKRA, PACT, RAX, DYT16		Protein kinase, interferon-inducible double-stranded RNA-dependent activator	603424	REc		Dystonia 16, 612067 (3)	
2.735	12	27	13	2q31.3	SCHLAP1, PCAT114, LINC00913		SWI/SNF complex antagonist associated with prostate cancer 1, noncoding	615568	REc			
2.736	8	8	13	2q31.3	SSFA2, CS1		Sperm-specific antigen 2	118990	REc			
2.737	1	16	14	2q31.3-q32.1	DA10		Arthrogryposis, distal, type 10	187370	Fd	max lod at D2S364	Arthrogryposis, distal, type 10 (2)	
2.738	11	7	01	2q31.1	ATF2, CREB2		Activating transcription factor 2	123811	REa, A			
2.739	1	8	95	2q31.1	DLX1		Distal-less homeo box-1	600029	REa, A, H			
2.740	1	8	95	2q31.1	DLX2, TES1		Distal-less homeo box-2	126255	REa, A			2(Dlx2)
2.741	1	15	96	2q32.2	INPP1		Inositol polyphosphate-1-phosphatase	147263	Psh, A			1(Inpp1)
2.742	5	11	00	2q33.3	KLF7, UKLF		Kruppel-like factor 7	604865	A			
2.743	8	27	09	2q32.3	MYO1B		Myosin IB	606537	R, REc			
2.744	11	4	99	2q31.3	NEUROD1, NIDDM		Neurogenic differentiation 1	601724	A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Maturity-onset diabetes of the young 6, 606394 (3)	2(Neurod)
2.745	11	30	00	2q32.3	PCGEM1		Prostate-specific gene PCGEM1	605443	A			
2.746	3	17	03	2q32.2	SLC40A1, SLC11A3, FPN1, IREG1, HFE4		Solute carrier family 40 (iron-regulated transporter), member 1	604653	A		Hemochromatosis, type 4, 606069 (3)	1(Slc11a3)
2.747	9	22	17	2q32.3	CAVIN2, SDPR, SDR		Caveolae-associated protein 2	606728	A			
2.748	5	29	01	2q32.3	TMEFF2, HPP1, TR		Transmembrane protein with EGF-like and 2 follistatin-like domains 2	605734	A			
2.749	1	11	89	2q34	RPE		Ribulose 5-phosphate 3-epimerase	180480	S, D			
2.750	8	8	91	2q32.2	GLS, GLS1		Glutaminase	138280	REa, A			1(Gls)
2.751	6	22	14	2q32.1	FSIP2		Fibrous sheath-interacting protein 2	615796				
2.752	12	5	03	2q32.1	NUP35, NP44		Nucleoporin, 35kD	608140	R, REc			
2.753	5	7	03	2q31.2	OSBPL6, ORP6		Oxysterol-binding protein-like protein 6	606734	REc			
2.754	8	30	09	2q32.1	PDE1A		Phosphodiesterase-1A	171890	REc			
2.755	2	21	10	2q31.3-q32.1	PPP1R1C, IPP5		Protein phosphatase 1, regulatory subunit 1C	613240	REc			
2.756	9	10	09	2q32.1	SCZD14		Schizophrenia 14	612361	Fd	associated with rs1344706	{Schizophrenia, susceptibility to, 14} (2)	
2.757	10	19	99	2q31.3	UBE2E3, UBCH9		Ubiquitin-conjugating enzyme E2E 3	604151	A, REa, R			
2.758	9	23	08	2q32.1	ZNF804A, C2orf10		Zinc finger protein 804A	612282	REc			
2.759	5	11	00	2q32.1	NCKAP1, NAP1		NCK-associated protein 1	604891	REa, A			
2.760	10	27	97	2q32.1-q32.3	ARVD4		Arrhythmogenic right ventricular dysplasia 4	602087	Fd		Arrhythmogenic right ventricular dysplasia 4 (2)	
2.761	4	10	90	2q34	MYL1		Myosin, light polypeptide-1, alkali; skeletal, fast	160780	REa, H			1(Mylt)
2.762	3	15	13	2q32.2	C2orf88, SMAKAP		Small membrane protein kinase A-anchoring protein	615117	REc			
2.763	12	22	17	2q32.2	COL3A1, EDSVASC		Collagen III, alpha-1 polypeptide	120180	REa, A	in same 35kb segment as COL5A2	Ehlers-Danlos syndrome, vascular type, 130050 (3)	1(Col3a1)
2.764	12	22	17	2q32.2	COL5A2, EDSCL2		Collagen V, alpha-2 polypeptide	120190	REa, A	very close to COL3A1	Ehlers-Danlos syndrome, classic type, 2, 130010 (3)	
2.765	12	23	05	2q32.2	FLJ25415		FLJ25415 gene	609803	REc			
2.766	8	13	11	2q32.2	GDF8, MSTN, MSLHP		Growth differentiation factor-8 (myostatin)	601788	H, R		Muscle hypertrophy, 614160 (3)	1(Cmpt, Gdf8)
2.767	1	8	07	2q32.2	HIBCH		3-hydroxyisobutyryl-CoA hydrolase	610690	REc		3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	
2.768	9	29	10	2q32.2	MFSD6, MMR2		Major facilitator superfamily domain-containing protein 6	613476	REc			
2.769	8	26	15	2q32.2	NEMP2, TMEM194B		Nuclear envelope integral membrane protein 2	616497	REc			
2.770	4	7	10	2q32.2	ORMDL1		ORM1-like protein 1	610073	REc	pseudogene on 10p14		
2.771	1	29	07	2q33.1	SUMO1, UBL1, SMT3, OFC10		Small ubiquitin-like modifier 1	601912	A, Ch	mutation identified in 1 OFC10 patient	?Orofacial cleft 10, 613705 (3)	1(Sumo1)
2.772	12	26	14	2q32.2	STAT1, CANDF7, IMD31A, IMD31B, IMD31C		Signal transducer and activator of transcription-1	600555	A		Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3); Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3); Immunodeficiency 31C, autosomal dominant, 614162 (3)	1(Stat1)
2.773	7	18	12	2q32.2-q32.3	STAT4, SLEB11		Signal transducer and activator of transcription-4	600558	A		{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	1(Stat4)
2.774	2	3	06	2q32.1-q32.2	GULP1, CED6		PTB domain-containing engulfment adaptor protein 1	608165	REc			
2.775	12	22	16	2q32.3	HECW2, NEDL2, KIAA1301, NDHSAL		HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2	617245	REc, Psh		Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3)	
2.776	6	26	08	2q32.3	OBFC2A, SSB2		Oligonucleotide/oligosaccharide-binding fold-containing protein 2A	612103	REc			
2.777	5	4	12	2q32.3	STK17B, DRAK2		Serine/threonine protein kinase 17b	604727	REc			
2.778	4	23	98	2q32.2	NAB1		NGFI-A-binding protein, ERG1-binding protein	600800	A			1(Nab1)
2.779	7	10	08	2q33.3	CREB1		cAMP-response element-binding protein-1	123810	REa, A	fusion gene with EWSR1	Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	1(Creb1)
2.780	7	1	02	2q33.3	ADAM23, MDC3		A disintegrin and metalloproteinase domain 23	603710	R			
2.781	9	21	12	2q33.1	ALS2, ALSJ, PLSJ, IAHSP		Alsin	606352	Fd, REc		Amyotrophic lateral sclerosis 2, juvenile, 205100 (3); Primary lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	
2.782	2	27	03	2q33.2	ALS2CR8, CARF		Amyotrophic lateral sclerosis 2 chromosome region, candidate 8 (calcium response factor)	607586	REc			
2.783	7	14	98	2q33.1	AOX1		Aldehyde oxidase-1	602841	Psh, A			
2.784	4	8	13	2q35	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1		bcs1, S. cerevisiae, homolog-like	603647	REc, Fd, LD		Mitochondrial complex III deficiency, nuclear type 1, 124000 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3); GRACILE syndrome, 603358 (3)	
2.785	2	13	14	2q33.1-q33.2	BMPR2, PPH1, POVD1		Bone morphogenetic receptor, type II	600799	Fd		Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3); Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3); Pulmonary venoocclusive disease 1, 265450 (3)	
2.786	7	26	10	2q33.1	BOLL, BOULE		BOL-like (Boule, Drosophila, homolog of)	606165	R, A, H			1(Boule)
2.787	11	18	14	2q33.1	CASP8, MCH5, ALPS2B		Caspase 8, apoptosis-related cysteine protease	601763	A	mutation identified in 1 ALPS2B family	?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3); Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)	1(Casp8)
2.788	12	7	07	2q33.1	CFLAR, FLIP, CASPER, FLAME1, CASH		CASP8- and FADD-like apoptosis regulator	603599	A, R			
2.789	8	16	99	2q33.1	CLK1, CLK, STY		CDC-like kinase 1	601951	A			
2.790	7	24	15	2q33.2	CTLA4, IDDM12, CELIAC3, ALPS5		Cytotoxic T-lymphocyte-associated serine esterase-4	123890	A, REn		{Hashimoto thyroiditis}, 140300 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Diabetes mellitus, insulin-dependent, 12}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3); Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	1(Ctla4)
2.791	11	6	01	2q32.2	DIRC1		Disrupted in renal cancer 1	606423	REc			
2.792	1	12	99	2q33.1	FZD7		Frizzled, Drosophila, homolog of, 7	603410	A			
2.793	1	30	01	2q33.2	ICOS, AILIM, CVID1		Inducible costimulator	604558	R		Immunodeficiency, common variable, 1, 607594 (3)	
2.794	4	19	01	2q33.1	NIF3L1		Ngg1 interacting factor 3, S. pombe, homolog of, like 1	605778	REc			1(Nif3l1)
2.795	4	9	96	2q33.1	ORC2, ORC2L		Origin recognition complex, subunit 2, S. cerevisiae, homolog of	601182	A			
2.796	2	18	02	2q33.1	PLDL1, PLCE, PLCL		Phospholipase C-like 1	600597	RE			
2.797	7	14	14	2q33.1	PPIL3		Peptidyl-prolyl isomerase-like 3	615811	REc			
2.798	10	21	96	2q34	PTHR2		Parathyroid hormone receptor 2	601469	A			
2.799	2	28	07	2q33	RLS4		Restless legs syndrome, susceptibility to, 4	610439	Fd	between D2S311 and D2S317	{Restless legs syndrome 4} (2)	
2.800	5	27	14	2q33.1	SATB2, KIAA1034, GLSS		Special AT-rich sequence-binding protein 2	608148	REc		Glass syndrome, 612313 (3)	
2.801	7	21	15	2q33.1	CASP10, MCH4, ALPS2		Caspase 10, apoptosis-related cysteine protease	601762	Psh, REc, A		Autoimmune lymphoproliferative syndrome, type II, 603909 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Gastric cancer, somatic, 613659 (3)	
2.802	8	24	92	2q33.2	CD28		CD28 antigen (Tp44)	186760	A, REn			1(Cd28)
2.803	4	30	15	2q37.1	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C		Cholinergic receptor, nicotinic, delta polypeptide	100720	H, REa, A, LD, RE	mutation identified in 1 CMS3A patient and 1 CMS3C family	?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3); Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3); ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrd)
2.804	4	22	15	2q37.1	CHRNG, ACHRG		Cholinergic receptor, nicotinic, gamma polypeptide	100730	H, REa, LD, RE, Fd	tightly linked to CHRND by RE	Escobar syndrome, 265000 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrg)
2.805	5	14	04	2q33.3	EEF1B2, EEF1B1		Eukaryotic translation elongation factor-1, beta-2	600655	Psh	pseudogene on chr.15		
2.806	7	1	97	2q33.3	FZD5		Polarity gene 'frizzled,' Drosophila, homolog of	601723	H			1(Mfz5)
2.807	12	5	91	2q35	IGFBP2		Insulin-like growth factor-binding protein-2, 36kD	146731	REa, A			1(Igfbp2)
2.808	1	5	06	2q33.2	NBEAL1, ALS2CR17		Neurobeachin-like 1	609816	REc			
2.809	8	25	04	2q33.3	NDUFS1		NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kD	157655	A		Mitochondrial complex I deficiency, 252010 (3)	
2.810	5	19	09	2q33.1	STRADB, ILPIP, ALS2CR2		STE20-related kinase adaptor beta	607333	REn	pseudogenes on chromosomes 1 and 9		
2.811	2	28	06	2q33.1	TRAK2, GRIF1, ALS2CR3, KIAA0549, OIP98		Gamma-aminobutyric acid receptor-interacting factor 1	607334	REn			
2.812	4	4	00	2q33.3	CRYGA, CRYG1		Crystallin, gamma A	123660	REa, A			1(Cryg1)
2.813	9	12	13	2q33.3	CRYGB, CRYG2, CTRCT39		Crystallin, gamma B	123670	REa, A		Cataract 39, multiple types, autosomal dominant, 615188 (3)	1(Len2)
2.814	5	3	13	2q33.3	CRYGC, CRYG3, CTRCT2, CCL		Crystallin, gamma C	123680	REa, A		Cataract 2, multiple types, 604307 (3)	
2.815	5	3	13	2q33.3	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC		Crystallin, gamma D	123690	REa, A		Cataract 4, multiple types, 115700 (3)	1(Crygd, Lop2)
2.816	1	29	04	2q35	IHH, BDA1		Indian hedgehog	600726	REa, A, Fd		Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1, 112500 (3)	
2.817	2	28	06	2q36.1	PI7, PN1, SERPINE2		Protease inhibitor 7 (protease nexin I)	177010	REa, M	near MYL1; ?COPD susceptibility		
2.818	10	10	11	2q33-q36	EJM9		Epilepsy, juvenile myoclonic, susceptibility to, 9	614280	Fd	max lod at D2S2248	{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)	
2.819	10	26	99	2q35	IGFBP5, IBP5		Insulin-like growth factor-binding protein 5	146734	H			1(Igfbp5)
2.820	1	4	93	2q35	INHA		Inhibin, alpha	147380	REa, RE	proximal to PAX3		1(Inha)
2.821	8	29	02	2q36.3	CCL20, SCYA20, MIP3A, LARC		Chemokine, C-C motif, ligand 20	601960	R, Psh			
2.822	8	18	98	2q35	CYP27A1, CYP27, CTX		Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)	606530	REa		Cerebrotendinous xanthomatosis, 213700 (3)	1(Cyp27)
2.823	2	18	09	2q33.1	ANIB9		Aneurysm, intracranial berry, 9	612586	Fd	associated with rs700651	{Aneurysm, intracranial berry, 9} (2)	
2.824	12	30	14	2q33.1	CDK15, PFTAIRE2, ALS2CR7		Cyclin-dependent kinase 15	616147	REc			
2.825	3	24	14	2q32.3	DNAH7, KIAA0944		Dynein, axonemal, heavy chain 7	610061	R, REc			
2.826	1	30	15	2q33.1	FTCDNL1, FONG		Formiminotransferase cyclodeaminase N-terminal like	614308	REc			
2.827	7	18	14	2q33.1	GTF3C3, TFIIIC102		General transcription factor 3C, polypeptide 3	604888	REc			
2.828	4	27	12	2q33.1	HSPD1, SPG13, HSP60, HLD4		Heat-shock 60kD protein 1	118190	Fd, REn, A		Spastic paraplegia 13, autosomal dominant, 605280 (3); Leukodystrophy, hypomyelinating, 4, 612233 (3)	
2.829	9	4	02	2q33.1	HSPE1, HSP10		Heat-shock 10kD protein	600141	REn			
2.830	12	22	16	2q33.1	MAIP1, C2orf47		Matrix AAA peptidase-interacting protein 1	617267	REc			
2.831	6	23	15	2q33.1	MARS2, SPAX3, COXPD25		Methionyl-tRNA synthetase 2	609728	R, REc, Fd	mutation identified in 1 COXPD25 family	Spastic ataxia 3, autosomal recessive, 611390 (3); ?Combined oxidative phosphorylation deficiency 25, 616430 (3)	
2.832	8	30	17	2q33.1	MOB4, MOBKL3, PREI3, MOB1, MOB3		MOB family, member 4	609361	R, REc			
2.833	1	8	16	2q33.1	NOP58, NOP5		Nop58, S. cerevisiae, homolog of	616742	REc			
2.834	2	25	16	2q33.1	PGAP1, MRT42		Post-GPI attachment to proteins 1	611655	REc		Mental retardation, autosomal recessive 42, 615802 (3)	
2.835	10	26	11	2q33.1	SF3B1, SF3B155, SAP155, MDS		Splicing factor 3B, subunit 1	605590	R, REc		Myelodysplastic syndrome, somatic, 614286 (3)	1(Sf3b1)
2.836	12	4	08	2q33.1	SGOL2, SGO2, TRIPIN		Shugoshin-like 2	612425	REc			
2.837	4	15	11	2q33.1	SPATS2L, SGNP		Spermatogenesis-associated serine-rich protein 2-like	613817	REc			
2.838	7	2	18	2q33.2	ABI2, AIP1		ABL interactor 2	606442	REc			
2.839	1	18	12	2q33.1	TMEM237, ALS2CR4, JBTS14		Transmembrane protein 237	614423	REc		Joubert syndrome 14, 614424 (3)	
2.840	10	28	15	2q33.2	WDR12		WD repeat-containing protein 12	616620	A, REc			1(Wdr12)
2.841	11	4	13	2q33.3	FASTKD2, KIAA0971		FAST kinase domains 2	612322	R, REc	mutation identified in 1 family	?Mitochondrial complex IV deficiency, 220110 (3)	
2.842	2	6	07	2q33.3	GPR1		G protein-coupled receptor-1	600239	R	conflicting assignment to 15q21.6		
2.843	8	28	17	2q33.3	GPR1AS		GPR1 antisense RNA	617636	REc			
2.844	6	4	13	2q33.3	METTL21A, FAM119A		Methyltransferase-like 21A	615257	REc			
2.845	4	15	09	2q33.3	OS4, GOA1		Osteoarthritis susceptibility 4	610839	Fd	max lod at D2S2358	{Osteoarthritis susceptibility 4} (2)	
2.846	1	14	13	2q34	IDH1		Isocitrate dehydrogenase, soluble	147700	S, D		{Glioma, susceptibility to, somatic}, 137800 (3)	1(Idh1)
2.847	8	1	16	2q33.3	ZDBF2, KIAA1571		Zinc finger DBF domain-containing protein 2	617059	REc, Psh			
2.848	1	18	13	2q35	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2		ATP-binding cassette, subfamily A, member 12	607800	R, H, Fd		Ichthyosis, congenital, autosomal recessive 4A, 601277 (3); Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3)	1(Abca12)
2.849	11	22	13	2q33.3	C2orf80, GONDA1		Chromosome 2 open reading frame 80	615536	REc			
2.850	8	24	04	2q35	CTDSP1, NLIIF, SCP1		C-terminal domain of RNA polymerase II polypeptide A, small phosphatase of, 1	605323	REc			
2.851	11	19	13	2q34	ERBB4, HER4, ALS19		Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4	600543	A		Amyotrophic lateral sclerosis 19, 615515 (3)	
2.852	12	28	17	2q35	FN1, FN, LETS, FNZ, GFND2, SMDCF		Fibronectin-1	135600	S, REa, A		Glomerulopathy with fibronectin deposits 2, 601894 (3); Spondylometaphyseal dysplasia, corner fracture type, 184255 (3); Plasma fibronectin deficiency, 614101 (1)	1(Fn1)
2.853	8	24	12	2q34	KANSL1L, C2orf67, MSL1V2		KAT8 regulatory NSL complex subunit 1-like	613833	REc			
2.854	9	5	01	2q34	LANCL1, GPR69A		LanC-like 1 (G protein-coupled receptor 69A)	604155	R, A			
2.855	12	9	98	2q34	IDDM13		Insulin-dependent diabetes mellitus-13	601318	Fd		{Diabetes mellitus, insulin-dependent, 13} (2)	
2.856	2	23	12	2q34	IKZF2, ANF1A2, HELIOS		Ikaros family zinc finger 2	606234	REc			
2.857	5	25	00	2q33.3	NRP2, VEGF1265R2, NPN2		Neuropilin 2	602070	REa, R			
2.858	8	1	08	2q34	SPAG16, PF20		Sperm-associated antigen 16	612173	A, H			1(Spag16)
2.859	1	10	89	2q34	TCL4		T-cell leukemia/lymphoma-4	186860	Ch, RE		Leukemia/lymphoma, T-cell (2)	
2.860	4	27	11	2q34	ACADL, LCAD		Acyl-Coenzyme A dehydrogenase, long chain	609576	A			1(Acadl)
2.861	9	18	08	2q36.1	ACSL3, FACL3, ACS3		Acyl-CoA synthetase long-chain family member 3	602371	Psh, A			
2.862	10	4	05	2q35	BARD1		BRCA1-associated RING domain 1	601593	Psh, REc		{Breast cancer, susceptibility to}, 114480 (3)	
2.863	10	23	87	2q34	MAP2		Microtubule-associated protein-2	157130	REa, A			
2.864	12	11	02	2q34-q35	SLEN2		Systemic lupus erythematosus with nephritis, susceptibility to, 2	607966	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)	
2.865	6	19	00	2q35	ZNF142		Zinc finger protein-142	604083	R, A			
2.866	8	7	14	2q35	CRYBA2, CTRCT42		Crystallin, beta A2	600836	REa	mutation identified in 1 CTRCT42 family	?Cataract 42, 115900 (3)	1(cryba2)
2.867	4	19	16	2q34-q36	DUP2q35, C2DUPq35, SDTY1, SD1		Chromosome 2q35 duplication syndrome (syndactyly, type I)	185900	Fd		Syndactyly, type 1, with or without craniosynostosis (4)	
2.868	1	24	02	2q35	SMARCAL1, HARP, SIOD		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like	606622	REc		Schimke immunoosseous dysplasia, 242900 (3)	1(Smarcal1)
2.869	1	16	07	2q37.3	AQP12A, AQPX2, AQP12		Aquaporin 12A	609789	REc			
2.870	5	25	13	2q35	AAMP		Angio-associated migratory cell protein	603488	REc			
2.871	6	27	17	2q35	ANKZF1, ZNF744		Ankyrin repeat- and zinc finger domain-containing 1	617541	REc			
2.872	2	1	11	2q35	ARPC2, ARC34		Actin-related protein 2/3 complex, subunit 2	604224	REc			
2.873	8	29	08	2q35	ATG9A, APG9L1		Autophagy 9, S. cerevisiae, homolog of, A	612204	REc			
2.874	6	7	04	2q35	ATIC, PURH, AICAR		5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase	601731	REc		AICA-ribosiduria due to ATIC deficiency, 608688 (3)	
2.875	7	25	17	2q35	CFAP65, CCDC108		Cilia- and flagella-associated protein 65	614270	REc			
2.876	1	24	01	2q35	CDK5R2, NCK5AI		Cyclin-dependent kinase 5, regulatory subunit 2	603764	A			
2.877	9	12	13	2q34	CPS1, PHN		Carbamoyl-phosphate synthetase 1, mitochondrial	608307	REa, Fd, A	urea cycle enzyme	Carbamoylphosphate synthetase I deficiency, 237300 (3); {Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3); {Venoocclusive disease after bone marrow transplantation} (3)	1(Cps)
2.878	7	8	11	2q35	CXCR1, IL8RA		Chemokine, CXC motif, receptor 1	146929	REa, A, Psh		{AIDS, slow progression to}, 609423 (3)	
2.879	2	8	11	2q35	CXCR2, IL8RB, IL8R2		Chemokine, CXC motif, receptor 2	146928	A, REa, Psh			1(Il8r2)
2.880	09	27	18	2q35	DES, CMD1I, MFM1, SCPNK		Desmin	125660	REa, A	1 family with LGMD2R identified with mutation	Myopathy, myofibrillar, 1, 601419 (3); Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	1(Des)
2.881	7	11	16	2q35	DNAJB2, HSJ1, HSPF3, DSMA5		DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1)	604139	R, REc		Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	
2.882	3	23	14	2q35	DNPEP, ASPEP, DAP		Aspartyl aminopeptidase	611367	REc			
2.883	11	19	13	2q35	GMPPA, AAMR		GDP-mannose pyrophosphorylase A	615495	REc		Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	
2.884	6	2	06	2q35	GPBAR1, BG37		G protein-coupled bile acid receptor 1	610147	REc			
2.885	6	7	10	2q35	MARCH4, RNF174, KIAA1399		Membrane-associated RING-CH finger protein 4	608208	R, REc			
2.886	3	23	09	2q35	MIR26B, MIRN26B		Micro RNA 26B	612152	REc			
2.887	3	23	09	2q35	MIR375, MIRN375		Micro RNA 375	611173	REc			
2.888	8	31	17	2q35	MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8		Myofibrillogenesis regulator 1	609023	Fd, REc		Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3)	
2.889	1	2	08	2q35	MREG, DSU		Melanoregulin	609207	REc, H			1(Dsu)
2.890	2	10	04	2q35	MTBS1		Mycobacterium tuberculosis, susceptibility to infection by	607949	Fd		{Tuberculosis, susceptibility to} (2)	
2.891	9	22	09	2q35	NBLST5		Neuroblastoma, susceptibility to, 5	613016	Fd	associated with rs6435862, rs3768716	{Neuroblastoma, susceptibility to, 5} (2)	
2.892	1	14	09	2q35	NHEJ1, XLF		Nonhomologous end-joining factor 1	611290	REc		Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	
2.893	8	24	09	2q35	OBSL1, KIAA0657, 3M2		Obscurin-like 1	610991	R, REc		3-M syndrome 2, 612921 (3)	
2.894	8	27	09	2q35	PECR, TERP		Peroxisomal trans-2-enoyl-CoA reductase	605843	REc			
2.895	1	28	10	2q34	PIKFYVE, PIP5K3		Phosphatidylinositol kinase, FYVE-finger containing	609414	Fd, REc		Corneal fleck dystrophy, 121850 (3)	
2.896	11	19	09	2q35	PRKAG3		Protein kinase, AMP-activated, noncatalytic, gamma 3	604976	REc			
2.897	5	4	09	2q35	RESP18		Regulated endocrine-specific protein 18	612721	REc			
2.898	9	22	14	2q35	RNF25, AO7		Ring finger protein 25	616014	REc			
2.899	3	29	10	2q35	RPL37A		Ribosomal protein L37A	613314	REc			
2.900	8	27	08	2q35	RQCD1, RCD1, CNOT9		Required for cell differentiation 1, S. pombe, homolog of	612054	REc			
2.901	12	21	09	2q35	NRAMP1, NRAMP, SLC11A1		Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1	600266	REn, REc, Psh, H, Fd	within 220 kb of VIL1	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3); {Buruli ulcer, susceptibility to}, 610446 (3)	1(Nramp)
2.902	9	19	14	2q35	SPEG, APEG1, CNM5		SPEG complex locus	615950	REc		Centronuclear myopathy 5, 615959 (3)	
2.903	3	25	03	2q35	STK36, FU, KIAA1278		Serine/threonine protein kinase 36	607652	R, REn			
2.904	8	19	13	2q35	TMBIM1, RECS1		Transmembrane BAX inhibitor motif-containing protein 1	610364	REc, R			
2.905	7	5	15	2q35	TUBA4A, TUBA1, ALS22		Tubulin, alpha-4A	191110	REc		Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3)	1(Tuba4a)
2.906	2	12	16	2q34	UNC80, C2orf21, KIAA1843		Unc-80 homolog, NALCN activator	612636	R, REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	
2.907	5	5	00	2q35	WNT6		Wingless-type MMTV integration site family, member 6	604663	A			1(Wnt6)
2.908	7	22	11	2q35	WNT10A, SSPS, STHAG4, OODD		Wingless-type MMTV integration site family, member 10A	606268	REc, Fd		Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)	
2.909	6	6	94	2q35	XRCC5		X-ray repair, complementing defective, repair in Chinese hamster cells-5	194364	REa, R, A	included in YAC contig spanning 2q33-q34		1(Xrcc5)
2.910	9	29	10	2q35	ZFAND2B, AIRAPL		Zinc finger AN1 domain-containing protein 2B	613474	REc			
2.911	1	22	08	2q35	ACCN4, ASIC4, BNAC4		Cation channel, amiloride-sensitive, neuronal, 4	606715	R, REc			
2.912	5	22	03	2q36.1	KCNE4, MIRP3		Potassium channel, voltage-gated, ISK-related subfamily, member 4	607775	REc			
2.913	1	11	05	2q35-q36	PSHK2		Pseudohyperkalemia, familial, 2, due to red cell leak	609153	Fd	max lod at D2S1338	Pseudohyperkalemia, familial, 2, due to red cell leak (2)	
2.914	2	3	99	2q36.1	SCG2, CHGC		Secretogranin II (chromogranin C)	118930	A			1(Scg2)
2.915	6	4	90	2q35	TNP1		Transition protein-1	190231	REa, A			1(Tp1)
2.916	2	18	08	2q35	TNS1, TNS		Tensin 1	600076	REa, H			1(Tns)
2.917	2	10	04	2q35	VIL1		Villin-1	193040	A		Cholestasis, progressive canalicular (1)	1(Vil)
2.918	6	4	97	2q35	PTPRN, IA2		Protein tyrosine phosphatase, receptor type N (islet cell antigen 2)	601773	A, R			1(Ptprn)
2.919	3	5	95	2q37.3	GPC1		Glypican 1	600395	A			
2.920	2	25	16	2q35	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2		ATP-binding cassette, subfamily B, member 6	605452	A, Fd		Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood group, Langereis system], 111600 (3); Dyschromatosis universalis hereditaria 3, 615402 (3); Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	
2.921	4	20	04	2q36	ACRPV		Acropectorovertebral dysplasia (F syndrome)	102510	Fd		Acropectorovertebral dysplasia (2)	
2.922	7	18	14	2q36.3	AGFG1, HRB, RIP, RAB		ADP-ribosylation factor GTPase-activating protein with FG repeats 1	600862	A			
2.923	6	5	18	2q36.1	FARSLB, FRSB, NEDBLLA		Phenylalanine-tRNA synthetase-like, beta subunit	609690	REc	mutation identified in 1 NEDBLLA patient	?Neurodevelopmental disorder with brain, liver, and lung abnormalities, 618007 (3)	
2.924	8	27	09	2q35	FEV		Fifth Ewing sarcoma variant	607150	REa, REc	fused with EWS in tumors		
2.925	5	23	11	2q36	IGAN2		IgA nephropathy, susceptibility to, 2	613944	Fd	between D2S1323 and D2S362	{IgA nephropathy, susceptibility to, 2} (2)	
2.926	1	11	07	2q36.3	IRS1		Insulin receptor substrate-1	147545	REa, A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); {Coronary artery disease, susceptibility to} (3)	1(Irs1)
2.927	9	9	13	2q36.1	MRPL44, COXPD16		Mitochondrial ribosomal protein L44	611849	R, REc	Mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 16, 615395 (3)	
2.928	10	9	94	2q35	SLC2C, AE3		Anion exchanger 3, neuronal	106195	A, Psh, Fd			1(Ae3)
2.929	12	18	07	2q36.3	SPHKAP, SKIP, KIAA1678		SPHK1 interactor, AKAP domain containing	611646	R, REc			
2.930	9	12	02	2q35	STK11IP, KIAA1898, LIP1		Serine/threonine kinase 11 interacting protein	607172	R			
2.931	11	22	99	2q37.3	AGXT, SPAT		Alanine-glyoxylate aminotransferase, liver-specific peroxisomal	604285	A, REa		Hyperoxaluria, primary, type 1, 259900 (3)	
2.932	5	4	12	2q36.3	COL4A3		Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	REa, A, RE	noncollagenous domain = Goodpasture antigen	Alport syndrome, autosomal recessive, 203780 (3); Hematuria, benign familial, 141200 (3); Alport syndrome, autosomal dominant, 104200 (3)	
2.933	5	8	97	2q36.3	COL4A4		Collagen IV, alpha-4 polypeptide	120131	REa, A	head-to-head with COL4A4 in same YAC	Alport syndrome, autosomal recessive, 203780 (3); Hematuria, familial benign (3)	
2.934	2	8	13	2q37.1	ECEL1, XCE, DA5D		Endothelin-converting enzyme-like 1	605896	A		Arthrogryposis, distal, type 5D, 615065 (3)	
2.935	2	18	98	2q37.2	GBX2		Gastrulation brain homeobox 2	601135	Psh, A			1(Gbx2)
2.936	5	12	89	2q24.2	GCG		Glucagon	138030	REa, A		[?Hyperproglucagonemia] (1)	2(Gcg)
2.937	8	15	97	2q37.1	INPP5D, SHIP		Inositol polyphosphate-5-phosphatase, 145kD	601582	A			1(Inpp5d)
2.938	4	7	14	2q37.1	PDE6D, JBTS22		Phosphodiesterase 6D, cGMP-specific, rod, delta	602676	A, R	mutation identified in 1 JBTS22 family	?Joubert syndrome 22, 615665 (3)	1(Pde6d)
2.939	8	27	09	2q37.1	PTMA, TMSA		Prothymosin, alpha (gene sequence 28)	188390	REa, REc			
2.940	2	14	01	2q37.3	RAMP1		Receptor activity-modifying protein 1	605153	R			1(Ramp1)
2.941	12	1	14	2q36.1	AP1S3, PSORS15		Adaptor-related protein complex 1, sigma-3 subunit	615781	REc		{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	
2.942	4	14	10	2q35	CHPF, CSS2		Chondroitin polymerizing factor	610405	REc			
2.943	9	27	17	2q36.1	EPHA4, HEK8, TYRO1		Ephrin receptor EphA4	602188	REc			
2.944	8	3	12	2q36.1	MOGAT1, MGAT1, DGAT2L1		Monoacylglycerol O-acyltransferase 1	610268	REc, R			
2.945	2	23	12	2q36.1	PAX3, WS1, HUP2, CDHS, WS3		Paired box homeotic gene-3	606597	Ch, Fd, H, A, Psh		Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type 3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)	1(Sp)
2.946	7	16	09	2q36.1	SGPP2, SPP2		Sphingosine-1-phosphate phosphatase 2	612827	REc			
2.947	8	10	18	2q36.1	WDFY1, FENS1		WD repeat-and FYVE domain-containing protein 1	618080	REc			
2.948	2	21	10	2q36.1-q36.3	SPDA3		Spondyloarthropathy, susceptibility to, 3	613238	Fd	max lod at D2S2228	{Spondyloarthropathy, susceptibility to, 3} (2)	
2.949	12	10	10	2q36.2	RJBS		Rajab syndrome	613658	Fd	between D2S351 and D2S2390	Rajab syndrome (2)	
2.950	10	13	09	2q36.2	DOCK10, KIAA0694, ZIZ3		Dedicator of cytokinesis 10	611518	R, REc			
2.951	2	27	12	2q36.2	CUL3, PHA2E		Cullin 3	603136	R, REc		Pseudohypoaldosteronism, type IIE, 614496 (3)	
2.952	8	25	16	2q36.3	MFF, C2orf33, EMPF2		Mitochondrial fission factor	614785	REc		Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3)	
2.953	12	10	13	2q36.3	NYPA2, KIAA1486		Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 2	615478	REc, R			
2.954	8	17	09	2q36.3	PID1, NYGGF4		Phosphotyrosine interaction domain-containing 1	612930	REc			
2.955	6	12	17	2q36.3	RHBDD1, RRP4, RHBDL4		Rhomboid domain-containing 1	617515	REc			
2.956	2	13	12	2q36.3	SLC19A3, THMD2, BBGD		Solute carrier family 19 (folate transporter), member 3	606152	A, H, Fd		Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	1(Slc19a3)
2.957	10	15	13	2q36.3	TM4SF20, SLI5		Transmembrane 4 L6 family, member 20	615404	REc		{Specific language impairment 5}, 615432 (3)	
2.958	11	7	17	2q36.3	TRIP12, MRD49		Thyroid hormone receptor interactor 12	604506	REa, REc		Mental retardation, autosomal dominant 49, 617752 (3)	
2.959	3	14	96	2q37.1	HTR2B		5-hydroxytryptamine (serotonin) receptor-2B	601122	A			
2.960	4	12	92	2q37.1	ALPP		Alkaline phosphatase, placental (Regan isozyme)	171800	REb, REa, A, RE			4(Akp2)
2.961	4	12	92	2q37.1	ALPPL2		Alkaline phosphatase, placental-like 2	171810	REa, A			
2.962	9	22	08	2q37.3	ASB1		Ankyrin repeat-containing SOCS box protein 1	605758	R, REc			1(Asb1)
2.963	10	14	15	2q37	BDMR, C2DELq37, DEL2q37		Chromosome 2q37 deletion syndrome	600430	Ch		Chromosome 2q37 deletion syndrome (4)	
2.964	7	20	15	2q37.3	COL6A3, DYT27, BTHLM1, UCMD1		Collagen VI, alpha-3 polypeptide	120250	REa, A	close to CRBP1	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); Dystonia 27, 616411 (3)	1(Col6a3)
2.965	8	11	15	2q37.3	ACKR3, CXCR7, CMKOR1, GPR159, RDC1		Atypical chemokine receptor 3	610376	A			
2.966	4	29	03	2q36.3	DNER		Delta-and notch-like egf-related receptor	607299	REc			
2.967	3	9	00	2q37.1	GPR55		G protein-coupled receptor 55	604107	A			
2.968	12	29	99	2q37.3	HDLBP, VGL		High-density lipoprotein-binding protein	142695	REa, A			
2.969	3	28	12	2q37	IBGC2		Basal ganglia calcification, idiopathic, 2	606656	Fd		Basal ganglia calcification, idiopathic, 2 (2)	
2.970	9	1	05	2q37.1	ITM2C, BRI3		Integral membrane protein 2C	609554	REc			
2.971	8	25	11	2q37.1	KCNJ13, SVD, LCA16		Potassium inwardly-rectifying channel, subfamily J, member 13	603208	R, Fd		Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital amaurosis 16, 614186 (3)	
2.972	10	3	11	2q37.3	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9		Kinesin family member 1A	601255	Psh, A	incorrectly assigned to chr.9	Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy, hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)	
2.973	5	31	05	2q37.3	MLPH		Melanophilin	606526	R, H		Griscelli syndrome, type 3, 609227 (3)	1(Mlph)
2.974	1	8	01	2q37.1	NEU2, SIAL2		Neuraminidase 2	605528	A, R			
2.975	7	17	01	2q37.1	NGEF		Neuronal guanine nucleotide exchange factor	605991	REc, A			1(Ngef)
2.976	10	1	07	2q37.3	SEPT2, NEDD5, DIFF6		Septin 2	601506	A			
2.977	3	26	02	2q37.1	TRPM8, TRPP8		Transient receptor potential cation channel, subfamily M, member 8	606678	REc			
2.978	6	7	10	2q37.1	UGT1A1, UGT1, GNT1, BILIQTL1		UDP glycosyltransferase 1 family, polypeptide A1	191740	REa		Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome], 143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transient neonatal, 237900 (3); [Bilirubin, serum level of, QTL1], 601816 (3)	1(Ugt1)
2.979	11	1	01	2q37.1	UGT1A3, UGT1C		UDP-glycosyltransferase 1 family, polypeptide A3	606428	REa, REn			
2.980	11	1	01	2q37.1	UGT1A4, UGT1D		UDP-glycosyltransferase 1 family, polypeptide A4	606429	REa, REn			
2.981	11	1	01	2q37.1	UGT1A5		UDP-glycosyltransferase 1 family, polypeptide A5	606430	REa, REn			
2.982	11	1	01	2q37.1	UGT1A8		UDP-glycosyltransferase 1 family, polypeptide A8	606433	REa, REn			
2.983	11	1	01	2q37.1	UGT1A6		UDP-glycosyltransferase 1 family, polypeptide A6	606431	REa, REn			
2.984	11	1	01	2q37.1	UGT1A7		UDP-glycosyltransferase 1 family, polypeptide A7	606432	REa, REn			
2.985	11	1	01	2q37.1	UGT1A9		UDP-glycosyltransferase 1 family, polypeptide A9	606434	REa, REn			
2.986	11	1	01	2q37.1	UGT1A10		UDP-glycosyltransferase 1 family, polypeptide A10	606435	REa, REn			
2.987	6	10	98	2q37.1	SPP2		Secreted phosphoprotein-2, 24kD	602637	R, A			
2.988	6	22	01	2q37.1	ALPI		Alkaline phosphatase, intestinal	171740	A, REa, RE, REc	close to ALPP; proximal to PAX3		1(Akp3)
2.989	7	20	12	2q37.1	ARL4C, ARL7		ADP-ribosylation factor-like 4C	604787	REc			
2.990	8	15	17	2q37.1	ARMC9, KIAA1868, JBTS30		Armadillo repeat-containing protein 9	617612	REc		Joubert syndrome 30, 617622 (3)	
2.991	8	2	16	2q37.1	ATG16L1, APG16L, IBD10		Autophagy 16-like 1	610767	REc		{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	
2.992	7	22	13	2q37.1	B3GNT7		Beta-1,3-N-acetylglucosaminyltransferase 7	615313	REc			
2.993	8	1	08	2q37.1	CAB39		Calcium-binding protein 39	612174	R, REc			
2.994	9	22	14	2q37.1	COPS7B		COP9 signalosome, subunit 7B	616010	REc			
2.995	1	9	07	2q37.1	DGKD		Diacylglycerol kinase, delta, 130kD	601826	REc			
2.996	2	18	08	2q37.1	EFHD1		EF-hand domain family, member D1	611617	REc			
2.997	2	21	06	2q37.1	EIF4E2, EIF4EL3, 4EHP		Eukaryotic translation initiation factor 4E family, member 2	605895	R, REc			
2.998	9	9	08	2q36.3	FBXO36, FBX36		F-box only protein 36	609105	REc			1(Fbxo36)
2.999	4	10	15	2q37.1	GIGYF2, KIAA0642, PARK11		GRB10-interacting GYF protein 2	612003	R, REc, Fd		{Parkinson disease 11}, 607688 (3)	1(Gigyf2)
2.1000	3	23	09	2q37.1	HJURP		Holliday junction recognition protein	612667	REc			
2.1001	3	23	06	2q37.1	MYP12		Myopia 12	609995	Fd	max lod at D2S2344	Myopia 12 (2)	
2.1002	5	19	06	2q37.1	NMUR1, GPR66, FM3		Neuromedin U receptor 1	604153	REc			
2.1003	4	15	11	2q37.1	PRSS56, MCOP6		Protease, serine, 56	613858	REc, Fd		Microphthalmia, isolated 6, 613517 (3)	
2.1004	1	22	18	2q37.1	PSMD1		Proteasome 26S subunit, non-ATPase, 1	617842	REc, A			
2.1005	2	25	14	2q37.1	SCARNA5		Small Cajal body-specific RNA 5	615640	REc	within intron 9 of ATG16L1		
2.1006	2	25	14	2q37.1	SCARNA6		Small Cajal body-specific RNA 6	615641	REc	within intron 12 of ATG16L1		
2.1007	7	7	05	2q37.1	SP100		Nuclear antigen SP100	604585	R, REc			
2.1008	10	11	06	2q37.1	SP110, IFI41, IFI75, VODI		SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)	604457	R, Fd		Hepatic venoocclusive disease with immunodeficiency, 235550 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
2.1009	4	23	09	2q37.1	SAG, RP47		S-antigen; retina and pineal gland (arrestin)	181031	REa, A, Fd		Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)	1(Sag)
2.1010	10	26	17	2q37.1	SP140L		Nuclear body protein SP140-like	617747	REc			
2.1011	9	7	10	2q37.1	STQTL21		Stature quantitative trait locus 21	613440	Fd	associated with rs6717918	{Stature QTL 21} (2)	
2.1012	9	10	09	2q37.1	TIGD1		TIGGER transposable element-derived gene 1	612972	REc			
2.1013	5	24	13	2q37.1	USP40		Ubiquitin-specific protease 40	610570	REc, R			
2.1014	2	5	01	2q37.2	SH3BP4, BOG25		SH3 domain-binding protein 4	605611	A			
2.1015	7	20	01	2q37.1-q37.3	HPE6		Holoprosencephaly 6	605934	Ch		Holoprosencephaly 6 (2)	
2.1016	3	16	12	2q37.1	DIS3L2, PRLMNS		Dis3 mitotic control, S. cerevisiae, homolog-like 2	614184	REc		Perlman syndrome, 267000 (3)	
2.1017	10	13	15	2q37.3	HDAC4, HDACA		Histone deacetylase 4	605314	A, Ch			
2.1018	4	2	16	2q37.3	ATG4B, APG4B, KIAA0943		Autophagy 4, S. cerevisiae, homolog of, B	611338	REc			
2.1019	9	27	17	2q37.3	BOK, BCL2L9		BCL2-related ovarian killer	605404	REc			
2.1020	4	17	09	2q37.3	CAPN10, NIDDM1		Calpain-10	605286	A, REc		{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	
2.1021	9	22	14	2q37.3	COPS8, CSN8		COP9 signalosome, subunit 8	616011	REc, H			1(Csn8)
2.1022	10	23	08	2q37.3	D2HGDH, D2HGD		D-2-hydroxyglutarate dehydrogenase	609186	REc		D-2-hydroxyglutaric aciduria, 600721 (3)	
2.1023	5	25	13	2q37.3	DTYMK, TYMK, CDC8		Deoxythymidylate kinase	188345	REc			
2.1024	2	15	18	2q37.3	ERFE, FAM132B, CTRP15		Erythroferrone	615099	REc			1(Fam132b)
2.1025	8	2	17	2q37.3	FARP2, FRG, FIR		FERM, ARHGEF, and pleckstrin domain-containing protein 2	617586	REc			
2.1026	2	7	07	2q37.3	GAL3ST2, GP3ST		Galactose-3-O-sulfotransferase 2	608237	REc			
2.1027	6	19	98	2q37.3	GPR35		G protein-coupled receptor-35	602646	A			
2.1028	8	31	06	2q37.3	HES6		Hairy/enhancer of split, Drosophila, homolog of, 6	610331	R, REc			
2.1029	3	15	04	2q37.3	ING5		Inhibitor of growth-5	608525	R, REc			
2.1030	7	1	11	2q37.3	LRRFIP1, GCF2, TRIP, FLAP1		Leucine-rich repeat in FLII-interacting protein 1	603256	REc			
2.1031	5	6	13	2q37.3	MIR149		Micro RNA 149	615209	REc			
2.1032	1	13	15	2q37.3	MTERF4, MTERFD2		Mitochondrial transcription termination factor 4	615393	REc			
2.1033	12	5	16	2q37.3	NDUFA10		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10	603835	REa, REc		Leigh syndrome, 256000 (3)	
2.1034	5	25	13	2q37.3	NEU4		Neuraminidase 4	608527	REc			1(Neu4)
2.1035	6	12	03	2q37.3	OTOSP		Otospiralin	607877	A, R			
2.1036	3	3	03	2q37.3	PASK, KIAA0135		Pas domain-containing serine-threonine kinase	607505	REc			
2.1037	1	6	11	2q37.3	PDCD1, SLEB2		Programmed cell death 1	600244	A, Fd		{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3); {Multiple sclerosis, disease progression, modifier of}, 126200 (3)	
2.1038	5	13	13	2q37.3	PER2, FASPS1, KIAA0347		Period, Drosophila, homolog of, 2	603426	Fd, A, REc		Advanced sleep phase syndrome, familial, 1, 604348 (3)	
2.1039	8	20	98	2q37.3	PPP1R7, SDS22		Protein phosphatase 1, regulatory subunit 7	602877	REa, REc			
2.1040	9	27	17	2q37.3	PRLH, PRRP		Prolactin-releasing hormone	602663	REc			
2.1041	10	28	09	2q37.3	RAB17		Ras-associated protein	602206	REc			
2.1042	9	28	00	2q37.3	RNPEPL1		Arginyl aminopeptidase-like 1 (aminopeptidase B-like)	605287	REn			
2.1043	8	21	07	2q37.3	SCLY, SCL		Selenocysteine lyase	611056	R, REc			
2.1044	11	18	15	2q37.3	SNED1, SNEP		SUSHI, NIDOGEN, and EGF-like domains protein 1	616634	REc			1(Sned1)
2.1045	9	20	14	2q37.3	STK25, SOK1, YSK1		Serine/threonine protein kinase 25	602255	REc			
2.1046	1	20	09	2q37.3	THAP4		THAP domain-containing protein 4	612533	REc			
2.1047	1	2	08	2q37.3	TMEM16G, PCANAP5, IPCA5, DTMPP, NGEP		Transmembrane protein 16G	605096	REc			
2.1048	11	4	15	2q37.3	TRAF3IP1, MIPT3, SLSN9		TNF receptor-associated factor 3-interacting protein 1	607380	REc		Senior-Loken syndrome 9, 616629 (3)	
2.1049	10	11	17	2q37.3	UBE2F, NCE2		Ubiquitin-conjugating enzyme E2F	617700	REc			
2.1050	8	11	15	2q37.3	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS		Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)	607556	REc		Focal facial dermal dysplasia 3, Setleis type, 227260 (3); Barber-Say syndrome, 209885 (3); Ablepharon-macrostomia syndrome, 200110 (3)	
2.1051	4	6	00	Chr.2	TSE2		Transsuppressor of expression 2	601136	M			
3.1	3	10	11	3pter-p25	DEL3pterp25, C3DELpterp25		3p- syndrome (chromosome 3pter-p25 deletion syndrome)	613792	Ch	contiguous gene deletion syndrome	3p- syndrome (4)	
3.2	12	22	89	3p22.1	CCK		Cholecystokinin	118440	REb, REa			9(Cck)
3.3	3	10	11	3p22.2	CX3CR1, GPR13, V28		Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470	REa		{Rapid progression to AIDS from HIV1 infection}, 609423 (3); {Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)	
3.4	2	15	96	3p21.31	SEP		SEP transmembrane protein	601053	REa			
3.5	3	17	05	3p26.2	CRBN, MRT2		Cereblon	609262	Fd, REc	between D3S3525 and D3S1560	Mental retardation, autosomal recessive 2, 607417 (3)	
3.6	12	17	07	3p26.1	EGO		Eosinophil granule ontogeny	611662	REc			
3.7	1	8	01	3p25.3	OGG1		8-hydroxyguanine DNA glycosylase	601982	A		Renal cell carcinoma, clear cell, somatic, 144700 (3)	6(Ogg1)
3.8	3	5	95	3p25.3	OXTR		Oxytocin receptor	167055	A, Psh	3p25 by others; within 7-10kb of CAV3		
3.9	10	23	15	3p26.1	ARL8B, GIE1		ADP-ribosylation factor-like 8B	616596	REc			
3.10	2	28	03	3p26.3	CHL1, CALL, L1CAM2		CHL1, mouse, homolog of (L1 cell adhesion molecule 2)	607416	A, D			6(Chl1)
3.11	4	3	03	3p26.1	EDEM, KIAA0212		ER degradation-enhancing alpha-mannosidase-like protein	607673	R			
3.12	4	19	12	3p26.1	GRM7, MGLUR7		Glutamate receptor, metabotropic, 7	604101	R, REc			
3.13	6	10	16	3p26.1	ITPR1, SCA15, SCA16, SCA29		Inositol 1,4,5-triphosphate receptor, type 1	147265	REa, A, Fd, REc		Spinocerebellar ataxia 15, 606658 (3); Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3); Gillespie syndrome, 206700 (3)	6(Itpr1)
3.14	5	12	17	3p25.3	SSUH2, C3orf32, FLS485		Ssu2, C. elegans, homolog of	617479	REc			
3.15	8	24	09	3p26.1-p25.1	ARHI2		Age-related hearing impairment 2	612976	Fd	associated with rs11928865, rs779701, and rs779706	{Age-related hearing impairment 2} (2)	
3.16	9	30	10	3p26.1	BHLHE40, HLHB2, STRA13, DEC1		Basic helix-loop-helix family, member E40	604256	A			
3.17	5	30	00	3p12.3	CNTN3, PANG		Contactin 3 (plasmocytoma-associated neuronal glycoprotein)	601325	REa, H			6(Pang)
3.18	5	1	08	3p26	HPC5		Prostate cancer, hereditary, 5	609299	Fd	between D3S1270 and D3S4559	{Prostate cancer, hereditary, 5}, 176807 (2)	
3.19	3	8	04	3p26	IBD9		Inflammatory bowel disease 9	608448	Fd		{Inflammatory bowel disease 9} (2)	
3.20	3	20	06	3p26.1	SETMAR, METNASE		SET and Mariner transposase domains-containing protein	609834	REc			
3.21	5	23	06	3p26	STQTL5		Stature quantitative trait locus 5	608982	Fd	max lod between D3S1297 and D3S1304	{Stature QTL 5} (2)	
3.22	10	29	03	3p26.1	SUMF1, FGE		Sulfatase-modifying factor-1	607939	REc, H		Multiple sulfatase deficiency, 272200 (3)	6(Sumf1)
3.23	5	25	05	3p25.3	ATP2B2, PMCA2		ATPase, Ca++ transporting, plasma membrane, 2	108733	REa		{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	
3.24	2	9	17	3p25.3	BRPF1, BR140, IDDDFP		Bromodomain- and PHD finger-containing protein 1, 140kD	602410	A		Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3)	
3.25	6	9	08	3p26.3-p26.2	CNTN4		Contactin 4	607280	REc, Fd			
3.26	10	17	02	3p26.3	CNTN6, NB3		Contactin 6	607220	A			
3.27	2	20	03	3p25.3	GHRL		Ghrelin	605353	REc		{Obesity, susceptibility to}, 601665 (3)	
3.28	11	5	02	3p25.3	VHL		VHL gene	608537	Fd, D, RE		von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma, somatic, 144700 (3); Pheochromocytoma, 171300 (3); Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3)	
3.29	9	12	08	3p26-p24.2	MYMY1, MYMY		Moyamoya disease	252350	Fd	max lod at D3S3050	Moyamoya disease (2)	
3.30	6	7	94	3p26.2	IL5RA		Interleukin-5 receptor, alpha	147851	REa, A			6(Il5r)
3.31	5	11	00	3p25.3	LMCD1		LIM and cysteine-rich domains 1	604859	R			6(Lmcd1)
3.32	11	11	14	3p25.3	ARPC4, ARC20		Actin-related protein 2/3 complex, subunit 4	604226	REc			
3.33	5	9	12	3p25.3	ATG7, APG7L, GSA7		Autophagy 7, S. cerevisiae, homolog of	608760	REc, R			
3.34	2	25	14	3p25.3	BRK1, C3orf10, HSPC300		BRICK1, SCAR/WAVE actin-nucleating complex subunit	611183	REc			
3.35	8	28	09	3p25.3	CAMK1, CAMKI		Calcium/calmodulin-dependent protein kinase I	604998	REa, REc			
3.36	4	24	03	3p25.3	CRELD1, AVSD2		Cysteine-rich protein with EGF-like domains 1	607170	R, REc, H		{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3); Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	6(Creld1)
3.37	3	14	01	3p25.3	FANCD2, FANCD, FACD, FAD		Fanconi anemia, complementation group D2	613984	M		Fanconi anemia, complementation group D2, 227646 (3)	
3.38	1	9	13	3p25.3	IL17RE		Interleukin 17 receptor E	614995	REc			
3.39	4	6	10	3p25.3	IRAK2		Interleukin 1 receptor-associated kinase 2	603304	REc			
3.40	9	24	14	3p25.3	JAGN1, SCN6		Jagunal, Drosophila, homolog of, 1	616012	REc		Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	6(Jagn1)
3.41	8	22	07	3p25.3	MTMR14, C3orf29, HJUMPY		Myotubularin-related protein 14	611089	REc		{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	
3.42	11	10	17	3p25.3	RPUSD3		RNA pseudouridylate synthase domain-containing protein 3	617759	REc			
3.43	4	29	14	3p25.3	SETD5, KIAA1757		SET domain-containing protein 5	615743	REc		Mental retardation, autosomal dominant 23, 615761 (3)	
3.44	2	2	10	3p25.3	SLC6A11, GAT3, GAT4		Solute carrier family 6 (neurotransmitter transporter, GABA), member 11	607952	REc			
3.45	4	26	10	3p25.3	TADA3, TADA3L, ADA3		Transcriptional adaptor 3	602945	R, REc			
3.46	7	6	15	3p25.3	IL17RC, IL17RL, CANDF9		Interleukin 17 receptor C	610925	REc		Candidiasis, familial, 9, 616445 (3)	
3.47	1	27	04	3p22.1	TRAK1, OIP106, KIAA1042		Trafficking protein, kinesin-binding 1	608112	R, REc			9(hyrt)
3.48	5	7	03	3p23	OSBPL10, ORP10		Oxysterol-binding protein-like protein 10	606738	REc			
3.49	2	25	15	3p25.2	CAND2, TIP120B, KIAA0667		Cullin-associated neddylation -dissociated 2	610403	R, REc			
3.50	8	19	13	3p25.2	IQSEC1, KIAA0763		IQ motif- and Sec7 domain-containing protein 1	610166	R, REc			
3.51	12	17	12	3p25.2	TAMM41, RAM41, C3orf31		Translocator assembly and maintenance, mitochondrial, S. cerevisiae, homolog of	614948	REc			
3.52	4	15	03	3p25.2-p25.1	UVM2		Melanoma, uveal, susceptibility to, 2	606661	Ch, D		{Melanoma, uveal, susceptibility to, 2} (2)	
3.53	11	29	04	3p25.1	BTD		Biotinidase	609019	A		Biotinidase deficiency, 253260 (3)	
3.54	09	25	18	3p25.3	CAV3, LQT9, MPDT, RMD2		Caveolin-3	601253	A, REc	within 7-10kb of OXTR	Rippling muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial hypertrophic, 192600 (3); Long QT syndrome 9, 611818 (3)	
3.55	5	23	13	3p25.3	CIDEC, FSP27, CIDE3, FPLD5		Cell death-inducing DFFA-like effector C	612120	REc	1 patient identified with mutation	?Lipodystrophy, familial partial, type 5, 615238 (3)	
3.56	4	30	15	3p25.1	COLQ, EAD, CMS5		Collagenic tail of endplate acetylcholinesterase	603033	A, R		Myasthenic syndrome, congenital, 5, 603034 (3)	
3.57	5	24	13	3p25.3	LHFPL4		LHFP-like protein 4	610240	REc			
3.58	2	2	04	3p25.2	MKRN2		Makorin 2	608426	REc			6(Mkrn2)
3.59	4	24	08	3p25.1	MRPS25		Mitochondrial ribosomal protein S25	611987	R, REc			
3.60	10	21	99	3p25.1	NR2C2, TR4, TAK1		Nuclear receptor subfamily 2, group C, member 2	601426	REa, A			
3.61	3	27	09	3p25.2	PPARG, PPARG1, PPARG2, CIMT1, GLM1		Peroxisome proliferator activated receptor, gamma	601487	REa, Fd, A	PPARG1, PPARG2 from same gene	Obesity, severe, 601665 (3); [Obesity, resistance to] (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3); Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)	
3.62	8	3	14	3p25.2	RAF1, CRAF, NS5, CMD1NN		Oncogene RAF1	164760	REa, Fd, A		Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3); Cardiomyopathy, dilated, 1NN, 615916 (3)	6(Raf1)
3.63	10	28	02	3p25.3	SRGAP3, KIAA0411, MEGAP		Slit-robo GTPase-activating protein, rho, 3	606525	R, Ch			
3.64	8	19	99	3p25	ST11, PETS1		Suppression of tumorigenicity 11, pancreas	602011	D		?Pancreatic endocrine tumors (1)	
3.65	11	2	04	3p25.2	SYN2		Synapsin II	600755	REa, H, REn		{Schizophrenia, susceptibility to}, 181500 (3)	6(Syn2)
3.66	10	3	02	3p25.2	TIMP4		Tissue inhibitor of metalloproteinase 4	601915	A			6(Timp4)
3.67	3	27	13	3p25.1	TMEM43, ARVD5, ARVC5, EDMD7		Transmembrane protein 43	612048	REc, Fd		Arrhythmogenic right ventricular dysplasia 5, 604400 (3); Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	
3.68	7	18	06	3p25.1	WNT7A		Wingless-type MMTV integration site family, member 7A	601570	A, Fd		Ulna and fibula, absence of, with severe limb deficiency, 276820 (3); Fuhrmann syndrome, 228930 (3)	
3.69	2	19	10	3p25.1	XPC, XPCC		XPC gene	613208	REa, A, RE		Xeroderma pigmentosum, group C, 278720 (3)	6(Xpc)
3.70	10	5	11	3p24.3	PLCL2, KIAA1092		Phospholipase C-like 2	614276	R, REc			
3.71	9	19	00	3p25.3	RAD18		Rad18, S. cerevisiae, homolog of	605256	A, R			
3.72	5	7	97	3p25.3	SEC13L1, D3S1231E, SEC13R		SEC13, S. cerevisiae, like 1	600152	Psh, A			6(Sec13n)
3.73	10	9	94	3p25.1	FBLN2		Fibulin-2	135821	A			6(Fbln2)
3.74	6	19	15	3p25.3	SLC6A1, GABATR, MAE		Solute carrier family 6 (neurotransmitter transporter, GABA), member 1	137165	A		Myoclonic-atonic epilepsy, 616421 (3)	
3.75	5	27	05	3p25-p22	OVCAS1		Ovarian cancer, susceptibility to, 1	607893	Fd	between D3S1597 and D3S3611	{Ovarian cancer, susceptibility to} (2)	
3.76	3	5	95	3p25.1	SLC6A6, TAUT		Solute carrier family 6 (neurotransmitter transporter, taurine), member 6	186854	REa, A			6(Slc6a6)
3.77	9	10	07	3p25.1	ANKRD28, PITK, KIAA0379		Ankyrin repeat domain-containing protein 28	611122	R, REc			
3.78	2	18	16	3p25.1	CCDC174, HSPC212, IHPM		Coiled-coil domain-containing protein 174	616735	Psh, REc		Hypotonia, infantile, with psychomotor retardation, 616816 (3)	
3.79	8	21	07	3p25.1	CHDH4, MIA40		Coiled-coil-helix-coiled-coil-helix domain-containing protein 4	611077	REc			
3.80	12	4	03	3p25.1	EAF1		ELL-associated factor 1	608315	R, REc			
3.81	8	31	12	3p25.1	FGD5		FYVE, RhoGEF, and PH domain-containing protein 5	614788	REc			
3.82	4	6	13	3p25.1	GALNT15, GALNACT15		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15	615131	REc			
3.83	6	22	14	3p25.1	HACL1, HPCL2		2-hydroxyacyl-CoA lyase 1	604300	REc			
3.84	8	28	09	3p25.1	NUP210, GP210, KIAA0906		Nucleoporin, 210kD	607703	R, REc			
3.85	11	19	10	3p25.1	SH3BP5, SAB		SH3 domain-binding protein 5	605612	REc, A	previously mapped to 1q431		14(Sh3bp5)
3.86	6	2	16	3p26.2	TRNT1, SIFD, RPEM		tRNA nucleotidyltransferase, CCA-adding, 1	612907	REc	pseudogenes on chromosomes 1 and 22	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3); Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	
3.87	11	21	02	3p25.1	LSM3		LSM3 protein	607283	REc			
3.88	7	8	16	3p25.1	RBSN,  ZFYVE20		Rabenosyn 5	609511	R, REc			
3.89	11	15	08	3p25.2	TSEN2, SEN2, PCH2B		tRNA splicing endonuclease 2, S. cerevisiae, homolog of	608753	REc		Pontocerebellar hypoplasia type 2B, 612389 (3)	
3.90	8	20	10	3p25.1-p23	LGMD1H		Muscular dystrophy, limb-girdle, type 1H	613530	Fd	between D3S1263 and D3S1277	Muscular dystrophy, limb-girdle, type 1H (2)	
3.91	10	23	15	3p25.1	COL6A4P1, DVWA, DIVA, LOC344875		Collagen, type VI, alpha 4, pseudogene 1	612397	REc			
3.92	8	21	07	3p25.1	DPH3, KTI11, ZCSL2, DELGIP1		DPH3, S. cerevisiae, homolog of	608959	R, REc			
3.93	4	15	09	3p24.3	OS6		Osteoarthritis susceptibility 6	612401	Fd	associated with rs11718863 and rs7639618	{Osteoarthritis susceptibility 6} (2)	
3.94	2	4	15	3p24.3	SGOL1, SGO, SGO1, CAID		Shugoshin-like 1	609168	REc		Chronic atrial and intestinal dysrhythmia, 616201 (3)	
3.95	4	29	14	3p24.3	TBC1D5, KIAA0210		TBC1 domain family, member 5	615740	REc, R			
3.96	9	4	08	3p24.2	THRB, ERBA2, THR1, PRTH		Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160	REa, A, RE, Fd		Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance, autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)	
3.97	8	3	12	3p24.2	UBE2E1, UBCH6		Ubiquitin-conjugating enzyme E2E 1	602916	REc			
3.98	10	2	12	3p24.2	NR1D2, RVR, BD73		Nuclear receptor subfamily 1, group D, member 2	602304	REc			
3.99	8	31	06	3p24.2	OXSM, KS		3-oxoacyl-ACP synthase, mitochondrial	610324	REc			14(Oxsm)
3.100	12	27	13	3p24.2	RPL15, DBA12		Ribosomal protein L15	604174	REa, R, REc	mutation identified in 1 family	?Diamond-Blackfan anemia 12, 615550 (3)	
3.101	3	5	98	3p24.3	UBE2E2		Ubiquitin-conjugating enzyme E2E 2 (homologous to yeast UBC4/5)	602163	A			
3.102	1	2	08	3p24.2-p23	FEB9		Febrile seizures, familial, 9	611634	Fd	between D3S3727 and D3S3567	Febrile seizures, familial, 9 (2)	
3.103	3	1	06	3p24.1	AZI2, AZ2, NAP1, TILP		5-azacytidine-induced gene 2, mouse, homolog of	609916	REc			
3.104	1	28	14	3p24-p23	GADL1		Glutamate decarboxylase-like 1	615601	REc			
3.105	7	11	17	3p24.1	TGFBR2, HNPCC6, AAT3, MFS2, LDS2		Transforming growth factor, beta receptor II, 70-80kD	190182	A, REa, Fd		Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome 2, 610168 (3)	9(Tgbfr2)
3.106	12	22	00	3p21.31	CELSR3, EGFL1, MEGF2		Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 1)	604264	R			
3.107	8	20	15	3p24	ATOD9		Dermatitis, atopic, 9	613519	Fd	max lod at D3S1768	{Dermatitis, atopic, susceptibility to, 9} (2)	
3.108	12	30	98	3p24.3	CAF		CREBBP-associated factor	602303	A			17(Caf)
3.109	11	28	01	3p25.1	CAPN7, PALBH		Calpain 7	606400	R			
3.110	10	17	00	3p22.3	CCR4, CKR4, CMKBR4		Chemokine (C-C) receptor-4	604836	R, REc			
3.111	4	17	13	3p24.1	CMC1, C3orf68		Cytochrome C oxidase assembly mitochondrial protein 1, S. cerevisiae, homolog of	615166	REc			
3.112	4	15	03	3p24.3	DAZL, DAZH, SPGYLA		Deleted in azoospermia-like	601486	A, R	?founding member of DAZ gene family	{Spermatogenic failure, susceptibility to} (3)	
3.113	6	9	15	3p24.2	NGLY1, PNG1, CDDG, CDG1V		N-glycanase 1	610661	R, REc		Congenital disorder of deglycosylation, 615273 (3)	
3.114	11	19	13	3p24.2	RARB, HAP, MCOPS12		Retinoic acid receptor, beta polypeptide	180220	REa, A	= HAP = HBV-activated protein	Microphthalmia, syndromic 12, 615524 (3)	14(Rarb)
3.115	1	30	01	3p24.2	TOP2B		Topoisomerase (DNA) II, beta, 180kD	126431	REa, Fd			
3.116	8	27	01	3p24.1	RBMS3		RNA-binding motif protein, single strand-interacting, 3	605786	A			
3.117	9	22	03	3p24-p22	HSN1B		Hereditary sensory neuropathy, type IB	608088	Fd	max lod at D3S2338	Neuropathy, hereditary sensory, type IB (2)	
3.118	8	18	98	3p24.3	RAB5A, RAB5		RAS-associated protein RAB5A	179512	A			
3.119	4	23	98	3p22.3-p22.2	STAC		SRC homology three (SH3) and cysteine-rich domain	602317	R, H			9(Stac)
3.120	3	14	06	3p24-p21	ASPG4		Asperger syndrome, susceptibility to, 4	609954	Fd	max lod at D3S2432	{Asperger syndrome susceptibility 4} (2)	
3.121	6	9	98	3p24.3	SATB1		Special AT-rich sequence binding protein-1	602075	A			
3.122	1	14	14	3p23	STT3B, SIMP, CDG1X		STT3B, subunit of the oligosaccharyltransferase complex (catalytic)	608605	REc	mutation identified in 1 family	?Congenital disorder of glycosylation, type Ix, 615597 (3)	
3.123	12	23	05	3p22.3	UBP1, LBP1A, LBP1B		Upstream binding protein 1	609784	R, REc			
3.124	8	4	09	3p22.2	ACAA1		Acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase)	604054	REa, A			
3.125	1	17	08	3p21.31	CDCP1, SIMA135		CUB domain-containing protein 1	611735	A			
3.126	1	11	89	3p23-p21	SCLC1		Small-cell cancer of lung	182280	Ch, D	centromeric to ERBA2	Small-cell cancer of lung (2)	
3.127	6	16	99	3p21.31	SMARCC1, BAF155		SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1	601732	R, Psh			
3.128	6	28	02	3p21.31	TDGF1		Teratocarcinoma-derived growth factor-1	187395	REa, A		Forebrain defects (3)	9(Tdgf1)
3.129	8	28	09	3p22.3	CLASP2		CLIP-associated protein 2	605853	R, REc			
3.130	12	5	11	3p22.3	CMTM6, CKLFSF6		CKLF-like marvel transmembrane domain-containing 6	607889	REc			9(Cklfsf6)
3.131	12	5	11	3p22.3	CMTM7, CKLFSF7		CKLF-like marvel transmembrane domain-containing 7	607890	REc			9(Cklfsf7)
3.132	12	5	11	3p22.3	CMTM8, CKLFSF8		CKLF-like marvel transmembrane domain-containing 8	607891	REc			9(Cklfsf8)
3.133	12	21	09	3p22.2	DCLK3, DCK3, CLR		Doublecortin-like kinase 3	613167	REc			9(Dclk2)
3.134	7	17	14	3p22.3	DYNC1LI1, LIC1		Dynein, cytoplasmic 1, light intermediate chain 1	615890	REc			
3.135	8	28	09	3p22.3	FBXL2, FBL2		F-box and leucine-rich repeat protein 2	605652	R, REc			
3.136	2	11	08	3p22.3	GPD1L, KIAA0089		Glycerol-3-phosphate dehydrogenase 1-like	611778	REc, Fd		Brugada syndrome 2, 611777 (3)	
3.137	9	16	03	3p22.3	PDCD6IP, AIP1, ALIX, KIAA1375		Programmed cell death 6-interacting protein	608074	R			
3.138	12	23	05	3p22.2	CMYA1, XIN		Cardiomyopathy-associated protein 1	609777	R, REc			
3.139	2	2	14	3p22.2	DDH2		Developmental dysplasia of the hip 2	615612	Fd	between rs4481097 and rs4626072	Developmental dysplasia of the hip 2 (2)	
3.140	9	8	11	3p22.2	LRRFIP2		Leucine-rich repeat in FLII-interacting protein 2	614043	REc			
3.141	3	23	09	3p22.2	MIR26A, MIRN26A1		Micro RNA 26A1	612151	REc			
3.142	12	4	13	3p22.2	SCN10A, FEPS2		Sodium channel, voltage-gated, type X, alpha subunit	604427	Psh, REc		Episodic pain syndrome, familial, 2, 615551 (3)	
3.143	12	3	13	3p22.2	SCN11A, HSAN7, FEPS3		Sodium channel, voltage-gated, type XI, alpha subunit	604385	R, REc		Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3); Episodic pain syndrome, familial, 3, 615552 (3)	9(Scn11a)
3.144	8	25	11	3p22.1-p21.3	ANO10, TMEM16K, SCAR10		Anoctamin 10	613726	REc		Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	
3.145	7	14	17	3p22.1	CTNNB1, MRD19, EVR7		Catenin (cadherin-associated protein), beta 1, 88kD	116806	A, REn, Psh, REc		Mental retardation, autosomal dominant 19, 615075 (3); Colorectal cancer, somatic, 114500 (3); Pilomatricoma, somatic, 132600 (3); Ovarian cancer, somatic, 167000 (3); Hepatocellular carcinoma, somatic, 114550 (3); Medulloblastoma, somatic, 155255 (3); Exudative vitreoretinopathy 7, 617572 (3)	9(Catnb)
3.146	2	25	15	3p22.2	EPM2AIP1, KIAA0766		EPM2A-interacting protein 1	607911	R, REc, H			9(Epm2aip1)
3.147	10	25	16	3p22.1	HHATL, MBOAT3, C3orf3, KIAA1173		Hedgehog acyltransferase-like protein	608116	REc			
3.148	8	2	13	3p22.1	KLHL40, SYRP, KBTBD5, NEM8		Kelch-like 40	615340	REc		Nemaline myopathy 8, autosomal recessive, 615348 (3)	
3.149	2	21	14	3p22.1	NKTR		Natural tumor-killer recognition sequence	161565	REa, REc	mouse gene close to Cck		9(Nktr)
3.150	10	14	18	3p22.1	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8		Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2	614828	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3)	
3.151	4	21	17	3p22.1	RPL14		Ribosomal protein L14	617414	Psh, REc			
3.152	7	14	14	3p22.1	SEC22C		Secretion deficient 22, S. cerevisiae, homolog of, C	604028	REc			
3.153	3	17	16	3p22.1	SLC25A38, SIDBA2		Solute carrier family 25, member 38	610819	REc		Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	9(Slc25a38)
3.154	6	22	12	3p22.1	SNORA62, RNU108, RNE2		Small nucleolar RNA, H/ACA box, 62	180646	REc			
3.155	6	27	16	3p22.1	ULK4, FAM7C1		Unc51-like kinase 4	617010	REc			9(Ulk4)
3.156	8	25	11	3p21.31	NBEAL2, KIAA0540, GPS, BDPLT4		Neurobeachin-like 2	614169	REc		Gray platelet syndrome, 139090 (3)	
3.157	11	28	01	3p22.2	AXUD1		Axin1 upregulated	606458	R			
3.158	9	9	08	3p22.1	CCR8, CMKBR8, CMKBRL2, CKRL1		Chemokine (C-C) receptor 8	601834	Psh			
3.159	10	6	11	3p22.3	CRTAP, CASP, OI7		Cartilage-associated protein	605497	A		Osteogenesis imperfecta, type VII, 610682 (3)	9(Crtap)
3.160	10	4	12	3p22	HHV8S		Human herpesvirus 8, susceptibility to	614836	Fd		{Human herpesvirus 8, susceptibility to} (2)	
3.161	3	23	09	3p22.3	MIR128-2, MIR128B, MIRN128-2		Micro RNA 128-2	611769	REc			
3.162	1	29	01	3p24.1	SLC4A7, NBC2, NBC3		Solute carrier family 4, sodium bicarbonate cotransporter, member 7	603353	A			
3.163	5	9	95	3p22.1	VIPR1		Vasoactive intestinal peptide receptor 1	192321	A	incorrectly assigned to 2q37		9(Vipr1)
3.164	7	8	95	3p21.31	TGM4		Transglutaminase-4, prostate	600585	A			
3.165	11	13	07	3p22.2	ACVR2B, ACTRIIB, HTX4		Activin A receptor, type IIB	602730	REc, A		Heterotaxy, visceral, 4, autosomal, 613751 (3)	
3.166	2	19	02	3p22.1	CYP8B1, CYP12		Cytochrome P450, subfamily VIIIB, polypeptide 1	602172	A, R			9(Cyp8b1)
3.167	4	17	00	3p22.2	DLEC1, DLC1		Deleted in lung and esophageal cancer 1	604050	REn		Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)	
3.168	8	9	99	3p22.2	GOLGA4		Golgi autoantigen, golgin subfamily a, 4	602509	REc			
3.169	2	22	11	3p22.2	EXOG, ENDOGL1, ENGL		Endo/exonuclease, ENDOG-like	604051	A			
3.170	9	18	12	3p22.2	MYD88, MYD88D		Myeloid differentiation primary response gene 88	602170	Psh		Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3); Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	9(Myd88)
3.171	8	9	99	3p22.2	OSR1		Oxidative stress-responsive 1	604046	REn			
3.172	8	25	11	3p22.2	PLCD1, NDNC3		Phospholipase C, delta-1	602142	A		Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	
3.173	8	5	97	3p21.31	TNA		Tetranectin (plasminogen-binding protein)	187520	Psh, R			
3.174	8	9	99	3p22.2	XYLB		Xylulokinase, H. influenzae, homolog of	604049	REn			
3.175	6	9	10	3p21.31	PTHR1, PTHR, PFE		Parathyroid hormone receptor-1	168468	REa, A, Psh		Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3); Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)	
3.176	2	28	03	3p22.1	MOBP		Myelin-associated oligodendrocyte basic protein	600948	R, H			9(Mobp)
3.177	1	30	01	3p21.31	PFKFB4		6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	605320	A			
3.178	6	18	90	3p21.31	ZNF35, HF10		Zinc finger protein-35 (HF.10)	194533	REa, A			
3.179	2	2	11	3p22.3	GLB1, MPS4B		Galactosidase, beta-1	611458	S, EM, A	3p14.2-p11 excluded	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II, 230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	9(Bgl)
3.180	8	28	09	3p22.2	GORASP1, GOLPH5, GRASP65, P65		Golgi reassembly stacking protein 1, 65kD	606867	R, A			
3.181	5	12	09	3p22.1	LYZL4		Lysozyme-like 4	612750	REc			
3.182	10	5	17	3p21.31	TOPAZ1, C3orf77		Testis- and ovary-specific PAZ domain protein 1	614412	REc			9(Topaz1)
3.183	7	31	08	3p22.2	WDR48, KIAA1449		WD repeat-containing protein 48	612167	REc			
3.184	2	14	08	3p22.1	MYRIP, SLAC2C		Myosin VIIA- and RAB-interacting protein	611790	REc			
3.185	6	7	10	3p21.32	MIR138-1, MIRN138-1		Micro RNA 138-1	613394	REc			
3.186	12	18	08	3p21.31	ALS2CL		ALS2 C-terminal-like protein	612402	REc			9(Als2cl)
3.187	3	14	14	3p21.31	AMIGO3, ALI3		Adhesion molecule with Ig-like domain 3	615691	REc			
3.188	3	9	00	3p21.31	BSN, ZNF231		Bassoon, mouse, homolog of	604020	A, R, Psh			
3.189	1	9	13	3p21.31	CAMKV, 1G5		CAM kinase-like vesicle-associated	614993	REc			9(Camkv)
3.190	7	2	18	3p21.31	CSPG5, NGC		Chondroitin sulfate proteoglycan 5	606775	A, REc			
3.191	12	19	17	3p21.31	DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL		DEAH box polypeptide 30	616423	R, REc		Neurodevelopmental disorder with severe motor impairment and absent language, 617804 (3)	
3.192	3	7	13	3p21.31	ELP6, TMEM103, C3orf75		Elongator acetyltransferase complex, subunit 6	615020	REc			
3.193	6	1	12	3p21.31	EXOSC7, RRP42		Exosome component 7	606488	REc			
3.194	09	27	18	3p21.31	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19		GDP-mannose pyrophosphorylase B	615320	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	
3.195	8	28	09	3p21.31	IHPK1, IP6K1, KIAA0263		Inositol hexaphosphate kinase 1	606991	R, Ch			
3.196	2	25	15	3p21.31	KIF9		Kinesin family member 9	607910	R, REc			
3.197	7	13	17	3p21.31	KIF15, KLP2, KNSL7		Kinesin family, member 15	617569	REc			
3.198	11	24	14	3p21.31	KLHDC8B, CHL		Kelch domain-containing protein 8B	613169	A, REc		{Hodgkin lymphoma, susceptibility to}, 236000 (3)	
3.199	4	25	08	3p21.31	LTF		Lactotransferrin	150210	REa, A			9(Ltf)
3.200	3	29	13	3p21.31	MIR191		Micro RNA 191	615150	REc			
3.201	11	23	16	3p21.31	MIR4271		Micro RNA 4271	617176	REc			
3.202	8	27	15	3p21.31	MON1A, SAND1		Mon1, S. cerevisiae, homolog of, A	611464	R, REc			6(Mon1a)
3.203	8	24	09	3p21.31	NDUFAF3		NADH dehydrogenase 1 alpha subcomplex, assembly factor 3	612911	REc		Mitochondrial complex I deficiency, 252010 (3)	
3.204	4	25	12	3p21.31	P4HTM, PH4		Prolyl 4-hydroxylase, transmembrane	614584	REc			
3.205	2	25	15	3p21.31	PRSS50		Protease, serine, 50	607950	REa, R			
3.206	5	17	18	3p21.31	QRICH1, VERBRAS		Glutamine-rich protein 1	617387	REc		Ververi-Brady syndrome, 617982 (3)	
3.207	2	24	12	3p21.31	RNF123, KPC1		Ring finger protein 123	614472	REc			
3.208	10	30	06	3p21.31	SCAP		SREBP cleavage-activating protein	601510	R, REc			
3.209	11	17	16	3p21.1	SELENOK, SELK, HSPC030		Selenoprotein K	607916	REc			
3.210	1	19	11	3p21.31	SLC25A20, CACT, CAC		Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)	613698	A	pseudogene on 6p12	Carnitine-acylcarnitine translocase deficiency, 212138 (3)	
3.211	7	14	14	3p21.31	TMA7, HSPC016		Translation machinery-associated 7, S. cerevisiae, homolog of	615808	REc			
3.212	2	5	16	3p21.31	TRAIP, TRIP, RNF206, SCKL9		TRAF-interacting protein	605958	R, REc		Seckel syndrome 9, 616777 (3)	
3.213	6	16	99	3p21.31	USP4, UNP		Ubiquitin-specific protease-4	603486	A, H, REc			9(Unp)
3.214	2	24	12	3p21.31	USP19, KIAA0891		Ubiquitin-specific protease 19	614471	REc			
3.215	2	1	11	3p21.31	WDR6		WD repeat-containing protein 6	606031	REc	previously assigned to 15q21 by FISH		
3.216	1	5	06	3p21.31	ZD1		Zygodactyly 1	609815	Fd	max lod at D3S2409	Zygodactyly 1 (2)	
3.217	10	11	16	3p21.31	ZDHHC3, DHHC3, GODZ		Zinc finger DHHC domain-containing protein 3	617150	REc			
3.218	8	11	15	3p22.1	ACKR2, CCBP2, CMKBR9, D6, CCR9, CCR10		Atypical chemokine receptor 2	602648	R, A			
3.219	11	19	11	3p21.1	BAP1, TPDS		BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089	A, R		Tumor predisposition syndrome, 614327 (3)	
3.220	7	2	02	3p21.31	CACNA2D2, KIAA0558		Calcium channel, voltage-dependent, alpha-2/delta subunit 2	607082	R, REc			
3.221	3	2	98	3p21.31	CAMP, FALL39		Cathelicidin antimicrobial peptide	600474	A			
3.222	12	19	11	3p21.2	CISH, BACTS2		Cytokine inducible SH2-containing protein	602441	Ch		{Tuberculosis, susceptibility to}, 607948 (3); {Malaria, susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)	9(Cish)
3.223	9	9	08	3p21.31	CCR3, CKR3, CMKBR3		Chemokine (C-C) receptor 3	601268	R, REc			
3.224	9	9	08	3p21.31	CCR9		Chemokine, CC motif, receptor 9	604738	R, A			
3.225	12	2	14	3p21.31	COL7A1, NDNC8		Collagen VII, alpha-1 polypeptide	120120	REa, A		Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis bullosa dystrophica, AR, 226600 (3); Epidermolysis bullosa, pretibial, 131850 (3); EBD, Bart type, 132000 (3); EBD, localisata variant (3); Transient bullous of the newborn, 131705 (3); Epidermolysis bullosa pruriginosa, 604129 (3); Toenail dystrophy, isolated, 607523 (3); EBD inversa, 226600 (3)	
3.226	4	26	08	3p21.31	CYB561D2, 101F6		Cytochrome b-561 domain containing 2	607068	REc			
3.227	7	24	17	3p21.1	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37		Dynein, axonemal, heavy chain-1	603332	Psh, A	mutation identified in 1 CILD37 family	Spermatogenic failure 18, 617576 (3); ?Ciliary dyskinesia, primary, 37, 617577 (3)	14(Dnah1)
3.228	9	28	00	3p22.1	ENTPD3, CD39L3		Ectonucleoside triphosphate diphosphohydrolase 3	603161	R, Psh			
3.229	8	6	13	3p21.31	FYCO1, CATC2, CTRCT18		FYVE and coiled-coil domain containing 1	607182	REc, Fd		Cataract 18, autosomal recessive, 610019 (3)	
3.230	6	27	02	3p21.31	FUS2		FUS2 gene	607073	REc			
3.231	8	25	11	3p21.31	GPX1, GPXD		Glutathione peroxidase-1	138320	S, REa, Psh, A	?pseudogene on 3p11-p12	Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	
3.232	6	16	99	3p21.31	HYAL2, LUCA2		Hyaluronoglucosaminidase 2	603551	REc, H			9(Hyal2)
3.233	8	31	99	3p21.31	HYAL3, LUCA3		Hyaluronoglucosaminidase 3	604038	REn			
3.234	9	9	08	3p21.3	IBD12		Inflammatory bowel disease 12	612241	Fd		{Inflammatory bowel disease 12} (2)	
3.235	9	28	98	3p21.31	IFRD2		Interferon-related developmental regulator-2	602725	REc			
3.236	3	9	00	3p22.2	ITGA9		Integrin, alpha-9	603963	REn			
3.237	7	22	16	3p21.31	LARS2, PRLTS4, HLASA		Leucyl-tRNA synthetase, mitochondrial	604544	REc	mutation identified in 1 HLASA patient	Perrault syndrome 4, 615300 (3); ?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	
3.238	2	22	00	3p21.31	LIMD1		LIM domain-containing protein 1	604543	REc			9(Limd1)
3.239	9	11	02	3p21.31	LRRC2		Leucine-rich repeat-containing 2	607180	REc			
3.240	10	16	14	3p21.31	LZTFL1, BBS17		Leucine zipper transcription factor-like 1	606568	REc		Bardet-Biedl syndrome 17, 615994 (3)	9(Lztfl1)
3.241	9	16	16	3p21.2	MAPKAP3, 3PK, MDPT3		Mitogen-activated protein kinase-activated protein kinase-3	602130	REc	mutation identified in 1 MDPT3 family	?Macular dystrophy, patterned, 3, 617111 (3)	
3.242	12	28	08	3q21.3	MGLL, MGL, HUK5		Monoglyceride lipase	609699	REc, H, R			6(Mgll)
3.243	1	16	08	3p22.2	MLH1, COCA2, HNPCC2		mutL, E. coli, homolog of, 1	120436	Fd, A		Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)	
3.244	4	25	08	3p21.31	NME6		Nonmetastatic cells 6, protein expressed in	608294	R			
3.245	8	22	16	3p21.31	MST1R, RON, NPCA3		Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	600168	A		{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3)	
3.246	9	22	16	3p21.31	NPR2L, NPRL2, FFEVF2		Npr2, S. cerevisiae, homolog of	607072	REc		Epilepsy, familial focal, with variable foci 2, 617116 (3)	
3.247	1	3	02	3p21.31	PTPN23, KIAA1471, HDPTP		Protein-tyrosine phosphatase, nonreceptor-type, 23	606584	R, REc			
3.248	2	12	07	3p21.31	RASSF1		RAS association domain family protein 1	605082	D, REc	epigenetically inactivated	Lung cancer, 211980 (2)	
3.249	8	3	12	3p21.31	RHOA, ARHA, ARH12, RHOH12		Ras homolog gene family, member A (oncogene RHO H12)	165390	A, Psh			
3.250	4	29	02	3p21.31	RMB5, LUCA15		RNA-binding motif protein 5	606884	REc			
3.251	4	29	02	3p21.31	RBM6, DEF3		RNA-binding motif protein 6	606886	REc			9(Rbm6)
3.252	10	12	14	3p22.1	RPSA, LAMR1, LAMBR, ICAS		Ribosomal protein SA	150370	A		Asplenia, isolated congenital, 271400 (3)	9(Lamr1)
3.253	4	30	09	3p21.31	RTP3, TMEM7		Receptor-transporting protein 3	607181	REc			
3.254	1	14	02	3p21.31	SACM1L, SAC1, KIAA0851		SAC1 suppressor of actin mutations 1-like	606569	REc			
3.255	3	15	96	3p21.31	SEMA3F, SEMA4		Semaphorin III/F	601124	REc			
3.256	7	8	96	3p21.31	SEMA5		Semaphorin A(V)	601281	REc			
3.257	2	2	17	3p21.31	SHISA5, SCOTIN		Shisa family, member 5	607290	REc	pseudogene on Xq13.1-q13.3		
3.258	4	20	10	3p21.31	SLC6A20, XT3		X transporter protein 3	605616	REc		Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)	9(Xt3)
3.259	5	2	06	3p21.31	SLC26A6		Solute carrier family 26 (anion transporter), member 6	610068	REc			
3.260	6	27	02	3p21.31	SLC38A3, SN1, G17		Solute carrier family 38, member 3	604437	REc			
3.261	12	27	01	3p21.2	TLR9		Toll-like receptor 9	605474	REc			
3.262	11	11	14	3p21.31	TMEM115, PL6		Transmembrane protein 115	607069	REc			
3.263	3	9	98	3p21.3	TRR		Transfer RNA arginine	601994	REc, A			
3.264	3	18	08	3p21.31	UCN2, SRP, UR		Urocortin II	605902	REc			
3.265	4	4	05	3p21.31	FUS1		FUS1 gene	607052	REc			
3.266	2	28	94	3p21.31	UQCRC1		Ubiquinol-cytochrome c reductase core protein I	191328	REn	close upstream of COL7A1		
3.267	10	15	13	3p21.31	ZMYND10, BLU		Zinc finger MYND domain-containing protein 10	607070	REc		Ciliary dyskinesia, primary, 22, 615444 (3)	
3.268	6	1	07	3p21.31	ATRIP		ATR-interacting protein	606605	REc			
3.269	3	8	00	3p24.1	EOMES, TBR2		Eomesodermin, Xenopus laevis, homolog of	604615	R	?translocation separating regulatory element from promoter		9(Tbr2)
3.270	2	11	15	3p21.31	HYAL1, MPS9		Hyaluronoglucosaminidase 1	607071	A	mutation identified in 1 MPS9 patient	?Mucopolysaccharidosis type IX, 601492 (3)	9(Hyal1)
3.271	6	16	99	3p21.31	PRKAR2A		Protein kinase, cAMP-dependent, regulatory, type II, alpha	176910	REa, Psh			
3.272	2	23	16	3p21.31	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS		SET domain-containing protein 2	612778	A, REc		Luscan-Lumish syndrome, 616831 (3)	
3.273	7	14	09	3p21.31	TREX1, AGS1, CRV, HERNS		3' repair exonuclease 1	606609	REc, Fd		Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3); Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
3.274	4	19	06	3p21.2	PARP3, ADPRTL3		Poly(ADP-ribose) polymerase 3	607726	REc, A, H			9(Adprtl3)
3.275	8	28	02	3p21.31	XCR1, CCXCR1, GPR5		Chemokine, C motif, receptor 1 (G protein-coupled receptor-5)	600552	A			
3.276	2	22	10	3p21.1	TNNC1, CMD1Z, CMH13		Troponin-C1, slow	191040	Psh, REa, R		Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, hypertrophic, 13, 613243 (3)	7(Tnnc1)
3.277	12	19	16	3p21.2	DCAF1, RIP, VPRBP, KIAA0800		DDB1- and CUL4-associated factor 1	617259	R, REc			
3.278	6	1	18	3p21.31	IMPDH2, IMPD2		Inosine-5'-monophosphate dehydrogenase, type II	146691	Psh, A		[IMPDH2 enzyme activity, variation in], 617995 (3)	
3.279	9	23	13	3p21.2	PCBP4, MGC10		Poly(rC)-binding protein 4	608503	REc, A			9(Pcbp4)
3.280	9	10	12	3p21.2	POC1A, PIX2, SOFT		POC1 centriolar protein, Chlamydomonas, homolog of, A	614783	REc		Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	
3.281	3	14	06	3p21.2	PPM1M, PP2CE		Protein phosphatase 1M (protein phosphatase 2C, eta isoform)	608979	R, REc			
3.282	6	21	01	3p21.31	AMT, NKH, GCE		Aminomethyltransferase (glycine cleavage system protein T)	238310	REa		Glycine encephalopathy, 605899 (3)	
3.283	4	8	02	3p21.2	GRM2, MGLUR2		Glutamate receptor, metabotropic, 2	604099	Psh, R			
3.284	10	2	09	3p14.3	HESX1, RPX, CPHD5		Homeo box gene expressed in ES cells	601802	A		Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency, combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)	14(Hesx1)
3.285	10	6	92	3p21.1	ITIH1		Inter-alpha (globulin) inhibitor, H1 polypeptide	147270	A, H			14(Intin1)
3.286	10	6	92	3p21.1	ITIH3		Inter-alpha (globulin) inhibitor, H3 polypeptide	146650	A, H			14(Intin3)
3.287	2	7	06	3p14.3	SPATA12, SRG5		Spermatogenesis-associated protein 12	609869	REc			
3.288	6	19	98	3p14.3	SLAP		Sarcolemmal-associated protein	602701	A			
3.289	5	27	05	3p21.1	ITIH4, PK120, ITIHL1		Inter-alpha (globulin) inhibitor, H4 polypeptide	600564	A		{Hypercholesterolemia, susceptibility to}, 143890 (3)	14(Itih4)
3.290	2	24	06	3p21.2	ACY1, ACY1D		Aminoacylase-1	104620	S, REa, REn		Aminoacylase 1 deficiency, 609924 (3)	9(Acy)
3.291	7	8	95	3p21.2	ALAS1		Aminolevulinate, delta-, synthase-1	125290	REa, A, R, Psh			
3.292	7	16	09	3p21.2	ARMET, ARP		Arginine-rich protein, mutated in early stage tumors	601916	REc, D			
3.293	11	1	13	3p21.1	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA		Calcium channel, voltage-dependent, L type, alpha 1D subunit	114206	REa, H, REc		Sinoatrial node dysfunction and deafness, 614896 (3); Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	14(Cch1a2)
3.294	11	28	01	3p21.1-p14.3	CACNA2D3		Calcium channel, voltage-dependent, alpha-2/delta subunit 3	606399	REc			
3.295	8	28	09	3p14.2	CADPS, CAPS		Ca(2+)-dependent activator protein for secretion	604667	Psh, REc			
3.296	3	20	06	3p21.1	DCP1A, SMIF		Decapping enzyme 1, X. cerevisiae, homolog of, A	607010	R, REc			
3.297	2	21	06	3p14.3	DNAH12, DNAHC3, HL19		Dynein, heavy chain-5	603340	REa, REc			
3.298	4	26	10	3p14.3-p14.2	FAM107A, DRR1, TU3A		Family with sequence similarity 107, member A (downregulated in renal cell carcinoma 1)	608295	REc, A			
3.299	4	19	05	3p21.1	GNL3, NS, E2IG3		Guanine nucleotide-binding protein-like 3	608011	R, REc			
3.300	5	13	02	3p21.2	GPR62		G protein-coupled receptor 62	606917	REc			
3.301	1	29	01	3p21.1	IL17RB, IL17BR, IL17RH1		Interleukin 17, receptor B	605458	R			
3.302	10	13	09	3p21.2	MIRLET7G, LET7G, MIRNLET7G		Micro RNA Let7G	612102	REc			
3.303	11	23	16	3p21.1	MUSTN1, MUSTANG		Musculoskeletal embryonic nuclear protein 1	617195	REc			
3.304	5	24	02	3p21.1	NEK4, STK2, NRK2		NIMA (never in mitosis gene a)-related kinase 4 (serine/threonine protein kinase-2)	601959	REa			
3.305	11	22	13	3p21.1	NISCH, IRAS, KIAA0975		Nischarin	615507	REc			
3.306	9	28	12	3p13	PROK2, PK2, BV8, HH4		Prokineticin 2	607002	R		Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	6(Prok2)
3.307	2	17	09	3p21.2	RBM15B, OTT3, HUMAGCGB		RNA-binding motif protein 15B	612602	REc			
3.308	5	15	08	3p21.1	RFT1, CDG1N		RFT1, S. cerevisiae, homolog of	611908	REc		Congenital disorder of glycosylation, type In, 612015 (3)	
3.309	9	9	13	3p21.1	SFMBT1, RU1		SCM-like protein with 4 MBT domains 1	607319	REc			
3.310	8	19	13	3p21.1	SPCS1, SPC12		Signal peptidase complex, subunit 1, S. cerevisiae, homolog of	610358	R, REc			
3.311	11	23	16	3p21.1	TMEM110, STIMATE		Transmembrane protein 110	617189	REc			
3.312	8	28	09	3p21.2	TWF2, PTK9L, A6RP		Twinfilin, actin-binding protein, Drosophila, homolog of, 2	607433	R, REc			
3.313	9	9	10	3p21.2	WDR82, TMEM113		WD repeat-containing protein 82	611059	R, REc			
3.314	8	11	15	3p14.3	APPL1, APPL, MODY14		Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1	604299	A		{Maturity-onset diabetes of the young, type 14}, 616511 (3)	
3.315	1	18	12	3p14.3	DNASE1L3, SLEB16		Deoxyribonuclease I-like 3	602244	A, R		Systemic lupus erythematosus 16, 614420 (3)	
3.316	1	14	02	3p21.33	ABHD5, CGI58, IECN2, NCIE2		Abhydrolase domain containing 5	604780	Fd, REc		Chanarin-Dorfman syndrome, 275630 (3)	
3.317	6	7	94	3p21.31	APEH, D3S48E		N-acylaminoacyl-peptide hydrolase	102645	REa, A, D			
3.318	8	28	09	3p21.31	ARIH2, ARI2, TRIAD1		Ariadne, Drosophila, homolog of, 2	605615	R, REc			
3.319	11	4	93	3p21.31	CDC25A		Cell division cycle 25A	116947	REa, Psh, A			
3.320	5	28	08	3p21	CELIAC9		Celiac disease, susceptibility to, 9	612007	Fd	associated with rs6441961	{Celiac disease, susceptibility to, 9} (2)	
3.321	9	9	08	3p21.31	CCR1, CMKBR1, CKR1, HM145		Chemokine (C-C) receptor 1	601159	A			9(Cmkbr1)
3.322	9	8	08	3p21.31	CCR2, CMKBR2		Chemokine (C-C) receptor 2	601267	REn		{HIV infection, susceptibility/resistance to} (3)	
3.323	1	27	04	3p21.31	CCRL2		Chemokine, CC motif, receptor-like protein 2	608379	REc			
3.324	1	13	09	3p21.31	CCR5, CMKBR5, CCCKR5, IDDM22		Chemokine (C-C) receptor 5	601373	REc, R		{HIV infection, susceptibility/resistance to} (3); {West nile virus, susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	
3.325	9	9	08	3p21.31	CXCR6, STRL33, BONZO		Chemokine, CXC motif, receptor 6	605163	REa, Psh			
3.326	09	27	18	3p21.31	DAG1, DAG, MDDGC9, MDDGA9, LGMDR16		Dystrophin-associated glycoprotein-1	128239	REa, A		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3); Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	9(Dag1)
3.327	11	20	98	3p21.2	DUSP7, MKPX, PYST2		Dual-specificity phosphatase-7	602749	Psh, A			9(Dusp7)
3.328	9	9	08	3p21.31	FBXW12, FBW12, FBXO35, FBXO12		F-box and WD40 domain protein 12	609075	REc			
3.329	4	15	11	3p21.2	GLYCTK, GLYCTK1		Glycerate kinase	610516	REc		D-glyceric aciduria, 220120 (3)	
3.330	8	10	98	3p21.31	GNAI2, GNAI2B, GIP		Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2	139360	REa, A	on 12p13-p12, GNAI2L	Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia, idiopathic, 192605 (3)	9(Gnai2)
3.331	2	8	18	3p21.31	GNAT1, CSNBAD3, CSNB1G		Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1	139330	REa, A		Night blindness, congenital stationary, autosomal dominant 3, 610444 (3); Night blindness, congenital stationary, type 1G, 616389 (3)	9(Gnat1)
3.332	1	25	11	3p21	HSCR6		Hirschsprung disease, susceptibility to, 6	606874	Fd		{Hirschsprung disease, susceptibility to, 6} (2)	
3.333	9	30	02	3p21.31	IHPK2, IP6K2		Inositol hexaphosphate kinase 2	606992	REc			
3.334	9	6	11	3p21.31	LAMB2, LAMS, NPHS5		Laminin, beta-2 (laminin S)	150325	REa, A		Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3)	
3.335	5	9	97	3p21.31	MAP4		Microtubule-associated protein 4	157132	A			9(Map4)
3.336	8	27	92	3p21.31	MST1, HGFL		Macrophage-stimulating-1 (hepatocyte growth factor-like)	142408	REn, H			9(Hgfl)
3.337	7	16	09	3p21.31	NCKIPSD, AF3P21, SPIN90		NCK-interacting protein with SH3 domain	606671	Ch			
3.338	10	13	09	3p21.31	NICN1		Nicolin 1	611516	REc	processed pseudogene on X		9(Nicn1)
3.339	7	13	09	3p21.1	PBRM1, PB1, BAF180		Polybromo 1, chicken, homolog of	606083	R, REc			
3.340	4	15	11	3p21	PSC		Cholangitis, primary sclerosing	613806	Fd		Cholangitis, primary sclerosing (2)	
3.341	4	29	14	3p21.31	QARS, GLNRS, MSCCA		Glutaminyl-tRNA synthetase	603727	REa, REc		Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	
3.342	9	24	09	3p22.2	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2		Sodium channel, voltage-gated, type V, alpha polypeptide	600163	Fd, A		Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)	
3.343	5	12	09	3p22.1	SNRK, KIAA0096		SNF-related kinase	612760	REc			
3.344	1	11	07	3p22.1	SS18L2		SS18-like gene 2	606473	A			
3.345	12	17	15	3p21.31	ZNF589, SZF1		Zinc finger protein 589	616702	A			
3.346	12	7	95	3p21.31	TCTA		T-cell leukemia translocation altered gene	600690	Ch			
3.347	12	11	02	3p21.31	TMIE, DFNB6		Transmembrane inner ear-expressed gene	607237	Fd, H		Deafness, autosomal recessive 6, 600971 (3)	?9(sr)
3.348	1	6	14	3p21.31	UBE7, UBE1L		Ubiquitin-activating enzyme-7	191325	RE			
3.349	1	30	01	3p13	GPR27, SREB1		G protein-coupled receptor 27	605187	R			
3.350	11	8	94	3p25.3	HRH1		Histamine receptor, subclass H1	600167	REa, A			6(Hrh1)
3.351	8	25	11	3p14.3	WNT5A		Wingless-type MMTV integration site family, member 5A	164975	Psh, A		Robinow syndrome, autosomal dominant 1, 180700 (3)	
3.352	3	14	96	3p14.1	TMF1		TATA element modulatory factor 1	601126	A			
3.353	6	30	08	3p14.3	ARHGEF3, XPLN		RHO guanine nucleotide exchange factor 3	612115	A			
3.354	3	11	09	3p21-p13	MPVQTL2		Mean platelet volume quantitative trait locus 2	612574	Fd	associated with rs12485738	[Mean platelet volume QTL2] (2)	
3.355	12	22	14	3q22.3	A4GNT		Alpha-1,4-N-acetylglucosaminyltransferase	616709	R			
3.356	6	2	16	3p14.3	ADHB6		Abhydrolase domain-containing protein 6	616966	REc			
3.357	2	27	17	3p14.3	ACOX2, BRCACOX, CBAS6		Acyl-Coenzyme A oxidase 2, branched chain	601641	A, Psh		Bile acid synthesis defect, congenital, 6, 617308 (3)	
3.358	12	15	16	3p14.3	ERC2, CAST, KIAA0378		ELKS/RAB6-interacting/CAST family, member 2	617250	Psh, REc			
3.359	7	29	15	3p14.3	FAM208A, RAP140, C3orf63, KIAA1105		Family with sequence similarity 208, member A	616493	REc, R			
3.360	1	31	12	3p14.3	FLNB, SCT, AOI, LRS1		Filamin B	603381	REa, REc, A, R, Fd		Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome, 150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)	
3.361	7	11	11	3p14.3	HESRG		Embryonic stem cell-related protein	611473	REc			
3.362	3	17	08	3p14.3	PXK, MONAKA		PXK domain-containing serine/threonine kinase	611450	REc			
3.363	9	23	13	3p14.3	RPP14		Ribonuclease P, 14kD subunit	606112	REc			
3.364	2	12	16	3p14.1	SLC25A26, SAMC, COXPD28		Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26	611037	REc		Combined oxidative phosphorylation deficiency 28, 616794 (3)	
3.365	7	22	16	3p21.1	TKT, SDDHD		Transketolase	606781	REa, A		Short stature, developmental delay, and congenital heart defects, 617044 (3)	
3.366	1	29	01	3p14.1	ADAMTS9		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 9	605421	A, Psh			
3.367	6	11	13	3p14.3	IL17RD, SEF, HH18		Interleukin 17, receptor D (Sef, zebrafish, homolog of)	606807	REc		Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	
3.368	5	28	13	3p14.2	FAM3D		Family with sequence similarity 3, member D	608619	REc, R			
3.369	8	5	02	3p14.2	FRA3B, FHIT		Fragile histidine triad gene	601153	REf, H	deleted in RCC		14(Fhit, Fra14A2)
3.370	3	22	93	3p14.2	PTPRG, PTPG		Protein tyrosine phosphatase, receptor type, gamma polypeptide	176886	REa, A, Fd			
3.371	6	1	09	3p14.2	FEZF2, ZNF312, FEZL, TOF		FEZ family zinc finger 2	607414	REc			
3.372	1	11	18	3p14.2	SNTN, S100AL, S100A1L		Sentan, cilia apical structural protein	617832	REc			
3.373	1	22	04	3p14.3	ARF4, ARF2		ADP-ribosylation factor 4	601177	REc, R			
3.374	2	15	12	3p14.1	ATXN7, SCA7, OPCA3		Ataxin 7	607640	Fd, REc		Spinocerebellar ataxia 7, 164500 (3)	
3.375	2	15	12	3p14.1	ATXN7AS1, SCAANT1		ATXN7 antisense noncoding transcript 1	614481	REc			
3.376	7	12	13	3p14.1	EOGT, EOGT1, C3orf64, AOS4		EGF domain-specific O-linked N-acetylglucosamine transferase	614789	REc		Adams-Oliver syndrome 4, 615297 (3)	
3.377	5	30	17	3p14.1	FAM19A1, TAFA1		Family with sequence similarity 19, member A1, CC motif chemokine-like	617495	REc			
3.378	5	30	17	3p14.1	FAM19A4, TAFA4		Family with sequence similarity 19, member A4, CC motif chemokine-like	617498	REc			
3.379	4	24	15	3p13	FOXP1, QRF1		Forkhead box P1	605515	REc		Mental retardation with language impairment and with or without autistic features, 613670 (3)	
3.380	4	26	17	3p14.1	FRMD4B, GRSP1, KIAA1013		FERM domain-containing protein 4B	617467	REc			
3.381	10	23	15	3p14.1	KBTBD8, TAKRP, KIAA1842		KELCH repeat- and BTB/POZ domain-containing protein 8	616607	REc			
3.382	1	5	15	3p14.1	LMOD3, NEM10		Leiomodin 3	616112	REc		Nemaline myopathy 10, 616165 (3)	
3.383	3	3	09	3p14.1	MAGI1, BAIAP1, WWP3, TNRC19		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 1	602625	A			
3.384	1	30	18	3p14.1	PSMD6, KIAA0107		Proteasome 26S subunit, non-ATPase, 6	617857	Psh, REc			
3.385	5	25	13	3p14.1	SUCLG2		Succinate-CoA ligase, GDP-forming, beta subunit	603922	REc			
3.386	4	23	08	3p14.1	THOC7, NIF3L1BP1		THO complex, subunit 7	611965	R, REc			
3.387	4	23	07	3p14.1-q12.3	HYT7		Hypertension, essential, susceptibility to, 7	610948	Fd		{Hypertension, essential, susceptibility to, 7} (2)	
3.388	1	26	17	3p13	MITF, WS2A, CMM8, COMMAD		Microphthalmia-associated transcription factor	156845	REa, A, Fd		Waardenburg syndrome, type 2A, 193510 (3); Waardenburg syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3); COMMAD syndrome, 617306 (3)	6(mi)
3.389	1	12	11	3p14.1	ARL6IP5		ADP-ribosylation-like factor 6-interacting protein 5	605709	REc			
3.390	2	16	04	3p21.2	DOCK3		Dedicator of cytokinesis 3	603123	R, Ch			
3.391	2	21	06	3p13	EIF4E3		Eukaryotic translation initiation factor 4E family, member 3	609896	R, REc			
3.392	2	25	09	3p14.1	LRIG1, LIG1		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 1	608868	A, H			6(Lrig1)
3.393	3	25	16	3p14.1	PRICKLE2		Prickle-like 2	608501	REc			
3.394	3	3	10	3p13	EBLN2		Endogenous Borna-like N element-containing protein 2	613250	REc			
3.395	4	20	04	3p14-q13	KTCN3		Keratoconus 3	608586	Fd		Keratoconus 3 (2)	
3.396	6	14	18	3q13.31	ATP6V1A, HO68, ARCL2D, IECEE3		ATPase, H+ transporting, V1 subunit A	607027	R, REc		Cutis laxa, autosomal recessive, type IID, 617403 (3); Epileptic encephalopathy, infantile or early childhood, 3, 618012 (3)	
3.397	3	29	10	3p13	GXYLT2, GLT8D4		Glucoside xylosyltransferase 2	613322	REc			
3.398	12	28	08	3p13	PDZRN3, KIAA1095		PDZ domain-containing ring finger protein 3	609729	REc			
3.399	4	7	11	3p13	PPP4R2, PP4R2		Protein phosphatase 4, regulatory subunit 2	613822	REc			
3.400	8	30	09	3p13	RYBP, YEAF1		Ring1- and YY1-binding protein	607535	R, REc			
3.401	4	6	16	3p13	SAMMSON, LINC01212		Survival-associated mitochondrial melanoma-specific oncogenic noncoding RNA	616895	REc			
3.402	12	14	10	3p13	SHQ1		Shq1, S. cerevisiae, homolog of	613663	REc			
3.403	7	22	11	3p14.3	PDHB, PDHBD		Pyruvate dehydrogenase, E1 beta polypeptide	179060	REa		Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	
3.404	3	29	07	3p12.3	ROBO2, SAX3, KIAA1568		Roundabout, Drosophila, homolog of, 2	602431	REc		Vesicoureteral reflux 2, 610878 (3)	16(Robo2)
3.405	6	28	17	3p12.1	CADM2, IGSF4D, SYNCAM2, NECL3		Cell adhesion molecule 2	609938	REc			16(Igsf4d)
3.406	9	21	12	3p12.2	GBE1, GSD4, APBD		Glycogen branching enzyme	607839	REa		Glycogen storage disease IV, 232500 (3); Polyglucosan body disease, adult form, 263570 (3)	
3.407	8	4	98	3p11.2-p11.1	HTR1F, HTR1EL, MR77		5-hydroxytryptamine receptor 1F	182134	R, A, Psh			
3.408	9	11	02	3p12.3	ROBO1, DUTT1, SAX3		Roundabout, Drosophila, homolog of, 1	602430	REc, D			
3.409	1	24	04	3p11.1	CGGBP1		CGG triplet repeat binding protein 1	603363	REc, REa, A			
3.410	9	28	10	3q11.2	ARL6, BBS3, RP55		ADP-ribosylation factor-like 6	608845	Fd, REc	mutation identified in 1 RPS55 family	Bardet-Biedl syndrome 3, 600151 (3); {Bardet-Biedl syndrome 1, modifier of}, 209900 (3); ?Retinitis pigmentosa 55, 613575 (3)	
3.411	4	30	02	3p12-q13	DYX5		Dyslexia, susceptibility to, 5	606896	Fd	?same locus as SSD	{Dyslexia, susceptibility to, 5} (2)	
3.412	4	6	18	3q13.12-q13.13	IFT57, ESRRBL1, HIPPI, OFD18		Intraflagellar transport 57, chlamydomonas, homolog of (HIP1 protein interactor)	606621	R, REc	mutation identified in 1 OFD18 family	?Orofaciodigital syndrome XVIII, 617927 (3)	
3.413	2	10	04	3p12-q13	SSD		Speech-sound disorder	608445	Fd	?same locus as DYX5	{Speech-sound disorder} (2)	
3.414	1	25	11	3p12-q13.2	PBC1		Biliary cirrhosis, primary, 1	109720	Fd	associated with rs6441286	Biliary cirrhosis, primary, 1 (2)	
3.415	5	3	93	3q25.33	IL12A		Interleukin-12A (natural killer cell stimulatory factor-1, cytotoxic lymphocyte maturation factor-1, p35)	161560	REa, Psh			
3.416	7	11	93	3q13.31	ZNF80		Zinc finger protein-80 (pT17)	194553	REa			
3.417	7	18	12	3p11.2	CHMP2B, DMT1, VPS2B, ALS17		CHMP family, member 2B	609512	Fd, REc		Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral sclerosis 17, 614696 (3)	
3.418	8	18	98	3p11.1	EPHA3, ETK1, HEK		Ephrin receptor EphA3 (human embryo kinase 1)	179611	REa, A			
3.419	10	2	09	3p11.2	POU1F1, PIT1, CPHD1		POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)	173110	Fd, A		Pituitary hormone deficiency, combined, 1, 613038 (3)	16(Pit1,dw)
3.420	9	11	02	3p	CRCL		Creatinine clearance QTL	607135	Fd	in African Americans	Creatinine clearance QTL (2)	
3.421	8	25	04	3p21.31	MYL3, CMH8		Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow	160790	REa, H		Cardiomyopathy, hypertrophic, 8, 608751 (3)	9(Mylc)
3.422	11	24	14	3p21.1	PRKCD, CVID9, ALPS3		Protein kinase C, delta	176977	REa, H	mutation identified in 1 family	Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	14(Pkcd)
3.423	9	8	11	3cen-q13	ERVK-5, HERV-KII		Endogenous retrovirus group K, member 5	614012	R, REc			
3.424	9	18	00	3q13.33	COX17		Cytochrome c oxidase assembly protein COX17	604813	R	pseudogene on chr. 13?		
3.425	10	20	99	3q12.3	RPL24		Ribosomal protein L24	604180	REa, R			
3.426	5	1	91	3q21.3	RPN1		Ribophorin I	180470	REa, Ch			6(Rpn1)
3.427	10	7	14	3q12.2	TFG, HMSNP, SPG57		TRK-fused gene	602498	A	fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3); ?Spastic paraplegia 57, autosomal recessive, 615658 (3)	
3.428	11	19	09	3q11.1-q11.2	ARL13B, ARL2L1, JBTS8		ADP-ribosylation factor-like 13B	608922	REc		Joubert syndrome 8, 612291 (3)	
3.429	10	13	15	3q11.2	DHFRL1		Dihydrofolate reductase-like 1	616588	REc			
3.430	5	25	13	3q11.2	EPHA6, HEK12, EHK2		Ephrin receptor EphA6	600066	REc			
3.431	12	30	14	3q12.3	IMPG2, IPM200, RP56, VMD5		Interphotoreceptor matrix proteoglycan 2	607056	R, A		Retinitis pigmentosa 56, 613581 (3); Macular dystrophy, vitelliform, 5, 616152 (3)	
3.432	5	30	17	3q11.2	NSUN3		NOP2/SUN RNA methyltransferase family, member 3	617491	REc			
3.433	3	1	12	3q11.1	PROS1, THPH5, THPH6		Protein S, alpha	176880	REa, REc	pseudogene PROSP contiguous on chr.3	Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	
3.434	4	1	96	3q11.2	GPR15		G protein-coupled receptor-15	601166	A			
3.435	3	16	10	3q11.2-q13.12	CAMPD1		Camptodactyly 1	114200	Fd	between D3S2465 and D3S3044	Camptodactyly 1 (2)	
3.436	4	30	09	3q11.2	CPOX		Coproporphyrinogen oxidase	612732	REa, A		Coproporphyria, 121300 (3); Harderoporphyria, 121300 (3)	
3.437	9	27	01	3q12.2	TARSH		Target of Nesh-SH3	606279	R			
3.438	8	20	07	3q12.1	TMEM30C, CDC50C		Transmembrane protein 30C	611030	REc			
3.439	11	28	88	3q13.2	MOX2		MRC OX-2 antigen	155970	REa, A			
3.440	7	11	91	3q12.1	COL8A1		Collagen VIII, alpha-1 polypeptide	120251	A			
3.441	2	21	13	3q12.1	DCBLD2, ESDN		Discoidin, CUB, and LCCL domain-containing protein 2	608698	REc, Psh			
3.442	9	2	09	3q12.1	FILIP1L		Filamin A-interacting protein 1-like	612993	REc			
3.443	6	10	08	3q11.2	MINA, MINA53, MDIG		MYC-induced nuclear antigen	612049	REc			
3.444	8	30	09	3q12.1	ST3GAL6, ST3GALVI		ST3 beta-galactoside alpha-2,3-sialyltransferase 6	607156	R, REc			
3.445	10	1	17	3q12.1-q12.2	TBC1D23, PCH11		TBC1 domain family, member 23	617687	REc		Pontocerebellar hypoplasia, type 11, 617695 (3)	
3.446	7	17	14	3q12.3	CEP97		Centrosomal protein, 97kD	615864	REc			
3.447	9	1	16	3q12.2	ADGRG7, GPR128		Adhesion G protein-coupled receptor G7	612307	REc			
3.448	1	29	16	3q12.2	NIT2		Nitrilase family member 2	616769	REc			
3.449	4	27	16	3q12.2	TMEM45A, DERP7, DNAPTP4		Transmembrane protein 45A	616928	REc			
3.450	9	27	17	3q12.2	TOMM70A		Translocase of outer mitochondrial membrane 70, yeast, homolog of, A	606081	REc, R			
3.451	8	19	13	3q21.3	CHST13, C4ST3		Carbohydrate sulfotransferase 13	610124	REc			
3.452	5	6	13	3q12.3	PCNP		PEST-containing nuclear protein	615210	REc			
3.453	7	9	09	3q12.3	SENP7, KIAA1707		Sentrin-specific protease family, member 7	612846	REc			
3.454	6	17	16	3q12.3	TRMT10C, RG9MTD1, MRPP1, COXPD30		tRNA methyltransferase 10, S. cerevisiae, homolog of, C	615423	REc		Combined oxidative phosphorylation deficiency 30, 616974 (3)	
3.455	8	18	14	3q12.3	ZPLD1		Zona pellucida-like domain-containing protein 1	615915	REc			
3.456	8	28	09	3q13.31	GAP43		Neuron growth-associated protein 43	162060	REa, REc			16(Gap43)
3.457	5	22	03	3q13.2	GCET2, HGAL		Germinal center-expressed transcript 2	607792	REc			
3.458	10	18	10	3q13.33	GOLGB1, GCP372		Golgi autoantigen, golgin subfamily B, 1	602500	REc			
3.459	9	29	96	3q13.33	HCLS1		Hematopoietic cell-specific Lyn substrate 1	601306	A			
3.460	9	21	11	3q21.1-q21.2	KALRN, HAPIP, DUO, CHDS5		Kalirin	604605	Fd, REc		{Coronary heart disease, susceptibility to, 5}, 608901 (3)	
3.461	4	14	05	3q27.1	MAGEF1		Melanoma antigen, family F, 1	609267	Psh, REc			
3.462	1	28	00	3q13.13	MORC1		MORC family CW-type zinc finger 1 (microrchidia, mouse, homolog of)	603205	H, A			16(Morc)
3.463	6	28	17	3q13.13	NECTIN3, PVRL3, PRR3		Nectin 3	607147	R, REc			
3.464	5	25	00	3q13.13	TRAT1, TRIM		T-cell receptor-associated transmembrane adaptor 1	604962	A			
3.465	4	16	11	3q21.2	UMPS, OPRT		Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase)	613891	S, A		Orotic aciduria, 258900 (3)	
3.466	1	3	02	3q13.33	NR1I2, PXR, SXR, PARq		Nuclear receptor subfamily 1, group I, member 2	603065	R, A			
3.467	1	13	09	3q13.2	CD200R1, MOX2R, OX2R		CD200 receptor 1	607546	REc			
3.468	12	13	00	3q13.13	GUCA1C, GCAP3		Guanylate cyclase activator 1C	605128	Psh, A			
3.469	11	25	96	3q13.1	MHS4		Malignant hyperthermia susceptibility 4	600467	Fd		{Malignant hyperthermia susceptibility 4} (2)	
3.470	12	10	15	3q13.11	CBLB		CAS-BR-M murine ecotropic retroviral transforming sequence B	604491	Psh, A			
3.471	7	20	09	3q12.3	NFKBIZ, INAP, MAIL, IKBZ		Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, zeta	608004	REc			16(Inap)
3.472	2	19	97	3q13.11	ALCAM		Activated leukocyte cell adhesion molecule	601662	A			
3.473	3	24	06	3p12.1	VGLL3, VGL3		Vestigial-like 3	609980	REc			
3.474	1	14	00	3q13.12	CD47, MER6, IAP		CD47 antigen (Rh-related antigen; integrin-associated protein)	601028	S, A			
3.475	10	28	15	3q13.12	DUBR, DUM, LINC0883		DPPA2 upstream-binding RNA, noncoding	616619	REc			16(Dubr)
3.476	8	25	11	3q13.1-q13.2	CD96, TACTILE		CD96 antigen	606037	R, REc, Ch		C syndrome, 211750 (3)	
3.477	5	17	18	3q13.13	CIP2A, KIAA1524, p90		Cell proliferation-regulating inhibitor of protein phosphatase 2A	610643	R, REc			
3.478	1	30	12	3q13.13	DPPA2, PESCRG1, ECAT15-2		Developmental pluripotency-associated gene 2	614445	REc			16(Dppa2)
3.479	7	27	11	3q13.13	DPPA4		Developmental pluripotency-associated gene 4	614125	REc			
3.480	7	13	17	3q13.13	DZIP3, KIAA0675		DAZ-interacting zinc finger protein 3	608672	Psh, REc			
3.481	5	25	13	3q13.13	HHLA2		Human endogenous retrovirus-H long terminal repeat-associating 2	604371	REc			
3.482	3	1	06	3q13.13	MYH15		Myosin, heavy chain 15	609929	REc			
3.483	7	14	14	3q13.13	RETNLB, RELMB, FIZZ2		Resistin-like protein, beta	605645	REc			
3.484	2	25	15	3q13.2	BTLA		B- and T-lymphocyte attenuator	607925	REc			
3.485	4	23	08	3q13.2	C3orf52, TTMP		Chromosome 3 open reading frame 52	611956	REc			
3.486	7	24	17	3q13.2	CFAP44, WDR52, SPGF20		Cilia- and flagella-associated protein 44	617559	REc	mutation identified in 1 SPGF20 patient	?Spermatogenic failure 20, 617593 (3)	
3.487	3	6	07	3q13.31	NAT13, NAT5, SAN		N-acetyltransferase 13	610834	REc			
3.488	8	30	16	3q13.2	NEPRO, C3orf17		Nucleolus and neural progenitor protein	617089	REc			
3.489	5	24	13	3q13.2	PHLDB2		Pleckstrin homology-like domain, family B, member 2	610298	REc, R			
3.490	7	1	16	3q13.2	PLCXD1		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 2	617015	REc			
3.491	7	2	18	3q13.2	SIDT1		SID1 transmembrane family, member 1	606816	REc			
3.492	4	30	09	3q13.2	SLC9A10		Solute carrier family 9, member 10	612738	REc			
3.493	11	3	11	3q13.2	SPICE1, CCDC52		Spindle- and centriole-associated protein 1	613447	REc			
3.494	9	9	13	3q13.2	TAGLN3, NP24, NP22		Transgelin 3	607953	REc, R			
3.495	12	5	03	3q13.2	URB, SSG1		Urb, mouse, homolog of	608298	R, H, REc			16(Urb)
3.496	7	11	17	3q13.2	USF3		Upstream transcription factor family, member 3	617568	REc			
3.497	5	28	13	3q13.13	ZBED2		Zinc finger BED domain-containing protein 2	615246	REc			
3.498	9	16	14	3q13.31	ZBTB20, ZNF288, DPZF, PRIMS		Zinc finger and BTB-domain containing 20	606025	A, R		Primrose syndrome, 259050 (3)	
3.499	2	28	03	3q13.33	PLA1A, PSPLA1		Phosphatidylserine-specific phospholipase A1-alpha	607460	A, H			16(Pla1a)
3.500	6	7	12	3q13.2-q13.33	STUT3		Stuttering, familial persistent, 3	614655	Fd	max lod at D3S1310	Stuttering, familial persistent, 3 (2)	
3.501	8	31	12	3q21.1	ADCY5, FDFM		Adenylate cyclase-5	600293	REa, A		Dyskinesia, familial, with facial myokymia, 606703 (3)	16(Adcy5)
3.502	11	3	98	3q13.31	LSAMP, LAMP		Limbic system-associated membrane protein	603241	A			16(Lsamp)
3.503	5	4	12	3q13.32-q13.33	ARHGAP31, CDGAP, KIAA1204, AOS1		Rho GTPase-activating protein 31	610911	R, REc		Adams-Oliver syndrome 1, 100300 (3)	
3.504	7	9	07	3q13.33	ARGFX		Arginine-fifty homeobox	611164	REc	pseudogenes on 5q23.2 and 17q11.2		
3.505	8	9	99	3q13.32	B4GALT4		Beta-1,4-galactosyltransferase 4	604015	REc			
3.506	11	22	17	3q13.31	DRD3, ETM1, FET1		Dopamine receptor D3	126451	REb, A		{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor, hereditary, 1}, 190300 (3)	
3.507	5	3	13	3q13.33	FSTL1, FRP, MIR198		Follistatin-like 1	605547	R, REc	FSTL1 mRNA can encode a protein or produce an micoRNA		
3.508	5	25	00	3q13.33	GSK3B		Glycogen synthase kinase 3-beta	605004	A, R, Psh			
3.509	8	27	08	3q21.2	MUC13		Mucin 13, cell surface-associated	612181	A			
3.510	5	4	00	3q13.33	POLQ		Polymerase, DNA, theta	604419	R			
3.511	10	15	09	3q13.33	POPDC2, POP2		Popeye domain-containing protein 2	605823	R, REc			
3.512	5	26	05	3q13.33	STXBP5L, LLGL4		Syntaxin-binding protein 5-like	609381	REc			
3.513	7	13	09	3q13.31	TIGIT		T-cell immunoreceptor with immunoglobulin and ITIM domains	612859	REc			
3.514	4	15	11	3q22.1	TRH		Thyrotropin-releasing hormone	613879	REa, H, A		Thyrotropin-releasing hormone deficiency, 275120 (1)	6(Trh)
3.515	4	23	98	3q13.32	UPK1B		Uroplakin 1B	602380	A			
3.516	4	17	13	3q13.33	MAATS1, AAT1, C3orf15		MYCBP-associated testis-expressed protein 1	609910	REc			
3.517	9	29	13	3q13.31	DEL3q13.31, C13DELq13.31		Chromosome 3q13.31 deletion syndrome	615433	Ch		Chromosome 3q13.31 deletion syndrome (4)	
3.518	10	24	14	3q13.31	TUSC7, LSAMPAS3, LOC285194		Tumor suppressor candidate 7, noncoding	616057	REc			
3.519	2	2	17	3q13.31	ZDHHC23, NIDD		Zinc finger DHHC-type containing 23	617334	REc			
3.520	6	13	12	3q13.33	ADPRH		ADP-ribosylarginine hydrolase	603081	REc			
3.521	11	11	14	3q13.33	EAF2		ELL-associated factor 2	607659	REc			
3.522	4	19	12	3q13.33	GPR156, GABABL		G protein-coupled receptor 156	610464	REc			
3.523	8	8	13	3q13.33	GTF2E1, TF2E1		General transcription factor IIE, polypeptide 1	189962	REc			
3.524	4	29	14	3q13.33	HGD, AKU		Homogentisate 1,2-dioxygenase (homogentisate oxidase)	607474	Fd, H, Psh, A, REc		Alkaptonuria, 203500 (3)	16(aku)
3.525	1	18	18	3q13.33	IQCB1, NPHP5, KIAA0036		IQ motif-containing protein B1	609237	REc		Senior-Loken syndrome 5, 609254 (3)	
3.526	5	25	13	3q13.33	NDUFB4		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 4	603840	REc			
3.527	09	27	18	3q13.33	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21		Protein O-glucosyltransferase 1	615618	REc	mutation identified in 1 LGMDR21 family	Dowling-Degos disease 4, 615696 (3); ?Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3)	
3.528	10	2	12	3q13.33	SLC15A2, PEPT2		Solute carrier family 15 (H+/peptide transporter), member 2	602339	REc			
3.529	6	28	17	3q13.33	TIMMDC1, C3orf1		Translocase of inner mitochondrial membrane domain-containing protein 1	615534	REc		Mitochondrial complex I deficiency, 252010 (3)	
3.530	12	4	03	3q21.3	ABTB1, BPOZ		Ankyrin repeat and BTB/POZ domain containing 1	608308	R			
3.531	4	1	01	3q21	ATOD1		Dermatitis, atopic, 1	603165	Fd	max lod at D3S3606	{Dermatitis, atopic, susceptibility to, 1} (2)	
3.532	12	9	95	3q13.33	CD80, CD28LG, LAB7		CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)	112203	REa, Psh, A			3(Cd80)
3.533	3	2	98	3q13.33	CD86, CD28LG2, LAB72		CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)	601020	A			16(Cd86)
3.534	10	23	15	3q22.1	COL6A4P2		Collagen, type VI, alpha-4, pseudogene 2	616612	REc			9(Col6a4)
3.535	10	23	15	3q22.1	COL6A5, COL29A1		Collagen, type VI, alpha-5	611916	REc			
3.536	10	24	15	3q22.1	COL6A6		Collagen, type VI, alpha-6	616613	REc			9(Col6a6)
3.537	1	13	16	3q21.1	CSTA, STFA, STF1, AREI, PSS4		Cystatin A (stefin A)	184600	REa, D		Peeling skin syndrome 4, 607936 (3)	16(Stf1)
3.538	10	30	02	3q21.1	DIRC2, RCC4		Disrupted in renal carcinoma 2	602773	Ch, REc	t(2;3)(q35;q21) in renal cell carcinoma	Renal cell carcinoma, 144700 (1)	
3.539	12	21	09	3q21.1	DTX3L, BBAP		DTX3-like	613143	REc	head-to-head with PARP9		
3.540	7	8	10	3q21	FGQTL6, BWQTL3, PGQTL1		Fasting plasma glucose level QTL 6; Birth weight QTL 3; Plasma glucose, 2-hour, QTL 1	613460	Fd	associated with rs11708067 and rs11708067	[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2); [Plasma glucose, 2-hour, QTL 1] (2)	
3.541	12	19	05	3q21.3	GP9		Glycoprotein IX, platelet	173515	REb, REc		Bernard-Soulier syndrome, type C, 231200 (3)	
3.542	4	10	14	3q21.3	GATA2, DCML, MONOMAC, IMD21		GATA-binding protein-2	137295	REa, REc		Immunodeficiency 21, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute myeloid, susceptibility to}, 601626 (3)	6(Gata2)
3.543	6	5	12	3q21.3-q22.1	IFT122, WDR10, CED1		Intraflagellar transport 122, homolog of	606045	A		Cranioectodermal dysplasia 1, 218330 (3)	
3.544	2	14	01	3q21.1	KPNA1, RCH2, SRP1		Karyopherin, alpha-1	600686	A			
3.545	9	16	16	3q22.2	KY, MFM7		Kyphoscoliosis peptidase	605739	R		Myopathy, myofibrillar, 7, 617114 (3)	9(ky)
3.546	6	2	16	3q21.3	MCM2, CDCL1, DFNA70		Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin)	116945	A	mutation identified in 1 DFNA70 family	?Deafness, autosomal dominant 70, 616968 (3)	
3.547	3	10	11	3q21.1	MYLK, MLCK, AAT7		Myosin-light-polypeptide kinase	600922	Psh, REc	pseudogene on 3p13	Aortic aneurysm, familial thoracic 7, 613780 (3)	
3.548	10	26	98	3q22.3	NCK		Non-catalytic region of tyrosine kinase	600508	A, REn, REa			
3.549	6	10	08	3q21.1	PARP9, BAL1, BAL		Poly(ADP-ribose) polymerase 9	612065	A, REa, REc, REn			
3.550	6	24	08	3q21.1	PARP15, BAL3		Poly(ADP-ribose) polymerase 15	612066	REc			
3.551	12	14	99	3q21	PSORS5		Psoriasis susceptibility 5	604316	Fd		{Psoriasis susceptibility 5} (2)	
3.552	3	3	03	3q21.3	RAB7, CMT2B, PSN		Ras-associated protein RAB7	602298	Psh, A, Fd		Charcot-Marie-Tooth disease, type 2B, 600882 (3)	9(Rab7)
3.553	6	16	99	3q21.3	RUVBL1, NMP238, TIP49		RUVB, E. coli, homolog-like 1	603449	A			
3.554	1	24	12	3q22.1-q22.2	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2		Solute carrier organic anion transporter family, member 2A1	601460	Psh, A		Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	
3.555	9	1	11	3q22.1	TF, TFQTL1		Transferrin	190000	S, H, REa, D, A		Atransferrinemia, 209300 (3)	9(Trf)
3.556	2	22	07	3q21.3	TXNRD3, TRXR3, TR2		Thioredoxin reductase 3	606235	REc			
3.557	12	22	16	3q21.2	ZNF148, ZFP148, GDACCF		Zinc finger protein-148	601897	REc, A		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3)	
3.558	12	27	01	3q21.3	KLF15, KKLF		Kruppel-like factor 15	606465	A			
3.559	11	2	99	3q21.3	MBD4, MED1		Methyl-CpG-binding domain protein 4	603574	A			6(Mdb4)
3.560	12	13	06	3q21-q22	HCFP1, MBS2		Facial paresis, hereditary congenital, 1	601471	Fd		Facial paresis, hereditary congenital, 1 (2)	
3.561	12	23	05	3q22.1	NEK11		Never in mitosis gene A-related kinase 11	609779	REc			
3.562	6	21	01	3q22.3	PCCB		Propionyl Coenzyme A carboxylase, beta polypeptide	232050	REa, A, D	pccB complementation group	Propionicacidemia, 606054 (3)	
3.563	12	22	89	3q23	RBP1, CRBP1		Retinol-binding protein-1, cellular	180260	REa, A	close to CRBP2		9(Crbp)
3.564	10	4	93	3q22.1	ACPP		Acid phosphatase, prostate	171790	REa, A			
3.565	11	5	97	3q22.2	EPHB1, EPHT2, NET		eph tyrosine kinase 2 (ephrin receptor EphB1)	600600	Psh, A			
3.566	5	29	12	3q23	GRK7, GPRK7		G protein-coupled receptor kinase 7	606987	R			
3.567	12	29	99	3q22.1	ATP2C1, BCPM, HHD		ATPase, Ca(2+)-sequestering	604384	Fd, REc		Hailey-Hailey disease, 169600 (3)	
3.568	6	4	97	3q21-q24	GLC1C		Glaucoma 1, open angle, C	601682	Fd		Glaucoma 1C, primary open angle (2)	
3.569	6	27	02	3q23	PCOLCE2		Procollagen C-endopeptidase enhancer-2	607064	REc			
3.570	1	31	13	3q22.1	RHO, RP4, OPN2, CSNBAD1		Rhodopsin (opsin 2)	180380	REa, A, Fd		Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3); Night blindness, congenital stationary, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)	6(Rho)
3.571	5	19	15	3q24	AGTR1, AGTR1A, AT2R1		Angiotensin receptor 1	106165	REa		{Hypertension, essential}, 145500 (3); Renal tubular dysgenesis, 267430 (3)	
3.572	5	24	12	3q22.1	BFSP2, CP49, CP47, CTRCT12		Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)	603212	REa		Cataract 12, multiple types, 611597 (3)	
3.573	8	25	11	3q25.1	CLRN1, USH3A, USH3, RP61		Clarin 1	606397	Fd, REc	frequent in Finland; ?digenic interaction with MYO7A	Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180 (3)	3(Ush3)
3.574	1	27	11	3q25.1	MED12L, NOPAR, KIAA1635		Mediator complex subunit 12-like	611318	Psh, REc			
3.575	2	3	99	3q25.1	TM4SF1, M3S1, TAAL6		Transmembrane-4 superfamily, member 1	191155	REa			
3.576	9	8	11	3q21-q25.2	ERVK-4, HERV-KI		Endogenous retrovirus group K, member 4	614011	R, REc			
3.577	8	22	16	3q25.2	MME, CD10, CALLA, NEP, CMT2T, SCA43		Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen)	120520	REa, A	mutation identified in 1 SCA43 family	Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3); ?Spinocerebellar ataxia 43, 617018 (3)	9(Mme)
3.578	1	1	95	3q27.3	SIAT1		Sialyltransferase-1 (beta-galactoside alpha-2,6-sialyltransferase)	109675	REa, A			
3.579	4	6	18	3q26.2	TERC, TRC3, TR, DKCA1, PFBMFT2		Telomerase RNA component	602322	H, Fd		Dyskeratosis congenita, autosomal dominant 1, 127550 (3); {Aplastic anemia}, 614743 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	3(Terc)
3.580	10	15	97	3q27.1	EPHB3, ETK2		EPH-like tyrosine kinase-2	601839	Psh			
3.581	12	2	99	3q21.3	PLXNA1, NOVP, NOV, PLXN1		Plexin A1 (NOV transmembrane protein)	601055	REa			
3.582	12	22	87	3q23	RBP2, CRBP2		Retinol-binding protein-2, cellular	180280	REa	close to CRBP1		9(Crbp2)
3.583	07	25	18	3q13.3-q21.1	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1		Calcium-sensing receptor	601199	Fd, REa	15cM from RHO	Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism, neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 601198 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3); {Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3); Hypercalciuric hypercalcemia (3)	16(Gprc2a)
3.584	10	11	16	3q21.1	CCDC14		Coiled-coil domain-containing protein 14	617147	REc			
3.585	09	06	18	3q21.1	FAM162A, ,C3orf28, E2IG5		Family with sequence similiarity 162, member A	608017	R, REc			
3.586	9	9	08	3q13.33	FBXO40, FBX40, KIAA1195		F-box only protein 40	609107	R, REc			16(Fbxo40)
3.587	3	28	11	3q13.33	ILDR1, DFNB42		Immunoglobulin-like domain-containing receptor 1	609739	REc		Deafness, autosomal recessive 42, 609646 (3)	
3.588	11	01	07	3q21.2	OSBPL11, ORP11		Oxysterol-binding protein-like protein 11	606739	REc	previously assigned to chr.8		
3.589	4	19	06	3q21.1	PARP14, KIAA1268		Poly(ADP-ribose) polymerase 14	610028	R, REc			
3.590	5	11	16	3q21.1	PDIA5, PDIR		Protein disulfide isomerase, family A, member 5	616942	REc			
3.591	8	18	14	3q21.1	PTPLB, HACD2		Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member B	615939	REc			
3.592	1	28	08	3q21.1	ROPN1, ODF6		Rhophilin-associated tail protein 1	611757	REc			
3.593	11	25	08	3q21.1	SEC22A, SEC22L2		Secretion deficient 22, S. cerevisiae, homolog of, A	612442	R, REc			
3.594	9	6	11	3q21.2	HEG1, KIAA1237		Heart of glass, zebrafish, homolog of, 1	614182	REc			
3.595	7	14	14	3q21.2	ITGB5		Integrin, beta-5	147561	REc			
3.596	8	26	15	3p14.3	PDE12		Phosphodiesterase 12	616519	REc			
3.597	3	8	07	3q21.2-q21.3	SLC41A3		Solute carrier family 41, member 3	610803	R, REc			
3.598	8	30	09	3q21.2	SNX4		Sorting nexin 4	605931	R, REc			
3.599	1	27	11	3q21.3	ALDH1L1, FTHFD		Aldehyde dehydrogenase 1 family, member L1	600249	REc			
3.600	2	13	14	3q21.3	CHCHD6, CHCM1		Coiled-coil-helix-coiled-coil-helix domain-containing protein 6	615634	REc			
3.601	7	19	18	3q21.3	CNBP, ZNF9, CNBP1, DM2, PROMM		CCHC-type zinc finger nucleic acid-binding protein	116955	REa, A, Fd		Myotonic dystrophy 2, 602668 (3)	
3.602	11	19	13	3q21.3	COPG1		Coatomer protein complex, subunit gamma-1	615525	REc			
3.603	6	21	13	3q21.3	DNAJB8, DJ6		DNAJ/HSP40 homolog, subfamily B, member 8	611337	REc, R			
3.604	9	9	13	3q21.3	EEFSEC, SELB, EFSEC		Eukaryotic elongation factor, selenocysteine-tRNA-specific	607695	REc			
3.605	11	11	14	3q21.3	H1FX, H1X		H1 histone family, member X	602785	REc			
3.606	5	12	09	3q21.3	ISY1, KIAA1160		ISY1 splicing factor, S. cerevisiae, homolog of	612764	R, REc			
3.607	10	29	15	3q21.3	PODXL2, EG		Podocalyxin-like 2	616627	REc			
3.608	8	1	16	3q21.3	SEC61A1, SEC61, HNFJ4		Sec61 complex, alpha-1 subunit	609213	REc		Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	
3.609	5	12	15	3q21.3	UROC1, UROCD		Urocanase domain-containing protein 1	613012	REc	mutation identified in 1 UROCD patient	?Urocanase deficiency, 276880 (3)	
3.610	5	22	14	3q21.3	ZXDC		ZCD family zinc finger protein C	615746	REc			
3.611	6	4	98	3q25.1	AADAC, DAC		Arylacetamide deacetylase (esterase)	600338	R			
3.612	8	11	15	3q22.1	ACKR4, CCRL1, PPR1		Atypical chemokine receptor 4	606065	A			
3.613	6	19	01	3q22	DFNA18		Deafness, autosomal dominant 18	606012	Fd		Deafness, autosomal dominant 18 (2)	
3.614	6	20	17	3q22.3	FAIM		Fax apoptotic inhibitory molecule	617535	REc			
3.615	9	9	10	3q22.1	NPHP3, NPH3, RHPD1, MKS7		Nephrocystin 3	608002	Fd, REc		Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia 1, 208540 (3); Meckel syndrome 7, 267010 (3)	
3.616	7	22	16	3q22	PARK21		Parkinson disease 21	616361	Fd	conflicting mapping on 20pter-p12	Parkinson disease 21 (2)	
3.617	8	28	09	3q22.1	PLXND1		Plexin D1	604282	REn, REc			
3.618	3	31	15	3q22.2-q22.3	PP2R3A, PR72, PR130		Protein phosphatase 2, regulatory subunit B'', alpha	604944	R, REc			
3.619	9	4	02	3q22	SLSN3		Senior-Loken syndrome 3	606995	Fd	?allelic with NPHP3	Senior-Loken syndrome 3 (2)	
3.620	10	11	16	3q22.1	UBA5, UBE1DC1, EIEE44, SCAR24		Ubiquitin-like modifier activating enzyme 5	610552	REc	mutation identified in 1 SCAR24 family	Epileptic encephalopathy, early infantile, 44, 617132 (3); ?Spinocerebellar ataxia, autosomal recessive 24, 617133 (3)	
3.621	4	13	98	3q23	ATP1B3		ATPase, Na+/K+ transporting, beta 3 polypeptide	601867	A			9(Atp1b3)
3.622	1	21	97	3q23	RASA2, GAP1M		RAS p21 protein activator 2	601589	A			
3.623	8	30	07	3q22-q24	AD15		Alzheimer disease 15	611155	Fd	max lod at D3S1579	{Alzheimer disease-15} (2)	
3.624	1	6	12	3q23	ATR, FRP1, SCKL1, FCTCS		Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1)	601215	A, Fd	mutation identified in 1 FCTCS family	Seckel syndrome 1, 210600 (3); ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	
3.625	4	20	11	3q22-q24	DWS, C3DELq22q24, DEL3q22q24		Dandy-Walker syndrome	220200	Ch	ZIC1 and ZIC4 good candidate genes	Dandy-Walker syndrome (4)	
3.626	6	12	07	3q22-q24	OTSC5		Otosclerosis 5	608787	Fd	max lod at D3S1569	Otosclerosis 5 (2)	
3.627	8	9	99	3q23	RNF7, ROC2, SAG		RING finger protein-7 (regulator of cullins 2; sensitive to apoptosis gene)	603863	A			
3.628	4	23	98	3q23	TRPC1, TRP1		Transient receptor potential channel 1	602343	A	also called Htrp-1		
3.629	5	4	00	3q22-q25	PABPL1		Polyadenylate-binding protein-like 1	173865	A			
3.630	10	18	11	3q22.1	ACAD11		Acyl-CoA dehydrogenase family, member 11	614288	REc			
3.631	5	25	13	3q22.1	CPNE4, CPN4		Copine IV	604208	REc			
3.632	7	13	16	3q22.1	DNAJC13, RME8, KIAA0678		DNAJ/HSP40 homolog, subfamily C, member 13	614334	R, REc			
3.633	4	27	12	3q22.1	MRPL3, MRL3, COXPD9		Mitochondrial ribosomal protein L3	607118	R, REc		Combined oxidative phosphorylation deficiency 9, 614582 (3)	
3.634	3	18	17	3q22.1	NUDT16		Nudix hydrolase 16	617381	REc			
3.635	9	27	17	3q22.1	PIK3R4		Phosphatidylinositol 3-kinase, regulatory subunit 4	602610	REc			
3.636	7	18	14	3q22.1	RAB6B		Ras-associated protein RAB6B	615852	REc			
3.637	3	29	16	3q22.1	SRPRB, APMCF1		Signal recognition particle receptor, beta subunit	616883	REc			
3.638	1	4	16	3q22.1	TMCC1, KIAA0779		Transmembrane and coiled-coil domain family 1	616242	REc			
3.639	2	24	17	3q22.1	TMEM108, RTLN, KIAA1690		Transmembrane protein 108	617361	REc			
3.640	8	30	09	3q22.1	TOPBP1, KIAA0259		DNA topoisomerase II-binding protein 1	607760	R, REc			
3.641	5	29	12	3q22.2	AMOTL2, KIAA0989		Angiomotin-like 2	614658	REc			
3.642	2	23	12	3q22.2	ANAPC13, APC13, SWM1		Anaphase-promoting complex, subunit 13	614484	REc			
3.643	3	7	14	3q22.2	CEP63, SCKL6		Centrosomal protein, 63kD	614724	REc	mutation identified in 1 family	?Seckel syndrome 6, 614728 (3)	
3.644	10	2	12	3q22.2	RYK, RYK1		RYK receptor-like tyrosine kinase	600524	REc, Ch			9(Ryk1)
3.645	10	25	11	3q22.3	CEP70		Centrosomal protein, 70kD	614310	REc			
3.646	9	20	14	3q22.3	DBR1		Debranching enzyme 1, S. cerevisiae, homolog of	607024	REc			
3.647	8	7	17	3q22.3	DZIP1L, DZIP2, PKD5		DAZ-interacting zinc finger protein 1-like	617570	REc		Polycystic kidney disease 5, 617610 (3)	9(Dzip1l)
3.648	12	11	15	3q22.3	ESYT3, FAM62C		Extended synaptotagmin-like protein 3	616692	REc			
3.649	2	2	04	3q22.3	MRAS, RRAS3		Muscle Ras viral oncogene homolog	608435	REc			
3.650	2	25	14	3q22.3	MSL2, KIAA1585		Male-specific lethal 2, Drosophila, homolog of	614802	REc			
3.651	9	9	08	3q22.3	PIK3CB, PI3KCB		Phosphatidylinositol 3-kinase, catalytic, beta	602925	R, REc			
3.652	12	15	17	3q22.3	SLC35G2, TMEM22		Solute carrier family 35, member G2	617812	REc			
3.653	3	3	15	3q23	CLSTN2		Calsyntenin 2	611323	REc			
3.654	12	8	17	3q23	COPB2, MCPH19		Coatomer protein complex, subunit beta-2	606990	A	mutation identified in 1 MCPH19 family	?Microcephaly 19, primary, autosomal recessive, 617800 (3)	
3.655	11	2	04	3q22.3	FOXL2, BPES, BPES1, PFRK, POF3		Forkhead transcription factor FOXL2	605597	Ch, Fd		Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)	
3.656	09	26	18	3q23	MRPS22, C3orf5, COXPD5, ODG7		Mitochondrial ribosomal protein S22	605810	REc		Combined oxidative phosphorylation deficiency 5, 611719 (3); Ovarian dysgenesis 7, 618117 (3)	
3.657	8	29	07	3q23	NMNAT3, PNAT3		Nicotinamide nucleotide adenylyltransferase 3	608702	R, REc			
3.658	4	19	12	3q23	PAQR9		Progestin and ADIPOQ receptor family, member 9	614580	REc			
3.659	8	28	09	3q23	PLS1		Plastin-1	602734	REa, REc			
3.660	10	19	99	3q24	PLSCR1, MMTRA1B		Phospholipid scramblase 1	604170	A			
3.661	3	10	03	3q24	PLSCR2		Phospholipid scramblase 2	607610	R			
3.662	3	10	03	3q24	PLSCR4		Phospholipid scramblase 4	607612	REc			
3.663	12	30	14	3q23	SLC25A36, PNC2		Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36	616149	REc			
3.664	6	5	00	3q22.3	SOX14		SRY-box 14	604747	A, R, REc			
3.665	12	18	07	3q23	SPSB4, SSB4		SPRY domain- and SOCS box-containing 4	611660	REc			
3.666	2	17	09	3q23	STQTL10		Stature quantitative trait locus 10	612221	Fd	associated with rs6440003	{Stature QTL 10} (2)	
3.667	3	5	98	3q23	TFDP2, DP2		Transcription factor Dp-2 (E2F dimerization partner 2)	602160	A			
3.668	1	24	18	3q23	U2SURP, SR140, KIAA0332		U2 small nuclear ribonucleoprotein-associated SURP domain-containing protein	617849	R, REc			
3.669	2	17	09	3q23	ZBTB38		Zinc finger- and BTB domain-containing protein 38	612218	REc			
3.670	6	4	02	3q24-q25	CP		Ceruloplasmin	117700	F, H, REa, A	~15cM from TF	[Hypoceruloplasminemia, hereditary], 604290 (3); Cerebellar ataxia, 604290 (3); Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	9(Cp)
3.671	2	13	15	3q24	PLOD2, LH2, TLH, BRKS2		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2	601865	Psh, A		Bruck syndrome 2, 609220 (3)	9(Plod2)
3.672	8	29	08	3q24	C3orf58, DIA1		Chromosome 3 open reading frame 58	612200	REc			
3.673	6	2	06	3q24	CHST2		Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase; N-acetylglucosamine-6-O-sulfotransferase)	603798	REc	mapped by FISH to 7q31		
3.674	8	28	09	3q24	CPA3		Carboxypeptidase A3, mast cell	114851	Psh, REc			
3.675	7	18	14	3q24	CPB1, PCPB, PASP		Carboxypeptidase B1, tissue	114852	REc			
3.676	8	28	15	3q25.31	GMPS		Guanine monophosphate synthetase	600358	A, Ch	fusion gene with MLL in AML		
3.677	11	28	01	3q25.1	GPR86		G protein-coupled receptor 86	606380	REc			
3.678	11	28	01	3q25.1	GPR87		G protein-coupled receptor 87	606379	REc			
3.679	7	16	01	3q24	HPS3		HPS gene 3	606118	HZ, Fd		Hermansky-Pudlak syndrome 3, 614072 (3)	3(Hps3)
3.680	12	27	13	3q24	SLC9A9, AUTS16		Solute carrier family 9 (sodium/hydrogen exchanger), member A9	608396	Ch, REc	mutation identified in 1 family	{?Autism susceptibility 16}, 613410 (3)	
3.681	11	18	16	3q25.1	SELENOT, SELT		Selenoprotein T	607912	REc			
3.682	7	17	12	3q25.1	WWTR1, TAZ		WW domain-containing transcription regulator 1	607392	R			
3.683	3	5	18	3q24	ZIC4		Zic family, member 4	608948	R, D			9(Zic4)
3.684	10	20	15	3q24	ZIC1, CRS6		Zic family, member 1	600470	A, D		Craniosynostosis 6, 616602 (3)	9(Zic1)
3.685	9	15	11	3q25.1	P2RY12, P2Y12, BDPLT8		Purinergic receptor P2Y, G protein-coupled, 12	600515	R		Bleeding disorder, platelet-type, 8, 609821 (3)	
3.686	9	9	08	3q25.31-q25.32	VEPH1, MELT, KIAA1692		Ventricular zone-expressed PH domain-containing protein, zebrafish, homolog of, 1	609594	R, REc			
3.687	2	5	14	3q24	GYG1, GSD15		Glycogenin 1	603942	A	mutation identified in 1 GSD15 patient	?Glycogen storage disease XV, 613507 (3); Polyglucosan body myopathy 2, 616199 (3)	
3.688	4	21	16	3q25.1	SUCNR1, GPR91		Succinate receptor 1	606381	REc			
3.689	3	8	07	3q24-q26	HDLCQ5		High density lipoprotein cholesterol level QTL 5	610761	Fd	max lod at D3S3053	[High density lipoprotein cholesterol level QTL 5] (2)	
3.690	1	30	02	3q24-q26	UVM1		Melanoma, uveal, susceptibility to, 1	606660	Ch		{Melanoma, uveal, susceptibility to, 1} (2)	
3.691	2	3	13	3q26.1	B3GALT3, GLCT3, GLOB		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3	603094	REc		[Blood group, globoside system], 615021 (3); [Blood group, P1PK system, P(k) phenotype], 111400 (3)	
3.692	2	6	08	3q25.32	IQCJ		IQ motif-containing protein J	611622	REc			
3.693	12	27	01	3q25.1-q25.2	MBNL1, KIAA0428, EXP		Muscleblind-like protein	606516	R, REc			
3.694	6	23	98	3q25.2	P2RY1, P2Y1		Purinergic receptor P2Y, G-protein coupled, 1	601167	Psh, REc			
3.695	5	5	98	3q25.32	PTX3		Pentraxin-3	602492	REa, A			
3.696	5	28	98	3q25.1	SIAH2		Seven in absentia, Drosophila, homolog of, 2	602213	A			
3.697	8	30	09	3q25.1	TM4SF4, ILTMP		Transmembrane 4 superfamily, member 4	606567	R, REc			
3.698	5	28	08	3q25-q26	CELIAC10		Celiac disease, susceptibility to, 10	612008	Fd	associated with rs17810546	{Celiac disease, susceptibility to, 10} (2)	
3.699	4	10	14	3q25-q26	ETL6		Epilepsy, familial temporal lobe, 6	615697	Fd	between D3S1584 and D3S3520	Epilepsy, familial temporal lobe, 6 (2)	
3.700	8	12	98	3q25.32	SHOX2, SHOT, OG12		Short stature homeo box 2	602504	A, R			3(Og12)
3.701	2	3	06	3q26.1	SI		Sucrase-isomaltase	609845	REa, A, Fd		Sucrase-isomaltase deficiency, congenital, 222900 (3)	3(Sis)
3.702	8	18	04	3q23	XRN1, SEP1		Exoribonuclease 1	607994	R			
3.703	6	7	04	3q25-q27	ASPG1		Asperger syndrome, susceptibility to, 1	608638	Fd	max lod with D3S3037	{Asperger syndrome susceptibility 1} (2)	
3.704	5	16	07	3q25-q27	AUTS8		Autism, susceptibility to, 8	607373	Fd		{Autism susceptibility 8} (2)	
3.705	8	27	01	3q26.2	EIF5A2		Eukaryotic translation initiation factor 5A2	605782	R			
3.706	5	31	05	3q27.1	MCCC1, MCCA		3-Methylcrotonyl-CoA carboxylase 1	609010	R, A		3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	
3.707	8	26	04	3q26.2	PRKCI		Protein kinase C, iota	600539	H, REc	pseudogene on X		3(Prkci)
3.708	12	22	15	3q25.1	COMMD2		COMM domain-containing protein 2	616699	REc			
3.709	3	19	09	3q25.1	EIF2A		Eukaryotic translation initiation factor 2A	609234	REc			
3.710	3	18	17	3q25.1	IGSF10		Immunoglobulin superfamily, member 10	617351	REc			
3.711	8	29	96	3q25.32	MLF1		Myeloid leukemia factor-1	601402	Ch		Leukemia, acute myeloid, 601626 (1)	
3.712	8	19	13	3q25.1	P2RY14, BPR105, KIAA0001		Purinergic receptor P2Y, G protein-coupled, 14	610116	Psh, REn			
3.713	9	21	17	3q25.1	SERP1, RAMP4		Stress-associated endoplasmic reticulum protein 1	617674	REc			
3.714	3	23	14	3q25.1	TMEM183B, C1orf37DUP		Transmembrane protein 183B	611365	REc			
3.715	10	25	17	3q25.1	TSC22D2, KIAA0669		TSC22 domain family, member 2	617724	REc, H			3(Tsc22d2)
3.716	2	20	97	3q25.1	PFN2, PFL, D3S1319E		Profilin-2	176590	REc	mapped previously to chr.1		
3.717	11	16	98	3q24	SMARCA3, SNF2L3, HIP116		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3	603257	Psh, A			
3.718	6	27	17	3q25.2	ARHGEF26, SGEF		Rho guanine nucleotide exchange factor 26	617552	REc			
3.719	4	30	09	3q25.2	DHX36, G4R1, RHAU, KIAA1488		DEAH (Asp-Glu-Ala-His) box polypeptide 36	612767	REc			
3.720	4	8	16	3q25.2	DWORF, LOC100507537		Dwarf open reading frame	616891	REc			
3.721	8	8	13	3q25.2	RAP2B		Ras-related protein 2B	179541	R, REc			
3.722	8	16	10	3q25.3	BWQTL2		Birth weight quantitative trait locus 2	613459	Fd	associated with rs900400	[Birth weight QTL 2] (2)	
3.723	4	7	05	3q25.32	LXN, ECI, TCI		Latexin	609305	R, REc			3(Lxn)
3.724	8	30	09	3q25.32	RARRES1, TIG1		Retinoic acid receptor responder 1	605090	R, REc			
3.725	5	5	10	3q25.31	CCNL1, ANIA6A		Cyclin L1	613384	REc			
3.726	8	27	15	3q25.31	LEKR1		Leucine-, glutamate-, and lysine-rich protein 1	613536	REc			
3.727	7	9	09	3q25.31	PLCH1, PLCL3, KIAA1069		Phospholipase C, eta-1	612835	REc			
3.728	4	27	12	3q25.31	SLC33A1, ACATN, AT1, SPG42, CCHLND		Solute carrier family 33 (acetyl-CoA transporter), member 1	603690	A, R, REc		Spastic paraplegia 42, autosomal dominant, 612539 (3); Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	3(Acatn)
3.729	6	13	12	3q25.31	SSR3, TRAPG		Signal sequence receptor, gamma	606213	R, REc			
3.730	12	17	08	3q25.31	TIPARP		TCDD-inducible poly(ADP-ribose) polymerase	612480	REc			
3.731	10	15	13	3q25.32	GFM1, EFG1, GFM, COXPD1		Mitochondrial elongation factor G1	606639	R, M, Fd, REc		Combined oxidative phosphorylation deficiency 1, 609060 (3)	
3.732	6	7	10	3q25.32	RSRC1, SRRP53		Arginine/serine-rich coiled-coil protein 1	613352	REc			
3.733	1	30	12	3q25.33	ARL14, ARF7		ADP-ribosylation factor-like 14	614439	REc			
3.734	1	17	18	3q25.33	IFT80, KIAA1374, WDR56, SRTD2, ATD2		Intraflagellar transport 80, Chlamydomonas, homolog of	611177	R, REn		Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	
3.735	2	25	14	3q25.33	SCARNA7		Small Cajal body-specific RNA 7	615644	REc			
3.736	4	1	15	3q21.3	ACAD9		Acyl-CoA dehydrogenase family, member 9	611103	REc		Mitochondrial complex I deficiency due to ACAD9 deficiency, 611126 (3)	
3.737	5	15	08	3q26	AGA1, MPB		Alopecia, androgenetic, 1	109200	Fd		Alopecia, androgenetic, 1 (2)	
3.738	8	10	18	3q27.1	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2		Chloride channel-2	600570	Psh		{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3); {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3); Leukoencephalopathy with ataxia, 615651 (3); Hyperaldosteronism, familial, type II, 605635 (3)	
3.739	3	20	08	3q26.31	FNDC3B, FAD104		Fibronectin domain III-containing protein 3B	611909	REc			3(Fndc3b)
3.740	10	9	94	3q26	MDS1		Myelodysplasia syndrome-1	600049	Ch, REc, A	cen--EVI1--MDS1--EAP--tel	Myelodysplasia syndrome-1 (3)	
3.741	1	8	16	3q26.2	MECOM, EVI1, RUSAT2		MDS1 and EVS1 complex locus	165215	A, Ch, REc		Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	3(Evi1)
3.742	4	13	05	3q26	MYP8		Myopia 8	609257	Fd		Myopia 8 (2)	
3.743	8	3	12	3q28	OSTN		Osteocrin	610280	REc, H			16(Ostn)
3.744	8	23	17	3q26.31	PLD1, CVDD		Phospholipase D1, phosphatidylcholine-specific	602382	REa, A		Cardiac valvular defect, developmental, 212093 (3)	3(Pld1)
3.745	10	7	99	3q26.1	SERPINI1, PI12		Protease inhibitor 12	602445	A		Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	
3.746	12	28	08	3q26.1	SLITRK3, KIAA0848		SLIT- and NTRK-like family, member 3	609679	R, REc, H			3(Slitrk3)
3.747	6	16	99	3q26.31	TNFSF10, TRAIL, APO2L		Tumor necrosis factor ligand superfamily, member 10	603598	A			
3.748	1	24	01	3q25.33	CAPC		Chromosome-associated protein C	605575	A			
3.749	11	4	98	3q25.31	KCNAB1, KCNA1B		Potassium voltage-gated channel, shaker-related subfamily, beta member 1	601141	Psh, A, REc			3(Kcna1b)
3.750	2	1	11	3q25.33	KPNA4, QIP1		Karyopherin alpha-4	602970	REc			
3.751	8	20	07	3q26.1	NMD3		NMD3, S. cerevisiae, homolog of	611021	R, REc			
3.752	1	25	05	3q26.1	PDCD10, TFAR15, CCM3		Programmed cell death 10	609118	REc, Fd		Cerebral cavernous malformations 3, 603285 (3)	
3.753	4	8	08	3q25.3-q26.1	PPM1L, PP2CE		Protein phosphatase 1-like	611931	REc			
3.754	9	7	12	3q26.1	SPTSSB, C3orf57, SSSPTB, ADMP		Serine palmitoyltransferase, small subunit B	610412	REc, R			
3.755	12	30	14	3q25.33	TRIM59, RNF104, MRF1, IFT80L		Tripartite motif-containing protein 59	616148	REc, H			3(Trim59)
3.756	4	25	18	3q26.1	BCHE, CHE1, BCHED		Butyrylcholinesterase	177400	F, D, A	distal to CP, TF	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3); Butyrylcholinesterase deficiency, 617936 (3)	
3.757	6	13	95	3q26.31	ECT2		Epithelial cell transforming sequence 2 oncogene	600586	A, Psh			3(Ect2)
3.758	2	5	01	3q26.1	SERPIN12, PI14, MEPI		Protease inhibitor 14	605587	REn, A			
3.759	8	7	01	3q26.1-q26.3	MNG3		Multinodular goiter-3	606082	Fd		Goiter, multinodular, 3 (2)	
3.760	12	5	13	3q26.2	SLC2A2, GLUT2		Solute carrier family 2 (facilitated glucose transporter), member 2	138160	REa, A, Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi-Bickel syndrome, 227810 (3)	
3.761	7	11	11	3q26.2	ARPM1		Actin-related protein M1	608534	REc			
3.762	8	28	09	3q26.2	GOLIM4, GOLPH4, GPP130		Golgi integral membrane protein 4	606805	R, REc			
3.763	9	12	13	3q26.2	MYNN		Myoneurin	606042	REc			
3.764	2	2	11	3q26.2	SEC62, TLOC1, HTP1		Sec62, S. cerevisiae, homolog of	602173	REc			
3.765	5	29	13	3q26.2	SKIL, SNO		SKI-like	165340	REc			
3.766	4	3	14	3q26.2	SLC7A14, KIAA1613, RP68		Solute carrier family 7, member 14	615720	REc		Retinitis pigmentosa 68, 615725 (3)	
3.767	7	18	14	3q26.2	TRV-AAC1-1, TRNAV24		Transfer RNA valine (AAC) 1-1	615310	REc			
3.768	1	26	01	3q26.2	CLDN11, OTM, OSP		Claudin 11 (oligodendrocyte transmembrane protein)	601326	REa, A			
3.769	6	16	99	3q26.33	USP13, ISOT3		Ubiquitin-specific protease-13	603591	R, Psh, REc			
3.770	7	15	16	3q26.2-q26.3	TNIK, KIAA0551, MRT54		TRAF2-and NCK-interacting kinase	610005	R, REc		Mental retardation, autosomal recessive 54, 617028 (3)	
3.771	11	26	12	3q26.2-q26.31	APMR2		Alopecia-mental retardation syndrome 2	610422	Fd	between D3S1564 and D3S2427	Alopecia-mental retardation syndrome 2 (2)	
3.772	3	19	09	3q26.2-q26.33	FEB10		Febrile seizures, familial, 10	612637	Fd	between D3S3656 and D3S1232	Febrile seizures, familial, 10 (2)	
3.773	8	21	07	3q26.33	PEX5L, PEX5R, PXR2B		Peroxisome biogenesis factor 5-like	611058	REc			
3.774	11	1	13	3q27.2	TRA2B, SFRS10		Splicing factor, arginine/serine-rich, 10 (transformer 2, drosophila, homolog of, beta)	602719	R			
3.775	5	1	91	3q29	APOD		Apolipoprotein D	107740	REb, A			16(Apod)
3.776	8	20	07	3q26.33	ACTL6A, BAF53, BAF53A		Actin-like 6A	604958	REc			
3.777	3	15	11	3q26.33	CCDC39		Coiled-coil domain-containing protein 39	613798	REc		Ciliary dyskinesia, primary, 14, 613807 (3)	
3.778	4	30	15	3q26.33	SOX2OT, NCRNA00043		SOX2 overlapping transcript, noncoding	616338	REc			
3.779	4	21	10	3q26.33	DCUN1D1, RP42		DCN1 domain-containing protein 1	605905	REc	previously mapped to 6q16		
3.780	7	3	06	3q26.33	DNAJC19, TIM14		DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)	608977	R, REc		3-methylglutaconic aciduria, type V, 610198 (3)	
3.781	5	6	13	3q26.33	GNB4, CMTD1F		Guanine nucleotide-binding protein, beta-4	610863	R, REc		Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	
3.782	2	13	15	3q26.31	GHSR, GHDP		Growth hormone secretagogue receptor	601898	REc		Growth hormone deficiency, isolated partial, 615925 (3)	
3.783	3	5	08	3q26.33	MRPL47		Mitochondrial ribosomal protein L47	611852	R, REc			
3.784	8	19	04	3q26.31	NAALADL2		N-acetylated alpha-linked acidic dipeptidase-like 2	608806	Ch, REc	?involved in Cornelia de Lange syndrome		
3.785	2	21	10	3q26.31	NCEH1, NCEH, KIAA1363		Neutral cholesterol ester hydrolase 1	613234	REc			
3.786	8	28	09	3q26.31	NLGN1		Neuroligin 1	600568	R, REc			
3.787	10	09	18	3q26.32	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO		Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	REa, A		Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Gastric cancer, somatic, 613659 (3); Hepatocellular carcinoma, somatic, 114550 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3); CLAPO syndrome, somatic, 613089 (3); Macrodactyly, somatic, 155500 (3)	
3.788	4	30	15	3q26.31	SPATA16, SPGF6		Spermatogenesis-associated protein 16	609856	R, REc, Fd	mutation identified in 1 SPGF6 family	?Spermatogenic failure 6, 102530 (3)	
3.789	4	30	01	3q27.1	DCLAMP		Lysosome-associated membrane glycoprotein, dendritic cell-specific	605883	A			
3.790	1	22	07	3q26.33	SOX2, MCOPS3		SRY (sex determining region Y)-box 2	184429	A, D		Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	
3.791	3	9	12	3q27.1	THPO, MGDF, MPLLG, TPO, THCYT1		Thrombopoietin (megakaryocyte growth and development factor)	600044	A		Thrombocythemia 1, 187950 (3)	16(Thpo)
3.792	11	13	01	3q26.32	WIG1		Wildtype p53-induced gene	606452	A			
3.793	1	29	01	3q26.32	KCNMB3		Potassium large conductance calcium-activated channel, subfamily M, beta member 3	605222	A, Psh, R			
3.794	11	26	12	3q26.3-q27.3	APMR1		Alopecia-mental retardation syndrome 1	203650	Fd	max lod at D3S3583	Alopecia-mental retardation syndrome 1 (2)	
3.795	5	24	13	3q29	ATP13A3, AFURS1		ATPase, type 13A3	610232	REc			
3.796	11	11	14	3q26.32	KCNMB2		Potassium channel, calcium-activated, large conductance, subfamily M, beta member 2	605214	R, REc			
3.797	5	11	16	3q26.32	TBL1XR1, TBLR1, IRA1, C21, MRD41		Transducin-beta-like 1 receptor 1	608628	REc, R		Mental retardation, autosomal dominant 41 , 616944 (3); Pierpont syndrome, 602342 (3)	
3.798	3	27	13	3q26.32-q28	FAME4, FCMTE4		Epilepsy, familial adult myoclonic, 4	615127	Fd	between D3S3730 and D3S1580	Epilepsy, myoclonic, familial adult, 4 (2)	
3.799	9	20	00	3q27.1	ABCC5, MRP5, MOATC		ATP-binding cassette, subfamily C, member 5	605251	R, A			
3.800	2	17	09	3q27.3	ADIPOQ, APM1, GBP28, ADIPQTL1		Adipocyte-, C1q-, and collagen domain-containing	605441	A, REc		Adiponectin deficiency, 612556 (3)	16(Apm1)
3.801	1	25	18	3q27.3	AHSG, APMR1		Alpha-2HS-glycoprotein	138680	F, S, D, REa, A, REn	mutation identified in 1 APMR1 family	?Alopecia-mental retardation syndrome 1, 203650 (3)	
3.802	6	22	04	3q27.1	ALG3, NOT56L, CDGS4, CDG1D		Alg3, S. cerevisiae, homolog of	608750	R		Congenital disorder of glycosylation, type Id, 601110 (3)	
3.803	9	9	14	3q27	AOMS1, SYNX		Abdominal obesity-metabolic syndrome QTL1	605552	Fd	epistatic gene on 17p12	Abdominal obesity-metabolic syndrome 1 (2)	
3.804	8	28	09	3q26.33	ATP11B, ATPIR		ATPase, class VI, type 11B	605869	REc			
3.805	4	3	01	3q27.3	BCL6		B-cell CLL/lymphoma-6	109565	Ch, A		Lymphoma, B-cell (2)	16(Bcl6)
3.806	6	16	99	3q27.1	CHRD		Chordin	603475	R, REc, REn	near THPO, CLCN2, EIF4G1		16(Chrd)
3.807	6	13	07	3q28	CLDN16, PCLN1, HOMG3		Claudin 16 (paracellin 1)	603959	Fd		Hypomagnesemia 3, renal, 248250 (3)	
3.808	8	6	13	3q27.3	CRYGS, CRYG8, CTRCT20		Crystallin, gamma S	123730	REa, Fd		Cataract 20, multiple types, 116100 (3)	
3.809	4	8	16	3q27.1	DVL3, DRS3		Dishevelled 3 (homologous to Drosophila dsh)	601368	Psh, A		Robinow syndrome, autosomal dominant 3, 616894 (3)	
3.810	1	28	14	3q27.2	EHHADH, PBFE, LBFP, FRTS3		Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase	607037	A, REn	mutation identified in 1 family	?Fanconi renotubular syndrome 3, 615605 (3)	
3.811	10	29	03	3q27.1	EIF2B5, LVWM, CACH, CLE		Eukaryotic translation initiation factor 2B, subunit 5	603945	Fd,R		Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
3.812	4	10	15	3q27.1	EIF4G1, EIF4G, PARK18		Eukaryotic translation initiation factor 4 gamma, 1	600495	Psh	amplified in squamous cell lung cancer	{Parkinson disease 18}, 614251 (3)	
3.813	7	5	01	3q27.3	FETUB		Fetuin B	605954	REc			
3.814	3	1	12	3q27.3	HRG, THPH11		Histidine-rich glycoprotein	142640	REa, A, Fd, REn		Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due to elevated HRG, 613116 (1)	
3.815	7	3	06	3q27.1	HTR3C		5-hydroxytryptamine receptor 3C	610121	A, REn			
3.816	7	3	06	3q27.1	HTR3D		5-hydroxytryptamine receptor 3, subunit D	610122	A, REn			
3.817	7	3	06	3q27.1	HTR3E		5-hydroxytryptamine receptor 3, subunit E	610123	A, REn			
3.818	10	28	08	3q27.3	KNG1, KNG		Kininogen 1	612358	Psh, A, REn		[Kininogen deficiency], 228960 (3); [High molecular weight kininogen deficiency], 228960 (3)	
3.819	11	30	06	3q27.1	MAPO6D1, SL21		MAP6 domain-containing protein 1	610593	REc			
3.820	1	19	07	3q27.2	MAP3K13, LZK		Mitogen-activated protein kinase kinase kinase 13 (leucine zipper-bearing kinase)	604915	R, REc			
3.821	5	22	07	3q27.1	PARL		Presenilin-associated rhomboid-like protein	607858	R, REc			
3.822	3	5	95	3q27.3	RFC4		Replication factor C4, 37kD (activator 1, 37kD)	102577	Psh, A			
3.823	2	28	03	3q27.3	RPL39L		Ribosomal protein L39-like	607547	REc			
3.824	7	1	05	3q27.3	RTP4		Receptor-transporting protein 4	609350	R, REc			
3.825	1	19	07	3q27.2	SENP2, SMT3IP2, AXAM2, KIAA1331		Sentrin-specific protease family, member 2	608261	R, REc			
3.826	9	22	08	3q28	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8		Tumor protein p63 (tumor protein p73-like)	603273	A, R		Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome, 603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)	16(Trp63)
3.827	6	16	99	3q27.2-q27.3	DGKG, DAGK3		Diacylglycerol kinase, gamma, 90-kD	601854	A			
3.828	7	16	14	3q27.2	LIPH, LAH2, ARWH2, HYPT7		Lipase H	607365	REc		Hypotrichosis 7, 604379 (3); Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	
3.829	10	10	14	3q27.3	MASP1, CRARF, 3MC1		Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor)	600521	A		3MC syndrome 1, 257920 (3)	16(Crarf)
3.830	9	7	00	3q27-q28	SPG14		Spastic paraplegia 14, autosomal recessive	605229	Fd		Spastic paraplegia 14, autosomal recessive (2)	
3.831	8	19	13	3q27.1	B3GNT5		Beta-1,3-N-acetylglucosaminyltransferase 5	615333	REc			
3.832	10	10	14	3q27.1	CAMK2N2, CAMKIIN		Calcium/calmodulin-dependent protein kinase II inhibitor 2	608721	R, REc			
3.833	2	25	14	3q27.1	ECE2, KIAA0604		Endothelin-converting enzyme 2	610145	REc, A, R			
3.834	1	13	17	3q27.1	KLHL24, KRIP6, EBSSH		Kelch-like 24	611295	REc		Epidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3)	
3.835	8	28	09	3q27.1	MIR1224, MIRN1224		Micro RNA 1224	611620	REc			
3.836	8	28	09	3q27.1	PSMD2, S2, TRAP2		Proteasome 26S subunit, non-APTase, 2	606223	R, REc			
3.837	4	26	10	3q27.1	YEATS2, KIAA1197		YEATS domain-containing protein 2	613373	REc			
3.838	7	25	18	3q27.3	DNAJB11, HEDJ, DJ9, ABBP2, PKD6		DNAJ/HSP40 homolog, subfamily B, member 11	611341	REc		Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3)	
3.839	9	7	11	3q27.1	KLHL6, FLJ00029		Kelch-like 6	614214	REc			
3.840	7	14	14	3q27.3	RTP1		Receptor-transporting protein 1	609137	REc			
3.841	7	14	14	3q27.3	RTP2		Receptor-transporting protein 2	609138	REc			
3.842	5	3	11	3q27.3	SNORA63, RNU107, RNE3		Small nucleolar RNA, H/ACA box, 63	180647	REc			
3.843	4	2	16	3q27.3	SNORA81		Small nucleolar RNA, H/ACA box, 81	611334	REc	in intron 3 of EIF2A		
3.844	9	28	00	3q27.1	AP2M1, CLAPM1		Adaptor-related protein complex 2, mu 1 subunit	601024	REa, A			
3.845	8	20	15	3q28	CCDC50, C3orf6, DFNA44		Coiled-coil domain-containing protein 50	611051	Fd, REc	mutation identified in 1 DFNA44 family	?Deafness, autosomal dominant 44, 607453 (3)	
3.846	5	28	08	3q28	CELIAC11		Celiac disease, susceptibility to, 11	612009	Fd	associated with rs1464510	{Celiac disease, susceptibility to, 11} (2)	
3.847	8	28	09	3q27.3	EIF4A2		Eukaryotic translation initiation factor-4A, isoform 2	601102	R, REc	previously 18p11.2 by FISH		16(Eif4a2)
3.848	1	26	97	3q27.2	ETV5, ERM		ets variant gene 5 (ets-related molecule)	601600	A			
3.849	4	26	17	3q28-q29	FGF12, FHF1, EIEE47		Fibroblast growth factor-12	601513	REa, H, A		Epileptic encephalopathy, early infantile, 47, 617166 (3)	16(Fhf1)
3.850	5	4	99	3q26.33	FXR1		Fragile X mental retardation, autosomal homolog	600819	REa, A	pseudogene on 12q12		
3.851	1	30	12	3q28	GMNC, GEMC1		Geminin coiled-coil domain-containing protein	614448	REc			
3.852	8	6	07	3q27.2	IGF2BP2, IMP2		Insulin-like growth factor 2 mRNA-binding protein 2	608289	R, Fd		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
3.853	11	4	98	3q28	IL1RAP		Interleukin 1 receptor accessory protein	602626	A, R			
3.854	9	2	11	3q28	LNCR5		Lung cancer susceptibility 5	614210	Fd	associated with rs4488809	{Lung cancer susceptibility 5} (2)	
3.855	10	1	95	3q27-q28	LPP		Lipoma-preferred-partner gene	600700	Ch, RE	fused with HMGIC in lipoma; fused with MLL in leukemia	Lipoma (3); Leukemia, acute myeloid, 601626 (3)	
3.856	3	23	09	3q28	MIR28, MIRN28		Micro RNA 28	612154	REc			
3.857	6	19	01	3q27.1	POLR2H, RPB8		Polymerase II, RNA, subunit H	606023	R			
3.858	3	25	14	3q28	PYDC2, POP2		Pyrin domain-containing protein 2	615701	REc			
3.859	10	23	87	3q27.3	SST		Somatostatin	182450	REa			16(Smst)
3.860	8	27	12	3q28	TMEM207		Transmembrane protein 207	614786	REc			
3.861	10	10	18	3q28	UTS2B, URP		Urotensin 2B	618134	REc			
3.862	7	19	06	3q28	CLDN1, SEMP1, ILVASC		Claudin 1	603718	REa, R, Fd		Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	
3.863	1	10	02	3q29	HRASLS		HRAS-like suppressor	606487	A			
3.864	1	7	03	3q29	HES1, HRY		Hairy and enhancer of split, Drosophila, homolog of	139605	A			
3.865	4	7	16	3q29	OPA1, NTG, NPG, BERHS, MTDPS14		Optic atrophy 1 gene	605290	Fd, REc	mutation identified in 1 MTDPS14 family	Optic atrophy 1, 165500 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Optic atrophy plus syndrome, 125250 (3); Behr syndrome, 210000 (3); ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	?16(Bst)
3.866	2	25	15	3q29	ATP13A4		ATPase, type 13A4	609556	A			
3.867	1	24	13	3q29	BDH1, BDH		3-hydroxybutyrate dehydrogenase 1	603063	REc			
3.868	8	28	09	3q29	CENTB2, KIAA0041, ACAP2		Centaurin, beta-2	607766	Psh, REc			
3.869	3	23	14	3q29	CEP19, C3orf34, MOSPGF		Centrosomal protein, 19kD	615586	REc, Fd	mutation identified in 1 family	Morbid obesity and spermatogenic failure, 615703 (3)	
3.870	8	22	05	3q29	CPN2		Carboxypeptidase N, polypeptide 2, 83-KD	603104	A, H, Ch	conflicting assignment to chr.8		16(Cpn2)
3.871	6	22	05	3q29	DLG1		Discs, large, Drosophila, homolog of, 1	601014	REc	deleted in 3q29 microdeletion syndrome		16(Dlgh1)
3.872	9	9	08	3q29	FBXO45, FBX45		F-box only protein 45	609112	REc			16(Fbxo45)
3.873	5	2	16	3q29	FYTTD1, UIF		Forty-two-three domain-containing protein 1	616933	REc			
3.874	8	8	13	3q29	GP5		Glycoprotein V, platelet	173511	A			
3.875	12	17	08	3q29	IQCG		IQ motif-containing protein G	612477	REc			
3.876	7	14	14	3q29	LMLN		Leishmanolysin-like	609380	REc			
3.877	2	22	07	3q29	LSG1		Large subunit GTPase 1, S. cerevisiae, homolog of	610780	R, REc			
3.878	10	23	87	3q29	MFI2, MAP97		Melanoma-associated antigen p97	155750	S, A			
3.879	4	15	08	3q29	DEL3q29, MICRODEL3q29		Chromosome 3q29 microdeletion syndrome	609425	Ch	contiguous gene deletion syndrome	Chromosome 3q29 microdeletion syndrome (4)	
3.880	5	24	13	3q29	MUC20		Mucin 20, cell surface-associated	610360	REc			
3.881	4	15	08	3q29	DUP3q29, MICRODUP3q29		Chromosome 3q29 microduplication syndrome	611936	Ch	contiguous gene duplication syndrome	Chromosome 3q29 microduplication syndrome (4)	
3.882	3	30	12	3q29	MIR570		Micro RNA 570	614538	REc			
3.883	8	8	91	3q29	MUC4		Mucin 4, tracheobronchial	158372	REa, A			
3.884	10	28	15	3q29	NCBP2, CBP20, NIP1		Nuclear CAP-binding protein 2	605133	REc			
3.885	7	22	13	3q29	NRROS, LRRC33		Negative regulator of oxygen species	615322	REc			
3.886	6	25	08	3q29	OSTA		Organic solute transporter, alpha	612084	REc			16(Osta)
3.887	2	3	15	3q28	P3H2, LEPREL1, MCVD		Prolyl 3-hydroxylase 2	610341	REc, H		Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	16(Leprel1)
3.888	6	22	05	3q29	PAK2, PAK65		p21-activated kinase 2	605022	REc	deleted in 3q29 microdeletion syndrome		
3.889	3	6	14	3q29	PCYT1A, CTPCT, PCYT1, SMDCRD		Phosphate cytidylyltransferase 1, choline, alpha isoform	123695	H, R		Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	16(Ctpct)
3.890	9	9	10	3q29	PIGX		Phosphatidylinositol glycan, class X	610276	REc			
3.891	12	17	07	3q29	PIGZ, SMP3		Phosphatidylinositol glycan, class Z	611671	REc			
3.892	5	8	97	3q29	PPP1R2, IPP2		Protein phosphatase-1, regulatory (inhibitor) subunit 2	601792	A	pseudogenes on chr. 5 and 6		
3.893	4	1	09	3q29	RNF168		RING finger protein 168	612688	REc		RIDDLE syndrome, 611943 (3)	
3.894	12	4	15	3q29	RUBCN, RUBICON, KIAA0226, SCAR15		RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein	613516	REc, R	mutation identified in 1 family	?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	
3.895	7	9	09	3q29	SENP5		Sentrin-specific protease family, member 5	612845	REc			
3.896	3	27	17	3q29	TCTEX1D2, SRTD17		TCTEX1 domain-containing protein 2	617353	REc		Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3)	
3.897	1	8	16	3q29	TFRC, TFR, CD71, IMD46		Transferrin receptor	190010	S, H, REa, A, R, F		Immunodeficiency 46, 616740 (3)	16(Trfr)
3.898	8	28	09	3q29	TNK2, ACK, ACK1		Tyrosine kinase, non-receptor, 2	606994	R, REc			
3.899	6	19	15	3q29	UBXN7, KIAA0794		UBX domain protein 7	616379	REc			
3.900	3	14	13	3q29	WDR53		WD repeat-containing protein 53	615110	REc			
3.901	4	2	12	3q29	XXYLT1, C3orf21		Xyloside xylosyltransferase 1	614552	REc			
3.902	5	28	98	3p21.2	RPL29, HIP		Ribosomal protein L29	601832	Psh, R, A			9(Rpl29)
3.903	1	13	09	3q29	RPL35A, DBA5		Ribosomal protein L35A	180468	REa, A	previous assignment to chr.18 in error	Diamond-Blackfan anemia 5, 612528 (3)	
4.1	1	7	02	4p16.3	ADD1		Adducin-1, alpha	102680	REa, REb		{Hypertension, essential, salt-sensitive}, 145500 (3)	5(Add1)
4.2	9	8	11	4p16.3	ATP5I, ATP5K		ATP synthase, H+ transporting, mitochondrial FO complex, subunit E	601519	REc			5(Atp5k)
4.3	7	20	12	4p16.3	C4orf48		chromosome 4 open reading frame 48	614690	REc			
4.4	5	17	18	4p16.3	CPLX1, CPX1, EIEE63		Complexin 1	605032	REc		Epileptic encephalopathy, early infantile, 63, 617976 (3)	
4.5	12	10	13	4p16.3	CRIPAK, FLJ3443		Cysteine-rich inhibitor of PAK1	610203	REc			
4.6	3	25	03	4p16.3	D4S234E, D4S234		D4S234E gene	607645	REc			
4.7	10	15	98	4p16.3	DGKQ, DAGK4		Diacylglycerol kinase, theta, 110kD	601207	REc, H			5(Dagk4)
4.8	12	5	16	4p16.3	FAM53A, DNTNP		Family with sequence similarity 53, member A	617229	REc			
4.9	10	11	06	4p16.3	FGFR3, ACH		Fibroblast growth factor receptor-3	134934	REn, Fd		Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic, 109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, epidermal, somatic, 162900 (3); Thanatophoric dysplasia, type II, 187601 (3); Spermatocytic seminoma, somatic, 273300 (3); SADDAN, 616482 (3)	5(Fgfr3)
4.10	5	29	12	4p16.3	GRK4, GPRK2L, GPRK4		G protein-coupled receptor kinase 4	137026	RE, H			5(Gprk2l)
4.11	11	1	10	4p16.3	HAUS3, DGT3, C4orf15		HAUS augmin-like complex, subunit 3	613430	REc			
4.12	4	20	17	4p16.3	HTT, HD, IT15, LOMARS		Huntingtin	613004	Fd	distal to D4S10	Huntington disease, 143100 (3); Lopes-Maciel-Rodan syndrome, 617435 (3)	5(Hdh)
4.13	10	29	03	4p16.3	IDUA, IDA		Iduronidase, alpha-L-	252800	REa, A, S		Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is, 607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)	5(Idua)
4.14	2	1	00	4p16.3	LETM1		Leucine zipper/EF-hand-containing transmembrane protein 1	604407	A			
4.15	9	30	13	4p16.3	LRPAP1, A2MRAP, MYP23		Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)	104225	A, REn		Myopia 23, autosomal recessive, 615431 (3)	
4.16	9	22	17	4p16.3	LYAR		Ly1 antibody-reactive protein, mouse, homolog of	617684	REc			1(Lyar)
4.17	8	30	09	4p16.3	MAEA, EMP		Macrophage erythroblast attacher	606801	R, REc			
4.18	11	30	11	4p16.3	MDCMP		Muscular dystrophy, congenital, merosin-positive	609456	Fd	max lod at D4S432	Muscular dystrophy, congenital, merosin-positive (2)	
4.19	3	22	93	4p16.3	MYL5		Myosin, light polypeptide-5, regulatory	160782	RE			
4.20	1	29	14	4p16.3	NAT8L, CML3, NACED		N-acetyltransferase 8-like	610647	REc	mutation identified in 1 patient	?N-acetylaspartate deficiency, 614063 (3)	
4.21	2	16	18	4p16.3	NKX1-1, SAX2		NK1 homeobox 1	617869	REc			
4.22	4	20	17	4p16.3	NSD2, WHSC1, MMSET		Nuclear receptor-binding SET domain protein 2	602952	REc, Ch			
4.23	7	13	09	4p16.3	NOP14, NOL14, RES425		Nop14, S. cerevisiae, homolog of	611526	REc			
4.24	6	27	17	4p16.3	PCGF3, RNF3, RNF3A		Polycomb group RING finger protein 3	617543	REc			
4.25	12	22	09	4p16.3	PDE6B, PDEB, RP40, CSNBAD2		Phosphodiesterase-6B, cGMP-specific, rod, beta	180072	REa, A, Fd		Night blindness, congenital stationary, autosomal dominant 2, 163500 (3); Retinitis pigmentosa-40, 613801 (3)	5(Pdeb, rd)
4.26	5	2	16	4p16.3	PIGG, GPI7, MRT53		Phosphatidylinositol glycan anchor biosynthesis class G protein	616918	REc		Mental retardation, autosomal recessive 53, 616917 (3)	
4.27	11	20	98	4p16.3	RNF4		RING finger protein-4	602850	REn			
4.28	6	9	08	4p16.3	RNF212, ZHP3		Ring finger protein 212	612041	REn		Recombination rate QTL 1, 612042 (3)	
4.29	5	30	01	4p16.3	SH3BP2, CRPM		SH3-domain binding protein 2	602104	REn, Fd		Cherubism, 118400 (3)	
4.30	3	27	01	4p16.3	SLBP, HBP		Histone stem-loop binding protein	602422	REc			
4.31	7	1	16	4p16.3	SLC26A1, SAT1, CAON		Solute carrier family 26 (sulfate transporter), member 1	610130	R	mutation identified in 1 CAON patient	?Nephrolithiasis, calcium oxalate, 167030 (3)	
4.32	5	11	01	4p16.3	SPON2		Spondin 2	605918	R			
4.33	5	5	15	4p16.3	TACC3		Transforming, acidic, coiled-coil-containing protein 3	605303	Psh, R			5(Tacc3)
4.34	5	22	07	4p16.3	TETRAN, TPO1		Tetracycline transporter-like protein	610977	REc			
4.35	9	22	14	4p16.3	TMEM129		Transmembrane protein 129	615975	REc			
4.36	11	24	15	4p16.3	TMEM175		Transmembrane protein 175	616660	REc			
4.37	12	29	06	4p16.3	TNIP2, ABIN2, FLIP1		TNFAIP3-interacting protein 2	610669	R, REc			
4.38	5	26	12	4p16.3	UVSSA, KIAA1530, UVSS3		UV-stimulated scaffold protein A	614632	R, REc		UV-sensitive syndrome 3, 614640 (3)	
4.39	6	10	10	4p16.3	WHS		Wolf-Hirschhorn syndrome	194190	Ch	contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere	Wolf-Hirschhorn syndrome (4)	
4.40	6	10	10	4p16.3	WHSC2		WHS candidate 2 gene	606026	REc			
4.41	2	25	15	4p16.3	ZBTB49, ZNF509		Zinc finger- and BTB domain-containing protein 49	616238	REc			
4.42	5	13	13	4p16.3	ZNF141, D4S90, PAPA6		Zinc finger protein-141 (clone pHZ-44)	194648	Psh, A, Ch	1 family identified with mutation	?Polydactyly, postaxial, type A6, 615226 (3)	
4.43	1	18	12	4p16.2	CYTL1, C17		Cytokine-like protein 1	607930	R, REc			
4.44	4	30	15	4p16.3	DOK7, C4orf25, CMS10		Downstream of tyrosine kinase 7	610285	REc	mutation identified in 1 FADS family	Myasthenic syndrome, congenital, 10, 254300 (3); ?Fetal akinesia deformation sequence, 208150 (3)	
4.45	5	23	13	4p16.1	JAKMIP1, JAMIP1, MARLIN1		Janus kinase and microtubule-interacting protein 1	611195	REc			
4.46	6	12	14	4p16.3	OTOP1		Otopetrin 1	607806	REc, H			5(Otop1)
4.47	4	17	07	4p16.3	POLN		Polymerase, DNA, nu	610887	REc, H			5(Poln)
4.48	7	16	13	4p16.3	RGS12		Regulator of G protein signaling 12	602512	REc, H			5(Rgs12)
4.49	2	23	09	4p16.3	ADRA2C, ADRA2L2		Adrenergic, alpha-2C-, receptor	104250	REa, Fd	linked to D4S10	{Congestive heart failure and beta-blocker response, modifier of} (3)	
4.50	1	5	12	4p16.1	AFAP1, AFAP, AFAP110		Actin filament-associated protein 1	608252	REc			
4.51	4	17	13	4p16.1	BLOC1S4, BLOS4, CNO		Biogenesis of lysosome-related organelles complex 1, subunit 4	605695	R, REc, H			5(cno)
4.52	1	11	16	4p15.33	BOD1L1, FAM44A		BOD1-like protein 1	616746	REc			
4.53	7	17	14	4p16.1	CLNK, MIST		Cytokine-dependent hematopoietic cell linker	611434	REc			
4.54	6	19	12	4p16.1	CPZ		Carboxypeptidase Z	603105	REc			
4.55	8	30	09	4p16.1	GPR78		G protein-coupled receptor 78	606921	REc			
4.56	6	27	08	4p16.1	HMX1, H6		Homeo box (H6 family) 1	142992	Psh, Fd		Oculoauricular syndrome, 612109 (3)	5(Hmx1)
4.57	1	16	07	4p16.1	HTRA3, PRSP		HTRA serine peptidase 3	608785	REc			
4.58	4	21	16	4p16.1	MRFAP1, PAM14, PGR1`		MORF4 family- associated protein 1	616905	REc			
4.59	12	17	12	4p16.2	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3		Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)	142983	REa, A, D, Fd		Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3); Orofacial cleft 5, 608874 (3); Ectodermal dysplasia 3, Witkop type, 189500 (3)	5(Hox7)
4.60	4	13	10	4p15.33	NKX3-2, BAPX1, SMMD		Bagpipe homeo box, Drosophila, homolog of	602183	Fd		Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	5(Bapx1)
4.61	8	30	09	4p16.1	SORCS2, KIAA1329		SORCS receptor 2	606284	R, REc			
4.62	4	26	10	4p16.1	TADA2B, ADA2B		Transcriptional adaptor 2B	608790	REc			
4.63	10	11	12	4p16.1	TBC1D14, KIAA1322		TBC1 domain family, member 14	614855	R, REc			
4.64	10	10	18	4p16.1	TRMT44, METTL19		tRNA methyltransferase 44, S. cerevisiae, homolog of	614309	REc			
4.65	7	21	15	4p16.1	USP17L9P, USP17		Ubiquitin-specific protease 17-like family member 9, pseudogene	607011	A			
4.66	1	14	14	4p16.1	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41		Wolframin	606201	Fd	mutation identified in 1 CTRCT41 family	Wolfram syndrome 1, 222300 (3); Deafness, autosomal dominant 6/14/38, 600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3); ?Cataract 41, 116400 (3)	
4.67	10	25	17	4p16.1	ZNF518B, KIAA1729		Zinc finger protein 518B	617734	REc			
4.68	4	8	98	4p16.2	CRMP1, DPYSL1, DRP1		Collapsin response mediator protein-1	602462	REc			
4.69	5	18	18	4p16.1	DRD5, DRD1B, DRD1L2		Dopamine receptor D5	126453	REa, A, REc, R, Psh, Fd	pseudogenes on 2p11 and 1q21	{Blepharospasm, primary benign}, 606798 (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	5(Drd5)
4.70	1	24	09	4p16.1	ABLIM2, KIAA1808		Actin-binding LIM protein family, member 2	612544	REc, H			5(Ablim2)
4.71	7	8	95	4p16	CRSA, CRS3		Craniosynostosis, Adelaide type	600593	Fd		Craniosynostosis, Adelaide type (2)	
4.72	3	27	18	4p16.3	CTBP1, HADDTS		C-terminal binding protein 1	602618	R		Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3)	
4.73	4	10	17	4p16.2	EVC		EVC gene	604831	Fd	mutation identified in 1 WAD patient	Ellis-van Creveld syndrome, 225500 (3); ?Weyers acrofacial dysostosis, 193530 (3)	
4.74	4	26	01	4p16.3	FGFRL1		Fibroblast growth factor receptor-like 1	605830	A			
4.75	3	9	98	4p16.3	GAK		Cyclin G associated kinase	602052	A			
4.76	3	11	09	4p16.1	GRPEL1, HMGE		GrpE, E. coli, homolog of	606173	REc			
4.77	5	4	00	4p16.3	HGFAC, HGFA		Hepatocyte growth factor activator	604552	A, REa			
4.78	5	7	03	4p15.32	KSP37		Killer-specific secretory protein, 37kD	607713	REc			
4.79	5	8	15	4p16.2	EVC2, LBN, WAD		EVC2 (limbin) gene	607261	H, REc, Fd		Ellis-van Creveld syndrome, 225500 (3); Weyers acrofacial dysostosis, 193530 (3)	5(Lbn)
4.80	1	13	09	4p16	PLSA1, PLSA		Primary lateral sclerosis, adult, 1	611637	Fd	max lod at D4S2936	Primary lateral sclerosis, adult, 1 (2)	
4.81	7	2	01	4p16.1	PPP2R2C, PR52		Protein phosphatase 2A, regulatory subunit B, gamma isoform	605997	R			
4.82	7	8	95	4p16.1	S100P		S100 calcium-binding protein P	600614	A			
4.83	9	6	11	4p16.3	ZFYVE28, LST2, KIAA1643		Zinc finger FYVE domain-containing protein 28	614176	R, REc			
4.84	1	24	09	4p16.1	SLC2A9, GLUT9, UAQTL2		Solute carrier family 2 (facilitated glucose transporter), member 9	606142	Psh, R		{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia, renal, 2, 612076 (3)	
4.85	12	21	00	4p16-p15.2	SLEB3		Systemic lupus erythematosus, susceptibility to, 3	605480	Fd		{Systemic lupus erythematosus, susceptibility to, 3} (2)	
4.86	2	26	08	4p16-p15	MNDEC		Microtia with nasolacrimal duct imperforation and eye coloboma	611863	REn	copy number variant (CNV) association	Microtia with nasolacrimal duct imperforation and eye coloboma (1)	
4.87	4	27	12	4p16-p15	SPG38		Spastic paraplegia 38, autosomal dominant	612335	Fd	between D4S432 and D4S1599	Spastic paraplegia 38, autosomal dominant (2)	
4.88	4	22	10	4p16-q34	INTLQ1		Intelligence quantitative trait locus 1	603783	Fd	associated with D4S2943, MSX1, and D4S1607	{Intelligence QTL1} (2)	
4.89	8	30	09	4p15.32	FBXL5, FBL5		F-box and leucine-rich repeat protein 5	605655	R, REc			
4.90	7	18	14	4p15.33	HS3ST1, 3OST, 3OST1		Heparan sulfate (glucosamine)3-O-sulfotransferase 1	603244	REc			
4.91	9	9	13	4p15.33	RAB28, CORD18		Ras-associated protein 28	612994	REc		Cone-rod dystrophy 18, 615374 (3)	
4.92	1	13	11	4p15.32	BST1		Bone marrow stromal cell antigen 1	600387	REc	previously assigned to 14q32.3		
4.93	5	24	13	4p15.32	MED28, EG1, MAGICIN		Mediator complex subunit 28	610311	REc			
4.94	4	8	16	4p15.32	TAPT1, CMVFR, OCLSBG		Transmembrane anterior posterior transformation 1	612758	REc		Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	5(Tapt1)
4.95	1	13	09	4p15.2	GBA3, CBGL1		Glucosidase, beta, acid 3	606619	R, REc			
4.96	1	29	16	4p15.31	MIR218-1		Micro RNA 218-1	616770	REn, REc	within intron of SLIT2		5(Mir218-1)
4.97	4	15	09	4p15.32	QDPR, DHPR		Quinoid dihydropteridine reductase	612676	S, A, REa, D		Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	5(Qdpr)
4.98	5	25	16	4p15.2	SLC34A2		Solute carrier family 34 (sodium/phosphate cotransporter), member 2	604217	REc, Fd		Pulmonary alveolar microlithiasis, 265100 (3)	
4.99	1	12	99	4p16.1	ACOX3		Acyl-coenzyme A oxidase 3, pristanoyl	603402	A			
4.100	7	8	10	4p15.32	CC2D2A, KIAA1345, MKS6		Coiled-coil and C2 domains-containing protein 2A	612013	REc		Joubert syndrome 9, 612285 (3); Meckel syndrome 6, 612284 (3); COACH syndrome, 216360 (3)	
4.101	4	30	09	4p15.2	DHX15, DDX15, DBP1, HRH2		DEAH (Asp-Glu-Ala-His) box polypeptide 15	603403	A			
4.102	8	30	09	4p15.32	FGFBP1, FGFBP, HBP17		Fibroblast growth factor-binding protein 1	607737	R, REc			
4.103	11	13	01	4p15.3	HDL3, HLN2		Huntington disease-like 3	604802	Fd		Huntington disease-like 3 (2)	
4.104	10	29	03	4p15.3-p15.2	KCNIP4, KCHIP4		Kv channel-interacting protein 4	608182	REc			
4.105	8	30	09	4p15.31	NCAPG, CAPG		Non-SMC condensin I complex subunit G	606280	R, REc			
4.106	2	17	09	4p15.31	LCORL, MLR1		Ligand-dependent nuclear receptor corepressor-like protein	611799	R, REc			
4.107	3	23	09	4p15.32	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4		Prominin 1	604365	Fd, REc		Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657 (3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)	
4.108	2	17	09	4p15.3	STQTL13		Stature quantitative trait locus 13	612226	Fd	associated with rs16896068	{Stature QTL 13} (2)	
4.109	12	1	03	4p15.2	SOD3		Superoxide dismutase-3, extracellular	185490	REa, R, Fd, A		[Superoxide dismutase, elevated extracellular] (3)	
4.110	8	30	09	4p15.2	ANAPC4, APC4		Anaphase-promoting complex, subunit 4	606947	R, REc			
4.111	9	1	16	4p15.2	ADGRA3, GPR125		Adhesion G protein-coupled receptor A3	612303	REc			
4.112	12	4	03	4p15.2	LGI2, KIAA1916		Leucine-rich gene, glioma-inactivated, 2	608301	REc			
4.113	6	27	08	4p15.2	PI4K2B		Phosphatidylinositol 4-kinase, type 2, beta	612101	R, REc			
4.114	9	10	12	4p15.2	RBPJ, RBPSUH, IGKJRB1, AOS3		Recombination signal-binding protein 1 for kappa J region	147183	REc	pseudogenes at 9q13, 9p13, and 3q25	Adams-Oliver syndrome 3, 614814 (3)	5(Rbpsuh)
4.115	3	28	11	4p15.2	SEPSECS, SLA, LP, PCH2D		O-phosphoserine tRNA-selenocysteine tRNA synthase	613009	R, REc		Pontocerebellar hypoplasia type 2D, 613811 (3)	
4.116	4	26	17	4p15.2	SMIM20, MITRAC7, C4orf52		Small integral membrane protein 20	617465	REc			
4.117	2	2	01	4p15.31	SLIT2		Slit, Drosophila, homolog of, 2	603746	A			
4.118	2	14	08	4p15.2	ZCCHC4		Zinc finger CCHC domain-containing protein 4	611792	R, REc			
4.119	6	15	99	4p15.2	CCKAR		Cholecystokinin A receptor	118444	Psh, H, A			5(Cckar)
4.120	3	27	09	4p15.2	PPARGC1A, PPARGC1		Peroxisome proliferator-activated receptor-gamma, coactivator 1, alpha	604517	R			
4.121	3	12	07	4p15.2	STIM2, KIAA1482		Stromal interaction molecule 2	610841	REc, R, H			5(Stim2)
4.122	3	1	01	4p14	UGDH, UDPGDH		UDP-glucose dehydrogenase	603370	H, R			5(Udgh)
4.123	9	9	03	4p14	KLHL5		Kelch-like 5	608064	REc			
4.124	4	23	08	4p15.1-q12	NPC1, NPCA1		Nasopharyngeal carcinoma 1	607107	Fd	?associated with acyl-CoA thioesterase 7-like	{Nasopharyngeal carcinoma 1} (2)	
4.125	5	22	03	4p14	CHRNA9		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 9	605116	A, R			
4.126	3	20	06	4p14	TBC1D1, KIAA1108		TBC1 domain family, member 1	609850	REa, H			5(Tbc1d1)
4.127	5	9	95	4p15.32	CD38		CD38 antigen (p45); ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase	107270	S, A			
4.128	10	7	02	4p15	EPPS		Epilepsy, partial, with pericentral spikes	607221	Fd		Epilepsy, partial, with pericentral spikes (2)	
4.129	2	4	99	4p15.32	LDB2, CLIM1		LIM domain-binding factor-2	603450	R			
4.130	11	20	98	4p15.1	PCDH7, BHPCDH		Protocadherin-7	602988	Psh			
4.131	10	08	08	4p15-p14	BMIQ7		Body mass index quantitative trait locus 7	608410	near D4S2912		{Obesity, susceptibility to, BMIQ7} (2)	
4.132	4	14	05	4p14-p13	APBB2, FE65L1		Amyloid beta A4 precursor protein-binding, family B, member 2 (Fe65-like 1)	602710	R, REc			
4.133	8	30	09	4p14	ARAP2, CENTD1, KIAA0580		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	606645	R, REc			
4.134	6	16	16	4p14	DTHD1		Death domain-containing protein 1	616979	REc			
4.135	11	20	98	4p14	HIP2		Huntingtin-interacting protein-2	602846	A			
4.136	9	10	07	4p14	KLB, BKL		Klotho, beta	611135	REc			
4.137	12	6	16	4p14	KLF3, BKLF		Kruppel-like factor 3	609392	REc			
4.138	3	20	16	4p14	LIAS, PDHLD, HGCLAS		Lipoic acid synthase	607031	REc		Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	
4.139	12	10	13	4p14	MIR574, MIR574-3p		Micro RNA 574	615469	REc			
4.140	5	30	17	4p14	NSUN7		NOP2/SUN RNA methyltransferase family, member 7	617185	REc			
4.141	10	3	11	4p14	PDS5A, KIAA0648, SCC112		PDS5, regulator of cohesion maintenance, S. Cerevisiae, homolog of, A	613200	R, REc			
4.142	5	26	13	4p14	RELL1		Relt-like 1	611212	R, REc			
4.143	2	21	10	4p14	TLR1, TIL. LPRS5		Toll-like receptor-1	601194	A		{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility to, 5}, 613223 (3)	
4.144	8	30	09	4p14	TLR6		Toll-like receptor 6	605403	REc			5(Tlr6)
4.145	7	2	18	4p14	TLR10		Toll-like receptor 10	606270	REc			
4.146	2	15	17	4p13	UCHL1, PARK5, SPG79, NDGOA		Ubiquitin C-terminal esterase L1	191342	A, Psh	mutation identified in 1 PARK5 family	{?Parkinson disease 5, susceptibility to}, 613643 (3); Spastic paraplegia 79, autosomal recessive, 615491 (3)	
4.147	1	9	13	4p14	UCH1LAS		Ubiquitin carboxyl-terminal esterase L1, antisense	614991	REn			
4.148	3	5	95	4p14	RFC1, RECC1		Replication factor C1, 145kD (activator 1, 145kD)	102579	A			5(Rfc1)
4.149	4	23	08	4p14	LOC344967		Acyl-CoA thioesterase 7-like	611963	REc	?associated with nasopharyngeal carcinoma		
4.150	4	10	15	4p14	WDR19, SRTD5, ATD5, NPHP13, CED4		WD repeat-containing protein 19	608151	R	mutation identified in 1 CED4 family and 1 SRTD5 family	Nephronophthisis 13, 614377 (3); ?Cranioectodermal dysplasia 4, 614378 (3); ?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3); Senior-Loken syndrome 8, 616307 (3)	
4.151	5	16	95	4p12	GABRA4		Gamma-aminobutyric acid (GABA) A receptor, alpha-4	137141	Psh	cluster with GABRA2, B1, G1; ?involved in autism		7(Gabra4)
4.152	10	23	87	4p14	PGM2		Phosphoglucomutase-2	172000	S			5(Pgm1)
4.153	1	30	91	4q21.21	BMP3		Bone morphogenetic protein-3	112263	H, REa			5(Bmp3)
4.154	8	21	92	4p12	GABRG1		Gamma-aminobutyric acid (GABA) A receptor, gamma-1	137166	Psh, REl			
4.155	3	5	98	4p14	ARHH, TTF		Ras homolog gene family, member H	602037	A			
4.156	2	19	10	4p12	GNPDA2, GNP2		Glucosamine-6-phosphate deaminase 2	613222	REc			
4.157	2	25	10	4p13	GRXCR1		Glutaredoxin, cysteine-rich, 1	613283	REc, H		Deafness, autosomal recessive 25, 613285 (3)	5(Grxcr1)
4.158	10	30	17	4p13	LIMCH1, LMO7B		LIM and calponin homology domains-containing protein 1	617750	REc			
4.159	6	15	99	4p14	RPL9		Ribosomal protein L9	603686	Psh, A	pseudogene on Xpter-p21		
4.160	2	2	17	4p13	SHISA3		Shisa family, member 3	617325	REc			
4.161	8	8	17	4p13	SLC30A9, C4orf1, HUEL, BILAPES		Solute carrier family 30 (zinc transporter), member 9	604604	A	mutation identified in 1 BILAPES family	?Birk-Landau-Perez syndrome, 617595 (3)	
4.162	1	25	12	4p12	GABRA2		Gamma-aminobutyric acid (GABA) A receptor, alpha-2	137140	A		{Alcohol dependence, susceptibility to}, 103780 (3)	5(Gabra2)
4.163	10	12	16	4p12	GABRB1, EIEE45		Gamma-aminobutyric acid (GABA) A receptor, beta-1	137190	A, Fd		Epileptic encephalopathy, early infantile, 45, 617153 (3)	5(Gabrb1)
4.164	1	6	09	4p13-q21	NRCLP2		Narcolepsy 2	605841	Fd	max lod at D4S2987	Narcolepsy 2 (2)	
4.165	11	20	15	4p12	COMMD8		COMM domain-containing protein 8	616656	REc			
4.166	4	27	12	4p12	CORIN, CRN, TMPRSS10, ATC2, PEE5		Corin, serine peptidase	605236	A, REc		Preeclampsia/eclampsia 5, 614595 (3)	
4.167	4	21	10	4p12	COX7B2		Cytochrome C oxidase subunit VIIb2	609811	REc			
4.168	8	10	16	4p12	GUF1, EF4, EIEE40		GTPase, S. cerevisiae, homolog of	617064	REc	mutation identified in 1 EIEE40 family	?Epileptic encephalopathy, early infantile, 40, 617065 (3)	
4.169	1	31	18	4p13	PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS		Paired mesoderm homeo box 2B	603851	R		Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)	
4.170	10	22	99	4p14	PTTG2		Pituitary tumor-transforming gene 2	604231	R			
4.171	12	13	95	4p12-p11	TEC		tec protein tyrosine kinase	600583	A			
4.172	10	12	94	4p12	TXK, BTKL		TXK tyrosine kinase	600058	A			5(Txk)
4.173	3	10	11	4p12	CNGA1, CNCG1, RP49		Cyclic nucleotide gated channel, alpha 1	123825	REa, Psh		Retinitis pigmentosa 49, 613756 (3)	5(Cncg)
4.174	2	25	15	4p11	SLAIN2, KIAA1458		SLAIN motif family, member 2	610492	REc, R, H			5(Slain2)
4.175	8	31	09	4p11	ZAR1		Zygote arrest 1	607520	REc			5(Zar1)
4.176	10	23	87	4p15.32	PEPS		Peptidase S	170250	S, EM			5(Pep7)
4.177	6	16	99	4p	MHW1		Mental health wellness 1	603663	Fd	at D4S2949	{Mental health wellness-1} (2)	
4.178	12	14	00	4p16.1	WDR1		WD repeat-containing protein 1	604734	R			
4.179	6	16	99	4q	MHW2		Mental health wellness 2	603664	Fd	at D4S397	{Mental health wellness-2} (2)	
4.180	10	8	96	4q	PSORS3		Psoriasis susceptibility 3	601454	Fd		{Psoriasis susceptibility 3} (2)	
4.181	9	20	00	4q25	RRH		Rhodopsin homolog, retinal pigment epithelium-derived (peropsin)	605224	H			3(Rrh)
4.182	2	28	07	4q	WM2		Macroglobulinemia, Waldenstrom, susceptibility to, 2	610430	Fd	between D4S2910 and D4S1539	{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)	
4.183	12	17	07	4q12	PDCL2		Phosducin-like 2	611676	REc			5(Pdcl2)
4.184	5	5	00	4q12	CHIC2, BTL		Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia)	604332	Ch		{Leukemia, acute myeloid}, 601626 (3)	
4.185	8	30	09	4q12	HOPX, HOP		HOP homeobox	607275	R, REc			
4.186	7	15	09	4q12	SPATA18, SPETEX1		Spermatogenesis-associated protein 18	612814	REc			
4.187	10	12	94	4q13.3	AFM, ALBA, ALB2		Afamin	104145	REn, Psh	10kb 3' of AFP		
4.188	9	20	14	4q13.3	AFP, HPAFP, AFPD		Alpha-fetoprotein	104150	H, A, Fd, F	order: 5'-ALB-3'--5'-AFP-3'	[Hereditary persistence of alpha-fetoprotein], 615970 (3); Alpha-fetoprotein deficiency, 615969 (3)	5(Afp)
4.189	9	10	14	4q13.3	ALB, ANALBA, FDAH		Albumin	103600	F, A, REa	linked to GC	Analbuminemia, 616000 (3); [Dysalbuminemic hyperthyroxinemia], 615999 (3)	5(Alb1)
4.190	10	23	87	4q13.3	STATH		Statherin	184470	REa			
4.191	12	5	11	4q12	AASDH, ACSF4		Aminoadipate-semialdehyde dehydrogenase	614365	REc			
4.192	12	18	08	4q12	ARL9		ADP-ribosylation factor-like 9	612405	REc			
4.193	5	3	17	4q12	CEP135, KIAA0635, MCPH8		Centrosomal protein, 135kD	611423	REc		Microcephaly 8, primary, autosomal recessive, 614673 (3)	
4.194	8	27	01	4q12	CLOCK		Circadian locomotor output cycles kaput	601851	R, H			5(Clock)
4.195	6	1	12	4q12	DANCR, ANCR, KIAA0114		Differentiation-antagonizing noncoding RNA	614625	REc, R			
4.196	9	9	09	4q12	DCUN1D4, KIAA0276		DCN1 domain-containing protein 4	612977	R, REc			
4.197	7	7	09	4q12	EXOC1, SEC3		Exocyst complex component 1	607879	R, REc			
4.198	5	28	03	4q12	FIP1L1		Fip1-like 1	607686	REn, REc	fused to PDGFRA in hypereosinophilic syndrome		
4.199	9	4	14	4q13.3	GC, DBP		Group-specific component (vitamin D-binding protein)	139200	F, Fc, H, D, Ch, REa, A	4q13-q21.1 by in situ hybridization		5(Gc)
4.200	12	4	03	4q13.2	GRINL1B		Glutamate receptor, ionotropic, N-methyl D-aspartate-like 1B	608311	A			
4.201	3	23	15	4q12	GSX2, GSH2		GS homeobox 2	616253	REc			
4.202	9	14	11	4q12	IGFBP7, MAC25, RAMSVPS		Insulin-like growth factor-binding protein-7	602867	A, Psh		Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	
4.203	12	28	08	4q12	LNX1, LNX, PDZRN2		Ligand of numb protein X1	609732	R			
4.204	6	1	12	4q12	MIR4449		Micro RNA 4449	614627	REc			
4.205	7	18	06	4q12	MYP9		Myopia 9	609258	Fd		Myopia 9 (2)	
4.206	09	27	18	4q12	SGCB, LGMDR4		Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)	600900	Psh, A, Fd, LD		Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3)	
4.207	12	24	08	4q12	KDR		Kinase insert domain receptor	191306	REa, A, REn	?mutant in TAPVR1	Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
4.208	6	25	18	4q12	KIT, PBT, MASTC		Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	REa, A, H, Ch, H, REn	same 700bp segment as PDGFRA	Piebaldism, 172800 (3); Gastrointestinal stromal tumor, familial, 606764 (3); Leukemia, acute myeloid, 601626 (3); Germ cell tumors, somatic, 273300 (3); Mastocytosis, cutaneous, 154800 (3); Mastocytosis, systemic, somatic, 154800 (3)	5(Kit; W)
4.209	12	12	12	4q12	NOA1, C4orf14		Nitric oxide-associated protein 1	614919	REc			
4.210	6	16	94	4q12	PAICS, AIRC		Phosphoribosylaminoimidazole carboxylase	172439	S, REn	bifunctional enzyme; ade-D; 625bp from PPAT		
4.211	4	11	03	4q12	PDGFRA		Platelet-derived growth factor receptor, alpha polypeptide	173490	A, REa, REn	same 700bp segment as KIT; fused to BCR or FIP1L1	Gastrointestinal stromal tumor, somatic, 606764 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	5(Pdgfra)
4.212	5	2	94	4q12	POL2RB		Polymerase (RNA) II (DNA directed) polypeptide B, 140kD	180661	A			
4.213	6	16	94	4q12	PPAT, GPAT		Phosphoribosylpyrophosphate amidotransferase	172450	S, H, A			
4.214	12	18	08	4q12	RASL11B		RAS-like, family 11, member B	612404	REc			
4.215	8	15	17	4q12	REST, NRSF, WT6, GINGF5, HGF5		RE1-silencing transcription factor	600571	R, REc		{Wilms tumor 6, susceptibility to}, 616806 (3); Fibromatosis, gingival, 5, 617626 (3)	
4.216	6	1	12	4q12	SNORA26		Small nucleolar RNA, H/ACA box, 26	614626	REc, R			
4.217	08	22	18	4q12	SPINK2, SPGF29		Serine protease inhibitor, Kazal-type, 2	605753	Psh, REc	mutation identified in 1 SPGF29 family	?Spermatogenic failure 29, 618091 (3)	
4.218	1	5	12	4q12	SRD5A3, SRD5A2L, CDG1Q, KRIZI		Steroid 5-alpha-reductase 3	611715	REc, Fd		Congenital disorder of glycosylation, type Iq, 612379 (3); Kahrizi syndrome, 612713 (3)	
4.219	4	10	14	4q12	SRP72, BMFS1		Signal recognition particle, 72kD	602122	R, REc		Bone marrow failure syndrome 1, 614675 (3)	
4.220	1	22	07	4q12	TAPVR1		Total anomalous pulmonary venous return 1	106700	Fd	between D4S1630 and D4S3019; ?mutation in KDR	Total anomalous pulmonary venous return (2)	
4.221	7	18	12	4q12	TMEM165, FT27, CDG2K		Transmembrane protein 165	614726	REc		Congenital disorder of glycosylation, type IIk, 614727 (3)	
4.222	7	9	09	4q12	USP46		Ubiquitin-specific peptidase 46	612849	REc			
4.223	8	28	02	4q13.3	CXCL1, GRO1, MGSA		Chemokine, C-X-C, ligand 1 (GRO1 oncogene; melanoma growth stimulating activity, alpha)	155730	REa, A	apparently cluster of 3 GRO genes		5(Mgsa)
4.224	8	29	02	4q13.3	CXCL2, GRO2, MIP2A		Chemokine, C-X-C motif, ligand 2 (GRO2 oncogene)	139110	REa, A			5(Mip2a)
4.225	8	29	02	4q13.3	CXCL3, GRO3, MIP2B		Chemokine, C-X-C motif, ligand 3 (GRO3 oncogene)	139111	REa, A			5(Mip2b)
4.226	8	30	02	4q13.3	CXCL5, SCYB5, ENA78		Chemokine, C-X-C motif, ligand 5 (epithelial-derived neutrophil-activating peptide 78)	600324	Psh, REc			
4.227	8	30	02	4q13.3	CXCL6, SCYB6, GCP2		Chemokine, C-X-C motif, ligand 6 (granulocyte chemotactic protein-2)	138965	Psh, REc			
4.228	4	30	97	4q13.3	IL8		Interleukin-8	146930	REa, A			
4.229	10	6	92	4q13.3	PF4		Platelet factor 4	173460	REa, A, REn	6kb from PF4V1		
4.230	10	6	92	4q13.3	PF4V1		Platelet factor 4, variant 1 (PF4-like)	173461	A, REa, REn	same region as PF4 and IP10		
4.231	8	25	11	4q13.3	PPBP, CXCL7, SCYB7, CTAP3, TGB		Pro-platelet basic protein	121010	Psh, A, REn	less than 7kb from PF4		
4.232	6	18	04	4q13.3	PPBPL1, TGB2		Pro-platelet basic protein-like 1 (thromboglobulin, beta-2)	188035	REn	in cluster with PPBP, PF4, and PF4V1		
4.233	11	19	11	4q12-q13.1	MRT31		Mental retardation, autosomal recessive 31	614329	Fd	between rs11944876 and rs6551838	Mental retardation, autosomal recessive 31 (2)	
4.234	12	4	08	4q12-q13.1	DFNA27		Deafness, autosomal dominant 27	612431	Fd	max lod at D4S398	Deafness, autosomal dominant 27 (2)	
4.235	3	13	06	4q12-q13.2	DFNB55		Deafness, autosomal recessive 55	609952	Fd	max lod at D4S2638	Deafness, autosomal recessive 55 (2)	
4.236	8	18	98	4q13.2	CENPC1, CENPC		Centromere autoantigen C1	117141	A	?pseudogene on chr.12		5(Cenpc)
4.237	3	30	12	4q21.21	RASGEF1B, GPIG4		RASGEF domain family, member 1B	614532	REc			
4.238	3	13	06	4q13.1-q13.2	EPHA5, TYRO4, HEK7		Ephrin receptor EphA5	600004	A			
4.239	7	9	06	4q13.3	GRSF1		G-rich RNA sequence-binding factor 1	604851	A			
4.240	3	29	90	4q13.3	HTN1		Histatin-1	142701	REa, A	3 genes in a 15kb segment		
4.241	6	16	97	4q13.3	HTN3, HTN2, HIS2		Histatin-3	142702	REa, A			
4.242	12	13	00	4q13.3	UGT2A1		Uridine diphosphate glycosyltransferase 2 family, member A1	604716	A			
4.243	6	2	15	4q13.2	UGT2A3		Uridine diphosphate glucuronosyltransferase 2 family, member A3	616382	REc			5(Ugt2a3)
4.244	6	23	98	4q13.3	UGT2B4, UGT2B11		UDP-glucuronyltransferase, family 2, beta-4	600067	Psh, REn, A	cluster in order B7--B4--B15 in 195kb		5(Ugt2b4)
4.245	6	23	98	4q13.2	UGT2B7, UGT2B9		UDP-glucuronyltransferase, family 2, beta-7	600068	Psh, REn, A			
4.246	6	23	98	4q13.2	UGT2B15, UGT2B8		UDP-glucuronyltransferase, family 2, beta-15	600069	Psh, REn, A			
4.247	5	25	13	4q13.2	UGT2B17, BMND12		UDP-glucuronyltransferase, family 2, beta-17	601903	A		{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	
4.248	11	19	11	4q13-q21	AIS4, VAMAS5		Autoimmune disease, susceptibility to, 4	609400	Fd	between D4S392 and D4S3042	{Autoimmune disease, susceptibility to, 4} (2)	
4.249	6	8	89	4q13.3	AREG		Amphiregulin	104640	REa, A			5(Areg)
4.250	10	1	95	4q13.3	BTC		Betacellulin	600345	H	tightly linked to Areg in mouse		5(Btc)
4.251	6	2	15	4q13.3	CSN3, CNS10, CSNK		Casein, kappa	601695	REc, A			
4.252	10	5	06	4q13.3	MUC7		Mucin 7, salivary	158375	A, Psh		{Asthma, protection against}, 600807 (3)	
4.253	9	22	11	4q21.1	SCARB2, CD36L2, LIMPII, AMRF, EPM4		Scavenger receptor class B, member 2	602257	Psh, Fd		Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	
4.254	6	30	15	4q13.1	ADGRL3, LPHN3, CIRL3, CL3, LEC3, KIAA0768		Adhesion G protein-coupled receptor L3	616417	REc			
4.255	6	13	18	4q31.21	GAB1, DFNB26		Grb2-associated binding protein 1	604439	A	mutation identified in 1 family	?Deafness, autosomal recessive 26, 605428 (3)	8(Gab1)
4.256	11	20	95	4q13.3	STE, EST		Sulfotransferase, estrogen-preferring	600043	Psh, A			5(Ste)
4.257	12	15	16	4q13.1	TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3		Trans-2,3-enoyl-CoA reductase-like protein	617242	REc		Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3)	
4.258	5	5	98	4q21.21	PRKG2, PRKGR2		Protein kinase, cGMP-dependent, type II	601591	Psh			
4.259	5	2	07	4q13.2	SYT14L, SYTDEP, CHR415SYT		Synaptotagmin 14-like protein	610892	REc			
4.260	11	11	14	4q13.2	STAP1, BRDG1		Signal transducing adaptor family member 1	604298	REc			
4.261	1	9	08	4q13.2	TMPRSS11A, ECRG1		Transmembrane protease, serine 11A	611704	REc			
4.262	8	18	14	4q13.2	UGT2B10		Uridine diphosphate glycosyltransferase 2 family, member B10	600070	REc			
4.263	4	4	05	4q13.2	UGT2B28		Uridine diphosphate glycosyltransferase 2 family, member B28	606497	REc			
4.264	6	19	12	4q13.2	UGT2B11		Uridine diphosphate glycosyltransferase 2 family, member B11	603064	REc			
4.265	1	3	17	4q13.2	YTHDC1, KIAA1966		TYH domain-containing protein 1	617283	REc			
4.266	2	28	03	4q13.3	GPR74, NPFF2, NPGPR		G protein-coupled receptor 74	607449	R			
4.267	11	6	14	4q13.2-q21.3	ETL3, FMTLE		Epilepsy, familial temporal lobe, 3	611630	Fd	max lod at D4S1517	Epilepsy, familial temporal lobe, 3 (2)	
4.268	8	4	17	4q13.3	AMTN, AI3B		Amelotin	610912	REc, H	mutation identified in 1 AI3B family	?Amelogenesis imperfecta, type IIIB, 617607 (3)	5(Amtn)
4.269	9	20	14	4q13.3	ANKRD17, GTAR		Ankyrin repeat domain-containing protein 17	615929	REc			
4.270	9	27	17	4q13.3	EREG		Epiregulin	602061	REc			
4.271	9	8	11	4q13.3	MTHFD2L		Methylenetetrahydrofolate dehydrogenase 2-like, NADP(+)-dependent	614047	REc			
4.272	2	15	14	4q13.3	ODAM, APIN		Odontogenic ameloblast-associated protein	614843	REc			
4.273	9	22	17	4q13.3	PARM1, CIPAR1		Prostate androgen-regulated mucin-like protein 1	617688	REc			
4.274	11	15	17	4q13.3	PPBPP2, PPBPL2		Pro-platelet basic protein pseudogene 2	611591	R, REc			
4.275	7	14	14	4q13.3	PROL1, PRL1, BPLP		Proline-rich lacrimal protein 1	608936	REc			
4.276	2	18	09	4q13.3	RASSF6		Ras association domain family, member 6	612620	REc			
4.277	8	19	13	4q13.3	RUFY3, SINGAR1, RIPX		FUN and FYVE domains-containing protein 3	611194	REc			
4.278	2	23	08	4q13.3	SMR3B, SMR1B, PRL3, PBII		Submaxillary gland androgen-regulated protein 3, mouse, homolog of, B	611593	REc			
4.279	8	8	13	4q13.3	SULT1B1, ST1B2		Sulfotransferase family 1B, member 1	608436	REc			
4.280	8	19	13	4q13.2	TMPRSS11E, DESC1		Transmembrane protease, serine 11E	610399	REc			5(Tmprss11e)
4.281	9	12	93	4q13.3	DCK		Deoxycytidine kinase	125450	Psh, A			
4.282	1	29	01	4q13.3	ADAMTS3		A Disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 3	605011	R, REa			
4.283	7	16	09	4q21.3-q22.1	AFF1, MLLT2, AF4		AF4/FMR2 family, member 1	159557	Ch, H	fuses with ALL1		5(Af4)
4.284	3	23	15	4q13.3	AMBN, AI1F		Ameloblastin	601259		mutation identified in 1 AI1F family	Amelogenesis imperfecta, type IF, 616270 (3)	5(Ambn)
4.285	1	18	13	4q21.21	ANTXR2, CMG2, HFS		Anthrax toxin receptor 2	608041	Fd, REc		Hyaline fibromatosis syndrome, 228600 (3)	
4.286	6	6	91	4q21.21	ANXA3, ANX3		Annexin A3 (lipocortin III)	106490	Psh, REa, A			
4.287	11	30	06	4q21.2-q21.3	ARHGAP24, RCGAP72, FILGAP		RHO GTPase-activating protein 24	610586	REc			
4.288	12	15	10	4q21	DEL4q21, C4DELq21		Chromosome 4q21 deletion syndrome	613509	Ch	contiguous gene deletion if at least 30 genes	Chromosome 4q21 deletion syndrome (4)	
4.289	6	15	99	4q21.23	CDS1		CDP-diacylglycerol synthase 1	603548	R, A			
4.290	8	29	02	4q21.1	CXCL9, MIG, SCYB9		Chemokine, C-X-C motif, ligand 9	601704	A, REn	close to INP10		
4.291	8	29	02	4q21.1	CXCL10, INP10		Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10)	147310	A, REa, F	?involved in monocytic leukemia with t(4;11)(q21;q23)		
4.292	8	30	02	4q21.1	CXCL13, SCYB13, BCA1, BLC		Chemokine, C-X-C motif, ligand 13	605149	REc			
4.293	1	23	09	4q22.1	DMP1, ARHR, ARHP		Dentin matrix acidic phosphoprotein	600980	Fd, REn, Psh, A		Hypophosphatemic rickets, AR, 241520 (3)	
4.294	8	4	09	4q13.3	ENAM, AIH2, AI1C		Enamelin	606585	REc		Amelogenesis imperfecta, type IB, 104500 (3); Amelogenesis imperfecta, type IC, 204650 (3)	
4.295	8	3	14	4q21.21	FGF5, TCMGLY		Fibroblast growth factor-5	165190	REa, A		Trichomegaly, 190330 (3)	5(Fgf5)
4.296	9	13	17	4q21.21	FRAS1, FRASRS1		FRAS1 gene	607830	Fd, REc		Fraser syndrome 1, 219000 (3)	5(bl, Fras1)
4.297	7	16	09	4q22.1	HSD17B11, RETSDR2, PAN1B		17-beta-hydroxysteroid dehydrogenase XI	612831	R, REc			
4.298	3	30	00	4q13.3	IGJ		Immunoglobulin J polypeptide, linker protein for	147790	REa, A			5(Igj)
4.299	11	11	14	4q21.22	PLAC8		Placenta-specific gene 8	607515	H, REc			5(Plac8)
4.300	11	2	99	4q13.3	SLC4A4, NBC1, KNBC		Solute carrier family 4, sodium bicarbonate cotransporter, member 4	603345	Psh		Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	
4.301	1	18	11	4q22.1	SNCA, NACP, PARK1, PARK4		Synuclein, alpha (non A4 component of amyloid precursor)	163890	Psh, A, Fd		Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3); Parkinson disease 1, 168601 (3)	
4.302	2	18	08	4q13.3	UTP3, CRL1, CRLZ1		UTP3, S. crevisiae, homolog of	611614	REc			5(Utp3)
4.303	6	12	17	4q21.23	WDFY3, ALFY, BCHS, MCPH18		WD repeat- and FYVE domain-containing protein 3	617485	REc	mutation identified in 1 MCPH18 family	?Microcephaly 18, primary, autosomal dominant, 617520 (3)	
4.304	8	7	13	4q21.22-q21.23	COQ2, COQ10D1, MSA1		CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)	609825	REc		Coenzyme Q10 deficiency, primary, 1, 607426 (3); {Multiple system atrophy, susceptibility to}, 146500 (3)	
4.305	9	22	09	4q22.3	HPGDS, PGDS		Prostaglandin D2 synthase, hematopoietic	602598	A			3(Pgds)
4.306	8	29	08	4q22.1	NAP1L5, DRLM		Nucleosome assembly protein 1-like 5	612203	REc			
4.307	6	12	17	4q21-q23	PFM3		Parietal foramina 3	609566	Fd	maximum lod between D4S2986 and D4S421	Parietal foramina 3 (2)	
4.308	11	3	09	4q22.1	PKD2		Polycystin-2	173910	Fd		Polycystic kidney disease 2, 613095 (3)	5(Pkd2)
4.309	8	9	99	4q22.3	UNC5C, UNC5H3		UNC5, C. elegans, homolog of, C	603610	R			3(Unc5c)
4.310	9	9	90	4q23	ADH5, FDH		Alcohol dehydrogenase (class III), chi polypeptide	103710	S, REa			
4.311	3	14	13	4q23	EIF4E, EIF4EL1, AUTS19		Eukaryotic translation initiation factor 4E	133440	Psh	pseudogene on 20	{Autism, susceptibility to, 19}, 615091 (3)	
4.312	9	12	93	4q21-q25	FECB		Fecundity gene, Boorla, of sheep, homolog of	134720	H	sheep chr.6		
4.313	2	18	96	4q22.1	IBSP		Integrin-binding sialoprotein (bone sialoprotein II)	147563	REa, A			5(Ibsp)
4.314	2	4	00	4q23	RAP1GDS1		RAP1, GTP-GDP dissociation stimulator 1	179502	A, REa, Ch	fusion partner with NUP98 in ALL	Lymphocytic leukemia, acute T-cell (3)	
4.315	1	27	97	4q22.1	SPP1, OPN		Secreted phosphoprotein-1 (osteopontin, bone sialoprotein)	166490	REa, REc			5(Spp1)
4.316	8	25	04	4q21-q31	OFC4		Orofacial cleft 4	608371	Fd, Ch		Orofacial cleft 4 (2)	
4.317	7	27	12	4q21.1	ART3		ADP-ribosyltransferase 3	603086	REa, A, REc			
4.318	10	5	17	4q21.1	ODAPH, C4orf26		Odontogenesis-associated phosphoprotein	614829	REc		Amelogenesis imperfecta, type IIA4, 614832 (3)	
4.319	7	20	12	4q21.1	CCNG2		Cyclin G2	603203	REc			
4.320	5	25	13	4q21.1	CDKL2, KKIAMRE, P56		Cyclin-dependent kinase-like 2	603442	REc			
4.321	7	25	18	4q21.1	CNOT6L, CCR4B		CCR4-NOT transcription complex, subunit 6-like	618069	REc			
4.322	5	24	13	4q13.3	COX18		Cytochrome c oxidase assembly protein COX18	610428	REc			
4.323	8	3	97	4q13.3	CSN1		Casein, alpha	115450	REa, A			
4.324	8	3	97	4q13.3	CSN2		Casein, beta	115460	Psh, A			5(Csn2)
4.325	5	7	01	4q22.1	MEPE		Matrix, extracellular, phosphoglycoprotein	605912	REa, R			
4.326	2	26	08	4q21.1	MRPL1		Mitochondrial ribosomal protein L1	611821	REc			
4.327	12	26	13	4q21.1	NAAA, ASAHL		N-acylethanolamine acid amidase	607469	A			
4.328	8	30	09	4q21.1	NUP54		Nucleoporin, 54kD	607607	R, REc			
4.329	10	15	13	4q21.21	PCAT4, GDEP		Prostate cancer-associated transcript 4	609717	R			
4.330	8	30	09	4q21.1	PPEF2		Protein phosphatase, EF hand calcium-binding domain-2	602256	Psh, REc			
4.331	11	11	14	4q21.1	RCHY1, ZNF363, PIRH2, ARNIP		Ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase	607680	REc, A			
4.332	1	27	04	4q21.22	SCD4, ACOD4		Stearoyl-CoA desaturase 4	608370	A, REc			
4.333	7	20	09	4q21.1	SEPT11		Septin 11	612887	REc			
4.334	4	18	07	4q21.1	SHROOM3, SHRM, KIAA1481		Shroom family member 3	604570	REa, REc			
4.335	1	20	09	4q21.1	THAP6		THAP domain-containing protein 6	612535	REc			
4.336	7	20	12	4q21.1	USO1, TAP, p115		USO1 vesicle docking protein, S. cerevisiae, homolog of	603344	REc			
4.337	12	1	98	4q21.22	HNRPD, AUF1, AUF1A		Heterogeneous nuclear ribonucleoprotein D	601324	REa, A			3(Hnrpd)
4.338	8	30	02	4q21.1	CXCL11, SCYB11, IP9, SCYB9B		Chemokine, C-X-C motif, ligand 11	604852	Psh, A, REc			5(Scyb11)
4.339	2	10	14	4q21.23	FAM175A, CCDC98, ABRAXAS, ABRA1		Family with sequence similarity 175, member A	611143	REc			
4.340	9	28	12	4q13.2	GNRHR, LHRHR, HH7		Gonadotropin-releasing hormone receptor	138850	REa, A, Psh	placed at 4q12 or 4q13 by some	Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	5(Gnrhr)
4.341	4	19	01	4q32.3	KLHL2, MAYVEN		Kelch-like 2	605774	REa			8(Klhl2)
4.342	9	1	16	4q21.23	NKX6-1, NKX6A		NK6, Drosophila, homolog of, 1	602563	A			
4.343	8	31	17	4q21.21	BMP2K, BIKE		BMP2-inducible kinase	617648	REc			
4.344	4	19	12	4q21.21	PAQR3, RKTG		Progestin and ADIPOQ receptor family, member 3	614577	REc			
4.345	11	17	15	4q21.21	PRDM8, EPM10		PR domain-containing protein 8	616639	REc	mutation identified in 1 EPM10 family	?Epilepsy, progressive myoclonic, 10, 616640 (3)	
4.346	09	27	18	4q21.22	HNRNPDL, HNRPDL, JKTBP, LGMDD3		Heterogeneous nuclear ribonucleoprotein D-like protein	607137	A, REc, Fd		Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3)	
4.347	9	22	14	4q21.22	COPS4, CSN4		COP9 signalosome, subunit 4	616008	REc			
4.348	4	20	10	4q21.22	LIN54		Lin54, C. elegans, homolog of	613367	REc			
4.349	3	30	12	4q21.22	SEC31A, SEC31L1, KIAA0905		Sec31, yeast, homolog of, A	610257	R, REc			
4.350	1	20	09	4q21.22	THAP9		THAP domain-containing protein 9	612537	REc			
4.351	1	9	17	4q21.22	TMEM150C, TTN3		Transmembrane protein 150C	617292	REc			
4.352	9	21	11	4q21.23	AGPAT9, GPAT3, MAG1		1-acylglycerol-3-phosphate O-acyltransferase 9	610958	REc			
4.353	3	30	12	4q21.23	HELQ, HEL308		Helicase, POLQ-like	606769	H, REc			5(Hel308)
4.354	4	24	08	4q21.23	MRPS18C, MRPS18-1		Mitochondrial ribosomal protein S18C	611983	REc	6 pseudogenes		
4.355	4	27	00	4q21.23	HPSE, HSE1, HPA		Heparanase	604724	A, R			
4.356	1	22	97	4q21.3	PTPN13		Protein tyrosine phosphatase, nonreceptor-type, 13 (APO-1/CD95 (Fas)-associated phosphatase)	600267	A, Psh	633bp upstream of JNK3		5(Ptpn13)
4.357	6	21	05	4q22.1	DSPP, DPP, DGI1, DFNA39, DTDP2		Dentin sialophosphoprotein	125485	REa, A, F, Fd		Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420 (3)	
4.358	9	23	13	4q21.3	MAPK10, PRKM10, JNK3		Mitogen-activated protein kinase 10	602897	REa, A, REn			
4.359	4	20	10	4q21.3	SLC10A6, SOAT		Solute carrier family 10 (sodium/bile acid cotransporter family), member 6	613366	REc			
4.360	3	29	12	4q22.1	ABCG2, BCRP, ABCP, UAQTL1, GOUT1		ATP-binding cassette, subfamily G, member 2	603756	R		[Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3)	6(Abcp)
4.361	8	26	02	4q23	ADH1A, ADH1		Alcohol dehydrogenase IA (class I), alpha polypeptide	103700	REa			
4.362	6	5	18	4q23	ADH1B, ADH2		Alcohol dehydrogenase IB (class I), beta polypeptide	103720	REa		{Alcohol dependence, protection against}, 103780 (3); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}, 103780 (3)	
4.363	11	14	10	4q23	ADH1C, ADH3		Alcohol dehydrogenase IC (class I), gamma polypeptide	103730	REa		{Alcohol dependence, protection against}, 103780 (3); {Parkinson disease, susceptibility to}, 168600 (3)	3(Adh3)
4.364	11	6	89	4q23	ADH4		Alcohol dehydrogenase (class II), pi polypeptide	103740	REa, A			
4.365	8	28	97	4q22.2	ATOH1, ATH1		Atonal, Drosophila, homolog of, 1	601461	REa, A			
4.366	8	9	01	4q22.3	ENH		Enigma-like LIM domain protein	605904	Psh			
4.367	1	30	15	4q22.1-q22.2	GRID2, SCAR18		Glutamate receptor, ionotropic, delta-2	602368	R, REc		Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	6(Grid2)
4.368	10	27	08	4q22	MUSQTL1		Musical aptitude quantitative trait locus 1	612343	Fd	near D4S423 and D4S2460	[Musical aptitude QTL 1] (2)	
4.369	1	2	91	4q22.3	PDHA2		Pyruvate dehydrogenase, E1-alpha polypeptide, testis specific form	179061	REa			19(Pdhal)
4.370	12	29	15	4q24	SLC39A8, BIGM103, CDG2N		Solute carrier family 39 (zinc transporter), member 8	608732	REc		Congenital disorder of glycosylation, type IIn, 616721 (3)	
4.371	3	9	17	4q22.3	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS		SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761	A		Adermatoglyphia, 136000 (3); Basan syndrome, 129200 (3)	
4.372	7	26	15	4q24	BANK1, FLJ20706, BANK		B-cell scaffold protein with ankyrin repeats 1	610292	REc			
4.373	12	18	07	4q24	CXXC4, IDAX		CXXC finger protein 4	611645	R, REc			
4.374	12	29	06	4q23	MTP		Microsomal triglyceride transfer protein, 88kD	157147	Psh, A		Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection against}, 605552 (3)	3(Mtp)
4.375	10	8	07	4q24	CISD2, WFS2, ZCD2, ERIS		CDGSH iron sulfur domain protein 2	611507	Fd, REc		Wolfram syndrome 2, 604928 (3)	
4.376	8	9	05	4q24	MANBA, MANB1		Mannosidase, beta A, lysosomal	609489	H, REa	linked in mouse to Adl-3	Mannosidosis, beta, 248510 (3)	3(Bmn)
4.377	3	17	06	4q25	HADHSC, SCHAD, HHF4		L-3-hydroxyacyl-CoA dehydrogenase, short chain	601609	A		3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3); Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	
4.378	3	23	06	4q22-q27	MYP11		Myopia 11	609994	Fd	max lod at D4S1564	Myopia 11 (2)	
4.379	8	20	15	4q22.1	ATOD8		Dermatitis, atopic, 8	613518	Fd		{Dermatitis, atopic, susceptibility to, 8} (2)	
4.380	3	16	10	4q22.1	FAM13A, FAM13A1, KIAA0914		Family with sequence similarity 13, member A	613299	R, REc	overlaps with FAM13AOS		
4.381	3	16	10	4q22.1	FAM13AOS, FAM13A1OS		FAM13A opposite strand	613300	REc	overlaps with FAM13A		
4.382	11	11	14	2q24.3	FIGN		Fidgetin	605295	REc, H			2(Fign)
4.383	5	26	13	4q22.1	GPRIN3, GRIN3		G protein-regulated inducer of neurite outgrowth 3	611241	REc			
4.384	11	11	14	4q22.1	HERC3		HECT domain and RCC1-like domain 3	605200	A, REc			
4.385	8	18	08	4q22.1	HSD17B13, SCDR9		17-beta-hydroxysteroid dehydrogenase XIII	612127	REc			
4.386	4	23	08	4q22.1	KLHL8, KIAA1378		Kelch-like 8	611967	REc			
4.387	9	26	17	4q22.1	MMRN1, ECM		Multimerin 1	601456	REc			
4.388	1	12	16	4q22.1	PIGY, HPMRS6		Phosphatidylinositol glycan, class Y	610662	REc		Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	
4.389	7	20	15	4q22.1	PPM1K, PP2CM, PTMP, MSUDMV		Protein phosphatase, PP2C domain-containing, 1K	611065	R, REc	mutation identified in 1 MSUDMV family	?Maple syrup urine disease, mild variant, 615135 (3)	
4.390	9	10	09	4q22.1	TIGD2		TIGGER transposable element-derived gene 2	612973	REc			
4.391	3	10	05	4q22.1	HERC5, CEB1		HECT domain and RCC1-like domain 5	608242	A, REa			
4.392	5	25	17	4q23	DNAJB14		DNAJ/HSP40 homolog, subfamily B, member 14	617478	REc			
4.393	7	18	12	4q23	LAMTOR3, MP1, MAPBP		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 3	603296	REc			
4.394	2	21	18	4q23	C4orf54, LOC285556, FOPV		Chromosome 4 open reading frame 54	617881	REc			
4.395	4	6	15	4q23	METAP1, KIAA0094		Methionyl aminopeptidase 1	610151	R, REc			
4.396	9	30	14	4q23	TRMT10A, RG9MTD2, MSSGM1		tRNA methyltransferase 10, S. cerevisiae, homolog of, A	616013	REc		Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	
4.397	12	21	09	4q23	TSPAN5, NET4		Tetraspanin 5	613136	REn			
4.398	3	1	00	4q23	TYS, HRZ		Sclerotylosis	181600	F, Fd		Huriez syndrome (2)	
4.399	8	26	02	4q23	ADH6		Alcohol dehydrogenase 6 (aldehyde reductase)	103735	REn			
4.400	12	19	96	4q23	ADH7		Alcohol dehydrogenase-7	600086	A			
4.401	3	8	16	4q22.3	BMPR1B, ALK6, AMDD, BDA2, BDA1D		Bone morphogenetic protein receptor, type IB	603248	A, R		Brachydactyly, type A2, 112600 (3); Acromesomelic dysplasia, Demirhan type, 609441 (3); Brachydactyly, type A1, D, 616849 (3)	
4.402	9	30	15	4q24	NFKB1, CVID12		Nuclear factor of kappa light chain gene enhancer in B-cells 1 (p105)	164011	REa, A		Immunodeficiency, common variable, 12, 616576 (3)	
4.403	7	9	06	4q25	LEF1		Lymphoid enhancer-binding factor-1	153245	REa, A		Sebaceous tumors, somatic (3)	3(Lef1)
4.404	2	16	11	4q24	AIMP1, SCYE1, EMAP2, EMAPII, HLD3		ARS-interacting multifunctional protein 1	603605	REc, R		Leukodystrophy, hypomyelinating, 3, 260600 (3)	
4.405	8	18	14	4q24	GSTCD		Glutathione S-transferase C-terminal domain-containing protein	615912	REc			
4.406	4	7	94	4q23	H2AZ		H2AZ histone	142763	REa, A			
4.407	3	24	14	4q24	INTS12, INT12		Integrator complex subunit 12	611355	R, REc			
4.408	4	4	02	4q24	MGR1, MA		Migraine with or without aura, susceptibility to, 1	157300	Fd		{Migraine with or without aura, susceptibility to, 1} (2)	
4.409	2	12	08	4q24	NHEDC2, NHA2		NA+/H+ exchanger domain-containing protein 2	611789	REc, H			3(Nhedc1)
4.410	10	13	09	4q24	NHEDC1		Na+/H+ exchanger domain-containing protein 1	611527	REc			
4.411	5	24	13	4q24	NPNT, POEM		Nephronectin	610306	REc			
4.412	10	8	13	4q24	OCA5		Albinism, oculocutaneous, type V	615312	Fd	max lod at D4S961	Albinism, oculocutaneous, type V (2)	
4.413	6	11	02	4q25	PAPSS1, ATPSK1		3'-phosphoadenosine 5'-phosphosulfate synthase 1 (ATP sulfurylase/APS kinase-1)	603262	R, A			3(Atpsk1)
4.414	4	21	16	4q24	TBCK, IHPRF3		TBC1 domain-containing kinase	616899	REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	
4.415	10	26	11	4q24	TET2, KIAA1546, MDS		TET oncogene family, member 2	612839	REc		Myelodysplastic syndrome, somatic, 614286 (3)	
4.416	8	1	16	4q24	UBE2D3, UBCH5C		Ubiquitin-conjugating enzyme E2D 3	602963	REc			
4.417	11	3	14	4q24	CENPE, MCPH13		Centromere autoantigen E, 312kD	117143	A	mutation identified in 1 MCPH13 family	?Microcephaly 13, primary, autosomal recessive, 616051 (3)	
4.418	8	30	09	4q24	DDIT4L, REDD2		DNA damage-inducible transcript 4-like	607730	R, REc			
4.419	1	22	18	4q24	PPP3CA, PPP2B, CALNA, CNA1, IECEE1		Protein phosphatase-3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha)	114105	REa, REc		Epileptic encephalopathy, infantile or early childhood, 1, 617711 (3)	
4.420	4	14	10	4q24-q28	HWE2		Epilepsy, hot water, 2	613340	Fd	between D4S1572 and D4S2277	Epilepsy, hot water, 2 (2)	
4.421	7	20	12	4q25	AGXT2L1		Alanine-glyoxylate aminotransferase 2-like 1	614682	REc			
4.422	1	28	08	4q25	ALPK1, LAK, KIAA1527		Alpha-kinase 1	607347	REc			
4.423	10	08	07	4q25	ATFB5		Atrial fibrillation, familial, 5	611494	Fd	association with rs2200733 and rs10033464	{Atrial fibrillation, familial, 5} (2)	
4.424	3	15	07	4q25	C4orf16, GBAR, 2C18		Gamma-1 adaptin brefeldin-A resistance protein	610851	REc			
4.425	10	15	13	4q25	CFI, FI, AHUS3, ARMD13		Complement factor I	217030	REa, Fd, A, RE	40kb distal to EGF	Complement factor I deficiency, 610984 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3); {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	
4.426	2	12	15	4q25	COL25A1, CLAC, CFEOM5		Collagen, type XXV, alpha-1 polypeptide	610004	REc		Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	
4.427	1	28	13	4q25	CYP2U1, SPG56		Cytochrome P450, family 2, subfamily U, polypeptide 1	610670	R, REc		Spastic paraplegia 56, autosomal recessive, 615030 (3)	
4.428	1	9	08	4q25	EGF, URG, HOMG4		Epidermal growth factor (urogastrone)	131530	REa, H, F, RE	linked to ADH3; cen-ADH3-EGF-IL2-qter	Hypomagnesemia 4, renal, 611718 (3)	3(Egf)
4.429	11	5	97	4q25	ENPEP		Glutamyl aminopeptidase (aminopeptidase A)	138297	Psh, A, R, H			
4.430	8	20	08	4q25	ELOVL6, LCE, FACE		Elongation of very long chain fatty acids-like 6	611546	REc			
4.431	4	27	09	4q25	NOLA1, GAR1		Nucleolar protein family A, member 1	606468	R, REc			
4.432	2	12	13	4q25	LARP7, PIP7S, ALAZS		La ribonucleoprotein domain family, member 7	612026	R, REc		Alazami syndrome, 615071 (3)	
4.433	7	23	09	4q25	LGV1		Longevity 1, QTL	152430	Fd	maximum lod at D4S1564	[Longevity 1] (2)	
4.434	1	31	13	4q25	LRIT3, FIGLER4, CSNB1F		Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3	615004	REc		Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	
4.435	11	19	13	4q25	MIR297		Micro RNA 297	615520	REc			
4.436	4	27	12	4q25	MIR302A		Micro RNA 302A	614596	REc			
4.437	4	27	12	4q25	MIR302B		Micro RNA 302B	614597	REc			
4.438	4	27	12	4q25	MIR302C		Micro RNA 302C	614598	REc			
4.439	4	27	12	4q25	MIR302D		Micro RNA 302D	614599	REc			
4.440	4	27	12	4q25	MIR367		Micro RNA 367	614600	REc			
4.441	6	21	12	4q25	NEUROG2, NGN2, ATOH4		Neurogenin 2	606624	REc			
4.442	1	3	17	4q25	PANCR		PITX2 adjacent noncoding RNA	617286	REc			
4.443	11	23	16	4q24	PPA2, SCFI, SCFAI		Pyrophosphatase, inorganic, 2	609988	REc	mutation identified in 1 SCFAI family	Sudden cardiac failure, infantile, 617222 (3); ?Sudden cardiac failure, alcohol-induced, 617223 (3)	
4.444	3	20	16	4q25	RPL34		Ribosomal protein L34	616862	REc			
4.445	3	13	15	4q25	SEC24B		Sec24-related gene family, member B	607184	R, REc			
4.446	12	07	07	4q25	SGMS2, SMS2		Sphingomyelin synthase 2	611574	R			
4.447	9	28	12	4q24	TACR3, NK3R, HH11		Tachykinin receptor 3	162332	REc		Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	
4.448	6	4	97	4q25	CASP6, MCH2		Caspase 6, apoptosis-related cysteine protease	601532	A, R			
4.449	10	1	17	4q25	TIFA, T2BP		TRAF-interacting protein with forkhead-associated domain	609028	REc			
4.450	12	18	07	4q25	PLA2G12A, GXII, ROSSY		Phospholipase A2, Group XIIA	611652	REc			
4.451	1	29	13	4q26	NDST4		N-deacetylase/N-sulfotransferase 4	615039	A, REn			
4.452	1	27	17	4q25	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4		Paired-like homeodomain transcription factor-2	601542	Ch, Fd, RE		Axenfeld-Rieger syndrome, type 1, 180500 (3); Ring dermoid of cornea, 180550 (3); Anterior segment dysgenesis 4, 137600 (3)	
4.453	2	21	06	4q26	PRSS12, BSSP3, MRT1		Protease, serine, 12	606709	A		Mental retardation, autosomal recessive 1, 249500 (3)	
4.454	9	12	08	4q25-q26	ANK2, LQT4		Ankyrin-2, nonerythrocytic	106410	REa, A, Fd		Long QT syndrome 4, 600919 (3); Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	
4.455	8	27	01	4q23	DAPP1, BAM32		Dual adaptor of phosphotyrosine and 3-phosphoinositides 1	605768	A			
4.456	7	5	92	4q28.1	FGF2, FGFB		Fibroblast growth factor-2 (basic)	134920	REa, A	many alternate names		3(Fgf2)
4.457	4	2	16	4q13.2	UBA6, UBE1L2		Ubiquitin activating enzyme 6	611361	R, REc			
4.458	2	28	03	4q21.1	GENEX3414		Genethonin 1	607406	R			
4.459	5	19	06	4q26	ARSJ		Arylsulfatase J	610010	REc			
4.460	8	30	09	4q26	CAMK2D		Calcium/calmodulin-dependent protein kinase II-delta	607708	R, REc			
4.461	8	7	15	4q26	METTL14, KIAA1627		Methyltransferase-like 14	616504	R, REc			
4.462	11	24	98	4q26	PDE5A		Phosphodiesterase 5A	603310	A, REc			
4.463	5	22	03	4q28.2	PGRMC2		Progesterone receptor membrane component 2	607735	REc			
4.464	4	7	15	4q26	SEC24D, KIAA0755, CLCRP2		Sec24-related gene family, member D	607186	R, REc		Cole-Carpenter syndrome 2, 616294 (3)	
4.465	6	12	17	4q26	TRAM1L1		Translocation-associated membrane protein 1-like 1	617505	REc			
4.466	1	22	13	4q26	UGT8, CGT		UDP glycosyltransferase 8 (cerebroside synthase)	601291	Psh, A			
4.467	4	20	17	4q26	USP53, KIAA1350		Ubiquitin-specific peptidase 53	617431	REc			
4.468	3	29	18	4q27	IL2		Interleukin-2	147680	REa, A, F			3(Il2)
4.469	5	22	14	4q27	IL21, CVID11		Interleukin 21	605384	R	mutation identified in 1 CVID11 patient	?Immunodeficiency, common variable, 11, 615767 (3)	3(Il21)
4.470	3	28	11	4q26	MYOZ2, CMH16		Myozenin 2	605602	REc		Cardiomyopathy, hypertrophic, 16, 613838 (3)	
4.471	5	4	12	4q27	ANXA5, ENX2, RPRGL3		Annexin A5 (endonexin II)	131230	REa, A, D		{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	3(Anx5)
4.472	7	27	11	4q27	ADAD1, TENR		Adenosine deaminase domain-containing protein 1, testis-specific	614130	REc			
4.473	10	16	14	4q27	BBS7		BBS7 gene	607590	REc, REn		Bardet-Biedl syndrome 7, 615984 (3)	
4.474	1	7	06	4q27	BBS12, FLJ35630, C4orf24		BBS12 gene	610683	Fd, REc	1Mb centromeric to BBS	Bardet-Biedl syndrome 12, 615989 (3)	
4.475	8	24	92	4q27	CCNA, CCN1		Cyclin A	123835	A			3(Cyca)
4.476	2	23	08	4q27	CELIAC6, AIS5		Celiac disease, susceptibility to, 6	611598	Fd		{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease, susceptibility to, 5} (2)	
4.477	7	25	18	4q27	EXOSC9, PMSCL1, PCH1D		Exosome component 9	606180	R, REc		Pontocerebellar hypoplasia, type 1D, 618065 (3)	
4.478	2	18	09	4q27	IDDM23		Diabetes mellitus, insulin-dependent, 23	612622	Fd	associated with rs6534347	{Diabetes mellitus, insulin-dependent, 23} (2)	
4.479	1	11	18	4q27	KIAA1109, ALKKUCS		KIAA1109 gene	611565	R, REc		Alkuraya-Kucinskas syndrome, 617822 (3)	
4.480	6	19	98	4q27	MAD2L1		Mitotic arrest deficient, yeast, homolog-like 1	601467	REa, R, A	previously mapped to 5q23-q31		
4.481	8	26	15	4q27	NDNF, C4orf31, NORD		Neuron-derived neurotrophic factor	616506	REc			
4.482	8	25	11	4q27	PRDM5, BCS2		PR domain-containing protein 5	614161	REc		Brittle cornea syndrome 2, 614170 (3)	
4.483	7	2	18	4q27	QRFPR, GPR103		Pyroglutamylated RFamide peptide receptor	606925	REc			
4.484	6	17	15	4q27	TRPC3, TRP3, SCA41		Transient receptor potential cation channel, subfamily C, member 3	602345	REc	mutation identified in one SCA41 patient	?Spinocerebellar ataxia 41, 616410 (3)	
4.485	1	12	15	4q28.1	PLK4, STK18, SAK, MCCRP2		Polo-like kinase 4 (serine/threonine protein kinase-18)	605031	A		Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	13(Sak)
4.486	10	4	16	4q27-q28.2	MRT29		Mental retardation, autosomal recessive 29	614333	Fd	between rs10518325 and rs10518608	Mental retardation, autosomal recessive 29 (2)	
4.487	9	19	14	4q31.3	FGA		Fibrinogen, alpha polypeptide	134820	RE, REa, H, D, LD, A		Dysfibrinogenemia, congenital, 616004 (3); Hypodysfibrinogenemia, congenital, 616004 (3); Amyloidosis, familial visceral, 105200 (3); Afibrinogenemia, congenital, 202400 (3)	
4.488	9	19	14	4q31.3	FGB		Fibrinogen, beta polypeptide	134830	RE, REa, D, LD, A	4q31 by A; proximal to GYPB/GYPA	Dysfibrinogenemia, congenital, 616004 (3); Afibrinogenemia, congenital, 202400 (3); Hypofibrinogenemia, congenital, 202400 (3)	
4.489	9	30	14	4q32.1	FGG		Fibrinogen, gamma polypeptide	134850	F, REa, H, RE, D, LD, A	linked to MN	Dysfibrinogenemia, congenital, 616004 (3); Hypofibrinogenemia, congenital, 202400 (3); Afibrinogenemia, congenital, 202400 (3); Hypodysfibrinogenemia, 616004 (3)	3(Fgg)
4.490	3	30	18	4q28.1	INTU, KIAA1284, PDZK6, SRTD20, OFD17		Inturned, Drosophila, homolog of	610621	R, REc	mutation identified in 1 SRTD20 patient and 1 OFD17 patient	?Short-rib thoracic dysplasia 20 with polydactyly, 617925 (3); ?Orofaciodigital syndrome XVII, 617926 (3)	
4.491	8	2	13	4q31.21	SMAD1, MADH1, MADR1, BSP1		Mothers against decapentaplegic, Drosophila, homolog of, 1	601595	Psh			
4.492	12	21	87	4q26	FABP2		Fatty acid-binding protein, intestinal	134640	REa, A			3(Fabpi)
4.493	3	30	18	4q31.21	GYPB, SS		Glycophorin B	617923	F, Fc, AAS, EM		[Blood group, Ss], 111740 (3); {Malaria, resistance to}, 611162 (3)	
4.494	4	30	91	4q31.21	GYPE, GPE		Glycophorin E	138590	REn, A	tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1		
4.495	3	2	98	4q31.1	MGST2, GST2		Microsomal glutathione S-transferase 2	601733	A			
4.496	10	23	87	4q28-q31	SF		Stoltzfus blood group	111800	F	~25cM from MNSs	[Blood group, Stoltzfus system] (2)	
4.497	2	17	09	4q31.21	HHIP, HIP		Hedgehog-interacting protein	606178	R, H			8(Hip)
4.498	9	24	14	4q28.1	FAT4, VMLDS2, HKLLS2		FAT tumor suppressor, Drosophila, homolog of, 4	612411	REc		Van Maldergem syndrome 2, 615546 (3); Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	
4.499	7	2	18	4q28.1	NUDT6, ASFGF2		Nudix hydrolase 6	606261	REc, Psh			
4.500	3	8	07	4q28.1	SLC25A31, ANT4, AAC4		Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 31	610796	REc			
4.501	9	30	15	4q28.1	SPATA5, SPAF, EHLMRS		Spermatogenesis-associated protein 5	613940	REc		Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	
4.502	5	25	09	4q28.1	SPRY1		Sprouty, Drosophila, homolog of	602465	R, REc			
4.503	1	8	15	4q28.2	MFSD8, MGC33302, CLN7, CCMD		Major facilitator superfamily domain-containing protein 8	611124	REc, Fd		Ceroid lipofuscinosis, neuronal, 7, 610951 (3); Macular dystrophy with central cone involvement, 616170 (3)	
4.504	5	26	13	4q28.2	PHF17, JADE1		PHD finger protein 17	610514	R, REc			
4.505	5	26	13	4q28.2	SCLT1, CAP1A		Sodium channel and clathrin linker 1	611399	REc			
4.506	3	30	18	4q31.21	GYPA, MN, GPA		Glycophorin A	617922	F, Fc, AAS, EM, A, D, Fc		[Blood group, MNSs system], 111300 (3); {Malaria, resistance to}, 611162 (3)	
4.507	6	4	99	4q31.1	NDUFC1		NADH-ubiquinone oxidoreductase 1, subcomplex C1	603844	R			
4.508	11	2	04	4q31.1	MAML3, MAM2, KIAA1816		Mastermind-like 3	608991	R, REc			
4.509	12	5	03	4q28.3	PCDH10, KIAA1400		Protocadherin 10	608286	R, REc			
4.510	2	25	15	4q28.3	SLC7A11, XCT		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11	607933	R, REc			
4.511	10	5	10	4q31	AAA2		Aortic aneurysm, familial abdominal 2	609782	Fd	max lod at D4S1644	Aortic aneurysm, familial abdominal 2 (2)	
4.512	11	1	99	4q31.21	ABCE1, RNASELI, RNS4I		ATP-binding cassette, subfamily E, member 1 (ribonuclease L inhibitor)	601213	A			
4.513	8	28	02	4q34.1	HMGB2, HMG2		High-mobility group box 2 (high-mobility group (nonhistone chromosomal) protein 2)	163906	A			
4.514	6	13	95	4q31.21	IL15		Interleukin-15	600554	A			
4.515	4	8	10	4q32.1	LRAT, LCA14		Lecithin retinol acyltransferase	604863	A		Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)	
4.516	2	20	97	4q32.1	NPY2R		Neuropeptide Y receptor Y2	162642	REa, A			3(Npy2r)
4.517	12	5	03	4q28.3	PCDH18, KIAA1562		Protocadherin 18	608287	R, REc			
4.518	5	5	09	4q31	STQTL12		Stature quantitative trait locus 12	612224	Fd	associated with rs6854783	{Stature QTL 12} (2)	
4.519	5	26	05	4q31.1	UCP1		Uncoupling protein 1 (mitochondrial, proton carrier)	113730	A		{Obesity, susceptibility to}, 601665 (3)	8(Ucp)
4.520	2	18	98	4q32.2	NPY5R		Neuropeptide Y receptor Y5	602001	REa, REc, REn			8(Npy5r)
4.521	10	11	17	4q32.1	TDO2, TPH2, TRPO, HYPTRP		Tryptophan oxygenase	191070	REa, A	mutation identified in 1 HYPTRP patient	[?Hypertryptophanemia], 600627 (3)	
4.522	3	22	06	4q31-q34	PAND3		Panic disorder 3	609985	Fd	max lod at D4S413	Panic disorder 3 (2)	
4.523	7	21	03	4q31-q34	PSORS9		Psoriasis susceptibility 9	607857	Fd	max lod at D4S1597	{Psoriasis susceptibility 9} (2)	
4.524	9	9	08	4q31.1	CCRN4L, CCR4L, CCR4		Carbon catabolite repression 4-like	608468	REc, H			3(Ccrn4l)
4.525	8	25	16	4q31.1	CLGN		Calmegin	601858	REc			
4.526	3	11	09	4q31.1	ELMOD2		ELMO domain-containing protein 2	610196	REc			
4.527	1	29	01	4q34.1	GALNT7		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7	605005	REc			
4.528	3	10	09	4q31.1	LOC152586		LOC152586 gene	610310	REc			
4.529	12	5	17	4q31.1	NAA15, NARG1, NATH, MRD50		N-alpha-acetyltransferase 15, NatA auxiliary subunit	608000	REc		Mental retardation, autosomal dominant 50, 617787 (3)	
4.530	7	7	00	4q31.23	NR3C2, MLR, MCR		Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)	600983	REa, M, A		Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	
4.531	5	3	13	4q31.1	RAB33B, SMC2		Ras-associated protein RAB33B	605950	REc		Smith-McCort dysplasia 2, 615222 (3)	
4.532	6	30	15	4q31.1	SETD7, SET7, KIAA1717		SET domain-containing protein 7	606594	R, REc			
4.533	3	11	03	4q31.21	MMAA		MMAA gene	607481	REc		Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	
4.534	1	12	99	4q31.21	SMARCA5, SNF2H		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5	603375	A			
4.535	9	1	05	4q31.21	ZNF330, NOA36		Zinc finger protein 330	609550	A, REc			
4.536	1	6	09	4q31.23	ARHGAP10, GRAF2, PSGAP		RHO GTPase-activating protein 10	609746	R, REc			
4.537	2	28	94	4q31.22	BRN3B		Brn3b POU domain transcription factor	113725	REa, A			
4.538	5	19	15	4q31.22-q31.23	EDNRA, MFDA		Endothelin receptor type A	131243	REa		{Migraine, resistance to}, 157300 (3); Mandibulofacial dysostosis with alopecia, 616367 (3)	
4.539	10	1	09	4q31.21	FREM3		FRAS1-related extracellular matrix protein 3	608946	REc			
4.540	8	30	09	4q31.22	LSM6		LSM6 protein	607286	R, REc			
4.541	1	22	08	4q31.21	OTUD4, KIAA1046, HIN1		OTD domain-containing protein 4	611744	REc			
4.542	6	15	99	4q31.3	RPS3A		Ribosomal protein S3a	180478	REa, A, R			
4.543	8	24	09	4q31.3	PLRG1, PRL1		Pleiotropic regulator 1	605961	R, REc			
4.544	2	17	11	4q31.21	ANAPC10, DOC1, APC10		Anaphase-promoting complex, subunit 10	613745	REc			8(Anapc10)
4.545	6	28	18	4q31.21	TBC1D9, KIAA0882		TBC1 domain family member 9	618035	REc, R			
4.546	4	26	11	4q31.23	TMEM184C, TMEM34		Transmembrane protein 184C	613937	REc			
4.547	5	9	18	4q31.21-q31.22	ZNF827		Zinc finger protein 827	617962	REc			
4.548	12	21	09	4q31.2-q31.3	DCLK2, DCK2, CLIK2, CL2		Doublecortin-like kinase 2	613166	REc			3(Dclk2)
4.549	12	9	14	4q31.23	PRMT9, PRMT10		Protein arginine methyltransferase 9	616125	REc			
4.550	10	13	09	4q31.3	DCHS2, CDHJ, PCDHJ		Dachsous, Drosophila, homolog of, 2	612486	REc, H			3(Dchs2)
4.551	9	9	08	4q31.3	FBXW7, AGO, CDC4		F-box and WD40 domain protein 7	606278	R			
4.552	11	23	16	4q31.3	GATB, PET112		Glutamyl-tRNA amidotransferase, subunit B	603645	TM			
4.553	6	13	18	4q32.1	GLRB, HKPX2		Glycine receptor, beta subunit	138492	A		Hyperekplexia 2, 614619 (3)	3(Glrb)
4.554	1	4	16	4q31.3	KIAA0922, TMEM131L		KIAA0922 gene	616243	REc			
4.555	7	6	12	4q31.3	LRBA, LBA, CDC4L, CVID8		Lipopolysaccharide-responsive, beige-like anchor protein	606453	REc, R		Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	
4.556	6	12	17	4q31.3	MAB21L2, MCSKS14		MAB21, C. elegans, homolog-like 2	604357	REc		Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3)	
4.557	8	27	15	4q31.3	MND1		Meiotic nuclear division 1, S. cerevisiae, homolog of	611422	REc			
4.558	2	11	98	4q32.1	PPID		Peptidylprolyl isomerase D (cyclophilin D)	601753	REa, A			
4.559	10	19	99	4q31.3	SFRP2, SARP1		Secreted frizzled-related protein 2	604157	REa, R, H			3(Sfrp2)
4.560	12	13	06	4q31.3	SH3D19, EBP		SH3 domain protein 19	608674	REc, Ch	fused with AML1 in t(4;21)		
4.561	11	11	14	4q31.3	SNORD73A, RNU73		Small nucleolar RNA, C/D box 73A	603568	A			
4.562	7	7	15	4q31.3	TRIM2, KIAA0517, CMT2R		Tripartite motif-containing protein 2	614141	R, REc		Charcot-Marie-Tooth disease, type 2R, 615490 (3)	
4.563	12	17	15	4q32.1	ASIC5, HINAC		Acid-sensing ion channel family member 5	616693	REc, H			3(Asic5)
4.564	6	10	94	4q32.2	NPY1R		Neuropeptide Y receptor	162641	A			8(Npy1r)
4.565	12	18	07	4q31.3-q32.3	HSCR9		Hirschsprung disease, susceptibility to, 9	611644	Fd	between D4S3049 and D4S1566	{Hirschsprung disease, susceptibility to, 9} (2)	
4.566	4	22	09	4q32.1	ASAP		Aster-associated protein	610070	REc			
4.567	4	29	14	4q32.1	GUCY1A3, GUC1A3, GUCSA3, MYMY6		Guanylate cyclase 1, soluble, alpha 3	139396	A		Moyamoya 6 with achalasia, 615750 (3)	
4.568	8	18	98	4q32.1	GUCY1B3, GUC1B3, GUCSB3		Guanylate cyclase 1, soluble, beta 3	139397	A			
4.569	2	16	04	4q32.1	PDGFC		Platelet-derived growth factor C	608452	R, REc			
4.570	8	18	15	4q32.1	RXFP1, LGR7		Relaxin/insulin-like family peptide receptor 1	606654	A			
4.571	4	5	13	4q31.3	TLR2, TIL4		Toll-like receptor-2	603028	A		{Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer, susceptibility to}, 114500 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
4.572	2	21	10	4q34.3	AGA		Aspartylglucosaminidase	613228	S, F, D, A		Aspartylglucosaminuria, 208400 (3)	8(Aga)
4.573	11	30	06	4p15.32	CPEB2		Cytoplasmic polyadenylation element-binding protein 2	610605	REc			5(Cpeb2)
4.574	3	1	94	4q32.1	GRIA2, GLUR2		Glutamate receptor, ionotropic, AMPA 2	138247	Psh, A			3(Glur2)
4.575	10	15	09	4q32.3	TLL1, TLL, ASD6		Tolloid-like 1	606742	A		Atrial septal defect 6, 613087 (3)	8(Tll1)
4.576	7	31	08	4q32-q34	RP29		Retinitis pigmentosa 29	612165	Fd	maximum lod at D4S415	Retinitis pigmentosa 29 (2)	
4.577	2	25	16	4q32.3	MSMO1, SC4MOL, ERG25, MCCPD		Methylsterol monooxygenase 1	607545	A		Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	
4.578	8	25	03	4q32.1	ETFDH, MADD		Electron transfer flavoprotein:ubiquinone oxidoreductase	231675	REa, A		Glutaric acidemia IIC, 231680 (3)	3(Etfdh)
4.579	2	5	15	4q32.1	C4orf46, RCDG1		Chromosome 4 open reading frame 46	616210	REc			
4.580	10	2	12	4q32.1	CTSO		Cathepsin O	600550	REc			
4.581	5	19	09	4q32.1	FNIP2, FNIPL, KIAA1450		Folliculin-interacting protein 2	612768	R, REc			
4.582	8	1	18	4q32.1	RAPGEF2, NRAPGEP, RAGEF, KIAA0313		Rap guanine nucleotide exchange factor 2	609530	R, REc	mutation identified in 1 FAME7 patient	?Epilepsy, familial adult myoclonic, 7, 618075 (3)	
4.583	1	27	11	4q32.1-q32.2	TRIP4q32.1q32.2, C4TRIPq32.1q32.2		Chromosome 4q32.1-q32.2 triplication syndrome	613603	Ch		Chromosome 4q32.1-q32.2 triplication syndrome (4)	
4.584	1	28	08	4q33	AADAT, KAT2		Alpha-aminoadipate aminotransferase	611754	A, REc, H			8(Aadat)
4.585	2	16	18	4q32.2	NAF1		Nuclear assembly factor 1 ribonucleoprotein	617868	REc			8(Naf1)
4.586	6	7	10	4q32.2-q32.3	MARCH1		Membrane-associated RING-CH finger protein 1	613331	REc			
4.587	8	30	09	4q32.3	ANP32C, PP32R1		Acidic leucine-rich nuclear phosphoprotein 32 family, member C	606877	Psh, REc			
4.588	8	25	17	4q32.3	ELA, LOC100506013		Elabela	615594	REc			
4.589	8	30	07	4q32.3	CINN		Cinnamon odor, pleasantness of	611109	Fd	max lod at AFM295YES	[Cinnamon odor, pleasantness of] (2)	
4.590	8	30	09	4q32.3	CPE		Carboxypeptidase E	114855	REa, H, REc			8(Cpe)
4.591	6	11	11	4q32.3	DDX60		DEAD box polypeptide 60	613974	REc			
4.592	1	4	16	4q32.3	DDX60L		DEAD box polypeptide 60-like	616725	REc			
4.593	12	17	07	4q32.3	HDLCQ4		High density lipoprotein cholesterol level QTL 4	610239	Fd	between D4S1597 and D4S1539	[High density lipoprotein cholesterol level QTL 4] (2)	
4.594	8	26	15	4q33	MFAP3L, KIAA0626		Microfibrillar-associated protein 3-like	616523	REc, Psh			
4.595	1	9	07	4q32.3	PALLD, KIAA0992, PNCA1		Palladin, mouse, homolog of	608092	R, REc, Fd		{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	
4.596	1	11	07	4q32.3	SPOCK3		SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 3	607989	REc			
4.597	1	12	07	4q32.3	ANXA10		Annexin A10	608008	A			8(Anxa10)
4.598	4	8	98	4q33	CLCN3		Chloride channel-3	600580	REc, Fd, A			8(Clcn3)
4.599	11	10	05	4q34.1	HAND2, DHAND2, DHAND		Heart- and neural crest derivative-expressed 2	602407	R			
4.600	5	19	16	4q33	HPF1, C4orf27		Histone parylation factor 1	616614	REc			
4.601	3	5	18	4q33	NEK1, SRTD6, SRPS2A, ALS24		Never in mitosis gene A-related kinase 1	604588	REc	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3); {Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3)	
4.602	10	20	98	4q34.1	GLRA3		Glycine receptor, alpha-3 polypeptide	600421	A			8(Glra3)
4.603	4	3	03	4q34.1	MORF4, SEN1, CSRB		Mortality factor 4 (senescence-related, cellular, 1)	116960	M, A			
4.604	10	7	02	4q33-qter	HCA1		Hypercalciuria, absorptive, 1	607258	Ch		Hypercalciuria, absorptive (2)	
4.605	1	29	01	4q34.1	ADAM29		A disintegrin and metalloproteinase domain 29	604778	R			
4.606	9	28	96	4q34.2	GPM6A, M6A		Glycoprotein M6A	601275	A			
4.607	11	2	04	4q34.2	WDR17		WD repeat-containing protein 17	609005	A			
4.608	8	11	14	4q34.3	VEGFC, VRP, LMPH1D		Vascular endothelial growth factor C	601528	REc		Lymphedema, hereditary, ID, 615907 (3)	
4.609	4	20	10	4q34.3-q35.1	SCA30		Spinocerebellar ataxia 30	613371	Fd	between rs1397413 and rs2175476; max lod 3.0	?Spinocerebellar ataxia 30 (2)	
4.610	10	16	12	4q34.3-q35.2	HMSN5		Hereditary motor and sensory neuropathy V	600361	Fd	D4S1552 and D4S2930	Hereditary motor and sensory neuropathy V (2)	
4.611	9	18	08	4q35.1	ACSL1, FACL2, FACL1, LACS, ACS1		Acyl-CoA synthetase long-chain family member 1	152425	REb, A			
4.612	2	18	96	4q35.2	FAT1, FAT		FAT tumor suppressor, Drosophila, homolog of, 1	600976	A			
4.613	1	24	12	4q34.1	HPGD, PGDH1, PHOAR1		Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688	REa, A		Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)	
4.614	9	9	08	4q34.1	FBXO8, FBX8, FBS		F-box only protein 8	605649	REc			8(Fbxo8)
4.615	4	6	13	4q34.1	GALNTL6, GALNACT20		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6	615138	REc			
4.616	12	6	16	4q34.1	HAND2AS1, UPH, DEIN		HAND2 antisense RNA 1, noncoding (Upperhand)	617240	REc			
4.617	3	23	15	4q34.1	MIR4276		Micro RNA 4276	616274	REc			
4.618	7	20	12	4q34.1	SAP30		SIN3-associated polypeptide, 30kD	603378	REc			
4.619	8	16	12	4q34.1	SCRG1		Scraptie-responsive gene 1	603163	REc			
4.620	3	22	06	4q34.2	SPATA4, TSARG2		Spermatogenesis-associated protein 4	609879	REc			
4.621	1	31	13	4q34.2	ASB5		Ankyrin repeat- and SOCS box-containing protein 5	615050	REc			
4.622	5	7	01	4q35.1	ALP		Actinin-associated LIM protein	605889	A			
4.623	5	8	97	4q35.1	CASP3, CPP32		Caspase 3, apoptosis-related cysteine protease	600636	A, REc			
4.624	10	25	12	4q35.2	DBET		D4A4 binding element transcript, noncoding	614865	REc			
4.625	3	19	03	4q35.1	DCTD		Deoxycytidylate deaminase	607638	A			
4.626	3	22	01	4q35	DKBI		Dyskeratosis, hereditary benign intraepithelial	127600	Fd		Dyskeratosis, hereditary benign intraepithelial (2)	
4.627	6	18	01	4q35.2	DUX4		Double homeo box protein 4	606009	REc			
4.628	12	27	13	4q35.2	DUX4L9, DUX4C		Double homeobox 4-like 9	615581	REc			
4.629	12	22	08	4q35.2	F11		Coagulation factor XI (plasma thromboplastin antecedent)	264900	A, H, Fd	not closely linked to MNS	Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI deficiency, autosomal dominant, 612416 (3)	8(cf11)
4.630	8	18	98	4q35.2	FRG1, FSG1		Facioscapulohumeral muscular dystrophy region gene-1	601278	REn			
4.631	11	22	05	4q35.2	FRG2		Facioscapulohumeral muscular dystrophy region gene 2	609032	REn			
4.632	7	19	04	4q35	FSHD1, FSHD1A		Facioscapulohumeral muscular dystrophy 1	158900	Fd, REc	due to D4Z4 macrosatellite repeat on 4q35	Facioscapulohumeral muscular dystrophy 1 (4)	?8(myd)
4.633	7	30	15	4q35.2	KLKB1, KLK3, PKKD		Kallikrein B plasma 1 (Fletcher factor)	229000	A	similar to F11	Fletcher factor (prekallikrein) deficiency, 612423 (3)	8(Kal3)
4.634	11	22	16	4q35.1	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2		Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220	REa, REb, A, Fd		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3); Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3); Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3)	8(Ant1)
4.635	2	24	17	4q35.1	STOX2, KIAA1392		Storkhead box 2	617359	Psh			
4.636	3	14	18	4q35.1	TLR3, IIAE2		Toll-like receptor-3	603029	A		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}, 613002 (3); {HIV1 infection, resistance to}, 609423 (3)	
4.637	9	27	01	4q35-qter	DFNA24		Deafness, autosomal dominant 24	606282	Fd		Deafness, autosomal dominant 24 (2)	
4.638	9	23	13	4q35.1	CCDC111, MYP22		Coiled-coil domain containing 111	615421	REc		Myopia 22, autosomal dominant, 615420 (3)	
4.639	8	18	14	4q35.1	CDKN2AIP, CARF		Cyclin-dependent kinase inhibitor 2A-interacting protein	615914	REc			
4.640	10	12	14	4q35.1	CFAP97, HMW, KIAA1430		Cilia- and flagella-associated protein 97	616047	R, REc			
4.641	5	31	05	4q35.1-q35.2	CYP4V2, BCD		Cytochrome P450, family 4, subfamily V, polypeptide 2	608614	Fd, REc		Bietti crystalline corneoretinal dystrophy, 210370 (3)	
4.642	6	28	16	4q35.1	ENPP6		Ectonucleotide pyrophosphatase/phosphodiesterase 6	616983	REc			
4.643	6	27	17	4q35.1	HELT, HESL, MGN		HELT basic helix-loop-helix transcription factor	617546	REc			8(Helt)
4.644	3	2	06	4q35.1	ING2, ING1L		Inhibitor of growth 2	604215	A, R			
4.645	11	4	93	4q35.1	IRF2		Interferon regulatory factor-2	147576	A			
4.646	8	1	05	4q35.1	KMHN1		Cancer/testis antigen KM-HN-1	609488	REc			
4.647	10	8	07	4q35.1	MLF1IP, CENPU, CENP50		MLF1-interacting protein (centromere protein U)	611511	REc, H			8(Mlf1ip)
4.648	10	22	95	4q35.2	MTNR1A		Melatonin receptor 1A	600665	REa, Psh			8(Mtnr1a)
4.649	5	19	15	4q35.1	SORBS2, ARGBP2, KIAA0777		Sorbin and SH3 domains-containing protein 2	616349	REc			
4.650	8	1	16	4q34.3-q35.1	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9		Teneurin transmembrane protein 3	610083	REc, R		Microphthalmia, isolated, with coloboma 9, 615145 (3)	
4.651	09	27	18	4q35.1	TRAPPC11, C4orf41, LGMDR18		Trafficking protein particle complex, subunit 11	614138	REc		Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3)	
4.652	5	11	18	4q35.1	UFSP2, C4orf20, BHD, SEMDDR		UFM1-specific peptidase 2	611482	REc	mutation identified in 1 BHD family	?Hip dysplasia, Beukes type, 142669 (3); ?Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3)	
4.653	10	2	12	4q35.2	DUX2		Double homeobox protein 2	611442	REc	?10q26.3		
4.654	4	19	12	4q35.2	ZFP42, REX1		Zinc finger protein 42	614572	REc, H			8(Zfp42)
4.655	1	9	94	Chr.4	LAG5		Leukocyte antigen group 5	151450	S		Neutropenia, neonatal alloimmune (1)	
4.656	12	21	09	4p16.1	MIR95, MIRN95		Micro RNA 95	613185	REc			
4.657	10	23	87	Chr.4	TS13		Temperature sensitivity complementation, ts13	187320	S			
5.1	7	13	15	5p15.33	NDUFS6		NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kD	603848	R		Mitochondrial complex I deficiency, 252010 (3)	
5.2	5	9	18	5p15.32	ICE1, KIAA0947		Interactor of little elongation complex ELL subunit 1	617958	REc			
5.3	1	11	93	5p15.31	ADCY2		Adenylyl cyclase-2, brain	103071	A, REa			13(Adcy2)
5.4	12	27	01	5p15.33	AHRR, KIAA1234		Arylhydrocarbon receptor repressor	606517	R, A			13(Ahrr)
5.5	8	17	01	5p15.33	IRX1		Iroquois homeo box protein 1	606197	A			
5.6	8	17	01	5p15.33	IRX2		Iroquois homeo box protein 2	606198	A			
5.7	7	3	06	5p15.33	IRX4		Iroquois homeobox protein 4	606199	REa, R, H			13(Irx4)
5.8	3	5	08	5p15.33	MRPL36		Mitochondrial ribosomal protein L36	611842	REc			
5.9	3	31	15	5p15.33	NKD2		Naked cuticle, Drosophila, homolog of, 2	607852	REc, R			
5.10	5	12	00	5p15.33	SLC12A7, KCC4		Solute carrier family 12 (potassium/chloride transporters), member 7	604879	R, REa			
5.11	7	5	18	5p15.33	SLC6A3, DAT1, PKDYS1		Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	126455	Psh, A, Fd		{Nicotine dependence, protection against}, 188890 (3); Parkinsonism-dystonia, infantile, 1, 613135 (3)	13(Dat1)
5.12	3	20	16	5p15.33	SLC9A3, NHE3, DIAR8		Solute carrier family 9 (sodium/hydrogen exchanger), member 3	182307	REa, Fd	pseudogene on chr.10	Diarrhea 8, secretory sodium, congenital, 616868 (3)	13(Slc9a3)
5.13	7	22	09	5p15.33	TPPP, P25, P24		Tubulin polymerization-promoting protein	608773	Psh, R			
5.14	2	25	15	5p15.33	AYTL2, LPCAT, LPCAT1		Acyltransferase-like 2	610472	REc			
5.15	10	6	09	5p15.33	BCC3		Basal cell carcinoma, susceptibility to, 3	613059	Fd		{Basal cell carcinoma, susceptibility to, 3} (2)	
5.16	5	26	13	5p15.33	CEI		Coordinated expression to IRXA2	610522	REc			
5.17	7	23	15	5p15.33	CEP72, KIAA1519		Centrosomal protein, 72kD	616475	REc			
5.18	2	17	09	5p15.33	CLPTM1L, CRR9		CLPTM1-like protein	612585	REc			
5.19	9	8	11	5p15.33	EXOC3, SEC6		Exocyst complex component 3	608186	REc			
5.20	11	26	09	5p15.33	GLM8		Glioma susceptibility 8	613033	Fd	associated with rs2736100	{Glioma susceptibility 8} (2)	
5.21	2	18	09	5p15.33	LNCR3		Lung cancer susceptibility 3	612571	Fd	associated with rs402710 and rs2736100	{Lung cancer susceptibility 3} (2)	
5.22	5	22	14	5p15.33	LSINCT5		Long stress-induced noncoding transcript 5	615764	REc			
5.23	11	11	14	5p15.33	PDCD6, ALG2		Programmed cell death 6	601057	REc			
5.24	9	9	09	5p15.33	SLC6A18, XTRP2		Solute carrier family 6 (neurotransmitter transporter), member 18	610300	REc			
5.25	4	20	10	5p15.33	SLC6A19, HND		Solute carrier family 6 (neurotransmitter transporter), member 19	608893	REc, Fd		Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	13(Slc6a19)
5.26	5	26	15	5p15.33	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9		Telomerase reverse transcriptase	187270	R, D	deleted in cri du chat	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3); {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3); {Dyskeratosis congenita, autosomal dominant 2}, 613989 (3); {Leukemia, acute myeloid}, 601626 (3); {Melanoma, cutaneous malignant, 9}, 615134 (3)	
5.27	7	27	17	5p15.33	TRIP13, 16E1BP, MVA3		Thyroid hormone receptor interactor 13	604507	REc		Mosaic variegated aneuploidy syndrome 3, 617598 (3)	
5.28	1	27	09	5p15.33-p15.2	MYP16		Myopia 16	612554	Fd	max lod at D5S2505	Myopia 16 (2)	
5.29	8	29	08	5p15.33-p13.1	MCDR3		Macular dystrophy, retinal, 3	608850	Fd	maximum lod at D5S630	Macular dystrophy, retinal, 3 (2)	
5.30	6	17	17	5p15.31	FASTKD3		Fast kinase domains 3	617530	REc			
5.31	6	1	15	5p15.31	LINC01018, SRHC		Long intergenic noncoding RNA 1018	616385	REc			
5.32	10	30	08	5p15.31	MED10, NUT2		Mediator complex subunit 10	612382	REc			
5.33	5	30	17	5p15.31	NSUN2, TRM4, SAKI, MISU, MRT5		NOP2/SUN RNA methyltransferase family, member 2	610916	REc		Mental retardation, autosomal recessive 5, 611091 (3)	13(Nsun2)
5.34	6	22	14	2q11.2	SEMA4C, SEMAF, KIAA1739		Semaphorin 4C	604462	REc			
5.35	7	18	14	5p15.31	UBE2QL1		Ubiquitin-conjugating enzyme E2Q family-like protein 1	615832	REc			
5.36	12	19	11	5p15.31-p15.1	FAME3, FCMTE3		Epilepsy, myoclonic, familial adult, 3	613608	Fd	between D5S580 and D5S2096	Epilepsy, myoclonic, familial adult, 3 (2)	
5.37	7	31	06	5p15.31	MTRR		Methionine synthase reductase	602568	Psh, A		Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	
5.38	5	30	06	5p15.2	CCT5, KIAA0098, CCTE		chaperonin containing TCP1, subunit 5 (epsilon)	610150	REc, Fd		Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	
5.39	4	26	10	5p15.2	CMBL		Carboxymethylenebutenolidase-like protein	613379	REc			15(Cmbl)
5.40	1	29	14	5p15.2	CTNND2, NPRAP		Catenin, delta-2	604275	Psh, A			
5.41	1	4	96	5p15.2	DAP		Death-associated protein	600954	REa			
5.42	8	30	16	5p15.2	LINC01194, TAG		Long intergenic noncoding RNA 1194	617097	REc			
5.43	3	16	10	5p15.2	MARCH6, TEB4, DOA10, KIAA0597		Membrane-associated RING-CH finger protein 6	613297	REc			
5.44	9	1	16	5p15.2	OTULIN, FAM105B, GUM, AIPDS		OTU deubiquitinase with linear linkage specificity	615712	REc		Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3)	15(Otulin)
5.45	1	28	08	5p15.2	ROPN1L, ASP		ROPN1-like protein	611756	R, REc			
5.46	10	14	09	5p15.31	SEMA5A, SEMF		Semaphorin 5a	609297	REc			15(Sema5a)
5.47	7	1	02	5p14.3	CDH18, CDH14		Cadherin 18	603019	R, Fd			
5.48	2	17	09	5p15.2-p14	ADIPQTL2, CAQ5		Adiponectin, serum level of, QTL 2	606770	Fd	near D5S817	{Adiponectin, serum level of, QTL2} (2)	
5.49	11	2	02	5p15.2	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD		Ank, mouse, homolog of	605145	R, Fd		Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2, 118600 (3)	15(ank)
5.50	7	14	06	5p15.2-p14.3	ANIB4		Aneurysm, intracranial berry, 4	610213	Fd	max lod at D5S1954	Aneurysm, intracranial berry, 4 (2)	
5.51	10	8	07	5q12.3	CEMPK, SOLT		Centromeric protein K	611502	REc			
5.52	11	13	09	5p15.1	FAM134B, HSAN2B		Family with sequence similarity 134, member B	613114	REc		Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	
5.53	8	31	09	5p15.1	FBXL7, FBL7		F-box and leucine-rich repeat protein 7	605656	R, REc			15(Fbxl7)
5.54	6	7	10	5p15.1	MARCH11		Membrane-associated RING-CH finger protein 11	613338	REc			
5.55	10	31	13	5p15.1	PVNH3		Periventricular nodular heterotopia 3	608098	A, Ch		Periventricular nodular heterotopia 3 (2)	
5.56	9	27	17	5p15.1	ZNF622, ZPR9		Zinc finger protein 622	608694	REc, R			
5.57	5	7	01	5p15.1	BASP1, CAP23, NAP22		Brain-abundant signal protein, membrane-attached, 1	605940	A			
5.58	7	1	02	5p13.3	CDH6		Cadherin 6	603007	R, Fd			
5.59	5	30	17	5p13.2	RXFP3, RLN3R1, SALPR, GPCR135		Relaxin/insulin-like family peptide receptor 3	609445	R			
5.60	9	6	16	5p15.2	TRIO, MRD44		Triple functional domain	601893	A		Mental retardation, autosomal dominant 44, 617061 (3)	
5.61	11	12	96	5p15.1	MYO10		Myosin X	601481	A			15(Myo10)
5.62	6	11	11	5p15.1-p13.3	MYP19		Myopia 19, autosomal dominant	613969	Fd	highest lod at D5S419	Myopia 19 (2)	
5.63	4	3	09	5p15.32	ADAMTS16		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 16	607510	REc			
5.64	8	25	11	5p15.33	SDHA, SDH1, SDHF, CMD1GG, PGL5		Succinate dehydrogenase complex, subunit A, flavoprotein	600857	A	copy on 3q29	Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)	
5.65	12	9	91	5p15.31	SRD5A1		Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)	184753	REa, A	pseudogene on X		13(Srd5a1)
5.66	5	9	18	5p15.31	TENT4A, POLS, TRF4, POLK		Terminal nucleotidyltransferase 4A	605198	REc			
5.67	4	5	00	5p15.31	TRB7, T2R1		Taste receptor, family B, member 7	604796	REc			15(T2R19)
5.68	11	22	10	5p15	TST2		Tuberculin skin test reactivity quantitative trait locus	613637	Fd	max lod at 16:2.70Mb	[Tuberculin skin test reactivity QTL] (2)	
5.69	12	4	08	5p15.2	DNAH5, HL1, PCD, CILD3		Dynein, axonemal, heavy chain 5	603335	REn, Fd		Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	15(Dnahc5)
5.70	4	26	17	5q14.3	POLR3G, RPC32, RPC7		Polymerase III, RNA, subunit G	617456	REc			
5.71	3	24	06	5p14.1	CDH9		Cadherin 9	609974	REc			
5.72	8	15	90	5p14	MLVI2		Moloney leukemia virus integration site-2	157960	REa, A			15(Mlvi2)
5.73	3	18	94	5p14.3	PMCHL1		Pro-melanin-concentrating hormone-like 1	176793	REa, A			
5.74	2	18	10	5p14.2	PRDM9		PR domain-containing protein 9	609760	REc			
5.75	3	8	00	5p14.2-p14.1	CDH10		Cadherin 10	604555	A			
5.76	9	14	95	5p14.3	CDH12, CDHB		Cadherin-12 (N-cadherin 2)	600562	A	pseudogene on 5q13 in SMA region		
5.77	10	23	87	5p12	HMGCS1		3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1	142940	S, REa, A	like HMGCR, regulated transcriptionally by steroid		
5.78	11	9	05	5p13.3	RNASEN, DROSHA, RANSE3L, RN3		Ribonuclease III, nuclear	608828	A			15(Rnasen)
5.79	1	1	96	5p13.3	NPR3, ANPRC		Natriuretic peptide receptor C	108962	REa, A		?Hypertension, salt-resistant (1)	
5.80	9	2	08	5p13.3	GOLPH3, GPP34, MIDAS		Golgi phosphoprotein 3	612207	R, REc			
5.81	8	31	09	5p13.3	MTMR12, 3PAP, KIAA1682		Myotubularin-related protein 12	606501	R, REa, REc			
5.82	8	9	13	5p13.2	SLC45A2, MATP, AIM1, SHEP5, OCA4		Solute carrier family 45, member 2	606202	REc		Albinism, oculocutaneous, type IV, 606574 (3); [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	
5.83	10	2	12	5p13.3	SUB1, PC4, p15		Sub1, S. cerevisiae, homolog of	600503	REc			
5.84	2	13	14	5p13.3	ZFR		Zinc finger RNA-binding protein	615635	REc			
5.85	12	17	14	5p13.3-p13.2	BDA1B		Brachydactyly, type A1, locus B	607004	Fd		Brachydactyly, type A1, B (2)	
5.86	12	10	98	5p13.2	RAD1		RAD1, S. pombe, homolog of	603153	A			
5.87	12	27	01	5p13.2	RAI14, KIAA1334		Retinoic acid-induced 14	606586	REa, A			
5.88	4	24	18	5p13.2	CPLANE1, C5orf42, JBTS17, OFD6		Ciliogenesis and planar polarity effector 1	614571	REc		Joubert syndrome 17, 614615 (3); Orofaciodigital syndrome VI, 277170 (3)	
5.89	8	1	16	5p13.2	DNAJC21, DNAJA5, BMFS3		DNAJ/HSP40 homolog, subfamily C, member 21	617048	R, REc		Bone marrow failure syndrome 3, 617052 (3)	
5.90	9	21	17	5p13.2-p13.1	EGFLAM, PIKA, AGRINL		EGF-like, fibronectin type III, and laminin G domains-containing protein	617683	REc			
5.91	2	23	09	5p13.2	MS3		Multiple sclerosis, susceptibility to, 3	612595	Fd	associated with rs6897932	{Multiple sclerosis, susceptibility to, 3} (2)	
5.92	10	12	14	5p13.2	NADK2, C5orf33, DECRD		NAD kinase 2, mitochondrial	615787	REc	mutation identified in 1 DECRD family	?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	
5.93	1	17	07	5p13.3	PDZD2, PAPIN, PIN1, AIPC		PDZ domain containing 2	610697	R, REc			
5.94	12	27	13	5p13.2	PRLR, MFAB, HPRL		Prolactin receptor	176761	REa, A, REc	mutation identified in 1 family with HPRL	Multiple fibroadenomas of the breast, 615554 (3); ?Hyperprolactinemia, 615555 (3)	
5.95	6	2	15	5p13.2	RANBP3L		RAN-binding protein 3-like	616391	REc			
5.96	8	19	13	5p13.2	SPEF2, KPL2, KIAA1770		Sperm flagellar 2	610172	Psh, REc			
5.97	6	2	15	5p13.2	TTC23L		Tetratricopeptide repeat domain-containing protein 23-like	616344	REc			
5.98	6	2	15	5p13.2	UGT3A1		Uridine diphosphate glucuronosyltransferase 3 family, member A1	616383	REc			15(Ugt3a1)
5.99	6	2	15	5p13.2	UGT3A2		Uridine diphosphate glucuronosyltransferase 3 family, member A2	616384	REc			15(Ugt3a2)
5.100	12	6	16	5p13.2	WDR70		WD repeat-containing protein 70	617233	REc			
5.101	10	26	11	5p13.2	AMACR, CBAS4, AMACRD		Alpha-methylacyl-CoA racemase	604489	TM		Alpha-methylacyl-CoA racemase deficiency, 614307 (3); Bile acid synthesis defect, congenital, 4, 214950 (3)	
5.102	4	21	17	5p13.1	FYB, SLAP130, ADAP, THC3		FYN-binding protein	602731	REc		Thrombocytopenia 3, 273900 (3)	
5.103	9	24	08	5p13.1	IBD18		Inflammatory bowel disease 18	612262	Fd	associated with rs1373692	{Inflammatory bowel disease 18} (2)	
5.104	2	10	04	5p13.1	LIFR, STWS, SWS, SJS2		Leukemia inhibitory factor receptor	151443	REa, Fd		Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	15(Lifr)
5.105	2	26	08	5p13.1	OSMR, OSMRB, PLCA1		Oncostatin M receptor	601743	REc, Fd		Amyloidosis, primary localized cutaneous, 1, 105250 (3)	
5.106	5	19	04	5p13.2	NIPBL, CDLS1		Nipped-B-like (delangin)	608667	Ch, REc		Cornelia de Lange syndrome 1, 122470 (3)	15(Nipbl)
5.107	7	1	16	5p13.1	PLCXD3		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 3	617016	REc			
5.108	12	14	99	5p13.1	PTGER4		Prostaglandin E receptor 4, EP4 subtype	601586	A			
5.109	09	06	18	5p13.1	RICTOR, AVO3, KIAA1999		Rapamycin-insensitive campion of mTOR	609022	REc			
5.110	3	23	06	5p13.1	CARD6, CINCIN1		Caspase recruitment domain-containing protein 6	609986	REc, H			15(Card6)
5.111	1	25	11	5p13.2	GDNF, HSCR3		Glial cell line derived neurotrophic factor	600837	A, Psh		Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma, modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)	
5.112	9	22	04	5p13	ADHD4		Attention deficit-hyperactivity disorder, susceptibility to, 4	608906	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
5.113	5	30	17	5p13.2	AGXT2, AGT2, BAIBA		Alanine-glyoxylate aminotransferase 2	612471	REc		[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3)	
5.114	6	9	08	5p13.2	C1ATNF3, CTRP3, CORS26		C1q- and tumor necrosis factor-related protein 3	612045	A, H			15(C1qtnf3)
5.115	12	4	08	5p13.1	C6		Complement component-6	217050	A, H, RE, Fd, LD		C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)	15(C6)
5.116	7	3	06	5p13.1	C7		Complement component-7	217070	A, H, RE, Fd, LD		C7 deficiency, 610102 (3)	15(C7)
5.117	1	7	14	5p13.1	C9, C9D, ARMD15		Complement component-9	120940	REa, A, Fd, LD		C9 deficiency, 613825 (3); {Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	
5.118	12	18	98	5p13.1	DAB2, DOC2		Disabled, Drosophila, homolog of, 2 (differentially expressed in ovarian cancer-2)	601236	A, REa			
5.119	2	16	10	5p13	DUP5p13, C5DUPp13		Chromosome 5p13 duplication syndrome	613174	Ch		Chromosome 5p13 duplication syndrome (4)	
5.120	1	20	09	5p13.2	IL7R, IL7RA, CD127		Interleukin-7 receptor	146661	REa, A		Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	
5.121	7	3	06	5p13	KYPSC1		Kyphoscoliosis 1	610170	Fd		Kyphoscoliosis 1 (2)	
5.122	5	22	14	5p13.2	NUP155, KIAA0791, ATFB15		Nucleoporin, 155kD	606694	A, R	mutation identified in 1 ATFB15 family	?Atrial fibrillation 15, 615770 (3)	
5.123	8	25	06	5p13.1	OXCT1, OXCT, SCOT		3-oxoacid CoA transferase 1	601424	A		Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	
5.124	9	23	96	5p13.2	SKP2		S-phase kinase-associated protein 2 (p45)	601436	A			
5.125	3	31	09	5p13.2	SLC1A3, EAAT1, EA6		Solute carrier family 1 (glial high affinity glutamate transporter), member 3	600111	A		Episodic ataxia, type 6, 612656 (3)	15(Eaat1)
5.126	5	2	06	5p12	FGF10		Fibroblast growth factor-10	602115	A		Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome, 149730 (3)	
5.127	5	17	18	5p13-p12	GHR, GHIP		Growth hormone receptor	600946	REa, A		Laron dwarfism, 262500 (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3); Increased responsiveness to growth hormone, 604271 (3); Growth hormone insensitivity, partial, 604271 (3)	15(Ghr)
5.128	10	23	87	5p13.3	TARS		Threonyl-tRNA synthetase	187790	S	linked to LARS		
5.129	7	18	06	5p13-q12	HYT6		Hypertension, essential, susceptibility to, 6	610262	Fd		{Hypertension, essential, susceptibility to, 6}, 145500 (2)	
5.130	5	24	13	5p12	ANXA2R, C5orf39, AX2R, AXIIR		Annexin A2 receptor	611296	Psh			
5.131	9	9	08	5p12	CCL28		Chemokine, C-C motif, ligand 28	605240	REc			13(Ccl28)
5.132	9	9	08	5p13.1	FBXO4, FBX4		F-box only protein 4	609090	A, REc			15(Fbxo4)
5.133	7	17	14	5p12	HCN1, BCNG1, EIEE24		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1	602780	REc		Epileptic encephalopathy, early infantile, 24, 615871 (3)	
5.134	10	11	16	5p12	NNT, GCCD4		Nicotinamide nucleotide transhydrogenase	607878	A		Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3)	13(Nnt)
5.135	8	20	07	5p12	PAIP1		Polyadenylate-binding protein-interacting protein 1	605184	REc			
5.136	11	20	98	5p13.1	PRKAA1		Protein kinase, AMP-activated, catalytic, alpha-1	602739	A			
5.137	5	4	00	5p12	ZNF131		Zinc finger protein -31	604073	A			
5.138	4	24	08	5p12	MRPS30		Mitochondrial ribosomal protein S30	611991	R, REc			
5.139	11	18	16	5p12	SELENOP, SEPP1		Selenoprotein P	601484	REa, A, R			
5.140	9	12	08	5p	ASD1		Atrial septal defect 1	108800	Fd	max lod at D5S406	Atrial septal defect 1 (2)	
5.141	8	4	97	5p	MHS6		Malignant hyperthermia susceptibility 6	601888	Fd		{Malignant hyperthermia susceptibility 6} (2)	
5.142	10	20	99	5p13.1	RPL37		Ribosomal protein L37	604181	REa, R			
5.143	5	19	06	5q	BSZQTL2		Bone size quantitative trait locus 2	609657	Fd		{Bone size QTL} (2)	
5.144	3	5	95	5q11.1	ISL1		ISL1 transcription factor, LIM/homeodomain (islet-1)	600366	Fd	between D5S395 and D5S407; proximal 5q		
5.145	10	2	09	5q35.3	PROP1, CPHD2		Prophet of Pit1, paired-like homeodomain transcription factor	601538	H, R		Pituitary hormone deficiency, combined, 2, 262600 (3)	11(df, Prop1)
5.146	5	6	13	5q11.2	ANKRD55		Ankyrin repeat domain-containing protein 55	615189	REc			
5.147	10	1	95	5q11.2	IL6ST		Interleukin-6 signal transducer (gp130, oncostatin M receptor)	600694	A			
5.148	11	4	13	5q11.2	MOCS2, MPTS, MOCODB		Molybdenum cofactor synthesis-2	603708	R		Molybdenum cofactor deficiency B, 252160 (3)	
5.149	8	13	98	5q11.2	GZMA, CTLA3, HFSP		Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease)	140050	REa			13(Ctla3)
5.150	9	1	16	5q14.1	MSH3, FAP4		mutS, E. coli, homolog of, 3	600887	REn	5' to DHFR	Endometrial carcinoma, somatic, 608089 (3); Familial adenomatous polyposis 4, 617100 (3)	13(Msh3)
5.151	2	1	11	5q14.1	ARSB, MPS6		Arylsulfatase B	611542	S		Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	13(As1)
5.152	11	16	00	5q13.3	IQGAP2		IQ motif-containing GTPase-activating protein-2	605401	Psh			
5.153	3	7	14	5q11.1	EMB, GP70		Embigin	615669	REc			
5.154	7	3	01	5q11.2	NDUFS4, AQDQ		NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kD (NADH-coenzyme Q reductase)	602694	REa, R		Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
5.155	10	4	12	5q11.2	ACTBL2		Actin, beta-like, 2	614835	REc			
5.156	7	17	14	5q11.2	CCNO, UNG2, CILD29		Cyclin O	607752	Psh, REc		Ciliary dyskinesia, primary, 29, 615872 (3)	
5.157	4	30	09	5q11.2	DHX29		DEAH (Asp-Glu-Ala-His) box polypeptide 29	612720	REc			
5.158	6	22	14	5q11.2	ESM1		Endothelial cell-specific molecule 1	601521	REc			
5.159	2	20	01	5q11.2	FST, FS		Follistatin	136470	A			
5.160	8	18	08	5q11.2	GPBP1, GPBP		GC-rich promoter-binding protein 1	608412	REc			
5.161	11	23	16	5q11.2	GPX8		Glutathione peroxidase 8	617172	REc			
5.162	9	26	17	5q11.2	GZMK, TRYP2		Granzyme K	600784	REc, A			
5.163	9	11	14	5q11.2	HSPB3, HSPL27, HMN2C, DHMN2C		Heat-shock 27kD protein 3	604624	A	mutation identified in 1 HMN2C family	?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	
5.164	7	22	11	5q11.2	IDAS		IDAS	614086	REc			
5.165	3	6	18	5q11.2	IL31RA, GLMR, GPL, PLCA2		Interleukin 31 receptor A	609510	REc, H	mutation identified in 1 PLCA2 patient	?Amyloidosis, primary localized cutaneous, 2, 613955 (3)	13(Il31ra)
5.166	8	31	09	5q11.2	ITGA1, VLA1		Integrin, alpha-1	192968	H, REc			13(Vla1)
5.167	8	29	11	5q11.2	MAP3K1, MEKK1, MEKK, SRXY6		Mitogen-activated protein kinase kinase kinase 1	600982	REa, REc		46XY sex reversal 6, 613762 (3)	13(Mekk)
5.168	12	2	09	5q11.2	MIR449A, MIRN449A		Micro RNA 449A	613131	REc			
5.169	12	2	09	5q11.2	MIR449B, MIRN449B		Micro RNA 449B	613132	REc			
5.170	10	10	18	5q11.2	MTREX, MTR4, SKIV2L2		MTR4 exosome RNA helicase	618122	REc			
5.171	3	22	01	5q11.2	PELO		Pelota, Drosophila, homolog of	605757	A			
5.172	10	26	17	5q11.2	PLPP1, PPAP2A		Phopshplipid phosphatase 1	607124	REc			
5.173	12	28	08	5q13.1-q13.2	SLC30A5, ZNT5, ZTL1		Solute carrier family 30 (zinc transporter), member 5	607819	REc			
5.174	3	31	15	5q11.2	SLC38A9, URLC11		Solute carrier family 38, member 9	616203	REc			
5.175	7	16	02	5q11.2	DDX4, VASA		DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 4 (vasa, Drosophila, homolog of)	605281	R, A			13(Ddx4)
5.176	12	19	11	5q12.3	SREK1, SFRS12, SRRp508		Splicing regulatory glutamine/lysine-rich protein 1	609268	REc			
5.177	6	7	12	5q12.3	HTR1A, ADRB2RL1, PFMCD		5-hydroxytryptamine (serotonin) receptor-1A	109760	REa, A, Fd		Periodic fever, menstrual cycle dependent, 614674 (3)	13(Htr1a)
5.178	12	4	01	5q13.2	TAF9, TAF2G, TAFII32		TAF9 RNA polymerase II, TATA box-binding protein-associated factor, 32kD	600822	REa, Psh, A			
5.179	3	31	11	5q14.1	DHFR		Dihydrofolate reductase	126060	S, REa, H, D		Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	13(Dhfr)
5.180	3	5	95	5q13.3	CRHBP		Corticotropin releasing hormone-binding protein	122559	Psh			13(Crhbp)
5.181	8	31	09	5q12.3	ADAMTS6		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 6	605008	REa, REc			
5.182	8	24	92	5q13.2	CCNB1		Cyclin B1	123836	A, REa			13(Cycb4)
5.183	1	23	13	5q12.3	CD180, LY64, RP105		CD180 antigen	602226	A			13(Ly64)
5.184	3	7	14	5q12	DEL5q12, C5DELq12		Chromosome 5q12 deletion syndrome	615668	Ch		Chromosome 5q12 deletion syndrome (4)	
5.185	6	11	02	5q12.3	ERBB2IP, ERBIN		ERBB2 interacting protein	606944	R, REc			
5.186	5	25	12	5q12.1	ERCC8, CKN1, CSA, UVSS2		Excision repair cross-complementing rodent repair deficiency, complementation group 8	609412	Psh		Cockayne syndrome, type A, 216400 (3); UV-sensitive syndrome 2, 614621 (3)	
5.187	2	2	16	5q13.3	GCNT4		Glucosaminyl (N-acetyl) transferase 4, core 2	616782	A			
5.188	6	1	00	5q12.1	PART1		Prostate androgen-regulated transcript 1	604991	R, A			
5.189	5	4	12	5q11.2-q12.1	PDE4D, DPDE3, STRK1, ACRDYS2		Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)	600129	REa, A, Fd		{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2, with or without hormone resistance, 614613 (3)	13(Pde4D)
5.190	8	27	01	5q13.2	ANKRA2, ANKRA		Ankyrin repeat-containing protein, family A, member 2	605787	R, Psh			
5.191	8	29	08	5q14.1	CMYA5, MYOSPRYN, TRIM76		Cardiomyopathy-associated protein 5	612193	REc			13(Cmya5)
5.192	4	24	96	5q13.2	FOXD1, FKHL8		Forkhead box D1	601091	A			
5.193	5	31	05	5q13.2	MCCC2, MCCB		3-Methylcrotonyl-CoA carboxylase 2	609014	R		3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	
5.194	8	9	05	5q11.2	PLK2, SNK		Polo-like kinase 2	607023	R			
5.195	3	18	94	5q13.2	PMCHL2		Pro-melanin-concentrating hormone-like 2	176794	REa, A			
5.196	10	11	07	5q12-q14	EJM4		Myoclonic epilepsy, juvenile, 4	611364	Fd	max lod at D5S459	Myoclonic epilepsy, juvenile, 4 (2)	
5.197	10	12	10	5q14.2-q14.3	VCAN, CSPG2, WGN, WGN1, ERVR		Versican (chondroitin sulfate proteoglycan-2)	118661	REa, A, H, Fd		Wagner syndrome 1, 143200 (3)	13(Cspg2)
5.198	11	3	14	5q12.1	DEPDC1B		DEP domain-containing protein 1B	616073	REc			
5.199	2	1	11	5q12.1	DIMT1L, DIM1, HUSSY5		Dimethyladenosine transferase 1-like	612499	REc	previously assigned to 8p12		
5.200	1	30	12	5q12.1	ELOVL7		Elongation of very long chain fatty acids-like 6	614451	REc			
5.201	3	29	07	5q12.1	IPO11, RANBP11, SLRN		Importin 11	610889	REc			
5.202	9	23	13	5q12.1	KIF2A, CDCBM3		Kinesin, heavy chain, 2	602591	R		Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	
5.203	4	24	08	5q13.2	MRPS36		Mitochondrial ribosomal protein S36	611996	REc	6 pseudogenes		
5.204	4	6	18	5q12.1	NDUFAF2, NDUFA12L, MMTN, B17.2L		NADH dehydrogenase 1 alpha subcomplex, assembly factor 2	609653	REc	pseudogene on chr.2	Mitochondrial complex I deficiency, 252010 (3)	
5.205	2	16	18	5q12.1	ZSWIM6, KIAA1577, AFND, NEDMAGA		Zinc finger SWIM domain-containing protein 6	615951	Psh, REc		Acromelic frontonasal dysostosis, 603671 (3); Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3)	
5.206	2	28	03	5q13.2	BIRC1, NAIP		Baculoviral IAP repeat-containing 1 (neuronal apoptosis inhibitory protein)	600355	REn, H	?involved in SMA		13(Naip)
5.207	4	19	01	5q14.1	DMGDH, DMGDHD		Dimethylglycine dehydrogenase	605849	A		Dimethylglycine dehydrogenase deficiency, 605850 (3)	
5.208	4	21	97	5q13.2	GTF2H2		General transcription factor IIH, polypeptide 2 (44kD subunit)	601748	REc	2 copies		
5.209	9	28	00	5q13.2	SERF1A, H4F5, SMAM1		Small EDRK-rich factor 1A	603011	REc, D			13(M4f5)
5.210	9	30	03	5q13.2	SMN1, SMA1, SMA2, SMA3, SMA4		Survival of motor neuron 1, telomeric	600354	REn		Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2, 253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)	13(Smn)
5.211	5	15	17	5q12.3	CWC27, SDCCAG10, RPSKA		CWC27 spliceosome-associated protein, X. cerevisiae, homolog of	617170	REc		Retinitis pigmentosa with or without skeletal anomalies, 250410 (3)	
5.212	10	13	09	5q12.3	NLN, KIAA1226, AGTBP		Neurolysin	611530	R, REc			
5.213	3	29	07	5q12.3	RGS7BP, R7BP		Regulator of G protein signaling 7-binding protein	610890	REc			13(Rgs7bp)
5.214	6	26	18	5q12.3	SHLD3, RINN1		Shield complex, subunit 3	618030	REc			
5.215	7	14	14	5q12.3	TRIM23, ARD1		Tripartite motif-containing protein 23	601747	REc			
5.216	9	22	14	5q12.3	RNF180, RINES		RING finger protein 180	616015	REc			
5.217	10	12	09	5q13.2	SMN2		Survival of motor neuron 2, centromeric	601627	REn		{Spinal muscular atrophy, type III, modifier of}, 253400 (3)	
5.218	9	30	02	5q13.2	BDP1, TFNR		B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	607012	A			
5.219	12	11	01	5q13.3	EFG2		Elongation factor G2	606544	REc			
5.220	9	20	00	5q13.3	ENC1, PIG10		Ectodermal-neural cortex 1	605173	A			13(Enc1)
5.221	11	4	93	5q13.3	F2R, CF2R, PAR1		Coagulation factor II (thrombin) receptor	187930	A, R, REc	within 900kb of GPR11		13(Cf2r)
5.222	6	28	00	5q13.3	F2RL1, GPR11, PAR2		Coagulation factor II, thrombin, receptor-like 1 (G protein-coupled receptor-11)	600933	A, R, REc	within 900kb of F2R		
5.223	8	24	98	5q13.3	F2RL2, PAR3		Coagulation factor II receptor-like 2 (protease-activated receptor 3)	601919	REn	order: PAR2-PAR1-PAR3		
5.224	11	23	09	5q13.3	HEXB		Hexosaminidase B, beta polypeptide	606873	S, Ch, D		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	13(Hex2)
5.225	3	22	93	5q13.2	MAP1B		Microtubule-associated protein-1B	157129	A, Fd			
5.226	6	1	18	5q12.3	MAST4		Microtubule-associated serine-threonine kinase 4	618002	REc			
5.227	8	25	11	5q13.3	PDE8B, PPNAD3, ADSD		Phosphodiesterase 8B	603390	R, Fd		Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3)	
5.228	9	22	14	5q13.1	PIK3R1, GRB1, AGM7, SHORT, IMD36		Phosphatidylinositol 3-kinase, regulatory, 1	171833	REa, A	mutation identified in 1 AGM7 family	?Agammaglobulinemia 7, autosomal recessive, 615214 (3); SHORT syndrome, 269880 (3); Immunodeficiency 36, 616005 (3)	13(Pik3r1)
5.229	7	16	09	5q11.2	RAB3C		Ras-associated protein RAB3C	612829	REc			
5.230	10	20	99	5q13.2	RAD17		RAD17, S. pombe, homolog of	603139	A, H			13(Rad17)
5.231	12	11	02	5q14.1	RASGRF2		Ras protein-specific guanine nucleotide-releasing factor 2	606614	A			13(Rasgrf2)
5.232	9	22	08	5q13	TSHQTL1		Thyroid-stimulating hormone level QTL 1	612306	Fd	associated with rs4704397	[Thyroid-stimulating hormone level QTL 1] (2)	
5.233	7	12	02	5q13-q14	AAT2, FAA2		Aortic aneurysm, familial thoracic 2	607087	Fd		Aortic aneurysm, familial thoracic 2 (2)	
5.234	9	3	15	5q14.2	XRCC4, SSMED		X-ray repair, complementing defective, repair in Chinese hamster cells-4	194363	S, REa, R	between D5S427 and D5S401	Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	
5.235	4	24	02	5q13-q22	GINGF2, GGF2, HGF2		Fibromatosis, gingival, 2	605544	Fd	formerly GINGF2 used for a locus on 2p16-p13	Fibromatosis, gingival, 2 (2)	
5.236	9	21	11	5q14.3	HAPLN1, CRTL1		Hyaluronan and proteoglycan link protein 1	115435	A			
5.237	9	5	91	5q21.3	RPS20A		Ribosomal protein S20A	180463	REa	?pseudogene		
5.238	12	29	06	5q13.2	MARVELD2, MARVD2, TRIC, DFNB49		Marvel domain-containing protein 2 (tricellulin)	610572	REc, Fd, REc		Deafness, autosomal recessive 49, 610153 (3)	13(tric)
5.239	3	27	17	5q13.2	OCLN, BLCPMG, PTORCH1		Occludin	602876	R, REc		Pseudo-TORCH syndrome 1, 251290 (3)	
5.240	2	20	01	5q13.3	POLK, POLQ, DINB1		Polymerase, DNA, kappa	605650	REa, A			
5.241	4	30	09	5q14.1	BHMT		Betaine-homocysteine methyltransferase	602888	REn			
5.242	5	7	01	5q14.1	BHMT2		Betaine-homocysteine methyltransferase 2	605932	A, R			13(Bhmt2)
5.243	5	5	15	5q13.2	CARTPT, CART		Cocaine- and amphetamine-regulated transcript prepropeptide	602606	REc	mutation identified in 1 family	{?Obesity, susceptibility to}, 601665 (3)	
5.244	3	24	11	5q13.2	CCDC125, KENAE		Coiled-coil domain-containing protein 125	613781	REc			
5.245	2	24	98	5q13.2	CDK7, STK1, CAK1		Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase)	601955	REa, REc	previously mapped to 2p15-cen		
5.246	4	10	14	5q13.2	CENPH		Centromeric protein H	605607	REc			
5.247	9	7	10	5q13.2	FCHO2		FCH domain-only protein 2	613438	REc			
5.248	11	5	99	5q14.1	JMY		Junction-mediating and regulatory protein	604279	A			
5.249	4	24	08	5q13.2	MRPS27, KIAA0264		Mitochondrial ribosomal protein S27	611989	R, REc			
5.250	11	10	13	5q13.2	PTCD2		Pentatricopeptide repeat domain-containing protein 2	615484	REc			
5.251	5	26	09	5q13.2	RGNEF, p190RHOGEF		Rgnef, mouse, homolog of	612790	REc			
5.252	12	10	12	5q13.2	TMEM174		Transmembrane protein 174	614909	REc			
5.253	4	19	06	5q13.2	TNPO1, KPNB2, MIP1		Transportin 1	602901	R			
5.254	2	4	15	5q13.2	UTP15		UTP15, U3 small nucleolar ribonucleoprotein, S. cerevisiae, homolog of	616194	REc			
5.255	4	6	15	5q13.2	ZNF366, DCSCRIPT		Zinc finger protein 366	610159	REc			
5.256	1	8	07	5q13.3	AGGF1, VG5Q, HUS84971, FLJ10283		Angiogenic factor with G patch and FHA domains 1	608464	Ch			
5.257	1	2	95	5q14.1	CKMT2		Creatine kinase, mitochondrial-2 (sarcomeric)	123295	Psh, A			
5.258	5	11	15	5q13.3	COL4A3BP, GPBP, CERT, MRD34		COL4A3-binding protein (ceramide transporter)	604677	REc		Mental retardation, autosomal dominant 34, 616351 (3)	
5.259	5	22	14	5q13.3	FAM169A, SLAP75, KIAA0888		Family with sequence similarity 169, member A	615769	REc			
5.260	3	8	00	5q14.1	OTP		Orthopedia, Drosophila, homolog of	604529	R, A			
5.261	10	29	09	5q14.3	RASA1, GAP, CMAVM, PKWS		RAS p21 protein activator 1 (GTPase activating protein)	139150	REa, A		Parkes Weber syndrome, 608355 (3); Capillary malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)	13(Gap)
5.262	7	3	06	5q13.3	S100Z		S100 calcium-binding protein, zeta	610103	REc			
5.263	12	4	02	5q14.1	SSBP2		Single-stranded DNA-binding protein 2	607389	REc			
5.264	8	3	12	5q13.3	SV2C		Synaptic vesicle glycoprotein 2C	610291	REc			
5.265	12	22	08	5q13.3	TINP1, NSA2, HUSSY29		Transforming growth factor-beta-inducible nuclear protein 1	612497	REc			
5.266	5	30	17	5q13.3-q14.1	WDR41		WD repeat-containing protein 41	617502	REc			
5.267	5	31	13	5q13.3	ZBED3		Zinc finger BED domain-containing protein 3	615250	REc			
5.268	6	19	98	5q14.3	CCNH, CAK		Cyclin H	601953	REa, A, REc			
5.269	5	18	09	5q13.3	HMGCR, LDLCQ3		3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910	REa, A		[Statins, attenuated cholesterol lowering by] (3); [Low density lipoprotein cholesterol level QTL 3] (3)	13(Hmgcr)
5.270	5	13	02	5q14.1	SCAMP1, SCAMP37		Secretory carrier membrane protein 1	606911	R			
5.271	6	15	99	5q14.3	COX7C		Cytochrome C oxidase, subunit VII C	603774	A, R	pseudogene on 13q14-q21		
5.272	4	1	96	5q15	GLRX, GRX		Glutaredoxin (thioltransferase)	600443	REa, A			
5.273	6	5	13	5q14	HBT		Telangiectasia, hereditary benign	187260	Fd	max lod at D5S641	Telangiectasia, hereditary benign (2)	
5.274	7	8	10	5q14.3	MEF2C, C5DELq14.3, DEL5q14.3		MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	600662	A, REa		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)	13(mef2c)
5.275	7	7	14	5q15	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS		Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)	132890	A		Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	13(Tcfcoup1)
5.276	2	28	94	5q21.1	PAM		Peptidylglycine alpha-amidating monooxygenase	170270	REa, A			1(Pam)
5.277	10	28	11	5q14.1	ACOT12, CACH		Acyl-CoA thioesterase 12	614315	REc			13(Acot12)
5.278	5	31	05	5q14.1	AP3B1, ADTB3A, HPS2		Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)	603401	REc		Hermansky-Pudlak syndrome 2, 608233 (3)	13(Ap3bi, pe)
5.279	12	28	08	5q14.1	LHFPL2, KIAA0206		LHFP-like protein 2	609718	R, REc			
5.280	4	2	12	5q14.1	SERINC5, C5orf12, TPO1		Serine incorporator 5	614551	REc			
5.281	09	05	18	5q14.1	SPZ1, PPP1R148		Spermatogenic leucine zipper protein 1	618068	REc			
5.282	5	9	18	5q14.1	TENT2, APD4, GLD2		Terminal nucleotidyltransferase 1	614121	REc			
5.283	9	26	17	5q14.1	THBS4		Thrombospondin IV	600715	REc			
5.284	9	16	12	5q14.1	ZFYVE16, ENDOFIN, KIAA0305		Zinc finger FYVE domain-containing protein 16	608880	REc			
5.285	5	9	12	5q14.1-q21.3	KTCN5		Keratoconus 5	614622	Fd	between D5S2499 and D5S495	Keratoconus 5 (2)	
5.286	3	8	07	5q14.1-q14.2	ATG10, APG10		Autophagy 10, S. cerevisiae, homolog of	610800	R, REc			
5.287	7	9	06	5q14.1	HOMER1, HOMER1B, HOMER1C, HOMER1A		Homer, homlog 1 (Drosophila)	604798	R			
5.288	8	11	17	5q14.2	RPS23, BTDD, MCINS		Ribosomal protein S23	603683	Psh, R, REc		Brachycephaly, trichomegaly, and developmental delay, 617412 (3)	
5.289	4	2	16	5q14.2	SCARNA18		Small cajal body-specific RNA 18	611329	REc	in intron 1 of TMEM167		
5.290	11	3	11	5q14.2	VUR4		Vesicoureteral reflux 4	614317	Fd	closest marker rs1501656	Vesicoureteral reflux 4 (2)	
5.291	5	13	02	5q15	LNPEP		Leucyl-cystinyl aminopeptidase	151300	A			
5.292	12	24	08	5q14.3	ARRDC3, TLIMP, KIAA1376		Arrestin domain-containing 3	612464	REc			
5.293	1	4	16	5q14.3	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C		Adhesion G protein-coupled receptor V1	602851	A, REc, R, Fd	mutation identified in 1 FEB4 family	?Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type 2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	13(Frings, mass1)
5.294	5	25	13	5q14.3	CETN3, CDC31		Centrin 3	602907	REc			
5.295	10	23	15	5q14.3	LINC00461, VISC		Long intergenic noncoding RNA 461	616611	REc			
5.296	3	23	09	5q14.3	MIR9-2, MIRN9-2		Micro RNA 9-2	611187	REc			
5.297	5	6	03	5q15	RHOBTB3, KIAA0878		Rho-related BTB domain-containing protein 3	607353	REc			
5.298	10	31	13	5q14.3-q15	PVNH5		Periventricular nodular heterotopia 5	612881	Ch	deletion range 6.3-17Mb, common range 5.8Mb	Periventricular nodular heterotopia 5 (4)	
5.299	5	19	06	5q15	ARSK		Arylsulfatase K	610011	REc			
5.300	6	10	08	5q15	ELL2		Elongation factor, RNA polymerase II, 2	601874	R, REc			
5.301	6	10	08	5q15	ERAP1, ALAP, ARTS1, PILSAP, KIAA0525		Endoplasmic reticulum aminopeptidase 1	606832	REc			
5.302	12	30	09	5q15	ERAP2, LRAP		Endoplasmic reticulum aminopeptidase 2	609497	REc			
5.303	12	22	16	5q15	KIAA0825		KIAA0825 gene	617266	REc			
5.304	5	24	13	5q15	LIX1		Limb expression 1, mouse, homolog of	610466	REc			
5.305	4	7	15	5q15	MCTP1		Multiple C2 domains-containing transmembrane protein 1	616296	REc			
5.306	10	31	17	5q15	RIOK2, RIO2		RIO kianse 2	617754	REc			
5.307	4	27	12	5q15	TTC37, KIAA0372		Tetratricopeptide repeat domain 37	614589	REc		Trichohepatoenteric syndrome 1, 222470 (3)	
5.308	4	7	15	5q15	CAST, PLACK		Calpastatin	114090	A, REb		Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	
5.309	9	21	17	5q15-q21	CHD1, PILBOS		Chromodomain helicase DNA binding protein-1	602118	REc		Pilarowski-Bjornsson syndrome, 617682 (3)	
5.310	10	29	08	5q15	PCSK1, NEC1, PC1, PC3, BMIQ12		Proprotein convertase subtilisin/kexin type 1	162150	A		Obesity with impaired prohormone processing, 600955 (3); {Obesity, susceptibility to, BMIQ12}, 612362 (3)	13(Nec1)
5.311	11	30	06	5q35.2	CPEB4, KIAA1673		Cytoplasmic polyadenylation element-binding protein 4	610607	REa, REc			
5.312	12	5	13	5q22.2	MCC		Mutated in colorectal cancers	159350	REn, D		Colorectal cancer, somatic, 114500 (3)	18(Mcc)
5.313	9	14	05	5q21	MGR8		Migraine, susceptibility to, 8	609570	Fd		{Migraine, susceptibility to, 8} (2)	
5.314	7	14	98	5q21.1	PST, PST1		Polysialyltransferase	602547	A			
5.315	1	24	06	5q22.2	DCP2		Decapping enzyme 2, S. cerevisiae, homolog of	609844	REc			
5.316	2	27	01	5q23.1	DMXL1		DMX-like 1	605671	A, R			
5.317	4	30	91	5q21.3	FER, TYK3		fer (fps/fes related) tyrosine kinase	176942	REa, A			11(Fert)
5.318	10	26	97	5q21.3	MAN2A1, MANA2		Mannosidase, alpha, class 2A, member 1	154582	REa, A			
5.319	5	27	93	5q22.2	SRP19		Signal recognition particle 19kD	182175	REn	within 100kb of APC		
5.320	12	4	90	5q22.1	CAMK4		Ca(2+)-calmodulin-dependent protein kinase type IV of brain	114080	REa, A, H			18(Camk4)
5.321	10	23	15	5q21.1	C5orf30		Chromosome 5 open reading frame 30	616608	REc			
5.322	12	18	07	5q21.1	HISPPD1, PPIP5K2, VIP2, KIAA0433		Histidine acid phosphatase domain-containing protein 1	611648	R, REc			
5.323	3	31	09	5q15	RGMB, DRAGON		RGM domain family, member B	612687	R, REc			
5.324	6	13	12	5q21.1	SLCO4C1, OATP4C1		Solute carrier organic anion transporter family, member 4C1	609013	REc			
5.325	4	20	10	5q21.1	SLCO6A1, GST		Solute carrier organic anion transporter family, member 6A1	613365	REc			
5.326	8	9	01	5q22.3	KCNN2, SK2		Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2	605879	REc			
5.327	9	26	17	5q21.3	EFNA5, EPLG7, LERK7		Ephrin A5	601535	REc			
5.328	9	9	08	5q21.3	FBXL17, FBL17, FBX13, FBXO13		F-box and leucine-rich repeat protein 17	609083	REc			17(Fbxl17)
5.329	8	18	04	5q23.1	FTMT		Ferritin, mitochondrial	608847	REc			
5.330	3	22	06	5q22.1	WDR36, TAWDRP, GLC1G		WD repeat-containing protein 36	609669	REc		Glaucoma 1, open angle, G, 609887 (3)	
5.331	11	17	14	5q21.3-q33.2	MDBS2		Macular dystrophy, butterfly-shaped pigmentary, 2	608970	Fd	between D5S433 and D5S410	Macular dystrophy, butterfly-shaped pigmentary, 2 (2)	
5.332	7	8	10	5q22	EOE2		Esophagitis, eosinophilic, 2	613412	Fd	association with rs3806932	{Esophagitis, eosinophilic, 2} (2)	
5.333	6	28	02	5q22.1	STARD4		Start domain-containing protein 4	607049	REc			
5.334	1	22	07	5q22.2	TSSK1, STK22D		Testis-specific serine/threonine kinase 1	610709	REc	pseudogene on chr22		16(Tssk1)
5.335	7	10	08	5q22.1-q22.2	EPB41L4A, EPB41L4, NBL4		Erythrocyte membrane protein band 4.1-like 4A	612141	A			
5.336	9	28	96	5q22.2	ZRSR1, U2AF1RS1		Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 1	601079	A			11(U2af1rs1)
5.337	8	9	99	5q22.3	CDO1		Cysteine dioxygenase, type 1	603943	Psh, A			18(Cdo1)
5.338	3	22	06	5q22.2	REEP5, D5S346, DP1, C5orf18		Receptor expression-enhancing protein 5	125265	REn			
5.339	8	31	09	5q22.1	C5orf13, P311, PTZ17		P311 protein	607332	R, REc			
5.340	9	9	08	5q22.1	TSLP		Thymic stromal lymphopoietin	607003	R			18(Tslp)
5.341	10	30	06	5q22.1-q32	GLC1M		Glaucoma 1, open angle, M	610535	Fd	between D5S2051 and D5S2090	Glaucoma 1, open angle, M (2)	
5.342	8	7	15	5q22.1	SLC25A46, HMSN6B		Solute carrier family 25, member 46	610826	REc		Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	8(Slc25a46)
5.343	11	21	14	5q22.2	APC, GS, FPC, BTPS2		Adenomatous polyposis coli	611731	D, Fd, REn	150kb distal to MCC	Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic, 613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3); Gardner syndrome, 175100 (3)	18(Min, Apc)
5.344	11	13	13	5q22.3	PGGT1B		Protein geranylgeranyltransferase type I, beta subunit	602031	REc			
5.345	8	17	17	5q22.3	TRIM36, RBCC728, ANPH		Tripartite motif-containing protein 36	609317	R, REc	mutation identified in 1 ANPH patient	?Anencephaly, 206500 (3)	
5.346	12	22	17	5q35.3	ADAMTS2, NPI, EDSDERMS		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)	604539	REa, H		Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3)	11(Adamts2)
5.347	3	16	99	5q31.1	CAMLG		Calcium-modulating cyclophilin ligand	601118	A			13(Camlg)
5.348	10	28	99	5q23.2	CSNK1G3		Casein kinase I, gamma-3	604253	R, A			
5.349	5	19	06	5q31.3	HBEGF, DTR, DTSF, HEGFL		Heparin-binding EGF-like growth factor (diphtheria toxin receptor)	126150	S, M		{Diphtheria, susceptibility to} (1)	18(Hegfl)
5.350	5	15	01	5q23.2	SNX2		Sorting nexin 2	605929	R			
5.351	12	4	14	5q23.3	FBN2, CCA, EOMD		Fibrillin-2	612570	Fd, A		Contractural arachnodactyly, congenital, 121050 (3); Macular degeneration, early-onset, 616118 (3)	18(Fbn2)
5.352	9	13	11	5q11.2	ITGA2, CD49B, BR, BDPLT9		Integrin, alpha-2 (CD49B; alpha-2 subunit of VLA-2 receptor; platelet antigen Br)	192974	S, Psh, A		?Glycoprotein Ia deficiency, 614200 (1)	
5.353	11	29	00	5q31.1	NEUROG1, NEUROD3		Neurogenin 1	601726	A			13(Neurod3)
5.354	6	15	99	5q31.2	NME5, NM23H5		Nonmetastatic cells 5, protein expressed in (nonmetastatic protein 23, homolog 5)	603575	R			
5.355	7	11	93	5q31.1	PPP2CA		Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform	176915	REa, A			
5.356	10	28	96	5q31.1	UBE2B, RAD6B		Ubiquitin-conjugating enzyme E2B (RAD6 homolog)	179095	A		?Male infertility (1)	
5.357	6	4	99	5q31.2	NRG2		Neuregulin 2	603818	R, REc			
5.358	8	18	98	5q33.3	FABP6, ILLBP		Fatty acid-binding protein 6, ileal (gastrotropin)	600422	H, REa			11(Illbp)
5.359	5	5	09	5q23-q35	SCZD1		Schizophrenia susceptibility locus, chromosome 5-related	181510	Fd	max lod at D5S820	{Schizophrenia}, 181500 (2)	
5.360	2	1	11	5q22.3-q23.1	AP3S1, CLAPS3		Adaptor-related protein complex 3, sigma 1 subunit	601507	REc	previously assigned to chr. 12 by FISH		
5.361	12	22	15	5q23.1	COMMD10		COMM domain-containing protein 10	616704	REc			
5.362	5	8	13	5q23.1	HSD17B4, PRLTS1		Hydroxysteroid (17-beta) dehydrogenase 4	601860	A		D-bifunctional protein deficiency, 261515 (3); Perrault syndrome 1, 233400 (3)	
5.363	6	9	06	5q23.1	LVRN		Laeverin	610046	R, REc			
5.364	8	18	14	5q23.1	PRR16, LARGEN		Proline-rich protein 16	615931	REc			
5.365	4	21	15	5q23.1	SEMA6A		Semaphorin 6A	605885	REc			
5.366	3	14	07	5q23.1	SRFBP1, P49		Serum response factor binding protein 1	610479	R, REc			
5.367	12	8	03	5q22.3	TIRP, TRAM		Toll/interleukin-1 receptor domain-containing protein	608321	REc			
5.368	6	30	08	5q23.1	TNFAIP8, SCCS2		Tumor necrosis factor-alpha-induced protein 8	612111	R, REc			
5.369	3	15	10	5q23.2	SNCAIP		Synuclein-alpha-interacting protein (synphilin 1)	603779	R			
5.370	11	7	17	5q23.2	CEP120, CCDC100, SRTD13, JBTS31		Centrosomal protein, 120kD	613446	REc		Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3); Joubert syndrome 31, 617761 (3)	
5.371	11	11	13	5q23.2	LMNB1, ADLD		Lamin B1	150340	H, A, Fd, REc		Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	18(Lmnb)
5.372	6	7	10	5q23.2	MARCH3		Membrane-associated RING-CH finger protein 3	613333	REc			
5.373	5	4	12	5q23.2	MEGF10, KIAA1780, EMARDD		Multiple epidermal growth factor-like domains 10	612453	REc		Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	
5.374	8	31	09	5q23.2	PPIC		Peptidyl-prolyl isomerase C	123842	R, REc			
5.375	7	22	16	5q23.2	PRDM6, PRISM, PDA3		PR domain-containing protein 6	616982	REc		Patent ductus arteriosus 3, 617039 (3)	
5.376	3	31	15	5q23.2	RNUXA, PHAX		RNA, U small nuclear, export adaptor	604924	REc			
5.377	11	30	06	5q31.1	FNIP1, KIAA1961		Folliculin-interacting protein 1	610594	REc			
5.378	3	3	16	5q23.3-q31.1	LYRM7, MZM1L, MC3DN8		LYR motif-containing protein 7	615831	REc		Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	
5.379	11	20	95	5q23.3	SLC12A2, NKCC1		Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840	A			
5.380	2	27	01	5q31.3	RNF14, ARA54		RING finger protein-14	605675	REa, R			
5.381	10	25	16	5q23.1	LOX, AAT10		Lysyl oxidase	153455	REa, A		Aortic aneurysm, familial thoracic 10, 617168 (3)	18(Lox)
5.382	9	18	08	5q31.1	ACSL6, FACL6, ACS2		Acyl-CoA synthetase long-chain family member 6	604443	Ch		Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)	
5.383	8	31	12	5q23.3	ADAMTS19		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 19	607513	REc			
5.384	5	19	15	5q31.1	AFF4, AF5Q31, CHOPS		AF4/FMR2 family, member 4	604417	Ch		CHOPS syndrome, 616368 (3)	
5.385	3	26	07	5q23.2	ALDH7A1, ATQ1, EPD, PDE		Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)	107323	A, Fd		Epilepsy, pyridoxine-dependent, 266100 (3)	18(Atq1)
5.386	8	31	09	5q31.3	APBB3, FE65L2		Amyloid beta (A4) precursor protein-binding, family B, member 3	602711	R, REc			
5.387	8	27	15	5q31.3	ARHGAP26, GRAF		RHO GTPase-activating protein 26	605370	Ch, A		Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	
5.388	3	22	93	5q31.2	CDC25C		Cell division cycle 25C	157680	A, REn			
5.389	2	16	04	5q31.1	CDKL3, NKIAMRE		Cyclin-dependent kinase-like 3	608459	A			
5.390	4	13	10	5q23.3	CHSY3, CSS3		Chondroitin sulfate synthase 3	609963	REc			
5.391	4	8	16	5q31.2	CTNNA1, MDPT2		Catenin (cadherin-associated protein), alpha 1, 102kD	116805	A, REa		Macular dystrophy, patterned, 2, 608970 (3)	18(Catna1)
5.392	8	28	02	5q31.1	CXCL14, SCYB14, BRAK		Chemokine, C-X-C motif, ligand 14	604186	REc			
5.393	11	13	15	5q31.3	DIAPH1, DFNA1, LFHL1, SCBMS		Diaphanous, Drosophila, homolog of, 1	602121	Fd, REc		Deafness, autosomal dominant 1, 124900 (3); Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	
5.394	2	20	14	5q31	DFNA54		Deafness, autosomal dominant 54	615649	Fd	between D5S1972 and D5S410	Deafness, autosomal dominant 54 (2)	
5.395	4	29	14	5q31.2	ECSCR, ECSM2, ARIA		Endothelial cell surface-expressed chemotaxis and apoptosis regulator	615736	A, REc			
5.396	6	10	94	5q31.3	FGF1, FGFA		Fibroblast growth factor-1 (acidic)	131220	REa, A, D			
5.397	3	2	01	5q31.2	GFRA3		GDNF family receptor alpha-3	605710	A			
5.398	2	19	10	5q31.3	GNPDA1, GNP1, GNPI, KIAA0060		Glucosamine 6-phosphate deaminase 1	601798	A			
5.399	8	15	00	5q31.3	HDAC3		Histone deacetylase 3	605166	A			
5.400	10	11	05	5q31.2	HNRPA0		Heterogeneous nuclear ribonucleoprotein A0	609409	REc			
5.401	1	31	02	5q31	IBD5		Inflammatory bowel disease 5	606348	Fd		{Inflammatory bowel disease 5} (2)	
5.402	10	30	03	5q31.1	IL13, ALRH, BHR1		Interleukin-13	147683	REn, Fd		{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis, susceptibility to}, 607154 (3)	
5.403	10	24	11	5q31.2	KDM3B, C5orf7, KIAA1082, JMJD1B		Lysine-specific demethylase 3B	609373	R, REc			
5.404	12	29	00	5q31.1	KIF3A		Kinesin family member 3A	604683	R			
5.405	3	12	03	5q31.2	KIF20A, RAB6KIFL		Kinesin family member 20A	605664	REc			
5.406	2	27	12	5q31.2	KLHL3, PHA2D		Kelch-like 3	605775	REc		Pseudohypoaldosteronism, type IID, 614495 (3)	
5.407	10	14	98	5q31.1	MADH5, SMAD5		Mothers against decapentaplegic, Drosophila, homolog of, 5	603110	REa, REc			
5.408	7	17	14	5q35.1	NEURL1B, NEUR2		Neuralized E3 ubiquitin protein ligase 1B	615893	REc			17(Neurl1b)
5.409	1	31	07	5q33.1	MYOZ3, FRP3		Myozenin 3	610735	REc			
5.410	2	18	98	5q31.2	NPY6R, PP2		Neuropeptide Y receptor Y6	601770	A, H	?nonfunctional pseudogene		18(Npy6r)
5.411	9	5	14	5q31.3	NR3C1, GCR, GRL, GCRST		Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	138040	S, REa, Fd, H, A, D, REn		Glucocorticoid resistance, 615962 (3)	18(Grl1)
5.412	12	6	16	5q31.1	P4HA2, MYP25		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2	600608	REc		Myopia 25, autosomal dominant, 617238 (3)	
5.413	5	23	18	5q31.3	PCDH12, VECAD2, PCDH12		Protocadherin 12 (cadherin, vascular endothelial, 2)	605622	REc		Microcephaly, seizures, spasticity, and brain calcification, 251280 (3)	
5.414	5	24	00	5q31	PCDHA@		Protocadherin-alpha gene cluster	604966	REc			
5.415	10	2	01	5q31.3	PCDHA1		Protocadherin-alpha 1	606307	REc			
5.416	10	2	01	5q31.3	PCDHA2		Protocadherin-alpha 2	606308	REc			
5.417	10	1	01	5q31.3	PCDHA3		Protocadherin-alpha 3	606309	REc			
5.418	10	2	01	5q31.3	PCDHA4		Protocadherin-alpha 4	606310	REc			
5.419	10	2	01	5q31.3	PCDHA5		Protocadherin-alpha 5	606311	REc			
5.420	10	2	01	5q31.3	PCDHA6		Protocadherin-alpha 6	606312	REc			
5.421	10	2	01	5q31.3	PCDHA7		Protocadherin-alpha 7	606313	REc			
5.422	10	2	01	5q31.3	PCDHA8		Protocadherin-alpha 8	606314	REc			
5.423	10	2	01	5q31.3	PCDHA9		Protocadherin-alpha 9	606315	REc			
5.424	10	2	01	5q31.3	PCDHA10		Protocadherin-alpha 10	606316	REc			
5.425	10	2	01	5q31.3	PCDHA11		Protocadherin-alpha 11	606317	REc			
5.426	10	2	01	5q31.3	PCDHA12		Protocadherin-alpha 12	606318	REc			
5.427	10	2	01	5q31.3	PCDHA13		Protocadherin-alpha 13	606319	REc			
5.428	10	2	01	5q31.3	PCDHAC1		Protocadherin-alpha, subfamily C, member 1	606320	REc			
5.429	10	2	01	5q31.3	PCDHAC2		Protocadherin-alpha, subfamily C, member 2	606321	REc			
5.430	5	24	00	5q31	PCDHB@		Protocadherin-beta gene cluster	604967	REc			
5.431	10	2	01	5q31.3	PCDHB1		Protocadherin-beta 1	606327	REc			
5.432	10	2	01	5q31.3	PCDHB2		Protocadherin-beta 2	606328	REc			
5.433	10	2	01	5q31.3	PCDHB3		Protocadherin-beta 3	606329	REc			
5.434	10	2	01	5q31.3	PCDHB4		Protocadherin-beta 4	606330	REc			
5.435	10	2	01	5q31.3	PCDHB5		Protocadherin-beta 5	606331	REc			
5.436	10	2	01	5q31.3	PCDHB6		Protocadherin-beta 6	606332	REc			
5.437	9	13	17	6p21.1	OARD1, C6orf130		O-acyl-ADP-ribose deacylase 1	614393	REc			
5.438	10	2	01	5q31.3	PCDHB7		Protocadherin-beta 7	606333	REc			
5.439	10	2	01	5q31.3	PCDHB8		Protocadherin-beta 8	606334	REc			
5.440	10	2	01	5q31.3	PCDHB9		Protocadherin-beta 9	606335	REc			
5.441	10	2	01	5q31.3	PCHB10		Protocadherin-beta 10	606336	REc			
5.442	10	2	01	5q31.3	PCDHB11		Protocadherin-beta 11	606337	REc			
5.443	10	2	01	5q31.3	PCDHB12		Protocadherin-beta 12	606338	REc			
5.444	10	2	01	5q31.3	PCDHB13		Protocadherin-beta 13	606339	REc			
5.445	10	2	01	5q31.3	PCDHB14		Protocadherin-beta 14	606340	REc			
5.446	10	2	01	5q31.3	PCDHB15		Protocadherin-beta 15	606341	REc			
5.447	10	2	01	5q31.3	PCDHB16		Protocadherin-beta 16	606345	REc			
5.448	5	24	00	5q31	PCDHG		Protocadherin-gamma gene cluster	604968	REc			
5.449	10	2	01	5q31.3	PCDHGA1		Protocadherin-gamma, subfamily A, member 1	606288	REc			
5.450	10	2	01	5q31.3	PCDHGA2		Protocadherin-gamma, subfamily A, member 2	606289	REc			
5.451	10	2	01	5q31.3	PCDHGA3		Protocadherin-gamma, subfamily A, member 3	606290	REc			
5.452	10	2	01	5q31.3	PCDHGA4		Protocadherin-gamma, subfamily A, member 4	606291	REc			
5.453	10	2	01	5q31.3	PCDHGA5		Protocadherin-gamma, subfamily A, member 5	606292	REc			
5.454	10	2	01	5q31.3	PCDHGA6		Protocadherin-gamma, subfamily A, member 6	606293	REc			
5.455	10	2	01	5q31.3	PCDHGA7		Protocadherin-gamma, subfamily A, member 7	606294	REc			
5.456	10	2	01	5q31.3	PCDHGA8		Protocadherin-gamma, subfamily A, member 8	606295	REc			
5.457	10	2	01	5q31.3	PCDHGA9		Protocadherin-gamma, subfamily A, member 9	606296	REc			
5.458	10	2	01	5q31.3	PCDHGA10		Protocadherin-gamma, subfamily A, member 10	606297	REc			
5.459	10	2	01	5q31.3	PCDHGA11		Protocadherin-gamma, subfamily A, member 11	606298	REc			
5.460	10	2	01	5q31.3	PCDHGA12		Protocadherin-gamma, subfamily A, member 12	603059	REc			
5.461	10	2	01	5q31.3	PCDHGB1		Protocadherin-gamma, subfamily B, member 1	606299	REc			
5.462	10	2	01	5q31.3	PCDHGB2		Protocadherin-gamma, subfamily B, member 2	606300	REc			
5.463	10	2	01	5q31.3	PCDHGB3		Protocadherin-gamma, subfamily B, member 3	606301	REc			
5.464	10	2	01	5q31.3	PCDHGB4		Protocadherin-gamma, subfamily B, member 4	603058	REc			
5.465	10	2	01	5q31.3	PCDHGB5		Protocadherin-gamma, subfamily B, member 5	606302	REc			
5.466	10	2	01	5q31.3	PCDHGB6		Protocadherin-gamma, subfamily B, member 6	606303	REc			
5.467	10	2	01	5q31.3	PCDHGB7		Protocadherin-gamma, subfamily B, member 7	606304	REc			
5.468	10	2	01	5q31.3	PCDHGC3		Protocadherin-gamma, subfamily C, member 3	603627	REc			
5.469	10	2	01	5q31.3	PCDHGC4		Protocadherin-gamma, subfamily C, member 4	606305	REc			
5.470	10	2	01	5q31.3	PCDHGC5		Protocadherin-gamma, subfamily C, member 5	606306	REc			
5.471	6	30	15	5q31	PDB4		Paget disease of bone 4	606263	Fd		Paget disease of bone 4 (2)	
5.472	7	9	06	5q31.3	PFDN1		Prefoldin 1	604897	R, REc			
5.473	11	1	12	5q31.1	PITX1, PTX1, BFT, POTX, CCF, LBNBG		Paired-like homeodomain transcription factor-1	602149	A		Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3); Liebenberg syndrome, 186550 (4)	13(Ptx1)
5.474	5	4	00	5q31.2	PKD2L2		Polycystin 2-like 2	604669	R, Psh			
5.475	7	13	98	5q32	POU4F3, BRN3C		POU domain, class 4, transcription factor-3	602460	REa, H		Deafness, autosomal dominant 15, 602459 (3)	18(pou4f3)
5.476	1	5	15	5q31.3	PURA, PUR1, MRD31		Purine-rich element binding protein A	600473	REa, A		Mental retardation, autosomal dominant 31, 616158 (3)	
5.477	10	12	09	5q31.1	RAD50, NBSLD		RAD50, S. cerevisiae, homolog of	604040	REc, REa		Nijmegen breakage syndrome-like disorder, 613078 (3)	
5.478	2	10	14	5q31.2	REEP2, C5orf19, SPG72		Receptor expression-enhancing protein 2	609347	R, REc	mutation identified in 1 family each SPG72 AR and AD	?Spastic paraplegia 72, autosomal recessive, 615625 (3); ?Spastic paraplegia 72, autosomal dominant, 615625 (3)	
5.479	5	6	13	5q31	RLS8		Restless legs syndrome, susceptibility to, 8	615197	Fd		{Restless legs syndrome 8} (2)	
5.480	12	7	05	5q31.2	SIL1, BAP, MSS		Sil1, S. cerevisiae, homolog of	608005	R, REc, Fd		Marinesco-Sjogren syndrome, 248800 (3)	
5.481	7	7	14	5q31.1	SKP1, SKP1A, TCEB1L, OCP2		S-phase kinase-associated protein 1 (p19A)	601434	A	pseudogene on chr.7		
5.482	4	7	09	5q31.1	SLC22A4, OCTN1		Solute carrier family 22 (organic cation transporter), member 4	604190	R		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
5.483	10	30	03	5q31.3	SLC25A2, ORNT2		Solute carrier family 25 (mitochondrial carrier, ornithine transporter), member 2	608157	R			
5.484	8	9	99	5q31.2	SPOCK		Testican	602264	A, REc	previously mapped to chr.21		
5.485	12	4	01	5q31.3	TAF7, TAF2F, TAFII55		TAF7 RNA polymerase II, TATA box-binding protein-associated factor, 55kD	600573	REc			18(Taf2f)
5.486	1	30	02	5q32	TCERG1, TAF2S, CA150		Transcription elongation regulator 1 (transcription factor CA150)	605409	R			18(Ca150)
5.487	1	19	07	5q31.1	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD		Transforming growth factor, beta-induced, 68kD	601692	REc, Fd		Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy, lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)	
5.488	09	25	18	5q31.2	MYOT, TTOD, MFM3		Myotilin (titin immunoglobulin domain protein)	604103	R		Myopathy, myofibrillar, 3, 609200 (3); Myopathy, spheroid body, 182920 (3)	
5.489	2	4	00	5q31.1	VDAC1		Voltage-dependent anion channel 1	604492	A			11(Vdac1)
5.490	4	1	09	5q31.3	VTRNA1-1, HVG1, VAULTRC1		Vault RNA 1-1	612695	REc			
5.491	3	31	09	5q31.3	VTRNA1-2, HVG2, VAULTRC2		Vault RNA 1-2	612696	REc			
5.492	4	1	09	5q31.3	VTRNA1-3, HVG3, VAULTRC3		Vault RNA 1-3	612697	REc			
5.493	12	17	12	5q31.1	VTRNA2-1, NC886, CBL3, VTRNA2		Vault RNA 2-1	614938	REn			
5.494	8	28	01	5q32	SLC6A7, PROT		Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	606205	REa, A			18(Slc6a7)
5.495	10	30	03	5q31-q33	AITD2		Autoimmune thyroid disease, susceptibility to, 2	608174	Fd		{Autoimmune thyroid disease, susceptibility to, 2} (2)	
5.496	10	12	09	5q31-q33	ATOD6		Dermatitis, atopic, 6	605845	Fd	between D5S436 and D5S643	{Dermatitis, atopic, susceptibility to, 6} (2)	
5.497	9	14	95	5q32	CDX1		Caudal type homeo box transcription factor 1	600746	REc, H, REn	100kb distal to CSF1R		18(Cdx1)
5.498	3	17	06	5q31-q33	CELIAC2		Celiac disease, susceptibility to, 2	609754	Fd		{Celiac disease, susceptibility to, 2} (2)	
5.499	9	9	08	5q33.2	CNOT8, CALIF, POP2		CCR4-NOT transcription complex, subunit 8	603731	REc			
5.500	10	26	97	5q31-q33	EOS		Eosinophilia, familial	131400	Fd		Eosinophilia, familial (2)	
5.501	6	9	98	5q32	HTR4		5-hydroxytryptamine (serotonin) receptor-4	602164	A			
5.502	1	25	05	5q31-q33	PFBI		Plasmodium falciparum blood infection levels	248310	Fd		{Malaria, intensity of infection} (2)	
5.503	12	29	99	5q32	PPP2R2B		Protein phosphatase 2, regulatory subunit B, beta	604325	R, REc		Spinocerebellar ataxia 12, 604326 (3)	
5.504	7	22	09	5q31.1	SEPT8, KIAA0202		Septin 8	608418	REc			11(Sept8)
5.505	10	11	02	5q33.1	SLC36A1, LYAAT1, PAT1		Solute carrier family 36 (proton/amino acid symporter), member 1 (lysosomal amino acid transporter 1)	606561	REc			
5.506	9	30	99	5q31-q33	SM1		Schistosoma mansoni infection, susceptibility/resistance to	181460	Fd		{Schistosoma mansoni infection, susceptibility/resistance to} (2)	
5.507	4	4	02	5q32	SCGB3A2, UGRP1		Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)	606531	H, A		{Asthma, susceptibility to}, 600807 (3)	18(Ugrp1)
5.508	11	15	05	5q31.1	C5orf20, DCNP1		Dendritic cell nuclear protein 1	609710	REc			
5.509	3	28	11	5q31.1	CATSPER3, CACRC		Cation channel, sperm-associated, 3	609120	REc			13(Catsper3)
5.510	7	11	93	5q31.3	CD14		CD14 antigen	158120	REa, A			18(Cd14)
5.511	6	15	99	5q31.2	CDC23, APC8		Cell division cycle 23 (anaphase-promoting complex 8)	603462	REc, A			
5.512	7	11	93	5q31.1	CSF2, GMCSF		Colony-stimulating factor-2 (granulocyte-macrophage)	138960	REa, A, RE, Fd	order: cen-CSF2-CSF1-FMS-qter		11(Csfgm)
5.513	1	24	18	5q31.1	DDX46, PRP5, KIAA0801		DEAD box helicase 46	617848	R, REc			
5.514	7	11	93	5q31.2	EGR1		Early growth response-1	128990	REa, A			18(Egr1)
5.515	10	24	00	5q31.2	ETF1, RF1, ERF1		Eukaryotic translation termination factor-1	600285	R			
5.516	6	13	12	5q31.1	FBXL21, FBL21, FBXL3B, FBL3B		F-box and leucine-rich repeat protein 21	609087	REc			
5.517	6	13	18	5q31.1	GDF9, POF14		Growth/differentiation factor 9	601918	REc	mutation identified in 1 patient	?Premature ovarian failure 14, 618014 (3)	
5.518	7	26	95	5q31.1	IGES		Immunoglobulin E concentration, serum	147061	Fd		{?Allergy and asthma susceptibility} (2)	
5.519	7	11	93	5q31.1	IL3		Interleukin-3	147740	REa, A, H, RE, D, Fd	9kb from CSF2; order: cen-5'IL3-5'CF2-qter		11(Il3)
5.520	7	11	93	5q31.1	IL4		Interleukin-4	147780	REa, A, RE			11(Il4)
5.521	3	22	93	5q31.1	IL5		Interleukin-5	147850	Ch, A, RE, REn	< 310kb from IL4		11(Il5)
5.522	7	11	93	5q31.1	IL9		Interleukin-9	146931	REa, A			13(Il9)
5.523	5	13	10	5q31.1	IRF1, MAR		Interferon regulatory factor-1	147575	Fd, REa, A, REn, D, Ch		Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia, acute (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3)	11(Irf1)
5.524	4	6	15	5q31.1	LEAP2		Liver-expressed antimicrobial peptide 2	611373	REc, R, H			11(Leap2)
5.525	2	24	15	5q31.1	MEIKIN		Meiotic kinetochore factor	616232	REc			
5.526	5	26	13	5q31.1	PHF15, JADE2, KIAA0239		PHD finger protein 15	610515	R, Psh, REc			11(Phf15)
5.527	3	14	07	5q31.1	RAPGEF6, RAGEF2, PDZGEF2		RAP guanine nucleotide exchange factor 6	610499	REc			
5.528	9	2	03	5q31.1	RIL		LIM domain protein ril	603422	REc		{Osteoporosis, susceptibility to}, 166710 (3)	
5.529	4	2	09	5q31.1	SAR1B, CMRD, SARA2, ANDD		Sar1a, S. cerevisiae, homolog 2	607690	REc		Chylomicron retention disease, 246700 (3)	
5.530	3	13	15	5q31.1	SEC24A		Sec24-related gene family, member A	607183	R, REc			
5.531	5	23	13	5q31.1	SHROOM1, APXL2, KIAA1960		SHROOM family member 1	611179	REc			
5.532	10	27	04	5q31.1	SLC22A5, OCTN2, CDSP, SCD		Solute carrier, family 22 (organic cation transporter), member 5	603377	Fd, H		Carnitine deficiency, systemic primary, 212140 (3)	11(jvs)
5.533	12	30	14	5q31.1	SLC25A48		Solute carrier family 25, member 48	616150	REc			
5.534	9	5	91	5q31.1	TCF7		Transcription factor-7, T-cell specific	189908	REa, A	originally called TCF-1		11(Tcf7)
5.535	11	16	17	5q31.1	TXNDC15, C5orf14, BUG		Thioredoxin domain-containing protein 15	617778	REc			
5.536	4	8	13	5q31.1	UQCRQ, QPC, MC3DN4		Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD	612080	R, REc		Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	
5.537	4	23	15	5q31.1	WSPAR, lncTCF7		WNT signaling pathway activating noncoding RNA	616333	REc			
5.538	3	26	96	5q31.1	HSPA4		Heat-shock 70kD protein-4	601113	A			
5.539	2	9	14	5q31.1-q32	DFNA52, DFNA42		Deafness, autosomal dominant 52	607683	Fd	max lod at D5S2017	Deafness, autosomal dominant 52 (2)	
5.540	10	14	98	5q31.1	LECT2		Leukocyte cell-derived chemotaxin 2	602882	A, REa			13(Lect2)
5.541	1	31	01	5q31.1-q33.1	IDDM18		Insulin-dependent diabetes mellitus-18	605598	Fd	close to IL12B	{Diabetes mellitus, insulin-dependent, 18} (2)	
5.542	2	26	09	5q31.1-q33.1	PSORS11		Psoriasis susceptibility 11	612599	Fd	associated with rs10045431	{Psoriasis susceptibility 11} (2)	
5.543	4	7	94	5q34	GABRA6		Gamma-aminobutyric acid (GABA) A receptor, alpha-6	137143	REa, Fd, REc			
5.544	9	27	17	5q31.2	BRD8, SMAP		Bromodomain-containing protein 8	602848	REc			
5.545	12	6	16	5q31.2	FAM53C, C5orf6		Family with sequence similarity 53, member C	609372	REc			
5.546	12	6	16	5q31.2	FAM13B, C5orf5		Family with sequence similarity 13, member B	609371	REc			18(C5orf5)
5.547	3	17	16	5q31.2	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4		Heat-shock 70kD protein-9 (mortalin)	600548	A, REc		Anemia, sideroblastic, 4, 182170 (3); Even-plus syndrome, 616854 (3)	18,X(mot2)
5.548	4	29	14	5q31.2	MATR3, MPD2, ALS21		Matrin 3	164015	R, REc		Amyotrophic lateral sclerosis 21, 606070 (3)	
5.549	9	23	08	5q31.3	NDUFA2		NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (8kD, B8)	602137	A, R		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
5.550	10	17	12	5q23.3	HINT1, PRKCNH1, NMAN		Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1)	601314	A		Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	
5.551	3	26	07	5q31.2	LRRTM2, KIAA0416		Leucine-rich repeat transmembrane protein 2	610868	REc, H			18(Lrrtm2)
5.552	4	29	14	5q31.2	MZB1, PACAP, MGC29506		Marginal zone B and B1 cell-specific protein	609447	REc			
5.553	8	20	07	5q31.2	PAIP2, PAIP2A		Polyadenylate-binding protein-interacting protein 2	605604	R, REc			
5.554	1	20	06	5q31.1	PCBD2, DCOH2, DCOHM		Pterin-4-alpha-carbinolamine dehydratase 2	609836	REc			
5.555	3	23	09	5q31.1	TIFAB		TRAF-interacting protein with forkhead-associated domain, family member B	612663	REc			13(Tifab)
5.556	8	12	14	5q31.2	TMEM173, STING, MPYS, SAVI		Transmembrane protein 173	612374	REc		STING-associated vasculopathy, infantile-onset, 615934 (3)	
5.557	6	13	12	5q31.2	UBE2D2, UBCH5B, UBC4		Ubiquitin-conjugating enzyme E2D 2	602962	REc			
5.558	8	20	14	5q31.2	WNT8A		Wingless-type MMTV integration site family, member 8A	606360	REc			
5.559	8	31	09	5q31.2	SLC23A1, SVCT1		Solute carrier family 23 (nucleobase transporter), member 1 (sodium-dependent vitamin C transporter 1)	603790	R, REn, H	opposite orientation to MATR3		18(Slc23a1)
5.560	4	15	11	5q32	PDE6A, PDEA, RP43		Phosphodiesterase-6A, cGMP-specific, rod, alpha	180071	REa, REn, A		Retinitis pigmentosa 43, 613810 (3)	18(Pde6a)
5.561	10	30	06	5q31.3	ANKHD1, MASK, KIAA1085, VBARP		Ankyrin repeat and KH domain-containing protein 1	610500	REc			
5.562	2	24	17	5q31.3	ARAP3, CENTD3		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	606647	R, REc			
5.563	5	12	09	5q31.2	CXXC5		CXXC finger protein 5	612752	REc			
5.564	5	25	05	5q31.3	DND1		Dead end, zebrafish, homolog of, 1	609385	REc			
5.565	7	6	17	5q31.3	FCHSD1, NWK2		FCH and double SH3 domains protein 1	617555	REc, H			18(Fchsd1)
5.566	11	3	15	5q31.3	HARS, USH3B, CMT2W		Histidyl-tRNA synthetase	142810	S, REc		Usher syndrome type 3B, 614504 (3); Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	
5.567	11	29	12	5q31.3	HARS2, HARSL, HARSR, HO3, PRLTS2		Histidyl-tRNA synthetase 2	600783	REc	mutation identified in 1 PRLTS2 family	?Perrault syndrome 2, 614926 (3)	
5.568	4	20	11	5q31.3	IK, RED		IK cytokine, downregulator of HLA II	600549	R, REc			
5.569	7	26	10	5q31.3	KCTD16, KIAA1317		Potassium channel tetramerization domain-containing 16	613423	R, REc			
5.570	4	29	14	5q31.3	KIAA0141, DELE		KIAA0141 gene	615741	REc			
5.571	6	10	08	5q31.3	NDFIP1, N4WBP5		NEDD4 family-interacting protein 1	612050	REc			
5.572	2	16	18	5q13.3	POC5, C5orf37		POC5 centriolar protein	617880	REc			
5.573	5	26	13	5q31.3	RELL2		Relt-like 2	611213	REc			
5.574	6	11	13	5q31.3	SPRY4, HH17		Sprouty, Drosophila, homolog of	607984	A		Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	
5.575	8	11	17	5q31.3	SPRY4IT1		SPRY4 intronic transcript 1, noncoding	617617	REc	in intron 2 of SPRY4		
5.576	8	31	09	5q31.3	SRA1		Steroid receptor RNA activator 1	603819	REc			
5.577	10	25	12	5q31.1	H2AFY, MH2A1		H2A histone family, member Y	610054	R			
5.578	12	22	10	5q31.3-q32	HHT3, ORW3		Hereditary hemorrhagic telangiectasia, type 3	601101	Fd		Telangiectasia, hereditary hemorrhagic, type 3 (2)	
5.579	8	6	15	5q33.1	SPARC, ON, OI17		Osteonectin (secreted protein, acidic, cysteine-rich)	182120	REa, A		Osteogenesis imperfecta, type XVII, 616507 (3)	11(Sparc)
5.580	11	23	09	5q33.1	GM2A		GM2 ganglioside activator protein	613109	S, REa, Psh, A	pseudogene on chr.3	GM2-gangliosidosis, AB variant, 272750 (3)	11(Gm2a)
5.581	4	2	16	5q32	ABLIM3, KIAA0843		Actin-binding LIM protein family, member 3	611305	R, REc			
5.582	5	19	06	5q32	ARSI		Arylsulfatase I	610009	REc			
5.583	3	1	00	5q33.1	ATOX1, HAH1		Antioxidant protein 1 (ATX, yeast, homolog of)	602270	A			
5.584	09	06	18	5q32	CAMK2A, KIAA0968, CAMKA, MRD53, MRT63		Calcium/calmodulin-dependent protein kinase II-alpha	114078	H, R, REc	mutation identified in 1 MRT63 family	Mental retardation, autosomal dominant 53, 617798 (3); ?Mental retardation, autosomal recessive 63, 618095 (3)	18(Camk2a)
5.585	6	10	94	5q33.1	CD74, DHLAG		CD74 antigen (invariant polypeptide of major histocompatibility class II antigen-associated)	142790	S, REb, REa, A			18(Ii)
5.586	1	9	13	5q32	CSF1R, FMS, HDLS		Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma)	164770	REa, A	FMS2 is 5' end	Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	18(Fim2)
5.587	1	13	11	5q32	CSNK1A1		Casein kinase-1, alpha-1 polypeptide	600505	REc	previously assigned to 13q13		
5.588	1	30	01	5q32	DPYSL3, ULIP, DRP3		Dihydropyrimidinase-like 3	601168	A			
5.589	6	13	18	5q33.1	GLRA1, STHE, HKPX1		Glycine receptor, alpha-1 polypeptide	138491	Fd, R, A		Hyperekplexia 1, 149400 (3)	11(spd)
5.590	7	7	14	5q32	GRXCR2, DFNB101		Glutaredoxin, cysteine-rich, 2	615762	REc	mutation identified in 1 DFNB101 family	?Deafness, autosomal recessive 101, 615837 (3)	18(Grxcr2)
5.591	3	23	06	5q31.3	HLA-HB1		Minor histocompatibility antigen HB-1	609961	REc			
5.592	3	27	13	5q33.3	ITK, EMT, LPFS1		T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase	186973	A		Lymphoproliferative syndrome 1, 613011 (3)	11(Itk)
5.593	5	23	13	5q32	JAKMIP2, JAMIP2, NECC1, KIAA0555		Janus kinase and microtubule-interacting protein 2	611197	REc, R			
5.594	9	23	14	5q32	LARS, LFIS, ILFS1		Leucyl-tRNA synthetase	151350	S, H, REc	mutation identified in 1 family	?Infantile liver failure syndrome 1, 615438 (3)	
5.595	10	13	15	5q32	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS		Platelet-derived growth factor receptor, beta polypeptide	173410	REa, A, REn	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	Myeloproliferative disorder with eosinophilia, 131440 (4); Basal ganglia calcification, idiopathic, 4, 615007 (3); Myofibromatosis, infantile, 1, 228550 (3); Premature aging syndrome, Penttinen type, 601812 (3); Kosaki overgrowth syndrome, 616592 (3)	18(Pdgfr)
5.596	5	13	10	5q33.1	RPS14, EMTB		Ribosomal protein S14	130620	S, REc		Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	
5.597	6	7	10	5q32	SH3RF2, HEPP1		SH3 domain-containing RING finger protein 2	613377	REc			
5.598	8	20	10	5q32	SH3TC2, KIAA1985, MNMN		SH3 domain and tetratricopeptide repeat domain 2	608206	REc		Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of the median nerve, mild, 613353 (3)	
5.599	11	22	13	5q33.1	SMIM3, NID67		Small integral membrane protein 3	608324	REc			
5.600	12	20	11	5q32	SPINK1, PSTI, PCTT, TATI, TCP		Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790	REb		Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)	
5.601	7	17	14	5q32	SPINK6		Serine peptidase inhibitor, KAZAL-type, 6	615868	REn			
5.602	5	6	13	5q32	SPINK13		Serine protease inhibitor, Kazal-type, 13	615205	REc			
5.603	7	31	17	5q32	SPINK5, LEKTI		Serine protease inhibitor, Kazal type, 5	605010	A, Fd		Netherton syndrome, 256500 (3)	
5.604	1	9	17	5q32	SPINK7, ECRG2		Serine peptidase inhibitor, Kazal-type, 7	617288	REc			
5.605	10	2	07	5q31.3	YIPF5, SMAP5, YIP1A		Yip1 domain family, member 5	611483	REc			
5.606	5	20	99	5q33.3	ADAM19, MLTNB		A disintegrin and metalloproteinase domain-19 (meltrin-beta, mouse, homolog of)	603640	R			11(Adam19)
5.607	11	16	17	5q33.1	FAT2, MEGF1, SCA45		Fat tumor suppressor, Drosophila, homolog of, 2	604269	R		Spinocerebellar ataxia 45, 617769 (3)	
5.608	8	28	01	5q35.1	GABRP		Gamma-aminobutyric acid receptor, pi	602729	REc			
5.609	6	15	99	5q31.3	PCDH1, PC42		Protocadherin 1 (cadherin-like 1)	603626	Psh			18(Pcdh1)
5.610	1	30	96	5q33.1	GPX3		Glutathione peroxidase-3, plasma	138321	REa, REn			
5.611	3	23	18	5q32	SLC26A2, DTD, DTDST, D5S1708, EDM4		Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	Fd, REn	distal to APC	Diastrophic dysplasia, 222600 (3); Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la Chapelle dysplasia, 256050 (3); Atelosteogenesis, type II, 256050 (3)	
5.612	1	31	11	5q32-q33	TCOF1, MFD1, TCS1		Treacle	606847	Ch, Fd	prox. to SPARC	Treacher Collins syndrome 1, 154500 (3)	18(Tcof1)
5.613	5	7	03	5q33.1	TNIP1, NAF1, KIAA0113		TNFAIP3-interacting protein 1	607714	REc			
5.614	3	5	98	5q33.3	TTC1, TPR1		Tetratricopeptide repeat domain-1	601963	REa			
5.615	6	13	95	5q33.2	MFAP3		Microfibrillar-associated protein-3	600491	REa			
5.616	12	4	14	5q33.1	NDST1, HSST, MRT46		N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase)	600853	REn		Mental retardation, autosomal recessive 46, 616116 (3)	
5.617	12	16	05	5q32	ADRB2		Adrenergic, beta-2-, receptor, surface	109690	S, REa, A, Fd, RE		{Asthma, nocturnal, susceptibility to}, 600807 (3); {Obesity, susceptibility to}, 601665 (3); Beta-2-adrenoreceptor agonist, reduced response to (3)	18(Adrb2)
5.618	2	1	90	5q33.1	ANXA6, CBP68		Annexin A6 (calcium-binding protein p68)	114070	REa, A, REn			
5.619	8	28	97	5q34	CCNG1		Cyclin G1	601578	A			11(Ccng1)
5.620	4	5	00	5q32	IL17B		Interleukin 17B	604627	R			
5.621	7	11	93	5q33.3	ADRA1B		Adrenergic, alpha-1B-, receptor	104220	REa, A, RE			11(Adra1)
5.622	3	1	94	5q33.2	GRIA1, GLUR1		Glutamate receptor, ionotropic, AMPA 1	138248	A, REa, R			11(Glur1)
5.623	2	28	08	5q33.2	MRPL22		Mitochondrial ribosomal protein L22	611835	R			
5.624	1	18	13	5q33.3	NIPAL4, ICHYN, ARCI6		NIPA-like domain-containing 4	609383	Fd, REc		Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	
5.625	4	17	06	5q32	PPARGC1B, PGC1B, PERC		Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta	608886	REc		{Obesity, variation in}, 601665 (3)	
5.626	9	3	99	5q33.3	PTTG1, EAP1, TUTR1		Pituitary tumor-transforming gene 1	604147	A, R			
5.627	09	27	18	5q33.2-q33.3	SGCD, SGD, LGMDR6, CMD1L		Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)	601411	REa, A, Fd	mutant in Syrian hamster cardiomyopathy	Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3); Cardiomyopathy, dilated, 1L, 606685 (3)	
5.628	12	29	06	5q35.3	F12, HAF, HAE3		Coagulation factor XII (Hageman factor)	610619	REa, A		Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III, 610618 (3)	
5.629	9	5	91	5q32	RPS20B		Ribosomal protein S20B	180464	REa	?pseudogene		
5.630	1	5	12	5q32	AFAP1L1		Actin filament-associated protein 1-like 1	614410	REc			
5.631	8	31	12	5q33.1	DCTN4, P62, DYN4		Dynactin 4	614758	REc			
5.632	12	24	13	5q32	FBXO38, FBX38, MOKA, HMN2D		F-box only protein 38	608533	REc		Neuronopathy, distal hereditary motor, type IID, 615575 (3)	18(Fbxo38)
5.633	9	2	11	5q33.1	G3BP1, G3BP		GTPase-activating protein SH3 domain-binding protein 1	608431	REc, R			
5.634	8	2	16	5q33.1	IRGM, LRG47, IFI1, IBD19		Immunity-related GTPase family, M	608212	REc		{Mycobacterium tuberculosis, protection against}, 607948 (3); {Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	
5.635	2	3	05	5q33.2	KIF4B		Kinesin family member 4B	609184	A			
5.636	3	23	09	5q32	MIR143, MIRN143		Micro RNA 143	612117	REc			
5.637	3	23	09	5q32	MIR145, MIRN145		Micro RNA 145	611795	REc			
5.638	3	23	09	5q32	MIR378, MIRN378		Micro RNA 378	611957	REc			
5.639	5	19	06	5q33.1	NMUR2, NMU2R, FM4		Neuromedin U receptor 2	605108	REc			
5.640	12	4	08	5q33.1	RBM22		RNA-binding motif protein 22	612430	REc			
5.641	4	20	10	5q33.1	SLC36A2, PAT2		Solute carrier family 36 (proton/amino acid symporter), member 2	608331	REc, H		Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	11(Slc36a2)
5.642	12	15	10	5q32	SPINK9, LEKTI2		Serine protease inhibitor, Kazal-type, 9	613511	REc			
5.643	3	22	07	5q33.1	SYNPO		Synaptopodin	608155	R, REc			
5.644	12	18	08	5q33.1	ZNF300		Zinc finger protein 300	612429	REc			
5.645	3	4	10	5q33.1-q35.2	FECD5, FCD3		Corneal dystrophy, Fuchs endothelial, 5	613269	Fd	flanked by D5S470 and D5S2108	Corneal dystrophy, Fuchs endothelial, 5 (2)	
5.646	1	26	97	5q35.1	LCP2, SLP76		Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD)	601603	Fd			
5.647	10	1	17	5q33.2	HAND1, EHAND		Heart- and neural crest derivatives-expressed 1	602406	REc			
5.648	1	27	04	5q33.2	GALNT10, GalNAcT10		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10	608043	R, REc			
5.649	8	31	09	5q33.2	GEMIN5		GEM-associated protein 5	607005	R, REc			
5.650	7	31	17	5q33.3	HAVCR1, HAVCR		Hepatitis A virus cellular receptor 1	606518	REc, H			
5.651	12	7	07	5q34	HMMR		Hyaluronan-mediated motility receptor (RHAMM)	600936	REa, H, REc		{Breast cancer, susceptibility to}, 114480 (3)	11(hmmr)
5.652	6	10	08	5q33.2	LARP1, LARP, KIAA0731		La ribonucleoprotein domain family, member 1	612059	REc	incorrectly mapped to chromosome 10		
5.653	8	19	13	5q33.2	SAP30L		SAP30-like protein	610398	REc			
5.654	1	30	02	5q33.3	TIM3		T-cell immunoglobulin- and mucin-domain-containing molecule	606652	REc			11(Tim3)
5.655	8	19	13	5q33.3	TIMED4, TIM4, SMUCKLER		T-cell immunoglobulin and mucin domains-containing protein 4	610096	REc, H			11(Tim4)
5.656	5	31	13	5q33.3	C5orf54, ZBED8, BUSTER3		Chromosome 5 open reading frame 54	615253	REc			
5.657	5	4	09	5q33.3	CLINT1, EPN4, EPNR, KIAA0171		Clathrin interactor 1 (epsin 4)	607265	R, Fd			
5.658	6	5	18	5q33.3	CYFIP2, EIEE65		Cytoplasmic FMRP interacting protein 2	606323	R, REc		Epileptic encephalopathy, early infantile, 65, 618008 (3)	
5.659	5	19	15	5q33.3	IL12B, NKSF2, IMD29		Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)	161561	R, REn, A, REc	between GLR1 and GABRA1	Immunodeficiency 29, mycobacteriosis, 614890 (3)	11(Il12b)
5.660	4	6	18	5q33.3	LSM11		Lsm11, U7 small nuclear RNA-associated protein	617910	REc			
5.661	8	31	09	5q33.3	MED7, CRSP9, CRSP33		Mediator complex subunit 7	605045	R, REc			
5.662	2	23	09	5q33.3	MIR146A, MIRN146A		Micro RNA 146A	610566	REc			
5.663	12	22	17	5q33.3	PWWP2A		PWWP domain-containing protein 2A	617823	REc			
5.664	7	2	18	5q33.3	SOX30		SRY-box 30	606698	REc			
5.665	2	7	06	5q33.3	UBLCP1		Ubiquitin-like domain-containing CTD phosphatase 1	609867	REc			
5.666	12	14	95	5q35.1	DUSP1, CL100, PTPN10		Dual specificity phosphatase-1	600714	A, REc			
5.667	8	10	98	5q33.3	EBF, OLF1		Early B-cell factor (olfactory neuronal transcription factor 1)	164343	REa, A			11(Ebf)
5.668	1	23	01	5q35.1	FGF18		Fibroblast growth factor-18	603726	R			
5.669	12	7	07	5q35.1	FOXI1, FKHL10, FREAC6		Forkhead box I1	601093	A	some patients have digenic mutations with SLC26A4	Enlarged vestibular aqueduct, 600791 (3)	
5.670	8	8	17	5q34	GABRG2, GEFSP3, CAE2, ECA2		Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	REn, R, Psh	in alpha/beta/gamma cluster	Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3)	
5.671	5	6	04	5q35.1	KCNMB1		Potassium large conductance calcium-activated channel, subfamily M, beta member 1	603951	Psh, A		{Hypertension, diastolic, resistance to}, 608622 (3)	
5.672	12	21	09	5q34	MIR103-1, MIRN103-1		Micro RNA 103-1	613187	REc			
5.673	1	29	16	5q34	MIR218-2		Micro RNA 218-2	616771	REn, REc	in intron of SLIT3		11(Mir218-2)
5.674	9	23	13	5q35.1	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2		NK2 homeobox-5 gene	600584	A, Psh, REc	near border with 5q35	Atrial septal defect 7, with or without AV conduction defects, 108900 (3); Tetralogy of Fallot, 187500 (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3); Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)	17(Csx)
5.675	1	3	02	5q35.1	RANBP17		RAN-binding protein 17	606141	Ch			
5.676	12	26	14	5q34	RARS, HLD9		Arginyl-tRNA synthetase	107820	S, REc		Leukodystrophy, hypomyelinating, 9, 616140 (3)	
5.677	2	5	15	5q34	TENM2, ODZ2, TNM2, KIAA1127		Teneurin transmembrane protein 2	610119	REc			
5.678	1	22	18	5q34	GABRB2, ICEE2		Gamma-aminobutyric acid (GABA) A receptor, beta-2	600232	Psh		Epileptic encephalopathy, infantile or early childhood, 2, 617829 (3)	
5.679	4	29	14	5q34	GABRA1, EJM5, ECA4, EIEE19		Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160	A, R, Fd, REn	in same 200kb as GABRG2	{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); {Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3); Epileptic encephalopathy, early infantile, 19, 615744 (3)	11(Gabra1)
5.680	6	15	99	5q35.3	GFPT2, GFAT2		Glutamine: fructose-6-phosphate amidotransferase 2	603865	R, H			11(Gfat2)
5.681	11	4	16	5q35.2	MSX2, CRS2, HOX8		msh, Drosophila, homeo box homolog of, 2	123101	Fd, REa, A		Craniosynostosis 2, 604757 (3); Parietal foramina 1, 168500 (3); Parietal foramina with cleidocranial dysplasia, 168550 (3)	
5.682	11	4	05	5q34-q35.2	NIDDM4		Diabetes mellitus, noninsulin-dependent, 4	608036	Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	
5.683	1	14	14	5q34	WWC1, KIBRA, KIAA0869, MEMRYQTL		WW, C2, and coiled-coil domain-containing 1	610533	REc		[Memory, enhanced, QTL], 615602 (3)	
5.684	8	28	01	5p13.3-p13.2	ADAMTS12		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 12	606184	REa, R			
5.685	8	28	01	5q35.3	BTNL3		Butyrophilin-like protein 3	606192	REa, R			
5.686	2	28	94	5q35.3	CANX		Calnexin	114217	REa, A			
5.687	10	23	87	5q35	CHR		Chromate resistance (sulfate transport)	118840	S			
5.688	2	25	15	5q35.3	CLK4		CDC-like kinase 4	607969	REc			
5.689	6	9	06	5q35.3	COL23A1		Collagen, type XXIII, alpha-1	610043	REc			11(Col23a1)
5.690	5	29	12	5q35.3	GRK6, GPRK6		G protein-coupled receptor kinase 6	600869	REa			
5.691	1	31	13	5q35.3	GRM6, MGLUR6, CSNB1B		Glutamate receptor, metabotropic, 6	604096	REa, A		Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	
5.692	7	1	11	5q35.3	LTC4S		Leukotriene C4 synthase	246530	A		Leukotriene C4 synthase deficiency, 614037 (1)	
5.693	2	23	09	5q35.3	MAML1		Mastermind, Drosophila, homolog of, 1	605424	R, REc			
5.694	11	20	98	5q35.3	MAPK9, PRKM9, JNK2		Mitogen-activated protein kinase 9	602896	A			
5.695	11	4	98	5q35.3	MGAT1, GLYT1		Mannosyl (alpha-1,3-)-glycoprotein beta-1,2, N-acetylglucosaminyltransferase	160995	REa, A			11(Glyt1)
5.696	3	8	00	5q35.3	MGAT4B		Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B	604561	A			
5.697	9	18	17	5q35.3	NSD1, ARA267, STO, SOTOS1		Nuclear receptor binding SET domain protein 1	606681	A	fusion gene with NUP98 in AML	Sotos syndrome 1, 117550 (3); Leukemia, acute myeloid, 601626 (1)	
5.698	8	27	15	5q35.1	NPM1		Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)	164040	Ch, A	fused with RARA in APL	Leukemia, acute myeloid, somatic, 601626 (3)	
5.699	7	9	06	5q34	PANK3		Pantothenate kinase 3	606161	REn			
5.700	3	25	02	5q35.3	SCGB3A1, HIN1		Secretoglobin, family 3A, member 1	606500	A			
5.701	5	25	17	5q35.3	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2		Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309	Psh, A, R, REc	mutation identified in 1 FRTS2 family	Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3); ?Fanconi renotubular syndrome 2, 613388 (3); Hypercalcemia, infantile, 2, 616963 (3)	13(Slc17a2)
5.702	6	15	99	5q34-q35	SLIT3, SLIL2, MEGF5		Slit, Drosophila, homolog of, 3	603745	R			
5.703	6	21	05	5q35.2	SNCB		Synuclein, beta	602569	A		Dementia, Lewy body, 127750 (3)	
5.704	11	23	16	5q35.3	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV		Sequestosome 1	601530	R, Fd		Paget disease of bone 3, 167250 (3); Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3); Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3); Myopathy, distal, with rimmed vacuoles, 617158 (3)	
5.705	6	5	08	5q35.1	UBTD2, DCUBP, MGC30022		Ubiquitin domain-containing protein 2	610174	REc			
5.706	2	25	08	5q35.2	UIMC1, RAP80		Ubiquitin interaction motif containing 1	609433	A			
5.707	8	20	07	5q35.1	ATP6V0E1, ATP6H		ATPase, H+ transporting, V0 subunit e1	603931	R, REc	previously mapped to Chr.2		
5.708	6	22	12	5q35.1	BNIP1, NIP1		BCL2/adenovirus E1B 19kD protein-interacting protein 1	603291	REc			
5.709	9	2	16	5q35.1	CREBRF, LRF, C5orf41		CREB3 recruitment factor	617109	REc			
5.710	6	23	15	5q35.1	DOCK2, IMD40		Dedicator of cytokinesis 2	603122	R, Psh, REc		Immunodeficiency 40, 616433 (3)	
5.711	8	24	92	5q35.2	DRD1		Dopamine receptor D1	126449	REa, A, Fd, REn, R	same 300kb fragment as GRL		
5.712	5	13	09	5q35.1	FBXW11, FBXW1B, BTRC2, BTRCP2		F-box and WD40 domain protein 11	605651	R, A			11(Fbxw11)
5.713	3	29	10	5q35.1	SH3PXD2B, TKS4, KIAA1295, FTHS		SH3 and PX domains-containing protein 2B	613293	REc		Frank-ter Haar syndrome, 249420 (3)	11(Sh3pxd2b)
5.714	4	2	16	5q35.1	SNORA74B		Small nucleolar RNA, H/ACA box, 74B	611331	REc	in intron 3 of ATP6V0E1		
5.715	6	3	15	5q35.1	SPDL1, CCDC99, SPINDLY		Spindly apparatus coiled-coil protein 1	616401	REc			
5.716	3	31	15	5q35.2	STC2, STCRP		Stanniocalcin 2	603665	REc			
5.717	6	22	99	5q35.1	STK10, LOK		Serine/threonine protein kinase-10	603919	A			11(Stk10)
5.718	7	15	02	5q35.1	TLX3, HOX11L2, RNX		T-cell leukemia, homeobox 3	604640	R, A	activated in T-cell ALL		11(Hox11l2)
5.719	2	20	03	5q35.2	FGFR4		Fibroblast growth factor receptor-4	134935	REa, A, R	distal to DRD1	{Cancer progression/metastasis} (3)	13(Fgfr4)
5.720	1	11	16	5q35.2	BOD1, FAM44B		Biorientation of chromosomes in cell division 1	616745	REc			
5.721	9	29	10	5q35.2	CLTB		Clathrin, light polypeptide (Lcb)	118970	REa, A, REc	previously mapped to chr. 4		
5.722	8	17	09	5q35.2	CPLX2, CPX2		Complexin 2	605033	R, REc			
5.723	5	9	18	5q35.1	ERGIC1, ERGIC32, KIAA1181, AMCN		Endoplasmic reticulum-golgi intermediate compartment protein 1	617946	REc	mutation identified in 1 AMCN family	?Arthrogryposis multiplex congenita, neurogenic type, 208100 (3)	
5.724	5	2	16	5q35.2	FAF2, ETEA, UBXD8, KIAA0887		Fas-associated factor family, member 2	616935	REc			
5.725	5	26	13	5q35.2	GPRIN1, GRIN1, KIAA1893		G protein-regulated inducer of neurite outgrowth 1	611239	REc			
5.726	9	28	96	5q35.2	HK3		Hexokinase-3, white cell	142570	A, Psh			
5.727	1	13	16	5q35.2	HMP19, NSG2		Hypothalamus golgi apparatus-expressed protein, 19kD	616752	REc			
5.728	7	2	18	5q35.2	HRH2		Histamine receptor H2	142703	REc			
5.729	7	7	09	5q35.2	MENOQ4		Menopause, natural, age at, QTL4	612886	Fd	associated with rs365132, rs7718874, rs402511, rs691141, rs2278493	{Menopause, natural, age at, QTL4} (2)	
5.730	7	13	09	5q35.2	NOP15, HSPC111		Nop16, S. cerevisiae, homolog of	612861	REc			
5.731	7	15	09	5q35.3	PFN3		Profilin 3	612812	REc			
5.732	12	29	13	5q35.2	SFXN1		Sideroflexin 1	615569	REc			13(Sfxn1)
5.733	09	06	18	5q35.2	SIMC1, PLEIAD		SUMO-interacting motifs-containing protein 1	618102	REc			
5.734	8	31	09	5q35.2	THOC3, TEX1		THO complex 3 (Tex1, yeast, homolog of)	606929	R, REc			
5.735	7	7	09	5q35.2	UNC5A, UNC5H1		UNC5, C. elegans, homolog of, A	607869	REc			
5.736	9	27	17	5q35.2	ZNF346, JAZ		Zinc finger protein 346	605308	REc			
5.737	12	22	17	5q35.3	B4GALT7, XGALT1, XGPT1, EDSSPD1		Beta-1,4-galactosyltransferase 7	604327	REc, A		Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3)	
5.738	2	2	14	5q35.3	BTNL8, BTN9.2		Butyrophilin-like protein 8	615606	REc			
5.739	9	9	08	5q35.3	CNOT6, CCR4, KIAA1194		CCR4-NOT transcription complex, subunit 6	608951	R, REc			
5.740	8	31	09	5q35.3	DBN1		Drebrin-1	126660	REb, REc			13(Dbn1)
5.741	3	25	16	5q35.3	DDX41, ABS, MPLPF		DEAD/H box 41	608170	R		{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	
5.742	7	26	10	5q35.3	DOK3, DOKL		Docking protein 3	611435	REc			
5.743	7	14	14	5q35.3	FAM193B, IRIZIO, KIAA1931		Family with sequence similarity 193, member B	615813	REc			
5.744	9	22	14	5q35.3	FLT4, VEGFR3, PCL, LMPH1A		fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352	A, R, Fd		Lymphedema, hereditary, IA, 153100 (3); Hemangioma, capillary infantile, somatic, 602089 (3)	11(Flt4)
5.745	8	8	13	5q35.3	GNB2L1, RACK1		Guanine nucleotide-binding protein, beta-2-like 1	176981	R, REc			
5.746	3	25	96	5q35.3	HNRPH1		Heterogeneous nuclear ribonucleoprotein H	601035	A			
5.747	6	30	05	5q35.3	MXD3, MAD3		MAX dimerization protein 3	609450	REc			
5.748	10	12	16	5q35.3	MRNIP, C5orf45		MRN complex-interacting protein	617154	REc			
5.749	7	1	11	5q35.3	NOLA2, NHP2, DKCB2		Nucleolar protein family A, member 2	606470	R, REc		Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	
5.750	3	8	04	5q35.3	PDLIM7, ENIGMA		PDZ and LIM domain 7 (enigma)	605903	R			
5.751	5	19	15	5q35.3	PHYKPL, AGXT2L2, PHLU		5-phosphohydroxy-L-lysine phospho-lyase	614683	REc	mutation identified in 1 PHLU patient	[?Phosphohydroxylysinuria], 615011 (3)	
5.752	8	31	09	5q35.3	RGS14		Regulator of G protein signaling 14	602513	REc			
5.753	7	22	09	5q35.3	PRELID1, PRELI, PX19		PRELI domain-containing protein 1	605733	R, REc			
5.754	12	18	08	5q35.3	RAB24		Ras-associated protein 24	612415	R, REc			
5.755	8	19	13	5q35.3	RUFY1		RUN and FYVE domains-containing protein 1	610327	R, REc			
5.756	6	28	18	5q35.3	TBC1D9B, KIAA0676		TBC domain family, member 9B	618039	R, REc			
5.757	3	18	98	5q35.3	TCF17, KID1		Transcription factor-17	602444	A			11(Tcf17)
5.758	7	1	05	5q35.3	TRIM7, GNIP		Tripartite motif-containing protein 7	609315	R, REc			
5.759	10	30	06	5q35.3	TRIM41		Tripartite motif-containing 41	610530	REc			
5.760	7	17	14	5q35.3	TRK-CTT2-4, TRNAK2, TRK2		Transfer RNA lysine (CTT) 2-4	612996	REc			
5.761	10	24	14	5q35.3	TRP-TGG3-5, TRNAP3, TRP3		Transfer RNA-Pro (TGG) 3-5	189912	REa, A			
5.762	10	24	14	5q35.3	TRT-TGT6-1, TRNAT1, TRT1		Transfer RNA-Thr (TGT) 6-1	189913	REa, A			
5.763	7	18	14	5q35.3	TRV-AAC1-4, TRNAV1, TRV1		Transfer RNA valine (AAC) 1-4	189921	REc			
5.764	7	17	14	5q35.3	TRV-CAC1-2, TRNAV2, TRV2		Transfer RNA valine (CAC) 1-2	612995	REc			
5.765	4	21	10	5q35.3	ZFP62		Zinc finger protein 62	610281	R, REc			11(Zfp62)
5.766	7	10	15	6q22.31	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3		Gap junction protein, alpha-1, 43kD (connexin 43)	121014	REa, REc	pseudogene on chr.5	Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III, 186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive, 257850 (3); Craniometaphyseal dysplasia, autosomal recessive, 218400 (3); Erythrokeratodermia variabilis et progressiva 3, 617525 (3); Palmoplantar keratoderma with congenital alopecia, 104100 (3)	10(Gja1)
6.1	1	16	07	6p21.2	ZFAND3, TEX27		Zinc finger AN1 domain-containing protein 3	607455	R, REc			
6.2	2	17	09	6pter-p24	DEL6pter, C6DELpter		Chromosome 6pter-p24 deletion syndrome	612582	Ch		Chromosome 6pter-p24 deletion syndrome (4)	
6.3	2	28	03	6p21.33	MDC1, NFBD1, KIAA0170		Mediator of DNA damage checkpoint protein 1	607593	Psh			
6.4	4	6	18	6p21.1	CNPY3, TNRC5, PRAT4A, ERDA5, EIEE60		Canopy 3, zebrafish, homolog of	610774	R, REc		Epileptic encephalopathy, early infantile, 60, 617929 (3)	
6.5	10	1	95	6p25.2	ELANH2, EI		Protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived	130135	Psh, R			
6.6	3	8	91	6p21.31	CLPS		Colipase, pancreatic	120105	REa			
6.7	5	9	07	6p21.31	ITPR3		Inositol 1,4,5-triphosphate receptor, type 3	147267	REa, A		{Diabetes, type 1, susceptibility to}, 222100 (2)	
6.8	2	12	16	6p25.3	DUSP22, LMWDSP2, MKPX, VHX, JKAP, JSP1		Dual-specificity phosphatase 22	616778	REc			
6.9	8	1	13	6p25.3	EXOC2, SEC5L1, SEC5		Exocyst complex component 2	615329	REc			
6.10	12	4	98	6p25.3	FOXF2, FKHL6, FREAC2		Forkhead box F2	603250	A, R			
6.11	11	15	05	6p25.3	HUS1B		Hydroxyurea-sensitive 1, S. pombe, homolog of, B	609713	REc			
6.12	12	4	03	6p24.3	CTAG3, CAGE1		Cancer/testis antigen 3	608304	REc			
6.13	4	22	10	6p25.3-p22.3	INTLQ3		Intelligence quantitative trait locus 3	610294	Fd		{Intelligence QTL3} (2)	
6.14	11	11	14	6p25.2	ECI2, PECI, DRS1		Enoyl-CoA delta isomerase 2	608024	R, REc			
6.15	7	20	12	6p25.2	FAM60B, X5L		Family with sequence similarity 50, member B	614686	A, REc			
6.16	9	10	09	6p25.2	PRPF4B, PRP4		Pre-mRNA processing factor 4, yeast, homolog of, B	602338	R, REc			
6.17	6	27	17	6p25.2	PSMG4, PAC4, C6orf86		Proteasome assembly chaperone 4	617550	REc			
6.18	09	13	18	6p25.2	RIPK1, RIP1, RIP, IMD57		Receptor-interacting serine/threonine kinase 1	603453	REc		Immunodeficiency 57, 618108 (3)	
6.19	1	2	08	6p25.2	SLC22A23, C6orf85		Solute carrier family 22, member 23	611697	REc			19(Slc22a23)
6.20	4	29	14	6p25.2	TUBB2A, CDCBM5		Tubulin, beta-2A	615101	REc		Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	
6.21	7	26	17	6p25.2	TUBB2B, CDCBM7		Tubulin, beta-2B	612850	REc	TUBB2A is 70kb telomeric to TUBB2B	Cortical dysplasia, complex, with other brain malformations 7, 610031 (3)	
6.22	6	8	15	6p24.3	TXNDC5, ERP46, ENDOPDI, HCC2		Thioredoxin domain-containing protein 5	616412	REc			13(Txndc5)
6.23	10	29	03	6p25.2	WRNIP1, WHIP		Werner helicase-interacting protein 1	608196	REc			
6.24	9	1	09	6p25.1	CDYL		Chromodomain protein on Y chromosome-like	603778	R, REc			13(Cdyl)
6.25	2	19	18	6p25.1	FARS2, FARS1, COXPD14, SPG77		Phenylalanyl-tRNA synthetase 2, mitochondrial	611592	R, REc		Combined oxidative phosphorylation deficiency 14, 614946 (3); Spastic paraplegia 77, autosomal recessive, 617046 (3)	
6.26	11	11	14	6p25.1	LY86, MD1		Lymphocyte antigen 86	605241	REc			
6.27	1	9	14	6p25.1	LYRM4, ISD11, C6orf149, COXPD19		LYR motif-containing protein 4	613311	REc	mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 19, 615595 (3)	
6.28	9	10	09	6p25.1	NRN1, NRN		Neuritin 1	607409	R, REc			
6.29	9	10	09	6p25.1	RPP40		Ribonuclease P, 40kD subunit	606117	R, REc			
6.30	9	18	08	6p24.3	EEF1E1		Eukaryotic translation elongation factor 1, epsilon-1	609206	REc			
6.31	10	26	98	6p25.2	BPHL		Biphenyl hydrolase-like	603156	A			
6.32	1	27	09	6p25	CLLS4		Leukemia, chronic lymphocytic susceptibility to, 4	612558	Fd	associated with rs872071	{Leukemia, chronic lymphocytic susceptibility to, 4} (2)	
6.33	1	26	17	6p25.3	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3		Forkhead, Drosophila, homolog-like 7	601090	A		Anterior segment dysgenesis 3, multiple subtypes, 601631 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3)	13(Fkhl7, ch, Mfl)
6.34	9	22	14	6p25.3	FOXCUT, LINC01379		FOXC1 upstream transcript, noncoding	615976	REc			
6.35	5	19	09	6p25.3	FOXQ1, HFH1		Forkhead box Q1	612788	A, REc, H			13(Foxq1)
6.36	11	20	98	6p25.3	GMDS		GDP-mannose 4,6-dehydratase	602884	A			
6.37	4	15	04	6p25	LRSL		Larsen-like syndrome	608545	Ch		Larsen-like syndrome (2)	
6.38	4	6	10	6p25.2	NQO2, NMOR2		NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)	160998	REa		{?Breast cancer susceptibility}, 114480 (1)	
6.39	11	5	97	6p25.2	PI9, CAP3, SERPINB9		Protease inhibitor 9, ovalbumin type	601799	A			
6.40	5	28	98	6p24.3	RREB1		RAS-responsive element binding protein-1	602209	Psh, R, A			
6.41	7	28	14	6p25.2	SERPINB6, PI6, PTI, SPI3, DFNB91		Protease inhibitor 6 (placental thrombin inhibitor)	173321	Psh, R, A	mutation identified in 1 DFNB91 family	?Deafness, autosomal recessive 91, 613453 (3)	13(Spi3)
6.42	11	2	11	6p25.1	F13A1, F13A		Coagulation factor XIII, A polypeptide	134570	F, Fd, A, D		Factor XIIIA deficiency, 613225 (3); {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)	
6.43	11	24	14	6p25.3	IRF4, LSIRF, SHEP8		Interferon regulatory factor-4	601900	A, Ch, Fd	dysregulated in t(6;14)	[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	
6.44	1	11	17	6p24.3	HIPSTR		Long noncoding RNA HIPSTR	617136	REc	overlaps TFAP2A		13(Hipstr)
6.45	9	2	08	6p24.3	HULC		Highly upregulated in liver cancer	612210	REc			
6.46	9	1	95	6p24.3	OFC1, CL		Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate)	119530	Fd, Ch	probable heterogeneity	Orofacial cleft-1 (2)	
6.47	4	17	13	6p24.3	BLOC1S5, BLOS5, MUTED		Biogenesis of lysosome-related organelles complex 1, subunit 5	607289	H, REc			13(mu)
6.48	10	31	17	6p24.3	RIOK1, RIO1		RIO kinase 1	617753	REc			
6.49	3	15	07	6p24.3	SLC35B3, PAPST2		Solute carrier family 25 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B3	610845	REc			
6.50	6	13	12	6p24.3	SSR1		Signal sequence receptor, alpha	600868	REc			
6.51	2	23	08	6p24.2	ELOVL2, SSC2		Elongation of very long chain fatty acids-like 2	611814	REc			
6.52	2	13	17	6p24.2	GCM2, GCMB, HRPT4		Glial cells missing, Drosophila, homolog of, 2	603716	REc		Hypoparathyroidism, familial isolated, 146200 (3); Hyperparathyroidism 4, 617343 (3)	
6.53	8	25	11	6p24.2	MAK, RP62		Male germ cell-associated kinase	154235	H, REc		Retinitis pigmentosa 62, 614181 (3)	13(Mak)
6.54	9	10	12	6p24.2	NEDD9, HEF1, CASL		Neural precursor cell expressed, developmentally downregulated 9	602265	R, REc			
6.55	12	28	08	6p24.2	PAK1IP1, PIP1		PAK1-interacting protein	607811	R, REc			
6.56	2	9	16	6p24.2	SYCP2L, C6orf177		Synaptonemal complex protein 2-like	616799	REc			
6.57	7	22	13	6p24.2	TMEM14C		Transmembrane protein 14C	615318	REc			
6.58	11	19	11	6p24.1	C6orf105, ADTRP		Chromosome 6 open reading frame 105 (androgen-dependent TFPI-regulating protein)	614348	REc			
6.59	5	26	13	6p24.2	ERVFRD-1		Endogenous retrovirus group FRD, member 1	610524	REc			
6.60	7	16	12	6p24.1	PHACTR1, KIAA1733		Phosphatase and actin regulator 1	608723	REc			
6.61	8	22	14	6p24.1	TBC1D7, PIG51, TBC7, MGCPH		TBC1 domain family, member 7	612655	REc		Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	
6.62	7	1	11	6p24.1-p22.3	DFNA21		Deafness, autosomal dominant 21	607017	Fd	previously mapped to 6p21.3	Deafness, autosomal dominant 21 (2)	
6.63	11	24	14	6p24.3	DSP, KPPS2, PPKS2, DCWHKTA		Desmoplakin	125647	REa, REc, Fd	splice variants result in DP I and DP II	Keratosis palmoplantaris striata II, 612908 (3); Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome, 607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3); Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	
6.64	11	19	11	6p24.3	OFCC1, MRDS1		OFC1 candidate gene 1	614287	REc			
6.65	6	27	08	6p24.3	TFAP2A, AP2TF, BOFS		Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha)	107580			Branchiooculofacial syndrome, 113620 (3)	13(Tcfap2)
6.66	2	18	98	6p24.3	BMP6		Bone morphogenetic protein-6	112266	REa, REc			
6.67	3	24	14	6p24.1	EDN1, ARCND3, QME, HDLCQ7		Endothelin-1	131240	REa, A, Fd		Auriculocondylar syndrome 3, 615706 (3); Question mark ears, isolated, 612798 (3); {High density lipoprotein cholesterol level QTL 7} (3)	13(Edn1)
6.68	5	6	15	6p24.3-p24.2	GCNT2, Ii, CTRCT13		Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429	A	previously assigned to 9q21	[Blood group, Ii], 110800 (3); Cataract 13 with adult i phenotype, 116700 (3); Adult i phenotype without cataract, 110800 (3)	
6.69	8	18	97	6p22.3	JMJ		Jumonji	601594	A			13(jmj)
6.70	11	3	92	6p24.1	HIVEP1, ZNF40		Human immunodeficiency virus type I enhancer-binding protein-1	194540	REa, A, REc			
6.71	5	4	00	6p23	CD83, HB15, BL11		CD83 antigen	604534	REc			13(Cd83)
6.72	12	13	96	6p22.3	ATXN1, ATX1, SCA1		Ataxin-1	601556	F, Fd, A		Spinocerebellar ataxia 1, 164400 (3)	13(Sca1, Atx1)
6.73	2	22	00	6p22.3	DEK, D6S231E		DEK oncogene	125264	Ch	fused with CAN in t(6;9)	Leukemia, acute nonlymphocytic (2)	
6.74	11	22	17	6p23	ETM3		Tremor, hereditary essential, 3	611456	Fd	max lod at D6S1630 and D6S1605	Essential tremor, hereditary, 3 (2)	
6.75	3	18	94	6p22.3	GMPR, GMPR1		Guanosine monophosphate reductase	139265	REb, A			
6.76	1	22	08	6p22.3	MBOAT1		Membrane-bound O-acetyltransferase domain-containing 1	611732	REc			
6.77	5	23	16	6p23	MCUR1, CCDC90A, FMP32		Mitochondrial calcium uniporter regulator 1	616952	REc			
6.78	1	5	09	6p23	NOL7		Nucleolar protein 7	611533	A			
6.79	6	13	02	6p23	RANBP9, RANBPM		RAN-binding protein 9	603854	R, REc			
6.80	12	14	98	6p23	SCZD3		Schizophrenia susceptibility locus, chromosome 6-related	600511	Fd	?same as DTNBP1; cognitive deficit type	{Schizophrenia}, 181500 (2)	
6.81	9	10	09	6p23	SIRT5		Sirtuin, S. cerevisiae, homolog 5	604483	R, REc			
6.82	4	26	06	6p22.3	MYLIP, MIR		Myosin regulatory light chain-interacting protein	610082	REc			
6.83	8	19	98	6p22.2	SLC17A1, NPT1		Solute carrier family 17, sodium phosphate, member-1 (Sodium phosphate transport 1, kidney)	182308	REa			13(Slc17a1)
6.84	1	19	07	6p23-p21	SCAR3, SCABD		Spinocerebellar ataxia, autosomal recessive 3	271250	Fd		Spinocerebellar ataxia, autosomal recessive 3 (2)	
6.85	7	1	05	6p22.1	TRIM31, HCGI		Tripartite motif-containing protein 31	609316	REc, R			
6.86	8	20	09	6p21.1	MEA1, MEA		Male-enhanced antigen 1	143170	REb, REa			
6.87	9	2	09	6p22.1	TRNAM2, TRNAMI2, RNTMI2		tRNA methionine-2	180620	REa	2 of 12+ RNTMI genes are on chr. 6		
6.88	9	1	09	6p22.2	TRNAM1, TRMI2, TRM2, RNTMT1		tRNA methionine-1	180621	REa			
6.89	3	7	14	6p22.3	ACOT13, THEM2		Acyl-CoA thioesterase 13	615652	REc			
6.90	5	6	13	6p22.3	BWQTL4		Birth weight quantitative trait locus 4	615192	Fd	associated with rs7756992	[Birth weight QTL4] (2)	
6.91	10	23	15	6p22.3	CASC15, LINC00340		Cancer susceptibility candidate 15, noncoding	616610	REc			
6.92	3	20	18	6p22.3	CDKAL1		CDK5 regulatory subunit-associated protein 1-like 1	611259	REc			
6.93	3	15	10	6p22.3	CIHL		Hearing loss, cisplatin-induced, susceptibility to	613290	Fd	associated with rs12201199	{?Hearing loss, cisplatin-induced, susceptibility to} (2)	
6.94	6	21	16	6p22.3	DTNBP1, HPS7		Dystrobrevin-binding protein 1 (dysbindin)	607145	R, Fd		Hermansky-Pudlak syndrome 7, 614076 (3)	13(Dtnbp1)
6.95	2	26	16	6p22.3	GMNN, MGORS6		Geminin	602842	R, REc		Meier-Gorlin syndrome 6, 616835 (3)	
6.96	10	13	09	6p22.3	KDM1B, LSD2, AOF1		Lysine-specific demethylase 1B	613081	REc			
6.97	7	20	12	6p22.3	KIF13A		Kinesin family member 13A	605433	REc			
6.98	9	12	03	6p22.3	NHLRC1, EPM2A, EPM2B		NHL repeat-containing 1 gene (malin)	608072	REc, Fd		Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	
6.99	9	10	09	6p22.3	NUP153		Nucleoporin, 153kD	603948	R, REc			
6.100	7	29	15	6p21.1	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11		Polymerase I, RNA, subunit C	610060	REc		Treacher Collins syndrome 3, 248390 (3); Leukodystrophy, hypomyelinating, 11, 616494 (3)	
6.101	8	2	17	6p22.3	RBM24, RNPC6		RNA-binding motif protein 24	617603	REc			
6.102	6	12	07	6p22.3-p21.3	OTSC3		Otosclerosis 3	608244	Fd		Otosclerosis 3 (2)	
6.103	9	30	98	6p22.3	SOX4		SRY (sex determining region Y)-box 4	184430	REa, A			13(Sox4)
6.104	4	19	16	6p22.3	TPMT, TPMTD		Thiopurine S-methyltransferase	187680	Psh, A		{Thiopurines, poor metabolism of, 1}, 610460 (3)	
6.105	8	11	15	6p22.3	FAM65B, C6orf32, KIAA0386, PL48, DFNB104		Family with sequence similarity 65, member B	611410	R, REc	mutation identified in 1 DFNB104 family	?Deafness, autosomal recessive 104, 616515 (3)	
6.106	9	2	09	6p22.3-p21.1	TRNAA1		tRNA alanine-1	601431	REa, A			
6.107	9	2	09	6p22.2	TRNAR3, TRR3		tRNA arginine-3	601432	REa, A			
6.108	5	23	16	6p22.3	TDP2, TTRAP		Tyrosyl-DNA phosphodiesterase 2	605764	REc		Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	
6.109	3	8	07	6p22.1	ZNF323		Zinc finger protein 323	610794	REc			
6.110	12	5	13	6p22.3-p22.2	CMAHP, CMAH		Cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene	603209	A	mutation inactivates gene in humans		13(Cmah)
6.111	09	04	18	6p22.2	CARMIL1, LRRC16A, LRRC16		Capping protein regulator and myosin 1 linker 1	609593	R, REc			13(Lrrc16)
6.112	12	15	10	6p22.2	HISTH2AA, H2AFR, H2AA		Histone gene cluster 1, H2A histone family, member A	613499	REc			
6.113	2	21	06	6p22.2	HIST1H2BA, TSH2B		Histone 1, H2BA	609904	REc			
6.114	7	7	17	6p22.3	KIAA0319		KIAA0319 gene	609269	REc			
6.115	7	22	13	6p22.2	TRNAR2		Transfer RNA arginine 2	615305	REc			
6.116	7	22	13	6p22.2	TRNAV21		Transfer RNA valine 21	615306	REc			
6.117	8	15	90	6p22.3	PRL		Prolactin	176760	REa, D	?between 6cen and GLO1		11(Prl)
6.118	8	24	09	6p22.1	ZSCAN12, ZNF96, KIAA0426		Zinc finger- and SCAN domain-containing protein 12	603978	R, REc			
6.119	2	1	11	6p22.2	BTN1A1, BTN		Butyrophilin	601610	REc			13(Btn)
6.120	2	1	11	6p22.2	BTN2A1, BTF1		Butyrophilin, subfamily 2, member A1	613590	REc			
6.121	2	1	11	6p22.2	BTN2A2, BTF2		Butyrophilin, subfamily 2, member A2	613591	REc			
6.122	2	1	11	6p22.2	BTN2A3		Butyrophilin, subfamily 2, member A3	613592	REc			
6.123	2	1	11	6p22.2	BTN3A1, BTF5, CD277		Butyrophilin, subfamily 3, member A1	613593	REc			
6.124	2	1	11	6p22.2	BTN3A2, BTF4		Butyrophilin, subfamily 3, member A2	613594	REc			
6.125	2	1	11	6p22.2	BTN3A3, BTF3		Butyrophilin, subfamily 3, member A3	613595	REc			
6.126	3	19	01	6p22.3	GPLD1, PIGPLD, GPIPLD		Phospholipase D1, glycosylphosphatidylinositol-specific	602515	A			13(Gpld1)
6.127	11	19	11	6p22.1	GPX5		Glutathione peroxidase 5 (epididymal)	603435	REc			13(Gpx5)
6.128	9	9	13	6p22.1	GPX6		Glutathione peroxidase 6	607913	REc			
6.129	3	6	08	6p22.3	KAAG1, RU2AS		Kidney-associated antigen 1	608211	A			
6.130	2	21	13	6p22.1	OR2J3, C3HEXS		Olfactory receptor, family 2, subfamily J, member 3	615016	REc		[C3HEX, ability to smell], 615082 (3)	
6.131	5	29	13	6p22.1	SCAND3, ZBED9, BUSTER4, KIAA1925		SCAN domain-containing protein 3	615254	REc			
6.132	7	22	09	6p22.1	STQTL18		Stature quantitative trait locus 18	612892	Fd	associated with rs10946808	{Stature QTL 18} (2)	
6.133	6	17	16	6p22.1	TRIM40, RNF35		Tripartite motif-containing protein 40	616976	REc			
6.134	7	17	14	6p22.1	TRS-TGA4-1, TRNAS3, TRS3		Transfer RNA serine (TGA) 4-1	606172	REc			
6.135	7	22	13	6p22.1	TRNAT15		Transfer RNA threonine 15	615309	REc			
6.136	7	22	13	6p22.1	TRNAV12		Transfer RNA valine 12	615307	REc			
6.137	7	22	13	6p22.1	TRNAV17		Transfer RNA valine 17	615308	REc			
6.138	7	18	14	6p22.1	TRS-AGA2-4, TRNAS2, TRS2, TRNS		Transfer RNA serine (AGA) 2-4	189910	REc			
6.139	11	15	08	6p22.1	ZFP57, TNDM1		Zinc finger protein 57, mouse, homolog of	612192	R, REc, Fd, Ch		Diabetes mellitus, transient neonatal, 1, 601410 (3)	
6.140	7	16	02	6p22.1	TRIM39, RNF23, TFP		Tripartite motif-containing 39	605700	A			
6.141	3	28	17	6p22.3	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC		Doublecortin domain-containing protein 2	605755	A	mutation identified in 1 DFNB66 family	Nephronophthisis 19, 616217 (3); ?Deafness, autosomal recessive 66, 610212 (3); Sclerosing cholangitis, neonatal, 617394 (3)	
6.142	5	26	09	6p22.1	ZKSCAN3, ZNF306		Zinc finger protein with KRAB and SCAN domains 3	612791	REc			
6.143	4	10	14	6p22.1	ZNRD1AS1, TCTEX4, HTEX4		ZNRD1 antisense RNA 1	615714	REc, H			17(Znrd1as1)
6.144	3	15	07	6p22.2	ZNF322A, ZNF489, ZNF322		Zinc finger protein 322A	610847	REc			
6.145	11	11	14	6p22.1	ZNRD1, TCTEX6, HTEX6		Zinc ribbon domain-containing protein 1	607525	REc			
6.146	7	23	15	6p22.1	ZSCAN26, SREZBP		Zinc finger- and SCAN domain-containing protein 26	616474	REc			
6.147	5	19	06	6p22.3	ALDH5A1, SSADH		Succinic semialdehyde dehydrogenase	610045	REa, REc		Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	
6.148	11	7	08	6p22	ALPQTL3		Alkaline phosphatase, plasma level of, QTL 3	612368	Fd	linkage with rs9467160	{Alkaline phosphatase, plasma level of, QTL3} (2)	
6.149	2	23	95	6p22.3	E2F3		E2F transcription factor 3	600427	A			
6.150	2	5	15	6p22.3	NBAT1		Neuroblastoma-associated transcript 1, noncoding	616206	REc			
6.151	9	22	09	6p22	NBLST4		Neuroblastoma, susceptibility to, 4	613015	Fd	associated with rs6939340, rs4712653, rs9295536	{Neuroblastoma, susceptibility to, 4} (2)	
6.152	11	17	15	6p22.3	NRSN1, VMP		Neurensin 1	616630	REc			
6.153	9	10	09	6p22.1	TRIM27, RFP		Tripartite motif-containing 27	602165	REc			
6.154	2	14	03	6p22.1	HIST1H1B, H1F5		Histone 1, H1b	142711	REa	~2Mb centromeric of H1F1 cluster		
6.155	1	14	13	6p22.1	HIST1H2AG, H2AG, H2AFP		Histone gene cluster 1, H2A histone family, member 6	615012	REc			
6.156	1	14	13	6p22.1	HIST1H2AH, H2AH		Histone gene cluster 1, H2A histone family, member H	615013	REc			
6.157	4	3	03	6p22.1	HIST1H2AI, H2AFC		Histone 1, H2ai	602787	REc			
6.158	4	3	03	6p22.1	HIST1H2AK, HIST1H2AI, H2AFD		Histone 1, H2ak	602788	REc			
6.159	4	3	03	6p22.1	HIST1H2AJ, HIST1H2AK, H2AFE		Histone 1, H2aj	602791	REc			
6.160	2	14	03	6p22.1	HIST1H2AL, H2AFI		Histone 1, H2al	602793	REc			
6.161	2	14	03	6p22.1	HIST1H2AM, H2AFN		Histone 1, H2am	602796	REc			
6.162	1	31	13	6p22.1	HIST1H2BJ, H2BJ		Histone gene cluster 1, H2B histone family, member J	615044	REc			
6.163	1	31	13	6p22.1	HIST1H2BK, H2BK		Histone gene cluster 1, H2B histone family, member K	615045	REc			
6.164	3	11	03	6p22.1	HIST1H2BL, H2BFC		Histone 1, H2bl	602800	REc			
6.165	3	11	03	6p22.1	HIST1H2BM, H2BFE		Histone 1, H2bm	602802	REc			
6.166	3	11	03	6p22.1	HIST1H2BN, H2BFD		Histone 1, H2bn	602801	REc			
6.167	4	3	03	6p22.1	HIST1H2BO, H2BFN		Histone 1, H2bo	602808	REc			
6.168	3	11	03	6p22.1	HIST1H3I, H3FF		Histone 1, H3i	602814	REc	in cluster of 16 histone genes centromeric of major cluster		
6.169	3	11	03	6p22.1	HIST1H3J, H3FJ		Histone 1, H3j	602817	REc	in 2nd cluster on 6p		
6.170	3	11	03	6p22.1	HIST1H3H, H3FK		Histone 1, H3h	602818	REc	in minor cluster on 6p		
6.171	3	11	03	6p22.1	HIST1H4J, H4FE		Histone 1, H4j	602826	REc			
6.172	3	11	03	6p22.1	HIST1H4K, H4FD		Histone 1, H4k	602825	REc			
6.173	3	11	03	6p22.1	HIST1H4L, H4FK		Histone 1, H4l	602831	REc			
6.174	6	13	95	6p22.3	ID4		Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	600581	A			
6.175	8	27	02	6p22.1	PRSS16, TSSP		Protease, serine, 16	607169	REc			13(Prss16)
6.176	10	19	99	6p22.2	SLC17A4		Solute carrier family 17 (sodium phosphate), member 4	604216	REa, R			
6.177	6	11	11	6p21.31	FANCE, FACE		Fanconi anemia, complementation group E gene	613976	Fd, LD		Fanconi anemia, complementation group E, 600901 (3)	
6.178	10	29	99	6p21.33	ABCF1, ABC50		ATP-binding cassette 50, TNF-alpha stimulated	603429	A			
6.179	12	5	13	6p21.33	ATAT1, MEC17, C6orf134		Alpha-tubulin acetyltransferase 1	615556	REc			
6.180	4	27	10	6p21.3	ATPLS		Antiphospholipid syndrome, familial	107320	Fd	possible linkage with HLA-DRB1*14	?Antiphospholipid syndrome, familial (2)	
6.181	4	28	10	6p21.33	AIF1, IRT1		Allograft inflammatory factor 1	601833	R, REn	part of TNF block		
6.182	9	22	09	6p21.33	FL1		Follicular lymphoma, susceptibility to, 1	613024	Fd	associated with rs6457327	{Follicular lymphoma, susceptibility to, 1} (2)	
6.183	4	21	17	6p21.33	G6B, C6orf25, THAMY		G6B protein	606520	REc	mutation identified in 1 THAMY family	?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3)	
6.184	3	14	18	6p22.1	GABBR1, GABABR1		Gamma-aminobutyric acid B receptor 1	603540	REc, H			17(Gabbr1)
6.185	2	18	09	6p21.33	LNCR4		Lung cancer susceptibility 4	612593	Fd	associated with rs3117582 and rs3131379	{Lung cancer susceptibility 4} (2)	
6.186	3	23	09	6p21.33	MIR877, MIRN877		Micro RNA 877	611619	REc			
6.187	6	26	16	6p21.33	MUC21, C6orf205		Mucin 21, cell surface-associated	616991	REc			17(Muc21)
6.188	4	20	17	6p21.33	MSH5, POF13		MutS, E. coli, homolog of, 5	603382	REc	mutation identified in POF13 family	?Premature ovarian failure 13, 617442 (3)	
6.189	7	20	12	6p21.33	VWA7, C6orf27, G7C		von Willebrand factor A domain-containing protein 7	609693	REc			17(G7c)
6.190	12	18	07	6p22.1	ZKSCAN4, ZNF307		Zinc finger with KRAB and SCAN domains 4	611643	REc			
6.191	2	21	06	6p21.32	EGFL8		Epidermal growth factor-like 8	609897	R, REc			17(Eglf8)
6.192	12	15	10	6p21.32	HLA-DQA2, HLA-DXA		Major histocompatibility complex, class II, DQ alpha-2	613503	REc			
6.193	8	17	13	6p21.32	HLA-DQB2, HLA-DXB		Major histocompatibility complex, class II, DQ beta-2	615161	REc			
6.194	3	23	09	6p21.32	MRI219-1, MIRN219-1		Micro RNA 219-1	611500	REc			
6.195	5	23	16	6p21.32	CUTA, ACHAP, C6orf82		CutA, E. coli, homolog of	616953	REc			
6.196	3	10	16	6p21.31	BRPF3, KIAA1286		Bromodomain- and PHD finger-containing protein 3	616856	REc			
6.197	9	2	08	6p21.31	C6orf106		Chromosome 6 open reading frame 106	612217	REc			
6.198	5	23	13	6p21.31	DEF6, IBP, SLAT		Def6, mouse, homolog of	610094	REc, H			17(Def6)
6.199	8	12	14	6p21.31	KCTD20		Potassium channel tetramerization domain-containing protein 20	615932	REc			
6.200	6	7	16	6p21.31	LEMD2, NET25, CTRCT42		LEM domain-containing protein 2	616312	REc		Cataract 46, juvenile-onset, 212500 (3)	
6.201	1	18	13	6p21.31	PNPLA1, ARCI10		Patatin-like phospholipase domain-containing protein 1	612121	REc		Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	
6.202	11	1	13	6p21.1	PRICKLE4, C6orf49, OBTP		Prickle, Drosophila, homolog of, 4	611389	REc			17(Prickle4)
6.203	3	7	14	6p21.31	RPL10A, CSA19		Ribosomal protein L10A	615660	REc			
6.204	7	3	13	6p21.31	SLC26A8, TAT1, SPGF3		Solute carrier family 26 (sulfate transporter), member 8	608480	REa, REc		Spermatogenic failure 3, 606766 (3)	
6.205	9	10	09	6p21.31	SNRPC		Small nuclear ribonucleoprotein polypeptide C	603522	R, REc			
6.206	10	1	17	6p21.31	SRPK1		Protein kinase, serine/arginine-specific, 1	601939	REc			
6.207	7	22	09	6p21.31	STQTL19		Stature quantitative trait locus 19	612893	Fd	associated with rs1776897	{Stature QTL 19} (2)	
6.208	9	10	09	6p21.31	TAF11, TAF2I, TAFII28		TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD	600772	R, REc			
6.209	10	14	18	6p21.31	UQCC2, C6orf126, M19, MC3DN7		Ubiquinol-cytochrome c reductase complex assembly factor 2	614461	REc		Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	
6.210	9	8	11	6p21.33	ABHD16A, BAT5, D6S82E		Abhydrolase domain-containing 16A	142620	RE			
6.211	1	11	95	6p21.32	AGER, RAGE		Advanced glycosylation end product-specific receptor	600214	RE, A	at junction of classes II, III MHC		
6.212	10	15	98	6p21.32	AGPAT1, LPAATA		1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha)	603099	REn			
6.213	11	2	04	6p21.31	ANKS1, ODIN, KIAA0229		Ankyrin repeat and sterile alpha motif domains-containing protein 1	608994	R, REc			
6.214	7	2	18	6p21.33	APOM, NG20		Apolipoprotein M	606907	REc			
6.215	9	10	09	6p21.32	ATF6B, CREBL1		Activating transcription factor 6 beta	600984	REc			
6.216	7	18	02	6p21.33	ATP6V1G2, ATP6G		ATPase, H+ transporting, V1 subunit G2	606853	REc			
6.217	11	4	98	6p21.32	B3GALT4		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4	603095	REc, REn			
6.218	9	8	11	6p21.33	BAG6, BAT3, D6S52E		BCL2-associated athanogene 6	142590	RE			
6.219	12	10	08	6p21.32	BRD2, RING3, FSRG1		Bromodomain-containing protein 2	601540	REn, Fd	between HLA-DNA and HLA-DMA		
6.220	11	7	08	6p21.32	BTNL2, SS2		Butyrophilin-like protein 2	606000	REc		{Sarcoidosis, susceptibility to, 2}, 612387 (3)	
6.221	12	27	13	6p21.33	C2, ARMD14		Complement component-2	613927	F, LD, RE	no crossover with BF	C2 deficiency, 217000 (3); {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	17(C2)
6.222	12	19	11	6p21.33	C4A, C4S, C4AD		Complement component-4A	120810	F, H, RE, Fd	order: HLA-B, C2, BF, C4A, C4B, CYP21, DR	C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3)	17(C4)
6.223	12	19	11	6p21.33	C4B, C4F, C4BD		Complement component-4B	120820	F, H, RE, Fd	10kb from C4S	C4B deficiency, 614379 (3)	17(C4)
6.224	9	15	10	6p21.31	C6orf1, LBH		Chromosome 6, open reading frame 1	611419	REc	opposite strand, tail-to-tail with HMGA1		
6.225	10	28	09	6p21.33	CCHCR1, HCR, C6orf18		Coiled-coil alpha-helical rod protein 1	605310	REn	?role in psoriasis		
6.226	11	10	14	6p21.33	CDSN, HTSS1, HYPT2, PSS1		Corneodesmosin	602593	REn, Fd		Hypotrichosis 2, 146520 (3); Peeling skin syndrome 1, 270300 (3)	
6.227	1	14	14	6p21.33	CFB, BF, GBG, AHUS4, ARMD14, CFBD		Complement factor B	138470	F, RE	mutation identified in 1 CFBD family	{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3); ?Complement factor B deficiency, 615561 (3)	17(Bf)
6.228	7	24	17	6p21.32	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB		Collagen XI, alpha-2 polypeptide	120290	REa, A, REn, Fd	45kb centromeric of HLA-DPB2; 3'--5'-cen	Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706 (3); Fibrochondrogenesis 2, 614524 (3); Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3)	17(Col11a2)
6.229	7	16	09	6p21.3	CTEPH1		Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to	612862	Fd	associated with DPB1*0202	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)	
6.230	10	11	96	6p21.33	CSNK2B		Casein kinase-2, beta polypeptide	115441	REb, A			
6.231	3	24	11	6p21.33	CYP21A2, CYP21, CA21H		Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)	613815	F, RE	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	17(Cyp21)
6.232	10	26	98	6p21.32	DAXX		Death-associated protein 6	603186	A			
6.233	11	6	00	6p21.33	DDAH2		Dimethylarginine dimethylaminohydrolase-2	604744	R, A			
6.234	9	8	11	6p21.33	DDX39B, BAT1, D6S81E		DEAD box polypeptide 39Bipt-1	142560	RE	5 BATs in 160kb segment including also TNFA, TNFB		
6.235	9	18	08	6p21.3	DFNA31		Deafness, autosomal dominant 31	608645	Fd	between D6S276 and D6S273	Deafness, autosomal dominant 31 (2)	
6.236	4	30	09	6p21.33	DHX16, DDX16, DBP2, PRP8		DEAH (Asp-Glu-Ala-His) box polypeptide 16	603405	R, A			
6.237	7	17	01	6p21.33	DOM3Z		DOM3, C. elegans, homolog of, Z	605996	REc			
6.238	4	26	11	6p21.33	DPCR1, C6orf37		Diffuse panbronchiolitis critical region gene 1	613928	REc			
6.239	7	7	17	6p22-p21	DYX2		Dyslexia, susceptibility to, 2	600202	Fd	?between D6S105 and TNFB	{Dyslexia, susceptibility to, 2} (2)	
6.240	6	1	11	6p21.33	EHMT2, GAT8, G9A, NG36		Euchromatic histone-lysine N-methyltransferase 2	604599	REc			
6.241	8	17	16	6p21.32	FKBPL, DIR1, WISP39		FK506-binding protein-like	617076	REc			
6.242	9	10	09	6p21.33	FLOT1		Flotillin 1	606998	R, REc			
6.243	1	29	01	6p21.33	G8		G8 protein	605447	REc			
6.244	9	14	95	6p21.33	GNL1, HSR1		Guanine nucleotide-binding protein-like 1	143024	REn			
6.245	9	8	11	6p21.33	GPANK1, BAT4, D6S54E		G patch domain- and ankyrin repeats-containing protein 1	142610	RE			
6.246	3	7	01	6p21.31	GRM4, MGLUR4		Glutamate receptor, metabotropic, 4	604100	R			
6.247	4	21	97	6p21.33	GTF2H4		General transcription factor IIH, polypeptide 4	601760	A			
6.248	6	7	10	6p21.33	HCP5, 6S2650E		Major histocompatibility complex, class I, gene P5-1	604676	REc			
6.249	6	22	14	6p21.3	HCG8, HCGVIII		HLA complex group 8	615801	REc			
6.250	6	22	14	6p22.1	HCG9, HCGIX, HCGIX4		HLA complex group 9, noncoding	615797	REc			
6.251	4	26	11	6p21.33	HCG22, PBMUCL2		HLA complex group 22	613918	REc			
6.252	3	11	03	6p22.2	HIST1H1A, H1F1		Histone 1, H1a	142709	Psh, A			
6.253	3	11	03	6p22.2	HIST1H1C, H1F2		Histone 1, H1c	142710	REa, A			13(Hist1)
6.254	3	11	03	6p22.2	HIST1H1D, H1F3		Histone 1, H1d	142210	A, Psh			
6.255	6	28	17	6p22.2	HIST1H1E, H1F4, RMNS		Histone 1, H1e	142220	A		Rahman syndrome, 617537 (3)	
6.256	3	11	03	6p22.2	HIST1H1T, H1FT		Histone 1, H1t	142712	REc			
6.257	2	14	03	6p22.2	HIST1H2AB, H2AFM		Histone 1, H2ab	602795	REc			
6.258	3	11	03	6p22.2	HIST1H2AC, H2AFL		Histone 1, H2ac	602794	REc			
6.259	3	11	03	6p22.2	HIST1H2AD, H2AFG		Histone 1, H2ad	602792	REn			
6.260	3	11	03	6p22.2	HIST1H2AE, H2AFA		Histone 1, H2ae	602786	REc			
6.261	2	14	03	6p22.2	HIST1H2BB, H2BFF		Histone 1, H2bb	602803	REc			
6.262	3	11	03	6p22.2	HIST1H2BC, H2BFL		Histone 1, H2bc	602847	REc			
6.263	3	11	03	6p22.2	HIST1H2BD, H2BFB		Histone 1, H2bd	602799	REc			
6.264	2	14	03	6p22.2	HIST1H2BE, H2BFH		Histone 1, H2be	602805	REc			
6.265	4	3	03	6p22.2	HIST1H2BF, H2BFG		Histone 1, H2bf	602804	REc			
6.266	2	14	03	6p22.2	HIST1H2BG, H2BFA		Histone 1, H2bg	602798	REc			
6.267	3	11	03	6p22.2	HIST1H2BH, H2BFJ		Histone 1, H2bh	602806	REc			
6.268	3	11	03	6p22.2	HIST1H2BI, H2BFK		Histone 1, H2bi	602807	REc			
6.269	3	11	03	6p22.2	HIST1H3A, H3FA		Histone 1, H3a	602810	REc			
6.270	3	11	03	6p22.2	HIST1H3B, H3FL		Histone 1, H3fl	602819	REc	in major cluster on 6p		
6.271	3	11	03	6p22.2	HIST1H3C, H3FC		Histone 1, H3c	602812	REc			
6.272	3	11	03	6p22.2	HIST1H3D, H3FB		Histone 1, H3d	602811	REc			
6.273	12	14	01	6p22.2	HIST1H3E, H3FD, H3.1		Histone 1, H3e	602813	REc	in cluster of 35 histone genes		
6.274	3	11	03	6p22.2	HIST1H3F		Histone 1, H3f	602816	REc			
6.275	3	11	03	6p22.2	HIST1H3G, H3FH		Histone 1, H3g	602815	REc			
6.276	3	11	03	6p22.2	HIST1H4A, H4FA		Histone 1, H4a	602822	REc			
6.277	3	11	03	6p22.2	HIST1H4B, H4FI		Histone 1, H4b	602829	REc			
6.278	3	11	02	6p22.2	HIST1H4C, H4FG		Histone 1, H4c	602827	REc			
6.279	3	11	03	6p22.2	HIST1H4D, H4FB		Histone 1, H4d	602823	REc			
6.280	3	11	03	6p22.2	HIST1H4E, H4FJ		Histone 1, H4e	602830	REc			
6.281	3	11	03	6p22.2	HIST1H4F, H4FC		Histone 1, H4f	602824	REc			
6.282	3	11	03	6p22.2	HIST1H4G, H4FL		Histone 1, H4g	602832	REc			
6.283	3	11	93	6p22.2	HIST1H4H, H4FH		Histone 1, H4h	602828	REc			
6.284	2	14	03	6p22.1	HIST1H4I, H4FM, H4M		Histone 1, H4i	602833	A			
6.285	9	1	11	6p22.2	HFE, HLA-H, HFE1, MVCD7, TFQTL2		Hemochromatosis gene	613609	LD, F		Hemochromatosis, 235200 (3); {Microvascular complications of diabetes 7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease, susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)	13(Mr2, Hfe)
6.286	6	13	11	6p22.1	HLA-A		Major histocompatibility complex, class I, A	142800	F		{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)	17(H2)
6.287	6	13	11	6p21.33	HLA-B, SPDA1		Major histocompatibility complex, class I, B	142830	F, REn, Fd		{Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir hypersensitivity, susceptibility to} (3); {Synovitis, chronic, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic epidermal necrolysis, susceptibility to}, 608579 (3); {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	
6.288	3	16	10	6p21.33	HLA-C, PSORS1		Major histocompatibility complex, class I, C	142840	F, REn		{Psoriasis susceptibility 1}, 177900 (3); {HIV-1 viremia, susceptibility to}, 609423 (3)	17(H2L)
6.289	5	24	90	6p22.1	HLA-F, HLA-CDA12, HLAF		Major histocompatibility complex, class I, F	143110	REn, Fd			
6.290	1	8	95	6p21.32	HLA-DMA, RING6		Major histocompatibility complex, class II, DM alpha	142855	D			
6.291	1	8	95	6p21.32	HLA-DMB, RING7		Major histocompatibility complex, class II, DM beta	142856	D			
6.292	7	6	95	6p21.32	HLA-DOB		Major histocompatibility complex, class II, DO beta	600629	RE			
6.293	10	23	87	6p21.32	HLA-DPA1, HLADP		Major histocompatibility complex, class II, DP alpha-1	142880	F, RE	2 different alpha, 2 different beta chains		
6.294	10	28	93	6p21.32	HLA-DPB1		Major histocompatibility complex, class II, DP beta-1	142858	F, RE		{Beryllium disease, chronic, susceptibility to} (3)	
6.295	10	31	07	6p21.32	HLA-DQA1, CELIAC1		Major histocompatibility complex, class II, DQ alpha-1	146880	F, RE		{Celiac disease, susceptibility to}, 212750 (3)	
6.296	10	31	07	6p21.32	HLA-DQB1, CELIAC1		Major histocompatibility complex, class II, DQ beta-1	604305	REc		{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)	
6.297	8	28	17	6p21.32	HLA-DRB1, SS1		Major histocompatibility complex, class II, DR beta-1	142857	F, RE		{Sarcoidosis, susceptibility to, 1}, 181000 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3)	
6.298	5	15	89	6p21.32	HLA-DRA		Major histocompatibility complex, class II, DR alpha	142860	F, RE	1 alpha, 3 different beta chains		17(H2I)
6.299	10	23	87	6p21.32	HLA-DNA		Major histocompatibility complex, class II, DN alpha	142930	F, RE			
6.300	5	5	09	6p21.3	HLA-DRB3, HLA-DR52		Major histocompatibility complex, class II, DR beta-3	612735	REn			
6.301	4	6	00	6p21.32	HLA-DRB5		Major histocompatibility complex, class II, DR beta-5	604776	REn			
6.302	6	8	89	6p22.1	HLA-E		Major histocompatibility complex, class I, E	143010	REn			
6.303	1	25	05	6p22.1	HLA-G		HLA-G histocompatibility antigen, class I	142871	REc, RE		{Asthma, susceptibility to}, 600807 (2)	17(Qa)
6.304	2	19	02	6p21.32	HSD17B8, FABGL, D6S2245E, HKE6		Hydroxysteroid (17-beta) dehydrogenase 8 (Ke6 gene, mouse, homolog of)	601417	REl			17(Ke6)
6.305	12	18	91	6p21.33	HSPA1A		Heat-shock 70kD protein-1A	140550	S, REa, A	also 14q22-q24, chr.21, and at least 1 other chromosome		17(Hsp70)
6.306	1	13	99	6p21.33	HSPA1B		Heat-shock 70kD protein-1B	603012	REc			
6.307	12	18	91	6p21.33	HSPA1L		Heat-shock 70kD protein-like-1	140559	REn			
6.308	10	22	08	6p21.3	IBD3		Inflammatory bowel disease 3	604519	Fd		{Inflammatory bowel disease 3} (2)	
6.309	6	11	01	6p21.3	IDDM1		Insulin-dependent diabetes mellitus-1	222100	F, LD	linkage or association, with HLA	{Diabetes mellitus, insulin-dependent-1} (2)	
6.310	11	3	98	6p21.33	IER3, DIF2, IEX1, PRG1, GLY96		Immediate early response-3	602996	A			
6.311	4	21	99	6p21.3	IGAD1		Immunoglobulin A deficiency	137100	Fd		Immunoglobulin A deficiency (2)	
6.312	4	24	88	6p21.3	IGLP1		Immune response to synthetic polypeptides-1	147080	F			
6.313	4	24	88	6p21.3	IGLP2		Immune response to synthetic polypeptides-2	147090	F			
6.314	3	9	92	6p21.3	IGAT		Immune response to synthetic polypeptide--IRGAT	146820	F	in B/D segment		
6.315	10	23	87	6p21.3	ISCW		Immune suppression to streptococcal antigen	146850	H, F	HLA-linked		
6.316	3	23	09	6p21.32	KIFC1, KNSL2, HSET		Kinesin family member C1	603763	REc			
6.317	1	31	08	6p21.31	LHFPL5, TMHS, DFNB67		LHFP-like protein 5	609427	H, REc, Fd		Deafness, autosomal recessive 67, 610265 (3)	17(Lhfp15)
6.318	9	10	09	6p21.33	LSM2, C6orf28		LSM2 protein	607282	R, REc			
6.319	1	6	09	6p21.33	LTA, TNFB		Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440	REa, A, RE, Fd	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)	17(Tnfb)
6.320	1	27	97	6p21.33	LTB, TNFC		Lymphotoxin B	600978	REn			
6.321	5	24	13	6p21.33	LY6G5B, G5B		Lymphocyte antigen 6 complex, locus G5B	610433	REc			
6.322	5	24	13	6p21.33	LY6G5C, G5C		Lymphocyte antigen 6 complex, locus G5C	610434	REc			
6.323	5	24	13	6p21.33	LY6G6C, G6C		Lymphocyte antigen 6 complex, locus G6C	610435	REc			
6.324	8	28	02	6p21.33	LY6G6D, MEGT1, G6D, C6orf23		Lymphocyte antigen 6 complex, locus G6D	606038	REn			
6.325	5	24	13	6p21.33	LY6G6E, G6E		Lymphocyte antigen 6 complex, locus G6E	610437	REc			
6.326	10	4	05	6p21.33	MCCD1		Mitochondrial coiled-coil domain 1	609624	REc			
6.327	12	14	95	6p21.33	MICA		MHC class I polypeptide-related sequence A	600169	REn			
6.328	3	18	98	6p21.33	MICB		MHC class I polypeptide-related sequence B	602436	REn			
6.329	1	7	95	6p21.31	MLN		Motilin	158270	REa, A, Fd			
6.330	11	4	13	6p21.2	MOCS1, MOCODA		Molybdenum cofactor synthesis-1	603707	LD, A		Molybdenum cofactor deficiency A, 252150 (3)	
6.331	7	27	15	6p22.1	MOG, NRCLP7		Myelin-oligodendrocyte glycoprotein	159465	A, REn	60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family	?Narcolepsy 7, 614250 (3)	17(Mog)
6.332	2	26	08	6p21.1	MRPL2		Mitochondrial ribosomal protein L2	611822	R			
6.333	2	26	08	6p21.1	MRPL14, MRPL32		Mitochondrial ribosomal protein L14	611827	R			
6.334	4	24	08	6p21.1	MRPS18A, MRPS18-3		Mitochondrial ribosomal protein S18A	611981	R, REc			
6.335	4	24	08	6p21.33	MRPS18B, MRPS18-2		Mitochondrial ribosomal protein S18B	611982	REc	pseudogenes on chromosomes 1 and 2		
6.336	10	18	11	6p21.33	MUC22, PBMUCL1		Mucin 22	613917	REc			
6.337	7	2	02	6p21.3	MYAS1		Myasthenia gravis with thymus hyperplasia	607085	Fd		Myasthenia gravis with thymus hyperplasia (2)	
6.338	3	20	08	6p21.33	NCR3, 1C7, NKP30, CD337, MALS		Natural cytotoxicity triggering receptor 3	611550	REc		{Malaria, mild, susceptibility to}, 609148 (3)	
6.339	6	1	99	6p21.33	NEP, EDDR1, NTRK4, TRKE		Neuroepithelial tyrosine kinase	600408	A			17(Nep)
6.340	12	3	03	6p21.33	NEU1, NEU, SIAL1		Neuraminidase 1 (lysosomal sialidase; sialidase 1)	608272	H, F, A		Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)	17(Neu1)
6.341	3	3	03	6p21.33	NFKBIL1		Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1	601022	REn, Fd		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
6.342	12	9	91	6p21.1	NFYA		Transcription factor NF-Y, A subunit	189903	REa, A			17(Nfya)
6.343	8	29	91	6p21.3	NKS1, EC1		Susceptibility to lysis by alloreactive natural killer cells	272370	F			17(Hh1)
6.344	12	11	12	6p21.3	MBNP		Membranous nephropathy, susceptibility to	614692	Fd		{?Membranous nephropathy, susceptibility to} (2)	
6.345	11	4	98	6p21.32	NOTCH4, INT3		Notch, Drosophila, homolog of, 4	164951	A, REc			
6.346	11	3	09	6p21.3	NPCA2		Nasopharyngeal carcinoma, susceptibility to, 2	161550	Fd	associated with rs2517713 and rs2975042	{Nasopharyngeal carcinoma, susceptibility to, 2} (2)	
6.347	7	9	95	6p22.1	OR2H3, OLFR2		Olfactory receptor, family 2, subfamily H, member 3 (olfactory receptor 2)	600578	RE	in class I MHC region		
6.348	9	10	09	6p21.3	PBC2		Biliary cirrhosis, primary, 2	613007	Fd	associated with rs2856683	{Biliary cirrhosis, primary, 2} (2)	
6.349	9	10	09	6p21.3	PBCA		Pancreatic beta cell, agenesis of	600089	D	uniparental disomy	?Diabetes mellitus, insulin-dependent, neonatal (2)	
6.350	4	10	00	6p21.3	PBLT		Panbronchiolitis, diffuse	604809	Fd		Panbronchiolitis, diffuse (2)	
6.351	9	12	96	6p21.32	PBX2, HOX12, G17		Pre-B-cell leukemia transcription factor-2	176311	A			
6.352	4	27	12	6p21.3	PDCOS		Podoconiosis, susceptibility to	614590	Fd		{Podoconiosis, susceptibility to} (2)	
6.353	5	25	13	6p21.33	PPP1R10, PNUTS		Protein phosphatase 1, regulatory subunit 10	603771	REc			
6.354	9	8	11	6p21.33	PRRC2A, BAT2, D6S51E		Proline-rich coiled-coil protein 2A	142580	RE			
6.355	4	19	02	6p21.1	PTCRA		Pre-T-cell receptor, alpha-chain precursor	606817	A, REc			17(Ptcra)
6.356	11	20	98	6p21.32	PHF1		PHD finger protein-1	602881	A			
6.357	9	12	93	6p21.33	POU5F1, OTF3, OCT3		Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3)	164177	REa, Fd, A, REn	OTF3L on 12; ?related pseudogene on chr.8		17(Otf3)
6.358	2	4	02	6p22.1	PPP1R11, TCTEX5		Protein phosphatase 1, regulatory subunit 11	606670	REc			17(Ppp1r11)
6.359	4	27	17	6p21.33	PPP1R18, KIAA1949		Protein phosphatase 1 regulatory subunit 18	610990	REc			
6.360	11	19	98	6p21.32	PPT2		Palmitoyl-protein thioesterase-2	603298	REc			
6.361	7	19	18	6p21.32	PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1		Proteasome subunit, beta type, 8 (large multifunctional protease-7)	177046	REn	between TAP1 and TAP2	Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3)	
6.362	7	19	18	6p21.32	PSMB9, LMP2, RING12, PRAAS3		Proteasome subunit, beta type, 9	177045	REn	mutation identified in 1 digenic family	?Proteasome-associated autoinflammatory syndrome 3, digenic, 617591 (3)	17(Lmp2)
6.363	3	5	98	6p21.32	RAB2L		RAB2, member RAS oncogene family-like	602306	A			
6.364	10	19	88	6p21.33	RDBP		RD RNA-binding protein	154040	REn	between C4 and BF		17(rd)
6.365	3	5	98	6p21.32	RING1, RNF1		RING finger protein-1	602045	REc			
6.366	6	10	98	6p21.32	RNF5, RING5		RING finger protein-5	602677	A, R			
6.367	1	2	08	6p21.2	RNF8, KIAA0646		Ring finger protein 8	611685	R, Psh			
6.368	2	28	01	6p22.1	RNF9, RFB30, HERF1		RING finger protein-9	605701	REc			
6.369	4	29	03	6p22.1	RNF39, HZFW, HZF, LIRF		Ring finger protein 39	607524	REc			
6.370	12	14	95	6p21.32	RPS18		Ribosomal protein S18	180473	REn			17(Ke3)
6.371	10	23	87	6p21.3	RWS		Ragweed sensitivity	179450	F	?linkage or association, with HLA	?Ragweed sensitivity (2)	
6.372	3	22	93	6p21.32	RXRB		Retinoid X receptor, beta	180246	H, REa, Psh, A			17(Rxrb)
6.373	7	11	12	6p21.31	SCUBE3		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 3	614708	REc			17(Scube3)
6.374	8	27	15	6p21.33	SEEK1, C6orf16, PSORS1C1		SEEK1 gene	613525	REc			
6.375	8	20	07	6p22.2	SLC17A2, NPT3		Solute carrier family 17 (sodium phosphate cotransporter), member 2	611049	REc			
6.376	2	25	16	6p22.2	SLC17A3, NPT4, UAQTL4, GOUT4		Solute carrier family 17 (sodium phosphate cotransporter), member 3	611034	REc, Fd		[Uric acid concentration, serum, QTL4], 612671 (3); {Gout susceptibility 4}, 612671 (3)	
6.377	6	1	04	6p21.32	SLC39A7, D6S2244E, HKE4		Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of)	601416	REl			17(Ke4)
6.378	8	7	17	6p21.33	SLC44A4, CTL4, C6orf29, DFNA72		Solute carrier family 44, member 4	606107	REc	mutation identified in 1 DFNA72 family	?Deafness, autosomal dominant 72, 617606 (3)	
6.379	8	25	04	6p21.31	SPDEF, PDEF		SAM pointed domain-containing ETS transcription factor	608144	REc			
6.380	5	25	00	6p21.33	STK19		Serine/threonine protein kinase 19	604977	REc			
6.381	3	7	13	6p21.32	SYNGAP1, MRD5		Synaptic Ras GTPase activating protein 1	603384	REc		Mental retardation, autosomal dominant 5, 612621 (3)	
6.382	10	14	05	6p21.32	TAP1, ABCB2, RING4, PSF1		Transporter 1, ATP-binding cassette, subfamily B	170260	REn	~7kb telomeric to TAP2	Bare lymphocyte syndrome, type I, 604571 (3)	17(Ham1)
6.383	09	11	18	6p21.32	TAP2, ABCB3, PSF2, RING11		Transporter 2, ATP-binding cassette, subfamily B	170261	REn	tel-TAP1-LMP2-LMP1-TAP2-cen	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	17(Ham2)
6.384	10	25	02	6p21.32	TAPBP, TPSN		TAP-binding protein (tapasin)	601962	A, REa		Bare lymphocyte syndrome, type I, 604571 (3)	17(Tapbp)
6.385	1	1	96	6p21.33	TCF19, SC1		Transcription factor-19 (SC1)	600912	REc			
6.386	8	9	99	6p21.31	TEAD3, TEF5, TEAD5		TEA domain family member 3 (transcriptional enhancer factor 5)	603170	A, R			17(Tead3)
6.387	6	23	06	6p21.33	TNF, TNFA		Tumor necrosis factor (cachectin)	191160	REa, A, RE	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	{Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock, susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to}, 157300 (3)	17(Tnfa)
6.388	5	31	18	6p21.33-p21.32	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8		Tenascin XB	600985	REn		Ehlers-Danlos syndrome, classic-like, 1 606408 (3); Vesicoureteral reflux 8, 615963 (3)	
6.389	1	7	16	6p21.33	TUBB, TUBB5, M40, CDCBM6, CSCSC1		Tubulin, beta polypeptide	191130	REa, D		Cortical dysplasia, complex, with other brain malformations 6, 615771 (3); Symmetric circumferential skin creases, congenital, 1, 156610 (3)	
6.390	3	28	11	6p21.31	TULP1, RP14, LCA15		Tubby-like protein-1	602280	Fd, A		Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15, 613843 (3)	
6.391	8	20	08	6p22.1	UBD, FAT10		Ubiquitin D	606050	REc			
6.392	12	8	17	6p21.33	VARS, VARS1, G7A, VARS2, NDMSCA		Valyl-tRNA synthetase	192150	REc		Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3)	17(Vars2)
6.393	8	5	14	6p21.33	VARS2, KIAA1885, COXPD20		Valyl-tRNA synthetase 2	612802	REc		Combined oxidative phosphorylation deficiency 20, 615917 (3)	
6.394	11	19	11	6p21.3	VAMAS6		Vitiligo-associated multiple autoimmune disease susceptibility 6	193200	Fd	possible second locus on 1p31.3-p32.2	{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2)	
6.395	7	18	14	6p21.32	VPS52, SACM2L		Vacuolar protein sorting 52 homolog (S. cerevisiae)	603443	REc			
6.396	8	27	15	6p21.32	WDR46, BING4		WD repeat-containing protein 46	611440	REc			
6.397	09	11	18	6p21.3	GPA, WG		Granulomatosis with polyangiitis	608710	Fd		Granulomatosis with polyangiitis (2)	
6.398	2	28	07	6p21.3	WM1		Macroglobulinemia, Waldenstrom, susceptibility to, 1	153600	Fd	linked to HLA	{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)	
6.399	8	27	15	6p21.32	ZBTB22, BING1		Zinc finger- and BTB domain-containing protein 22	611439	REc			
6.400	12	4	95	6p22.1	ZNF173		Zinc finger protein-173	600830	REn			
6.401	10	20	99	6p22.1	ZNF184		Zinc finger protein-184	602277	REf			
6.402	3	5	98	6p22.1	ZNF192		Zinc finger protein-192	602240	REc			
6.403	3	5	98	6p22.1	ZNF193		Zinc finger protein-193	602246	REc			
6.404	11	17	98	6p21.3	ZNF204		Zinc finger protein-204	603282	A, Psh	?pseudogene		
6.405	8	26	98	6p21.31	BAK1		BCL2-antagonist/killer 1	600516	REa, H, REc	centromeric to MHC region		17(bak)
6.406	9	16	88	6p21.3-p21.2	CP20		Lymphocyte cytosolic protein, molecular weight 20kD	153380	LD			
6.407	5	31	05	6p21.31	FKBP5, FKBP51		FK506-binding protein 5	602623	REc		{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	
6.408	1	20	11	6p21.2	GLO1		Glyoxalase I	138750	F, S, Fd	~3cM proximal to HLA		17(Glo1)
6.409	10	23	87	6p21.3-p21.2	LAP		Laryngeal adductor paralysis	150270	F	?linkage to HLA and GLO1	?Laryngeal adductor paralysis (2)	
6.410	12	4	95	6p21.31	MAPK14, CSBP1		Mitogen-activated protein kinase 14 (cytokine suppressive anti-inflammatory drug binding protein 1)	600289	Psh, A			
6.411	5	29	12	6p21.3-p21.2	MPVQTL4		Mean platelet volume quantitative trait locus 4	614644	Fd	associated with rs210134	Mean platelet volume QTL4 (2)	
6.412	11	5	92	6p21.31	TCP11, D6S230E		T-complex homolog tcp-11	186982	REa, R, A, REc	expressed only in testis at same time as ZNF76 (day 20 after birth)		17(tcp11)
6.413	11	5	92	6p21.31	ZNF76, D6S229E		Zinc finger protein-76 (expressed in testis)	194549	REa, R, A, REc	same 300kb fragment as TCP11		17(Znf76)
6.414	10	11	99	6p21.33	LST1, D6S49E, B144		Leukocyte-specific transcript 1 (B144 protein)	109170	RE, REn	10kb 3' from TNFA		
6.415	3	27	90	6p21.1	PGC		Preprogastricsin	169740	REa, F, REb	cen-PGG-GLO1-HLA		17(Upg1)
6.416	8	12	91	6p21.1	TCTE1		T-complex-associated-testis-expressed-1	186975	A, Fd			
6.417	3	7	13	6p21.2	AD17		Alzheimer disease 17	615080	Fd	associated with rs75932628T	Alzheimer disease 17 (2)	
6.418	11	20	15	6p21.2	C6orf89, BRAP, AMFION		Bombesin receptor-activated protein	616642	REc			
6.419	2	4	15	6p21.2	CMTR1, MTR1, ISG95, FTSJD2, KIAA0082		CAP methyltransferase 1	616189	REc, R			
6.420	9	10	09	6p21.2	DAAM2, KIAA0381		Dishevelled-associated activator of morphogenesis 2	606627	R, REc			
6.421	11	11	14	6p21.2	FGD2		FYVE, RhoGEF, and PH domain-containing protein 2	605091	R, H			17(Fgd2)
6.422	7	15	09	6p21.2-p21.1	LRFN2, SALM1, KIAA1246		Leucine-rich repeat and fibronectin type III domain-containing protein 2	612808	R, REc, H			17(Lrfn2)
6.423	11	23	16	6p21.2	PANDAR		Promoter of CDKN1A antisense DNA damage-activated RNA	617179	REn, REc			
6.424	11	6	92	6p21.2	PIM1		Oncogene PIM1	164960	REa, D, Fd			17(Pim1)
6.425	10	17	95	6p21.2	CDKN1A, WAF1, CIP1, CDKN1		Cyclin-dependent kinase inhibitor 1A (p21, Cip1)	116899	A			17(Waf1)
6.426	9	7	12	6p21.2	MTCH1, PSAP		Mitochondrial carrier homolog 1	610449	REc, R			
6.427	3	29	16	6p21.2	TBC1D22B, C6orf197		TBC1 domain family, member 22B	616880	REc			
6.428	6	2	15	6p21.2	TP53COR1		Tumor protein p53 pathway corepressor 1, noncoding	616343	REc			17(Tp53cor1)
6.429	12	11	02	6p21.1	TREM2		Triggering receptor expressed on myeloid cells 2	605086	REa		Nasu-Hakola disease, 221770 (3)	
6.430	4	30	09	6p12.3	CRISP1, AEGL1		Cysteine-rich secretory protein 1	601193	A			17(Aeg1)
6.431	5	22	18	6p21.1	GTPBP2, JABELS		GTP-binding protein 2	607434	A, R, REc		Jaberi-Elahi syndrome, 617988 (3)	17(Gtpbp2)
6.432	11	22	02	6p21.2	KCNK16, TALK1		Potassium channel, subfamily K, member 16	607369	REc			
6.433	11	22	02	6p21.2	KCNK17, TASK4, TALK2		Potassium channel, subfamily K, member 17	607370	REc			
6.434	1	16	96	6p12.3	MEP1A		Meprin A, alpha	600388	REa, R, REc, Fd			17(Mep1a)
6.435	9	23	96	6p21.31	PPARD, NUC1		Peroxisome proliferative activated receptor, delta	600409	Psh, A			
6.436	1	29	01	6p21.1	SLC22A7, OAT2		Solute carrier family 22 (organic anion transporter), member 7	604995	R			
6.437	3	5	98	6p21.1	SLC29A1, ENT1		Solute carrier family 29 (nucleoside transporters), member 1 (equilibrative nucleoside transporter-1)	602193	A			
6.438	3	6	14	6p21.2	TDRG1, LINC00532		Testis development-related gene 1, noncoding	615676	REc			
6.439	12	23	05	6p21.1	YIPF3, KLIP1		YIP1 domain family, member 3	609775	R			
6.440	10	18	11	6p12.3	PLA2G7, PAFAH, PAFAD		Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)	601690	A		Platelet-activating factor acetylhydrolase deficiency, 614278 (3); {Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)	
6.441	2	18	96	6p22.1	ZNF165, LD65		Zinc finger protein-165	600834	REa, A, REc			
6.442	8	11	14	6p21.1	AARS2, KIAA1270, MTALARS, COXPD8, LKENP		Alanyl-tRNA synthetase 2	612035	R, REc		Combined oxidative phosphorylation deficiency 8, 614096 (3); Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	
6.443	12	24	08	6p21.1	ABCC10, MRP7		ATP-binding cassette, subfamily C, member 10	612509	Psh, R, REc, A			
6.444	6	18	99	6p21.1	BYSL		By the ribosomal protein S6 gene, Drosophila, homolog-like (bystin)	603871	A			
6.445	4	17	14	6p21.1	CUL7, 3M1		Cullin 7	609577	REa, Fd		3-M syndrome 1, 273750 (3)	
6.446	6	13	12	6p21.1	CUL9, PARC, KIAA0708		Cullin 9	607489	REc			
6.447	6	26	16	6p21.1	ENPP4, NPP4, KIAA0879		Ectonucleotide pyrophosphatase/phosphodiesterase 4	617000	R, REc			
6.448	6	26	16	6p21.1	ENPP5, NPP5		Ectonucleotide pyrophosphatase/phosphodiesterase 5	617001	REc			
6.449	9	15	10	6p21.1	FOXP4		Forkhead box P4	608924	REc			
6.450	4	28	10	6p21.1	GUCA1A, GCAP, COD3, CORD14		Guanylate cyclase activator 1A, retina	600364	Psh, A		Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)	
6.451	3	24	11	6p21.1	GUCA1B, GCAP2, GUCA2, RP48		Guanylate cyclase activator 1B, retina	602275	REa, A		Retinitis pigmentosa 48, 613827 (3)	
6.452	9	8	08	6p21.1	HSP90AB1, HSPCB, HSPC2, HSP90B		Heas-shock protein, 90kD, alpha, class B, member 1	140572	Psh, REn			
6.453	8	19	13	6p21.1	KLHDC3, PEAS		KELCH domain-containing protein 3	611248	REc			17(Klhdc3)
6.454	10	09	18	6p21.1	MAD2L1BP		MAD2L1-binding protein	618136	REc			
6.455	7	22	09	6p21.1	MED20, TRFP		Mediator complex subunit 20	612915	REc			
6.456	12	28	08	6p21.1	NCR2, LY95, NKP44		Natural cytotoxicity triggering receptor 2 (lymphocyte antigen 95, mouse, homolog of)	604531	REa, REc			17(Ncr2)
6.457	10	18	15	6p21.1	NFKBIE, IKBE		Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, epsilon	604548	REc			
6.458	10	26	15	6p21.1	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2		Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498	REa, H, A		Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3); Peroxisome biogenesis disorder 4B, 614863 (3); Heimler syndrome 2, 616617 (3)	17(Pxaaa1)
6.459	5	28	99	6p21.2	PPIL1, CYPL1		Peptidylprolyl isomerase (cyclophilin)-like 1	601301	A, R	previously assigned to chr.2		
6.460	5	12	15	6p21.1	PPP2R5D, MRD35		Protein phosphatase-2, regulatory subunit B (B56), delta isoform	601646	A		Mental retardation, autosomal dominant 35, 616355 (3)	
6.461	11	30	10	6p21.1	PPR1		Photoparoxysmal response 1	132100	Fd	max lod at D6S2427	Photoparoxysmal response 1 (2)	
6.462	4	21	17	6p21.1	RPL7L1		Ribosomal protein L7-like 1	617417	REc			
6.463	9	29	10	6p21.1	RRP36, C6orf153		Ribosomal RNA-processing factor, 36	613475	REc			
6.464	3	19	09	6p21.1	RSPH9, CILD12		Radial spoke head 9, Chlamydomonas, homolog of	612648	REc		Ciliary dyskinesia, primary, 12, 612650 (3)	
6.465	10	2	12	6p21.1	SRF		Serum response factor	600589	REc			
6.466	11	22	13	6p21.1	SUPT3H, SPT3		Suppressor of Ty 3, S. cerevisiae, homolog of	602947	REc			
6.467	8	18	14	6p21.1	TBCC, CFC		Tubulin-specific chaperone C	602971	REc			
6.468	3	23	09	6p21.1	TJAP1, PILT, TJP4		Tight junction-associated protein 1	612658	REc			
6.469	1	12	15	6p21.1	TOMM6, TOM6		Translocase of outer mitochondrial membrane 6, yeast, homolog of	616168	REc			
6.470	8	19	13	6p21.1	TRERF1, TREP132		Transcriptional regulating factor 1	610322	REc, R			
6.471	12	28	08	6p21.1	TREM1		Triggering receptor expressed on myeloid cells 1	605085	REa			17(Trem1)
6.472	12	28	08	6p21.1	TREML1, TLT1		Triggering receptor expressed on myeloid cells-like protein 1	609714	REc, H			17(Treml1)
6.473	12	28	08	6p21.1	TREML2, TLT2		Triggering receptor expressed on myeloid cells-like protein 2	609715	REc, H			17(Treml2)
6.474	12	28	08	6p21.1	TREML3, TLT3		Triggering receptor expressed on myeloid cells-like protein 3	609716	REc, H			17(Treml3)
6.475	4	1	08	6p21.1	UBR2, C6orf133, KIAA0349		Ubiquitin-protein ligase E3 component N-recognin 2	609134	R, A, H			17(Ubr2)
6.476	4	26	17	6p21.1	UNC5CL, ZUD		Unc5 family C-terminal-like protein	617464	REc			
6.477	12	23	05	6p21.1	XPO5, KIAA1291		Exportin 5	607845	R, REc			
6.478	6	12	17	6p21.1	ZNF318, TZF, ZFP318		Zinc finger protein 318	617512	REc			
6.479	11	24	14	6p21.1	CLIC5, DFNB103		Chloride intracellular channel 5	607293	REc	mutation identified in 1 DFNB103 family	?Deafness, autosomal recessive 103, 616042 (3)	
6.480	4	23	08	6p21.1	MRPS10		Mitochondrial ribosomal protein S10	611976	REc	5 pseudogenes on chromosomes 1, 3, and 9		
6.481	7	3	06	6p12.3	TFAP2D, TFAP2BL1		Transcription factor AP2-delta	610161	REc			
6.482	2	21	03	6p21.1-p12.2	MGR3		Migraine with or without aura, susceptibility to, 3	607498	Fd	lod 5.78 at D6S452	{Migraine with or without aura, susceptibility to, 3} (2)	
6.483	6	25	97	6p21.1	PTK7		PTK7 protein tyrosine kinase 7	601890	REa, A			
6.484	4	19	02	6p12.3	PGK2		Phosphoglycerate kinase-2 (testicular PGK)	172270	REa, A, REb	pseudogene on chr.12		17(Pgk2)
6.485	1	23	01	6p21.1	POLH, XPV		Polymerase, DNA, eta	603968	R, REa, A		Xeroderma pigmentosum, variant type, 278750 (3)	
6.486	5	7	01	6p12.3	CYP39A1		Cytochrome P450, subfamily XXXIXA (oxysterol 7-alpha-hydroxylase), polypeptide 1	605994	R			17(Cyp39a1)
6.487	5	17	18	6p12.3	RHAG, RH50A, OHST, RHNR		Rhesus blood group-associated glycoprotein	180297	REa, A		Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Overhydrated hereditary stomatocytosis, 185000 (3)	
6.488	7	19	18	6p21.1	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1		Peripherin 2, mouse, homolog of	179605	REa, A	digenic RP with ROM1	Retinitis pigmentosa 7 and digenic form, 608133 (3); Leber congenital amaurosis 18, 608133 (3); Macular dystrophy, patterned, 1, 169150 (3); Retinitis punctata albescens, 136880 (3); Choroidal dystrophy, central areolar 2, 613105 (3); Macular dystrophy, vitelliform, 3, 608161 (3)	17(rds)
6.489	1	29	01	6p21.1	APOBEC2		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2	604797	R, H			17(Apobec2)
6.490	7	16	09	6p21.2	BTBD9, KIAA1880		BTB/POZ domain-containing protein 9	611237	REc			
6.491	7	12	92	6p21.1	CCND3		Cyclin D3	123834	REa, A	pseudogene also on 6p21		
6.492	8	11	98	6p21.1	CDC5L		Cell division cycle 5, S. pombe, homolog-like	602868	REc, A			
6.493	10	20	99	6p21.2	CPNE5, CPN5		Copine V	604209	REc			
6.494	9	5	07	6p21.2	DNAH8, HDHC9		Dynein, axonemal, heavy chain 8	603337	REc			
6.495	8	25	04	6p21	EJM3		Epilepsy, juvenile myoclonic 3	608816	Fd		Epilepsy, juvenile myoclonic 3 (2)	
6.496	7	22	09	6p21.31	ETV7, TEL2, TELB		ETS variant gene 7	605255	A, REc			
6.497	5	9	95	6p21.2	GLP1R		Glucagon-like peptide 1 receptor	138032	A			17(Glp1r)
6.498	5	23	11	6p21.31	HMGA1, HMGIY		High-mobility group AT-hook 1	600701	Psh, R		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
6.499	9	30	02	6p21.31	IHPK3, INSP6K3, IP6K3		Inositol hexaphosphate kinase 3	606993	REc	pseudogene on 6p24.1		
6.500	6	18	99	6p21.2	KCNK5, TASK2		Potassium channel, subfamily K, member 5	603493	R			
6.501	4	26	11	6p21.2	KIF6		Kinesin family member 6	613919	REc			
6.502	4	29	02	6p21	LATD		Laterality defects, autosomal dominant	601086	Fd	max lod 2.95 at theta = 0		
6.503	3	31	09	6p22.1	MAS1L, MRG		MAS1 oncogene-like	607235	REc			
6.504	10	4	05	6p21.2	MDGA1, GPIM		MAM domain-containing glycosylphosphatidylinositol anchor 1	609626	REc			
6.505	7	6	00	6p21.1	MDFI		MYOD family inhibitor	604971	R			17(Mdfi)
6.506	5	31	05	6p12.3	MUT, MCM		Methylmalonyl Coenzyme A mutase	609058	REa, A, F, D		Methylmalonic aciduria, mut(0) type, 251000 (3)	17(Mut)
6.507	12	27	01	6p21.31	PACSIN1, KIAA1379		Protein kinase C and casein kinase substrate in neurons 1	606512	R			
6.508	7	16	09	6p21	RLS6		Restless legs syndrome, susceptibility to, 6	611185	Fd	associated with rs9296249 and rs9357271	{Restless legs syndrome 6} (2)	
6.509	1	13	09	6p22.1	RPP21		Ribonuclease P/MRP, 21kD subunit	612524	REc			
6.510	3	15	13	6p21.1	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD		Runt-related transcription factor 2	600211	A, REc, Ch, Fd		Cleidocranial dysplasia, 119600 (3); Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3); Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3); Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	17(Cbfa1)
6.511	4	27	12	6p21.33	SKIV2L, SKI2, SKI2W, THES2		Superkiller viralicidic activity 2, S. cerevisiae, homolog, like	600478	A		Trichohepatoenteric syndrome 2, 614602 (3)	
6.512	12	19	11	6p21.3-p21.2	SRSF3, SFRS3, SRP20		Splicing factor, arginine/serine-rich, 3	603364	R, REc			17(Sfrs3)
6.513	9	10	09	6p21.31	STK38, NDR		Serine/threonine protein kinase 38	606964	R, REc			
6.514	10	1	95	6p21.1	TFEB, TCFEB		Transcription factor EB	600744	H			17(Tcfeb)
6.515	5	29	12	6p21.1	TREML4, TLT4		Triggering receptor expressed on myeloid cells-like protein 4	614664	REc			17(Treml4)
6.516	4	20	17	6p12.3	ADGRF1, GPR110		Adhesion G protein-coupled receptor F1	617430	REc			
6.517	9	1	16	6p12.3	ADGRF4, GPR115		Adhesion G protein-coupled receptor F4	614268	REc			
6.518	10	8	07	6p12.3	CENPQ		Centromeric protein Q	611506	REc			
6.519	7	25	18	6p12.3	CRISP3, SGP28		Cysteine-rich secretory protein 3	618062	REc			
6.520	8	21	12	6p12.3	GLYATL3		Glycine N-acyltransferase-like 3	614763	REc			
6.521	4	6	18	6p12.1	ICK, MRK, KIAA0936, ECO, EJM10		Intestinal cell kinase	612325	R, REc		Endocrine-cerebroosteodysplasia, 612651 (3); {Epilepsy, juvenile myoclonic, susceptibility to, 10}, 617924 (3)	
6.522	3	7	14	6p12.3	OPN5, GRP136, PGR12		Opsin 5	609042	REc			
6.523	4	21	16	6p12.3	PTCHD4, PTCH53, C6orf138		Patched domain-containing protein 4	616908	REc			
6.524	9	24	08	6p12.3	RCAN2, ZAKI4, DSCR1L1, MCIP2, CSP2		Regulator of calcineurin 2	604876	R, REc			
6.525	7	8	11	6p12.3	SLC25A27, UCP4		Solute carrier family 25, member 17	613725	REc			
6.526	5	26	13	6p12.3	TDRD6		TUDOR domain-containing protein 6	611200	REc			
6.527	10	29	03	6p12.1	LRRC1, LANO		Leucine-rich repeat-containing protein 1	608195	REc			
6.528	8	7	17	6p12.3-p12.2	FCYT, PKHD1, ARPKD, PKD4		Fibrocystin	606702	Fd, H, REc		Polycystic kidney disease 4, with or without hepatic disease, 263200 (3)	13(Pkhd1)
6.529	3	24	06	6p12.1	COL21A1		Collagen, type XXI, alpha-1 polypeptide	610002	R, REc			
6.530	9	9	08	6p12.1	FBXO9, FBX9		F-box only protein 9	609091	REc			9(Fbxo9)
6.531	3	6	94	6p12.2	GSTA1		Glutathione S-transferase A1	138359	REn, REc			
6.532	12	6	91	6p12.2	GSTA2, GST2		Glutathione S-transferase A2	138360	A, REa			9(Gsta)
6.533	3	11	03	6p12.2	GSTA3		Glutathione S-transferase, alpha-3	605449	R, REc			
6.534	3	11	03	6p12.2	GSTA4		Glutathione S-transferase, alpha-4	605450	A, REc			
6.535	3	10	03	6p12.2	GSTA5		Glutathione S-transferase, alpha-5	607605	REc			
6.536	11	16	98	6p12.2	IL17A, IL17, CTLA8		Interleukin-17a	603149	A, REc	previously mapped to 2q31		1(Il17)
6.537	12	12	12	6p12.2	LINCMD1		Long intergenic noncoding RNA, muscle differentiation 1	614933	REc			
6.538	3	20	16	6p12.2	TMEM14A		Transmembrane protein 14A	616870	REc			
6.539	3	23	09	6p12.2	MIR133B, MIRN133B		Micro RNA 133B	610946	REc			
6.540	3	23	09	6p12.2	MIR206, MIRN206		Micro RNA 206	611599	REc			1(Mirn206)
6.541	8	8	13	6p12.2	TRAM2, KIAA0057		Translocation-associated membrane protein 2	608485	REc, Psh			
6.542	11	19	11	6p12.2-q12	MRT24		Mental retardation, autosomal recessive 24	614345	Fd	between rs651733 and rs1508668	Mental retardation, autosomal recessive 24 (2)	
6.543	9	1	09	6p12.1	BMP5		Bone morphogenetic protein-5	112265	REa, REc			
6.544	3	31	15	6p12.1	GCM1, GCMA		Glial cells missing, Drosophila, homolog of, 1	603715	A, REc			
6.545	1	30	18	6p12.1	GFRAL, GRAL		GDNF family receptor alpha-like protein	617837	REc			
6.546	9	27	17	6p12.1	HCRTR2, OX2R		Hypocretin receptor 2	602393	REc, R			
6.547	9	8	11	6p12.1	MLIP, C6orf142		Muscular LMNA-interating protein	614106	REc			
6.548	12	7	04	6p12.2	RN7SK, 7SK		RNA, 7SK small nuclear	606515	REa			
6.549	3	25	14	6p12.1	ZNF451, COASTER		Zinc finger protein 451	615708	REc			
6.550	3	8	07	6p21.1	SLC35B2, PAPST1, SLL		Solute carrier family 35 (3'-phosphoadenosine 5')-phosphosulfate transporter), member B2	610788	REc			
6.551	4	19	12	6p12.2	PAQR8, C6orf33, LMPB1, MPRB		Progestin and ADIPOQ receptor family, member 8	607780	REn			
6.552	1	29	01	6p21.1	CAPN11		Calpain 11	604822	REa, R			
6.553	10	28	08	6p12.3	CD2AP, CMS		CD2-associated protein	604241	R, REc		Glomerulosclerosis, focal segmental, 3, 607832 (3)	
6.554	4	30	09	6p12.3	CRISP2, TPX1, TSP1		Cysteine-rich secretory protein 2	187430	REa			17(Tpx1)
6.555	5	23	13	6p12.3	DEFB114, DEFB14		Defensin, beta, 114	615243	REc			
6.556	9	20	14	6p12.1	ELOVL5, HELO1, SCA38		Elongation of very long chain fatty acids-like 5	611805	REc		Spinocerebellar ataxia 38, 615957 (3)	
6.557	1	6	09	6p12.1	GCLC, GLCLC		Glutamate-cysteine ligase, catalytic subunit	606857	REa, Psh, A, Fd		Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)	9(Glclc)
6.558	1	24	02	6p21.1	GNMT		Glycine N-methyltransferase	606628	A		Glycine N-methyltransferase deficiency, 606664 (3)	
6.559	6	22	15	6p12.2	IL17F, ML1, CANDF6		Interleukin 17F	606496	R	mutation identified in 1 CANDF6 family	?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	
6.560	2	7	07	6p12.1	KLHL31, KLHL		Kelch-like 31	610749	REc, H			9(Klhl31)
6.561	11	4	98	6p12.2	MCM3		Minichromosome maintenance, S. cerevisiae, homolog of, 3	602693	A			
6.562	4	16	14	6p12	NYS2, NYSA		Nystagmus 2, congenital, autosomal dominant	164100	Fd		Nystagmus 2, congenital, autosomal dominant (2)	
6.563	7	14	16	6p12.3	TFAP2B, CHAR, PDA2		Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	601601	A, Fd		Char syndrome, 169100 (3); Patent ductus arteriosus 2, 617035 (3)	1(Tfap2b)
6.564	2	18	09	6p21.1	VEGF, MVCD1		Vascular endothelial growth factor	192240	A		{Microvascular complications of diabetes 1}, 603933 (3)	
6.565	3	3	03	6p12.1	TINAG, TIN1, TIN2		Tubulointerstitial nephritis antigen	606749	A			
6.566	10	1	95	6p11.2	PRIM2A		Primase polypeptide 2A, 58kD	176636	Psh, A			2(Prim2)
6.567	7	30	14	6p12.1	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2		Dystonin (bullous pemphigoid antigen 1)	113810	A, REa	?mutation identified in 1 HSAN6 family	?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3); Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	1(Bpag1)
6.568	10	6	09	6p12.2	EFHC1, FLJ10466, EJM1, JAE, EJA1		EF hand domain (C-terminal)-containing 1	608815	REc		{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3); {Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	
6.569	7	22	13	6p12-q12	CTRCT28, ARCC1		Cataract 28	609026	Fd		{Cataract 28, age-related cortical, susceptibility to} (2)	
6.570	5	25	13	6p12.1	BAG2		BCL2-associated athanogene 2	603882	REc			
6.571	10	30	03	6p11	AITD1		Autoimmune thyroid disease, susceptibility to, 1	608173	Fd		{Autoimmune thyroid disease, susceptibility to, 1} (2)	
6.572	5	31	07	6p12.1-p11.2	RAB23		Ras-associated protein RAB23	606144	REc, Fd		Carpenter syndrome, 201000 (3)	
6.573	10	23	87	6p	CSCI		Corticosterone side-chain isomerase	122550	H	?linked to MHC		
6.574	3	29	10	6p21.31	RPS10, DBA9		Ribosomal protein S10	603632	R, RE		Diamond-Blackfan anemia 9, 613308 (3)	
6.575	4	14	05	6q	BPPV		Vertigo, benign paroxysmal positional	193007	Fd	max lod at D6S1556	Vestibulopathy, familial (2)	
6.576	8	9	99	6q23.2	RPS12		Ribosomal protein S12	603660	Psh, R			
6.577	8	31	10	6q11-q14	DEL6q11q14, C6DELq11q14		Chromosome 6q11-q14 deletion syndrome	613544	Ch	contiguous gene deletion syndrome	Chromosome 6q11-q14 deletion syndrome (4)	
6.578	5	24	13	6q11.1	KHDRBS2, SLM1		KH domain-containing, RNA-binding, signal transduction-associated protein 2	610487	REc			
6.579	9	30	04	6q12	ADHD3		Attention deficit-hyperactivity disorder, susceptibility to, 2	608905	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
6.580	9	1	16	6q12-q13	ADGRB3, BAI3		Adhesion G protein-coupled receptor B3	602684	A			
6.581	9	5	03	6q14.1	COX7A2		Cytochrome c oxidase, subunit VIIa, polypeptide-2, liver	123996	R	previously thought to be on chr.4		
6.582	11	20	08	6q12	EYS, RP25		Eyes shut, Drosophila, homolog of	612424	Fd, REc		Retinitis pigmentosa 25, 602772 (3)	
6.583	10	23	87	6q14.2	ME1		Malic enzyme, cytoplasmic	154250	S			9(Mod1)
6.584	6	27	14	6q14.1	PGM3, AGM1, IMD23		Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1)	172100	S, F, OT, REa		Immunodeficiency 23, 615816 (3)	9(Pgm3)
6.585	5	22	03	6q12	PHF3, KIAA0244		PHD finger protein 3	607789	A, R			
6.586	3	1	01	6q12	PTP4A1, HH72, PRL1		Protein tyrosine phosphatase, type 4A, 1	601585	A			
6.587	12	4	03	6q13	DDX43, HAGE		DEAD/H box 43	606286	R			
6.588	10	11	07	6q13	RIMS1, RIM1, RIM, KIAA0340, CORD7		Regulating synaptic membrane exocytosis 1	606629	R, REc, Fd		Cone-rod dystrophy 7, 603649 (3)	
6.589	3	2	01	6q13	COL19A1, D6S228E, COL9A1L		Collagen XIX, alpha-1 polypeptide	120165	A, REa			1(Col19a1)
6.590	11	19	11	6q12-q15	MRT30		Mental retardation, autosomal recessive 30	614342	Fd	between rs4612125 and rs285651	Mental retardation, autosomal recessive 30 (2)	
6.591	1	30	01	6q12-q16	CMD1K		Cardiomyopathy, dilated, 1K	605582	Fd		Cardiomyopathy, dilated, 1K (2)	
6.592	5	29	91	6q14.3	CGA		Chorionic gonadotropin, alpha polypeptide	118850	REa, A	shared with LH, FSH, TSH		4(Tsha)
6.593	1	11	07	6q13	CD109		CD109 antigen	608859	REc			
6.594	12	8	14	6q13	COL9A1, EDM6, STL4		Collagen IX, alpha-1 polypeptide	120210	A	mutation identified in 1 EDM6 family	?Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome, type IV, 614134 (3)	1(Col9a1)
6.595	8	22	07	6q13	DPPA5, ESG1		Developmental pluripotency-associated gene 5	611111	R, REc			
6.596	3	3	03	6q13	GLCATS, KIAA1963		UDP-glucuronyltransferase S	607497	REc			1(Glcats)
6.597	8	20	92	6q14.1	HTR1B		5-hydroxytryptamine (serotonin) receptor-1B	182131	REa, A			
6.598	1	2	08	6q13	KHDC1		KH homology domain-containing protein 1	611688	REc			1(Khdc1)
6.599	3	7	13	6q13	KHDC3L, C6orf221, ECAT1, HYDM2		KH domain containing 3-like, subcortical maternal complex member	611687	REc		Hydatidiform mole, recurrent, 2, 614293 (3)	
6.600	10	17	12	6q13	LMBRD1, LMBD1, NESI, MAHCF		LMBR1 domain-containing protein 1	612625	REc		Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	
6.601	4	6	18	6q13	CGAS, MB21D1, C6orf150		Cyclic GMP-AMP synthase	613973	REc			
6.602	3	23	09	6q13	MIR30A, MIRN30A		Micro RNA 30A	612329	REc			
6.603	7	18	12	6q13	MTO1, COXPD10		Mitochondrial translation optimization 1, S. cerevisiae, homolog of	614667	REc		Combined oxidative phosphorylation deficiency 10, 614702 (3)	
6.604	1	7	11	6q14.1	MYO6, DFNA22, DFNB37		Myosin VI	600970	A, H, Fd		Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	9(Sv, Myo6)
6.605	1	2	08	6q13	OOEP, KHDC2		Oocyte-expressed protein, Dog, homolog of	611689	REc			9(Ooep)
6.606	12	28	08	6q14.1	SENP6, SSP1, SUSP1		Sentrin-specific protease family, member 6	605003	REc, R			
6.607	4	21	16	6q13	SMAP1		Small ADP-ribosylation factor GTPase-activating protein 1	611372	REc			
6.608	10	15	04	6q14.1	IBTK		Inhibitor of Bruton agammaglobulinemia tyrosine kinase	606457	R			
6.609	4	5	18	6q13-q14	COL12A1, UCMD2, BTHLM2, EDSMYP		Collagen, type XII, alpha-1	120320	REc	mutation identified in 1 UCMD2 family	?Ullrich congenital muscular dystrophy 2, 616470 (3); Bethlem myopathy 2, 616471 (3)	
6.610	12	30	14	6q14.1	IMPG1, IPM150, VMD4		Interphotoreceptor matrix proteoglycan-1	602870	Psh, A		Macular dystrophy, vitelliform, 4, 616151 (3)	
6.611	12	7	07	6q13-q16.1	OTSC7		Otosclerosis 7	611572	Fd	between D6S1036 and D6S300	Otosclerosis 7 (2)	
6.612	2	2	01	6q14.1	TTK, MPS1L1, PYT		TTK protein kinase	604092	REa, R			
6.613	5	5	09	6q13-q26	SCZD5		Schizophrenia susceptibility locus, chromosome 6q-related	603175	Fd	max lod at D6S1626 and D6S292	{Schizophrenia}, 181500 (2)	
6.614	10	30	06	6q14.1	BCKDHB, E1B		Branched chain keto acid dehydrogenase E1, beta polypeptide	248611	REa, A, REc		Maple syrup urine disease, type Ib, 248600 (3)	
6.615	8	20	98	6q13	EEF1A1, EF1A		Eukaryotic translation elongation factor-1, alpha-1	130590	A, Psh			
6.616	7	31	17	6q14.1	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34		Elongation of very long chain fatty acids 4	605512	Fd, REc		Stargardt disease 3, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3); Spinocerebellar ataxia 34, 133190 (3)	
6.617	8	4	17	6q13	KCNQ5, MRD46		Potassium channel, voltage-gated, KQT-like subfamily, member 5	607357	A		Mental retardation, autosomal dominant 46, 617601 (3)	
6.618	6	1	18	6q14.1	PHIP, DIDOD		Pleckstrin homology domain-interacting protein	612870	R, REc		Developmental delay, intellectual disability, obesity, and dysmorphic features, 617991 (3)	
6.619	5	3	18	6q14.1	TENT5A, FAM46A, C6orf37, OI18		Terminal nucleotidyltransferase 5A	611357	REc		Osteogenesis imperfecta, type XVIII, 617952 (3)	9(Fam46a)
6.620	8	19	98	6q15	CNR1		Cannabinoid receptor-1, brain	114610	Fd, A			4(Cnr1)
6.621	3	20	09	6q14.2	CYB5R4, NCB5OR		Cytochrome b5 reductase 4	608343	REc			
6.622	10	13	94	6q14.3	HTR1E		5-hydroxytryptamine (serotonin) receptor-1E	182132	Psh, A			
6.623	12	30	99	6q13	SLC17A5, SIASD, SLD		Solute carrier family 17 (sodium phosphate), member 5	604322	Fd, LD, REc		Salla disease, 604369 (3); Sialic acid storage disorder, infantile, 269920 (3)	
6.624	8	13	91	6q14.1	TPBG		Trophoblast glycoprotein	190920	REa			
6.625	12	29	06	6q15	ANKRD6, KIAA0957		Ankyrin repeat domain-containing protein 6	610583	R, REc			
6.626	10	5	07	6q14-q16	ATFB2		Atrial fibrillation, familial, 2	608988	Fd	max lod between D6S286 and D6S1021	Atrial fibrillation, familial, 2 (2)	
6.627	6	16	99	6q14-q16.2	PBCRA, CRAPB		Progressive bifocal chorioretinal atrophy	600790	Fd		Chorioretinal atrophy, progressive bifocal (2)	
6.628	5	22	92	6q15	GABRR1		Gamma-aminobutyric acid (GABA) A receptor, rho-1	137161	Psh, H			4(Gabbr1)
6.629	5	22	92	6q15	GABRR2		Gamma-aminobutyric acid (GABA) A receptor, rho-2	137162	Psh, H			4(Gabbr2)
6.630	7	8	11	6q14.3	NT5E, NT5		5' nucleotidase, ecto (CD73)	129190	S		Calcification of joints and arteries, 211800 (3)	
6.631	2	18	16	6q14.1	DOPEY1, DOP1, KIAA1117		DOPEY family member 1	616823	R, REc			
6.632	10	4	16	6q15	MAP3K7, TAK1, CSCF, FMD2		Mitogen-activated protein kinase kinase kinase 7	602614	Psh, REc		Cardiospondylocarpofacial syndrome, 157800 (3); Frontometaphyseal dysplasia 2, 617137 (3)	
6.633	9	2	09	6q14.1	FILIP, KIAA1275		Filamin A-interacting protein	607307	R, REc			
6.634	9	10	09	6q14.1	HMGN3, TRIP7		High-mobility group nucleosomal binding protein 3 (thyroid hormone receptor interactor 7)	604502	R, REc			
6.635	9	9	13	6q14.1	IRAK1BP1, SIMPL		Interleukin 1 receptor-associated kinase 1-binding protein 1	615375	REc			
6.636	9	10	07	6q14.1	LCA5, C6orf152		Lebercilin	611408	Fd, REc		Leber congenital amaurosis 5, 604537 (3)	
6.637	9	24	15	6q14.2	RIPPLY2, C6orf59, SCDO6		Ripply2, zebrafish, homolog of	609891	REc	mutation identified in 1 SCDO6 family	?Spondylocostal dysostosis 6, 616566 (3)	
6.638	3	7	14	6q14.1	SH3BGRL2		SH3 domain-binding glutamic acid-rich protein-like protein 2	615678	REc			
6.639	1	9	13	6q14.1	SHFLD2		Split-hand/foot malformation with long bone deficiency 2	610685	Fd	between rs623155 and rs1547251	Split-hand/foot malformation with long bone deficiency 2 (2)	
6.640	5	23	13	5q14.1	TBCA		Tubulin-specific chaperone A	610058	REc			
6.641	8	20	07	6q14.1	TMEM30A, CDC50A		Transmembrane protein 30A	611028	REc			
6.642	12	22	08	6q14.1	UBE2CBP, H10BH		Ubiquitin-conjugating enzyme E2C-binding protein	612495	REc			
6.643	4	29	16	6q14.2	MRAP2, C6orf117, BMIQ18		Melanocortin 2 receptor accessory protein 2	615410	REc	mutation identified in 1 BMIQ18 individual	{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	
6.644	2	25	15	6q14.2	SNAP91, AP180, KIAA0656		Synaptosomal-associated protein, 91kD	607923	REc, R			
6.645	6	4	15	6q14.2-q14.3	CEP162, KIAA1009		Centrosomal protein, 162kD	610201	R, REc			
6.646	5	13	15	6q14.3	SNX14, SCAR20		Sorting nexin 14	616105	REc		Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	
6.647	12	9	15	6q14.3	SYNCRIP, NSAP1, GRYRBP, HNRNPQ		Synaptotagmin-binding cytoplasmic RNA-interacting protein	616686	REc			
6.648	12	3	15	6q14.3	TBX18, CAKUT2		T-box 18	604613	REc		Congenital anomalies of kidney and urinary tract 2, 143400 (3)	
6.649	2	5	15	6q14.3	ZNF292, ZFP292, KIAA0530		Zinc finger protein 292	616213	REc, R, H			4(Znf292)
6.650	4	17	13	6q15	AKIRIN2		Akirin 2	615165	REc			
6.651	11	28	01	6q15	BACH2		BTB and CNC homology 2	605394	A			
6.652	8	31	17	3q22.3	STAG1, MRD47		Stromal antigen 1	604358	REc		Mental retardation, autosomal dominant 47, 617635 (3)	
6.653	9	1	09	6q15	CASP8AP2, FLASH		Caspase 8-associated protein 2	606880	R, REc			
6.654	4	1	08	6q15	GJA10, CX62		Gap junction protein, alpha-10	611924	REc			
6.655	4	1	08	6q14-q15	GJB7, CX25		Gap junction protein, beta-7	611921	REc			
6.656	9	10	09	6q15	ORC3, ORC3L, LAT		Origin recognition complex, subunit 3, S. cerevisiae, homolog of	604972	H, REc			4(Orc3)
6.657	8	18	14	6q15	PM20D2, ACY1L2		Peptidase M20 domain-containing 2	615913	REc			
6.658	3	11	08	6q15	PNRC1, PROL2		Proline-rich nuclear receptor coactivator 1	606714	R, REc			
6.659	7	10	07	6q15	SLC35A1, CST, CDG2F		Solute carrier family 35 (CMP-sialic acid transporter), member 1	605634	R, REc		Congenital disorder of glycosylation, type IIf, 603585 (3)	
6.660	3	4	10	6q14.3	SNHG5, U50HG		Small nucleolar RNA host gene 5	613263	REc			
6.661	11	12	09	6q14.3	SNORD50A, RNU50		Small nucleolar RNA, C/D box, 50A	613117	REc			
6.662	3	4	10	6q14.3	SNORD50B		Small nucleolar RNA, C/D box	613264	REc			
6.663	2	4	15	6q15	UBE2J1, UBC6E		Ubiquitin-conjugating enzyme E2J 1	616175	REc			
6.664	3	6	08	6q15	RRAGD, RAGD		RAS-related GTP-binding protein D	608268	R, REc			
6.665	5	5	09	6q15	SPACA1, SAMP32		Sperm acrosome-associated 1	612739	REc			
6.666	4	22	02	6q16.1	FUT9		Fucosyltransferase 9	606865	A			
6.667	10	7	08	6q16.1	MANEA, ENDO		Mannosidase, endo-alpha	612327	REc			
6.668	5	9	95	6q16.1	POU3F2, OCT7		POU domain, class 3, transcription factor 2	600494	REa, A			4(Pou3f2)
6.669	6	18	99	6q15	RNGTT, HCE1, CAP1A		RNA guanylyltransferase and 5'-phosphatase	603512	RE, R			
6.670	8	19	14	6q16.1	EPHA7, HEK11		Ephrin receptor EphA7	602190	REc			
6.671	10	28	08	6q21	MICAL1, NICAL, MICAL		Microtubule-associated monooxygenase, calponin and LIM domains-containing 1	607129	R, REc			
6.672	2	2	14	6q16.1	MMS22L, C6orf167		MMS22-like protein	615614	REc			
6.673	7	22	09	6q16.1	NDUFAF4, HRPAP20, C6orf66		NADH dehydrogenase 1 alpha subcomplex, assembly factor 4	611776	REc, Fd		Mitochondrial complex I deficiency, 252010 (3)	
6.674	4	22	15	6q16.1	PNKY		Long intergenic noncoding RNA Pinky	616328	REc			
6.675	10	15	07	6q15	RARS2, RARSL, PCH6		Arginyl-tRNA synthetase 2	611524	REc, Fd		Pontocerebellar hypoplasia, type 6, 611523 (3)	
6.676	2	4	15	6q16.1	UFL1, KIAA0776, NLBP		UFM1-specific ligase 1	613372	R, REc			
6.677	11	1	13	6q16.1-q16.2	FBXL4, FBL4, MTDPS13		F-box and leucine-rich repeat protein 4	605654	REc		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	4(Fbxl4)
6.678	2	2	10	6q16.1	FHL5, ACT		Four-and-a-half LIM domains 5	605126	REc, A			
6.679	5	13	02	6q16.1	GPR63		G protein-coupled receptor 63	606915	REc			
6.680	3	3	16	6q16.2	DHS6S1, MCDR1		DNase1 hypersensitivity, chromosome 6, site 1	616842	REn, Fd	upstream of PRDM13 and CCNC	Macular dystrophy, North Carolina type, 136550 (3)	
6.681	11	20	15	6q16.2	PNISR, SRRP130, SFRS18		PNN-interacting serine/arginine-rich protein	616653	REc			
6.682	1	8	16	6q16.2	PRDM13		PR domain-containing protein 13	616741	REc			
6.683	7	18	01	6q16.2	MCHR2, MCH2R, SLT, MCH2		Melanin-concentrating hormone receptor 2	606111	REc, R, A			
6.684	4	23	08	6q16.2-q22.1	LMPH1B		Lymphedema, hereditary, IB	611944	Fd	max lod at D6S1671	Lymphedema, hereditary, IB (2)	
6.685	9	8	11	6q16.3	ASCC3, p200		Activating signal cointegrator 1 complex, subunit 3	614217	REc			
6.686	4	5	00	6q16.3	SIM1		Single-minded, Drosophila, homolog of, 1	603128	A, R, Ch		Obesity, severe, 601665 (3)	10(Sim1)
6.687	9	11	12	6q16.3-q22.31	GEFSP8		Generalized epilepsy with febrile seizures plus, type 8	613828	Fd	between D6S962 and D6S287	Epilepsy, generalized, with febrile seizures plus, type 8 (2)	
6.688	4	26	17	6q21	AFG1L, AFG1, LACE1		AFG1-like ATPase	617469	REc			
6.689	7	11	97	6q21	AIM1, ST4		Absent in melanoma 1	601797	M, A			10(Aim1)
6.690	9	9	13	6q21	AK9		Adenylate kinase 9	615358	REc			
6.691	7	24	17	6q21	ATG5, APG5, APG5L, ASP, SCAR25		Autophagy 5, S. cerevisiae, homolog of	604261	A	mutation identified in one SCAR25 family	?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3)	
6.692	5	19	15	6q21	BEND3, KIAA1553		BEN domain-containing protein 3	616374	Psh, REc			
6.693	4	10	90	6q21	BKMA1		Banded krait minor satellite DNA-1	109780	A	related to heterogametic sex		17(Bkma1)
6.694	09	27	18	6q21	BVES, HBVES, POPDC1, CARICK		Blood vessel epicardial substance	604577	REc	mutation identified in 1 CARICK family	?Cardiac arrhythmia with increased serum creatine kinase, 616812 (3)	
6.695	7	10	95	6q16.2	CCNC		Cyclin C	123838	A			
6.696	9	7	12	6q21	CD24		CD24 antigen	600074	A, Psh	pseudogenes at 15q21-q22; Yq11		
6.697	6	2	16	6q21	CD164, DFNA66		CD164 antigen	603356	REc	mutation identified in 1 DFNA66 family	?Deafness, autosomal dominant 66, 616969 (3)	
6.698	7	18	12	6q21	CDK19, KIAA1028		Cyclin-dependent kinase 19	614720	REc, R			
6.699	8	8	13	6q21	DDO, DASOX		D-aspartate oxidase	124450	REc			
6.700	2	25	16	6q21	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP		Fig4, S. cerevisiae, homolog of	609390	R, REc, Fd	mutation identified in 1 BTOP family	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral sclerosis 11, 612577 (3); Yunis-Varon syndrome, 216340 (3); ?Polymicrogyria, bilateral temporooccipital, 612691 (3)	
6.701	9	9	08	6q21	FOXO3A, FOXO3, FKHRL1		Forkhead box O3A	602681	A			
6.702	1	4	93	6q21	FYN		FYN oncogene related to SRC, FGR, YES	137025	REa, A	proximal 6q21		10(Fyn)
6.703	4	30	15	6q22.1	GOPC, PIST, FIG, CAL		Golgi-associated PDZ and coiled-coil domains-containing protein	606845	REc			
6.704	10	15	07	6q16.3	GRIK2, GLUR6, MRT6		Glutamate receptor, ionotropic, kainate 2	138244	REa, R, Fd		Mental retardation, autosomal recessive, 6, 611092 (3)	
6.705	2	11	08	6q21	GTF3C6, C6orf51		General transcription factor 3C, polypeptide 6	611784	REc			
6.706	2	5	16	6q16.3	HACE1, KIAA1320, SPPRS		HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1	610876	REc		Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	
6.707	1	8	01	6q21	HDAC2		Histone deacetylase 2	605164	Psh, A			10(Hdac2)
6.708	2	13	06	6q22.31	HEY2, HERP1, GRL		Hairy/enhancer of split-related with YRPW motif 2	604674	A, R			
6.709	10	4	01	6q21	HTX3		Heterotaxy, visceral, 3, autosomal	606325	Ch		?Heterotaxy, visceral, 3, autosomal (2)	
6.710	12	9	98	6q21	IDDM15		Insulin-dependent diabetes mellitus-15	601666	Fd		{Diabetes mellitus, insulin-dependent, 15} (2)	
6.711	5	24	13	6q21	LAMA4, LAMA3, CMD1JJ		Laminin, alpha-4	600133	A, REb		Cardiomyopathy, dilated, 1JJ, 615235 (3)	
6.712	7	23	09	6q21	LGV2		Longevity 2	606460	Fd	associated with rs2802292	[Longevity 2] (2)	
6.713	8	20	07	6q16-q21	LIN28B		Lin28, C. elegans, homolog of, B	611044	REc, H			6(Lin28b)
6.714	1	31	11	6q21	MCOPS8, MMEP		Microphthalmia, syndromic 8	601349	Ch	translocation with 13q12	Microphthalmia, syndromic 8 (2)	
6.715	7	20	09	6q21	MENAQ2		Menarche, age at, QTL2	612882	Fd	associated with rs7759938	{Menarche, age at, QTL2} (2)	
6.716	2	2	17	6q21	MFSD4B, NAGLT1, Kiaa1919		Major facilitator superfamily domain-containing protein 4B	617331	REc			
6.717	5	14	09	6q22.31	NKAIN2, TCBA		Na+/K+ transporting ATPase interacting 2	609758	REc, Ch	fused with SUSP1 in T-cell lymphoma/leukemia		
6.718	6	4	99	6q21	NR2E1, TLX		Nuclear receptor subfamily 2, group E, member 1 (tailless, Drosophila, homolog of)	603849	REc			
6.719	10	3	07	6q21	OSTM1, GL, OPTB5		Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)	607649	REc		Osteopetrosis, autosomal recessive 5, 259720 (3)	
6.720	5	24	12	6q21	PDSS2, DLP1, C6orf210, COQ10D3		Prenyl diphosphate synthase, subunit 2	610564	REc		Coenzyme Q10 deficiency, primary, 3, 614652 (3)	
6.721	10	14	09	6q21	POPDC3, POP3		Popeye domain-containing protein 3	605824	R, REc			
6.722	11	23	16	6q21	QRSL1, GATA		Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like protein 1	617209	REc			
6.723	12	27	16	6q21	REV3L, POLZ, REV3		Rev-3, yeast, homolog-like (polymerase, DNA, zeta)	602776	REn			
6.724	1	6	16	6q21	RTN4IP1, NIMP, OPA10		Reticulon 4-interacting protein 1	610502	REc		Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	
6.725	7	22	16	6q21	SEC63, PCLD2		Sec63, S. cerevisiae, homolog of	608648	A		Polycystic liver disease 2, 617004 (3)	
6.726	1	11	07	6q21	SESN1, SEST1, PA26		Sestrin 1	606103	REa, A, Ch			4(Pa26)
6.727	3	22	07	6q21	SLC22A16, FLIPT2, CT2		Solute carrier family 22 (organic cation transporter), member 16	608276	REc, A			
6.728	7	25	06	6q21	SNX3		Sorting nexin 3	605930	R, REc, Ch	t(6;13)(q21;q12)		
6.729	12	16	10	6q21	SOBP, JXC1, MRAMS		Sine oculis-binding protein, Drosophila, homolog of	613667	REc		Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	
6.730	11	15	13	6q21	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8		TRAF3-interacting protein 2	607043	REc	mutation identified in 1 family with CANDF8	{Psoriasis susceptibility 13}, 614070 (3); ?Candidiasis, familial, 8, 615527 (3)	
6.731	7	22	09	6q21	TUBE1, TUBE		Tubulin, epsilon-1	607345	REc			
6.732	3	24	06	6q22.1	VGLL2, VGL2, VITO1		Vestigial-like 2	609979	REc			
6.733	7	1	11	6q21	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2		Zinc finger- and BTB domain-containing protein 24	614064	R, REc		Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3)	
6.734	11	20	95	6q21	AMD1		S-adenosylmethionine decarboxylase-1	180980	REa	pseudogene AMD2 on Xq28		
6.735	8	18	04	6q21-q22	PLF		Pulmonary function	608852	Fd	close to D6S281	{Pulmonary function} (2)	
6.736	2	28	03	6q21	SLC16A10, TAT1		Solute carrier family 16 (monocarboxylic acid transporter), member 10	607550	R, A			
6.737	11	13	17	6q21	WASF1, WAVE, WAVE1, SCAR1		WAS protein family member 1	605035	R, A			
6.738	6	12	95	6q21	GPR6		G protein-coupled receptor-6	600553	A			
6.739	6	18	99	6q21	PRDM1, BLIMP1		PR domain-containing protein 1 (B-lymphocyte-induced maturation protein 1)	603423	REc, Psh			10(Blimp1)
6.740	8	9	99	6q22.1	COL10A1		Collagen X, alpha-1 polypeptide	120110	REa, A		Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	10(Col10a1)
6.741	1	7	02	6q22.1	FRK, RAK, GTK		FYN-related kinase	606573	REc			
6.742	8	11	91	6q24.1	NMBR		Neuromedin B receptor	162341	Psh			
6.743	11	8	17	6q22.1	DSE, SART2, EDSMC2		Dermatan sulfate epimerase	605942	REc		Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	
6.744	9	28	00	6q23.2	ENPP3, PDNP3		Ectonucleotide pyrophosphatase/phosphodiesterase 3	602182	A			
6.745	9	10	09	6q22.31	MAN1A1		Mannosidase, alpha, class 1A, member 1	604344	REc			
6.746	12	07	07	6q23.3	MYB		Avian myeloblastosis viral (v-myb) oncogene homolog	189990	REa, A, Ch		{T-cell acute lymphoblastic leukemia} (3)	10(Myb)
6.747	2	10	97	6q21	PREP		Prolyl endopeptidase	600400	A			
6.748	1	4	93	6q22.1	ROS1, MCF3		Avian UR2 sarcoma virus oncogene (v-ros) homolog 1	165020	REa, A			10(Ros1)
6.749	2	17	09	6q23.3	BCLAF1, BTF, KIAA0164		BCL2-associated transcription factor 1	612588	R, REc			
6.750	7	2	14	6q23.2	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED		Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	A, H		{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized, of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3); Cole disease, 615522 (3)	10(Ly41, Pca1)
6.751	11	3	98	6q23.1-q23.2	EPB41L2		Erythrocyte membrane protein band 4.1-like 2	603237	A			
6.752	3	18	10	6q22.31	FABP7, FABPB, BLBP		Fatty acid-binding protein 7	602965	REc			
6.753	1	7	14	6q22-q23	IGAN1		IgA nephropathy, susceptibility to, 1	161950	Fd		{IgA nephropathy, susceptibility to, 1} (2)	
6.754	10	09	18	6q22.33	LAMA2, LAMM, MDC1A		Laminin, alpha-2 (merosin)	156225	REa, A, Fd		Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3); Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3)	10(dy, Lamm)
6.755	4	17	00	6q22-q23	SM2		Hepatic fibrosis susceptibility due to Schistosoma mansoni infection	604201	Fd	?polymorphism of INFGR1	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2)	
6.756	10	15	13	6q22.31	TRDN, TDN, CPVT5		Triadin	603283	A		Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	
6.757	7	19	04	6q22.1	TSPYL1, TSPYL, SIDDT		Y-encoded testis-specific protein-like	604714	REa, A, H		Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	10(Tspyl)
6.758	8	19	04	6q21	WISP3, PPAC, PPD		Wnt-1 inducible signaling pathway protein 3	603400	R, A, Fd		Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3); Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	
6.759	6	7	10	6q22.33	ARHGAP18		RHO GTPase-activating protein 18	613351	REc			
6.760	8	9	05	6q22-q24	FEB5		Febrile seizures, familial, 5	609255	Fd	between D6S1572 and D6S472	Febrile seizures, familial, 5 (2)	
6.761	6	27	08	6q22-q24	FIQTL1		Fasting insulin level quantitative trait locus 1	606035	Fd	max lod at D6S1569	[Fasting insulin level quantitative trait locus 1] (2)	
6.762	10	18	00	6q23.3	MAP7, EMAP115		Microtubule-associated protein-7	604108	H			10(Map7)
6.763	9	8	11	6q22.1	BET3L, TRAPPC3L		Bet3, S. cerevisiae, homolog-like	614137	REc			
6.764	5	21	03	6q21	CDC40, PRP17		Cell division cycle 40, S. cerevisiae, homolog of	605585	REn			
6.765	1	20	17	6q22.1	FAM26F, INAM		Family with sequence similarity 26, member F	617305	REc			
6.766	4	25	14	6q22.1	KPNA5		Karyopherin alpha-5	604545	REc			
6.767	4	11	11	6q22.31	PLN, PLB, CMD1P, CMH18		Phospholamban	172405	REc, A		Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, hypertrophic, 18, 613874 (3)	
6.768	3	19	09	6q22.1	RSPH4A, CILD11		Radial spoke head 4, Chlamydomonas, homolog of, A	612647	REc		Ciliary dyskinesia, primary, 11, 612649 (3)	
6.769	8	17	15	6q22.31	MCM9, MCMDC1, ODG4		Minichromosome maintenance complex component 9	610098	REc		Ovarian dysgenesis 4, 616185 (3)	10(Mcm9)
6.770	8	18	08	6q22.33	RNF146		Ring finger protein 146	612137	REc			
6.771	6	29	94	6q21	MRACKS, MACS, PKCSL		Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)	177061	REb, REa	monomorphic		10(Macs)
6.772	4	16	14	6q22.1	RFX6, RFXDC1, MTCHRS		Regulatory factor X, 6	612659	REc		Mitchell-Riley syndrome, 615710 (3)	
6.773	5	26	13	6q22.33	RSPO3, PWTSR, CRISTIN1		R-spondin family member 3	610574	REc			10(Rspo3)
6.774	5	20	99	6q22.33	PTPRK		Protein-tyrosine phosphatase, receptor type, kappa	602545	REa, A, REc			10(Ptprk)
6.775	4	20	10	6q23.2	C6orf192		Chromosome 6 open reading frame 192	613361	REc			
6.776	8	23	05	6q22.31	HSF2		Heat-shock transcription factor 2	140581	R, REc			
6.777	2	3	05	6q22.31	ASF1A, CIA		Anti-silencing function 1, S. cerevisiae, homolog of, A	609189	REc			
6.778	5	11	16	6q22.31	CLVS2		Clavesin 2	616945	REc			
6.779	6	30	05	6q21-q22	HS3ST5, 3OST5		Heparan sulfate 3-O-sulfotransferase 5	609407	REc			
6.780	1	22	18	6q22.1	NUS1, NGBR, C6orf68, CDG1AA, MRD55		Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of	610463	REc	mutation identified in 1 CDG1AA family	?Congenital disorder of glycosylation, type 1aa, 617082 (3); Mental retardation, autosomal dominant 55, with seizures, 617831 (3)	
6.781	9	10	09	6q22.31	PKIB		Protein kinase, cAMP-dependent catalytic, inhibitor beta	606914	R, REc			
6.782	4	2	12	6q22.31	SERINC1, TMS2, KIAA1253		Serine incorporator 1	614548	REc			
6.783	1	29	07	6q22.31	SMPDL3A, ASML3A		Sphingomyelin phosphodiesterase, acid-like, 3A	610728	REc, R			
6.784	7	3	14	6q22.31	TBC1D32, BROMI		TBC1 domain family, member 32	615867	REc			10(Tbc1d32)
6.785	5	25	13	6q22.31	TPD52L1, D53		Tumor protein D52-like 1	604069	REc, A			10(Tdp52l1)
6.786	4	6	13	6q22.32	CEMPW, C6orf173, CUG2		Centromeric protein W	611264	REc			
6.787	8	18	08	6q22.33	ECHDC1		Enoyl coenzyme A hydratase domain-containing protein 1	612136	REc			
6.788	3	24	06	6q22.32	HINT3		Histidine triad nucleotide-binding protein 3	609998	REc			
6.789	6	23	99	6q23.3	MAP3K5, MEKK5, MAPKKK5, ASK1		Mitogen-activated protein kinase kinase kinase 5	602448	R			
6.790	12	23	05	6q22.31-q22.32	NCOA7, ERAP140		Nuclear receptor coactivator 7	609752	REc			
6.791	1	27	11	6q22.33	THEMIS, GASP, SPOT, C6orf190		Thymocyte-expressed molecule involved in selection	613607	REc			10(Themis)
6.792	11	13	07	6q22.3-q23.1	HBFQTL2, FCP		Fetal hemoglobin quantitative trait locus 2	142470	Fd		Fetal hemoglobin quantitative trait locus 2 (2)	
6.793	10	9	96	6q25.1	PCMT1		Protein-L-isoaspartate (D-aspartate) O-methyltransferase	176851	REa, A			10(Pcmt1)
6.794	12	3	03	6q23.2	ARG1		Arginase, liver	608313	REa		Argininemia, 207800 (3)	
6.795	4	4	11	6q23	CMD1F, CDCD3, LGMD1D		Cardiomyopathy, dilated-1F, autosomal dominant	602067	Fd		Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	
6.796	5	24	18	6q23.2	EYA4, DFNA10, CMD1J		Eyes absent, Drosophila, homolog of, 4	603550	R, Fd, A	mutation identified in 1 CMD1J family	Deafness, autosomal dominant 10, 601316 (3); ?Cardiomyopathy, dilated, 1J, 605362 (3)	
6.797	3	15	10	6q23	HCHGQ1		Hematocrit/hemoglobin quantitative trait locus 1	609319	Fd		[Hematocrit/hemoglobin quantitative trait locus 1] (2)	
6.798	3	19	01	6q23.3	IL20RA		Interleukin 20 receptor, alpha	605620	REc			
6.799	2	25	12	6q23	RP63		Retinitis pigmentosa 63	614494	Fd	between D6S457 and D6S1656	Retinitis pigmentosa 63 (2)	
6.800	1	31	08	6q23	RA		Rheumatoid arthritis, susceptibility to	180300	REc	associated with SNP rs10499194 and rs6920220	{Rheumatoid arthritis, susceptibility to} (2)	
6.801	1	13	99	6q23.2	SGK1		Serum/glucocorticoid-regulated kinase 1	602958	A			
6.802	10	30	08	6q23	SLEB13		Systemic lupus erythematosus, susceptibility to, 13	612378	Fd	associated with rs5029939	{Systemic lupus erythematosus, susceptibility to, 13} (2)	
6.803	7	13	98	6q22.31	STL		Six-twelve leukemia gene	602532	REc			
6.804	1	13	16	6q23.3	TNFAIP3, A20, OTUD7C, AISBL		Tumor necrosis factor-alpha-induced protein 3	191163	REc		Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	
6.805	6	17	16	6q24.2	HIVEP2, MRD43		Human immunodeficiency virus type I enhancer-binding protein-2	143054	REa, A		Mental retardation, autosomal dominant 43, 616977 (3)	
6.806	5	2	08	6q23-q24	MAFD6, BPAD		Major affective disorder 6	611536	Fd		{Major affective disorder 6} (2)	
6.807	3	5	98	6q23-q24	NTT		Noncoding transcript in T cells	602154	A			
6.808	12	21	09	6q23.3	PBOV1, UROC28, UC28		Prostate and breast cancer overexpressed 1	605669	A			
6.809	11	23	98	6q23.2	TCF21, POD1		Transcription factor-21 (epicardin; podocyte-expressed 1)	603306	H			10(Tcf21)
6.810	12	17	07	6q23.2	VNN1, HDLCQ8		Vanin 1	603570	A, H, Psh		[High density lipoprotein cholesterol level QTL 8] (3)	10(Vnn1)
6.811	6	18	99	6q23.2	VNN2		Vanin 2	603571	A, Psh, REc			
6.812	2	20	02	6q23.2	VNN3		Vanin 3	606592	REc			10(Vnn3)
6.813	4	27	12	6q23-q24.1	SPG25		Spastic paraplegia 25, autosomal recessive, with disc herniation	608220	Fd		Spastic paraplegia 25, autosomal recessive (2)	
6.814	10	08	08	6q23-q25	BMIQ3		Body mass index quantitative trait locus 3	607446	Fd	max lod at D6S305	[Body mass index QTL3] (2)	
6.815	9	22	04	6q23-q25	LNCR1		Lung cancer 1	608935	Fd	max hlod at D6S2436	{Lung cancer susceptibility} (2)	
6.816	7	11	93	6q23.2	CTGF, NOV2		Connective tissue growth factor	121009	REa, A	proximal to MYB		
6.817	7	1	05	6q23.2	TAAR1, TA1		Trace amine-associated receptor 1	609333	R, REc			10(Taar1)
6.818	11	2	04	6q23.2	MOXD1, MOX		Monooxygenase, DBH-like, 1	609000	R, REc			
6.819	3	27	18	6q24.1	REPS1, NBIA7		RALBP1-associated EPS domain-containing protein 1	614825	REc	mutation identified in 1 NBIA7 family	?Neurodegeneration with brain iron accumulation 7, 617916 (3)	
6.820	9	1	09	6q23.3	ALDH8A1, ALDH12		Aldehyde dehydrogenase 8 family, member A1	606467	R, REc			
6.821	5	28	02	6q23.2	GPR102, TA5		G protein-coupled receptor 102	606927	REc, R			
6.822	9	26	11	6q23.2	MED23, MRT18		Mediator complex subunit 23	605042	REc		Mental retardation, autosomal recessive 18, 614249 (3)	
6.823	2	28	03	6q23.2	PNR		Putative neurotransmitter receptor	607405	A, REc			
6.824	8	19	13	6q23.2	SLC2A12, GLUT12		Solute carrier family 2 (facilitated glucose transporter), member 12	610372	REc, R			10(Slc2a12)
6.825	9	22	04	6q23.2	STX7		Syntaxin 7	603217	REa, REc			
6.826	12	5	03	6q23.2	TAR3, TA3		Trace amine receptor 3	608282	R			
6.827	10	24	14	6q23.2	TARID		TCF21 antisense RNA inducing promoter demethylation	616058	REc			
6.828	5	5	09	6q23.2	TAAR6, TRAR4		Trace amine-associated receptor 6	608923	REc			
6.829	9	15	04	6q23.3	AHI1		Abelson helper integration site 1	608894	Fd, REc, R		Joubert syndrome 3, 608629 (3)	
6.830	1	18	12	6q24.1	CITED2, MRG1, P35SRJ, VSD2, ASD8		CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2	602937	REc	?pseudogene on 1q22	Ventricular septal defect 2, 614431 (3); Atrial septal defect 8, 614433 (3)	
6.831	9	22	14	6q23.3	IFNGR1, IMD27A, IMD27B		Immune interferon, receptor for	107470	S, A, Fd, REc		Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3); {H. pylori infection, susceptibility to}, 600263 (3); {Tuberculosis, susceptibility to}, 607948 (3); Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3); {Tuberculosis infection, protection against}, 607948 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)	10(Ifgr)
6.832	5	29	12	6q23.3	MPVQTL5		Mean platelet volume quantitative trait locus 5	614645	Fd	associated with rs9399137	Mean platelet volume QTL5 (2)	
6.833	7	1	05	6q23.3	OLIG3, BHLHB7		Oligodendrocyte lineage transcription factor 3	609323	REc			
6.834	7	17	14	6q23.3	PDE7B		Phosphodiesterase 7B, cAMP-specific, high-affinity	604645	REc			
6.835	12	6	16	6q23.3	PERP		p53 effector related to PMP22	609301	REc			
6.836	1	11	16	6q23.3	PEX7, RCDP1, PBD9B		Peroxisomal biogenesis factor-7	601757	REa, R, REc		Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Peroxisome biogenesis disorder 9B, 614879 (3)	
6.837	1	7	09	6q23.3	SLC35D3		Solute carrier family 35, member D3	612519	REc, H			10(Slc35d3)
6.838	3	28	17	6q23.3-q24.1	ARFGEF3, BIG3, KIAA1244		ADP-ribosylation factor guanine nucleotide exchange factor 3	617411	REc			
6.839	8	27	01	6q24.1	C6orf34, SOUL		Soul, chicken, homolog of	605825	REc			
6.840	2	27	03	6q24.3	EPM2A, MELF, EPM2		Laforin	607566	Fd		Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	
6.841	9	9	08	6q24.3	FBXO30, FBX30		F-box only protein 30	609101	REc			10(Fbxo30)
6.842	9	18	17	6q24.3	GRM1, MGLUR1, GRM1A, SCAR13, SCA44		Glutamate receptor, metabotropic, 1	604473	REa, A		Spinocerebellar ataxia, autosomal recessive 13, 614831 (3); Spinocerebellar ataxia 44, 617691 (3)	
6.843	12	24	08	6q23.3	HBS1L, KIAA1038, ERFS		HBS1-like protein	612450	REc			
6.844	11	15	08	6q24.2	HYMAI		Hydatidiform mole-associated and imprinted transcript	606546	REc, Ch, Fd			
6.845	2	28	03	6q24.2	PLAGL1, ZAC, LOT1		Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor)	603044	A, REc, Ch, Fd	relaxed imprinting in TNDM	{Diabetes mellitus, transient neonatal}, 601410 (1)	10(Zac)
6.846	3	13	06	6q24.2	STX11, FHL4, HPLH4, HLH4		Syntaxin-11	605014	Fd, REc		Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	
6.847	4	26	05	6q23.2	TAAR2, GPR58		Trace amine-associated receptor 2	604849	A			
6.848	7	8	96	6q24.2	UTRN, DMDL, DRP1		Utrophin (homologous to dystrophin)	128240	REa, F, Fd, A	near dy in mouse		10(Dmdl)
6.849	9	30	10	6q24-q25	DEL6q24q25, C6DELq25q25		Chromosome 6q24-q25 deletion syndrome	612863	Ch		Chromosome 6q25-q25 deletion syndrome (4)	
6.850	9	29	09	6q25.1	IYD, DEHAL1, TDH4		Iodotyrosine deiodinase	612025	REc		Thyroid dyshormonogenesis 4, 274800 (3)	
6.851	10	8	09	6q25.2	OPRM1		Opioid receptor, mu-1	600018	A			10(Oprm)
6.852	3	10	03	6q25.1	PPIL4		Peptidyl-prolyl isomerase-like 4	607609	REc, Psh			
6.853	2	17	09	6q24-q25	STQTL1		Stature quantitative trait locus 1	606255	Fd	associated with rs4896582 and rs3748069	{Stature QTL 1} (2)	
6.854	8	28	92	6q25.3	MAS1		Oncogene MAS1	165180	A, REa			17(Mas1)
6.855	4	17	07	6q24.1-q24.2	C6orf55, SBP1, LIP5, VTA1, DRG1		SKD1-binding protein 1	610902	R, REc			
6.856	8	2	13	6q24.1	CCDC28A, C6orf80		Coiled-coil domain-containing 28A	615353	REc			
6.857	8	31	16	6q24.2	ADGRG6, PR126, VIGR, LCCS9		Adhesion G protein-coupled receptor G6	612243	REc, H		Lethal congenital contracture syndrome 9, 616503 (3)	10(Gpr126)
6.858	2	25	15	6q24.1	HECA, HDC		Headcase, Drosophila, homolog of	607977	REc			
6.859	1	30	02	6q23.3	IL22BP, IL22RA2		Interleukin 22-binding protein	606648	REc, R			
6.860	9	9	13	6q24.2	ADAT2, TAD2		Adenosine deaminase, tRNA-specific, 2	615388	REc			
6.861	2	24	12	6q24.2	FUCA2		Fucosidase, alpha-L- 2, plasma	136820	F	linked to PLG		
6.862	3	9	17	6q24.2	PEX3, PBD10A, PBD10B		Peroxisomal biogenesis factor-3	603164	REc, A	mutation identified in 1 PBD10B patient	Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3); ?Peroxisome biogenesis disorder 10B, 617370 (3)	
6.863	7	16	12	6q24.2	PHACTR2, KIAA0680		Phosphatase and actin regulator 2	608724	R, REc			
6.864	1	24	18	6q24.2	SF3B5, SF3B10		Splicing factor 3B, subunit 5	617847	REc			
6.865	5	5	09	6q24.2-q25.2	DUH1, DUH		Dyschromatosis universalis hereditaria 1	127500	Fd	max lod at D6S1553	Dyschromatosis universalis hereditaria 1 (2)	
6.866	8	20	07	6q25.1	RAET1L		Retinoic acid early transcript 1L	611047	REc			
6.867	6	1	12	6q24.3	ADGB		Androglobin	614630	REc			
6.868	12	5	03	6q25.1	NUP43		Nucleoporin, 43kD	608141	R, REc			
6.869	2	21	10	6q25.1	PPP1R14C, KEPI		Protein phosphatase 1, regulatory subunit 14C	613242	REc			
6.870	7	22	09	6q24.3	RAB32		Ras-associated protein RAB32	612906	REc			
6.871	2	26	09	6q24.3-q25.1	SASH1, KIAA0790		Sterile alpha motifs- and SH3 domain-containing protein 1	607955	R, REc			
6.872	8	24	04	6q24.3	STXBP5		Syntaxin-binding protein 5 (tomosyn)	604586	R, REc			
6.873	6	30	08	6q25	BMND11		Bone mineral density quantitative trait locus 11	612114	Fd	associated with rs4870044, rs1038304, and rs1999805	[Bone mineral density QTL 11] (2)	
6.874	3	23	06	6q25.3	FNDC1, AGS8, KIAA1866		Fibronectin type III domain-containing protein 1	609991	R, REc			
6.875	1	7	09	6q25	IDDM21		Diabetes mellitus, insulin-dependent, 21	612521	Fd	associated with rs1738074	{Diabetes mellitus, insulin-dependent, 21} (2)	
6.876	2	12	16	6q25.2	MYCT1, MTLC		MYC target in myeloid cells 1	616805	REc			
6.877	11	12	12	6q25.1	RMND1, COXPD11		Required for meiotic nuclear division 1, S. cerevisiae, homolog of	614917	REc		Combined oxidative phosphorylation deficiency 11, 614922 (3)	
6.878	11	20	13	6q25.2	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4		Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441	A, Fd, REc		Spinocerebellar ataxia, autosomal recessive 8, 610743 (3); Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	
6.879	5	31	05	6q25.1	SUMO4, IDDM5		Small ubiquitin-like modifier 4	608829	Fd, REc		{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	
6.880	1	11	16	6q25.1	TAB2, MAP3K7IP2, KIAA0733, CHTD2		Tak1 (MAP3K7) binding protein 2	605101	R, REc		Congenital heart defects, nonsyndromic, 2, 614980 (3)	
6.881	9	10	09	6q25.3	TFB1M, CGI75		Transcription factor B1, mitochondrial	607033	R, REc			
6.882	2	28	01	6q25.1	ULBP1		UL16-binding protein 1	605697	REn			
6.883	2	28	01	6q25.1	ULBP2		UL16-binding protein 2	605698	REn			
6.884	2	28	01	6q25.1	ULBP3		UL16-binding protein 3	605699	REn			
6.885	9	9	08	6q25.2	FBXO5, FBX5, EMI1		F-box only protein 5	606013	A, H			10(Fbxo5)
6.886	12	29	89	6q25-q26	RCD1		Retinal cone dystrophy-1	180020	Ch		?Retinal cone dystrophy-1 (2)	
6.887	12	9	98	6q25-q27	IDDM8		Insulin-dependent diabetes mellitus-8	600883	Fd		{Diabetes mellitus, insulin-dependent, 8} (2)	
6.888	1	29	04	6q26	PACRG		Parkin coregulated gene	608427	REc	shares 5' regulatory region and both 3' UTRs with PARK2		17(Pacrg)
6.889	4	28	16	6q25.3	ARID1B, BAF250B, KIAA1235, MRD12, CSS1		AT-rich interaction domain-containing protein 1B	614556	R, REc		Coffin-Siris syndrome 1, 135900 (3)	
6.890	4	30	15	6q25.1	ARMT1, C6orf211		Acidic residue methyltransferase 1	616332	REc			
6.891	8	19	13	6q25.1-q25.2	ESR1, ESR, ESTRR		Estrogen receptor 1	133430	REa, A		Estrogen resistance, 615363 (3); {HDL response to hormone replacement, augmented} (3); {Migraine, susceptibility to}, 157300 (3); {Atherosclerosis, susceptibility to} (3); {Myocardial infarction, susceptibility to}, 608446 (3); {Breast cancer}, 114480 (1)	10(Esr)
6.892	9	10	09	6q25.1	KATNA1		Katanin, p60 subunit, A1	606696	R, REc			
6.893	7	19	12	6q25.1	LATS1		Large tumor suppressor, Drosophila, homolog of, 1	603473	REc			
6.894	9	10	09	6q25.3	NOX3		NADPH oxidase 3	607105	REc			
6.895	2	12	07	6q25.1	UST		Uronyl 2-sulfotransferase	610752	R, REc			
6.896	6	13	07	6q25.1	ZC3H12D, p34, C6orf95		Zinc finger CCCH domain-containing protein 12D	611106	REc			
6.897	10	23	15	6q25.1	ZBTB2, ZNF437, KIAA1483		Zinc finger- and BTB domain-containing protein 2	616595	REc			
6.898	5	10	17	6q25.2	CNKSR3, CNK3		CNKSR family, member 3	617476	REc			
6.899	2	3	14	6q25.1	MTHFD1L, MTC1THFS		Methylenetetrahydrofolate dehydrogenase 1-like, NADP(+)-dependent	611427	REc			
6.900	9	30	14	6q25.2	SCAF8, KIAA1116		SR-related C-terminal domain-associated factor 8	616024	R, REc			
6.901	8	28	97	6q25.3	TCTEL1		T-complex-associated-testis-expressed 1-like 1	601554	A			
6.902	10	2	12	6q25.2-q25.3	TIAM2		T-cell lymphoma invasion and metastasis 2	604709	REc			
6.903	1	29	04	6q26	PRKN, PARK2, PDJ, LPRS2		Parkin	602544	Fd, D	shares 5' regulatory region and both 3' UTRs with PACRG	Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)	17(Park2)
6.904	5	28	08	6q25.3	CELIAC12		Celiac disease, susceptibility to, 12	612010	Fd	in LD block containing TAGAP	{Celiac disease, susceptibility to, 12} (2)	
6.905	4	6	15	6q25.3	EZR, VIL2, CVL		Ezrin	123900	REa, A	coamplified with MYB		
6.906	6	2	15	6q25.3	GTF2H5, TTD3, TFB5, C6orf175, TTDA		General transcription factor IIH, polypeptide 5	608780	REc, REn		Trichothiodystrophy 3, photosensitive, 616395 (3)	
6.907	2	28	08	6q25.3	MRPL18		Mitochondrial ribosomal protein L18	611831	REc			
6.908	7	25	14	6q25.3	RSPH3, RSHL2, RSP3, CILD32		Radial spoke head 3, Chlamydomonas, homolog of	615876	REc		Ciliary dyskinesia, primary, 32, 616481 (3)	
6.909	7	25	12	6q25.3	SERAC1, MEGDEL		Serine active site-containing protein 1	614725	REc		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	
6.910	7	9	09	6q25.3	SOD2, MNSOD, MVCD6		Superoxide dismutase-2, mitochondrial	147460	S, D, REa, A		{Microvascular complications of diabetes 6}, 612634 (3)	17(Sod2)
6.911	6	30	05	6q25.3	SYNJ2, KIAA0348		Synaptojanin 2	609410	R, H			17(Synj2)
6.912	12	28	08	6q25.3	TAGAP		T-cell activation GTPase-activating protein	609667	R, REc			
6.913	2	18	10	6q25.3	TMEM181, GPR178, KIAA1423		Transmembrane protein 181	613209	REc			
6.914	12	10	15	6q25.3	WTAP		Wilms tumor 1-associating protein	605442	REa, A			17(Wtap)
6.915	9	28	96	6q25.3	ACAT2		Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	100678	A	encoded on strand opposite TCP1	?ACAT2 deficiency, 614055 (1)	
6.916	9	28	96	6q25.3	TCP1		T-complex locus TCP-1	186980	REa, H, A, Fd, REn	tightly linked to PLG; ~15cM proximal to TCP10; overlap with ACAT2		17(Tcp1)
6.917	9	2	12	6q26	AGPAT4		1-acylglycerol-3-phosphate O-acyltransferase 4	614795	REc			
6.918	3	3	10	6q25.3	AIRN, AIR		Antisense IGF2R RNA, noncoding	604893	REc			17(Airn)
6.919	9	20	14	6q26	CAHM, LINC00468		Colorectal adenocarcinoma hypermethylated gene, noncoding	615930	REc			
6.920	12	5	13	6q25.3	IGF2R, MPRI		Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)	147280	REa, A	behaves as a tumor suppressor	Hepatocellular carcinoma, somatic, 114550 (3)	17(Igf2r)
6.921	9	10	09	6q26	MAP3K4, MEKK4, MTK1, MAPKKK4		Mitogen-activated protein kinase kinase kinase 4	602425	REa, REc			
6.922	9	4	14	6q26	PLG		Plasminogen	173350	REa, A, LD, F	20cM from TCP10A	Dysplasminogenemia, 217090 (3); Plasminogen deficiency, type I, 217090 (3)	17(Plg)
6.923	8	23	12	6q26	QKI, QK1		Quaking, mouse, homolog of	609590	REc			
6.924	6	9	98	6q25.3	SLC22A1, OCT1		Solute carrier family 22 (organic cation transporter), member 1	602607	Psh, A			
6.925	6	9	98	6q25.3	SLC22A2, OCT2		Solute carrier family 22 (organic cation transporter), member 2	602608	Psh, A			17(Slc22a2)
6.926	1	27	04	6q26-q27	DFNB38		Deafness, autosomal recessive 38	608219	Fd		Deafness, autosomal recessive 38 (2)	
6.927	9	24	08	6q27	FAM120B, PGCC1, CCPG, KIAA1838		Family with sequence similarity 120, member B	612266	REc			17(Fam120b)
6.928	12	17	07	6q25.3	LPAL2, APOARGC		Lipoprotein(a)-like 2	611682	REc			
6.929	11	19	11	6q26-q27	MRT28		Mental retardation, autosomal recessive 28	614347	Fd	between rs6935718 and rs3886091	Mental retardation, autosomal recessive 28 (2)	
6.930	11	22	88	6q25.2	VIP		Vasoactive intestinal peptide	192320	REa, A, REb			
6.931	9	10	09	6q25.3	SNX9, SH3PX1		Sorting nexin 9	605952	R, REc			
6.932	5	8	17	6q27	AFDN, MLLT4, AF6		Afadin	159559	Ch, A			
6.933	7	26	12	6q27	BRP44L, MPC1, MPYCD		Brain protein 44-like	614738	REc		Mitochondrial pyruvate carrier deficiency, 614741 (3)	
6.934	6	26	16	6q27	C6orf120		Chromosome 6 open reading frame 120	616987	REc			
6.935	9	9	08	6q27	CCR6, CMKBR6, CKRL3, GPR29, GPRCY4		Chemokine (C-C) receptor 6	601835	REa			
6.936	7	22	16	6q27	CHDM		Chordoma	215400	Fd, Ch	associated with duplication of the T gene	{Chordoma, susceptibility to} (4)	
6.937	9	10	09	6q27	DACT2, DPR2, DAPPER2		Dapper, antagonist of beta-catenin, 2	608966	REc			
6.938	7	2	18	6q27	DLL1, DELTA1		Delta-like 1	606582	A			
6.939	11	27	13	6q27	ERMARD, C6orf70, PVNH6		Endoplasmic reticulum membrane-associated RNA degradation protein	615532	REc		?Periventricular nodular heterotopia 6, 615544 (3)	
6.940	5	21	03	6q27	FGFR1OP, FOP		Fibroblast growth factor receptor-1 oncogene partner	605392	REc	fusion gene with ZNF198, CEP1, and FGFR1	Myeloproliferative disorder (2)	
6.941	3	5	98	6q27	GPR31		G protein-coupled receptor-31	602043	A			
6.942	3	8	16	6q27	HPAT5		Human pluripotency-associated transcript 5, noncoding	616837	REc			
6.943	2	14	13	6q27	KAZA3		Kala-azar, susceptibility to, 3	611382	Fd		{Kala-azar, susceptibility to, 3} (2)	
6.944	3	22	06	6q27	KIF25, KNSL3		Kinesin family member 25	603815	A			
6.945	5	22	03	6q25-q26	LPA		Apolipoprotein Lp(a)	152200	REa, A, F, Fd	absent in mice	{Coronary artery disease, susceptibility to} (1); [LPA deficiency, congenital] (3)	
6.946	12	14	95	6q27	PDCD2		Programmed cell death 2	600866	A, H			17(Pdcd2)
6.947	5	2	16	6q27	PDE10A, IOLOD, ADSD2		Phosphodiesterase 10A	610652	A, REc		Dyskinesia, limb and orofacial, infantile-onset, 616921 (3); Striatal degeneration, autosomal dominant, 616922 (3)	
6.948	10	13	09	6q27	PHF10, BAF45A		PHD finger protein 10	613069	REc			
6.949	6	9	06	6q27	PSMB1		Proteasome subunit, beta type, 1	602017	REc	incorrectly assigned to 7p		
6.950	8	24	09	6q27	RNASET2, RNASE6PL		Ribonuclease T2	612944	REc		Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	
6.951	12	9	98	6q27	RPS6KA2, RSK3		Ribosomal protein S6 kinase, 90kD, 2	601685	REa, A			
6.952	10	17	00	6q25.3	SLC22A3, EMT		Solute carrier family 22 (extraneuronal monoamine transporter), member 3	604842	A, REc			17(Slc22a3)
6.953	1	26	12	6q27	SMOC2, SMAP2, DTDP1		Secreted modular calcium-binding protein 2	607223	R, REc		Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	
6.954	4	29	14	6q27	T, TFT, SAVA		Brachyury, mouse, homolog of	601397	A, Fd		{Neural tube defects, susceptibility to}, 182940 (3); Sacral agenesis with vertebral anomalies, 615709 (3)	17(T)
6.955	11	15	10	6q27	TBP, SCA17, HDL4		TATA box binding protein	600075	REa, A, Fd		Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease, susceptibility to}, 168600 (3)	17(Tbp)
6.956	8	21	92	6q27	TCTE3		T-complex-associated-testis-expressed-3	186977	REa, A			
6.957	6	26	08	6q27	THBS2		Thrombospondin 2	188061	REa, A		{Lumbar disc herniation, susceptibility to}, 603932 (3)	17(Thbs2)
6.958	8	28	92	6q27	TCP10		T-complex 10 (a murine tcp homolog)	187020	Fd			17(Tcp10)
6.959	1	12	07	6q27	UNC93A		UNC93, C. elegans, homolog of, A	607995	REc			
6.960	9	10	09	Chr.6	BEVI		Baboon M7 virus replication	109180	S			
6.961	10	23	87	Chr.6	FEA		F9 embryonic antigen	137010	H			
6.962	9	10	09	Chr.6	LAKLG, LAKL		Lymphokine-activated killer cell ligand	153435	S			
6.963	10	23	87	Chr.6	MRBC		Monkey RBC receptor	158050	S			
6.964	10	23	87	Chr.6	TS546		Temperature sensitivity complementation, cell cycle specific, ts546 cells	187330	S			
7.1	9	12	93	7p22.3	PRKAR1B		Protein kinase, cAMP-dependent, regulatory, type I, beta	176911	Fd			
7.2	4	17	13	7p22.3	AMZ1, KIAA1950		Archaelysin family metallopeptidase 1	615168	REc			
7.3	08	10	18	7p22.3	BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS		BRCA1-associated ATM activator 1	614506	REc		Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3); Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3)	
7.4	5	10	04	7p22.3	CENTA1		Centaurin, alpha-1	608114	REc			
7.5	3	19	13	7p22.3	COX19		Cytochrome c oxidase assembly protein Cox19	610429	REc			
7.6	9	20	14	7p22.3	CYP2W1		Cytochrome P450, family 2, subfamily W, polypeptide 1	615967	REc			
7.7	12	17	12	7p22.3	ELFN1, PPP1R28		Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1	614964	REc			
7.8	9	8	10	7p22.3	GET4, C7orf20, CEE		Golgi to ER traffic protein 4, S. cerevisiae, homolog of	612056	REc			
7.9	10	25	17	7p22.3	DNAAF5, HEATR2, CILD18		Dynein axonemal assembly factor 5	614864	REc		Ciliary dyskinesia, primary, 18, 614874 (3)	
7.10	3	23	14	7p22.3	INTS1, INT1, KIAA1440		Integrator complex subunit 1	611345	REc			
7.11	8	28	17	7p22.3	IQCE, KIAA1023, PAPA7		IQ domain-containing protein E	617631	REc	mutation identified in 1 PAPA7 family	?Polydactyly, postaxial, type A7, 617642 (3)	
7.12	9	22	14	7p22.3	MIR339		Micro RNA 339	615977	REc			
7.13	6	17	17	7p22.3	PSMG3, PAC3		Proteasome assembly chaperone 3	617528	REc			
7.14	12	10	12	7p22.3	SNX8		Sorting nexin 8	614905	REc			
7.15	9	30	09	7p22.3	UNC84A, KIAA0810, SUN1		UNC84, C. elegans, homolog of, A	607723	R, REc			
7.16	1	16	07	7p22.3	ZFAND2A, AIRAP		Zinc finger AN1 domain-containing protein 2A	610699	REc			
7.17	9	28	11	7p22.3-p21.3	HYPT10		Hypotrichosis 10	614238	Fd	between D7S1532 and D7S3047	Hypotrichosis 10 (2)	
7.18	10	3	07	7p22.3	EIF3B, EIF3S9, PRT1		Eukaryotic translation initiation factor 3, subunit B	603917	REc			
7.19	3	11	08	7p22.3-p22.2	GNA12		Guanine nucleotide-binding protein, alpha-12	604394	R, REc			
7.20	10	18	15	7p22.2	SDK1		Sidekick, Drosophila, homolog of, 1	607216	REc			5(Sdk1)
7.21	6	9	08	7p13	TMED4		Transmembrane p24 trafficking protein 4	612038	REc			
7.22	3	9	17	7p22.1	WIPI2		WD40 repeat protein interacting with phosphoinositides 2	609225	Psh			
7.23	9	18	12	7p22.1	AP5Z1, KIAA0415, SPG48		Adaptor-related protein complex 5, zeta-1 subunit	613653	R, REc		Spastic paraplegia 48, autosomal recessive, 613647 (3)	
7.24	9	30	09	7p22.1	CYTH3, PSCD3, ARNO3, GRP1		Cytohesin 3	605081	R, REc			
7.25	9	8	11	7p22.1	DAGLB		Diacylglycerol lipase, beta	614016	REc			
7.26	11	22	10	7p22.1	EIF2AK1, HRI		Eukaryotic translation initiation factor 2-alpha kinase 1	613635	REc			
7.27	10	28	15	7p22.1	FAM220A, SIPAR, ACPIN1, C7orf70		Family with sequence similarity 220, member A	616628	REc			5(Fam220A)
7.28	6	13	12	7p22.1	FBXL18, FBL18		F-box and leucine-rich repeat protein 18	609084	REc			
7.29	4	10	15	7p22.1	FOXK1, MNF		Forkhead box K1	616302	REc, H			5(Foxk1)
7.30	4	19	12	7p22.1	MMD2, PAQR10		Monocyte-to-macrophage differentiation-associated protein 2	614581	REc			
7.31	7	19	06	7p22.1	PAPOLB, TPAP		Poly(A) polymerase, beta	607436	REc			
7.32	10	31	17	7p22.1	RAC1, MRD48		Ras-related C3 botulinum toxin substrate 1	602048	REc		Mental retardation, autosomal dominant 48, 617751 (3)	
7.33	10	2	07	7p22.1	RADIL, KIAA1849		RAP GTPase interactor	611491	REc			
7.34	11	11	14	7p22.1	RBAK		RB-associated KRAB repressor	608191	R, REc			
7.35	2	4	13	7p22.1	SLC29A4, PMAT, ENT4		Solute carrier family 29 (monoamine transporter), member 4	609149	REc			
7.36	10	4	05	7p22.1	STBMS1		Strabismus, susceptibility to, 1	185100	Fd	max lod at marker 1911/1912	{Strabismus, susceptibility to, 1} (2)	
7.37	6	13	95	7p21.2	MEOX2		Mesenchyme homeo box 2	600535	A			
7.38	6	5	18	7p22.1	AIMP2, JTV1, HLD17		Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2	600859	A		Leukodystrophy, hypomyelinating, 17, 618006 (3)	
7.39	8	25	17	7p22.2	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A		Caspase recruitment domain-containing protein 11	607210	R, REc		B-cell expansion with NFKB and T-cell anergy, 616452 (3); Immunodeficiency 11A, 615206 (3); Immunodeficiency 11B with atopic dermatitis, 617638 (3)	
7.40	8	19	13	7p22.3	CHST12, C4ST2		Carbohydrate sulfotransferase 12	610129	R			
7.41	9	8	11	7p22	ERVK-6		Endogenous retroviral group K, member 6	605626	A			
7.42	8	18	02	7p22.1	FSCN1, SNL		Fascin homolog 1, actin-bundling protein (singed, Drosophila, homolog-like)	602689	A			
7.43	6	11	02	7p22.3	FTSJ2, FJH1		FTSJ, E. coli, homolog of, 2	606906	R			
7.44	1	1	12	7p21.3	GLCCI1, TSSN1, GCTR		Glucocorticoid-induced transcript 1	614283	REc		{Glucocorticoid therapy, response to}, 614400 (3)	6(Glcci1)
7.45	6	21	10	7p22.3	GPER, CMKRL2, GPR30		G protein-coupled estrogen receptor 1	601805	Psh			
7.46	2	20	97	7p21.3	ICA1		Islet cell autoantigen 1, 69kD	147625	A			6(Ica1)
7.47	9	11	14	7p22.3	LFNG, SCDO3		Lunatic fringe	602576	REa, R, A	mutation identified in 1 SDO3 family	?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	5(Lfng)
7.48	8	29	01	7p22.3	MAD1L1, TXBP181		Mitotic arrest-deficient 1, yeast, homolog-like 1	602686	R		Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)	5(Mad1l1)
7.49	7	10	95	7p21.2	ETV1		ETS variant gene-1	600541	Ch, A	fused with EWS in some Ewing sarcoma		
7.50	8	21	07	7p22.3	FAM20C, DMP4		Family with sequence similarity 20, member C	611061	R, REc, Ch		Raine syndrome, 259775 (3)	
7.51	8	9	99	7p22.3	MAFK, NFE2U		V-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein K (nuclear factor erythroid 2, ubiquitous subunit)	600197	A			5(Nfe2u)
7.52	6	8	95	7p22.3	NUDT1, MTH1		Nudix-type motif 1	600312	A			
7.53	8	28	92	7p22.3	PDGFA		Platelet-derived growth factor, alpha polypeptide	173430	REa, A			
7.54	11	19	11	7p22.1	PMS2, PMSL2, HNPCC4		Postmeiotic segregation increased, S. cerevisiae, 2, homolog of	600259	REa, A		Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	
7.55	7	23	13	7p22.1	RNF216, TRIAD3, ZIN, CAHH		RING finger protein 216	609948	REc		Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	
7.56	4	7	94	7p21.3	RPA3		Replication protein A3, 14kD	179837	REa, Psh, A			
7.57	6	7	91	7p22.1	ZNF12		Zinc finger protein-12 (KOX3)	194536	REa, A			
7.58	12	4	90	7p14.1	RALA		RAS-like protein A (Simian leukemia viral (v-ral) oncogene homolog A, ras-related)	179550	REb, A			13(Ral)
7.59	7	1	11	7p22-p14	CPVT3		Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	Fd	between D7S526 and D7S481	Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)	
7.60	5	24	12	7p22.1	ACTB, BRWS1		Actin, beta	102630	REa, A	~20 pseudogenes also; mutation identified in twin DJO patients	?Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 1, 243310 (3)	5(Actb)
7.61	11	28	01	7p21.1	AGR2, AG2		Anterior gradient 2, Xenopus, homolog of	606358	R, A			
7.62	9	24	08	7p21.1	AGR3, BCMP11		Anterior gradient 3, Xenopus, homolog of	609482	REc			
7.63	3	23	06	7p21.3	COL28A1		Collagen, type XXVIII, alpha-1 polypeptide	609996	REc			6(Col28a1)
7.64	8	7	13	7p21.3	MIOS		Missing oocyte/meiosis regulator, Drosophila, homolog of	615359	REc			
7.65	5	25	13	7p21.3	NDUFA4		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 4	603833	REc			
7.66	7	18	14	7p21.3	NXPH1, NPH1		Neurexophilin 1	604639	REc			
7.67	7	26	10	7p21.3	SCIN, KIAA1905		Scinderin	613416	R, REc			
7.68	9	24	08	7p21.3	THSD7A, KIAA0960		Thrombospondin type-1 domain-containing protein 7A	612249	R, REc			
7.69	5	9	18	7p21.3	TMEM106B, HLD16		Transmembrane protein 106B	613413	REc		Leukodystrophy, hypomyelinating, 16, 617964 (3)	
7.70	6	26	16	7p21.3-p21.2	LOC105375159		Long intergenic noncoding RNA AC011288.2	616986	REc			
7.71	4	26	11	7p21.2	AGMO, TMEM195		Alkylglycerol monooxygenase	613738	REc			
7.72	9	29	09	7p21.2	DGKB, DGK, KIAA0718		Diacylglycerol kinase, beta, 90kD	604070	R, REc			
7.73	09	27	18	7p21.2-p21.1	ISPD, MDDGA7, MDDGC7, LGMDR20		Isoprenoid synthase domain-containing protein	614631	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	
7.74	10	30	07	7p21.1	PRPS1L1, PRPS3		Phosphoribosylpyrophosphate synthetase 1-like 1	611566	REa, R			
7.75	12	28	08	7p21.2	SOSTDC1, ECTODIN, USAG1		Sclerostin domain-containing protein 1	609675	REc			
7.76	7	8	10	7p21.2	FGQTL4		Fasting plasma glucose level QTL 4	613462	Fd	associated with rs2191349	[Fasting plasma glucose level QTL 4] (2)	
7.77	8	2	17	7p21.1	FERD3L, NTWIST, NATO3, PTFB		Fer3, Drosophila, homolog of	617578	REc, H			12(Ferd3l)
7.78	3	11	09	7p21.1	MACC1		Metastasis-associated gene in colon cancer 1	612646	REc			
7.79	4	18	05	7p21.1	SNX13, KIAA0713		Sorting nexin 13	606589	R, REc			
7.80	12	21	09	7p21.1	TSPAN13, NET6		Tetraspanin 13	613139	REn			
7.81	9	28	10	7p21.2-p14.3	EDSS2		Ectodermal dysplasia-syndactyly syndrome 2	613576	Fd	between D7S488 and D7S817	Ectodermal dysplasia-syndactyly syndrome 2 (2)	
7.82	12	3	08	7p15.3	DNAH11, DNAHC11, CILD7, DNAHBL		Dynein, axonemal, heavy chain-11	603339	REa, REn		Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	
7.83	1	24	09	7p15.3	IL6, IFNB2, BSF2, HSF, HGF		Interleukin-6 (interferon, beta-2)	147620	REa, A, Fd		{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)	5(Il6)
7.84	12	8	03	7p21.1	SP8, BTD		Transcription factor Sp8	608306	REc			
7.85	10	26	17	7p21.1	TWIST1, ACS3, SCS, CRS1, SWCOS		TWIST, Drosophila, homolog of, 1	601622	Fd, Ch, A, REa		Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3); Craniosynostosis 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3); Sweeney-Cox syndrome, 617746 (3)	12(Twist)
7.86	12	4	03	7p21.1	TWISTNB		TWIST neighbor	608312	REc	pseudogene on 6q14.3		12(Twistnb)
7.87	3	5	98	7p14.3	CRHR2, CRFR2		Corticotropin releasing hormone receptor-2	602034	R, A			6(Crhr2)
7.88	12	11	01	7p21.1	HDAC9, MITR, HDAC7B, KIAA0744		Histone deacetylase 9	606543	R, REc			
7.89	4	7	94	7p21-p15	MDDC		Macular dystrophy, dominant cystoid	153880	Fd	?allelic to RP9	Macular dystrophy, dominant cystoid (2)	
7.90	9	30	02	7p15.3	MPP6, VAM1, PALS2		Membrane protein, palmitoylated 6	606959	A			6(Pals2)
7.91	4	1	08	7q22.1	TSC22D4, THG1		TSC22 domain family, member 4	611914	REc			
7.92	5	10	04	7p14.3	FAPP2		Phosphatidylinositol 4-phosphate adaptor protein 2	608639	REc			
7.93	2	11	08	7p21.1	ABCB5		ATP-binding cassette, subfamily B, member 5	611785	REc			
7.94	11	3	14	7p15.3	C7orf31		Chromosome 7 open reading frame 31	616071	REc			
7.95	8	10	98	7p14.3	CHN2, ARHGAP3, RHOGAP3		Chimerin 2 (GTPase-activating protein, rho, 3)	602857	A			
7.96	12	5	08	7p15.3	FAM126A, DRCTNNB1A, HLD5		Hyccin	610531	A		Leukodystrophy, hypomyelinating, 5, 610532 (3)	
7.97	3	27	18	7p15.3	GPNMB, PLCA3		Glycoprotein NMB	604368	REc		Amyloidosis, primary localized cutaneous, 3, 617920 (3)	
7.98	9	28	05	7p15.2	HOXA1, HOX1F, BSAS		Homeo box-A1	142955	RE, A, Fd		Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem dysgenesis syndrome, 601536 (3)	6(Hox1.6)
7.99	9	1	16	7p15.3	KLHL7, RP42, CISS3		Kelch-like 7	611119	REc		Retinitis pigmentosa 42, 612943 (3); Cold-induced sweating syndrome 3, 617055 (3)	
7.100	5	8	12	7p15.3	MALSU1, C7orf30		Mitochondrial assembly of ribosomal large subunit 1	614624	REc			
7.101	6	26	16	7p15.3	NPVF, RFRP, C7orf9		Neuropeptide VF precursor	616984	Psh, REc			
7.102	9	30	09	7p15.3	STK31		Serine/threonine kinase 31	605790	R, REc			
7.103	12	18	13	7p15.3	TOMM7		Translocase of outer mitochondrial membrane 7, yeast, homolog of	607980	REc			
7.104	5	25	13	7p15.3	TRA2A		Transformer 2, Drosophila, homolog of	602718	REc			
7.105	5	11	00	7p14.3	INMT		Indolethylamine N-methyltransferase	604854	REa, A			
7.106	11	11	14	7p15.2	CBX3		Chromobox homolog 3	604477	R, REc			
7.107	1	14	09	7p15.3	CYCS, CYC, THC4		Cytochrome C, somatic	123970	REc		Thrombocytopenia 4, 612004 (3)	
7.108	8	8	13	7p15.2	HIBADH		3-hydroxyisobutyrate dehydrogenase	608475	REc, R			
7.109	7	1	11	7p15.2	HOTTIP, NCRNA00213		HOXA distal transcript antisense RNA	614060	REc			
7.110	9	20	14	7p15.2	HOXA11AS		Homeo box A11, antisense	607530	REc			6(Hoxa11s)
7.111	11	3	14	7p15.2	HOXAAS2		HOXA cluster antisense RNA 2	616068	REc			
7.112	5	15	11	7p15.2	MIR148A, MIRN148A		Micro RNA 148A	613786	REc			
7.113	6	22	14	7p15.2	SKAP2, SCAP2, SKAP55R		src kinase associated phosphoprotein 2	605215	REc			
7.114	2	21	13	7p15.2	SNX10, OPTB8		Sorting nexin 10	614780	REc		Osteopetrosis, autosomal recessive 8, 615085 (3)	
7.115	12	22	17	7p14.3	FKBP14, EDSKSCL2		FK506-binding protein 14	614505	REc		Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3)	
7.116	5	9	95	7p15.3	NPY		Neuropeptide Y	162640	REa, H, A			6(Npy)
7.117	12	4	08	7p14.3	WIPF3, CR16		WAS/WASL-interacting protein family, member 3	612432	REc			
7.118	6	10	08	7p14.3	ZNRF2		Zinc finger and ring finger protein 2	612061	REc			
7.119	10	19	97	7p21.1	AHR		Aryl hydrocarbon receptor	600253	REa, A, Psh			
7.120	12	28	08	7p15.3	CDCA7L, R1, JPO2		Cell division cycle-associated protein 7-like	609685	REc			
7.121	6	8	07	7p14.3	GARS, SMAD1, CMT2D, HMN5		Glycyl-tRNA synthetase	600287	A, Fd		Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal hereditary motor, type VA, 600794 (3)	
7.122	8	28	17	7p15.3	GSDME, DFNA5		Gasdermin E	608798	Fd, REc, H		Deafness, autosomal dominant 5, 600994 (3)	6(Dfna5)
7.123	12	30	03	7p14.3	GSBS		G-substrate	604088	R		{Hypercholesterolemia, susceptibility to}, 143890 (3)	
7.124	10	7	13	7p15.2	HNRPA2B1, IBMPFD2		Heterogeneous nuclear ribonucleoprotein A2/B1	600124	A	mutation identified in 1 family	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	
7.125	3	22	06	7p15.3	IGF2BP3, IMP3, KOC1, VICKZ3		Insulin-like growth factor 2 mRNA-binding protein 3	608259	A, H			6(Imp3)
7.126	6	22	14	7p15.2-p15.1	JAZF1, TIP27		JAZF1 gene	606246	Ch	fused with JJAZ1		
7.127	8	21	91	7p15	MYCLK1		Avian myelocytomatosis viral (v-myc) oncogene homolog like 1	164865	A			
7.128	3	2	10	7p15	MYP17, MYP4		Myopia 17	608367	Fd	previously assigned to 7q36 (MYP4)	Myopia 17 (2)	
7.129	5	7	03	7p15.3	OSBPL3, ORP3, KIAA0704		Oxysterol-binding protein-like protein 3	606732	R, REc			
7.130	6	13	95	7p15.3	SP4		Sp4 transcription factor	600540	Psh, A			
7.131	5	5	09	7p15	STQTL17		Stature quantitative trait locus 17	612737	Fd	associated with rs1635852 and rs849140	{Stature QTL 17} (2)	
7.132	9	30	09	7p15.2	TAX1BP1, TXBP151		TAX1-binding protein 1	605326	R, REc			
7.133	12	20	05	7p14.3	CPVL, HVLP		Carboxypeptidase, vitellogenic-like	609780	REc			
7.134	12	24	08	7p14.3	GGCT, GCTG, C7orf24		Gamma-glutamylcyclotransferase	137170	S, REc			6(Ggc)
7.135	7	16	09	7p14.3	GHRHR, GHRFR, IGHD1B		Growth hormone releasing hormone receptor	139191	REa, A		Growth hormone deficiency, isolated, type IB, 612781 (3)	6(Lit, Ghrhr)
7.136	1	23	07	7p14.3	NOD1, CARD4		Nucleotide-binding oligomerization domain protein 1	605980	REc			
7.137	7	11	11	7p14.1	TARP		T-cell antigen receptor, gamma subunit, alternate reading frame protein	609642	REc			
7.138	2	26	93	7p15.2	HOXA3, HOX1E		Homeo box-A3	142954	RE	homolog of Drosophila zen1, zen2		6(Hox1.5)
7.139	2	26	93	7p15.2	HOXA4, HOX1D		Homeo box-A4	142953	A, REa, H, RE	homolog of Drosophila Dfd		6(Hox1.4)
7.140	2	26	93	7p15.2	HOXA5, HOX1C		Homeo box-A5	142952	A, REa, H, RE			6(Hox1.3)
7.141	2	26	93	7p15.2	HOXA6, HOX1B		Homeo box-A6	142951	A, REa, H, RE			6(Hox1.2)
7.142	2	26	93	7p15.2	HOXA7, HOX1A		Homeo box-A7	142950	A, REa, H, RE	homolog of Drosophila Antp		6(Hox1.1)
7.143	2	26	93	7p15.2	HOXA9, HOX1G		Homeo box-A9	142956	RE, Ch	homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia		6(Hox1.7)
7.144	2	26	93	7p15.2	HOXA10, HOX1H		Homeo box-A10	142957	A, REa, H, RE			
7.145	11	8	16	7p15.2	HOXA11, HOX1I, RUSAT1		Homeo box-A11	142958	A, REa, H, RE		Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	
7.146	5	17	02	7p15.2	HOXA13, HOX1J		Homeo box-A13	142959	RE, Fd		Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305 (3)	6(Hoxa13, Hd)
7.147	3	23	09	7p15.2	MIR196B, MIRN196B		Micro RNA 196B	609688	REc			
7.148	4	21	04	7p14.3	AAA1		Asthma-associated alternatively spliced gene 1	608596	REc			
7.149	3	23	95	7p15.2	EVX1		Even-skipped homeo box-1 (homolog of Drosophila)	142996	REn	at 5' end of HOX1 cluster		
7.150	4	24	18	7p15.2	HOXA2, MCOHI		Homeobox A2	604685	REc	mutation identified in 1 MCOHICP family	?Microtia, hearing impairment, and cleft palate (AR), 612290 (3); Microtia with or without hearing impairment (AD), 612290 (3)	
7.151	10	08	07	7p14.3	NEUROD6, ATOH2, MATH2		Neurogenic differentiation 6	611513	REc			
7.152	10	20	99	7p15.2	NFE2L3, NRF3		Nuclear factor erythroid 2-like 3	604135	A			
7.153	5	21	09	7p14.3	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2		Neuropeptide S receptor 1	608595	REc		{Asthma, susceptibility to, 2}, 608584 (3)	
7.154	11	19	13	7p14.3	NT5C3A, NT5C3, UMPH1, PSN1		5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)	606224	REc	pseudogenes on chr.4 and chr.7	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	
7.155	8	29	07	7p14.2	TBX20, ASD4		T-box 20	606061	REc		Atrial septal defect 4, 611363 (3)	
7.156	7	8	10	7p15-p13	FGQTL2, BWQTL1		Fasting plasma glucose level QTL 2; Birth weight QTL 1	613219	Fd	associated with rs4607517	[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)	
7.157	8	12	15	7p13	GCK, HHF3		Glucokinase (hexokinase-4)	138079	Psh, Fd	proximal to TCRB	MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
7.158	2	4	89	7p14.1	INHBA		Inhibin, beta-1	147290	REa			13(Inhba)
7.159	8	17	09	7p14.3	AVL9, KIAA0241		AVL9, S. cerevisiae, homolog of	612927	R, REc			
7.160	3	28	11	7p14.3	BMPER, CV2		BMP binding endothelial regulator	608699	REc		Diaphanospondylodysostosis, 608022 (3)	9(Bmper)
7.161	7	15	11	7p14.2	DPY19L1, KIAA0877		DPY19-like 1	613892	REc			7p14.3
7.162	9	30	09	7p14.3	LSM5		LSM5 protein	607285	R, REc			
7.163	10	14	18	7p14.3	PDE1C, HCAM3, DFNA74		Phosphodiesterase 1C	602987	REc	mutation identified in 1 DFNA74 family	?Deafness, autosomal dominant 74, 618140 (3)	
7.164	4	26	10	7p14.3	TRIL, KIAA0644		TLR4 interactor with leucine-rich repeats	613356	REc			
7.165	12	17	12	7p14.3	SCRN1, SES1, KIAA0193		Secernin 1	614965	REc, R			
7.166	9	30	14	7p14.2	ANLN, FSFS8		Actin-binding protein anillin	616027	REc		Focal segmental glomerulosclerosis 8, 616032 (3)	
7.167	11	23	16	7p14.2	EEPD1, KIAA1706		Endonuclease/exonuclease/phosphatase family domain-containing protein 1	617192	REc			
7.168	3	21	14	7p14.3	RP9, PAP1		RP9 gene (pim1-associated protein, mouse, homolog of)	607331	Fd, REc	mutation identified in 1 patient	?Retinitis pigmentosa 9, 180104 (3)	
7.169	2	24	17	7p14.1	CDK13, CDC2L5, CHED, CHDFIDD		Cyclin-dependent kinase 13	603309	REc		Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3)	
7.170	6	13	12	7p14.1	GPR141, PGR13		G protein -coupled receptor 141	609045	REc			13(Gpr141)
7.171	3	14	13	7p14.1	NME8, TXNDC3, SPTRX2, CILD6		NME/NM23 family member 8	607421	R		Ciliary dyskinesia, primary, 6, 610852 (3)	
7.172	7	14	16	7p14.1	SFRP4, FRPHE, PYL		Secreted frizzled-related protein 4	606570	H, REc		Pyle disease, 265900 (3)	13(Sfrp4)
7.173	10	15	13	7p14.1	TRGC1		T-cell receptor gamma chain constant region 1	186970	REa, A, Ch			13(Tcrg)
7.174	10	15	13	7p14.1	TRGC2		T-cell receptor gamma chain constant region 2	615450	REc			
7.175	10	15	13	7p14.1	TRGV@		T-cell receptor gamma chain variable gene cluster	615454	REc			
7.176	10	15	13	7p14.1	TRGJ@		T-cell receptor gamma chain joining gene cluster	615455	REc			
7.177	9	30	09	7p14.1	VPS41		Vacuolar protein sorting 41, Yeast, homolog of	605485	R, REc			
7.178	1	7	95	7p14.3	ADCYAP1R1, PACAPR		Adenylate cyclase activating polypeptide-1 (pituitary) receptor type 1	102981	Psh, A			
7.179	2	5	18	7p14.3	AQP1, CHIP28, CO		Aquaporin-1 (channel-forming integral protein, 28kD)	107776	REa, A, Fd		[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency], 110450 (3)	6(Aqp1)
7.180	7	24	15	7p14.1	C7orf10, GA3		Chromosome 7 open reading frame 10	609187	A		Glutaric aciduria III, 231690 (3)	
7.181	12	7	17	7p13	CAMK2B, MRD54		Calcium/calmodulin-dependent protein kinase II-beta	607707	REc		Mental retardation, autosomal dominant 54, 617799 (3)	
7.182	9	30	09	7p14.2-p14.1	ELMO1, CED12		Engulfment and cell motility gene 1	606420	REc			
7.183	12	29	06	7p14	HHT4		Telangiectasia, hereditary hemorrhagic, type 4	610655	Fd	between D7S2252 and D7S510	Telangiectasia, hereditary hemorrhagic, type 4 (2)	
7.184	6	2	15	7p14.1	MPLKIP, C7orf11, ABHS, TTDN1, TTD4		M-phase specific PLK1 interacting protein	609188	A		Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	
7.185	2	28	08	7p14.1	MRPL32		Mitochondrial ribosomal protein L32	611839	R			
7.186	4	24	08	7p13	MRPS24		Mitochondrial ribosomal protein S24	611986	R, REc			
7.187	10	16	14	7p14.3	PTHB1, BBS9		Parathyroid hormone-responsive B1 gene	607968	REc, Fd		Bardet-Biedl syndrome 9, 615986 (3)	
7.188	10	1	07	7p14.2	SEPT7, CDC10		Septin 7	603151	REc			
7.189	3	26	95	7p14.1	AMPH		Amphiphysin	600418	Psh, A			13(Amph)
7.190	11	8	06	7p22.1-p21.3	C1GALT1		Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	610555	REc			
7.191	4	6	00	7p14-p13	HPVC1, PE5L		Human papillomavirus E5 central sequence-like 1	600762	A			
7.192	9	21	09	7p13	OGDH		Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase)	613022	REa, A		Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	
7.193	12	7	04	7p14.1	POU6F2, WTSL, WT5		POU domain, class 6, transcription factor 2	609062	Ch, D, REc		{Wilms tumor susceptibility-5}, 601583 (3)	
7.194	1	28	08	7p14.1	STARD3NL, MENTHO		STARD3 N-terminal like	611759	REc			
7.195	10	13	94	7p14.2	AOAH		Acyloxyacyl hydrolase (neutrophil)	102593	A			
7.196	2	9	92	7p12.3	IGFBP1		Insulin-like growth factor-binding protein-1	146730	REa, A, REn			
7.197	2	9	92	7p12.3	IGFBP3		Insulin-like growth factor-binding protein-3	146732	REn	tail-to-tail 20kb from IGFBP1		
7.198	5	31	18	7p13	AEBP1, ACLP		AE-binding protein 1	602981	REc		Ehlers-Danlos syndrome, classic-like, 2, 618000 (3)	
7.199	8	16	11	7p13	BLVRA		Biliverdin reductase A	109750	S, A		Hyperbiliverdinemia, 614156 (3)	2(Blvr)
7.200	2	10	04	7p13	C7orf22, CCM2, MGC4067		Malcavernin	607929	Fd, REc		Cerebral cavernous malformations-2, 603284 (3)	
7.201	8	21	12	7p13	COA1, C7orf44		Cytochrome c oxidase assembly factor 1, S. cerevisiae, homolog of	614769	REc			
7.202	8	29	13	7p13	DBNL, HIP55		Drebrin-like	610106	REc, R			
7.203	11	11	14	7p13	DDX56, NOH61		DEAD/H box 56	608023	R, REc			
7.204	8	5	11	7p14.1	GLI3, PAPA, PAPB		GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	REa, A, Fd	amplified in glioblastoma	Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas, somatic}, 241800 (3)	13(Xt)
7.205	8	19	13	7p14-p13	HECW1, NEDL1, KIAA0322		HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 1	610384	REc, R			
7.206	9	8	11	7p13	MYL7, MYL2A, MLC2A, MYLC2A		Myosin, light chain 7, regulatory	613993	R, REc			11(Myl7)
7.207	7	2	14	7p13	MYO1G, HA2, HLA-HA2		Myosin IG	600642	A			
7.208	5	24	13	7p13	NUDCD3, KIAA1068, NUDCL		NUDC domain-containing protein 3	610296	REc, R			
7.209	5	9	18	7p13	NPC1L1, LDLCQ7		NPC1-like 1	608010	REa, A		[Ezetimibe, nonresponse to], 617966 (3); [Low density lipoprotein cholesterol level QTL 7], 617966 (3)	
7.210	9	30	09	7p13	POLD2		Polymerase (DNA directed), delta 2, regulatory subunit, 50kD	600815	Psh, REc			
7.211	9	20	14	7p13	POLM		Polymerase, DNA, mu	606344	REc			
7.212	4	30	97	7p13	PPIA		Peptidylprolyl isomerase A (cyclophilin A)	123840	Psh, A			
7.213	6	9	06	7p14.1	PSMA2, PSC2, HC3		Proteasome (prosome, macropain) subunit, alpha type, 2	176842	REc	incorrectly assigned to 6q		
7.214	9	16	12	7p13	PURB		Purine-rich element-binding protein B	608887	REc			
7.215	2	23	08	7p12.3	SEPT13		Septin 13	611563	REc			
7.216	4	2	16	7p13	SNORA5C		Small nucleolar RNA, H/ACA box, 5C	611335	REc	in intron 3 of TBRG4		
7.217	8	28	17	7p13	SPDYE1, SPDYB2L2, RINGO1		SPEEDY/RINGO cell cycle regulator family, member E1	617623	REc			
7.218	10	2	12	7p13	STK17A, DRAK1		Serine/threonine protein kinase 17A	604726	REc			
7.219	4	6	15	7p13	TBRG4, KIAA0948, CPR2		Transforming growth factor-beta regulator 4	611325	A, REc			
7.220	2	19	10	7p13	URGCP, URG4		Upregulator of cell proliferation	610337	REc			
7.221	7	2	18	7p13	YKT6		Ykt6, S. cerevisiae, homolog of	606209	REc			
7.222	5	23	13	7p13	ZMIZ2, KIAA1886, ZIMP7		Zinc finger MIZ-domain containing 2	611196	REc			
7.223	8	17	09	7p13	PGAM2, PGAMM, GSD10		Phosphoglycerate mutase, muscle form	612931	REa, A		Glycogen storage disease X, 261670 (3)	
7.224	7	17	14	7p12.3	ADCY1, DFNB44		Adenylate cyclase-1, brain	103072	A, REa, Fd	mutation identified in 1 DFNB44 family	?Deafness, autosomal recessive 44, 610154 (3)	11(Adcy1, brl)
7.225	6	16	99	7p12.3	HUS1		Hydroxyurea-sensitive 1, S. pombe, homolog of	603760	A, R			
7.226	11	23	16	7p12.3	PKD1L1, HTX8		Polycystin 1L1	609721	A		Heterotaxy, visceral, 8, autosomal, 617205 (3)	11(Pkd1l1)
7.227	2	15	01	7p13	RAMP3		Receptor activity-modifying protein 3	605155	R			11(Ramp3)
7.228	2	23	92	7p22.1	OCM		Oncomodulin	164795	REa			5(Ocm)
7.229	12	28	08	7p12.3	ABCA13		ATP-binding cassette, subfamily A, member 13	607807	REc, H			11(Abca13)
7.230	1	2	08	7p12.3	TNS3, TEM6		Tensin 3	606825	R, REc			
7.231	1	23	08	7p12.3	UPP1, UP		Uridine phosphorylase 1	191730	S, REc			
7.232	11	3	14	7p11.2	EGFR, NISBD2		Epidermal growth factor receptor	131550	S, Fd, D, REa	same as oncogene ERBB; mutation identified in 1 NISBD2 family	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3); Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3); {Nonsmall cell lung cancer, susceptibility to}, 211980 (3); ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	11(Erbb)
7.233	10	13	09	7p12.2	ALL2		Leukemia, acute lymphoblastic, susceptibility to, 2	613067	Fd	associated with rs11978267	{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)	
7.234	6	13	07	7p12.2	VWC2, BRORIN		von Willebrand factor C domain-containing protein 2	611108	REc			
7.235	8	8	13	7p12.2	ZPBP, SP38		Zona pellucida-binding protein	608498	REc			
7.236	9	9	13	7p12.2	FIGNL1		Fidgetin-like protein 1	615383	REc			
7.237	6	7	12	7p12.1-q21	CMH21		Cardiomyopathy, familial hypertrophic, 21	614676	Fd	max lod at D7S669	Cardiomyopathy, hypertrophic, 21 (2)	
7.238	8	19	13	7p12.1	COBL, KIAA0633		Cordon-bleu, mouse, homolog of	610317	REc			11(Cobl)
7.239	3	12	15	7p14.3	FKBP9, FKBP60, FKBP63		FK506-binding protein 9	616257	A			
7.240	12	15	98	7p11.2	GBAS, NIPSNAP2		Glioblastoma amplified sequence	603004	R			
7.241	3	25	16	7p12.2	IKZF1, ZNFN1A1, IK1, LYF1, CVID13		Ikaros family zinc finger 1	603023	REa, Ch	fused with BCL6 in DLBL	Immunodeficiency, common variable, 13, 616873 (3)	11(Ikaros)
7.242	1	7	02	7p12.1	GRB10, RSS		Growth factor receptor-bound protein-10	601523	REa, R, A			11(Grb1)
7.243	7	11	93	7p12-cen	TTIM1		T-cell tumor invasion and metastasis-1 (invasion-metastasis of neoplasms, chromosome 7 determined)	147830	S			
7.244	10	12	90	7p11.2	PHKG1		Phosphorylase kinase, gamma 1, muscle	172470	REa, A	presumed pseudogene on 11		5(Phkg)
7.245	8	8	13	7p11.2	CCT6A, CCT6, HTR3, TCP20		Chaperonin containing T-complex polypeptide 1, subunit 6A	104613	REc			
7.246	12	28	15	7p11.2	CHCHD2, PARK22		Coiled-coil-helix-coiled-coil-helix domain-containing protein 2	616244	REc		Parkinson disease 22, autosomal dominant, 616710 (3)	
7.247	7	22	09	7p11.2	LANCL2, TASP		LanC-like 2	612919	REc			
7.248	4	14	14	7p11.2	NYS3		Nystagmus 3, congenital, autosomal dominant	608345	Ch	translocation t(7;15)(p11.2;q11.2)	Nystagmus 3, congenital, autosomal dominant (2)	
7.249	3	24	14	7p11.2	PSPH, PSP, PSPHD		Phosphoserine phosphatase	172480	S, D		Phosphoserine phosphatase deficiency, 614023 (3)	5(Psph)
7.250	7	7	16	7p11.2	SEC61G		Sec61 complex, gamma subunit	609215	REc			
7.251	7	10	08	7p11.2	SEPT14		Septin 14	612140	Psh, REc			
7.252	5	27	09	7p11.2	SRS, RSS		Silver-Russell syndrome	180860	Ch	maternal uniparental disomy of chromosome 7	Silver-Russell syndrome (4)	
7.253	2	25	15	7p11.2	SUMF2		Sulfatase-modifying factor 2	607940	REc			
7.254	5	24	13	7p11.2	VOPP1, ECOP, GASP		Vesicular, overexpressed in cancer, prosurvival protein 1	611915	REc			
7.255	4	20	17	7p11.2	ZNF479, KR19		Zinc finger protein 479	617444	REc			
7.256	1	12	15	7p11.2	ZNF713		Zinc finger protein 713	616181	REc			
7.257	8	25	04	7p12.2-p12.1	DDC		DOPA decarboxylase (aromatic L-amino acid decarboxylase)	107930	REa, A		Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	
7.258	12	4	03	7q11.21	ASL		Argininosuccinate lyase	608310	S, REa, A		Argininosuccinic aciduria, 207900 (3)	5(Asl)
7.259	2	1	01	7p21.3	ARL4		ADP-ribosylation factor-like 4	604786	H			12(Arl4)
7.260	10	25	11	7q	MLSM7, DEL7q, C7DELq		Monosomy 7 of bone marrow	252270	Ch		Myelodysplasia and leukemia syndrome with monosomy 7 (4)	
7.261	8	11	91	7q	HRX		Hyperreflexia	145290	F	linked to KEL		
7.262	12	1	98	7q11.23	CLDN3, CPETR2		Claudin-3 (Clostridium perfringens enterotoxin receptor 2)	602910	REa, R			
7.263	7	22	15	7q11.21	SBDS, SDS		SBDS gene	607444	Fd, REc		Shwachman-Diamond syndrome, 260400 (3); {Aplastic anemia, susceptibility to}, 609135 (3)	
7.264	2	28	01	7q11.23	BAZ1B, WSTF, WBSCR9		Bromodomain adjacent to zinc finger domain, 1B	605681	REa			
7.265	4	23	08	7p11.2	MRPS17		Mitochondrial ribosomal protein S17	611980	R, REc	9 pseudogenes		
7.266	8	16	06	7p11-q21	HPC4		Prostate cancer, hereditary, 4	608658	Fd		{Prostate cancer, susceptibility to, 4}, 176807 (2)	
7.267	10	19	01	7q11.2	ANIB1		Aneurysm, intracranial berry, 1	105800	Fd	in or near ELN	Aneurysm, intracranial berry, 1 (2)	
7.268	2	28	08	7q22.1	ARMC10, SVH		Armadillo repeat-containing 10	611864	REc			
7.269	7	18	14	7q11.22	KIAA0442, MRD26		KIAA0442 gene	607270	A, Ch	translocation break at 7q11.2	Mental retardation, autosomal dominant 26, 615834 (3)	
7.270	7	16	09	7q11.23	CCL26, SCYA26		Chemokine, C-C motif, ligand 26	604697	A			
7.271	5	30	17	7q11.23	ELN, SVAS, ADCL1		Elastin	130160	REa, A, F, Fd		Supravalvar aortic stenosis, 185500 (3); Cutis laxa, autosomal dominant, 123700 (3)	5(Eln)
7.272	7	8	10	7q11.2	EOE1, EE		Esophagitis, eosinophilic, 1	610247	Fd	associated with rs2302009	{Esophagitis, eosinophilic, 1} (2)	
7.273	2	1	01	7q11.21	ERV3		Endogenous retroviral sequence-3 (includes zinc finger protein H-plk)	131170	REa, R			
7.274	9	30	09	7q11.23	FGL2		Fibrinogen-like 2	605351	R, REc			
7.275	3	22	06	7q22.1	POLR2J2, RPB11		RNA polymerase II polypeptide J-related gene	609881	REc			
7.276	3	22	00	7q11.23	POMZP3		POM121/ZP3 fusion protein	600587	A			
7.277	1	27	11	7q11.23	POR		Cytochrome P450 oxidoreductase	124015	REa, A		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3); Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	
7.278	3	23	14	7p11.2	PSPHP1, PSPHL, CO9		Phosphoserine phosphatase-like (pseudogene)	604239	TM			
7.279	6	16	99	7q11.23	STX1A, STX1		Syntaxin 1A, brain	186590	A, Psh			
7.280	6	6	00	7q11.21	ZNF107		Zinc finger protein-107	603989	A			
7.281	9	12	93	7q11.21	ZNF117		Zinc finger protein-117	194624	A			
7.282	2	20	03	7q21.2	CCM1, CAM, KRIT1		KREV interaction trapped 1	604214	Fd, A		Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860 (3)	
7.283	10	6	92	7q11.2-q21.3	EEC1		Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1	129900	Ch		?EEC syndrome-1 (2)	
7.284	8	20	12	7q11.21	KCTD7, EPM3, CLN14		Potassium channel tetramerization domain containing 7	611725	REc, Fd		Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	
7.285	12	28	08	7q11.21	RABGEF1, RABEX5		RAB guanine nucleotide exchange factor 1	609700	R, REc			
7.286	9	30	09	7q11.21	TPST1		Tyrosylprotein sulfotransferase 1	603125	REc			
7.287	5	26	13	7q11.21	TYW1		tRNA-wybutosine-synthesizing protein 1, S. cerevisiae, homolog of	611243	REc, R			
7.288	9	16	12	7q11.21	VKORC1L1		Vitamin K epoxide reductase complex, subunit 1-like 1	608838	REc			
7.289	2	1	11	7q11.21	ZNF92		Zinc finger protein-92	603974	REa, A, REc	sequence aligns with sequence on 19p13.1-p12		
7.290	9	27	17	7q11.21	ZNF273, HZF9		Zinc finger protein 273	604756	REc			
7.291	2	2	01	7q11.21	ZNF138		Zinc finger protein-138	604080	A, REa			
7.292	4	6	13	7q11.22	WBSCR17, GALNTL3, GALNACT17		Williams-Beuren syndrome chromosome region 17	615137	REc			
7.293	4	17	01	7q11.23	BCL7B		B-cell CLL/lymphoma 7B	605846	REc			
7.294	11	10	17	7q11.23	BUD23, WBSCR22, MERM1		rRNA methyltransferase and ribosome maturation factor Bud23	615733	REc, H			5(Wbscr22)
7.295	8	29	02	7q11.23	CCL24, SCYA24, MPIF2		Chemokine, C-C motif, ligand 24	602495	Psh, REc, R			
7.296	10	4	05	7q11.23	CLDN4, CPETR1, CPER		Claudin 4	602909	Psh, H			5(Cldn4)
7.297	2	11	09	7q11.23	CLIP2, CYLN2, WBSCR4, WSCR4		CAP-GLY domain-containing linker protein 2	603432	A, H	?neurodevelopmental defect of Williams syndrome		5(Cyln2)
7.298	2	22	11	7q11.23	DEL7q11.23, C7DELq11.23		Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	Ch	contiguous gene deletion syndrome	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	
7.299	12	21	09	7q11.23	DTX2, KIAA1528		Deltex, Drosophila, homolog of, 2	613141	R, REc			
7.300	1	15	09	7q11.23	DUP7q11.23, C7DUPq11.23		Chromosome 7q11.23 duplication syndrome	609757	Ch		Chromosome 7q11.23 duplication syndrome (4)	
7.301	2	12	09	7q11.23	EIF4H, WBSCR1, WSCR1		Eukaryotic translation initiation factor 4H	603431	REc			
7.302	5	11	00	7q11.23	FKBP6		FK506-binding protein 6	604839	REc			
7.303	8	28	97	7q11.23	FZD9, FZD3		Frizzled, Drosophila, homolog of, 9	601766	REn			
7.304	7	14	16	7q11.23	GATSL2, CASTOR2		GATS protein-like 2	617033	REc			
7.305	1	9	14	7q11.23	GSAP, PION		Gamma-secretase-activating protein	613552	REc			
7.306	9	12	06	7q11.23	GTF2I, BAP135, WBS		General transcription factor II-I (BTK-associated protein, 135kD)	601679	D			
7.307	9	12	06	7q11.23	GTF2IRD1, GTF3, MUSTRD1, WBS		GTF21 repeat domain-containing protein 1	604318	REc			
7.308	2	28	03	7q11.23	HIP1		Huntingtin interacting protein-1	601767	A, R		{Prostate cancer, progression of}, 176807 (1)	5(Hip1)
7.309	6	8	07	7q11.23	HSPB1, HSP27, CMT2F, HMN2B		Heat-shock 27kD protein-1	602195	REa, H, REc, Fd		Neuropathy, distal hereditary motor, type IIB, 608634 (3); Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	5(Hsp105)
7.310	2	12	09	7q11.23	LAT2, WBSCR5, LAB, NTAL		Linker for activation of T cells family, member 2	605719	REc			5(Wbscr5)
7.311	9	3	96	7q11.23	LIMK1		LIM domain kinase 1	601329	REn, Ch, A			5(Limk1)
7.312	2	10	17	7q11.23	MDH2, EIEE51		Malate dehydrogenase, mitochondrial	154100	S, REc		Epileptic encephalopathy, early infantile, 51, 617339 (3)	5(Mor1)
7.313	3	17	08	7q11.23	MLXIPL, WBSCR14, MONDOB, CHREBP		MLX interacting protein-like	605678	REn			
7.314	2	12	13	7q11.23	MIR590		Micro RNA 590	615070	REc			
7.315	10	12	90	7q11.23	NCF1		Neutrophil cytosolic factor-1, 47kD	608512	REa, A		Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	
7.316	5	30	17	7q11.23	NSUN5, WBSCR20, WBSCR20A		NOP2/SUN RNA methyltransferase family, member 5	615732	REc			
7.317	6	22	14	7q11.23	POM121, POM121A, KIAA0618		POM121 transmembrane nucleoporin	615753	R, REc			
7.318	6	22	14	7q11.23	POM121C, POM121-2		POM121 Transmembrane nucleoporin C	615754	REc			
7.319	12	5	13	7q11.23	PTPN12, PTPG1		Protein tyrosine phosphatase, nonreceptor-type, 12	600079	A		Colon cancer, somatic, 114500 (3)	5(Ptpn12)
7.320	3	6	95	7q11.23	RFC2		Replication factor C2, 40kD (activator 1, 40kD)	600404	Psh, A			
7.321	5	6	13	7q11.23	RHBDD2		Rhomboid domain-containing protein 2	615203	REc			
7.322	3	19	03	7q11.23	SRCRB4D		Protein with 4 group B scavenger receptor cysteine-rich domains	607639	REc, R			
7.323	12	17	15	7q11.23	STYXL1, MKSTYX, DUSP24		Serine/threonine/tyrosine-interacting protein-like 1	616695	REc			
7.324	4	17	01	7q11.23	TBL2		Transducin-beta-like 2	605842	H, R			5(Tbl2)
7.325	9	24	15	7q11.23	TMEM120A, TMPIT, NET29		Transmembrane protein 120A	616550	REc			
7.326	1	24	09	7q11.23	TRIM50, TRIM50A		Tripartite motif-containing protein 50	612548	REc, H			5(Trim50)
7.327	1	24	09	7q11.23	TRIM73, TRIM50B		Tripartite motif-containing protein 73	612549	REc			
7.328	1	24	09	7q11.23	TRIM74, TRIM50C		Tripartite motif-containing protein 74	612550	REc			
7.329	3	11	08	7q11.23	UPK3B, UPIIIB, P35		Uroplakin 3B	611887	REn			
7.330	6	9	06	7q11.23	VPS37D, WBSCR24		Vacuolar protein sorting 37, yeast, homolog of, D	610039	REc			
7.331	1	13	09	7q11.23	WBS, WMS, WS, DEL7q11, C7DELq11		Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome)	194050	Ch	contiguous gene syndrome	Williams-Beuren syndrome (4)	
7.332	1	24	09	7q11.23	WBSCR26		Williams-Beuren syndrome chromosome region 26	612545	REc, H			5(Wbscr26)
7.333	1	24	09	7q11.23	WBSCR27		Williams-Beuren syndrome chromosome region 27	612546	REc, H			5(Wbscr27)
7.334	1	24	09	7q11.23	WBSCR28		Williams-Beuren syndrome chromosome region 28	612547	REc, H			5(Wbscr28)
7.335	9	21	17	7q11.23	YWHAG, EIEE56		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform	605356	A, R		Epileptic encephalopathy, early infantile, 56, 617665 (3)	
7.336	10	10	17	7q11.23	ZP3, ZP3A, ZP3B, OOMD3		Zona pellucida glycoprotein-3 (sperm receptor)	182889	REa, A		Oocyte maturation defect 3, 617712 (3)	5(Zp3)
7.337	2	2	16	7q11.23-q21.11	PHTF2		Putative homeodomain transcription factor 2	616785	REc			
7.338	6	23	15	7q21.11	PCLO, PCH3		Piccolo, mouse, homolog of	604918	R, REc, Fd	mutation identified in 1 PCHD3 family	?Pontocerebellar hypoplasia, type 3, 608027 (3)	
7.339	6	24	16	7q31.1	PPP1R3A, PPP1R3		Protein phosphatase 1, regulatory subunit 3A	600917	R		Insulin resistance, severe, digenic, 125853 (3)	
7.340	4	12	18	7q21.12	ADAM22, EIEE61		A disintegrin and metalloproteinase domain 22	603709	R	mutation identified in 1 EIEE61 patient	?Epileptic encephalopathy, early infantile, 61, 617933 (3)	
7.341	10	12	14	7q11.23	APTR		Alu-mediated CDKN1A/p21 transcriptional regulator, noncoding	616048	REc			
7.342	8	1	17	7q21.3	BHLHA15, MIST1		Basic helix-loop-helix family, member A15	608606	REc			
7.343	1	2	08	7q21.3	CASD1, C7orf12		CAS1 domain-containing protein 1	611686	REc			
7.344	8	19	13	7q21.13	CLKDN12		Claudin 12	611232	REc			
7.345	4	6	18	7q22.1	EPO, MVCD2, ECYT5, DBAL		Erythropoietin	133170	REa, A, REb, Fd	mutation identified in 1 DBAL family	{Microvascular complications of diabetes 2}, 612623 (3); Erythrocytosis, familial, 5, 617907 (3); ?Diamond-Blackfan anemia-like, 617911 (3)	5(Epo)
7.346	1	12	99	7q21.13	FZD1		Frizzled, Drosophila, homolog of, 1	603408	A			
7.347	6	1	88	7q21.11	GNAI1		Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1	139310	REa, A			5(Gnai1)
7.348	2	10	00	7q22.1	GNB2		Guanine nucleotide-binding protein, beta polypeptide-2	139390	REa, REn	30-70kb from EPO		5(Gnb2)
7.349	07	27	18	7q21.11	MAGI2, AIP1, KIAA0705, NPHS15		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2	606382	R		Nephrotic syndrome, type 15, 617609 (3)	
7.350	1	27	11	7q21	MAGI2IT, PR47		MAGI2 intronic transcript	608950	REc			
7.351	12	22	05	7q21.3	PEG10, KIAA1051		Paternally expressed gene 10	609810	R, REc			6(Peg10)
7.352	7	26	16	7q21.2	SAMD9, NFTC, MIRAGE		Sterile alpha motif domain-containing protein 9	610456	REn		Tumoral calcinosis, familial, normophosphatemic, 610455 (3); MIRAGE syndrome, 617053 (3)	
7.353	9	9	03	7q21.3	SGCE, DYT11		Sarcoglycan, epsilon	604149	R, H, Fd	pseudogene on 2q21; maternally imprinted	Dystonia-11, myoclonic, 159900 (3)	6(Sgce)
7.354	1	31	00	7q21.13	STEAP		Six-transmembrane epithelial antigen of the prostate	604415	R			
7.355	1	2	03	7q21.13	STEAP2, STAMP1, IPCA1, PCANAP1		Six-transmembrane epithelial antigen of prostate 2	605094	REc			
7.356	8	22	07	7q21.12	STEAP4, STAMP2, TIARP		Six-transmembrane epithelial antigen of prostate 4	611098	REc			
7.357	2	17	09	7q21	STQTL11		Stature quantitative trait locus 11	612223	Fd	associated with rs2282978	{Stature QTL 11} (2)	
7.358	2	26	08	7q21.2	AKAP9, YOTIAO, AKAP450		A-kinase anchor protein 9	604001	REc	mutation identified in 1 LQT11 family	?Long QT syndrome-11, 611820 (3)	
7.359	3	15	10	7q22.1	ARPC1A, SOP2L		Actin-related protein 2/3 complex, subunit 1A	604220	REc			
7.360	10	25	17	7q22.1	ARPC1B, ARC41, PLTEID		Actin-related protein 2/3 complex, subunit 1B	604223	REc		Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, 617718 (3)	
7.361	7	17	01	7q21.3	ASB4		Ankyrin repeat-containing SOCS box protein 4	605761	REc			6(Asb4)
7.362	8	5	97	7q21.11	CACNA2, CACNL2A		Calcium channel, voltage-dependent, L type, alpha 2/delta subunit	114204	Psh, Fd, A			
7.363	6	6	00	7q22.1	CPSF4, CPSF30, NEB1		Cleavage-polyadenylation specificity factor 4, 30kD	603052	R			
7.364	11	5	14	7q21.2	CDK6, PLSTIRE, MCPH12		Cyclin-dependent kinase 6	603368	R, REc, Psh	mutation identified in 1 MCPH12 family	?Microcephaly 12, primary, autosomal recessive, 616080 (3)	
7.365	5	2	16	7q21.2	ERVW1, ERVWE1, HERVW		Endogenous retroviral family W, member 1 (syncytin)	604659	REc			
7.366	8	5	97	7q21-q22	MHS3		Malignant hyperthermia susceptibility 3	154276	Fd	?mutation in CACNA2	{Malignant hyperthermia susceptibility 3} (2)	
7.367	10	28	15	7q21.2	PEX1, ZWS1, PBD1A, PBD1B, HMLR1		Peroxisome biogenesis factor-1	602136	Ch, REc		Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3); Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3); Heimler syndrome 1, 234580 (3)	
7.368	8	9	99	7q21.3	TAC1, TAC2, NKNA		Tachykinin 1 (substance K; neurokinin A; neurokinin 2; neuromedin L; neuropeptide gamma; tachykinin 2)	162320	REa, A, H			6(Nkna)
7.369	9	28	96	7q22.1	ZNF36, KOX18		Zinc finger protein-36 (KOX 18)	601260	A, REc			
7.370	9	28	96	7q22.1	ZNF38, KOX25		Zinc finger protein-38 (KOX 25)	601261	A, REc			
7.371	12	24	13	7q21.3	ASNS, ASNSD		Asparagine synthetase	108370	S, REa, A	temperature sensitive G1 mutant	Asparagine synthetase deficiency, 615574 (3)	
7.372	12	7	12	7q21.12	ABCB4, PGY3, MDR3, ICP3		ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	RE	within 500kb of MDR1	Cholestasis, progressive familial intrahepatic 3, 602347 (3); Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3); Gallbladder disease 1, 600803 (3)	
7.373	5	4	12	7q21.12	ABCB1, PGY1, MDR1, IBD13, CLCs		ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050	REa, A, REb		{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13}, 612244 (3)	5(Pgy1)
7.374	7	11	01	7q21.12	CROT, COT		Carnitine octanoyltransferase	606090	REc			
7.375	8	24	09	7q21.11	HGF, DFNB39		Hepatic growth factor	142409	REb, A, REa		Deafness, autosomal recessive 39, 608265 (3)	
7.376	6	4	89	7q21.12	SRI, SCN		Sorcin (class 4 gene)	182520	REa, H			
7.377	6	4	98	7q21.11-q21.12	GRM3		Glutamate receptor, metabotropic-3	601115	A			
7.378	1	30	01	7q22.1	SMURF1		SMAD ubiquitination regulatory factor 1	605568	REc			
7.379	9	1	16	7q21.11	CD36, CHDS7, BDPLT10		CD36 antigen (collagen type I)	173510	A, REc		[Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency, 608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility to, 7}, 610938 (3)	
7.380	7	17	14	7q21.11	GNAT3, GDCA		Guanine nucleotide-binding protein, alpha-transducing activity polypeptide 3	139395	REc			
7.381	8	21	91	7q11.21	GUSB, MPS7		Glucuronidase, beta-	611499	S, D, EM		Mucopolysaccharidosis VII, 253220 (3)	5(Gus)
7.382	6	11	13	7q21.11	SEMA3A, SEMAD, COLL1, HH16		Semaphorin 3A	603961	REc, R		{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	
7.383	4	21	15	7q21.11	SEMA3C		Semaphorin 3C	602645	REc			
7.384	4	21	15	7q21.11	SEMA3D		Semaphorin 3D	609907	R, REc			
7.385	8	8	13	7q21.12	DMTF1, DMP1		Cyclin D-binding MYB-like transcription factor 1	608491	REc			
7.386	1	13	16	7q21.11	SEMA3E, SEMAH, KIAA0331		Semaphorin 3E	608166	R, REc	mutation identified in 1 CHARGE patient	?CHARGE syndrome, 214800 (3)	
7.387	9	8	11	7q21.12	KIAA1324L, EIG121L		KIAA1324-like gene	614048	REc			
7.388	1	9	17	7q21.12	RUNDC3B, RPIP9		RUN domain-containing protein 3B	617295	REc			
7.389	3	12	07	7q21.12	SLC25A40		Solute carrier family 25, member 40	610821	REc			5(Slc25a40)
7.390	6	26	16	7q21.12	TMEM243, C7orf23, MMTRAG		Transmembrane protein 243	616993	REc			
7.391	6	23	15	7q21.12	TP53TG1		TP53 target gene 1	616403	REc			
7.392	4	17	13	7q21.13	CDK14, PFTK1, PFTAIRE1, KIAA0834		Cyclin-dependent kinase 14	610679	R			
7.393	5	9	18	7q21.13	CFAP69, C7orf63, SPGF24		Cilia- and flagella-associated protein 69	617949	REc		Spermatogenic failure 24, 617959 (3)	5(Cfap69)
7.394	4	18	07	7q21.13	GTPBP10, OBGH2		GTP-binding protein 10	610920	R, REc			
7.395	4	22	15	7q21.2	GATAD1, ODAG, CMD2B		GATA zinc finger domain-containing protein 1	614518	REc	mutation identified in 1 GATAD1 family	?Cardiomyopathy, dilated, 2B, 614672 (3)	
7.396	10	7	13	7q21.2	MTERF		Transcription termination factor, mitochondrial	602318	REc			
7.397	8	1	16	7q21.2	SAMD9L, ATXPC		Sterile alpha motif domain-containing 9-like	611170	REc		Ataxia-pancytopenia syndrome, 159550 (3)	
7.398	3	5	03	7q21.2	CYP51A1, CYP51		Cytochrome P450, family 51, subfamily A, polypeptide 1 (lanosterol 14-alpha-demethylase)	601637	Psh, REc			
7.399	9	8	11	7q21.2	HEPACAM2, MIKI		Hepacam family member 2	614133	REc			
7.400	4	21	11	7q21.2-q21.3	SHFM1, SHFD1, SHSF1		Split hand/foot malformation (ectrodactyly) type 1	183600	Ch	contiguous gene deletion syndrome	Split hand/foot malformation 1 (4)	
7.401	7	20	15	7q21.2-q21.3	VPS50, CCDC132, KIAA1861		VPS50, EARP/GARPII complex subunit	616465	REc			
7.402	9	4	98	7q22.1	TRRAP		Transformation/transcription domain-associated protein	603015	R			
7.403	5	22	14	7q21.3	ACN9		Acn9, S. cerevisiae, homolog of	615773	REc			
7.404	11	22	99	7q21.12	ASK, DBF4		Activator of S-phase kinase	604281	A			5(Dbf4)
7.405	7	14	14	7q21.3	BET1		Bet1 golgi vesicular membrane-trafficking protein	605456	REc			
7.406	2	13	14	7q21.3	BRI3		Brain protein I3	615628	REc			
7.407	3	16	99	7q21.3	CALCR, CRT		Calcitonin receptor	114131	A, Psh	not deleted in Williams syndrome	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	6(Calcr)
7.408	5	25	13	7q21.3	GNG11		Guanine nucleotide-binding protein, gamma 11	604390	REc			
7.409	6	16	99	7q21.3	GNGT1		Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 1	189970	Psh, REc			
7.410	3	30	12	7q21.3	MIR489		Micro RNA 489	614523	REc	in intron 4 of CALCR		
7.411	7	8	10	7q21.3	PON1, PON, ESA, MVCD5		Paraoxonase-1	168820	F, Fd, REc		{Coronary artery disease, susceptibility to} (3); {Coronary artery spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)	6(Pon1)
7.412	9	9	98	7q21.3	PON2		Paraoxonase-2	602447	REc		{Coronary artery disease, susceptibility to} (3)	
7.413	9	9	98	7q21.3	PON3		Paraoxonase-3	602720	REc			
7.414	10	20	04	7q21.3	PPP1R9A, NRBI, NRB1, KIAA1222		Protein phosphatase 1, regulatory subunit 9A (neurabin I)	602468	R, REc			
7.415	8	20	02	7q21.3	SLC25A13, CTLN2		Solute carrier family 25 (mitochondrial carrier, citrin), member 13	603859	Fd, LD		Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia, type II, neonatal-onset, 605814 (3)	
7.416	8	31	12	7q21.3	TECPR1, KIAA1358		Tectonin beta-propeller repeat-containing 1	614781	R, REc			
7.417	1	7	95	7q22.1	PCOLCE		Procollagen C-endopeptidase enhancer	600270	REa, A			5(Pcolce)
7.418	4	13	10	7q22.1	PAI1, PLANH1, SERPINE1		Plasminogen activator inhibitor, type I	173360	REa, REb, Fd, A, D		Plasminogen activator inhibitor-1 deficiency, 613329 (3); {Transcription of plasminogen activator inhibitor, modulator of} (3)	
7.419	8	28	01	7q11.21	RCP		Calcitonin gene-related peptide receptor component protein	606121	REc			
7.420	3	5	08	7q21.3-q22.1	BAIAP2L1, IRTKS		BAI1-associated protein 2-like 1	611877	REc			
7.421	6	16	99	7q21.3	DNCI1		Dynein, cytoplasmic, intermediate chain 1	603772	REc			6(Dnci1)
7.422	5	22	07	7q21.3	LMTK2, KPI2, BREK, KIAA1079		Lemur tyrosine kinase 2	610989	R, REc			
7.423	8	18	97	7q22.1	MCM7, MCM2		Minichromosome maintenance deficient, S. cerevisiae, homolog of, 7	600592	A			
7.424	9	20	95	7q22.1	NPTX2		Pentraxin II	600750	A			
7.425	11	4	98	7q21.3	PDK4		Pyruvate dehydrogenase kinase, isoenzyme 4	602527	REc			
7.426	11	29	17	7q21.3	SEM!, DSS1		Proteasome 26S subunit SEM1	601285	D	?gene mutant in SHFM1		
7.427	8	28	92	7q22.1	ACHE, YT		Acetylcholinesterase (YT blood group)	100740	Psh, A, Fd, REb	blood group YT (112100) = epitope of ACHE	[Blood group, Yt system], 112100 (3)	5(Ache)
7.428	12	24	08	7q22.1	ACTL6B, BAF53B		Actin-like 6B	612458	REc			
7.429	1	31	01	7q22.1	APS		Adaptor protein containing PH and SH2 domains	605300	REc			
7.430	5	16	07	7q22	AUTS1		Autism, susceptibility to, 1	209850	Fd		{Autism susceptibility 1} (2)	
7.431	10	09	18	7q22.1	CUX1, CUTL1, CDP		Cut-like homeobox 1	116896	REa			
7.432	2	16	12	7q21.3	DLX5, SHFM1D		Distal-less homeo box-5	600028	REa, A, D	mutation identified in 1 family	?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	6(Dlx5)
7.433	1	8	95	7q21.3	DLX6		Distal-less homeo box-6	600030	REa, A			
7.434	1	13	17	7q22.1	EPHB4, HTK, MYK1, HFASD		Ephrin receptor EphB4 (hepatoma transmembrane kinase)	600011	REa, REc		{Hydrops fetalis, nonimmune, and/or atrial septal defect}, 617300 (3)	
7.435	9	30	09	7q22.1	DNAJC2, ZRF1, MPP11		DnaJ (Hsp40) homolog, subfamily C, member 2	605502	R, REc			
7.436	9	9	08	7q22.1	FBXO24, FBX24		F-box only protein 24	609097	REc			5(Fbxo24)
7.437	2	7	07	7q22.1	GAL3ST4		Galactose-3-O-sulfotransferase 4	608235	REc			
7.438	1	18	11	7q22	IBD11		Inflammatory bowel disease 11	191390	Fd	associated with MUC3A	{Inflammatory bowel disease 11} (2)	
7.439	3	14	14	7q22.3	KMT2E, MLL5		Lysine (K)-specific methyltransferase 2E	608444	REc			
7.440	10	13	09	7q22.1	MEPCE, BCDIN3		Methylphosphate capping enzyme	611478	A			
7.441	9	2	09	7q22.1	MIR93, MIRN9		Micro RNA 93	612984	REc			
7.442	9	3	09	7q22.1	MIR106B, MIRN106B		Micro RNA 106B	612983	REc			
7.443	1	18	11	7q22.1	MUC3A		Mucin 3A, intestinal	158371	REa, A			
7.444	2	12	01	7q22	MUC3B		Mucin 3B, intestinal	605633	A			
7.445	1	4	08	7q22.1	MUC12, MUC11		Mucin 12	604609	A			
7.446	11	5	08	7q22.1	MUC17		Mucin 17	608424	R			
7.447	4	15	04	7q22	MYH16		Myosin, heavy chain 16, skeletal muscle	608580	REc	inactivated in humans; expressed in masticatory muscles in nonhuman primates		
7.448	8	24	04	7q22	PAPA4		Polydactyly, postaxial, type A4	608562	Fd	highest lod with D7S1799	Polydactyly, postaxial, type A4 (2)	
7.449	9	20	00	7q22.3	PIK3CG		Phosphatidylinositol 3-kinase, catalytic, gamma	601232	A			
7.450	1	31	01	7q22.1	PILRA		Paired immunoglobulin-like receptor, alpha	605341	REc, R			
7.451	1	31	01	7q22.1	PILRB		Paired immunoglobulin-like receptor, beta	605342	REc, REn			
7.452	12	16	08	7q22.1	PLOD3, LH3		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)	603066	REa, A	previously assigned to 7q36	Lysyl hydroxylase 3 deficiency, 612394 (3)	5(Plod3)
7.453	9	30	09	7q22.1	POP7, RPP20		Processing of precursor 7, S. cerevisiae, homolog of	606113	R, REc			
7.454	5	23	95	7q22.3	PRKAR2B		Protein kinase, cAMP-dependent, regulatory, type II, beta	176912	Fd, A, REc			
7.455	9	7	10	7q22.1	RASA4, CAPRI, GAPL, KIAA0538		Ras p21 protein activator 4	607943	REc			
7.456	6	23	15	7q22.1	RELN, RL, LIS2, ETL7		Reelin	600514	A, REc		Lissencephaly 2 (Norman-Roberts type), 257320 (3); {Epilepsy, familial temporal lobe, 7}, 616436 (3)	5(rl)
7.457	3	16	16	7q22.1	SLC12A9, CIP1, CCC6		Solute carrier family 12 (potassium/chloride transporter), member 9	616861	Psh			
7.458	2	23	12	7q22.1	SRRT, ARS2		Serrate RNA effector molecule, arabidopsis, homolog of	614469	REc			
7.459	4	8	16	7q22.1	STAG3, POF8		Stromalin 3	608489	Psh, R, H, REc		Premature ovarian failure 8, 615723 (3)	5(Stag3)
7.460	9	15	96	7q21.3	TFPI2		Tissue factor pathway inhibitor-2	600033	A			
7.461	5	3	00	7q22.1	TFR2, HFE3		Transferrin receptor 2	604720	R		Hemochromatosis, type 3, 604250 (3)	
7.462	11	20	98	7q22.1	TRIP6, OIP1		Thyroid hormone receptor interactor-6	602933	R			
7.463	3	5	98	7q22.1	VGF		VGF nerve growth factor inducible	602186	A			
7.464	6	19	98	7q22.1	ZAN		Zonadhesin	602372	A			5(Zan)
7.465	9	21	17	7q22.1	ZASP		ZO2-associated speckle protein	617677	REc			5(Zasp)
7.466	6	16	99	7q31.1	IFRD1		Interferon-related developmental regulator 1	603502	REc			
7.467	8	4	97	7q22.3	GPR22		G protein-coupled receptor-22	601910	A			
7.468	10	19	99	7q22.1	POLR2J		Polymerase II, RNA, subunit J	604150	REc			
7.469	6	22	14	7q22.3-q31.1	SLC26A3, DRA, CLD		Solute carrier family 26 (sulfate transporter), member 3	126650	A, REc, Fd	5' and close to PDS	Diarrhea 1, secretory chloride, congenital, 214700 (3)	
7.470	9	14	89	7q22-q32	G7P1		Kinase-like protein	148750	REa, Fd			
7.471	11	4	04	7q22-q32	SCA18, SMNA		Spinal cerebellar ataxia 18	607458	Fd	between D7S2418 and D7S1804	Spinocerebellar ataxia 18 (2)	
7.472	9	9	08	7q33	CNOT4, NOT4		CCR4-NOT transcription complex, subunit 4	604911	REc			
7.473	7	20	12	7q22-qter	NM, NCR		Neutrophil migration, abnormal	162820	D		?Neutrophil chemotactic response, abnormal (2)	
7.474	7	18	14	7q22.1	AGFG2, HRBL, RABR		ADP-ribosylation factor GTPase-activating protein with FG repeats 2	604019	REc			
7.475	3	16	10	7q22.1	ALKBH4, ABH4		AlkB, E. coli, homolog of, 4	613302	REc			
7.476	1	14	13	7q22.1	AP1S1, CLAPS1, AP19, MEDNIK		Adaptor-related protein complex 1, sigma 1 subunit	603531	REa, REc		MEDNIK syndrome, 609313 (3)	
7.477	4	27	12	7q22.1	AP4M1, SPG50, CPSQ3		Adaptor-related protein complex 4, mu-1 subunit	602296	REc		Spastic paraplegia 50, autosomal recessive, 612936 (3)	
7.478	3	18	94	7q22.1	AZGP1, ZAG		Alpha-2-glycoprotein, zinc	194460	REa, A			
7.479	5	25	13	7q22.1	BUD31, G10		Bud31, S. cerevisiae, homolog of	603477	REc			
7.480	6	22	14	7q22.1	CLDN15		Claudin 15	615778	REc			
7.481	4	23	09	7q22.1	CNPY4, PRAT4B, MGC40499		Canopy 4, zebrafish, homolog of	610047	R, REc			
7.482	12	22	17	7q21.3	COL1A2, EDSCV, EDSARTH2		Collagen I, alpha-2 polypeptide	120160	S, REa, D, A	~17cM from CF	Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3); Osteogenesis imperfecta, type IV, 166220 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type II, 166210 (3); {Osteoporosis, postmenopausal}, 166710 (3); Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3)	6(Cola2)
7.483	7	18	12	7q22.1	COPS6, CSN6		COP9 signalosome, subunit 6	614729	REc			
7.484	12	14	95	7q22.1	CYP3A4		Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4	124010	REa, D, Fd, A			6(Cyp3)
7.485	1	25	05	7q22.1	CYP3A5, P450PCN3		Cytochrome P450, subfamily IIIA, polypeptide 5	605325	REc, REn		{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	
7.486	12	7	03	7q22.1	CYP3A7		Cytochrome P450, subfamily IIIA, polypeptide 7	605340	REn			
7.487	12	11	01	7q22.1	CYP3A43		Cytochrome P450, subfamily IIIa, polypeptide 43	606534	REc			
7.488	6	13	12	7q22.1	EBXL13, FBL13		F-box and leucine-rich repeat protein 13	609080	REc			5(Fbxl13)
7.489	8	18	08	7q22.1	GAEC1		Gene amplified in esophageal cancer 1	612130	REc			
7.490	6	10	08	7q22.1	GIGYF1		GRB10-interacting GYF protein 1	612064	REc, H			5(Gigyf1)
7.491	4	1	08	7q22.1	GJC3, CX30.2, CX31.3		Gap junction protein, gamma-3	611925	R, REc			
7.492	9	8	11	7q22.1	KPNA7		Karyopherin alpha 7	614107	REc			
7.493	12	28	08	7q22.2-q22.3	LHFPL3		LHFP-like protein 3	609719	R, REc			
7.494	4	17	13	7q22.1	LRWD1, ORCA		Leucine-rich repeats- and WD repeat domain-containing protein 1	615167	REc			5(Lrwd1)
7.495	3	23	09	7q22.1	MIR25, MIRN25		Micro RNA 25	612150	REc			
7.496	8	3	12	7q22.1	MOGAT3, MGAT3		Monoacylglycerol O-acyltransferase 3	610184	REc			
7.497	11	23	16	7q22.1	MYL10, PLRLC		Myosin light chain 10	617177	REc			
7.498	10	7	08	7q22.1	NAPEPLD		N-acyl phosphatidylethanolamine-hydrolyzing phospholipase D	612334	REc			
7.499	6	22	14	7q22.1	NAT16		N-acetyltransferase 16	615783	REc			
7.500	8	18	08	7q22.1	NFE4		Transcription factor NFE4	612133	REc			
7.501	12	10	13	7q22.1	NYPA1		Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1	615477	REc			
7.502	7	22	09	7q22.1	ORAI2, MEM142B, C7orf19		ORAI calcium release-activated calcium modulator 2	610929	REc			
7.503	2	18	98	7q22.1-q22.2	ORC5, ORC5L		Origin recognition complex, subunit 5, S. cerevisiae, homolog of	602331	REa, Psh, A, REc			
7.504	9	30	09	7q22.1	PDAP1, PAP1, PAP		PDGFA-associated protein 1	607075	R, REc			
7.505	5	3	18	7q22.1	PMPCB, MPPB		Peptidase, mitochondrial processing, beta	603131	REc		Multiple mitochondrial dysfunctions syndrome 6, 617954 (3)	
7.506	11	11	14	7q22.1	PMS2P1, PMS2L1, PMS3		Postmeiotic segregation increased 2 pseudogene 1	605038	Psh, A, REc			
7.507	4	26	17	7q22.1	PRKRIP1, C114		PRKR-interacting protein 1, IL11-inducible	617458	REc			
7.508	8	21	12	7q22.1	PTCD1, KIAA0632		Pentatricopeptide repeat domain 1	614774	R, REc			
7.509	7	27	16	7q22.1	PVRIG, CD112R, C7orf15		Poliovirus receptor-related immunoglobulin domain-containing protein	617012	REc			
7.510	6	9	15	7q22.1	SLC26A5, PRES, DFNB61		Solute carrier family 26, member 5	604943	REc	mutation identified in 1 DFNB61 family	?Deafness, autosomal recessive 61, 613865 (3)	
7.511	8	28	17	7q22.1	SPDYE3, SPDYB2		SPEEDY/RINGO cell cycle regulator family, member E3	617625	REc			5(Spdye3)
7.512	9	22	16	7q22.1	TAF6, TAF2E, TAFII80, ALYUS		TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD	602955	R, REc		Alazami-Yuan syndrome, 617126 (3)	
7.513	6	26	16	7q22.1	TRIM56		Tripartite motif-containing protein 56	616996	REc			
7.514	5	24	13	7q22.1	ZKSCAN5, ZFP95, KIAA1015		Zinc finger protein with KRAB and SCAN domains 5	611272	REc, R, A			5(Zkscan5)
7.515	11	2	04	7q22.1	TTC11, FIS1		Tetratricopeptide repeat domain 11	609003	R, REc			
7.516	10	13	09	7q22.1	UFSP1		UFM1-specific peptidase 1	611481	REc			
7.517	9	30	09	7q22.1	ZNF3		Zinc finger protein-3	194510	R, REc	?relation to ZNF4, ZNF5; previous assignment to Chr.5		
7.518	3	1	18	7q22.1	ZNF655, VIK		Zinc finger protein 655	617891	REc			
7.519	11	4	98	7q22.1	PSMC2, MSS1, S7		Proteasome 26S subunit, ATPase, 2	154365	A			
7.520	4	8	08	7q22.3	NAMPT, PBEF1, VF, PBEF		Nicotinamide phosphoribosyltransferase	608764	R, REc			
7.521	10	9	08	7q22.3	CBLL1, HAKAI, RNF188		Cas-Br-M murine ectopic retroviral transforming sequence like-1	606872	R, REc			
7.522	2	2	14	7q22.3	CDHR3		Cadherin-related family, member 3	615610	REc			
7.523	12	22	15	7q22.3	HBP1		HMG-box transcription factor 1	616714	REc			
7.524	5	29	12	7q22.3	MPVQTL6		Mean platelet volume quantitative trait locus 6	614646	Fd	associated with rs342293	Mean platelet volume QTL6 (2)	
7.525	3	12	15	7q22.3	PUS7, KIAA1897		Pseudouridylate synthase 7, putative	616261	REc			
7.526	7	19	12	7q22.3	RINT1		RAD50-interacting protein 1	610089	REc			
7.527	12	1	15	7q22.3	SYPL1, SYPL		Synaptophysin-like 1	616665	REc			
7.528	3	1	06	7q22.3-q31.1	CMD1Q		Cardiomyopathy, dilated, 1Q	609915	Fd	between D7S2545 and D7S2554	Cardiomyopathy, dilated, 1Q (2)	
7.529	11	19	13	7q31	AUTS9		Autism, susceptibility to, 9	611015	Fd	max lod near D7S530	{Autism, susceptibility to, 9} (2)	
7.530	1	18	11	7q22.3	COG5, GOLTC1, GTC90, CDG2I		Component of oligomeric golgi complex 5	606821	REc		Congenital disorder of glycosylation, type IIi, 613612 (3)	
7.531	12	20	05	7q31.31	CTTNBP2, CORTBP2, KIAA1758		Cortactin-binding protein 2	609772	REn			
7.532	5	20	99	7q31	DFNB14		Deafness, autosomal recessive 14	603678	Fd	?same as DFNB17	Deafness, autosomal recessive 14 (2)	
7.533	9	9	98	7q31	DFNB17		Deafness, autosomal recessive 17	603010	Fd		Deafness, autosomal recessive 17 (2)	
7.534	4	9	03	7q31.1	DOCK4, KIAA0716		Dedicator of cytokinesis 4	607679	REc			12(Dock4)
7.535	11	4	98	7q31.33	GPR37		G protein-coupled receptor-37	602583	REc			
7.536	9	15	00	7q31.1	GPR85, SREB2		G protein-coupled receptor-85	605188	R			
7.537	5	4	00	7q31.32	HYAL4		Hyaluronoglucosaminidase 4	604510	A, REc			
7.538	10	6	08	7q31.1	IMMP2L, IMP2		Inner mitochondrial membrane peptidase, subunit 2, S. cerevisiae, homolog of	605977	Ch			
7.539	1	27	03	7q31.31	ING3, P47ING3		Inhibitor of growth family, member 3	607493	REc			
7.540	11	27	00	7q31.31	KCND2, KIAA1044		Potassium voltage-gated channel, Shal-related subfamily, member 2	605410	R			
7.541	4	21	16	7q31.2	MET, DFNB97, OSFD		Oncogene MET	164860	REa, A, F	mutation identified in 1 DFNB97 family	Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3); Hepatocellular carcinoma, childhood type, somatic, 114550 (3); ?Deafness, autosomal recessive 97, 616705 (3); {Osteofibrous dysplasia, susceptibility to}, 607278 (3)	6(Met)
7.542	5	4	15	7q31.1	PNPLA8, MMLA		Patatin-like phospholipase domain-containing protein 8	612123	REc	mutation identified in 1 MMLA family	?Mitochondrial myopathy with lactic acidosis, 251950 (3)	
7.543	7	6	12	7q22.3	SLC26A4, PDS, DFNB4, EVA, TDH2B		Solute carrier family 26 (sulfate transporter), member 4	605646	Fd	some patients have digenic mutations with FOXI1	Pendred syndrome, 274600 (3); Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	
7.544	11	13	95	7q31.32	SPAM1		Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)	600930	A			
7.545	3	23	06	7q33	STRA8		Stimulated by retinoic acid 8, mouse, homolog of	609987	REc			
7.546	11	26	01	7q31.1	FOXP2, SPCH1, TNRC10, CAGH44		Forkhead box P2	605317	Fd, Ch, REc		Speech-language disorder-1, 602081 (3)	
7.547	9	8	11	7q33	EXOC4, SEC8, KIAA1699		Exocyst complex component 4	608185	REc, R			
7.548	5	9	18	7q31.32	TAS2R16, T2R16, BGLPT		Taste receptor type 2, member 16	604867	REc		[Beta-glycopyranoside tasting], 617956 (3) {Alcohol dependence, susceptibility to}, 103780 (3)	6(T2r18)
7.549	6	10	94	7q31.2	WNT2, INT1L1		Wingless-type MMTV integration site family, member 2	147870	C	isolated by CMGT with MET		6(Irp, Wnt2)
7.550	12	4	90	7q36.1	ABP1		Amiloride-binding protein-1	104610	A			
7.551	3	20	08	7q32.1	CCDC136, NAG6, KIAA1793		Coiled-coil domain-containing protein 136	611902	REn			
7.552	3	7	13	7q31.1	DLD, LAD, PHE3, DLDD		Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)	238331	REa		Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	12(Dld)
7.553	8	28	01	7q31.32	SLC13A1, NAS1		Solute carrier family 13 (sodium/sulfate symporters), member 1	606193	R			
7.554	7	22	16	7q32.1	SMOH, SMO, CRJS		Smoothened, Drosophila, homolog of	601500	A		Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)	
7.555	4	16	11	7q33	BPGM		2,3-bisphosphoglycerate mutase	613896	A		Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)	
7.556	1	30	18	7q31.1	BMT2, SAMTOR, C7orf60		Base methyltransferase of 25S rRNA 2, S. cerevisiae, homolog of	617855	REc			
7.557	4	10	14	7q31.2	CAV1, BSCL3, CGL3, PPH3, LCCNS		Caveolin-1	601047	REc	mutation identified in 1 CGL3 family; mutation identified in 1 LCCNS family	?Lipodystrophy, congenital generalized, type 3, 612526 (3); Pulmonary hypertension, primary, 3, 615343 (3); ?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	
7.558	3	29	99	7q31.2	CAV2		Caveolin-2	601048	REc			6(Cav2)
7.559	2	1	11	7q31.1	DNAJB9, MDG1		DnaJ, E. coli, homolog of, subfamily B, member 9 (microvascular endothelial differentiation gene-1)	602634	REc	previously assigned to chr.14 by FISH		
7.560	6	2	15	7q31.1	LAMB4		Laminin, beta-4	616380	REc			
7.561	3	29	12	7q31.1-q31.2	MDFIC, HIC		MYOD family inhibitor domain-containing protein	614511	REc			
7.562	11	7	01	7q31.2	ST7, TSG7, RAY1, FAM4A1		Suppressor of tumorigenicity 7 (breast)	600833	C, D			
7.563	3	29	10	7q31.31	TSPAN12, NET2, EVR5		Tetraspanin 12	613138	REc		Exudative vitreoretinopathy 5, 613310 (3)	6(Tspan12)
7.564	1	20	09	7q31.1	THAP5		THAP domain-containing protein 5	612534	REc			
7.565	1	29	01	7q31.1	ZNF277		Zinc finger protein-277	605465	REn			
7.566	1	21	97	7q31.1	NRCAM		Neuronal cell adhesion molecule	601581	A			
7.567	4	23	13	7q31.1	LAMB1, LIS5		Laminin, beta-1	150240	REa, A, Ch		Lissencephaly 5, 615191 (3)	1(Lamb1)
7.568	4	9	18	7q31.2	CFTR, ABCC7, CF, MRP7		Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	F, Fd	distal and 5' to MET	Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, hereditary}, 167800 (3); {Hypertrypsinemia, neonatal} (3); {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	6(Cftr)
7.569	7	11	01	7q31.2	TES		Testin	606085	REc			6(Tes)
7.570	7	17	14	7q31.2	TFEC, TFECL		Transcription factor EC	604732	REc			
7.571	2	19	97	7q31.2	CAPZA2, CAPPA2		Capping protein (actin filament) muscle Z-line, alpha 2	601571	Psh, REn			6(Cappa2)
7.572	8	9	00	7q31.32	AASS		Alpha-aminoadipic semialdehyde synthase	605113	R		Hyperlysinemia, 238700 (3); Saccharopinuria, 268700 (1)	
7.573	1	30	07	7q31.31	ANKRD7		Ankyrin repeat domain-containing protein 7	610731	REc			
7.574	5	12	99	7q32.1	ARF5		ADP-ribosylation factor 5	103188	REc			
7.575	4	30	09	7q31.2	ASZ1, ALP1, ANKL1, GASZ		Ankyrin repeat, SAM, and basic leucine zipper domain-containing 1	605797	REc			
7.576	3	24	06	7q31.32	CADPS2, KIAA1591		Calcium-dependent activator protein for secretion 2	609978	A			
7.577	5	28	13	7q31.31	FAM3C		Family with sequence similarity 3, member C	608618	REc, R			
7.578	2	6	14	7q31.32	FEZF1, FEZ, ZNF312B, HH22		FEZ family zinc finger protein 1	613301	REc		Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	
7.579	11	25	14	7q31.32	LMOD2, CLMOD		Leiomodin 2	608006	REc			
7.580	6	22	14	7q32.1	FSCN3		Fascin actin-bundling protein 3, testicular	615800	A			
7.581	12	11	12	7q32.1	LEP, OB, LEPD		Leptin (murine obesity homolog)	164160	H, REa, REc, A	in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel	Obesity, morbid, due to leptin deficiency, 614962 (3)	6(ob)
7.582	1	23	01	7q32.1	P100, SND1		EBNA-2 coactivator p100	602181	REc, REa, A			
7.583	7	13	18	7q31.32	PTPRZ1, PTP18		Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide	176891	REa, A			
7.584	2	17	09	7q31.3	STQTL2		Stature quantitative trait locus 2	606256	Fd	max lod at D7S195	{Stature QTL 2} (2)	
7.585	2	25	15	7q31.32	WASL, NWASP		Wiskott-Aldrich syndrome gene-like	605056	REc			
7.586	7	19	12	7q31.31	WNT16		Wingless-type MMTV integration site family, member 16	606267	REc			
7.587	3	19	14	7q31.31	LSM8		LSM8, S. cerevisiae, homolog of, U6 small nuclear RNA associated	607288	REc			
7.588	3	31	11	7q32.1	IMPDH1, RP10, LCA11		Inosine-5'-monophosphate dehydrogenase, type I	146690	Psh, A, Fd	pseudogene on 16p13.13	Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11, 613837 (3)	
7.589	8	30	10	7q32.1	OPN1SW, BCP, CBT		Blue cone pigment (opsin 1, short-wave-sensitive)	613522	REa, A		Colorblindness, tritan, 190900 (3)	6(Bcp)
7.590	4	28	00	7q34	TAS2R3, T2R3		Taste receptor type 2, member 3	604868	REc			
7.591	4	28	00	7q34	TAS2R4, T2R4		Taste receptor type 2, member 4	604869	REc			6(T2R8)
7.592	1	31	01	7q34	TAS2R5, T2R5		Taste receptor type 2, member 5	605062	REc			
7.593	6	4	98	7q31.33	GRM8		Glutamate receptor, metabotropic-8	601116	A			
7.594	9	24	15	7q31.33	POT1, CMM10, GLM9		Protection of telomeres 1	606478	REc		{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3); {Glioma susceptibility 9}, 616568 (3)	
7.595	10	6	09	7q32	BCC6		Basal cell carcinoma, susceptibility to, 6	613063	Fd	associated with rs157935	{Basal cell carcinoma, susceptibility to, 6} (2)	
7.596	2	9	12	7q32.2	CEP41, TSGA14, JBTS15		Centrosomal protein, 41kD	610523	REc		Joubert syndrome 15, 614464 (3)	
7.597	5	26	13	7q32.2	COPG2IT1, CIT1		Coatomer protein complex, subunit gamma-2, intronic transcript 1	610581	REc			
7.598	3	20	03	7q32.2	CPA4, CPA3		Carboxypeptidase A4	607635	RE			
7.599	11	12	96	7q32.2	MEST, PEG1		Mesoderm specific transcript, mouse, homolog of	601029	A, H, REc	imprinted maternally		6(Mest)
7.600	1	13	99	7q32.1	CALU		Calumenin	603420				7(Calu)
7.601	4	19	01	7q32	CATR1		CATR tumorigenic conversion 1	600676	REc			
7.602	2	1	00	7q32.2	COPG2		Coatomer protein complex, subunit gamma-2	604355	REc			
7.603	4	19	01	7q32.2	CPA2		Carboxypeptidase A2, pancreatic	600688	REc			
7.604	7	22	16	7q32.1	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5		Filamin C (actin-binding protein-280)	102565	REa, R, H		Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065 (3); Cardiomyopathy, familial hypertrophic, 26 (3); Cardiomyopathy, familial restrictive 5, 617047 (3)	6(Fln2)
7.605	9	24	08	7q32.1	IRF5, IBD14, SLEB10		Interferon regulatory factor 5	607218	REc		{Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	
7.606	2	9	01	7q32.3	MKLN1		Muskelin 1	605623	REc, A			6(Mkln1)
7.607	5	8	97	7q31.32	NDUFA5, UQOR13		NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (13kD, B13)	601677	REa, A			
7.608	4	1	96	7q32.2	NRF1		Nuclear respiratory factor 1	600879	Psh, A	earlier location = 7q31		
7.609	8	5	15	7q32.1	PAX4, MODY9, KPD		Paired box homeotic gene-4	167413	REa, A		Maturity-onset diabetes of the young, type IX, 612225 (3); Diabetes mellitus, type 2, 125853 (3); {Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	6(Pax4)
7.610	9	12	11	7q32	PBC4		Biliary cirrhosis, primary, 4	614220	Fd	associated with rs10488631	Biliary cirrhosis, primary, 4 (2)	
7.611	9	28	05	7q32	PPR3		Photoparoxysmal response 3	609573	Fd	max lod at D7S1804	Photoparoxysmal response 3 (2)	
7.612	4	19	01	7q32.2	UBE2H, UBCH2, UBC8		Ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8)	601082	REa, REc			
7.613	1	23	09	7q33	AKR1D1, SRD5B1, CBAS2		Bile acid synthesis defect, congenital, 2	604741	REc		Bile acid synthesis defect, congenital, 2, 235555 (3)	
7.614	11	4	98	7q32.3	PODXL, PCLP		Podocalyxin-like	602632	A, Psh			
7.615	4	19	11	7q32-q33	SCA32		Spinocerebellar ataxia 32	613909	Fd	between rs3847110 and rs2241728	Spinocerebellar ataxia 32 (2)	
7.616	4	24	08	7q34	MRPS33		Mitochondrial ribosomal protein S33	611993	REc	4 pseudogenes		
7.617	8	14	15	7q33-q34	TRIM24, TIF1, TIF1A, PTC6		Tripartite motif-containing protein 24 (Transcriptional intermediary factor 1)	603406	A	fused with RET to form PTC6		
7.618	11	5	97	7q34-q35	EPHA1, EPHT1		eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1)	179610	REa, A			
7.619	7	13	89	7q34	PIP		Prolactin-inducible protein	176720	REa, A			
7.620	6	11	91	7q32.2	CPA1		Carboxypeptidase A	114850	REa, Fd	both CPA and TRY1 = serine proteases		6(Cpa)
7.621	8	26	16	7q32.1	AHCYL2		Adenosylhomocysteinase-like 2	616520	REc			
7.622	4	23	09	7q32.1	GCC1, GCC88		GRIP and coiled-coil domains-containing protein 1	607418	R			
7.623	3	13	18	7q32.1	HILPDA, HIG2		Hypoxia-inducible lipid droplet-associated protein	617905	REc			
7.624	2	25	15	7q32.1	LRRC4		Leucine-rich repeat-containing protein 4	610486	REc			
7.625	2	9	15	7q32.1	RBM28, ANES		RNA-binding motif protein 28	612074	R, REc, Fd	mutation identified in 1 ANES family	?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	
7.626	3	23	18	7q32.1	STRIP2, FAR11B, FAM40B		Striatin-interacting protein 2	617919	REc			
7.627	09	27	18	7q32.1	TNPO3, TRNSR, LGMDD2		Transportin 3	610032	R, REc, Fd		Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3)	
7.628	3	20	14	7q32.1	TSPAN33, PEN		Tetraspanin 33	610120	REc, A			
7.629	4	8	13	7q32.2	KLHDC10, SLIM		KELCH domain-containing protein 10	615152	R, REc			
7.630	6	26	11	7q32.2	LKF14, BTEB5		Kruppel-like factor 14	609393	REc			6(Klf14)
7.631	10	12	09	7q32.2	MIR96, MIRN96, DFNA50		Micro RNA 96	611606	REc		Deafness, autosomal dominant 50, 613074 (3)	6(Mirn96)
7.632	3	23	09	7q32.2	MIR182, MIRN182		Micro RNA 182	611607	REc, H			6(Mirn182)
7.633	3	23	09	7q32.2	MIR183, MIRN183		Micro RNA 183	611608	R, REc			
7.634	9	12	11	7q32.2-q36.1	HYSP3		Hypospadias 3, autosomal	146450	Fd	between D7S2519 and D7S2442.	Hypospadias 3, autosomal (2)	
7.635	7	1	05	7q32.1	KCP		Kielin/chordin-like protein	609344	REc			6(Kcp)
7.636	3	23	09	7q32.3	MIR29A, MIRN29A		Micro RNA 29A	610782	REc			
7.637	10	08	08	7q32.3	BMIQ1		Body mass index quantitative trait locus 1	606641	Fd	max lod at D7S1804	[Body mass index QTL1] (2)	
7.638	3	23	09	7q32.3	MIR29B1, MIRN29B1		Micro RNA 29B1	610783	REc			
7.639	9	30	09	7q32.3	PLXNA4		Plexin A4	604280	TM, REc			
7.640	2	2	01	7q33	DGKI		Diacylglycerol kinase, iota, 130-kD	604072	A			
7.641	2	21	11	7q32-q33	CHCHD3		Coiled-coil-helix-coiled-coil-helix domain-containing protein 3	613748	REc			
7.642	2	9	17	7q33	AGBL3, CCP3		ATP/GTP-binding protein-like 3	617346	REc			
7.643	5	29	12	7q33	AKR1B10, ARL1		Aldo-keto reductase family 1, member B10	604707	REc			
7.644	4	30	15	7q33	AKR1B15, AKR1B10L, AKR1R1B7		Aldo-keto reductase family 1, member B15	616336	REc			
7.645	1	5	93	7q33	CALD1, CDM		Caldesmon-1	114213	A			
7.646	3	24	06	7q34	CLEC5A, CLECSF5, MDL1		C-type lectin domain family 5, member A	604987	A			
7.647	9	16	12	7q33	CREB3L2, BBF2H7		cAMP response element-binding protein 3-like 2	608834	REc			
7.648	08	10	18	7q33	CYREN, C7orf49, MRI		Cell cycle regulator of nonhomologous end joining	616980	REc			
7.649	9	11	12	7q34	KEL		Kell blood group	613883	Fd, REa, A		[Blood group, Kell], 110900 (3)	
7.650	8	26	15	7q33	LRGUK		Leucine-rich repeats- and guanylate kinase domain-containing protein	616478	REc			
7.651	4	23	09	7q33	LUZP6, MPD6		Leucine zipper protein 6	611050	REc			
7.652	6	2	16	7q33	MIR490		Micro RNA 490	616972	REc			
7.653	4	7	16	7q33	NUP205, C7orf14, KIAA0225, NPHS13		Nucleoporin, 205kD	614352	R, REc	mutation identified in 1 NPHS13 family	?Nephrotic syndrome, type 13, 616893 (3)	
7.654	9	27	94	7q33	PTN, NEGF1		Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)	162095	REa, A			6(Ptn)
7.655	12	14	99	7q33	SLC13A4, SUT1		Solute carrier family 13 (sodium/sulfate symporters), member 4 (sulfate transporter 1)	604309	REc			
7.656	4	18	07	7q33	SLC35B4		Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4	610923	REc			
7.657	5	23	16	7q33	WDR91, SORF1		WD repeat-containing protein 91	616303	REc			
7.658	7	16	02	7q34	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR		ATPase, H+ transporting, V0 subunit a4	605239	Fd		Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	
7.659	4	23	02	7q34	HIPK2		Homeodomain-interacting protein kinase 2	606868	A			
7.660	5	7	03	7q34	TRPV6, ECAC2, CAT1, CATL		Transient receptor potential cation channel, subfamily V, member 6	606680	A			
7.661	1	23	01	7q35	ARHGEF5, TIM		Rho guanine nucleotide exchange factor-5 (oncogene TIM)	600888	REa, A			
7.662	7	10	98	7q34	EPHB6, HEP		Ephrin receptor EPHB6	602757	A			
7.663	1	10	02	7q33	MTPN		Myotrophin	606484	A			
7.664	7	23	13	7q34	AGK, MULK, MTDPS10, CATC5, CTRCT38		Acylglycerol kinase	610345	REc		Sengers syndrome, 212350 (3); Cataract 38, autosomal recessive, 614691 (3)	
7.665	2	8	11	7q34	BRAF, NS7		Murine sarcoma viral (v-raf) oncogene homolog B1	164757	A, REa	pseudogene BRAF2 on Xq13 or 7q	Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3); Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7, 613706 (3); LEOPARD syndrome 3, 613707 (3)	10(Braf)
7.666	10	2	12	7q34	GSTK1		Glutathione S-transferase, kappa-1	602321	REc			
7.667	4	26	10	7q34	KIAA1549		KIAA1549 gene	613344	Psh, REc			
7.668	9	30	09	7q34	LUC7L2		Luc7, S. cerevisiae, homolog of, 2	613056	REc, H			6(Luc7l2)
7.669	4	1	03	7q34	MGAM, MGA		Maltase-glucoamylase	154360	REc	similar to EST GS1365		
7.670	12	17	08	7q34	PARP12, ZC3HDC1, FLJ22693		Poly(ADP-ribose) polymerase family, member 12	612481	REc			
7.671	1	18	96	7q34	SSBP1, SSBP		Single-stranded DNA-binding protein 1	600439	Psh, A			
7.672	1	2	08	7q34	SVOPL		SV2-related protein-like	611700	REc			6(Svopl)
7.673	9	21	11	7q34	TBXAS1, GHOSAL, CYP5, BDPLT14		Thromboxane A synthase 1, platelet	274180	A, Fd		Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase deficiency, 614158 (1)	6(Tbxas1)
7.674	5	10	18	7q34	TAS2R38, T2R61, PTC, THIOT		Taste receptor, type 2, member 38	607751	Fd, REc		[Phenylthiocarbamide tasting], 171200 (3)	
7.675	6	27	11	7q34	TAS2R40, T2R40		Taste receptor, type 2, member 40	613964	REc			
7.676	8	26	15	7q34	TMEM139		Transmembrane protein 139	616524	REc			
7.677	2	13	12	7q35	TPK1, THMD5		Thiamine pyrophosphokinase	606370	A		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	
7.678	10	15	13	7q34	TRBC1		T-cell receptor beta chain constant region 1	186930	REa, A			6(Tcrb)
7.679	10	15	13	7q34	TRBC2		T-cell receptor beta chain constant region 2	615445	REc			
7.680	10	15	13	7q34	TRBV@		T-cell receptor beta chain variable gene cluster	615446	REc			
7.681	10	15	13	7q34	TRBJ@		T-cell receptor beta chain joining gene cluster	615449	REc			
7.682	10	15	13	7q34	TRBD1		T-cell receptor beta chain diversity gene 1	615447	REn			
7.683	10	15	13	7q34	TRBD2		T-cell receptor beta chain diversity gene 2	615448	REc			
7.684	4	27	17	7q34	TTC26, IFT56		Tetratricopeptide repeat domain-containing protein 26	617453	REc			
7.685	3	31	11	7q34	UBN2		Ubinuclein 2	613841	REc			
7.686	6	10	18	7q34	WEE2, WEE1B, OOMD5		Wee1, S. pombe, homolog of, 2	614084	REc		Oocyte maturation defect 5, 617996 (3)	
7.687	11	30	06	7q34	ZC3HAV1, ZAP, FLJ13288, FLB6421		Zinc finger CCCH domain-containing antiviral protein 1	607312	REc			6(Zap)
7.688	9	30	98	7q34	ZYX		Zyxin	602002	Psh, A			
7.689	10	16	12	7q34-q36	DHMN1		Neuronopathy, distal hereditary motor, type I	182960	Fd	between D7S2513 and D7S637	Neuronopathy, distal hereditary motor, type I (2)	
7.690	10	15	98	7q34-q36	DFNB13		Deafness, autosomal recessive 13	603098	Fd		Deafness, autosomal recessive 13 (2)	
7.691	3	12	01	7q34-q36	OTSC2		Otosclerosis 2	605727	Fd		Otosclerosis 2 (2)	
7.692	1	22	08	7q36.1	ACCN3, ASIC3, TNAC1, DRASIC		Cation channel, amiloride-sensitive, neuronal 3	611741	R			
7.693	12	2	99	7q33	AKR1B1, ALDR1		Aldo-keto reductase family 1, member B1	103880	REa, A			
7.694	8	30	95	7q34	CLCN1		Chloride channel-1, skeletal muscle	118425	H, REa, Fd		Myotonia congenita, recessive, 255700 (3); Myotonia congenita, dominant, 160800 (3); Myotonia levior, recessive (3)	6(adr, Clc1)
7.695	8	19	98	7q34	CASP2, NEDD2, ICH1		Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2)	600639	R			
7.696	5	20	13	7q36.1	EZH2, EZH1, WVS		Enhancer of zeste, Drosophila, homolog of, 2	601573	REc, Psh, A	pseudogene on 21q22	Weaver syndrome, 277590 (3)	6(Ezh2)
7.697	10	6	08	7q36.1	FASTK, FAST		Fas-activated serine/threonine kinase	606965	R, REc			
7.698	2	4	15	7q35	NOBOX, POF5		Newborn ovary homeobox, mouse, homolog of	610934	REc		Premature ovarian failure 5, 611548 (3)	6(Nobox)
7.699	8	8	13	7q35	OR2F1, OLF3		Olfactory receptor, family 2, subfamily F, member 1	608497	REa, Psh			
7.700	7	1	11	7q34	PRSS1, TRY1		Protease, serine, 1 (trypsin 1)	276000	REa, Fd, REn, R	8 trypsinogen genes embedded in TCRB locus	Pancreatitis, hereditary, 167800 (3); Trypsinogen deficiency, 614044 (1)	6(Try1)
7.701	5	31	06	7q34	PRSS2, TRY2		Protease, serine, 2 (trypsin 2)	601564	REn, Fd		{Pancreatitis, chronic, protection against}, 167800 (3)	
7.702	6	26	11	7q35	TAS2R41, T2R59		Taste receptor, type 2, member 41	613965	REa, REc			
7.703	6	26	11	7q35	TAS2R60, T2R60		Taste receptor, type 2, member 60	613968	REa, REc			
7.704	1	4	16	7q35	TCAF1, FAM115A, KIAA0738		TRPM8 channel-associated factor 1	616251	R, REc			
7.705	1	4	16	7q35	TCAF2, FAM115C, FAM139A		TRPM8 channel-associated factor 2	616252	REc			
7.706	5	7	03	7q34	TRPV5, ECAC1, CAT2		Transient receptor potential cation channel, subfamily V, member 5	606679	R, A			
7.707	1	29	01	7q36.1	ABCB8, MABC1		ATP-binding cassette, subfamily B, member 8	605464	REc, REa			
7.708	2	19	10	7q35-q36	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1		Contactin-associated protein-like 2	604569	REc		Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)	
7.709	8	11	91	7q33	CHRM2		Cholinergic receptor, muscarinic, 2	118493	A, REa, Fd			
7.710	1	23	90	7q35-q36	D7S437, MS3315		Minisatellite 33.15	157570	REa, A			
7.711	11	3	98	7q35-q36	GPDS1, PDS1		Glaucoma-related pigment dispersion syndrome-1	600510	Fd		Pigment dispersion syndrome (2)	
7.712	1	13	11	7q36.1	KCNH2, LQT2, HERG, SQT1		Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)	152427	Fd, REn, A		Long QT syndrome 2, 613688 (3); {Long QT syndrome 2, acquired, susceptibility to}, 613688 (3); Short QT syndrome 1, 609620 (3)	
7.713	11	28	94	7q36.1	SLC4A2, AE2, EPB3L1		Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)	109280	REa, A			5(Ae2)
7.714	1	5	09	7q35-q36	SLI4		Specific language impairment 4	612514	Fd	associated with rs1723629	{Specific language impairment 4} (2)	
7.715	6	16	99	7q36.1	SMARCD3, BAF60C		SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 3	601737	Psh, R			
7.716	12	24	08	7q36.1	ABCF2, HUSSY18		ATP-binding cassette, subfamily F, member 2	612510	Psh, R, REc			
7.717	6	14	01	7q36	ACRPS		Acropectoral syndrome	605967	Fd		Acropectoral syndrome (2)	
7.718	10	7	05	7q36	AD10		Alzheimer disease-10	609636	Fd	max lod with D7S798	Alzheimer disease-10 (2)	
7.719	6	12	12	7q36.1	ATP6V0E2		ATPase, H+ transporting, V0 subunit e2	611019	REc			
7.720	11	19	13	7q36	AUTS10		Autism, susceptibility to, 10	611016	Fd	max lod at D7S483	{Autism, susceptibility to, 10} (2)	
7.721	2	16	04	7q36.3	BLACE		B-cell acute lymphoblastic leukemia-expressed gene	608450	R			
7.722	5	24	13	7q36.3	C7orf13		Chromosome 7 open reading frame 13	610242	REc	overlaps RNF32 on the opposite strand		
7.723	5	4	15	7q36.1	CDK5, LIS7		Cyclin-dependent kinase 5	123831	A	mutation identified in 1 LIS7 family	?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	5(cdk5)
7.724	11	19	13	7q36.3	EN2		Engrailed-2	131310	REa, A			5(En2)
7.725	6	16	99	7q36.1	GBX1		Gastrulation brain homeobox 1	603354	A			5(Gbx1)
7.726	11	5	97	7q36.3	INSIG1		Insulin-induced gene 1	602055	A			
7.727	11	14	17	7q36.1	KMT2C, MLL3, KIAA1506, KLEFS2		Lysine (K)-specific methyltransferase 2C	606833	A		Kleefstra syndrome 2, 617768 (3)	
7.728	11	6	14	7q36.3	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS		Limb region 1, mouse, homolog of	605522	Fd, HZ, Fd		Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3); Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3); Hypoplastic or aplastic tibia with polydactyly, 188740 (3); Laurin-Sandrow syndrome, 135750 (3)	5(Lmbr1)
7.729	2	21	10	7q36.3	MNX1, HLXB9, HOXHB9, SCRA1		Motor neuron and pancreas homeobox 1	142994	Fd, REc		Currarino syndrome, 176450 (3)	
7.730	5	26	13	7q36.3	NOM1, C7orf3		Nucleolar protein with MIF4G domain 1	611269	REc			5(Nom1)
7.731	7	8	10	7q36.1	NOS3		Nitric oxide synthase 3, endothelial cell	163729	REa, A, Psh		{Coronary artery spasm 1, susceptibility to} (3); {Alzheimer disease, late-onset, susceptibility to}, 104300 (3); {Hypertension, susceptibility to}, 145500 (3); {Hypertension, pregnancy-induced}, 189800 (3); {Placental abruption} (3); {Ischemic stroke, susceptibility to}, 601367 (3)	5(Nos3)
7.732	10	11	05	7q36.2	PAXIP1, PAXIP1L, PTIP		PAX transcription activation domain-interacting protein 1	608254	R, A			
7.733	1	22	09	7q36.1	PRKAG2, WPWS, CMH6		Protein kinase, AMP-activated, noncatalytic, gamma-2	602743	REc, R, Fd		Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)	
7.734	3	23	06	7q36.3	PTPRN2, IAR, ICAAR		Protein-tyrosine phosphatase, receptor-type, N, polypeptide 2	601698	A, R			
7.735	9	10	09	7q36.1	RHEB, RHEB2		Ras homolog enriched in brain	601293	A			
7.736	5	24	13	7q36.3	RNF32		RING finger protein 32	610241	REc			
7.737	7	12	02	7q36.1	RNY1, Y1		RNA, Y1 small cytoplasmic	601821	REa, REc			
7.738	7	12	02	7q36.1	RNY3, Y3		RNA, Y3 small cytoplasmic	601822	REa, REc			
7.739	7	12	02	7q36.1	RNY4, Y4		RNA, Y4 small cytoplasmic	601823	REa, REc			
7.740	7	12	02	7q36.1	RNY5, Y5		RNA, Y5 small cytoplasmic	601824	REa, REc			
7.741	2	7	12	7q36.3	SHH, HPE3, HLP3, SMMCI, MCOPCB5		Sonic hedgehog	600725	Fd, Psh, Ch	separate from TPT1	Holoprosencephaly 3, 142945 (3); Single median maxillary central incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)	
7.742	2	12	16	7q36.1	AGAP3, CENTG3, CRAG		ARF GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 3	616813	REc			
7.743	8	6	13	7q36.1	ASB10, GLC1F		Ankyrin repeat- and SOCS box-containing protein 10	615054	REc, Fd		Glaucoma 1, open angle, F, 603383 (3)	
7.744	10	2	13	7q36.1	ATG9B, NOS3AS, APG9L2, SONE		Autophagy 9, S. cerevisiae, homolog of, B	612205	REc			
7.745	2	1	11	7q36.1	CHPF2, KIAA1402, CSGlcAT		Chondroitin polymerizing factor 2	608037	REc			
7.746	6	13	12	7q36.1	CUL1		Cullin 1	603134	REc			
7.747	4	6	13	7q36.1	GALNT11, GALNACT11		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11	615130	REc, H			5(Galnt11)
7.748	4	6	13	7q36.1	GALNTL5, GALNACT19		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5	615133	REc			
7.749	7	23	96	7q36.2	HTR5A		5-hydroxytryptamine (serotonin) receptor-5A	601305	Psh, REc			5(Htr5a)
7.750	1	27	11	7q36.1	GIMAP1, IMAP1		GTPase, IMAP family, member 1	608084	REc			
7.751	1	27	11	7q36.1	GIMAP2, IMAP2		GTPase, IMAP family, member 2	608085	REc			
7.752	1	27	11	7q36.1	GIMAP4, IMAP4, IAN1		GTPase, IMAP family, member 4	608087	REc			
7.753	1	27	11	7q36.1	GIMAP5, IAN4L1, IMAP3		GTPase, IMAP family, member 5	608086	REc			6
7.754	6	2	16	7q36.1	GIMAP6		GTPase, IMAP family, member 6	616960	REc			
7.755	6	2	16	7q36.1	GIMAP7		GTPase IMAP family, member 7	616961	REc			
7.756	6	2	16	7q36.1	GIMAP8		GTPase, IMAP family, member 8	616962	REc			
7.757	4	17	13	7q36.1	LOC100134040		LOC100134040 gene	615171	REc			
7.758	8	19	13	7q36.1	LR8		LR8 protein	610385	REc			
7.759	5	23	13	7q36.1	MIR671		Micro RNA 671	615245	REc			
7.760	6	24	13	7q36.1	NUB1		Negative regulator of ubiquitin-like proteins 1	607981	R, REc			
7.761	5	11	09	7q36.1	RARRES2, TIG2		Retinoic acid receptor responder 2	601973	REc			
7.762	2	24	17	7q36.1	SSPO		Subcommissural organ spondin	617356	REc, H			6(Sspo)
7.763	8	19	13	7q36.1	TEM176A, HCA112, GS188		Transmembrane protein 176A	610334	R, REc			6(Gs188)
7.764	9	2	12	7q36.1	TMUB1, DULP, SB144, C7orf21		Transmembrane and ubiquitin-like domain-containing protein 1	614792	REc			
7.765	12	15	16	7q36.1	XRCC2, FANCU		X-ray repair, complementing defective, repair in Chinese hamster cells-2	600375	REa, R, C	mutation identified in 1 FANCU patient	?Fanconi anemia, complementation group U, 617247 (3)	
7.766	5	31	13	7q36.1	ZBED6CL, C7orf29		ZBED6 C terminus-like protein	615252	REc			
7.767	3	17	06	7q36.1	ZNF212, ZNFC150, ZNF182		Zinc finger protein 212	602386	Psh			
7.768	7	20	12	7q36.1	ZNF282, HUB1		Zinc finger protein 282	603397	REc			
7.769	9	8	11	7q36.1	ZNF467, EZI, ZFP467		Zinc finger protein 467	614040	REc			
7.770	4	19	11	7q36.1	ZNF746, PARIS		Zinc finger protein 746	613914	REc			
7.771	4	14	15	7q36.2	DPP6, VF2, MRD33		Dipeptidylpeptidase VI	126141	Psh, REc		{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3); Mental retardation, autosomal dominant 33, 616311 (3)	5(Dppx, Dpp6)
7.772	5	24	13	7q36.3	NCAPG2, CAPG2, MTB		Non-SMC condensin II complex subunit G2	608532	REc			
7.773	12	22	08	7q36.3	CNPY1		Canopy 1, zebrafish, homolog of	612493	REc			
7.774	09	27	18	7q36.3	DNAJB6, MRJ, DJ4, LGMDD1		DNAJ/HSP40 homolog, subfamily B, member 6	611332	REc, Fd		Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3)	
7.775	12	11	15	7q36.3	ESYT2, FAM62B		Extended synaptotagmin-like protein 2	616691	REc			
7.776	11	22	11	7q36.3	SCZD16, C16DUPq36.3, DUP7q36.3		Chromosome 7q36.3 duplication syndrome, 362kb	613959	Ch	362kb duplication that includes VIPR2	Schizophrenia 16 (4)	
7.777	1	30	12	7q36.3	UBE3C, HECTH2, KIAA0010, KIAA10		Ubiquitin protein ligase E3C	614454	Psh, REc			
7.778	11	22	11	7q36.3	VIPR2		Vasoactive intestinal peptide receptor 2	601970	A			12(Vipr2)
7.779	2	11	14	7q36.3	WDR60, SRTD8, SRPS6		WD repeat containing protein 60	615462	REc		Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	
7.780	11	19	11	Chr.7	AIS2, VAMAS3		Autoimmune disease, susceptibility to, 2	608391	Fd		{Autoimmune disease, susceptibility to, 2} (2)	
7.781	10	23	87	Chr.7	NHCP2		Nonhistone chromosomal protein-2	118880	S			
8.1	9	9	08	8p23.3	FBXO25, FBX25		F-box only protein 25	609098	REc			8(Fbxo25)
8.2	6	16	99	8p23.3	MYOM2		Myomesin 2	603509	Psh, A			
8.3	7	20	01	8p23.3-p22	DBA2		Diamond-Blackfan anemia 2	606129	Fd		Diamond-Blackfan anemia 2 (2)	
8.4	9	2	12	8p23.1	AGPAT5		1-acylglycerol-3-phosphate O-acyltransferase 5	614796	REc			
8.5	5	26	13	8p23.1	CLDN23		Claudin 23	609203	REc, REn			
8.6	9	9	08	8p23.1	DEFA1, DEF1, MRS		Defensin, alpha-1, myeloid-related sequence	125220	REa, A			8(Defcr)
8.7	9	9	08	8p23.1	DEFA5, DEF5		Defensin, alpha-5, Paneth cell-specific	600472	REa			
8.8	2	11	96	8p23.1	DEFA6, DEF6		Defensin, alpha-6, Paneth cell-specific	600471	REa			
8.9	9	9	08	8p23.1	DEFB1		Defensin, beta-1	602056	A			8(Defb1)
8.10	3	9	12	8p23.1	DEFB4A, DEFB4, DEFB2		Defensin, beta-4a (formerly defensin, beta-2)	602215	A, REc, Ch			
8.11	4	18	07	8p23.1	DEFB103A, DEFB3, HBD3, HBP3		Defensin, beta 103A	606611	REc, Ch			
8.12	12	29	05	8p23.1	DIH2		Hernia, congenital diaphragmatic 2	222400	Ch		Hernia, congenital diaphragmatic 2 (2)	
8.13	12	18	14	8p23.1	FAM86B1		Family with sequence similarity 86, member B1	616122	REc			
8.14	12	18	14	8p23.1	FAM86B2		Family with sequence similarity 86, member B2	616123	REc			
8.15	9	30	09	8p23.1	FAM90A3		Family with sequence similarity 90, member A3	613042	REc	copy 2		
8.16	9	30	09	8p23.1	FAM90A5		Family with sequence similarity 90, member A5	613043	REc	copy 5		
8.17	9	30	09	8p23.1	FAM90A7		Family with sequence similarity 90, member A7	613044	REc	copy 8		
8.18	9	30	09	8p23.1	FAM90A8		Family with sequence similarity 90, member A8	613045	REc	copy 15		
8.19	9	30	09	8p23.1	FAM90A9		Family with sequence similarity 90, member A9	613046	REc	copy 18		
8.20	9	30	09	8p23.1	FAM90A10		Family with sequence similarity 90, member A10	613047	REc	copy 19		
8.21	9	30	09	8p23.1	FAM90A12		Family with sequence similarity 90, member A12	613048	REc	copy 22		
8.22	9	30	09	8p23.1	FAM90A13		Family with sequence similarity 90, member A13	613049	REc	copy 4		
8.23	9	30	09	8p23.1	FAM90A14		Family with sequence similarity 90, member A14	613050	REc	copy 12		
8.24	9	30	09	8p23.1	FAM90A15		Family with sequence similarity 90, member A15	613051	REc	copy 1		
8.25	9	30	09	8p23.1	FAM90A18		Family with sequence similarity 90, member A18	613052	REc	copy 13		
8.26	9	30	09	8p23.1	FAM90A19		Family with sequence similarity 90, member A19	613053	REc	copy 17		
8.27	9	30	09	8p23.1	FAM90A20		Family with sequence similarity 90, member A20	613054	REc	copy 6		
8.28	11	26	01	8p23.1	MFHAS1, MASL1		Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1	605352	REc		Malignant fibrous histiocytoma (2)	
8.29	3	23	09	8p23.1	MIR124-1, MIR124A		Micro RNA 124-1	609327	REc			
8.30	9	26	17	8p23.1	MSRA		Peptide methionine sulfoxide reductase	601250	REc, H			14(Msra)
8.31	6	6	17	8p23.1	NEIL2, NEI2		Endonuclease VIII-like 2	608933	REc			
8.32	2	9	17	8p23.1	PRAG1, PRAGMIN, NACK		PEAK1-related kinase-activating pseudokinase 1	617344	REc			
8.33	4	8	13	8p23.1	PRSS55, TSP1		Protease, serine, 55	615144	REc			
8.34	9	24	08	8p23.1	SLEB12		Systemic lupus erythematosus, susceptibility to, 12	612254	Fd	associated with rs13277113	{Systemic lupus erythematosus, susceptibility to, 12} (2)	
8.35	3	20	14	8p23.1	USP17L2, DUB3		Ubiquitin specific peptidase 17-like family member 2	610186	REc			
8.36	11	20	95	8p22	NAT1, AAC1		Arylamine N-acetyltransferase-1	108345	REa, A			8(Nat1)
8.37	8	29	08	8p22	NAT2, AAC2		Arylamine N-acetyltransferase-2	612182	REa, A, H	acetylation polymorphism	[Acetylation, slow], 243400 (3)	8(Nat2)
8.38	8	19	98	8p23.1	FDFT1, DGPT		Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase)	184420	Psh, A			
8.39	9	11	14	8p23.1	GATA4, ASD2, VSD1, TACHD, TOF		GATA-binding protein-4	600576	REa, H, A	mutations identified in 1 TACHD family	Atrial septal defect 2, 607941 (3); Ventricular septal defect 1, 614429 (3); Atrioventricular septal defect 4, 614430 (3); ?Testicular anomalies with or without congenital heart disease, 615542 (3); Tetralogy of Fallot, 187500 (3)	14(Gata4)
8.40	8	20	02	8p23.1	ANGPT2, ANG2		Angiopoietin 2	601922	R, A	close to MCPH1		8(Angpt2)
8.41	9	17	14	8p23.3	ARHGEF10, KIAA0294, SNCV		Rho guanine nucleotide exchange factor 10	608136	REc	mutation identified in 1 SNCV family	?Slowed nerve conduction velocity, AD, 608236 (3)	
8.42	9	9	08	8p23.3	CLN8, EPMR		CLN8 gene	607837	Fd, H		Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	8(mnd)
8.43	1	27	04	8p23.2	CSMD1, KIAA1890		Cub and Sushi multiple domains 1	608397	REc			
8.44	10	6	09	8p23.1	DEFA4, DEF4, HP4		Defensin, alpha-4, corticostatin	601157	REa, REc			
8.45	5	13	11	8p23.1	MCPH1		Microcephalin	607117	Fd, REc	genetic heterogeneity	Microcephaly 1, primary, autosomal recessive, 251200 (3)	8(Mcph1)
8.46	4	13	05	8p23	MYP10		Myopia 10	609259	Fd		Myopia 10 (2)	
8.47	12	27	01	8p23.1	PINX1		PIN2-interacting protein 1	606505	REc			
8.48	5	26	13	8p23.1	PPP1R3B, GL		Protein phosphatase 1, regulatory subunit 3B	610541	A			
8.49	1	27	11	8p23.1	RP1L1		RP1-like protein 1	608581	REc		Occult macular dystrophy, 613587 (3)	14(Rp1l1)
8.50	3	16	10	8p23	WS2C		Waardenburg syndrome, type 2C	606662	Ch		Waardenburg syndrome, type 2C (2)	
8.51	4	22	10	8p23.1	BLK, MODY11		BLK nonreceptor tyrosine kinase	191305	REa, A		Maturity-onset diabetes of the young, type 11, 613375 (3)	14(Blk)
8.52	8	29	08	8p23.1	FAM167A, C8orf13		Family with sequence similarity 167, member A	610085	REc			
8.53	10	15	97	8p23-p22	KWE		Keratolytic winter erythema	148370	Fd		Keratolytic winter erythema (2)	
8.54	9	5	02	8p23.1	MTMR9, MTMR8		Myotubularin-related protein 9	606260	REc			
8.55	12	27	01	8p23.1	SPAG11, HE2, EP2		Sperm-associated antigen 11	606560	REc			
8.56	4	17	13	8p23-p22	TDH		L-threonine dehydrogenase, pseudogene	615174	REc			
8.57	1	13	99	8p21.3	EGR3		Early growth response 3	602419	A			
8.58	9	11	12	8p23-p21	GEFSP6		Generalized epilepsy with febrile seizures plus, type 6	612279	Fd	between D8S1706 and D8S549	Epilepsy, generalized, with febrile seizures plus, type 6 (2)	
8.59	11	1	12	8p22	VPS37A, HCRP1, SPG53		Vacuolar protein sorting 37A	609927	REc		Spastic paraplegia 53, autosomal recessive, 614898 (3)	
8.60	10	18	11	8p22	ANIB11		Aneurysm, intracranial berry, 11	614252	Fd	max lod at D8S552	Aneurysm, intracranial berry, 11 (2)	
8.61	6	9	08	8p22	CHDS9		Coronary heart disease, susceptibility to, 9	612030	Fd	max lod at D8S1106	{Coronary heart disease, susceptibility to, 9} (2)	
8.62	09	06	18	8p23.1	CTSB, CPSB, RECEUP		Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included)	116810	REa, A, Psh, D	KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element	Keratolytic winter erythema, 148370 (4)	8(Ctsb)
8.63	10	7	09	8p22	FGL1, HFREP1		Fibrinogen-like 1	605776	R, REc			
8.64	2	25	14	8p22	KIAA1456, TRM9L		KIAA1456 gene	615666	REc			
8.65	12	17	07	8p21.3	LPL, LIPD, HDLCQ11		Lipoprotein lipase	609708	REa, A, Fd		Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia, familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11] (3)	8(Lpl)
8.66	12	11	01	8p21.3	LZTS1, F37, FEZ1		Leucine zipper, putative tumor suppressor 1	606551	Ch, LOH		Esophageal squamous cell carcinoma, 133239 (3)	
8.67	1	14	14	8p22	MICU3, EFHA2		Mitochondrial calcium uptake protein 3	610633	REc			
8.68	3	27	18	8p22	MSR1, SCARA1, SRA		Macrophage scavenger receptor	153622	REa, Fd, A	~11cM distal to LPL	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.69	6	16	99	8p22	MTMR7		Myotubularin-related protein 7	603562	R, Psh			
8.70	6	19	01	8q22.2	POLR2K, RPB12		Polymerase II, RNA, subunit K	606033	R			
8.71	1	30	12	8p22	PSD3, HCA67, EFA6R		Pleckstrin and Sec7 domains-containing protein 3	614440	REc			
8.72	11	11	14	8p22	SGCZ, ZSG1		Sarcoglycan, zeta	608113	R, H			
8.73	12	17	12	8p21.3	SH2D4A, SH2A, PPP1R38		SH2 domain-containing protein 4A	614968	REc			
8.74	3	2	98	8p22	SLC7A2, ATRC2, HCAT2		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2	601872	A			
8.75	8	29	08	8p23.1	SOX7		SRY-box 7	612202	A, H			14(Sox7)
8.76	11	18	11	8p22	TUSC3, M33, D8S1992, MRT7, MRT22		Tumor suppressor candidate 3	601385	REn, Fd		Mental retardation, autosomal recessive 7, 611093 (3)	
8.77	7	20	12	8p22	ASAH1, AC, SMAPME		N-acylsphingosine amidohydrolase (acid ceramidase) 1	613468	REc		Farber lipogranulomatosis, 228000 (3); Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	
8.78	9	9	08	8p22	CNOT7, CAF1		CCR4-NOT transcription complex, subunit 7	604913	REc			
8.79	6	11	09	8p22-p21.3	DFNB71		Deafness, autosomal recessive 71	612789	Fd	max lod at D8S261	Deafness, autosomal recessive 71 (2)	
8.80	8	6	15	8p22	DLC1		Deleted in liver cancer 1	604258	A		Colorectal cancer, somatic, 114500 (3)	
8.81	4	10	14	8p22	FGF20, RHDA2		Fibroblast growth factor-20	605558	REc	mutation identified in 1 RHDA2 family	?Renal hypodysplasia/aplasia 2, 615721 (3)	
8.82	8	14	15	8p22	PCM1, PTC4		Pericentriolar material 1	600299	A, REn, Ch	fused with RET to form PTC4		
8.83	2	19	13	8p22	PDGFRL, PDGRL, PRLTS		Platelet-derived growth factor receptor-like	604584	REc		Hepatocellular cancer, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3)	
8.84	11	16	05	8p21.3	TNFRSF10B, DR5, TRAILR2		Tumor necrosis factor receptor superfamily, member 10B	603612	R, A		Squamous cell carcinoma, head and neck, 275355 (3)	
8.85	8	17	99	8p21.3	TNFRSF10C, DCR1, TRAILR3, TRID		Tumor necrosis factor receptor superfamily, member 10C	603613	R			
8.86	1	12	99	8p21.2	PTK2B, FAK2, PYK2		Protein tyrosine kinase-2, beta (focal adhesion kinase 2)	601212	Psh, A			
8.87	5	23	13	3p25.1	TPRXL		Tetrapeptide repeat homeobox-like	611167	REc			
8.88	11	4	93	8p11.21	FNTA		Farnesyltransferase, CAAX box, alpha	134635	REa, Psh, A	related FNTAL1 on 11, FNTAL2 on 13		8(Fnta)
8.89	7	3	06	8p22-q11	MPD3		Myopathy, distal 3	610099	Fd	possible locus on 12q13-q22	Myopathy, distal 3 (2)	
8.90	7	13	93	8p12	NRG1, HGL, HRGA, ARIA		Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator)	142445	Psh, A		{?Schizophrenia, susceptibility to}, 603013 (1)	7(Nrg1)
8.91	5	23	16	8p21.3	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2		ATPase, H+ transporting, V1 subunit B2	606939	R, REc		Zimmermann-Laband syndrome 2, 616455 (3); Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	
8.92	10	6	09	8p21.3	BIN3		Bridging integrator 3	606396	R, REc			
8.93	8	11	17	8p21.3	CCAR2, DBC1, KIAA1967		Cell division cycle and apoptosis regulator 2	607359	REc			
8.94	9	10	07	8p21.3	CHMP7		CHMP family, member 7	611130	REc			
8.95	10	28	15	8p21.3	CSGALNACT1		Chondroitin sulfate N-acetylgalactosaminyltransferase 1	616615	REc			
8.96	7	26	10	8p21.3	DOK2, P56DOK		Docking protein 2	604997	REc			
8.97	1	13	16	8p21.3	ENTPD4, LYSAL1, LAP70, KIAA0392		Ectonucleoside triphosphate diphosphohydrolase 4	607577	R, REc			
8.98	6	11	13	8p21.3	FGF17, HH20		Fibroblast growth factor 17	603725	REc		Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	
8.99	3	24	14	8p21.3	INTS10, INT10		Integrator complex subunit 10	611353	R, REc			
8.100	12	4	03	8p21.3	LGI3		Leucine-rich gene, glioma-inactivated, 3	608302	R			14(Lgi3)
8.101	7	22	11	8p21.3	MIR320A, MIRN320A		Micro RNA 320A	614112	REc			
8.102	9	16	03	8p21.3	NPM2		Nucleophosmin/nucleoplasmin family, member 2	608073	REc			14(Npm2)
8.103	6	22	14	8p21.3	NUDT18, MTH3		Nucleoside diphosphate-linked moiety X motif 18	615791	REc			
8.104	12	19	08	8p21.3	PIWIL2, MILI		PIWI-like 2	610312	REc			14(Piwil2)
8.105	7	1	05	8p21.3	REEP4, C8orf20		Receptor expression-enhancing protein 4	609349	R, REc			
8.106	9	29	96	8p21.3	SLC18A1, VMAT1, VAT1, CGAT		Solute carrier family 18 (vesicular monoamine), member 1	193002	REa, A			19(Slc18a1)
8.107	5	6	13	8p23.1	SLC35G5, AMAC, AMAC1L2		Solute carrier family 35, member G5	615199	REc			
8.108	5	9	18	8p21.3	SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN		Solute carrier family 39 (zinc transporter), member 14	608736	REc	mutation identified in 1 HCTN family	Hypermanganesemia with dystonia 2, 617013 (3); ?Hyperostosis cranalis interna, 144755 (3)	
8.109	3	8	07	8p21.3	SORBS3, SCAM1, SH3D4		Sorbin and SH3 domains-containing 3	610795	REc			
8.110	8	3	12	8p21.3	XPO7, RANBP16, KIAA0745		Exportin 7	606140	R, REc			
8.111	2	4	02	8p21.3	LOXL2		Lysyl oxidase-like 2	606663	R, A			
8.112	4	21	16	8p21.2	DOCK5		Dedicator of cytokinesis 5	616904	REc			
8.113	3	22	06	8p21.2	EBF2		Early B-cell factor 2	609934	R, REc			
8.114	7	16	14	8p21.3	HR, AU, MUHH1, HYPT4		Hairless, mouse, homolog of	602302	H, R, Fd, LD		Alopecia universalis, 203655 (3); Atrichia with papular lesions, 209500 (3); Hypotrichosis 4, 146550 (3)	14(hr)
8.115	12	22	16	8p21.2	KCTD9, BTBD27		Potassium channel tetramerization domain-containing protein 9	617265	REc			
8.116	12	28	08	8p21.3	PDLIM2, MYSTIQUE		PDZ and LIM domain protein 2	609722	REc			
8.117	12	17	08	8p21.3	PEPB4, CORK1		Phosphatidylethanolamine-binding protein 4	612473	REc			
8.118	3	4	17	8p21.2	PNMA2, MA2, MM2		Paraneoplastic MA antigen 2	603970	REc			
8.119	6	4	18	8p21.3	RHOBTB2, DBC2, KIAA0717, EIEE64		Rho-related BTB domain-containing protein 2	607352	R, REc		Epileptic encephalopathy, early infantile, 64, 618004 (3)	
8.120	11	21	02	8p12	LEPROTL1		Leptin receptor overlapping transcript-like 1	607338	R			
8.121	5	7	09	8p21.1	ELP3, KAT9		Elongation protein 3, S. cerevisiae, homolog of	612722	REc			
8.122	12	28	05	8p21.1	ESCO2		Establishment of cohesion 1, S. cerevisiae, homolog of, 2	609353	REc, Fd		Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)	
8.123	11	20	95	8p21.3	EPB49, DMT		Erythrocyte membrane protein band 49 (dematin)	125305	REa, A			14(Epb4.9)
8.124	9	9	08	8p21.1	FBXO16, FBX16		F-box only protein 16	608519	REc	?8p12		14(Fbxo16)
8.125	10	23	87	8p12	GSR		Glutathione reductase	138300	S, D		Hemolytic anemia due to glutathione reductase deficiency (1)	8(Gr1)
8.126	8	4	97	8p21.1	GULOP, GULO		Gulonolactone (L-) oxidase pseudogene	240400	REb, A		Scurvy (3)	
8.127	3	23	14	8p21.1	INTS9, INT9, RC74		Integrator complex subunit 9	611352	REc			
8.128	8	19	13	8p21.1	PBK, TOPK		PDZ-binding kinase	611210	REc			
8.129	12	10	13	8p21.1	SCARA5		Scavenger receptor class A, member 5	611306	REc			
8.130	6	27	16	8p21.2	TRIM35, MAIR, HLS5, KIAA1098		Tripartite motif-containing protein 35	617007	REc			
8.131	9	27	17	8p21.1	ZNF395, PBF, HDBP2		Zinc finger protein 395	609494	REc			
8.132	4	27	12	8p21.1-q13.3	SPG37		Spastic paraplegia 37	611945	Fd	max lod at D8S601	Spastic paraplegia 37, autosomal dominant (2)	
8.133	9	14	92	8p21.2	ADRA1C		Adrenergic, alpha-1C-, receptor	104221	REc, Fd	.03cM from NEFL		
8.134	10	11	12	8p21.3	BMP1, OI13		Bone morphogenetic protein-1	112264	H, REa, A	1kb 3' to SFTP2	Osteogenesis imperfecta, type XIII, 614856 (3)	14(Bmp1)
8.135	10	26	00	8p21.2	BNIP3L, NIX		BCL2/adenovirus E1B 19-kD protein-interacting protein 3-like	605368	A			
8.136	8	28	06	8p21.2	CHRNA2		Cholinergic receptor, nicotinic, alpha polypeptide-2	118502	REa		Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	14(Acra2)
8.137	5	1	98	8p21.2	DPYSL2, DRP2, CRMP2		Dihydropyrimidinase-like 2	602463	TM			
8.138	4	17	17	8p21.1	EXTL3, EXTR1, ISDNA		Exostosin-like 3	605744	R, Psh, A, REc		Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3)	
8.139	8	28	01	8p21.1	FZD3		Frizzled, Drosophila, homolog of, 3	606143	A			14(Fzd3)
8.140	7	15	99	8p21.3	GFRA2, GDNFRB		GDNF family receptor alpha-2	601956	A			14(Gdnfrb)
8.141	5	19	06	3p24-p21.2	TRICY1		Trichilemmal cyst 1	609649	Fd	max lod at D3S1277	Trichilemmal cyst 1 (2)	
8.142	7	17	14	8p21.2	NEFM, NEF3, NFM		Neurofilament protein, medium polypeptide	162250	REn			
8.143	3	6	18	8p21.2	NEFL, CMT2E, CMT1F, CMTDIG		Neurofilament, light polypeptide	162280	REa, A, Fd		Charcot-Marie-Tooth disease, type 2E, 607684 (3); Charcot-Marie-Tooth disease, type 1F, 607734 (3); Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3)	14(Nfl)
8.144	7	18	14	8p21.2	NKX2-6, CSX2, CTHM		NK2, Drosophila, homolog of, 6	611770	R		Persistent truncus arteriosus, 217095 (3); Conotruncal heart malformations, 217095 (3)	
8.145	4	14	10	8p21.2	NKX3-1, NKX3A, BAPX2		NK3 homeo box 1	602041	A			
8.146	10	18	96	8p21.1	PNOC, PPNOC		Prepronociceptin	601459	REc			
8.147	9	5	02	8p21.1	SCARA3, MSLR1, CSR		Scavenger receptor class A, member 3	602728	REc			
8.148	12	15	98	8p21	SCZD6		Schizophrenia susceptibility locus, chromosome 8p-related	603013	Fd	?neuregulin 1	{Schizophrenia}, 181500 (2)	
8.149	5	21	07	8p21.3	SFTPC, SFTP2, SMDP2		Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)	178620	REa, A, Fd		Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	14(Sftp2)
8.150	8	19	13	8p21.2	SLC25A37, MFRN, MFRN1		Solute carrier family 25 (mitochondrial iron carrier), member 37	610387	REc			14(Slc25a37)
8.151	8	17	99	8p21.3	TNFRSF10A, DR4, TRAILR1, APO2		Tumor necrosis factor receptor superfamily, member 10A	603611	R			
8.152	8	17	99	8p21.3	TNFRSF10D, DCR2, TRAILR4		Tumor necrosis factor receptor superfamily, member 10D	603614	R			
8.153	3	30	00	8p21.1	CLU, CLI, SGP2, TRPM2		Clusterin (complement lysis inhibitor, SP-40,40; sulfated glycoprotein 2; testosterone-repressed prostate message-2; apolipoprotein J)	185430	REa, REb, A, RE			14(Sgp2, Clu)
8.154	5	26	05	8p21.2-p21.1	EPHX2		Epoxide hydrolase 2, cytoplasmic	132811	A		{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	14(Ephx2)
8.155	5	11	16	8p12	GTF2E2, TTD6		General transcription factor IIE, polypeptide 2, beta subunit, 34kD	189964	REc		Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	
8.156	11	19	14	8p21.2	GNRH1, LNRH, HH12		Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone)	152760	REa, A	mutation identified in 1 HH12 family	?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	14(Gnrh)
8.157	1	7	99	8p21.2	STC1, STC		Stanniocalcin 1	601185	A			
8.158	10	29	02	8p21.2	ADAM7		A disintegrin and metalloproteinase domain 7	607310	REc			
8.159	10	29	02	8p21.2	ADAM28, MDCL		A disintegrin and metalloproteinase domain 28	606188	REc			
8.160	2	28	03	8p21.2	ADAMDEC1, DECYSIN		A disintegrin and metalloproteinase domain-like protein decysin 1	606393	REn			
8.161	9	1	16	8p11.23	ADGRA2, GPR124, TEM5, KIAA1531		Adhesion G protein-coupled receptor A2	606823	R, REc			
8.162	6	19	98	8p11.23	EIF4EBP1, 4EBP1		Eukaryotic translation initiation factor-4E binding protein-1	602223	A			8(Eif4ebp1)
8.163	5	2	16	8p12	FUT10, FUCTX		Fucosyltransferase 10	616931	REc			
8.164	8	18	08	8p11.21	IDO2, INDOL1		Indoleamine 2,3-dioxygenase 2	612129	REc			
8.165	7	20	12	8p12	KIF13B, GAKIN, KIAA0639		Kinesin family member 13B	607350	R			
8.166	4	15	08	8p12	MBOAT4, GOAT		Membrane-bound O-acetyltransferase domain-containing 4	611940	REc			
8.167	4	20	17	8p11.23	NSD3, WHSC1L1		Nuclear receptor-binding SET domain protein 3	607083	A, Ch	pseudogene on 17q21; fusion partner with NUP98 in AML	Leukemia, acute myeloid, 601626 (3)	
8.168	10	28	08	8p11.21	PLAT, TPA		Plasminogen activator, tissue type	173370	REa, A, REb		Thrombophilia, familial, due to decreased release of PLAT, 612348 (1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	8(Plat)
8.169	6	28	18	8p12	PURG, PURGA, PURGB		Purine-rich element-binding protein G	618041	REc			
8.170	12	1	15	8p12	SNORD13		Small nucleolar RNA, C/D box, 13	616664	REc			
8.171	5	9	18	8p12	TEX15, SPGF25		Testis-expressed gene 15	605795	R		Spermatogenic failure 25, 617960 (3)	
8.172	3	1	12	8p12	THPH9		Thrombophilia due to decreased release of tissue plasminogen activator	612348	LD		?Thrombophilia due to decreased release of tissue plasminogen (1)	
8.173	8	21	12	8p12	TMEM66, SARAF		Transmembrane protein 66	614768	REc			
8.174	11	22	13	8p12	TTI2, C8orf41, MRT39		TELO2-interacting protein 2	614426	REc		Mental retardation, autosomal recessive 39, 615541 (3)	
8.175	7	29	15	8p12	UNC5D, UNC5H4		Unc5. C. elegans, homolog of, D	616466	REc			
8.176	6	1	05	8p11.23	ADRB3		Adrenergic, beta-3-, receptor	109691	A		{Obesity, susceptibility to}, 601665 (3)	8(Adrb3)
8.177	7	13	93	8p12	PPP2CB		Protein phosphatase-2 (formerly 2A), catalytic subunit, beta isoform	176916	Psh, A, REc	pseudogene on 16		
8.178	8	12	03	8p12	RECQL2, RECQ3, WRN		DNA helicase, RecQ-like 2	604611	Fd, LD		Werner syndrome, 277700 (3)	8(wrn)
8.179	3	29	10	8p12	UBXN8, D8S2298E, REP8		UBX domain protein 8	602155	A			
8.180	10	22	99	8p11.21	SFRP1, FRP, SARP2		Secreted frizzled-related protein 1	604156	R, A			
8.181	9	10	09	8p12	DCTN6, WS3, P27		Dynactin 6	612963	A, Psh			
8.182	11	20	98	8p12	DUSP4, MKP2, HVH2		Dual-specificity phosphatase-4 (MAP kinase phosphatase-2)	602747	A			
8.183	9	9	08	8p11.21	IDO1, INDO, IDO		Indoleamine 2,3-dioxygenase	147435	Psh, REa, A			
8.184	1	20	09	8p12	RBPMS		RNA-binding protein gene with multiple splicing	601558	REc			
8.185	6	4	07	8p12-q22	AD12		Alzheimer disease 12	611073	Fd	max lod at D8S1119	{Alzheimer disease 12} (2)	
8.186	12	29	06	8p11.23	RAB11FIP1, RCP		RAB11 family-interacting protein 1	608737	REc			
8.187	8	19	13	8p11.22	TM2D2, BLP1		TM2 domain-containing protein 2	610081	R, REc			
8.188	10	15	09	8p11.22	ADAM9, MDC9, MCMP, CORD9		A disintegrin and metalloproteinase domain 9	602713	REc		Cone-rod dystrophy 9, 612775 (3)	
8.189	11	29	12	8p11.23	BAG4, SODD		Bcl2-associated athanogene 4	603884	REc			
8.190	10	6	09	8p11.23	BRF2, BRFU, TFIIIB50		BRF2 subunit of RNA polymerase III transcription initiation factor	607013	R, REc			
8.191	1	29	13	8p11.23	DDHD2, KIAA0725, SPG54		DDHD domain-containing protein 2	615003	REc		Spastic paraplegia 54, autosomal recessive, 615033 (3)	
8.192	1	16	07	8p11.22	HTRA4		HTRA serine peptidase 4	610700	REc			
8.193	5	6	13	8p11.23	KCNU1, SLO3		Potassium channel, subfamily U, member 1	615215	REc			
8.194	10	26	17	8p11.23	PLPP5, PPAPDC1B, HTPAP		Phospholipid phosphatase 5	610626	REc			
8.195	8	6	13	8p11.23	LSM1		LSM1 protein	607281	R, REc			
8.196	7	22	16	8p11.23	ZNF703, ZEPPO1, NLZ1		Zinc finger protein 703	617045	REc			
8.197	6	9	08	8p11.21	AGPAT6, LPAATZ		1-acylglycerol-3-phosphate O-acyltransferase 6	608143	REc			
8.198	5	5	10	8p11.21	CHRNA6		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 6	606888	REc			
8.199	11	30	06	8p11.21	GINS4, SLD5		GINS complex subunit 4	610611	R, REc			
8.200	7	7	09	8p11.21	HOOK3, HK3		Hook, Drosophila, homolog of, 3	607825	REc			
8.201	12	27	13	8p11.21	SLC20A2, MLVAR, GLVR2, IBGC1		Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for)	158378	S, REa		Basal ganglia calcification, idiopathic, 1, 213600 (3)	
8.202	5	14	09	8p11.21	THAP1, DYT6		THAP domain-containing protein 1	609520	REc		Dystonia 6, torsion, 602629 (3)	
8.203	2	20	07	8p11.21	NKX6-3, NKX6.3		NK6, Drosophila, homolog of	610772	REc			8(Nkx6-3)
8.204	11	16	05	8p11.22	ADAM2, FTNB, PH30, CRYN1, CRYN2		A disintegrin and metalloproteinase domain 2 (fertilin, beta)	601533	A, H			14(Ftnb)
8.205	11	17	15	8p11.21	ANK1, SPH1		Ankyrin-1, erythrocytic	612641	F, Ch, D, REa, A, Fd, REb		Spherocytosis, type 1, 182900 (3)	8(nb)
8.206	5	24	13	8p11.21	AP3M2, CLA20		Adaptor-related protein complex 3, mu-2 subunit	610469	A			
8.207	1	29	01	8p11.23	ASH2L, ASH2L2, ASH2L1		ASH2, Drosophila, homolog of	604782	REc			
8.208	6	10	94	8p11.21	CHRNB3		Cholinergic receptor, nicotinic, beta polypeptide-3	118508	REa, A			
8.209	4	27	12	8p11.23	ERLIN2, SPFH2, C8orf2, SPG18		Endoplasmic reticulum lipid raft-associated protein 2	611605	REc		Spastic paraplegia 18, autosomal recessive, 611225 (3)	
8.210	1	7	14	8p11.21	IKBKB, NFKBIKB, IMD15		Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, beta	603258	A, R		Immunodeficiency 15, 615592 (3)	
8.211	3	8	95	8p11.21	POLB		Polymerase (DNA directed), beta	174760	REa, Fd, A			8(Polb)
8.212	1	9	17	8p11.23	PROSC, EPVB6D		Proline synthetase cotranscribed, bacteria, homolog of	604436	REn		Epilepsy, early-onset, vitamin B6-dependent, 617290 (3)	
8.213	5	29	12	8p11.21	RNF170, SNAX1		RING finger protein 170	614649	REc		Ataxia, sensory, 1, autosomal dominant, 608984 (3)	
8.214	9	27	17	8p11.21	TCIM, C8orf4		Transcriptional and immune response regulator	607702	A			
8.215	2	12	96	8p11.23	STAR		Steroidogenic acute regulatory protein	600617	REa, A		Lipoid adrenal hyperplasia, 201710 (3)	
8.216	4	19	06	8p11.21	VDAC3		Voltage-dependent anion channel 3	610029	A, H			8(Vdac3)
8.217	11	20	95	8q11.21	CEBPD		CCAAT/enhancer-binding protein (C/EBP), delta	116898	A, REa	earlier mapped to 8q11		16(Cebpd)
8.218	3	3	03	8p11.21	DKK4		Dickkopf, Xenopus, homolog of, 4	605417	A			
8.219	4	8	16	8p11.23	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL		Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	REa, A	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3); Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3); Hartsfield syndrome, 615465 (3); Encephalocraniocutaneous lipomatosis, 613001 (3)	
8.220	9	10	15	8p11.2-p11.1	HGSNAT, TMEM76, MPS3C, RP73		Heparan-alpha-glucosaminide N-acetyltransferase	610453	Fd, REc		Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3); Retinitis pigmentosa 73, 616544 (3)	
8.221	3	23	15	8p11.21	KAT6A, MYST3, MOZ, ZNF220, MRD32		K(lysine) acetyltransferase 6A	601408	Ch		Mental retardation, autosomal dominant 32, 616268 (3)	
8.222	11	24	14	8p11.21	POMK, SGK196, MDDGA12, MDDGC12		Protein-O-mannose kinase	615247	REc	mutation in 1 MDDGC12 family has been reported	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3); ?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	
8.223	1	13	11	8p11	SCLL		Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma)	613523	Ch	translocation of FGFR1 (8p11) and various partners	Chromosome 8p11 myeloproliferative syndrome (4)	
8.224	1	31	01	8p11.22	TACC1		Transforming, acidic, coiled-coil-containing protein-1	605301	REc			
8.225	11	30	00	8p23.3	DLGAP2, DAP2		Discs large associated protein 2	605438	REc, R			
8.226	6	15	99	8q	CCAL1		Chondrocalcinosis 1	600668	Fd		Chondrocalcinosis with early-onset osteoarthritis (2)	
8.227	11	13	07	8q	HBFQTL4		Fetal hemoglobin quantitative trait locus 4	606789	Fd		Fetal hemoglobin quantitative trait locus 4 (2)	
8.228	10	23	87	8q	GPB		Glycerol phosphatase, beta-	109640	S			
8.229	10	20	99	8q21.11	RPL7		Ribosomal protein L7	604166	REa, R	pseudogene on chr.5		
8.230	10	20	99	8q24.3	RPL8		Ribosomal protein L8	604177	REa, R			
8.231	12	14	00	8q24.13	ZHX1		Zinc finger and homeodomain protein 1	604764	REa, R			
8.232	7	13	93	8q12.1	MOS		Oncogene MOS, Moloney murine sarcoma virus	190060	REa, A, REb			4(Mos)
8.233	8	31	15	8q11.21	PRKDC, HYRC1, DNPK1, IMD26		Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)	600899	C, A		Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	16(scid)
8.234	8	18	14	8q11.22-q11.23	PXDNL, PMR1, VPO2		Peroxidasin, Drosophila, homolog-like	615904	REc			
8.235	2	20	03	8q11.23	RB1CC1, CC1, KIAA0203		RB1-inducible coiled-coil 1	606837	R		Breast cancer, somatic, 114480 (3)	
8.236	1	21	11	8q11.21	SNAI2, SLUG, WS2D		snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)	602150	Psh, R		Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)	16(Slug)
8.237	11	30	06	8q11.21	SNTG1, SYN4		Syntrophin, gamma-1	608714	REc, R	implicated in idiopathic scoliosis		
8.238	2	21	06	8q12.1	TGS1, NCOA6IP, PIMT		Trimethylguanosine synthase, S. cerevisiae, homolog of	606461	REc			
8.239	2	21	10	8q12.1	CA8, CALS, CARP, CAMRQ3		Carbonic anhydrase VIII	114815	REa, A		Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	4(Car)
8.240	10	7	02	8q24.3	CHARC1, CHARC15, YCL1		Chromatin accessibility complex, subunit 1	607268	REc			
8.241	11	19	98	8q12.1	CYP7A1, CYP7		Cytochrome P450, subfamily VII (cholesterol 7-alpha-monooxygenase), polypeptide 1	118455	REa, A			
8.242	1	21	04	8q11.2-q12.1	RP1, ORP1		Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1)	603937	Fd, R, A		Retinitis pigmentosa 1, 180100 (3)	
8.243	2	25	15	8q11.1	BEYLA		BEYLA gene	609543	REc			
8.244	1	16	18	8q11.21	MCM4, NKGCD, NKCD, IMD54		Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4	602638	A, Fd		Immunodeficiency 54, 609981 (3)	
8.245	3	18	94	8q11.23	OPRK1		Opiate receptor, kappa-1	165196	REa, A			
8.246	9	9	13	8q11.21	SPIDR, KIAA0146		Scaffolding protein involved in DNA repair	615384	REc			
8.247	6	13	12	8q11.21	UBE2V2, UEV2, DDVIT1, EDPF1, MMS2		Ubiquitin-conjugating enzyme E2 variant 2	603001	REc			
8.248	2	11	11	8q11.23	NPBWR1, GPR7		Neuropeptides B and W receptor 1	600730	A, REc	previously assigned to 10q11.2-q21.1 by FISH		
8.249	10	12	16	8q11.23	ST18, ZNF387, KIAA0535		Suppression of tumorigenicity 18	617155	REc			
8.250	12	15	98	8q11.23	TCEA1, TF2S, GTF2S		Transcription elongation factor A, SII, 1	601425	REa, A	previously mapped to 3p22-p21.3		
8.251	2	26	08	8q11.23	MRPL15		Mitochondrial ribosomal protein L15	611828	R			
8.252	4	28	10	8q11.2-q13.2	GCCD3, FGD3, GCCD2		Glucocorticoid deficiency 3	609197	Fd	between D8S285 and D8S1718	Glucocorticoid deficiency 3 (2)	
8.253	4	1	03	8q11.1-q13.3	PAFC		Preauricular fistulae, congenital	128700	Fd	between D8S532 and D8S279	?Preauricular fistulae, congenital (2)	
8.254	7	23	07	8q12.1	CHCHD7		Coiled-coil-helix-coiled-coil-helix domain-containing protein 7	611238	REn			
8.255	3	12	15	8q12	IS3		Scoliosis, isolated, susceptibility to, 3	608765	Fd		{Scoliosis, isolated, susceptibility to, 3} (2)	
8.256	12	11	15	8q12.1	PLAG1, SGPA, PSA		Pleomorphic adenoma gene 1	603026	REc, A	fused with CTNNB1 in SGPA	Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	
8.257	4	10	90	8q21.13	IL7		Interleukin-7	146660	REa, A			
8.258	8	20	07	8q12-q13	MTBS2		Mycobacterium tuberculosis, susceptibility to, 2	611046	Fd	max lod at D8S1723	{Mycobacterium tuberculosis, susceptibility to, 2} (2)	
8.259	10	24	00	8q12.1	NSMAF, FAN		Neutral sphingomyelinase activation-associated factor	603043	A			
8.260	12	21	10	8q11.23	SOX17, VUR3		SRY-box 17	610928	REc		Vesicoureteral reflux 3, 613674 (3)	
8.261	2	18	09	8q12.1	ANIB10		Aneurysm, intracranial berry, 10	612587	Fd	associated with rs10958409	{Aneurysm, intracranial berry, 10} (2)	
8.262	7	15	14	8q12.3	ASPH, HAAH, FDLAB		Aspartate beta-hydroxylase (junctin; junctate)	600582	REc, A		Traboulsi syndrome, 601552 (3)	
8.263	3	12	14	8q12.2	CHD7, HH5		Chromodomain helicase DNA binding protein 7	608892	R, REc		CHARGE syndrome, 214800 (3); Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	
8.264	4	2	16	8q12.1	FAM110B, C8orf72		Family with sequence similarity 110, member B	611394	REc			
8.265	7	22	11	8q12.1	IMPAD1, GPAPP, IMPA3		Inositol monophosphatase domain-containing protein 1	614010	REc		Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	
8.266	2	28	03	8q12.1-q12.2	RAB2, RAB2A		Ras-associated protein RAB2	179509	REc			
8.267	11	2	04	8q12.1	RDHE2		Retinal dehydrogenase, epidermal, 2	608989	REc			
8.268	9	19	00	8q12.1	RPS20		Ribosomal protein S20	603682	REa, R, REc			
8.269	9	20	14	8q12.1	SDCBP, TACIP18, MDA9		Syndecan-binding protein	602217	REc			
8.270	3	22	13	8q12.1	TOX, KIAA0808		Thymus high mobility group box protein, mouse, homolog of	606863	R, REc			
8.271	6	2	15	8q12.1	UBXN2B, LOC137886, p37		UBX domain protein 2B	610686	REc			
8.272	5	11	16	8q12.2-q12.3	CLVS1, RLBP1L1, CRALBPL		Clavesin 1	611292	REc			
8.273	5	4	12	8q12.2-q21.2	DEL8q12q21, C8DELq12q21		Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome)	600257	Ch		Bor-Duane hydrocephalus contiguous gene syndrome (4)	
8.274	7	16	09	8q12.3	NKAIN3		Na+/K+ transporting ATPase-interacting 3	612872	REc			4(Nkain3)
8.275	2	22	13	8q12.2-q21.2	HDCPH1		Hydrocephalus, autosomal dominant	123155	Ch		?Hydrocephalus, autosomal dominant (2)	
8.276	7	18	06	8q12.3	GGH		Gamma-glutamyl hydrolase	601509	REc			
8.277	5	24	13	8q13.1	SGK3, SGKL, CISK		Serum/glucocorticoid-regulated kinase 3	607591	R			
8.278	8	31	99	8q13.2	ARFGEF1, ARFGEP1, BIG1, P200		ADP-ribosylation factor guanine nucleotide exchange factor 1	604141	R			
8.279	9	30	10	8q12.3	BHLHE22, BHLHB5, BETA3		Basic helix-loop-helix family, member E22	613483	A, H			3(Bhlhe22)
8.280	1	18	12	8q13.2	CPA6, CPAH, ETL5, FEB11		Carboxypeptidase A6	609562	REc		Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures, familial, 11, 614418 (3)	
8.281	9	3	09	8q13.1	CRH		Corticotropin releasing hormone	122560	REa, A			3(Crh)
8.282	10	29	10	8q13	DEL8q13, C8DELq13		Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome)	600383	REc	contiguous gene deletion of SULF1 and SLCO5A1	Mesomelia-synostoses syndrome (4)	
8.283	8	9	99	8q13	DURS1, DUS		Duane retraction syndrome 1	126800	Ch		Duane retraction syndrome 1 (2)	
8.284	9	2	08	8q13.1	SNHG6, U87HG		Small nucleolar RNA host gene 6	612215	R, REc			
8.285	6	29	98	8q21.11	TERF1, TRF1		Telomeric repeat binding factor 1	600951	A, Psh			17(Trf1)
8.286	9	2	08	8q13.1	SNORD87, U87		Small nucleolar RNA, C/D box, 87	612216	REc	within intron 2 of SNHG6		
8.287	7	28	17	8q21.11	TRPA1, ANKTM1, FEPS1		Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1)	604775	A	mutation identified in 1 FEPS1 family	?Episodic pain syndrome, familial, 1, 615040 (3)	
8.288	1	22	08	8q13.1	VCPIP1 VCIP135, KIAA1850		VCP/p47 complex-interacting protein 1	611745	R, REc			
8.289	8	9	05	8q13-q21	FEB1		Febrile seizures, familial, 1	121210	Fd		Febrile seizures, familial, 1 (2)	
8.290	2	18	96	8q22.1	GEM		GTP-binding protein overexpressed in skeletal muscle	600164	Fd			4(Gem)
8.291	5	14	01	8q21.11	STAU2		Staufen, Drosophila, homolog of, 2	605920	REc			
8.292	11	3	11	8q21.11	UBE2W, UBC16		Ubiquitin-conjugating enzyme 2W	614277	REc			
8.293	10	13	94	8q13.1	PDE7A, HCP1		Phosphodiesterase-7A	171885	REa			
8.294	3	25	15	8q13-q23	CMT2H		Charcot-Marie-Tooth disease, axonal, type 2H	607731	Fd	between D8S1807 and D8S548	Charcot-Marie-Tooth disease, axonal, type 2H (2)	
8.295	8	22	90	8q12.1	LYN		Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog	165120	REa			4(Lyn)
8.296	8	21	07	8q13.1	ADHFE1, HOT, ADH8		Alcohol dehydrogenase, iron-containing, 1	611083	REc			
8.297	5	23	11	8q13.1	DNAJC5B		DNAJ/HSP40 homolog, subfamily C, member 5, beta	613945	REc			
8.298	6	27	17	8q13.1	MCMDC2, C8orf45		Minichromosome maintenance domain-containing protein 2	617545	REc			
8.299	10	25	17	8q13.1	PPP1R42, TLRR, LRRC67		Protein phosphatase 1, rebulatory subunit 42	617720	REc			
8.300	2	5	13	8q13.1	TRIM55, RNF29, MURF2		Tripartite motif containing 55	606469	REc, R			
8.301	10	10	11	8q13.2	PREX2, DEPDC2		Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 2	612139	REc			
8.302	12	11	95	8q12.3	TTPA, TTP1, AVED		Tocopherol, alpha, transfer protein	600415	Fd, LD, REc, A, REa		Ataxia with isolated vitamin E deficiency, 277460 (3)	
8.303	6	13	12	8q13.1	COPS5, JAB1, SGN5		COP9, subunit 5	604850	REc			
8.304	2	21	14	8q13.1-q13.2	CSPP1, CSPP, JBTS21		Centrosome spindle pole-associated protein 1	611654	REc		Joubert syndrome 21, 615636 (3)	
8.305	9	7	10	8q13.3	NCOA2, GRIP1, TIF2, SRC2		Nuclear receptor coactivator 2	601993	fused with MOZ in AML			
8.306	1	5	17	8q13.3	EYA1, BOR, BOS1, OFC1		Eyes absent, Drosophila, homolog of, 1	601653	REc, Fd, Ch	mutation identified in 1 OFC1 family	Branchiootorenal syndrome 1, with or without cataracts, 113650 (3); Anterior segment anomalies with or without cataract, 602588 (3); Branchiootic syndrome 1, 602588 (3); ?Otofaciocervical syndrome, 166780 (3)	
8.307	8	18	14	8q13.3	MSC, ABF1, MYOR		Musculin	603628	REc			
8.308	10	7	13	8q24.13	NDUFB9, UQOR22		NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22)	601445	REc	mutation identified in 1 family	?Mitochondrial complex I deficiency, 252010 (3)	
8.309	2	11	08	8q13.3	PRDM14, PFM11		PR domain-containing protein 14	611781	A			
8.310	8	27	15	8q13.3	SLCO5A1, OATPRP4, SLC21A15, OATPJ, OATP5A1		Solute carrier organic anion transporter family, member 5A1	613543	REc			
8.311	5	19	06	8q13.2-q13.3	SULF1, KIAA1077		Sulfatase 1	610012	REc			1(Sulf1)
8.312	11	27	13	8p21.3	POLR3D, BN51T, TSBN51		Polymerase III, RNA, subunit D	187280	REa, A			
8.313	12	9	15	8q21.11	JPH1, JP1, CMT2K		Junctophilin 1	605266	A	mutation identified in 1 CMT2K family	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	
8.314	9	18	08	8q21.3	CNGB3, ACHM3, ACHM1		Cyclic nucleotide-gated channel, beta-3	605080	REc, Fd		Achromatopsia 3, 262300 (3); Macular degeneration, juvenile, 248200 (3)	
8.315	11	10	06	8q21-q22	OPA6		Optic atrophy 6	258500	Fd	between D8S1702 and D8S1794	Optic atrophy 6 (2)	
8.316	12	14	06	8q24.3	CYP11B1, P450C11, FHI		Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))	610613	REa, A, Ch	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)	
8.317	12	14	06	8q24.3	CYP11B2		Cytochrome P450, subfamily XIB, polypeptide 2	124080	REa		Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3); Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3); {Low renin hypertension, susceptibility to} (3); Aldosterone to renin ratio raised (3)	
8.318	6	19	98	8q21.13	FABP4		Fatty acid-binding protein-4, adipocyte	600434	A			
8.319	10	7	09	8q21.13	HNF4G		Hepatocyte nuclear factor 4-gamma	605966	Psh, REc			3(Hnf4g)
8.320	3	2	98	8q21.3	MMP16		Matrix metalloproteinase 16 (membrane-inserted)	602262	A			
8.321	1	7	16	8q21.3	NBN, NBS1		Nibrin	602667	Fd, M		Nijmegen breakage syndrome, 251260 (3); Aplastic anemia, 609135 (3); Leukemia, acute lymphoblastic, 613065 (3)	
8.322	5	25	13	8q21.13	TPD52, D52		Tumor protein D52	604068	A			
8.323	8	24	09	8q21.3	WWP1, TIUL1		WW domain-containing protein 1	602307	A			
8.324	10	25	12	8q21.13	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3		Peroxisome biogenesis factor 2	170993	RE		Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3); Peroxisome biogenesis disorder 5B, 614867 (3)	3(Pxmp3)
8.325	4	24	08	8q21.13	MRPS28, MRPS35		Mitochondrial ribosomal protein S28	611990	R, REc			
8.326	10	23	87	8q21.1-qter	GLYB		Glycine auxotroph B, complementation of hamster	138480	S	gly(-)B		
8.327	9	21	11	8q21.11	DEL8q21.11, C8DELq21.11		Chromosome 8q21.11 deletion syndrome	614230	Ch	contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239	Chromosome 8q21.11 deletion syndrome (4)	
8.328	8	29	13	8q21.11	GDAP1, CMT4A, CMT2K, CMTRIA		Ganglioside-induced differentiation-associated protein 1	606598	Fd, REc		Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	
8.329	5	30	13	8q21.11	LY96, MD2		Lymphocyte antigen 96	605243	REc			
8.330	7	1	11	8q21.11	TMEM70, MC5DN2		Transmembrane protein 70	612418	REc		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	
8.331	4	23	12	8q21.13	CHMP4C, SNF7-3		CHMP family, member 4C	610899	REc			
8.332	6	11	02	8q21.13	ZFHX4, ZFH4		Zinc finger homeobox 4	606940	H, Ch		?Ptosis, congenital, 178300 (2)	
8.333	10	6	09	8q21.13	FABP5, PAFABP, EFABP		Fatty acid-binding protein 5	605168	H, REc			3(Fabp5)
8.334	9	20	14	8q21.13	PI15, P25TI		Protease inhibitor 15	607076	REc			
8.335	12	10	12	8q21.13	SNX16		Sorting nexin 16	614903	REc			
8.336	5	4	12	8q21.13	STMN2, SCGN10, SCG10		Stathmin-like 2	600621	R, REc			
8.337	2	17	09	8q21.13	STQTL15		Stature quantitative trait locus 15	612578	Fd	associated with rs2220456	{Stature QTL 15} (2)	
8.338	2	2	17	8q21.13	IMPA1, MRT59		Inositol(myo)-1(or 4)-monophosphatase-1	602064	Psh, REc		Mental retardation, autosomal recessive 59, 617323 (3)	
8.339	11	4	15	8q22.1	TMEM67, MKS3, JBTS6, NPHP11		Transmembrane protein 67 (meckelin)	609884	Fd, REc		Meckel syndrome 3, 607361 (3); Joubert syndrome 6, 610688 (3); {Bardet-Biedl syndrome 14, modifier of}, 615991 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)	
8.340	8	18	14	8q21.2	E2F5		E2F transcription factor 5	600967	REc			
8.341	11	29	17	8q21.2	LRRCC1, CLERK, KIAA1764		Leucine-rich repeat- and coiled-coil domain-containing centrosomal protein 1	617791	REc			
8.342	5	18	12	8q21.2	RALYL		RALY-like protein	614648	REc			
8.343	3	1	16	8q22.3	SLC25A32, MFT, RREI		Solute carrier family 25 (mitochondrial carrier, folate), member 32	610815	REc	mutation identified in 1 RREI patient	?Exercise intolerance, riboflavin-responsive, 616839 (3)	15(Slc25a32)
8.344	3	22	06	8q21.3	TMEM55A		Transmembrane protein 55A	609864	REc			
8.345	7	25	18	8q21.3	ATP6V0D2		ATPase, H+ transporting, V0 subunit D2	618072	REc			
8.346	10	6	09	8q21.3	CPNE3, CPN3		Copine III	604207	R, REc			
8.347	4	25	12	8q12.3	CYP7B1, CBAS3, SPG5A		Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1	603711	R, Fd		Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic paraplegia 5A, autosomal recessive, 270800 (3)	
8.348	9	23	14	8q21.3	DECR1		2,4-dienoyl CoA reductase	222745	A			
8.349	3	4	08	8q21.3	FAM82B, RMD1		Family with sequence similarity 82, member B	611871	REc			
8.350	3	23	14	8q21.3	OSGIN2, C8orf1		Oxidative stress-induced growth inhibitor family member 2	604598	REc			
8.351	5	3	17	8q21.3	OTUD6B, DUBA5, IDDFSDA		OTU domain-containing protein 6B	612021	REc		Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3)	
8.352	5	21	14	8q21.3	RIPK2, CARDIAK, RIP2, RICK		Receptor-interacting serine/threonine kinase 2	603455	REc			
8.353	12	15	16	8q21.3	SLC7A13, AGT1, XAT2		Solute carrier family 7, member 13	617256	REc			
8.354	12	5	13	8q22.1	RAD54B		RAD54, S. cerevisiae, homolog of, B	604289	A		Lymphoma, non-Hodgkin, somatic, 605027 (3); Colon cancer, somatic, 114500 (3)	
8.355	9	13	99	8q21.3	CALB1		Calbindin 1, 28kD	114050	REa, A			4(Calb)
8.356	10	4	93	8q21.13	PMP2		Peripheral myelin protein-2	170715	REb, A	not involved in CMT4A		
8.357	6	28	99	8q23.1	ANGPT1, ANG1		Angiopoietin-1	601667	A, R, H			15(Angpt1)
8.358	10	13	94	8q21.2	CA1		Carbonic anhydrase I	114800	REa, H, A			3(Car1)
8.359	10	3	07	8q21.2	CA2		Carbonic anhydrase II	611492	REa, H	CA1, CA2 linked in monkey and mouse	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	3(Car2)
8.360	6	4	90	8q21.2	CA3		Carbonic anhydrase III	114750	REa, A			3(Car3)
8.361	4	14	10	8q22.3	DPYS, DHP		Dihydropyrimidinase	613326	A		Dihydropyrimidinuria, 222748 (3)	
8.362	6	28	18	8q22.3	GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4		Grainyhead-like 2	608576	REc		Deafness, autosomal dominant 28, 608641 (3); Ectodermal dysplasia/short stature syndrome, 616029 (3); Corneal dystrophy, posterior polymorphous, 4, 618031 (3)	
8.363	6	30	05	8q22.2	HRSP12, PSP, UK114		Heat-responsive protein 12	602487	REc			
8.364	1	25	05	8q22	HTC1		Hypertrichosis universalis congenita, Ambras type	145701	Ch		?Hypertrichosis universalis congenita, Ambras type (2)	
8.365	11	20	98	8q22.2	KCNS2		Potassium voltage-gated channel, delayed-rectifier, subfamily S, member-2	602906	REc			
8.366	1	23	01	8q22.1-q22.2	MATN2		Matrilin 2	602108	A			
8.367	9	19	91	8q13.1	MYBL1		Avian myeloblastosis viral (v-myb) oncogene homolog like-1	159405	REa, A			
8.368	11	27	94	8q22.3	ODF1		Outer dense fiber of sperm tails 1	182878	REa, A			15(Odf1)
8.369	3	22	16	8q22.2	POP1, ANXD2		Processing of precursor 1, S. cerevisiae, homolog of	602486	A		Anauxetic dysplasia 2, 617396 (3)	
8.370	2	10	14	8q22.1	PTDSS1, PSS1, KIAA0024, LMHD		Phosphatidylserine synthase 1	612792	Psh, H, REc		Lenz-Majewski hyperostotic dwarfism, 151050 (3)	13(Pss1)
8.371	4	24	12	8q21.3	RUNX1T1, CBFA2T1, AML1T1, ETO		unt-related transcription factor 1, translocated to, 1, cyclin D-related	133435	Ch	fused with AML1 in t(8;21)		4(Cbfa2t1h)
8.372	1	28	01	8q22.1	TP53DINP1, P53DINP1		Tumor protein p53 inducible nuclear protein 1	606185	A			
8.373	5	4	00	8q22.3	PABPC1, PAB1, PABP1, PABP		Polyadenylate-binding protein, cytoplasmic, 1	604679	Psh			
8.374	11	11	13	8q22.2	SPAG1, CILD28		Sperm-associated antigen-1	603395	R		Ciliary dyskinesia, primary, 28, 615505 (3)	
8.375	5	19	06	8q22.3	TM7SF4, DCSTAMP, FIND		Transmembrane 7 superfamily, member 4	605933	A			
8.376	7	18	12	8q22.1	TSPYL5, KIAA1750		TSPY-like 5	614721	REc			
8.377	4	8	13	8q22.1	UQCRB, UQBP, QPC, MC3DN3		Ubiquinol-cytochrome c reductase binding protein	191330	REa		Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	
8.378	6	16	99	8q22.2	COX6C		Cytochrome c oxidase, subunit VIc	124090	A, R	pseudogene on 16p12		
8.379	10	3	07	8q23.1	EIF3E, EIF3S6, INT6		Eukaryotic translation initiation factor 3, subunit E (oncogene INT6)	602210	Psh, H			15(Int6)
8.380	9	9	09	8q22.1	MTDH, AEG1, LYRIC		Metadherin	610323	A, REc			15(Mtdh)
8.381	7	22	13	8q22.2	VPS13B, KIAA0532, COH1		Vacuolar protein sorting 13, yeast, homolog of, B	607817	Fd, REc		Cohen syndrome, 216550 (3)	
8.382	8	19	98	8q22.1	SDC2, HSPG1		Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated; fibroglycan)	142460	REa, A			
8.383	3	28	17	8q22.1	C8orf37, CORD16, RP64, BBS21		Chromosome 8 open reading frame 37	614477	REc		Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500 (3); Bardet-Biedl syndrome 21, 617406 (3)	
8.384	3	31	15	8q22.1	CCNE2		Cyclin E2	603775	REc			
8.385	11	4	98	8q22.1	CDH17, CDH16, HPT1		Cadherin-17, liver-intestine	603017	Psh, A			
8.386	4	28	14	8q22.1	DUP8q22.1, C8DUPq22.1		Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis)	151200	Ch	duplication of 0.9-1.2 Mb on 8q22.1	Leri pleonosteosis chromosome duplication syndrome (4)	
8.387	12	27	16	8q22.1	FAM92A, FAM92A1		Family with sequence similarity 92, member A	617273	REc			
8.388	4	10	15	8q22.1	FSBP		Fibrinogen silencer-binding protein	616306	REc			
8.389	3	23	14	8q22.1	INTS8, INT8		Integrator complex subunit 8	611351	R, REc			
8.390	7	9	15	8q22.1	KIAA1429		KIAA1429 gene	616447	REc			
8.391	5	2	16	8q22.1	MTERF3, MTERFD1		Transcription termination factor 3, mitochondrial	616930	REc			
8.392	3	14	13	8q22.1	NDUFAF6, C8orf38		NADH dehydrogenase (ubiquinone) complex I, assembly factor 6	612392	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
8.393	5	4	12	8q22.1	NMLFS, DEL8q22.1, C8DELq22.1		Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome)	608156	Ch		Nablus mask-like facial syndrome (4)	
8.394	4	15	11	8q22.1	DPY19L4		DPY19-like 4	613895	REc			
8.395	6	13	18	8q22.1	ESRP1, RMB35A, DFNB109		Epithelial splicing regulatory protein 1	612959	REc	mutation identified in 1 DFNB109 family	?Deafness, autosomal recessive 109, 618013 (3)	
8.396	3	5	18	8q22.1	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4		Growth/differentiation factor 6	601147	REc, Ch		Klippel-Feil syndrome 1, autosomal dominant, 118100 (3); Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3); Leber congenital amaurosis 17, 615360 (3); Multiple synostoses syndrome 4, 617898 (3)	
8.397	3	16	10	8q22.1	LAPTM4B		Lysosome-associated protein, transmembrane 4, beta	613296	REc	pseudogenes on 1q, 3q,3p, 4q, and 7q33-q35		
8.398	2	2	10	8q22.1	PDP1, PPM2C, PDPC		Pyruvate dehydrogenase phosphatase catalytic subunit 1	605993	R, REc		Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	
8.399	5	6	13	8q22.1	PLEKHF2, EAPF, PHAFIN2		Pleckstrin homology domain-containing protein, family F, member 2	615208	REc			
8.400	5	13	13	8q22.3	KLF10, TIEG		Kruppel-like factor 10	601878	REc, H			1(Klf10)
8.401	6	17	02	8q22.3	NCALD		Neurocalcin, delta	606722	R			
8.402	2	25	14	8q22.2	RGS22		Regulator of G protein signaling 22	615650	REc			
8.403	11	11	14	8q22.2	STK3, MST2, KRS1		Serine/threonine protein kinase 3	605030	REc			
8.404	10	6	09	8q22.3	ATP6V1C1, ATP6C, ATP6D		ATPase, H+ transporting, V1 subunit C1	603097	R, REc			
8.405	8	18	08	8q22.3	AZIN1, OAZIN		Antizyme inhibitor 1	607909	R, REc			
8.406	1	11	02	8q22.3	BAALC		Brain and acute leukemia gene, cytoplasmic	606602	REc			
8.407	10	5	11	8q22.3	CTHRC1		Collagen triple-helix repeat-containing protein 1	610635	R, REc		Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.408	2	4	15	8q22.3	DCAF13, WDSOF1		DDB1- and CUL4-associated factor 13	616196	REc			
8.409	9	9	08	8q22.2	FBXO43, EMI2, ERP1, FBX43		F-box only protein 43	609110	REc, H			15(Fbxo43)
8.410	1	8	06	8q22.3	KTWS, KTS		Klippel-Trenaunay-Weber syndrome	149000	Ch	translocation with 14q13	Klippel-Trenaunay-Weber syndrome (2)	
8.411	10	8	12	8q22.3	UBR5, EDD1, HYD, KIAA0896		Ubiquitin protein ligase E3 component n-recognin 5	608413	A			
8.412	3	24	10	8q22.3	YWHAZ		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide	601288	A	pseudogene on 2p25		
8.413	3	29	10	8q22.3	MMD2		Miyoshi muscular dystrophy 2	613318	Fd	max lod at D10S2325	Miyoshi muscular dystrophy 2 (2)	
8.414	8	25	11	8q22.3	FZD6, NDNC10		Frizzled, Drosophila, homolog of, 6	603409	A		Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	15(Mfz6)
8.415	3	22	07	8q23.2	KCNV1, KV8.1		Potassium channel, voltage-gated, subfamily V, member 1	608164	A			
8.416	12	7	07	8q23.1	ABRA, STARS		Actin-binding RHO-activating protein	609747	REc			
8.417	7	17	01	8q23.1	CML66		Immunogenic tumor antigen CML66	606109	A			
8.418	6	16	99	8q24.12	COL14A1, UND		Collagen, type XIV, alpha-1 (undulin)	120324	A			
8.419	8	20	08	8q23	CRCS6		Colorectal cancer, susceptibility to, 6	612231	Fd	associated with rs16892766	{Colorectal cancer, susceptibility to, 6} (2)	
8.420	4	19	01	8q23.2	EBAG9, RCAS1, EB9		Estrogen receptor-binding site-associated antigen 9	605772	A			
8.421	9	9	98	8q23	GLC1D		Glaucoma 1, open angle, D	602429	Fd		Glaucoma 1D, primary open angle (2)	
8.422	12	7	07	8q23.2	GOLSYN, SYBU, KIAA1472		Golgi-localized syntaphilin-related protein	611568	REc, H			15(Golsyn)
8.423	12	17	07	8q23	HDLCQ2		High density lipoprotein cholesterol level QTL 2	607053	Fd		[High density lipoprotein cholesterol level QTL 2] (2)	
8.424	5	4	09	8q23	LBMQTL1		Lean body mass quantitative trait locus 1	612729	Fd	associated with rs16892496 and rs7832552	[Lean body mass QTL 1] (2)	
8.425	10	24	12	8q23	MYMY3		Moyamoya disease 3	608796	Fd	max lod at D8S546	Moyamoya disease 3 (2)	
8.426	7	30	09	8q22.2	OSR2		Odd-skipped-related 2	611297	REc			
8.427	2	5	01	8q23.1	OXR1		Oxidation resistance 1	605609	REc	?pseudogene on chr.15		
8.428	9	2	09	8q23.1-q23.2	PKHD1L1		PKHD1-like 1	607843	REc			
8.429	7	18	14	8q22.3	RIMS2, KIAA0751, RIM2, OBOE		Regulating synaptic membrane exocytosis-2	606630	R, REc			
8.430	5	27	05	8q23.1	TRHR		Thyrotropin-releasing hormone receptor	188545	A, H, REa		Thyrotropin-releasing hormone resistance, generalized (3)	15(Trhr)
8.431	11	3	14	8q23.1	ZFPM2, FOG2, DIH3, SRXY9		Zinc finger protein, multitype 2 (friend of GATA2)	603693	R, REc		Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3); 46XY sex reversal 9, 616067 (3)	
8.432	1	10	02	8q23-q24	HT		Hashimoto thyroiditis	140300	Fd	?chr.12	Hashimoto thyroiditis (2)	
8.433	10	11	07	8q23-q24	MGS		Mungan syndrome	611376	Fd	between D8S1830 and D8S1799	Mungan syndrome (2)	
8.434	10	23	87	8q12.1	PENK		Proenkephalin	131330	REa, A			
8.435	1	8	95	8q24.12	SNT2B1, A1B, SNTB1		Syntrophin, beta 1 (dystrophin-associated protein A1, 59kD, basic basic component 1)	600026	REa, A			
8.436	4	18	07	8q24.22	ZFAT1, ZNF406, AITD3		Zinc finger gene in autoimmune thyroid disease 1	610931	REn		{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	
8.437	4	17	17	8q24.12	COLEC10, CLL1, 3MC3		Collectin 10	607620	A		3MC syndrome 3, 248340 (3)	
8.438	2	25	15	8q23.1	EMC2, KIAA0103		ER membrane protein complex subunit 2	607722	REa			
8.439	12	27	10	8q22.3	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B		Ribonucleotide reductase M2 B, TP53 inducible	604712	A		Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3); Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	
8.440	6	22	18	8q23.1	RSPO2, CRISTIN2, TETAMS2, HHRRD		R-spondin family, member 2	610575	REc	mutation identified in 1 HHRRD family	Tetraamelia syndrome 2, 618021 (3); ?Humerofemoral hypoplasia with radiotibial ray deficiency, 618022 (3)	15(Rspo2)
8.441	4	26	11	8q23.1	TMEM74		Transmembrane protein 74	613935	REc			
8.442	1	27	04	8q23.3	CSMD3, KIAA1894		Cub and Sushi multiple domains 3	608399	REc			
8.443	12	24	08	8q24.3	ARC, KIAA0278		Activity-regulated cytoskeleton-associated protein	612461	R, A			
8.444	9	1	16	8q24.3	ADGRB1, BAI1, GDAIF		Adhesion G protein-coupled receptor B1	602682	A			
8.445	11	30	06	8q24.3	BOP1, KIAA0124		Block of proliferation 1	610596	Psh, REc			
8.446	12	29	06	8q24	BSZQTL3		Bone size quantitative trait locus 3	610649	Fd		[Bone size quantitative trait locus 3] (2)	
8.447	8	20	08	8q24	CRCS2		Colorectal cancer, susceptibility to, 2	611469	Fd	associated with rs7014346	{Colorectal cancer, susceptibility to, 2} (2)	
8.448	11	11	98	8q24	ECA1		Epilepsy, childhood absence, 1	600131	Fd		Epilepsy, childhood absence, 1 (2)	
8.449	10	28	10	8q24	EIG1		Epilepsy, idiopathic generalized, susceptibility to 1	600669	Fd	?same as EBN2	{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)	
8.450	5	11	16	8q24.3	AGO2, EIF2C2		Argonaute 2, RISC catalytic component	606229	R, REc			
8.451	5	17	18	8q24.21	FAM149B		Family with sequence similarity 49, member B	617978	REc			
8.452	12	15	17	8q24.3	GPAA1, GAA1, GPIBD15		Glycophosphatidylinositol anchor attachment protein 1	603048	A, R		Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3)	
8.453	8	10	99	8q24.22	HHLA1		Human endogenous retrovirus-H long terminal repeat-associating 1	604109	A, R			
8.454	8	9	07	8q24	HPC10		Prostate cancer, hereditary, 10	611100	Fd	strongest assoc. with rs1447295	{Prostate cancer, hereditary, 10} (2)	
8.455	2	22	92	8q24	HPV18I1		Human papillomavirus type 18 integration site-1	167959	A			
8.456	10	7	09	8q24.3	JRK, JH8		Jerky, mouse, homolog of	603210	R, A			15(Jrk)
8.457	2	2	18	8q24.22	KCNQ3, EBN2, BFNC2		Potassium voltage-gated channel, KQT-like subfamily, member 3	602232	Psh, R, Fd		Seizures, benign neonatal, 2, 121201 (3)	
8.458	3	30	18	8q24.3	MAFA, RIPE3B1, INSDM		v-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog A	610303	REc		Insulinomatosis and diabetes mellitus, 147630 (3)	
8.459	8	10	99	8q24.22	OC90, PLA2L		Otoconin 90 (phospholipase A2-like)	601658	A, R	PLA2L = fusion between HHLA1 and OC90		
8.460	10	12	14	8q24.21	PCAT1		Prostate cancer-associated transcript 1, noncoding	616043	REc			
8.461	09	27	18	8q24.3	PLEC1, PLEC, PLTN, EBS1, LGMDR17, EBSOG, EBSPA, EBSMD, EBSND		Plectin 1	601282	A, Psh, Fd	mutation identified in 1 EBSND family	Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3); Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3); ?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	
8.462	10	15	13	8q24.21	PRNCR1, PCAT8		Prostate cancer-associated noncoding RNA 1	615452	REc			
8.463	4	20	17	8q24.22	PTCSC1, NCRNA00197		Papillary thyroid carcinoma susceptibility candidate 1 gene	617440	REc			
8.464	10	23	87	8q24.21	PVT1		Oncogene PVT-1 (MYC activator)	165140	RE, Ch			
8.465	09	07	18	8q24.11	RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS		Rad21, S. pombe, homolog of	606462	REa, A	mutation identified in 1 MGS family	Cornelia de Lange syndrome 4, 614701 (3); ?Mungan syndrome, 611376 (3)	
8.466	3	26	07	8q24.3	SPATC1		Spermatogenesis- and centriole-associated 1 (speriolin)	610874	REc, H			15(Spatc1)
8.467	6	30	15	8q24.12	TNFRSF11B, OPG, OCIF, PDB5		Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)	602643	R		Paget disease of bone 5, juvenile-onset, 239000 (3)	
8.468	7	13	93	8q24.3	ZNF7, KOX4		Zinc finger protein-7 (KOX4)	194531	A, REa			
8.469	9	28	96	8q24.3	ZNF16, KOX9		Zinc finger protein-16 (KOX 9)	601262	A, REc			
8.470	8	28	01	8q24.3	LY6D, E48		Lymphocyte antigen 6 complex, locus D	606204	REa, A	?pseudogene ono 15q22		
8.471	7	6	99	8q24.3	PTK2, FADK		PTK2 protein tyrosine kinase	600758	Psh, H			15(Fadk)
8.472	9	28	00	8q24.12	ENPP2, PDNP2		Ectonucleotide pyrophosphatase/phosphodiesterase 2	601060	A			
8.473	2	26	04	8q24.13	MTSS1, MIM, KIAA0429		Metastasis suppressor 1	608486	R, REc			
8.474	7	13	93	8q24.12	NOV		Nephroblastoma overexpressed gene	164958	REa, A	proximal to MYC		15(nov)
8.475	8	20	07	8q24.13	RNF139, TRC8, RCA1		RING finger protein 139	603046	Ch		Renal cell carcinoma, 144700 (3)	
8.476	8	1	18	8q24.11-q24.12	SAMD12		Sterile alpha motif domain containing 12	618073	REc		Epilepsy, familial adult myoclonic, 1, 601068 (3)	
8.477	8	16	99	8q24.13	SQLE		Squalene epoxidase	602019	R, Psh, A			
8.478	10	1	99	8q24.1	THM		Tibial hemimelia	275220	D		?Tibial hemimelia (2)	
8.479	10	16	98	8q24.13	ANX13, ISA		Annexin XIII	602573	A			
8.480	7	20	15	8q24.21-q24.22	ASAP1, DDEF1		Arf GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 1	605953	R			
8.481	10	13	09	8q24.21	GSDMC, MLZE		Gasdermin C	608384	A			
8.482	9	23	08	8q24.3	KCNK9, TASK3		Potassium channel, subfamily K, member 9	605874	REc		Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	
8.483	5	16	01	8q24.12	MTBP		Mouse double minute 2 homolog, binding protein of	605927	A			
8.484	3	29	99	8q24.22	WISP1		Wnt-1 inducible signaling pathway protein 1	603398	R			
8.485	10	3	07	8q23.3-q24.1	EIF3H, EIF3S3		Eukaryotic translation initiation factor 3, subunit H	603912	REc			
8.486	1	27	11	8q24.11	MED30, TRAP25, THRAP6		Mediator complex subunit 30	610237	A			
8.487	2	25	08	8q24.11	SLC30A8, ZNT8		Solute carrier family 30 (zinc transporter), member 8	611145	REc		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	15(Slc30a8)
8.488	1	27	04	8q24.11	EXT1		Exostosin 1	608177	Ch, Fd	distal to TRPS1	Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)	15(Ext1)
8.489	12	14	10	8q24.11-q24.13	TRPS2, LGCR, LGS		Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)	150230	Ch	contiguous gene syndrome involving TRPS1 and EXT1	Trichorhinophalangeal syndrome, type II (4)	
8.490	9	10	09	8q24.12	DEPDC6, DEPTOR		DEP domain-containing protein 6	612974	REc			
8.491	2	2	10	8q24.12	DSCC1, DCC1		Defective in sister chromatid cohesion 1, S. cerevisiae, homolog of	613203	REc			
8.492	6	19	98	8q24.13	HAS2		Hyaluronan synthase-2	601636	Psh, REc			15(Has2)
8.493	4	6	15	8q24.12	MRPL13, RPML13, L13A		Mitochondrial ribosomal protein L13	610200	R, REc			
8.494	1	14	14	8q24.12	TAF2, TAF2B, TAFII150, CIF150, MRT40		TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD	604912	REc		Mental retardation, autosomal recessive 40, 615599 (3)	
8.495	7	20	06	8q23.3	TRPS1		Zinc finger transcription factor TRPS1	604386	Ch, REc		Trichorhinophalangeal syndrome, type I, 190350 (3); Trichorhinophalangeal syndrome, type III, 190351 (3)	
8.496	12	9	91	8q24.21	MYC		Avian myelocytomatosis viral (v-myc) oncogene homolog	190080	REa, A	cen-5'-3'-ter	Burkitt lymphoma, 113970 (3)	15(Myc)
8.497	11	4	93	8q24.3	ZNF34, KOX32		Zinc finger protein-34 (KOX32)	194526	REa, A, D			
8.498	4	15	08	8q24.13	ATAD2, ANCCA		ATPase family, AAA domain-containing, member 2	611941	R, REc			
8.499	5	24	13	8q24.13	DERL1, DER1		DER1-like domain family, member 1	608813	REc			
8.500	9	9	08	8q24.13	FBXO32, MAFBX, FLJ32424, ATROGIN1		F-box only protein 32	606604	REc			15(Fbxo32)
8.501	12	1	11	8q24.13	HAS2AS1, HASNT		HAS2 antisense RNA 1	614353	REn			
8.502	12	15	16	8q24.13	NSMCE2, NSE2, MMS21		Non-SMC element 2, S. cerevisiae, homolog of	617246	REc		Seckel syndrome 10, 617253 (3)	
8.503	10	28	15	8q24.13	TMEM65		Transmembrane protein 65	616609	REc			2(Tmem65)
8.504	6	11	12	8q24.13	TRIB1, TRB1, SKIP1, C8FW		Tribbles, Drosophila, homolog of, 1	609461	REc			
8.505	5	26	13	8q24.13	TRMT12, TRM12		tRNA methyltransferase 12, S. cerevisiae, homolog of	611244	R, REc			
8.506	4	20	17	8q24.13	WSHC5, KIAA0196, SPG8, RTSC1		WASH complex, subunit 5	610657	Fd, REc, R		Spastic paraplegia 8, autosomal dominant, 603563 (3); Ritscher-Schinzel syndrome 1, 220210 (3)	
8.507	12	17	12	8q24.13-q24.21	PPKP1B		Keratoderma, palmoplantar, punctate type IB	614936	Fd	between D8S1804 and D8S1720	Keratoderma, palmoplantar, punctate type IB (2)	
8.508	12	22	08	8q24.13-q24.22	ARHI1		Age-related hearing impairment 1	612448	Fd	between rs3765212 and rs4601326	{Age-related hearing impairment 1} (2)	
8.509	9	19	94	8q24.22	ADCY8, ADCY3		Adenylyl cyclase-8, brain	103070	A			
8.510	4	19	06	8q24.2-q24.3	COL22A1		Collagen, type XXII, alpha-1 polypeptide	610026	REc			15(Col22a1)
8.511	2	18	08	8q24.22	EFR3A, KIAA0143		EFR3, S. cerevisiae, homolog of, A	611798	Psh, REc, H			15(Efr3a)
8.512	2	28	07	8q24.23	KHDRBS3, TSTAR, SALP, SLM2, ETOILE		KH domain-containing, RNA-binding, signal transduction-associated protein 3	610421	REc			15(Khdrbs3)
8.513	4	8	98	8q24.3	PSCA		Prostate stem cell antigen	602470	A			
8.514	8	4	97	8q24.3	GPR20		G protein-coupled receptor-20	601908	A			
8.515	9	11	98	8q24.22	SLA		Src-like-adaptor	601099	REa, REn	in intron of TG		15(Slap)
8.516	10	11	17	8q24.21	CASC8, LINC00860, CARLO1		Cancer susceptibility candidate 8, noncoding	617701	REc			
8.517	10	11	17	8q24.21	CASC11, LINC00990, CARLO7		Cancer susceptibility candidate 11, noncoding	617704	REc			
8.518	10	11	17	8q24.21	CASC19, LINC01245, CARLO6		Cancer susceptibility candidate 19, noncoding	617703	REc			
8.519	10	11	17	8q24.21	CASC21, LINC01244, CARLO2		Cancer susceptibility candidate 21, noncoding	617702	REc			
8.520	10	1	17	8q24.21	CCAT1, CARLO5		Colon cancer-associated transcript 1, noncoding	617705	REc			
8.521	9	29	09	8q24.22	TG, AITD3, TDH3		Thyroglobulin	188450	A, REa, REb	distal to MYC	Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	15(Tgn; cog)
8.522	9	30	09	8q24.21	CCD26, RAM		Coiled-coil domain-containing protein 26	613040	REc			
8.523	9	24	08	8q24.21	FAM84B, BCMP101		Family with sequence similarity 84, member B	609483	REc			
8.524	4	17	13	8q24.21	GLM7		Glioma susceptibility 7	613032	Fd	associated with rs55705857	{Glioma susceptibility 7} (2)	
8.525	9	21	17	8q24.21	PCAT2, PCA2, CARLO4		Prostate cancer-associated transcript 2, noncoding	617678	REc			
8.526	4	29	14	8q24.21	POU5F1B, POU5F1P1, OCT4PG1		POU domain, class 5, transcription factor 1B	615739	REc			
8.527	11	29	12	8q24.22	LRRC6, LRTP, CILD19		Leucine-rich repeat-containing protein 6	614930	REc		Ciliary dyskinesia, primary, 19, 614935 (3)	
8.528	7	17	14	8q24.3	ARHGAP39, VILSE, KIAA1688		RHO GTPase-activating protein 39	615880	REc, R			
8.529	6	26	16	8q24.3	C8orf17, MOST1		Chromosome 8 open reading frame 17	616992	REc			
8.530	11	18	15	8q24.3	CYHR1, KIAA0496		Cysteine- and histidine-rich protein 1	616635	REc			
8.531	6	9	08	8q24.3	COMMD5, HCARG		COMM domain-containing protein 5	608216	REc			
8.532	10	15	13	8q24.3	CYC1, MC3DN6		Cytochrome c1	123980	REa, A		Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	
8.533	5	30	17	8q24.3	DENND3, KIAA0870		DENN domain-containing protein 3	617503	REc			
8.534	6	26	14	8q24.3	DGAT1, ARGP1, DIAR7		Diacylglycerol O-acyltransferase 1	604900	A, H, REc	mutation identified in 1 DIAR7 family	?Diarrhea 7, 615863 (3)	15(Dgat)
8.535	9	18	08	8q24.3	EEF1D, EF1D		Eukaryotic translation elongation factor 1, delta	130592	REc			
8.536	8	18	14	8q24.3	EPPK1		Epiplakin 1	607553	REc			
8.537	6	1	12	8q24.3	EXOSC4, RRP41		Exosome component 4	606491	REc			
8.538	8	4	17	8q24.3	FAM83H, AI3A		Family with sequence similarity 83, member H	611927	Fd, REc		Amelogenesis imperfecta, type IIIA, 130900 (3)	
8.539	3	30	99	8q24.3	FAST1		Forkhead activin signal transducer 1, Xenopus, homolog of	603621	A			
8.540	6	13	12	8q24.3	FBXL6, FBL6, FBL6A		F-box and leucine-rich repeat protein 6	609076	R, REc			15(FBXL6)
8.541	9	29	96	8q24.3	GLI4, HKR4		GLI-Kruppel family member GLI4 (oncogene HKR4)	165280	REa, A			
8.542	6	19	98	8q24.3	GML		Glycosylphosphatidylinositol-anchored molecule-like protein	602370	A			
8.543	8	22	14	8q24.3	GPIHBP1, HYPL1D		Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	612757	REc		Hyperlipoproteinemia, type 1D, 615947 (3)	
8.544	7	22	16	8q24.3	GSDMD, GSDMDC1, DFNA5L		Gasdermin D	617042	REc			
8.545	5	19	16	8q24.3	KIFC2		Kinesin family member C2	615216	REc			
8.546	7	11	12	8q24.3	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2		Solute carrier family 52, riboflavin transporter, member 2	607882	REc		Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	
8.547	6	17	99	8q24.3	GPT, GPT1, AAT1		Glutamic-pyruvate transaminase (alanine aminotransferase)	138200	S, EM, H, Fd, D, A			15(Gpt1)
8.548	3	14	96	8q24.3	GRINA, NMDARA1		Glutamate receptor, ionotropic, N-methyl	138251	REa, A, R			
8.549	9	9	08	8q24.3	HSF1		Heat-shock transcription factor 1	140580	R, REc			
8.550	1	7	99	8q24.3	LY6E, RIGE, SCA2		Lymphocyte antigen 6 complex, locus E (retinoic acid induced gene E)	601384	A			15(Ly6e)
8.551	8	17	99	8q24.3	LY6H		Lymphocyte antigen 6 complex, locus H	603625	A			
8.552	3	14	13	8q24.3	LY6K		Lymphocyte antigen 6 complex, locus K	615093	REc			
8.553	1	28	11	8q24.3	MAF1		Maf1, S. cerevisiae, homolog of	610210	R, REc			
8.554	1	31	11	8q24.3	MIR661, MIRN661		Micro RNA 661	613716	REc			
8.555	3	17	08	8q24.3	NAPRT1		Nicotinate phosphoribosyltransferase domain-containing 1	611552	REc			
8.556	10	2	03	8q24.22	NDRG1, HMSNL, CMT4D		N-myc downstream-regulated gene 1	605262	REc, Fd, LD		Charcot-Marie-Tooth disease, type 4D, 601455 (3)	
8.557	9	7	00	8q24.3	NFKBIL2, IKBR		Nuclear factor of kappa light chain gene enhancer in B cells inhibitor-like 2	604546	Psh, A			
8.558	12	27	13	8q24.3	NRBP2		Nuclear receptor-binding protein 2	615563	REc			
8.559	7	13	09	8q24.3	OFC12		Orofacial cleft 12	612858	Fd	associated with rs987525	Orofacial cleft 12 (2)	
8.560	3	30	12	8q24.3	OPLAH, OPLAHD		5-oxoprolinase (ATP-hydrolyzing)	614243	REc		5-oxoprolinase deficiency, 260005 (3)	
8.561	12	6	01	8q24.3	PTP4A3, PRL3		Protein-tyrosine phosphatase, type 4A, 3	606449	R			
8.562	1	7	14	8q24.3	PUF60, FIR, SIAHBP1, VRJS		Poly-U-binding splicing factor, 60kD	604819	REc		Verheij syndrome, 615583 (3)	
8.563	6	3	15	8q24.3	PYCRL, PYCR3		Pyrroline-5-carboxylate reductase-like	616408	REc			
8.564	5	22	14	8q24.3	RECQL4, RTS, RECQ4		DNA helicase, RecQ-like 4	603780	Ch, A		Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280 (3); Baller-Gerold syndrome, 218600 (3)	
8.565	8	18	14	8q24.3	RHPN1, ODF5		Rhophilin 1	601031	REc			
8.566	10	16	13	8q24.3	SCRIB, SCRB1, KIAA0147		Scribble, Drosophila, homolog of	607733	R, REc			
8.567	4	25	08	8q24.3	SCXA, SCX		Scleraxis, mouse, homolog of, A	609067	REc			
8.568	3	11	08	8q24.3	SHARPIN, SIPL1		SHANK-associated RH domain interactor	611885	REc			
8.569	6	24	02	8q24.3	SLC39A4, ZIP4		Solute carrier family 36 (zinc transporter), member 4	607059	REc, Fd		Acrodermatitis enteropathica, 201100 (3)	
8.570	10	15	01	8q24.3	TOP1MT		Topoisomerase I, mitochondrial	606387	A			
8.571	12	30	09	8q24.3	TRAPPC9, NIBP, KIAA1882, MRT13		Trafficking protein particle complex 9	611966	REc		Mental retardation, autosomal recessive 13, 613192 (3)	
8.572	11	20	98	8q24.3	TSTA3		Tissue-specific transplantation antigen-3	137020	A			
8.573	4	23	08	8q24.3	VPS28		Vacuolar protein sorting 28, yeast, homolog of	611952	R, REc			
8.574	8	23	01	8q24.3	SLURP1, MDM		Secreted LY6/uPAR-related protein 1	606119	Fd, R		Meleda disease, 248300 (3)	
8.575	11	19	11	Chr.8	AIS3, VAMAS4		Autoimmune disease, susceptibility to, 3	608392	Fd		{Autoimmune disease, susceptibility to, 3} (2)	
8.576	5	28	99	Chr.8	IFNB3		Interferon, beta-3, fibroblast	147860	S, REa	previously assigned to 2p23-qter		
8.577	5	22	03	8q21.11	KCNB2, KV2.2		Potassium channel, voltage-gated, shab-related subfamily, member 2	607738	R			
8.578	3	17	03	8q24.3	LYNX1		Lynx1, mouse, homolog of	606110	R			
8.579	1	30	01	8q11.23	LYPLA1		Lysophospholipase I	605599	R			
8.580	8	27	01	8q21.13	PAG		Phosphoprotein associated with glycosphingolipid-enriched microdomains	605767	R			
8.581	6	26	01	8q21.13	PKIA		Protein kinase, cAMP-dependent catalytic, inhibitor alpha	606059	R			
8.582	5	22	03	8p11.22	PLEKHA2, TAPP2		Pleckstrin homology domain-containing protein, family A, member 2	607773	R			
8.583	1	22	93	8p21.3	PPP3CC, CALNA3		Protein phosphatase-3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)	114107	REa			
8.584	3	10	03	8q21.11	RDH10		Retinol dehydrogenase 10	607599	R			
8.585	7	13	92	8q22.2	RPL30		Ribosomal protein L30	180467	Psh			
8.586	6	21	01	8q24.3	SCRT1		Scratch, mouse, homolog of	605858	REc			
8.587	2	21	03	8q21.11	TCEB1		Transcription elongation factor B, polypeptide 1, 15kD (elongin C)	600788	R			
8.588	8	27	02	8p23.1	TNKS		TRF1-interacting, ankyrin-related ADP-ribose polymerase (tankyrase)	603303	R			8(Tnks)
8.589	9	20	00	8q13.3	TRAM		Translocating chain-associating membrane protein	605190	R			
8.590	9	14	89	Chr.8	ZNF1		Zinc finger protein-1	194490	REa			8(Zfp2)
9.1	10	23	87	9p24.1	RLN1		Relaxin, H1	179730	REa			19(Rln1)
9.2	10	23	87	9p24.1	RLN2		Relaxin, H2	179740	REa			
9.3	8	21	07	9p24.3	CBWD1		Cobalamin synthetase W domain-containing protein 1	611078	REc			19(Cbwd)
9.4	8	29	11	9p24.3	DEL9p24.3, C9DELp24.3, SRXY4		Chromosome 9p24.3 deletion syndrome	154230	A, Ch		46XY sex reversal 4 (4)	
9.5	6	23	99	9p24.3	DMRT1, DMT1		Double sex and mab-3-related transcription factor-1	602424	A, Ch			
9.6	5	12	00	9p24.3	DMRT2		Double sex and mab-3-related transcription factor-2	604935	A			
9.7	8	3	12	9p24.3	DMRT3, DMRTA3		Doublesex-and mab3-related transcription factor 3	614754	REc			
9.8	5	4	12	9p24.3	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2		KN motif- and ankyrin repeat domain-containing protein 1	607704	REc		Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	
9.9	4	20	17	9p24.3	WASHC1, WASH1		WASH complex, subunit 1	613632	REc	pseudogenes on 1p, 15q, 16p, Xq/Yq		
9.10	5	19	16	9p24.2	GLIS3, ZNF515, NDH		GLIS family zinc finger protein 3	610192	REc		Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	19(Glis3)
9.11	8	8	08	9p24-p23	PTPRD, PTPD, HPTP		Protein tyrosine phosphatase, receptor type, delta polypeptide	601598	H, REc			4(Ptprd)
9.12	3	31	10	9p24.2	KCNV2, KV11.1, RCD3B		Potassium channel, voltage-gated, subfamily V, member 2	607604	REc		Retinal cone dystrophy 3B, 610356 (3)	
9.13	3	23	06	9p24.2	KIAA0020, HLA-HA8		Minor histocompatibility antigen HA-8	609960	R, REc			
9.14	3	19	01	9p24.1	PDCD1L2, PDL2		Programmed cell death 1 ligand 2	605723	REc			19(Pdcd1l2)
9.15	5	25	13	9p24.2	RFX3		Regulatory factor X, 3	601337	REc			
9.16	7	1	13	9p24.1	AK3, AK3L1		Adenylate kinase 3	609290	REc, Psh			4(Ak3)
9.17	8	19	13	9p24.1	CDC37L1, HARC, FLJ20639		CDC37-like 1	610346	REc			
9.18	8	19	13	9p24.1	CIP150, KIAA1432		Connexin 43-interacting protein, 150kD	610354	R, REc			
9.19	4	1	08	9p24.1	IL33, C9orf26, NFEHEV		Interleukin 33	608678	REc, H			19(Il33)
9.20	7	20	12	9p24.1	KDM4C, JMJD2C, GASC1, KIAA0780		Lysine-specific demethylase 4C	605469	R, REc			
9.21	1	30	01	9p24.1	MLANA, MART1		Melan A	605513	R			
9.22	3	23	09	9p24.1	MIR101-2, MIRN101-2		Micro RNA 101-2	612512	REc	another locus, MIRN101-1, on 1p31		
9.23	10	1	95	9p23-p22	NFIB		Nuclear factor I/B	600728	A, Ch			4(Nfib)
9.24	10	25	17	9p24.1	PLPP6, PPAPDC2		PPAP2 domain-containing protein 2	611666	R, REc		Phospholipid phosphatase 6, 611666 (3)	
9.25	5	26	13	9p24.1	RCL1, RPCL1, RNAC		RNA terminal phosphate cyclase-like 1	611405	R, REc			
9.26	7	11	17	9p24.1	TPD52L3		Tumor protein D52-like 3	617567	REc			
9.27	12	22	16	9p24.1	TMEM261, DMAC1, C9orf123		Transmembrane protein 261	617261	REc			
9.28	5	6	13	9p24.1	UHRF2, NIRF		Ubiquitin-like protein containing PDH and RING finger domains 2, E3 ubiquitin protein ligase	615211	REc			
9.29	3	4	10	9p24.1-p22.1	FECD7, FCD4		Corneal dystrophy, Fuchs endothelial, 7	613271	Fd	max lod at D9S256	Corneal dystrophy, Fuchs endothelial, 7 (2)	
9.30	11	13	17	9p24.1	CD274, PDCD1LG1, B7H1		CD274 molecule	605402	REc			
9.31	8	4	15	9p24.3	DOCK8		Dedicator of cytokinesis 8	611432	REc		Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	
9.32	4	23	09	9p24.1	ERMP1, KIAA1815, FXNA		Endoplasmic reticulum metallopeptidase 1	611156	R, REc			
9.33	5	24	13	9p24.2	SLC1A1, EAAC1, SCZD18, DCBXA		Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)	133550	REa, A	mutation identified in 1 SCZD18 family	{?Schizophrenia susceptibility 18}, 615232 (3); Dicarboxylic aminoaciduria, 222730 (3)	
9.34	11	6	95	9p24.1	INSL4		Insulin-like 4, placenta	600910	A			
9.35	11	1	01	9p24.1	INSL6		Insulin-like 6	606414	R			19(Insl6)
9.36	8	23	17	9p24.1	JAK2, THCYT3		Janus kinase 2 (a protein-tyrosine kinase)	147796	A		Polycythemia vera, somatic, 263300 (3); Thrombocythemia 3, 614521 (3); Myelofibrosis, somatic, 254450 (3); Erythrocytosis, somatic, 133100 (3); Leukemia, acute myeloid, somatic, 601626 (3); {Budd-Chiari syndrome, somatic}, 600880 (3)	19(Jak2)
9.37	11	30	15	9p24	MRD2		Mental retardation, autosomal dominant 2	614113	Ch	2 patients reported with genomic deletion or rearrangement including disruption of DOCK8	Mental retardation, autosomal dominant 2 (4)	
9.38	2	21	10	9p24.2	VLDLR, CAMRQ1		Very low density lipoprotein receptor	192977	A, Psh		Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	19(Vldlr)
9.39	10	30	08	9p24-p22	RLS3		Restless legs syndrome, susceptibility to, 3	610438	Fd	associated with rs4626664 and rs1975197	{Restless legs syndrome 3} (2)	
9.40	5	4	12	9p24.3	SMARCA2, SNF2L2, NCBRS		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	600014	A		Nicolaides-Baraitser syndrome, 601358 (3)	19(Snf2l2)
9.41	12	30	14	9p23	LURAP1L, LRAP35B		Leucine-rich adaptor protein 1-like	616130	REc			
9.42	09	06	18	9p23	MPDZ, MUPP1, HYC2		Multiple PDZ domain protein	603785	R, Psh		Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3)	
9.43	2	25	16	9p23	TYRP1, CAS2, GP75, SHEP11		Tyrosinase-related protein 1	115501	Psh, REa, A, Fd		Albinism, oculocutaneous, type III, 203290 (3); [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	4(b;trp1)
9.44	9	6	11	9p23-p13.3	MRT16		Mental retardation, autosomal recessive 16	614208	Fd	between rs10738277 and rs12376565	Mental retardation, autosomal recessive 16 (2)	
9.45	9	5	01	9p23-p11	FRDA2		Friedreich ataxia 2	601992	Fd		Friedreich ataxia 2 (2)	
9.46	1	7	11	9p23-p21.2	DFNB83		Deafness, autosomal recessive 83	613685	Fd	between rs4742645 and rs1471364	Deafness, autosomal recessive 83 (2)	
9.47	2	20	12	9p22.3	FREM1, C9orf154, BNAR, MOTA, TRIGNO2		FRAS1-related extracellular matrix protein 1	608944	REc, R		Bifid nose with or without anorectal and renal anomalies, 608980 (3); Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)	
9.48	10	2	12	9p22.3	SNAPC3, SNAP50		Small nuclear RNA-activating protein complex, polypeptide 3	602348	REc			
9.49	10	5	10	9p22.3	TTC39B		Tetratricopeptide repeat domain 39B	613574	REc			
9.50	4	27	12	9p22.3	ZDHHC21, DHHC21		Zinc finger DHHC domain-containing protein 21	614605	REc			
9.51	3	4	08	9p22.2	CNTLN, C9orf101, C9orf39		Centlein	611870	REc			
9.52	8	3	06	9p22.3	PSIP1, LEDGF		PC4- and SFRS1-interacting protein 1	603620	A			
9.53	12	15	10	9p22.1	ACER2		Alkaline ceramidase 2	613492	REc			
9.54	7	12	06	9p22.1	AD11		Alzheimer disease 11	609790	Fd	between D9S157 and D9S259	Alzheimer disease-11 (2)	
9.55	6	7	04	9p22.3-p22.2	BNC2		Basonuclin 2	608669	REc			4(Bnc2)
9.56	9	7	10	9p22.1	HAUS6, DGT6, FAM29A		HAUS, augmin-like complex, subunit 6	613433	REc			
9.57	1	21	01	9p22.1	PLIN2		Perilipin 2	103195	REc			4(Plin2)
9.58	8	29	08	9p22.1	RRAGA, RAGA, FIP1		Ras-related GTP-binding protein A	612194	R, REc			
9.59	4	10	15	9p22.1	SAXO1, FAM154A		Stabilizer of axonemal microtubules 1	616292	REc			
9.60	2	25	14	9p22.1	SCARNA8		Small Cajal body-specific RNA 8	615646	REc			
9.61	12	24	08	9p13.3	UBE2R2, UBC3B		Ubiquitin-conjugating enzyme E2R 2	612506	REc			
9.62	5	27	09	9p22.2-p22.1	ADAMTSL1		ADAMTS-like protein 1	609198	REc, H			4(Adamtsl1)
9.63	6	14	99	9p22.3	CER1		Cerebrus 1, Xenopus, homolog of	603777	R, H			4(Cer1)
9.64	5	4	01	9p24.1	GLDC, HYGN1, GCSP, GCE, NKH		Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)	238300	Ch, A		Glycine encephalopathy, 605899 (3)	19(Gldc)
9.65	12	14	95	9p21.3	IFNA1, IFNA@		Interferon, alpha-1	147660	REa, A, RE	very close to IFF by Fd, LD; 15-30 genes	Interferon, alpha, deficiency (1)	4(Ifa)
9.66	12	14	95	9p21.3	IFNA2		Interferon, alpha-2	147562	D			
9.67	12	14	95	9p21.3	IFNA4		Interferon, alpha-4	147564	D			
9.68	12	14	95	9p21.3	IFNA5		Interferon, alpha-5	147565	D			
9.69	12	14	95	9p21.3	IFNA6		Interferon, alpha-6	147566	D			
9.70	12	14	95	9p21.3	IFNA7		Interferon, alpha-7	147567	D			
9.71	12	15	95	9p21.3	IFNA8		Interferon, alpha-8	147568	D			
9.72	12	15	95	9p21.3	IFNA10		Interferon, alpha-10	147577	D			
9.73	12	15	95	9p21.3	IFNA13		Interferon, alpha-13	147578	D			4(Ifna13)
9.74	12	15	95	9p21.3	IFNA14		Interferon, alpha-14	147579	D			
9.75	12	15	95	9p21.3	IFNA16		Interferon, alpha-16	147580	D			
9.76	12	15	95	9p21.3	IFNA17		Interferon, alpha-17	147583	D			
9.77	12	15	95	9p21.3	IFNA21		Interferon, alpha-21	147584	D			
9.78	7	13	93	9p21.3	MLLT3, AF9		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 3	159558	Ch	fuses with ALL1		
9.79	5	4	00	9p22.2	SH3GL2, SH3P4		SH3 domain, GRB2-like, 2	604465	REa, A			
9.80	1	20	06	9p22.1-p21.3	SLC24A2, NCKX2		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2	609838	REc			
9.81	1	6	11	9p22-p21	DFNA47, DFNB83		Deafness, autosomal dominant 47	608652	Fd	between D9S268 and D9S942; possibly allelic to DFNB83	Deafness, autosomal dominant 47 (2)	
9.82	11	7	89	9p22-p21	LALL		Lymphomatous acute lymphoblastic leukemia	247640	Ch		Leukemia, acute lymphoblastic (2)	
9.83	12	20	05	9p13.3	UBAP1, UBAP		Ubiquitin-associated protein 1	609787	REc			
9.84	12	23	05	9p21.2-p21.1	LRRN6C, LINGO2, LERN3		Leucine-rich repeat protein, neuronal, 6C	609793	REc			
9.85	2	20	11	9p21.1	ACO1, IREB1		Aconitase, soluble (iron-responsive element-binding protein-1)	100880	S, REc			4(Aco1)
9.86	8	31	17	9p21.2	EMICER1		EQTN, MOB3B, IFNK, and C9orf72 enhancer RNA I, noncoding	617651	REc			
9.87	8	31	17	9p21.2	EQTN, AFAF, SPACA8, C9orf11		Equatorin	617653	REc			
9.88	7	23	13	9p21.2	IFNK		Interferon, kappa	615326	R			
9.89	9	22	16	9p21.2	IFT74, CCDC2, CMG1, BBS20		Intraflagellar transport 74, Chlamydomonas, homolog of	608040	REc	mutation identified in 1 BBS20 patient	?Bardet-Biedl syndrome 20, 617119 (3)	
9.90	8	30	17	9p21.2	MOB3B, MOB1D, MOBKL2B, C9orf35		MOB kinase activator 3B	617652	REn			
9.91	6	27	17	9p21.2	PLAA, PLAP, NDMSBA		Phospholipase A2-activating protein	603873	REc		Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3)	
9.92	4	10	15	9p21.1	DDX58, RIGI, SGMRT2		DEAD box polypeptide 58	609631	REc		Singleton-Merten syndrome 2, 616298 (3)	
9.93	12	30	14	9p21.1	MIR873		Micro RNA 873	616137	REc			
9.94	12	15	17	9p21.1	SMU1		DNA replication regulator and spliceosomal factor SMU1	617811	REc			
9.95	3	13	08	9p21	AAA3		Aneurysm, familial abdominal 3	611891	Fd	associated with rs10757278	{Aneurysm, familial abdominal 3} (2)	
9.96	3	13	08	9p21	ANIB6		Aneurysm, intracranial berry, 6	611892	Fd	associated with rs10757278	{Aneurysm, intracranial berry, 6} (2)	
9.97	10	6	09	9p21	BCC5		Basal cell carcinoma, susceptibility to, 5	613062	Fd	associated with rs2151280	{Basal cell carcinoma, susceptibility to, 5} (2)	
9.98	7	7	15	9p21.2	C9orf72, FTDALS1, FTDALS, ALSFTD		Chromosome 9 open reading frame 72	614260	REc		Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	
9.99	3	3	03	9p21.3	CDKN2A, MTS1, P16, MLM, CMM2		Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160	RE, D, Fd		{Melanoma, cutaneous malignant, 2}, 155601 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple, (3)	4(Cdkn2a)
9.100	7	10	95	9p21.3	CDKN2B, MTS2, P15, INK4B		Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)	600431	A	tandem with MTS1		
9.101	12	21	09	9p21.3	CDKN2BAS, ANRIL		CDKN2B antisense RNA	613149	REc			
9.102	2	23	08	9p21	CHDS8		Coronary heart disease, susceptibility to, 8	611139	Fd	strongest linkage with dbSNP rs1333049	{Coronary heart disease, susceptibility to, 8} (2)	
9.103	2	24	97	9p21.3	ELAVL2, HELN1, HUB		Embryonic lethal, abnormal vision, Drosophila, homolog of, like-2 (Hu antigen B)	601673	Psh, A, H			4(Hub)
9.104	4	10	90	9p21.3	IFNB1		Interferon, beta-1, fibroblast	147640	REa, A, Fd, LD, RE	distal to IFL; ?9p23-p22; IFF duplicate in some		4(Ifb)
9.105	5	6	13	9p21.3	IFNE, INFE1, IFNT1		Interferon, epsilon	615223	REc			
9.106	5	6	97	9p21.3	IFNW1		Interferon, omega-1	147553	D	pseudogene IFNWP2; interspersed with IFNA		
9.107	6	16	08	9p21	MFT2, TEM		Trichoepithelioma, multiple familial, 2	612099	Fd	max lod at D9S171	Trichoepithelioma, multiple familial, 2 (2)	
9.108	9	10	12	9p21.3	DMRTA1, DMRT4		Doublesex- and MAB3-related transcription factor A1	614803	REc			4(Dmrta1))
9.109	5	4	12	9p21.3	FOCAD, KIAA1797		Focadhesin	614606	REc			
9.110	4	13	10	9p21.3	GLM5		Glioma susceptibility 5	613030	Fd	associated with rs4977756	{Glioma susceptibility 5} (2)	
9.111	5	6	13	9p21.3	KLHL9, KIAA1354		Kelch-like 9	611201	REc			4(Klhl9)
9.112	3	23	09	9p21.3	MIR31, MIRN31		Micro RNA 31	612155	REc			
9.113	6	2	15	9p21.3	MIR31HG, LOC554202		Micro RNA 31 host gene, noncoding	616356	REc			
9.114	8	18	14	9p21.3	PTPLAD2, HACD4		Protein tyrosine phosphatase-like A domain-containing protein 2	615941	REc			
9.115	5	4	12	9p21.3	MTAP, DMSMFH		Methylthioadenosine phosphorylase	156540	S, D, Fd		Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	
9.116	1	6	93	9p22.1	RPS6		Ribosomal protein S6	180460	Psh, A			
9.117	12	23	16	9p21.2	TEK, TIE2, VMCM, GLC3E		TEK tyrosine kinase, endothelial	600221	A, D, REc		Venous malformations, multiple cutaneous and mucosal, 600195 (3); Glaucoma 3, primary congenital, E, 617272 (3)	4(tek)
9.118	11	13	07	9p21.1	TOPORS, P53BP3, LUN, RP31		Topoisomerase I-binding arginine/serine-rich protein	609507	Fd, A, REc		Retinitis pigmentosa 31, 609923 (3)	
9.119	10	30	06	9p21.2	TUSC1, TSG9		Tumor suppressor candidate 1	610529	REc			4(Tusc1)
9.120	8	26	15	9p13.3	NPR2, ANPRB, AMDM, ECDM, SNSK		Natiuretic peptide receptor 2	108961	REa, A, Fd		Acromesomelic dysplasia, Maroteaux type, 602875 (3); Epiphyseal chondrodysplasia, Miura type, 615923 (3); Short stature with nonspecific skeletal abnormalities, 616255 (3)	
9.121	10	17	05	9p13.3	RMRP, RMRPR, CHH		Mitochondrial RNA-processing endoribonuclease	157660	REa, A, Fd, LD, REc		Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without hypotrichosis, 250460 (3); Anauxetic dysplasia 1, 607095 (3)	4(Rmrpn)
9.122	5	24	13	9p12	CNTNAP3, KIAA1714		Contactin-associated protein-like 3	610517	REc			
9.123	9	9	08	9p13.2	FBXO10, FBX10		F-box only protein 10	609092	REc			4(Fbxo10)
9.124	9	7	12	9p13.1	IGFBPL1, IGFBPRP4		Insulin-like growth factor binding protein-like 1	610413	REc, R			
9.125	11	27	17	9p13.3	RUSC2, KIAA0375, IPORIN, MRT61		RUN and SH3 domain-containing 2	611053	REc		Mental retardation, autosomal recessive 61, 617773 (3)	
9.126	12	4	03	9p13.3	STOML2		Stomatin-like protein 2	608292	REc, R			
9.127	6	27	08	9p13.1-q21.11	OTSC8		Otosclerosis 8	612096	Fd	between D9S970 and D9S1799	Otosclerosis 8 (2)	
9.128	6	1	12	9p21.1	APTX, AOA, AOA1		Aprataxin	606350	REc, Fd		Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	
9.129	2	1	11	9p13.3	CA9, MN		Carbonic anhydrase IX	603179	REc	previously assigned to 17q21.2		
9.130	4	10	14	9p13.3	CCIN		Calicin	603960	REc			
9.131	4	17	07	9p13.3	CHMP5		CHMP family, member 5	610900	REc			
9.132	1	13	11	9p13.3	CLTA		Clathrin, light polypeptide (Lca)	118960	REc	previously mapped to 12q23-q24		
9.133	9	16	16	9p13.3	CREB3, LZIP		cAMP response element-binding protein 3	606443	R, REc			
9.134	2	6	13	9p13.3	DNAI1, CILD1, ICS, PCD		Dynein, axonemal, intermediate chain 1	604366	Psh, A, REc		Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	
9.135	3	23	14	9p13.3	DNAJB5, KIAA1045, HSC40		DNAJ/HSP40 homolog, subfamily B, member 5	611328	REc			
9.136	4	17	13	9p13.3	GBA2, KIAA1605, SPG46		Glucosidase, beta, acid 2	609471	REc		Spastic paraplegia 46, autosomal recessive, 614409 (3)	
9.137	2	21	13	9p13.3	GLIPR2, GAPR1, C9orf19		GLI pathogenesis-related 2	607141	REc			
9.138	12	10	15	9p13.3	GNE, GLCNE, IBM2, DMRV, NM		UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824	TM, R, Fd		Sialuria, 269921 (3); Nonaka myopathy, 605820 (3)	
9.139	2	21	11	9p13.3	KIF24		Kinesin family member 24	613747	REc			
9.140	10	15	13	9p13.3	MSMP, PSMP		Microseminoprotein, prostate-associated	612191	REc			4(Psmp)
9.141	11	11	14	9p13.3	NFX1		Nuclear transcription factor, X box-binding, protein 1	603255	REc, H			4(Nfx1)
9.142	8	27	15	9p13.3	PTENP1		Phosphatase and tensin homolog pseudogene 1 (functional)	613531	Psh, REc			
9.143	4	29	14	9p13.3	RGP1, KIAA0258		RGP1 retrograde golgi transport, S. cerevisiae, homolog of	615742	REc, R			
9.144	8	28	17	9p13.3	SPAAR, LINC00961		Small regulatory polypeptide of amino acid response	617627	REc			
9.145	4	25	11	9p13.3	SPINK4, PEC60		Serine protease inhibitor, Kazal-type, 4	613929	REc			
9.146	4	8	16	9p13.3	TMEM8B, NGX6, NAG5		Transmembrane protein 8B	616888	REc			
9.147	6	13	12	9p13.2	EXOSC3, RRP40, PCH1B		Exosome component 3	606489	REc		Pontocerebellar hypoplasia, type 1B, 614678 (3)	
9.148	4	27	16	9p13.2	FRMPD1, FRMD2, KIAA0967		FERM and PDZ domains-containing protein 1	616919	REc			
9.149	1	12	15	9p13.2	TOMM5, TOM5		Translocase of outer mitochondrial membrane 5, yeast, homolog of	616169	REc			
9.150	10	13	15	9p13.2	ZBTB5, KIAA0354		Zinc finger- and BTB domain-containing protein 5	616590	REc, R			
9.151	8	2	13	9p13.3	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4		Tropomyosin-2, beta	190990	REa, A, R, Fd		Arthrogryposis multiplex congenita, distal, type 1, 108120 (3); Arthrogryposis, distal, type 2B, 601680 (3); Nemaline myopathy 4, autosomal dominant, 609285 (3); CAP myopathy 2, 609285 (3)	
9.152	4	2	01	9p13.1	ALDH1B1, ALDH5		Aldehyde dehydrogenase 1 family, member B1	100670	REa, A			
9.153	2	28	03	9p13.3	AQP3		Aquaporin-3	600170	A	incorrectly mapped to chr.7	[Blood group GIL], 607457 (3)	
9.154	1	5	12	9p13.3	AQP7, GLYCQTL		Aquaporin-7	602974	A		[Glycerol quantitative trait locus], 614411 (3)	
9.155	7	11	02	9p21.1	B4GALT1, GGTB2, GT1, GTB, CDG2D		Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22)	137060	REa, A		Congenital disorder of glycosylation, type IId, 607091 (3)	4(Ggtb)
9.156	8	29	02	9p13.3	CCL19, SCYA19, ELC, MIP3B		Chemokine, C-C motif, ligand 19	602227	Psh, REa, R			
9.157	8	29	02	9p13.3	CCL21, SCYA21, SLC		Chemokine, C-C motif, ligand 21	602737	REa, R, REc			
9.158	8	29	02	9p13.3	CCL27, SCYA27, ILC, CTACK		Chemokine, C-C motif, ligand 27	604833	REc			4(Scya27)
9.159	1	2	96	9p13.3	CNTFR		Ciliary neurotrophic factor receptor	118946	Psh, R, A			4(Cntfr)
9.160	12	4	02	9p13.3	DCTN3, DCTN22		Dynactin 3	607387	R			
9.161	6	10	02	9p13.3	GALT		Galactose-1-phosphate uridyltransferase	606999	S, D, F		Galactosemia, 230400 (3)	4(Galt)
9.162	8	25	11	9p13.3	IL11RA, CRSDA		Interleukin-11 receptor, alpha	600939	A		Craniosynostosis and dental anomalies, 614188 (3)	4(Il11ra, Etl2)
9.163	1	5	09	9p13.3	NOL6, NRAP		Nucleolar protein 6	611532	REc			
9.164	9	3	99	9p13.3	NUDT2, APAH1		Nudix-type motif 1 (AP4A hydrolase-1)	602852	A			
9.165	2	21	14	9p13.2	PAX5, BSAP, ALL3		Paired box homeotic gene-5 (B-cell lineage specific activator protein)	167414	REa, A, Fd, Ch		{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	4(Pax5)
9.166	10	11	05	9p13	PEE3		Preeclampsia/eclampsia 3	609403	Fd		Preeclampsia/eclampsia 3 (2)	
9.167	8	20	12	9p13.3	PIGO, HPMRS2		Phosphatidylinositol glycan, class O	614730	REc		Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	
9.168	10	5	10	9p13.3	PRSS3, TRY3, T9		Protease, serine, 3	613578	REc			
9.169	12	14	10	9q21.2	PRUNE2, BMCC1, KIAA0367		PRUNE, Drosophila, homolog of, 2	610691	R, REc			
9.170	12	24	08	9p13.2	RNF38		Ring finger protein 38	612488	REc			
9.171	10	23	15	9p13.3	SIGMAR1, SRBP, ALS16, DSMA2		Sigma nonopioid intracellular receptor 1	601978	Psh, A	mutation identified in 1 ALS16 family and 1 DSMA2 family	?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3); ?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	
9.172	5	15	97	9p13.3	TESK1		Testis-specific protein kinase-1	601782	A			
9.173	7	13	11	9p13.3	XRCC9, FANCG		X-ray repair, complementing defective, in Chinese hamster, 9	602956	A, Fd, LD		Fanconi anemia, complementation group G, 614082 (3)	
9.174	9	20	00	9p13.3	RECK, ST15		Reversion-inducing cysteine-rich protein with kazal motifs (suppressor of tumorigenicity 15)	605227	REc			
9.175	2	20	02	9p13.3	SIT		SHP2-interacting transmembrane adaptor protein	604964	A			
9.176	3	19	01	9p13.3	SPAG8, SMP1		Sperm-associated antigen 8	605731	R, A			
9.177	12	17	15	9p13.3	VCP, IBMPFD1, ALS14, CMT2Y		Valosin-containing protein	601023	REa, A		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3); Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3); Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	4(Vcp)
9.178	11	13	96	9p13.3	BAG1		BCL2-associated athanogene	601497	REa, A			
9.179	6	8	95	9p13.1	SHB		SHB adaptor protein (a Src homology 2 protein)	600314	Psh, A			
9.180	11	6	00	9p12-q12	ACP		Cerebral palsy, ataxic, autosomal recessive	605388	Fd, HZ		Cerebral palsy, ataxic, autosomal recessive (2)	
9.181	2	18	96	9q21.11	PGM5		Phosphoglucomutase-5	600981	A			19(Pgm5)
9.182	8	26	15	9q21.11	FOXD4L4, FOXD4L2		Forkhead box D4-like 4	611085	REc			
9.183	3	24	06	9p13.3	HINT2		Histidine triad nucleotide-binding protein 2	609997	REc			
9.184	3	8	95	9p11	MROS		Melkersson-Rosenthal syndrome	155900	Ch		?Melkersson-Rosenthal syndrome (2)	
9.185	11	4	91	9p13.3	CD72, LYB2		CD72 antigen	107272	REa			4(Lyb2)
9.186	1	24	09	9p	DEL9p, C9DELp		Chromosome 9p deletion syndrome	158170	Ch		Chromosome 9p deletion syndrome (4)	
9.187	12	17	07	9p	HDLCQ1		High density lipoprotein cholesterol level QTL 1	606613	Fd		[High density lipoprotein cholesterol level QTL 1] (2)	
9.188	10	1	95	9p13.3	TLN1		Talin 1	186745	Psh			
9.189	11	22	99	9p13.2	GRHPR, GLXR		Glyoxylate reductase/hydroxypyruvate reductase	604296	R, Fd		Hyperoxaluria, primary, type II, 260000 (3)	
9.190	6	11	94	9q34.11	FPGS		Folylpolyglutamate synthetase	136510	S, H			2(Fpgs)
9.191	3	15	10	9q	HCHGQ2		Hematocrit/hemoglobin quantitative trait locus 2	609320	Fd		[Hematocrit/hemoglobin quantitative trait locus 2] (2)	
9.192	4	27	12	9q	SPG19		Spastic paraplegia-19	607152	Fd		Spastic paraplegia 19, autosomal dominant (2)	
9.193	1	25	91	9q21.13	ANXA1, LPC1		Annexin A1 (lipocortin I)	151690	REa, A			19(Lpc1)
9.194	1	29	01	9q22.32	BARX1		BarH-like homeo box gene 1	603260	R			
9.195	10	23	87	9q12	DNCM		Cytoplasmic membrane DNA	126330	A	in 9qh		
9.196	10	13	15	9q12	SPATA31A7, AEP1, FAM75A7, C9orf36		Spermatogenesis-associated protein 31, subfamily A, member 7	616584	REc			
9.197	7	17	14	9q21.11	TJP2, ZO2, PFIC4		Tight junction protein 2	607709	REc, Fd		Hypercholanemia, familial, 607748 (3); Cholestasis, progressive familial intrahepatic 4, 615878 (3)	
9.198	1	13	99	9q21.12	BTEB1, BTEB		Basic transcription element-binding protein 1	602902	Psh, A			
9.199	8	21	07	9q21.11	CBWD3		Cobalamin synthetase W domain-containing protein 3	611080	REc			
9.200	11	12	96	9q13	CMD1B, CMPD1, FDC		Cardiomyopathy, dilated-1B, autosomal dominant	600884	Fd		Cardiomyopathy, dilated 1B (2)	
9.201	8	21	07	9q21.11	FOXD4L3		Forkhead box D4-like 3	611086	REc			
9.202	11	30	06	9q21.11	FXN, FRDA, FARR, X25		Frataxin	606829	Fd		Friedreich ataxia, 229300 (3); Friedreich ataxia with retained reflexes, 229300 (3)	
9.203	4	10	02	9q21.13	GCNT1		Glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)	600391	A, Psh, R			13(Gcnt1)
9.204	9	18	98	9q21.11	PIP5K1B, STM7, MSS4		Phosphatidylinositol-4-phosphate 5-kinase, type I, beta	602745	REn, REc			
9.205	2	13	98	9q13-q21	GSM1, GSP		Geniospasm 1	190100	Fd		Geniospasm (2)	
9.206	2	26	02	9q21.13	TMC1, DFNB7, DFNB11, DFNA36		Transmembrane channel-like protein 1	606706	Fd, REc		Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal dominant 36, 606705 (3)	19(Tmc1, dn, Bth)
9.207	4	26	01	9q21.13	TMEM2		Transmembrane protein 2	605835	REc			19(Tmem2)
9.208	5	7	03	9q21.12	X123		X123 gene	607710	REc			
9.209	1	16	07	9q21.13	ZFAND5, ZNF216		Zinc finger AN1 domain-containing protein 5	604761	REc			19(Znf216)
9.210	7	22	13	9q13-q22	CTRCT26, CAAR		Cataract 26, multiple types	605749	Fd		Cataract 26, multiple types (2)	
9.211	1	28	88	9q21.13	ALDH1A1		Aldehyde dehydrogenase-1 family, member A1, soluble	100640	REa, A			19(Ahd2)
9.212	1	3	00	9q21.2	GNA14		Guanine nucleotide-binding protein, alpha-14	604397	A, REc			
9.213	6	11	13	9q21.2	GNAQ, SWS, CMC1		Guanine nucleotide-binding protein (G protein), q	600998	REa, A	pseudogene on 2q	Sturge-Weber syndrome, somatic, mosaic, 185300 (3); Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	
9.214	8	31	16	9q22.31	IARS, GRIDHH		Isoleucine-tRNA synthetase	600709	Psh, A		Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, 617093 (3)	
9.215	10	15	09	9q21	PVOP2		Pelvic organ prolapse, susceptibility to, 2	613088	Fd	between rs4077632 and rs10868525	{Pelvic organ prolapse, susceptibility to, 2} (2)	
9.216	2	29	04	9q21.2	VPS13A, CHAC		Vacuolar protein sorting 13A (chorein)	605978	Fd, LD		Choreoacanthocytosis, 200150 (3)	
9.217	10	20	92	9q22.33	COL15A1		Collagen XV, alpha-1 polypeptide	120325	REa, A			4(Col15a1)
9.218	3	22	93	9q21.33	CTSL		Cathepsin L	116880	REa, A, Psh	\'like\' sequence on 10q23-q24		13(Ctsl)
9.219	1	10	12	9q21-q22	ETL4, ETOLM		Epilepsy, familial temporal lobe, 4	611631	Fd	between GATA152H04 and D9S253	Epilepsy, familial temporal lobe, 4 (2)	
9.220	1	12	08	9q21.32	FRMD3, EPB41LO		FERM domain-containing 3	607619	REc			
9.221	1	29	01	9q21.2	PCA3, DD3		Prostate cancer antigen 3	604845	REa			
9.222	12	27	16	9q21.11	FAM122A, C9orf42		Family with sequence similarity 122, member A	617249	REc			
9.223	9	16	09	9q21.13	RFK		Riboflavin kinase	613010	REc			
9.224	11	1	10	9q21.11	DFNA51, C9DUPq21.11, DUP9q21.11		Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)	613558	Ch	259kb duplication involving TJP2 and FAM189A2	Deafness, autosomal dominant 51 (4)	
9.225	10	2	13	9p24.3	FOXD4, FKHL9		Forkhead box D4	601092	A, REc			19(Foxd4)
9.226	7	20	09	9q21.12	MAMDC2		MAM domain-containing 2	612879	REc			
9.227	12	28	15	9q21.12	MIR204, MIRN204, RDICC		Micro RNA 204	610942	REc	mutation identified in 1 RDICC family	?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	
9.228	9	1	16	9q21.11	PRKACG, BDPLT19		Protein kinase, cAMP-dependent, catalytic, gamma	176893	REa, A, REc	mutation identified in 1 BDPLT19 family	?Bleeding disorder, platelet-type, 19, 616176 (3)	
9.229	10	4	05	9q21.12	SMC5L1, SMC5, KIAA0594		Structural maintenance of chromosomes 5-like 1	609386	R, REc			
9.230	1	4	16	9q21.11	ZNF658		Zinc finger protein 658	616290	REc			
9.231	8	20	98	9q21.12	APBA1, X11, D9S411E, MINT1, LIN10		Amyloid beta A4 precursor protein-binding, family A, member 1	602414	RE, REc			
9.232	10	31	08	9q21.12-q21.13	TRPM3, MLSN2, LTRPC3, KIAA1616		Transient receptor potential cation channel, subfamily M, member 3	608961	REc			
9.233	4	24	18	9q21.13	ABHD17B, FAM108B1		Abhydrolase domain-containing protein 17B	617943	REc			
9.234	9	24	15	9q21.13	CARNMT1, C9orf41, UPF0586		Carnosine N-methyltransferase 1	616552	REc			
9.235	9	9	13	9q21.13	GDA, CYPIN		Guanine deaminase	139260	REc			
9.236	8	3	18	9q21.13	NMRK1, C9orf95		Nicotinamide riboside kinase 1	608704	REc			
9.237	12	27	16	9q21.13	OSTF1, OSF, SH3P2		Osteoclast-stimulating factor 1	610180	REc			
9.238	12	6	16	9q21.2	CEP78, CRDHL		Centrosomal protein, 78kD	617110	REc		Cone-rod dystrophy and hearing loss, 617236 (3)	
9.239	6	26	00	9q21.32	UBQLN1, DA41		Ubiquilin 1 (Da41, rat, homolog of)	605046	A			
9.240	8	11	17	9q21.33	ISCA1, HBLD2, HISCA, MMDS5		Iron-sulfur cluster assembly 1, S. cerevisiae, homolog of	611006	REc		Multiple mitochondrial dysfunctions syndrome 5, 617613 (3)	
9.241	5	1	97	9q21.13	PCSK5		Proprotein convertase subtilisin/kexin type 5	600488	REa, A, REc	?close to LPC1 on 9q		19(Pcsk5)
9.242	2	3	06	9q21.32	TLE1, ESG1		Transducin-like enhancer of split 1 (homolog of Drosophila E(spl))	600189	REa, A, REn, R	conflicting assignment to chr.19		
9.243	4	15	09	9q22.31	ASPN, PLAP1, OS3		Asporin	608135	REc		{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc degeneration}, 603932 (3)	
9.244	3	13	06	9q21.3-q22	FHL1, HPLH1, HLH1		Hemophagocytic lymphohistiocytosis, familial, 1	267700	Fd		Hemophagocytic lymphohistiocytosis, familial, 1 (2)	
9.245	3	18	94	9q21.33	GAS1		Growth arrest-specific gene-1	139185	Psh, A			13(Gas1)
9.246	10	2	14	9q21.2	PSAT1, PSAT, EPIP, PSATD, NLS2		Phosphoserine aminotransferase 1	610936	REc	mutation identified in 1 PSATD family	?Phosphoserine aminotransferase deficiency, 610992 (3); Neu-Laxova syndrome 2, 616038 (3)	
9.247	3	23	14	9q21.32	C9orf64		Chromosome 9 open reading frame 64	611342	REc			
9.248	3	23	14	9q21.32	C9orf103		Chromosome 9 open reading frame 103	611343	REc			
9.249	4	2	16	9q21.32	GKAP1, GKAP42		G kinase-anchoring protein 1	611356	REc			
9.250	5	26	13	9q21.32	KIF27		Kinesin family member 27	611253	REc			
9.251	5	24	13	9q21.32	MIR7-1		Micro RNA 7-1	615239	REc			
9.252	2	23	14	9q21.32	RASEF		RAS and EF-hand domains-containing protein	611344	REc			
9.253	08	21	18	9q21.32	RMI1, BLAP75, C9orf76		RecQ-mediated genome instability 1, S. cerevisiae, homolog of	610404	REc			
9.254	10	13	15	9q21.32	HNRNPK, HNRPK, AUKS		Heterogeneous nuclear ribonucleoprotein K	600712	REa, A		Au-Kline syndrome, 616580 (3)	
9.255	4	6	11	9q21.33	AGTPBP1, NNA1, KIAA1035, CCP1		ATP/GTP-binding protein 1	606830	REc			
9.256	8	14	14	9q21.33	GOLM1, GOLPH2, GP73, C9orf155		Golgi membrane protein 1	606804	REc			
9.257	1	22	18	9q21.33	NTRK2, TRKB, OBHD, EIEE58		Neurotrophic tyrosine kinase, receptor, type 2	600456	REa, A		Obesity, hyperphagia, and developmental delay, 613886 (3); Epileptic encephalopathy, early infantile, 58, 617830 (3)	
9.258	3	23	15	9q21.33	ZCCHC6, TUT7, KIAA1711		Zinc finger CCHC domain-containing protein 6	613467	REc			
9.259	4	30	15	9q22.33	ALG2, CDGII, CMSTA3, CMS14		Alg2, S. cerevisiae, homolog of	607905	REc	mutation identified in 1 CDGII patient	?Congenital disorder of glycosylation, type Ii, 607906 (3); Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	
9.260	9	2	08	9q31.1	CSMF		Chondrosarcoma, extraskeletal myxoid, fused to EWS in	600542	Ch, A	t(9;17)(q22;q11); t(9;22)(q22;q11-q12)	Chondrosarcoma, extraskeletal myxoid, 612237 (3)	
9.261	9	2	15	9q22.33	FOXE1, FKHL15, TITF2, TTF2, NMTC4		Forkhead box E1 (thyroid transcription factor-2)	602617	Psh, REc		Bamforth-Lazarus syndrome, 241850 (3); {Thyroid cancer, nonmedullary, 4}, 616534 (3)	4(Titf2)
9.262	10	5	10	9q22.33	GALNT12, CRCS1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12	610290	REc		{Colorectal cancer, susceptibility to, 1}, 608812 (3)	
9.263	1	23	07	9q22.33	HEMGN, EDAG		Hemogen	610715	A			4(Hemgn)
9.264	11	17	94	9q22.32	HSD17B3, EDH17B3		Hydroxysteroid (17-beta) dehydrogenase 3	605573	A		Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	
9.265	8	25	04	9q22	JOAG2		Glaucoma, primary open angle, juvenile-onset, 2	608695	Fd	between D9S1803 and D9S196	Glaucoma, primary open angle, juvenile-onset, 2 (2)	
9.266	6	9	98	9q22.31	NINJ1		Ninjurin	602062	A			13(Ninj1)
9.267	2	2	01	9q22.31	PHF2		PHD finger protein-2	604351	REn, REc, R			
9.268	8	14	00	9q22.31	ROR2, BDB1, BDB, NTRKR2		Receptor tyrosine kinase-like orphan receptor 2	602337	Fd, R, REc, Ch		Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal recessive, 268310 (3)	13(Ror2)
9.269	12	3	98	9q21.13	RORB, RZRB		RAR-related orphan receptor B	601972	A			4(Rorb)
9.270	7	3	06	9q22	STQTL8		Stature quantitative trait locus 8	610114	Fd	between GATA81C04M and ATA18A07M	{Stature QTL 8} (2)	
9.271	1	7	95	9q22.2	SYK		Spleen tyrosine kinase	600085	A			13(Syk)
9.272	4	7	14	9q22.33	TGFBR1, ALK5, AAT5, LDS1, MSSE		Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)	190181	Psh, A		Loeys-Dietz syndrome 1, 609192 (3); {Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	4(Tgfbr1)
9.273	9	30	02	9q21.13	TRPM6, CHAK2, HOMG1		Transient receptor potential cation channel, subfamily M, member 6	607009	REc		Hypomagnesemia 1, intestinal, 602014 (3)	
9.274	4	8	08	9q31.1	ABCA1, ABC1, HDLDT1, TGD		ATP-binding cassette 1	600046	A, REc		Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3); {Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	
9.275	12	27	01	9q22.33	TRIM14, KIAA0129		Tripartite motif-containing protein 14	606556	REa, R			
9.276	10	15	98	9q31.1	ZNF189		Zinc finger protein-189	603132	A			
9.277	4	17	13	9q22.1	CDK20, CCRK, CDCH, P42		Cyclin-dependent kinase 20	610076	R, REc			
9.278	4	6	18	9q22.33	GABBR2, GPR51, EIEE59, NDPLHS		Gamma-aminobutyric acid B receptor 2	607340	R, A		{Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine dependence, protection against}, 188890 (3); Epileptic encephalopathy, early infantile, 59, 617904 (3); Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3)	
9.279	7	12	13	9q22.1	NXNL2, RDCVF2		Nucleoredoxin-like protein 2	615299	REc, H			13(Nxnl2)
9.280	11	11	14	9q22.1	SHC3, NSHC, RAI, SHCC		SHC transforming protein 3	605263	R, REc			
9.281	9	18	08	9q22.1	S1PR3, EDG3		Sphingosine-1-phosphate receptor 3	601965	A			
9.282	5	25	00	9q22.2	GADD45G, GRP17		Growth arrest- and DNA damage-inducible gene 45, gamma	604949	A, R			
9.283	10	11	00	9q22.31	NFIL3, NFIL3A, E4BP4		Nuclear factor, interleukin 3-regulated	605327	REc			
9.284	3	2	06	9q22.1	SPIN, SPIN1		Spindlin	609936	REc			
9.285	3	5	01	9q22.31	SPTLC1, LBC1, SPT1, HSN1, HSAN		Serine palmitoyltransferase, long-chain base subunit 1	605712	Fd		Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	
9.286	3	31	15	9q22.2	CKS2		CDC2-associated protein CKS2	116901	A, REc			
9.287	7	12	01	9q22.33	CTSL2, CTSV		Cathepsin L2	603308	A			
9.288	3	31	15	9q22.2	DIRAS2		DIRAS family, GTP-binding Ras-like protein 2	607863	R, REc			
9.289	11	9	05	9q22.2	SECISBP2, SBP2		Selenocysteine insertion sequence-binding protein 2	607693	REc		Thyroid hormone metabolism, abnormal, 609698 (3)	
9.290	9	27	17	9q22.2	SEMA4D, SEMAJ, CD100, COLL4		Semaphorin 4D	601866	REc			
9.291	3	22	07	9q21.32-q21.33	SLC28A3, CNT3		Solute carrier family (sodium-coupled nucleoside transporter), member 3	608269	A, REc			
9.292	11	13	07	9q22.32	FBP1		Fructose-bisphosphatase 1	611570	A, Fd, REc		Fructose-1,6-bisphosphatase deficiency, 229700 (3)	
9.293	4	30	09	9q31.1	ALDOB		Aldolase B, fructose-bisphosphatase	612724	REb, REa, A, D, REc		Fructose intolerance, hereditary, 229600 (3)	4(Aldo2)
9.294	5	2	03	9q31.1	BAAT		Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase)	602938	REc, H		Hypercholanemia, familial, 607748 (3)	4(Baat)
9.295	7	12	13	9q22.31	BICD2, KIAA0699, SMALED2		Bicaudal D, Drosophila, homolog of, 2	609797	R, REc		Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	
9.296	10	20	99	9q22.33	CORO2A, WDR2, IR10		Coronin 2A	602159	REc			
9.297	6	14	99	9q22.31	ECM2		Extracellular matrix protein-2	603479	A			
9.298	4	19	11	9q22.32	FANCC, FACC		Fanconi anemia, complementation group C	613899	Fd, REc		Fanconi anemia, complementation group C, 227645 (3)	13(Facc)
9.299	5	4	00	9q22.31	OGN, OIF		Osteoglycin	602383	R, A			
9.300	3	1	07	9q22.32	PTCH1, NBCCS, BCNS, HPE7		Patched, Drosophila, homolog of	601309	R, Fd, D		Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3)	13(Ptc)
9.301	2	3	05	9q22.32	SLC35D2, HFRC1, SQV7L		Solute carrier family 35, member D2	609182	REc			
9.302	3	22	06	9q22.33	TBC1D2, PARIS1		TBC1 domain family, member 2	609871	REc			
9.303	5	20	99	9q22.33	TMOD		Tropomodulin	190930	A, REc			4(Tmod)
9.304	5	26	05	9q22.31	WNK2, PRKWNK2		WNK lysine deficient protein kinase 2	606249	R, REc			
9.305	8	30	07	9q22.33	XPA, XPAC		XPA complementing gene	611153	S, A, M, REc		Xeroderma pigmentosum, group A, 278700 (3)	4(Xpa)
9.306	1	12	99	9q22.32	ZNF169		Zinc finger protein-169	603404	A, REn			
9.307	5	9	97	9q22.33	NCBP1		Nuclear cap binding protein 1, 80kD	600469	REa, REc	in 500kb of XPA		4(Ncbp)
9.308	8	9	12	9q22.31	AUH		AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase)	600529	R, REc		3-methylglutaconic aciduria, type I, 250950 (3)	
9.309	10	08	07	9q22.31	CENPP		Centromeric protein P	611505	R, REc			
9.310	9	24	08	9q22.31	FAM120A, C9orf10, KIAA0183		Family with sequence similarity 120, member A	612265	REc			
9.311	6	30	17	9q22.31	FGD3, ZFYVE5		FYVE, RhoGEF, and Ph domain-containing protein 3	617554	REc			
9.312	6	23	15	9q22.31	SUSD3		SUSHI domain-containing protein 3	616429	REc			
9.313	10	25	17	9q22.31	CARD19, BINCARD, C9orf89		Caspase recruitment domain-containing protein 19	617726	REc			
9.314	4	10	14	9q22.32	ERCC6L2, RAD26L, BMFS2		ERCC6-like 2	615667	REc		Bone marrow failure syndrome 2, 615715 (3)	
9.315	3	23	09	9q22.32	MIR189, MIRN24-1		Micro RNA 24-1	609705	REc			
9.316	3	23	09	9q22.32	MIR23B, MIRN23B		Micro RNA 23B	610723	REc			
9.317	3	23	09	9q22.32	MIR27B, MIRN27B		Micro RNA 27B	610636	REc			
9.318	3	23	09	9q22.32	MIRLET7A1, LET7A1, MIRNLET7A1		Micro RNA Let7a1	605386	REc			
9.319	3	23	09	9q22.32	MIRLET7D, LET7D, MIRNLET7D		Micro RNA Let7d	612145	REc			
9.320	3	23	09	9q22.32	MIRLET7F1, LET7F1, MIRNLET7F1		Micro RNA Let7f1	612146	REc			
9.321	8	20	08	9q22.31	NOL8, NOP132		Nucleolar protein 8	611534	REc			
9.322	8	19	13	9q22.32	ZNF367, AFF29		Zinc finger protein 367	610160	REc			
9.323	3	13	12	9q22.32-q22.33	CDC14B		Cell division cycle 14, S. cerevisiae, homolog B	603505	R, REc			
9.324	9	9	13	9q22.33	ANKS6, PKDR1, NPHP16		Ankyrin repeat and sterile alpha motif domains-containing protein 6	615370	REc		Nephronophthisis 16, 615382 (3)	
9.325	8	29	16	9q22.33	NANS, SAS, SEMDCG		N-acetylneuraminic acid synthase (sialic acid synthase)	605202	R, REc		Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3)	
9.326	7	7	16	9q22.33	SEC61B		Sec61 complex, beta subunit	609214	REc			
9.327	7	23	13	9q22.33	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36		Tudor domain-containing protein 7	611258	REc, R, Ch		Cataract 36, 613887 (3)	
9.328	1	12	07	9q31.3	ACTL7A		Actin-like 7A	604303	REa, REn, H			4(Actl7a)
9.329	1	12	07	9q31.3	ACTL7B		Actin-like 7B	604304	REc, REn, H			4(Actl7b)
9.330	10	11	17	9q31.1	CAVIN4, MURC		Caveolae-associated protein 4	617714	REc			
9.331	09	27	18	9q31.2	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4		Fukutin	607440	Fd, LD		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy, dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	
9.332	3	20	06	9q31.2	FSD1NL, FSD1L, MIR1, CCDC10		FSD1 N-terminus-like protein	609829	REc			
9.333	2	2	11	9q31	HSCR5		Hirschsprung disease, susceptibility to, 5	600156	LD		{Hirschsprung disease, susceptibility to, 5} (2)	
9.334	4	5	01	9q31.3	IKBKAP, IKAP		Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein	603722	REc, Fd		Dysautonomia, familial, 223900 (3)	
9.335	8	12	03	9q31.1	INVS, INV, NPHP2, NPH2		Inversin	243305	REc, A, Fd		Nephronophthisis 2, infantile, 602088 (3)	
9.336	1	29	01	9q31.2	KLF4, EZF, GKLF		Kruppel-like factor 4	602253	R			4(Ezf)
9.337	12	20	05	9q31	PAND2		Panic disorder 2	607853	Fd	max lod at D9S271	Panic disorder 2 (2)	
9.338	12	19	01	9q34.11	SIAT7D, SIAT3C		Sialyltransferase 7D	606378	A, R, REc			
9.339	12	8	04	9q31.1	STX17		Syntaxin 17	604204	REc			
9.340	8	28	15	9q31.2	TAL2		T-cell acute lymphocytic leukemia-2	186855	REa, A, RE, Ch	33kb from breakpoint in t(7;9)	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Tal2)
9.341	6	14	99	9q31.1	TMEFF1, C9orf2		Transmembrane protein with EGF-like and 2 follistatin-like domains 1	603421	A, REa			
9.342	5	9	95	9q31.3	TXN		Thioredoxin	187700	A, Psh	incorrectly assigned to 3		4(Txn)
9.343	8	10	98	9q31.3	UGCG, GCS		UDP-glucose ceramide glucosyltransferase	602874	A			4(Ugcg)
9.344	4	21	10	9q31.3	EPB41L4B, EHM2		Erythrocyte membrane protein band 4.1-like 4B	610340	REc			
9.345	6	29	05	9q31-q32	HNP1		Hypertensive nephropathy	608026	Fd		Hypertensive nephropathy (2)	
9.346	11	4	98	9q32	SLC31A1, COPT1, CTR1		Solute carrier family 31 (copper transporter), member 1	603085	REn			
9.347	12	13	00	9q32	SLC13A2, COPT2, CTR2		Solute carrier family 31 (copper transporter), member 2	603088	REn			
9.348	11	22	04	9q31.3	AKAP2, AKAPKL, KIAA0920, PALM2		A-kinase anchor protein 2	604582	R	multiple splice variants		
9.349	8	8	14	9q32	PRPF4, PRP4, HPRP4, RP70		Precursor mRNA-processing factor 4, S. cerevisiae, homolog of	607795	A		Retinitis pigmentosa 70, 615922 (3)	
9.350	3	5	98	9q32	RGS3		Regulator of G-protein signaling-3	602189	R			
9.351	12	17	07	9q32	SLC46A2, TSCOT		Solute carrier family 46, member 2	608956	H, REc			4(Slc46a2)
9.352	1	19	07	9q31-q34	SPDA2		Spondyloarthropathy, susceptibility to, 2	183840	Fd	max lod at D9S1776	{Spondyloarthropathy, susceptibility to, 2} (2)	
9.353	09	27	18	9q33.1	TRIM32, HT2A, LGMDR8, BBS11		Tripartite-motif-containing protein 32	602290	Fd, REc	mutation identified in 1 BBS11 family	Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3); ?Bardet-Biedl syndrome 11, 615988 (3)	
9.354	11	30	12	9q31.1	CHDT3		Congenital heart defects, multiple types, 3	614954	Fd	max lod at D9S1690	Congenital heart defects, multiple types, 3 (2)	
9.355	3	24	09	9q31.1	CYLC2		Cylicin 2	604035	REc			
9.356	3	24	09	9q31.1	GRIN3A, NR3A		Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	606650	REc			
9.357	3	5	08	9q31.1	MRPL50		Mitochondrial ribosomal protein L50	611854	REc	pseudogenes on 2, 5, and 10		
9.358	9	16	12	9q31.1	NIPSNAP3A, TASSC		NIPSNAP, C. elegans, homolog of, 3A	608871	REc			
9.359	4	15	11	9q31.1	PPP3R2, PPP3RL, CBLP		Protein phosphatase 3, regulatory subunit B, beta	613821	R, REc			
9.360	4	21	14	9q31.1	RNF20, BRE1A		Ring finger protein 20	607699	REc			
9.361	12	23	15	9q31.1	TEX10		Testis-expressed gene 10	616717	REc			
9.362	10	7	13	9q31.1	TXNDC4, KIAA0573		Thioredoxin domain-containing protein 4	609170	R, REc			
9.363	1	12	07	9q31.3	CTNNAL1		Catenin, alpha-like, 1	604785	R, A, REn			
9.364	7	20	09	9q31.2	MENAQ3		Menarche, age at, QTL3	612883	Fd	associated with rs2090409	{Menarche, age at, QTL3} (2)	
9.365	7	18	14	9q31.2	RAD23B		RAD23 (Saccharomyces cerevisiae) homolog of, B	600062	A, RE, REc	previously 3p25.1		4(Rad23b)
9.366	4	24	09	9q31.1-q31.2	SLC44A1, CTL1, CDW92		Solute carrier family 44, member 1	606105	REc			
9.367	2	8	13	9q31.2	TMEM38B, TRICB, OI14		Transmembrane protein 38B	611236	REc		Osteogenesis imperfecta, type XIV, 615066 (3)	
9.368	3	18	17	9q31.2	ZNF462, KIAA1803		Zinc finger protein 462	617371	REc			
9.369	9	22	08	9q31.2-q34.2	IS4		Scoliosis, idiopathic, susceptibility to, 4	612238	Fd	max lod at D9S2157	{Scoliosis, idiopathic, susceptibility to, 4} (2)	
9.370	6	28	18	9q31.3	C9orf84, SHOC1, ZIP2		Chromosome 9 open reading frame 84	618038	REc			
9.371	6	26	16	9q31.3	FRRS1L, C9orf4, CG6, EIEE37		Ferric-chelate reductase 1-like	604574	REc, REa		Epileptic encephalopathy, early infantile, 37, 616981 (3)	
9.372	5	25	13	9q31.3	GNG10		Guanine nucleotide-binding protein, gamma 10	604389	REc			
9.373	12	17	15	9q31.3	KIAA0368, ECM29		KIAA0368 gene	616694	R, REc			
9.374	9	18	08	9q31.3	LPAR1, EDG2, LPA1, VZG1		Lysophosphatidic acid receptor 1	602282	R, REc			4(vzg1)
9.375	3	23	09	9q31.3	MIR32, MIRN32		Micro RNA 32	609355	REc			
9.376	4	10	14	9q31.3	PTGR1, LTB4DH		Prostaglandin reductase 1	601274	REc			
9.377	8	8	13	9q31.3	PTPN3, PTPH1		Protein-tyrosine phosphatase, nonreceptor-type, 3	176877	A, REc			
9.378	8	4	15	9q31.3	MUSK, CMS9, FADS		Receptor tyrosine kinase MuSK	601296	A		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3); Fetal akinesia deformation sequence, 208150 (3)	4(Musk)
9.379	08	08	18	9q32	ATP6V1G1, ATP6G1		ATPase, H+ transporting, V1 subunit G1	607296	R, REc			
9.380	3	30	12	9q32	CDC26, APC12		Cell division cycle 26, S. cerevisiae, homolog of	614533	REc	pseudogene on 7q32.1		
9.381	08	01	18	9q32	COL27A1, KIAA1870, STLS		Collagen, type XXVII, alpha-1	608461	REc		Steel syndrome, 615155 (3)	4(Col27a1)
9.382	4	17	00	9q33.1	DEC1		Deleted in esophageal cancer 1	604767	D		Esophageal squamous cell carcinoma, 133239 (1)	
9.383	3	27	17	9q32	FKBP15, FKBP133, KIAA0674, WAFL		FK506-binding protein 15	617398	REc			
9.384	4	30	09	9q32	IBD16		Inflammatory bowel disease 16, susceptibility to	612259	Fd		{Inflammatory bowel disease 16} (2)	
9.385	8	2	17	9q32	INIP, C9orf80, SOSSC		INST3- and NABP-interacting protein	613273	REc			
9.386	3	9	17	9q32	KIAA1958		KIAA1958 gene	617390	REc			
9.387	8	19	13	9q32	KIF12		Kinesin family member 12	611278	REc			
9.388	1	2	08	9q31.3	SVEP1, POLYDOM, SELOB		Sushi, von willebrand factor type A, EGF, and pentraxin domain-containing 1	611691	A, H, REc			4(Svep1)
9.389	9	26	08	9q32	TNFSF15, TL1, VEGI		Tumor necrosis factor ligand superfamily, member 15 (vascular endothelial growth inhibitor)	604052	R, A			
9.390	11	29	17	9q31.3	TXNDC8, SPTRX3		Thioredoxin domain-containing protein 8	617789	REc			
9.391	8	10	98	9q32	ZFP37		Zinc finger protein-37, mouse, homolog of	602951	REa, A	?candidate for Nager syndrome		4(Zfp37)
9.392	8	17	16	9q32	ZNF618, NEDD10, KIAA1952		Zinc finger protein 618	617077	REc			
9.393	1	6	93	9q32	AMBP, ITIL, ITI, HCP		Alpha-1-microglobulin/bikunin precursor (inter-alpha-trypsin inhibitor, light chain; protein HC)	176870	REa, A, H			4(Intin4)
9.394	5	5	16	9q32-q33	ARMD10		Macular degeneration, age-related, 10	611488	Fd		Macular degeneration, age-related, 10 (2)	
9.395	10	6	09	9q32-q33	EIG3		Epilepsy, idiopathic generalized, susceptibility to 3	608762	Fd		{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)	
9.396	5	5	16	9q33.1	TLR4		Toll-like receptor-4	603030	A			
9.397	12	24	08	9q33.2	MEGF9, EGFL5		Multiple epidermal growth factor-like domains 9	604268	R			
9.398	1	7	95	9q33.2	PTGS1, COX1, PGHS1, COX3, PCOX1		Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)	176805	REa, A			
9.399	10	11	07	9q32	WHRN, CIP98, KIAA1526, DFNB31, USH2D		Whirlin	607928	Fd, REc		Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type 2D, 611383 (3)	4(Whrn)
9.400	1	8	01	9q33.2	MRFF, RRF		Ribosome-recycling factor, mitochondrial	604602	R			
9.401	3	29	10	9q33	ASRT8		Asthma-related traits, susceptibility to, 8	613207	Fd	associated with rs3789873	{Asthma-related traits, susceptibility to, 8} (2)	
9.402	1	30	01	9q33.2	CEP1, CEP110, FAN		Centrosomal protein 1	605496	R			2(Cep1)
9.403	5	5	10	9q33.2	DAB2IP, AIP1, KIAA1743		DAB2-interacting protein	609205	REc			
9.404	8	4	97	9q33.2	GPR21		G protein-coupled receptor-21	601909	A			
9.405	5	30	17	9q33.3	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4		Nuclear receptor subfamily 5, group A, member 1	184757	A		46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964 (3); Adrenocortical insufficiency, 612964 (3); 46, XX sex reversal 4, 617480 (3); Spermatogenic failure 8, 613957 (3)	2(Ftzf1)
9.406	10	7	02	9q32	POLE3, CHARAC17, YBL1		Polymerase, DNA, epsilon-3	607267	REc			
9.407	2	10	14	9q33.1	TNC, HXB, DFNA56		Tenascin C (hexabrachion)	187380	REa, A	proximal to ABL	Deafness, autosomal dominant 56, 615629 (3)	4(Hxb)
9.408	6	14	99	9q32-q33	TNFSF8, CD30L, CD30LG		Tumor necrosis factor ligand superfamily, member 8 (CD30 ligand)	603875	A			4(Cd30l)
9.409	8	20	98	9q33.3	GCNF		Germ cell nuclear factor	602778	A			
9.410	12	22	17	9q33.2	GGTA1P, GGTA1		Glycoprotein, alpha-galactosyltransferase-1 pseudogene	104175	REa, A	processed pseudogene GGTA1P on 12q14-q15		
9.411	7	27	11	9q34.12	LAMC3, OCCM		Laminin, gamma-3	604349	REc, A		Cortical malformations, occipital, 614115 (3)	
9.412	6	11	94	9q33.3	PBX3		Pre-B-cell leukemia transcription factor-3	176312	A, H			2(Pbx3)
9.413	9	29	10	9q34.11	SPTAN1, NEAS, EIEE5		Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	REa, A		Epileptic encephalopathy, early infantile, 5, 613477 (3)	2(Spna2)
9.414	3	2	98	9q33.2	TRAF1		TNF receptor-associated factor 2	601711	A			
9.415	6	30	08	8q24	BMND10		Bone mineral density quantitative trait locus 10	612113	Fd	associated with rs6469804 and rs6993813	[Bone mineral density QTL 10] (2)	
9.416	7	12	99	9q33.3	LHX2, LH2		LIM/homeodomain protein LHX2	603759	REa, A			
9.417	7	13	09	9q33.1	ASTN2, KIAA0634		Astrotactin 2	612856	R, REc			
9.418	4	29	14	9q33.1	BRINP1, DBC1, DBCCR1		Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 1	602865	REc			
9.419	1	8	07	9q33.1	DIPAS		DIPLA1, antisense	610689	REc			
9.420	7	13	93	9q33.1	PAPPA		Pregnancy-associated plasma protein A	176385	A			4(Pappa)
9.421	11	22	10	9q33.3	DENND1A, KIAA1608		DENN/MADD domain-containing protein 1A	613633	R, REc			
9.422	12	10	13	9q33.2	LHX6		LIM homeobox gene 6	608215	REc			
9.423	9	8	17	9q33.2	PSMD5, S5B		Proteasome 26S subunit, non-ATPase, 5	604452	REa			
9.424	3	31	09	9q33.2	RAB14		Ras-associated protein	612673	REc			
9.425	7	17	14	9q33.2-q33.3	RABGAP1, GAPCENA, TBC1D11		RAB GTPase-activating protein 1	615882	REc			
9.426	6	15	99	9q33.2	NDUFA8		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 8	603359	R, Psh			
9.427	2	25	15	9q33.3	ANGPTL2, ARP2		Angiopoietin-like 2	605001	REc			
9.428	4	25	05	9q33.2	CDK5RAP2, KIAA1633, MCPH3		CDK5 regulatory subunit-associated protein 2	608201	REc, Fd		Microcephaly 3, primary, autosomal recessive, 604804 (3)	
9.429	2	17	15	9q33.3	CRB2, FSGS9, VMCKD		Crumbs, Drosophila, homolog of	609720	REc		Focal segmental glomerulosclerosis 9, 616220 (3); Ventriculomegaly with cystic kidney disease, 219730 (3)	2(Crb2)
9.430	1	4	08	9q33.3	GAPVD1, RAP6, GAPEX5, KIAA1521		GTPase-activating protein and VPS9 domains 1	611714	REc			
9.431	5	25	13	9q33.3	GOLGA1		Golgi autoantigen, golgin subfamily A, 1	602502	REc			
9.432	5	26	13	9q33.3	MAPKAP1, SIN1, MIP1, JC310		Mitogen-activated protein kinase-associated protein 1	610558	REc, R			
9.433	5	11	09	9q33.3	MIR181A2, MIRN181A2		Micro RNA 181A2	612743	REc			
9.434	5	11	09	9q33.3	MIR181B2, MIRN181B2		Micro RNA 181B2	612745	REc			
9.435	8	1	14	9q33.3	OLFML2A		Olfactomedin-like 2A	615899	REc			
9.436	12	23	05	9q33.2	PHF19		PHD finger protein 19	609740	REc			
9.437	4	15	09	9q33.3	PPP6C		Protein phosphatase 6, catalytic subunit	612725	A, REc	highly related sequence on Xq22.3		
9.438	1	30	12	9q33.3	RALGPS1, RALGEF2, KIAA0351		Ral guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 1	614444	R, REc			
9.439	8	21	07	9q33.3	RPL12		Ribosomal protein L12	180475	REc			
9.440	1	2	08	9q33.3	ZBTB34, KIAA1993		Zinc finger- and BTB domain-containing protein 34	611692	REc			
9.441	1	19	12	9q33.3-q34.1	LRSAM1, TAL, RIFLE, CMT2P		Leucine-rich repeat- and sterile alpha motif-containing 1	610933	REc		Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3)	
9.442	5	11	00	9q33.3	NEK6		Never-in-mitosis gene A-related kinase 6	604884	R			
9.443	10	29	99	9q34.3	ABCA2, ABC2		ATP-binding cassette 2	600047	A			
9.444	11	18	14	9q34.2	ABO		ABO glycosyltransferase	110300	F, Fc	linked to AK1	[Blood group, ABO system], 616093 (3)	
9.445	3	5	04	9q34.2	ADAMTS13, VWFCP, TTP		A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13	604134	Fd, REc		Thrombotic thrombocytopenic purpura, familial, 274150 (3)	
9.446	5	19	09	9q32	ALAD, ALADH, PBGS		Aminolevulinate, delta-, dehydratase	125270	F, S, A, REa	linked to ABO; ORM-ALAD-AK-ABO	Porphyria, acute hepatic, 612740 (3); {Lead poisoning, susceptibility to}, 612740 (3)	4(Lv)
9.447	4	8	02	9q34.13	BARHL1		BARH-like 1	605211	R			2(Barh1)
9.448	3	28	15	9q34.3	CACNA1B, CACNL1A5, DYT23		Calcium channel, voltage-dependent, L type, alpha 1B subunit	601012	A	mutation identified in 1 DYT23 family	?Dystonia 23, 614860 (3)	
9.449	10	9	12	9q34.11	CIZ1, ZNF356, LSFR1, NP94		CDKN1A-interacting zinc finger protein 1	611420	R, A			
9.450	9	24	08	9q34.3	COBRA1, NELFB, KIAA1182		Cofactor of BRCA1	611180	R, REc			
9.451	6	13	12	9q33.2	FBXW2, FBW2, FWD2		F-box and WD40 domain protein 2	609071	A			2(Fbxw2)
9.452	11	7	08	9q34.13	MED27, CRSP8, CRAP34		Mediator complex subunit 27	605044	R			
9.453	11	16	10	9q34.2	DBH		Dopamine-beta-hydroxylase	609312	F, A	tightly linked to ABO	[Dopamine-beta-hydroxylase activity levels, plasma] (3); Dopamine beta-hydroxylase deficiency, 223360 (3)	2(Dbh)
9.454	5	8	15	9q34.11	DNM1, EIEE31		Dynamin-1	602377	A, REa		Epileptic encephalopathy, early infantile, 31, 616346 (3)	2(Dnm1)
9.455	10	21	15	9q34.11	DYT1, TOR1A		Torsin A	605204	Fd		Dystonia-1, torsion, 128100 (3); {Dystonia-1, modifier of} (3)	
9.456	9	28	00	9q34.3	ENTPD2, CD39L1		Ectonucleoside triphosphate diphosphohydrolase 2	602012	Psh, REc	same cosmid as ABC2		
9.457	1	13	16	9q34.3	ENTPD8		Ectonucleoside triphosphate diphosphohydrolase 8	616748	REc			
9.458	2	26	04	9q34.11	FNBP1, FBP17		Formin-binding protein 17	606191	Ch, REc	fused with MLL in chronic myeloid leukemia		
9.459	6	5	97	9q34.3	FCN1		Ficolin (collagen/fibrinogen domain-containing) 1	601252	A, Psh			
9.460	6	5	97	9q34.3	FCN2		Ficolin (collagen/fibrinogen domain-containing lectin) 2	601624	A			
9.461	3	3	03	9q34.11	FREQ, NCS1		Frequenin, Drosophila, homolog of	603315	REc			
9.462	7	17	01	9q34.2	GBGT1, FS		Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Forssman synthetase)	606074	REc			
9.463	2	9	92	9q33.2	GSN		Gelsolin	137350	A, REa, RE	40kb proximal to ABL	Amyloidosis, Finnish type, 105120 (3)	2(Gsn)
9.464	8	5	97	9q33.3	HSPA5, GRP78		Heat-shock 70kD protein-5 (glucose-regulated protein, 78kD)	138120	REa, H, Psh, A			2(Grp78)
9.465	3	13	08	9q34.11	GLE1, GLE1L, LCCS, LCCS1		Gle1, RNA export mediator, S. cerevisiae, homolog of	603371	Fd, REc		Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	
9.466	5	9	12	9q34	KTCN6		Keratoconus 6	614623	Fd	max lod at 159cM	Keratoconus 6 (2)	
9.467	10	13	94	9q34.3	LCN1		Lipocalin 1 (protein migrating faster than albumin, tear prealbumin)	151675	A, Psh, Fd			2(Lcn1)
9.468	11	22	94	9q34.11	LCN2, NGAL		Lipocalin 2 (oncogene 24p3)	600181	REa			2(Lcn2)
9.469	5	23	05	9q34.3	LCN6		Lipocalin 6	609379	REc			
9.470	7	22	09	9q34.3	LCN8		Lipocalin 8	612902	REc, H			2(Lcn8)
9.471	7	22	09	9q34.3	LCN9		Lipocalin 9	612903	REc, H			2(Lcn9)
9.472	7	22	09	9q34.3	LCN10		Lipocalin 10	612904	REc, H			2(Lcn10)
9.473	7	22	09	9q34.3	LCN12		Lipocalin 12	612905	REc, H			2(Lcn12)
9.474	5	9	18	9q34.3	MRPS2, COXPD36		Mitochondrial ribosomal protein S2	611971	R, REc		Combined oxidative phosphorylation deficiency 36, 617950 (3)	
9.475	6	15	99	9q34.11	ODF2, ODF84		Outer dense fiber of sperm tails 2	602015	A			
9.476	2	28	00	9q34.3	OBP2A		Odorant-binding protein 2A	164320	REc			
9.477	2	28	00	9q34.2	OBP2B		Odorant-binding protein 2B	604606	REc			
9.478	9	4	91	9q34.3	PAEP, PP14		Progestagen-associated endometrial protein (placental protein 14)	173310	REa, A, H			2(Paep)
9.479	10	1	95	9q34.11	PPP2R4, PTPA		Protein phosphatase-2A, regulatory subunit B' (PR 53)	600756	A	proximal to ABL		
9.480	8	18	97	9q34.1-q34.2	RALGDS		ral guanine nucleotide dissociation stimulator	601619	R, REc			
9.481	5	24	13	9q33.2	RC3H2, MNAB		RING finger and CCCH-type zinc finger domains-containing protein 2	615231	REc			
9.482	9	28	05	9q34.2	REXO4, XPMC2H		RNA exonuclease 4, S. cerevisiae, homolog of	602930	REc			
9.483	12	3	96	9q34.2	RING3L, ORFX		RING3-like gene (open reading frame X)	601541	REn			
9.484	5	27	93	9q34.2	RPL7A, SURF3		Ribosomal protein L7a (surfeit-3)	185640	REa, A	in cluster with SURF1		2(Surf3)
9.485	3	23	15	9q34.13	SETX, SCAR1, AOA2, ALS4		Senataxin	608465	Fd, REc		Amyotrophic lateral sclerosis 4, juvenile, 602433 (3); Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	
9.486	09	06	18	9q34.11	SET, MRD58		SET gene	600960	A	fused with CAIN in acute undifferentiated leukemia	Mental retardation, autosomal dominant 58, 618106 (3)	
9.487	4	4	02	9q34.2	SLC2A6		Solute carrier family 2, member 6	606813	REc			
9.488	10	12	09	9q34.11	SLC27A4, FATP4, IPS		Solute carrier family 27 (fatty acid transporter), member 4	604194	R, REc		Ichthyosis prematurity syndrome, 608649 (3)	
9.489	2	14	06	9q34.3	SLC34A3, NPTIIC, HHRH		Solute carrier family 34 (sodium/phosphate cotransporter), member 3	609826	REc, Fd		Hypophosphatemic rickets with hypercalciuria, 241530 (3)	
9.490	9	10	07	9q33.3	STRBP, SPNR, p74		Spermatid perinuclear RNA-binding protein	611138	A, H			2(Spnr)
9.491	12	17	15	9q34.2	SURF1, CMT4K		Surfeit-1	185620	REa, A	distal to ABL, CAN	Leigh syndrome, due to COX IV deficiency, 256000 (3); Charcot-Marie-Tooth disease, type 4K, 616684 (3)	2(Surf)
9.492	5	27	93	9q34.2	SURF2		Surfeit-2	185630	REa, A			2(Surf2)
9.493	5	27	93	9q34.2	SURF4		Surfeit-4	185660	REa, A			2(Surf4)
9.494	5	27	93	9q34.2	SURF5		Surfeit-5	185641	H, A			2(Surf5)
9.495	8	25	03	9q34.11	TOR1B, DQ1		Torsin 1B	608050	REc	centromeric to TOR1A; pseudogene on chr.2		
9.496	4	20	17	9q34.13	TSC1, LAM		Hamartin (tuberous sclerosis 1 gene)	605284	F, Fd	linked to ABO, ABL	Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690 (3); Focal cortical dysplasia, type II, somatic, 607341 (3)	
9.497	5	27	93	9q34.2	SURF6		Surfeit-6	185642	H, A			2(Surf6)
9.498	8	2	17	19p13.2	TSPAN16, TM4SF16		Tetraspanin 16	617580	REc			
9.499	5	14	95	9q34.2	VAV2		Oncogene VAV2	600428	RE			
9.500	7	13	93	9q33.3	ZNF79		Zinc finger protein-79 (pT7)	194552	REa			
9.501	8	1	17	9q34.12	ABL1, CHDSKM		Abelson murine leukemia viral (v-abl) oncogene homolog 1	189980	REa, Ch, A	fusion hybrid gene with BCR1 in CML	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3); Congenital heart defects and skeletal malformations syndrome, 617602 (3)	2(Abl)
9.502	2	23	09	9q34.11	AK1		Adenylate kinase-1	103000	F, S, D, Fc	proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	2(Ak1)
9.503	9	28	09	9q34.11	ASS1, ASS		Argininosuccinate synthetase 1	603470	S, D, REa, Fd	14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12	Citrullinemia, 215700 (3)	2(Ass1)
9.504	9	30	14	9q33.2	C5, C5D, ECLZB		Complement component-5	120900	REa, A		C5 deficiency, 609536 (3); [Eculizumab, poor response to], 615749 (3)	2(Hc)
9.505	11	5	98	9q34.11	CDK9, CDC2L4		Cyclin-dependent kinase-9	603251	Psh			
9.506	1	27	09	9q34.1	CLLS3		Leukemia, chronic lymphocytic, susceptibility to, 3	612557	Fd	associated with SNP -6531 upstream of DAPK1 promoter	{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)	
9.507	3	27	18	9q34.11	CRAT, CAT1, NBIA8		Carnitine acetyltransferase	600184	REa	mutation identified in 1 NBIA8 patient	?Neurodegeneration with brain iron accumulation 8, 617917 (3)	
9.508	10	14	95	9q21.33	DAPK1		Death-associated protein kinase-1	600831	REa, A			
9.509	3	29	12	9q34.11	DOLPP1, LSFR2		Dolichyl pyrophosphate phosphatase 1	614516	R, A			
9.510	3	9	95	9q34.11	ENDOG		Endonuclease G	600440	Psh, A			
9.511	10	13	97	9q34.11	ENG, END, HHT1, ORW		Endoglin	131195	A, H, Fd		Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	2(Eng)
9.512	6	7	10	9q34.12	FIBCD1		Fibrinogene C domain-containing protein 1	613357	REc			
9.513	6	1	09	9q33.3	LMX1B, NPS1		LIM homeo box transcription factor 1, beta	602575	F, Fd, Ch		Nail-patella syndrome, 161200 (3)	2(Lmx1b)
9.514	8	27	15	9q34.13	NUP214, D9S46E, CAN, CAIN		Nucleoporin, 214kD	114350	Ch	fused with DEK in AML; fused with ABL1 in T-ALL	Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	2(D2H9S46E)
9.515	09	27	18	9q34.13	POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11		Protein O-mannosyltransferase 1	607423	R, REa, Fd		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	
9.516	7	29	15	9q34.12	PRDM12, HSAN8		PR domain-containing protein 12	616458	REc		Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	
9.517	2	6	01	9q34.11	PRRX2, PRX2		Paired-related homeo box gene 2	604675	A			
9.518	12	10	15	9q33.2	STOM, EPB72, BND7		Stomatin (erythrocyte membrane protein band 7.2)	133090	REa, Ch, A	proximal to ABL		2(Epb7.2)
9.519	8	29	08	9q34.11	STXBP1, UNC18, EIEE4		Syntaxin-binding protein 1	602926	A		Epileptic encephalopathy, early infantile, 4, 612164 (3)	
9.520	8	20	88	9q32	ORM1, AGP1		Orosomucoid-1 (alpha-1-acid glycoprotein-1)	138600	F, S, REa, Fc, A	linked to ABO, AK1, ALAD		4(Orm1)
9.521	8	20	88	9q32	ORM2		Orosomucoid-2	138610	RE, LD			4(Orm2)
9.522	1	31	13	9q34.11	ASB6		Ankyrin repeat- and SOCS box-containing protein 6	615051	REc			
9.523	12	29	06	9q34.11	C9orf90, NAIF1		Nuclear apoptosis-inducing factor 1	610673	REc			
9.524	12	29	06	9q34.11	CCBL1		Cysteine conjugate beta-lyase 1	600547	Psh, REc			
9.525	10	28	15	9q34.11	CERCAM		Cerebral endothelial cell adhesion molecule	616626	REc			
9.526	3	27	17	9q34.11	DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M		Dolichol kinase	610746	R, REc		Congenital disorder of glycosylation, type Im, 610768 (3)	
9.527	1	31	13	9q34.11	DPM2, CDG1U		Dolichyl-phosphate mannosyltransferase 2, regulatory subunit	603564	REc		Congenital disorder of glycosylation, type Iu, 615042 (3)	
9.528	8	26	15	9q34.11	GOLGA2, GM130		Golgi autoantigen, golgin subfamily A, 2	602580	REc			
9.529	9	2	12	9q34.11	MIR199B		Micro RNA 199B	614791	REc			
9.530	7	8	10	9q34.11	MIR2861, MIRN2861, BMND15		Micro RNA 2861	613405	REc		[Bone mineral density QTL 15], 613418 (3)	
9.531	7	17	14	9q34.11	NTMT1, METTL11A, NRMT, C9orf32		N-terminal X-Pro-Lys N-methyltransferase 1	613560	REc			
9.532	1	6	14	9q34.11	NUP188, KIAA1069		Nucleoporin, 188kD	615587	R, REc			
9.533	7	13	09	9q34.11	PIP5KL1, PIPKH		Phosphatidylinositol-4-phosphate-5-kinase-like 1	612865	REc			
9.534	2	7	07	9q34.11	PKN3		Protein kinase N3	610714	REc			
9.535	8	23	12	9q34.11	SH2D3C, NSP3		SH2 domain-containing protein 3C	604722	REc			
9.536	8	9	17	9q34.11	SPOUT1, CENP32, C9orf114		SPOUT domain-containing methyltransferase 1	617614	REc			
9.537	3	20	14	9q34.11	ST6GALNAC6, SIAT7F		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	610135	REc, R			
9.538	8	26	15	9q34.11	SWI5, SAE3, C9orf119		SWi5 homologous recombination repair protein	616528	REc			
9.539	2	17	15	9q34.11	TBC1D13		TBC1 domain family, member 13	616218	REc			
9.540	7	17	14	9q34.11	TOR2A, TORP1		Torsin 2A	608052	REc			
9.541	1	29	07	9q34.11	TRUB2		TRUB pseudouridine synthase, E. coli, homolog of, 2	610727	REc			
9.542	3	31	09	9q34.11	URM1		Ubiquitin-related modifier 1, S. cerevisiae, homolog of	612693	REc			
9.543	4	8	13	9q34.11	USP20, VDU2		Ubiquitin-specific protease 20	615143	REc			
9.544	2	9	14	9q34.11	WDR34, SRTD11		WD repeat-containing protein 34	613363	REc		Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	
9.545	11	10	17	9q34.11	ZER1, ZYG11BL, C9orf60		Zyg11-related cell cycle regulator	617764	REc			
9.546	5	25	13	9q34.11-q34.12	FUBP3, FBP3		FAR upstream element-binding protein 3	603536	REc			
9.547	8	17	99	9q33.3	PSMB7		Proteasome subunit, beta-type, 7	604030	A			
9.548	11	10	17	9q34.12	EXOSC2, RRP4, SHRF		Exosome component 2	602238	REc		Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3)	
9.549	9	16	12	9q34.12	QRFP, P518, 26RFA		Pyroglutamylated FR-amide peptide precursor protein	609795	REc			
9.550	8	11	13	9q34.13	AK8		Adenylate kinase 8	615365	REc			
9.551	11	7	08	9q34.13	ALPQTL1		Alkaline phosphatase, plasma level of, QTL 1	171720	Fd	linkage with rs657152	{Alkaline phosphatase, plasma level of, QTL1} (2)	
9.552	3	28	15	9q34.11	COQ4, COQ10D7		Coenzyme Q4, S. cerevisiae, homolog of	612898	REc		Coenzyme Q10 deficiency, primary, 7, 616276 (3)	
9.553	8	27	15	9q34.13	DDX31, PPP1R25		DEAD box polypeptide 31	616533	REc			
9.554	3	29	07	9q34.11	FAM102A, EEIG1		Family with sequence similarity 102, member A	610891	REc			
9.555	9	8	11	9q34.11	FAM129B, MINERVA		Family with sequence similarity 129, member B	614045	REc			
9.556	2	2	14	9q34.13	GFI1B, BDPLT17		Growth factor-independent 1B	604383	REc		Bleeding disorder, platelet-type, 17, 187900 (3)	
9.557	3	28	16	9q34.11	LRRC8A, KIAA1437, AGM5		Leucine-rich repeat-containing 8A	608360	REc, R, Ch	mutation identified in 1 AGM5 patient	?Agammaglobulinemia 5, 613506 (3)	2(Lrrc8)
9.558	3	22	07	9q34.11	PTGES2, PGES2, GBF1		Prostaglandin E synthase 2	608152	REc, REn			
9.559	9	26	17	9q34.13	TTF1		Transcription termination factor, RNA polymerase I	600777	REc			
9.560	8	31	11	9q34.2	ADAMTSL2, KIAA0605, GPHYSD1		ADAMTS-like protein 2	612277	R, REc		Geleophysic dysplasia 1, 231050 (3)	
9.561	08	10	18	9q34.2	CACFD1, FLOWER, C9orf7		Calcium channel FLOWER-domain containing protein 1	613104	REc			
9.562	7	18	14	9q34.13	GTF3C5, TFIIIC63		General transcription factor 3C, polypeptide 5	604890	REc			
9.563	7	25	17	9q34.2	MYMK, TMEM8C		Myomaker	615345	REc		Carey-Fineman-Ziter syndrome, 254940 (3)	
9.564	9	26	17	9q34.2	RNU6ATAC, U6ATAC		RNA, U6ATAC small nuclear	601429	REc			
9.565	7	1	05	9q34.13	UCK1		Uridine/cytidine kinase 1	609328	REc			
9.566	1	31	13	9q34.2	SARDH, SARD, SAR		Sarcosine dehydrogenase	604455	H, REc		[Sarcosinemia], 268900 (3)	2(sar)
9.567	12	22	17	9q34.3	COL5A1, EDSCL1		Collagen V, alpha-1 polypeptide	120215	REa, A, Fd		Ehlers-Danlos syndrome, classic type, 1, 130000 (3)	2(Col5a1)
9.568	6	11	94	9q34.3	PTGDS		Prostaglandin D2 synthase (21kD, brain)	176803	A, H	distal to ABL		2(Ptgds)
9.569	5	5	04	9q34.3	AGPAT2, LPAAB, BSCL, BSCL1		1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta)	603100	A, Fd		Lipodystrophy, congenital generalized, type 1, 608594 (3)	
9.570	11	26	97	9q34.3	C8G		Complement component-8, gamma polypeptide	120930	REa, H, Fd			2(C8g)
9.571	3	29	12	9q34.3	C9orf116, PIERCE1		p53-induced expression in RB-null cells 1	614502	REc, H			2(Pierce1)
9.572	3	24	11	9q34.3	CAMSAP1		Calmodulin-regulated spectrin-associated protein 1	613774	REc			
9.573	4	26	10	9q34.3	CARD9, CANDF2		Caspase recruitment domain-containing protein 9	607212	REc		Candidiasis, familial, 2, autosomal recessive, 212050 (3)	
9.574	8	17	14	9q34.3	CCDC183, KIAA1984		Coiled-coil domain-containing protein 183	615955	REc			
9.575	11	30	06	9q34.13	CEL, BSSL, CELL, MODY8		Carboxyl-ester lipase (bile-salt stimulated lipase)	114840	REa, A		Maturity-onset diabetes of the young, type VIII, 609812 (3)	
9.576	5	26	13	9q34.3	DPP7, QPP		Dipeptidyl peptidase VII	610537	R, REc			
9.577	11	12	09	9q34.3	EGFL7		Epidermal growth factor-like 7	608582	A, R			2(Egfl7)
9.578	11	15	17	9q34.3	EHMT1, EUHMTASE1, DEL9q34, KLEFS1		Euchromatic histone methyltransferase 1	607001	REc, Ch		Kleefstra syndrome 1, 610253 (3)	
9.579	4	2	12	9q34.3	FAM69B		Family with sequence similarity 69, member B	614543	REc			
9.580	6	13	12	9q34.3	FBXW5, FBW5		F-box and WD40 domain protein 5	609072	REc			2(Fbxw5)
9.581	1	16	18	9q34.3	GRIN1, NMDAR1, NDHMSR, NDHMSD		Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249	REb, A, Fd		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3); Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3)	
9.582	1	20	11	9q34.3	GLT6D1, GT6M7, GLTDC1		Glycosyltransferase 6 domain-containing 1	613699	REc			
9.583	8	15	14	9q34.3	INPP5E, MORMS, JBTS1, CORS1		Inositol polyphosphate-5-phosphatase, 72kD	613037	REc		Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)	
9.584	1	9	13	9q34.3	KCNT1, KIAA1422, EIEE14, ENFL5		Potassium channel, subfamily T, member 1	608167	R, REc		Epileptic encephalopathy, early infantile, 14, 614959 (3); Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	
9.585	10	2	09	9q34.3	LHX3, CPHD3		LIM/homeodomain protein LHX3	600577	H, A, REa	in mouse, close to Notch1; centromeric to ABL	Pituitary hormone deficiency, combined, 3, 221750 (3)	2(Lhx3)
9.586	12	15	10	9q34.3	LRRC26, CAPC		Leucine-rich repeat-containing protein 26	613505	REc			
9.587	9	1	11	9q34.3	MAN1B1, MRT15		Mannosidase, alpha, class 1B member 1	604346	REc		Mental retardation, autosomal recessive 15, 614202 (3)	
9.588	3	23	09	9q34.3	MIR126, MIRN126		Micro RNA 126	611767	REc			
9.589	3	5	08	9q34.3	MRPL41, MRPL27		Mitochondrial ribosomal protein L41	611846	R, REc			
9.590	11	23	16	9q34.3	MAMDC4		MAM domain-containing protein 4	617208	REc			
9.591	6	22	14	9q34.3	NACC2, RBB		NACC family, member 2, BEN and BTB/POZ domains-containing	615786	REc			
9.592	3	14	13	9q34.3	NSMF, NELF, HH9		NMDA receptor synaptonuclear signaling and neuronal migration factor	608137	R, REc		Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	
9.593	9	30	14	9q34.3	NOTCH1, TAN1, AOS5, AOVD1		Notch, Drosophila, homolog of, 1, translocation-associated	190198	Ch, H, A		Aortic valve disease 1, 109730 (3); Adams-Oliver syndrome 5, 616028 (3)	2(Notch1)
9.594	5	26	13	9q34.3	NOXA1		NADPH oxidase activator 1	611255	REc			2(Noxa1)
9.595	7	17	01	9q34.3	NR1		NADPH-dependent FMN- and FAD-containing oxidoreductase	606073	A			
9.596	4	14	15	9q34.3	PAXX, C9orf142		Paralog of XRCC4 and XLF	616315	REc			
9.597	7	3	06	9q34.3	PHPT1		Phosphohistidine phosphatase 1	610167	REc			
9.598	2	5	16	9q34.3	PMPCA, KIAA0123, SCAR2		Peptidase, mitochondrial processing, alpha	613036	REc		Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	
9.599	8	27	08	9q34.3	PNPLA7		Patatin-like phospholipase domain containing 7	612122	REc			
9.600	6	1	12	9q34.3	PPP1R26, KIAA0649		Protein phosphatase 1, regulatory subunit 26	614056	REc, R			
9.601	8	23	00	9q34.11	PTGES, PGES, PIG12, MGST1L1		Prostaglandin E synthase	605172	A			
9.602	7	13	09	9q34.3	QSOX2, SOXN		Quiescin Q6 sulfhydryl oxidase 2	612860	A			
9.603	8	3	17	9q34.3	RABL6, PARF, C9orf86		RAB-like protein 6	610615	R, REc			
9.604	3	14	07	9q34.13	RAPGEF1, GRF2, C3G		RAP guanine nucleotide exchange factor 1	600303	A			
9.605	5	19	94	9q34.2	RXRA		Retinoid X receptor, alpha	180245	Psh, A	distal to DBH		2(Rxra)
9.606	08	10	18	9q34.3	SAPCD2, C9orf140, P42.3		Suppressor APC domain-containing protein 2	612057	REc, H			2(P42.3)
9.607	7	13	09	9q34.3	SEC16A, SEC16L, KIAA0310, p250		Sec16, S. Cerevisiae, homolog of, A	612854	R, REc			
9.608	10	2	12	9q34.3	SNAPC4, SNAP190		Small nuclear RNA-activating protein complex, polypeptide 4	602777	REc			
9.609	09	12	18	9q34.3	SOHLH1, NOHLH, TEB2, ODG5, SPGF32		Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1	610224	REc		Ovarian dysgenesis 5, 617690 (3); Spermatogenic failure 32, 618115 (3)	
9.610	4	17	07	9q34.3	SSNA1, NA14		Sjogren syndrome nuclear autoantigen 1	610882	REc			
9.611	9	12	15	9q34.3	TMEM203		Transmembrane protein 203	616499	REc			
9.612	4	20	10	9q34.3	TPRN, C9orf75, DFNB79		Taperin	613354	REc, H, Fd		Deafness, autosomal recessive 79, 613307 (3)	2(Tprn)
9.613	8	19	14	9q34.3	TRAF2, TRAP		TNF receptor-associated factor 2	601895	REc			
9.614	2	16	18	9q34.3	TUBB4B, TUBB2C, LCAEOD		Tubulin, beta-4B	602660	REc		Leber congenital amaurosis with early-onset deafness, 617879 (3)	
9.615	4	1	09	9q34.3	UBAC1, GBDR1		Ubiquitin-associated domain-containing protein 1	608129	Psh, REc			
9.616	2	18	10	9q34.3	WDR85		WD repeat-containing protein 85	613210	REc			
9.617	9	18	08	9q34.3	ZMYND19, MIZIP		Zinc finger MYND domain-containing protein 19	611424	REc, H			2(Zmynd19)
9.618	5	16	02	9q34.3	ANAPC2, APC2, KIAA1406		Anaphase-promoting complex, subunit 2	606946	R			
9.619	1	24	01	9q31.1	CAPE		Chromosome-associated protein E	605576	R			
9.620	12	27	01	9q34.3	CLIC3		Chloride intracellular channel 3	606533	R			
9.621	7	15	02	9q22.32	FBP2		Fructose-1,6-bisphosphatase 2	603027	R			
9.622	3	5	98	9q34.3	FUT7		Fucosyltransferase 7 (alpha (1,3) fucosyltransferase)	602030	REa			
9.623	10	23	87	Chr.9	H142T		Temperature sensitivity complementation, H142	187290	S			
9.624	6	13	02	9p13.2	MELK, KIAA0175		Maternal embryonic leucine zipper kinase	607025	REa			4(Melk)
9.625	8	27	01	9q34.3	NPDC1, CAB1		Neural proliferation, differentiation, and control protein 1	605798	R			
9.626	12	14	01	9q34.3	OLFM1, AMY		Olfactomedin 1	605366	R			
9.627	5	4	00	9q33.2	PDCL		Phosducin-like	604421	REa, R			
9.628	2	21	03	9q32	ROD1		Regulator of differentiation 1	607527	R			
9.629	11	15	00	9q33.3	SLC2A8, GLUT8		Solute carrier family 2, (facilitated glucose transporter) member 8	605245	R			
9.630	4	26	01	9p13.3	UNC13, MUNC13		UNC13, C. elegans, homolog of	605836	R			
10.1	3	6	94	10p15.1	CALML3		Calmodulin-like 3	114184	REa, Psh, A			
10.2	10	15	97	10p13	PHYH, PAHX		Phytanoyl-CoA hydroxylase	602026	LD, R		Refsum disease, 266500 (3)	
10.3	3	6	00	10pter-q11	ST12, PAC1		Suppression of tumorigenicity 12, prostate	601188	M		Prostate adenocarcinoma (2)	
10.4	8	29	07	10p15.3	DIP2C, KIAA0934		Disco-interacting protein 2, Drosophila, homolog of, C	611380	R, REc			
10.5	8	26	15	10p15.3	LARP4B, LARP5, KIAA0217		La ribonucleoprotein domain family, member 4B	616513	R, REc			
10.6	2	2	16	10p15.3	TUBB8, OOMD2		Tubulin, beta 8	616768	REc		Oocyte maturation defect 2, 616780 (3)	
10.7	2	9	92	10p15.2	PFKP		Phosphofructokinase, platelet type	171840	S, A, D			
10.8	6	20	18	10p15.1	ANKRD16		Ankyrin repeat domain-containing protein 16	618017	REc			
10.9	1	31	13	10p15.1	ASB13		Ankyrin repeat- and SOCS box-containing protein 13	615055	REc			
10.10	4	25	17	10p15.1	AKR1E2, HTSP, TAKR		Aldo-keto reductase family 1, member E2	617451	REc			
10.11	8	26	09	10p14	ATP5C1, ATP5CL1, ATP5C		ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide-1	108729	REa, REc			
10.12	9	9	08	10p15.1	FBXO18, FBH1, FBX18		F-box only protein 18	607222	REc			2(Fbxo18)
10.13	7	20	15	10p15.1	IL2RA, CD25, IL2R, IDDM10, IMD41		Interleukin-2 receptor, alpha	147730	REa, A, Fd, LD		Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	2(Il2ra)
10.14	2	23	09	10p15.1	MS2		Multiple sclerosis, susceptibility to, 2	612594	Fd	associated with rs12722489 and rs2104286	{Multiple sclerosis, susceptibility to, 2} (2)	
10.15	7	2	18	10p15.1	NET1		Neuroepithelial cell transforming gene 1	606450	REc			
10.16	9	17	07	10p15.1	RBM17, SPF45		RNA binding motif protein 17	606935	REc			
10.17	7	9	09	10p13	TRDMT1, DMNT2		tRNA aspartic acid methyltransferase 1 (DNA methyltransferase 2)	602478	R, A			
10.18	3	6	98	10p15.3	ADARB2, RED2		Adenosine deaminase, RNA-specific, B2 (homolog of rat BLUE)	602065	REa			
10.19	8	3	11	10p14	GATA3, HDR, HDRS		GATA-binding protein-3	131320	A, Ch		Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	2(Gata3)
10.20	1	13	99	10p15.1	GDI2, RABGDIB		GDP dissociation inhibitor 2	600767	A	pseudogene on chr.7		
10.21	9	9	13	10p15.3	IDI1		Isopentenyl-diphosphate delta isomerase 1	604055	REc			13(Idi1)
10.22	9	9	13	10p15.3	IDI2, IPPI2		Isopentenyl-diphosphate delta isomerase 2	615389	REc			13(Idi2)
10.23	9	9	13	10p15.3	IDI2AS1		IDI2 antisense RNA 1, noncoding	615391	REc			
10.24	10	6	92	10p14	ITIH2		Inter-alpha (globulin) inhibitor, H2 polypeptide	146640	A, H			2(Intin2)
10.25	12	20	05	10p14	ITIH5		Inter-alpha-trypsin inhibitor, heavy chain 5	609783	REc			
10.26	10	7	05	10p15.2	KLF6, COPEB, BCD1, ZF9		Kruppel-like factor-6	602053	REa, A		Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic, 613659 (3)	
10.27	8	2	13	10p15	PFFE1		Plasmodium falciparum fever episodes QTL1	611384	Fd		{Plasmodium falciparum fever episodes QTL1} (2)	
10.28	9	27	95	10p15.1	PRKCQ		Protein kinase C, theta	600448	A			2(Pkcq)
10.29	8	18	99	10p15.1	AKR1C1, DDH1, DD1, HAKRC		Aldo-keto reductase family 1, member 1 (dihydrodiol dehydrogenase, type 1)	600449	Psh, A			
10.30	4	24	18	10p15.1	AKR1C2, DDH2, DD2, HAKRD, SRXY8		Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)	600450	Psh, A		46XY sex reversal 8, 614279 (3)	
10.31	8	18	99	10p15.1	AKR1C3, HAKRB, DD3		Aldo-keto reductase family 1, member C3	603966	REa, A			
10.32	10	10	11	10p15.1	AKR1C4, CHDR, CDR, HAKRA, DD4		Aldo-keto reductase family 1, member C4 (chlordecone reductase)	600451	REa, A		{46XY sex reversal 8, modifier of}, 614279 (3)	
10.33	2	15	96	10p15.1	IL15RA		Interleukin-15 receptor, alpha	601070	A			2(Il15ra)
10.34	2	26	01	10p14	KIN, KIN17, BTCD		Antigenic determinant of recombination protein A, mouse, homolog of	601720	A			2(kin17)
10.35	7	26	10	10p13	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12		Optineurin	602432	Fd		Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)	
10.36	1	31	01	10p15.1	PFKFB3, IPFK2		6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	605319	A			
10.37	3	11	03	10p14	UPF2, RENT2		UPF2 regulator of nonsense transcripts, yeast, homolog of	605529	R			
10.38	8	20	08	10p14	CRCS5		Colorectal cancer, susceptibility to, 5	612230	Fd	associated with rs10795668	{Colorectal cancer, susceptibility to, 5} (2)	
10.39	11	21	14	10p14	DHTKD1, KIAA1630, AMOXAD, CMT2Q		Dehydrogenase E1 and transketolase domains-containing protein 1	614984	Psh, REc	mutation identified in 1 CMT2Q family	2-aminoadipic 2-oxoadipic aciduria, 204750 (3); ?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	
10.40	10	11	12	10p14	TAF3, TAFII140		TAF3 RNA polymerase II, TATA box-binding protein-associated factor, 140kD	606576	REc			
10.41	1	20	17	10p12.1	YME1L1, YME1L, PAMP, OPA11		Mitochondrial escape 1-like 1	607472	REc	mutation identified in1 OPA11 family	?Optic atrophy 11, 617302 (3)	
10.42	9	9	13	10p14	SFMBT2, KIAA1617		SCM-like protein with 4 MBT domains 2	615392	REc			2(Sfmbt2)
10.43	11	6	14	10p15.3	ZMYND11, BS69, BRAM1, MRD30		Zinc finger MYND domain-containing protein 11	608668	A		Mental retardation, autosomal dominant 30, 616083 (3)	
10.44	10	1	17	10p14-p13	CDC123		Cell division cycle 123	617708	REc			
10.45	9	2	96	10p14-p13	DGCR2, DGS2		DiGeorge syndrome chromosome region-2	601362	Ch		DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	
10.46	3	2	98	10p12.33	STAM		Signal transducing adaptor molecule	601899	A			2(Stam)
10.47	1	6	00	10p14-p12	ARVD6		Arrhythmogenic right ventricular dysplasia 6	604401	Fd		Arrhythmogenic right ventricular dysplasia 6 (2)	
10.48	12	15	05	10p13	AD7		Alzheimer disease 7	606187	Fd	max LOD at D10S1423	Alzheimer disease-7 (2)	
10.49	5	26	13	10p13	ARMETL1, CDNF		Arginine-rich protein mutated in early stage tumors-like 1	611233	REc			
10.50	11	4	93	10p12.2	BMI1		Oncogene BMI-1	164831	A			
10.51	5	13	13	10p13	C1QL3, CTRP13, K100		Complement component 1, q subcomponent-like 3	615227	REc, H			1(C1ql3)
10.52	2	25	15	10p13	CAMK1D, CKLIK		Calcium/calmodulin-dependent protein kinase I-delta	607957	REc			
10.53	8	2	13	10p14	CELF2, CUGBP2, ETR3, BRUNOL3		CUGbp- and ELAV-like family, member 2	602538	REc			
10.54	2	17	16	10p13	FRMD4A, KIAA1294, CCAFCA		FERM domain-containing protein 4A	616305	R, REc	mutation identified in 1 CCAFCA family	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	
10.55	4	10	14	10p13	ITGA8, RHDA1		Integrin, alpha-8	604063	REc		Renal hypodysplasia/aplasia 1, 191830 (3)	
10.56	2	16	06	10p13	LPRS		Leprosy, paucibacillary type, susceptibility to	609888	Fd		{Leprosy, paucibacillary type, susceptibility to} (2)	
10.57	5	16	05	10p13	MCM10, CNA43		Minichromosome maintenance 10, S. cerevisiae, homolog of	609357	R, REc			
10.58	9	6	11	10p13	MEIG1		Meiosis-expressed gene 1, mouse, homolog of	614174	REc			
10.59	8	3	17	10p13	MINDY3, C10orf97, CARP		MINDY lysine-48 deubiquitinase 3	611649	REc			
10.60	10	14	94	10p12.33	MRC1, MMR		Mannose receptor, C type 1	153618	Psh, A			2(Mrc1)
10.61	9	17	08	10p13	NMT2		N-myristoyltransferase 2	603801	REc			
10.62	8	26	09	10p13	PRPF18, PRP18		Prp18, S. cerevisiae, homolog of	604993	R, REc			
10.63	8	26	09	10p13	RPP38		Ribonuclease P, 38-kD subunit	606116	R, REc			
10.64	8	26	09	10p13	RSU1		Ras suppressor protein 1	179555	REa, REc			
10.65	3	24	11	10p13	SEPHS1, SPS1		Selenophosphate synthetase 1	600902	REc			
10.66	8	26	09	10p13	SUV39H2, FLJ23414		Suppressor of variegation 3-9, Drosophila, homolog of, 2	606503	R, REc			2(Suv39h2)
10.67	8	25	04	10p14	USP6NL, RNTRE		USP6 N-terminal-like	605405	Ch			
10.68	5	10	17	10p13	VIM, CTRCT30		Vimentin	193060	REa		Cataract 30, pulverulent, 116300 (3)	2(Vim)
10.69	1	12	09	10p12.31	NEBL		Nebulette	605491	R, A			
10.70	6	4	10	10p11.22	ARHGAP12		Rho GTPase-activating protein 12	610577	REc			
10.71	1	8	16	10p12.33	HACD1, PTPLA		3-hydroxyacyl-CoA dehydratase 1	610467	REc			
10.72	1	23	13	10p12.31	ARL5B, ARL8		ADP-ribosylation factor-like 5B	608909	REc			
10.73	10	11	17	10p12.31	MALRD1, C10orf112, DIET1		MAM and LDL receptor class A domain-containing protein 1	617715	REc, H			2(Malrd1)
10.74	8	19	13	10p12.31	DNAJC1, HTJ1		DNAJ/HSP40 homolog, subfamily C, member 1	611207	REc, R			
10.75	5	6	13	10p12.31	MIR1915		Micro RNA 1915	615202	REc			
10.76	11	23	16	10p12.31	NSUN6		NOP2/SUN RNA methyltransferase family, member 6	617199	REc			
10.77	4	6	15	10p12.33	ST8SIA6, SIAT8F		ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	610139	REc			
10.78	3	22	06	10p12.1	ARHGAP21, KIAA1424		GTPase-activating protein, Rho, 21	609870	REc	pseudogene on chr.6		
10.79	3	3	10	10p12.31	EBLN1		Endogenous Borna-like N element-containing protein 1	613249	REc			
10.80	9	9	08	10p13	HSPA14, HSP70L1		Heat-shock 70kD protein 14	610369	REc			
10.81	11	30	06	10p12.31	PLXDC2, TEM7R		Plexin domain containing 2	606827	R			
10.82	7	19	06	10p12.1	BAMBI, NMA		BMP and activin membrane-bound inhibitor, xenopus, homolog of	604444	Psh, A			
10.83	8	18	14	10p12.2	PTF1A, PACA, PAGEN2		Pancreas transcription factor 1, alpha subunit	607194	REc, Fd		Pancreatic and cerebellar agenesis, 609069 (3); Pancreatic agenesis 2, 615935 (3)	
10.84	5	26	13	10p12.2	ARMC3		Armadillo repeat-containing protein 3	611226	REc			
10.85	12	22	15	10p12.2	COMMD3		COMM domain-containing protein 3	616700	REc			
10.86	2	24	17	10p12.2-p12.1	KIAA1217, SKT		KIAA1217 gene	617367	REc			
10.87	6	5	08	10p12.2	OTUD1, DUBA7		OTU domain-containing protein 1	612022	REc			
10.88	7	22	16	10p12.2	PIP4K2A, PI5P4KA, PIP5K2A		Phosphatidylinositol 5-phosphate 4-kinase, type II, alpha	603140	R, REc			
10.89	10	28	15	10p12.1	ACBD5, KIAA1996		Acyl-CoA-binding domain-containing protein 5	616618	REc			
10.90	2	24	11	10p12.1	ANKRD26, KIAA1074, THC2		Ankyrin repeat domain-containing protein 26	610855	REc		Thrombocytopenia 2, 188000 (3)	6(Ankrd26)
10.91	10	15	13	10p12.1	ARMC4, CILD23		Armadillo repeat-containing protein 4	615408	REc		Ciliary dyskinesia, primary, 23, 615451 (3)	
10.92	2	21	03	10p13	CUBN, IFCR, MGA1		Cubilin (intrinsic factor-cobalamin receptor)	602997	A, R, REc		Megaloblastic anemia-1, Finnish type, 261100 (3)	
10.93	7	14	14	10p12.1	ENKUR, C10orf63		Enkurin, TRPC channel-interacting protein	611025	REc			2(4933434I06Rik)
10.94	4	19	12	10p12.1	GPR158, KIAA1136		G protein-coupled receptor 158	614573	REc			2(Gpr158)
10.95	11	1	16	10p12.1	MASTL, FLJ14813, GWL		Microtubule-associated serine/threonine kinase-like	608221	Fd, REc			
10.96	4	1	09	10p12.1	MKX, IFRX, IRXL1		Mohawk homeobox	601332	Psh, Fd			18(Mkx)
10.97	5	21	07	10p12.1	MPP7		Membrane protein, palmitoylated 7	610973	REc			
10.98	5	24	12	10p12.1	PDSS1, TPT, COQ1, COQ10D2		Prenyl diphosphate synthase, subunit 1	607429	R, REc		Coenzyme Q10 deficiency, primary, 2, 614651 (3)	
10.99	2	12	07	10p12.1	PRTFDC1		Phosphoribosyl transferase domain-containing protein 1	610751	R, REc			
10.100	2	14	08	10p12.1	PTCHD3		Patched domain-containing protein 3	611791	REc			
10.101	9	17	11	10p12.1	RAB18, WARBM3		Ras-associated protein RAB18	602207	H, REc		Warburg micro syndrome 3, 614222 (3)	18(Rab18)
10.102	5	26	13	10p12.1	THNSL1, TSH1		Threonine synthase-like 1	611260	REc			
10.103	3	6	94	10p11.21	CREM		cAMP-responsive element modulator	123812	A			18(Crem)
10.104	1	13	16	10p12.1	WAC, KIAA1844, DESSH		WW domain-containing adaptor with coiled-coil region	615049	REc		Desanto-Shinawi syndrome, 616708 (3)	
10.105	8	28	15	10p12.31	AF10		ALL1 fused gene from chromosome 10	602409	A, Ch	fuses with MLL and HEAB	Leukemia, acute myeloid, 601626 (3)	
10.106	3	5	08	10p12.33-p12.31	CACNB2		Calcium channel, voltage-dependent, beta 2 subunit	600003	A, REc		Brugada syndrome 4, 611876 (3)	
10.107	3	24	11	10p12.2	MSRB2, CBS1		Methionine sulfoxide reductase B2	613782	R			
10.108	5	25	00	10p11.22	NRP1, NRP, VEGF165R		Neuropilin 1	602069	REa, R			
10.109	5	4	00	10p13	PTER		Phosphotriesterase-related protein	604446	A			
10.110	3	19	01	10p12.2	SPAG6		Sperm-associated antigen 6	605730	A			
10.111	3	9	95	10p12.1	GAD2		Glutamate decarboxylase-2, pancreas	138275	A			2(Gad2)
10.112	5	12	09	10p11.23	LYZL2		Lysozyme-like 2	612748	REc			
10.113	10	27	16	10p11.23	MTPAP, PAPD1, SPAX4		Mitochondrial poly(A) polymerase	613669	REc	mutation identified in 1 SPAX4 family	?Spastic ataxia 4, autosomal recessive, 613672 (3)	
10.114	5	5	09	10p11.23-q21.1	DFNB33		Deafness, autosomal recessive 33	607239	Fd	prev. assignment to chr. 9 an error	Deafness, autosomal recessive 33 (2)	
10.115	4	15	08	10p11.22	EIG5		Epilepsy, idiopathic generalized, susceptibility to, 5	611934	Fd	max lod at D10S1426	{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)	
10.116	9	23	13	10p11.22	KIF5B, KNS1, UKHC		Kinesin 1	602809	REc			18(Ukhc)
10.117	4	21	16	10p11.22	ZEB1AS1		ZEB1 antisense RNA 1, noncoding	616915	REc			
10.118	3	20	07	10p11.21	ANKRD30A		Ankyrin repeat domain-containing protein 30A	610856	REc			
10.119	4	1	08	10p11.21	GJD4, CX40.1		Gap junction protein, delta-4	611922	REc			
10.120	8	26	09	10p11.22-p11.21	PARD3, PAR3		Partitioning-defective protein 3, C. elegans, homolog of	606745	R, REc			
10.121	1	9	13	10p11.21-q21.1	USH1K		Usher syndrome, type IK	614990	Fd	max lod at D10S539	Usher syndrome, type IK (2)	
10.122	10	7	98	10p12.1	ABI1		ABL-interactor 1	603050	Ch			
10.123	5	19	09	10p11.21	CCNY, CFP1, CCNX, C10orf9		Cyclin Y	612786	REc			
10.124	8	28	01	10p11.21	FZD8		Frizzled, Drosophila, homolog of, 8	606146	A			18(Fzd8)
10.125	3	13	92	10p11.22	ITGB1, FNRB		Integrin, beta-1 (fibronectin receptor, beta polypeptide; antigen CD29 includes MDF2, MSK12)	135630	REb, REa, F, A, S	pseudogene FNRBL on 19p		
10.126	10	4	05	10p11.23	MAP3K8, COT, EST, TPL2		Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene)	191195	Psh, A, H		Lung cancer, somatic, 211980 (3)	18(Tpl2)
10.127	8	17	99	10p11.23	SVIL		Supervillin	604126	A			
10.128	2	25	10	10p11.22	ZEB1, TCF8, NIL2A, PPCD3, FECD6		Zinc finger E box-binding homeobox 1	189909	REa, A, Fd		Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	
10.129	5	12	09	10p11.21	CUL2		Cullin 2	603135	A			
10.130	8	20	92	10p11.21	ZNF25, KOX19		Zinc finger protein-25 (KOX 19)	194528	REa, A			
10.131	8	27	15	10p12.1	MYO3A, DFNB30		Myosin IIIA	606808	REa, R, Fd		Deafness, autosomal recessive 30, 607101 (3)	
10.132	11	11	14	10p11.1	ZNF37A, KOX21, ZNF37		Zinc finger protein 37A	616085	REc			
10.133	8	20	07	10p11.22	EPC1		Enhancer of polycomb, Drosophila, homolog of, 1	610999	R			
10.134	12	19	11	10p11.23	KIAA1462, JCAD		KIAA1462 gene	614398	REc			
10.135	2	21	03	10p	BULN		Bulimia nervosa, susceptibility to	607499	Fd	between D10S1430 and D10S1423	{Bulimia nervosa, susceptibility to} (2)	
10.136	9	14	05	10p13	DCLRE1C, ARTEMIS, SCIDA		DNA cross-link repair protein 1C	605988	Fd, REc		Severe combined immunodeficiency, Athabascan type, 602450 (3); Omenn syndrome, 603554 (3)	
10.137	10	8	08	10p	BMIQ8		Body mass index quantitative trait locus 8	603188	Fd		{Obesity, susceptibility to, BMIQ8} (2)	
10.138	10	30	03	10q	AITD4		Autoimmune thyroid disease, susceptibility to, 4	608176	Fd		{Autoimmune thyroid disease, susceptibility to, 4} (2)	
10.139	1	12	99	10q26.11	TIAL1, TIAR, TCBP		Tia1 cytotoxic granule-associated RNA-binding protein-like 1	603413	REc, R			
10.140	5	26	13	10q11.22-q11.23	ARHGAP22		Rho GTPase-activating protein 22	610585	REc			
10.141	5	19	16	10q11.23	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11		Excision repair cross complementing rodent repair deficiency, complementation group 6	609413	A, M		Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to, 5}, 613761 (3); UV-sensitive syndrome 1, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3); Premature ovarian failure 11, 616946 (3)	
10.142	8	18	98	10q22.1	TACR2, TAC2R, NKNAR		Tachykinin receptor 2 (substance K receptor; neurokinin 2 receptor)	162321	REa, A			
10.143	10	24	11	10q22.2	ADK		Adenosine kinase	102750	S, D, EM		Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	14(Adk)
10.144	8	30	02	10q11.21	CXCL12, SDF1		Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)	600835	A		{AIDS, resistance to}, 609423 (3)	
10.145	9	16	03	10q11.22	SYT15		Synaptotagmin 15	608081	REc			14(Syt15)
10.146	5	27	05	10q11.21	ALOX5		Arachidonate 5-lipoxygenase	152390	Psh		{Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	
10.147	3	6	98	10q11.22	ANXA8		Annexin A8	602396	A			14(Anx8)
10.148	4	30	15	10q11.23	CHAT, CMS6		Choline acetyltransferase	118490	REa, A		Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	
10.149	1	29	01	10q21.1	DKK1		Dickkopf, Xenopus, homolog of, 1	605189	A			
10.150	3	23	06	10q11.22	MAPK8, PRKM8, JNK1, SAPK1		Mitogen-activated protein kinase 8	601158	R, REc			
10.151	4	23	08	10q11.22	MSMB, HPC13		Microseminoprotein, beta	157145	REa, A		{Prostate cancer, hereditary, 13}, 611928 (3)	
10.152	8	14	15	10q11.22	NCOA4, ELE1, PTC3		Nuclear receptor coactivator 4	601984	REn	fused with RET to form PTC3		
10.153	8	10	13	10q11.22	PTPN20A		Protein tyrosine phosphatase, nonreceptor-type, 20A	610630	Psh, A			
10.154	8	19	13	10q11.22	PTPN20B		Protein tyrosine phosphatase, nonreceptor-type, 20B	610631	Psh, A			
10.155	9	29	13	10q11.2-q21.1	PRKG1, PRKG1B, PRKGR1B, AAT8		Protein kinase, cGMP-dependent, regulatory, type I	176894	REa, A		Aortic aneurysm, familial thoracic 8, 615436 (3)	
10.156	6	4	13	10q11.22	RBP3, RP66		Retinol-binding protein-3, interstitial	180290	REa, A, Fd	1 family identified with mutation	?Retinitis pigmentosa 66, 615233 (3)	14(Rbp3)
10.157	4	24	17	10q11.21	RET, MEN2A, HSCR1		RET transforming sequence; oncogene RET	164761	A, REn, Fd, Ch, D		Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3); {Hirschsprung disease, protection against}, 142623 (3)	
10.158	12	7	07	10q11.23	SGMS1, SMS1, TMEM23, MOB		Sphingomyelin synthase 1	611573	REc			
10.159	12	6	16	10q11.23	SLC18A3, VACHT, CMS21		Solute carrier family 18 (vesicular acetylcholine), member 3	600336	REn		Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3)	
10.160	8	28	92	10q11.21	ZNF22, KOX15		Zinc finger protein-22 (KOX15)	194529	A, REa			
10.161	3	12	07	10p11.1	ZNF33A, NF11A, KOX2		Zinc finger protein-33a	194521	REa, A			
10.162	3	12	07	10q11.21	ZNF33B, ZNF11B, KOX2		Zinc finger protein-33b	194522	REa, A			
10.163	8	26	09	10q11.21	ZNF239, MOK2		Zinc finger protein-239	601069	R, REc	previously 19q13.2-q13.3		6(Mok2)
10.164	12	21	12	10q21.1	MBL2, MBL, MBP1, MBL2D, MBPD		Mannose-binding lectin 2, soluble (opsonic defect)	154545	REa, A, Fd	near MEN2A	{Chronic infections, due to MBL deficiency}, 614372 (3)	14(Mbl1)
10.165	1	30	09	10q11.2-q21	STHAG5		Tooth agenesis, selective, 5	610926	Fd	D10S604 and D10S568	Tooth agenesis, selective, 5 (2)	
10.166	12	5	07	10q21.1	UBE2D1, UBCH5A, UBCH5		Ubiquitin-conjugating enzyme E2D 1	602961	Psh, R			
10.167	2	18	98	10q11.22	PPYR1, NPY4R, PP1		Pancreatic polypeptide receptor-1	601790	REa, REc			14(Ppyr1)
10.168	8	5	14	10q11.21	BMS1, BMS1L, KIAA0187, ACC		Bms1, ribosome assembly protein, S. cerevisiae, homolog of	611448	REc	mutation identified in one ACC family	?Aplasia cutis congenita, nonsyndromic, 107600 (3)	
10.169	4	6	15	10q11.21	C10orf10, DEPP, FIG		Chromosome 10 open reading frame 10	611309	REc			
10.170	4	27	16	10q11.21	FXYD4, CHIF		FXYD domain-containing ion transport regulator 4	616926	REc			
10.171	6	7	10	10q11.21-q11.22	MARCH8		Membrane-associated RING-CH finger protein 8	613335	REc			
10.172	3	30	12	10q11.21	RASFEF1A		RASGEF domain family, member 1A	614531	REc			
10.173	5	26	13	10q11.21	RASSF4, AD037		Ras association domain family, member 4	610559	REc			
10.174	3	25	96	10q11.21	HNRPF		Heterogeneous nuclear ribonucleoprotein F	601037	A			
10.175	1	29	01	10q11.22	TIMM23		Translocase of inner mitochondrial membrane 23, Yeast, homolog of	605034	A			
10.176	10	28	15	10q11.21	CSGALNACT2		Chondroitin sulfate N-acetylgalactosaminyltransferase 2	616616	REc			
10.177	3	29	10	10q11.22	FRMPD2		FERM and PDZ domains-containing protein 2	613323	REc			
10.178	11	11	13	10q11.22	GDF2, BMP9, HHT5		Growth differentiation factor 2 (bone morphogenetic protein 9)	605120	REc		Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	
10.179	9	26	17	10q11.22	GDF10, BMP3B		Growth/differentiation factor 10	601361	REc, Psh			
10.180	5	26	13	10q11.22	GPRIN2, GRIN2		G protein-regulated inducer of neurite outgrowth 2	611240	REc			
10.181	4	20	17	10q11.22	WASHC2C, FAM21C, VPEF, KIAA0592		WASH complex, subunit 2C	613631	R, REc			
10.182	3	29	10	10q11.23	WDFY4, KIAA1607		WD repeat- and FYVE domain-containing protein 4	613316	Psh, REc			
10.183	5	26	13	10q11.23	ASAH2		N-acylsphingosine amidohydrolase 2	611202	REc			
10.184	5	22	07	10q11.23	ASAH2C, ASAH2L		N-acylsphingosine amidohydrolase 2C	610987	REc			
10.185	8	26	09	10q11.23	DRGX, DRG11		Dorsal root ganglia homeobox	606701	REc			
10.186	6	12	17	10q11.23	OGDHL, KIAA1290		Oxoglutarate dehydrogenase-like protein	617513	R, REc			
10.187	2	20	01	10q11.23	PARG		Poly(ADP-ribose) glycohydrolase	603501	A			14(Parg)
10.188	9	28	11	10q11.23-q22.3	HYPT9		Hypotrichosis 9	614237	Fd	between D10S538 and D10S2327	Hypotrichosis 9 (2)	
10.189	10	13	09	10q21	ALL1		Leukemia, acute lymphocytic, susceptibility to, 1	613065	Fd	associated with rs10821936	{Leukemia, acute lymphocytic, susceptibility to, 1} (2)	
10.190	11	7	08	10q21	ALPQTL4		Alkaline phosphatase, plasma level of, QTL 4	612369	Fd	linkage with rs12355784	{Alkaline phosphatase, plasma level of, QTL4} (2)	
10.191	11	11	13	10q21.2	ANK3, MRT37		Ankyrin-3, node of Ranvier	600465	A	mutation identified in 1 family	?Mental retardation, autosomal recessive, 37, 615493 (3)	10(Ank3)
10.192	8	14	15	10q21.2	CCDC6, D10S170, H4, TST1		Coiled-coil domain-containing 6	601985	REn	fused with RET to form PTC1		
10.193	2	2	14	10q21.3	CTNNA3, ARVD13		Catenin, alpha-3	607667	A, Psh		Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	
10.194	7	9	06	10q22.1	DDX21		DEAD/H box 21	606357	R, REc			10(Ddx21)
10.195	9	24	08	10q21	IBD15		Inflammatory bowel disease 15	612255	Fd	association with rs10761659	{Inflammatory bowel disease 15} (2)	
10.196	3	20	06	10q21.1	IPMK		Inositol polyphosphate multikinase	609851	REc			
10.197	10	30	08	10q21	MAFD8		Major affective disorder 8	612357	Fd	associated with rs20994336	{Major affective disorder-8, susceptibility to} (2)	
10.198	2	28	03	10q22.1	NPFF1		Neuropeptide FF1	607448	R			
10.199	10	17	16	10q21.1	TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15		Transcription factor A, mitochondrial	600438	Psh, A	mutation identified in 1 MTDPS15 family	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3)	10(Tfam)
10.200	8	26	17	10q22.1	CDH23, USH1D, DFNB12, PITA5		Cadherin-23 (otocadherin)	605516	Fd, REc	between D10S529 and D10S573	Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive 12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3); {Pituitary adenoma 5, multiple types}, 617540 (3)	10(Cdh23, v)
10.201	6	19	98	10q22.1	EIF4EBP2, 4EBP2		Eukaryotic translation initiation factor-4E binding protein-1	602224	A			10(Eif4ebp2)
10.202	3	18	08	10q21.1	PCDH15, DFNB23, USH1F		Protocadherin 15	605514	REc		Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive 23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	10(av)
10.203	9	29	96	10q22.2	PPP3CB, CALNB		Protein phosphatase-3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)	114106	REa			
10.204	7	7	09	10q22.1	UNC5B, UNC5H2		Unc5, C. elegans, homolog of, B	607870	R, REc			
10.205	2	2	16	10q21.1	ZWINT, SIP30		ZW10 interacting kinetochore protein	609177	REc			
10.206	1	11	07	10q22.1	SPOCK2, KIAA0275		SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 2	607988	R, REc			
10.207	5	14	95	10q23.31	HTR7		5-hydroxytryptamine (serotonin) receptor-7, adenylate cyclase-coupled	182137	REa, Fd			
10.208	6	14	10	10q21.2	CDK1, CDC2		Cyclin-dependent kinase 1	116940	REa, A			10(Cdc2a)
10.209	4	8	08	10q21.1	CISD1, MITONEET		CDGSH iron sulfur domain protein 1	611932	REc			
10.210	3	9	17	10q21.3	DNAJC12, JDP1, HPANBH4		DNAJ/HSP40 homolog, subfamily C, member 12	606060	REc		Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3)	
10.211	5	4	09	10q21.1	MYP15		Myopia 15	612717	Fd	max lod at D10S1643	Myopia 15 (2)	
10.212	2	7	13	10q21.3	MYPN, CMD1DD, CMH22, RCM4, NEM11		Myopalladin	608517	REc		Cardiomyopathy, dilated, 1KK, 615248 (3); Cardiomyopathy, hypertrophic, 22, 615248 (3); Cardiomyopathy, familial restrictive, 4, 615248 (3); Nemaline myopathy 11, autosomal recessive, 617336 (3)	
10.213	8	29	08	10q21.3	PBLD, MAWBP, MAWDBP		Phenazine biosynthesis-like protein domain-containing protein	612189	Psh, R			
10.214	5	6	03	10q21.2	RHOBTB1, KIAA0740		Rho-related BTB domain-containing protein 1	607351	REc			
10.215	8	19	13	10q21.3	RUFY2, KIAA1537		RUN and FYVE domains-containing protein 2	610328	REc, R			
10.216	12	29	00	10q22.1	VPS26A, VPS26, HB58		Vacuolar protein sorting 26, yeast, homolog of, A	605506	R			
10.217	10	13	94	10q22.2	ANXA7, SNX		Annexin A7 (synexin)	186360	REa, A			14(Anx7)
10.218	4	25	03	10q21.3	EGR2, KROX20		KROX-20, Drosophila, homolog of (early growth response-2)	129010	D, REa, A, F		Neuropathy, congenital hypomyelinating, 1, 605253 (3); Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)	10(Krox20; Egr2)
10.219	9	10	09	10q21.2	ARID5B, MRF2, DESRT		AT-rich interaction domain-containing protein 5B	608538	R, REc			
10.220	2	22	18	10q21.1	BICC1, BICC, CYSRD		Bicaudal C, Drosophila, homolog of, 1	614295	REc		{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	10(Bicc1)
10.221	2	27	15	10q21.2	MRLN, LINC00948		Myoregulin	616246	REc, H			10(Mrln)
10.222	9	28	11	10q21.2	SLC16A9, MCT9		Solute carrier family 16 (monocarboxylic acid transporter), member 9	614242	REc			
10.223	12	8	17	10q21.2	TMEM26		Transmembrane protein 26	617803	REc			
10.224	5	31	05	10q21.2	ZNF365, UAN		Zinc finger protein 365	607818	Fd, REc		{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	
10.225	12	20	12	10q21.3	ADO, C10orf22		2-aminoethanethiol dioxygenase	611392	REc			
10.226	2	12	09	10q21.3	CCAR1, CARP1		Cell division cycle and apoptosis regulator 1	612569	REc			
10.227	4	6	16	10q21.3	JMJD1C, TRIP8, KIAA1380		Jumonji domain-containing protein 1C	604503	REc			
10.228	3	26	07	10q21.3	LRRTM3		Leucine-rich repeat transmembrane protein 3	610869	REc, H			10(Lrrtm3)
10.229	1	9	13	10q21.3	MSE		Myelinating Schwann cell element	614996	REc, REn			
10.230	1	6	09	10q22.1	NEUROG3, NGN3, ATOH5		Neurogenin 3	604882	REc		Diarrhea 4, malabsorptive, congenital, 610370 (3)	
10.231	7	23	15	10q21.3	NRBF2, COPR		Nuclear receptor-binding factor 2	616477	REc			
10.232	7	1	05	10q22.1	OIT3, LZP		Oncoprotein-induced transcript 3, mouse, homolog of	609330	REc			10(Lzp)
10.233	3	24	06	10q22.1	PP		Inorganic pyrophosphatase	179030	S, D, R			10(Pyp)
10.234	7	1	05	10q21.3	REEP3, C10orf74		Receptor expression-enhancing protein 3	609348	R, REc			
10.235	9	9	08	10q21.3	SIRT1, SIR2L1		Sirtuin, S. cerevisiae, homolog 1	604479	REc			
10.236	8	25	14	10q21.3	ATOH7, PHPVAR, NCRNA		Atonal, Drosophila, homolog of, 7	609875	A, H, Fd		Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	10(Atoh7)
10.237	6	3	14	10q21.3	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8		DNA replication helicase 2, yeast, homolog of	601810	A	mutation identified in 1 SCKL8 family	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3); ?Seckel syndrome 8, 615807 (3)	
10.238	4	16	14	10q21.3-q22.1	HCFP2		Facial paresis, hereditary congenital, 2	604185	Fd		Facial paresis, hereditary congenital, 2 (2)	
10.239	8	2	99	10q21.3	SLC25A16, D10S105E, GDA		Solute carrier family 25 (mitochondrial carrier), member 16 (Graves disease autoantigen)	139080	A			
10.240	4	10	90	10q22.1	P4HA1, P4HA		Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1	176710	REa, A, REn			
10.241	4	14	10	10q21.3-q22.3	HWE1		Epilepsy, hot water, 1	613339	Fd	max lod at D10S412	Epilepsy, hot water, 1 (2)	
10.242	3	6	98	10q22.2	CAMK2G, CAMKG		Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma	602123	REa, A	in intron of PCDH15		14(Camkg)
10.243	12	30	15	10q22.1	COL13A1, CMS19		Collagen XIII, alpha-1 polypeptide	120350	REa, A	~550kb proximal to P4HA	Myasthenic syndrome, congenital, 19, 616720 (3)	
10.244	8	25	11	10q24.2	GOLGA7B, C10orf132		Golgin A7 family, member B	614189	REc			
10.245	1	5	07	10q23.1-q23.2	GRID1, KIAA1220		Glutamate receptor, inotropic, delta 1	610659	R, H, REc			14(Grid1)
10.246	4	27	17	10q22.1	HK1, HKD, HMSNR, RP79		Hexokinase-1	142600	S, D, A, REa	10p11.2 conflicting assignment; ?2 loci on chr.10	Hemolytic anemia due to hexokinase deficiency, 235700 (3); Neuropathy, hereditary motor and sensory, Russe type, 605285 (3); Retinitis pigmentosa 79, 617460 (3)	10(Hk1)
10.247	6	19	98	10q21.3	HNRPH3, 2H9		Heterogeneous nuclear ribonucleoprotein H3	602324	A			
10.248	4	19	12	10q22.2	KAT6B, MYST4, MORF, GTPTS		Lysine acetyltransferase 6B	605880	A		SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)	
10.249	9	18	08	10q22.3	MAT1A, MATA1, SAMS1		Methionine adenosyltransferase I, alpha	610550	A		Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	
10.250	11	16	98	10q22.2	NDST2		N-deacetylase/N-sulfotransferase 2	603268	A	in intron of PCDH15		
10.251	1	8	01	10q23.1	NRG3		Neuregulin 3	605533	REa			
10.252	1	30	15	10q22.1	PCBD1, DCOH		Pterin-4a-carbinolamine dehydratase 1	126090	REa, H, A		Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	10(Dcoh)
10.253	7	22	15	10q22.1	PRF1, HPLH2, FLH2		Perforin	170280	A	mistakenly assigned to chr.17	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3); Lymphoma, non-Hodgkin, 605027 (3); Aplastic anemia, 609135 (3)	10(Prf1)
10.254	5	9	07	10q22	SQTL1		Smoking as a quantitative trait locus 1	611003	Fd	near D10S1432	{Smoking as a quantitative trait locus 1} (2)	
10.255	5	28	09	10q21.3	TET1, CXXC6, LCX, KIAA1676		tet oncogene 1	607790	REc, A			
10.256	2	4	00	10q22.2	VDAC2		Voltage-dependent anion channel 2	193245	A			14(Vdac2)
10.257	12	5	01	10q23.32	BTAF1, TAFII170, TAF172, MOT1		BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kD (Mot1, S. cerevisiae, homolog of)	605191	A, R			
10.258	4	23	08	10q21.1	CSTF2T, KIAA0689		Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD, tau variant	611968	Psh, R			19(Cstf2t)
10.259	6	27	08	10q22-q23	MGR12		Migraine, with or without aura, susceptibility to, 12	611706	Fd	max lod at 100cM	{Migraine, with or without aura, susceptibility to, 12} (2)	
10.260	3	1	00	10q22.3	PPIF, CYP3		Peptidylprolyl-cis-trans-isomerase, mitochondrial	604486	Fd			
10.261	3	11	09	10q22.3	SFTPA2, SPA2, COLEC5		Surfactant, pulmonary-associated protein A2	178642	Psh	contiguous with SFTPA1	Pulmonary fibrosis, idiopathic, 178500 (3)	
10.262	12	29	06	10q22.3	RPS24, DBA3		Ribosomal protein S24	602412	R, Psh		Diamond-blackfan anemia 3, 610629 (3)	
10.263	7	1	11	10q23.31	ACTA2, ACTSA, AAT6, MYMY5		Actin, alpha-2, smooth muscle, aorta	102620	REa, A		Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)	
10.264	8	29	07	10q23.31	MPHOSPH1, MPP1		M-phase phosphoprotein 1	605498	R, REc			
10.265	1	14	13	10q23.2-q23.3	PAPSS2, ATPSK2, BCYM4		3'-phosphoadenosine 5'-phosphosulfate synthase 2	603005	REc, A		Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	19(Atpsk2, bm)
10.266	10	5	07	10q22-q24	ATFB1		Atrial fibrillation, familial, 1	608583	Fd		Atrial fibrillation, familial, 1 (2)	
10.267	11	11	14	10q22.1	ADAMTS14		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 14	607506	REc			
10.268	7	26	10	10q22.1	ANAPC16, MSAG, C10orf104		Anaphase-promoting complex, subunit 16	613427	REc			
10.269	3	25	16	10q22.1	ASCC1, p50, SMABF2		Activating signal cointegrator 1 complex, subunit 1	614215	REc	mutation identified in 1 SMABF2 family	Barrett esophagus/esophageal adenocarcinoma, 614266 (3); ?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	
10.270	3	3	09	10q22.1	C10orf27		chromosome 10 open reading frame 27	612640	REc			
10.271	11	18	10	10q22.1	CHST3, C6ST, C6ST1, HSD		Carbohydrate sulfotransferase 3	603799	REc		Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	
10.272	8	19	13	10q22.1	DDX50, GUB		DEAD/H box 50	610373	REc			10(Ddx50)
10.273	11	23	16	10q22.1	HKDC1		Hexokinase domain-containing protein 1	617221	REc			
10.274	5	29	12	10q22.1	KIAA1274, PALD		Paladin, mouse, homolog of	614656	REc, R			
10.275	7	1	05	10q22.1	KIAA1279		KIAA1279 gene	609367	R, REc		Goldberg-Shprintzen megacolon syndrome, 609460 (3)	
10.276	9	2	11	10q22.1	MCU, CCDC109A		Mitochondrial calcium uniporter	614197	REc			
10.277	3	5	14	10q22.1	MICU1, CBARA1, MPXPS		Mitochondrial calcium uptake protein 1	605084	REc		Myopathy with extrapyramidal signs, 615673 (3)	
10.278	1	5	07	10q22.2	MRPS16, COXPD2		Mitochondrial ribosomal protein S16	609204	R, REc		Combined oxidative phosphorylation deficiency 2, 610498 (3)	
10.279	1	30	01	10q22.2	MYOZ1		Myozenin 1 (calsarcin 2)	605603	R			
10.280	8	26	09	10q22.1	NODAL, HTX5		Nodal, mouse, homolog of	601265	R, REc		Heterotaxy, visceral, 5, 270100 (3)	10(nodal)
10.281	12	18	07	10q22.1	PLA2G12B, GXIIB		Phospholipase A2, group XIIB	611653	REc			
10.282	1	22	08	10q22.1	PSAP, SAP1		Prosaposin (sphingolipid activator protein-1)	176801	S, REa, A, D, Fd		Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3); Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)	10(Psap)
10.283	5	22	03	10q22.1	SARA1, SAR1A		Sar1a, S. cerevisiae, homolog 1	607691	REc, R			
10.284	4	18	12	10q22.1	SLC29A3, ENT3, PHID, HCLAP		Solute carrier family 29 (nucleoside transporter), member 3	612373	R, REc		Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	
10.285	07	27	18	10q22.1	SGPL1, SPL, NPHS14		Sphingosine-1-phosphate lyase 1	603729	H, REc		Nephrotic syndrome, type 14, 617575 (3)	10(Spl)
10.286	12	21	09	10q22.1	SRGN, PRG1, PRG		Serglycin	177040	REa, A			
10.287	10	11	05	10q22.1	STOX1, PEE4		Storkhead box 1	609397	REc, Fd		Preeclampsia/eclampsia 4, 609404 (3)	
10.288	1	31	01	10q22.1	SUPV3L1		Suv3-like 1	605122	A			
10.289	12	21	09	10q22.1	TSPAN15, NET7		Tetraspanin 15	613140	REn			
10.290	8	20	07	10q22.1	TYSND1		Trypsin domain-containing protein 1	611017	R, REc			
10.291	08	10	18	10q22.1	VSIR, C10orf54, B7H5		V-set immunoregulatory receptor	615608	REc			
10.292	2	2	04	10q22.3	RAI17, KIAA1224, ZIMP10		Retinoic acid-induced gene 17	607159	REc			
10.293	3	3	10	10q22.2	VCL, CMD1W, CMH15		Vinculin	193065	REa, Fd, REb		Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, hypertrophic, 15, 613255 (3)	
10.294	4	27	12	10q22.1-q24.1	SPG27		Spastic paraplegia-27, autosomal recessive	609041	Fd	between D10S606 and D10S1758	Spastic paraplegia 27, autosomal recessive (2)	
10.295	5	24	13	10q22.2	AP3M1		Adaptor-related protein complex 3, mu-1 subunit	610366	R, REc			
10.296	1	27	04	10q22.1	DNAJB12, DJ10, FLJ0027		DNAJ, E. coli, homolog of, subfamily B, member 12	608376	R			
10.297	9	24	08	10q22.2	DNAJC9, JDD1, KIAA0974		DNAJ/HSP40 homolog, subfamily C, member 9	611206	R, REc			
10.298	12	21	09	10q22.2	DUSP13, TMDP, MDSP		Dual-specificity phosphatase 13	613191	REc			
10.299	7	13	15	10q22.2	ECD, SGT1		Ecdysoneless, Drosophila, homolog of	616464	REc			
10.300	8	21	12	10q22.2	MSS51, ZMYND17		MSS51 mitochondrial translational activator, S. cerevisiae, homolog of	614773	REc			
10.301	12	7	07	10q22.2	SAMD8, SMSR		Sterile alpha motif domain-containing 8	611575	REc			
10.302	3	13	15	10q22.2	SEC24C, KIAA0079		Sec24-related gene family, member C	607185	R, REc			
10.303	4	26	11	10q22.2	ZNF503, NOLZ1		Zinc finger protein 503	613902	REc			
10.304	3	20	18	10q22.3	SFTPA1, SFTP1		Surfactant, pulmonary-associated protein A1	178630	REa, A	contiguous with SFTPA2		14(Sftp1)
10.305	4	21	15	10q23.2	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3		LIM domain binding 3	605906	R, Psh, Fd		Myopathy, myofibrillar, 4, 609452 (3); Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3); Cardiomyopathy, hypertrophic, 24, 601493 (3); Left ventricular noncompaction 3, 601493 (3)	
10.306	1	2	08	10q23.2	BMPR1A, ACVRLK3, ALK3		Bone morphogenetic protein receptor, type IA	601299	R, A		Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome, hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)	
10.307	2	4	15	10q22.1	H2AFY2		H2A histone family, member Y2	616141	REc			
10.308	8	31	17	10q22.3	KCNMA1, SLO, PNKD3, CADEDS		Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	Psh, REc, Fd	mutation identified in 1 CADEDS family	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3); ?Cerebellar atrophy, developmental delay, and seizures, 617643 (3)	
10.309	07	19	18	10q22.2-q22.3	LRMDA, C10orf11, OCA7		Leucine-rich melanocyte differentiation-associated protein	614537	REc		Albinism, oculocutaneous, type VII, 615179 (3)	
10.310	7	13	09	10q22.3	PLAC9		Placenta-specific gene 9	612857	REc, H			15(Plac9)
10.311	10	3	11	10q22.3	POLR3A, RPC1, RPC155, ADDH, HLD7		Polymerase III, RNA, subunit A	614258	REc		Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	
10.312	9	22	03	10q22.3	SCZD11		Schizophrenia susceptibility locus, chromosome 10q-related	608078	Fd	between D10S1677 and D10S1753	{Schizophrenia}, 181500 (2)	
10.313	12	11	03	10q22.3	SLEN1		Systemic lupus erythematosus with nephritis, susceptibility to, 1	607965	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)	
10.314	11	07	08	10q22.3	SS3		Sarcoidosis, susceptibility to, 3	612388	Fd	associated with rs2789679 and rs1049550	{Sarcoidosis, susceptibility to, 3} (2)	
10.315	1	29	18	10q22.3	ANXA11, ANX11, ALS23		Annexin A11 (annexin XI)	602572	A		Amytrophic lateral sclerosis 23, 617839 (3)	
10.316	3	28	15	10q23	DEL10q23, C10DELq23		Chromosome 10q22.3-q23.2 deletion syndrome	612242	DS		Chromosome 10q22.3-q23.2 deletion syndrome (4)	
10.317	3	9	00	10q23.31	CH25H		Cholesterol 25-hydroxylase	604551	A, R			
10.318	5	31	05	10q22.3	DLG5, PDLG, KIAA0583		Discs large, Drosophila, homolog of, 5	604090	R			
10.319	3	15	13	10q23.31	KLLN, CWS4		Killin	612105	REc		Cowden syndrome 4, 615107 (3)	
10.320	5	31	05	10q23.2	MINPP1, HIPER1		Multiple inositol polyphosphate phosphatase 1	605391	A, R, REc		Thyroid carcinoma, follicular, 188470 (3)	19(Minpp1)
10.321	7	9	06	10q23.31	PANK1		Pantothenate kinase 1	606160	REn			
10.322	1	26	07	10q23.33	PLCE1, KIAA1516, NPHS3		Phospholipase C, epsilon-1	608414	R, REc		Nephrotic syndrome, type 3, 610725 (3)	
10.323	8	26	09	10q24.32	POLL		Polymerase, DNA, lambda	606343	R, REc			
10.324	2	25	11	10q23.1	RGR, RP44		Retinal G protein coupled receptor	600342	A		Retinitis pigmentosa 44, 613769 (3)	
10.325	3	16	99	10q25.2	SMNR, SPF30		Survival motor neuron-related protein	603519	Psh, R			
10.326	10	28	08	10q23.31	STAMBPL1, KIAA1373		STAM-binding protein-like 1	612352	R, REc			19(Stambpl1)
10.327	5	22	03	10q24.2	CNNM1, ACDP1		Cyclin M1 (ancient conserved domain protein 1)	607802	R			
10.328	3	31	08	10q23-q24	CPROTQ		C-reactive protein QTL	611920	Fd	max lod at D10S1239	[C-reactive protein QTL] (2)	
10.329	6	15	99	10q23.33	CYP26A1		Cytochrome p450, subfamily XXVIA, polypeptide 1	602239	A			19(Cyp26a1)
10.330	10	23	87	10q24.1	DNTT, TDT		Terminal deoxynucleotidyltransferase	187410	REa, A, Ch			19(Tdt)
10.331	1	14	16	10q24.2	ENTPD7, LALP1		Ectonucleoside triphosphate diphosphohydrolase 7	616753	REc			
10.332	3	15	13	10q24.2	HPSE2, HPA2, UFS1		Heparanase 2	613469	R		Urofacial syndrome 1, 236730 (3)	
10.333	10	21	08	10q23-q24	IBD20		Inflammatory bowel disease 20	612288	Fd	associated with rs11190140	{Inflammatory bowel disease 20} (2)	
10.334	8	20	01	10q23.32	PPP1R3C, PPP1R5		Phosphatase 1, regulatory subunit 3C	602999	R			
10.335	3	6	02	10q24.1	TLL2, KIAA0932		Tolloid-like 2	606743	A			19(Tll2)
10.336	11	4	93	10q11.21	ZNF32, KOX30		Zinc finger protein-32 (KOX30)	194539	A			8(Zfp4)
10.337	2	9	92	10q23.33	IDE		Insulin-degrading enzyme	146680	REa, A			19(Ide)
10.338	11	14	17	10q23.1	C10orf99, CSBF, AP57		Chromosome 10 open reading frame 99	617775	REc			
10.339	10	8	12	10q23.1	CDHR1, PCDH21, PRCAD, CORD15, RP65		Cadherin-related family, member 1	609502	REc		Cone-rod dystrophy 15, 613660 (3); Retinitis pigmentosa 65, 613660 (3)	
10.340	4	8	13	10q23.1	DYDC1		DPY30 domain-containing protein 1	615154	REc			
10.341	10	25	16	10q23.1	FAM213A, PAMM		Family with sequence similarity 213, member A	617165	REc			
10.342	4	20	17	10q23.1	HOST2		Long noncoding RNA HOST2	617434	REc			
10.343	6	11	02	10q24.2	HPS1		HPS gene 1	604982	LD, Fd		Hermansky-Pudlak syndrome 1, 203300 (3)	19(ep, ru)
10.344	11	24	14	10q23.1	LRIT1, PAL		Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 1	616103		REc, A		
10.345	1	11	18	10q24.1	BLNK, SLP65, AGM4		B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)	604515	A	mutation identified in 1 AGM4 family	?Agammaglobulinemia 4, 613502 (3)	
10.346	8	19	13	10q23.2	MIR346		Micro RNA 346	611190	REc			
10.347	4	10	15	10q23.2	OPN4		Opsin 4	606665	R, REc			
10.348	6	26	18	10q23.2	SHLD2, RINN2, FAM35A		Shield complex, subunit 2	618029	REc			
10.349	2	12	07	10q23.2	WAPAL, KIAA0261, FOE, WAPL		Wings apart-like protein, Drosophila, homolog of	610754	R, REc			
10.350	10	15	98	10q23.2	SNCG, BCSG1		Synuclein, gamma (breast cancer-specific gene 1)	602998	R, A			
10.351	12	3	98	10q24.31	NDUFB8		NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (8kD, AGGG)	602140	R	previously assigned to 12q21		
10.352	4	23	04	10q24.32	ARL3, ARFL3		ADP-ribosylation factor-like 3	604695	REa, R			
10.353	11	30	06	10q23.32	CPEB3, KIAA0940		Cytoplasmic polyadenylation element-binding protein 3	610606	R, REc			
10.354	6	22	18	10q23.33	CYP2C8, CYP2C8DM		Cytochrome P450, subfamily IIc, polypeptide 8	601129	REc		{Drug metabolism, altered, CYP2C8-related}, 618018 (3)	
10.355	1	15	13	10q23.33	CYP26C1, FFDD4		Cytochrome P450, subfamily XXVIC, polypeptide 1	608428	REc		Focal facial dermal dysplasia 4, 614974 (3)	
10.356	2	21	02	10q23.2	GLUD1		Glutamate dehydrogenase-1	138130	REa, A	pseudogene on Xq26-q28	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	14(Glud)
10.357	5	4	00	10q23.31	IFIT1, IFI56, G10P1, IFNAI1		Interferon-induced protein with tetratricopeptide repeats 1	147690	REa, A	10q25-q26 = conflicting site		
10.358	5	4	00	10q23.31	IFIT4		Interferon-induced protein with tetratricopeptide repeats 4	604650	A			
10.359	5	4	00	10q23.31	IFIT2, IFI54, G10P2		Interferon-induced protein with tetratricopeptide repeats 2	147040	A, REa			
10.360	6	7	10	10q23.32-q23.33	MARCH5		Membrane-associated RING-CH finger protein 5	610637	R, REc			
10.361	11	18	08	10q23.3	RCM2		Cardiomyopathy, familial restrictive, 2	609578	Fd	max lod at D10S1242	Cardiomyopathy, familial restrictive, 2 (2)	
10.362	8	19	98	10q22.3	SFTPD, SFTP4		Surfactant, pulmonary-associated protein D	178635	Psh			
10.363	8	2	16	10q23.31	SLC16A12, MCT12, CTRCT47		Solute carrier family 16 (monocarboxylic acid transporter), member 12	611910	REc, Fd	mutation identified in 1 CTRCT47 family	Cataract 47, juvenile, with microcornea, 612018 (3)	
10.364	10	10	01	10q25.1	SORCS1		SORCS receptor 1	606283	REc			
10.365	10	10	01	10q25.1	SORCS3, KIAA1059		SORCS receptor 3	606285	R, REc			
10.366	2	8	08	10q23.33	C10orf4, FRA10AC1, FRA10A		Chromosome 10 open reading frame 4	608866	REc			
10.367	9	27	17	10q23.33	CEP55, MARCH		Centrosomal protein, 55kD	610000	REc		Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3)	
10.368	9	26	17	10q23.33	CYP2C18		Cytochrome P450, subfamily IIC, polypeptide 18	601131	REc, REn			
10.369	12	28	08	10q23.33	EXOC6, SEC15L1, SEC15L, SEC15		Exocyst complex component 6	609672	R, REc			
10.370	3	14	13	10q23.33	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10		Free fatty acid receptor 4	609044	REc		{Obesity, susceptibility to}, 607514 (3)	
10.371	5	29	12	10q23.33	KIF11, KNSL1, MCLMR		Kinesin family member 11	148760	A, REc		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	18(Kns)
10.372	9	9	09	10q23.31	RNLS, C10orf59		Renalase	609360	REc			
10.373	10	25	16	10q23.33	SLC35G1, POST, TMEM20, C10orf60		Solute carrier family 35, member G1	617167	REc			
10.374	7	18	06	10q24.1	SORBS1, SH3D5, SH3P12, KIAA1296		Sorbin and SH3 domain containing 1	605264	R, REc, REn			
10.375	4	21	16	10q23.33	HELLS, LSH, ICF4		Helicase, lymphoid-specific	603946	A, H		Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	19(Hells)
10.376	10	28	14	10q23.31	ANKRD1, CARP		Ankyrin repeat domain-containing protein 1	609599	REc			
10.377	6	10	18	10q23.31	ATAD1, THORASE, HKPX4		ATPase family, AAA domain-containing, member 1	614452	REc		Hyperekplexia 4, 618011 (3)	
10.378	9	9	09	10q23.31	IDDM24		Diabetes mellitus, insulin-dependent, 24	613006	Fd	associated with rs10509540	{Diabetes mellitus, insulin-dependent, 24} (2)	
10.379	12	30	14	10q23.31	IFIT5, RI58, ISG58		Interferon-induced protein with tetratricopeptide repeats 5	616135	REc			
10.380	12	15	10	10q23.31	LIPA, CESD		Lipase A, lysosomal acid, cholesterol esterase	613497	S, H	?close to GOT	Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000 (3)	19(Lip1)
10.381	9	27	17	10q23.31	LIPF		Lipase F, gastric type	601980	REc, R			
10.382	4	26	11	10q23.31	LIPM, LIPL3		Lipase family, member M	613923	REc, H			19(Lipm)
10.383	1	18	13	10q23.31	LIPN, LIPL4, ARCI8, LI4		Lipase family, member N	613924	REc, H		Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	19(Lipn)
10.384	4	26	11	10q23.31	LIPK, LIPL2		Lipase family, member K	613922	REc, H			19(Lipk)
10.385	4	26	11	10q23.31	LIPJ, LIPL1		Lipase J	613921	REc, H			19(Lipj)
10.386	12	21	09	10q23.31	MIR107, MIRN107		Micro RNA 107	613189	REc			
10.387	3	14	13	10q23.31	PTEN, MMAC1, GLM2, CWS1		Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	REc, REa, A, Ch		Cowden syndrome 1, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3); {Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); PTEN hamartoma tumor syndrome (3); VATER association with macrocephaly and ventriculomegaly, 276950 (3); {Prostate cancer, somatic}, 176807 (3)	19(Pten)
10.388	8	26	09	10q23.31	RPP30		Ribonuclease P, 30kD subunit	606115	R, REc			
10.389	1	30	07	10q24.2	ANKRD2, ARPP		Ankyrin repeat domain-containing protein 2	610734	R			
10.390	3	28	17	10q23.32	PCGF5		Polycomb group ring finger protein 5	617407	REc, H			19(Pcgf5)
10.391	11	1	99	10q24.2	ABCC2, CMOAT		ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)	601107	A		Dubin-Johnson syndrome, 237500 (3)	19(Cmoat)
10.392	7	26	16	10q24	AD6		Alzheimer disease 6	605526	Fd		Alzheimer disease 6 (2)	
10.393	2	23	08	10q24.32	AS3MT, CYT19		Arsenic (+3 oxidation state) methyltransferase	611806	REc			
10.394	12	17	02	10q24.31	CHUK, IKBKA, NFKBIKA, IKKA, IKK1		Conserved helix-loop-helix ubiquitous kinase	600664	A, Psh		Cocoon syndrome, 613630 (3)	
10.395	4	25	13	10q24.2	COX15, CEMCOX2		Cytochrome c oxidase, subunit 15	603646	REc, Fd		Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3); Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3)	
10.396	7	3	06	10q24.2	CUTC		CutC copper transporter, E. coli, homolog of	610101	REc			
10.397	8	3	99	10q23.33	CYP2C9		Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9	601130	REn, H		Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)	7(War)
10.398	10	14	15	10q24.1	ENTPD1, CD39, SPG64		Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen)	601752	REc		Spastic paraplegia 64, autosomal recessive, 615683 (3)	
10.399	9	22	08	10q24.31	FAM178A, C10orf6		Family with sequence similarity 178, member A	610348	REc			
10.400	5	2	07	10q24.32	FBXW4, DAC, FBW4, FBWD4		F-box and WD repeat domain containing 4	608071	H, REc			19(Dac)
10.401	9	28	12	10q24.32	FGF8, HH6		Fibroblast growth factor-8	600483	H, REa, A, Fd		Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	19(Fgf8)
10.402	6	15	99	10q24.32	GBF1		Golgi-specific brefeldin-A resistance factor 1	603698	REa, A			
10.403	3	3	03	10q23.33	HHEX, PRHX, PRH		Hematopoietically expressed homeo box	604420	REc, A			
10.404	12	11	02	10q24.31	HIF1AN, FIH1		Hypoxia-inducible factor 1-alpha inhibitor	606615	REc			
10.405	1	10	12	10q23.33	LGI1, EPT, ETL1, ADLTE, ADPEAF		Leucine-rich gene, glioma-inactivated, 1	604619	Ch, Fd		Epilepsy, familial temporal lobe, 1, 600512 (3)	
10.406	10	26	99	10q24.32	LBX1, LBX1H		Lady bird late, Drosophila, homolog of, 1	604255	A			19(Lbx1)
10.407	2	28	03	10q24.2	LOXL4		Lysyl oxidate-like 4	607318	REc			
10.408	3	5	08	10q24.31	MRPL43		Mitochondrial ribosomal protein L43	611848	R, REc			
10.409	5	31	12	10q23.33	MYOF, FER1L3		Myoferlin	604603	REc, REn			
10.410	12	27	13	10q24.32	NFKB2, LYT10, CVID10		Nuclear factor of kappa light chain gene enhancer in B-cells 2 (p49/p100); oncogene Lyt-10	164012	REa, A, Ch		Immunodeficiency, common variable, 10, 615577 (3)	
10.411	2	16	07	10q23.33	NOC3L, FAD24		Nucleolar complex-associated 3, S. cerevisiae, homolog of	610769	REc			
10.412	11	21	16	10q24.1	OPALIN, TMEM10, TMP10		Oligodendrocytic myelin paranodal and inner loop protein	617200	REc			
10.413	3	20	08	10q25.2	PDCD4		Programmed cell death 4	608610	A			
10.414	11	3	09	10q23.33	PDE6C, PDEA2, COD4		Phosphodiesterase-6C, cGMP-specific, cone, alpha prime	600827	A		Cone dystrophy 4, 613093 (3)	
10.415	3	18	08	10q24.2	PI4K2A		Phosphatidylinositol 4-kinase type 2 alpha	609763	R, REc			
10.416	9	12	11	10q22.2	PLAU, URK, QPD, BDPLT5		Plasminogen activator, urokinase	191840	REa, A, Psh	proximal to HOX11	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3); Quebec platelet disorder, 601709 (3)	14(Plau)
10.417	2	18	98	10q24.32	PSD		Pleckstrin and Sec7 domain protein	602327	REn			
10.418	6	19	15	10q23.33	RBP4, RDCCAS, MCOPCB10		Retinol-binding protein-4, interstitial	180250	REa, A	just centromeric of CYP2C cluster	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3); Microphthalmia, isolated, with coloboma 10, 616428 (3)	19(Rbp4)
10.419	8	10	10	10q24	SHFM3, SHSF3, DUP10q24, C10DUPq24		Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome)	246560	Fd	contiguous gene duplication syndrome	Split-hand/foot malformation 3, gene duplication syndrome (4)	
10.420	1	12	06	10q24.2	SLC25A28, MRS4L, NPD016		Solute carrier family 25 (mitochondrial carrier), member 28	609767	Psh, REn			
10.421	5	4	09	10q24.31	TD1		TLX1 divergent gene	612734	REc			
10.422	7	17	02	10q24.31	TLX1, HOX11, TCL3		T-cell leukemia, homeobox 1	186770	Ch, RE, H	t(7;10) or t(10;4) in T-ALL		
10.423	3	28	17	10q24.31	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5		Twinkle mtDNA helicase	606075	Fd, REc	PEO digenic with POLG	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3); Perrault syndrome 5, 616138 (3)	
10.424	12	10	13	10q24.33	USMG5, DAPIT		Upregulated during skeletal muscle growth 5, mouse, homolog of	615204	REc			19(Usmg5)
10.425	8	29	96	10q24.31	WNT8B		Wingless-type MMTV integration site family, member 8B	601396	Psh, A			
10.426	1	13	16	10q24.1	ZDHHC16, APH2		Zinc finger DHHC domain-containing protein 16	616750	REc			
10.427	8	18	99	10q24.32	BTRC, BTRCP		Beta-transducin repeat-containing protein	603482	R, A			
10.428	8	26	09	10q25.1	GSTO1		Glutathione S-transferase, omega-1	605482	REc, REn			
10.429	10	6	08	10q25.1	GSTO2		Glutathione S-transferase, omega-2	612314	REc			
10.430	2	4	99	10q24.32	LDB1, CLIM2, NLI		LIM domain-binding factor-1	603451	R, H			19(Ldb1)
10.431	3	9	00	10q24.31	PKD2L1, PKDL, PKD2L		Polycystin L	604532	A, R, REa			19(Pkdl)
10.432	11	7	17	10q24.32	SUFU, SUFUXL, SUFUH, JBTS32		Suppressor of fused	607035	A, R		Medulloblastoma, desmoplastic, 155255 (3); {Meningioma, familial, susceptibility to}, 607174 (3); Basal cell nevus syndrome, 109400 (3); Joubert syndrome 32, 617757 (3)	
10.433	12	4	01	10q24.33	TAF5, TAF2D, TAFII100		TAF5 RNA polymerase II, TATA box binding protein-associated factor, 100kD	601787	REa, A			
10.434	3	7	92	10q25.2	ADRA2A, ADRA2R		Adrenergic, alpha-2A-, receptor	104210	REa, A, Fd, RE			19(Adra2)
10.435	2	23	09	10q25.3	ADRB1, ADRB1R, RHR		Adrenergic, beta-1-, receptor	109630	REa, Fd, A	close linkage to ADRA2R	[Resting heart rate], 607276 (3); {Congestive heart failure and beta-blocker response, modifier of} (3)	19(Adrb1)
10.436	6	6	00	10q26.13	BUB3		Budding uninhibited by benzimidazoles 3, S. cerevisiae, homolog of	603719	R			
10.437	1	13	99	10q25.2	GPAM		Glycerol-3-phosphate acyltransferase	602395	H			19(Gpam)
10.438	1	10	02	10q24.32	NPM3		Nucleophosmin/nucleoplasmin family, member 3	606456	REc			19(Npm3)
10.439	11	20	98	10q25.3	NRAP		Nebulin-related anchoring protein	602873	R, H			19(Nrap)
10.440	5	29	12	10q26.11	GRK5, GPRK5		G protein-coupled receptor kinase 5	600870	REa			
10.441	12	7	07	10q24.1	ARHGAP19		RHO GTPase-activating protein 19	611587	REc			
10.442	6	1	12	10q24.1	EXOSC1, CSL4		Exosome component 1	606493	REc			
10.443	12	30	14	10q23.31	FAS, TNFRSF6, APT1, CD95, ALPS1A		Fas cell surface death receptor	134637	A		{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	19(Fas1)
10.444	8	27	01	10q24.1	FRAT2		Frequently rearranged in advanced T-cell lymphomas 2	605006	REc			
10.445	2	18	08	10q24.1	LCOR, MLR2, KIAA1795		Ligand-dependent nuclear receptor corepressor	607698	R, REc			
10.446	8	31	12	10q24.1	MMS19, MMS19L		MMS19 nucleotide excision repair, S. Cerevisiae, homolog of	614777	A, REc, R			
10.447	9	20	14	10q24.1	PIK3AP1, BCAP, FLJ35564		Phosphoinositide 3-kinase adaptor protein 1	607942	R, REc			
10.448	10	25	17	10q24.1	RRP12, KIAA0690		Ribosomal RNA-processing protein 12, S. cerevisiae, homolog of	617723	REc, R			
10.449	10	22	99	10q24.2	SFRP5, SARP3		Secreted frizzled-related protein 5	604158	A, R, Psh			
10.450	12	10	13	10q24.1	SLIT1, SLIL1, MEGF4		Slit, Drosophila, homolog of, 1	603742	Psh, REc			
10.451	9	10	12	10q24.1	TCTN3, TECT3, C10orf61, OFD4, JBTS18		Tectonic family, member 3	613847	REc		Orofaciodigital syndrome IV, 258860 (3); Joubert syndrome 18, 614815 (3)	
10.452	3	24	16	10q24.1	TM9SF3, SMBP		Transmembrane 9 superfamily, member 3	616872	REc			
10.453	10	25	17	10q24.1	ZNF518A, KIAA0335		Zinc finger protein 518A	617733	R, REc			
10.454	6	1	15	10q24.1-q24.2	UBTD1		Ubiquitin domain-containing protein 1	616388	REc			
10.455	11	24	15	10q23.33	CYP2C, CYP2C19		Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	REa, A	4 genes in order: cen-C18-C19-C9-C8-tel	Mephenytoin poor metabolizer, 609535 (3); Omeprazole poor metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)	19(P4502c)
10.456	8	31	99	10q24.32	MGEA5		Meningioma-expressed antigen 5	604039	Psh, A			
10.457	7	25	12	10q24.1-q25.1	CMTDIA		Charcot-Marie-Tooth disease, dominant intermediate A	606483	Fd		Charcot-Marie-Tooth disease, dominant intermediate A (2)	
10.458	1	18	12	10q24.2	GOT1, ASTQTL1		Glutamic-oxaloacetic transaminase-1, soluble (EC 2.6.1.1)	138180	S, D, H, A	10q26.1 = conflicting localization	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	19(Got1)
10.459	3	10	03	10q24.2	CPN1, SCPN, CPN		Carboxypeptidase N, polypeptide 1, 50-kD	603103	Psh, R		Carboxypeptidase N deficiency, 212070 (3)	
10.460	7	2	18	10q24.2	CRTAC1, CEP68, LOTUS		Cartilage acidic protein 1	606276	REc			
10.461	5	26	13	10q24.2	DNMBP, TUBA, KIAA1010		Dynamin-binding protein	611282	R, REc			19(Dnmbp)
10.462	12	17	12	10q24.2	HOGA1, DHDPSL, HP3		4-hydroxy-2-oxoglutarate aldolase 1	613597	REc		Hyperoxaluria, primary, type III, 613616 (3)	
10.463	6	26	16	10q24.2	MARVELD1, MARVD1		Marvel domain-containing protein 1	616970	REc			
10.464	10	25	17	10q24.2	MORN4, RTP, UTA		MORN repeat-containing protein 4	617736	REc			
10.465	6	16	08	10q24.2	NKX2C, NK2.3, CSX3		NK2, Drosophila, homolog of, C	606727	REc			
10.466	3	1	18	10q24.2	PYROXD2, C10orf33, YUEF		Pyridine nucleotide-disulphide oxidoreductase domain-containing protein 2	617889	REc			
10.467	4	27	12	10q24.2	ZFYVE27, SPG33		Zinc finger FYVE domain-containing protein 27	610243	REc		Spastic paraplegia 33, autosomal dominant, 610244 (3)	
10.468	6	30	16	10q25.1-q25.2	ADD3, ADDL, CPSQ3		Adducin-3, gamma	601568	A, Ch	fusion with NUP98 in T-ALL	Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	
10.469	4	26	17	10q24.32	PPRC1, PRC, KIAA0595		Peroxisome proliferator-activated receptor-gamma, coactivator-related protein 1	617462	REc			
10.470	10	7	08	10q24.33	PDCD11, ALG4, NFBP, KIAA0185		Programmed cell death 11	612333	A			
10.471	10	23	15	10q24.1	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3		Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	S, A	GOT1 and GSAS in same pathway	Cutis laxa, autosomal recessive, type IIIA, 219150 (3); Spastic paraplegia 9A, autosomal dominant, 601162 (3); Spastic paraplegia 9B, autosomal recessive, 616586 (3); Cutis laxa, autosomal dominant 3, 616603 (3)	
10.472	9	24	15	10q25.1	COL17A1, BPAG2, ERED		Collagen XVII, alpha-1 polypeptide	113811	A, H		Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa, junctional, localisata variant, 226650 (3); Epithelial recurrent erosion dystrophy, 122400 (3)	19(Bpag2)
10.473	8	9	05	10q24.32	CYP17A1, CYP17, P450C17		Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)	609300	REa, H, A	at least 2 genes; distal to GOT1	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase deficiency, isolated, 202110 (3)	19(Cyp17)
10.474	5	24	13	10q24.31	LZTS2, KIAA1813, LAPSER1		Leucine zipper, putative tumor suppressor 2	610454	REc			
10.475	10	14	15	10q24.32-q24.33	NT5C2, NT5B, PNT5, SPG45		5' nucleotidase, cytosolic II	600417	R, REc		Spastic paraplegia 45, autosomal recessive, 613162 (3)	
10.476	6	1	18	10q24.31	PDZD7, DFNB57		PDZ domain-containing 7	612971	REc		{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3); Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3); Deafness, autosomal recessive 57, 618003 (3)	
10.477	3	30	12	10q24.31	SEC31B, SEC31L2		Sec31, yeast, homolog of, B	610258	REc			
10.478	7	10	02	10q24.32	TRIM8, RNF27, GERP		Tripartite motif-containing 8	606125	REc			
10.479	10	23	15	10q24.31	PAX2, PAPRS, FSGS7		Paired box homeotic gene-2	167409	REa, A		Papillorenal syndrome, 120330 (3); Glomerulosclerosis, focal segmental, 7, 616002 (3)	19(Pax2)
10.480	8	28	97	10q26.3	CYP2E, CYP2E1, P450C2E		Cytochrome P450, subfamily IIE, ethanol-inducible	124040	REa			7(Cyp2e)
10.481	12	28	08	10q24.31	BLOC1S2, BLOS2		Biogenesis of lysosome-related organelles complex 1, subunit 2	609768	R			
10.482	8	23	16	10q24.31	CWF19L1, C19L1, SCAR17		CWF19-like protein 1	616120	REc		Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	
10.483	5	23	16	10q24.31	ERLIN1, SPG62		Endoplasmic reticulum lipid raft-associated protein 1	611604	R, REc		Spastic paraplegia 62, 615681 (3)	
10.484	2	25	15	10q24.31	OLMALINC, LINC00263, OLMALINCAS		Oligodendrocyte maturation-associated long intergenic noncoding RNA	616240	REc	OLMALINCAS is on opposite strand overlapping exon 1 of OLMALINC		
10.485	8	26	09	10q24.31	SCD		Stearoyl-CoA desaturase	604031	REa, REc	pseudogene on chr.17		19(ab)
10.486	12	27	13	10q24.31	SFXN3		Sideroflexin 3	615571	REc			
10.487	4	2	16	10q24.31	SNORA12		Small nucleolar RNA, H/ACA box, 12	611330	REc	in intron 11 of CWF19L1		
10.488	8	31	12	10q24.32	ACTR1A, ARP1		Actin-related protein 1A	605143	REc			
10.489	10	23	15	10q24.32	BORCS7, C10orf32		BLOC1-related complex, subunit 7	616600	REc			
10.490	9	10	07	10q24.32	C10orf26, OPAL1		Chromosome 10 open reading frame 26	611129	R, REc			
10.491	8	6	11	10q24.32	CUEDC2		Cue domain-containing protein 2	614142	REc			
10.492	7	28	15	10q24.32	DPCD		Deleted in primary ciliary dyskinesia, mouse, homolog of	616467	REc, H			19(Dpcd)
10.493	2	23	08	10q24.32	ELOVL3, CIG30		Elongation of very long chain fatty acids-like 3	611815	REc			
10.494	5	24	13	10q24.32	FBXL15, JET		F-box and leucine-rich repeat protein 15	610287	REc			
10.495	1	29	03	10q24.32	HPS6, RU		HPS gene 6	607522	REc		Hermansky-Pudlak syndrome 6, 614075 (3)	19(ru)
10.496	5	26	13	10q24.32	MIR146B		Micro RNA 146B	610567	REc			
10.497	10	2	12	10q24.32	NOLC1, p130, NOPP140		Nucleolar and coiled-body phosphoprotein 1	602394	REc			
10.498	12	27	13	10q24.32	SFXN2		Sideroflexin 2	615570	REc			
10.499	11	14	12	10q24.32-q25.1	ECTD5		Ectodermal dysplasia 5, hair/nail type	614927	Fd	between D10S1239 and D10S1264	Ectodermal dysplasia 5, hair/nail type (2)	
10.500	9	8	08	10q24.33	CALHM1, FAM26C		Calcium homeostasis modulator 1	612234	REc	?Alzheimer disease, 605526		
10.501	9	8	08	10q24.33	CALHM2, FAM26B		Calcium homeostasis modulator 2	612235	REc			
10.502	6	17	15	10q24.32	CNNM2, ACDP2, HOMG6, HOMGSMR		Cyclin M2	607803	R, REc		Hypomagnesemia 6, renal, 613882 (3); Hypomagnesemia, seizures, and mental retardation, 616418 (3)	19(Cnnm2)
10.503	1	27	11	10q22.1	DDIT4, REDD1, RTP801		DNA damage-inducible transcript 4	607729	REc			
10.504	2	10	17	10q24.33	STN1, OBFC1, AAF44		STN1, CST complex subunit	613128	REc		Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3)	19(Obfc1)
10.505	12	28	08	10q24.33	PCGF6, RNF134, MBLR		Polycomb group ring finger 6	607816	R, REc			
10.506	9	24	15	10q24.3-q25.1	SLK, LOSK, KIAA0204		STE20-like protein kinase	616563	R, REc			
10.507	11	13	15	10q25.2	SMC3, CSPG6, HCAP, BAM, CDLS3		Structural maintenance of chromosomes 3	606062	R, H		Cornelia de Lange syndrome 3, 610759 (3)	19(Bam)
10.508	11	4	98	10q25.2	DUSP5, HVH3		Dual-specificity phosphatase-5	603069	A			
10.509	12	9	98	10q25	IDDM17		Insulin-dependent diabetes mellitus-17	603266	Fd		{Diabetes mellitus, insulin-dependent, 17} (2)	
10.510	2	18	98	10q25.3	LIMAB1		LIM actin-binding protein-1	602330	A, R			19(Limab1)
10.511	11	29	99	10q25.2	MXI1		MAX-interacting protein 1	600020	A, D		Neurofibrosarcoma (3); {Prostate cancer, susceptibility to}, 176807 (3)	19(Mxi1)
10.512	1	26	17	10q24.32	PITX3, CTPP4, CTRCT11, ASGD1		Paired-like homeodomain transcription factor-3	602669	R		Anterior segment dysgenesis 1, multiple subtypes, 107250 (3); Cataract 11, multiple types, 610623 (3); Cataract 11, syndromic, 610623 (3)	19(Pitx3)
10.513	10	12	09	10q25.2	SHOC2, SIAA0862, SOC2, SUR8		Suppressor of clear, C. elegans, homolog of	602775	A		Noonan-like syndrome with loose anagen hair, 607721 (3)	
10.514	7	5	18	10q25.3	SLC18A2, VAT2, SVMT, PKDYS2		Solute carrier family 18 (vesicular monoamine), member 2	193001	REa, A	mutation identified in 1 PKDYS2 family	?Parkinsonism-dystonia, infantile, 2, 618049 (3)	19(Slc18a2)
10.515	5	19	06	10q26.13	ACADSB, SBCAD		Acyl-Coenzyme A dehydrogenase, short/branched chain	600301	REa, A		2-methylbutyrylglycinuria, 610006 (3)	
10.516	12	2	05	10q25-q26	EIG4		Epilepsy, idiopathic generalized, susceptibility to 4	609750	Fd	between D16S397 and D16S3095	{Epilepsy, idiopathic generalized, susceptibility to 4} (2)	
10.517	9	1	15	10q25.3	HABP2, PHBP, HGFAL, FSAP, NMTC5		Hyaluronan-binding protein 2	603924	A	mutation identified in 1 NMTC5 family	{?Thyroid cancer, nonmedullary, 5}, 616535 (3); {Venous thromboembolism, susceptibility to}, 188050 (3)	
10.518	12	14	00	10q26.11	PRDX3, AOP1		Peroxiredoxin 3 (antioxidant protein 1)	604769	A			19(Aop1)
10.519	10	15	91	10q26.2	MKI67		Proliferation-related Ki-67 antigen	176741	S, REa, A			7(Mki67)
10.520	7	24	17	10q25.1	CFAP43, WDR96, C10orf79, SPGF19		Cilia- and flagella-associated protein 43	617558	REc		Spermatogenic failure 19, 617592 (3)	
10.521	12	28	08	10q25.3	DCLRE1A, SNM1, SNM1A, KIAA0086		DNA cross-link repair protein 1A	609682	Psh, REc			
10.522	7	17	14	10q24.33	NEURL1, NEURL, NEUR1		Neuralized E3 ubiquitin protein ligase 1	603804	R, A			
10.523	8	26	15	10q25.1	SFR1, MEI5, C10orf78		SWI5-dependent homologous recombination repair protein 1	616527	REc			
10.524	9	18	08	10q25.2	ACSL5, FACL5, ACS5		Acyl-CoA synthetase long-chain family member 5	605677	REc			
10.525	7	1	97	10q25.3	CASP7, MCH3		Caspase 7, apoptosis-related cysteine protease	601761	R			
10.526	10	24	14	10q25.2	BBIP1, NCRNA00081, BBIP10, BBS18		BBSome interacting protein 1	613605	REc	mutation identified in 1 BBS18 family	?Bardet-Biedl syndrome 18, 615995 (3)	
10.527	12	21	09	10q25.2	RBM20		RNA-binding motif protein 20	613171	REc		Cardiomyopathy, dilated, 1DD, 613172 (3)	
10.528	11	10	14	10q25.2	VTI1A, VTI1RP2, MMDS3		VTI1, S. cerevisiae, homolog of, A	614316	REc			
10.529	1	27	04	10q26.3	DPYSL4, CRMP3, ULIP4		Dihydropyrimidinase-like 4	608407	A, H			7(Ulip4)
10.530	8	6	13	10q26.11	BAG3, MFM6		BCL2-associated athanogene 3	603883	REc		Myopathy, myofibrillar, 6, 612954 (3); Cardiomyopathy, dilated, 1HH, 613881 (3)	
10.531	9	27	17	10q25.2	TECTB		Tectorin, beta	602653	REc			
10.532	3	20	97	10q26.13	HMX2		Homeo box (H6 family) 2	600647	REa			
10.533	5	14	02	10q26.2	UROS		Uroporphyrinogen III synthase	606938	REa, Psh		Porphyria, congenital erythropoietic, 263700 (3)	7(Uros)
10.534	12	18	08	10q25.3	AFAP1L2, XB130, KIAA1914		Actin filament-associated protein 1-like protein 2	612420	A, REc			
10.535	1	26	17	10q25.3	FAM160B1, KIAA1600		Family with sequence similarity 160, member B1	617312	REc			
10.536	4	24	18	10q25.3	SHTN1, KIAA1598, SHOOTIN1		Shootin1	611171	REc, R			
10.537	11	22	10	10q25.3	KCNK18, TRESK, TRIK, MGR13		Potassium channel, subfamily K, member 18	613655	REc, H		{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	19(Kcnk18)
10.538	6	5	89	10q24.1	PGAM1		Phosphoglycerate mutase A, nonmuscle form	172250	D, H			19(Pgam1)
10.539	3	18	12	10q25.3	PNLIPRP1, PLRP1		Pancreatic lipase-related protein 1	604422	REc			
10.540	8	23	10	10q25.3	PNLIPRP2, PLRP2		Pancreatic lipase-related protein 2	604423	REc			
10.541	7	3	06	10q25.2-q25.3	TCF7L2, TCF4		Transcription factor 7-like 2	602228	A, Fd		{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
10.542	8	26	09	10q25.3	TDRD1		Tudor domain protein 1	605796	R, REc			
10.543	1	29	07	10q25.3	TRUB1, PUS4		TRUB pseudouridine synthase, E. coli, homolog of, 1	610726	REc			
10.544	10	11	05	10q25.1	XPNPEP1, SAMP, XPNPEPL		X-prolyl aminopeptidase P1	602443	A, REa			
10.545	11	5	95	10q26.11	GPR10		G protein-coupled receptor-10	600895	A			
10.546	10	29	09	10q26.13	DMBT1		Deleted in malignant brain tumors 1	601969	D			
10.547	9	21	11	10q25.3-q26.1	PDZD8		PDZ domain-containing protein 8	614235	REc			
10.548	3	11	08	10q26.2	BCCIP, TOK1		BRCA2- and CDKN1A-interacting protein	611883	A, REc			
10.549	2	3	16	10q26.13	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2		HTRA serine peptidase 1	602194	A		{Macular degeneration, age-related, 7}, 610149 (3); {Macular degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3); Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	
10.550	2	25	16	10q26.13	PLEKHA1, TAPP1		Pleckstrin homology domain-containing protein, family A, member 1	607772	REc			
10.551	8	20	98	10q25.3-q26.3	ADORA2L1, ADORA2L		Adenosine A2 receptor-like 1	102777	A			
10.552	7	20	09	10q25.3	ATRNL1, KIAA0534, ALP		Attractin-like 1	612869	R, REc			
10.553	7	1	09	10q26.11	CASC2		Cancer susceptibility candidate 2	608598	REc	head-to-head orientation with RAB11FIP2		
10.554	9	7	10	10q26.13	CHST15, BRAG, KIAA0598		Carbohydrate sulfotransferase 15	608277	R, REa			
10.555	4	7	13	10q26	CORD17		Cone-rod dystrophy 17	615163	Fd	between D10S1757 and D10S1782	Cone-rod dystrophy 17 (2)	
10.556	11	16	08	10q26	DEL10q26, C10q26DEL		Chromosome 10q26 deletion syndrome	609625	Ch		Chromosome 10q26 deletion syndrome (4)	
10.557	4	30	09	10q26.2	DHX32, DDX32		DEAH (Asp-Glu-Ala-His) box polypeptide 32	607960	REc			
10.558	10	3	07	10q26.11	EIF3A, EIF3S10, P167		Eukaryotic translation initiation factor 3, subunit A	602039	REc, A			
10.559	9	1	05	10q26	ENDO1		Endometriosis, susceptibility to, 1	131200	Fd	max lod at D10S587	{Endometriosis, susceptibility to, 1} (2)	
10.560	2	19	04	10q26.13	FGFR2, BEK, CFD1, JWS, TK14, BBDS		Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	A, Psh, Fd		Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600 (3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3); Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 613659 (3); Craniofacial-skeletal-dermatologic dysplasia, 101600 (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3); Scaphocephaly and Axenfeld-Rieger anomaly (3); LADD syndrome, 149730 (3); Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3); Bent bone dysplasia syndrome, 614592 (3)	7(Fgfr2)
10.561	6	29	98	10q25.3	GFRA1, GDNFRA, GDNFR		GDNF family receptor, alpha-1	601496	A, R			19(Gfra1)
10.562	9	12	93	10q26.3	MGMT		Methylguanine-DNA methyltransferase	156569	REa, A			
10.563	7	28	17	10q26.3	NKX6-2, NKX6B, NKX6.2, SPAX8		NK6 transcription factor related, locus 2 (Drosophila)	605955	REc, R		Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3)	7(Nkx6b)
10.564	4	20	10	10q26.13	OAT, GACR		Ornithine aminotransferase	613349	S, REa, A, Fd	pseudogene at Xp11.2	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	7(Oat)
10.565	5	7	01	10q23.33	PDLIM1, CLP36, CLIM1		PDZ and LIM domain protein 1	605900	A, R, REa			
10.566	1	1	96	10q26.2	PTPRE		Protein tyrosine phosphatase, receptor type, epsilon	600926	A			7(Ptpre)
10.567	12	29	06	10q26.11	RAB11FIP2, KIAA0941		RAB11 family-interacting protein 2	608599	REc			
10.568	1	25	05	10q26	RRIS		Respiratory rhythmicity in sleep	609116	Fd		[Respiratory rhythmicity in sleep] (2)	
10.569	1	31	01	10q26.13	TACC2		Transforming, acidic, coiled-coil-containing protein 2	605302	REc			
10.570	8	17	99	10q26.3	UTF1		Undifferentiated embryonic cell transcription factor 1	604130	A			7(Utf1)
10.571	10	11	12	10q26.12	WDR11, DR11, KIAA1351, BRWD2, HH14		WD repeat-containing protein 11	606417	REc, Ch		Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	
10.572	4	15	02	10q26.11	EMX2		Empty spiracles, Drosophila, homolog of, 2	600035	REa, A	close to VAX1	Schizencephaly, 269160 (3)	19(Emx2)
10.573	5	23	14	10q26.3	JAKMIP3, C10orf39, NECC2, JAMIP3		Janus kinase and microtubule interacting protein 3	611198	REc			
10.574	3	20	03	10q26.11	EMX2OS		EMX2 opposite strand	607637	REc	non-coding RNA		19(Emx2os)
10.575	5	30	17	10q25.3	PNLIP, PNLIPD		Pancreatic lipase	246600	REa, A	mutation identified in 1 family	?Pancreatic lipase deficiency, 614338 (3)	
10.576	2	2	15	10q25.3	VAX1, MCOPS11		Ventral anterior homeo box 1	604294	H, REc	mutation identified in one MCOPS11 family	?Microphthalmia, syndromic 11, 614402 (3)	19(Vax1)
10.577	12	6	16	10q26.11	INPP5F, SAC2, KIAA0966		Inositol polyphosphate 5-phosphatase F	609389	REc			
10.578	4	17	07	10q26.11	MCMBP, C10orf119		Minichromosome maintenance complex-binding protein	610909	R, REc			
10.579	9	23	13	10q26.11	NANOS1, NOS1, SPGF12		NANOS, Drosophila, homolog of, 1	608226	R, REc		Spermatogenic failure 12, 615413 (3)	
10.580	1	2	14	10q26.11	SFXN4, COXPD18		Sideroflexin 4	615564	REc		Combined oxidative phosphorylation deficiency 18, 615578 (3)	
10.581	1	25	18	10q26.11-q26.12	SEC23IP		Sec23-interacting protein	617852	REc			
10.582	1	16	07	10q25.3	HSPA12A, KIAA0417		Heat-shock 70kD protein 12A	610701	R, REc			19(Hspa12a)
10.583	2	10	17	10q26.13	CPXM2, CPX2		Carboxypeptidase X, M14 family, member 2	617348	REc			
10.584	4	23	08	10q26.13	CTBP2		C-terminal-binding protein 2	602619	REc			
10.585	11	20	15	10q26.13	CUZD1, ERG1, ITMAP1		Cub and zona pellucida-like domains 1	616644	REc			
10.586	12	6	17	10q26.13	EEF1AKMT2, METTL10		EEF1A lysine methyltransferase 2	617794	REc			
10.587	1	9	17	10q26.13	FAM53B, KIAA0140		Family with sequence similarity 53, member B	617289	Psh, REc			
10.588	4	23	09	10q26.13	FAM175B, ABRO1, KIAA0157		Family with sequence similarity 175, member B	611144	Psh, REc			
10.589	4	26	10	10q26.13	HMX3, NKX5.1		H6 family homeobox 3	613380	REc			7(Hmx3)
10.590	9	27	17	10q26.13	IFZF5, ZNFN1A5, PEGASUS		Ikaros family zinc finger 5	606238	REc			
10.591	12	5	16	10q26.13	LHPP		Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	617231	REc			
10.592	3	10	11	10q26.13	LOC387715, ARMD8		LOC387715 gene	611313	REc, Fd		{Macular degeneration, age-related, 8}, 613778 (3)	
10.593	1	20	16	10q26.2	MMP21, HTX7		Matrix metalloproteinase 21	608416	REc		Heterotaxy, visceral, 7, autosomal, 616749 (3)	
10.594	9	9	09	10q26.13	NSMCE4A, NSE4A		Non-SMC element 4, S. cerevisiae, homolog of, A	612987	REc			
10.595	4	6	15	10q26.13	PSTK, C10orf89		Phosphoseryl-tRNA kinase	611310	R, REc			
10.596	1	23	08	10q26.13	ZRANB1, TRABID		Zinc finger- and RAN-binding domain-containing protein 1	611749	R, REc			
10.597	6	3	98	10q26.2	DOCK1, DOCK180		Dedicator of cytokinesis-1	601403	A			
10.598	10	25	17	10q26.2	C10orf90, FATS		Chromosome 10 open reading frame 90	617735	REc			
10.599	9	26	16	10q26.2	FAM196A, C10orf141, INSYN2		Family with sequence similarity 196, member A	617129	REc			
10.600	12	18	07	10q26.2	FANK1		Fibronectin type III and ankyrin repeat domains 1	611640	R, REc			
10.601	11	23	16	10q26.2	FOXI2		Forkhead box I2	617202	REc			
10.602	8	17	09	10q26.2	NPS		Neuropeptide S	609513	REc			
10.603	3	27	15	10q26.3	ECHS1, SCEH, ECHS1D		Enoyl-CoA hydratase, short-chain, 1, mitochondrial	602292	A		Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	
10.604	5	11	00	10q26.13	GPR26		G protein-coupled receptor 26	604847	A			
10.605	7	13	98	10q26.3	ADAM8, CD156		A disintegrin and metalloprotease domain 8	602267	A			7(Adam8)
10.606	12	11	98	10q26.2	ADAM12, MLTN		A disintegrin and metalloproteinase domain 12 (Meltrin-alpha, mouse, homolog of)	602714	A, R			
10.607	9	1	16	10q26.3	ADGRA1, GPR123, KIAA1828		Adhesion G protein-coupled receptor A1	612302	REc			
10.608	6	10	11	10q26.3	BNIP3, NIP3		BCL2/adenovirus E1B 19-kD protein-interacting protein 3	603293	REc			
10.609	6	27	14	10q26.3	CALY, DRD1IP		Calcyon neuron-specific vesicular protein	604647	REc			
10.610	2	9	17	10q26.3	EBF3, COE3, HADDS		Early B-cell factor 3	607407	REc		Hypotonia, ataxia, and delayed development syndrome, 617330 (3)	
10.611	10	25	17	10q26.3	FUOM, FUCU		Fucose mutarotase	617725	REc			
10.612	5	12	09	10q26.3	GLRX3, PICOT		Glutaredoxin 3	612754	REc			
10.613	1	20	98	10q26.3	INPP5A		Inositol polyphosphate-5-phosphatase, 40kD	600106	A			
10.614	2	25	15	10q26.3	KNDC1, RASGEF2, KIAA1768		Kinase noncatalytic C-lobe domain-containing protein 1	616237	R, REc			
10.615	7	18	14	10q26.3	PAOX, PAO		Polyamine oxidase	615853	REc			7(Paox)
10.616	9	8	11	10q26.3	PPP2R2D		Protein phosphatase 2, regulatory subunit B, delta	613992	REc			
10.617	12	20	05	10q26.3	PRAP1		Proline-rich acidic protein 1	609776	R, REc			
10.618	12	1	06	10q26.3	SPRN, SHADOO, SHO		Shadow of prion protein	610447	REc			7(Sprn)
10.619	5	23	16	10q26.3	SYCE1, POF12, SPGF15		Synaptonemal complex central element protein 1	611486	REc	mutation identified in 1 POF12 and 1 SPGF15 family	?Premature ovarian failure 12, 616947 (3); ?Spermatogenic failure 15, 616950 (3)	
10.620	12	22	17	10q26.3	TUBGCP2, GCP2, GRIP103, SPC97, ALP4		Tubulin-gamma complex-associated protein 2	617817	REc			
10.621	6	12	12	10q26.3	VENTX, VENTX2, HPX42B		VENT homeobox	607158	A			
11.1	2	22	18	11q14.1	ALG8, CDG1H, PCLD3		Alg8, S. cerevisiae, homolog of	608103	REc		Congenital disorder of glycosylation, type Ih, 608104 (3); Polycystic liver disease 3 with or without kidney cysts, 617874 (3)	
11.2	12	11	01	11p15.2	RRAS2, TC21		Related Ras viral oncogene homolog 2	600098	R		Ovarian carcinoma (3)	
11.3	7	20	09	11p15.4	AMPD3		Adenosine monophosphate deaminase-3, isoform E	102772	REa		[AMP deaminase deficiency, erythrocytic], 612874 (3)	7(Ampd3)
11.4	5	4	12	11p13	CD44, MDU2, MDU3, MIC4, IN		CD44 antigen (homing function)	107269	S		[Blood group, Indian system], 609027 (3)	2(Ly24)
11.5	3	6	94	11pter-p11.2	TP250		T-cell activation antigen p250	186710	S			
11.6	5	12	08	11p15.5	AP2A2, KIAA0899		Adaptor-related protein complex 2, alpha-2 subunit	607242	R, REc			
11.7	8	4	97	11p15.5	ASCL2		Achaete-scute complex, Drosophila, homolog-like 2	601886	A			
11.8	9	23	13	11p15.5	BET1L, GS15		BET1-like protein	615417	REc			
11.9	5	23	13	11p15.5	BRSK2, SAD1, PEN11B		BR serine/threonine kinase 2	609236	A			
11.10	8	20	07	11p15.5	C11orf21		Chromosome 11 open reading frame 21	611033	REc			
11.11	11	4	93	11p15.4	CARS		Cysteinyl-tRNA synthetase	123859	REa, A			
11.12	7	20	06	11p15.5	CD151, PETA3, SFA1, MER2		CD151 antigen	602243	A, S, REa		Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3); [Blood group, Raph], 179620 (3)	
11.13	12	10	10	11p15.5	CDHR5, MUCDHL		Cadherin-related family, member 5	606839	REc			
11.14	7	20	12	11p15.4	CDKN1C, KIP2, BWS, IMAGE		Cyclin-dependent kinase inhibitor 1C (p57, Kip2)	600856	A, Ch, Fd	rare cause of BWS	Beckwith-Wiedemann syndrome, 130650 (3); IMAGE syndrome, 614732 (3)	7(Kip2)
11.15	12	19	11	11p15.5	CEND1, BM88		Cell cycle exit and neuronal differentiation 1	608213	REc, A			
11.16	3	14	14	11p15.5	CHID1, SICLP		Chitinase domain-containing protein 1	615692	REc			
11.17	11	28	01	11p15.4	CHRNA10		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10	606372	A, R			
11.18	5	31	06	11p15.5	CTSD, CPSD, CLN10		Cathepsin D (lysosomal aspartyl protease)	116840	REa, A		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	
11.19	11	15	16	11p15.5	DEAF1, SPN, ZMYND5, MRD24		Deaf1, Drosophila, homolog of	602635	REc	mutation identified in 1 DYSEIDD family	Mental retardation, autosomal dominant 24, 615828 (3); ?Dyskinesia, seizures, and intellectual developmental disorder, 617171 (3)	
11.20	11	16	10	11p15.5	DRD4		Dopamine receptor D4	126452	Fd	proximal to HRAS	Autonomic nervous system dysfunction (3); [Novelty seeking personality], 601696 (1); {Attention deficit-hyperactivity disorder}, 143465 (3)	
11.21	3	9	98	11p15.5	DUSP8, HVH8		Dual specificity phosphatase-8	602038	A	pseudogene on 10q11.2		7(Dusp8)
11.22	9	6	11	11p15.5	EFCAB4A, CRACR2B		EF-hand calcium-binding domain-containing protein 4A	614177	REc			
11.23	7	23	09	11p15.5	H19, D11S813E, ASM1, BWS, WT2		H19 gene	103280	REa, A, RE	same 200kb fragment as IGF2	Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome, 180860 (3); Wilms tumor 2, 194071 (3)	7(H19)
11.24	4	23	08	11p15.5	HCCA2		HCCA2 gene	611969	REc			
11.25	2	3	15	11p15.5	ICR1		H19-IGF2-imprinting control region	616186	REn		Beckwith-Wiedemann syndrome, 130650 (3)	
11.26	8	9	12	11p15.5	IFITM1, IFI17, LEU13		Interferon-induced transmembrane protein 1	604456	R, REc			
11.27	8	9	12	11p15.5	IFITM2		Interferon-induced transmembrane protein 1	605578	R, REc			
11.28	7	20	12	11p15.5	IFITM3		Interferon-induced transmembrane protein 3	605579	R, REc		{Influenza, severe, susceptibility to}, 614680 (3)	
11.29	9	21	12	11p15.5	IFITM5, OI5		Interferon-induced transmembrane protein 5	614757	REc		Osteogenesis imperfecta, type V, 610967 (3)	
11.30	5	13	15	11p15.5	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39		Interferon regulatory factor 7	605047	REc	mutation identified in 1 family	?Immunodeficiency 39, 616345 (3)	
11.31	10	28	10	11p15.5-p15.4	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2		Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	Fd		Long QT syndrome 1, 192500 (3); Jervell and Lange-Nielsen syndrome, 220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome 2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	7(Kcnq1)
11.32	8	25	03	11p15.4	LCRB		Locus control region beta	152424	REc		Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	
11.33	9	9	09	11p15.5	MIR210, MIRN210		Micro RNA 210	612982	REc			
11.34	3	31	09	11p15.4	MRGPRG, MRGG		MAS-related G protein-coupled receptor family, member G	607234	REc			
11.35	8	28	92	11p15.5	MUC2		Mucin 2, intestinal/tracheal	158370	REa			
11.36	6	13	95	11p15.5	MUC5AC, MUC5		Mucin 5, subtypes A and C, tracheobronchial/gastric	158373	REa, A			
11.37	6	14	18	11p15.4	HBB, ECYT6		Hemoglobin beta	141900	LD, AAS, F, Fd	pseudogene HBBP1 between HBG and HBD loci	Sickle cell anemia, 603903 (3); Thalassemia, beta, 613985 (3); Methmoglobinemia, beta type, 617971 (3); Heinz body anemia, 140700 (3); Thalassemia-beta, dominant inclusion-body, 603902 (3); Delta-beta thalassemia, 141749 (3); Hereditary persistence of fetal hemoglobin, 141749 (3); {Malaria, resistance to}, 611162 (3); Erythrocytosis 6, 617980 (3)	7(Hbb)
11.38	6	16	97	11p15.4	HBD		Hemoglobin delta	142000	AAS		Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)	
11.39	11	13	07	11p15.4	HBG1		Hemoglobin, gamma A	142200	RE		Fetal hemoglobin quantitative trait locus 1, 141749 (3)	
11.40	6	15	11	11p15.4	HBG2, TNCY		Hemoglobin, gamma G	142250	RE		Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis, transient neonatal, 613977 (3)	
11.41	3	1	89	11p15.4	HBE1		Hemoglobin epsilon	142100	RE			
11.42	6	18	15	11p15.5	HRAS		Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	S	pseudogene HRASP on X	{Bladder cancer, somatic}, 109800 (3); Costello syndrome, 218040 (3); {Thyroid carcinoma, follicular, somatic}, 188470 (3); Congenital myopathy with excess of muscle spindles, 218040 (3); {Nevus sebaceous or woolly hair nevus, somatic}, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); {Spitz nevus or nevus spilus, somatic}, 137550 (3)	7(Hras1)
11.43	7	28	15	11p15.5	IGF2, GRDF		Insulin-like growth factor-2, or somatomedin A	147470	REa, A, RE	mutation identified in 1 GRDF family	?Growth restriction, severe, with distinctive facies, 616489 (3)	7(Igf2)
11.44	7	8	13	11p15.5	IGF2AS, PEG8		Insulin-like growth factor II, antisense	610146	REc			
11.45	2	5	15	11p15.5	INS, MODY10, IDDM2		Insulin	176730	HS, A, REb, Fd, D	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Hyperproinsulinemia, 616214 (3); Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal, 606176 (3); Diabetes mellitus, insulin-dependent, 2, 125852 (3)	6(Ins1); 7(Ins2)
11.46	2	28	03	11p15.5	IRDN, ILPR		Insulin-related DNA polymorphism (insulin-related VNTR)	147510	Fd			
11.47	5	22	07	11p15.4	KCNQ1DN		KCNQ1 downstream neighbor	610980	REc			
11.48	4	29	17	11p15.5	PHRF1, KIAA1542		PHD and RING finger domain-containing protein 1	611780	R, REc			
11.49	8	16	99	11p15.5	KCNQ1OT1, LIT1		KCNQ1-overlapping transcript 1	604115	REc		Beckwith-Wiedemann syndrome, 130650 (3)	7(Kcnq10t1)
11.50	12	19	90	11p15.5	KRTAP5-1, KRN1L		Keratin associated protein 5-1	148022	A			
11.51	3	23	93	11p15.5	LSP1		Lymphocyte-specific protein pp52	153432	A			
11.52	11	22	13	11p15.5	MIR675		Micro RNA 675	615509	REc			
11.53	3	7	06	11p15.5	NALP6, PYPAF5		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 6	609650	REc			
11.54	6	9	98	11p15.4	NAP1L4, NAP2L, NAP2		Nucleosome assembly protein 1-like 4	601651	REc			
11.55	1	27	04	11p15.5	ODF3, SHIPPO1		Outer dense fiber of sperm tails 3	608356	REc			7(Odf3)
11.56	5	23	13	11p15.4	PGAP2, FRAG1, HPMRS3, MRT17, MRT21		Post-GPI attachment to proteins 2	615187	A, R		Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	
11.57	7	14	16	11p15.5	PGGHG, ATHL1		Protein-glucosylgalactosylhydroxylysine glucosidase	617032	REc			
11.58	10	28	04	11p15.4	PHLDA2, TSSC3, IPL, BRW1C		Pleckstrin homology-like domain, family A, member 2	602131	REn			7(Ipl)
11.59	11	11	14	11p15.5	PIDD1, LRDD		p53-induced death domain protein 1	605247	REc, H			
11.60	1	24	07	11p15.5	PNPLA2, TTS2, ATGL		Patatin-like phospholipase domain-containing protein 2	609059	R		Neutral lipid storage disease with myopathy, 610717 (3)	7(Pnpla2)
11.61	9	24	12	11p15.5	PSMD13, S11		Proteasome 26S subunit, non-ATPase, 13	603481	REc, R			
11.62	5	26	09	11p15.5	PTDSS2, PSS2		Phosphatidylserine synthase 2	612793	REc			
11.63	9	7	12	11p15.5	RASSF7, C11orf13, HRC1		RAS association domain family, member 7	143023	REn	29kb 5' to HRAS1; divergently transcribed		
11.64	12	10	12	11p15.5	RIC8A		Ric8, C. elegans, homolog of, A	609146	REc, R			
11.65	1	22	15	11p15.5	RNH1, RNH		Ribonuclease/angiogenin inhibitor 1	173320	REa, A			
11.66	12	22	98	11p15.5	RPL23L, L23MRP, MRPL23		Ribosomal protein L23-like (L23 mitochondrial-related protein)	600789	REn			
11.67	6	22	12	11p15.5	RPLP2		Ribosomal phosphoprotein, large, P2	180530	REc			
11.68	7	13	93	11p15.4	RRM1		Ribonucleotide reductase, M1 polypeptide	180410	S, REa, A			7(Rrm1)
11.69	2	25	15	11p15.5	SCGB1C1, RYD5		Secretoglobin, family 1C, member 1	610176	REc			
11.70	2	14	01	11p15.5	SCT		Secretin	182099	R			
11.71	1	30	01	11p15.5	SIGIRR		Single immunoglobulin domain-containing IL1R-related protein	605478	R			
11.72	5	4	00	11p15.5	SIRT3, SIR2L3		Sirtuin, S. cerevisiae, homolog 3	604481	REc			
11.73	2	3	00	11p15.4	SLC22A1LS, ORCTL2S, BWSCR1B		Solute carrier family 22, member 1-like-antisense	603240	REc			
11.74	6	23	11	11p15.4	SLC22A1L, BWSCR1A, IMPT1		Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631	REn		Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210 (3); Lung cancer, somatic, 211980 (3)	
11.75	4	7	05	11p15.5	SLC25A22, GC1, EIEE3		Solute carrier family 25 (mitochondrial carrier, glutamate), member 22	609302	REc, Fd		Epileptic encephalopathy, early infantile, 3, 609304 (3)	
11.76	12	11	03	11p15.5	SLEN3		Systemic lupus erythematosus with nephritis, susceptibility to, 3	607967	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)	
11.77	7	17	14	11p15.4	STIM1, TAM1, IMD10, STRMK		Stromal interaction molecule 1	605921	REn		Immunodeficiency 10, 612783 (3); Myopathy, tubular aggregate, 1 160565 (3); Stormorken syndrome, 185070 (3)	
11.78	5	22	13	11p15.5	SYT8		Synaptotagmin 8	607719	REc			
11.79	1	20	09	11p15.5	TH, TYH		Tyrosine hydroxylase	191290	REa, A, Fd, RE	distal to HRAS1	Segawa syndrome, recessive, 605407 (3)	7(Th)
11.80	3	3	03	11p15.5	TNNI2, AMCD2B, DA2B, FSSV		Troponin I, fast-twitch skeletal muscle isoform	191043	R, Fd		Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	
11.81	8	11	03	11p15.5	TNNT3, AMCD2B, DA2B, FSSV		Troponin-T3, skeletal, fast	600692	REa, A, Fd		Arthrogryposis, distal, type 2B, 601680 (3)	7(Tnnt3)
11.82	3	8	07	11p15.4	TRIM21, SSA1, RO52		Tripartite motif-containing protein 21	109092	A			
11.83	7	9	06	11p15.5	TOLLIP		Toll-interacting protein	606277	R, REc			
11.84	1	14	14	11p15.4	TPP1, CLN2, SCAR7		Tripeptidyl peptidase 1	607998	Fd, LD		Ceroid lipofuscinosis, neuronal, 2, 204500 (3); Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	
11.85	1	14	02	11p15.5	TRPM5, MTR1		Transient receptor potential cation channel, subfamily M, member 5 (MLSN1- and TRP-related gene 1)	604600	REc	maternal allele imprinted		7(Mtr1)
11.86	1	20	06	11p15.5	TSPAN4, TM4SF7, NAG2		Tetraspanin 4	602644	REc			
11.87	1	20	06	11p15.5	TSPAN32, PHEMX, TSSC6		Tetraspanin 32	603853	RE	not imprinted		
11.88	11	2	04	11p15.4	TSSC2		Tumor-suppressing subtransferable fragment candidate gene 2	608999	REc			
11.89	8	31	99	11p15.5	TSSC4		Tumor-suppressing subchromosomal transferable fragment cDNA 4	603852	RE	not imprinted		
11.90	3	9	98	11p15.4	ZNF195		Zinc finger protein-195	602187	REc			
11.91	12	4	02	11p15.4	FXC1, TIMM10B		Fracture callus 1, rat, homolog of	607388	A, R			
11.92	7	13	93	11p15.4	ARHG		ras homolog gene family, member G (rho G)	179505	A			
11.93	3	6	94	11p15.4	CCKBR, GASR		Cholecystokinin B receptor	118445	REa, A			7(Cckbr)
11.94	12	17	87	11p15.4	HPX		Hemopexin	142290	REa, A			
11.95	6	25	99	11p15.4	ILK, P59		Integrin-linked kinase	602366	A			
11.96	2	26	08	11p15.4	MRPL17		Mitochondrial ribosomal protein L17	611830	R			
11.97	2	20	97	11p15.5	MUC6		Mucin 6, gastric	158374	A	order: tel-HRAS-MUC6-MUC2-MUC5AC-MUC5B-IGF2-cen		
11.98	8	9	01	11p15.5	TALDO1		Transaldolase-1	602063	REa, A, R	pseudogene on chr.1	Transaldolase deficiency, 606003 (3)	
11.99	10	16	89	11p15.1	LDHC, LDH3		Lactate dehydrogenase C	150150	REa, A, REb	closely linked to LDHB in other species; in man syntenic with LDHA; ?close to LDHA		7(Ldh3)
11.100	7	15	99	11p15.4	ADM		Adrenomedullin	103275	REa			7(Adm)
11.101	10	2	12	11p15.4	ARFIP2, POR1		ADP-ribosylation factor-interacting protein 2	601638	REc			
11.102	4	13	15	11p15.4	BGLT3, LINC01083		Beta-globin locus transcript 3, noncoding	616308	REc			
11.103	3	20	09	11p15.4	CYB5R2		Cytochrome b5 reductase 2	608342	REc			
11.104	11	17	15	11p15.4	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2		Dachsous, Drosophila, homolog of, 1	603057	REc		Van Maldergem syndrome 1, 601390 (3); Mitral valve prolapse 2, 607829 (3)	
11.105	1	11	17	11p15.4	DENND5A, RAB6IP1, KIAA1091, EIEE49		DENN domain-containing protein 5A	617278	REc		Epileptic encephalopathy, early infantile, 49, 617281 (3)	
11.106	12	27	16	11p15.4	DHND1, FLJ00251		Dynein heavy chain domain 1	617277	REc			
11.107	10	3	07	11p15.4	EIF3F, EIF3S5		Eukaryotic translation initiation factor 3, subunit F	603914	REc			
11.108	12	8	14	11p15.4	GVINP1, VLIG1		GTPase, very large interferon-inducible, pseudogene 1	616121	REc			7(Gvin1)
11.109	8	17	09	11p15.1	LDHA, LDH1, GSD11		Lactate dehydrogenase A	150000	S, D, REb, C, A		Glycogen storage disease XI, 612933 (3)	7(Ldh1)
11.110	3	31	09	11p15.4	MRGPRE, MRGE		Mas-related G protein-coupled receptor family, member E	607232	REc			
11.111	4	30	91	11p15.1	MYOD1, MYF3		Myogenic factor-3	159970	REa, A	proximal to CALCA, HBB, BWS, PTH; ?11p14.3		7(Myod1)
11.112	4	17	13	11p15.4	NLRP1, NALP14, NOD5		NLR family, pyrin domain containing 1	609665	REc			
11.113	8	8	13	11p15.4	OR10A1		Olfactory receptor, family 10, subfamily A, member 1	608493	REc, A			
11.114	8	8	13	11p15.4	OR2D2		Olfactory receptor, family 2, subfamily D, member 2	608494	REc, A			
11.115	8	19	13	11p15.4	OR51E1, DGPCR, PSGR2		Olfactory receptor, family 51, subfamily E, member 1	611267	REn			
11.116	8	19	13	11p15.4	OR51E2, PSGR		Olfactory receptor, family 51, subfamily E, member 2	611268	REn			
11.117	5	7	03	11p15.4	OSBPL5, ORP5, KIAA1534		Oxysterol-binding protein-like protein 5	606733	R, REc			
11.118	12	10	12	11p15.4	RIC3		Resistance to inhibitors of cholinesterase 3, C. elegans, homolog of	610509	REc			
11.119	7	18	14	11p15.4	RRP8, NML, KIAA0409		Ribosomal RNA processing protein 8, homolog of	615818	R, REc			
11.120	4	19	12	11p15.4	SCUBE2		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 2	611747	REc			
11.121	4	2	16	11p15.4	SNORA3B, SNORA45		Small nucleolar RNA, H/ACA box 3B	611333	REc			
11.122	8	17	10	11p15.4	SYT9		Synaptotagmin 9	613528	REc			
11.123	4	17	12	11p15.4	TRIM3, RNF22, BERP		Tripartite motif-containing 3	605493	R, REc			
11.124	4	23	08	11p15.4	TRIM66, TIF1D, KIAA0298		Tripartite motif-containing protein 66	612000	R, REc			
11.125	12	21	09	11p15.4	TRIM68, SS56, GC109		Tripartite motif-containing protein 68	613184	REc	incorrectly assigned to 2p24 by FISH		
11.126	2	3	15	11p15.4	TUB, RDOB		Tubby, mouse, homolog of	601197	REc, H	mutation identified in 1 RDOB family	?Retinal dystrophy and obesity, 616188 (3)	
11.127	6	26	00	11p15.4	ZNF214		Zinc finger protein-214	605015	REc			
11.128	6	26	00	11p15.4	ZNF215		Zinc finger protein-215	605016	REc			
11.129	2	25	15	11p15.4	MRVI1, IRAG		Murine retrovirus integration site 1, homolog of	604673	REc			
11.130	2	28	01	11p15.4	TRIM34, RNF21, IFP1		Tripartite motif-containing 34 (RING finger protein-21)	605684	A			
11.131	6	6	00	11p15.4	ZNF143, SBF		Zinc finger protein-143	603433	A			
11.132	3	31	03	11p15.4	SMPD1, NPD		Sphingomyelin phosphodiesterase-1, acid lysosomal	607608	REa, A		Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type B, 607616 (3)	7(Smpd1)
11.133	9	11	08	11p15.4	AKIP1, BCA3, C11orf17		Protein kinase A-interacting protein 1	609191	R, REc			7(Akip1)
11.134	4	6	13	11p15.4	GALNT18, GALNACT18, GALNTL4		UPD-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18	615136	REc			
11.135	10	28	08	11p15.3	MICAL2, KIAA0750		Microtubule-associated monooxygenase, calponin and LIM domains-containing 2	608881	R, REc			
11.136	10	28	08	11p15.3	MICALCL, EBITEIN1		MICAL C terminus-like protein	612355	REc			
11.137	12	2	09	11p15.4	NRIP3		Nuclear receptor-interacting protein 3	613125	REc			
11.138	5	16	05	11p15.4	SH2BP1, KIAA0155, p150		SH2 domain-binding protein 1	609366	Psh, REc			7(Sh2bl1)
11.139	4	3	03	11p15.4	STK33		Serine/threonine protein kinase 33	607670	REc, H			7(Stk33)
11.140	12	4	01	11p15.4	TAF10, TAF2H, TAF2A		TAF10 RNA polymerase II, TATA box-binding protein-associated factor, 30kD	600475	A			
11.141	2	23	12	11p15.3	USP47		Ubiquitin-specific protease 47	614460	REc			
11.142	5	29	13	11p15.4	ZBED5, BUSTER1		Zinc finger BED domain-containing protein 5	615251	REc			
11.143	10	7	02	11p15.2	SOX6		SRY-box 6	607257	A			7(Sox6)
11.144	7	20	06	11p15.3	PTH		Parathyroid hormone	168450	REa, REb, A, Fd	~9cM distal to CALC1; distal to MYOD	Hypoparathyroidism, autosomal dominant, 146200 (3); Hypoparathyroidism, autosomal recessive, 146200 (3)	7(Pth)
11.145	3	23	93	11p15.4	WEE1		wee1+, S. pombe, homolog of	193525	A			
11.146	8	21	91	11p15.1	TPH1, TPH		Tryptophan hydroxylase 1 (tryptophan-5-monooxygenase)	191060	REa, A			7(Tph)
11.147	8	12	14	11p15.3	BTBD10		BTB/POZ domain-containing protein 10	615933	REc			
11.148	10	15	10	11p15.2	COPB1, COPB		Coatomer protein complex, subunit beta 1	600959	REc			
11.149	7	20	04	11p15.2	CYP2R1		Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)	608713	REc		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	
11.150	1	5	15	11p15.3	FAR1, MLSTD2, PFCRD		Fatty acyl CoA reductase 1	616107	REc		Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	7(Far1)
11.151	12	29	06	11p15.2	INSC		Inscuteable, Drosophila, homolog of	610668	REc			
11.152	7	18	12	11p15.3	RASSF10		Ras association domain family, member 10	614713	REc			
11.153	9	18	06	11p15.3	TEAD1, TCF13, REF1		TEA domain family member 1	189967	Psh, R		Sveinsson chorioretinal atrophy, 108985 (3)	
11.154	5	8	97	11p15.2	CALCA, CALC1		Calcitonin/calcitonin-related polypeptide, alpha	114130	REa, A, REb, D, Fd, REn	same 220kb fragment as CALCB		7(Calc)
11.155	3	23	93	11p15.2	CALCB, CALC2		Calcitonin-related polypeptide, beta	114160	A, REa, REb, D			
11.156	6	19	98	11p15.1	NELL1		Nel-like 1	602319	A			
11.157	2	18	96	11p15.1	PTPN5, STEP		Protein tyrosine phosphatase, nonreceptor-type, 5 (striatum-enriched)	176879	Psh, A			7(Ptpn5)
11.158	5	10	12	11p15.1	SLC6A5, GLYT2, HKPX3		Solute carrier family 6 (neurotransmitter transporter, glycine), member 5	604159	R		Hyperekplexia 3, 614618 (3)	
11.159	08	16	18	11p15.1	TSG101		Tumor susceptibility gene 101	601387	R, A			
11.160	4	27	07	11p15.1	UEVLD, UEV3, ATTP		Ubiquitin E2 variant and lactate/malate dehydrogenase domains-containing protein	610985	REc			
11.161	7	14	98	11p14.3	GAS2		Growth arrest-specific 2	602835	R, A, H			7(Gas2)
11.162	8	31	06	11p15.1	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2		ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	A, REn, Fd, LD		Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3); Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2, 610374 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
11.163	1	31	11	11p15.1	B7H6		B7 homolog 6	613714	REc			
11.164	6	24	08	11p15.1	CSRP3, CRP3, CLP, CMD1M, CMH12		Cysteine- and glycine-rich protein 3	600824	A	mutation identified in 1 CMD1M family	?Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, hypertrophic, 12, 612124 (3)	
11.165	8	11	15	11p15.3	DKK3, RIG		Dickkopf, Xenopus, homolog of, 3	605416	A			
11.166	6	9	08	11p15.1	E2F8		E2F transcription factor 8	612047	REc			7(E2f8)
11.167	6	1	04	11p15.1	HTATIP2, TIP30, CC3		HIV-1 TAT-interacting protein 2, 30kD	605628	R, REc			
11.168	1	31	17	11p15.1	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13		Potassium inwardly-rectifying channel, subfamily J, member 11	600937	A, REn, Fd, LD	4.5kb 3' of SUR	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3); Diabetes, permanent neonatal, with or without neurologic features, 606176 (3); {Diabetes mellitus, type 2, susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3); Maturity-onset diabetes of the young, type 13, 616329 (3)	
11.169	3	31	09	11p15.1	MRGPRX1, MRGX1		Mas-related G protein-coupled receptor family, member X1	607227	REc			
11.170	3	31	09	11p15.1	MRGPRX2, MRGX2		Mas-related G protein-coupled receptor family, member X2	607228	REc			
11.171	3	31	09	11p15.1	MRGPRX3, MRGX3		Mas-related G protein-coupled receptor family, member X3	607229	REc			
11.172	3	31	09	11p15.1	MRGPRX4, MRGX4		Mas-related G protein-coupled receptor family, member X4	607230	REc			
11.173	1	2	08	11p15.1	NAV2, RAINB1, KIAA1419		Neuron navigator 2	607026	R, REc			
11.174	3	31	15	11p15.1	PIK3C2A, CPK		Phosphatidylinositol 3-kinase, class 2, alpha	603601	REc			
11.175	3	31	09	11p15.2-p15.1	PLEKHA7		Pleckstrin homology domain-containing protein, family A, member 7	612686	REc			
11.176	1	13	99	11p15.2	PSMA1, PROS30		Proteasome subunit, alpha-type, 1	602854	A			
11.177	3	18	94	11p15.1	SAA1		Serum amyloid A1	104750	REa, H, A, Psh			7(Saa1)
11.178	3	18	94	11p15.1	SAA2		Serum amyloid A2	104751	REn, A, Fd, Psh	pseudogene = SAA3		
11.179	3	18	94	11p15.1	SAA4		Serum amyloid A4, constitutive	104752	REn, A, Psh			7(Saa4)
11.180	11	29	12	11p15.1	USH1C, DFNB18A		Harmonin (Usher syndrome 1C gene)	605242	Fd	Acadian and Samaritan variety	Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive 18A, 602092 (3)	
11.181	7	15	09	11p15.1	ZDHHC13, HIP14L		Zinc finger DHHC domain-containing protein 13	612815	REc			
11.182	3	18	95	11p15.1	GTF2H1		General transcription factor IIH, polypeptide 1 (62kD subunit)	189972	A, REn	within 50kb of LDHA		
11.183	6	19	98	11p15.4	APBB1, FE65		Amyloid beta A4 precursor protein-binding, family B, member-1	602709	A			7(Apbb1)
11.184	8	20	98	11p15.3	ARNTL, BMAL1, TIC		Aryl hydrocarbon receptor nuclear translocator-like	602550	A			7(Arntl)
11.185	2	24	97	11p15.4	ART1		ADP-ribosyltransferase 1	601625	REa			7(Art1)
11.186	11	30	06	11p15.4	ART5		ADP-ribosyltransferase 5	610625	REc			7(Art5)
11.187	6	19	98	11p15.4	EIF4G2, DAP5		Eukaryotic translation initiation factor 4G-like 1	602325	A, H			7(Eif4G2)
11.188	8	23	17	11p15.5	EPS8L2, EPS8R2, DFNB106		EPS8-like protein 2	614988	REc		Deafness autosomal recessive 106, 617637 (3)	7(Eps8l2)
11.189	12	29	99	11p14.3	FANCF		Fanconi anemia, complementation group F	613897	REc		Fanconi anemia, complementation group F, 603467 (3)	
11.190	8	20	07	11p15	GINGF4, HGF4, GGF4		Fibromatosis, gingival, 4	611010	Fd	between D11S1984 and D11S1338	Fibromatosis, gingival, 4 (2)	
11.191	2	12	07	11p15	IH, HHP		Hemihyperplasia, isolated	235000	Fd	epigenetic or uniparental disomy	Hemihypertrophy (2)	
11.192	2	4	15	11p15.1	KCNC1, EPM7		Potassium voltage-gated channel, Shaw-related subfamily, member 1	176258	A, REn		Epilepsy, progressive myoclonic 7, 616187 (3)	7(Kcnc1)
11.193	4	17	97	11p15.4	LMO1, RBTN1, RHOM1		LIM domain only 1 (rhombotin 1)	186921	Ch, D		Leukemia, T-cell acute lymphoblastic (2)	7(Ttg1)
11.194	7	26	10	11p15	LVNC2		Left ventricular noncompaction 2	609470	Fd	max lod at D11S902	Left ventricular noncompaction 2 (2)	
11.195	1	8	01	11p15.4	MMP26		Matrix metalloproteinase 26 (matrilysin 2)	605470	REa, R			
11.196	7	22	11	11p15.5	MUC5B		Mucin 5, subtype B, tracheobronchial	600770	REa, A		{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
11.197	2	5	16	11p15	NBLST7		Neuroblastoma, susceptibility to, 7	616792	Fd	associated with rs2168101	{Neuroblastoma, susceptibility to, 7} (2)	
11.198	4	17	13	11p15.4	NLRP10, NALP10, PYNOD, NOD8		NLR family, pyrin domain containing 10	609662	REc			
11.199	2	4	00	11p15.4	NUP98		Nucleoporin, 98kD	601021	Ch, REc, Psh	fused with HOXA9, NSD1, NSD3, PMX1, HOXC13, DDX10, TOP1, HOXD11 in myeloid leukemia		
11.200	7	9	14	11p15.4	OR6A2, OR6A1		Olfactory receptor, family 6, subfamily A, member 2	608495	REc, A			
11.201	10	29	09	11p15.3	PARVA		Parvin, alpha	608120	REc			
11.202	3	9	98	11p15.2	PDE3B		Phosphodiesterase-3B, cGMP-inhibited	602047	A, Psh			
11.203	3	6	01	11p15.5	PKP3		Plakophilin-3	605561	A			
11.204	2	16	01	11p15.5	POLR2L, RPB10		Polymerase II, RNA, subunit L	601189	A			
11.205	9	24	08	11p15.4	RBMXL2, HNRNPGT, HNRPGT		RNA-binding motif protein, X chromosome, like 2	605444	A, R			
11.206	11	20	15	11p15.4	RNF141, ZNF230		RING finger protein 141	616641	REc			7(Rnf141)
11.207	2	20	01	11p15.4	RPL27A		Ribosomal protein L27a	603637	RE, R			7(Rpl27a)
11.208	11	16	05	11p15.4	SBF2, MTMR13, CMT4B2		SET binding factor 2 (myotubularin-related 13)	607697	Fd, REc		Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	
11.209	10	23	92	11p15.4	ST5, HTS1		Suppression of tumorigenicity-5	140750	S, REa, A			
11.210	5	23	00	11p15.4	SWAP70		Switch-associated protein 70	604762	A, H			7(Swap70)
11.211	2	26	04	11p15.4	TRIM5, RNF88		Tripartite motif-containing protein 5	608487	R			
11.212	2	19	03	11p15.4	TRIM6		Tripartite motif-containing protein 6	607564	R			
11.213	2	19	03	11p15.4	TRIM22, STAF50		Tripartite motif-containing protein 22	606559	A, R			
11.214	1	30	01	11p15.4	UBQLN3		Ubiquilin 3	605473	R			
11.215	1	20	09	11p15-p14	DEL11p15p14, C11DELp15p14		Chromosome 11p15-p14 deletion syndrome (homozygous)	606528	Ch	contiguous gene deletion syndrome	Chromosome 11p15-p14 deletion syndrome (4)	
11.216	1	12	07	11p15.1	NUCB2, NEFA		Nucleobindin 2	608020	REc			
11.217	1	9	01	11p13	ELF5, ESE2		E74-like factor 5 (epithelium-specific ETS factor 2)	605169	Psh, R			
11.218	1	29	03	11p15.1	HPS5, RU2, KIAA1017		HPS gene 5 (ruby-eye 2, mouse, homolog of)	607521	REc, H		Hermansky-Pudlak syndrome 5, 614074 (3)	7(ru2)
11.219	09	27	18	11p14.3	ANO5, TMEM16E, GDD1, LGMDR12		Anoctamin 5	608662	REn, H, Fd		Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)	7(Tmem16e)
11.220	11	29	12	11p15.1	OTOG, OTGN, DFNB18B		Otogelin	604487	A		Deafness, autosomal recessive 18B, 614945 (3)	7(Otog)
11.221	2	19	03	11p14.3	SLC17A6, VGLUT2, DNPI		Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6	607563	A			
11.222	4	10	90	11p14.3-p12	ST2		Suppression of tumorigenicity-2	185440	Ch			
11.223	9	28	11	11p14.2	BBOX1, BBOX		Butyrobetaine-gamma, 2-oxoglutarate dioxygenase 1	603312	R, REc			
11.224	8	22	16	11p14.2	FIBIN		Fin bud initiation factor, zebrafish, homolog of	617085	REc, H			2(Fibin)
11.225	12	24	08	11p14.2	SLC5A12, SMCT2		Solute carrier family 5 (sodium/glucose cotransporter), member 12	612455	REc			
11.226	3	19	09	11p14.2-q12.3	DFNA59		Deafness, autosomal dominant 59	612642	Fd	between D22S929 and D11S480	Deafness, autosomal dominant 59 (2)	
11.227	10	6	08	11p14.1	CCDC34		Coiled-coil domain-containing protein 34	612324	REc			
11.228	10	6	08	11p14.1	DCDC5, KIAA1493		Doublecortin domain-containing protein 5	612321	REc, H			2(Dcdc5)
11.229	9	8	08	11p14.1	HSP90AA2, HSPCAL3		Heat-shock protein, 90kD, alpha, class A, member 2	140575	REa, A			
11.230	7	22	13	11p14.1	LGR4, GPR48, BNMD17		Leucine-rich repeat-containing G protein-coupled receptor 4	606666	REc, Psh, R	previously mapped to 5q34-q35.1	{Bone mineral density, low, susceptibility to}, 615311 (3)	
11.231	10	7	08	11p14.1	LIN7C, VELI3, MALS3		Lin7, C. elegans, homolog of, C	612332	REc			
11.232	3	23	09	11p14.1	MIR610, MIRN610		Micro RNA 610	612330	REc			
11.233	9	23	08	11p14.1	C11orf46		Chromosome 11 open reading frame 46	612295	REc			
11.234	9	23	08	11p13	LOC283267		LOC283267 gene	612296	REc			
11.235	4	20	10	11p14.1-p11.2	SPG41		Spastic paraplegia 41	613364	Fd	max lod 2.36; between D11S1324 and D11S1993	?Spastic paraplegia 41, autosomal dominant (2)	
11.236	1	28	13	11p14.3-p14.2	ANO3, TMEM16C, C11orf25, DYT24		Anoctamin 3	610110	REc		Dystonia 24, 615034 (3)	
11.237	8	27	15	11p14.1	BDNFAS, BDNFOS		BDNF antisense RNA	611468	REc			
11.238	8	19	13	11p14.1	KIF18A		Kinesin family member 18A	611271	REc			
11.239	8	1	13	11p15.1	SERGEF, DELGEF		Secretion-regulating guanine nucleotide exchange factor	606051	REc, Psh			
11.240	11	10	10	11p14	TST1		Tuberculin skin test reactivity, absence of	613636	Fd	at chr11:26.37M	[Tuberculin skin test reactivity, absence of] (2)	
11.241	1	27	04	11p14.3	LUZP2		Leucine zipper protein 2	608178	R			
11.242	3	16	10	11p14.1	MPPED2, C11orf8, D11S302E, 239FB		Metallophosphoesterase domain-containing protein 2	600911	REn			
11.243	12	22	08	11p13	APIP, CGI29, MMRP19		APAF1-interacting protein	612491	REc			
11.244	4	25	18	11p14.1	BDNF		Brain-derived neurotrophic factor	113505	A, REa, D	homeology with NRF3 on 12p; at p14 boundary		1(Bdnf)
11.245	4	21	16	11p13	DEL11p13, C11DELp13		Chromosome 11p13 deletion syndrome, distal	616902	Ch		Chromosome 11p13 deletion syndrome, distal, 616902 (4)	
11.246	12	14	10	11p13	DEL11p13, C11DELp13, WAGR		Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)	194072	Ch	deletion of WT1 and PAX6 genes	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	
11.247	9	23	08	11p13	C11orf41, G2		Chromosome 11 open reading frame 41	612297	REc, REn			
11.248	11	19	13	11p13	CAPRIN1, M11S1, GPIAP1, GRIP137		Cell cycle associated protein 1	601178	REc			
11.249	9	21	11	11p13	CAT		Catalase	115500	S, D, Fd	cen-CAT-WT1-AN2-pter	Acatalasemia, 614097 (3)	2(Cas1)
11.250	10	7	08	11p13	CCDC73		Coiled-coil domain-containing protein 73	612328	REc			
11.251	9	23	08	11p13	CD59, MIC11		CD59 antigen (p18-20)	107271	REa, A, D	in mouse Ly-6 = multigene complex	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	15(Ly6)
11.252	9	23	08	11p13	COMM9		COMM domain-containing protein 9	612299	REc, REn			
11.253	5	25	13	11p13	CSTF3		Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD	600367	REc			
11.254	8	29	03	11p14-p13	DCDC1		Doublecortin domain-containing protein 1	608062	REc			
11.255	9	23	08	11p13	DEPDC7, TR2		DEP domain-containing protein 7	612294	REc, REn			
11.256	8	21	07	11p13	DPH4		DPH4, S. cerevisiae, homolog of	611072	R, REc			
11.257	3	9	10	11p13	ECT, BECTS		Centrotemporal epilepsy	117100	Fd	previously assigned to 15q14	Centrotemporal epilepsy (2)	
11.258	10	3	07	11p13	EIF3M, PCID1, B5, GA17		Eukaryotic translation initiation factor 3, subunit M	609641	REc			
11.259	10	3	16	11p13	ELP4, PAX6NEB, AN2		Elongation protein 4, S. cerevisiae, homolog of	606985	REc	mutation identified in 1 AN2 patient	?Aniridia 2, 617141 (3)	
11.260	9	9	08	11p13	FBXO3, FBX3, FBA		F-box only protein 3	609089	REc			2(Fbxo3)
11.261	8	29	08	11p13	FJX1		Four-jointed box, Drosophila, homolog of, 1	612206	REc			
11.262	4	6	15	11p14.1	FSHB, HH24		Follicle-stimulating hormone, beta polypeptide	136530	D, REa	distal to AN2	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	2(Fshb)
11.263	10	24	00	11p13	HIPK3, PKY, DYRK6		Homeodomain-interacting protein kinase-3	604424	A			
11.264	10	6	08	11p13	IMMP1L, IMP1		Inner mitochondrial membrane peptidase, subunit 1, S. cerevisiae, homolog of	612323	REc			
11.265	5	17	18	11p13	LDLRAD3, LRAD3		Low density lipoprotein receptor class A domain-containing protein 3	617986	REc			
11.266	12	11	95	11p13	LMO2, RBTNL1, RHOM2, TTG2		LIM domain only 2 (rhombotin-like 1)	180385	REa, REc	3rd rhombotin gene not on 11	Leukemia, acute T-cell (2)	
11.267	4	13	05	11p13	MYP7		Myopia 7	609256	Fd		Myopia 7 (2)	
11.268	5	9	14	11p13	NAT10, ALP, KIAA1709		N-acetyltransferase 10	609221	REc, REn			
11.269	1	27	17	11p13	PAX6, AN2, MGDA, FVH1, ASGD5		Paired box homeotic gene-6	607108	Ch, Fd	mutation identified in 1 patient each with MDGA, COLBN, or COLB	Aniridia, 106210 (3); Cataract with late-onset corneal dystrophy, 106210 (3); Anterior segment dysgenesis 5, multiple subtypes, 604229 (3); Foveal hypoplasia 1, 136520 (3); Keratitis, 148190 (3); Optic nerve hypoplasia, 165550 (3); ?Morning glory disc anomaly, 120430 (3); ?Coloboma of optic nerve, 120430 (3); ?Coloboma, ocular, 120200 (3)	2(Sey)
11.270	12	15	17	11p13	PDHX, PDX1, E3BP, PDHXD		Pyruvate dehydrogenase complex, lipoyl-containing component X	608769	A, R, Psh, REc		Lacticacidemia due to PDX1 deficiency, 245349 (3)	
11.271	1	2	08	11p13	PRRG4, PRGP4, TMG4		Proline-rich gamma-carboxyglutamic acid protein 4	611690	REc			
11.272	6	9	08	11p12	RAG1		Recombination activating gene-1	179615	REa, D	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag1)
11.273	6	9	08	11p12	RAG2		Recombination activating gene-2	179616	REa, D	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag2)
11.274	7	13	98	11p13	RCN1		Reticulocalbin 1	602735	REc			2(Rcn1)
11.275	10	3	16	11p13	TRIM44, AN3		Tripartite motif-containing protein 44	612298	REc, REn	mutation identified in 1 AN3 family	?Aniridia 3, 617142 (3)	
11.276	8	16	11	11p13	WT1, NPHS4		Wilms tumor-1	607102	Ch	clumped: pter-FSHB-AN2-WT1-CAT	Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3); Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)	2(Wt1)
11.277	2	12	16	11p13	WT1AS, WIT1		WT1 antisense RNA	607899	REc			
11.278	3	13	06	11p13-p12	DFNB51		Deafness, autosomal recessive 51	609941	Fd	max lod at D11S4102	Deafness, autosomal recessive 51 (2)	
11.279	4	6	01	11p13-p12	EVR3		Exudative vitreoretinopathy 3	605750	Fd		Exudative vitreoretinopathy 3 (2)	
11.280	11	24	15	11p13-p12	PRR5L, PROTOR2, FLJ14213		Proline-rich protein 5-like	611728	R, REc			
11.281	2	24	97	11p11.2	PSMC3, TBP1		Proteasome (prosome, macropain) 26S subunit, ATPase, 3	186852	Psh, A			
11.282	9	22	16	11p13	SLC1A2, EAAT2, EIEE41		Solute carrier family 1 (glial high affinity glutamate transporter), member 2	600300	A, REa		Epileptic encephalopathy, early infantile, 41, 617105 (3)	2(Eaat2)
11.283	12	24	08	11p13-p12	WAGRO, DEL11p14p12		Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome	612469	Ch	contiguous gene deletion syndrome	WAGRO syndrome (4)	
11.284	7	20	09	11q14.3	FOLH1B, PSMAL, GCP3		Folate hydrolase 1B	609020	A, REc			
11.285	4	26	10	11p13-q12	CANDF3, CANDN1, FCNC		Candidiasis, familial, 3	607644	Fd	between D11S1312 and D11S4191	Candidiasis, familial, 3 (2)	
11.286	11	18	11	11p13-q14.1	MRT23		Mental retardation, autosomal recessive 23	614344	Fd	between rs604518 and rs10899421	Mental retardation, autosomal recessive 23 (2)	
11.287	12	23	05	11p12	API5, AAC11		Apoptosis inhibitor 5	609774	REc			
11.288	1	22	08	11p12	BMND8		Bone mineral density QTL 8	611739	Fd	between D11S1392 and D11S4102	{Osteoporosis}, 166710 (2)	
11.289	1	29	01	11p13	EHF, ESE3		ETS homologous factor	605439	REa, A			
11.290	9	12	08	11p12	LRRC4C, NGL1, KIAA1580		Leucine rich repeat containing 4C (netrin-G1 ligand)	608817	R, REc			
11.291	3	13	06	11p12	TRAF6		TNF receptor-associated factor 6	602355	REc, R			
11.292	3	15	92	11p11.2	CHRM4		Cholinergic receptor, muscarinic, 4	118495	A, REa, Fd			
11.293	4	30	15	11p11.2	LRP4, MEGF7, CLSS, SOST2, CMS17		Low density lipoprotein receptor-related protein 4	604270	R	mutation identified in 1 CMS17 family	Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2, 614305 (3); ?Myasthenic syndrome, congenital, 17, 616304 (3)	
11.294	3	1	00	11p11.2	MAPK8IP1, IB1		Mitogen-activated protein kinase 8-interacting protein 1	604641	R, A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
11.295	12	28	16	11p11.2	PEX16, PBD8A, PBD8B		Peroxisome biogenesis factor 16	603360	R, H		Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3); Peroxisome biogenesis disorder 8B, 614877 (3)	2(Pex16)
11.296	12	13	96	11p11.2	DDB2		Damage-specific DNA binding protein 2, 48kD	600811	A		Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	
11.297	12	29	15	11p11.2	EXT2, SSMS		Exostosin 2	608210	Fd, D	mutation identified in 1 SSMS family	Exostoses, multiple, type 2, 133701 (3); ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	2(Ext2)
11.298	4	17	07	11p12-p11	PSNP3		Supranuclear palsy, progressive, 3	610898	Fd		Supranuclear palsy, progressive, 3 (2)	
11.299	3	14	07	11p11.2	ARHGAP1, RHOGAP1, CDC42GAP		RHO GTPase-activating protein 1	602732	R, REc			
11.300	10	2	91	11q24.2	ACRV1		Acrosomal vesicle protein-1	102525	REa			
11.301	4	20	11	11p11.2	ACP2		Acid phosphatase 2, lysosomal	171650	S, REa		?Lysosomal acid phosphatase deficiency, 200950 (1)	2(Acp2)
11.302	2	9	17	11p11.2	AGBL2, CCP2		ATP/GTP-binding protein-like 2	617345	REc			
11.303	11	19	13	11p11.2	ALX4, PFM2, FPP, FND2, CRS5		Aristaless-like 4, mouse, homolog of	605420	REc, Fd		Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3); {Craniosynostosis 5, susceptibility to}, 615529 (3)	
11.304	9	9	10	11p11.2	AMBRA1, KIAA1736		Activating molecule in beclin 1-regulated autophagy	611359	R, REc			
11.305	3	14	13	11p11.2	ATG13, KIAA0652, PARATARG8		Autophagy 13, S. cerevisiae, homolog of	615088	REc, R			
11.306	12	10	12	11p11.2	C1QTNF4, CTRP4		C1q- and tumor necrosis factor-related protein 4	614911	REc, R			
11.307	1	20	06	11p11.2	CD82, SAR2, KAI1, ST6		CD82 antigen	600623	M		{Prostate cancer, susceptibility to}, 176807 (2)	
11.308	2	23	08	11p11.2	CKAP5, CHTOG, MSPS, KIAA0097		Cytoskeleton-associated protein 5	611142	REa, REc			
11.309	08	07	18	11p11.2	CREB3L1, OASIS, OI16		cAMP response element-binding protein 3-like 1	616215	REc		Osteogenesis imperfecta, type XVI, 616229 (3)	
11.310	2	11	15	11p11.2	DGKZ		Diacylglycerol kinase, zeta, 104kD	601441	REc			
11.311	6	4	13	11p11.2	FNBP4, FBP30, KIAA1014		Formin-binding protein 4	615265	REc			
11.312	10	11	00	11p11.12	FOLH1, FOLH, PSM, PSMA		Folate hydrolase 1 (prostate-specific membrane antigen)	600934	A, REc	?pseudogene on 11q14		
11.313	11	15	05	11p11.2	GYLTL1B, LARGE2		Glycosyltransferase-like 1B	609709	REc			
11.314	3	7	13	11p11.2	HARBI1		Harbinger transposase-derived gene 1	615086	REc, Ch			
11.315	8	31	17	11p11.2	KBTBD4, HSPC252, BKLHD4		KELCH repeat- and BTB/POZ domain-containing protein 4	617645	REc			
11.316	5	12	99	11p11.2	MADD, DENN		MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells)	603584	A			
11.317	6	13	12	17p12-p11	NCOR1		Nuclear receptor corepressor 1	600849	REc			
11.318	9	14	94	11p11.2	MDK, NEGF2		Midkine (neurite growth-promoting factor 2)	162096	REa, A			2(Mdk)
11.319	6	22	14	11p11.2	NUP160, KIAA0197		Nucleoporin, 160kD	607614	Psh, REc			
11.320	9	9	13	11p11.2	MYBPC3, CMH4, CMD1MM, LVNC10		Myosin-binding protein C, cardiac	600958	A, Fd		Cardiomyopathy, hypertrophic, 4, 115197 (3); Cardiomyopathy, dilated, 1MM, 615396 (3); Left ventricular noncompaction 10, 615396 (3)	
11.321	10	1	17	11p11.2	NR1H3, LXRA		Nuclear receptor subfamily 1, group H, member 3	602423	REc			
11.322	9	28	10	11p11.2	PHF21A, BHC80, KIAA1696		PHD finger protein 21A	608325	R, REc			
11.323	5	19	15	11p11.2	PRDM11, PFM8		PR domain-containing protein 11	616347	REc			
11.324	5	13	10	11p11.2	PSS		Potocki-Shaffer syndrome	601224	Ch	contiguous gene syndrome caused by deletion of 11p11.2	Potocki-Shaffer syndrome (4)	
11.325	6	27	02	11p11.2	PTPRJ, DEP1		Protein tyrosine phosphatase, receptor type, J polypeptide	600925	H, A		Colon cancer, somatic, 114500 (3)	2(Ptprj)
11.326	2	10	05	11p11.2	SLC35C1, FUCT1, CDG2C		Solute carrier family 35, member C1 (GDP-Fucose transporter 1)	605881	REc		Congenital disorder of glycosylation, type IIc, 266265 (3)	
11.327	4	5	18	11p11.2	SLC39A13, ZIP13, EDSSPD3		Solute carrier family 39 (zinc transporter), member 13	608735	REc		Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3)	
11.328	2	10	00	11p11.2	SPI1, SFPI1		Oncogene SPI1	165170	REa, A			
11.329	2	16	18	11p11.2	TP53I11, PIG11		Tumor protein p53-inducible protein 11	617867	REc			
11.330	9	19	88	11p11.2	TYRL		Tyrosinase-like	191270	REa, A			
11.331	7	21	15	11p11.2	ZNF408, EVR6, RP72		Zinc finger protein 408	616454	REc	mutation identified in 1 EVR6 family	?Exudative vitreoretinopathy 6, 616468 (3); Retinitis pigmentosa 72, 616469 (3)	
11.332	12	4	08	11p11.2	ARFGAP2, ZNF289		ADP-ribosylation factor GTPase-activating protein 2	606908	R, REc			
11.333	9	3	04	11p11.2	CHST1, KSGAL6ST		Carbohydrate sulfotransferase-1	603797	A, R			
11.334	4	30	15	11p11.2	RAPSN, CMS1D, CMS11, FADS		Receptor-associated protein of the synapse, 43kD	601592	REa		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3); Fetal akinesia deformation sequence, 208150 (3)	
11.335	3	8	07	11q12.1	SLC43A1, LAT3, POV1		Solute carrier family 43 (L-type amino acid transporter), member 1	603733	A			
11.336	11	30	06	11p11.2	ALKBH3, PCA1, DEPC1, ABH3		AlkB, E. coli, homolog of, 3	610603	REc			
11.337	10	5	11	11q11	OR4C46		Olfactory receptor, family 4, subfamily C, member 46	614273	REc			
11.338	7	20	01	11q14.3	RNF18		RING finger protein-18	606124	R			
11.339	12	17	12	11p11.2	NDUFS3		NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kD	603846	REa, R		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
11.340	1	31	12	11p11.2	ACCS, ACS, PHACS		1-aminocyclopropane-1-carboxylate synthase	608405	REc			
11.341	8	2	13	11p11.2	CELF1, CUGBP1, NAB50, BRUNOL2, CUGBP		CUGbp and ELAV-like family, member 1	601074	REc			
11.342	5	22	14	11p11	CLLS1		Leukemia, chronic lymphocytic, susceptibility to, 1	609630	Fd		{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)	
11.343	12	27	01	11p11.2	PACSIN3		Protein kinase C and casein kinase substrate in neurons 3	606513	R			
11.344	5	4	12	11p11.2	F2, THPH1, RPRGL2		Coagulation factor II (thrombin)	176930	REa, A		Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3); Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	2(Cf2)
11.345	12	15	10	11p15.5	CD81, TAPA1, CVID6		CD81 antigen (target of antiproliferative antibody-1)	186845	REa		Immunodeficiency, common variable, 6, 613496 (3)	7(Tapa1)
11.346	3	10	00	11p	HYPLIP2		Hyperlipidemia, combined, 2	604499	Fd		Hyperlipidemia, combined, 2 (2)	
11.347	12	15	98	11p	NNO1		Nanophthalmos 1	600165	Fd		Nanophthalmos-1 (2)	
11.348	8	9	99	11p15.1	RPS13		Ribosomal protein S13	180476	Psh, R			
11.349	4	4	02	11q12.1	PRG2, MBP		Proteoglycan 2	605601	R, A			
11.350	4	4	02	11q12.1	PRG3, MBPH		Proteoglycan 3	606814	A			
11.351	2	11	93	11q13.2	ADRBK1		Adrenergic, beta, receptor kinase-1	109635	REa			19(Adrbk1)
11.352	9	16	03	11q14.2	ME3		Malic enzyme 3	604626	R			
11.353	12	23	15	11q12.1	TMX2		Thioredoxin-related transmembrane protein 2	616715	REc			
11.354	9	21	17	11q12.1	CTNND1, CTNND, BCDS2		Catenin (cadherin-associated protein), delta 1	601045	A		Blepharocheilodontic syndrome 2, 617681 (3)	2(Catns)
11.355	8	30	07	11q12.2	VWC1, URG11		von Willebrand factor C and EGF domain-containing protein	611115	R, REn			
11.356	9	12	91	11q12.1	TCN1, TC1		Transcobalamin I	189905	A			
11.357	1	24	09	11q12.1	C1NH, HAE1, HAE2, SERPING1		Complement component-1 inhibitor	606860	REa, A		Angioedema, hereditary, types I and II, 106100 (3); Complement component 4, partial deficiency of, 120790 (3)	2(C1nh)
11.358	5	24	13	11q12.2	CCDC86, CYCLON		Coiled-coil domain-containing protein 86	611293	REc			19(Ccdc86)
11.359	1	9	14	11q12.1	APLNR, AGTRL1, APJ		Apelin receptor	600052	Psh, A			
11.360	11	5	97	11q13.1	ESRRA, ESRL1		Estrogen-related receptor, alpha	601998	A			19(Estrra)
11.361	3	18	95	11q12.2	FEN1		Flap structure-specific endonuclease 1	600393	A, R			19(Fen1)
11.362	6	10	09	11q13.1	KIND3, URP2, MIG2B, FERMT3		Kindlin 3	607901	REc		Leukocyte adhesion deficiency, type III, 612840 (3)	
11.363	12	15	17	11q13.1	LTBP3, LTBP2, DASS, GPHYSD3		Latent transforming growth factor beta binding protein-3	602090	Psh, A, REc		Dental anomalies and short stature, 601216 (3); Geleophysic dysplasia 3, 617809 (3)	19(Ltbp2)
11.364	4	30	09	11q12.1	MIR130A, MIRN130A		Micro RNA 130A	610175	REc			
11.365	1	2	08	11q13.1	NAALADL1, I100		N-acetylated alpha-linked acidic dipeptidase-like 1	602640	A			
11.366	7	14	98	11q12.1	P2RX3, P2X3		Purinergic receptor P2X, ligand-gated ion channel, 3	600843	A			2(P2rx3)
11.367	11	2	04	11q13.4	P4HA3		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 3	608987	REc			
11.368	5	24	13	11q21	PIWIL4, HIWI2, MIWI2		PIWI-like 4	610315	REc			
11.369	4	11	11	11q12	SCA20, DUP11q12, C11DUPq12		Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)	608687	Fd	contiguous gene duplication syndrome	Spinocerebellar ataxia 20 (4)	
11.370	5	15	14	11q12.2	SLC15A3, PHT2		Solute carrier family 15 (oligopeptide transporter), member 3	610408	REc			
11.371	2	2	01	11q12.1	SSRP1, FACT		Structure-specific recognition protein 1	604328	REa			
11.372	8	11	17	11q12.2	TMEM258, C11orf10		Transmembrane protein 258	617615	REc			
11.373	7	12	02	11q12.1	TNKS1BP1, TAB182, KIAA1741		Tankyrase 1-binding protein 1, 182kD	607104	REc			
11.374	2	1	01	11q12.1	UBE2L6, UBCH8		Ubiquitin-conjugating enzyme E2L 6	603890	A			
11.375	8	6	97	11q12.3	AHNAK		AHNAK nucleoprotein (desmoyokin)	103390	REa, A, REc			
11.376	5	5	16	11q12.3	B3GAT3, GLCATI, JDSCD		Beta-1,3-glucuronyltransferase 3	606374	A	pseudogene on chr.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	
11.377	8	29	02	11q13.1	CDC42EP2, CEP2, BORG1		CDC42 effector protein 2	606132	REc			
11.378	12	15	13	11q12.2	DDB1		Damage-specific DNA binding protein 1, 127kD	600045	A, H			19(Ddb1)
11.379	2	3	05	11q13.4	DHCR7, SLOS		Delta-7-dehydrocholesterol reductase	602858	R		Smith-Lemli-Opitz syndrome, 270400 (3)	
11.380	1	29	01	11q13.1	FLRT1		Fibronectin-like domain-containing leucine-rich transmembrane protein-1	604806	A			
11.381	11	19	13	11q12.3	FTH1, FTHL6, HFE5		Ferritin, heavy polypeptide 1	134770	REa, H, REn, R	mutation identified in 1 family	?Hemochromatosis, type 5, 615517 (3)	19(Fth)
11.382	2	16	16	11q13.2	KLC2, SPOAN		Kinesin, light chain 2	611729	REc, H, Fd		Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	19(Klc2)
11.383	5	21	07	11q13.1	MARK2, EMK1		MAP/microtubule affinity-regulating kinase 2	600526	A, REa, REn			19(Emk1)
11.384	11	29	01	11q12.1	MS4A3, HTM4, CD20L		Membrane-spanning 4-domains, subfamily A, member 3	606498	A			
11.385	12	27	01	11q12.2	MS4A4A, MS4A4		Membrane-spanning 4-domains, subfamily A, member 4A	606547	REc			
11.386	11	29	01	11q12.2	MS4A5, TETM4, CD20L2		Membrane-spanning 4-domains, subfamily A, member 5	606499	A, R			
11.387	12	27	01	11q12.2	MS4A6A, MS4A6		Membrane-spanning 4-domains, subfamily A, member 6A	606548	REc			
11.388	11	27	01	11q12.2	MS4A7, CFFM4		Membrane-spanning 4-domains, subfamily A, member 7	606502	REc			
11.389	12	27	01	11q12.2	MS4A8B		Membrane-spanning 4-domains, subfamily A, member 8B	606549	REc			
11.390	12	27	01	11q12.2	MS4A12		Membrane-spanning 4-domains, subfamily A, member 12	606550	REc			
11.391	12	21	03	11q12.3	NXF1, TAP, MEX67		Nuclear RNA export factor 1	602647	REc			
11.392	11	15	95	11q13.1	RELA, NFKB3		v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	164014	A, REa			
11.393	12	11	02	11q13.2	DPP3		Dipeptidyl peptidase III	606818	A			
11.394	5	27	09	11q12.2	FADS1		Fatty acid desaturase 1	606148	REc			
11.395	5	27	09	11q12.2	FADS2		Fatty acid desaturase 2	606149	REc			
11.396	5	27	09	11q12.2	FADS3		Fatty acid desaturase 3	606150	REc			
11.397	2	26	08	11q12.1	MRPL16		Mitochondrial ribosomal protein L16	611829	R			
11.398	1	27	04	11q12.2	MS4A4E		Membrane-spanning 4-domains, subfamily A, member 4E	608401	REc			
11.399	1	27	04	11q12.2	MS4A6E		Membrane-spanning 4-domains, subfamily A, member 6E	608402	REc			
11.400	1	27	04	11q12.2	MS4A10		Membrane-spanning 4-domains, subfamily A, member 10	608403	REc			
11.401	6	22	14	11q12.3	MTA2, MTA1L1		Metastasis-associated protein 2	603947	A			
11.402	7	20	09	11q12-q13.1	PURAQTL1		Polyunsaturated fatty acids plasma level QTL1	612795	Fd	associated with rs174537	[Polyunsaturated fatty acids plasma level QTL1] (2)	
11.403	3	6	01	11q14.1	RAB30		Ras-associated protein RAB30	605693	REa, REc			
11.404	5	22	14	11q12.1	CLP1, HEAB, PCH10		Cleavage and polyadenylation factor I subunit 1, yeast, homolog of	608757	REc, Psh, A, Ch		Pontocerebellar hypoplasia, type 10, 615803 (3)	
11.405	12	2	14	11q12.1	DTX4, RNF155, KIAA0937		Deltex, Drosoophila, homolog of, 4	616110	REc			
11.406	7	23	13	11q12.1	FAM111A, KIAA1895, KCS2, GCLEB		Family with sequence similarity 111, member A	615292	REc		Kenny-Caffey syndrome, type 2, 127000 (3); Gracile bone dysplasia, 602361 (3)	
11.407	3	26	14	11q12.1	FAM111B, POIKTMP		Family with sequence similarity 111, member B	615584	REc		Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	
11.408	8	21	12	11q12.1	GLYAT, ACGNAT, CAT		Glycine-N-acyltransferase	607424	R, REc			
11.409	8	21	12	11q12.1	GLYATL1		Glycine-N-acyltransferase-like 1	614761	REc			
11.410	8	21	12	11q12.1	GLYATL2		Glycine N-acyltransferase-like 2	614762	REc			
11.411	9	8	17	11q12.1	LPXN		Leupaxin	605390	R			
11.412	5	6	13	11q12.1	LRRC55		Leucine-rich repeat-containing protein 55	615213	REc			
11.413	11	7	08	11q12.1	MED19		Mediator complex subunit 19	612385	REc			
11.414	8	19	13	11q12.1	MPEG1, MPG1		Macrophage expressed gene 1	610390	R, REc			
11.415	2	19	10	11p11.2	MTCH2		Mitochondrial carrier homolog 2	613221	REc			
11.416	3	25	14	11q12.1	OR5AN1		Olfactory receptor, family 5, subfamily AN, member 1	615702	REc			
11.417	8	8	13	11q12.1	OR5F1		Olfactory receptor, family 5, subfamily F, member 1	608492	REc, A			
11.418	8	8	13	11q12.1	OR5I1, OLF1		Olfactory receptor, family 5, subfamily I, member 1	608496	REc, Psh			
11.419	5	7	03	11q12.1	OSBP		Oxysterol-binding protein	167040	REa, R			19(Osbp)
11.420	5	29	12	11q12.1	PATL1, PAT1B		Protein associated with topoisomerase II, S. cerevisiae, homolog of, 1	614660	REc			
11.421	5	24	13	11q12.1	RTN4RL2, NGRH1, NGR2		Reticulon 4 receptor-like 2	610462	REc			
11.422	11	18	16	11q12.1	SELENOH, SELH		Selenoprotein H	607914	REc			
11.423	6	28	18	11q12.1	SLC43A3, EEG1, ENBT1		Solute carrier family 43, member 3	618034	REc			
11.424	12	14	10	11q12.1	SMTNL1, CHASM		Smoothelin-like 1	613664	REc			
11.425	1	21	11	11q12.1	STX3, STX3A		Syntaxin 3	600876	REc			
11.426	12	28	08	11q12.1	YPEL4		Yippee-like 4	609725	REc			2(Ypel4)
11.427	4	27	12	11q12.1	ZDHHC5, DHHC5, ZNF375, KIAA1748		Zinc finger DHHC domain-containing protein 5	614586	REc			
11.428	12	4	02	11q12.1	TIMM10, TIM10A, TIM10		Translocase of inner mitochondrial membrane 10, yeast, homolog of	602251	A, R			
11.429	10	23	87	11q12.1-q13.5	FNL2		Fibronectin-like-2	135610	S, A			
11.430	7	13	93	11q12.1	CNTF		Ciliary neurotrophic factor	118945	REa, A			19(Cntf)
11.431	9	8	11	11q12.2	DAGLA, KIAA0659		Diacylglycerol lipase, alpha	614015	REc, R			
11.432	7	18	14	11q12.2	DAK		Dihydroxyacetone kinase 2, S. cerevisiae, homolog of	615844	REc			
11.433	10	10	18	11q12.2	MYRF, 11orf9, KIAA0954, MMERV		Myelin regulatory factor	608329	REc		Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3)	
11.434	2	23	09	11q12.2	PRPF19, PRP19, PSO4, NMP200		Precursor mRNA-processing factor 19, S. cerevisiae, homolog of	608330	R, REc			
11.435	7	23	15	11q12.2	PTGDR2, GPR44		Prostaglandin D2 receptor 2	604837	A			
11.436	2	24	17	11q12.2	TMEM132A, KIAA1583		Transmembrane protein 132A	617363	REc			
11.437	2	9	12	11q12.2	TMEM138, JBTS16		Transmembrane protein 138	614459	REc		Joubert syndrome 16, 614465 (3)	
11.438	2	24	12	11q12.2	TMEM216, JBTS2, CORS2, MKS2		Transmembrane protein 216	613277	REc, Fd		Joubert syndrome 2, 608091 (3); Meckel syndrome 2, 603194 (3)	
11.439	6	9	06	11q12.2	VPS37C		Vacuolar protein sorting 37, yeast, homolog of, C	610038	R, REc			
11.440	2	11	16	11q12.2	ZP1, OOMD1		Zona pellucida glycoprotein 1	195000	REc		Oocyte maturation defect 1, 615774 (3)	
11.441	3	5	18	11q12.3	CSKMT, METTL12		Citrate synthase lysine methyltransferase	617897	REc			
11.442	9	18	08	11q12.3	EEF1G, EF1G		Eukaryotic translation elongation factor 1, gamma	130593	REc			
11.443	10	10	18	11q12.3	EML3, EMAP3, EMAP95		Echinoderm microtubule-associated protein-like 3	618118	REc			
11.444	4	7	11	11q12.3	HRASLS2		HRAS-like suppressor 2	613866	REc			
11.445	11	11	14	11q12.3	INCENP		Inner centromere protein	604411	R, REc			
11.446	3	23	14	11q12.3	INTS5, INT5, KIAA1698		Integrator complex subunit 5	611349	REc			
11.447	2	22	13	11q12.3	SCGB2A1, MGB2, LPNC		Secretoglobin, family 2A, member 1 (mammaglobin 2)	604398	A, REc			
11.448	2	22	13	11q12.3	SCGB1D1, LPNA		Secretoglobin, family 1D, member 1	615060	REc	previously mapped to 15q12-q13		
11.449	2	22	13	11q12.3	SCGB1D2, LPNB		Secretoglobin, family 1D, member 2	615061	REc	previously mapped to 10q23		
11.450	2	22	13	11q12.3	SCGB1D4, IIS		Secretoglobin, family 1D, member 4	615062	REc			
11.451	8	18	14	11q12.3	SLC22A9, OAT4, UST3		Solute carrier family 22 (organic anion/cation transporter), member 9	607579	REc			
11.452	8	18	14	11q12.3	SLC22A10, OAT5		Solute carrier family 22 (organic anion/cation transporter), member 10	607580	REc			
11.453	1	2	08	11q12.3	SLC22A24		Solute carrier family 22, member 24	611698	REc			19(Slc22a24)
11.454	1	21	11	11q12.3	STX5, STX5A		Syntaxin 5	603189	REc			
11.455	5	29	15	11q12.3	UBXN1, SAKS1		UBX domain protein 1	616378	REc			
11.456	12	1	14	11q12.3	UQCC3, C11orf83, MC3DN9		Ubiquinol-cytochrome C reductase complex assembly factor 3	616097	REc	mutation identified in 1 MC3DN9 patient	?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	
11.457	3	8	07	11q12.3	UST6		Organic anion transporter UST6	610792	REc			
11.458	4	24	18	11q12.3	WDR74		WD repeat-containing protein 74	617947	REc			
11.459	3	23	02	11q12.3	MGB1, SCGB2A2		Mammaglobin 1 (secretoglobin, family 2A, member 2)	605562	A, R			
11.460	4	6	11	11q12.3-q13.1	PLA2G16, HRASLS3, HRSL3, HREV107		Phospholipase A2, group XVI	613867	REc			
11.461	10	16	14	11q12.3	SCGB1A1, UGB, CC10, CCSP		Secretoglobin, family 1A, member 1 (uteroglobin)	192020	REa, Fd, REc, A			
11.462	11	24	08	11q13.3	ANO1, TMEM16A, FLJ10261		Anoctamin 1, calcium activated chloride channel	610108	REc			7(Tmem16a)
11.463	8	26	98	11q13.1	ARL2		ADP=ribosylation factor-like 2	601175	REc			
11.464	12	11	95	11q13.4	ARRB1		Arrestin, beta 1	107940	A			
11.465	3	5	03	11q13.2	BBS1		BBS1 gene	209901	Fd		Bardet-Biedl syndrome 1, 209900 (3)	
11.466	8	18	14	11q12.3	BSCL2, SPG17, HMN5, PELD		Seipin	606158	Fd		Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type VA, 600794 (3); Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	
11.467	3	29	07	11q13.2	C11orf24		Chromosome 11 open reading frame 24	610880	REc			
11.468	3	23	14	11q13.1	C11orf95		Chromosome 11 open reading frame 95	615699	REc			
11.469	5	6	16	11q13.1	CAPN1, SPG76		Calpain, large polypeptide L1	114220	REb		Spastic paraplegia 76, autosomal recessive, 616907 (3)	
11.470	4	20	10	11q13.2	CARNS1, ATPGD1, KIAA1394		Carnosine synthase 1	613368	REc			19(Carns1)
11.471	2	13	14	11q13.3	CCND1, PRAD1, BCL1		Cyclin D1	168461	REn, R, REa, A	pseudogene on 11q13	{Colorectal cancer, susceptibility to}, 114500 (3); {von Hippel-Lindau syndrome, modifier of}, 193300 (3); {Multiple myeloma, susceptibility to}, 254500 (3)	
11.472	5	25	00	11q13.2	CCS		Copper chaperone for superoxide dismutase	603864	A			9(Ccs)
11.473	6	8	89	11q12.2	CD5, LEU1		CD5 antigen (p56-62)	153340	REa, A			19(Ly1)
11.474	12	7	07	11q13.2	CD248, TEM1		CD248 antigen	606064	REa, REc			
11.475	9	8	11	11q13.1	CDC42BPG, MRCKG		CDC42-binding protein kinase, gamma	613991	REc			
11.476	1	8	97	11q13.1	CFL1		Cofilin 1 (non-muscle)	601442	REn, A, Psh, R			19(Cfl1)
11.477	8	6	97	11q12.3	CHRM1		Cholinergic receptor, muscarinic, 1	118510	REa, A, REn			
11.478	2	25	16	11q13.1	COX8A		Cytochrome c oxidase, subunit VIIIA	123870	A, R, REn	mutation identified in 1 COX4D patient	?Mitochondrial complex IV deficiency, 220110 (3)	
11.479	10	8	98	11q13.3	CPT1A		Carnitine palmitoyltransferase I, liver	600528	Psh, A		CPT deficiency, hepatic, type IA, 255120 (3)	
11.480	8	5	97	11q13.1	CST6		Cystatin-M	601891	A			
11.481	9	24	08	11q13.3	CTTN, EMS1		Cortactin	164765	RE	amplified in breast cancer and squamous cell cancer		
11.482	3	12	01	11q13.1	DANJC4, HSPF2		DnaJ, E. coli, homolog of, subfamily C, member 4 (heat-shock 40kD protein 2)	604189	REc			
11.483	6	28	18	11q13.1	DPF2, REQ, UBID4, CSS7		D4, zinc, and double PHD fingers family, member 2	601671	A		Coffin-Siris syndrome 7, 618027 (3)	6(Req)
11.484	1	30	12	11q13.1	EFEMP2, FBLN4, UPH1, ARCL1B		EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4)	604633	REc		Cutis laxa, autosomal recessive, type IB, 614437 (3)	
11.485	5	2	01	11q13.1	EHD1		EH domain-containing 1 protein	605888	REc, R			19(Ehd1)
11.486	9	12	93	11q13.1	FAU		Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived)	134690	A, REa, REc, R			19(Fau)
11.487	3	8	92	11q13.3	FGF4, HSTF1		Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene)	164980	A, REa, RE	coamplified with FGF3 in melanoma		7(Hstf1)
11.488	1	22	07	11q13.3	FGF3, INT2		Fibroblast growth factor-3 (oncogene INT2)	164950	REa, A, RE	35kb 5' to HST1	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	7(Int2)
11.489	12	28	93	11q13.1	FOSL1		FOS-like antigen-1	136515	REl			
11.490	2	7	07	11q13.1	GAL3ST3, GAL3ST2		Galactose-3-O-sulfotransferase 3	608234	REc			
11.491	5	31	05	11q12.1	GIF, IF		Gastric intrinsic factor	609342	REa, H		Intrinsic factor deficiency, 261000 (3)	19(Gif)
11.492	7	6	99	11q13.2	GSTP1, GST3		Glutathione S-transferase pi	134660	S, A, REa, R, Fd	formerly called GST1		19(Gst3)
11.493	3	15	04	11q14.1	HBXAP, RSF1		Hepatitis B virus X-associated protein	608522	A, REc			
11.494	4	23	08	11q13	HPC14		Prostate cancer, hereditary, 14	611958	Fd	associated with rs7931342	{Prostate cancer, hereditary, 14} (2)	
11.495	12	9	98	11q13	IDDM4		Insulin-dependent diabetes mellitus-4	600319	Fd		{Diabetes mellitus, insulin-dependent, 4} (2)	
11.496	12	8	09	11q13.1	KAT5, HTATIP, TIP60, ESA1, PLIP		K(lysine) acetyltransferase 5	601409	R, REc			
11.497	3	7	01	11q13.1	KCNK4, TRAAK		Potassium channel, subfamily K, member 4	605720	R			
11.498	6	6	00	11q13.1	KCNK7		Potassium channel, subfamily K, member 7	603940	R			
11.499	4	18	05	11q12.3	LGALS12		Lectin, galactoside-binding, soluble, 12	606096	REc			
11.500	9	20	99	11q13.1	MAP4K2, RAB8IP, GCK		Mitogen-activating protein kinase kinase kinase kinase 2 (RAB8-interacting protein; germinal center kinase)	603166	REc			
11.501	2	9	11	11q13.1	MEN1		Menin	613733	Fd, D	linked distal to PYGM	Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Angiofibroma, somatic (3); Adrenal adenoma, somatic (3)	19(Men1)
11.502	9	26	17	11q13.3	CUPID1, LINC01488, BRCAT8		CCND1 upstream intergenic DNA repair 1, noncoding	617696	REc			
11.503	9	28	17	11q13	CUPID2		CCND1 upstream intergenic DNA repair 2, noncoding	617697	REc			
11.504	2	22	11	11q13.4	MIR326, MIRN326		Micro RNA 326	613755	REc			
11.505	4	29	02	11q13.1	MRPL49, NOF1		Mitochondrial ribosomal protein L49	606866	REc			19(Mrpl49)
11.506	9	27	01	11q12.1	MS4A2, FCER1B		Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide)	147138	Fd, REn		{Atopy, susceptibility to}, 147050 (3)	
11.507	12	15	10	11q12.2	MS4A1, CD20, CVID5		Membrane-spanning 4-domains, subfamily A, member 1	112210	REa, A, R		Immunodeficiency, common variable, 5, 613495 (3)	19(Ly44)
11.508	1	7	02	11q13.1	MUS81		Mus81, S. cerevisiae, homolog of	606591	A, REc			
11.509	12	17	12	11q13.2	NDUFS8		NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kD (NADH-coenzyme Q reductase)	602141	A, REc, R	previously assigned to 3q28	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
11.510	12	14	11	11q13.2	NDUFV1, UQOR1		NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kD	161015	REa, A		Mitochondrial complex I deficiency, 252010 (3)	
11.511	8	29	08	11q13.2	NPAS4, NXF		Neuronal PAS domain protein 4	608554	REc			
11.512	6	6	00	11q13.1	NRXN2		Neurexin 2	600566	REc			
11.513	8	28	15	11q13.4	NUMA1		Nuclear mitotic apparatus protein-1	164009	A, Ch	fused with RARA in APL	Leukemia, acute promyelocytic, somatic, 612376 (3)	
11.514	12	7	07	11q13.3	ORAOV1, TAOS1		Oral cancer overexpressed gene 1	607224	REc, H			7(Oraov1)
11.515	5	4	12	11q13	OTDD, DEL11q13, C11DELq13		Otodental dysplasia (chromosome 11q13 deletion syndrome)	166750	Ch	between rs9666584 and rs41408348	Otodental dysplasia chromosome deletion syndrome (4)	
11.516	7	15	99	11q13.1	OVOL1		Ovo, Drosophila, homolog-like, 1	602313	H, Psh, A			19(Ovol1)
11.517	10	23	87	11q13	PGA3		Pepsinogen A3	169710	REa, RE, A			
11.518	10	23	87	11q12.2	PGA4		Pepsinogen A4	169720	REa, RE, A			
11.519	10	23	87	11q12.2	PGA5		Pepsinogen A5	169730	REa, A	pter-5'HRAS--5'INS--cen		
11.520	1	7	95	11q13.1	PLCB3		Phospholipase C, beta 3 (phosphatidylinositol-specific)	600230	REn, Ch	within 900kb of MEN1		19(Plcb3)
11.521	10	13	09	11q13.2	POLD4, POLDS, P12		Polymerase, DNA-directed, delta 4	611525	R, REc			
11.522	12	18	08	11q13.2	RBM14, PSP2, COAA, SIP		RNA-binding motif protein 14	612409	REc			
11.523	12	29	15	11q13.1	SCYL1, NTKL, SCAR21		SCY1-like 1	607982	REc		Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	
11.524	3	14	18	11q13.2	UNC93B1, IIAE1		UNC93, C. elegans, homolog of, B1	608204	A		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3)	
11.525	7	17	01	11q13.1	PPP1R14B, PLCB3N, PNG		Protein phosphatase 1, regulatory subunit 14B	601140	REc			
11.526	8	20	98	11q13.2	PPP1CA, PPP1A		Protein phosphatase-1, catalytic subunit, alpha isoform	176875	REa, A, R			7(Ppp1a)
11.527	10	19	97	11q13.1	PPP2R5B		Protein phosphatase-2, regulatory subunit B (B56), beta isoform	601644	A, REc			
11.528	1	7	02	11q13.1	PRDX5, AOEB166		Peroxiredoxin 5	606583	R			
11.529	3	9	04	11q13.1	PYGM		Phosphorylase, glycogen, muscle	608455	REb, Fd, REn		McArdle disease, 232600 (3)	19(Pygm)
11.530	7	17	14	11q13.1	RASGRP2, CDC25L		Ras guanyl nucleotide-releasing protein 2	605577	REc	mutation identified in 1 BDPLT18 family	?Bleeding disorder, platelet-type, 18, 615888 (3)	
11.531	6	25	99	11q13.2	RBM4. LARK		RNA-binding motif protein-4 (lark, Drosophila, homolog of)	602571	A, R			
11.532	12	18	13	11q13.2	RCE1		Ras converting CAAX endopeptidase 1	605385	R, REc			
11.533	2	25	15	11q12.3	RNU22		RNA, U22 small nucleolar	603223	A, R			
11.534	2	25	15	11q12.3	RNU25		RNA, U25 small nucleolar	603224	A, R			
11.535	11	11	14	11q12.3	RNU26		RNA, U26 small nucleolar	603225	A, R			
11.536	11	11	14	11q12.3	RNU27		RNA, U27 small nucleolar	603226	A, R			
11.537	11	11	14	11q12.3	RNU28		RNA, U28 small nucleolar	603227	A, R			
11.538	11	11	14	11q12.3	RNU29		RNA, U29 small nucleolar	603228	A, R			
11.539	11	1	14	11q12.3	RNU30		RNA, U30 small nucleolar	603229	A, R			
11.540	11	11	14	11q12.3	RNU31		RNA, U31 small nucleolar	603230	A, R			
11.541	7	19	18	11q12.3	ROM1, ROSP1, RP7		Rod outer segment membrane protein-1	180721	REa, A	digenic RP with RDS	Retinitis pigmentosa 7, digenic form, 608133 (3)	19(Rosp1)
11.542	10	22	99	11q13.1	RTN3, NSPL2		Reticulon 3	604249	REa, R, REc	pseudogene on chr.4		
11.543	3	29	07	11q13.2	SAPS3, PP6R3, C11orf23, KIAA1558		SAPS domain family, member 3	610879	Psh, REc			
11.544	9	17	92	11q13	SEA		Oncogene SEA (S13 avian erythroblastosis)	165110	REa, A, R			19(Sea)
11.545	1	28	01	11q13.1	SF1, ZNF162, D11S636, ZFM1		Splicing factor 1 (zinc finger protein-162)	601516	REf, REa, A			
11.546	5	30	00	11q12.3	SLC3A2, MDU1, NACAE		Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2	158070	S, H	prob. 11q13		19(Mdu1)
11.547	7	12	02	11q13.1	SLC22A11, OAT4		Solute carrier family 22 (organic anion/cation transporter), member 11	607097	REc			
11.548	7	12	02	11q13.1	SLC22A12, OAT4L, URAT1		Solute carrier family 22 (urate transporter), member 12	607096	REc		Hypouricemia, renal, 220150 (3)	
11.549	3	9	98	11q13.2	SLC29A2, HNP36, DER12		Solute carrier family 29 (nucleoside transporters), member 2 (hydrophobic nucleolar protein, 36kD)	602110	A			19(Hnp36)
11.550	7	2	02	11q13	SMAR		Spinal muscular atrophy, chronic distal, autosomal recessive	607088	Fd	no mutations found in IGHMBP2	Spinal muscular atrophy, chronic distal, autosomal recessive (2)	
11.551	5	25	01	11q13.1	SNX15		Sorting nexin 15	605964	REc			
11.552	9	9	13	11q13.2	SPTBN2, SCA5, SCAR14		Spectrin, beta, nonerythrocytic, 2	604985	R, H, Fd		Spinocerebellar ataxia 5, 600224 (3); Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	19(Spnb3)
11.553	12	9	91	11q13	ST3		Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)	191181	S, D		Cervical carcinoma (2)	
11.554	3	18	17	11q13.4	STARD10		START domain-containing protein 10	617382	REc			
11.555	1	31	01	11q13.1	STIP1, HOP		Stress-induced phosphoprotein 1	605063	R			
11.556	6	6	00	11q12.2	SYT7		Synaptotagmin 7	604146	REc			
11.557	12	7	05	11q13.1	SYVN1, HRD1, KIAA1810		Synovial apoptosis inhibitor 1	608046	R, REc			
11.558	1	13	99	11q13.1	TM7SF2, ANG1		Transmembrane 7 superfamily, member 2	603414	REc			
11.559	3	14	07	11q13.1	TRPT1		Transfer RNA phosphotransferase 1	610470	REc			
11.560	10	08	08	11q13.4	UCP2, BMIQ4		Uncoupling protein-2	601693	REc, Fd, REn		{Obesity, susceptibility to, BMIQ4}, 607447 (3)	7(Ucp2)
11.561	5	31	05	11q13.4	UCP3		Uncoupling protein-3	602044	REn, R, Psh		{Obesity, severe, and type II diabetes}, 601665 (3)	
11.562	11	5	98	11q12.3	UHG, U22HG		U22 host gene	603222	A, R			
11.563	6	25	99	11q13.5	UVRAG		UV radiation resistance-associated gene	602493	A, Psh			
11.564	10	5	15	11q12.3	BEST1, VMD2, ARB, RP50		Bestrophin 1	607854	Fd, Psh		Macular dystrophy, vitelliform, 2, 153700 (3); Bestrophinopathy, autosomal recessive, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)	
11.565	1	27	97	11q13.1	VEGFB, VRF		Vascular endothelial growth factor B	601398	REc, Psh			
11.566	2	16	18	11q22.1	YAP1, COB1		Yes-associated protein 1, 65kD	606608	A, REa		Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3)	
11.567	10	2	07	11q13.2	YIF1A, YIF1		Yip1-interacting factor, S. cerevisiae, homolog of, A	611484	R, REc			
11.568	2	22	11	11q13.1	ZNHIT2, C11orf5, FON		Zinc finger HIT domain containing protein 2	604575	REc			
11.569	10	30	17	11q13.2	ACTN3, ACTN3D		Actinin, alpha-3	102574	REa, A		[Alpha-actinin-3 deficiency], 617749 (3); [Sprinting performance], 617749 (3)	19(Actn3)
11.570	11	23	09	11q13.4	KCNE3, HOKPP, HYPP		Potassium voltage-gated channel, ISK-related subfamily, member 3	604433	R		Brugada syndrome 6, 613119 (3)	
11.571	6	25	99	11q13.5-q14.1	PAK1		p21/CDC42/RAC1-activated kinase 1	602590	REc			
11.572	3	25	03	11q13.4	PLEKHB1, PHR1, KPL1		Pleckstrin homology domain-containing protein, family B, member 1	607651	A, R, H			7(Tyr)
11.573	10	23	87	11q13-q22	ESA4		Esterase-A4	133220	S			9(Es17)
11.574	7	15	16	11q12.3	GANAB, PKD3		Neutral alpha-glucosidase AB	104160	S		Polycystic kidney disease 3, 600666 (3)	
11.575	9	18	12	11q13.1	AP5B1, DKFZp761E198		Adaptor-related protein complex 5, beta-1 subunit	614367	REc			
11.576	2	17	15	11q13.1	ATG2A, KIAA0404		Autophagy 2, S. cerevisiae, homolog of, A	616225	R, REc			
11.577	2	13	14	11q13.1	ATL3, HSN1F		Atlastin 3	609369	REc		Neuropathy, hereditary sensory, type IF, 615632 (3)	
11.578	11	16	09	11q13.1	BAD, BCL2L8		BCL1 antagonist of cell death	603167	REc			
11.579	7	1	11	11q13.1	BANF1, BAF, NGPS		Barrier to autointegration factor 1	603811	R		Nestor-Guillermo progeria syndrome, 614008 (3)	
11.580	1	15	13	11q13.1	BATF2, SARI		Basic leucine zipper transcription factor, ATF-like 2	614983	REc			
11.581	10	26	12	11q13.2	CABP2, DFNB93		Calcium-binding protein 2	607314	A, REn		Deafness, autosomal recessive 93, 614899 (3)	
11.582	6	21	15	11q13.2	CABP4, CRSD, CSNB2B		Calcium-binding protein 4	608965	REc		Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	
11.583	11	3	11	11q13.1	CATSPER1, CATSPER, SPGF7		Cation channel, sperm-associated, 1	606389	REc		Spermatogenic failure 7, 612997 (3)	
11.584	6	12	17	11q13.1	CATSPERZ, TEX40		Cation channel, sperm-associated, auxiliary subunit zeta	617511	REc, H			11(Catsperz)
11.585	6	22	14	11q13.1	DIPA		Delta antigen-interacting protein A	605360	R, REc			
11.586	8	30	11	11q13.1	CCDC88B, GIPIE		Coiled-coil domain-containing protein 88B	611205	REc			
11.587	4	5	11	11q13.1	CDCA5, SORORIN		Cell division cycle-associated protein 5 (sororin)	609374	R, REc			
11.588	8	19	13	11q13.2	CTSF, CLN13		Cathepsin F	603539	A, REa		Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	
11.589	2	12	99	11q13.1	CTSW		Cathepsin W	602364	A			
11.590	9	20	14	11q13.1	DRAP1		DR1-associated protein 1	602289	REc			
11.591	12	18	14	11q13.1	FAM89B, MTVR, LRAP25		Family with sequence similarity 89, member B	616128	REc			19(Fam89b)
11.592	11	16	06	11q13.3	FGF19		Fibroblast growth factor 19	603891	REc			7(Fgf15)
11.593	9	16	16	11q13.1	FIBP, TROFAS		Fibroblast growth factor, acidic, intracellular binding protein	608296	A		Thauvin-Robinet-Faivre syndrome, 617107 (3)	
11.594	9	27	17	11q13.1	GPHA2, GPA2		Glycoprotein hormone, alpha-2	609651	REc			
11.595	7	15	09	11q13.2	LRFN4, SALM3		Leucine-rich repeat and fibronectin type III domain-containing protein 4	612810	REc, H			19(Lrfn4)
11.596	2	25	15	11q13.1	MACROD1, LRP16		Macro domain-containing 1	610400	R, REc			
11.597	9	26	16	11q13.1	MAJIN, C11orf85		Membrane-anchored junction protein	617130	REc			
11.598	5	19	09	11q13.1	MALAT1, PRO1073		Metastasis-associated lung adenocarcinoma transcript 1	607924	Ch, REc	fused with TFEB in renal tumors		
11.599	3	23	09	11q13.1	MIR192, MIRN192		Micro RNA 192	610939	REc			
11.600	3	23	09	11q13.1	MIR194-2, MIRN194-2		Micro RNA 194-2	610941	REc			
11.601	3	1	01	11q13.3	MYEOV		Myeloma overexpressed gene	605625	A			
11.602	7	11	16	11q13.1	NEAT1, TNCRNA		Noncoding nuclear-enriched abundant transcript 1	612769	REc, H			19(Ncrna00084)
11.603	6	5	08	11q13.1	OTUB1, OTU1, OTB1		OTU domain-containing ubiquitin aldehyde-binding protein 1	608337	REc			
11.604	7	29	16	11q13.1-q13.2	PACS1, SHMS, MRD17		Phosphofurin acidic cluster sorting protein 1	607492	REc		Schuurs-Hoeijmakers syndrome, 615009 (3)	
11.605	8	31	17	11q13.1	PCNX3		Pecanex, Drosophila, homolog of, 3	617657	REc			19(Pcnx3)
11.606	10	15	97	11q12.3	POLR2G		Polymerase (RNA) II (DNA directed) polypeptide G	602013	R, REc			
11.607	2	4	09	11q13.2	RAB1B		Ras-associated protein RAB1B	612565	REc			
11.608	10	12	14	11q13.1	RCOR2		Rest corepressor 2	616019	REc			
11.609	5	25	13	11q13.1	RPS6KA4, RSKB, MSK2		Ribosomal protein S6 kinase, 90kD, 4	603606	REc			
11.610	9	17	09	11q12.2	SDHAF2, SDH5, PGL2		Succinate dehydrogenase complex assembly factor 2	613019	REc, Fd		Paragangliomas 2, 601650 (3)	
11.611	1	2	08	11q13.1	SLC22A20, OAT6		Solute carrier family 22, member 20	611696	REc			19(Slc22a20)
11.612	3	12	07	11q13.1	SLC25A45		Solute carrier family 25, member 45	610825	REc			19(Slc25a45)
11.613	9	8	11	11q13.1	SPDYC, RINGOC		Speedy, xenopus, homolog of, C	614030	REc			
11.614	3	8	07	11q13.2	TBC1D10C, CARABIN		TBC1 domain family, member 10C	610831	REc			
11.615	4	29	14	11q13.1	VPS51, ANG2		Vacuolar protein sorting 51, S. cerevisiae, homolog of	615738	REc			
11.616	9	13	01	11q13.2	BRMS1		Breast cancer metastasis suppressor 1	606259	A			
11.617	6	25	99	11q13.2	RAD9A, RAD9		RAD9, S. pombe, homolog of	603761	A, RE			
11.618	2	27	03	11q12.3	SLC22A6, OAT1, PAHT		Solute carrier family 22 (organic anion transporter), member 6	607582	REa, R, A			
11.619	12	13	00	11q13.2	TBX10		T-box 10	604648	A, REc			19(Tbx10)
11.620	3	23	93	11q13.1	FKBP2		FK506-binding protein-2, 13kD	186946	A			
11.621	1	8	95	11q13.1	MAP3K11, MLK3, PTK1, SPRK		Mitogen-activated protein kinase kinase kinase 11	600050	A			
11.622	1	5	12	11q13.2	ACY3, HCBP1		Aminoacylase 3	614413	REc			19(Acy3)
11.623	4	6	13	11q13.2	ANKRD13D		Ankyrin repeat domain-containing protein 13D	615126	REc			
11.624	1	11	18	11q13.2	B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13		Beta-1,4glucuronyltransferase 1	605517	R, REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	
11.625	12	1	14	11q13.2	C11orf80		Chromosome 11 open reading frame 80	616109	A, REc			
11.626	5	24	13	11q13.2	CNIH2, CNIL		Cornichon, Drosophila, homolog of, 2	611288	REc			
11.627	7	22	11	11q13.2	CHKA, CHK		Choline kinase, alpha	118491	REc			
11.628	1	24	06	11q13.2	CORO1B		Coronin 1B	609849	REc			19(Coro1b)
11.629	12	5	17	11q13.2	KMT5B, SUV420H1, CGI85, MRD51		Lysine methyltransferase 5B	610881	REc		Mental retardation, autosomal dominant 51, 617788 (3)	
11.630	3	31	09	11q13.3	MRGPRD, MRGD		Mas-related G protein-coupled receptor family, member D	607231	REc			
11.631	3	31	09	11q13.3	MRGPRF, MRGF, RTA		Mas-related G protein-coupled receptor family, member F	607233	REc			
11.632	2	28	08	11q13.3	MRPL21		Mitochondrial ribosomal protein L21	611834	REc			
11.633	3	5	08	11q13.4	MRPL48		Mitochondrial ribosomal protein L48	611853	REc	pseudogene on 6		
11.634	12	5	03	11q13.4	NADSYN1		NAD synthetase 1	608285	R, REc			
11.635	9	2	12	11q13.2	PELI3		Pellino, Drosophila, homolog of, 3	609827	REc			
11.636	10	15	07	11q13.1	RNASEH2C, AYP1, FLJ20974, AGS3		Ribonuclease H2, subunit C	610330	REc, Fd		Aicardi-Goutieres syndrome 3, 610329 (3)	
11.637	4	3	12	11q13.2	SSH3		Slingshot, Drosophila, homolog of, 3	606780	R			
11.638	6	7	10	11q13.2	SYT12, SRG1		Synaptotagmin 12	606436	REc			
11.639	9	24	08	11q13.3	TPCN2, TPC2, SHEP10		Two-pore segment channel 2	612163	REc		[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	
11.640	2	2	01	11q13.3	MTL5, TESMIN		Metallothionein-like 5, testis-specific	604374	A			19(Mtl5)
11.641	1	5	15	11q13.3	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S		Immunoglobulin mu binding protein 2	600502	A		Neuronopathy, distal hereditary motor, type VI, 604320 (3); Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	19(Ighmbp2)
11.642	9	27	17	11q13.2	AIP, XAP2, ARA9, PITA1		Aryl hydrocarbon receptor-interacting protein	605555	REa, A		Pituitary adenoma 1, multiple types, 102200 (3); Pituitary adenoma predisposition, 102000 (3)	
11.643	11	10	14	11q13.2	CLCF1, BSF3, CLC, CISS2		Cardiotrophin-like cytokine	607672	A, R		Cold-induced sweating syndrome 2, 610313 (3)	
11.644	9	1	16	11q13.4	DNAJB13, TSARG6, CILD34		DNAJ/HSP40 homolog, subfamily B, member 13	610263	REc		Ciliary dyskinesia, primary, 34, 617091 (3)	
11.645	3	10	11	11q13.3	FADD		FAS-associating protein with death domain	602457	REa, A		Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3)	
11.646	2	26	08	11q13.2	MRPL11		Mitochondrial ribosomal protein L11	611826	R			
11.647	8	21	07	11q13.3	PPFIA1, LIP1		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha-1	611054	R, REc			
11.648	8	28	97	11q13.2	PTPRCAP, LPAP		Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein	601577	A			
11.649	10	17	05	11q13.1	SIPA1, SPA1		Signal-induced proliferation-associated gene-1	602180	A, REc, H			19(Spa1)
11.650	12	23	05	11q13.4	XRRA1		X-ray radiation resistance-associated 1	609788	REc			
11.651	11	24	08	11q13.4	LRTOMT, LRTOMT1, LRTOMT2, DFNB63		Leucine-rich transmembrane O-methyltransferase	612414	REc, REn		Deafness, autosomal recessive 63, 611451 (3)	7(Lrrc51, Tomt)
11.652	3	20	03	11q13.4	PHOX2A, ARIX, CFEOM2		Paired-like (astraless) homeobox 2a	602753	REa, A, Fd		Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	7(Arix)
11.653	9	7	10	11q13.3-q13.4	SHANK2, CORTBP1, AUTS17		SH3 and multiple ankyrin repeat domains 2	603290	R, REc		{Autism susceptibility 17}, 613436 (3)	
11.654	3	23	93	11q13.3-q13.4	ZNF126		Zinc finger protein-126 (HZF-2)	194633	A			
11.655	10	12	09	11q13.4	FOLR1		Folate receptor-1, adult	136430	REa, A, Fd, REn	telomeric of FGF3	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	
11.656	10	20	92	11q13.4	FOLR2		Folate receptor-2 (fetal)	136425	A, REn	23kb from FOLR1		
11.657	7	13	15	11q13.2	GAL, GALN, GLNN, ETL8		Galanin	137035	Psh, A	mutation identified in 1 ETL8 family	?Epilepsy, familial temporal lobe, 8, 616461 (3)	19(Glnn)
11.658	3	18	95	11q13.4	RNU15A		RNA, U15a small nucleolar	600455	Psh, A, REn	processed from intron of RPS3		
11.659	3	18	95	11q13.4	RPS3		Ribosomal protein S3	600454	Psh, A, REn			
11.660	7	13	12	11q13.4	ANAPC15, APC15		Anaphase-promoting complex, subunit 15	614717	REc			
11.661	2	23	17	11q13.4	ARAP1, CENTD2, KIAA0782		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1	606646	R, REc			
11.662	7	22	16	11q13.4	ARHGEF17, RHOGEF17, TEM4, KIAA0337		Rho guanine nucleotide exchange factor 17	617043	R, REc			
11.663	8	22	14	11q13.4	C2CD3, OFD14		C2 calcium-dependent domain-containing protein 3	615944	REc	mutation identified in 1 OFD14 patient and 1 OFD14 fetus	?Orofaciodigital syndrome XIV, 615948 (3)	
11.664	1	12	07	11q13.4	CHCHD8, E2IG2		Coiled-coil-helix-coiled-coil-helix domain containing 8	608016	REc, R			
11.665	12	2	09	11q13.4	CHRDL2, CHL2, BNF1		Chordin-like 2	613127	REc, H			7(Chrdl2)
11.666	3	23	15	11q13.4	CLPB, SKD3, MEGCANN, MGCA7		Caseinolytic peptidase B	616254	REc		3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	
11.667	12	18	14	11q13.4	FAM86C1		Family with sequence similarity 86, member C1	616124	REc			
11.668	7	6	17	11q13.4	FCHSD2, KIAA0769, NWK		FCH and double SH3 domains protein 2	617556	REc, H			7(Fchsd2)
11.669	9	27	17	11q13.4	FOLR3		Folate receptor 3	602469	REc			
11.670	4	22	15	11q13.4	RAM168A, TCRP1, KIAA0280		Family with sequence similarity 168, member A	616316	Psh, REc			
11.671	8	22	13	11q13.4	IL18BP		Interleukin 18-binding protein	604113	REc			
11.672	2	5	15	11q13.4	LAMTOR1, C11orf59, PDRO		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 1	613510	REc			
11.673	9	15	17	11q13.4	LIPT2		Lipoyl(octanoyl) transferase 2	617659	REc		Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3)	
11.674	2	22	18	11q13.2	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4		Low density lipoprotein receptor-related protein-5	603506	H, A, R		Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710 (3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3); Polycystic liver disease 4 with or without kidney cysts, 617875 (3)	19(Lrp5)
11.675	3	7	13	11q13.4	MIR139, MIR139-3p		Micro RNA 139	615017	REc			
11.676	5	25	13	11q13.4	PDE2A		Phosphodiesterase 2A	602658	REc			
11.677	2	18	08	11q13.4	PGM2L1		Phosphoglucomutase 2-like 1	611610	R, REc			
11.678	9	10	07	11q13.4	PPME1		Protein phosphatase methylesterase 1	611117	R, REc			
11.679	10	12	90	11q13.4	RAB6A, RAB6		Oncogene RAB6	179513	A, REc	previously assigned to 2q14-q21		
11.680	9	18	08	11q13.4	RELT, TNFRSF19L		Receptor expressed in lymphoid tissues	611211	R, REc			
11.681	4	20	04	11q13.5	EMSY, C11orf30		EMSY gene	608574	A, R, REn	100kb from GARP		
11.682	3	3	03	11q14.1	GAB2		GRB2-associated binding protein 2	606203	R, A			7(Gab2)
11.683	2	19	10	11q13.4-q13.5	GDPD5, GDE2, PP1665		Glycerophosphodiester phosphodiesterase domain-containing protein 3	609632	REc			
11.684	8	25	04	11q13.2	PC		Pyruvate carboxylase	608786	REa, H, A		Pyruvate carboxylase deficiency, 266150 (3)	19(Pc)
11.685	6	26	00	11q13.2	TCIRG1, TIRC7, OC116, OPTB1		T-cell immune regulator 1	604592	A, Fd, H		Osteopetrosis, autosomal recessive 1, 259700 (3)	19(oc)
11.686	1	9	94	11p14.1	KCNA4, KCNA8		Potassium voltage-gated channel, shaker-related subfamily, member 4	176266	REa, A, H	other map to 11p		2(Kcna4)
11.687	3	23	93	11q13.5	OMP		Olfactory marker protein	164340	REa, A			7(Omp)
11.688	11	10	17	11q13.5	ACER3, APHC, PHCA, PLDECO		Alkaline ceramidase 3	617036	REc	mutation identified in 1 PLDECO family	?Leukodystrophy, progressive, early childhood-onset, 617762 (3)	
11.689	10	12	09	11q13.5	ATOD7		Dermatitis, atopic, 7	613064	Fd	associated with rs7927894	{Dermatitis, atopic, susceptibility to, 7} (2)	
11.690	2	18	16	11q13.5	DGAT2		Diacylglycerol O-acyltransferase 2	606983	R, REc			
11.691	10	4	91	11q13.4	KRTAP5-9, KRN1		Keratin associated protein 5-9	148021	A, R			
11.692	6	21	12	11q13.5	LRRC32, GARP, D11S833E		Leucine rich repeat containing 32	137207	A, REn			7(Garp)
11.693	9	27	17	11q13.5	MAP6, MTAP6, STOP, KIAA1878		Microtubule-associated protein 6	601783	R, REc, A			
11.694	8	3	12	11q13.5	MOGAT2, MGAT2		Monoacylglycerol O-acyltransferase 2	610270	REc			
11.695	11	26	97	11q13.5	MYO7A, USH1B, DFNB2, DFNA11		Myosin VIIA	276903	Fd		Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2, 600060 (3); Deafness, autosomal dominant 11, 601317 (3)	7(sh1, Myo7a)
11.696	3	9	00	11q13.4	NEU3, SIAL3		Neuraminidase 3 (membrane sialidase; sialidase 3)	604617	A			
11.697	7	15	99	11q13.4	P2RY2, P2Y2, P2U		Purinergic receptor P2Y, G-protein coupled, 2	600041	Psh, A			
11.698	7	15	99	11q13.4	P2RY6, P2Y6		Pyrimidinergic receptor P2Y, G protein-coupled, 6	602451	Psh, A			
11.699	7	14	14	11q13.5	PRKRIR		PRKR inhibitor, repressor of	607374	REc			
11.700	10	12	16	11q13.5	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10		Serpin peptidase inhibitor, clade H, member 1	600943	A		{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3); Osteogenesis imperfecta, type X, 613848 (3)	
11.701	6	9	98	11q14.1	THRSP		Thyroid hormone responsive SPOT14, rat, homolog of	601926	A			
11.702	1	12	07	11q13.5	TSKU, E2IG4, TSK		Tsukushin	608015	REc			
11.703	6	25	99	11q13.5	WNT11		Wingless-type MMTV integration site family, member 11	603699	A, Psh			
11.704	3	9	98	11q14.1	CLNS1A, CLNS1B		Chloride channel, nucleotide-sensitive, 1A	602158	A	CLNS1B on 6p12.1-q13 = pseudogene?		
11.705	11	21	02	11q14.2	RAB38		Ras-family, member RAB38	606281	R, H, REc			7(Rab38, cht)
11.706	3	1	06	11q14.1	AQP11, AQPX1		Aquaporin 11	609914	REc			
11.707	7	22	13	11q13.5	B3GNT6		Beta-1,3-N-acetylglucosaminyltransferase 6	615315	REc			
11.708	2	21	14	11q13.5	CAPN5, HTRA3, VRNI		Calpain 5	602537	R, Fd		Vitreoretinopathy, neovascular inflammatory, 193235 (3)	
11.709	4	17	07	11q14	GCRG224		Gastric cancer-related gene 224	610888	REc			
11.710	8	27	15	11q14.2	PICALM, CALM, CLTH, LAP		Phosphatidylinositol-binding clathrin assembly protein	603025	Ch	fuses with AF10 in t(10;11)	Leukemia, acute myeloid, somatic, 601626 (3)	
11.711	6	9	98	11q14.1	PRCP, PCP		Prolylcarboxypeptidase (angiotensinase C)	176785	Psh, REc, R			
11.712	10	28	02	11q14	SLEH1		Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1	607279	Fd		{Systemic lupus erythematosus with hemolytic anemia} (2)	
11.713	7	20	09	11q14.1	SYTL2, SLP2, SLP2A, EXO4, KIAA1597		Synaptotagmin-like 2	612880	R, REc			
11.714	12	14	98	11q14-q21	SCZD2		Schizophrenia susceptibility locus, chromosome 11-related	603342	Ch		{?Schizophrenia}, 181500 (2)	
11.715	8	25	14	11q14.2	FZD4, EVR1		Frizzled, Drosophila, homolog of, 4	604579	A, Fd		Exudative vitreoretinopathy 1, 133780 (3); Retinopathy of prematurity, 133780 (3)	
11.716	10	8	13	11q14.3	TYR, SHEP3, CMM8, OCA1A, ATN		Tyrosinase	606933	REa, A, H, F		Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	7(Tyr)
11.717	5	15	08	11q14-q22	IHPS3		Pyloric stenosis, infantile hypertrophic, 3	612017	Fd	max lod at rs541821	Pyloric stenosis, infantile hypertrophic, 3 (2)	
11.718	7	2	18	11q14.1	CREBZF, ZF		CREB/ATF bZIP transcription factor	606444	REc			
11.719	7	2	18	11q14.1	DDIAS, NOXIN, C11orf82		DNA damage-induced apoptosis suppressor	618045	REc			7(Ddias)
11.720	3	23	14	11q14.1	INTS4, INT4		Integrator complex subunit 4	611348	REc			
11.721	2	25	15	11q14.1	NARS2, COXPD24		Asparaginyl-tRNA synthetase 2	612803	REc		Combined oxidative phosphorylation deficiency 24, 616239 (3)	
11.722	5	25	13	11q14.1	NDUFC2		NADH-ubiquinone oxidoreductase 1, subunit C2	603845	REc			
11.723	9	16	12	11q14.1	PCF11, KIAA0824		PCF11, yeast, homolog of	608876	REc			
11.724	11	22	17	11q14.1	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5		Teneurin transmembrane protein 4	610084	REc, R, H		Essential tremor, hereditary, 5, 616736 (3)	7(Odz4)
11.725	8	1	16	11q14.1	TMEM126B		Transmembrane protein 126B	615533	REc		Mitochondrial complex I deficiency, 252010 (3)	
11.726	12	21	12	11q14.2	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD		Cathepsin C	602365	A, REc, Fd		Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010 (3); Periodontitis 1, juvenile, 170650 (3)	7(Ctsc)
11.727	9	2	09	11q14.1	TMEM126A, OPA7		Transmembrane protein 126A	612988	REc		Optic atrophy 7, 612989 (3)	
11.728	8	9	17	11q14.2	HIKESHI, C11orf73, HLD13		Hikeshi	614908	REc		Leukodystrophy, hypomyelinating, 13, 616881 (3)	
11.729	5	19	15	11q14.2	TMEM135, PMP52		Transmembrane protein 135	616360	REc			
11.730	4	19	12	11q14.2-q14.3	GRM5, MGLUR5		Glutamate receptor, metabotropic, 5	604102	REc			7(Grm5)
11.731	7	12	02	11q14.3	NOX4, RENOX		NADPH oxidase 4	605261	REc, A			
11.732	7	11	17	11q14.2	EED, WAIT1, COGIS		Embryonic ectoderm development protein, mouse, homolog of	605984	A		Cohen-Gibson syndrome, 617561 (3)	
11.733	8	3	12	11q13.2	RHOD, ARHD, RHOHP1		Ras homolog gene family, member D	605781	R			
11.734	3	24	11	11q21	SLC36A4, PAT4		Solute carrier family 36, member 4	613760	REc			
11.735	1	18	11	11q14.3	UBTFL1, HMGPI		Upstream binding transcription factor (RNA polymerase I)-like 1	613696	REc			
11.736	12	17	08	11q14.3	FAT3		FAT tumor suppressor, Drosophila, homolog of, 3	612483	R, REc			
11.737	1	2	08	11q14.3	NAALAD2		N-acetylated alpha-linked acidic dipeptidase 2	611636	A			
11.738	5	29	12	11q21	AMOTL1, JEAP		Angiomotin-like 1	614657	REc			
11.739	7	14	14	11q21	C11orf54, PTOD012		Chromosome 11 open reading frame 54	615810	REc			
11.740	9	21	11	11q21	C11orf75, FN5		FN5, pufferfish, homolog of	609477	R, Psh			
11.741	7	28	11	11q21	CEP57, PIG8, TSP57, KIAA0092, MVA2		Centrosomal protein 57kD	607951	REc		Mosaic variegated aneuploidy syndrome 2, 614114 (3)	
11.742	10	25	17	11q21	CEP295, KIAA1731		Centrosomal protein, 295kD	617728	REc			
11.743	10	11	16	11q21	DEUP1, CCDC67		Deuterosome assembly protein 1	617148	REc			
11.744	6	25	99	11q14.1	DLG2		Discs large, Drosophila, homolog of, 2 (channel-associated protein of synapses, 110kD)	603583	R, REc			
11.745	4	22	05	11q21	GPR83, GIR, GPR72		G protein-coupled receptor 83	605569	R			9(Gpr83)
11.746	4	29	14	11q21	FOLR4		Folate receptor 4	615737	REc			9(Folr4)
11.747	5	19	94	11q21	FUT4, FCT3A, CD15		Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)	104230	S, REa, R			9(Fut4)
11.748	11	3	98	11q21	JRKL, HHMJG		Jerky, mouse, homolog-like	603211	A			
11.749	5	16	18	11q21	KDM4D, JMJD2D		Lysine demethylase 4D	609766	REc, REn			
11.750	9	29	15	11q21	KDM4E, JMJD2E		Lysine-specific demethylase 4E	616581	REc			
11.751	3	3	03	11q21	MAML2, MAM3		Mastermind-like 2	607537	Ch	t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
11.752	12	21	10	11q21	MED17, CRSP6, CRSP77, TRAP80, DRIP80		Mediator complex subunit 17	603810	R, REc		Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	
11.753	12	29	99	11q21	MRE11A, MRE11, ATLD		Meiotic recombination 11, S. cerevisiae, homolog A of	600814	REa, A		Ataxia-telangiectasia-like disorder 1, 604391 (3)	
11.754	8	8	13	11q21	PANX1, PX1		Pannexin 1	608420	REc, R			
11.755	5	13	03	11q21	SEST3		Sestrin 3	607768	A			10(Sest3)
11.756	7	16	09	11q21	TAF1D, RAFI41, JOSD3		TATA box-binding protein-associated factor 1D	612823	REc			
11.757	2	21	10	11q21-q22	FGQTL3		Fasting plasma glucose level QTL 3	613233	Fd	associated with rs10830963	[Fasting plasma glucose level QTL 3] (2)	
11.758	8	18	98	11q22.3	GUCY1A2, GUC1A2		Guanylate cyclase 1, soluble, alpha 2	601244	A			
11.759	9	29	96	11q22.2	MMP7		Matrix metalloproteinase 7 (matrilysin, uterine)	178990	H, REa, Psh, A			
11.760	11	15	94	11q22.2	MMP8, CLG1		Matrix metalloproteinase 8 (neutrophil collagenase)	120355	A			
11.761	3	30	12	11q14.3	MTNR1B		Melatonin receptor 1B	600804	REa		{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
11.762	9	9	13	11q21	MIR1260B		Micro RNA 1260B	615372	REc			
11.763	7	6	05	11q22.1	TRPC6, TRP6, FSGS2		Transient receptor potential channel-6	603652	A, Fd		Glomerulosclerosis, focal segmental, 2, 603965 (3)	
11.764	10	17	02	11q22.1	CNTN5, NB2		Contactin 5	607219	A			
11.765	4	1	03	11q22.1	ANGPTL5		Angiopoietin-like 5	607666	REc			
11.766	3	21	14	11q22.3	CARD16, COP1		Caspase recruitment domain-containing protein 16	615680	REn			
11.767	10	27	92	11q22.3	FDX1, ADX		Ferredoxin-1 (adrenodoxin)	103260	REa, A	pseudogene on 20q11-q12		
11.768	8	1	05	11q22.3	INCA		Inhibitory caspase recruitment domain protein	609490	REc			
11.769	5	28	03	11q21	MTMR2, CMT4B1		Myotubularin-related protein 2	603557	A, R, Psh		Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	
11.770	10	21	02	11q22.1	PGR		Progesterone receptor	607311	REa, A, REb	11q13 = earlier regionalization	?Progesterone resistance, 264080 (2)	9(Pgr)
11.771	12	19	11	11q21	SRSF8, SFRS2B, SRp46		Splicing factor, arginine/serine-rich, 8	603269	A			
11.772	9	22	98	11q22.2	API2, HAIP1		Apoptosis inhibitor-2	601721	A	fused with MALT1 in MALT lymphoma		
11.773	7	6	99	11q22.2	API1, HIAP2		Apoptosis inhibitor-1	601712	A			
11.774	11	4	98	11q24.2	CHEK1, CHK1		Checkpoint kinase 1, S. pombe, homolog of	603078	R			
11.775	2	17	09	11q24.1	CRTAM		Cytotoxic and regulatory T-cell molecule	612597	REc, H			9(Crtam)
11.776	1	7	99	11q22.3	CUL5, VACM1		Cullin-5 (vasopressin-activated calcium-mobilizing receptor-1)	601741	REc			
11.777	4	30	96	11q22.3	DDX10		DEAD/H box-10 (RNA helicase)	601235	REa, Ch	400kb telomeric to ATM; pseudogene on 9q21-q22; fused with NUP98 in AML		
11.778	2	16	17	11q22.3	GRIA4, GLUR4, NEDSGA		Glutamate receptor, ionotropic, AMPA 4	138246	Psh, A		Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3)	9(Glur4)
11.779	3	9	98	11q23.1	HSPB2		Heat-shock 27kD protein-2	602179	REc			
11.780	6	24	08	11q22.2	MMP1, CLG		Matrix metalloproteinase 1 (interstitial collagenase)	120353	REn		COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	
11.781	5	28	98	11q22.3	SLN		Sarcolipin	602203	Psh, R			
11.782	10	15	98	11q23.1	PPP2R1B		Protein phosphatase 2, structural/regulatory subunit A, beta	603113	REc, R		Lung cancer, 211980 (3)	
11.783	6	27	08	11q23.3	TECTA, DFNA8, DFNA12, DFNB21		Tectorin, alpha	602574	Psh, REc		Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal recessive 21, 603629 (3)	
11.784	4	24	90	11q22-qter	ANC		Anal canal carcinoma	105580	Ch	3p22 also deleted	?Anal canal carcinoma (2)	
11.785	8	12	14	11q22.1	ARHGAP42, GRAF3		Rho GTPase-activating protein 42	615936	REc			
11.786	8	3	18	11q22.1	CFAP300, C11orf70, CILD38		Cilia- and flagella-associated protein 300	618058	REc		Ciliary dyskinesia, primary, 38, 618063 (3)	
11.787	6	1	12	11q22.1	KIAA1377		KIAA1377 gene	614634	R, REc			
11.788	7	9	06	11q22.2	TMEM123, PORIMIN		Transmembrane protein 123	606356	REc			
11.789	09	06	18	11q22.2	MMP27		Matrix metalloproteinase 27	618101	REc			
11.790	8	20	98	11q22.3	CASP1, IL1BC		Caspase 1, apoptosis-related cysteine protease (interleukin-1, beta convertase)	147678	REa, A			9(Ilb1bc)
11.791	3	16	99	11q22.3	CASP4		Caspase 4, apoptosis-related cysteine protease	602664	REc			
11.792	3	16	99	11q22.3	CASP5		Caspase 5, apoptosis-related cysteine protease	602665	REc			
11.793	6	25	99	11q23.1	IL18, IGIF		Interleukin-18	600953	R, Psh			
11.794	5	19	97	11q22.2	MMP12		Matrix metalloproteinase 12 (macrophage elastase)	601046	A			
11.795	12	6	16	11q22.3	AASDHPPT		Alpha-aminoadipate semialdehyde dehydrogenase-phosphopantetheinyl transferase	607756	REc			
11.796	3	16	10	11q22.3	ALKBH8, ABH8		AlkB, E. coli, homolog of, 8	613306	REc			
11.797	1	27	16	11q22.3	ATM, ATA, AT1		Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)	607585	Fd, C, M		Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin, somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell, somatic (3); T-cell prolymphocytic leukemia, somatic (3)	9(Atm)
11.798	5	5	17	11q23.3	ATP5JG		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G	617473	REc			
11.799	3	21	14	11q22.3	CARD18, ICEBERG		Caspase recruitment domain-containing protein 18	605354	REc			
11.800	5	31	05	11q22.3	CASP12, CASP12P1		Caspase 12, apoptosis-related cysteine protease	608633	REc		{Sepsis, susceptibility to} (3)	
11.801	8	26	15	11q22.3	DCUN1D5, SCCRO5		DCN1 domain-containing protein 5	616522	REc, Ch			
11.802	2	11	14	11q22.3	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3		Dynein, cytoplasmic-2, heavy chain-1	603297	Psh, R, REc	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	
11.803	12	10	13	11q22.3	ELMOD1		ELMO/CED12 domain-containing protein 1	615456	REc			
11.804	1	24	13	11q22.3	EXPH5, SLAC2B, KIAA0624		Exophilin 5	612878	R, REc		Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	
11.805	1	7	95	11q23.3	GRIK4		Glutamate receptor, ionotropic, kainate 4	600282	REa, A			9(Grik4)
11.806	8	1	16	11q22.2	MMP13, CLG3, MANDP1, MDST		Matrix metalloproteinase 13 (collagenase 3)	600108	A, REn, Fd		Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3); Metaphyseal anadysplasia 1, 602111 (3); Metaphyseal dysplasia, Spahr type, 250400 (3)	
11.807	1	12	99	11q22.3	NPAT, E14		Nuclear protein, ataxia-telangiectasia locus	601448	REn, REc			
11.808	12	28	08	11q22.3	PDGFD, SCDGFB, IEGF		Platelet-derived growth factor D	609673	REc, R			
11.809	1	9	13	11q22.3	ZC3H12C, MCPIP3		Zinc finger CCCH domain-containing protein 12C	615001	REc			
11.810	7	13	94	11q22.2	MMP10, STMY2		Matrix metalloproteinase 10 (stromelysin 2)	185260	A			
11.811	8	4	09	11q22.2	MMP20, AI2A2		Matrix metalloproteinase-20 (enamelysin)	604629	A		Amelogenesis imperfecta, type IIA2, 612529 (3)	
11.812	10	29	03	11q22.3	ACAT1		Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase)	607809	A	cluster: cen-STMY2-CLG-STMY1-ter	Alpha-methylacetoacetic aciduria, 203750 (3)	
11.813	1	4	18	11q23.1	BCO2, BCDO2		Beta-carotene oxygenase 2	611740	R, REc			
11.814	8	6	13	11q23.1	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2		Crystallin, alpha B	123590	REa, A, Ch		Myopathy, myofibrillar, 2, 608810 (3); Cataract 16, multiple types, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3); Cardiomyopathy, dilated, 1II, 615184 (3)	
11.815	4	15	09	11q23.1	PTS		6-pyruvoyltetrahydropterin synthase	612719	A		Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	
11.816	5	19	16	11q23.1	ALG9, DIBD1, CDG1L, GIKANIS		Alg9, yeast, homolog of	606941	REc, Ch		Congenital disorder of glycosylation, type Il, 608776 (3); Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	
11.817	12	20	05	11q23.3	AMICA1, JAML		Adhesion molecule, interacts with CXADR antigen 1	609770	REc			
11.818	7	21	06	11q23.3	APOA1		Apolipoprotein A-I	107680	REa, RE, Fd, F, D		ApoA-I and apoC-III deficiency, combined (3); Hypoalphalipoproteinemia, 604091 (3); Corneal clouding, autosomal recessive (3); Amyloidosis, 3 or more types, 105200 (3)	9(Apoa1)
11.819	11	24	14	11q23.3	APOC3, HALP2		Apolipoprotein C-III	107720	REa, RE, F	2.6kb 3' to APOA1	Apolipoprotein C-III deficiency, 614028 (3)	
11.820	3	15	91	11q23.3	APOA4		Apolipoprotein A-IV	107690	F, RE	12 kb 3' to APOA1		9(Apoa4)
11.821	11	14	05	11q23.3	APOA5		Apolipoprotein A-V	606368	REc	proximal to APOA1, APOC3, APOA4	{Hypertriglyceridemia, susceptibility to}, 145750 (3); Hyperchylomicronemia, late-onset, 144650 (3)	
11.822	5	18	05	11q23	BMND5		Bone mineral density QTL 5	609354	Fd	between D11S901 and D11S925	[Bone mineral density QTL 5] (2)	
11.823	2	27	01	11q23.1	BTG4, PC3B		B-cell translocation gene 4	605673	R			
11.824	2	5	14	11q23.3	CD3D, T3D, IMD19		CD3D antigen, delta polypeptide (TiT3 complex)	186790	REa, A, RE	3 CD3 genes in 50kb	Immunodeficiency 19, 615617 (3)	9(T3d)
11.825	2	10	14	11q23.3	CD3E, IMD18		CD3E antigen, epsilon polypeptide (TiT3 complex)	186830	REa, A, RE		Immunodeficiency 18, 615615 (3); Immunodeficiency 18, SCID variant, 615615 (3)	9(T3e)
11.826	2	2	14	11q23.3	CD3G, IMD17		CD3G antigen, gamma polypeptide (TiT3 complex)	186740	RE, REa, A		Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	9(T3g)
11.827	3	23	14	11q23.1	COLCA1		Colorectal cancer-associated gene 1	615693	REc			
11.828	3	23	14	11q23.1	COLCA2		Colorectal cancer-associated gene 2	615694	REc	opposite strand from COLCA1		
11.829	8	20	08	11q23	CRCS7		Colorectal cancer, susceptibility to, 7	612232	Fd	associated with rs3802842	{Colorectal cancer, susceptibility to, 7} (2)	
11.830	2	11	08	11q23.3	DSCAML1, KIAA1132		Down syndrome cell adhesion molecule-like 1	611782	R, A, H			9(Dscaml1)
11.831	8	3	12	11q24.2	EI24, PIG8, EPG4		Etoposide-induced 1.4 mRNA	605170	A			9(Ei24)
11.832	11	1	00	11q23.3	FXYD2, ATP1G1, HOMG2		FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)	601814	REc, Fd		Hypomagnesemia 2, renal, 154020 (3)	
11.833	11	21	00	11q23	GTS		Gilles de la Tourette syndrome	137580	Fd	several loci suspected (e.g., 17q25)	Tourette syndrome (2)	
11.834	3	7	13	11q13.4	INPPL1, OPSMD		Inositol polyphosphate phosphatase-like 1	600829	Psh		Opsismodysplasia, 258480 (3)	
11.835	7	20	06	11q23	JBS		Jacobsen syndrome	147791	Ch	contiguous gene deletion syndrome	Jacobsen syndrome (4)	
11.836	3	14	14	11q23.3	KMT2A, MLL, HRX, HTRX1, WDSTS		Lysine (K)-specific methyltransferase 2E	159555	Ch, RE	fuses with ENL, AF4, AF9, GMPS	Wiedemann-Steiner syndrome, 605130 (3); Leukemia, myeloid/lymphoid or mixed-lineage (2)	9(All1)
11.837	5	4	12	11q23.3	MFRP, MCOP5, NNO2		Membrane-type frizzled-related protein	606227	REc		Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)	
11.838	3	31	03	11q22.2	MMP3, STMY1, CHDS6		Matrix metalloproteinase 3 (stromelysin 1, progelatinase)	185250	REa, A		{Coronary heart disease, susceptibility to, 6}, 614466 (3)	
11.839	6	7	10	11q23	NAFLD2		Fatty liver disease, nonalcoholic, susceptibility to, 2	613387	Fd	associated with rs2854116, rs2854117	{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)	
11.840	10	2	98	11q23.3	PAFAH1B2		Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit	602508	R, REc, A			
11.841	1	5	07	11q23.3	PDZD3, IKEPP		PDZ domain-containing 3	607146	REc			
11.842	1	31	01	11q12.3	RARRES3, TIG3		Retinoic acid receptor responder 3	605092	REc			
11.843	8	22	07	11q22.3	RDX, DFNB24		Radixin	179410	REa, Psh, A		Deafness, autosomal recessive 24, 611022 (3)	
11.844	7	20	01	11q23.3	RNF26		RING finger protein-26	606130	REc			
11.845	9	9	13	11q23.3	SCN2B, ATFB14		Sodium channel, voltage-gated, type II, beta polypeptide	601327	H, A, REc, R		Atrial fibrillation, familial, 14, 615378 (3)	9(Scn2b)
11.846	7	30	14	11q23.3	SCN4B, LQT10, ATFB17		Sodium channel, voltage-gated, type IV, beta subunit	608256	REc		Long QT syndrome-10, 611819 (3); Atrial fibrillation, familial, 17, 611819 (3)	
11.847	07	28	18	11q23.1	SDHD, PGL1		Succinate dehydrogenase complex, subunit D, integral membrane protein	602690	A		Paragangliomas 1, with or without deafness, 168000 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Mitochondrial complex II deficiency, 252011 (3)	
11.848	5	19	09	11q23.3	SLC37A4, G6PT1		Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671	Fd, Psh, R		Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic, 232240 (3)	
11.849	6	20	94	11q23	TCPT		Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)	188025	Ch	contiguous gene deletion of 11q23	?Thrombocytopenia, Paris-Trousseau type (4)	
11.850	6	9	06	11q23.3	TMPRSS13, MSPL, MSPS		Transmembrane protease, serine 13	610050	R, REc			
11.851	1	24	18	11q23.3	TREH, TREHD		Trehalase	275360	H, REc		Trehalase deficiency, 612119 (3)	9(Treh)
11.852	12	31	99	11q23	TSG11		Tumor suppressor gene on chromosome 11	603040	D		{Nonsmall cell lung cancer} (2)	
11.853	2	7	07	11q23.2	USP28, KIAA1515		Ubiquitin-specific protease 28	610748	R, REc			
11.854	7	20	12	11q24.2	VWA5A, LOH11CR2A, BCSC1		von Willebrand factor A domain-containing protein 5A	602929	REc			
11.855	2	23	09	11q23-q24	ADIPQTL4		Adiponectin, serum level of, quantitative trait locus locus 4	612629	Fd	between D11S925 and D11S968	{Adiponectin, serum level of, QTL4} (2)	
11.856	3	29	16	11q24.2	SRPRA, SRPR, DP		Signal recognition particle receptor, alpha subunit	182180	REa, A, Psh			
11.857	12	19	11	11q24.2	TIRAP, BACTS1		TIR domain-containing adaptor protein	606252	R		{Pneumococcal disease, invasive, protection against}, 610799 (3); {Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)	
11.858	7	8	17	11q24.2	ROBO3, RBIG1, RIG1, HGPPS1		Roundabout, Drosophila, homolog of, 3	608630	Fd, R, REc		Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3)	
11.859	2	25	15	11q23.1	DIXDC1, CCD1, KIAA1735		DIX domain-containing protein 1	610493	REc			
11.860	1	23	09	11q23.1	DLAT, PDCE2		Dihydrolipoamide S-acetyltransferase	608770	A		Pyruvate dehydrogenase E2 deficiency, 245348 (3)	
11.861	10	20	15	11q23.2	DRD2		Dopamine receptor D2	126450	Fd, REa, Ch	11q22-q23 junction; 150kb 5' to NCAM; centromeric to APOA1; telomeric to STMY1		
11.862	10	23	87	11q23.1	EBVM1		Epstein-Barr virus modification site-1	132860	V			
11.863	3	9	00	11q23.2	HTR3B		5-hydroxytryptamine receptor 3B	604654	REc			
11.864	3	23	14	11q23.1	MIR34B		Micro RNA 34B	611374	REc			
11.865	4	2	16	11q23.1	MIR34C		Micro RNA 34C	611375	REc			
11.866	8	20	98	11q23.2	NCAM1, MSK39		Neural cell adhesion molecule 1	116930	A, Fd	defective in "staggerer" in mice		9(Ncam)
11.867	10	4	05	11q23.2	NNMT		Nicotinamide N-methyltransferase	600008	A		Homocysteine plasma level (2)	
11.868	4	23	96	11q23.1	POU2AF1, OBF1		POU domain, class 2, associating factor 1	601206	REa, A			
11.869	8	21	12	11q23.1	SIK2, KIAA0781		Salt-inducible kinase 2	608973	R, REc			
11.870	7	2	18	11q23.1	TIMM8B, DDP2		Translocase of inner mitochondrial membrane 8, yeast, homolog of, B	606659	REc			
11.871	12	4	08	11q23.2	ZBTB16, ZNF145, PLZF		Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger)	176797	Ch, A	fused with RARA in APL of t(11;17) type	Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	9(lu)
11.872	12	9	95	11q23.2	HTR3		5-hydroxytryptamine (serotonin) receptor-3	182139	REa, A			
11.873	12	18	08	11q23.2	RBM7		RNA-binding motif protein 7	612413	REc			
11.874	9	28	05	11q23.2	REXO2, RFN		RNA exonuclease 2, S. cerevisiae, homolog of	607149	REc			
11.875	3	23	93	11q24.3	ZNF123		Zinc finger protein-123 (HZF-1)	194630	A			
11.876	3	23	93	11q23.1-q23.2	ZNF125		Zinc finger protein-125 (HZF-3)	194632	A			
11.877	5	23	18	11q23.2	ANKK1		Ankyrin repeat and kinase domain containing 1	608774	REc, REn			
11.878	5	14	09	11q23.1	C11orf34, PLET1		Chromosome 11 open reading frame 34	611904	REc, H			9(Plet1)
11.879	6	28	17	11q23.3	CADM1, IGSF4, TSLC1		Cell adhesion molecule 1	605686	REc			
11.880	10	10	18	11q23.2	NXPE4, C11orf33		Neurexophilin and PC-esterase domain family, member 4	618133	REc			
11.881	5	28	99	11q23.3	TAGLN, SMCC, SM22		Transgelin	600818	Psh, R			9(Tagln)
11.882	1	30	07	11q23.2	TTC12, TPARM		Tetratricopeptide repeat domain 12	610732	REc			
11.883	2	2	16	11q23.2	ZW10		Zeste-white 10, Drosophila, homolog of	603954	R			
11.884	3	2	98	11q23.3	H2AX		H2AX histone	601772	A			
11.885	7	26	16	11q24.1	SORL1, LR11, SORLA		Sortilin-related receptor, L(DLR class) A repeats-containing	602005	A			
11.886	5	22	03	11q23.3	ABCG4, WHITE2		ATP-binding cassette, subfamily G, member 4	607784	REc, H			9(Abcg4)
11.887	10	25	16	11q23.3	ARCN1, SRMMD		Archain 1	600820	Ch	60kb telomeric to MLL	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3)	
11.888	6	25	15	11q23.3	ARHGEF12, LARG, KIAA0382		Rho guanine nucleotide exchange factor 12, leukemia-associated	604763	A, R	fused with MLL in AML		
11.889	2	20	01	11q23.3	BACE1, BACE		Beta-site amyloid beta A4 precursor protein-cleaving enzyme (secretase, beta; memapsin 2)	604252	REc, R			
11.890	10	3	11	11q23.3	BACE1AS		BACE1 antisense RNA	614263	REc			
11.891	11	2	04	11q23.3	BCL9L		B-cell CLL/lymphoma 9-like	609004	REc			
11.892	5	31	05	11q23.3	C1QTNF5, CTRP5, LORD		C1q- and tumor necrosis factor-related protein 5	608752	REn, REc		Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	
11.893	5	19	16	11q23.3	CBL, CBL2, NSLL		Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2)	165360	REa, Ch	mutation identified in 1 JMML family	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3); ?Juvenile myelomonocytic leukemia, 607785 (3)	9(Cbl2)
11.894	8	2	17	11q23.3	C2CD2L, TMEM24		C2 calcium-dependent domain-containing protein 2-like	617582	REc			
11.895	10	4	12	11q23.3	CEP164, KIAA1052		Centrosomal protein, 164kD	614848	R, REc		Nephronophthisis 15, 614845 (3)	
11.896	9	9	08	11q23.3	CXCR5, BLR1		Chemokine, CXC motif, receptor 5	601613	REc			
11.897	3	4	96	11q23.3	DDX6, HLR2		DEAD/H box-6 (RNA helicase, 54kD)	600326	Ch, REn			9(Ddx6)
11.898	4	30	15	11q23.3	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13		Dolichyl-phosphate N-acetylglucosamine phosphotransferase	191350	R, REa, A		Congenital disorder of glycosylation, type Ij, 608093 (3); Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	17(Dpagt2)
11.899	1	13	93	11q24.3	ETS1		Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1	164720	REa, A, Ch	shown by HSR; 19cM distal to THY1; Ewing sarcoma breakpoint region-2 splices to EWSR1		9(Ets1, Fli1)
11.900	4	29	14	11q23.3	FOXR1, FOXN5		Forkhead box R1	615755	REc			
11.901	7	18	12	11q23.3	HDLCQ14, HYLAP		High density lipoprotein cholesterol level quantitative trait locus 14	605201	Fd		High density lipoprotein cholesterol level QTL14 (2)	
11.902	1	13	06	11q23.3	HMBS, PBGD, UPS		Hydroxymethylbilane synthase	609806	S, D, Fd, REn		Porphyria, acute intermittent, 176000 (3); Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	9(Ups)
11.903	1	12	11	11q23.3	IL10RA, IL10R, IBD28		Interleukin-10 receptor, alpha	146933	REa, A		Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	
11.904	5	24	13	11q23.3	LRRC35, EL		Leucine-rich repeat-containing protein 35	610451	REc, R			
11.905	6	18	12	11q23.3	MCAM, MUC18, CD146		Melanoma adhesion molecule	155735	R, REc			
11.906	1	2	08	11q23.3	MPZL3		Myelin protein zero-like 3	611707	REc			9(Mpzl3)
11.907	5	23	16	11q23.3	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1		Nectin 1	600644	A		Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3); Orofacial cleft 7, 225060 (3)	
11.908	4	23	08	11q23.3	NLRX1, NOD9, CLR11.3		NLR family member X1	611947	REc			
11.909	8	3	12	11q23.3	PCSK7, PC8, PC7, LPC		Proprotein convertase, subtilisin/kexin-type, 7	604872	REc			
11.910	7	16	09	11q23.3	PHLDB1, LL5A, KIAA0638		Pleckstrin homology-like domain, family B, member 1	612834	R, REc			
11.911	12	4	02	11q23.3	POU2F3, OCT11		POU domain, class 2, transcription factor 3	607394	A			9(Oct11)
11.912	3	18	94	11q23.3	RPS25		Ribosomal protein S25	180465	A			
11.913	11	1	02	11q23.3-q24.1	SC5DL, ERG3		Sterol C5-desaturase-like	602286	A		Lathosterolosis, 607330 (3)	
11.914	8	1	14	11q24.1	SCN3B, SCNB3, BRGDA7, ATFB16		Sodium channel, voltage-gated, type III, beta subunit	608214	R		Brugada syndrome 7, 613120 (3); Atrial fibrillation, familial, 16, 613120 (3)	
11.915	8	29	17	11q23.3	SIDT2		SID1 transmembrane family, member 2	617551	REc			9(Sidt2)
11.916	8	21	12	11q23.3	SIK3, KIAA0999		Salt-inducible kinase 3	614776	REc, R			
11.917	1	7	14	11q24.2	STT3A, ITM1, TMC		STT3A, subunit of the oligosaccharyltransferase complex (catalytic)	601134	REa, H, A, REc	mutation identified in 1 family	?Congenital disorder of glycosylation, type Iw, 615596 (3)	9(Itm1)
11.918	7	4	95	11q23.3	THY1		Thy-1 T-cell antigen	188230	REa, H, A, Fd, REn			9(Thy1)
11.919	4	26	11	11q23.3	TMEM25		Transmembrane protein 25	613934	REc			9(Tmem25)
11.920	12	17	01	11q23.3	TMPRSS4		Transmembrane protease, serine 4	606565	R			
11.921	3	3	03	11q23.2	TMPRSS5		Transmembrane protease, serine 5	606751	REc			
11.922	5	21	07	11q23.3	TRAPPC4		Trafficking protein particle complex, subunit 4 (synbindin)	610971	R, REc			
11.923	9	27	17	11q23.3	TRIM29, ATDC		Tripartite motif-containing protein 29	610658	REc, R			
11.924	3	17	08	11q23.3	UPK2, UP2, UPII		Uroplakin 2	611558	REc			
11.925	1	12	16	11q23.3	VPS11, HLD12		Vacuolar protein sorting 11, yeast, homolog of	608549	REc		Leukodystrophy, hypomyelinating, 12, 616683 (3)	
11.926	6	25	99	11q24.1	ZNF202		Zinc finger protein-202	603430	D			
11.927	12	21	15	11q23.3	ZPR1, ZNF259		ZPR1 zinc finger protein	603901	REc			
11.928	7	12	02	11q23.3-q24	AAT1, FAA1		Aortic aneurysm, familial thoracic 1	607086	Fd		Aortic aneurysm, familial thoracic 1 (2)	
11.929	10	4	95	11q24.1	HSPA8, HSP73		Heat-shock 70kD protein-8 (HSP73)	600816	REa, A			
11.930	10	24	00	11q24.3	APLP2		Amyloid beta (A4) precursor-like protein-2	104776	REa, A			9(Aplp2)
11.931	5	5	17	11q24.3	FLI1, BDPLT21		Friend leukemia virus integration 1	193067	REa, Ch, A	fused with EWS in Ewing sarcoma	Bleeding disorder, platelet-type, 21, 617443 (3)	
11.932	4	3	03	11q24.2	GRTH		Gonadotropin-regulated testicular RNA helicase	607663	A, H			9(Grth)
11.933	5	23	11	11q24.2	HEPACAM, MLC2A, MLC2B		Hepatocyte cell adhesion molecule	611642	REc		Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	
11.934	8	23	04	11q24.3	KCNJ1, ROMK1		Potassium inwardly-rectifying channel, subfamily J, member 1	600359	A		Bartter syndrome, type 2, 241200 (3)	
11.935	6	11	11	11q24.3	KCNJ5, GIRK4, KATP1, LQT13		Potassium inwardly-rectifying channel, subfamily J, member 5	600734	Psh, R, REc		Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type III, 613677 (3)	9(Girk4)
11.936	4	21	01	11q24	MGR9		Migraine with aura, susceptibility to, 9	609670	Fd	max lod at GATA64D03	{Migraine with aura, susceptibility to, 9} (2)	
11.937	1	2	08	11q23.3	MPZL2, EVA1, EVA, DFNB111		Myelin protein zero-like 2	604873	REc		Deafness, autosomal recessive 111, 618145 (3)	9(Eva)
11.938	10	7	05	11q24	NEDE		Nephropathy, progressive, with deafness	609469	Fd	max lod at D11S4464	Nephropathy, progressive, with deafness (2)	
11.939	6	19	98	11q24.2	NRGN		Neurogranin	602350	REc			9(Nrgn)
11.940	4	18	02	11q24.2	PATE		Prostate- and testis-expressed gene	606861	REc			
11.941	1	26	12	11q24.2	SIAE, AIS6		Sialic acid acetylesterase	610079	R		{Autoimmune disease, susceptibility to, 6}, 613551 (3)	
11.942	6	22	14	11q24.3	TP53AIP1, P53AIP1		Tumor protein p53-regulated apoptosis-inducing protein 1	605426	A			
11.943	7	10	08	11q24-q25	ANIB7		Aneurysm, intracranial berry, 7	612161	Fd	between rs618176 and rs1940033	Aneurysm, intracranial berry, 7 (2)	
11.944	10	21	92	11q24.3	NFRKB		Nuclear factor related to kappa B-binding protein	164013	REa, A	most telomeric 11q marker		
11.945	10	2	09	11q24.2	PKNOX2, PREP2		PBX/Knotted 1 homeobox 2	613066	A			
11.946	4	10	14	11q24.3	ST14, MTSP1, ARCI11		Suppression of tumorigenicity 14	606797	A		Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	
11.947	9	24	08	11q24.1	BLID, BRCC@		BH3-like motif-containing cell death inducer	608853	REc, REn	distal to SORL1		
11.948	8	21	07	11q24.1	BSX1		Brain-specific homeobox, mouse, homolog of	611074	REc, H			9(Bsx)
11.949	1	27	09	11q24.1	CLLS5		Leukemia, chronic lymphocytic susceptibility to, 5	612559	Fd	associated with rs735665	{Leukemia, chronic lymphocytic susceptibility to, 5} (2)	
11.950	5	24	13	11q24.1	CLMP, ASAM, ACAM, CSBS		Coxsackievirus- and adenovirus receptor-like membrane protein	611693	REc		Congenital short bowel syndrome, 615237 (3)	9(Clmp)
11.951	7	30	18	11q24.1	JHY, C11orf63		Jhy, mouse, homology of	617594	REc			9(Jhy)
11.952	12	21	09	11q24.1	MIR100, MIRN100		Micro RNA 100	613186	REc, REn			
11.953	9	20	14	11q24.1	MIR100HG, AGD1		MIR100-LET7A2 cluster host gene, noncoding	615965	REc			
11.954	3	23	09	11q24.1	MIR125B1, MIRN125B1		Micro RNA 125B-1	610104	REc			
11.955	3	23	09	11q24.1	MIRLET7A2, LET7A2, MIRNLET7A2		Micro RNA let7a2	612142	REc			
11.956	7	14	14	11q24.3	SENCR, lncRNA9		Smooth muscle- and endothelial cell-enriched migration/differentiation-associated long noncoding RNA	615815	REc			
11.957	7	10	08	11q24.1	UBASH3B, STS1, KIAA1959, P70		Ubiquitin-associated and SH3 domain-containing protein B	609201	R, REc			
11.958	9	21	11	11q24.2	CDON, CDO, HPE11		Cell adhesion molecule-related/downregulated by oncogenes	608707	R, REc		Holoprosencephaly 11, 614226 (3)	
11.959	7	13	15	11q24.2	DCPS, HINT5, DCS1, ARS		Decapping enzyme, scavenger	610534	REc		Al-Raqad syndrome, 616459 (3)	
11.960	10	10	11	11q24.2	ESAM		Endothelial cell adhesion molecule	614281	REc			
11.961	10	13	15	11q24.2	FAM118B		Family with sequence similarity 118, member B	616587	REc			
11.962	11	16	11	11q24.2	FEZ1		Fasciculation and elongation protein zeta 1	604825	R, REc			
11.963	10	25	11	11q24.2	FOXRED1		FAD-dependent oxidoreductase domain-containing protein 1	613622	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
11.964	12	18	07	11q24.2	HEPN1		Cancer susceptibility gene HEPN1	611641	REc			
11.965	1	10	07	11q24.2	HYLS1, FLJ32915		HYLS1 gene	610693	Fd, REc		Hydrolethalus syndrome, 236680 (3)	
11.966	4	25	18	11q24.2	KIRREL3, NEPH2, KIAA1867, KIRRE		Kin of IRRE-like 3	607761	R			
11.967	4	25	18	11q24.2	MRD4		Mental retardation, autosomal dominant 4	612581	Ch	translocation t(11;16)(q24.2;q24)	Mental retardation, autosomal dominant 4 (2)	
11.968	11	2	14	11q24.2	PANX3, PX3		Pannexin 3	608422	R, REc			
11.969	7	25	16	11q24.2	PUS3, MRT55		Pseudouridylate synthase 3	616283	REc	mutation identified in 1 MRT55 family	?Mental retardation, autosomal recessive 55, 617051 (3)	
11.970	2	21	03	11q24.2	ROBO4		Roundabout, Drosophila, homolog of, 4	607528	REc			
11.971	11	12	17	11q24.2	RPUSD4		RNA pseudouridylate synthase domain-containing protein 4	617488	REc			
11.972	7	14	14	11q24.2	ST3GAL4, SIAT4C, SIAT4, CGS23, NANTA3		ST3 beta-galactoside alpha-2,3-sialyltransferase 4	104240	S, Psh, REc			
11.973	11	30	06	11q24.2	TBRG1, NIAM		Transforming growth factor-beta regulator 1	610614	R, REc			
11.974	9	27	17	11q24.2	VSIG2, CTXL		V-set and immunoglobulin domains-containing protein 2	606011	R, REc			
11.975	11	11	14	11q24.3	ADAMTS15		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 15	607509	REc			
11.976	12	10	12	11q24.3	ARHGAP32, RICS, GRIT, p200RHOGAP, p250GAP		Rho GTPase activating protein 32	608541	REc, R			
11.977	8	30	07	11q25	ACAD8		Acyl-CoA dehydrogenase family, member 8	604773	REc		Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	
11.978	1	31	01	11q24.3	ADAMTS8, METH2		A disintegrin-like and metalloproteinase with thrombospondin type-1 motif, 8	605175	R, H			9(Adamts8)
11.979	4	17	07	11q25	B3GAT1, GLCATP, CD57, HNK1		Beta-1,3-glucuronyltransferase 1	151290	A, S			
11.980	1	29	01	11q24.3	BARX2		BarH-like homeo box gene 2	604823	A			
11.981	2	24	11	11q25	IGSF9B, KIAA1030		Immunoglobulin superfamily, member 9B	613773	R, REc			
11.982	2	11	11	11q25	JAM3		Junctional adhesion molecule 3	606871	REc		Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	
11.983	5	17	18	11q25	NCAPD3, CAPD3, KIAA0056, MCPH22		Non-SMC condensin II complex subunit D3	609276	REc, R		Microcephaly 22, primary, autosomal recessive, 617984 (3)	
11.984	1	11	07	11q25	NTM, HNT		Neurotrimin	607938	REc			9(Ntm)
11.985	2	11	09	11q25	OPCML		Opioid-binding protein/cell adhesion molecule-like	600632	REa, H, REc		{Ovarian cancer, somatic}, 167000 (3)	9(Obcam)
11.986	12	23	05	11q25	SPATA19		Spermatogenesis-associated protein 19	609805	REc			
11.987	2	8	11	11q25	THYN1, HSPC144, THY28		Thymocyte nuclear protein 1	613739	R, REc			
11.988	4	19	06	11q25	VPS26B		Vacuolar protein sorting 26, yeast, homolog of, B	610027	REc			9(Vps26b)
11.989	10	20	99	11q25-qter	DFNB20		Deafness, autosomal recessive 20	604060	Fd		Deafness, autosomal recessive 20 (2)	
11.990	4	2	01	11q13.2	ALDH3B1, ALDH7		Aldehyde dehydrogenase 3 family, member B1	600466	R			
11.991	7	9	01	Chr.11	AOCH		Acromegaloid features, overgrowth, cleft palate, and hernia	606049	Ch	pericentric inversion (46,XY,inv(11)(p15.3;q23.3))	Acromegaloid features, overgrowth, cleft palate, and hernia (2)	
11.992	4	2	01	11q13.2	ALDH3B2, ALDH8		Aldehyde dehydrogenase 3 family, member B2	601917	R			
11.993	7	3	88	11q12.2	CD6, TP120		CD6 antigen	186720	S			
11.994	4	28	99	11p11.2	CRY2		Cryptochrome 2	603732	R			2(Cry2)
11.995	2	20	01	11q13.2	FBXL11, FBL11		F-box and leucine-rich repeat protein-11	605657	R			
11.996	2	21	02	11q23.3	FXYD6		FXYD domain-containing ion transport regulator 6	606683	R			
11.997	7	15	02	11q23.3	HYOU1		Hypoxia-upregulated 1	601746	R			
11.998	3	11	03	11p15.4	IPO7, RANBP7		Importin 7	605586	R			
11.999	2	28	01	11p15.4	LYVE1		Lymphatic vessel endothelial hyaluronan receptor 1	605702	R			
11.1000	7	12	02	11q23.3	MIZF		MBD2-interaction zinc finger protein	607099	R			
11.1001	5	7	01	11q13.1	SART1, HOMS1		Squamous cell carcinoma antigen recognized by T cells 1	605941	R			
11.1002	2	5	01	11q13.1	SF3B2, SF3B145, SAP145		Splicing factor 3B, subunit 2	605591	R			
11.1003	1	29	01	11q13.4	SLC21A9, OATPB		Solute carrier family 21 (organic anion transporter), member 9	604988	R			
11.1004	2	27	03	11q12.3	SLC22A8, OAT3		Solute carrier family 22 (organic anion transporter), member 8	607581	R			
11.1005	1	29	01	11p15.2	SPON1		F-spondin, Rat, homolog of	604989	R			
11.1006	5	7	03	11p11.2	SYT13, KIAA1427		Synaptotagmin 13	607716	R			
11.1007	3	29	01	11q23.1	TEX12		Testis-expressed gene 12	605791	R			
11.1008	6	6	00	11q23.3	UBE4A, UFD2, E4		Ubiquitination factor E4A	603753	REa			
12.1	1	24	06	12p13.33	DCP1B, DCP1		Decapping enzyme 1, S. cerevisiae, homolog of	609843	REc, R			
12.2	6	13	12	12p13.33	FBXL14, FBL14		F-box and leucine-rich repeat protein 14	609081	REc			6(Fbxl14)
12.3	4	20	17	12p13.33	ITFG2, FGGAP1		Integrin-alpha FG-GAP repeat-containing protein 2	617421	REc			
12.4	11	7	14	12p13.32	C12orf4		Chromosome 12 open reading frame 4	616082	REc			
12.5	12	18	14	12p13.33	RHNO1, RHINO, C12orf32		Rad9-, Rad1-, and Hus1-interacting nuclear orphan 1	614085	REc			
12.6	4	10	12	12p13.33	FKBP4, FKBP52		FK506-binding protein 4	600611	REc			
12.7	6	30	08	12p13.33	IQSEC3, KIAA1110		IQ motif- and SEC7 domain-containing protein 3	612118	R, REc			
12.8	4	8	13	12p13.32	DYRK4		Dual-specificity tyrosine phosphorylation-regulated kinase 4	609181	REc			
12.9	9	6	11	12p13.32	EFCAB4B, CRACR2A		EF-hand calcium-binding domain-containing protein 4B	614178	REc			
12.10	2	22	92	12p13.31	LAG3		Lymphocyte activation gene-3	153337	A			
12.11	12	21	09	12p13.33-p13.32	TSPAN9, NET5		Tetraspanin 9	613137	REc			
12.12	12	1	11	12p13.31	ACSM4		Acyl-CoA synthetase medium-chain family, member 4	614360	REc			
12.13	1	4	12	12p13.33	ADIPOR2, FLJ21432		Adiponectin receptor 2	607946	REc			6(Adipor2)
12.14	2	17	09	12p13.31	ATN1, DRPLA, HRS, NOD		Atrophin 1	607462	Fd, D, A		Dentatorubro-pallidoluysian atrophy, 125370 (3)	6(Drpla)
12.15	7	6	18	12p13.31	A2ML1, OMS		Alpha-2-macroglobulin-like 1	610627	REc		{Otitis media, susceptibility to}, 166760 (3)	
12.16	11	2	04	12p13.31	C1RL, CLSPA, C1RLP		Complement component C1r-like protein	608974	REc			
12.17	11	11	14	12p13.31	C3AR1, C3AR		Complement component 3a receptor 1	605246	REc			
12.18	5	23	11	12p13.31	CD4		CD4 antigen (p55)	186940	REa, A	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	OKT4 epitope deficiency, 613949 (3)	6(Ly4)
12.19	1	13	09	12p13.31	CLEC2A		C-type lectin domain family 2, member A	612087	REc			
12.20	9	24	08	12p13.2	CLEC9A, DNGR1		C-type lectin domain family 9, member A	612252	REc			
12.21	2	12	14	12p13.31	CLECL1, DCAL1		C-type lectin-like 1	607467	REc			
12.22	9	22	14	12p13.31	COPS7A, CSN7		COP9 signalosome, subunit 7A	616009	REc			
12.23	1	27	04	12p13.31	DPPA3		Developmental pluripotency-associated gene 3	608408	REc, H			6(Dppa3)
12.24	9	30	09	12p13.31	FAM90A1		Family with sequence similarity 90, member A1	613041	REc	other family members on chr. 8		
12.25	2	25	15	12p13.31	IFFO1		Intermediate filament family orphan 1	610495	REc			
12.26	3	15	04	12p13.31	ING4		Inhibitor of growth-4	608524	R, REc, D			
12.27	3	23	14	12p13.31	KLRG1, MAFA, MAFAL		Killer cell lectin-like receptor, subfamily G, member 1	604874	Psh, REc			6(Klrg1)
12.28	10	25	16	12p13.31	LPCAT3, MBOAT5, NESSY		Lysophosphatidylcholine acyltransferase 3	611950	REc			
12.29	3	23	09	12p13.31	MIR141, MIRN141		Micro RNA 141	612093	REc			
12.30	3	23	09	12p13.31	MIR200C, MIRN200C		Micro RNA 200C	612092	REc			
12.31	6	13	12	12p13.31	NANOG		Homeobox transcription factor NANOG	607937	REc, H			6(Nanog)
12.32	5	27	18	12p13.31	NCAPD2, CNAP1, KIAA0159, MCPH21		Non-SMC condensin I complex subunit D2	615638	Psh, REc	mutation identified in 1 MCPH21 patient	?Microcephaly 21, primary, autosomal recessive, 617983 (3)	
12.33	7	7	14	12p13.31	NECAP1, EIEE21		NECAP endocytosis-associated protein 1	611623	REc	mutation identified in 1 EIEE21 family	?Epileptic encephalopathy, early infantile, 21, 615833 (3)	
12.34	9	23	13	12p13.31	PHC1, EDR1, HPH1, RAE28, MCPH11		Polyhomeotic-like 1	602978	REc	mutations identified in 1 family	?Microcephaly 11, primary, autosomal recessive, 615414 (3)	
12.35	11	3	14	12p13.31	PIANP, PANP, LEDA1		PILR-alpha-associated neural protein	616065	REc			
12.36	4	24	18	12p13.31	PLEKHG6, MYOGEF		Pleckstrin homology domain- and RhoGEF domain-containing protein G6	611743	REc			
12.37	7	8	11	12p13.31	PTMS		Parathymosin	168440	REc	previously assigned to 17q12-q22		
12.38	2	28	08	12p13.31	RBP5, CRBP3		Retinol-binding protein 5	611866	REc			
12.39	7	1	11	12p13.31	RIMKLB, NAAGS		Ribosomal modification protein RimK-like family, member B	614054	R, REc			
12.40	2	16	18	12p13.31	RNU7-1, RNU7		RNA, U7 small nuclear, 1	617876	REc			6(Rnu7-1)
12.41	3	7	13	12p13.31	SCARNA10		Small cajal body-specific RNA 10	615639	REc, REn	in intron 4 of NCAPD2		
12.42	2	25	14	12p13.31	SCARNA12		Small Cajal body-specific RNA 12	615642	REc			
12.43	12	18	07	12p13.31	SPSB2, SSB2		SPRY domain- and SOCS box-containing 2	611658	REc			
12.44	6	27	14	12p13.31	VAMP1, SYB1, SPAX1		Vesicle-associated membrane protein-1 (synaptobrevin-1)	185880	REa, Fd		Spastic ataxia 1, autosomal dominant, 108600 (3)	6(Syb1)
12.45	10	5	10	12p13.31	CLEC6A, CLEC4N		C-type lectin domain family 6, member A	613579	REc			
12.46	10	23	87	12p13.31	GAPDH, GAPD		Glyceraldehyde-3-phosphate dehydrogenase	138400	S, D, R	pseudogene on Xp21-q11		6(Gapd)
12.47	9	2	08	12p13.33	B4GALNT3		Beta-1,4-N-acetylgalactosaminyltransferase 3	612220	REc			
12.48	3	5	08	12p13.33	CACNA1C, CACNL1A1, CCHL1A1, TS		Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	Psh, Fd, REa, A		Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)	
12.49	10	11	06	12p13.33	CACNA2D4, RCD4		Calcium channel, voltage-dependent, alpha-2/delta subunit 4	608171	REc		Retinal cone dystrophy 4, 610478 (3)	
12.50	1	23	01	12p13.31	CD163		CD163 antigen (hemoglobin scavenger receptor)	605545	A, REa, R			
12.51	9	30	09	12p13.31	CD164L1, CD163B, M160		CD164 antigen-like 1	606079	A, R			
12.52	6	1	18	12p13.32	FGF23, ADHR, HPDR2, PHPTC, HFTC2		Fibroblast growth factor 23	605380	Fd, REc		Hypophosphatemic rickets, autosomal dominant, 193100 (3); Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3)	6(Fgf23)
12.53	1	27	04	12p13.32	GALNT8		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8	606250	REc			
12.54	1	2	03	12p13.1	GPRC5D		G protein-coupled receptor, family C, group 5, member D	607437	REc			
12.55	10	30	08	12p13.3	MAFD9		Major affective disorder 9	612372	Fd	associated with rs1006737	{Major affective disorder-9, susceptibility to} (2)	
12.56	12	23	15	12p13.32	PARP11, ARTD11		Poly(ADP-ribose) polymerase family, member 11	616706	REc			
12.57	12	23	15	12p13.31	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5		Peroxisome biogenesis factor 5	600414	REa, A, R		Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3); Peroxisome biogenesis disorder 2B, 202370 (3); Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	
12.58	4	6	15	12p13.32	PRMT8, HRMT1L3, HRMT1L4		Protein arginine methyltransferase 8	610086	REc, H			6(Prmt8)
12.59	11	28	94	12p13.31	SLC2A3, GLUT3		Solute carrier family 2 (facilitated glucose transporter), member 3	138170	A	pseudogene SLC2A3P on 5q34		
12.60	8	20	07	12p13.31	SLC2A14, GLUT14		Solute carrier family 2 (facilitated glucose transporter), member 14	611039	REc			
12.61	3	14	13	12p13.33	SLC6A13, GAT2, GAT3		Solute carrier family 6 (neurotransmitter transporter, GABA), member 13	615097	REc			
12.62	7	2	02	12p13.31	TAPBPR		TAP-binding protein-related protein	607081	REc			
12.63	2	20	07	12p13.32	TIGAR, C12orf5		TP53-induced glycolysis and apoptosis regulator	610775	REc			
12.64	10	4	10	12p13.31	VWF, F8VWF		Coagulation factor VIII VWF (von Willebrand factor)	613160	A, REa, REb, Fd	pseudogene on chr. 22	von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3); von Willebrand disease, type 1, 193400 (3); von Willibrand disease, type 3, 277480 (3)	6(Vwf)
12.65	11	4	04	12p13.33	WNT5B		Wingless-type MMTV integration site family, member 5B	606361	REc			
12.66	10	15	98	12p13.33	TEAD4, TCF13L1, RTEF1		TEA domain family, member 4	601714	A			6(Tcf13l1)
12.67	7	1	11	12p13.31	A2M , A2MD		Alpha-2-macroglobulin	103950	REa, A	cluster of genes	Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer disease, susceptibility to}, 104300 (3)	6(A2m)
12.68	3	5	08	12p13.31	MRPL51, MRP64		Mitochondrial ribosomal protein L51	611855	R, REc			
12.69	12	28	15	12p13.2	LRP6, ADCAD2, STHAG7		Low density lipoprotein receptor-related protein 6	603507	A, R		{Coronary artery disease, autosomal dominant, 2}, 610947 (3); Tooth agenesis, selective, 7, 616724 (3)	6(Lrp6)
12.70	12	24	08	12p13.1	APOLD1, VERGE		Apolipoprotein L domain-containing 1	612456	REc			
12.71	10	23	15	12p13.2	BORCS5, LOH12CR1, MYRLYSIN		BLOC1-related complex, subunit 5	616598	REc			
12.72	7	13	17	12p13.2	CLEC12B		C-type lectin domain family 12, member B	617573	REc			6(Clec12b)
12.73	3	27	90	12p13.2	PRB1		Proline-rich protein BstNI, subfamily-1	180989	F, RE			
12.74	3	27	90	12p13.2	PRB2		Proline-rich protein BstNI, subfamily-2 (parotid size variant)	168810	F, RE	Ps allele		
12.75	3	27	90	12p13.2	PRB3		Proline-rich protein BstNI, subfamily-3 (parotid salivary glycoprotein)	168840	LD, F, RE	G1 allele		
12.76	3	27	90	12p13.2	PRB4		Proline-rich protein BstNI, subfamily-4	180990	F, RE	Po, CON1, CON2 alleles		
12.77	4	10	90	12p13.2	PRH1		Proline-rich protein HaeIII, subfamily-1	168730	F, LD, RE	Pa, Db, PIF alleles		
12.78	3	27	90	12p13.2	PRH2		Proline-rich protein HaeIII, subfamily-2	168790	F, LD, RE	Pr allele		
12.79	1	28	88	12p13.2	PCS		Parotid proline-rich salivary protein Pc	168710	F	linked to PRB2		
12.80	8	27	15	12p13.2	STYK1, NOK		Serine/threonine/tyrosine kinase 1	611433	REc			
12.81	6	11	11	12p13.2	TAS2R20, T2R56		Taste receptor, type 2, member 20	613962	Psh, REc			
12.82	6	27	11	12p13.2	TAS2R30, T2R30, T2R47		Taste receptor, type 2, member 30	613963	REc	previously assigned to chr.1		
12.83	6	26	11	12p13.2	TAS2R45, T2R45		Taste receptor, type 2, member 45	613967	REc			
12.84	3	23	09	12p13.2	TAS2R43, T2R52		Taste receptor, type 2, member 43	612668	REc			
12.85	1	24	12	12p13.2	TAS2R31, TAS2R44, T2R53		Taste receptor, type 2, member 31	612669	REc			
12.86	9	15	09	12p13.2	TAS2R46, T2R46, T2R54		Taste receptor, type 2, member 46	612774	REc			
12.87	11	4	08	12p13.2	TAS2R50, T2R50, TAS2R51, T2R51		Taste receptor, type 2, member 50	609627	Psh, REc			
12.88	9	7	12	12p13.31	TNFRSF1A, TNFR1, TNFAR, FPF, MS5		Tumor necrosis factor receptor superfamily, member 1A	191190	REa, A, Psh		Periodic fever, familial, 142680 (3); {Multiple sclerosis, susceptibility to, 5}, 614810 (3)	6(Tnfr2)
12.89	11	12	07	12p13.32	RAD51AP1, PIR51		Rad51-associated protein 1	603070	A			6(Pir51)
12.90	2	15	02	12p13.31	CLEC4C, CLECSF11, DLEC, BDCA2		C-type lectin domain family 4, member C	606677	REc			
12.91	9	8	11	12p13.2	CLEC7A, CLECSF12, DECTIN1, CANDF4		C-type lectin domain family 7, member A	606264	A, REc	in natural killer gene complex	Candidiasis, familial, 4, autosomal recessive, 613108 (3); {Aspergillosis, susceptibility to}, 614079 (3)	
12.92	1	13	99	12p13.1	GPR19		G protein-coupled receptor-19	602927	A, REn			
12.93	1	13	99	12p13.2	KLRC1, NKG2, NKG2A		Killer cell lectin-like receptor, subfamily C, member 1	161555	REa, A	family of at least 3 genes on 12		6(Klrc1)
12.94	1	13	99	12p13.2	KLRC2, NKG2C		Killer cell lectin-like receptor, subfamily C, member 2	602891	REc			
12.95	1	13	99	12p13.2	KLRC3, NKG2E		Killer cell lectin-like receptor, subfamily C, member 3	602892	REc			
12.96	9	3	98	12p13.2	KLRC4, NKG2F, D12S2489E		Killer cell lectin-like receptor, subfamily C, member 4	602893	REc			
12.97	1	13	99	12p13.2	KLRD1, CD94		Killer cell lectin-like receptor, subfamily D, member 1	602894	REc			
12.98	1	29	01	12p13.31	KLRF1		Killer cell lectin-like receptor, subfamily F, member 1	605029	REc			
12.99	2	26	08	12p13.2	KLRK1, NKG2D		Kill cell lectin-like receptor, subfamily K, member 1	611817	REc			
12.100	7	18	06	12p13.2-p11.23	DFNB62		Deafness, autosomal recessive 62	610143	Fd	between D12S358 and D12S1042	Deafness, autosomal recessive 62 (2)	
12.101	1	6	97	12p13.2-q24.1	IBD2		Inflammatory bowel disease 2	601458	Fd, LD	mainly ulcerative colitis	{Inflammatory bowel disease 2} (2)	
12.102	1	7	95	12p13.31	APOBEC1, BEDP		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1	600130	A			
12.103	11	22	10	12p13.1	ATF7IP, AM, MCAF, MCAF1		Activating transcription factor 7-interacting protein	613644	REc			
12.104	1	22	99	12p13.2	CSDA, DBPA		Cold-shock domain protein A	603437	A			
12.105	10	7	13	12p13.1	DDX47		DEAD box polypeptide 47	615428	REc			
12.106	1	30	18	12p13.1	FAM234B, KIAA1467		Family with sequence similarity 234, member B	617838	REc			
12.107	1	20	11	12p13.31	GDF3, KFS3, MCOPCB6, MCOP7		Growth differentiation factor 3	606522	R		Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)	
12.108	10	12	14	12p13.1	GNAI2P1, GNAI2L, GNAI2A		Guanine nucleotide-binding protein (G protein), alpha-inhibiting, polypeptide 2 pseudogene 1	139180	REa, A			
12.109	2	8	13	12p12.3	HIST4H4		Histone gene cluster 4, H4 histone	615069	REc			
12.110	1	8	15	12p13.31	MFAP5, MAGP2, AAT9		Microfibril-associated protein 5	601103	A		Aortic aneurysm, familial thoracic 9, 616166 (3)	
12.111	11	25	14	12p12.3	MGP		Matrix Gla protein	154870	REa, R, Fd, LD		Keutel syndrome, 245150 (3)	6(Mglap)
12.112	4	17	12	12p13.1	GPRC5A, RAI3, RAIG1		G protein-coupled receptor, family C, group 5, member A	604138	R, REc			
12.113	9	19	00	12p13.31	AICDA, AID, HIGM2		Activation-induced cytidine deaminase	605257	A, Fd		Immunodeficiency with hyper-IgM, type 2, 605258 (3)	
12.114	11	24	08	12p13.31	ANO2, TMEM16B, C12orf3		Anoctamin 2	610109	REc			
12.115	10	29	16	12p13.31	C1R, EDSPD1		Complement component-1, r subcomponent	613785	REa, Fd, RE, A		Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3)	
12.116	10	29	16	12p13.31	C1S, EDSPD2		Complement component-1, s subcomponent	120580	REa, Fd, RE, A		C1s deficiency, 613783 (3); Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3)	
12.117	4	23	13	12p13.31	C12orf57, C10, TEMTYS		Chromosome 12 open reading frame 57	615140	REc, H		Temtamy syndrome, 218340 (3)	6(C12orf57)
12.118	8	22	14	12p13.32	CCND2, MPPH3		Cyclin D2	123833	REa, A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	
12.119	6	5	89	12p13.31	CD9, MIC3		CD9 antigen (p24)	143030	S, REa, A			
12.120	5	22	07	12p13.1	CDKN1B, KIP1, CDKN4, MEN4		Cyclin-dependent kinase inhibitor 1B (p27, Kip1)	600778	Psh, A, REc, REn		Multiple endocrine neoplasia, type IV, 610755 (3)	7(Cdkn1b)
12.121	10	18	16	12p13.31	CHD4, SIHIWES		Chromodomain helicase DNA-binding protein-4	603277	A		Sifrim-Hitz-Weiss syndrome, 617159 (3)	
12.122	3	26	02	12p13.2	CLEC1A, CLEC1		C-type lectin domain family 1, member A	606782	REa			
12.123	3	26	02	12p13.3-p13.2	CLEC2B, CLEC2		C-type lectin domain family 1, member B	606783	REa			
12.124	3	23	06	12p13.31	CLEC4D, CLECSF8, CLEC6		C-type lectin domain family 4, member D	609964	REc			
12.125	3	24	06	12p13.31	CLEC2D, LLT1		C-type lectin domain family 2, member D	605659	REc			
12.126	3	23	06	12p13.31	CLEC4E, MINCLE		C-type lectin domain family 4, member E	609962	REc			6(Clec4e)
12.127	1	31	01	12p13.31	CLEC4A, CLECSF6, DCIR, DDB27		C-type lectin domain family 4, member A	605306	REa, R			
12.128	6	27	08	12p13.31	CLEC12A, MICL		C-type lectin domain family 12, member A	612088	REc, H			6(Clec12a)
12.129	3	23	13	12p13.31	CLSTN3, KIAA0726		Calsyntenin 3	611324	R, REc			
12.130	6	25	99	12p13.1	CREBL2		Cyclic AMP response element-binding protein-like 2	603476	D, A			
12.131	5	13	98	12p13.31	DDX12, CHLR2		DEAD/H box-12	601151	Psh, A			
12.132	8	24	09	12p13.31	EMG1, NEP1, C2F, BWCNS		Essential for mitotic growth 1, S. cerevisiae, homolog of	611531	REc, Fd		Bowen-Conradi syndrome, 211180 (3)	
12.133	8	11	91	12p13.31	ENO2		Enolase-2, gamma, neuronal	131360	S, D, A, REa			
12.134	2	13	15	12p13.2	ETV6, TEL, THC5		ETS variant gene-6 (TEL oncogene)	600618	RE, Fd, D	fused to PDGFRB or AML1 in leukemia	Leukemia, acute myeloid, somatic, 601626 (3); Thrombocytopenia 5, 616216 (3)	
12.135	3	18	94	12p13.32	FGF6		Fibroblast growth factor-6	134921	A, Ch, Psh			
12.136	11	9	98	12p13.33	FOXM1, FKHL16, HFH11		Forkhead box M1	602341	Psh, R, A			
12.137	7	11	16	12p13.31	GNB3, CSNB1H		Guanine nucleotide-binding protein, beta polypeptide-3	139130	REa, A		{Hypertension, essential, susceptibility to}, 145500 (3); Night blindness, congenital stationary, type 1H, 617024 (3)	6(Gnb3)
12.138	2	11	96	12p13.32	KCNA1, AEMK, EA1		Potassium voltage-gated channel, shaker-related subfamily, member 1	176260	REa, Fd, A, H	close to VWF	Episodic ataxia/myokymia syndrome, 160120 (3)	6(Kcna1)
12.139	9	8	08	12p13.32	KCNA5, ATFB7		Potassium voltage-gated channel, shaker-related subfamily, member 5	176267	REa, Fd, H		Atrial fibrillation, familial, 7, 612240 (3)	6(Kcna5)
12.140	3	17	94	12p13.32	KCNA6		Potassium voltage-gated channel, shaker-related subfamily, member 6	176257	REa			6(Kcna6)
12.141	4	19	16	12p13.31	P3H3, LEPREL2		Prolyl 3-hydroxylase 3	610342	REc			
12.142	8	21	98	12p12.3	LMO3, RBTNL2, RHOM3		LIM domain only 3 (rhombotin-like 2)	180386	A, Ch	expressed mainly in brain		
12.143	4	24	08	12p13.31	LPAR5, GPR92, GPR93, LPA5		Lysophosphatidic acid receptor 5	606926	REc			
12.144	8	21	98	12p13.31	LTBR, TNFCR		Lymphotoxin-beta receptor (tumor necrosis factor C receptor)	600979	H	tightly linked to TNFR1 in mouse		6(Tnfcr)
12.145	12	4	95	12p13.31	M6PR		Mannose-6-phosphate receptor, cation-dependent	154540	REa, Psh, A			6(Mprd)
12.146	8	29	96	12p13.31	MLF2		Myeloid leukemia factor-2	601401	A, REc			
12.147	4	29	03	12p13.33	NINJ2		Nerve injury-induced protein 2	607297	REc			
12.148	10	15	94	12p13.31	NOL1		Nucleolar protein 1, 120kD	164031	Psh, A			
12.149	6	21	91	12p13.31	NTF3		Neurotrophin-3	162660	A, REa			6(Ntf3)
12.150	10	25	12	12p12.3	PDE6H, RCD3, ACHM6		Phosphodiesterase 6H, cGMP-specific, cone, gamma	601190	A		Retinal cone dystrophy 3, 610024 (3); Achromatopsia 6, 610024 (3)	
12.151	1	17	07	12p13.31	PHB2, REA		Prohibitin 2	610704	R, REc			
12.152	12	30	14	Xp21.1	PRRG1, PRGP1		Proline-rich gamma-carboxyglutamic acid protein 1	300935	REc			
12.153	1	6	93	12p13.31	PTPN6		Protein tyrosine phosphatase, nonreceptor-type, 6	176883	A			6(Hcph)
12.154	09	19	18	12p13.31	SCNN1A, BESC2, LIDLS3		Sodium channel, nonvoltage-gated 1, alpha	600228	REa, Psh, A, Fd	mutation identified in 1 LIDLS3 patient	Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 2, 613021 (3); ?Liddle syndrome 3, 618126 (3)	6(Scnn1)
12.155	10	2	98	12p13.33	SLC6A12		Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	603080	A			
12.156	6	11	11	12p13.2	TAS2R19, T2R19, T2R48		Taste receptor, type 2, member 19	613961	REc			
12.157	6	26	11	12p13.2	TAS2R42, T2R42, T2R55		Taste receptor, type 2, member 42	613966	REc			
12.158	6	27	17	12p13.31	CD27, TNFRSF7, S152. LPFS2		CD27 antigen	186711	Psh, A		Lymphoproliferative syndrome 2, 615122 (3)	
12.159	11	13	13	12p13.31	TPI1, TPID		Triosephosphate isomerase-1	190450	S, D, R, REa		Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	6(Tpi1)
12.160	4	5	00	12p13.2	TRB1, T2R14		Taste receptor, family B, member 1	604790	REc			
12.161	4	5	00	12p13.2	TRB2, T2R10		Taste receptor, family B, member 2	604791	REc			
12.162	4	5	00	12p13.2	TRB3, T2R13		Taste receptor, family B, member 3	604792	REc			
12.163	4	5	00	12p13.2	TRB4, T2R7		Taste receptor, family B, member 4	604793	REc			
12.164	4	5	00	12p13.2	TRB5, T2R8		Taste receptor, family B, member 5	604794	REc			
12.165	4	5	00	12p13.2	TRB6, T2R9		Taste receptor, family B, member 6	604795	REc			
12.166	12	14	00	12p13.33	TULP3		Tubby-like protein 3	604730	R			6(Tulp3)
12.167	2	5	99	12p13.31	USP5, ISOT		Ubiquitin-specific protease-5 (ubiquitin isopeptidase T)	601447	REn			
12.168	2	27	12	12p13.33	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2		WNK lysine deficient protein kinase 1	605232	Fd, REc		Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	
12.169	6	8	89	12p13.31	PZP		Pregnancy zone protein	176420	REa, A			
12.170	3	18	95	12p13.33	RAD52		RAD52, yeast, homolog of	600392	Psh, A			
12.171	10	24	14	12p12.3	ART4, DO, DOK1		ADP-ribosyltransferase-4 (Dombrock blood group)	110600	A, Psh		[Blood group, Dombrock], 616060 (3)	
12.172	3	1	94	12p13.31	CD69		CD69 antigen (p60, early T-cell activation antigen)	107273	REa, A			
12.173	3	24	06	12p13.31	CLEC2B, CLECSF2, AICL		C-type lectin domain family 2, member B	603242	REc			
12.174	11	3	99	12p13.2	KLRA1, LY49L		Killer cell lectin-like receptor, subfamily A, member 1	604274	H, REc	?functional		6(Ly49)
12.175	1	13	99	12p13.31	KLRB1, NKRP1A		Killer cell lectin-like receptor, subfamily B, member 1	602890	Psh, A, REc			
12.176	11	29	11	12p13.2	OLR1, LOX1		Low density lipoprotein, oxidized, receptor 1	602601	A, REn		{Myocardial infarction, susceptibility to}, 608446 (3)	
12.177	9	6	11	12p12.3	PTPRO, GLEPP1, NPHS6		Protein tyrosine phosphatase, receptor type, O	600579	A		Nephrotic syndrome, type 6, 614196 (3)	
12.178	6	21	94	12q13.3	ATP5B, ATPSB		ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	102910	REa, REb			
12.179	4	24	18	12p12.3	AEBP2		AE-binding protein 2	617934	REc			
12.180	7	14	98	12p12.3	ARHGDIB, GDID4, D4		Rho GDP dissociation inhibitor (GDI) beta	602843	A			
12.181	10	10	18	Xp11.3	PPP1R2C		Protein phosphatase 1, regulatory subunit 2C	301017	REc			
12.182	10	20	99	12p13.1	EMP1, TMP		Epithelial membrane protein-1	602333	REa, A, R			6(Emp1)
12.183	9	2	14	12p12.3	EPS8, DFNB102		Epidermal growth factor receptor pathway substrate-8	600206	REa, A	mutation identified in 1 DFNB102 family	?Deafness, autosomal recessive 102, 615974 (3)	
12.184	2	28	03	12p13.2	GABARAPL1, GEC1		GABA-A receptor-associated protein-like protein 1	607420	R, REc			
12.185	11	22	16	12p12.3	PLCZ1, SPGF17		Phospholipase C, zeta-1	608075	REc	mutation identified in 1 SPGF17 family	?Spermatogenic failure 17, 617214 (3)	
12.186	7	18	14	12p11.23	STK38L, NDR2, KIAA0965		Serine/threonine protein kinase 38-like protein	615836	R, REc			6(Stk38l)
12.187	5	18	10	12p12.3	STRAP, UNRIP, MAWD		Serine/threonine kinase receptor-associated protein	605986	R, REc	previously assigned to 12q		
12.188	8	10	18	12p12.3	WBP11, NPWBP, SIPP1		WW-binding protein 11	618083	REc			
12.189	4	25	93	12p12.1	IAPP		Islet amyloid polypeptide (diabetes-associated peptide; amylin)	147940	REa, A			
12.190	4	23	13	12p12.1	GYS2		Glycogen synthase-2, liver	138571	A, Fd		Glycogen storage disease 0, liver, 240600 (3)	
12.191	6	23	15	12p12.2	PDE3A, HTNB		Phosphodiesterase 3A, cGMP-inhibited	123805	REc, Fd		Hypertension and brachydactyly syndrome, 112410 (3)	
12.192	1	18	12	12p12.2	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR		Solute carrier organic anion transporter family, member 1B3	605495	REc	HBLRR digenic with SLCO1B1	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.193	6	21	04	12p12.2-p12.1	HYT4		Hypertension, essential, susceptibility to, 4	608742	Fd		{Hypertension, essential, susceptibility to, 4}, 145500 (2)	
12.194	9	4	15	12p12.1	LDHB, LDHBD		Lactate dehydrogenase B	150100	S, D, Fd		[Lactate dehydrogenase-B deficiency], 614128 (3)	6(Ldh2)
12.195	7	6	12	12p12.1	ABCC9, SUR2, CMD1O, ATFB12, CANTU		ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	A		Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation, familial, 12, 614050 (3); Hypertrichotic osteochondrodysplasia, 239850 (3)	
12.196	6	28	18	12p12.1	C2CD5, CDP138, KIAA0528		C2 calcium-dependent domain-containing protein 5	618044	REc, R			
12.197	4	19	16	12p12.1	CASC1, LAS1, PPP1R54		Cancer susceptibility candidate 1	616906	REc, H			6(Casc1)
12.198	4	19	06	12p12.1	CMAS		Cytidine monophosphate N-acetylneuraminic acid synthetase	603316	REn			
12.199	3	7	13	12p12.1	GOLT1B, GOT1B, GCT2		Golgi transport 1B	615078	REc			
12.200	6	20	13	12p12.1	KRAS, KRAS2, RASK2, NS, CFC2, RALD		Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog	190070	REa, A, Fd	pseudogene KRAS1P on 6p12-p11	Lung cancer, somatic, 211980 (3); Bladder cancer, somatic, 109800 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, somatic, 137215 (3); Leukemia, acute myeloid, 601626 (3); Noonan syndrome 3, 609942 (3); Cardiofaciocutaneous syndrome 2, 615278 (3); Breast cancer, somatic, 114480 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); RAS-associated autoimmune leukoproliferative disorder, 614470 (3); Arteriovenous malformation of the brain, somatic, 108010 (3)	6(Kras2)
12.201	12	15	16	12p12.1	LMNTD1, IFLTD1, LMNARS1, PAS1C1		Lamin tail domain-containing protein 1	617254	REc			
12.202	4	29	14	12p12.1	LRMP, JAW1		Lymphoid-restricted membrane protein	602003	REc			
12.203	12	19	16	12p12.1	PYROXD1, MFM8		Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1	617220	REc		Myopathy, myofibrillar, 8, 617258 (3)	
12.204	9	7	12	12p12.1	RASSF8, C12orf2		RAS association domain family, member 8	608231	REc			
12.205	2	12	16	12p12.1	SOX5, LAMSHF		SRY-box 5	604975	A, H	some LAMSHF patients have 12p12 deletions	Lamb-Shaffer syndrome, 616803 (3)	6(Sox5)
12.206	8	24	09	12p12.1	BHLHE41, BHLHB3, DEC2, SHARP1		Basic helix-loop-helix domain-containing protein, member E41	606200	A		[Short sleeper], 612975 (3)	6(Dec2)
12.207	3	20	06	12p12.1	ETNK1, EKI1		Ethanolamine kinase 1	609858	REc			12(Etnk1)
12.208	3	22	06	12p12.1	DADR		DAD1-related gene	609860	A			
12.209	4	24	18	12p11.22	PTHLH, BDE2		Parathyroid hormone-like hormone	168470	REa, A		Brachydactyly, type E2, 613382 (3)	6(Pthlh)
12.210	3	14	96	12p12.1	SIAT8		Sialyltransferase-8 (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase)	601123	Psh, A			6(Siat8)
12.211	7	6	00	12q13.13	TARBP2		TAR RNA-binding protein 2	605053	Psh	pseudogene on 8q22-qter		15(Tarbp2)
12.212	9	15	98	12p12.1	BCAT1, BCT1		Branched chain aminotransferase-1, cytosolic	113520	S, H		?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	6(Bcat1)
12.213	8	30	01	12p13.2	BCLG		Apoptosis regulator BCLG	606126	REc			
12.214	6	10	04	12p12.3	CAPZA3, CAPPA3		Capping protein, actin, alpha-3	608722	REc			6(Capza3)
12.215	6	27	12	12p13.2	DUSP16, MKP7, KIAA1700		Dual-specificity phosphatase 16	607175	REc			
12.216	12	26	14	12p13.1	GRIN2B, NMDAR2B, MRD6, EIEE27		Glutamate receptor, ionotropic, N-methyl D-aspartate 2B	138252	A, REa		Mental retardation, autosomal dominant 6, 613970 (3); Epileptic encephalopathy, early infantile, 27, 616139 (3)	6(Nmdar2b)
12.217	5	29	12	12p12.3	GUCY2C, GUC2C, DIAR6, MECIL		Guanylate cyclase 2C (heat stable enterotoxin receptor)	601330	A		Diarrhea 6, 614616 (3); Meconium ileus, 614665 (3)	6(Gucy2c)
12.218	8	25	09	12p12.3	PEPP2, KIAA1686		Phosphatidylinositol 3-phosphate-binding PH domain protein 2	607770	R, REc			
12.219	11	2	04	12p12.3	PIK3C2G		Phosphatidylinositol 3-kinase, class 2, gamma	609001	A, H			6(Pik3c2g)
12.220	3	23	09	12p12.3	RERG		Ras-like and estrogen-regulated growth inhibitor	612664	REc			
12.221	7	7	14	12p12.3	SKP1P2, SKP1B		S-phase kinase-associated protein 1 pseudogene 2 (p19B)	601435	A			
12.222	1	13	99	12p12.1	SLC21A3, OATP		Solute carrier family 21 (organic anion transporter), member 3	602883	Psh, A			
12.223	1	18	12	12p12.1	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR		Solute carrier organic anion transporter family, member 1B1	604843	R, REn	HBLRR digenic with SLCO1B3	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.224	6	7	10	12p12.2	SLCO1C1, OATPF, OATP14, SLC21A14		Solute carrier organic anion transporter family, member 1C1	613389	REc			
12.225	3	14	06	12p13.31	ZNF384, CIZ, CAGH1, NMP4		Zinc finger protein 384	609951	REc, H			6(Znf384)
12.226	5	22	14	12p12.1	RECQL, RECQL1		RecQ helicase-like (DNA helicase, RecQ-like 1)	600537	Psh, A			
12.227	11	19	13	12p11.21	CAPRIN2, C1QDC1, EEG1, KIAA1873		Caprin family, member 2	610375	REc			
12.228	12	27	16	12p11.21	DENND5B		DENN domain-containing protein 5B	617279	REc			
12.229	11	8	17	12p11.21	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5		Dynamin 1-like	603850	R, REc		Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3); Optic atrophy 5, 610708 (3)	
12.230	4	6	18	12p11.21	ETFBKMT, METTL20, C12orf72		Electron transfer flavoprotein beta-subunit lysine methyltransferase	615256	REc			
12.231	12	30	14	12p11.21	H3F3C		H3 histone, family 3C	616134	REc, A			
12.232	9	17	10	12p11.21	YARS2, TYRRS, MLASA2		Tyrosyl-tRNA synthetase 2	610957	R, REc		Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	
12.233	3	29	12	12p11.23	ARNTL2, BMAL2, CLIF		Aryl hydrocarbon receptor nuclear translocator-like protein 2	614517	A, REc			
12.234	3	7	13	12p11.23	ASUN, MAT89BB, GCT1		Asunder, spermatogenesis regulator	615079	REc			
12.235	1	8	15	12p11.22	FAR2, MLSTD1		Fatty acyl CoA reductase 2	616156	REc			12(Far2)
12.236	2	5	15	12p12.1	KCNJ8		Potassium inwardly-rectifying channel, subfamily J, member 8	600935	A			
12.237	7	22	09	12p11.23	MED21, SURB7, SRB7		Mediator complex subunit 21	603800	REc			
12.238	7	25	16	12p11.23-q13.12	AD5		Alzheimer disease, familial, type 5	602096	Fd		Alzheimer disease-5 (2)	
12.239	2	24	17	12p11.22	CCDC91		Coiled-coil domain-containing protein 91	617366	REc			
12.240	9	22	08	12p11.22	ERGIC2, CDA14, PTX1		Endoplasmic reticulum-golgi intermediate compartment protein 2	612236	Psh, REc			
12.241	3	15	07	12p11.22	REP15		Rab15 effector protein	610848	R, REc			
12.242	7	18	14	12p11.22	TMTC1		Transmembrane and tetratricopeptide repeat domains-containing protein 1	615855	REc			
12.243	7	2	07	12p11.21	FGD4, FRABIN, CMT4H		FYVE, RhoGEF, and PH domain-containing protein 4	611104	R, Fd		Charcot-Marie-Tooth disease, type 4H, 609311 (3)	
12.244	1	26	97	12p12.1	SSPN, KRAG		Sarcospan (Kirsten-ras associated gene)	601599	A			
12.245	5	28	98	12p11.21	BICD1		Bicaudal-D, Drosophila, homolog of, 1	602204	REc	second homolog on 9q		
12.246	1	18	13	12p11.2-q13.1	ARCI7		Ichthyosis, congenital, autosomal recessive 7	615022	Fd	between D12S345 and D12S390	Ichthyosis, congenital, autosomal recessive 7 (2)	
12.247	2	17	09	12p11.2-q14	STQTL3		Stature quantitative trait locus 3	606257	Fd	max lod at D12S398 and D12S10990	{Stature QTL 3} (2)	
12.248	2	5	14	12p11.1	ALG10, KCR1		Alg10, S. cerevisiae, homolog of	603313	REc		{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	
12.249	6	14	10	12p11.21	DDX11, CHLR1, KRG2		DEAD/H box-11 (CHL1-related helicase gene-1)	601150	Psh, A		Warsaw breakage syndrome, 613398 (3)	
12.250	4	3	15	12p11.23	ITPR2, ANHD		Inositol 1,4,5-triphosphate receptor, type 2	600144	A	mutation has been identified in 1 ANHD family	?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	
12.251	7	9	09	12p13.33	KDM5A, JARID1A, RBP2, RBBP2		Lysine(K)-specific demethylase 5A	180202	Psh, A			
12.252	12	30	04	12p11.21	PKP2, ARVD9		Plakophilin-2	602861	A, Psh	pseudogene on 12p13	Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	
12.253	11	10	17	12p11.21	SINHCAF, FAM60A		SIN3-HDAC complex associated factor	615027	REc			
12.254	9	9	13	12p11-q13	VUR7		Vesicoureteral reflux 7	615390	Fd	max lod at D12S1048	Vesicoureteral reflux 7 (2)	
12.255	1	28	88	12p	KAR		Aromatic alpha-keto acid reductase	107920	S	?same as MDH1		
12.256	2	23	12	12p13.32	NDUFA9		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 9	603834	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
12.257	5	7	03	12q21.2	OSBPL8, ORP8, KIAA1451		Oxysterol-binding protein-like protein 8	606736	R, REc			
12.258	5	4	12	12p	PKS		Pallister-Killian syndrome	601803	Ch		Pallister-Killian syndrome (4)	
12.259	5	15	95	12q21.2	SYT1		Synaptotagmin-1	185605	REa, H			10(Syt1)
12.260	7	8	10	12q	IHPS1, IHPS		Pyloric stenosis, infantile hypertrophic 1	179010	Fd		Pyloric stenosis, infantile hypertrophic 1 (2)	
12.261	6	25	99	12q24.13	RPL6		Ribosomal protein L6	603703	Psh, R			
12.262	3	29	10	12q13.2	RPS26, DBA10		Ribosomal protein S26	603701	Psh, R		Diamond-Blackfan anemia 10, 613309 (3)	
12.263	5	22	03	12q13.13	SMUG1		Single-strand-selective monofunctional uracil-DNA glycosylase 1	607753	REc			
12.264	1	2	08	12q12	ADAMTS20		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 20	611681	REc			
12.265	10	29	99	12q12	ABCD2, ALDR, ALDL1		ATP-binding cassette, subfamily D, member 2	601081	A, Psh			15(Aldl1)
12.266	7	7	14	12q12	CNTN1, MYPCN		Contactin 1	600016	A	mutation identified in 1 MYPCN family	?Myopathy, congenital, Compton-North, 612540 (3)	
12.267	1	31	01	12p11.23	TM7SF3		Transmembrane 7 superfamily, member 3	605181	A, R			
12.268	1	25	93	12q13.13	ITGA5, FNRA, VLA5A		Integrin, alpha-5 (fibronectin receptor, alpha subunit; very late activation protein-5, alpha subunit)	135620	REa, A			15(Itga5)
12.269	6	7	95	12q13.13	KRT2, KRT2A, KRT2E		Keratin 2	600194	Fd		Ichthyosis bullosa of Siemens, 146800 (3)	
12.270	3	3	09	12q13.11-q13.12	CCNT1, CCNT		Cyclin T1	143055	R, REc			
12.271	12	11	97	12q13.13	ACVRL1, ACVRLK1, ALK1, HHT2		Activin A receptor, type II-like kinase 1	601284	REc		Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	
12.272	1	13	99	12q13.12	ACCN2		Cation channel, amiloride-sensitive, neuronal, 2	602866	A			
12.273	9	15	11	12q12	ANO6, TMEM16F, SCTS, BDPLT7		Anoctamin 6	608663	REc		Scott syndrome, 262890 (3)	15(Tmem16f)
12.274	12	15	17	12q12	ARID2, BAF200, KIAA1557, CSS6		AT-rich interaction domain-containing protein 2	609539	REc		Coffin-Siris syndrome 6, 617808 (3)	
12.275	3	29	10	12q12	GXYLT1, GLT8D3		Glucoside xylosyltransferase 1	613321	REc			
12.276	3	8	07	12q12	IRAK4, REN64, IPD1		Interleukin 1 receptor-associated kinase 4	606883	REc		IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	
12.277	2	17	10	12q12	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B		Kinesin family member 21A	608283	Fd, REc		Fibrosis of extraocular muscles, congenital, 1, 135700 (3); Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	15(Kif21a)
12.278	4	10	15	12q12	LRRK2, PARK8		Leucine-rich repeat kinase 2 (dardarin)	609007	Fd, REc		{Parkinson disease 8}, 607060 (3)	
12.279	7	31	08	12q12	MUC19		Mucin 19, oligomeric	612170	REc			15(Muc19)
12.280	12	28	08	12q12	PDZRN4		PDZ domain-containing ring finger protein 4	609730	REc			
12.281	7	9	06	12q13.13	PFDN5, MM1		Prefoldin 5	604899	R			
12.282	3	22	07	12q12	PPHLN1		Periphilin 1	608150	REc			
12.283	12	24	08	12q12	PRICKLE1, RILP, EPM1B		Prickle-like 1	608500	REc		Epilepsy, progressive myoclonic 1B, 612437 (3)	15(Prickle1)
12.284	8	20	07	12q12	SLC2A13, HMIT		Solute carrier family 2 (facilitated glucose transporter), member 13	611036	R, REc			
12.285	4	19	07	12q12	TWF1, PTK9		Twinfilin, Drosophila, homolog of, 1	610932	R, REc			
12.286	8	18	14	12q12	YAF2		YY1-associated factor 2	607534	REc			
12.287	2	12	07	12q12	ZCRB1, MADP1		Zinc finger CCHC domain- and RNA-binding motif-containing protein 1	610750	REc	possible pseudogenes on chr16, X, and 6		
12.288	3	31	15	12q13.12	ADCY6, LCCS8		Adenylate cyclase-6	600294	A, REa	mutation identified in 1 LCCS8 family	?Lethal congenital contracture syndrome 8, 616287 (3)	15(Adcy6)
12.289	10	1	95	12q13.2	CD63, MLA1		CD63 antigen (melanoma 1 antigen)	155740	REa, A			10(Cd63)
12.290	2	21	12	12q13.12	GPD1, HTGTI		Glycerol-3-phosphate dehydrogenase, soluble	138420	S, R		Hypertriglyceridemia, transient infantile, 614480 (3)	15(Gdc1)
12.291	5	27	05	12q13.12	PRPH		Peripherin	170710	A		{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	15(Prph)
12.292	6	25	99	12q13.3	TIMELESS, TIM, TIM1		Timeless, Drosophila, homolog of	603887	A, R, H			10(Tim)
12.293	5	6	13	12q13.12	WNT1, INT1, OI15, BMND16		Wingless-type MMTV integration site family, member 1 (oncogene INT1)	164820	REa, A		Osteogenesis imperfecta, type XV, 615220 (3); {Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	15(Int1, Wnt1)
12.294	2	1	11	12q12	SCAF11, SFRS2IP, SIP1, CASP11, SRRP129		SR-related C-terminal domain-associated factor 11	603668	REc	previously assigned to 21q22.3		
12.295	12	13	95	12q13.13	KRT7		Keratin 7	148059	REa, A			
12.296	12	17	07	12q13.12	TUBA1A, TUBA3, LIS3		Tubulin, alpha-1A	602529	REc		Lissencephaly 3, 611603 (3)	
12.297	11	16	05	12q13.11	VDR		Vitamin D (1,25-dihydroxyvitamin D3) receptor	601769	REa, A		Rickets, vitamin D-resistant, type IIA, 277440 (3); ?Osteoporosis, involutional, 166710 (1)	
12.298	2	28	07	12q12-q21	RLS1		Restless legs syndrome, susceptibility to, 1	102300	Fd	between D12S1044 and D12S78	{Restless legs syndrome 1} (2)	
12.299	11	1	00	12q13.13	AAAS, AAA		Aladin	605378	Fd, REc		Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	
12.300	4	26	01	12q13.13	ACVR1B, ACVRLK4, ALK4		Activin A receptor, type IB	601300	REa, A		Pancreatic cancer, somatic (3)	
12.301	8	21	98	12q13.13	AMHR2, AMHR		Anti-Mullerian hormone receptor, type II	600956	A		Persistent Mullerian duct syndrome, type II, 261550 (3)	15(Amhr)
12.302	11	16	05	12q13.12	AQP2		Aquaporin-2 (collecting duct)	107777	A		Diabetes insipidus, nephrogenic, 125800 (3)	
12.303	11	5	97	12q13.12	AQP6, AQP2L		Aquaporin-6, kidney specific	601383	Psh, A			
12.304	10	7	13	12q13.12	AQP5, PPKB		Aquaporin-5	600442	A, Fd		Palmoplantar keratoderma, Bothnian type, 600231 (3)	15(Aqp2)
12.305	5	6	98	12q13.12	ARF3		ADP-ribosylation factor-3	103190	REc, A			
12.306	1	31	13	12q13.11	ASB8		Ankyrin repeat- and SOCS box-containing protein 8	615053	R, REc			
12.307	2	1	01	12q13.12	ATF1, TREB36		Activating transcription factor 1	123803	A, Ch	fused with EWS in soft tissue clear cell sarcoma, with FUS in angiomatoid fibrous histiocytoma		
12.308	10	6	09	12q13	BCC4		Basal cell carcinoma, susceptibility to, 4	613061	Fd	associated with rs11170164	{Basal cell carcinoma, susceptibility to, 4} (2)	
12.309	5	13	13	12q13.12	C1QL4, CTRP11		Complement component 1, q subcomponent-like 4	615229	REc			5(C1ql4)
12.310	7	17	13	12q13.13	C12orf10, MYG1		Chromosome 12 open reading frame 10	611366	REc			
12.311	10	19	97	12q13.12	CACNB3		Calcium channel, voltage-dependent, beta 3 subunit	601958	A			
12.312	5	19	94	12q13.2	CDK2		Cyclin-dependent kinase 2	116953	A			
12.313	9	2	12	12q13.13	CELA1, ELA1		Chymotrypsin-like elastase family, member 1	130120	REa, A, REc	on proximal 12p		15(Ela1)
12.314	1	12	15	12q13	CMTS		Chronic mountain sickness, susceptibility to	616182	Fd		{Chronic mountain sickness, susceptibility to} (2)	
12.315	8	23	07	12q13.2	ERBB3, LCCS2		Transformation gene ERBB-3	190151	A		Lethal congenital contractural syndrome 2, 607598 (3)	
12.316	3	10	09	12q13.13	ESPL1, ESP1		Extra spindle poles-like 1	604143	REc	prev. mapping to chr.8		
12.317	7	20	04	12q13.12	FAIM2, LFG, NMP35		FAS apoptotic inhibitory molecule 2	604306	Psh, A, REc			
12.318	5	26	13	12q13.12	FKBP11, FKBP19		FK506-binding protein 11	610571	REc			
12.319	3	31	15	12q13.12	FMNL3, FRL2		Formin-like 3	616288	REc			
12.320	1	27	04	12q13.13	GALNT6, GalNAcT6		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6	605148	A			
12.321	5	19	09	12q13.3	GLS2, GA		Glutaminase, liver	606365	R, REc			
12.322	3	30	12	12q14.3	HELB, HDHB		Helicase, DNA, B	614539	REc			
12.323	2	4	02	12q13.3	HSE		3-alpha-hydroxysteroid epimerase	606623	A			
12.324	2	26	93	12q13.13	HOXC4, HOX3E		Homeo box-C4	142974	RE			
12.325	2	26	93	12q13.13	HOXC5, HOX3D		Homeo box-C5	142973	RE			15(Hox6.2)
12.326	2	26	93	12q13.13	HOXC6, HOX3C		Homeo box-C6	142972	RE			15(Hox6.1)
12.327	2	26	93	12q13.13	HOXC8, HOX3A		Homeo box-C8	142970	RE			15(Hox3.1)
12.328	2	26	93	12q13.13	HOXC9, HOX3B		Homeo box-C9	142971	RE			15(Hox3.2)
12.329	2	26	93	12q13.13	HOXC12, HOX3F		Homeo box-C12	142975	RE			
12.330	11	19	12	12q13.13	HOXC13, HOX3G, ECTD9		Homeo box-C13	142976	RE	fused with NUP98 in AML	Ectodermal dysplasia 9, hair/nail type, 614931 (3)	
12.331	12	9	91	12q13	HPV18I2		Human papillomavirus type 18 integration site-2	167960	REa, A	on 8 near MYC in HeLa		
12.332	8	29	08	12q13.11	HRG1		Heme-responsive gene 1	612187	REc			
12.333	9	10	07	12q13.2	IKZF4, ZNFN1A4, EOS, KIAA1782		Ikaros family zinc finger 4	606239	R, REc			
12.334	2	2	10	12q13.2	ITGA7		Integrin, alpha-7	600536	A		Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	
12.335	8	27	01	12q13.12	KCNH3, BEC1		Potassium voltage-gated channel, subfamily H (eag-related), member 3	604527	REc			
12.336	3	30	18	12q13.3	KIF5A, NKHC, SPG10, NEIMY, ALS25		Kinesin family member 5A	602821	A, REc, Fd		Spastic paraplegia 10, autosomal dominant, 604187 (3); Myoclonus, intractable, neonatal, 617235 (3); {Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3)	2(Nkhc)
12.337	2	3	12	12q13.13	KRT1, EPPK, NEPPK, EHK		Keratin 1	139350	H, REa, A	close to Hox-3 in mouse; class II keratin	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)	15(Krt2)
12.338	10	27	97	12q13.13	KRT3		Keratin 3	148043	A, Fd, R		Meesmann corneal dystrophy, 122100 (3)	
12.339	5	22	14	12q13.13	KRT4, CYK4, WSN1		Keratin 4	123940	REa, A	class II keratin	White sponge nevus 1, 193900 (3)	
12.340	11	1	13	12q13.13	KRT5, DDD1		Keratin 5	148040	A, Fd		Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex-MP, 131960 (3); Dowling-Degos disease 1, 179850 (3); Epidermolysis bullosa simplex-MCR, 609352 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3)	
12.341	4	10	14	12q13.13	KRT6A, PC3		Keratin 6A	148041	REa, A		Pachyonychia congenita 3, 615726 (3)	
12.342	4	10	14	12q13.13	KRT6B, PC4		Keratin 6B	148042	REa		Pachyonychia congenita 4, 615728 (3)	
12.343	11	5	13	12q13.13	KRT8		Keratin 8	148060	Psh		Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.344	12	5	13	12q13.13	KRT18		Keratin 18	148070	REn, A	contiguous to KRT8, type II heteromer partner	Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.345	7	17	14	12q13.13	KRT71, K6IRS1, KRT6IRS1, HYPT13		Keratin 71	608245	REc	mutation identified in 1 HYPT13 family	?Hypotrichosis 13, 615896 (3)	
12.346	3	22	07	12q13.13	KRT72, K6IRS2, KRT6IRS2		Keratin 72	608246	REc, REn			
12.347	3	22	07	12q13.13	KRT73, K6IRS3, KRT6IRS3		Keratin 73	608247	REc, REn			
12.348	2	17	15	12q13.13	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH		Keratin 74	608248	REc, Fd	mutation identified in 1 HYPT3 family and ECTD7 family	Woolly hair, autosomal dominant, 194300 (3); ?Hypotrichosis 3, 613981 (3); ?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	
12.349	10	9	08	12q13.13	KRT75, K6HF, PFB		Keratin 75	609025	REc		{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	
12.350	3	7	08	12q13.13	KRT81, KRTHB1, HB1		Keratin 81	602153	A, Fd		Monilethrix, 158000 (3)	
12.351	11	1	17	12q13.13	KRT83, KRTHB3, HB3, MNLIX, EKVP5		Keratin 83	602765	REc		Monilethrix, 158000 (3); Erythrokeratodermia variabilis et progressiva 5, 617756 (3)	
12.352	12	17	12	12q13.13	KRT85, KRTHB5, HB5, ECTD4		Keratin 85	602767	REc		Ectodermal dysplasia 4, hair/nail type, 602032 (3)	
12.353	3	7	08	12q13.13	KRT86, KRTHB6, HB6		Keratin 86	601928	A, Fd		Monilethrix, 158000 (3)	
12.354	12	18	02	12q13.2	LACRT		Lacritin	607360	A			
12.355	10	23	87	12q13.11	LALBA		Lactalbumin, alpha	149750	REa, A			
12.356	08	10	18	12q13.12	LIMA1, EPLIN, SREBP3, LDLCQ8		LIM domain and actin-binding protein 1	608364	REc		[Low density lipoprotein cholesterol level QTL 8], 618079 (3)	
12.357	2	2	01	12q14.1	METTL1		Methyltransferase-like 1	604466	R			
12.358	8	6	13	12q13.3	MIP, AQP0, CTRCT15		Major intrinsic protein of lens fiber	154050	REa, A	slightly distal to AQP2	Cataract 15, multiple types, 615274 (3)	10(Mip)
12.359	3	23	09	12q13.13	MIR196A2, MIRN196A2		Micro RNA 196A2	609687	REc			
12.360	1	2	08	12q13.2	NEUROD4, MATH3		Neurogenic differentiation 4	611635	R, REc			10(Neurod4)
12.361	10	15	94	12q13.13	NFE2		Nuclear factor, erythroid-derived 2, 45kD	601490	A, H			15(Nfe2)
12.362	9	15	99	12q13.13	MAP3K12, ZPK		Mitogen-activated protein kinase kinase kinase 12	600447	REa, A			
12.363	9	7	90	12q13.13	NR4A1, HMR, NP10, GFRP1		Nuclear receptor subfamily 4, group A, member 1	139139	A			15(np10)
12.364	3	17	16	12q13.12	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1		Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2	600523	A		Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	15(Nramp2, mk)
12.365	12	28	08	12q13.3-q14.1	OS9		Amplified in osteosarcoma 9	609677	REc, Psh, A			
12.366	6	4	98	12q13.2	PA2G4		Proliferation-associated 2G4, 38kD	602145	A	family of genes on 7 chromosomes		
12.367	9	28	98	12q13.2	PDE1B1, PDES1B, PDE1B		Phosphodiesterase-1B	171891	Psh, REc			15(Pde1b)
12.368	11	5	97	12q13.3	PRIM1		Primase, polypeptide-1, 49kD	176635	Psh, A, REc, H			10(Prim1)
12.369	8	18	99	12q13.2	RAB5B		Ras-associated protein RAB5B	179514	A			
12.370	8	11	91	12q13.13	RARG		Retinoic acid receptor, gamma polypeptide	180190	A, REa			15(Rarg)
12.371	9	8	11	12q13.2	SARNP, CIP29, HCC1, HSPC316		SAP domain-containing ribonucleoprotein	610049	REc	fused with MLL in AML		
12.372	8	22	16	12q13.13	SCN8A, CIAT, EIEE13, BFIS5		Sodium channel, voltage gated, type VIII, alpha polypeptide	600702	REa, A	mutation identified in 1 CIAT family	?Cognitive impairment with or without cerebellar ataxia, 614306 (3); Epileptic encephalopathy, early infantile, 13, 614558 (3); Seizures, benign familial infantile, 5, 617080 (3)	2(med, Scn8a)
12.373	7	13	93	12q13.3	SHMT2, GLYA		Serine hydroxymethyltransferase	138450	S, R, A	glycine A auxotroph		
12.374	8	18	99	12q14.1	SLC16A7, MCT2		Solute carrier family 16 (monocarboxylic acid transporters), member 7	603654	REa, A			
12.375	8	29	03	12q13.11	SLC38A4, NAT3, ATA3		Solute carrier family 38 (amino acid transporter), member 4	608065	REc, Psh, A			
12.376	9	9	03	12q13.13	SOAT2, ACACT2		Sterol O-acyltransferase 2	601311	REc			
12.377	9	10	14	12q13	SPDT		Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	Fd		Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)	
12.378	6	10	98	12q13.3	STAT6		Signal transducer and activator of transcription-6, interleukin-4 induced	601512	A, H, REc			10(Stat6)
12.379	4	24	96	12q13.12-q13.13	TFCP2		Transcription factor CP2, alpha globin	189889	REa, H, A			
12.380	8	17	16	12q13.12	WNT10B, SHFM6, STHAG8		Wingless-type MMTV integration site family, member 10B	601906	A		Split-hand/foot malformation 6, 225300 (3); Tooth agenesis, selective, 8, 617073 (3)	
12.381	12	17	15	12q13-q14	DFNA48		Deafness, autosomal dominant 48	607841	Fd		Deafness, autosomal dominant 48 (2)	
12.382	10	18	96	12q13.2	GCN5L1		GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1	601444	A			
12.383	3	11	03	12p11.21	IPO8, RANBP8		Importin 8	605600	R			
12.384	5	28	99	12q13-q14	PABPL2		Poly(A)-binding protein-like 2	604681	A	?pseudogenes on 3q and 13q		
12.385	6	2	99	12q13.2	RDH5		Retinol dehydrogenase-5	601617	REa, A		Fundus albipunctatus, 136880 (3)	
12.386	8	31	98	12q13.2	SILV, D12S53E, PMEL17		Silver, mouse, homolog of	155550	REa			10(si)
12.387	6	25	99	12q13.2	SMARCC2, BAF170		SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2	601734	Psh, R			
12.388	6	25	99	12q13.12	SMARCD1, BAF60A		SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1	601735	Psh, R			
12.389	1	5	07	12q14.1	TSFM, COXPD3		Ts translation elongation factor, mitochondrial	604723	REa, A		Combined oxidative phosphorylation deficiency 3, 610505 (3)	
12.390	1	20	06	12q14.1	TSPAN31, SAS		Tetraspanin 31	181035	REa, A			
12.391	12	17	15	12q13.3	MYO1A		Myosin IA	601478	A			10(Myo1a)
12.392	6	2	98	12q15	YEATS4, GAS41		YEATS domain-containing protein 4	602116	REc			
12.393	9	30	95	12q13-q21	ENUR2		Enuresis, nocturnal, 2	600808	Fd		Enuresis, nocturnal, 2 (2)	
12.394	9	28	12	12q13.3	TAC3, NKNB, HH10		Tachykinin 3 (neuromedin K, neurokinin B)	162330	REa, A		Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	
12.395	3	18	94	12q24.33	ZNF10, KOX1		Zinc finger protein-10 (KOX 1)	194538	REa	same 300kb fragment as ZNF26		
12.396	12	21	03	12q13.2	DCD		Dermcidin	606634	R			
12.397	11	30	06	12q13.12	DDN, KIAA0749		Dendrin	610588	R, REc			
12.398	8	14	09	12q13.12	DHH, SRXY7, GDXYM		Desert hedgehog	605423	A		46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3); 46XY sex reversal 7, 233420 (3)	
12.399	2	21	14	12q13.11	ENDOU, PP11		Endonuclease polyU-specific	606720	REc			
12.400	4	25	93	12q13.1-q13.2	HEM1		Hematopoietic protein-1	141180	REb, A			
12.401	11	5	13	12q13.13	HNRNPA1, IBMPFD3, ALS20		Heterogeneous nuclear ribonucleoprotein A1	164017	A	mutation identified in 1 family with IBMPFD3	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3); Amyotrophic lateral sclerosis 20, 615426 (3)	
12.402	1	27	97	12q13.3	INHBC		Inhibin, beta C	601233	A			10(Inhbc)
12.403	1	13	99	12q13.12	PRKAG1		Protein kinase, AMP-activated, noncatalytic, gamma-1	602742	A			
12.404	7	10	08	12q13.11	SENP1		Sentrin-specific protease family, member 1	612157	REc			
12.405	11	4	93	12q13.13	SP1		Sp1 transcription factor	189906	REa, A			15(Sp1)
12.406	10	12	10	12q13.3	DDIT3, GADD153, CHOP10		DNA-damage-inducible transcript-3	126337	REa, A, Ch	fused with FUS in myxoid liposarcoma	Myxoid liposarcoma, 613488 (1)	
12.407	8	26	03	12q13.2	DRIP78, HDJ3		Dopamine receptor-interacting protein, 78kD	606092	REc			
12.408	4	17	06	12q14.1	CYP27B1, VDD1, PDDR		Cytochrome P450, subfamily XXVIIB, polypeptide 1	609506	A, Fd		Vitamin D-dependent rickets, type I, 264700 (3)	
12.409	11	23	16	12q13.3	LRP1, A2MR, KPA		Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor)	107770	A	mutation identified in 1 KPA family	?Keratosis pilaris atrophicans, 604093 (3)	15(A2mr)
12.410	3	12	14	12q13.11	AMIGO2, ALI1		Adhesion molecule with Ig-like domain 2	615690	REc, H			15(Amigo2)
12.411	9	30	13	12q13.11	ANP32D, PP32R2		Acidic leucine-rich nuclear phosphoprotein 32 family, member D	606878	REc			
12.412	9	30	14	12q13.3	ARHGEF25, GEFT		Rho guanine nucleotide exchange factor 25	610215	REc			
12.413	12	10	13	12q13.11	KANSL2, NSL2, C12orf41		KAT8 regulatory NSL complex, subunit 2	615488	REc			15(Kansl2)
12.414	10	13	09	12q13.11	RPAP3		RNA polymerase II-associated protein 3	611477	REc			
12.415	3	12	04	12q13.11	SLC38A1		Solute carrier family 38 (amino acid transporter), member 1	608490	REc, R			
12.416	3	15	14	12q13.11	SLC38A2, ATA2, KIAA1382		Solute carrier family 38, member 2	605180	REc			
12.417	4	8	16	12q13.11	SNORA2C, SNORA34, ACA34, MIR1291		Small nucleolar RNA, H/ACA box, 34	615487	REc, REn	MIR1291 in intron of SNORA34		
12.418	5	16	11	12q13.11	ZNF641		Zinc finger protein 641	613906	REc			
12.419	6	19	98	12q12	NELL2		Nel-like 2	602320	A			
12.420	10	13	15	12q13.11	COL2A1		Collagen II, alpha-1 polypeptide	120140	REa, A		Stickler syndrome, type I, 108300 (3); Kniest dysplasia, 156550 (3); Achondrogenesis, type II or hypochondrogenesis, 200610 (3); SED congenita, 183900 (3); SMED Strudwick type, 184250 (3); Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3); Spondyloperipheral dysplasia, 271700 (3); Osteoarthritis with mild chondrodysplasia, 604864 (3); Vitreoretinopathy with phalangeal epiphyseal dysplasia (3); Platyspondylic skeletal dysplasia, Torrance type, 151210 (3); Avascular necrosis of the femoral head, 608805 (3); Legg-Calve-Perthes disease, 150600 (3); Stickler sydrome, type I, nonsyndromic ocular, 609508 (3); Czech dysplasia, 609162 (3); Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	15(Col2a1, seds)
12.421	11	19	11	12q13.11-q15	MRT25		Mental retardation, autosomal recessive 25	614346	Fd	between rs4760658 and rs1882033	Mental retardation, autosomal recessive 25 (2)	
12.422	11	11	13	12q13.12	CCDC65, CILD27		Coiled-coil domain-containing protein 65	611088	REc		Ciliary dyskinesia, primary, 27, 615504 (3)	
12.423	8	2	13	12q13.12	CERS5, LASS5, TRH4		Ceramide synthase 5	615335	REc			
12.424	9	8	14	12q13.12	COX14, C12orf62		Cytochrome c oxidase assembly protein COX14	614478	REc, H	mutation identified in 1 Cox4 deficient family	?Mitochondrial complex IV deficiency, 220110 (3)	15(C12orf62)
12.425	8	27	08	12q13.12	DDX23, PRP28		Dead box polypeptide 23	612172	REc			
12.426	8	29	07	12q13.12	DIP2B, KIAA1463		Disco-interacting protein 2, Drosophila, homolog of, B	611379	A, REc		Mental retardation, FRA12A type, 136630 (3)	
12.427	3	14	14	12q13.12	KMT2D, MLL2, ALR, KABUK1		Lysine (K)-specific methyltransferase 2D	602113	Psh, R		Kabuki syndrome 1, 147920 (3)	
12.428	3	28	06	12q13.12	LMBR1L, LIMR, KIAA1174		Limb region 1 homolog-like	610007	R, REc			
12.429	2	25	15	12q13.12	MCRS1, MSP58, MCRS2		Microspherule protein 1 (microspherule protein 2, included)	609504	R, REc			
12.430	3	14	13	12q13.12	NCKAP5L, KIAA1602		NCK-associated protein 5-like	615104	REc			
12.431	5	13	13	12q13.12	RCGAP1, MGCRACGAP, CYK4		GTPase-activating protein, Rac, 1	604980	R, REc			
12.432	6	13	12	12q13.12	RND1, RHO6		Rho family GTPase 1	609038	REc, A			
12.433	6	22	14	12q13.12	TMBIM6, TEGT		Transmembrane BAX inhibitor motif-containing protein 6	600748	REa, A			15(Tegt)
12.434	9	27	17	12q13.12	TUBA1B		Tubulin, alpha-1B	602530	REc			15(Tuba1b)
12.435	3	9	98	12q13.13	PCBP2		Poly(rC)-binding protein-2	601210	A			
12.436	3	14	13	12q13.13	ATG101, C12orf44		Autophagy-related protein 101	615089	REc			
12.437	5	7	01	12q13.13	BIN2		Bridging integrator 2	605936	A, REc	previously mapped to 4q22.1		
12.438	11	11	14	12q13.13	CBX5, HP1		Chromobox homolog 5	604478	R, REc			
12.439	12	10	13	12q13.13	COPZ1, COPZ		Coatomer protein complex, subunit zeta-1	615472	REc			
12.440	9	28	15	12q13.13	CSAD, CSD, PCAP		Cysteine sulfinic acid decarboxylase	616569	REc			
12.441	5	25	13	12q13.13	EIF4B		Eukaryotic translation initiation factor 4B	603928	REc			
12.442	3	8	04	12q13.2	GDF11, BMP11		Growth/differentiation factor 11	603936	R, REc			
12.443	11	28	01	12q13.13	GPR84		G protein-coupled receptor 84	606383	REc			15(Gpr84)
12.444	6	5	08	12q13.13	GRASP, TAMALIN		GRP1-associated scaffold protein	612027	R, REc			
12.445	12	4	08	12q13.13	HOTAIR		Hox transcript antisense RNA	611400	R, REc			
12.446	7	12	92	12q13.13	ITGB7		Integrin, beta-7	147559	REa, A			15(Itgb7)
12.447	4	11	14	12q13.13	KRT6C, PPKNEFD		Keratin 6C	612315	REc		Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	
12.448	12	2	15	12q13.13	KRT76, K76, KRT2P		Keratin 76, type II	616671	REc			
12.449	2	25	08	12q13.13	KRT77, K1B		Keratin 77	611158	REc			
12.450	2	25	08	12q13.13	KRT78, K5B		Keratin 78	611159	REc			
12.451	3	7	08	12q13.13	KRT79,  KRT6L, K6L		Keratin 79	611160	REc			
12.452	2	28	08	12q13.13	KRT80, KB20		Keratin 80	611161	REc			
12.453	11	13	13	12q13.13	KRT82, KRTHB2, HB2		Keratin 82	601078	REc			
12.454	11	13	13	12q13.13	KRT84, KRTHB4, HB4		Keratin 84	602766	REc			
12.455	5	13	11	12q13.13	MIR148B, MIRN148B		Micro RNA 148B	613787	REc			
12.456	7	20	09	12q13.2	MYL6B, MLC1SA		Myosin, light chain 6B, alkali, smooth muscle and nonmuscle, slow	609930	R, REc			
12.457	6	28	18	12q13.13	POU6F1, BRN5, MPOU		POU domain, class 6, transcription factor 1	618043	REc			
12.458	5	24	13	12q13.13	PRR13, TXR1		Proline-rich protein 13	610459	REc			
12.459	08	31	18	12q13.13	SP7, OSX, OI12		Transcription factor Sp7	606633	A, H		Osteogenesis imperfecta, type XII, 613849 (3)	15(Sp7)
12.460	3	3	16	12q13.13	TNS2, TENC1, C1TEN, KIAA1075		Tensin 2	607717	R, REc			
12.461	10	27	08	12q13.13	ZNF385A, ZNF385, RZF, HZF		Zinc finger protein 385A	609124	REc			
12.462	12	1	15	12q13.2	ESYT1, MBC2, FAM62A		Extended synaptotagmin-like protein 1	616670	REc			
12.463	5	17	17	12q13.13	GTSF1, FAM112B		Gametocyte-specific factor 1	617484	REc			
12.464	2	6	09	12q13.3	IL23A, SGRF, P19, IL23P19		Interleukin 23, p19 subunit	605580	R, REc			
12.465	2	25	09	12q14.1	LIRG3, LIG3		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 3	608870	A, H			10(Lrig3)
12.466	3	1	06	12q13.2	MYL6		Myosin light chain 6, alkali, smooth muscle and nonmuscle	609931	R, REc			
12.467	4	7	10	12q13.2	ORMDL2		ORM1-like protein 2	610074	REc	pseudogene on 8q22.1		
12.468	3	3	10	12q13.2	PPP1R1A, IPP1, I1		Protein phosphatase 1, regulatory subunit 1A	613246	REc			
12.469	3	29	10	12q13.2	RPL41, HG12		Ribosomal protein L41	613315	REc			
12.470	3	20	07	12q13.2	SBEM		Small breast epithelial mucin	610857	REc			
12.471	12	17	07	12q13.12	SPATS2, SPATA10, P59SCR, SCR59		Spermatogenesis-associated serine-rich protein 2	611667	REc			
12.472	12	1	15	12q13.3	STAT2, IMD44		Signal transducer and activator of transcription 2	600556	R, REc		Immunodeficiency 44, 616636 (3)	
12.473	3	7	14	12q13.2	TESPA1, KIAA0748		Thymocyte-expressed positive selection-associated protein 1	615664	REc			
12.474	11	23	09	12q13.3	CS		Citrate synthase, mitochondrial	118950	S, D, REc			10(Cs)
12.475	09	19	18	12q13.3	GLI, PAPA8		Glioma-associated oncogene homolog (zinc finger protein)	165220	REa, A		Polydactyly, postaxial, type A8, 618123 (3)	10(Gli)
12.476	12	19	11	12q13.3	AAA4		Aortic aneurysm, familial abdominal, 4	614375	Fd	associated with rs1466535	Aortic aneurysm, familial abdominal, 4 (2)	
12.477	12	3	13	12q13.3	APOF, LTIP		Apolipoprotein F	107760	REc, Psh			
12.478	2	25	16	12q13.3	B4GALNT1, GALGT, GALNACT, SPG26		Beta-1,4-N-acetylgalactosaminyltransferase 1	601873	A, Fd		Spastic paraplegia 26, autosomal recessive, 609195 (3)	
12.479	12	17	15	12q13.3	DCTN2, DCTN50		Dynactin 2	607376	R, REc			
12.480	10	15	98	12q13.2	DGKA, DAGK1		Diacylglycerol kinase, alpha, 80kD	125855	REa, A, H			10(Dagk1)
12.481	12	21	09	12q13.3	DTX3		Deltex, Drosophila, homolog of, 3	613142	REc			
12.482	6	9	08	12q13.3	INHBE		Inhibin, beta E	612031	REc			
12.483	6	19	15	12q13.3	MARS, MTRNS, METRS, ILLD, CMT2U		Methioninyl-tRNA synthetase	156560	S, REc		Interstitial lung and liver disease, 615486 (3); Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	
12.484	2	20	12	12q13.3	MIR616		Micro RNA 616	614489	REc			
12.485	1	13	16	12q13.3	NEMP1, TMEM194A		Nuclear envelope integral membrane protein 1	616496	REc			
12.486	11	3	14	12q13.3	NXPH4, NPH4		Neuroexophilin 4	604637	REc			
12.487	6	26	08	12q13.3	OBFC2B, SSB1		Oligonucleotide/oligosaccharide-binding fold-containing protein 2B	612104	REc			
12.488	5	19	17	12q13.3	PAN2, USP52, KIAA0710		PABP-dependent poly(A) nuclease 2	617447	R, REc			
12.489	3	12	07	12q13.11	PFKM, GSD7		Phosphofructokinase, muscle type	610681	Psh, A, Fd	incorrectly assigned to chr.1	Glycogen storage disease VII, 232800 (3)	15(Pfk4)
12.490	9	1	16	12q13.3	PIP4K2C, PIP5K2C		Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma	617104	REc			
12.491	3	1	11	12q13.3	PTGES3, P23, CPGES		Prostaglandin E synthase 3	607061	R, REc			
12.492	9	20	14	12q13.3	RBMS2, SCR3		RNA-binding motif protein, single strand interacting, 2	602387	REc			
12.493	7	14	17	12q13.3	SDR9C7, SDRO, ARCI13		Short chain dehydrogenase/reductase family 9C member 7	609769	REc		Ichthyosis, congenital, autosomal recessive 13, 617574 (3)	10(Sdro)
12.494	8	22	14	12q13.3	SLC39A5, MYP24		Solute carrier family 39 (zinc transporter), member 5	608730	REc		Myopia 24, autosomal dominant, 615946 (3)	
12.495	08	22	18	12q13.3	STAC3, NAM, MYPBB		SH3 and cystein-rich domains 3	615521	REc		Myopathy, congenital, Baily-Bloch, 255995 (3)	
12.496	6	19	98	12q13.3	NAB2		NGFIA-binding protein-2	602381	A			10(Nab2)
12.497	6	7	10	12q14.1	AVIL		Advillin	613397	A, H			10(Avil)
12.498	5	12	11	12q14.1	CDK4, CMM3		Cyclin-dependent kinase 4	123829	A		{Melanoma, cutaneous malignant, 3}, 609048 (3)	
12.499	11	5	13	12q13.3	ARHGAP9		Rho GTPase-activating protein 9	610576	REc			
12.500	2	3	05	12q15	DYRK2		Dual-specificity tyrosine phosphorylation-regulated kinase 2	603496	REc			
12.501	5	6	13	12q14	GLC1P		Glaucoma 1, open angle, P	177700	Ch	caused by 300kb duplication	Glaucoma 1, open angle, P (4)	
12.502	3	27	03	12q14.3	GNS, G6S		N-acetylglucosamine-6-sulfatase	607664	A, REa		Mucopolysaccharidosis type IIID, 252940 (3)	
12.503	2	22	10	12q15	IFNG, IFG, IFI		Interferon, gamma	147570	REa, A	3 introns; none in IFF, IFL	{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of}, 609532 (3)	10(Ifg)
12.504	6	26	17	12q14.3	LEMD3, MAN1		LEM domain-containing 3	607844	R, Fd		Osteopoikilosis with or without melorheostosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3)	
12.505	9	24	15	12q13.2	MMP19, MMP18, CODA		Matrix metalloproteinase-19	601807	A, Fd	triplication in upstream regulatory region	Cavitary optic disc anomalies, 611543 (3)	
12.506	12	1	11	12q14	PRO2268		PRO2268 gene	614354	REc			
12.507	9	15	89	12q15	RAP1B		RAS-related protein RAP1B	179530	A			
12.508	8	5	97	12q14.2	AVPR1A		Arginine vasopressin receptor-1A	600821	Psh, A			
12.509	3	22	06	12q21.2	ZDHHC17, HIP14		Zinc finger DHHC domain-containing protein 17	607799	A			
12.510	2	11	16	12q14.1	AGAP2, CENTG1, PIKE		ARF-GAP with GTP-binding protein-like, ankyrin repeat, and pleckstrin homology domains 2	605476	REc			
12.511	12	5	17	12q14.1	EEF1AKMT3, METTL21B, FAM119B		EEF1A lysine methyltransferase 3	615258	REc			
12.512	5	30	17	12q14.1	FAM19A2, TAFA2		Family with sequence similarity 19, member A2, CC motif chemokine-like	617496	REc			
12.513	6	7	10	12q14.1	MARCH9		Membrane-associated RING-CH finger protein 9	613336	REc			
12.514	10	6	09	12q14.1	MIR26A2, MIRN26A2		Micro RNA 26A2	613057	REc			
12.515	3	23	09	12q14.1	MIRLET7I, LET7I, MIRNLET7I		Micro RNA Let7i	612148	REc			
12.516	2	17	16	12q14.1	MON2, KIAA1040		Mon2, S. cerevisiae, homolog of	616822	REc			
12.517	9	30	02	12q14.2	RASSF3		Ras association domain family protein 3	607019	REc			
12.518	10	2	12	12q14.1	USP15		Ubiquitin-specific protease 15	604731	REc			
12.519	9	30	14	12q14.1-q14.2	PPM1H, KIAA1157		Protein phosphatase, magnesium/manganese-dependent, 1H	616016	REc			
12.520	9	20	00	12q15	KCNMB4		Potassium large conductance calcium-activated channel, subfamily M, beta member 4	605223	REc			
12.521	1	20	06	12q21.1	TSPAN8, TM4SF3		Tetraspanin 8	600769	REc			
12.522	8	23	09	12q14.2	AUTS13		Autism, susceptibility to, 13	610908	Fd	linkage with rs1445442	{Autism susceptibility 13} (2)	
12.523	4	20	17	12q14.2	C12orf66		Chromosome 12 open reading frame 66	617420	REc			
12.524	6	11	11	12q14.2	DPY19L2, SPGF9		DPY19-like 2	613893	REc	pseudogene on 7p14.3	Spermatogenic failure 9, 613958 (3)	9(Dpy19l2)
12.525	9	1	15	12q14.2	SRGAP1, KIAA1304, NMTC2		Slit-robo GTPase-activating protein, rho, 1	606523	R, REc		{Thyroid cancer, nonmedullary, 2}, 188470 (3)	
12.526	3	14	18	12q14.2	TBK1, NAK, FTDALS4, IIAE8		TANK-binding kinase 1	604834	REc		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3); {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3)	
12.527	1	16	18	12q14.2	RXYLT1, TMEM5, MDDGA10		Ribitol xylosyltransferase 1	605862	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	
12.528	9	8	06	12q15	BEST3, VMD2L3		Bestrophin 3	607337	A			
12.529	9	13	17	12q14.3	GRIP1, FRASRS3		Glutamate receptor-interacting protein 1	604597	REc		Fraser syndrome 3, 617667 (3)	
12.530	2	25	16	12q14.3	HMGA2, HMGIC, BABL		High-mobility group AT-hook 2	600698	A, Psh, Ch, RE, Fd	fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas	Leiomyoma, uterine, somatic, 150699 (1)	10(pg, Hmgic)
12.531	5	31	07	12q14.3	IRAK3, IRAKM, ASRT5		Interleukin 1 receptor-associated kinase 3	604459	REc		{Asthma susceptibility 5}, 611064 (3)	
12.532	6	26	16	12q14.3	LLPH		LLP, Aplysia, homolog of	616998	REc			
12.533	2	1	11	12q14.3	MSRB3, DFNB74		Methionine sulfoxide reductase B3	613719	REc		Deafness, autosomal recessive 74, 613718 (3)	
12.534	2	17	09	12q14.3	STQTL9		Stature quantitative trait locus 9	611547	Fd	associated with rs1042725	{Stature QTL 9} (2)	
12.535	3	7	13	12q14.3	TBC1D30, KIAA0984		TBC1 domain family, member 30	615077	REc			
12.536	3	25	16	12q14.3	TMBIM4, GAAP		Transmembrane BAX inhibitor motif-containing protein 4	616874	REc			
12.537	6	13	12	12q14-q15	CAND1, TIP120A, TIP120, KIAA0829		Cullin-associated neddylation-dissociated protein 1	607727	A, REc			
12.538	12	19	11	12q15	MDM2, ACTFS		Mouse double minute 2, homolog of (p53-binding protein)	164785	REa, A		{Accelerated tumor formation, susceptibility to}, 614401 (3)	10(Mdm2)
12.539	4	30	03	12q21.1-q21.2	CAPS2		Calcyphosine 2	607724	REc			
12.540	9	9	08	12q15	CNOT2, NOT2		CCR4-NOT transcription complex, subunit 2	604909	REc			
12.541	4	23	09	12q13.3	CNPY4, TMEM4, MSAP		Canopy 2, zebrafish, homolog of	605861	R, REc			
12.542	2	18	96	12q15	CPM		Carboxypeptidase M	114860	Psh, REc, A			
12.543	4	8	16	12q15	FRS2, FRS1A, SNT1		Fibroblast growth factor receptor substrate 2	607743	REc			
12.544	3	3	09	12q15	IBD26		Inflammatory bowel disease 26	612639	Fd	associated with rs1558744	{Inflammatory bowel disease 26} (2)	
12.545	10	17	00	12q15	IL22, IL21, ILTIF		Interleukin 22	605330	R			
12.546	11	26	01	12q15	IL26, AK155		Interleukin 26	605679	REc			
12.547	3	15	07	12q15	LRRC10, HRLRRP		Leucine-rich repeat-containing protein 10	610846	R, REc			
12.548	1	9	09	12q15	LYZ		Lysozyme	153450	REa, REc		Amyloidosis, renal, 105200 (3)	
12.549	3	15	11	12q15	MDM1		Mouse double minute 1 homolog	613813	REc			10(Mdm1)
12.550	08	07	18	12q15	NUP107, NUP84, NPHS11, ODG6		Nucleoporin, 107kD	607617	R	mutation identified in 1 ODG6 family	Nephrotic syndrome, type 11, 616730 (3); ?Ovarian dysgenesis 6, 618078 (3)	
12.551	7	17	14	12q15	PTPRR, PCPTP1		Protein-tyrosine phosphatase, receptor type, R	602853	REc			
12.552	4	25	93	12q15	PTPRB		Protein tyrosine phosphatase, receptor type, beta polypeptide	176882	A			
12.553	2	16	02	12q21.1	TRHDE		Thyrotropin-releasing hormone-degrading ectoenzyme	606950	A			
12.554	1	31	01	12q21.2	PHLDA1, TDAG51		Pleckstrin homology-like domain, family A, member 1	605335	R			
12.555	8	30	01	12q21.2-q21.3	PPP1R12A, MYPT1		Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1)	602021	A, R			
12.556	2	4	02	12q21.1	GPR49, LGR5		G protein-coupled receptor-49	606667	R, A			
12.557	12	24	13	12q21.1	ATXN7L3B		Ataxin 7-like 3B	615579	REc			
12.558	4	10	14	12q21.33	EPYC, DSPG3		Epiphycan	601657	A, REc			
12.559	2	23	09	12q21.2	GLIPR1, GLIPR, RTVP1		Glioma pathogenesis-related protein 1	602692	REc			10(Glipr1)
12.560	8	19	13	12q21.2	GLIPR1L1		GLIPR1-like protein 1	610395	REc			10(Glipr1l1)
12.561	8	19	13	12q21.2	GLIPR1L2		GLIPR1-like protein 2	610394	REc			10(Glipr1l2)
12.562	12	4	02	12q21.31-q21.32	GNTIVH		UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV	607385	A			
12.563	10	27	97	12q21.31	MYF5		Myogenic factor-5	159990	REa, A, RE			
12.564	11	7	17	12q21.31	MYF6, CNM3		Myogenic factor-6	159991	REa, A, RE, REc	6.5kb upstream from MYF5; both prob. 12q15, by H	Centronuclear myopathy 3, 614408 (3)	10(Myf6)
12.565	5	2	16	12q23.3	MTERF2, MTERFD3		Transcription termination factor 2, mitochondrial	616929	REc			
12.566	8	28	97	12q21.31	NTS		Neurotensin	162650	REa, A			
12.567	12	15	98	12q21.2	PAWR, PAR4		PRKC, apoptosis, WT1, regulator	601936	A, Psh, R			
12.568	10	23	87	12q21	PEPB		Peptidase B	169900	S			10(Pep2)
12.569	1	27	11	12q23.1	RMST, NCRMS, NCRNA00054		Rhabdomyosarcoma 2-associated transcript	607045	REc			
12.570	4	12	92	12q21.33	ATP2B1, PMCA1		ATPase, Ca++ transporting, plasma membrane, 1	108731	REa, A			
12.571	5	5	09	12q21-q23	DUH2		Dyschromatosis universalis hereditaria 2	612715	Fd	between rs1921045 and rs2373584	Dyschromatosis universalis hereditaria 2 (2)	
12.572	11	12	98	12q21-q23	MYP3		Myopia, high grade, 3, autosomal dominant	603221	Fd		Myopia-3 (2)	
12.573	11	24	98	12q21.2	CSRP2, LMO5		Cysteine and glycine-rich protein-2 (LIM domain only 5, smooth muscle)	601871	A, R	pseudogene on 3q21.1		
12.574	2	2	17	12q21.1	KCNC2		Potassium voltage-gated channel, Shaw-related subfamily, member 2	176256	R, REc	previously on 19q13.3-q13.4		10(Kcnc2)
12.575	2	6	08	12q21.2	NAV3, POMFIl1, KIAA0938		Neuron navigator 3	611629	R, REc			
12.576	12	18	08	12q21.1	RAB21, KIAA0118		RAB-associated protein RAB21	612398	R, REc			
12.577	3	23	09	12q21.1	TBC1D15		TBC1 domain family, member 15	612662	REc			
12.578	1	20	09	12q21.1	THAP2		THAP domain-containing protein 2	612531	REc			
12.579	9	8	09	12q21.1	TPH2, NTPH, ADHD7		Tryptophan hydroxylase 2	607478	REc		{Unipolar depression, susceptibility to}, 608516 (3); {Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	
12.580	4	24	08	12p11.22	MRPS35, MRPS28		Mitochondrial ribosomal protein S35	611995	REc	3 pseudogenes		
12.581	10	16	14	12q21.2	BBS10, C12orf58, FLJ23560		BBS10 gene	610148	REc, Fd		Bardet-Biedl syndrome 10, 615987 (3)	
12.582	6	11	09	12q21.2	KRR1		KRR1, yeast, homolog of	612817	REc			
12.583	5	19	06	12q21.2	NAP1L1, NAP1L		Nucleosome assembly protein 1-like 1	164060	R, REc			
12.584	9	12	17	12q21.31	PTPRQ, PTPGMC1, DFNB84A, DFNA73		Protein-tyrosine phosphatase, receptor-type, Q	603317	A, REc	mutation identified in 1 DFNA73 family	Deafness, autosomal recessive 84A, 613391 (3); Deafness, autosomal dominant 73, 617663 (3)	10(Ptpgmc1)
12.585	10	11	14	12q21.32	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14		Centrosomal protein, 290kD	610142	R, REc, Fd	mutation identified in 1 BBS14 family	Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3); Leber congenital amaurosis 10, 611755 (3); Meckel syndrome 4, 611134 (3); ?Bardet-Biedl syndrome 14, 615991 (3)	
12.586	3	11	09	12q21.33	DCN, CSCD		Decorin	125255	REa, A	conflicting assignments to 12q23 and 12q13.2	Corneal dystrophy, congenital stromal, 610048 (3)	10(Dcn)
12.587	6	9	08	12q21.2	E2F7		E2F transcription factor 7	612046	REc			10(E2f7)
12.588	5	19	14	12q21.31	ALX1, CART1, FND3		Aristaless-like homeobox 1 (cartilage homeoprotein 1)	601527	REa, REc	mutation identified in 1 FND3 patient	?Frontonasal dysplasia 3, 613456 (3)	
12.589	6	25	99	12q21.33	GALNT4, GalNAcT4		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4	603565	A, Fd			
12.590	5	27	97	12q21.33	LUM, LDC		Lumican	600616	A, Psh			10(Ldc)
12.591	4	26	12	12q21.31	SLC6A15, SBAT1		Solute carrier family 6 (neurotransmitter transporter), member 15	607971	R, REc			
12.592	12	1	11	12q21.31	ACSS3		Acyl-CoA synthetase short-chain family, member 3	614356	REc			
12.593	10	1	17	12q21.31	LIN7A, VELI1, MALS1		Lin7, C. elegans, homolog of, A	603380	REc			
12.594	12	29	06	12q24.31	MLXIP, MONDOA, KIAA0867		MLX-interacting protein	608090	R, A			
12.595	11	20	12	12q21.31	OTOGL, C12orf64, DFNB84B		Otogelin-like protein	614925	REc		Deafness, autosomal recessive 84B, 614944 (3)	
12.596	7	18	12	12q21.31	RASSF9, PAMCI, PCIP1		Ras association domain family, member 9	610383	REc			
12.597	7	18	14	12q21.31	TMTC2		Transmembrane and tetratricopeptide repeat domains-containing protein 2	615856	REc			
12.598	12	19	16	12q21.32	TMTC3, SMILE, LIS8		Transmembrane and tetratricopeptide repeat domains-containing protein 3	617218	REc		Lissencephaly 8, 617255 (3)	
12.599	7	22	16	12q21.33	CNA1		Cornea plana 1, autosomal dominant	121400	Fd	between D12S82 and D12S351	Cornea plana 1, autosomal dominant (2)	
12.600	6	11	13	12q21.33	DUSP6, MKP3, PYST1, HH19		Dual-specificity phosphatase-6	602748	Psh, A, REc		Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	
12.601	5	24	16	12q21.33	PACD		Corneal dystrophy, posterior amorphous	612868	REc	contiguous gene deletion syndrome	Corneal dystrophy, posterior amorphous (4)	
12.602	9	24	14	12q21.33	POC1B, PIX1, CORD20		POC1 centriolar protein, Chlamydomonas, homolog of, B	614784	REc		Cone-rod dystrophy 20, 615973 (3)	
12.603	12	19	16	12q22	CRADD, RAIDD, MRT34		Caspase and RIP adaptor with death domain	603454	R		Mental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3)	10(Raidd)
12.604	3	17	94	12q21.33	BTG1		B-cell translocation gene 1, anti-proliferative	109580	Ch			
12.605	6	27	14	12q22	CEP83, CCDC41, NPHP18		Centrosomal protein, 83kD	615847	REc		Nephronophthisis 18, 615862 (3)	
12.606	6	26	16	12q22	CLLU1		Chronic lymphocytic leukemia upregulated gene 1	616988	REc			
12.607	6	26	16	12q22	CLLU1OS		Chronic lymphocytic leukemia upregulated 1, opposite strand	616989	REc			
12.608	7	10	13	12q22	EEA1		Early endosome antigen 1	605070	REc, R			
12.609	8	27	15	12q22	FGD6, ZFYVE24		FYVE, RhoGEF, and ph domain-containing protein 6	613520	REc			
12.610	3	6	01	12q21.33	KERA, CNA2		Keratocan	603288	H, Fd, LD, A		Cornea plana 2, autosomal recessive, 217300 (3)	10(Kera)
12.611	5	27	16	12q21.32	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69		KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	REa, A	associated with dbSNP rs12821256	[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3); Hyperpigmentation with or without hypopigmentation, 145250 (3); Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	10(Sl; Scf)
12.612	10	1	95	12q23.1	LTA4H		Leukotriene A4 hydrolase	151570	A			
12.613	8	3	12	12q22	METAP2, p67		Methionine aminopeptidase 2	601870	REc			
12.614	12	19	11	12q22	MIR492		Micro RNA 492	614384	REc	within KRT19		
12.615	3	5	08	12q22	MRPL42, MRPL31, MRPS32		Mitochondrial ribosomal protein L42	611847	R, REc			
12.616	3	30	12	12q22	NDUFA12		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12	614530	REc		Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)	
12.617	3	18	95	12q23.1	NEDD1		Neural precursor cell expressed, developmentally down-regulated 1	600372	A			
12.618	9	27	17	12q22	NR2C1, TR2		Nuclear receptor subfamily 2, group C, member 1	601529	R, REc			
12.619	12	22	16	12q22	SOCS2AS1		SOCS2 antisense RNA 1	617269	REc			
12.620	2	12	09	12q23.2	SPIC		SPIC transcription factor	612568	REc			
12.621	4	26	17	12q22	TMCC3		Transmembrane and coiled-coil domain family, member 3	617459	REc			
12.622	2	3	17	12q23.1	TMPO, LAP2		Thymopoietin	188380	A			10(Tmpo)
12.623	8	18	14	12q22	UBE2N, UBCHBEN; UBC13		Ubiquitin-conjugating enzyme E2N	603679	REc			
12.624	1	13	06	12q23.2	ASCL1, ASH1		Achaete-scute complex, Drosophila, homolog-like 1	100790	REa, A	distal to PAH and proximal to TRA1	Central hypoventilation syndrome, congenital, 209880 (3); Haddad syndrome, 209880 (3)	
12.625	12	17	07	12q24.13	DDX54, DP97		Dead/H Box 54	611665	REc			
12.626	8	9	05	12q23.1	HAL, HSTD		Histidine ammonia-lyase (histidase)	609457	REa, A		[Histidinemia], 235800 (3)	10(Hstd)
12.627	9	18	06	12q22	NTN4		Netrin 4	610401	A			
12.628	1	11	07	12q23.1-q23.2	SLC5A8, AIT, SMCT		Solute carrier family (iodide transporter), member 8	608044	REc			
12.629	8	21	07	12q23.3	NT5DC3, TU12B1TY, GNN		5' nucleotidase domain-containing protein 3	611076	A, REc			10(Nt5dc3)
12.630	6	7	04	12q22-q23.2	MDD1		Major depressive disorder	608520	Fd	max lod with D12S1706	Major depressive disorder 1, 608516 (2)	
12.631	1	10	12	12q22-q23.3	ETL2, FTLE		Epilepsy, familial temporal lobe	608096	Fd	max lod at D12S1706	Epilepsy, familial temporal lobe, 2 (2)	
12.632	8	25	04	12q23.2	IGF1		Insulin-like growth factor-1, or somatomedin C	147440	REa, A, Fd		Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	10(Igf1)
12.633	4	30	02	12q24.31	ACADS, SCAD		Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain	606885	REa, A		Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	5(Bcd1)
12.634	10	24	00	12q23.1	APAF1		Apoptotic protease activating factor 1	602233	A			
12.635	1	12	11	12q23.2	C12orf48, AROM, PARPBP		Chromosome 12 open reading frame 48	613687	REc			
12.636	4	6	15	12q23.3	CHST11, C4ST1		Carbohydrate sulfotransferase 11	610128	R			
12.637	1	7	95	12q23.1	ELK3, SAP2, ERP		ELK3, ETS-domain protein (SRF accessory protein 2)	600247	REa			6(Scnn1)
12.638	2	7	06	12q23.1	IKIP		I-kappa-B kinase-interacting protein	609861	REc			
12.639	9	24	08	12q23.1	SLC17A8, VGLUT3, DFNA25		Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)	607557	REc, Fd		Deafness, autosomal dominant 25, 605583 (3)	
12.640	2	19	07	12q23.1	SLC25A3, PHC		Solute carrier family 25 (mitochondrial carrier), member 3	600370	REa, A		Mitochondrial phosphate carrier deficiency, 610773 (3)	
12.641	2	12	16	12q23.2	SYCP3, SCP3, COR1, SPGF4, RPRGL4		Synaptonemal complex protein 3	604759	REc		Spermatogenic failure 4, 270960 (3); Pregnancy loss, recurrent, 4, 270960 (3)	
12.642	11	24	08	12q23.1	TMEM16D, FLJ34272		Transmembrane protein 16D	610111	REc			
12.643	5	22	07	12q22	USP44		Ubiquitin-specific protease 44	610993	R, REc			
12.644	3	18	94	12q23.2	PMCH		Pro-melanin-concentrating hormone	176795	REa, A			
12.645	8	16	99	12q24.13	RASAL1, RASAL		Ras protein activator-like 1	604118	R			
12.646	4	27	12	12q23-q24	SPG36		Spastic paraplegia-36	613096	Fd	between D12S360 and D12S354	Spastic paraplegia 36, autosomal dominant (2)	
12.647	12	22	08	12q24.11	USP30		Ubiquitin-specific protease 30	612492	REc			
12.648	2	25	03	12q24.11	ATP2A2, ATP2B, DAR		ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740	REa, A, Fd		Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)	11(Atpb2)
12.649	5	30	17	12q23.3	CRY1, PHLL1, DSPD		Cryptochrome 1 (photolyase-like)	601933	A		{Delayed sleep phase disorder, susceptibility to}, 614163 (3)	10(Cry1)
12.650	9	2	09	12q23.3	EID3, NSMCE4B, NSE4B		E1A-like inhibitor of differentiation 3	612986	REc			10(Eid3)
12.651	1	27	97	12q13.3	NACA		Nascent-polypeptide-associated complex alpha polypeptide	601234	A, REa			
12.652	4	10	96	12q24.31	PLA2G1B, PLA2A, PLA2, PPLA2		Phospholipase A2, group IB, pancreas	172410	REa, Fd			
12.653	4	19	01	12q23.3	PRDM4, PFM1		PR domain-containing protein 4	605780	REc, Psh			
12.654	12	4	03	12q24.31	RNF34, RFI		Ring finger protein 34	608299	A			
12.655	2	20	98	12q23.3	TXNRD1, TXNR		Thioredoxin reductase-1	601112	A			
12.656	6	15	12	12q24.11	UNG, DGU, HIGM5		Uracil-DNA glycosylase	191525	REa, R		Immunodeficiency with hyper IgM, type 5, 608106 (3)	
12.657	6	16	10	12q24.11	MYL2, CMH10		Myosin, light polypeptide-2, regulatory, cardiac, slow	160781	A, REa		Cardiomyopathy, hypertrophic, 10, 608758 (3)	
12.658	12	28	08	12q23.1	ANKS1B, EB1		Ankyrin repeat and sterile alpha motif domain-containing protein 1B	607815	R, REc			
12.659	7	18	14	12q23.1	CDK17, PCTK2, PCTAIRE2		Cyclin-dependent kinase 17	603440	REc			
12.660	11	23	16	12q23.1	GAS2L3, G2L3		Growth arrest-specific 2-like 3	617224	REc			
12.661	8	1	16	12q23.1	NR1H4, FXR, RIP14, PFIC5		Nuclear receptor subfamily 1 group H member 4	603826	REc		Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	10(Fxr)
12.662	5	25	13	12q23.1	SNRPF		Small nuclear ribonucleoprotein polypeptide F	603541	REc			
12.663	5	19	15	12q23.1	SCYL2, CVAK104, KIAA1360		SCY1-like protein 2	616365	REc			
12.664	7	20	12	12q23.2	ARL1		ADP-ribosylation factor-like 1	603425	REc			
12.665	1	11	16	12q23.2	CHPT1, CPT, CPT1		Choline phosphotransferase 1	616747	REc			
12.666	4	20	10	12q23.2	DRAM1		Damage-regulated autophagy modulator 1	610776	R, REc			
12.667	1	9	13	12q23.2	HELLPAR, lncHELLP		HELLP syndrome-associated long noncoding RNA	614985	REc			
12.668	12	12	12	12q23.2	MYBPC1, LCCS4		Myosin-binding protein C, slow type	160794	REa, REc		Arthrogryposis, distal, type 1B, 614335 (3); Lethal congenital contracture syndrome 4, 614915 (3)	
12.669	4	14	05	12q23.2	NUP37, p37		Nucleoporin, 37kD	609264	REc			
12.670	7	16	09	12q23.2	UTP20, DRIM		UTP20, S. cerevisiae, homolog of	612822	A			
12.671	4	6	15	12q23.3	ALDH1L2		Aldehyde dehydrogenase 1 family, member L2	613584	REc			
12.672	11	30	06	12q24.11	ALKBH2, ABH2		AlkB, E. coli, homolog of, 2	610602	REc			
12.673	3	13	08	12q23.2	GNPTAB, GNPTA		N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits	607840	F, S, D, REc	conflicting assignment to 4q	Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II alpha/beta, 252500 (3)	
12.674	9	7	04	12q23.3	HCFC2, HCF2		Host cell factor C2	607926	R, REc			
12.675	9	8	08	12q23.3	HSP90B1, TRA1, GRP94, GP96		Heat-shock protein, 90kD, beta, 1	191175	REa, A, REc			10(Tra1)
12.676	8	29	13	12q23.3	NFYB		Transcription factor NF-Y, B subunit	189904	REa, A, REc			10(Nfyb)
12.677	5	29	12	12q23.3	NUAK1, ARK5,  KIAA0537		NUAK family, SNF1-like kinase, 1	608130	REc, R			
12.678	12	19	11	12q23.3	POLR3B, RPC2, C128, HLD8		Polymerase III, RNA, subunit B	614366	REc		Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	
12.679	12	10	12	12q23.3	RIC8B		Ric8, C. elegans, homolog of, B	609147	REc			
12.680	2	27	07	12q23.3	SLC41A2		Solute carrier family 41, member 2	610802	REc			10(Slc41a2)
12.681	4	20	17	12q23.3	WASHC4, KIAA1033, SWIP, MRT43		WASH complex, subunit 4	615748	REc, Psh	mutation identified in 1 MRT43 family	?Mental retardation, autosomal recessive 43, 615817 (3)	
12.682	1	29	01	12q24.31	ABCB9		ATP-binding cassette, subfamily B, member 9	605453	REc			
12.683	4	14	15	12q24.12	ATXN2, ATX2, SCA2, ASL13		Ataxin-2	601517	Fd		Spinocerebellar ataxia 2, 183090 (3); {Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3)	
12.684	3	9	09	12q24.12	BRAP, BRAP2, IMP		BRCA1-associated protein	604986	REc			
12.685	5	28	08	12q24	CELIAC13		Celiac disease, susceptibility to, 13	612011	Fd	associated with rs3184504	{Celiac disease, susceptibility to, 13} (2)	
12.686	2	10	04	12q24	CIMT		Carotid intimal medial thickness	608447	Fd	161cM from pter; near SCARB1	Carotid intimal medial thickness (2)	
12.687	5	16	18	12q24.11	DAO, DAMOX		D-amino-acid oxidase	124050	REa, Fd, LD			
12.688	1	19	01	12q24.13	DTX1		Deltex, Drosophila, homolog of, 1	602582	R, A			
12.689	6	8	07	12q24.23	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A		Heat-shock 22-kD protein 8	608014	REc, Fd		Neuropathy, distal hereditary motor, type IIA, 158590 (3); Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	
12.690	2	5	16	12q24.21	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD		Mediator complex subunit 13-like	608771	A, REc		Transposition of the great arteries, dextro-looped 1, 608808 (3); Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	5(Med13l)
12.691	2	20	03	12q24.11	MMAB		MMAB gene	607568	Fd		Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	
12.692	11	7	15	12q24.11	MVK, MVLK, POROK3		Mevalonate kinase	251170	REa, A		Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3); Porokeratosis 3, multiple types, 175900 (3)	
12.693	2	1	00	12q24.31	NCOR2, SMRT		Nuclear receptor corepressor 2	600848	A			
12.694	6	8	15	12q24.31	ORAI1, TMEM142A, CRACM1, IMD9, TAM2		ORAI calcium release-activated calcium modulator 1	610277	Fd, REc		Immunodeficiency 9, 612782 (3); Myopathy, tubular aggregate, 2, 615883 (3)	
12.695	1	27	09	12q24.31	P2RX7, P2X7		Purinergic receptor P2X, ligand-gated ion channel, 7	602566	A, R			
12.696	8	17	12	12q24	PDA1		Patent ductus arteriosus	607411	Fd		{Patent ductus arteriosus, susceptibility to} (2)	
12.697	6	25	99	12q24.23	PXN		Paxillin	602505	A			
12.698	12	30	03	12q24.11	RAD9B		RAD9, S. pombe, homolog of, A	608368	REc			5(Rad9b)
12.699	10	1	95	12q24.11	SELPLG, PSGL1		Selectin P ligand	600738	REa, A			5(Selpl)
12.700	7	12	11	12q24.12	SH2B3, LNK		SH2B adaptor protein 3	605093	R, Fd		Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3); Erythrocytosis, somatic, 133100 (3)	
12.701	3	30	18	12q24.13	SLC8B1, SLC24A6, NCKX6		Solute carrier family 8 member B1	609841	REc			5(Slc24a6)
12.702	2	16	04	12q24	SLEB4		Systemic lupus erythematosus, susceptibility to, 4	608437	Fd		{Systemic lupus erythematosus, susceptibility to, 4} (2)	
12.703	11	2	05	12q24.31	HPD		4-hydroxyphenylpyruvate dioxygenase	609695	REa, A		Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)	
12.704	6	9	98	12q24.11	ACACB, ACCB, ACC2		Acetyl-Coenzyme A carboxylase, beta	601557	A			
12.705	2	25	14	12q24.12	ACAD10		Acyl-CoA dehydrogenase family, member 10	611181	REc			
12.706	2	20	07	12q23.3	APPL2, FLJ10659		Adaptor protein, phosphotyrosine interaction, PH domain, and leucine zipper-containing protein 2	606231	Ch, REc			
12.707	8	21	98	12q24.31	BCL7A, BCL7		B-cell CLL/lymphoma-7A	601406	Ch		B-cell non-Hodgkin lymphoma, high-grade (3)	
12.708	3	16	99	12q23.3	CMKLR1		Chemokine-like receptor 1	602351	A			
12.709	1	31	01	12q24.11	CORO1C		Coronin 1C	605269	A			
12.710	10	09	18	12q24.11-q24.12	CUX2, CDP2, CUTL2, EIEE67		Cut-like homeobox 2	610648	REc		Epileptic encephalopathy, early infantile, 67, 618141 (3)	
12.711	6	30	05	12q24.11	FOXN4		Forkhead box N4	609429	R, REc			
12.712	4	13	10	12q23.3	ISCU, HML		Iron-sulfur cluster scaffold, E. coli, homolog of	611911	R, REc, Fd		Myopathy with lactic acidosis, hereditary, 255125 (3)	
12.713	3	24	09	12q23.2	PAH, PKU1		Phenylalanine hydroxylase	612349	REa, A, Fd	close to IGF1	Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild], 261600 (3)	10(Pah)
12.714	12	28	08	12q24.11	PPTC7, TAPP2C		PTC7 protein phosphatase, S. cerevisiae, homolog of	609668	R, REc			
12.715	1	13	99	12q24.23	PRKAB1		Protein kinase, AMP-activated, noncatalytic, beta-1	602740	A			
12.716	8	27	15	12q24.13	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS		Protein tyrosine phosphatase, nonreceptor-type, 11	176876	A, Fd		Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3); Leukemia, juvenile myelomonocytic, somatic, 607785 (3); Metachondromatosis, 156250 (3)	
12.717	7	10	08	12q24.13	RPH3A, KIAA0985		Rabphilin 3A	612159	R, REc			
12.718	10	16	14	12q23.3	SART3, P100, KIAA0156, TIP110		Squamous cell carcinoma antigen recognized by T cells 3	611684	Fd, Psh, REc, H			5(Sart3)
12.719	5	2	07	12q24.1	STUT2		Stuttering, familial persistent, 2	609261	Fd	max lod with PAH	Stuttering, familial persistent, 2 (2)	
12.720	1	2	08	12q24.11	SVOP		SV2-related protein	611699	REc			5(Svop)
12.721	8	4	97	12q24.21	TBX3		T-box 3	601621	REc, A		Ulnar-mammary syndrome, 181450 (3)	5(Tbx3)
12.722	2	19	97	12q24.21	TBX5		T-box 5	601620	Fd, REc, Ch		Holt-Oram syndrome, 142900 (3)	5(Tbx5)
12.723	3	23	09	12q24.11	TCHP		Trichoplein	612654	R, REc			
12.724	6	2	98	12q23.3	TDG		Thymine-DNA glycosylase	601423	A			10(Tdg)
12.725	8	25	11	12q24.11	TECT1, JBTS13		Tectonic family, member 1	609863	REc, R		Joubert syndrome 13, 614173 (3)	5(Tect1)
12.726	5	19	06	12q24.13	TPCN1, TPC1, KIAA1169		Two-pore segment channel 1	609666	R, REc			
12.727	7	18	12	12q24.11	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3		Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	REc, Fd	mutation identified in 1 ANFH2 family	Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3); Digital arthropathy-brachydactyly, familial, 606835 (3); ?Avascular necrosis of femoral head, primary, 2, 617383 (3)	5(Vroac)
12.728	8	16	94	12q24.11	PPP1CC		Protein phosphatase-1, catalytic subunit, gamma isoform	176914	REa, A			10(Ppp1cc)
12.729	11	13	12	12q24.1-q24.2	POROK2, PPPD1		Porokeratosis 2, palmar, plantar, and disseminated	175850	Fd	between D12S1613 and D12S1341	Porokeratosis 2, palmar, plantar, and disseminated (2)	
12.730	9	2	16	12q24.23	CIT, STK21, CRIK, MCPH17		Citron rho-interacting serine/threonine kinase	605629	REc		Microcephaly 17, primary, autosomal recessive, 617090 (3)	
12.731	12	10	98	12q24.31	MSI1		Musashi, Drosophila, homolog of, 1	603328	A, Psh, REc			
12.732	8	18	14	12q24.11	ANAPC7, APC7		Anaphase-promoting complex, subunit 7	606949	REc			
12.733	4	5	13	12q24.11	ANKRD13A		Ankyrin repeat domain-containing protein 13A	615123	REc			
12.734	11	11	14	12q24.11	ARPC3, ARC21		Actin-related protein 2/3 complex, subunit 3	604225	REc			
12.735	5	9	18	12q24.11	CCDC63, ODA5		Coiled-coil domain-containing protein 63	617969	REc			
12.736	11	1	13	12q24.11	GLTP		Glycolipid transfer protein	608949	REc			
12.737	1	3	12	12q24.11	HVCN1, HV1, VSOP		Hydrogen voltage-gated channel 1	611227	REc			
12.738	7	26	10	12q24.11	KCTD10		Potassium channel tetramerization domain-containing 10	613421	REc			
12.739	6	1	12	12q24.11	MYO1H		Myosin IH	614636	REc			
12.740	4	3	12	12q24.11	SSH1, KIAA1298		Slingshot, Drosophila, homolog of, 1	606778	R			
12.741	4	10	15	12q24.11	UBE3B, BPIDS, KOS		Ubiquitin-protein ligase E3B	608047	REc		Kaufman oculocerebrofacial syndrome, 244450 (3)	5(Ube3b)
12.742	9	30	11	12q24.12	FAM109A, SES1, IPIP27A		Family with sequence similarity 109, member A	614239	REc			
12.743	7	8	10	12q24.12-q24.13	MAPKAPK5, PRAK		Mitogen-activated protein kinase-activated protein kinase 5	606723	R, REc			
12.744	3	5	18	12q24.11	IFT81, DV1, CDV1R, SRTD19		Intraflagellar transport 81, Chlamydomonas, homolog of	605489	H, REc		Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3)	5(Cdv1, Cdv1r)
12.745	5	12	09	12q24.13	MDM20, C12orf30		Mitochondrial distribution and morphology 20, yeast, homolog of	612755	REc			
12.746	5	25	13	12q24.13	SDS, SDH		Serine dehydratase	182128	REc			
12.747	12	29	09	12q24.13	TRAFD1, FLN29		TRAF-type zinc finger domain-containing 1	613197	REc			
12.748	6	30	15	12q24.13-q24.21	RBM19, KIAA0682		RNA-binding motif protein 19	616444	R, REc			
12.749	7	8	10	12q24.12	ALDH2		Aldehyde dehydrogenase 2 family, mitochondrial	100650	REa, A, H		Alcohol sensitivity, acute, 610251 (3); {Hangover, susceptibility to}, 610251 (3); {Sublingual nitroglycerin, susceptibility to poor response to} (3); {Esophageal cancer, alcohol-related, susceptibility to} (3)	4(Aldh2)
12.750	1	9	13	12q24.31	CAMKK2, KIAA0787, CAMKKB		Calcium/calmodulin-dependent protein kinase kinase 2, beta	615002	REc			
12.751	10	9	14	12q24.31	COX6A1, CMTRID		Cytochrome c oxidase, subunit VIa, polypeptide-1	602072	REc	pseudogenes on chr.7 and chr.6	Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	
12.752	2	21	06	12q24.31	DYNLL1, DNCL1, DLC1, PIN		Dynein, light chain, LC8-type 1	601562	A, REc, REn	possible pseudogene on 14q24		
12.753	2	9	01	12q24.23	GCN1L1		General control of amino acid synthesis 1, yeast, homolog-like 1	605614	R, REa			
12.754	3	29	12	12q24.31	HNF1A, TCF1, MODY3, IDDM20		HNF1 homeobox B	142410	A, Fd		MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes mellitus, insulin-dependent, 20, 612520 (3)	5(Tcf1)
12.755	8	8	13	12q24.22	HRK, DP5		Harakiri	603447	REc			
12.756	1	31	07	12q24.22-q24.23	KSR2		Kinase suppressor of RAS 2	610737	REc			
12.757	12	11	02	12q24.2	NIDDM2		Diabetes mellitus, noninsulin-dependent, 2	601407	Fd	no mutations found in HNF1A	Diabetes mellitus, noninsulin-dependent, 2 (2)	
12.758	7	3	18	12q24.13	OAS1, OIAS		2',5'-oligoadenylate synthetase-1	164350	REa, A, REc			
12.759	6	24	99	12q24.13	OAS2		2',5'-oligoadenylate synthetase-2	603350	A, REc			
12.760	6	24	99	12q24.13	OAS3		2',5'-oligoadenylate synthetase-3	603351	A, REc			
12.761	11	16	98	12q24.31	OASL, TRIP14		2',5'-oligoadenylate synthetase-like	603281	REc			
12.762	12	7	07	12q24.22	TESC, TSC		Tescalcin, mouse, homolog of	611585	R, REc, H			5(Tesc)
12.763	6	26	16	12q24.23	BICDL1, BICDR1, CCDC64		BICD family-like cargo adaptor 1	617002	REc			
12.764	9	9	08	12q24.22	FBXO21, FBX21, KIAA0875		F-box only protein 21	609095	REc			5(Fbxo21)
12.765	9	9	08	12q24.22	FBXW8, FBW8, FBXW6, FBW6, FBXO29, FBX29		F-box and WD40 domain protein 8	609073	REc			5(Fbxw8)
12.766	9	8	08	12q24.23	PEBP1, PBP, RKIP		Phosphatidylethanolamine-binding protein 1	604591	R, REc			
12.767	10	26	15	12q24.23	RAB35		Ras-associated protein Rab35	604199	REc			
12.768	11	11	09	12q24.23	SRRM4, KIAA1853, NSR100		Serine/arginine repetitive matrix protein 4	613103	R, REc			
12.769	12	22	15	12q24.23	TAOK3, JIK, DPK		TAO kinase 3	616711	REc			
12.770	8	18	16	12q24.2-q24.3	RPL21P1, ALFN1, HALF1		Ribosomal protein L21 pseudogene 1	603416	A			
12.771	7	23	13	12q24.2-q24.3	CTRCT37, CCA5		Cataract 37	614422	Fd	between D12S1718 and D12S1723	Cataract 37, autosomal dominant (2)	
12.772	5	19	09	12q24.31	HIP1R, HIP12		Huntingtin-interacting protein 1-related protein	605613	A			
12.773	11	16	98	12q24.31	PSMD9		Proteasome 26S subunit, non-ATPase, 9	603146	A			
12.774	7	8	10	12q24.22	NOS1		Nitric oxide synthase 1, neuronal	163731	REa, A			5(Nos1)
12.775	3	18	95	12q24.23	RFC5		Replication factor C5, 36.5kD (activator 1, 36.5kD)	600407	Psh, A			
12.776	1	30	12	12q24.31	ATP6V0A2, WSS, ARCL2A		ATPase, H+ transporting, V0 subunit A2	611716	R, REc, Fd		Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin syndrome, 278250 (3)	
12.777	6	15	15	12q24.31	CLIP1, RSN, CYLN1, CLIP170		CAP-GLY domain containing linker protein 1	179838	A			
12.778	10	19	97	12q24.33	MUC8		Mucin 8, tracheobronchial	601932	REa, A			
12.779	4	27	13	12q24.33	POLE1, CRCS12, FILS		Polymerase (DNA directed), epsilon-1	174762	REa, A		{Colorectal cancer, susceptibility to, 12}, 615083 (3); FILS syndrome, 615139 (3)	5(Pole)
12.780	6	1	09	12q24.33	RAN, ARA24		Ras-related nuclear protein	601179	REc			
12.781	5	26	13	12q24.33	TMEM132D, KIAA1944, MOLT		Transmembrane protein 132D	611257	REc			
12.782	2	9	92	12q24.31	UBC		Ubiquitin C	191340	REa, A			
12.783	6	25	99	12q24.33	ULK1, UNC51		UNC51-like kinase 1	603168	Psh, R, A			
12.784	3	24	04	12q24.33	ZNF268		Zinc finger protein 268	604753	REc			
12.785	3	1	18	12q24.31	ZNF664, ZFOC1		Zinc finger protein 664	617890	REc, A			
12.786	2	28	01	12q13.3	BAZ2A		Bromodomain adjacent to zinc finger domain, 2A	605682	REa, R			
12.787	12	6	11	12q24.31	AACS, ACSF1		Acetoacetyl-CoA synthetase	614364	REc			
12.788	10	23	14	12q24.31	ARL6IP4		ADP-ribosylation-like factor 6 interacting protein 4	607668	R, REc			
12.789	4	26	10	12q24.31	B3GNT4		Beta-1,3-N-acetylglucosaminyltransferase 4	605864	REc			
12.790	2	13	14	12q24.31	BRI3BP		BRI3-binding protein	615627	REc			
12.791	12	5	13	12q24.31	C12orf65, COXPD7, SPG55		Chromosome 12 open reading frame 65	613541	REc		Combined oxidative phosphorylation deficiency 7, 613559 (3); Spastic paraplegia 55, autosomal recessive, 615035 (3)	
12.792	9	29	10	12q24.31	CCDC62, ERAP75		Coiled-coil domain-containing protein 62	613481	REc			
12.793	5	19	15	12q24.31	COQ5		Coq5, S. cerevisiae, homolog of	616359	REc			
12.794	2	24	17	12q24.31	DHX37, KIAA1517		DEAH box polypeptide 37	617362	R, REc			
12.795	12	10	15	12q24.31	EIF2B1, EIF2BA		Eukaryotic translation initiation factor 2B, subunit 1	606686	R, REc		Leukoencephalopathy with vanishing white matter, 603896 (3)	
12.796	10	1	17	12q24.31	GTF2H3, TFB4		General transcription factor IIH, polypeptide 3	601750	REc			
12.797	3	25	14	12q24.31	DENR, DRP		Density-regulated protein	604550	REc			
12.798	11	23	16	12q24.31	GATC		Glutamyl-tRNA amidotransferase, subunit C	617210	REc			
12.799	2	5	15	12q24.31	NRAV, DYNLL1AS1		Negative regulator of antiviral response, noncoding	616207	REc	overlaps intron 1 of DYNLL1 in antisense orientation		
12.800	8	18	14	12q24.31	FAM101A, CFM2		Family with sequence similarity 101, member A	615927	REc			
12.801	8	25	11	12q24.31	SMAC, DIABLO, DFNA64		Second mitochondria-derived activator of caspase	605219	REc		Deafness, autosomal dominant 64, 614152 (3)	
12.802	2	21	06	12q24.31	DNAH10		Dynein, axonemal, heavy chain 10	605884	A, R, REc	previously assigned to 13q14		
12.803	6	26	01	12q24.31	CDK2AP1, DOC1		CDK-associated protein 1 (deleted in oral cancer-1)	602198	A			
12.804	7	14	14	12q24.31	HCAR1, GPR81, TAGPCR		Hydroxycarboxylic acid receptor 1	606923	REc			
12.805	7	14	14	12q24.31	HCAR2, GPR109A, HM74A		Hydroxycarboxylic acid receptor 2	609163	REc			
12.806	7	14	14	12q24.31	HCAR3, GPR109B, HM74, PUMAG		Hydroxycarboxylic acid receptor 3	606039	REn			
12.807	2	25	15	12q24.31	IL31		Interleukin 31	609509	REc			
12.808	5	6	15	12q24.31	KDM2B, FBXL10, FBL10, CXXC2, JHDM1B		Lysine-specific demethylase 2B	609078	REc			
12.809	2	1	11	12q24.31	KNTC1, ROD, KIAA0166		Kinetochore-associated protein 1	607363	REc	previously assigned to chr.17		
12.810	3	15	11	12q24.31	MLEC, KIAA0152		Malectin	613802	REc			
12.811	3	11	09	12q24.31	MPVQTL1		Mean platelet volume quantitative trait locus 1	612573	Fd	associated with rs7961894	[Mean platelet volume QTL1] (2)	
12.812	3	23	06	12q24.31	POP5, HSPC004		Processing of precursor 5, S. cerevisiae, homolog of	609992	R			
12.813	7	22	11	12q24.31	RILPL1, RLP1, GOSPEL		RAB-interacting lysosomal protein-like 1	614092	REc, H			5(Rilpl1)
12.814	7	22	11	12q24.31	RILPL2, RLP2		RAB-interacting lysosomal protein-like 2	614093	REc			
12.815	9	22	14	12q24.31	RNF10, KIAA0262		RING finger protein 10	615998	R, REc, H			5(Rnf10)
12.816	10	5	11	12q24.31	SBNO1		Strawberry notch, Drosophila, homolog of, 1	614274	REc			
12.817	1	31	11	12q24.31	SCARB1, CD36L1, CLA1, HDLQTL6		Scavenger receptor class B, member 1 (CD36 antigen-like 1)	601040	Psh, REc		[High density lipoprotein cholesterol level QTL6], 610762 (3)	
12.818	8	21	07	12q24.31	SETD1B, SET1B, KIAA1076		SET domain-containing protein 1B	611055	R, REc			
12.819	3	31	15	12q24.23-q24.31	SIRT4, SIR2L4		Sirtuin, S. cerevisiae, homolog 4	604482	REc			
12.820	3	22	07	12q24.31	SPPL3, IMP2		Signal peptide peptidase-like 3	608240	R, REc			
12.821	12	19	11	12q24.31	SRSF9, SFRS9, SRp30c		Splicing factor, serine/arginine-rich, 9	601943	REc			
12.822	11	23	15	12q24.31	TCTN2, TECT2, MKS8, JBTS24		Tectonic family, member 2	613846	REc	mutation identified in 1 MKS8 family	?Meckel syndrome 8, 613885 (3); Joubert syndrome 24, 616654 (3)	
12.823	2	2	14	12q24.31	THRIL, LINC1992, BRI3BPAS1		TNF- and HNRNPL-related immunoregulatory long noncoding RNA	615622	REc			
12.824	9	24	15	12q24.31	TMEM120B		Transmembrane protein 120B	616551	REc			
12.825	12	17	12	12q24.31	TRIAP1, HSPC132		TP53-regulated inhibitor of apoptosis 1	614943	REc			
12.826	1	26	17	12q24.31	VPS33A, MPSPS		Vacuolar protein sorting 33, yeast, homolog of, A	610034	R, REc		Mucopolysaccharidosis-plus syndrome, 617303 (3)	
12.827	6	1	15	12q24.31	ZCCHC8		Zinc finger CCHC domain-containing protein 8	616381	REc			
12.828	6	9	06	12q24.31	VPS37B		Vacuolar protein sorting 37, yeast, homolog of, B	610037	R, REc			
12.829	10	14	18	12q24.31	WDR66, CFAP251		WD repeat-containing protein 66	618146	REc			
12.830	6	8	01	12q24.13	LHX5		LIM homeo box protein 5	605992	A			
12.831	7	14	98	12q24.31	P2RX4, P2X4		Purinergic receptor P2X, ligand-gated ion channel, 4	600846	A			
12.832	6	22	14	12q24.33	SLC15A4, PHT1, PTR4		Solute carrier family 15 (oligopeptide transporter), member 4	615806	REc			
12.833	6	19	00	12q24.33	ZNF140		Zinc finger protein-140	604082	A			
12.834	9	1	16	12q24.33	ADGRD1, GPR133, PGR25		Adhesion G protein-coupled receptor D1	613639	REc			
12.835	12	9	15	12q24.33	ANKLE2, LEM4, KIAA0692, MCPH16		Ankyrin repeat- and LEM domain-containing protein 2	616062	R, REc	mutation identified in 1 MCPH16 family	?Microcephaly 16, primary, autosomal recessive, 616681 (3)	
12.836	5	25	09	12q24.33	CHFR		Checkpoint protein with FHA and ring-finger domains	605209	REc			
12.837	2	21	02	12q24.33	EP400, TNRC12, KIAA1498		p400 SWI2/SNF2-related protein	606265	R			
12.838	4	6	13	12q24.33	GALNT9, GALNACT9		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9	606251		REc		
12.839	9	30	09	12q24.33	STX2, EPIM, STX2C, STX2B, STX2A		Epimorphin (syntaxin 2)	132350	A, REc			5(Epim)
12.840	8	30	01	12q24.33	FZD10		Frizzled, Drosophila, homolog of, 10	606147	A			
12.841	5	12	99	12q24.33	MMP17		Matrix metalloproteinase 17	602285	A, Psh, R			5(Mmp17)
12.842	7	15	09	12q24.33	NOC4L, NOC4		Nucleolar complex-associated protein 4, S. cerevisiae, homolog of	612819	REc			
12.843	11	25	13	12q24.33	P2RX2, P2X2, DFNA41		Purinergic receptor P2X, ligand-gated ion channel, 2	600844	REc, Fd		Deafness, autosomal dominant 41, 608224 (3)	
12.844	11	29	12	12q24.33	PGAM5		Phosphogycerate mutase family, member 5	614939	REc			
12.845	3	17	16	12q24.33	PUS1, MLASA1		Pseudourine synthase 1	608109	R, REc		Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	
12.846	3	27	17	12q24.33	PXMP2		Peroxisomal membrane protein 2	617399	REc			
12.847	2	19	08	12q24.33	RIMBP2, KIAA0318		RIMS-binding protein 2	611602	R, REc			
12.848	4	29	14	12q24.33	SFSWAP, SFRS8, SWAP		Splicing factor, suppressor-of-white-apricot family	601945	REc			
12.849	6	7	91	12q24.33	ZNF26		Zinc finger protein-26 (KOX20)	194537	REa, A			
12.850	5	16	02	12q24.31	ANAPC5, APC5		Anaphase-promoting complex, subunit 5	606948	R			
12.851	11	28	01	12q13.13	ATF7		Activating transcription factor 7	606371	R			
12.852	11	5	98	12q13.13	ATP5G2		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 2	603193	REn			
12.853	12	11	02	12q24.13	C12orf8, ERP28, ERP29		Endoplasmic reticulum lumenal protein 28	602287	R			
12.854	1	31	01	12q15	CCT2, CCTB		Chaperonin containing T-complex polypeptide 1, subunit 2	605139	R			
12.855	2	6	01	12q15	CPSF6, CFIM		Cleavage and polyadenylation specific factor 6, 68kD subunit	604979	R			
12.856	8	21	98	12p12.3	MGST1, GST12		Microsomal glutathione S-transferase 1	138330	RE, REa	pseudogene at 12q13-q14		
12.857	7	17	01	12q13.11	EPAC		cAMP-regulated guanine nucleotide exchange factor I	606057	R			
12.858	5	12	03	12q24.33	GOLGA3		Golgi autoantigen, golgin subfamily A, 3	602581	R			
12.859	12	11	01	12q13.11	HDAC7A, HDAC7		Histone deacetylase 7A	606542	R			
12.860	8	27	01	12p13.1	HEBP1, HBP		Heme-binding protein 1	605826	R			
12.861	1	19	01	12q13.13	HOXC10		Homeo box-C10	605560	REc			15(Hoxc10)
12.862	1	19	01	12q13.13	HOXC11		Homeo box-C11	605559	REc			15(Hoxc11)
12.863	1	25	93	12q13.13	IGFBP6		Insulin-like growth factor-binding protein-6	146735	Psh			
12.864	1	30	01	12q24.31	MPHOSPH9, MPP9		M-phase phosphoprotein 9	605501	R			
12.865	1	23	01	12q24.33	PIWIL1		Piwi, Drosophila, homolog of	605571	R			
12.866	1	28	02	12p13.2	PROL4, LPRP		Proline rich 4, lacrimal	605359	R			
12.867	4	15	02	12q24.23	RPLP0		Ribosomal phosphoprotein, large, P0	180510	R			
12.868	1	29	01	12q13.13	SLC4A8, NBC3		Solute carrier family 4 (sodium bicarbonate cotransporter), member 8	605024	R			
12.869	5	9	02	12q13.2	SUOX		Sulfite oxidase	606887	R		Sulfite oxidase deficiency, 272300 (3)	
12.870	4	16	93	Chr.12	TUBAL1		Tubulin, alpha-like-1	191120	REa			
12.871	10	28	99	12q22	VESPR		Virus-encoded semaphorin protein receptor	604259	R			
12.872	4	3	02	12q14.3	WIF1		WNT inhibitory factor 1	605186	R			
13.1	9	2	11	13pter-q12.13	FECD2, FCD1		Corneal dystrophy, Fuchs endothelial, 2	610158	Fd	max lod at D13S1304	Corneal dystrophy, Fuchs endothelial, 2 (2)	
13.2	4	26	90	13p12	RNR1		Ribosomal RNA-1	180450	A			
13.3	2	28	03	13q12.11	IL17D		Interleukin 17D	607587	REc	?associated with Hodgkin lymphoma		
13.4	2	20	07	13q	CLQTL1, CLF		Cholesterol level quantitative trait locus 1	604595	Fd		[Cholesterol level QTL 1] (2)	
13.5	7	25	13	13q12.11	GJA3, CX46, CZP3, CAE3, CTRCT14		Gap junction protein, alpha-3, 46kD (connexin 46)	121015	REa, A, Fd		Cataract 14, multiple types, 601885 (3)	14(Gja3)
13.6	4	19	06	13q12.12	PARP4, ADPRTL1, VPARP, KIAA0177		Poly(ADP-ribose) polymerase 4	607519	REc			
13.7	6	15	99	13q12.11	TUBA2		Tubulin, alpha 2	602528	REc			
13.8	10	25	17	13q12.11	FGF9, SYNS3		Fibroblast growth factor-9 (glia-activating factor)	600921	A		Multiple synostoses syndrome 3, 612961 (3)	
13.9	3	6	09	13q12.11	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID		Gap junction protein, beta-2, 26kD (connexin 26)	121011	REa, A, Fd		Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)	14(Gjb2)
13.10	5	11	00	13q12.11	LATS2		Large tumor suppressor, Drosophila, homolog of, 2	604861	A			14(Lats2)
13.11	1	6	09	13q12.3	ALOX5AP, FLAP		Arachidonate 5-lipoxygenase-activating protein	603700	R, A, REc		{Stroke, susceptibility to}, 601367 (3)	
13.12	7	2	13	13q12.13	ATP8A2, ATPIB, CAMRQ4		ATPase, class I, type 8A, member 2	605870	A		?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	
13.13	10	26	98	13q12.13	CDK8		Cyclin-dependent kinase 8	603184	REc			
13.14	1	2	91	13q12.3	FLT1		fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor)	165070	REa, A	150kb from FLT3		
13.15	8	27	15	13q12.2	FLT3		fms-related tyrosine kinase-3	136351	A, Psh, REn		Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3)	5(Flt3)
13.16	12	17	12	13q12.11	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2		Gap junction protein, beta-6 (connexin-30)	604418	Fd, H		Deafness, autosomal dominant 3B, 612643 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3); Ectodermal dysplasia 2, Clouston type, 129500 (3)	
13.17	10	1	95	13q12.13	GPR12		G protein-coupled receptor-12	600752	A			
13.18	8	28	02	13q12.3	HMGB1, HMG1		High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1)	163905	A			5(Hmg1)
13.19	6	1	18	13q13.1	KL, KLOTHO, HFTC3		Klotho	604824	A, REc	mutation identified in 1 HFTC3 patient	?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3)	
13.20	5	7	03	13q13.3-q14.1	LHFP		Lipoma HMGIC fusion partner	606710	REc			
13.21	1	6	09	13q12	MCI2		Myocardial infarction, susceptibility to, 2	608557	Fd	defined by 4-SNP haplotype HapA	{Myocardial infarction, susceptibility to, 2} (2)	
13.22	12	6	98	13q12.12	MIPEP, COXPD31		Mitochondrial intermediate peptidase	602241	A		Combined oxidative phosphorylation deficiency 31, 617228 (3)	
13.23	6	15	99	13q12.13	MTMR6		Myotubularin-related protein 6	603561	R, REc, Psh			
13.24	2	1	00	13q12.12	SACS, ARSACS		Sacsin	604490	LD, Fd		Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	1(Sacs)
13.25	09	27	18	13q12.12	SGCG, LGMDR5, DMDA1, SCG3		Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)	608896	Fd, LD, A		Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3)	
13.26	11	13	17	13q12.13	WASF3, WAVE3, SCAR3		WAS protein family member 3	605068	A			
13.27	12	14	00	13q12.3	UBL3		Ubiquitin-like 3	604711	REa, R			5(Ubl3)
13.28	10	12	09	13q12-q14	ATOD5		Dermatitis, atopic, 5	605844	Fd	max lod at D13S218	{Dermatitis, atopic, susceptibility to, 5} (2)	
13.29	8	2	13	13q13.3	MADH9, SMAD9, MADH6, PPH2		Mothers against decapentaplegic, Drosophila, homolog of, 9	603295	R, A		Pulmonary hypertension, primary, 2, 615342 (3)	
13.30	5	1	08	13q14.11	RGC32		Response gene to complement 32	610077	Psh, R			
13.31	3	29	99	13q14.13	TPT1, HRF		Tumor protein, translationally-controlled 1	600763	Psh, R			
13.32	8	3	14	13q12.11	IFT88, D13S1056E, TG737		Intraflagellar transport 88, Chlamydomonas, homolog of	600595	A			14(TgN737Rpw)
13.33	10	26	15	13q12.13	NUP58, NUPL1, KIAA0410		Nucleoporin 58kDa	607615	R, REc			
13.34	8	22	16	13q12.2	PDX1, IPF1, MODY4, PAGEN1		Pancreas/duodenum homeobox protein 1	600733	Psh, A		Pancreatic agenesis 1, 260370 (3); MODY, type IV, 606392 (3); {Diabetes mellitus, type II, susceptibility to}, 125853 (3)	5(Ipf1)
13.35	7	27	09	13q12.12	RNF17		RING finger protein-17	605793	R, REc			
13.36	11	8	00	13q12.12	ATP12A, ATP1AL1		ATPase, H+/K+ transporting, nongastric, alpha polypeptide	182360	REa, Fd			
13.37	9	23	08	13q12.11	ADHD6		Attention deficit-hyperactivity disorder, susceptibility to, 6	612312	Fd	max lod at rs1974047	{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)	
13.38	2	22	10	13q12.11	CFEOM3C, FEOM4		Fibrosis of extraocular muscles, congenital, 3C	609384	Ch		Fibrosis of extraocular muscles, congenital, 3C (2)	
13.39	2	7	06	13q12.11	CRYL1		Crystallin, lambda-1	609877	R, REc, H			14(Cryl1)
13.40	11	29	17	13q12.11	EEF1AKMT1, N6AMT2		EEF1A lysine methyltransferase 1	617793	REc			
13.41	1	14	14	13q12.11	MICU2, EFHA1		Mitochondrial calcium uptake protein 2	610632	REc			
13.42	2	6	08	13q12.11	MPHOSPH8, TWA3		M-phase phosphoprotein 8	611626	REc			
13.43	4	24	08	13q12.11	MRP63		Mitochondrial ribosomal protein 63	611997	R, REc	10 pseudogenes		
13.44	12	18	08	13q12.11	PSPC1, PSP1		Paraspeckle component 1	612408	REc			
13.45	10	17	02	13q12.13	RNF6		RING finger protein-6	604242	A, REn		Esophageal carcinoma, somatic, 133239 (3)	
13.46	8	3	12	13q12.11	SAP18		Sin3-associated polypeptide, 18kD	602949	REc			
13.47	7	14	14	13q12.11	TPTE2, TPIP		Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	606791	REc			
13.48	5	11	18	13q12.11	ZDHHC20, DHHC20		Zinc finger DHHC domain-containing protein 20	617972	REc			
13.49	6	30	15	13q12.11	ZMYM2, ZNF198, RAMP, FIM		Zinc finger, MYM-type 2	602221	REc, R, Ch			
13.50	6	30	15	13q12.11	ZMYM5, ZNF237, ZNF198L1		Zinc finger, MYM-type 5	616443	A, R, REc			
13.51	8	30	01	13q12.12	TAJ, TROY		Toxicity and JNK inducer	606122	REc			14(Troy)
13.52	11	19	11	13q12.12	C1QTNF9A, CTRP9, C1QTNF9		C1q- and tumor necrosis factor-related protein 9A	614285	REc			14(C1qtnf9a)
13.53	8	5	11	13q12.12	C1QTNF9B, CTRP9B		C1q- and tumor necrosis factor-related protein 9B	614148	REc			
13.54	9	22	16	13q12.12	C1QTNF9BAS1, PCOTH		C1QTNF9B antisense RNA 1	617122	REc			
13.55	8	25	11	13q12.12	MYP20		Myopia 20, autosomal dominant	614166	Fd	associated with rs9318086	Myopia 20, autosomal dominant (2)	
13.56	3	29	10	13q12.12	SPATA13, ASEF2		Spermatogenesis-associated protein 13	613324	REc			
13.57	5	29	12	13q12.13	FAM123A, AMER2		Family with sequence similarity 123, member A (APC membrane recruitment protein 2)	614659	REc			
13.58	2	2	17	13q12.13	SHISA2, C13orf13, TMEM46		Shisa family, member 2	617324	REc			
13.59	12	5	17	13q12.13	USP12, UBH1		Ubiquitin-specific protease 12	603091	REc			
13.60	4	25	05	13q12.12-q12.13	CENPJ, CPAP, MCPH6, SCKL4		Centromeric protein J	609279	Fd, REc	mutation identified in 1 SCKL4 family	Microcephaly 6, primary, autosomal recessive, 608393 (3); ?Seckel syndrome 4, 613676 (3)	
13.61	9	3	15	13q12.2	GSX1, GSH1		GS homeobox 1	616542	REc			5(Gsx1)
13.62	12	28	08	13q12.2	LNX2, PDZRN1		Ligand of numb protein X2	609733	REc			
13.63	5	19	17	13q12.2	PAN3		PABP-dependent poly(A) nuclease 3	617448	REc			
13.64	1	31	11	13q12.2	POLR1D, RPA16, RPAC2, TCS2		Polymerase I, RNA, subunit D	613715	REc		Treacher Collins syndrome 2, 613717 (3)	
13.65	12	18	08	13q12.2	RASL11A		RAS-like, family 11, member A	612403	REc			
13.66	7	17	14	13q12.2	RPL21, HYPT12		Ribosomal protein L21	603636	REa, R, REc		Hypotrichosis 12, 615885 (3)	
13.67	6	22	14	13q12.2	URAD		Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase	615804	REc			
13.68	4	17	00	13q12.2-q13	MBS, MBS1		Moebius syndrome	157900	Ch		?Moebius syndrome (2)	
13.69	10	16	00	13q13.1	AS3		Androgen-induced prostate proliferative shutoff-associated protein	605333	REc			
13.70	2	19	16	13q12.3	B3GLCT, B3GALTL, B3GTL		Beta 3-glucosyltransferase	610308	REc		Peters-plus syndrome, 261540 (3)	
13.71	11	16	15	13q13.1	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2		BRCA2 gene	600185	Fd		{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia, complementation group D1, 605724 (3); {Prostate cancer}, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3); {Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pancreatic cancer 2}, 613347 (3)	5(Brca2)
13.72	8	21	98	13q12.2	CDX2, CDX3		Caudal type homeo box transcription factor 2	600297	A, Psh			5(Cdx2)
13.73	1	16	07	13q12.3	HSPH1, HSP105, KIAA0201		Heat-shock 105/110kD protein 1	610703	R, REc			
13.74	8	21	12	13q12.3	KATNAL1		Katanin p60 subunit A-like 1	614764	REc			
13.75	7	19	18	13q12.3	POMP, UMP1, PRAAS2		Proteasome maturation protein	613386	REc		Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3); Proteasome-associated autoinflammatory syndrome 2, 618048 (3)	
13.76	8	21	98	13q12.3	SLC7A1, ATRC1		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1	104615	Fd, A, REa	distal to ATP1AL1		5(Rec1)
13.77	1	20	16	13q12.3	SLC46A3		Solute carrier family 46, member 3	616764	REc			
13.78	7	26	02	13q13.3	SPG20		Spartin	607111	REc		Troyer syndrome, 275900 (3)	
13.79	3	22	06	13q13.1-q13.2	STARD13, DLC2		Start domain-containing protein 13	609866	REc			
13.80	4	28	17	13q12.3	USPL1		Ubiquitin-specific peptidase-like 1	617470	REc			
13.81	6	6	00	13q13.3	CCNA1		Cyclin A1	604036	R			
13.82	3	20	95	13q13.2	RFC3		Replication factor C3, 38kD (activator 1, 38kD)	600405	Psh, A			
13.83	12	17	95	13q12.2	GTF3A, TFIIIA		General transcription factor IIIA	600860	A			
13.84	12	21	09	13q13.3	DCLK1, DCAMKL1, CLICK1, CL1, KIAA0369		Doublecortin-like kinase 1	604742	R, A			3(Dclk1)
13.85	10	18	96	13q13.3	MAB21L1		mab-21 (C. elegans)-like 1	601280	REa, Fd, R			
13.86	12	7	03	13q13.3	STOML3, SRO		Stomatin-like protein 3	608327	REc			
13.87	7	4	95	13q13-q14.3	ENUR1		Enuresis, nocturnal, 1	600631	Fd		Enuresis, nocturnal, 1 (2)	
13.88	11	11	14	13q13.3	EXOSC8, OIP2, RRP43, PCH1C		Exosome component 8	606019	R, REc		Pontocerebellar hypoplasia, type 1C, 616081 (3)	
13.89	9	14	12	13q13.1	FRY, C13orf14		Furry, Drosophila, homolog of	614818	REc			
13.90	6	27	08	13q13.1	HPRHP		Hypophosphatemic rickets and hyperparathyroidism	612089	Ch	?due to altered KLOTHO expression	Hypophosphatemic rickets and hyperparathyroidism (2)	
13.91	8	5	15	13q13.1	LGR8, GREAT		Leucine-rich repeat-containing G protein-coupled receptor 8	606655	REc			
13.92	6	22	14	13q13.1	N4BP2L2, PFAAP5		NEDD4-binding protein 2-like 2	615788	REc			
13.93	3	3	03	13q13.3	TRPC4, TRP4		Transient receptor potential cation channel, subfamily C, member 4	603651	A			
13.94	3	14	06	13q13.3	NBEA		Neurobeachin	604889	REc, R, REa, Ch	site of FRA13A		3(Nbea)
13.95	3	25	14	13q13.3	ALG5		Alg5, S. cerevisiae, homolog of	604565	REc			
13.96	8	14	13	13q14.11	COG6, COD2, KIAA1134, CDG2L, SHNS		Component of oligomeric golgi complex 6	606977	R, REc		Congenital disorder of glycosylation, type IIl, 614576 (3); Shaheen syndrome, 615328 (3)	
13.97	2	28	03	13q14.11	EPSTI1		Epithelial stromal interaction 1	607441	REc, REa			
13.98	7	26	10	13q13.3	FAM48A, P38IP, C13orf19		Family with sequence similarity 48, member A	613417	A, R			
13.99	9	13	17	13q13.3	FREM2, FRASRS2		FRAS1-related extracellular matrix protein 2	608945	REc		Fraser syndrome 2, 617666 (3)	3(my)
13.100	6	9	09	13q13.3	IBD27		Inflammatory bowel disease 27	612796	Fd		{Inflammatory bowel disease 27} (2)	
13.101	4	24	08	13q14.11	MRPS31		Mitochondrial ribosomal protein S31	611992	REc	4 pseudogenes		
13.102	11	3	14	13q13.3	SOHLH2		Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 2	616066	REc			3(Sohlh2)
13.103	2	11	13	13q13.3-q21	PAPA5		Polydactyly, postaxial, type A5	263450	Fd	between D13S1288 and D13S632	Polydactyly, postaxial, type A5 (2)	
13.104	3	23	09	13q13.3	POSTN, OSF2, PN		Periostin	608777	R, REc			
13.105	3	5	18	13q13.3	UFM1, HLD14		Ubiquitin-fold modifier 1	610553	REc		Leukodystrophy, hypomyelinating, 14, 617899 (3)	
13.106	10	8	08	13q14	BMIQ2		Body mass index quantitative trait locus 2	606643	Fd	max lod at D13S257	[Body mass index QTL2] (2)	
13.107	6	30	08	13q14	BMND9		Bone mineral density quantitative trait locus 9	612110	Fd	associated with rs9594759	[Bone mineral density QTL 9] (2)	
13.108	12	7	07	13q14.3	CKAP2, TMAP, LB1		Cytoskeleton-associated protein 2	611569	A			
13.109	10	28	08	13q14.2	CLLD6, C13orf1		Chronic lymphocytic leukemia deletion region gene 6	607866	REc			
13.110	8	29	02	13q14.2	CYSLTR2, CYSLT2		Cysteinyl leukotriene receptor 2	605666	R			
13.111	10	28	08	13q14	CLLS2, D13S25, DBM		Leukemia, chronic lymphocytic, susceptibility to, 2	109543	D	>530kb telomeric to RB1	{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	
13.112	5	6	11	13q14	DEL13q14, C13DELq14		Chromosome 13q14 deletion syndrome	613884	Ch		Chromosome 13q14 deletion syndrome (4)	
13.113	4	19	01	13q14.2-q14.3	DLEU1, LEU1		Deleted in lymphocytic leukemia 1	605765	REc			
13.114	4	19	01	13q14.2	DLEU2, LEU2, BCMSUN		Deleted in lymphocytic leukemia 2	605766	REc			
13.115	10	24	00	13q14	GER		Gastroesophageal reflux	109350	Fd		Gastroesophageal reflux (2)	
13.116	11	11	14	13q14.2	ITM2B, BRI, ABRI, FBD, RDGCA		Integral membrane protein 2B (BRI gene)	603904	A	mutation identified in 1 RDGCA family	Dementia, familial British, 176500 (3); Dementia, familial Danish, 117300 (3); ?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	
13.117	12	18	08	13q14.1-q14.2	LRCH1, KIAA1016		Leucine-rich repeats and calponin homology domain-containing 1	610368	R, REc			
13.118	2	1	01	13q14.12	NUFIP1, NUFIP		Nuclear fragile X mental retardation protein-interacting protein 1	604354	REa, A	pseudogene on 6q12		
13.119	11	15	16	13q14.2	RCBTB1, CLLD7, GLP, RDEOA		RCC1 domain- and BTB domain-containing protein 1	607867	REc		Retinal dystrophy with or without extraocular anomalies, 617175 (3)	
13.120	11	2	98	13q13.3	RFXAP		Regulatory factor X-associated protein	601861	R		Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	
13.121	12	4	96	13q14	RIEG2, RGS2		Rieger syndrome, type 2	601499	Fd, Ch		Rieger syndrome, type 2 (2)	
13.122	10	28	08	13q14.2	SETDB2, CLLD8		SET domain protein, bifurcated, 2	607865	REc			
13.123	6	4	99	13q14.11	SLC25A15, ORNT1, HHH		Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)	603861	D, Ch, REc	with deficiency of factors VII and X in 3 unrelated cases	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	
13.124	4	27	12	13q14	SPG24		Spastic paraplegia 24, autosomal recessive	607584	Fd		Spastic paraplegia 24, autosomal recessive (2)	
13.125	2	19	07	13q14.11	TSC22D1, TSC22		TSC22 domain family, member 1	607715	A			
13.126	12	7	07	13q14.11	TNFSF11, OPGL, TRANCE, OPTB2		Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)	602642	R, H		Osteopetrosis, autosomal recessive 2, 259710 (3)	14(Trance)
13.127	10	23	87	13q14	XRS		X-ray sensitivity	194370	Ch			
13.128	7	19	12	13q14.3	CTAGE3		Cutaneous T-cell lymphoma-associated antigen 3	608857	REc			
13.129	5	31	06	13q14.2	HTR2A		5-hydroxytryptamine (serotonin) receptor-2A	182135	REa, A, Fd		{Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3); {Seasonal affective disorder, susceptibility to}, 608516 (3); {Alcohol dependence, susceptibility to}, 103780 (3); {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3)	14(Htr2)
13.130	3	11	03	13q14.3	LECT1, CHM1		Leukocyte cell derived chemotaxin 1 (chondromodulin)	605147	A			
13.131	3	23	09	13q14.2	MLNR, GPR38		Motilin receptor	602885	A			
13.132	8	2	13	13q14.11	DNAJC15, MCJ		DNAJ/HSP40 homolog, subfamily C, member 15	615339	A, REc			
13.133	8	28	02	13q14.11	FOXO1A, FKHR		Forkhead box O1A (forkhead in rhabdomyosarcoma)	136533	Ch	chimeric with PAX3 in t(2;13); fuses with PAX3	Rhabdomyosarcoma, alveolar, 268220 (3)	
13.134	8	1	17	13q14.2	PHF11, NYREN34		PHD finger protein 11	607796	REc			
13.135	1	6	09	13q14.3	RNASEH2B, DLEU8, FLJ11712, AGS2		Ribonuclease H2, subunit B	610326	REc, Fd		Aicardi-Goutieres syndrome 2, 610181 (3)	
13.136	6	16	97	13q14.2	RB1		Retinoblastoma-1	614041	Ch, F, Fd		Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3); Bladder cancer, somatic, 109800 (3); Small cell cancer of the lung, somatic, 182280 (3); Retinoblastoma, trilateral, 180200 (3)	14(Rb1)
13.137	10	23	87	13q14.13	LCP1		Lymphocyte cytosolic protein-1 (plasmin)	153430	F, D			
13.138	1	8	01	13q14.11	MTRF1		Translational release factor, mitochondrial, 1	604601	R			
13.139	12	10	13	13q14.11	AKAP11, AKAP220		A-kinase anchor protein 11	604696	REc, R			
13.140	2	11	15	13q14.11	DGKH		Diacylglycerol kinase, eta, 130kD	604071	REc			
13.141	9	23	13	13q14.11	LACC1, C13orf31		Laccase (multicopper reductase) domain-containing protein 1	613409	REc			
13.142	7	6	10	13q14.11	CCDC122		Coiled-coil domain-containing protein 122	613408	REc			
13.143	8	5	99	13q14.13	CPB2, CPU, TAFI		Carboxypeptidase B2, plasma (carboxypeptidase U)	603101	Psh			
13.144	8	8	13	13q14.11	ELF1, RIA1, EFTUD1		E74-like factor 1	189973	A, REc			
13.145	4	4	07	13q14.11	ENOX1, CNOX		ECTO-NOX disulfide-thiol exchanger 1	610914	REc			
13.146	10	23	87	13q14.2	ESD		Esterase D; S-formylglutathione hydrolase	133280	S, F, D	proximal to RB1, WND		14(Es10)
13.147	10	25	17	13q14.11	KBTBD6		Kelch repeat- and BTB domain-containing protein 6	617738	REc			
13.148	10	25	17	13q14.11	KBTBD7		Kelch repeat- and BTB domain-containing protein 7	617739	REc			
13.149	7	8	10	13q14.11	LPRS6		Leprosy, susceptibility to, 6	613407	Fd	associated with rs9533634 and rs3764147	{Leprosy, susceptibility to, 6} (2)	
13.150	3	8	07	13q14.13	SLC25A30, KMCP1		Solute carrier family 25 (mitochondrial carrier, kidney), member 30	610793	REc			
13.151	6	12	17	13q14.11	VWA8, KIAA0564		von Willebrand factor A domain-containing protein 8	617509	REc, H			14(Vwa8)
13.152	3	31	15	13q14.11	WBP4, FBP21		WW domain-containing binding protein 4	604981	REc			
13.153	7	27	09	13q14.13	COG3, SEC34		Component of oligomeric golgi complex 3	606975	REc			
13.154	2	2	14	13q14.13	SIAH3		SIAH E3 ubiquitin protein ligase family, member 3	615609	REc			
13.155	5	25	13	13q14.12-q14.13	GTF2F2, TF2F2, RAP30		General transcription factor IIF, polypeptide 2, 30kD	189969	REc			
13.156	11	3	11	13q14.2	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8		Lysophosphatidic acid receptor 6	609239	REc, Fd	in intron 17 of RB gene	Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	
13.157	7	13	15	13q14.13	ZC3H13, KIAA0853		Zinc finger CCCH domain-containing protein 13	616453	R, REc			
13.158	8	1	08	13q14.2	CAB39L		Calcium-binding protein 39-like protein	612175	REc			
13.159	2	7	17	13q14.2	EBPL		Emopamil-binding protein-like	617335	REc			
13.160	6	22	14	13q14.2	FNDC3A, KIAA0970, HUGO		Fibronectin type III domain-containing protein 3A	615794	REc			
13.161	3	23	06	13q14.2	MED4, DRIP36, HSPC126		Mediator of RNA polymerase II transcription, subunit 4, S. cerevisiae, homolog of	605718	REc			
13.162	7	17	02	13q14.3	NEK3		Never in mitosis gene A-related kinase 3	604044	REa, R			
13.163	4	19	16	13q14.2	NUDT15, MTH2, NUDT15D		Nucleoside diphosphate-linked moiety X motif 15	615792	REc		{Thiopurines, poor metabolism of, 2}, 616903 (3)	
13.164	6	2	15	13q14.2	SUCLA2, MTDPS5		Succinate-CoA ligase, ADP-forming, beta subunit	603921	REc		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	
13.165	8	15	03	13q14.2-q14.1	AUTS3		Autism, susceptibility to, 3	608049	Ch		{Autism susceptibility 3} (2)	
13.166	12	14	10	13q14.3	ALG11, KIAA1266, CDG1P		Alg11, S. cerevisiae, homolog of	613666	R, REc		Congenital disorder of glycosylation, type Ip, 613661 (3)	
13.167	1	29	09	13q14.2	ARL11, ARLTS1		ADP-ribosylation factor-like 11	609351	REc			
13.168	12	30	14	13q14.3	DHRS12, SDR40C1		Short-chain dehydrogenase reductase family, member 12	616163	REc			
13.169	6	15	99	13q14.3	GUCY1B2		Guanylate cyclase 1, soluble, beta-2	603695	A, Fd			
13.170	3	23	14	13q14.3	INTS6, DDX26, DICE1		Integrator complex subunit 6	604331	Ch, REc			
13.171	2	25	15	13q14.2	KCNRG, DLTET		Potassium channel regulator	607947	REc, H			14(Kcnrg)
13.172	8	5	97	13q14.2	KPNA3		Karyopherin (importin) alpha-3	601892	A			
13.173	3	23	09	13q14.2	MIR15A, MIRN15A		Micro RNA 15A	609703	REc			
13.174	3	23	09	13q14.2	MIR16-1, MIRN16-1		Micro RNA 16-1	609704	REc			
13.175	1	13	16	13q14.3	NEK5		Never in mitosis gene A-related kinase 5	616731	REc			
13.176	7	1	11	13q14.3	OLFM4, GC1, GW112		Olfactomedin 4	614061	A, R			
13.177	6	15	99	13q14.3	PCDH8		Protocadherin 8	603580	REc, H			14(Pcdh8)
13.178	1	27	11	13q14.2	RCBTB2, CHC1L		RCC1 domain- and BTB domain-containing protein 2	603524	REc			
13.179	7	22	09	13q14.3	STQTL20		Stature quantitative trait locus 20	612894	Fd	associated with rs3118914	{Stature QTL 20} (2)	
13.180	7	20	12	13q14.3	SUGT1, SGT1		Suppressor of G2 allele of Skp1, S. Cerevisiae, homolog of	604098	REc			
13.181	2	16	16	13q14.3	THSD1, TMTSP		Thrombospondin type 1 domain-containing protein 1	616821	REc			
13.182	8	20	07	13q14.2	TRIM13, RFP2, LEU5		Tripartite motif-containing protein 13	605661	REc, H			14(Trim13)
13.183	4	17	07	13q14.3	VPS36, EAP45		Vacuolar protein sorting 36, S. cerevisiae, homolog of	610903	R, REc			
13.184	5	24	13	13q14.3	WDFY2		WD repeat- and FYVE domain-containing protein 2	610418	REc, R			
13.185	4	30	02	13q14.3	ATP7B, WND		ATPase, Cu++ transporting, beta polypeptide	606882	F, Fd		Wilson disease, 277900 (3)	8(Atp7b)
13.186	3	15	10	13q21	ATXN8		Ataxin 8	613289	REc	CAG repeat results in polyglutamine expansion protein	Spinocerebellar ataxia 8, 608768 (3)	
13.187	3	9	10	13q21.33	ATXN8OS, SCA8, KLHL1AS		Ataxin 8 opposite strand	603680	REc	due to CTG repeat in untranslated DNA	Spinocerebellar ataxia 8, 608768 (3)	
13.188	10	13	00	13q21.33	KLHL1		Kelch-like 1	605332	REc			
13.189	5	26	13	13q22.3	KCTD12, PFET1, KIAA1778, C13orf2		Potassium channel tetramerization domain-containing protein 12	610521	REc, A			14(Kctd12)
13.190	11	7	05	13q21	SLI3		Specific language impairment QTL, 3	607134	Fd	max with D13S1317	Specific language impairment QTL, 3 (2)	
13.191	2	3	03	13q21.33	DIS3, KIAA1008		Dis3, S. pombe, homolog of	607533	REc			
13.192	11	10	17	13q21.3-q22.1	PIBF1, JBTS33		Progesterone-induced blocking factor 1	607532	REc		Joubert syndrome 33, 617767 (3)	
13.193	9	9	08	13q22.2	LMO7, FBXO20, FBX20, KIAA0858		LIM domain only 7	604362	REa, REc			14(Lmo7)
13.194	10	27	97	13q21-q32	PAPA2		Postaxial polydactyly, type A2	602085	Fd		Postaxial polydactyly, type A2 (2)	
13.195	6	15	99	13q21.32	PCDH9		Protocadherin 9	603581	A, D, H			14(Pcdh9)
13.196	1	29	08	13q21.1	PCDH17, PCDH68		Protocadherin 17	611760	R, REc			
13.197	2	28	97	13q31.1	POU4F1, BRN3A		POU domain, class 4, transcription factor 1	601632	Psh, REc			
13.198	4	19	12	13q21.2	DIAPH3, DIA2, DRF3, AUNA1, NSDAN		Diaphanous, Drosophila, homolog of, 3	614567	Fd, REc		Auditory neuropathy, autosomal dominant, 1, 609129 (3)	
13.199	1	30	12	13q21.2	PCDH20, PCDH13		Protocadherin 20	614449	REc			
13.200	1	1	12	13q21.2	TDRD3		Tudor domain-containing protein 3	614392	REc			
13.201	9	9	10	13q21.33	C13orf37, MOZART1		Mitotic spindle-organizing protein associated with a ring of gamma-tubulin	613448	REc			
13.202	3	11	09	13q22.2	COMMD6		COMM domain-containing protein 6	612377	REc, H			14(Commd6)
13.203	5	21	99	13q21.33	DACH		Dachshund, Drosophila, homolog of	603803	R, A			13(Dach)
13.204	2	2	14	13q22	DDH1		Developmental dysplasia of the hip 1	142700	Fd		Developmental dysplasia of the hip 1 (2)	
13.205	3	16	10	13q22.3	EDNRB, HSCR2, ABCDS, WS4A		Endothelin receptor type B	131244	REa, Ch, LD	?piebald lethal in mouse	{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)	
13.206	2	15	01	13q22.3	FBXL3A, FBL3A, FBL3		F-box and leucine-rich repeat protein 3A	605653	A			14(Fbxl3)
13.207	2	3	03	13q22.1	KLF12, AP2REP		Kruppel-like factor 12	607531	A			
13.208	8	19	13	13q22.3	MYCBP2, PAM, KIAA0916		Myc-binding protein 2	610392	REc			
13.209	8	10	99	13q22.3	SCEL		Sciellin	604112	A			
13.210	10	15	01	13q22.3	TNFRSF11B, OPG, OCIF		Tumor necrosis factor receptor superfamily, member 11B	602543	A			
13.211	3	11	09	13q22.2	UCHL3		Ubiquitin carboxyl-terminal esterase L3	603090	REc, H			14(Uchl3)
13.212	12	20	04	13q22-q32	PAND1		Panic disorder syndrome 1	167870	?locus on 22		Panic disorder syndrome 1 (2)	
13.213	5	26	13	13q21.33	BORA, C13orf34		Aurora borealis	610510	REc			
13.214	6	9	06	13q31.1	NDFIP2, N4WBP5A, KIAA1165		NEDD4 family-interacting protein 2	610041	R, REc			
13.215	12	30	14	13q22.2	TBC1D4, AS160, KIAA0603, NIDDM5		TPC1 domain family, member 4	612465	REc, R		{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	
13.216	3	2	18	13q22.3	ACOD1, IRG1		Aconitate decarboxylase 1	615275	REc			
13.217	5	17	18	13q22.3	lncRNA-ACOD1, LOC105370268		Long noncoding RNA near ACOD1	617979	REc			
13.218	7	18	14	13q22.3	CLN5		CLN5 gene	608102	Fd, REc		Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	
13.219	4	6	15	13q22.3	SLAIN1		SLAIN motif family, member 1	610491	REc			14(Slain1)
13.220	11	30	06	13q34	ADPRHL1, ARH2		ADP-ribosylhydrolase-like 1	610620	REc			
13.221	7	13	17	13q32.1	DZIP1, KIAA0996		DAZ-interacting zinc finger protein 1	608671	REc			
13.222	5	19	15	13q32.1	GPR180, ITR		G protein-coupled receptor 180	607787	A			
13.223	8	5	15	13q31.1	SLITRK1, KIAA1910, TTM		SLIT- and NTRK-like family, member 1	609678	REc, H	mutation identified in 1 TTM patient	Tourette syndrome, 137580 (3); ?Trichotillomania, 613229 (3)	17(Slitrk1)
13.224	12	28	08	13q31.2	SLITRK5, KIAA0918		SLIT- and NTRK-like family, member 5	609680	R, REc, H			14(Slitrk5)
13.225	11	22	13	13q31.1	SLITRK6, DFNMYP		SLIT- and NTRK-like family, member 6	609681	REc, H		Deafness and myopia, 221200 (3)	14(Slitrk6)
13.226	8	21	98	13q32.1	DCT, TYRP2		Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2)	191275	A			14(Tyrp2)
13.227	1	29	01	13q32.1	SOX21		SRY-box 21	604974	Psh, A			
13.228	7	27	09	13q32.2	STK24, MST3, MST3B		Serine/threonine protein kinase 24	604984	REc			
13.229	4	16	14	13q31-q33	NYS4		Nystagmus 4, congenital, autosomal dominant	193003	Fd		Nystagmus 4, congenital, autosomal dominant (2)	
13.230	8	18	14	13q31.1	RNF219, C13orf7		Ring finger protein 219	615906	REc			
13.231	2	17	16	13q31.1	SPRY2, IGAN3		Sprouty, Drosophila, homolog of, 2	602466	R, REc	mutation identified in 1 IGAN3 family	{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	
13.232	5	13	13	13q31.1	LNCR13Q1		Long noncoding RNA on 13q (TCONS_00021856)	615230	REc			
13.233	3	23	09	13q31.3	MIR17, MIR91, MIRN17		Micro RNA 17	609416	A, REc	within C13orf25; sequence encodes 2 micro RNAs		
13.234	11	3	11	13q31.3	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2		Micro RNA 17 host gene	609415	A, REc		Feingold syndrome 2, 614326 (3)	
13.235	3	23	09	13q31.3	MIR18A, MIRN18A		Micro RNA 18A	609417	A, REc	within C13orf25		
13.236	3	23	09	13q31.3	MIR19A, MIRN19A		Micro RNA 19A	609418	A, REc	within C13orf25		
13.237	3	23	09	13q31.3	MIR19B1, MIRN19B1		Micro RNA 19B1	609419	A, REc	within C13orf25		
13.238	3	23	09	13q31.3	MIR20A, MIRN20A		Micro RNA 20A	609420	A, REc	within C13orf25		
13.239	9	7	10	13q31.3	MIR92A1, MIR92-1, MIRN92-1		Micro RNA 92A1	609422	A, REc	within C13orf25		
13.240	9	28	05	13q31.3	PPR2		Photoparoxysmal response 2	609572	Fd	max lod at D13S1230	Photoparoxysmal response 2 (2)	
13.241	3	8	07	13q31.3-q32.1	MMVP3		Mitral valve prolapse, myxomatous 3	610840	Fd	max lod at D13S132	Mitral valve prolapse, myxomatous 3 (2)	
13.242	9	1	00	13q32.1	ABCC4, MRP4, MOATB		ATP-binding cassette, subfamily C, member 4	605250	R, A			
13.243	12	23	05	13q32.3	CLYBL, CLB		Citrate lyase beta-like	609686	R, REc			
13.244	2	4	15	13q32.1	DNAJC3, PRKRI, P58, ACPHD		DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)	601184	A	mutation identified in 1 ACPHD family	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	
13.245	6	15	99	13q31.3	GPC5		Glypican 5	602446	A			
13.246	10	15	09	13q31.3-q32.1	GPC6, OMIMD1		Glypican 6	604404	R, A		Omodysplasia 1, 258315 (3)	
13.247	6	18	98	13q32.3	GPR18		G protein-coupled receptor-18	602042	A			14(Gpr18)
13.248	6	1	12	13q32	KTCN7		Keratoconus 7	614629	Fd	max lod at D13S159	Keratoconus 7 (2)	
13.249	5	19	15	13q32	MCOR, C13DELq32, DEL13q32		Microcoria, congenital (chromosome 13q32 deletion syndrome)	156600	Fd, Ch	35-80kb deletion encompassing TGDS and GPR180	Microcoria, congenital (4)	
13.250	6	21	01	13q32.3	PCCA		Propionyl Coenzyme A carboxylase, alpha polypeptide	232000	REa, D, A, Fd		Propionicacidemia, 606054 (3)	14(Pcca)
13.251	12	15	98	13q32	SCZD7		Schizophrenia susceptibility locus, chromosome 13q-related	603176	Fd		{Schizophrenia}, 181500 (2)	
13.252	2	21	06	13q32	SLEB5		Systemic lupus erythematosus, susceptibility to, 5	609903	Fd	max lod at D13S892	{Systemic lupus erythematosus, susceptibility to, 5} (2)	
13.253	10	7	05	13q32.3	ZIC2, HPE5		ZIC family, member 2	603073	Ch		Holoprosencephaly 5, 609637 (3)	
13.254	6	30	05	13q32.1	HS6ST3		Heparan sulfate 6-O-sulfotransferase 3	609401	REc			
13.255	2	17	09	13q32-q33	STQTL4		Stature quantitative trait locus 4	606258	Fd	max lod at D13S779 and D13S797	{Stature QTL 4} (2)	
13.256	9	15	93	13q33.1	TPP2		Tripeptidyl peptidase II	190470	REa, A			1(Tpp2)
13.257	8	4	99	13q33.3	TNFSF13B, BLYS, BAFF		Tumor necrosis factor ligand superfamily, member 13B	603969	TM			
13.258	9	15	17	13q32.1	CLDN10, OSPL, CPETRL3, HELIX		Claudin 10	617579	REc		HELIX syndrome, 617671 (3)	
13.259	10	27	08	13q32.1	GPR80		G protein-coupled receptor 80	606922	REc			
13.260	2	13	15	13q32.1	TGDS, SDR2E1, CATMANS		TDP-glucose 4,6-dehydratase	616146	REc		Catel-Manzke syndrome, 616145 (3)	
13.261	8	27	09	13q32.1	UGGT2, HUGT2		UDP-glucose glycoprotein glucosyltransferase 2	605898	REc			
13.262	12	10	13	13q32.2	FARP1, CDEP		FERM, ARHGEF, and pleckstrin domain-containing protein 1	602654	REc			
13.263	9	27	17	13q32.2	IPO5, RANBP5, KPNB3		Importin 5	602008	REc			
13.264	4	26	10	13q32.3	A2LD1, GGACT		AIG1-like domain-containing protein 1	613378	REc			
13.265	9	29	10	13q32.3	GPR183, EBI2		G protein-coupled receptor 183	605741	R			
13.266	7	18	14	13q32.3	TM9SF2		Transmembrane 9 superfamily, member 2	604678	REc			
13.267	3	5	18	13q32.3	ZIC5, OPR		Zic family, member 5	617896	REc			
13.268	7	27	09	13q32.3	ZIZ1, KIAA1058		Zizimin 1	607325	R, REc			
13.269	9	28	15	13q33.1	ERCC5, XPG, COFS3		Excision-repair, complementing defective, in Chinese hamster, number 5	133530	S, A		Xeroderma pigmentosum, group G, 278780 (3); Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3); Cerebrooculofacioskeletal syndrome 3, 616570 (3)	1(Ercc5)
13.270	11	5	97	13q33.3	EFNB2, EPLG5, LERK5, HTKL		eph-related receptor tyrosine kinase ligand 5 (ephrin-B2)	600527	A			8(Lerk5)
13.271	10	21	99	13q33.1	ITGBL1, TIED		Integrin, beta-like 1	604234	A			
13.272	2	18	08	13q33.1	KDELC1, EP58		KDEL motif-containing 1	611613	REc			
13.273	3	16	10	13q33.1	SLC10A2, NTCP2, PBAM		Solute carrier family 10 (sodium/bile acid cotransporter family), member 2	601295	REa, A		Bile acid malabsorption, primary, 613291 (3)	8(Slc10a2)
13.274	8	21	98	13q32.2-q32.3	SLC15A1, HPECT1		Solute carrier family 15 (oligopeptide transporter), member 1	600544	REa, A			
13.275	6	4	13	13q33.1	METTL21C, C13orf39		Methyltransferase-like 21C	615259	REc			
13.276	2	11	16	13q32.3-q33.1	NALCN, IHPRF1, CLIFAHDD		Sodium leak channel, nonselective	611549	R, REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3); Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	
13.277	4	22	10	13q33.1-q34	OFC9		Orofacial cleft 9	610361	Fd	associated with rs1830756	Orofacial cleft 9 (2)	
13.278	11	3	11	13q33.2	VUR5		Vesicoureteral reflux 5	614318	Fd	nearest marker rs4476030	Vesicoureteral reflux 5 (2)	
13.279	9	8	11	13q33.3	ARGLU1		Arginine- and glutamate-rich protein 1	614046	REc			
13.280	11	13	13	13q33.3	MYO16, MYAP3, KIAA0865		Myosin XVI	615479	REc, R			
13.281	7	17	14	13q33.3	LIG4, LIG4S		Ligase IV, DNA, ATP-dependent	601837	A		LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500 (3)	
13.282	7	27	09	13q34	ARHGEF7, PIXB, COOL1		Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor, beta)	605477	R, REc			
13.283	1	23	93	13q34	ATP4B		ATPase, H+, K+ transporting, beta	137217	A			
13.284	7	27	09	13q34	ATP11A, ATPIS, ATPIH		ATPase, class VI, type 11A	605868	REc			
13.285	8	18	14	13q34	CARKD		Carbohydrate kinase domain-containing protein	615910	REc			
13.286	12	3	15	13q34	CARS2, COXPD27		Cysteinyl-tRNA synthetase 2	612800	R, REc		Combined oxidative phosphorylation deficiency 27, 616672 (3)	
13.287	8	8	13	13q34	CDC16, APC6		Cell division cycle 16, S. cerevisiae, homolog of	603461	REc			
13.288	9	29	15	13q34	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40		Chromosome alignment-maintaining phosphoprotein 1	616327	REc		Mental retardation, autosomal dominant 40, 616579 (3)	
13.289	9	28	17	13q34	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR		Collagen IV, alpha-1 polypeptide	120130	REa, A, REb, RE, Fd	mutation identified in 1 RATOR family	Porencephaly 1, 175780 (3); Brain small vessel disease with or without ocular anomalies, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3); ?Retinal arteries, tortuosity of, 180000 (3); Schizencephaly, 269160 (3)	8(Col4a1)
13.290	3	18	13	13q34	COL4A2, POREN2, ICH		Collagen IV, alpha-2 polypeptide	120090	REa, A, RE, Fd		Porencephaly 2, 614483 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	8(Col4a2)
13.291	10	29	09	13q34	CUL4A		Cullin 4A	603137	Psh, A			
13.292	5	19	09	13q33.2	DAOA, G72		D-amino acid oxidase activator	607408	Fd		{Schizophrenia}, 181500 (2)	
13.293	1	27	11	13q33.2	DAOAAS, G30		DAOA antisense RAN	607415	REn			
13.294	9	15	11	13q34	DFNA33		Deafness, autosomal dominant 33	614211	Fd	maximum lod at D13S285	Deafness, autosomal dominant 33 (2)	
13.295	4	15	11	13q34	F7		Coagulation factor VII	613878	D		Factor VII deficiency, 227500 (3); {Myocardial infarction, decreased susceptibility to}, 608446 (3)	
13.296	10	23	87	13q34	F10		Coagulation factor X	613872	D, A, REa		Factor X deficiency, 227600 (3)	8(Cf10)
13.297	8	9	05	13q33.1	FGF14, FHF4, SCA27		Fibroblast growth factor-14	601515	REa, H, Fd		Spinocerebellar ataxia 27, 609307 (3)	14(Fhf4)
13.298	2	15	96	13q34	GAS6, AXLLG, AXSF		Growth arrest-specific 6	600441	A			8(Gas6)
13.299	4	2	07	13q34	GRK1, RHOK, RK		G protein-dependent receptor kinase 1 (rhodopsin kinase)	180381	REa, A		Oguchi disease-2, 613411 (3)	
13.300	11	16	05	13q34	ING1		Inhibitor of growth 1	601566	A, R		Squamous cell carcinoma, head and neck, somatic, 275355 (3)	
13.301	2	5	01	13q34	IRS2		Insulin receptor substrate 2	600797	R, REc		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
13.302	2	9	92	13q34	LAMP1		Lysosome-associated membrane protein-1	153330	A, REa			8(Lamp1)
13.303	9	26	11	13q34	MCF2L, OST, KIAA0362		MCF2-like protein	609499	R, REc			
13.304	1	31	11	13q34	PCID2		PCI domain-containing protein 2	613713	REc			
13.305	4	10	15	13q34	PROZ, PZ		Protein Z	176895	REc		[Protein Z deficiency], 614024 (3)	
13.306	7	17	91	13q32.1	RAP2A		RAP2, member of RAS oncogene family (K-rev)	179540	A			
13.307	7	27	09	13q34	RASA3		Ras p21 protein activator 3	605182	R, REc			
13.308	6	9	98	13q34	SOX1		SRY (sex determining region Y)-box 1	602148	A			
13.309	11	1	99	13q34	TFDP1, DP1, DRTF1		Transcription factor Dp-1	189902	A	pseudogene on 1q32.3		
13.310	9	29	16	13q34	TMCO3, C13orf11		Transmembrane and coiled-coil domains protein 3	617134	REc			
13.311	12	22	17	13q34	TUBGCP3, GCP3, GRIP104, SPC98, ALP6		Tubulin-gamma complex-associated protein 3	617818	REc			
13.312	2	1	11	13q34	UPF3A, RENT3A		UPF3 regulator of nonsense transcripts, yeast, homolog of, A	605530	REc			
14.1	4	26	90	14p12	RNR2		Ribosomal RNA-2	180451	A			
14.2	2	17	09	14p11.2-q13	ADIPQTL3, CAQ14		Adiponectin, serum level of, quantitative trait locus 3	606771	Fd	between D14S608 and D14S599	{Adiponectin, serum level of, QTL3} (2)	
14.3	1	31	01	14q12	ADAP6, ADAP100		A-kinase anchor protein 6	604691	R, REc			
14.4	8	14	15	14q32.12	GOLGA5, RFG5		Golgi autoantigen, golgin subfamily A, 5	606918	REc	fused with RET to form PTC5		
14.5	4	21	98	14q23.2-q23.3	ESR2		Estrogen receptor-2 (ER beta)	601663	REa, R			
14.6	6	2	98	14q21.1	MGEA, MEA6		Meningioma-expressed antigen 6	602132	A	?pseudogenes on other chromosomes		
14.7	8	18	14	14q21.3	RPS29, DBA13		Ribosomal protein S29	603633	R,		Diamond-Blackfan anemia 13, 615909 (3)	
14.8	7	7	17	14q32.2	YY1, GADEVS		YY1 transcription factor	600013	REa, H		Gabriele-de Vries syndrome, 617557 (3)	12(Yy1)
14.9	3	30	11	14q11.2	RPGRIP1, LCA6, CORD13		Retinitis pigmentosa GTPase regulator-interacting protein	605446	R, REa		Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13, 608194 (3)	
14.10	9	2	09	14q11.2	TRNAP1, TRP1		tRNA proline-1	189930	REa, A, Fd			
14.11	1	16	18	14q11	ZFHX2AS1		ZFHX2 antisense RNA 1	617833	REc, H			14(Zfhx2as1)
14.12	6	26	00	14q11.2	ZNF219		Zinc finger protein-219	605036	REc			
14.13	5	6	09	14q11.2	DAD1		Defender against cell death 1	600243	A			14(Dad1)
14.14	2	21	02	14q11-q12	IBD4		Inflammatory bowel disease 4	606675	Fd		{Inflammatory bowel disease 4} (2)	
14.15	10	7	13	14q11.2	MMP14, WNCHRS		Matrix metalloproteinase 14 (membrane-inserted)	600754	A	mutation identified in 1 family	?Winchester syndrome, 277950 (3)	
14.16	3	28	15	14q11.2	TRL-AAG2-1, TRNAL1, TRL1		tRNA leucine (AAG) 2-1	189932	REa, A, Fd			
14.17	9	2	09	14q11.2	TRNAP2, TRP2		tRNA proline-2	189931	REa, A, Fd			
14.18	9	2	09	14q11.2	TRNAT2, TRT2		tRNA threonine-2	189933	REa, A, Fd			
14.19	4	27	12	14q22.1	ATL1, SPG3A, HSN1D		Atlastin GTPase 1	606439	REc, Fd		Spastic paraplegia 3A, autosomal dominant, 182600 (3); Neuropathy, hereditary sensory, type ID, 613708 (3)	
14.20	1	21	07	14q12	GMPR2		Guanosine monophosphate reductase 2	610781	REc			
14.21	9	29	10	14q11-q22	DEL14q11q22, C14DELq11q22		Chromosome 14q11-q22 deletion syndrome	613457	Ch	contiguous gene syndrome	Chromosome 14q11-q22 deletion syndrome (4)	
14.22	1	27	04	14q11.2	C14orf18, HEI10		Human enhancer of invasion 10	608249	REc			
14.23	12	17	08	14q11.2	METTL3, IME4		Methyltransferase-like 3	612472	R, REc			
14.24	3	7	05	14q11-q12	NRL, D14S46E, RP27		Neural retina leucine zipper	162080	REa, A, Fd		Retinitis pigmentosa 27, 613750 (3); Retinal degeneration, autosomal recessive, clumped pigment type (3)	14(Nrl)
14.25	1	14	03	14q11.2	RAB2B		Ras-associated protein RAB2B	607466	REc			
14.26	9	8	14	14q11.2	SALL2, HSAL2, COLB		Sal-like 2	602219	A	mutation identified in 1 COLB family	?Coloboma, ocular, autosomal recessive, 216820 (3)	
14.27	4	30	12	14q11.2	ACIN1, KIAA0670		Acinus	604562	R, REc			
14.28	5	16	95	14q12	ADCY4		Adenylate cyclase-4	600292	REa			14(Adcy4)
14.29	12	18	08	14q11.2	ANG, RNASE5, ALS9		Angiogenin	105850	A, REa, Fd, REn	proximal to TCRA/TCRD	Amyotrophic lateral sclerosis 9, 611895 (3)	14(Ang)
14.30	5	27	05	14q11.2	CEBPE, CRP1		CCAAT/enhancer-binding protein (C/EBP), epsilon	600749	H, A		Specific granule deficiency, 245480 (3)	14(Cebpe)
14.31	1	24	13	14q11.2	CHD8, DUPLIN, KIAA1564, AUTS18		Chromodomain helicase DNA-binding protein 8	610528	R, REc		{Autism, susceptibility to, 18}, 615032 (3)	
14.32	1	21	00	14q12	CMA1		Chymase-1, mast cell	118938	REa, REn			
14.33	12	5	11	14q11.2	CMTM5, CKLFSF5		CKLF-like marvel transmembrane domain-containing 5	607888	REc			14(Cklfsf5)
14.34	2	28	01	14q11.2	CPNE6		Copine VI	605688	R, REc			
14.35	4	25	93	14q12	CTSG		Cathepsin G	116830	A, REn			
14.36	3	29	10	14q12	DCAF11, WDR23		DDB1- and CUL4-associated factor 11	613317	REc			
14.37	5	6	13	14q11.2	DHRS2, HEP27		Short-chain dehydrogenase/reductase family, member 2	615194	A, REc			
14.38	2	23	08	14q11.2	DHRS4, NRDR		Short-chain dehydrogenase/reductase family, member 4	611596	REc			
14.39	4	27	16	14q11.2	DHRS4AS1, AS1DHRS4, C14orf67		DDHRS4 antisense RNA 1, noncoding	616925	REc			
14.40	5	6	13	14q11.2	DHRS4L1		Short-chain dehydrogenase/reductase family, member 4-like 1	615195	REc			
14.41	5	6	13	14q11.2	DHRS4L2		Short-chain dehydrogenase/reductase family, member 4-like 2	615196	REc			
14.42	4	12	18	14q11.2	EDDM3A, FAM12A, HE3A		Epididymal protein 3A	611580	R, REc			
14.43	12	7	07	14q11.2	FAM12B, HE3B		Family with sequence similarity 12, member B	611582	REc			
14.44	8	21	98	14q12	GZMB, CTLA1, CSPB		Granzyme B (cytotoxic T-lymphocyte-associated serine esterase-1; cathepsin G-like 1)	123910	A, REa, RE			14(Ctla1)
14.45	8	20	98	14q12	GZMH, CTSGL2		Granzyme H (cathepsin G-like 2)	116831	A, REn			
14.46	9	7	10	14q11.2	HAUS4, C14orf94		HAUS augmin-like complex, subunit 4	613431	REc			
14.47	6	1	12	14q11.2	HNRNPC, HNRPC		Heterogeneous nuclear ribonucleoprotein C	164020	R, REc			
14.48	11	11	14	14q11.2	HOMEZ, KIAA1443		Homeodomain leucine zipper-containing factor	608119	REc, H			14(Homez)
14.49	2	2	07	14q11.2	IL25, IL17E		Interleukin 25	605658	REc			
14.50	6	22	99	14q12	ISGF3, ISGF3G		Interferon-stimulated gene transcription factor 3, gamma, 48kD	147574	RE			
14.51	3	1	06	14q11.2	LRP10, LRP9		Low density lipoprotein receptor-related protein 10	609921	R, H			14(Lrp10)
14.52	7	18	12	14q11.2	LRRC16B		Leucine-rich repeat-containing protein 16B	614716	REc			
14.53	11	24	14	14q11.2	METTL17, METT11D1		Methyltransferase-like 17	616091	REc			
14.54	11	24	14	14q11.2	MHRT		Myosin heavy chain-associated RNA transcript, noncoding	616096	REc, H			14(Mhrt)
14.55	1	27	11	14q11.2	MIR208B, MIRN208B		Micro RNA 208B	613613	REc			14(Mir208b)
14.56	3	5	08	14q11.2	MRPL52		Mitochondrial ribosomal protein L52	611856	R, REc			
14.57	9	19	00	14q11.2	NDRG2		N-myc downstream-regulated gene 2	605272	R			
14.58	2	20	07	14q11.2	NGDN, NGD		Neuroguidin	610777	R, REc			
14.59	7	13	09	14q11.2	NRCLP5		Narcolepsy 5	612851	Fd	associated with rs1154155, rs12587781, rs1263646	{Narcolepsy 5} (2)	
14.60	2	15	96	14q11.2	OXA1L		Oxidase (cytochrome c) assembly 1-like	601066	A			
14.61	4	19	06	14q11.2	PARP2, ADPRTL2, ADPRT2		Poly(ADP-ribose) polymerase 2	607725	R, A			14(Adprtl2)
14.62	6	19	98	14q11.2	PSMB5, LMPX		Proteasome subunit, beta type, 5	600306	REn			
14.63	9	10	07	14q11.2	PSMB11		Proteasome subunit, beta-type, 11	611137	REc			
14.64	6	19	98	14q12	PSME1, IFI5111		Proteasome activator subunit-1	600654	A			
14.65	6	19	98	14q12	PSME2		Proteasome activator subunit-2	602161	A			
14.66	3	2	98	14q12	RABGGTA		Rab geranylgeranyltransferase, alpha subunit	601905	REa, A			
14.67	6	2	16	14q11.2	REM2		RRAD- and GEM-like GTPase 2	616955	REc			
14.68	8	27	01	14q12	RIPK3, RIP3		Receptor-interacting serine/threonine kinase 3	605817	A			
14.69	12	18	08	14q11.2	RNASE1, RNS1		Ribonuclease, RNase A family, 1 (pancreatic)	180440	H, REn			14(Rib1)
14.70	12	18	08	14q11.2	RNASE2, RNS2, EDN		Ribonuclease, RNase A family, 2, liver (eosinophil-derived neurotoxin)	131410	REa, A, REn			
14.71	12	18	08	14q11.2	RNASE3, RNS3, ECP		Ribonuclease, RNase A family, 3 (eosinophil cationic protein)	131398	REa, A, REn			
14.72	12	18	08	14q11.2	RNASE4, RNS4		Ribonuclease, RNase A family, 4	601030	Psh, REn			
14.73	12	18	08	14q11.2	RNASE6		Ribonuclease, RNase A family, k6	601981	Psh, REn			
14.74	12	24	08	14q11.2	RNASE7		Ribonuclease A family 7	612484	REc			
14.75	12	18	08	14q11.2	RNASE8		Ribonuclease A family, 8	612485	REn			
14.76	9	8	11	14q11.2	RNAE9		Ribonuclease A family, 9	614014	REc			
14.77	12	24	08	14q12	RNF31, ZIBRA		Ring finger protein 31	612487	REc			
14.78	9	23	13	14q11.2	RPPH1, H1RNA		Ribonuclease P, RNA component H1	608513	REc			
14.79	12	8	00	14q11.2	RSCIS		Radiation sensitivity/chromosome instability syndrome, autosomal dominant	605463	Ch		Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)	
14.80	3	10	99	14q11.2	SLC7A7, LPI		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7	603593	A, Fd, LD		Lysinuric protein intolerance, 222700 (3)	
14.81	10	22	99	14q11.2	SLC7A8, LAT2		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8	604235	R			
14.82	10	13	09	14q11.2	SLC22A17, NGALR, BOIT, BOCT, NGALR2, NGALR3		Solute carrier family 22, organic cation transporter, member 17	611461	R, REc			
14.83	2	26	03	14q13.3	SLC25A21, ODC		Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21	607571	A			
14.84	7	31	08	14q11.2	SLC39A2, ZIP2		Solute carrier family 39 (zinc transporter), member 2	612166	R, REc			
14.85	4	25	06	14q11.2	SOLO, FLJ10357		SOLO gene	610018	REc			
14.86	2	25	15	14q11.2	SUPT16H, SPT16		Suppressor of ty 16, S. cerevisiae, homolog of	605012	REc			
14.87	10	15	13	14q11.2	TRAC, TRCA, TRA, IMD7		T-cell receptor alpha	186880	H, REa, A, REn	cen--V-C--ter	Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	14(Tcra)
14.88	10	15	13	14q11.2	TRDC		T-cell receptor delta chain constant region	186810	RE, Ch, REc	in midst of TCRA		14(Tcrd)
14.89	10	15	13	14q11.2	TRDD@		T-cell receptor delta chain diversity gene cluster	615460	REc			
14.90	10	15	13	14q11.2	TRDV@		T-cell receptor delta chain variable gene cluster	615459	REc			
14.91	10	15	13	14q11.2	TRDJ@		T-cell receptor delta chain joining gene cluster	615461	REc			
14.92	5	28	98	14q11.2	TEP1, TP1		Telomerase-associated protein-1	601686	A, H			14(Tep1)
14.93	1	18	13	14q12	TGM1, ICR2, ARCI1		Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)	190195	REa, A, Fd		Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	
14.94	2	18	08	14q11.2	THTPA		Thiamine triphosphatase	611612	REc			
14.95	6	8	11	14q11.2	TOX4, LCP1, KIAA0737		TOX high mobility group box family member 4	614032	R, REc			
14.96	6	2	16	14q11.2	TPPP2, p18		Tubulin polymerization-promoting protein family, member 2	616956	REc			
14.97	10	15	13	14q11.2	TRAJ@		T-cell receptor alpha chain joining gene cluster	615443	REc, Ch			
14.98	10	15	13	14q11.2	TRAV@		T-cell receptor alpha chain variable gene cluster	615442	REn, Ch			
14.99	1	22	07	14q12	TSSK4, TSSK5		Testis-specific serine/threonine kinase 4	610711	REc			
14.100	1	16	18	14q11.2	ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS		Zinc finger homeobox 2	617828	REc	mutation identified in 1 MARSIS family	?Marsili syndrome, 147430 (3)	
14.101	3	3	98	14q11.2	BCL2L2, BCLW		BCL2-like 2	601931	A			
14.102	3	16	06	14q11.2-q12	DFNA53		Deafness, autosomal dominant 53	609965	Fd	max lod at D14S1280	Deafness, autosomal dominant 53 (2)	
14.103	3	16	06	14q11.2	EFS		Embryonal FYN-associated substrate	609906	A			
14.104	10	15	98	14q12	LTB4R, CMKRL1, P2RY7, BLTR		Leukotriene b4 receptor (purinergic receptor P2Y, G protein-coupled, 7; chemokine receptor-like 1)	601531	A			
14.105	8	27	01	14q12	LTB4R2, BLTR2, BLT2		Leukotriene B4 receptor 2	605773	REc			
14.106	12	20	11	14q11.2-q12	MRT9, MRT26		Mental retardation, autosomal recessive, 9/26	611095	Fd	between rs1998463 and rs243286	Mental retardation, autosomal recessive, 9/26 (2)	
14.107	5	24	13	14q11.2-q12	PAURT1		Preauricular tag, isolated, autosomal dominant, 1	610420	Fd	between D14S990 and D14S264	Preauricular tag, isolated, autosomal dominant, 1 (2)	
14.108	7	11	11	14q11-q12	PCK2, PEPCK2		Phosphoenolpyruvate carboxykinase 2, mitochondrial	614095	A		PEPCK deficiency, mitochondrial, 261650 (1)	
14.109	10	31	17	14q11.2	OSGEP, FLJ20411, GAMOS3		O-sialoglycoprotein endopeptidase	610107	REc		Galloway-Mowat syndrome 3, 617729 (3)	
14.110	10	29	03	14q12	REC8L1, REC8		Rec8, S. pombe, homolog of	608193	A			
14.111	1	30	12	14q11.2-q13	HHPP		Hyperhidrosis palmaris et plantaris	144110	Fd	between D14S283 and D14S264	Hyperhidrosis palmaris et plantaris (2)	
14.112	11	16	05	14q11.2	PABPN1, PABP2, PAB2		Poly(A)-binding protein, nuclear 1	602279	REc, Fd		Oculopharyngeal muscular dystrophy, 164300 (3)	
14.113	7	19	06	14q11.2-q12	SPD3		Synpolydactyly 3	610234	Fd	max lod at D14S264	Synpolydactyly 3 (2)	
14.114	4	27	12	14q12	AP4S1, CPSQ6, SPG52		Adaptor-related protein complex 4, sigma-1 subunit	607243	R, REc		Spastic paraplegia 52, autosomal recessive, 614067 (3)	
14.115	6	24	94	14q11.2	APEX, APE		APEX nuclease (multifunctional DNA repair enzyme)	107748	Psh, A			14(Apex)
14.116	3	14	07	14q12	ARHGAP5, RHOGAP5		RHO GTPase-activating protein 5	602680	R, REc			
14.117	9	9	09	14q12	CBLN3		Precerebellin 3	612978	REc			14(Cbln3)
14.118	8	2	13	14q13.1	CFL2, NEM7		Cofilin 2, muscle	601443	Psh, REc		Nemaline myopathy 7, autosomal recessive, 610687 (3)	
14.119	3	29	07	14q12	CHMP4A, SNF7		CHMP family, member 4A	610051	R, REc			
14.120	12	3	96	14q12	DFNB5		Deafness, autosomal recessive 5	600792	Fd		Deafness, autosomal recessive 5 (2)	
14.121	2	16	18	14q12	FITM1, FIT1		Fat storage-inducing transmembrane protein 1	612028	R, REc			
14.122	5	24	13	14q12	G2E3, KIAA1333		G2/M phase-specific E3 ubiquitin ligase	611299	REc			
14.123	2	25	14	14q12	GPR33		G protein-coupled receptor 33	610118	REc, A			
14.124	1	27	11	14q11.2	MIR208A, MIRN208A, MIR208, MIRN208		Micro RNA 208A	611116	REc			
14.125	7	22	11	14q11.2	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3		Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	REa, RE, D, A, Fd		Cardiomyopathy, hypertrophic, 14, 613251 (3); Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)	14(Myhca)
14.126	6	9	15	14q11.2	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD		Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	REa, RE, D, A	5'-B-4.5kb-A-3'	Cardiomyopathy, hypertrophic, 1, 192600 (3); Cardiomyopathy, dilated, 1S, 613426 (3); Myopathy, myosin storage, autosomal dominant, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3); Left ventricular noncompaction 5, 613426 (3); Myopathy, myosin storage, autosomal recessive, 255160 (3)	
14.127	6	13	12	14q12	NEDD8		Neural precursor cel expressed, developmentally downregulated 8	603171	REc			
14.128	1	27	11	14q12	NUBPL, IND1		Nucleotide-binding protein-like protein	613621	REc		Mitochondrial complex I deficiency, 252010 (3)	
14.129	2	24	17	14q12	PRKD1, PRKCM, PKD, CHDED		Protein kinase D1	605435	REa, R, REc		Congenital heart defects and ectodermal dysplasia, 617364 (3)	
14.130	12	30	14	14q12	SDR39U1		Short-chain dehydrogenase/reductase family 39U, member 1	616162	REc			
14.131	8	21	12	14q12	STRN3, SG2NA		Striatin, calmodulin-binding protein 3	614766	REc, A			
14.132	11	18	11	14q12	STXBP6, AMISYN, HSPC156		Syntaxin-binding protein 6	607958	R, REc			
14.133	12	24	11	14q12	TINF2, TIN2, DKCA3		TRF1-interacting nuclear factor 2	604319	REc		Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz syndrome, 268130 (3)	
14.134	5	29	13	1p34.3	ZMYM6, ZNF258		Zinc finger, MYM-type 6	613567	A			
14.135	2	28	01	14q13.1-q13.2	BAZ1A		Bromodomain adjacent to zinc finger domain, 1A	605680	REa, R			
14.136	08	27	18	14q12	COCH, DFNA9, DFNB110		Cochlin	603196	Fd, A	mutation identified in 1 DFNB110 family	Deafness, autosomal dominant 9, 601369 (3); ?Deafness, autosomal recessive 110, 618094 (3)	12(Coch5B2)
14.137	2	11	08	14q13.3	NKX2-8, NKX2H, NKX2.8		NK2 homeobox 8	603245	REn, H			12(Nkx2-9)
14.138	4	24	09	14q13.3	PAX9, STHAG3		Paired box gene 9	167416	REa, A		Tooth agenesis, selective, 3, 604625 (3)	
14.139	4	27	12	14q12-q21	SPG32		Spastic paraplegia-32	611252	Fd	between D14S264 and D14S978	Spastic paraplegia 32, autosomal recessive (2)	
14.140	10	27	97	14q12-q22	ARVD3		Arrhythmogenic right ventricular dysplasia 3	602086	Fd	?distinct from ARVD1	Arrhythmogenic right ventricular dysplasia 3 (2)	
14.141	1	2	03	14q21.1	FOXA1, HNF3A		Forkhead box A1 (hepatocyte nuclear factor-3, alpha)	602294	A, D			12(Hnf3a)
14.142	7	22	11	14q12	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1		Forkhead box G1B	164874	REa, A		Rett syndrome, congenital variant, 613454 (3)	
14.143	3	1	07	14q13	HPE8		Holoprosencephaly 8	609408	Fd	between D14S49 and D14S1014	Holoprosencephaly 8 (2)	
14.144	3	14	06	14q13.2	KIAA0391		KIAA0391 gene	609947	R, REc			
14.145	11	6	14	14q13.3-q21.1	MIPOL1		MIPOL1 gene	606850	Ch			
14.146	7	10	08	14q13.2	NFKBIA, IKBA		Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha	164008	A		Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	12(ikba)
14.147	9	1	15	14q13.3	NKX2-1, TITF1, NKX2A, TTF1, NMTC1		NK2 homeobox 1	600635	A		{Thyroid cancer, nonmedullary, 1}, 188550 (3); Chorea, hereditary benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	
14.148	9	8	17	14q12	NOVA1		NOVA alternative splicing regulator 1	602157	H, REc			12(Nova1)
14.149	3	24	06	14q13.1	NPAS3, MOP6		Neuronal PAS domain protein 3	609430	REc, H			12(Npas3)
14.150	11	2	11	14q13.2	PSMA6, PROS27, P27K		Proteasome subunit, alpha-type, 6	602855	A		{Myocardial infarction, susceptibility to}, 608446 (3)	
14.151	4	25	93	14q21.1	SSTR1		Somatostatin receptor-1	182451	REa			12(Sstr1)
14.152	5	23	00	14q21.3	POLE2, DPE2		Polymerase, DNA, epsilon-2	602670	REa, A			
14.153	8	25	04	14q13-q21	RLS2		Restless legs syndrome, susceptibility to, 2	608831	Fd	max lod at D14S288	{Restless legs syndrome 2} (2)	
14.154	9	11	02	14q22.1	WW45, SAV		WW domain-containing protein, 45kD	607203	R			
14.155	4	27	12	14q13.1	EGLN3, PHD3, HIFP4H3		Egl9, C. elegans, homolog of, 3	606426	REc			
14.156	12	17	09	14q11.2	PNP, NP		Purine nucleoside phosphorylase	164050	S, D	centromeric to TCRA	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	14(Np1,2)
14.157	12	10	12	14q13.1	SNX6		Sorting nexin 6	606098	R, REc			
14.158	9	8	11	14q13.2	INSM2, IA6		Insulinoma-associated 2	614027	REc			
14.159	9	10	12	14q13.1	SPTSSA, C14orf147, SSSPTA		Serine palmitoyltransferase, small subunit, A	613540	REc			
14.160	8	19	14	14q13.2	PPP2RC2, G5PR		Protein phosphatase 2, regulatory subunit B-double prime, gamma	615902	REc			
14.161	7	9	06	14q13.2	SRP54		Signal recognition particle, 54kD	604857	R			
14.162	6	22	10	14q13.2	RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884		Ral GTPase activating protein, alpha subunit 1 (catalytic)	608884	Psh, A	pseudogene on 9q31.1		12(Garnl1)
14.163	2	4	09	14q21.1	FBXO33, FBX33, BMND12		F-box only protein 33	609103	REc			12(Fbxo33)
14.164	6	30	05	14q13.3	MBIP		MAP3K12-binding inhibitory protein	609431	R, REc			
14.165	9	14	12	14q13.3	PTCSC3		PTCSC3 gene	614821	REc			
14.166	1	3	18	14q13.3	SFTA3, SPH		Surfactant-associated protein 3	617860	REc			
14.167	2	1	11	14q13.3-q21.1	HPV6AI1		Human papillomavirus type 6A integration site 1	604461	REc	previously assigned to 10q24		
14.168	5	28	02	14q22.1	GNG2		Guanine nucleotide-binding protein, gamma-2	606981	Psh, A			14(Gng2)
14.169	9	10	07	14q21.3	MDGA2		MAM domain-containing glycosylphosphatidylinositol anchor 2	611128	REc, H			12(Mdga2)
14.170	4	16	10	14q21.3	MGAT2, CDGS2, CDG2A		Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase	602616	A		Congenital disorder of glycosylation, type IIa, 212066 (3)	
14.171	9	2	12	14q22.3	PELI2		Pellino, Drosophila, homolog of, 2	614798	REc			
14.172	9	24	15	14q21.3	SOS2, NS9		Son of sevenless, Drosophila, homolog of, 2	601247	A		Noonan syndrome 9, 616559 (3)	12(Sos2)
14.173	12	4	02	14q23.1	TIMM9, TIM9		Translocase of inner mitochondrial membrane 9, yeast, homolog of	607384	REc, A, R			
14.174	10	15	97	14q22.3	LGALS3, MAC2, GALBP		Lectin, galactose-binding, soluble, 3	153619	A	assigned earlier to 1p13		
14.175	9	4	98	14q23.1	RTN1, NSP		Reticulon 1 (neuroendocrine-specific protein)	600865	A			
14.176	6	15	99	14q23.2	HIF1A, MOP1		Hypoxia-inducible factor 1, alpha subunit	603348	A,			12(Hif1a)
14.177	12	27	01	14q22.1	TRIM9, SPRING, KIAA0282		Tripartite motif-containing protein 9	606555	R			
14.178	3	3	16	14q21.1	CLEC14A		C-type lectin domain family 14, member A	616845	REc			
14.179	9	30	15	14q21.1	GEMIN2, SIP1		GEM-associated protein 2	602595	A			
14.180	11	1	06	14q21.1	SEC23A, CLSD		Sec23, S. cerevisiae, homolog of, A	610511	R, Fd		Craniolenticulosutural dysplasia, 607812 (3)	
14.181	2	16	18	14q21.1	TRAPPC6B, TPC6, NEDMEBA		Trafficking protein particle complex, subunit 6B	610397	REc, R		Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3)	12(Trappc6b)
14.182	3	10	11	14q21.2	FKBP3, FKBP25		FK506-binding protein 3	186947	REc			
14.183	7	15	09	14q21.1	LRFN5, SALM5		Leucine-rich repeat and fibronectin type III domain-containing protein 5	612811	REc, H			12(Lrfn5)
14.184	10	09	18	14q21.2	MIS18BP, C14orf106		Mis18-binding protein 1	618139	REc			
14.185	12	10	12	14q21.2	PRPF39		Precursor mRNA-processing factor 39, S. cerevisiae, homolog of	614907	REc			
14.186	8	11	17	14q21.2	TOGARAM1, FAM179B, KIAA0423		TOG array regulator of axonemal microtubules 1	617618	REc			
14.187	3	3	03	14q21.2-q22.3	MGR4, MGOA		Migraine without aura, susceptibility to, 4	607501	Fd	between D14S976 and D14S978	{Migraine without aura, susceptibility to, 4} (2)	
14.188	9	16	12	14q21.3	ARF6		ADP-ribosylation factor 6	600464	REc			
14.189	5	25	13	14q21.3	CDKL1, KKIALRE, p42		Cyclin-dependent kinase-like 1	603441	REc			
14.190	9	7	12	14q12	DHRS1		Short-chain dehydrogenase/reductase family, member 1	610410	REc			
14.191	08	27	18	14q21.2	FANCM, KIAA1596, SPGF28, POF15		FANCM gene	609644	REc	mutation identified in 1 POF15 family	Spermatogenic failure 28, 618086 (3); ?Premature ovarian failure 15, 618096 (3)	
14.192	2	11	08	14q21.2	FSCB, C14orf155		Fibrous sheath cabyr-binding protein	611779	REc			12(Fscb)
14.193	5	26	13	14q21.3	KLHDC1		KELCH domain-containing protein 1	611281	REc			
14.194	5	26	13	14q21.3	KLHDC2, HCLP1		KELCH domain-containing protein 2	611280	REc			
14.195	1	7	09	14q21.3	KTU, C14orf104, CILD10		Kintoun, Medaka, homolog of	612517	REc		Ciliary dyskinesia, primary, 10, 612518 (3)	
14.196	1	10	18	14q21.3	VCPKMT, METTL21D, C14orf138		Valosin-containing protein lysine methyltransferase	615260	REc			
14.197	12	22	16	14q21.3	NEMF, SDCCAG1		Nuclear export mediator factor	608378	A			
14.198	9	14	95	14q22.2	CDKN3		Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)	123832	A			
14.199	4	1	96	14q22.3	KTN1, CG1		Kinectin	600381	REa, A			
14.200	8	21	07	14q22.1	PTGER2		Prostaglandin E receptor 2, EP2 subtype, 53kD	176804	A		{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	15(Ptgerep2)
14.201	7	22	13	14q22-q23	CTRCT32, CTAA1, CAP, CTPP5		Cataract 32, multiple types	115650	Ch, Fd	between D14S980 and D14S1069	Cataract 32, multiple types (2)	
14.202	3	8	07	14q23.1	PRKCH, PKCL, PRKCL		Protein kinase C, eta	605437	A, REc		{Cerebral infarction, susceptibility to}, 601367 (3)	
14.203	4	29	17	14q24.2	ZFYVE1, ZNFN2A1, DFCP1, TAFF1		Zinc finger FYVE type-containing protein 1	605471	REc			
14.204	12	19	01	14q24.1	ZFP36L1, BRF1, ERF1		Zinc finger protein 36, C3H type-like 1 (butyrate response factor 1; EGF-response factor 1)	601064	A			
14.205	3	20	07	14q22.1	C14orf166, CGI99		Chromosome 14 open reading frame 166	610858	R, REc			
14.206	1	29	13	14q22.1	DDHD1, PAPLA1, KIAA1705, SPG28		DDHD domain-containing protein 1	614603	REc, Fd		Spastic paraplegia 28, autosomal recessive, 609340 (3)	
14.207	10	7	13	14q22.1	ERO1L, ERO1LA		Endoplasmic reticulum oxidoreduction 1-like	615435	A, H, REc			14(Ero1l)
14.208	4	30	09	14q22.2	GCRRF1, CGR19		Cell growth regulator with ring finger domain 1	606138	R, REc			
14.209	8	26	15	14q22.1	GNPNAT1, GNA1		Glucosamine-phosphate N-acetyltransferase 1	616510	REc			
14.210	3	31	08	14q22.1	FERMT2, PLEKHC1, MIG2, UNC112, KIND2		Fermitin family, Drosophila, homolog of, 2	607746	R, REc			
14.211	4	2	12	14q22.1	FRMD6, WILLIN, C14orf31		FERM domain-containing protein 6	614555	REc			
14.212	10	7	05	14q21.3	L2HGDH, C14orf160, L2HGA		L-2-hydroxyglutarate dehydrogenase	609584	REc		L-2-hydroxyglutaric aciduria, 236792 (3)	
14.213	5	1	16	14q22.1	NIN, KIAA1565, SCKL7		Ninein	608684	REc	mutation identified in 1 SCKL7 family	?Seckel syndrome 7, 614851 (3)	
14.214	8	27	08	14q21.3	RN7SL1, 7SL, 7L1A		RNA, 7SL, cytoplasmic 1	612177	REc			
14.215	8	27	08	14q21.3	RN7SL2, 7L1C		RNA, 7SL, cytoplasmic 2	612179	REc			
14.216	8	27	08	14q21.3	RN7SL3		RNA, 7SL, cytoplasmic 3	612180	REc			
14.217	2	1	11	14q22.1	PSMC6		Proteasome 26S subunit, ATPase, 6	602708	REc	previously assigned to 12q15 by FISH		
14.218	12	9	04	14q22.1	PTGDR, AS1, ASRT1		Prostaglandin D2 receptor	604687	Fd, REc		{Asthma, susceptibility to, 1}, 607277 (3)	
14.219	6	23	98	14q22.1	PYGL		Phosphorylase, glycogen, liver	613741	REb, Fd, REc		Glycogen storage disease VI, 232700 (3)	12(Pygl)
14.220	7	16	09	14q23.2	SGPP1, SPPASE1		Sphingosine-1-phosphate phosphatase 1	612826	REc			
14.221	7	14	14	14q22.1	STYX		Serine/threonine/tyrosine-interacting protein	615814	REc			
14.222	10	27	06	14q22.1	TXNDC1, TMX		Thioredoxin domain-containing 1	610527	REc			
14.223	2	4	15	14q22.1	TXNDC16, KIAA1344		Thioredoxin domain-containing protein 16	616179	REc			
14.224	5	4	09	14q22.2	GCH1, DYT5, HPABH4B		GTP cyclohydrolase 1	600225	Psh, A		Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3); Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	
14.225	6	3	14	14q22.1-q22.3	FRIASS, DEL14q22, C14DELq22		Frias syndrome	609640	Ch	deletion spans 4.1 Mb on 14q22.1-q22.3	Frias syndrome (4)	
14.226	3	7	11	14q22.1-q24.2	MYP18		Myopia 18	255500	Fd	between D14S984 and D14S999	Myopia 18 (2)	
14.227	3	7	14	14q22.2	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11		Bone morphogenetic protein-4	112262	H, REa, A, Ch, REc		Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625 (3)	14(Bmp2b1)
14.228	5	25	13	14q22.2	CNIH, TGAM77		Cornichon, Drosophila, homolog of	611287	REc			
14.229	2	23	09	14q22.2	CRCS8		Colorectal cancer, susceptibility to, 8	612589	Fd	associated with rs4444235	{Colorectal cancer, susceptibility to, 8} (2)	
14.230	9	9	08	14q22.3	FBXO34, FBX34		F-box only protein 34	609104	REc			14(Fbxo34)
14.231	9	27	17	14q22.2	GMFB, GMF		Glia maturation factor, beta	601713	REc			
14.232	2	7	07	14q22.2	SAMD4A, SMAUG1, KIAA1053		Sterile alpha motif domain-containing 4A	610747	REc			14(Samd4a)
14.233	11	11	14	14q22.2-q22.3	WDHD1, AND1		WD repeat and HMG-box DNA binding protein 1	608126	R, REc			
14.234	9	18	12	14q22.3	AP5M1, MUDENG, MUD, C14orf108		Adaptor-related protein complex 5, mu-1 subunit	614368	REc			
14.235	8	27	15	14q22.3	ATG14, ATG14L, KIAA0831, BARKOR		Autophagy 14, S. cerevisiae, homolog of	613515	R, REc			
14.236	5	1	17	14q23.1	DACT1, DPR1, DAPPER1, FRODO, TBS2		Dapper, antagonist of beta-catenin, 1	607861	REc	mutation identified in 1 TBS2 family	?Townes-Brocks syndrome 2, 617466 (3)	
14.237	1	31	18	14q22.3	DLGAP5, DLG7, HURP, KIAA0008		Discs large-associated protein 5	617859	Psh, REc			
14.238	9	8	11	14q22.3	EXOC5, SEC10L1		Exocyst complex component 5	604469	REc			
14.239	11	23	16	14q22.3	MAP1IP1L, MISS		Mitogen-activated protein kinase 1-interacting protein 1-like protein	617226	REc			
14.240	6	1	18	14q22.3	NAA30, NAT12, MAK3, C14orf35		N-alpha-acetyltransferase 30, NatC catalytic subunit	617989	REc			
14.241	5	8	15	14q22.3	OTX2, MCOPS5, CPHD6		Orthodenticle, Drosophila, homolog of, 2	600037	A, REa		Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	
14.242	4	30	15	14q22.3	SOCS4, SOCS7		Suppressor of cytokine signaling 4	616337	REc			
14.243	4	24	17	14q22.3	TMEM260, C14orf101, SHDRA		Transmembrane protein 260	617449	REc		Structural heart defects and renal anomalies syndrome, 617478 (3)	
14.244	7	10	08	14q23	ANIB8		Aneurysm, intracranial berry, 8	612162	Fd	associated with rs767603	Aneurysm, intracranial berry, 8 (2)	
14.245	10	6	09	14q23	EIG2		Epilepsy, idiopathic generalized, susceptibility to, 2	606972	Fd		{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)	
14.246	6	6	18	14q23.3	FUT8, CDGF		Fucosyltransferase 8	602589	REc, A		Congenital disorder of glycosylation with defective fucosylation, 618005 (3)	
14.247	8	14	11	14q23.3	MAX		MAX protein	154950	A	interacts with MYC	{Pheochromocytoma, susceptibility to}, 171300 (3)	12 (Myn)
14.248	6	15	99	14q23.1	MNAT1, MAT1		Menage a trois 1	602659	A,			
14.249	12	9	97	14q23.1	PSMA3		Proteasome (prosome, macropain) subunit, alpha type, 3	176843	Fd			
14.250	8	1	06	14q23.1	SIX1, BOS3, DFNA23		Sine oculis homeo box, Drosophila, homolog of, 1	601205	REa, A		Branchiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23, 605192 (3)	
14.251	10	4	01	14q23.1	SIX4		Sine oculis homeo box, Drosophila, homolog of, 4	606342	A			
14.252	4	10	15	14q23.1	SIX6, ODRMD		Sine oculis homeo box, Drosophila, homolog of, 6	606326	A, R, D		Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	
14.253	11	20	13	14q23.2	SYNE2, NUANCE, KIAA1011, EDMD5		Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2)	608442	A		Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	
14.254	11	4	93	14q23.3	FNTB		Farnesyltransferase, CAAX box, beta	134636	REa, Psh, A	related FNTBL1 on 9		
14.255	1	4	12	14q23.3	ZBTB25, ZNF46, KUP		Zinc finger and BTB domain containing 25	194541	A			
14.256	12	28	08	14q23.1	ARID4A, RBP1, RBBP1		AT-rich interactive domain-containing protein 4A	180201	R, REc			
14.257	1	26	17	14q23.1	C14orf39, SIX6OS1		Chromosome 14 open reading frame 39	617307	REc			
14.258	4	30	12	14q23.1	DAAM1, KIAA0666		Dishevelled-associated activator of morphogenesis 1	606626	R, REc			
14.259	7	16	09	14q23.1	DHRS7, RETSDR4		Short-chain dehydrogenase/reductase family, member 7	612833	REc			
14.260	2	25	15	14q23.1	GPR135		G protein-coupled receptor 135	607970	R, REc			12(Gpr135)
14.261	5	23	13	14q23.1	JKAMP, C24orf100, JAMP		JNK1/MAPK8-associated membrane protein	611176	REc			
14.262	9	21	15	14q23.1	KIAA0586, TALPID3, JBTS23, SRTD14		KIAA0586 gene	610178	REc, R		Joubert syndrome 23, 616490 (3); Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	
14.263	9	10	12	14q23.1	L3HYPDH, C14orf149		L-3-hydroxyproline dehydratase, trans	614811	REc			
14.264	10	12	14	14q23.1	PPM1A, PP2CA		Protein phosphatase, magnesium/manganese-dependent, 1A	606108	REc			
14.265	10	7	05	14q23.2	PPP2R5E		Protein phosphatase-2, regulatory subunit B (B56), epsilon isoform	601647	REc	incorrectly assigned to 7p12-p11.2 by FISH		
14.266	8	26	15	14q23.1	SLC38A6, SNAT6		Solute carrier family 38 (amino acid transporter), member 6	616518	REc			
14.267	5	2	07	14q23.2	SYT16, STREP14		Synaptotagmin 16	610950	REc			
14.268	8	20	07	14q23.1	TMEM30B, CDC50B		Transmembrane protein 30B	611029	REc			
14.269	9	4	15	14q23.1	TRMT5, TRM5, KIAA1393, COXPD26		tRNA methyltransferase 5, S. cerevisiae, homolog of	611023	R, REc		Combined oxidative phosphorylation deficiency 26, 616539 (3)	
14.270	9	27	17	14q23.2	GPHB5, GPB5		Glycoprotein hormone, beta-5	609652	REc			
14.271	3	30	12	14q23.2	HIF1AAS1		HIF1A antisense RNA 1	614528	REc			
14.272	3	30	12	14q23.2	HIF1AAS2		HIF1A antisense RNA 2	614529	REc			
14.273	4	30	12	14q23.2	KCNH5		Potassium voltage-gated channel, subfamily H, member 5	605716	REc			
14.274	4	30	12	14q23.2	RHOJ, ARHJ, TCL		Ras homolog gene family, member J	607653	REc			
14.275	10	2	12	14q23.2	SNAPC1, SNAP43		Small nuclear RNA-activating protein complex, polypeptide 1	600591	REc			
14.276	2	28	06	14q23.2	TELM		Telomere length, mean leukocyte	609113	Fd	suggestive QTL on 12, 10q, 3p	[Telomere length, mean leukocyte] (2)	
14.277	2	25	15	14q23.3	AKAP5, AKAP79		A-kinase anchor protein 5	604688	REc			
14.278	9	26	16	14q23.3	CHURC1, CHCH, C14orf52		Churchill domain-containing 1	608577	REc			
14.279	7	22	13	14q23.3	MPP5, PALS1		Membrane protein, palmitoylated 5	606958	R, REc			12(Pals1)
14.280	7	17	14	14q23.3-q24.1	PLEK2		Pleckstrin 2	608007	REc			
14.281	4	24	18	14q23.3	PLEKHG2, ARHGEF43, KIAA0599		Pleckstrin homology domain- and RhoGEF domain-containing protein G3	617940	R, REc			
14.282	12	1	14	14q24.1	RDH11, PSDR1, RALR1, RDJCSS		Retinol dehydrogenase 11	607849	R, REn	mutation identified in 1 RDJCSS family	?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	12(Rdh11)
14.283	9	23	04	14q24.1	RDH12, LCA13		Retinol dehydrogenase 12	608830	Fd, REn	near RDH11	Leber congenital amaurosis 13, 612712 (3)	
14.284	4	25	18	14q23.3	SPTB, SPH2, EL3, HS2		Spectrin, beta, erythrocytic	182870	REb, F, H, REa, A, RE		Elliptocytosis-3, 617948 (3); Spherocytosis, type 2, 616649 (3); Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3)	12(Sptb1)
14.285	9	28	15	14q23.3	ZBTB1		Zinc finger- and BTB domain-containing protein 1	616578	REc			12(Zbtb1)
14.286	8	25	11	14q24.1	RAD51L1		RAD51. S. cerevisiae, homolog of, like 1	602948	REc, A, R	fused with HMGA2 in uterine leiomyoma		
14.287	11	30	06	14q24.3	ALKBH1, ALKB		AlkB, E. coli, homolog of, 1	605345	A			
14.288	12	6	16	14q23.3	ATP6V1D, ATP6M		ATPase, H+ transporting, V1 subunit D	609398	REc			
14.289	12	17	08	14q24.3	BATF, BATF1, SFA2		Basic leucine zipper transcription factor, ATF-like	612476	A			
14.290	10	29	03	14q24.3	EIF2B2		Eukaryotic translation initiation factor 2B, subunit 2	606454	R, Fd		Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
14.291	9	28	00	14q24.3	ENTPD5, CD39L4		Ectonucleoside triphosphate diphosphohydrolase 5	603162	R,			12(Cd39l4)
14.292	11	8	17	14q24.3	ERG28, C14orf1		Ergosterol biosynthesis 28 homolog	604576	R			
14.293	11	4	13	14q23.3-q24.1	GPHN, GPH, KIAA1385, GEPH, MOCODC		Gephyrin	603930	REc, Ch		Molybdenum cofactor deficiency C, 615501 (3)	
14.294	11	20	17	14q24.3	LTBP2, LTBP3, GLC3D, MSPKA, WMS3		Latent transforming growth factor beta binding protein-2	602091	RE, A	mutation identified in 1 WMS3 family	Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3); ?Weill-Marchesani syndrome 3, recessive, 614819 (3)	
14.295	11	21	17	14q23.3	MTHFD1, MTHFC, CIMAH		Methylenetetrahydrofolate dehydrogenase 1	172460	S, REa, A	trifunctional protein	{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3); Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3)	
14.296	9	28	00	14q24.3	NGB		Neuroglobin	605304	R			
14.297	7	14	15	14q24.3	TGFB3, ARVD1, RNHF, LDS5		Transforming growth factor, beta-3	190230	REa, A		Arrhythmogenic right ventricular dysplasia 1, 107970 (3); Loeys-Dietz syndrome 5, 615582 (3)	12(Tgfb3)
14.298	5	10	04	14q24.3	ZADH1		Zinc-binding alcohol dehydrogenase domain-containing protein 1	608642	REc			
14.299	3	12	15	14q32.11	CALM1, PHKD, CPVT4, LQT14		Calmodulin-1 (phosphorylase kinase, delta)	114180	REa, Psh, A		Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3); Long QT syndrome 14, 616247 (3)	
14.300	3	14	96	14q24.3	PGF, PLGF		Placental growth factor, vascular endothelial growth factor-related protein	601121	A			12(Plgf)
14.301	1	29	01	14q31.3	FLRT2		Fibronectin-like domain-containing leucine-rich transmembrane protein-2	604807	R, REc			
14.302	5	3	13	14q24.1	ACTN1, BDPLT15		Actinin, alpha-1	102575	REa, A, REc		Bleeding disorder, platelet-type, 15, 615193 (3)	12(Actn1)
14.303	6	6	00	14q24.2	ADAM20		A disintegrin and metalloproteinase domain 20	603712	R			
14.304	6	6	00	14q24.2	ADAM21		A disintegrin and metalloproteinase domain 21	603713	R			
14.305	7	25	18	14q24.2	COX16		Cytochrome c oxidase assembly factor 16	618064	REc			
14.306	6	29	07	14q24.1	ERH		Enhancer of rudimentary, Drosophila, homolog of	601191	REc	possible pseudogene on 7q34		
14.307	5	9	16	14q24.1	EXD2, EXDL2		Exonuclease 3'-to-5' domain-containing protein 2	616940	REc			
14.308	4	6	13	14q24.1	GALNT16, GALNACT16, GALNTL1, KIAA1130		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16	615132	R, REc			
14.309	4	9	96	14q23.3	GPX2		Glutathione peroxidase-2, gastrointestinal	138319	REa, A			
14.310	10	15	94	14q23.3	HSPA2		Heat-shock 70kD protein-2	140560	REa, A			12(Hspa2)
14.311	6	22	18	14q24.1	PIGH		Phosphatidylinositol glycan, class H	600154	H, REc		Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3)	12(Pigh)
14.312	10	4	02	14q24.1	SLC10A1, NTCP1		Solute carrier family 10 (sodium/bile acid cotransporter family), member 1	182396	REa, REc			12(Slc10a1)
14.313	2	21	11	14q24.2	SMOC1, OAS		SPARC-related modular calcium-binding 1	608488	REc		Microphthalmia with limb anomalies, 206920 (3)	
14.314	1	15	16	14q24.1	SUSD6, DRAGO, KIAA0247		SUSHI domain-containing protein 6	616761	R, REc			
14.315	9	23	13	14q24.1	VTI1B, VTI1, VTI1L		Vti1, S. cerevisiae, homolog of, B	603207	REc			
14.316	4	27	12	14q24.1	ZFYVE26, KIAA0321, SPG15		Zinc finger FYVE domain-containing protein 26	612012	R, REc, Fd		Spastic paraplegia 15, autosomal recessive, 270700 (3)	
14.317	9	9	10	14q24.1	DCAF5, WDR22, BCRP2, D14S1461E		DDB1- and CUL4-associated factor 5	603812	REc			
14.318	6	15	99	14q24.1	ARG2		Arginase II	107830	A, R, Psh			
14.319	11	21	02	14q32.11	KCNK13, THIK1		Potassium channel, subfamily K, member 13	607367	REc			
14.320	5	19	15	14q24.2	DCAF4, WDR21, WDR21A		DDB1- and CUL4-associated factor 4	616372	REc			
14.321	11	27	17	14q24.2	PAPLN, PPN		Papilin, proteoglycan-like sulfated glycoprotein	617785	REc			
14.322	8	31	17	14q24.2	PCNX1, KIAA0995		Pecanex, Drosophila, homolog of, 1	617655	R, REc			12(Pcnx1)
14.323	12	22	08	14q24.2	RBM25, RED120		RNA-binding motif protein 25	612427	REc			
14.324	6	13	17	14q24.2	SIPA1L1, E6TP1, KIAA0440		SIPA1-like protein 1	617504	REc			
14.325	12	19	11	14q24.1	SRSF5, SFRS5, SRp40		Splicing factor, serine/arginine-rich, 5	600914	R, REc			
14.326	6	30	05	14q24.2	SYNJ2BP, OMP25, ARIP2		Synaptojanin 2-binding protein	609411	R, REc			
14.327	2	25	15	14q24.2	TTC9, KIAA0227		Tetratricopeptide repeat domain-containing protein 9	610488	Psh, REc			
14.328	10	17	12	14q24.3	ABCD4, PXMP1L, P79R, PMP69, MAHCJ		ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)	603214	Psh, A		Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	
14.329	10	25	11	14q24.3	ACOT1		Acyl-CoA thioesterase 1	614313	REc			12(Acot1)
14.330	3	17	06	14q24.3	ACOT2, PTE2, MTE1		Acyl-CoA thioesterase 2	609972	REc, R			12(Acot2)
14.331	10	28	11	14q24.3	ACOT4		Acyl-CoA thioesterase 4	614314	REc	?pseudogene on 19q13.12		12(Acot4)
14.332	10	5	11	14q24.3	ACOT6		Acyl-CoA thioesterase 6	614267	REc, H			12(Acot6)
14.333	5	25	00	14q24.3	ACYP1, ACYPE		Acylphosphatase, erythrocyte	600875	A, REa			
14.334	8	8	13	14q24.3	AHSA1, AHA1		Activator of heat-shock 90kD protein ATPase 1	608466	REc, R			
14.335	8	3	11	14q24.3	ALDH6A1, MMSDH		Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)	603178	REc		Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	
14.336	9	9	13	14q24.3	AREL1, KIAA0317		Apoptosis-resistant E3 ubiquitin protein ligase 1	615380	REc			
14.337	2	16	18	14q24.3	RIOX1, C14orf169, NO66, MAPJD		Ribosomal oxygenase 1	611919	R, REc			
14.338	7	17	06	14q24.3	CHX10, HOX10, MCOP2, MCOPCB3		C. elegans ceh-10 homeo domain-containing homolog	142993	REa, A		Microphthalmia with coloboma 3, 610092 (3); Microphthalmia, isolated 2, 610093 (3)	12(Hox10)
14.339	6	26	16	14q24.3	CIPC, KIAA1737		Clock-interacting pacemaker	616995	REc			
14.340	5	24	12	14q24.3	COQ6, CGI10, COQ10D6		Coq6, S. cerevisiae, homolog of	614647	REc		Coenzyme Q10 deficiency, primary, 6, 614650 (3)	
14.341	11	9	05	14q31.1	DIO2, TXDI2, D2		Deiodinase, iodothyronine, type II	601413	R, A			
14.342	10	15	94	14q24.3	DLST		Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)	126063	A			
14.343	6	8	11	14q24.3	DNAL1, C14orf168, CILD16		Dynein, axonemal, light chain 1	610062	REc		Ciliary dyskinesia, primary, 16, 614017 (3)	12(Dnal1)
14.344	2	7	08	14q24.3	ESRRB, ESRL2, DFNB35		Estrogen-related receptor beta	602167	A, Fd		Deafness, autosomal recessive 35, 608565 (3)	12(Estrrb)
14.345	4	20	10	14q24.3	FLVCR2, C14orf58, CCT, PVHH, EPV		Feline leukemia virus subgroup C receptor 2	610865	REc		Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3)	12(Flvcr2)
14.346	6	5	92	14q24.3	FOS		FBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)	164810	REa, A			12(Fos)
14.347	10	14	09	14q24.3	GLC3C		Glaucoma 3, primary congenital, C	613085	Fd	between D14S61 and D14S1000	Glaucoma 3, primary congenital, C (2)	
14.348	7	26	17	14q24.3	GSTZ1, MAAI, MAAID		Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)	603758	A, R		[Maleylacetoacetate isomerase deficiency], 617596 (3)	
14.349	2	9	18	14q24.3	IFT43, C14orf179, CED3, SRTD18, RP81		Intraflagellar transport 43, Chlamydomonas, homolog of	614068	REc	mutation identified in 1 CED3 family and 1 RP81 family	?Cranioectodermal dysplasia 3, 614099 (3); Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3); ?Retinitis pigmentosa 81, 617871 (3)	
14.350	08	20	18	14q24.3	IRF2BPL, C14orf4, EAP1, NEDAMSS		Interferon regulatory factor 2-binding protein like	611720	R, REc		Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3)	
14.351	5	19	15	14q24.3	ISCA2, MMDS4		Iron-sulfur cluster assembly 2, S. cerevisiae, homolog of	615317	REc		Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	
14.352	3	31	09	14q24.3	ISM2, THSD3, TAIL1		Isthmin 2, zebrafish, homolog of	612684	REc			
14.353	7	24	13	14q24.3	JDP2		JUN dimerization protein 2	608657	REc			
14.354	5	9	12	14q24.3	KTCN8		Keratoconus 8	614628	Fd	between rs1074501 and rs755212	Keratoconus 8 (2)	
14.355	10	28	08	14q24.3	MUSTQTL1		Muscle strength quantitative trait locus 1	612083	Fd		Muscle strength quantitative trait locus 1 (2)	
14.356	3	31	03	14q24.3	NPC2, HE1		Epididymal secretory protein HE1	601015	REc, R		Niemann-pick disease, type C2, 607625 (3)	
14.357	6	22	14	14q24.3	MLH3, HNPCC7		Mismatch repair gene MLH3	604395	A		Colorectal cancer, somatic, 114500 (3); Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3); {Endometrial cancer, susceptibility to}, 608089 (3)	12(Mlh3)
14.358	7	11	16	14q24.3	NEK9, NERCC1, LCCS10, APUG, NC		Never in mitosis gene A-related kinase 9	609798	REc	mutation identified in 1 APUG family	Lethal congenital contracture syndrome 10, 617022 (3); ?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3); Nevus comedonicus, somatic, 617025 (3)	
14.359	6	15	99	14q24.2-q24.3	NUMB, S171		Numb, Drosophila, homolog of	603728	REn			
14.360	3	7	14	14q24.3	PNMA1, MA1		Paraneoplastic MA antigen 1	604010	REc			
14.361	09	27	18	14q24.3	POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14		Putative protein O-mannosyltransferase 2	607439	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	
14.362	3	14	13	14q24.3	PROX2		Prospero-related homeobox 2	615094	REc, H			12(Prox2)
14.363	1	11	18	14q24.2	PSEN1, AD3, ACNINV3		Presenilin 1	104311	Fd	mutation identified in 1 ACNINV3 family	Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia, frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); ?Acne inversa, familial, 3, 613737 (3)	
14.364	8	18	99	14q24.2	RGS6		Regulator of G protein signaling 6	603894	REa, R			
14.365	6	13	12	14q24.3	SKIIP, SKIP, SNW1, BX42		SKI-interacting protein	603055	REc			
14.366	12	21	09	14q24.3	SLIRP, C14orf156		SRA stem loop-interacting RNA-binding protein	610211	REc			
14.367	11	19	11	14q24.3	SYNDIG1L, TMEM90A, CAPUCIN		Synapse differentiation-induced gene 1-like	609999	REc			12(Capucin)
14.368	7	15	14	14q24.3	TTLL5, STAMP, KIAA0998, CORD19		Tubulin tyrosine ligase-like family, member 5	612268	REc		Cone-rod dystrophy 19, 615860 (3)	
14.369	5	23	06	14q24.3	TMED10, TMP21		Transmembrane p24 trafficking protein 10	605406	Fd			
14.370	3	14	13	14q24.3	VIPAS39, VIPAR, SPE39, C14orf133		VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog	613401	REc		Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	
14.371	5	6	98	14q22.3	UBE2L1, UBCL, UBC4		Ubiquitin-conjugating enzyme E2L 1	600012	Psh, A			
14.372	5	19	09	14q31.3-q32.1	FOXN3, CHES1		Forkhead box N3	602628	Fd			
14.373	12	9	98	14q24.3-q31	IDDM11		Insulin-dependent diabetes mellitus-11	601208	Fd		{Diabetes mellitus, insulin-dependent, 11} (2)	
14.374	12	17	95	14q24.2	MAP3K9, MLK1		Mitogen-activated protein kinase kinase kinase 9	600136	REa, A			
14.375	11	17	10	14q24.3	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C		Serine palmitoyltransferase, long-chain base subunit 2	605713	REc, R		Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	12(Sptlc2)
14.376	11	5	08	14q24.2	DPF3, CERD4		D4, zinc and double PHD fingers, family 3	601672	A			
14.377	10	4	02	14q24.3-q31.1	NRXN3		Neurexin 3	600567	REc			
14.378	11	1	13	14q32.13	DICER1, HERNA, KIAA0928, MNG1, RMSE2		Dicer, Drosophila, homolog of, 1	606241	REa, R		Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3); Rhabdomyosarcoma, embryonal, 2, 180295 (3)	
14.379	5	1	02	14q31.3	GALC		Galactosylceramidase	606890	REa, A, H, Fd		Krabbe disease, 245200 (3)	12(tw)
14.380	10	14	09	14q31	GRD1		Graves disease, susceptibility to, 1	275000	Fd	associated with rs2268458	{Graves disease, susceptibility to, 1} (2)	
14.381	11	22	16	14q32.11	GPR68, OGR1, AI2A6		G protein-coupled receptor 68	601404	Psh, A		Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3)	
14.382	8	25	11	14q31	HPPD		Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	Fd		Hypertelorism, preauricular sinus, punctal pits, and deafness (2)	
14.383	4	24	01	14q31.3	KCNK10, TREK2		Potassium channel, subfamily K, member 10	605873	REc			
14.384	2	18	98	14q31.1	SEL1L		Suppressor of lin 12 (sel-1), C. elegans, homolog of	602329	Psh, A, R			
14.385	2	21	06	14q31.1	TSHR, CHNG1		Thyroid-stimulating hormone receptor	603372	REa, Fd, A, R		Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid adenoma, hyperfunctioning, somatic (3); Hyperthyroidism, nonautoimmune, 609152 (3); Thyroid carcinoma with thyrotoxicosis (3); Hyperthyroidism, familial gestational, 603373 (3)	12(Tshr)
14.386	10	24	00	14q32.11	RPS6KA5, MSK1		Ribosomal protein S6 kinase, 90kD, 5	603607	R			
14.387	12	11	02	14q32.11	TDP1		Tyrosyl-DNA phosphodiesterase 1	607198	REc, Fd		Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	
14.388	2	21	10	14q32.12	TRIP11, TRIP230, CEV14, ACG1A		Thyroid hormone receptor interactor 11	604505	REa, A		Achondrogenesis, type IA, 200600 (3)	
14.389	3	9	00	14q31.3	GPR65, TDAG8		G protein-coupled receptor 65	604620	A			
14.390	4	16	10	14q32.13	SERPINA4, KST, PI4		Serpin peptidase inhibitor, clade A, member 4	147935	REa, A	in cluster with related AAT, AACT, CBG, PCI		
14.391	10	2	12	14q31.1	GTF2A1, TF2A1		General transcription factor IIA, alpha/beta subunits	600520	REc			
14.392	10	10	18	14q31.3	EML5		Echinoderm microtubule-associated protein-like 5	618119	REc			
14.393	8	8	13	14q31.1	STON2, STN2, STNB		Stonin 2	608467	REc, R			
14.394	6	19	12	14q31.3	PTPN21, PTPD1		Protein-tyrosine phosphatase, nonreceptor-type, 21	603271	REc			
14.395	1	3	13	14q31.3	SPATA7, HSD3, LCA3		Spermatogenesis-associated protein 7	609868	REc		Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	
14.396	9	22	16	14q31.3	ZC3H14, SUT2, MRT56		Zinc finger CCCH domain-containing protein 14	613279	REc		Mental retardation, autosomal recessive 56, 617125 (3)	
14.397	2	21	03	14q32.32	AMN		Amnionless, mouse, homolog of	605799	REc, Fd		Megaloblastic anemia-1, Norwegian type, 261100 (3)	12(Amn)
14.398	6	15	99	14q32.2	CCNK		Cyclin K	603544	A			
14.399	12	4	03	14q32	CHDS4		Coronary heart disease, susceptibility to, 4	608318	Fd	highest LOD with D14S1426	{Coronary heart disease, susceptibility to, 4} (2)	
14.400	12	24	89	14q32.12	CHGA		Chromogranin A, parathyroid secretory protein-1	118910	REa, A			12(Chga)
14.401	11	19	13	14q32.33	CKB, CKBB, BCK		Creatine kinase, brain type	123280	S, REa, Fd	distal to PI and AACT; closely linked to AKT1 and IGH; proximal to IGH		
14.402	10	23	87	14q32	CKBE		Creatine kinase, ectopic expression	123270	F	linked to IGH, PI; ?same locus as CKBB	[Creatine kinase, brain type, ectopic expression of] (2)	
14.403	8	30	01	14q32.12	DDX24		DEAD/H box 24	606181	R			
14.404	5	25	00	14q32.31	DIO3, TXDI3		Deiodinase, iodothyronine, type 3	601038	A			12(Dio3)
14.405	3	15	04	14q32.31	DIO3OS		Deiodinase, iodothyronine, type 3, opposite strand	608523	REc			12(Dio3os)
14.406	5	2	01	14q32.2	DLK1, PREF1, FA1		Delta, Drosophila, homolog-like 1	176290	A			
14.407	10	21	15	14q32	DUP14q32, C14DUPq32		Chromosome 14q32 duplication syndrome, 700kB	616604	Ch	heterozygous germline duplication of 700kb	{Myeloproliferative neoplasms, familial, susceptibility to} (4)	
14.408	10	28	14	14q32.31	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1		Dynein, cytoplasmic-1, heavy chain-1	600112	REa, H, REc, Fd		Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3); Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	14(Dnecl)
14.409	9	22	16	14q32.2	EML1, EMAPL, EMAP, BH		Echinoderm microtubule associated protein like 1	602033	REn, REc		Band heterotopia, 600348 (3)	
14.410	9	7	04	14q32	GEVQ1		Gene expression, variation in, quantitative trait locus on chromosome 14	608875	Fd		{Gene expression, variation in, QTL} (2)	
14.411	3	20	16	14q32.13	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC		Glutaredoxin 5	609588	REc, H		Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3); Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	
14.412	1	28	02	14q32	HFM		Hemifacial microsomia	164210	Fd		Hemifacial microsomia (2)	
14.413	12	17	95	14q32.12	IFI27		Interferon, alpha-inducible protein-27	600009	A			
14.414	2	4	02	14q32.33	JAG2		Jagged 2	602570	A			12(Jag2)
14.415	1	4	16	14q32	KAOGS		Kagami-Ogata syndrome	608149	Ch	uniparental isodisomy of imprinted region of chromosome 14	Kagami-Ogata syndrome (4)	
14.416	7	25	06	14q32	MCOP1		Microphthalmia, isolated 1	251600	Fd		Microphthalmia, isolated 1 (2)	
14.417	11	22	10	14q32.2-q32.3	MEG8		Maternally expressed gene 8	613648	REc			
14.418	11	22	10	14q32.31	MIR380, MIRN380		Micro RNA 380	613654	REc, H			12(Mir380)
14.419	8	27	01	14q32.31	RAGE, MOK		Renal tumor antigen	605762	REc			
14.420	3	6	14	14q32.13	SERPINA9, GCET1, CENTERIN		Serpin peptidase inhibitor, clade A, member 9	615677	REc			
14.421	3	24	14	14q32.31	SNORD114-1		Small nucleolar RNA, C/D box, 114-1	613651	REc			
14.422	2	17	15	14q32	TEMPS		Temple syndrome (maternal uniparental disomy chromosome 14)	616222	Ch		Temple syndrome (4)	
14.423	4	10	14	14q32.2	TUNAR, TUNA, LINC00617		TCL1 upstream neural differentiation-associated RNA	615719	REc			
14.424	11	20	98	14q32.32	TNFAIP2		Tumor necrosis factor, alpha-induced protein-2	603300	Psh, A			
14.425	9	20	14	14q32.12	SLC24A4, NCKX4, SHEP6, AI2A5		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840	REc		[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3); [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3); Amelogenesis imperfecta, type IIA5, 615887 (3)	
14.426	2	22	13	14q32.2	SLC25A29, CACL, ORNT3		Solute carrier family 25 (carnitine/acylcarnitine translocase), member 29	615064	REc			
14.427	11	22	10	14q32.2	SNORD112		Small nucleolar, C/D box, 112	613649	REc	located in an intron of MEG8		
14.428	11	22	10	14q32.31	SNORD113-1		Small nucleolar RNA, C/D box, 113-1	613650	REc			
14.429	11	3	09	14q32.2	VRK1, PCH1A		Vaccinia-related kinase-1	602168	R		Pontocerebellar hypoplasia type 1A, 607596 (3)	
14.430	7	25	18	14q32.2	WDR25		WD repeat-containing protein 25	618059	REc			
14.431	09	06	18	14q32.2	BCL11B, CTIP2, IMD49, IDDFSTA		C-cell CLL/lymphoma 11B	606558	REc		Immunodeficiency 49, 617237 (3); Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3)	
14.432	9	8	06	14q32.12	BTBD7, FUP1		BTB/POX domain-containing protein 7	610386	R, REc			
14.433	10	4	07	14q32.13	CBG, SERPINA6		Corticosteroid-binding globulin	122500	A, REn		Corticosteroid-binding globulin deficiency, 611489 (3)	
14.434	3	5	03	14q32.2	CYP46A1, CYP46		Cytochrome P450, family 46, subfamily A, polypeptide 1 (cholesterol 24-hydroxylase)	604087	A, R			
14.435	12	22	15	14q32.12	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD		Fibulin 5	604580	A		Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa, autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3); Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	
14.436	4	10	14	14q32.13	GSC, SAMS		Goosecoid	138890	REa, A		Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	12(Gsc)
14.437	1	23	02	14q32.12	LGMN, PRSC1		Legumain (protease, cysteine, 1)	602620	A			
14.438	12	5	13	14q32.1	SERPINA2P, PIL, ATR, ARGS		Serpin peptidase inhibitor, clade A, member 2, pseudogene	107410	REn	?pseudogene		
14.439	8	17	10	14q32.13	SERPINA1, PI, AAT		Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400	F, S, A, D, EM, Fd		Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	12(Aat)
14.440	1	8	00	14q32.13	SERPINA3, AACT, ACT		Alpha-1-antichymotrypsin	107280	REa, A, Fd, REn	220kb from PI	Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)	
14.441	4	16	10	14q32.13	SERPNA5, PCI		Serpin peptidase inhibitor, clade A, member 5 (protein C inhibitor)	601841	Psh, REn			
14.442	6	17	15	14q32.13	SERPINA10, ZPI		Serine (or cysteine) proteinase inhibitor, clade A, member 10 (protein Z-dependent protease inhibitor precursor)	605271	REc			
14.443	5	3	17	14q32.13	SERPINA12, VASPIN		Serpin peptidase inhibitor, clade A, member 12 (vaspin)	617471	REc			
14.444	12	21	98	14q32.13	TCL1A, TCL1		T-cell lymphoma/leukemia 1A	186960	Ch, RE		Leukemia/lymphoma, T-cell (2)	
14.445	12	13	00	14q32.13	TCL1B, TML1		T-cell lymphoma/leukemia 1B	603769	Psh		Leukemia/lymphoma, T-cell (2)	
14.446	9	9	08	14q32.13	TCL6, TNG1, TNG2		T-cell leukemia/lymphoma 6	604412	REc			
14.447	10	16	14	14q31.3	TTC8, BBS8, RP51		Tetratricopeptide repeat domain 8	608132	REc	mutation identified in 1 RP51 family	Bardet-Biedl syndrome 8, 615985 (3); ?Retinitis pigmentosa 51, 613464 (3)	
14.448	2	11	96	14q32.2	BDKRB1		Bradykinin receptor B1	600337	A			
14.449	2	11	96	14q32.2	BDKRB2		Bradykinin receptor B2	113503	Psh, A			
14.450	3	16	01	14q32.2	PAPOLA, PAP		Poly(A) polymerase	605553	A, R			
14.451	7	9	18	14q32.11-q32.12	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40		Coiled-coil domain-containing protein 88C	611204	REc, R	mutation identified in 1 SCA40 family	Hydrocephalus, congenital, 1, 236600 (3); ?Spinocerebellar ataxia 40, 616053 (3)	
14.452	2	1	11	14q32.11	PSMC1, S4		Proteasome 26S subunit, ATPase, 1	602706	REc	previously assigned to 19p13.3 by FISH		12(Psmc1)
14.453	4	30	12	14q32.12	ASB2		Ankyrin repeat-containing SOCS box protein 2	605759	R, REc			12(Asb2)
14.454	2	7	14	14q32.12	ATXN3, MJD, SCA3		Ataxin-3 (josephin)	607047	Fd, REc		Machado-Joseph disease, 109150 (3)	
14.455	3	28	11	14q32.12	CATSPERB, C14orf161		Cation channel, sperm-associated, beta	611169	REc			
14.456	3	10	16	14q32.12	COX8C		Cytochrome c oxidase, subunit 8c	616855	REc			12(Cox8c)
14.457	10	13	17	14q32.12	GON7, C14orf142		Gon7, S. cerevisiae, homolog of	617436	REc			
14.458	4	2	16	14q32.12	IFI27L2, FAM14A, ISG12B		Interferon alpha inducible protein 27 like 2	611319	REc			
14.459	8	18	14	14q32.12	ITPK1, ITRPK1		Inositol 1,3,4-trisphosphate 5/6-kinase	601838	REc			
14.460	3	7	14	14q32.12	MOAP1, MAP1, PNMA4		Modulator of apoptosis 1	609485	REc			
14.461	5	25	13	14q32.12	NDUFB1		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 1	603837	REc			
14.462	6	5	08	14q32.12	OTUB2, OTU2, OTB2, C14orf137		OTU domain-containing ubiquitin aldehyde-binding protein 2	608338	REc			
14.463	3	31	11	14q32.12	PRIMA1, PRIMA		Proline-rich membrane anchor 1	613851	REc			
14.464	2	6	16	14q32.12	PPP4R3A, SMEK1, PP4R3A, KIAA2010		Protein phosphatase 4, regulatory subunit 3, alpha	610351	REc, R			
14.465	4	15	11	14q32.12	UBR7		Ubiquitin protein ligase E3 component N-recognin 7	613816	REc			
14.466	3	30	16	14q32.12	UNC79		Unc79, C. elegans, homolog of	616884	REc			12(Unc79)
14.467	9	10	07	14q32.13	CLMN, KIAA1188		Calmin	611121	R, REc			
14.468	2	5	16	14q32.12-q32.13	PPP4R4, PP4R4, KIAA1622		Protein phosphatase 4, regulatory subunit 4	616790	REc			
14.469	11	13	07	14q32.13	SYNE3, C14orf49		Spectrin repeat-containing nuclear envelope protein 3 (nesprin 3)	610861	REc			12(C14orf49)
14.470	5	9	18	14q32.2	AK7, SPGF27		Adenylate kinase 7	615364	REc	mutation identified in 1 SPGF27 family	?Spermatogenic failure 27, 617965 (3)	
14.471	2	17	15	14q32.2	ATG2B		Autophagy 2, S. cerevisiae, homolog of, B	616226	REc			
14.472	7	18	14	14q32.2	DEGS2, DES2		Delta(4)-desaturase, sphingolipid, 2	610862	R, REc			
14.473	4	21	16	14q32.2	EVL		ENAH/VASP-like protein	616912	REc			
14.474	10	20	15	14q32.2	GSKIP, C14orf129		GSK3B-interacting protein	616605	REc			
14.475	9	8	08	14q32.31	HSP90AA1, HSPCA, HSPC1, HSP90A, HSP89A, HSPCAL4, LAP2		Heat-shock protein, 90kD, alpha, class A, member 1	140571	REa			
14.476	3	17	08	14q32.2	RTL1, PEG11		Retrotransposon-like gene 1	611896	REn, H			12(Rtl1)
14.477	3	7	14	14q32.2	SETD3		SET domain-containing protein 3	615671	REc			
14.478	3	15	13	14q32.33	AKT1, CWS6		Murine thymoma viral (v-akt) oncogene homolog-1	164730	REa, A	proximal to IGH	Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Ovarian cancer, somatic, 167000 (3); {Schizophrenia, susceptibility to}, 181500 (2); Proteus syndrome, somatic, 176920 (3); Cowden syndrome 6, 615109 (3)	12(Akt)
14.479	7	1	11	14q32.32	CDC42BPB, MRCKB		CDC42-binding protein kinase, beta	614062	R, A			
14.480	6	15	99	14q32.33	CRIP2, CRP2		Cysteine-rich intestinal protein 2	601183	A, REa			
14.481	5	25	10	14q32.32	EIF5		Eukaryotic translation initiation factor 5	601710	REc			
14.482	2	7	05	14q32.33	GPR132, G2A		G protein-coupled receptor-132	606167	A			
14.483	3	9	07	14q32.33	KLC1, KNS2, KNS2A		Kinesin, light chain 1	600025	REa, A			
14.484	6	10	98	14q32.32-q32.33	MARK3		MAP/microtubule affinity-regulating kinase-3	602678	A			
14.485	1	12	05	14q32.2	MEG3, GTL2		Maternally expressed gene 3	605636	REc, REn	100kb from DLK1		
14.486	5	22	03	14q32.33	MTA1		Metastasis-associated gene 1	603526	A			12(Mta1)
14.487	5	12	11	14q32.33	XRCC3, CMM6		X-ray-repair, complementing defective, repair in Chinese hamster cells-3	600675	REa, A		{Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer, susceptibility to}, 114480 (3)	
14.488	4	20	10	14q32.31	CINP		CDK2-interacting protein	613362	REc			
14.489	10	10	14	14q32.2	HDMCP, C14orf68		Hepatocellular carcinoma-downregulated mitochondrial carrier protein	609911	REc, H			12(Hdmcp)
14.490	3	23	09	14q32.2	MIR127, MIRN127		Micro RNA 127	611709	R			
14.491	3	23	09	14q32.31	MIR134		Micro RNA 134	610164	REc			
14.492	3	23	09	14q32.2	MIR136, MIRN136		Micro RNA 136	611710	R			
14.493	6	22	14	14q32.31	MIR376C, MIR368		Micro RNA 368C	610983	REc			
14.494	7	1	11	14q32.31	MIR369, MIR369-3, MIRN369-3		Micro RNA 369	611794	REc			
14.495	1	24	09	14q32.31	MIR370, MIRN370		Micro RNA 370	612553	REc			
14.496	3	23	09	14q32.31	MIR376A-1, MIRN376A-1		Micro RNA 376A-1	610959	R			
14.497	3	23	09	14q32.31	MIR376A-2, MIRN376A-2		Micro RNA 376A-2	610960	R			
14.498	3	23	09	14q32.31	MIR376B, MIRN376B		Micro RNA 376b	610961	R			
14.499	5	19	15	14q32.31	MIR379		Micro RNA 379	616358	REc			12(Mir379)
14.500	7	1	11	14q32.31	MIR409, MIRN409		Micro RNA 409	614057	REc			
14.501	1	29	13	14q32.31	MIR410		Micro RNA 410	615036	REc			
14.502	3	23	09	14q32.2	MIR431, MIRN431		Micro RNA 431	611708	R			
14.503	3	23	09	14q32.2	MIR433, MIRN433		Micro RNA 433	611711	R			
14.504	9	9	13	14q32.31	MIR485		Micro RNA 485	615385	REc			
14.505	1	29	13	14q32.31	MIR487B		Micro RNA 487B	615037	REc			
14.506	10	12	14	14q32.31	MIR494		Micro RNA 494	616036	REc			
14.507	4	8	13	14q32.31	MIR551A		Micro RNA 495	615149	REc			
14.508	5	19	15	14q32.31	MIR656		Micro RNA 656	616376	REc			
14.509	6	4	97	14q32.31	PPP2R5C		Protein phosphatase-2, regulatory subunit B (B56), gamma isoform	601645	A	pseudogene on 3p21		
14.510	1	29	13	14q32.31	TECPR2, KIAA0329, SPG49		Tectonin beta-propeller repeat-containing protein 2	615000	REc, R		Spastic paraplegia 49, autosomal recessive, 615031 (3)	
14.511	10	25	17	14q32.2	WARS, HMN9		Tryptophanyl-tRNA synthetase	191050	S, A, Fd		Neuronopathy, distal hereditary motor, type IX, 617721 (3)	
14.512	10	25	17	14q32.31	WDR20		WD repeat-containing protein 20	617741	REc			
14.513	3	14	18	14q32.32	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5		TNF receptor-associated factor 3	601896	REc	mutation identified in 1 IIAE5 patient	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3)	
14.514	7	15	16	14q32.33	ADSSL1, MPD5		Adenylosuccinate synthase-like 1	612498	REc		Myopathy, distal, 5, 617030 (3)	
14.515	10	12	14	14q32.33	APOPT1, APOP		Apoptogenic protein 1, mitochondrial	616003	REc		Mitochondrial complex IV deficiency, 220110 (3)	12(Apopt1)
14.516	2	3	15	14q32.33	BRF1, TAF3C, GTF3B, TF3B90, CFDS		BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)	604902	R, REc		Cerebellofaciodental syndrome, 616202 (3)	
14.517	9	24	08	14q32.33	CDCA4, HEPP		Cell division cycle-associated protein 4	612270	REc			
14.518	11	15	05	14q32.33	CRIP1, CRIP		Cysteine-rich intestinal protein 1	123875	Psh, R, H	previously assigned to 7q11.23		12(Crip)
14.519	3	9	00	14q32.33	C14orf2, MP68		MP68, rat, homolog of	604573	R			
14.520	4	8	08	14q32.33	IGHD@		Immunoglobulin heavy chain diversity gene cluster	146910	RE, REa, A	many genes		
14.521	10	23	87	14q32.33	IGHA1		Constant region of heavy chain of IgA1	146900	REa, A	Fused with IRTA1 in multiple myeloma		
14.522	10	23	87	14q32.33	IGHA2		Constant region of heavy chain of IgA2	147000	REa, A			
14.523	4	30	91	14q32.33	IGHD		Constant region of heavy chain of IgD	147170	REa, A, Fd			
14.524	4	8	08	14q32.33	IGHD3-3, DXP4		Immunoglobulin heavy chain diversity gene 3-3	611937	REn			
14.525	10	23	87	14q32.33	IGHE		Constant region of heavy chain of IgE	147180	REa, A	pseudogene IGHEP1 nearby; IGHEP2 on chr.9		
14.526	10	23	87	14q32.33	IGHG1		Constant region of heavy chain of IgG1	147100	REa, A			
14.527	4	8	98	14q32.33	IGHG2		Constant region of heavy chain of IgG2	147110	REa, A	5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein	IgG2 deficiency, selective (3)	
14.528	4	30	91	14q32.33	IGHG3		Constant region of heavy chain of IgG3	147120	REa, A, Fd			
14.529	10	23	87	14q32.33	IGHG4		Constant region of heavy chain of IgG4	147130	REa, A			
14.530	4	15	08	14q32.33	IGHJ@		Immunoglobulin heavy chain joining gene cluster	147010	RE, REa, A	more than 4 genes		
14.531	8	10	10	14q32.33	IGHM, MU, AGM1		Constant region of heavy chain of IgM	147020	REa, A		Agammaglobulinemia 1, 601495 (3)	
14.532	9	15	89	14q32.33	IGHR		Immunoglobulin heavy chain regulator	144120	F		?Hyperimmunoglobulin G1 syndrome (2)	
14.533	4	15	08	14q32.33	IGHV@		Immunoglobin heavy polypeptide, variable gene cluster	147070	REa, RE, A	~250 genes; orientation: cen-PI-D14S1-IGH-IGHV--qter; 3' centromeric, 5' telomeric; IgM telomeric to IgG		
14.534	2	21	10	14q32.33	KIF26A, KIAA1236		Kinesin family member 26A	613231	R, REc			
14.535	4	15	08	14q32.33	IGHV3-23, IGHV323, DP47, VH26		Immunoglobulin heavy chain variable gene 3-23	611939	REn			
14.536	1	30	12	14q32.33	INF2, FSGS5, C14orf173, CMTDIE		Inverted formin 2	610982	REc		Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	
14.537	10	28	15	14q32.33	KIAA0125, FAM30A, C14orf110		KIAA0125 gene, noncoding	616623	Psh, REc			
14.538	3	23	09	14q32.33	MIR203, MIRN203		Micro RNA 203	611899	REc			
14.539	8	3	18	14q32.33	PACS2, KIAA0602, EIEE66		Phosphofurin acidic cluster sorting protein 2	610423	R, REc		Epileptic encephalopathy, early infantile, 66, 618067 (3)	
14.540	7	2	18	14q32.33	PPP1R13B, ASPP1, KIAA0771		Protein phosphatase 1, regulatory subunit 13B	606455	REc			
14.541	09	07	18	14q32.33	TDRD9, C14orf75, HLS, SPNE, SPGF30		TUDOR domain-containing protein 9	617963	REc	mutation identified in one SPGF30 family	?Spermatogenic failure 30, 618110 (3)	
14.542	2	25	15	14q32.33	ZBTB42, ZNF925, LCCS6		Zinc finger- and BTB domain-containing protein 42	613915	REc	mutation identified in 1 LCCS6 family	?Lethal congenital contracture syndrome 6, 616248 (3)	
14.543	12	15	10	14q32.33	ZFYVE21, ZF21		Zinc finger FYVE domain-containing protein 21	613504	REc			
14.544	10	23	87	Chr.14	LCH		Lentil agglutinin-binding	151020	S			
14.545	5	12	00	14q22.1	MAP4K5, MAPKKKK5		Mitogen-activated protein kinase kinase kinase kinase-5	604923	R			
14.546	9	3	02	14q12	NFATC4		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4	602699	R			
14.547	11	21	02	14q22.1	NID2		Nidogen 2	605399	H			14(Nid2)
14.548	1	27	04	Chr.14	PHOBS		Phobia, specific	608251	Fd		Phobia, specific (2)	
14.549	9	20	00	14q21.1	PNN, DRS		Pinin	603154	R			
14.550	10	21	15	Chr.14	RC14S		Ring chromosome 14 syndrome	616606	Ch		Ring chromosome 14 syndrome (4)	
14.551	4	4	03	14q32.31-q32.32	RCOR, COREST, KIAA0071		REST corepressor	607675	R			
14.552	1	28	02	14q21.3	RPL36AL, RPL36A		Ribosomal protein L36a-like	180469	Psh			
15.1	4	26	90	15p12	RNR3		Ribosomal RNA-3	180452	A			
15.2	11	16	98	15q13.1	APBA2		Amyloid beta A4 precursor protein-binding, family A, member 2	602712	R			7(Apba2)
15.3	2	1	00	15q	HYT2		Hypertension, essential, susceptibility to, 2	604329	Fd		{Hypertension, essential, susceptibility to, 2}, 145500 (2)	
15.4	5	24	01	15q	LCS1, CHLS		Cholestasis-lymphedema syndrome	214900	Fd, HZ		Cholestasis-lymphedema syndrome (2)	
15.5	1	13	99	15q21.3	NEDD4		Neural precursor cell expressed, developmentally downregulated-4	602278	H, A			
15.6	10	20	99	15q22.31	RPL4		Ribosomal protein L4	180479	REa, R			
15.7	1	13	09	15q25.2	RPS17, RPS17L1, RPS17L2, DBA4		Ribosomal protein S17	180472	Psh, R	previously on chr.11; pseudogenes on 5q33-qter and 17q	Diamond-Blackfan anemia 4, 612527 (3)	
15.8	5	16	07	15q11	AUTS4		Autism, susceptibility to, 4	608636	Ch		{Autism susceptibility 4} (2)	
15.9	11	15	08	15q11.2	CYFIP1, KIAA0068		Cytoplasmic FMRP interacting protein 1	606322	R, REc			
15.10	7	17	91	15q11-q12	IGHDY2		Immunoglobulin heavy chain diversity region-2	146990	A	?functional		
15.11	10	23	87	15q11-q12	MIC7		Attached cell antigen 28.3.7	108990	S			
15.12	6	5	03	15q12	ATP10A, ATP10C, ATPVC		ATPase, class V, type 10A	605855	R, REc, D			
15.13	4	4	06	15q11-q13	CELIAC5, GSES		Celiac disease, susceptibility to, 5	607202	Fd	in homogeneous Finnish population	{Celiac disease, susceptibility to, 5} (2)	
15.14	11	28	05	15q11-q13	GLC1I		Glaucoma 1, open angle, I	609745	Fd	max lod at GABRB3	Glaucoma 1, open angle, I (2)	
15.15	11	8	96	15q11.2	IPW		Imprinted in Prader-Willi syndrome	601491	REc			
15.16	1	25	93	15q24.2	MAN2C1, MANA		Mannosidase, alpha, class 2C, member 1	154580	S, D			
15.17	8	1	13	15q11.2	MKRN3, ZFP127, ZNF127, CPPB2		Makorin 3	603856	REc	expressed only from paternal allele	Precocious puberty, central, 2, 615346 (3)	7(Znf127)
15.18	11	3	99	15q11-q13	MRKN3AS, ZNF127AS		MKRN3 antisense RNA	603857	REc			
15.19	4	5	00	15q11.2	NDN		Necdin	602117	A, Psh, REc		Prader-Willi syndrome, 176270 (3)	7(Ndn)
15.20	11	13	94	15q11.2	D15S227E, PAR1		Prader-Willi/Angelman region-1	600161	REn	paternally imprinted		
15.21	11	13	94	15q11.2	D15S226E, PAR5		Prader-Willi/Angelman syndrome-5	600162	REn	paternally imprinted		
15.22	2	20	97	15q11.2	UBE3A, ANCR		Ubiquitin protein ligase E3A	601623	Ch, D, REc	same location as PWS	Angelman syndrome, 105830 (3)	
15.23	6	6	12	15q13.3	SCG5, SGNE1		Secretogranin V (7B2 protein )	173120	A			2(Sgne1)
15.24	5	3	10	15q11-q21.1	RCHTS		Roifman-Chitayat syndrome	613328	Fd	?1p36.23-p33	?Roifman-Chitayat syndrome (2)	
15.25	10	29	91	15q11-q22	MIC12		Antigen identified by monoclonal antibody 30.2A8	107254	S	in myoblasts, but not myotubes		
15.26	7	5	92	15q11-qter	HCVS		Human coronavirus sensitivity	122460	S			
15.27	5	2	01	15q15.1	EHD4		EH domain-containing 4	605892	R			
15.28	4	27	12	15q11.2	NIPA1, SPG6		Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1	608145	Fd, REc		Spastic paraplegia 6, autosomal dominant, 600363 (3)	7(Nipa1)
15.29	3	7	14	15q11.2	DEL15q11.2, C15DELq11.2		Chromosome 15q11.2 deletion syndrome	615656	Ch	deleted region spans 300-500kb between BP1 and BP2	Chromosome 15q11.2 deletion syndrome (4)	
15.30	4	7	15	15q11.2	MAGEL2, NDNL1, SHFYNG		MAGE-like 2	605283	REc		Schaaf-Yang syndrome, 615547 (3)	7(Magel2)
15.31	7	21	14	15q11.2	NBEAP1, BCL8		Neurobeachin pseudogene 1	601889	REc, A			
15.32	4	25	06	15q11.2	NIPA2		Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 2	608146	REc, H			7(Nipa2)
15.33	5	26	13	15q11.2	PWRN1		Prader-Willi region noncoding RNA 1	611215	REc			
15.34	5	26	13	15q11.2	PWRN2		Prader-Willi region noncoding RNA 2	611217	REc			
15.35	3	23	15	15q11.2	SNHG14, LNCAT, UBE3AATS		Small nucleolar RNA host gene 14	616259	REc, H			7(Snhg14)
15.36	3	16	10	15q11.2	SNORD115-1, RNHBII52		Small nucleolar RNA, C/D box, 115-1	609837	REn, REc			
15.37	3	16	10	15q11.2	SNORD116-1, PWCR1		Small nucleolar RNA, C/D box, 116-1	605436	REc			
15.38	11	21	03	15q11.2	TUBGCP5, GCP5, KIAA1899		Tubulin-gamma complex-associated protein 5	608147	REc, H			7(Gcp5)
15.39	9	22	16	15q12	GABRB3, ECA5, EIEE43		Gamma-aminobutyric acid (GABA) A receptor, beta-3	137192	A, H, D, REn		{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3); Epileptic encephalopathy, early infantile, 43, 617113 (3)	7(Gabrb3)
15.40	1	9	95	15q12	GABRA5		Gamma-aminobutyric acid (GABA) A receptor, alpha-5	137142	A, REa, REb, D, REn	100kb from GABRB3		7(Gabra5)
15.41	1	9	95	15q12	GABRG3		Gamma-aminobutyric acid (GABA) A receptor, gamma-3	600233	REn	cen--G3--A5--B3		
15.42	4	18	05	15q11.2-q12	MGR7		Migraine with aura, susceptibility to, 7	609179	Fd	between D15S113 and D15S1019	{Migraine with aura, susceptibility to, 7} (2)	
15.43	1	17	08	15q12-q13	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1		Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	D, REa, Fd	?hypopigmentation in PWS and AS	Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	7(p)
15.44	8	21	07	15q12	HPC7		Prostate cancer, hereditary, 7	610321	Fd		{Prostate cancer, hereditary, 7} (2)	
15.45	12	14	10	15q13.3	KLF13, RFLAT1, FKLF2		Kruppel-like factor 13	605328	REc			
15.46	6	15	12	15q11.2	NPAP1, C15orf2		Nuclear pore associated protein 1	610922	REc			
15.47	4	5	00	15q11.2	SNRPN		Small nuclear ribonucleoprotein polypeptide N	182279	REa, D		Prader-Willi syndrome, 176270 (3)	7(Snrpn)
15.48	7	25	06	15q12-q15	MCOPCB2		Microphthalmia, isolated, with coloboma 2	605738	Fd		Microphthalmia with coloboma 2 (2)	
15.49	1	13	17	15q15.1	MAPKBP1, JNKBP1, NPHP20		Mitogen-activated protein kinase-binding protein 1	616786	REc		Nephronophthisis 20, 617271 (3)	
15.50	2	11	14	15q13	SRTD1, ATD1		Short-rib thoracic dysplasia 1 with or without polydactyly	208500	Fd		Short-rib thoracic dysplasia 1 with or without polydactyly (2)	
15.51	9	22	09	15q13	SCZD13		Schizophrenia 13	613025	Ch	associated with deletion at 15q13.3	{Schizophrenia, susceptibility to, 13} (2)	
15.52	2	18	96	15q13.1	TJP1		Tight junction protein 1 (zona occludens 1)	601009	A			7(Tjp1)
15.53	8	21	98	15q13.3	FMN, LD		Formin (limb deformity)	136535	REa, A, Fd, Psh			2(ld)
15.54	10	7	02	15q14	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN		Solute carrier family 12 (potassium/chloride transporters), member 6	604878	A, R, REa, Fd		Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	
15.55	1	31	13	15q13.3	TRPM1, MLSN1, CSNB1C		Transient receptor potential cation channel, subfamily M, member 1 (melastatin)	603576	R		Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	7(Mlsn1)
15.56	10	23	87	15q13-q15	B2MR		Beta-2-microglobulin regulator	109710	D			
15.57	6	15	12	15q13.3	GREM1, CKTSF1B1		Gremlin 1 homolog, cystine knot superfamily	603054	Psh, R			
15.58	11	13	94	15q15.3	MAP1A, MAP1L		Microtubule-associated protein 1A	600178	Psh			
15.59	11	19	13	15q13.1	HERC2, SHEP1, MRT38		HECT domain and RCC1-like domain 2	605837	Psh, R, REc	mutations in intron 4	[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3); Mental retardation, autosomal recessive 38, 615516 (3)	
15.60	12	5	16	15q13.1	NSMCE3, NDNL2, MAGEG1, LICS		NSE3 homolog, SMC5-SMC6 complex component	608243	REc, H		Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3)	7(Ndnl2)
15.61	5	11	04	15q13.1-q15.1	CILD4		Ciliary dyskinesia, primary, 4	608646	Fd	between D15S1012 and D15S1048	Ciliary dyskinesia, primary, 4 (2)	
15.62	11	30	06	15q13.3	ARHGAP11A, KIAA0013		RHO GTPase-activating protein 11A	610589	Psh, REc			
15.63	4	10	15	15q13.2	ARHGAP11B, FAM7B1		RHO GTPase-activating protein 11B	616310	REc			
15.64	9	16	09	15q14	SPRED1, NFLS		Sprouty-related EVH1 domain-containing protein 1	609291	REc		Legius syndrome, 611431 (3)	2(Spred1)
15.65	9	14	12	15q13.3	FAN1, MTMR15, KIAA1018, KMIN		FANCD2/FANCI-associated nuclease 1	613534	REc		Interstitial nephritis, karyomegalic, 614817 (3)	
15.66	7	11	11	15q15.1	CHP		Calcineurin B homologous protein	606988	R, REc			
15.67	9	22	09	15q13.3	DEL15q13.3, MICRODEL15q13.3		Chromosome 15q13.3 microdeletion syndrome	612001	Ch		Chromosome 15q13.3 microdeletion syndrome (4)	
15.68	2	22	11	15q13.3	MIR211, MIRN211		Micro RNA 211	613753	REc			
15.69	10	18	11	15q15.1	NDUFAF1, CIA30, CGI65		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, assembly factor 1	606934	REc		Mitochondrial complex I deficiency, 252010 (3)	
15.70	6	5	08	15q13.3	OTUD7A, OTUD7, C16orf15, CEZANNE2		OTU domain-containing protein 7A	612024	REc			
15.71	6	16	10	15q14	ACTC1, CMD1R, CMH11, ASD5, LVNC4		Actin, alpha, cardiac muscle	102540	REa, Fd, A		Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)	2(Actc1)
15.72	6	9	08	15q14	AGPAT7, AYTL3		1-acylglycerol-3-phosphate O-acyltransferase 7	612039	REc			
15.73	5	26	13	15q14	AQR, IBP160, KIAA0560		Aquarius, mouse, homolog of	610548	R, REc			2(Aqr)
15.74	7	9	06	15q15.1	BMF		BCL2-modifying factor	606266	REn			
15.75	2	13	14	15q14	C15orf41		Chromosome 15 open reading fram 41	615626	REc		Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	
15.76	8	14	17	15q13.3	CHRNA7		Cholinergic receptor, nicotinic, alpha polypeptide-7	118511	A			7(Acra7)
15.77	11	22	13	15q15.1	CHST14, D4ST1, ATCS, EDSMC1		Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	608429	REc		Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	
15.78	9	22	09	15q14	EIG7, EJM2		Epilepsy, idiopathic generalized, susceptibility to, 7	604827	Fd	?role of CHRNA7	{Epilepsy, idiopathic generalized, susceptibility to, 7} (2); Epilepsy, juvenile myoclonic (2)	
15.79	2	25	15	15q14	EMC4, TMEM85, PIG17		ER membrane protein complex subunit 4	616245	REc			
15.80	1	12	15	15q14	FAM98B		Family with sequence similarity 98, member B	616142	REc			
15.81	6	22	14	15q14	FSIP1, HSD10		Fibrous sheath-interacting protein 1	615795	REc			
15.82	12	27	07	15q14	GJD2, GJA9, CX36		Gap junction protein, delta-2 (connexin 36)	607058	A, H			2(Gja9)
15.83	1	12	15	15q14	GOLGA8A, KIAA0855		Golgin A8 family, member A	616180	R, REc			
15.84	10	5	04	15q14	GOLGA8B, KIAA0855		Golgi autoantigen, golgin subfamily A, 8B	609619	R, REc			
15.85	2	25	15	15q14	KATNBL1, C15orf29		Katanin, p80 subunit, B-like 1	616235	REc			
15.86	8	29	08	15q14-q15	GPR176		G protein-coupled receptor 176	612183	R, REc			
15.87	4	7	16	15q14	DEL15q14, C15DELq14		Chromosome 15q14 deletion syndrome	616898	Ch		Chromosome 15q14 deletion syndrome (4)	
15.88	3	31	03	15q15.1	IVD		Isovaleryl Coenzyme A dehydrogenase	607036	REa		Isovaleric acidemia, 243500 (3)	
15.89	12	28	11	15q14	NOLA3, NOP10, DKCB1		Nucleolar protein family A, member 3	606471	R, Fd		Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	
15.90	11	4	93	15q13-q14	RYR3		Ryanodine receptor-3	180903	A, Psh			2(Ryr3)
15.91	10	16	92	15q15.1	ITPKA		Inositol 1,4,5-trisphosphate 3-kinase A	147521	A			
15.92	5	17	19	15q14	MEIS2, MRG1, CPCMR		Meis1, mouse, homolog of, 2	601740	Psh		Cleft palate, cardiac defects, and mental retardation, 600987 (3)	2(Mrg1)
15.93	6	9	17	15q21.1	BLOC1S6, BLOS6, PLDN, PA, HPS9		Biogenesis of lysosome-related organelles complex 1, subunit 6	604310	R	mutation identified in 1 HPS9 patient	?Hermansky-pudlak syndrome 9, 614171 (3)	2(Pa)
15.94	2	19	13	15q15.1	BUB1B, BUBR1, MVA1		Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta	602860	A		Colorectal cancer, somatic, 114500 (3); Mosaic variegated aneuploidy syndrome 1, 257300 (3); [Premature chromatid separation trait], 176430 (3)	
15.95	2	13	14	15q15.2	CDAN1, CDA1, CDAN1A		Codanin 1	607465	Fd, LD		Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	
15.96	7	26	10	15q15.3	CKMT1A		Creatine kinase, mitochondrial 1A	613415	REc	telomeric to CKMT1B		
15.97	1	9	95	15q15.3	CKMT1B, CKMT1		Creatine kinase, mitochondrial 1B	123290	REa, A	centromeric to CKMT1A		2(Ckmt1)
15.98	5	19	09	15q21.1	DUOXA1		Dual oxidase maturation factor 1	612771	REc	tail-to-tail with DUOXA2		
15.99	9	29	09	15q21.1	DUOXA2, TDH5		Dual oxidase maturation factor 2	612772	REc	head-to-head with DUOX2	Thyroid dyshormonogenesis 5, 274900 (3)	
15.100	11	18	15	15q15.2	EPB42, SPH5		Erythrocyte surface protein band 4.2	177070	A		Spherocytosis, type 5, 612690 (3)	2(Epb4.2)
15.101	4	13	98	15q15.3	GRP58		Glucose regulated protein, 58kD	602046	A			2(Grp58)
15.102	10	24	14	15q15.1	MGA, KIAA0518		MAX dimerization protein MGA	616061	R, REc			2(Mga)
15.103	7	13	09	15q15.1	PLA2G4D		Phospholipase A2, Group IVD	612864	REc			
15.104	6	10	02	15q15.1	PLCB2		Phospholipase C, beta-2	604114	REa, A		Platelet PLC beta-2 deficiency (1)	
15.105	8	9	99	15q14	RASGRP1		Ras guanyl nucleotide releasing protein-1	603962	A			2(Rasgrp1)
15.106	8	3	12	15q15	SCZD10		Schizophrenia 10	605419	Fd	between D15S1042 and D15S659	{Schizophrenia 10} (2)	
15.107	8	30	01	15q21.1	SLC28A2, CNT2, SPNT1		Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2	606208	R, A			2(Slc28a2)
15.108	6	1	12	15q15.2	STARD9, KIAA1300		START domain-containing protein 9	614642	R, REc			
15.109	11	8	01	15q15.3	STRC, DFNB16		Stereocilin	606440	REc, Fd		Deafness, autosomal recessive 16, 603720 (3)	
15.110	6	5	90	15q14	THBS1		Thrombospondin 1	188060	REa, A			2(Thbs1)
15.111	5	4	15	15q15.3	TUBGCP4, GCP4, MCCRP3		Tubulin-gamma complex-associated protein 4	609610	R, REc		Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	
15.112	1	12	95	15q15.3	MFAP1		Microfibrillar-associated protein-1	600215	REa, A, REc			
15.113	9	20	00	15q15.3	TP53BP1, 53BP1		Tumor protein p53-binding protein-1	605230	A			
15.114	6	19	98	15q21.1	DUT		dUTP pyrophosphatase	601266	A			
15.115	5	29	98	15q21.2	FGF7		Fibroblast growth factor-7 (keratinocyte growth factor)	148180	A, H			2(Fgf7)
15.116	8	23	04	15q21.1	SLC12A1, NKCC2		Solute carrier family 12 (sodium/potassium/chloride transporters), member 1	600839	H, Fd, LD		Bartter syndrome, type 1, 601678 (3)	2(Slc12a1)
15.117	12	7	05	15q15.2	UBR1, JBS		Ubiquitin-protein ligase E3-alpha	605981	H, REc, Fd		Johanson-Blizzard syndrome, 243800 (3)	2(Ubr1)
15.118	4	15	11	15q15.1	BAHD1, KIAA0945		BROMO-adjacent homology domain-containing protein 1	613880	R, REc			
15.119	3	3	16	15q15.1	DNAJC17		DNAJ/HSP40 homolog, subfamily C, member 17	616844	REc			2(Dnajc17)
15.120	10	7	14	15q15.1	KNSTRN, C15orf23, SKAP		Kinetochore-localized astrin/SPAG5 binding protein	614718	REc			
15.121	4	27	12	15q15.1	CHAC1		ChaC, E. coli, homolog of, 1	614587	REc			
15.122	2	13	14	15q15.1	EIF2AK4, GCN2, KIAA1338, PVOD2		Eukaryotic translation initiation factor 2-alpha kinase 4	609280	REc		Pulmonary venoocclusive disease 2, 234810 (3)	
15.123	9	23	08	15q15.1	FAM82A2, FAM82C, RMD3, PTPIP51		Family with sequence similarity 82, member A2	611873	REc			
15.124	5	25	13	15q15.1	GCHFR, GFRP		GTP cyclohydrolase I feedback regulatory protein	602437	REc			
15.125	7	9	15	15q15.1	INO80, INOC1		INO80 complex subunit	610169	REc			
15.126	6	12	17	15q15.1	KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4		Kinetochore scaffold 1	609173	A, REc		Microcephaly 4, primary, autosomal recessive, 604321 (3)	
15.127	7	15	09	15q15.1	NUSAP1, ANKT, NUSAP		Nucleolar and spindle-associated protein 1	612818	REc			
15.128	10	09	18	15q15.1	OIP5, MIS18B		OPA-interacting protein 5	606020	REc			
15.129	5	10	11	15q15.1	PAK6		p21-activated kinase 6	608110	R, REc			
15.130	3	3	10	15q15.1	PPP1R14D, GBPI1		Protein phosphatase 1, regulatory subunit 14D	613256	REc			
15.131	12	15	16	15q15.1	RAD51A, RECA, MRMV2, FANCR		RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)	179617	REa, A	mutation identified in 1 FANCR patient	{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2, 614508 (3); ?Fanconi anemia, complementation group R, 617244 (3)	2(Rad51)
15.132	10	13	09	15q15.1	RPAP1, KIAA1403		RNA polymerase II-associated protein 1	611475	R, REc			
15.133	9	2	10	15q15.1	RTF1, KIAA0252		RTF1, S. cerevisiae, homolog of	611633	R			
15.134	9	16	16	15q15.1	TYRO3		TYRO3 protein tyrosine kinase	600341	REa, Psh, REn			2(Tyro3)
15.135	11	19	15	15q15.1	VPS18		Vacuolar protein sorting 18, yeast, homolog of	608551	REc			
15.136	8	29	08	15q15.1	VPS39, VAM6, TLP, KIAA0770		Vacuolar protein sorting 39, yeast, homolog of	612188	R, REc			
15.137	1	2	03	15q15.1	GANC		Neutral alpha-glucosidase C	104180	S, REc			
15.138	4	9	15	15q15.3	CATSPER2		Cation channel, sperm-associated, 2	607249	A, REc, H	in region with tandem duplication containing a CATSPER2 pseudogene		2(Catsper2)
15.139	09	25	18	15q15.1	CAPN3, CANP3, LGMDR1, LGMDD4		Calpain, large polypeptide L3	114240	REb, Fd, A, REn, H		Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3); Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3)	2(Canp3)
15.140	1	9	95	15q15.1	LTK, TYK1		Leukocyte tyrosine kinase	151520	REa, Psh			2(Ltk)
15.141	9	7	10	15q15.2	HAUS2, CEP27		HAUS augmin-like complex, subunit 2	613429	REc			
15.142	11	10	14	15q15.2	TGM5, TGX, PSS2		Transglutaminase 5	603805	A, Fd		Peeling skin syndrome 2, 609796 (3)	
15.143	3	26	02	15q15.2-q15.3	TGM7, TGMZ		Transglutaminase 7	606776	Psh, R			2(Tgm7)
15.144	1	2	08	15q15.2	TTBK2, SCA11		Tau tubulin kinase 2	611695	Fd, REc		Spinocerebellar ataxia 11, 604432 (3)	
15.145	1	15	09	15q15.3	DEL15q15.3, C15DELq15.3		Chromosome 15q15.3 deletion syndrome	611102	Ch		Deafness and male infertility (4)	
15.146	1	11	07	15q21.1	DUOX1, THOX1		Dual oxidase 1 (thyroid oxidase 1)	606758	A, R, H			2(Duox1)
15.147	9	29	09	15q21.1	DUOX2, THOX2, TDH6		Dual oxidase 2 (thyroid oxidase 2)	606759	A, R, H		Thyroid dyshormonogenesis 6, 607200 (3)	2(Duox2)
15.148	10	3	07	15q21.1	EIF3J, EIF3S1		Eukaryotic translation initiation factor 3, subunit J	603910	REc			
15.149	2	10	06	15q15.3	ELL3		Elongation factor, RNA polymerase II, 3	609885	R, REc			
15.150	4	13	15	15q15.3	FRMD5		FERM domain-containing protein 5	616309	REc			
15.151	6	7	10	15q15.3	FRTS1, FRTS, RFS		Fanconi renotubular syndrome	134600	Fd		Fanconi renotubular syndrome 1 (2)	
15.152	5	19	09	15q15.3	HYPK		Huntingtin-interacting protein K	612784	REc			
15.153	5	26	13	15q15.3	LCMT2, TYW4, KIAA0547		Leucine carboxyl methyltransferase 2	611246	REc			
15.154	10	30	06	15q21.2	LEO1, RDL		LEO1 RNA polymerase II associated factor, S. cerevisiae, homolog of	610507	REc			
15.155	9	3	15	15q15.3	PPIP5K1, HISPPD2A, IPS1, KIAA0377		Diphosphoinositol pentakisphosphate kinase 1	610979	R, REc			
15.156	3	25	14	15q15.3	SERF2, H4F5REL		Small EDRK-rich factor 2	605054	REc			
15.157	4	2	12	15q15.3	SERINC4		Serine incorporator 4	614550	REc			
15.158	8	31	99	15q21.1	SORD, SORD1		Sorbitol dehydrogenase	182500	S, H, A, REa, Psh		?Cataract, congenital (2)	2(Sdh1)
15.159	11	12	03	15q21.2	SPPL2A, IMP3		Signal peptide peptidase-like 2A	608238	REc			
15.160	6	15	12	15q15.3-q22.1	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq		Polyposis syndrome, mixed, hereditary 1	601228	Fd	duplication of 40kb of 15q resulting in overexpression of GREM1	Polyposis syndrome, mixed hereditary 1 (4); {Colorectal cancer, susceptibility to, 4} (4)	
15.161	6	13	02	15q21.2	BCL2L10		BCL2-like 10	606910	REc, R			9(Bcl2l10)
15.162	3	20	95	15q21	CDAN3, CDA3		Congenital dyserythropoietic anemia, type III	105600	Fd		Dyserythropoietic anemia, congenital, type III (2)	
15.163	4	29	17	15q21.3	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25		Dynein, axonemal, assembly factor 4	608706	Fd, REc	not confirmed by some studies	{Dyslexia, susceptibility to, 1}, 127700 (3); Ciliary dyskinesia, primary, 25, 615482 (3)	
15.164	6	20	13	15q22.31	MAP2K1, PRKMK1, MKK1, MEK1, CFC3		Mitogen-activated protein kinase kinase 1	176872	R, REa, A	pseudogene on 8p21	Cardiofaciocutaneous syndrome 3, 615279 (3)	9(Mek1)
15.165	4	28	10	15q21.2	MYO5A, MYH12, GS1		Myosin Va	160777	REa, A, Fd		Griscelli syndrome, type 1, 214450 (3)	9(d, Myh12)
15.166	4	19	06	15q21.2	MYO5C		Myosin Vc	610022	REc			
15.167	6	25	08	15q22.31	OSTB		Organic solute transporter, beta	612085	REc			9(Ostb)
15.168	3	17	03	15q21.3	RAB27A, RAM, GS2		Ras-associated protein RAB27A	603868	A, REc		Griscelli syndrome, type 2, 607624 (3)	9(ash, Rab27a)
15.169	5	29	01	15q15.1	SPTBN5, BSPECV		Spectrin, beta, non-erythrocytic 5	605916	REc			
15.170	7	22	13	15q21.3	TCF12, HTF4, CRS3		Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)	600480	REa, A, REc		Craniosynostosis 3, 615314 (3)	
15.171	5	2	06	15q21.2	TRPM7, LTRPC7, CHAK, ALSPDC		Transient receptor potential cation channel, subfamily M, member 7	605692	REc		{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	
15.172	10	29	03	15q22.31	ACP33, MAST, SPG21		Acidic cluster protein, 33kD, (maspardin)	608181	REc, Fd		Mast syndrome, 248900 (3)	
15.173	3	19	91	15q22.2	ANXA2, ANX2L4, LPC2D, LIP2		Annexin A2 (lipocortin I)	151740	REa, Psh	pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13; ANX2P3 on 10q24-q22		
15.174	11	17	15	15q21.1	B2M, IMD43		Beta-2-microglobulin	109700	S, D, H	mutation identified in 1 FVA family	Immunodeficiency 43, 241600 (3); ?Amyloidosis, familial visceral, 105200 (3)	2(B2m)
15.175	7	22	13	15q21-q22	CTRCT25, CCSSO		Cataract 25	605728	Fd		Cataract 25 (2)	
15.176	2	21	14	15q21.2	HDC		Histidine decarboxylase	142704	REa, Psh, A		{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3)	2(Hdc)
15.177	8	2	11	15q22.2	MYO1E, MYO1C, FSGS6		Myosin IE	601479	A		Glomerulosclerosis, focal segmental, 6, 614131 (3)	9(Myo1e)
15.178	8	16	99	15q21.3	PIGB		Phosphatidylinositol glycan, class B	604122	A			
15.179	11	3	09	15q22.31	PPIB, CYPB, OI9		Peptidyl-prolyl isomerase B	123841	REc		Osteogenesis imperfecta, type IX, 259440 (3)	
15.180	7	25	18	15q22.2	RORA, IDDECA		RAR-related orphan receptor A	600825	A		Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3)	9(Rora)
15.181	4	20	17	15q22.31	SMAD6, MADH6, AOVD2		Mothers against decapentaplegic, Drosophila, homolog of, 6	602931	Psh, REc		Aortic valve disease 2, 614823 (3); {Craniosynostosis 7, susceptibility to}, 617439 (3)	
15.182	4	17	01	15q15.1-q15.2	SNAP23		Synaptosomal-associated protein, 23kD	602534	A			
15.183	1	5	12	15q23	CLN6, CLN4A		CLN6 gene	606725	Fd, LD		Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	9(nclf, Cln6)
15.184	1	4	13	15q21.1	CEP152, KIAA0912, MCPH9, SCKL5		Centrosomal protein, 152kD	613529	R, REc		Microcephaly 9, primary, autosomal recessive, 614852 (3); Seckel syndrome 5, 613823 (3)	
15.185	9	20	10	15q21.2	CYP19A1, CYP19, ARO		Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)	107910	REa, A, H	close to CYP11 in mouse	Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3)	9(Cyp19)
15.186	10	15	15	15q15.1	DLL4, AOS6		Delta-like 4	605185	R		Adams-Oliver syndrome 6, 616589 (3)	2(Dll4)
15.187	3	9	17	15q21.1	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS		Fibrillin-1	134797	A, Fd		Marfan syndrome, 154700 (3); Marfan lipodystrophy syndrome, 616914 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)	2(Fbn1)
15.188	4	19	16	15q21.1	GATM, AGAT, CCDS3		L-arginine:glycine amidinotransferase	602360	Psh, R, H, REc		Cerebral creatine deficiency syndrome 3, 612718 (3)	2(Gatn)
15.189	4	2	16	15q21.1	HMGN2P46, C15orf21		High mobility group nucleosomal binding domain 2 pseudogene 46	611314	REc			
15.190	1	27	04	15q21.1	NMES1		Normal mucosa of esophagus-specific gene 1	608409	R			
15.191	10	26	17	15q21.1	PATL2, PAT1A, OOMD4		Protein associated with topoisomerase II, S. Cerevisiae, homolog of	614661	REc		Oocyte maturation defect 4, 617743 (3)	
15.192	4	29	14	15q21.1	SECISBP2L, SBP2L, KIAA0256		Selenocysteine insertion sequence-binding protein 2-like	615756	R, REc			
15.193	4	21	15	15q21.1	SEMA6D, KIAA1479		Semaphorin 6D	609295	REc			
15.194	3	18	17	15q21.1	SHC4, RALP, SHCD		SHC transforming protein 4	617372	REc			
15.195	2	2	17	15q21.1	SHF		SH2 domain-containing adaptor protein F	617313	REc			
15.196	8	8	13	15q21.1	SLC24A5, NCKX5, SHEP4, OCA6		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5	609802	REc, R		[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3); Albinism, oculocutaneous, type VI, 113750 (3)	
15.197	9	12	01	15q21.1	SLC30A4, ZNT4		Solute carrier family 30 (zinc transporter), member 4	602095	A, REc, H			2(lm, Slc30a4)
15.198	12	1	15	15q21.1	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X		Spastascin	610844	Fd, R		Spastic paraplegia 11, autosomal recessive, 604360 (3); Amyotrophic lateral sclerosis 5, juvenile, 602099 (3); Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	
15.199	9	1	17	15q21.1	SQOR, SQRDL		Sulfide quinone oxidoreductase	617658	REc			
15.200	9	26	16	15q21.1	TERB2, C15orf43		Telomere repeat-binding bouquet formation protein 2	617131	REc			
15.201	9	30	14	15q21.1	TRIM69, TRIF, RNF36		Tripartite motif-containing protein 69	616017	REc, H			2(Trim69)
15.202	2	24	17	15q21.1	EID1, CRI1, C15orf3		EP300-interacting inhibitor of differentiation 1	605894	R			
15.203	10	20	99	15q21.3	ONECUT1, HNF6A, HNF6		One cut domain, family member 1 (hepatocyte nuclear factor 6-alpha)	604164	A			
15.204	4	17	01	15q21.2	TMOD2		Tropomodulin 2, neuronal	602928	R			9(Tmod2)
15.205	4	17	01	15q21.2	TMOD3		Tropomodulin 3	605112	R, REc			9(Tmod3)
15.206	3	16	16	15q21.2	AP4E1, SPG51, CPSQ4, STUT1		Adaptor-related protein complex 4, epsilon-1 subunit	607244	REc		Spastic paraplegia 51, autosomal recessive, 613744 (3); Stuttering, familial persistent, 1, 184450 (3)	
15.207	8	7	17	15q21.2	DMXL2, RC3, KIAA0856, PEPNS, DFNA71		DMX-like 2	612186	R, REc	mutation identified in 1 PEPNS family and 1 DFNA71 family	?Polyendocrine-polyneuropathy syndrome, 616113 (3); ?Deafness, autosomal dominant 71, 617605 (3)	
15.208	11	22	16	15q21.2	GNB5, GB5, IDDCA, LADCI		Guanine nucleotide-binding protein, beta-5	604447	R, REc		Intellectual developmental disorder with cardiac arrhythmia, 617173 (3); Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia, 617182 (3)	
15.209	11	22	16	15q21.2	GLDN, CRGL2, LCCS11		Gliomedin	608603	REc		Lethal congenital contracture syndrome 11, 617194 (3)	
15.210	8	28	02	15q21.2	SLC27A2, FACVL1, VLACS		Solute carrier family 27 (fatty acid transporter), member 2 (fatty acid CoA ligase, very long-chain 1)	603247	A			
15.211	7	11	03	15q21.2	GABPB, BABPB2, GABPB1, E4TF1B, NRF2B1		GA-binding protein transcription factor, beta subunit	600610	A			
15.212	6	30	15	15q21.2	TNFAIP8L3, TIPE3		Tumor necrosis factor-alpha-induced protein 8-like 3	616438	REc			
15.213	1	29	01	15q21.1	TRIP15, SGN2, COPS2		Thyroid hormone receptor interactor-15	604508	REc			2(Cops2)
15.214	9	26	17	15q21.2	USP8, HUMORF8, PITA4		Ubiquitin-specific protease 8	603158	REc		Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)	
15.215	1	11	07	15q21.3	CGNL1, FLJ14957, KIAA1749		Cingulin-like 1	607856	REc, REn			
15.216	1	9	14	15q21.3	ADAM10, MADM, RAK, AD18		A disintegrin and metalloprotease domain 10	602192	R, REc		Reticulate acropigmentation of Kitamura, 615537 (3); {Alzheimer disease 18, susceptibility to}, 615590 (3)	
15.217	6	10	14	15q21.3	ALDH1A2, RALDH2		Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2)	603687	R, REc			
15.218	4	21	10	15q22.2	C2CD4B, NLF2		C2 calcium-dependent domain containing 4B	610344	REc			
15.219	4	2	16	15q21.3	CCPG1, KIAA1254, CPR8		Cell cycle progression 1	611326	R, REc			
15.220	4	10	02	15q22.2	GCNT3		Glucosaminyl (N-acetyl) transferase 3, mucin-type	606836	Psh, R, A			
15.221	7	1	11	15q21.3	LIPC, HL, LIPH, HDLCQ12		Lipase C, hepatic	151670	REa, A		[High density lipoprotein cholesterol level QTL 12], 612797 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)	9(Hl)
15.222	2	16	07	15q21.3	MNS1, FLJ11222		Meiosis-specific nuclear structural protein 1	610766	REc			
15.223	3	6	07	15q22.2	NARG2		NMDA receptor-regulated 2	610835	REc, H	pseudogenes on chr.4 and chr.3		9(narg2)
15.224	4	21	10	15q22.2	C2CD4A, NLF1		C2 calcium-dependent domain containing 4A	610343	REc			
15.225	3	4	10	15q21.3	PRTG		Protogenin, chicken, homolog of	613261	REc, H			9(Prtg)
15.226	7	2	18	15q21.3	PYGO1		Pygopus, Drosophila, homolog of, 1	606902	REc			
15.227	3	23	09	15q21.3	RFX7, RFXDC2		Regulatory factor X, 7	612660	REc			
15.228	3	4	10	15q21.3	RSL24D1, RLP24		Ribosomal protein L24 domain-containing protein 1	613262	REc			
15.229	2	18	08	15q21.2	SCG3		Secretogranin III	611796	REc			
15.230	4	19	12	15q21.3	UNC13C		Unc13, C. elegans, homolog of, C	614568	REc			
15.231	9	18	12	15q21.3	GUP, GCOM1, MYOZAP		GRINL1A complex locus upstream gene	614071	REc			
15.232	7	11	14	15q21.3	WDR72, AI2A3		WD repeat-containing protein 72	613214	REc		Amelogenesis imperfecta, type IIA3, 613211 (3)	
15.233	1	30	01	15q22.31	RAB11A		Ras family, member RAB11A	605570	R, A			
15.234	3	17	06	15q21.3	AQP9		Aquaporin 9	602914	R, REc			
15.235	12	21	10	15q22.2	CA12		Carbonic anhydrase XII	603263	A		Hyperchlorhidrosis, isolated, 143860 (3)	
15.236	5	26	05	15q22.31	CILP		Cartilage intermediate layer protein	603489	A		{Lumbar disc disease, susceptibility to}, 603932 (3)	
15.237	12	11	02	15q22.31	DPP8		Dipeptidyl peptidase 8	606819	A			
15.238	4	21	10	15q24.1	GOLGA6, GLP		Golgi autoantigen, golgin subfamily A, 6	610288	REc, A			
15.239	4	18	02	15q23	PIAS1, DDXBP1, GBP		protein inhibitor of activated STAT, 1	603566	A			
15.240	11	17	15	15q23	PKM, PKM2, PK3, THBP1		Pyruvate kinase, muscle	179050	S, D, A			9(Pk3)
15.241	9	23	97	15q24.1	PML, MYL		Promyelocytic leukemia, inducer of	102578	Ch, RE	fused with RARA in APL	Leukemia, acute promyelocytic, PML/RARA type (3)	9(Pml)
15.242	10	11	10	15q23	SPESP1		Sperm equatorial segment protein 1	609399	REc			
15.243	1	31	13	15q22.31	SLC24A1, NCKX1, CSNB1D		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1	603617	A, R		Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	
15.244	12	17	95	15q15.1	SRP14		Signal recognition particle 14kD (homologous Alu RNA-binding protein)	600708	REa			
15.245	12	7	03	15q24.1	STOML1, STORP		Stomatin-like protein 1	608326	A, REc			
15.246	2	11	96	15q23	TLE3, ESG		Transducin-like enhancer of split 3, homolog of Drosophila a E(spl)	600190	REa, Psh, A			
15.247	5	11	00	15q23	MYO9A		Myosin IXa	604875	R			
15.248	3	3	09	15q22-q23	USH1H		Usher syndrome, type 1H	612632	Fd	max lod at D15S980	Usher syndrome, type 1H (2)	
15.249	3	14	14	15q22-q24	GLC1N		Glaucoma 1, open angle, N	611274	Fd	max lod at D15S125	Glaucoma 1, open angle, N (2)	
15.250	5	26	98	15q24.1	MPI, PMI1, CDG1B		Mannosephosphate isomerase (phosphomannose isomerase 1)	154550	S		Congenital disorder of glycosylation, type Ib, 602579 (3)	9(Mpi1)
15.251	1	9	95	15q25.2	NMB		Neuromedin B	162340	REa, Psh			
15.252	6	13	12	15q22.31	FBXL22, FBL22		F-box and leucine-rich repeat protein 22	609088	REc			9(Fbxl22)
15.253	2	16	04	15q22.2	LACTB		Lactamase, beta	608440	R, REc			9(Lactb)
15.254	1	11	07	15q22.31	PAF, OEATC1, KIAA0101		PCNA-associated factor, 15kD	610696	Psh, REc			
15.255	9	18	12	15q21.3	POLR2M, GDOWN, GRINL1A		Polymerase II, RNA, subunit M	606485	A			9(Grinl1a)
15.256	9	9	13	15q22.2	TPM1, CMH3, CMD1Y , LVNC9		Tropomyosin 1, alpha	191010	Fd, R		Cardiomyopathy, hypertrophic, 3, 115196 (3); Cardiomyopathy, dilated, 1Y, 611878 (3); Left ventricular noncompaction 9, 611878 (3)	9(Tpm1)
15.257	3	20	16	15q22.2	VPS13C, KIAA1421, PARK23		Vacuolar protein sorting 13, yeast, homolog of, C	608879	REc		Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	
15.258	7	19	12	15q22.1-q22.2	RNF111		Ring finger protein 111	605840	REc			
15.259	7	9	06	15q22.31	CSNK1G1		Casein kinase I, gamma-1	606274	A			
15.260	6	10	09	15q22.2	APH1B		Anterior pharynx defective 1, C. elegans, homolog of, B	607630	R, REc			
15.261	6	22	12	15q22.2	BNIP2, NIP2		BCL2/adenovirus E1B 19kD protein-interacting protein 2	603292	REc			
15.262	11	11	14	15q22.2	CCNB2		Cyclin B2	602755	REc			
15.263	10	2	12	15q22.2	GTF2A2, TF2A2		General transcription factor IIA, gamma subunit	600519	REc	pseudogenes on chr. 1, 8, 9		
15.264	9	30	14	15q22.2	MIR190A		Micro RNA 190A	615845	REc			
15.265	4	6	15	15q22.2	RAB8B		Ras-associated protein RAB8B	613532	REc			
15.266	6	10	08	15q22.2	RPS27L		Ribosomal protein S27-like	612055	REc			
15.267	7	18	14	15q22.2	TLN2, KIAA0320		Talin 2	607349	R, REc			
15.268	8	26	15	5q22.2	YTHDC2, CAHL		YTH domain-containing protein 2	616530	REc			
15.269	4	18	05	15q22.31	SNX1, SNX1A		Sorting nexin 1	601272	R, REc			
15.270	1	24	07	15q22.31	TIPIN		Timeless-interacting protein	610716	REc, H			9(Tipin)
15.271	4	18	05	15q22.31	USP3		Ubiquitin-specific protease 3	604728	A			
15.272	3	21	06	15q22.31	ZWILCH		Zwilch, Drosophila, homolog of	609984	R, REc			
15.273	2	15	02	15q23	ANP32A, PHAP1		Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A	600832	A			
15.274	10	16	14	15q24.1	BBS4		BBS4 gene	600374	Fd, LD, REc		Bardet-Biedl syndrome 4, 615982 (3)	
15.275	7	31	97	15q24.1	NEO1, NGN		Neogenin, chicken, homolog of, 1	601907	A			
15.276	10	20	99	15q22.31	PUNC		Putative neuronal cell adhesion molecule	604184	A, REa, H			9(Punc)
15.277	12	23	05	15q24.1	UBL7		Ubiquitin-like 7	609748	REc			
15.278	6	20	18	15q22.31	CLPX, EPP2		Caseinolytic mitochondrial matrix peptidase chaperone subunit	615611	R, REa, REc	mutation identified in 1 EPP2 family	?Protoporphyria, erythropoietic, 2, 618015 (3)	
15.279	9	28	15	15q22.31	DAPK2, DRP1		Death-associated protein kinase 2	616567	REc			
15.280	5	25	13	15q22.31	DENND4A		DENN/MADD domain containing 4A	600382	REc			
15.281	8	25	11	15q22.31	DIS3L, DIS3L1, KIAA1955		Dis3 mitotic control, S. cerevisiae, homolog-like	614183	REc			
15.282	7	14	16	15q22.31	HERC1, MDFPMR		HECT domain and RCC1-like domain 1	605109	A, REc		Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	
15.283	2	12	16	15q22.31	IGDCC4, NOPE, KIAA1628		Immunoglobulin superfamily, DCC subclass, member 4	616810	REc, H			9(Nope)
15.284	1	7	09	15q23	IQCH, NYDSP5		IQ motif-containing protein H	612523	REc			
15.285	8	2	13	15q22.31	KBTBD13, NEM6		Kelch repeat and BTB/POZ domains-containing protein 13	613727	REc		Nemaline myopathy 6, autosomal dominant, 609273 (3)	
15.286	8	2	16	15q22.31	LCTL, KLG, KLPH		Lactase-like protein	617060	REc			
15.287	12	24	08	15q22.31	MEGF11, KIAA1781		Multiple epidermal growth factor-like domains 11	612454	REc			
15.288	12	15	12	15q22.31	MTFMT, COXPD15		Mitochondrial methionyl-tRNA formyltransferase	611766	R, REc		Combined oxidative phosphorylation deficiency 15, 614947 (3)	
15.289	5	25	13	15q22.31	OAZ2		Ornithine decarboxylase antizyme 2	604152	REc			
15.290	3	22	07	15q22.31	PDCD7		Programmed cell death 7	608138	R, REc			
15.291	5	21	07	15q22.31	PIF1, PIF		Pif1, S. cerevisiae, homolog of	610953	REc			
15.292	8	18	14	15q22.31	PTPLAD1, BIND1, HACD3		Protein tyrosine phosphatase-like A domain-containing protein 1	615940	REc			
15.293	6	24	08	15q22.31	RNU5A, RNU5		RNA, U5A small nuclear	180691	REc			
15.294	9	6	12	15q22.33	SMAD3, MADH3, LDS3		Mothers against decapentaplegic, Drosophila, homolog of, 3	603109	REa, REc		Loeys-Dietz syndrome 3, 613795 (3)	
15.295	10	2	12	15q22.31	SNAPC5, SNAP19		Small nuclear RNA-activating protein complex, polypeptide 5	605979	REc			
15.296	8	10	16	15q22.31	TRIP4, ASC1, SMABF1, MDCDC		Thyroid hormone receptor interactor 4	604501	REc	mutation identified in 1 MDCDC family	Spinal muscular atrophy with congenital bone fractures 1, 616866 (3); ?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	
15.297	5	8	17	15q22.31	ZNF609, KIAA0295		Zinc finger ptoein 609	617474	REc, H			9(Zfp609)
15.298	2	17	09	15q22.32	STQTL16		Stature quantitative trait locus 16	612579	Fd	associated with rs8038652	{Stature QTL 16} (2)	
15.299	12	12	12	15q23	AAGAB, p34, PPKP1A, PPKP1, KPPP1		Alpha- and gamma-adaptin-binding protein	614888	REc, Fd		Keratoderma, palmoplantar, punctate type IA, 148600 (3)	
15.300	10	13	09	15q23	CORO2B, CLIPINC		Coronin 2B	605002	R, REc			
15.301	6	1	15	15q23	DRAIC		Downregulated RNA in androgen-independent cells, noncoding	616387	REc			
15.302	7	29	15	15q23	EWSAT1, LINC00277		Ewing sarcoma-associated transcript 1, noncoding	616492	REc			
15.303	9	9	08	15q24.2	FBXO22, FBX22		F-box only protein 22	609096	REc			9(Fbxo22)
15.304	8	27	15	15q23	FEM1B, KIAA0396		Fem1, C. elegans, homolog of, B	613539	R, REc			9(Fem1b)
15.305	8	18	08	15q23	GLCE, HSEPI, KIAA0836		Glucuronic acid epimerase	612134	R, REc			
15.306	4	6	00	15q23	ITGA11		Integrin, alpha-11	604789	A, REa			
15.307	3	2	06	15q23	KIF23, KNSL5, MKLP1		Kinesin family member 23	605064	R, REc			
15.308	3	23	14	15q23	LARP6, ACHN		La ribonucleoprotein domain family, member 6	611300	REc			
15.309	6	10	09	15q23	LBXCOR1, CORL1		LBX1 corepressor 1, mouse, homolog of	611273	REc			
15.310	6	10	09	15q23	MAP2K5, PRKMK5, MEK5, MAPKK5		Mitogen-activated protein kinase kinase 5	602520	REc			
15.311	1	24	13	15q23	NOX5		NADPH oxidase 5	606572	REc			
15.312	7	9	07	15q23	NR2E3, PNR, ESCS, RP37		Nuclear receptor subfamily 2, group E, member 3	604485	A, R	near BBS4	Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37, 611131 (3)	9(rd7)
15.313	4	19	12	15q23	PAQR5, MPRG		Progestin and ADIPOQ receptor family, member 5	607781	REc			
15.314	3	23	15	15q23	PCAT29		Prostate cancer-associated transcript 29, noncoding	616273	REc			
15.315	6	10	98	15q24.3	RCN2, ERC55		Reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD)	602584	R, A			
15.316	6	24	08	15q23	RNU6-1, RNU6A, RNU6		RNA, U6 small nuclear 1	180692	REc			
15.317	2	25	11	15q24.2	SCAMP5		Secretory carrier membrane protein 5	613766	REc			
15.318	6	13	12	15q23	SENP8, NEDP1, DEN1		Sentrin-specific protease family, member 8	608659	REc			
15.319	1	20	09	15q23	THAP10		THAP domain-containing protein 10	612538	REc			
15.320	2	21	12	15q23	THSD4, ADAMTSL6		Thrombospondin type-1 domain-containing 4	614476	REc			9(Thsd4)
15.321	10	13	09	15q24.2	UBE2Q2, LOC92912		Ubiquitin-conjugating enzyme E2Q 2	612501	REc			
15.322	12	1	11	15q25.1	ACSBG1, BG, BG1, KIAA0631		Acyl-CoA synthetase, bubble gum family, member 1	614362	R, REc			
15.323	3	23	09	15q24.1	CD276, B7H3		CD276 molecule	605715	REc			9(B7h3)
15.324	5	7	02	15q23	HEXA, TSD		Hexosaminidase A, alpha polypeptide	606869	S, D, A	on 15q+ in APL	Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms, 272800 (3); [Hex A pseudodeficiency], 272800 (3)	9(Hexa)
15.325	6	9	98	15q24.1	ISLR		Immunoglobulin superfamily containing leucine-rich repeat	602059	A			
15.326	8	14	92	15q24.1	CSK		c-src tyrosine kinase	124095	A			
15.327	8	25	03	15q24.2-q24.3	ETFA, GA2, MADD		Electron transfer flavoprotein, alpha polypeptide	608053	REa, A		Glutaric acidemia IIA, 231680 (3)	13(Etfa)
15.328	4	30	91	15q25.1	FAH		Fumarylacetoacetase	613871	A, REa		Tyrosinemia, type I, 276700 (3)	
15.329	10	29	09	15q23-q26.3	GLM4		Glioma susceptibility 4	607248	Fd	max lod at D15S130	{Glioma susceptibility 4} (2)	
15.330	2	15	18	15q26.3	ADAMTS17, WMS4		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 17	607511	REc		Weill-Marchesani 4 syndrome, recessive, 613195 (3)	
15.331	12	24	08	15q24.1	ARID3B, DRIL2, BDP		AT-rich interactive domain-containing protein 3B	612457	REc			
15.332	3	1	01	15q24.1	ARIH1, ARI, UBCH7BP		Ariadne, Drosophila, homolog of, 1	605624	R, A			
15.333	8	12	14	15q25.1	ARNT2, WEDAS		Aryl hydrocarbon receptor nuclear translocator 2	606036	R	mutation identified in 1 WEDAS family	?Webb-Dattani syndrome, 615926 (3)	
15.334	8	2	13	15q23	CELF6, BRUNOL6		CUGbp- and ELAV-like family, member 6	612681	REc			
15.335	8	4	97	15q25.1	CRABP1, RBP5		Cellular retinoic acid-binding protein-1	180230	REa, Ch, A	distal to APL breakpoint		9(Rbp5)
15.336	7	5	92	15q25.1	CHRNB4		Cholinergic receptor, neuronal nicotinic, beta polypeptide-4	118509	REa, H, A, REn			9(Acrb4)
15.337	10	17	12	15q25.1	CIB2, KIP2		Calcium- and integrin-binding protein 2	605564	R, A		Deafness, autosomal recessive 48, 609439 (3); Usher syndrome, type IJ, 614869 (3)	
15.338	6	15	99	15q24.1	CLK3		CDC-like kinase 3	602990	Psh, A			
15.339	11	11	98	15q24	ENFL2		Epilepsy, nocturnal frontal lobe, type 2	603204	Fd	some ENFL not on 20q or 15q	Epilepsy, nocturnal frontal lobe, type 2 (2)	
15.340	1	8	01	15q24.3	HMG20A		High mobility group protein 20A	605534	REc, A, R			
15.341	9	2	09	15q24.2	IMP3, MRPS4, BRMS2		Imp3, S. cerevisiae, homolog of	612980	REc			
15.342	1	27	04	15q25.1	KIAA1199		KIAA1199 gene	608366	REc			
15.343	09	06	18	15q24.3	LINGO1, LRRN6A, LERN1, MRT64		Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1	609791	REc, A		Mental retardation, autosomal recessive 64, 618103 (3)	
15.344	6	6	03	15q25.1	MORF4L1, MRG15		Mortality factor 4-like 1	607303	A			
15.345	6	11	98	15q24	MRST		Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	Fd		Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)	
15.346	2	18	08	15q24.3	SCAPER, KIAA1454		S-phase cyclin A-associated protein in the endoplasmic reticulum	611611	R, REc			
15.347	8	9	99	15q25.2	SH3GL3		SH3-domain GRB2-like 3	603362	Psh, A			
15.348	8	17	16	15q24.2	SIN3A, WITKOS		Sin3, yeast, homolog of, A	607776	A		Witteveen-Kolk syndrome, 613406 (3)	
15.349	1	6	09	15q23	UACA, NUCLING		Uveal autoantigen with coiled-coil domains and ankyrin repeats	612516	REc			
15.350	6	13	02	15q25.3	AKAP13, HT31, LBC, BRX		A-kinase anchor protein 13	604686	A			
15.351	12	3	08	15q24-q25	CILD8		Ciliary dyskinesia, primary, 8	612274	Fd	max lod at D15S154	Ciliary dyskinesia, primary, 8 (2)	
15.352	1	9	94	15q25.1	CTSH		Cathepsin H	116820	REa, A			9(Ctsh)
15.353	12	2	09	15q24.1	HCN4, SSS2		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206	A		Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)	
15.354	3	5	08	15q25.3	MRPL46		Mitochondrial ribosomal protein L46	611851	R, REc			
15.355	5	3	04	15q24.3	PSTPIP1, PSTPIP, CD2BP1, PAPAS		Proline-serine-threonine phosphatase-interacting protein 1	606347	R, Fd		Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	
15.356	12	27	01	15q25.2	TM6SF1		Transmembrane 6 superfamily, member 1	606562	REc			
15.357	2	26	08	15q24.1	ADPGK		ADP-dependent glucokinase	611861	R, REc			9(Adpgk)
15.358	9	26	16	15q24.1	C15orf59, INSYN1		Chromosome 15 open reading frame 59	617128	REc			
15.359	4	28	10	15q24.1	CYP1A1, CYP1		Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 1	108330	S, REa, H	head-to-head with CYP1A2		9(Cyp1a1)
15.360	4	28	10	15q24.1	CYP1A2		Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 2	124060	REa, H, REc	23.3kb from CYP1A1		9(Cyp1a2)
15.361	10	7	13	15q24.1	CYP11A1, P450SCC		Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)	118485	REa, H, A, Fd		Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	9(Cyp11a)
15.362	7	13	15	15q24.1	EDC3, YJDC, MRT50		Enhancer of mRNA decapping 3, S. cerevisiae, homolog of	609842	REc	mutation identified in 1 MRT50 family	?Mental retardation, autosomal recessive 50, 616460 (3)	
15.363	9	6	11	15q24.1	ISLR2, LINX, KIAA1464		Immunoglobulin superfamily containing leucine-rich repeat 2	614179	REc, Psh			
15.364	2	9	16	15q24.1	LOXL1, LOXL		Lysyl oxidase-like 1	153456	A, H, REc		{Exfoliation syndrome, susceptibility to}, 177650 (3)	9(Loxl1)
15.365	2	9	16	15q24.1	LOXL1AS1		LOXL1 antisense RNA 1	616800	REc			
15.366	1	29	13	15q24.1	NPTN, SDFR1, GP55, NP55, GP65, NP65		Neuroplastin	612820	R, REc			
15.367	4	17	13	15q24.1	NPTNIT1		NPTN intronic transcript 1, noncoding	615176	REc			
15.368	4	17	07	15q24.2	NRG4, HRG4		Neuregulin 4	610894	R, REc			
15.369	9	13	17	15q24.1	SEMA7A, SEMAL, SEMAK1, CDW108, JMH		Semaphorin 7A	607961	A, REc		[Blood group, John-Milton-Hagen system], 614745 (3)	9(Sema7a)
15.370	11	30	12	15q24.1	STRA6, MCOPS9, MCOPCB8		Stimulated by retinoic acid 6, mouse, homolog of	610745	REc, R		Microphthalmia, syndromic 9, 601186 (3); Microphthalmia, isolated, with coloboma 8, 601186 (3)	
15.371	9	29	10	15q24.1	ULK3		UNC51-like kinase 3	613472	REc			
15.372	12	22	15	15q24.2	COMMD4		COMM domain-containing protein 4	616701	REc			
15.373	4	27	12	15q24.2	CSPG4, MCSPG, MSK16, NG2		Chondroitin sulfate proteoglycan	601172	REa, REc			
15.374	9	16	12	15q24.2	NEIL1, NEI1, FPG1		Endonuclease VIII-like 1	608844	REc			
15.375	3	20	06	15q24.2	PPCDC		Phosphopantothenoylcysteine decarboxylase	609854	REc			
15.376	5	25	13	15q24.2	PTPN9		Protein-tyrosine phosphatase, nonreceptor-type, 9	600768	REc			
15.377	6	9	98	15q25.1	BCL2A1		BCL2-related protein A1	601056	REa, A			9(Bcl2a1)
15.378	12	21	15	15q25.2	HOMER2, HOMER2B, HOMER2A, DFNA68		Homer, homolog 2 (Drosophila)	604799	R, REc	mutation identified in 1 DFNA68 family	?Deafness, autosomal dominant 68, 616707 (3)	
15.379	9	26	11	15q24.3	PEAK1, KIAA2002		Pseudopodium-enriched atypical kinase 1	614248	REc			
15.380	12	2	09	15q24.3	TSPAN3		Tetraspanin 3	613134	REc			
15.381	6	14	99	15q24.2	COX5A		Cytochrome C oxidase, subunit Va	603773	A, R	pseudogene on 14q22		
15.382	10	26	11	15q25	DEL15q25, C15DELq25		Chromosome 15q25 deletion syndrome	614294	Ch	chr15:82,889,423-83,552,890, NCBI36	Chromosome 15q25 deletion syndrome (4)	
15.383	11	20	15	15q25.2	HRP3, HDGFRP3		Hepatoma-derived growth factor-related protein 3	616643	A			
15.384	6	2	98	15q26.1	MAN2A2, MANA2X		Mannosidase, alpha-, type II, isozyme X	600988	A			
15.385	6	14	99	15q26.1	MFGE8		Milk fat globule-EGF factor 8	602281	A			
15.386	4	23	08	15q25.3	MRPS11		Mitochondrial ribosomal protein S11	611977	R, REc			
15.387	10	19	97	15q25.3	NTRK3, TRKC		Neurotrophic tyrosine kinase, receptor, type 3	191316	Psh, A			
15.388	3	25	16	15q26.1	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS		Polymerase (DNA directed), gamma	174763	A	PEO also digenic with C10orf2	Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3); Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	7(Polg)
15.389	11	6	00	15q26.1	RHCG, RHGK		Rhesus blood group-associated kidney homolog	605381	A			
15.390	12	16	93	15q26.1	ANPEP, PEPN, CD13		Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)	151530	REa, A			
15.391	11	13	01	15q25-q26	DFNA30		Deafness, autosomal dominant 30	606451	Fd		Deafness, autosomal dominant 30 (2)	
15.392	8	21	07	15q26.1	FANCI, KIAA1794		FANCI gene	611360	REc		Fanconi anemia, complementation group I, 609053 (3)	
15.393	12	23	02	15q26.1	FURIN, PACE, FUR, PCSK3		Furin (paired basic amino acid cleaving enzyme)	136950	RE	less than 1.1kb 5' to FES		7(Fur, Pcsk3)
15.394	4	30	09	15q26.3	IGF1R		Insulin-like growth factor-1 receptor	147370	REa, A, D		Insulin-like growth factor I, resistance to, 270450 (3)	7(Igf1r)
15.395	8	30	01	15q25.3	SLC28A1, CNT1		Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	606207	A			
15.396	5	12	08	15q26.1	UNC45A, SMAP1, GCUNC45		UNC45, C. elegans, homolog of, A	611219	REc, R, H			7(Unc45a)
15.397	4	24	18	15q25.1	ABHD17C, FAM108C1		Abhydrolase domain-containing protein 17C	617944	REc			
15.398	3	22	13	15q25.1	ADAMTS7		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 7	605009	REa, REc			
15.399	12	7	12	15q25.1	AGPHD1		Aminoglycoside phosphotransferase domain-containing protein 1	614681	REc			
15.400	6	7	04	15q25.2	BNC1		Basonuclin	601930	Psh, REc			
15.401	5	28	09	15q25.1	CHRNA3, LNCR2, PAOD2		Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3	118503	REa, H, A, REn		{Lung cancer susceptibility 2}, 612052 (3)	9(Acra3)
15.402	4	27	12	15q25.1	CHRNA5, LNCR2		Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5	118505	REa, H, Fd, A		{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence, susceptibility to}, 612052 (3)	9(Acra5)
15.403	10	16	09	15q25.1	IREB2		Iron-responsive element-binding protein-2	147582	REa, REc			
15.404	07	19	18	15q25.1	KIAA1024, MINAR1		Major intrinsically disordered NOTCH2-binding receptor 1	618054	REc			
15.405	12	10	13	15q25.1	MESDC1		Mesoderm development candidate 1	615466	R, REc, H			7(Mesdc1)
15.406	5	4	12	15q25.1	MIR184, MIRN184, KTCNCT, EDICT		Micro RNA 184	613146	REc		EDICT syndrome, 614303 (3)	9(Mir184)
15.407	5	25	13	15q25.1	MTHFS		5,10-methenyltetrahydrofolate synthetase	604197	REc			
15.408	12	17	07	15q25.1	PSMA4, PSC9, HC9		Proteasome subunit, alpha-type, 4	176846	R, REc			
15.409	7	2	18	15q25.1	RASGRF1, GRF55		Ras protein-specific guanine nucleotide-releasing factor 1	606600	A, REc			9(Rasgrf1)
15.410	11	23	15	15q25.1	TMC3		Transmembrane channel-like protein 3	617196	REc			7(Tmc3)
15.411	1	16	07	15q25.1	ZFAND6, ZA20D3, AWP1		Zinc finger AN1 domain-containing protein 6	610183	REc			
15.412	4	9	96	15q25.1	IDH3A		Isocitrate dehydrogenase 3 (NAD+) alpha	601149	A			
15.413	11	11	12	15q25.1-q26.1	POROK4, DSAP2		Porokeratosis 4, disseminated superficial actinic	607728	Fd	between D15S1023 and D15S1030	Porokeratosis 4, disseminated superficial actinic (2)	
15.414	5	27	09	15q25.2	ADAMTSL3, KIAA1233		ADAMTS-like protein 3	609199	REc, H			7(Adamtsl3)
15.415	07	25	18	15q25.3	ALPK3, MIDORI, KIAA1330, CMH27		Alpha kinase 3	617608	REc		Cardiomyopathy, familial hypertrophic 27, 618052 (3)	
15.416	1	11	17	15q25.2	AP3B2, NAPTB, EIEE48		Adaptor-related protein complex 3, beta 2 subunit	602166	H, REc		Epileptic encephalopathy, early infantile, 48, 617276 (3)	7(Naptb)
15.417	5	25	13	15q25.2	CPEB1		Cytoplasmic polyadenylation element-binding protein 1	607342	REc			
15.418	4	24	18	15q25.2	EFL1, RIA1, EFTUD1, FAM42A, SDS2		Elongation factor-like GTPase 1	617538	REc		Shwachman-Diamond syndrome 2, 617941 (3)	
15.419	4	2	12	15q25.2	FAM103A1, RAM		Family with sequence similarity 103, member A1	614547	REc			
15.420	8	20	07	15q25.2	MEX3B, RKHD3		Mex-3, C. elegans, homolog of, B	611008	REc			
15.421	5	24	13	15q25.2	SCAND2		SCAN domain-containing 2	610417	REc, A			
15.422	3	31	09	15q25.2	SCARNA15, ACA45		Small cajal body-specific RNA 15	612675	REc			
15.423	11	13	17	15q25.2	WDR73, HSPC264, GAMOS1		WD repeat-containing protein 73	616144	REc		Galloway-Mowat syndrome 1, 251300 (3)	
15.424	4	21	16	15q25.2	WHAMM, KIAA1971		Was protein homolog associated with actin, golgi membranes, and microtubules	612393	REc			
15.425	11	19	13	15q25.3	AGBL1, CCP4, FECD8		ATP/GTP-binding protein-like 1	615496	REc, REn		Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	
15.426	5	23	14	15q26.1	DET1		De-etiolated 1, Arabidopsis, homolog of	608727	REc			
15.427	9	1	15	15q25.3	ZNF592, KIAA0211		Zinc finger protein 592	613624	Fd, REc			
15.428	2	21	06	15q25.3-q26.1	CHNG3, RTSH		Hypothyroidism, congenital, nongoitrous, 3	609893	Fd	max lod at D15S655	Hypothyroidism, congenital, nongoitrous, 3 (2)	
15.429	12	18	01	15q26.1	CIB, KIP		Calcium- and integrin-binding protein (kinase-interacting protein)	602293	Psh, R, A			
15.430	5	21	07	15q25.3	PDE8A		Phosphodiesterase 8A	602972	REc			
15.431	6	7	04	15q25.3-q26.2	MDD2		Major depressive disorder 2	608691	Fd		Major depressive disorder 2, 608516 (2)	
15.432	3	15	13	15q26.3	ALDH1A3, ALDH6, MCOP8		Aldehyde dehydrogenase 1 family, member A3	600463	A		Microphthalmia, isolated 8, 615113 (3)	
15.433	8	19	13	15q26.1	CHD2, EEOC		Chromodomain helicase DNA binding protein-2	602119	R		Epileptic encephalopathy, childhood-onset, 615369 (3)	
15.434	12	4	90	15q14	CHRM5		Cholinergic receptor, muscarinic, 5	118496	A, REa			
15.435	12	9	98	15q26	IDDM3		Insulin-dependent diabetes mellitus-3	600318	Fd		{Diabetes mellitus, insulin-dependent, 3} (2)	
15.436	2	6	01	15q26.1	IQGAP1, SAR1		RASGAP-like with IQ motifs (sar1, S. pombe, homolog of)	603379	REa, REc	amplified in gastric cancer		
15.437	2	7	01	15q26.1	ISG20, HEM45		Interferon-stimulated gene, 20kD	604533	A			
15.438	3	23	14	15q26.3	LINS1, WINS1, FLJ10583, MRT27		Lines, Drosophila, homolog of, 1	610350	REc, Fd		Mental retardation, autosomal recessive 27, 614340 (3)	
15.439	12	3	03	15q26.3	MEF2A, ADCAD1		MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	600660	A, REa		{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	7(Mef2a)
15.440	4	25	93	15q26.3	PCSK6, PACE4, SPC4		Proprotein convertase subtilisin/kexin type 6	167405	REa, A			7(Pcsk6)
15.441	4	16	11	15q26.1	PLIN1, PLIN, FPLD4		Perilipin 1	170290	A, H		Lipodystrophy, familial partial, type 4, 613877 (3)	7(Plin)
15.442	4	2	09	15q26.1	RLBP1		Retinaldehyde-binding protein-1, cellular	180090	REa, A		Fundus albipunctatus, 136880 (3); Retinitis punctata albescens, 136880 (3); Newfoundland rod-cone dystrophy, 607476 (3); Bothnia retinal dystrophy, 607475 (3)	7(Rlbp1)
15.443	12	4	08	15q26.1	SLCO3A1, OATPD, OATP3A1		Solute carrier organic anion transporter family, member 3A1	612435	R, REn			
15.444	6	28	02	15q25.1	STARD5		Start domain-containing protein 5	607050	REc			
15.445	7	13	98	15q26.1	STX		Sialyltransferase X	602546	A			
15.446	12	26	14	15q26	VVS		Syncope, familial vasovagal	609289	Fd		Syncope, familial vasovagal (2)	
15.447	3	19	09	15q26-qter	DEL15q26qter, C15DELq26qter		Chromosome 15q26-qter deletion syndrome	612626	Ch	contiguous gene deletion syndrome	Chromosome 15q26-qter deletion syndrome (4)	
15.448	10	25	12	15q26-qter	LVSKS		Levy-Shanske syndrome (tetrasomy 15q26)	614846	Ch		Levy-Shanske syndrome (4)	
15.449	8	29	08	15q26.1	ABHD2, LABH2		Abhydrolase domain-containing 2	612196	REc			16(Abhd2)
15.450	10	11	17	15q26.1	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD		Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760	S, A, Fd	mutation identified in 1 SEDK family and 1 SEMDAG family	?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3); ?Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3)	7(Agc1)
15.451	10	1	17	15q26.1	AP3S2		Adaptor-related protein complex 3, sigma-2 subunit	602416	REc			
15.452	11	27	13	15q26.1	C15orf38, ARPIN		Chromosome 15 open reading frame 38	615543	REc			
15.453	3	16	10	15q26.1	C15orf42, TRESLIN		Treslin	613298	REc			
15.454	10	27	08	15q26.1	CRTC3, TORC3		CREB-regulated transcription coactivator 3	608986	R, REc			
15.455	12	29	05	15q26.1	DIH1, HCD		Hernia, congenital diaphragmatic 1	142340	Ch		Hernia, congenital diaphragmatic 1 (2)	
15.456	7	13	93	15q26.1	FES		Oncogene FES, feline sarcoma virus	190030	S, A			7(Fes)
15.457	12	14	10	15q26.1	IDH2, IDPM, D2HGA2		Isocitrate dehydrogenase, mitochondrial	147650	S, A		D-2-hydroxyglutaric aciduria 2, 613657 (3)	7(Idh2)
15.458	6	16	06	15q26.1	ISG20L1, AEN		Interferon-stimulated exonuclease gene 20kD-like 1	610177	R, REc			
15.459	11	3	99	15q25.1	IL16, LCF		Interleukin 16	603035	Psh, A			7(Il16)
15.460	1	21	16	15q26.1	KIF7, HLS2, ACLS, JBTS12, AGBK		Kinesin family member 7	611254	REc	mutation identified in 1 HLS2 family and 1 AGBK family	?Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome, 200990 (3); Joubert syndrome 12, 200990 (3); ?Al-Gazali-Bakalinova syndrome, 607131 (3)	
15.461	10	13	15	15q26.1	MESP1		Mesoderm posterior bHLH transcription factor 1	608689	REc			
15.462	6	4	04	15q26.1	MESP2, SCDO2		Mesoderm posterior bHLH transcription factor 2	605195	REc		Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	
15.463	3	23	09	15q26.1	MIR9-3, MIRN9-3		Micro RNA 9-3	611188	REc			
15.464	12	23	15	15q26.1	NGRN		Neurite outgrowth-associated protein	616718	REc			
15.465	10	25	12	15q26.1	PEX11A		Peroxisome biogenesis factor 11A	603866	R, REc			
15.466	5	29	10	15q26.1	PRC1		Protein regulating cytokinesis 1	603484	REc			
15.467	6	1	18	15q26.1	RCCD1		RCC1 domain-containing protein 1	617997	REc			
15.468	09	06	18	15q26.1	RECQL3, RECQ2, BLM, BS, MGRISCE1		DNA helicase, RecQ-like 3	604610	M, LD		Bloom syndrome, 210900 (3)	
15.469	2	28	03	15q26.1	RGMA		RGM domain family, member A (repulsive guidance molecule)	607362	REc			4(Ephb2)
15.470	7	14	16	15q26.1	SEMA4B		Semaphorin 4B	617029	REc			
15.471	5	24	13	15q26.1	SV2B, KIAA0735		Synaptic vesicle glycoprotein 2B	185861	REc, R			
15.472	7	8	10	15q26.1	VPS33B		Vacuolar protein sorting 33, yeast, homolog of, B	608552	R		Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	
15.473	5	22	14	15q26.2	NR2F2, TFCOUP2, ARP1, CHTD4		Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)	107773	REa, A		Congenital heart defects, multiple types, 4, 615779 (3)	7(Tcfcoup2)
15.474	4	8	98	15q26.1-qter	OTSC1, OTS		Otosclerosis 1	166800	Fd		Otosclerosis 1 (2)	
15.475	4	7	15	15q26.2	MCTP2		Multiple C2 domains-containing transmembrane protein 2	616297	REc			
15.476	5	3	11	15q26.2	SPATA8, SRG8		Spermatogenesis-associated protein 8	613948	REc			
15.477	1	31	13	15q26.3	ASB7		Ankyrin repeat- and SOCS box-containing protein 7	615052	REc			
15.478	7	9	13	15q26.3	CERS3, LASS3, ARCI9		Ceramide synthase 3	615276	REc, Fd		Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	
15.479	2	24	11	15q26.3	CHSY1, KIAA0990, TPBS		Carbohydrate synthase 1	608183	REc, R		Temtamy preaxial brachydactyly syndrome, 605282 (3)	
15.480	4	27	07	15q26.3	LRRK1		Leucine-rich repeat kinase 1	610986	REc			
15.481	11	17	16	15q26.3	SELENOS, SEPS1, SELS, VIMP, ADO15		Selenoprotein S	607918	REc			
15.482	8	22	07	15q26.3	SNRPA1		Small nuclear ribonucleoprotein polypeptide A'	603521	R, Psh, A			7(Snrpa1)
15.483	4	19	06	15q26.3	TM2D3, BLP2		TM2 domain-containing protein 3	610014	R, REc			
15.484	1	30	01	15q21.2	ARPP19, ARPP16		cAMP-regulated phosphoprotein, 19kD	605487	R			
15.485	1	31	01	15q14	AVEN		Cell death regulator AVEN	605265	REc			
15.486	7	12	02	15q15.2	CCNDBP1, GCIP		Cyclin D-type-binding protein 1	607089	R			
15.487	4	26	90	Chr.15	COL1AR		Collagen I, alpha, receptor	120340	S			
15.488	3	3	03	15q15.1	DISPB, KIAA1742		Dispatched, Drosophila, homolog of, B	607503	R			
15.489	7	11	01	15q26.3	DMN		Desmuslin	606087	R			
15.490	1	24	93	15q21.1-q21.2	GALK2, GK2		Galactokinase-2	137028	Psh			
15.491	5	22	03	15q25.1	MESDC2, MESD, BOCA, KIAA0081		Mesoderm development candidate gene 2	607783	Psh, H			7(Mesdc2)
15.492	7	11	01	15q15.1	PLA2G4B		Phospholipase A2, group IVB	606088	REc			
15.493	4	15	02	15q23	RPLP1		Ribosomal phosphoprotein, Large, P1	180520	R			
15.494	5	13	02	15q24.1	SCAMP2		Secretory carrier membrane protein 2	606912	R			
16.1	10	26	99	16p13.3	SYNGR3		Synaptogyrin 3	603927	A			
16.2	5	22	18	16p13.3	HBA1, HBH, METHBA, ECYT7		Hemoglobin alpha-1	141800	HS	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Thalassemias, alpha-, 604131 (3); Erythrocytosis, 7, 617981 (3); Hemoglobin H disease, nondeletional, 613978 (3); Methemoglobinemia, alpha type, 617973 (3); Heinz body anemias, alpha-, 140700 (3)	11(Hba)
16.3	6	14	18	16p13.3	HBA2, HBH, ECYT7		Hemoglobin alpha-2	141850	HS		Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3); Hemoglobin H disease, deletional and nondeletional, 613978 (3); Erythrocytosis 7, 617981 (3)	11(Hba)
16.4	1	12	89	16p13.3	HBQ1		Hemoglobin theta-1	142240	RE			
16.5	7	17	91	16p13.3	HBZ		Hemoglobin, zeta	142310	RE			
16.6	6	11	93	16pter-p13.3	HBHR, ATR1		Alpha-thalassemia/mental retardation syndrome, type 1	141750	Fd, RE, D	contiguous gene syndrome involving deletion of HBA1 and HBA2	Alpha-thalassemia/mental retardation syndrome, type 1 (4)	
16.7	10	15	95	16p13.3	MPG, MDG		N-methylpurine DNA glycosylase	156565	REa, REn	75kb upstream of HBZ		11(Mpg)
16.8	2	28	03	16pter-p13	CHDS1		Coronary heart disease, susceptibility to, 1	607339	Fd		{Coronary heart disease, susceptibility to} (2)	
16.9	1	26	97	16p13.3	ZNF75A		Zinc finger protein-75A	601473	REa			
16.10	12	21	09	16p13.2	ABAT, GABAT		4-aminobutyrate aminotransferase	137150	R		GABA-transaminase deficiency, 613163 (3)	
16.11	5	21	07	16p13.3	ABCA3, ABC3, SMDP3		ATP-binding cassette-3	601615	REc		Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	
16.12	11	20	98	16p13.3	ADCY9		Adenylate cyclase-9	603302	A			16(Adcy9)
16.13	8	24	04	16p13.3	ALG1, HMAT1, HMT1, CDG1K		Alg1, yeast, homolog of (beta-1,4 mannosyltransferase)	605907	REc		Congenital disorder of glycosylation, type Ik, 608540 (3)	
16.14	1	26	17	16p13.3	ANKS3		Ankyrin repeat and sterile alpha motif domains-containing protein 3	617310	REc			
16.15	1	8	15	16p13.3	AXIN1, AXIN		Axis inhibitor 1	603816	REc	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	Hepatocellular carcinoma, somatic, 114550 (3); ?Caudal duplication anomaly, 607864 (3)	
16.16	7	18	02	16p13.3	ATP6V0C, ATP6L, ATP6C		ATPase, H+ transporting, V0 subunit c	108745	REc			
16.17	10	26	99	16p13.3	BAIAP3, BAP3		BAI1-associated protein 3	604009	A, R			
16.18	6	26	16	16p13.3	BICDL2, BICDR2, CCDC64B		BICD family-like cargo adaptor 2	617003	REc			
16.19	8	5	11	16p13.3	C1QTNF8, CTRP8		C1q- and tumor necrosis factor-related protein 8	614147	REc			
16.20	7	25	18	16p13.3	CDIP1, C16orf5		Cell death-inducing p53 target 1	610503	A, Psh			
16.21	7	14	16	16p13.3	CACNA1H, EIG6, ECA6, HALD4		Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	R, A		{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3); {Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3); Hyperaldosteronism, familial, type IV, 617027 (3)	17(Cacna1h)
16.22	8	29	08	16p13.3	CASKIN1, KIAA1306		CASK-interacting protein 1	612184	R, REc			
16.23	11	7	17	16p13.3	CCDC78, C16orf25, CNM4		Coiled-coil domain-containing protein 78	614666	REc	mutation identified in 1 CNM4 family	?Centronuclear myopathy 4, 614807 (3)	
16.24	1	12	95	16p13.3	CCNF, FBX1		Cyclin F	600227	REn			17(Ccnf)
16.25	8	30	07	16p13.3	CEMP1, CP23		Cementum protein 1	611113	R, REc			
16.26	2	2	10	16p13.3	CHTF18, CHL12, CTF18		Chromosome transmission fidelity factor 18, S. cerevisiae, homolog of	613201	REc			
16.27	6	22	14	16p13.3	CLDN6		Claudin 6	615798	REc			
16.28	6	22	14	16p13.3	CLDN9		Claudin 9	615799	REc			
16.29	10	13	09	16p13.3	CORO7, POD1, CRN7		Coronin 7	611668	REc			
16.30	2	8	17	16p13.3	CREBBP, CBP, RSTS1		CREB binding protein	600140	A, Ch	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	Rubinstein-Taybi syndrome 1, 180849 (3)	
16.31	7	18	14	16p13.3	DECR2, PDCR		2,4-dienoyl-CoA reductase 2, peroxisomal	615839	REc			
16.32	1	27	04	16p13.3	DNAJA3, TID1		DNAJ, E. coli, homolog of, subfamily A, member 3	608382	REc			
16.33	5	26	05	16p13.3	DNASE1, DNL1		Deoxyribonuclease I	125505	Psh		{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
16.34	9	9	10	16p13.3	DUP16p13.3, C16DUPq13.3		Chromosome 16p13.3 duplication syndrome	613458	Ch	contiguous gene duplication syndrome	Chromosome 16p13.3 duplication syndrome (4)	
16.35	9	10	98	16p13.3	E4F1, E4F		E4F transcription factor 1	603022	REc, Psh, A			17(E4fl)
16.36	7	18	14	16p13.3	ECI1, DCI		Enoyl-CoA delta isomerase 1	600305	Psh, A			
16.37	12	18	14	16p13.3	EEF2KMT, FAM86A		Eukaryotic elongation factor 2 lysine methyltransferase	615263	REc			
16.38	4	17	07	16p13.3	EME2		Essential meiotic endonuclease 1, S. pombe, homolog of, 2	610886	REc			
16.39	4	22	15	16p13.3	FAHD1, FLJ36880		Fumarylacetoacetate hydrolase domain-containing protein 1	616320	REc			
16.40	6	13	12	16p13.3	FBXL16, FBL16, C16orf22		F-box and leucine-rich repeat protein 16	609082	REc			17(Fbxl16)
16.41	11	13	07	16p13.3	GLIS2, NPHP7		GLIS family zinc finger protein 2	608539	REc		Nephronophthisis 7, 611498 (3)	16(Glis2)
16.42	4	29	03	16p13.3	GNG13		Guanine nucleotide-binding protein, gamma-13	607298	REc			
16.43	10	10	05	16p13.3	HBM		Hemoglobin mu	609639	REc	?functional		
16.44	5	23	94	16p13.3	HMOX2		Heme oxygenase 2	141251	Psh, A			
16.45	11	22	17	16p13.3	IFT140, KIAA0590, SRTD9, MZSDS, RP80		Intraflagellar transport 140, Chlamydomonas, homolog of	614620	REc		Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3); Retinitis pigmentosa 80, 617781 (3)	
16.46	9	20	14	16p13.3	IGFALS, ALS, ACLSD		Insulin-like growth factor-binding protein, acid-labile subunit	601489	REc		Acid-labile subunit, deficiency of, 615961 (3)	
16.47	5	2	05	16p13.3	IL32, NK4		Interleukin 32	606001	REc			
16.48	5	26	13	16p13.3	KCTD5		Potassium channel tetramerization domain-containing protein 5	611285	REc, R			
16.49	2	21	06	16p13.3	KREMEN2, KRM2		Kringle domain-containing transmembrane protein 2	609899	REc			
16.50	1	29	08	16p13.3	LMF1, TMEM112		Lipase maturation factor 1	611761	REc, H		Lipase deficiency, combined, 246650 (3)	17(Lmf1)
16.51	5	22	03	16p13.3	LUC7L		Luc7, S. cerevisiae, homolog of	607782	REc			17(Luc7l)
16.52	7	14	14	16p13.3	MAPK8IP3, SYD2, JSAP1, JIP3		Mitogen-activated protein kinase 8-interacting protein 3	605431	REc			
16.53	10	1	17	16p13.3	MEIOB, SPGF22		Meiosis-specific protein with OB domains	617670	REc	mutation identified in one SPGF22 family	?Spermatogenic failure 22, 617706 (3)	
16.54	7	26	06	16p13.3	MCOPCT1		Microphthalmia with cataract 1	156850	Ch	proximal to HBA1	Microphthalmia with cataract 1 (2)	
16.55	7	11	01	16p13.3	MSLN		Mesothelin	601051	R			
16.56	11	18	16	16p13.3	MSRB1, SEPX1, SELX		Methionine sulfoxide reductase B1	606216	R, REc			
16.57	8	20	07	16p13.3	METRN		Meteorin	610998	REc			17(Metrn)
16.58	2	12	03	16p13.3	MGRN1, KIAA0544		Mahogunin, ring finger 1	607559	R			16(Mgrn1)
16.59	3	23	09	16p13.3	MIR1225, MIRN1225		Micro RNA 1225	611621	REc			
16.60	8	8	13	16p13.3	MMP25, MMP20A		Matrix metalloproteinase 25	608482	REc, R			
16.61	3	11	08	16p13.3	MRPL28, MAAT1		Mitochondrial ribosomal protein L28	604853	R, REc			
16.62	3	31	11	16p13.3	MLST8, GBL, LST8, WAT1, POP3		MTOR-associated protein LST8	612190	REc			
16.63	9	24	11	16p13.3	NAA60, NAT15		N-alpha-acetyltransferase 60, NatF catalytic subunit	614246	REc			
16.64	3	2	10	16p13.3	NAGPA, UCE		N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	607985	R, REc			
16.65	9	10	07	16p13.3	NARFL, IOP1		Nuclear prelamin A recognition factor-like	611118	REc			
16.66	6	15	99	16p13.3	NDUFB10		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 10	603843	R			
16.67	3	7	14	16p13.3	NLRC3		NLR family, Caspase recruitment domain-containing 3	615648	REc			
16.68	6	18	97	16p13.3	NME4		Non-metastatic cells 4, protein expressed in	601818	REa, A			
16.69	12	11	17	16p13.3	GLYR1, NP60		Glyoxylate reductase 1 homolog	610660	REc			
16.70	9	22	16	16p13.3	NPRL3, CGTHBA, FFEVF3		Nitrogen permease regulator-like 3	600928	REn		Epilepsy, familial focal, with variable foci 3, 617118 (3)	
16.71	2	25	15	16p13.3	NPW, PPNPW, PPL8		Neuropeptide W	607997	REc			
16.72	4	24	18	16p13.3	NTN3, NTN2L		Netrin 3	602349	REf			
16.73	2	22	07	16p13.3	NUBP2, CFD1		Nucleotide-binding protein 2	610779	R, H			17(Nubp2)
16.74	2	7	17	16p13.3	NUDT16L1, SDOS		Nudix hydrolase 16-like 1	617338	REc			
16.75	3	28	15	16p13.3	PAM16, MAGMAS, SMDMDM		Presequence translocase-associated motor 16, S. cerevisiae, homolog of	614336	REc		Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	
16.76	4	19	12	16p13.3	PAQR4		Progestin and ADIPOQ receptor family, member 4	614578	REc			
16.77	8	22	07	16p13.3	PDIA2, PDIP		Protein disulfide isomerase, family A, member 2	608012	Psh, A			
16.78	1	31	01	16p13.3	PDPK1, PDK1		3-phosphoinositide-dependent protein kinase 1	605213	REc			
16.79	10	12	90	16p13.3	PGP		Phosphoglycolate phosphatase	172280	S, F, Fd	no recombination with PKD1		
16.80	8	1	16	16p13.3	PIGQ		Phosphatidylinositol glycan anchor biosynthesis class Q protein	605754	REc			
16.81	9	21	11	16p13.3	PKDTS		Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	RE, Ch	contiguous gene syndrome caused by deletion of TSC2 and PKD1	Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)	
16.82	8	8	13	16p13.3	PKMYT1, MYT1		Protein kinase, membrane-associated tyrosine/threonine, 1	602474	REc			
16.83	9	27	17	16p13.3	POLR3K, RPC11		Polymerase III, RNA, subunit K	606007	REc			
16.84	8	22	90	16p13.13	PRM1		Sperm protamine P1	182880	REa, A	16q21 = conflicting localization		16(Prm1)
16.85	8	22	90	16p13.13	PRM2		Sperm protamine P2	182890	H, RE	in same 4.8kb fragment as PRM2		16(Prm2)
16.86	3	22	07	16p13.3	PRSS21, ESP1		Protease, serine, 21 (testisin)	608159	A, R			
16.87	7	1	05	16p13.3	PRSS22		Protease, serine, 22	609343	REc			17(Prss22)
16.88	4	14	11	16p13.3	PRSS33, EOS		Protease, serine, 33	613797	REc			
16.89	9	7	10	16p13.3	PTX4		Pentraxin 4, long	613442	REc			17(Ptx4)
16.90	12	29	06	16p13.3	RAB11FIP3, EFERIN, KIAA0665		RAB11 family-interacting protein 3	608738	R, REc			
16.91	12	8	00	16p13.3	RAB26		RAS-associated protein RAB26	605455	Psh, R			
16.92	1	1	12	16p13.3	RHBDF1, IRHOM1, DIST1		Rhomboid 5, Drosophila, homolog of, 1	614403	REc, REn, H			11(Rhbdf1)
16.93	6	24	10	16p13.3	RHBDL, RRP		Rhomboid, Drosophila, homolog of	603264	REc			
16.94	4	15	11	16p13.3	RHOT2, MIRO2, ARHT2		Ras homolog gene family, member T2	613889	REc			17(Rhot2)
16.95	7	2	18	16p13.3	RNPS1		RNA-binding protein S1	606447	REc			
16.96	5	8	12	16p13.3	ROGDI, KTZS		Rogdi, Drosophila, homolog of	614574	REc		Kohlschutter-Tonz syndrome, 226750 (3)	
16.97	4	21	17	16p13.3	RPL3L		Ribosomal protein L3-like	617416	REc			
16.98	8	20	99	16p13.3	RS11		Regulator of G protein signaling 11	603895	REc			
16.99	8	20	99	16p13.3	RPS2		Ribosomal protein S2	603624	REa			
16.100	12	29	06	16p13.3	DEL16p13.3, RSTSS		Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome)	610543	Ch	contiguous gene deletion syndrome	Chromosome 16p13.3 deletion syndrome (4)	
16.101	9	18	12	16p13.3	SEPT12, SPGF10		Septin 12	611562	REc		Spermatogenic failure 10, 614822 (3)	
16.102	1	7	02	16p13.3	SLC9A3R2, SIP1, NHERF2		Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 2	606553	REc			
16.103	5	23	11	16p13.3	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP		Slx4, S. cerevisiae, homolog of	613278	REc		Fanconi anemia, complementation group P, 613951 (3)	
16.104	11	10	98	16p13.3	SOLH		Small optic lobes, Drosophila, homolog of	603267	A	conflicting localization to Xq24		
16.105	4	11	01	16p13.3	SOX8		SRY-box 8	605923	REc			
16.106	12	18	07	16p13.3	SPSB3, SSB3		SPRY domain- and SOCS box-containing 3	611659	REc			
16.107	1	29	01	16p13.3	SRL		Sarcalumenin	604992	REc			
16.108	12	5	08	16p13.3	SSTR5		Somatostatin receptor-5	182455	REa, A		Somatostatin analog, resistance to (3)	17(Sstr5)
16.109	5	22	14	16p13.3	STUB1, CHIP, SCAR16		STIP1 homologous and U box-containing protein 1	607207	R, REc		Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	
16.110	10	15	14	16p13.3	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65		TBC1 domain family, member 24	613577	REc, Fd		Myoclonic epilepsy, infantile, familial, 605021 (3); Epileptic encephalopathy, early infantile, 16, 615338 (3); DOORS syndrome, 220500 (3); Deafness , autosomal recessive 86, 614617 (3); Deafness, autosomal dominant 65, 616044 (3)	
16.111	5	14	01	16p13.3	TBL3		Transducin-beta-like 3	605915	REa, R			
16.112	9	26	17	16p13.3	TCEB2, ELOB		Transcription elongation factor B, polypeptide 2	600787	REc			
16.113	6	26	16	16p13.3	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS		Telomere maintenance 2, S. cerevisiae, homolog of	611140	R		You-Hoover-Fong syndrome, 616954 (3)	
16.114	2	25	16	16p13.3	THOC6, FSAP35, BBIS		THO complex subunit 6	615403	REc, Fd		Beaulieu-Boycott-Innes syndrome, 613680 (3)	
16.115	12	7	07	16p13.2	TMEM114		Transmembrane protein 114	611579	REc			
16.116	7	14	14	16p13.3	TMEM204, C16orf30, CLP24		Transmembrane protein 204	611002	REc			
16.117	12	23	02	16p13.3	TNFRSF12A, FN14, TWEAKR		Tumor necrosis factor receptor superfamily, member 12A	605914	A			17(Fn14)
16.118	4	25	93	16p13.13	TNP2		Transition protein-2 (during histone to protamine replacement)	190232	REn, A	in 13kb segment with PRM1 and PRM2		16(Tnp2)
16.119	3	23	05	16p13.3	TPSAB1, TPS1		Tryptase, alpha/beta-1	191080	REa, REn, A			
16.120	3	23	05	16p13.3	TPSB2, TPS2		Tryptase, beta 2	191081	REa, REn, A			
16.121	3	23	05	16p13.3	TPSD1, MCP7L1		Tryptase, delta-1	609272	A, REc			
16.122	7	1	05	16p13.3	TPSG1, TMT		Tryptase, gamma-1	609341	Psh, REc			17(Tpsg1)
16.123	2	26	10	16p13.3	TRAF7, RFWD1		TNF receptor-associated factor 7	606692	R, REc			
16.124	9	8	08	16p13.3	TRAP1, HSP75, HSP90L		Tumor necrosis factor receptor-associated protein 1	606219	REc			
16.125	4	20	17	16p13.3	TSC2, LAM		Tuberin (tuberous sclerosis 2 gene)	191092	Fd, Ch, D, REn	somatic mutation identified in 1 FCORD2 patient	Tuberous sclerosis-2, 613254 (3); Lymphangioleiomyomatosis, somatic, 606690 (3); ?Focal cortical dysplasia, type II, somatic, 607341 (3)	17(Tsc2)
16.126	8	1	16	16p13.3	TSR3		TSR3, aminocarboxypropyl transferase ribosome maturation factor	617058	REc			
16.127	2	24	97	16p13.3	UBE2I		Ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9)	601661	A			
16.128	12	20	05	16p13.3	UBN1		Ubinuclein 1	609771	REc			16(Ubn1)
16.129	4	26	17	16p13.3	UNKL, ZC3H5L, C16orf28		Unkempt family-like zinc finger	617463	REc			
16.130	2	3	99	16p13.2	USP7, HAUSP		Ubiquitin-specific protease-7, herpes virus-associated	602519	REc	previously reported to map to 3p21		
16.131	8	19	04	16p13.3	VASN		Vasorin	608843	REc			
16.132	3	29	07	16p13.3	WFIKKN1, WFIKKN		WAP, follistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 1	608021	REc			
16.133	6	15	99	16p13.3	ZNF174		Zinc finger protein-174	603900	REa, A			
16.134	6	18	99	16p13.3	ZNF205, ZNF210		Zinc finger protein-205	603436	REc			
16.135	1	27	04	16p13.3	ZNF213, CR53		Zinc finger protein 213	608387	REn, REc			
16.136	5	25	13	16p13.3	ZNF263		Zinc finger protein 263	604191	REc			
16.137	7	20	12	16p13.3	ZNF597		Zinc finger protein 597	614685	REc			
16.138	6	12	17	16p13.3	ZNF598		Zinc finger protein 598	617508	REc			
16.139	9	15	98	16q21	CSNK2A2		Casein kinase-2, alpha-prime polypeptide	115442	REa, A			8(Csnk2a2)
16.140	6	15	15	16p13.3	NTHL1, OCTS3, FAP3		Endonuclease III, E. coli, homolog of	602656	A		Familial adenomatous polyposis 3, 616415 (3)	
16.141	4	16	10	16p13.2	PMM2, CDG1A		Phosphomannomutase 2	601785	REa, REc, Fd, R		Congenital disorder of glycosylation, type Ia, 212065 (3)	
16.142	10	13	15	16p13.12	ERCC4, XPF, FANCQ, XFEPS		Excision-repair, complementing defective, in Chinese hamster, number 4	133520	S, A	mutation identified in 1 XFEPS patient	Xeroderma pigmentosum, group F, 278760 (3); ?XFE progeroid syndrome, 610965 (3); Fanconi anemia, complementation group Q, 615272 (3); Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	
16.143	10	12	09	16p13.3	GFER, ERV1, ALR		Growth factor, erv1, S. cerevisiae, homolog of (augmenter of liver regeneration)	600924	REn		Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	17(Gfer)
16.144	7	27	17	16p13.3	PKD1		Polycystin-1	601313	F, Fd, REn		Polycystic kidney disease 1, 173900 (3)	17(Pkd1)
16.145	5	28	03	16p13.13	LITAF, CMT1C		LPS-induced TNFA factor	603795	A, Fd		Charcot-Marie-Tooth disease, type 1C, 601098 (3)	
16.146	3	30	16	16p13.2	CARHSP1, CRHSP24		Calcium-regulated heat-stable protein 1	616885	REc			
16.147	3	25	16	16p13.2	DEL16p13.2, C16DELp13.2		Chromosome 16p13.2 deletion syndrome	616863	Ch		Chromosome 16p13.2 deletion syndrome (4)	
16.148	6	27	14	16p13.13	EMP2, NPHS10		Epithelial membrane protein 2	602334	REa, R, REc		Nephrotic syndrome, type 10, 615861 (3)	16(Emp2)
16.149	6	4	13	16p13.2	METTL22, C16orf68		Methyltransferase-like 22	615261	REc			
16.150	1	2	03	16p13.13	SOCS1, SSI1, CIS1, CISH1		Suppressor of cytokine signaling 1	603597	REc			
16.151	11	22	10	16p13.2-p13.1	ATF7IP2, MCAF2		Activating transcription factor 7-interacting protein 2	613645	REc			
16.152	2	21	11	16p13.13	BCAR4		Breast cancer antiestrogen resistance 4	613746	REc			
16.153	9	15	10	16p13.13	CLEC16A, KIAA0350		C-type lectin domain family 16, member A	611303	REc, R			
16.154	4	27	12	16p13.11	MARF1, KIAA0430, LKAP		Meiosis regulator and mRNA stability factor 1	614593	R, REc			
16.155	7	25	18	16p13.13	RMI2, C16orf75, BLAP18		RecQ-mediated genome instability 2	612426	REc			
16.156	11	29	17	16p13.13	TXNDC11, EFP1		Thioredoxin domain-containing protein 11	617792	REc			
16.157	2	28	06	16p13.11	MYH11, AAT4, FAA4		Myosin, heavy polypeptide-11, smooth muscle	160745	REa, A, Ch, Fd	fused with CBFB by inversion in acute myelomonocytic leukemia	Aortic aneurysm, familial thoracic 4, 132900 (3)	16(Myh11)
16.158	1	15	14	16p13.12	CPPED1		Calcineurin-like phosphoesterase domain-containing protein 1	615603	REc			
16.159	7	20	12	16p13.12	MIR193B		Micro RNA 193B	614734	REc			16(Mir193b)
16.160	7	20	12	16p13.12	MIR365A		Micro RNA 365A	614735	REc			16(Mir365a)
16.161	3	20	14	16p13.12	MKL2, MRTFB		MKL1/myocardin-like 2	609463	REc			
16.162	6	1	15	16p13.12	PARN, DAN, DKCB6, PFBMFT4		Polyadenylate-specific ribonuclease	604212	R, REc		Dyskeratosis congenita, autosomal recessive 6, 616353 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	
16.163	2	26	17	16p13.12	SHISA9, CKAMP44		Shisa family, member 9	613346	REc			16(Shisa9)
16.164	6	10	08	16p12.3	ACSM3, SAH		Acyl-CoA synthetase medium-chain family member 3	145505	REa, A		{?Hypertension, essential} (1)	
16.165	4	6	18	16p13.13	DEXI, MYLE		Dexamethasone-induced gene	617901	REc, H			15(Dexi)
16.166	10	11	16	16p13.11	FOPNL, FOR20, C16orf63		FGFR1OP N-terminal domain-like protein	617149	REc			
16.167	9	24	13	16p13.11	NOMO1		Nodal modulator 1	609157	REc			
16.168	9	24	13	16p13.11	NOMO3		Nodal modulator 3	609159	REc			
16.169	8	19	13	16p13.11	NTAN1		N-terminal asparagine amidase	615367	REc			
16.170	9	28	11	16p13.11	PDXDC1, KIAA0251		Pyridoxal-dependent decarboxylase domain-containing protein 1	614244	REc			
16.171	5	12	15	16p12.2	CRYM, DFNA40		Crystallin, mu	123740	Psh		Deafness, autosomal dominant 40, 616357 (3)	
16.172	11	1	99	16p13.11	ABCC1, MRP1, MRP		ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1)	158343	A			
16.173	2	24	12	16p13.11	ABCC6, ARA, ABC34, MLP1, PXE, GACI2		ATP-binding cassette, subfamily C, member 6	603234	A, Fd, LD		Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum, forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)	
16.174	8	17	92	16p13.13	GSPT1		G1 to S phase transition-1	139259	REa, A			
16.175	09	06	18	16p13.11	MPV17L		MPV17-like protein	618100	REc			16(Mpv17l)
16.176	10	13	17	16p13.11	NDE1, NUDE, LIS4, MHAC		nudE neurodevelopment protein 1	609449	R, REc, Fd	mutation identified in 1 MHAC family	Lissencephaly 4 (with microcephaly), 614019 (3); ?Microhydranencephaly, 605013 (3)	
16.177	11	2	01	16p13.11	NPIP		Nuclear pore complex-interacting protein	606406	A			
16.178	2	22	07	16p13.13	NUBP1, NBP		Nucleotide-binding protein 1	600280	R, H			16(Nubp1)
16.179	12	18	98	16p13.13	TNFRSF17, BCMA		Tumor necrosis factor receptor superfamily, member 17 (B-cell maturation factor)	109545	Ch			
16.180	5	22	14	16p12.3	XYLT1, XT1, DBQD2		Xylosyltransferase 1	608124	R		{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Desbuquois dysplasia 2, 615777 (3)	
16.181	11	2	01	16p12.1	CACNG3		Calcium channel, voltage-dependent, gamma-3 subunit	606403	REc			
16.182	8	21	91	16p12.2	CDR2		Cerebellar degeneration-related antigen-2, 62kD	117340	REa, A			7(Cdr2)
16.183	1	13	16	16p12.3	COQ7, CLK1, COQ10D8		COQ7, S. cerevisiae, homolog of	601683	Psh, A, R	mutation identified in 1 COQ10D8 patient	?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	
16.184	6	18	99	16p13.12	PLA2G10, SPLA2, GXSPLA2		Phospholipase A2, group X	603603	A			
16.185	12	30	09	16p11.2	TAOK2, TAO2, KIAA0881, PSK, PSK1		Tao kinase 2	613199	R, REc			
16.186	11	19	12	16p12.2	EARS2, KIAA1970, COXPD12		Glutamyl-tRNA synthetase 2	612799	REc		Combined oxidative phosphorylation deficiency 12, 614924 (3)	
16.187	1	31	01	16p11.2	MVP, LRP		Major vault protein, rat, homolog of	605088	A			
16.188	9	22	04	16p13	ADHD1		Attention deficit-hyperactivity disorder, susceptibility to, 1	608903	Fd	max lod at D16S3114	{Attention deficit-hyperactivity disorder}, 143465 (2)	
16.189	10	08	08	16p13	BMIQ5		Body mass index quantitative trait locus 5	608558	Fd	near D16S404 and D16S764	[Body mass index QTL5] (2)	
16.190	10	4	16	16p13.13	CIITA, MHC2TA, C2TA		Class II major histocompatibility complex transactivator	600005	A, R		Bare lymphocyte syndrome, type II, complementation group A, 209920 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
16.191	11	19	13	16p13.2	GRIN2A, NMDAR2A, FESD, LKS		Glutamate receptor, ionotropic, N-methyl D-aspartate 2A	138253	A		Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	
16.192	2	8	16	16p13.3	CLUAP1, QILIN, FAP22, KIAA0643		Clusterin-associated protein 1	616787	R, REc			
16.193	10	3	07	16p13.3	CLCN7, CLC7, OPTA2, OPTB4		Chloride channel-7	602727	A		Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis, autosomal dominant 2, 166600 (3)	
16.194	7	1	11	16p13.3	HAGH, GLO2		Hydroxyacyl glutathione hydrolase; glyoxalase II	138760	S		[Glyoxalase II deficiency], 614033 (1)	
16.195	8	30	01	16p12.2	IGSF6, DORA		Immunoglobulin superfamily, member 6	606222	R			7(Igsf6)
16.196	1	24	09	16p13.3	MEFV, MEF, FMF		Pyrin (marenostrin)	608107	Fd, LD	between D16S80 and D16S283	Familial Mediterranean fever, AR, 249100 (3); Familial Mediterranean fever, AD, 134610 (3)	16(Mefv)
16.197	5	26	13	16p13.3	NOXO1		NADPH oxidase organizer 1	611256	REc			17(Noxo1)
16.198	11	5	98	16p13.3	OR1F1, OLFMF		Olfactory receptor, family 1, subfamily F, member 1	603232	REn			
16.199	8	10	98	16p13.3	PPL		Periplakin	602871	R, H			16(Ppl)
16.200	9	8	11	16p13.3	RBFOX1, 2BP1, FOX1, HRNBP1		RNA-binding protein FOX1, C. elegans, homolog of, 1	605104	Ch, A, REc			
16.201	7	17	14	16p13.13	RSL1D1, CSIG, PBK1		Ribosomal L1 domain-containing protein 1	615874	REc			
16.202	9	15	98	16p13.13	SNN		Stannin	603032	Psh, H			16(Snn)
16.203	8	24	09	16p13.3	TIGD7, SANCHO		Tigger transposable element-derived gene 7	612969	REc			
16.204	5	16	17	16p11.2	TP53TG3		TP53 target gene 3	617482	REc			
16.205	11	5	98	16p13.3	ZNF200		Zinc finger protein-200	603231	REn			
16.206	7	19	06	16p13-p12	IHPS2		Pyloric stenosis, infantile hypertrophic, 2	610260	Fd		Pyloric stenosis, infantile hypertrophic, 2 (2)	
16.207	09	17	18	16p12.2	SCNN1B, BESC1, LIDLS1		Sodium channel, nonvoltage-gated 1, beta	600760	REa, Fd, A, REc		Liddle syndrome 1, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	7(Scnn1b)
16.208	09	12	18	16p12.2	SCNN1G, PHA1, BESC3, LDLS2		Sodium channel, nonvoltage-gated 1, gamma	600761	Fd, REn, A, REc	same 400kb fragment as SCNN1B	Liddle syndrome, 618114 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	7(Scnn1g)
16.209	10	15	95	16p13.3	TFAP4		Transcription factor AP-4 (activating enhancer-binding protein 4)	600743	H			16(Tfp4)
16.210	12	1	11	16p12.3	ACSM1, MACS1		Acyl-CoA synthetase medium-chain family, member 1	614357	REc			
16.211	12	1	11	16p12.3	ACSM2A		Acyl-CoA synthetase medium-chain family, member 2A	614358	REc			
16.212	12	1	11	16p12.3	ACSM2B, HXMA		Acyl-CoA synthetase medium-chain family, member 2B	614359	REc			
16.213	12	1	11	16p12.3	ACSM5		Acyl-CoA synthetase medium-chain family, member 5	614361	REc			
16.214	4	8	13	16p12.3	CCP110, CP110, KIAA0419		Centrosomal coiled-coil protein, 110kD	609544	R, REc			
16.215	1	8	15	16p12.3	DCUN1D3, SCCRO3		DCN1 domain-containing protein 3	616167	REc			
16.216	2	1	11	16p12.3	GP2		Glycoprotein 2, zymogen granule membrane	602977	REc	previously assigned to chr.9		
16.217	7	11	12	16p12.3	LYRM1		LYR motif-containing protein 1	614709	REc			
16.218	9	24	13	16p12.3	NOMO2		Nodal modulator 2	609158	REc			
16.219	11	23	16	16p12.3	TMC5		Transmembrane channel-like protein 5	617197	REc			7(Tmc5)
16.220	11	23	16	16p12.3	TMC7		Transmembrane channel-like protein 7	617198	REc			7(Tmc7)
16.221	4	6	15	16p12.3	TMEM159		Transmembrane protein 159	611304	REc			
16.222	12	1	15	16p12.3	THUMPD1		THUMP domain-containing protein 1	616662	REc			
16.223	11	3	09	16p12.3	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2		Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)	191845	REa, Fd		Hyperuricemic nephropathy, familial juvenile 1, 162000 (3); Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	7(Umod)
16.224	5	7	01	16p12.3	GPRC5B, RAIG2		G protein-coupled receptor, family C, group 5, member B	605948	REc			
16.225	4	21	10	16p12.1	LCMT1		Leucine carboxyl methyltransferase 1	610286	R, REc			
16.226	6	15	99	16p12.2	NDUFAB1		NADH-ubiquinone oxidoreductase 1, alpha/beta subcomplex, 1	603836	R			
16.227	5	12	98	16p12.3-p12.1	RP22		Retinitis pigmentosa-22	602594	Fd		Retinitis pigmentosa 22 (2)	
16.228	3	9	10	16p12.2	ANKS4B, HARP, FLJ38819		Ankyrin repeat and sterile alpha motif domain-containing protein 4B	609901	REc, H			7(Harp)
16.229	3	14	07	16p12.1	ARHGAP17, RICH1		RHO GTPase-activating protein 17	608293	R, REc			
16.230	9	10	09	16p12.2	DCTN5, p25		Dynactin 5	612962	REc			
16.231	12	10	13	16p12.2	ERN2		Endoplasmic reticulum-to-nucleus signaling 2	604034	R, H, REc			7(Ern2)
16.232	12	6	16	16p12.2	METTL9, DREV		Methyltransferase-like 9	609388	REc			
16.233	9	27	17	16p12.2	PLK1, STPK13		Polo-like kinase 1	602098	REc			
16.234	12	22	17	16p12.2	POLR3E, SIN, KIAA1452		Polymerase III, RNA, subunit E	617815	R, REc			
16.235	6	18	02	16p12.2	OTOA, DFNB22		Otoancorin	607038	REc, Fd		Deafness, autosomal recessive 22, 607039 (3)	
16.236	11	1	10	16p12.2-p11.2	DEL16p12.1p11.2, C16DELp12.1p11.2		Chromosome 16p12.2-p11.2 deletion syndrome	613604	Ch	17.1-8.7 Mb contiguous gene deletion syndrome	Chromosome 16p12.2-p11.2 deletion syndrome (4)	
16.237	9	25	12	16p12.2-q12.1	MRT10, MRT20		611096	611096	Fd	between rs724466 and rs3901517, rs7197568 and rs71972227	Mental retardation, autosomal recessive 10/20 (2)	
16.238	1	5	12	16p12.1	CLN3, BTS		Battenin	607042	F, Fd		Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	7(Cln3)
16.239	10	25	16	16p12.1	GSG1L		GSG1-like protein	617161	REc			
16.240	7	17	14	16p12.1	GTF3C1		General transcription factor 3C, polypeptide 1	603246	REc			
16.241	2	8	18	16p12.1	KATNIP, KIAA0556		Katanin-interacting protein	616650	R, REc		Joubert syndrome 26, 616784 (3)	
16.242	5	16	18	16p12.1	KDM8, JMJD5		Lysine demethylase 8	611917	REc			
16.243	12	22	16	16p12.1	NSMCE1, NSE1		Non-SMC element 1, S. cerevisiae, homolog of	617263	REc			
16.244	3	23	14	16p11.2	PYDC1, POP1, PYC1, ASC2		Pyrin domain-containing protein 1	615700	REc			
16.245	5	24	13	16p12.1	SLC5A11, KST1, SGLT6, SMIT2		Solute carrier family 5 (sodium/glucose cotransporter), member 11	610238	REc, A			
16.246	1	27	04	16p12.1	XPO6, EXP6, KIAA0370		Exportin 6	608411	R, REc			
16.247	3	20	06	16p12.1	IL4R, IL4RA		Interleukin-4 receptor	147781	A, REa		{Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to}, 609423 (3)	7(Il4r)
16.248	1	11	07	16p12.1-p11.2	MMVP1, MVP, PMV		Mitral valve prolapse, myxomatous 1	157700	Fd		Mitral valve prolapse, myxomatous 1 (2)	
16.249	1	9	09	16p11.2	PHKG2, GSD9C		Phosphorylase kinase, gamma 2 (testis/liver)	172471	REa		Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver phosphorylase kinase deficiency (3)	
16.250	5	27	97	16p11.2	SULT1A1, STP1, STP, PST		Sulfotransferase family 1A, phenol-preferring, member 1	171150	Psh			7(Stp)
16.251	8	18	99	16p11.2	SULT1A2, STP2		Sulfotransferase family 1A, phenol-preferring, member 2	601292	Psh, REn	45kb from STP1		7(Stp)
16.252	10	8	96	16p11.2	ATP2A1, SERCA1		ATPase, Ca++ transporting, fast-twitch, 1	108730	REa, A		Brody myopathy, 601003 (3)	7(Atp2a1)
16.253	5	4	12	16p12	DEL16p12.1, C16DELp12.1		Chromosome 16p12.1 deletion syndrome, 520kb	136570	Ch	between 21.85-22.37 Mb	Chromosome 16p12.1 deletion syndrome, 520kb (4)	
16.254	4	27	01	16p12.3	DNAH3, DNAHC3B		Dynein, axonemal, heavy chain 3	603334	A, R			
16.255	6	6	00	16p12.2	HS3ST2, 30ST2		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 2	604056	REc			7(30st2)
16.256	10	5	07	16p12	MAFD4, BPAD		Major affective disorder 4	611247	Fd	max lod at D16S769	Major affective disorder 4 (2)	
16.257	4	22	10	16p12.2	PALB2, FANCN, PNCA3		Partner and localizer of BRCA2	610355	REc		Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)	
16.258	9	14	05	16p13.11	RRN3, TIFIA		RRN3, S. cerevisiae, homolog of	605121	REc			
16.259	6	27	02	16p12.3	SMG1, LIP, KIAA0421		SMG1, C. elegans, homolog of	607032	R, A			
16.260	8	11	18	16p12.1	TNRC6A, GW182, KIAA1460, FAME6		Trinucleotide repeat-containing gene 6A	610739	R, REc	mutation identified in 1 FAME6 family	?Epilepsy, familial adult myoclonic, 6, 618074 (3)	
16.261	3	8	13	16p12.2	UQCRC2, MC3DN5		Ubiquinol-cytochrome c reductase core protein II	191329	A		Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	
16.262	7	19	10	16p12.3-p12.2	ZP2		Zona pellucida glycoprotein 2	182888	REc			
16.263	5	2	01	16p12.1	AQP8		Aquaporin 8	603750	REa, A, H			7(Aqp8)
16.264	3	7	14	16p12.3	ARL6IP1, KIAA0069, SPG61		ADP-ribosylation factor-like 6 interacting protein 1	607669	A	mutation identified in 1 family	?Spastic paraplegia 61, autosomal recessive, 615685 (3)	7(Arl6ip)
16.265	6	24	05	16p12-p11.2	EPRPDC		Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	Fd	between D16S3133 and D16S3131	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp (2)	
16.266	2	17	09	16p12.3	GDE1, MIR16		Glycerophosphodiester phosphodiesterase 1	605943	REc			
16.267	2	15	12	16p11.2	HSD3B7, CBAS1		3-beta-hydroxy-delta-5-C27-steroid oxidoreductase	607764	R		Bile acid synthesis defect, congenital, 1, 607765 (3)	
16.268	4	10	02	16p11.2	PYCARD, TMS1, ASC		PYD and CARD domain-containing protein (target of methylation-induced silencing 1)	606838	A, R			
16.269	8	4	98	16p12.1	RBBP6		Retinoblastoma-binding protein-6	600938	A			
16.270	1	13	99	16p11.2	PPP4C, PP4, PPX		Protein phosphatase 4, catalytic subunit	602035	A			
16.271	8	24	09	16p11.2	ALDOA, GSD12		Aldolase A, fructose-bisphosphatase	103850	REa, REb, A, REc	pseudogenes on 3 and 10	Glycogen storage disease XII, 611881 (3)	
16.272	6	3	14	16p12.1	APOBR, APOB48R		Apolipoprotein B receptor	605220	A, REc			
16.273	8	22	14	16p11.2	ARMC5, AIMAH2		Armadillo repeat-containing protein 5	615549	REc		ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	
16.274	11	12	12	16p11.2	BCKDK, BDK, BCKDKD		Branched-chain alpha-keto acid dehydrogenase kinase	614901	REc		Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	
16.275	4	26	10	16p11.2	CCDC101, STAF36		Coiled-coil domain-containing protein 101	613374	REc			
16.276	12	15	10	16p11.2	CD19, CVID3		CD19 antigen	107265	Psh, A		Immunodeficiency, common variable, 3, 613493 (3)	
16.277	11	11	14	16p11.2	CD2BP2		CD2 antigen-binding protein 2	604470	REc			
16.278	9	12	13	16p11.2	CORO1A, TACO, CLIPINA, IMD8		Coronin 1A	605000	REc		Immunodeficiency 8, 615401 (3)	
16.279	9	27	17	16p11.2	COX6A2		Cytochrome c oxidase, subunit 6A2	602009	REc, Psh			7(Cox6a2)
16.280	12	6	11	16p11.2	BMIQ16, DEL16p.11.2, C16DELp11.2		Chromosome 16p11.2 deletion syndrome, 220kb	613444	Ch		Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass index QTL16] (4)	
16.281	7	18	14	16p11.2	DCTPP1		dCTP pyrophosphatase 1	615840	REc			
16.282	6	7	12	16p11.2	DEL16p11.2, C16DELp11.2, AUTS14A		Chromosome 16p11.2 deletion syndrome, 593kb	611913	Ch		Chromosome 16p11.2 deletion syndrome, 593kb (4); {Autism susceptibility 14A} (2)	
16.283	6	7	12	16p11.2	DUP16p11.2, C16DUPp11.2, AUTS14B		Chromosome 16p11.2 duplication syndrome	614671	Ch		Chromosome 16p11.2 duplication syndrome (4); {Autism, susceptibility to, 14B} (2)	
16.284	1	12	07	16p11.2	DOC2A		Double C2-like domain-containing protein, alpha	604567	R, REc			
16.285	10	3	07	16p11.2	EIF3C, EIF3S8		Eukaryotic translation initiation factor 3, subunit C	603916	REc			
16.286	1	25	05	16p11.2	ERAF, EDRF, AHSP		Erythroid-associated factor (alpha-hemoglobin stabilizing protein)	605821	REc			
16.287	4	17	13	16p11.2	FAM57B		Family with sequence similarity 57, member B	615175	REc			
16.288	1	11	16	16p11.2	FBRS, FBS1		Fibrosin	608601	REc			
16.289	7	1	11	16p11.2	FBXL19, FBL19		F-box and leucine-rich repeat protein 19	609085	REc			
16.290	11	22	17	16p11.2	FUS, TLS, ALS6, ETM4		Fusion, derived from 12-16 translocation, malignant liposarcoma	137070	Ch, RE, REc	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3); Essential tremor, hereditary, 4, 614782 (3)	
16.291	4	22	15	16p11.2	GDPD3, GDE7		Glycerophosphodiester phosphodiesterase domain-containing protein 3	616318	REc			
16.292	7	20	12	16p11.2	HIRIP3		HIRA-interacting protein 3	603365	REc			
16.293	6	6	00	16p12.1	HS3ST4, 30ST4		Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4	604059	REc			7(30st4)
16.294	3	31	98	16p11.2	ITGAD, CD11D		Integrin, alpha D	602453	A			
16.295	6	11	92	16p11.2	ITGAL, CD11A, LFA1A		Integrin, alpha-L (antigen CD11A (p180), lymphocyte function-associated antigen-1, alpha polypeptide)	153370	S, REa, A			7(Ly15)
16.296	9	24	08	16p11.2	ITGAM, CR3A, CD11B, MAC1A, SLEB6		Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide)	120980	RE, A	?in same restriction fragment as LFA1A	{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	
16.297	1	9	94	16p11.2	ITGAX, CD11C		Integrin, alpha-X (antigen CD11C (p150), alpha polypeptide)	151510	REa, A			
16.298	8	29	13	16p11.2	KAT8, MYST1, MOF		K(lysine) acetyltransferase 8	609912	REc			
16.299	10	1	04	16p11.2	KCTD13, POLDIP1, FKSG86		Potassium channel tetramerization domain-containing 13	608947	A			
16.300	1	25	12	16p11.2	KIF22, KNSL4, KID, OBP, SEMDJL2		Kinesin family member 22	603213	REc, A		Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	
16.301	6	8	17	16p11.2	LAT, IMD52		Linker for activation of T cells	602354	A		Immunodeficiency 52, 617514 (3)	
16.302	5	19	97	16p11.2	MAPK3, PRKM3, ERK1		Mitogen-activated protein kinase 3	601795	REa, A			7(Prkm3)
16.303	10	26	98	16p11.2	MAZ, ZF87, PUR1		MYC-associated zinc finger protein	600999	A			
16.304	3	18	17	16p11.2	MYLPF, MLC2B, MRLC2, MYL11		Myosin light chain, phosphorylatable, fast skeletal muscle	617378	REc			
16.305	3	30	12	16p11.2	NFATC2IP, NIP45		NFATC2-interacting protein	614525	REc			
16.306	9	10	12	16p11.2	NUPR1, COM1, p8		Nuclear protein, transcriptional regulator, 1	614812	Psh			
16.307	7	22	09	16p11.2	ORAI3, TMEM142C		ORAI calcium release-activated calcium modulator 3	610930	REc			
16.308	7	14	14	16p11.2	PAGR1, C16orf53, PA1		PAXIP1-associated glutamate-rich protein 1	612033	REc			
16.309	8	13	91	16p12.2-p12.1	PRKCB1, PKCB		Protein kinase C, beta 1 polypeptide	176970	REa, A			
16.310	4	20	17	16p11.2	PRR14		Proline-rich protein 14	617423	REc			
16.311	11	21	12	16p11.2	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA		Proline-rich transmembrane protein 2	614386	Fd, REc		Episodic kinesigenic dyskinesia 1, 128200 (3); Seizures, benign familial infantile, 2, 605751 (3); Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	
16.312	5	26	13	16p11.2	PRSS53, POL3S		Protease, serine, 53	610561	REc			
16.313	4	1	96	16p11.2	PRSS8		Protease, serine, 8 (prostasin)	600823	A			
16.314	5	26	13	16p11.2	PRSS36		Protease, serine, 36	610560	REc			
16.315	7	9	06	16p11.2	QPRT		Quinolinate phosphoribosyltransferase	606248	R			
16.316	10	2	13	16p11.2	RABEP2		RAB GTPase-binding effector protein 2	611869	REc			
16.317	4	21	14	16p11.2	RNF40, BRE1B, RBP95, KIAA0661		Ring finger protein 40	607700	REc			
16.318	2	15	12	16p11.2	SRCAP, SWR1, KIAA0309, FLHS		SNF2-related CBP activator protein	611421	R, REc		Floating-Harbor syndrome, 136140 (3)	
16.319	2	1	11	16p11.2	SEPHS2, SPS2		Selenophosphate synthetase 2	606218	REc			7(Sps2)
16.320	7	22	09	16p11.2	SEPT1, DIFF6		Septin 1	612897	REc			
16.321	8	21	07	16p11.2	SETD1A, SET1A, SET1, KIAA0339		SET domain-containing protein 1A	611052	R, REc			
16.322	12	1	15	16p11.2	SEZ6L2, BSRPA		SEZ6-like protein 2	616667	REc			
16.323	6	3	14	16p11.2	SH2B1, SH2B, KIAA1299		SH2B adaptor protein 1	608937	REc, R			7(Sh2b)
16.324	12	10	02	16p11.2	SLC5A2, SGLT2		Solute carrier family 5 (sodium/glucose cotransporter), member 2	182381	REa		Renal glucosuria, 233100 (3)	
16.325	7	14	14	16p11.2	SLX1A, GIYD1		SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, A	615822	REc			
16.326	7	14	14	16p11.2	SLX1B, GIYD2		SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, B	615823	REc			
16.327	10	12	90	16p11.2	SPN, LSN, CD43		Sialophorin (leukosialin)	182160	REa, A			7(Ly48)
16.328	2	17	09	16p11.2	SPNS1, SPIN1		Spinster, Drosophila, homolog of, 1	612583	REc			
16.329	1	21	11	16p11.2	STX4, STX4A		Syntaxin 4	186591	REc			
16.330	8	18	99	16p11.2	SULT1A3, STM		Sulfotransferase family 1A, phenol-preferring, member 3	600641	REa, Psh			
16.331	7	14	14	16p11.2	SULT1A4		Sulfotransferase family 1A, cytosolic, phenol-preferring, member 4	615819	REc			
16.332	1	12	15	16p11.2	STX1B, GEFSP9		Syntaxin 1B	601485	A		Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	
16.333	1	27	11	16p11.2	TBC1D10B		TBC1 domain family, member 10B	613620	REc			
16.334	9	24	15	16p11.2	TBX6, SCDO5		T-box 6	602427	A, H, R		Spondylocostal dysostosis 5, 122600 (3)	7(Tbx6)
16.335	4	23	09	16p11.2	TGFB1I1, ARA55, HIC5		Transforming growth factor, beta-1-induced 1	602353	Psh, A			
16.336	3	9	10	16p11.2	TRIM72, MG53		Tripartite motif-containing protein 72	613288	REc			
16.337	1	5	07	16p11.2	TUFM, EFTU, COXPD4		Tu translation elongation factor, mitochondrial	602389	Psh, A	pseudogene on chr.17	Combined oxidative phosphorylation deficiency 4, 610678 (3)	
16.338	4	21	04	16p11.2	VKORC1, VKOR, VKCFD2, FLJ00289		Vitamin K epoxide reductase complex, subunit 1	608547	REn, REc, Fd, H		Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3); Warfarin resistance, 122700 (3)	
16.339	12	28	08	16p11.2	YPEL3		Yippee-like 3	609724	REc			7(Ypel3)
16.340	1	26	17	16p11.2	ZG16, ZG16A, JCLN1		Zymogen granule protein, 16-kD	617311	REc			
16.341	9	1	16	16p11.2	ZNF668		Zinc finger protein 668	617103	REc			
16.342	6	28	18	16p11.2	ZNF768		Zinc finger protein 768	618032	REc			
16.343	6	28	18	16p11.2	ZNF689, TIPUH1		Zinc finger protein 689	618033	REc			
16.344	1	31	01	16p11.2	CTF1, CT1		Cardiotrophin 1	600435	A, R			
16.345	7	21	14	16p11	INV16p11		Chromosome 16p11 inversion (0.45Mb)	615835	Ch			
16.346	11	5	04	16p11.2	ATXN2L, A2D		Ataxin 2-like	607931	A	pseudogene at 7p21		
16.347	4	17	01	16p11.2	BCL7C		B-cell CLL/lymphoma 7C	605847	A			
16.348	3	13	18	16p12.1	IL21R, IMD56		Interleukin 21 receptor	605383	R, REc, Ch	fusion partner with BCL6	[IgE, elevated level of], 147050 (3); Immunodeficiency 56, 615207 (3)	
16.349	3	22	07	16p12.1-p11.2	IL27, IL30		Interleukin 27	608273	REc			
16.350	7	7	04	16p12.2	COG7, CDG2E		Component of oligomeric golgi complex 7	606978	REc		Congenital disorder of glycosylation, type IIe, 608779 (3)	
16.351	3	13	08	16p13.3	GNPTAG		N-acetylglucosamine-1-phosphotransferase, gamma subunit	607838	REc		Mucolipidosis III gamma, 252605 (3)	
16.352	1	31	02	16p	IBD8		Inflammatory bowel disease 8	606668	Fd		{Inflammatory bowel disease 8} (2)	
16.353	8	20	99	16p12.3	RPS15A		Ribosomal protein S15a	603674	REa, R			
16.354	8	30	02	16q21	CX3CL1, SCYD1, NTT, NTN		Chemokine, C-X3-C motif, ligand 1 (fractalkine; neurotactin)	601880	R, Psh, REc			8(Ntt)
16.355	1	22	07	16q	PSORS8		Psoriasis susceptibility 8	610707	Fd	proximal to D16S3034	{Psoriasis susceptibility 8} (2)	
16.356	2	27	02	16q	SLI1		Specific language impairment QTL, 1	606711	Fd		Specific language impairment QTL, 1 (2)	
16.357	9	2	96	16q	WT3		Wilms tumor-3	194090	D	loss of heterozygosity	Wilms tumor, type 3 (2)	
16.358	7	23	03	16q12.1	NEOT2		Neuropilin and tolloid like 2	607974	REc			
16.359	2	12	07	16q11-q22	AA2		Alopecia areata 2	610753	Fd	max lod at D16S415	Alopecia areata 2 (2)	
16.360	12	9	05	16q11.1-q22	DUPC1		Dupuytren contracture 1	126900	Fd	max lod at D16S415	Dupuytren contracture 1 (2)	
16.361	12	21	09	16p11.2	BOLA2		BolA, E. coli, homolog of, 2	613182	REc			
16.362	7	10	08	16q11.2	MYLK3, MLCK		Myosin light chain kinase 3	612147	REc, H			8(Mylk3)
16.363	9	14	17	16q11.2	VPS35, MEM3, PARK17		Vacuolar protein sorting 35, yeast, homolog of	601501	REc, H		{Parkinson disease 17}, 614203 (3)	8(Mem3)
16.364	8	20	07	16q11.2	SHCBP1, PAL		SHC SH2 domain-binding protein 1	611027	R, REc			
16.365	7	12	12	16q12.2	IRX5, HMMS		Iroquois homeo box protein 5	606195	A		Hamamy syndrome, 611174 (3)	
16.366	7	8	03	16q12.2	IRX6, IRX7		Iroquois homeo box protein 6	606196	A			
16.367	3	31	15	16q12.1	NKD1		Naked cuticle, Drosophila, homolog of, 1	607851	REc			
16.368	1	31	17	16q12.1	NOD2, CARD15, IBD1, CD, YAOS, BLAUS		Nucleotide-binding oligomerization domain protein 2	605956	REc, Fd		{Inflammatory bowel disease 1, Crohn disease}, 266600 (3); Blau syndrome, 186580 (3); {Yao syndrome}, 617321 (3); {Psoriatic arthritis, susceptibility to}, 607507 (2)	
16.369	3	15	11	16q11.2	ORC6, ORC6L		Origin recognition complex, subunit 6, S. cerevisiae, homolog of	607213	REc		Meier-Gorlin syndrome 3, 613803 (3)	
16.370	5	28	98	16q12.1	SIAH1		Seven in absentia, Drosophila, homolog of, 1	602212	A			
16.371	10	25	12	16q12.1	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19		Zinc finger protein 423	604557	R		Nephronophthisis 14, 614844 (3); Joubert syndrome 19, 614844 (3)	8(Zfp423)
16.372	3	21	95	16q12.1	ADCY7		Adenylate cyclase-7	600385	Psh, REc			
16.373	6	17	08	16q12.1	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS		CYLD gene	605018	Fd, REc	behaves as tumor suppressor	Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome, 605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)	
16.374	2	10	00	16q12.1	PHKB		Phosphorylase kinase, beta polypeptide	172490	REa, A		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	
16.375	1	27	11	16q12.1	ABCC11, MRP8, EWWD, WW		ATP-binding cassette, subfamily C, member 11	607040	R, REc, Fd		[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in], 117800 (3); [Colostrum secretion, variation in], 117800 (3)	
16.376	6	28	02	16q12.1	ABCC12, MRP9		ATP-binding cassette, subfamily C, member 12	607041	R, REc			
16.377	3	20	16	16q12.1	CNEP1R1, NEP1R1, TMEM188		C-terminal domain nuclear envelope phosphatase 1 regulatory subunit 1	616869	REc			
16.378	9	9	09	16q12.1	CLN1		Precerebellin 1	600432	REc			8(Cbln1)
16.379	11	4	08	16q11.2	DNAJA2, DJ3, CPR3		DNAJ/HSP40 homolog, subfamily A, member 2	611322	R, REc			
16.380	9	22	16	16q11.2	GPT2, ALT2, MRT49		Glutamate pyruvate transaminase 2	138210	REc		Mental retardation, autosomal recessive 49, 616281 (3)	
16.381	12	17	12	16q12.1	HEATR3, SYO1		HEAT repeat-containing protein 3	614951	REc			
16.382	2	23	08	16q12.1	ITFG1, TIP		Integrin-alpha FG-gap repeat-containing protein 1	611803	R, REc			
16.383	11	14	17	16q12.1	LONP2, PLON, PSLON		LON peptidase 2, peroxisomal	617774	REc			
16.384	6	29	04	16q12.1	SALL1, HSAL1, TBS		Sal-like 1	602218	Ch, A		Townes-Brocks syndrome 1, 107480 (3); Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	8(Sall1)
16.385	2	25	10	16q12.1	SNX20, SLIC1		Sorting nexin 20	613281	REc			
16.386	4	24	09	16q12.1	STHAG2, HYD2		Tooth agenesis, selective, 2	602639	Fd		Tooth agenesis, selective, 2 (2)	
16.387	5	9	18	16q12.1	TENT4B, PAPD5, TUT3		Terminal nucleotidyltransferase 4B	605540	REc			
16.388	6	7	12	16q12.1-q23.1	STUT4		Stuttering, familial persistent, 4	614668	Fd	max lod at D16S3043	Stuttering, familial persistent, 4 (2)	
16.389	5	21	07	16q12.2	AKTIP, FTS, FT1		AKT_interacting protein	608483	REc			
16.390	5	2	16	16q12.2	CHD9, CREMM, PRIC320, KIAA0308		Chromodomain helicase DNA-binding protein 9	616936	R			
16.391	2	13	14	16q12.2	CRNDE		Colorectal neoplasia differentially expressed gene, noncoding	615624	REc			
16.392	11	13	15	16q12.2	FTO, GDFD, BMIQ14		Fat mass- and obesity-associated gene	610966	REc		Growth retardation, developmental delay, facial dysmorphism, 612938 (3); {Obesity, susceptibility to, BMIQ14}, 612460 (3)	
16.393	9	2	09	16q12.2	IRX3, IRXB1		Iroquois homeobox protein 3	612985	R, REc			
16.394	6	9	08	16q12.2	LPCAT1, AYTL1		Lysophosphatidylcholine acyltransferase 2	612040	R, REc			
16.395	6	13	16	16q13	NUDT21, CPSF5, CFIM25		Nudix hydrolase 21	604978	R, REc			
16.396	7	8	10	16q12.2	RPGRIP1L, KIAA1005, JBTS7, MKS5		RPGRIP1-like	610937	R, REc		Joubert syndrome 7, 611560 (3); Meckel syndrome 5, 611561 (3); COACH syndrome, 216360 (3)	
16.397	3	22	00	16q12.2	SLC6A2, NAT1, NET1		Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive	163970	REa, A, Fd		Orthostatic intolerance, 604715 (3)	8(Slc6a2)
16.398	5	23	94	16q12.2	RBL2		Retinoblastoma-like 2	180203	A			
16.399	9	16	03	16q13	HERPUD1, MIF1, HERP, KIAA0025		Homocysteine- and endoplasmic reticulum stress-inducible protein, ubiquitin-like domain-containing, 1	608070	REa, REc			
16.400	9	1	16	16q21	ADGRG1, GPR56, TM7XN1, BFPP, BPPR		Adhesion G protein-coupled receptor G1	604110	A, R, REc, Fd		Polymicrogyria, bilateral frontoparietal, 606854 (3); Polymicrogyria, bilateral perisylvian, 615752 (3)	8(Gpr56)
16.401	9	29	13	16q13	ARL2BP, BART		ADP ribosylation factor-like 2-binding protein	615407	REc		Retinitis pigmentosa with or without situs inversus, 615434 (3)	
16.402	8	29	02	16q21	CCL17, SCYA17, TARC		Chemokine, C-C motif, ligand 17	601520	R, Psh, REc			
16.403	8	29	02	16q21	CCL22, SCYA22		Chemokine, C-C motif, ligand 22	602957	R, Psh, REc			
16.404	7	10	09	16q21	CNGB1, CNCG3L, CNCG2, RP45		Cyclic nucleotide gated channel, beta 1	600724	Psh, A		Retinitis pigmentosa 45, 613767 (3)	
16.405	5	25	13	16q13	CPNE2, CPN2		Copine II	604206	REc			
16.406	5	24	12	16q21	COQ9, C16orf49, COQ10D5		Coq9, S. cerevisiae, homolog of	612837	REc		Coenzyme Q10 deficiency, primary, 5, 614654 (3)	
16.407	12	11	03	16q21	DOK4		Docking protein 4	608333	REc			
16.408	11	10	17	16q13	FAM192A, NIP30, C16orf94		Family with sequence similarity 192, member A	617766	REc			8(Fam192a)
16.409	6	12	17	16q13	GNAO1, EIEE17, NEDIM		Guanine nucleotide-binding protein (G protein), alpha-activating activity	139311	REa, H	close to MT1 in mouse	Epileptic encephalopathy, early infantile, 17, 615473 (3); Neurodevelopmental disorder with involuntary movements, 617493 (3)	8(Gnao1)
16.410	6	7	10	16q13	MIR138-2, MIRN138-2		Micro RNA 138-2	613395	REc			
16.411	11	1	13	16q12.2	MMP2, CLG4A, MONA		Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)	120360	REa, A, Ch	near MT1,2	Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	8(Mmp2)
16.412	2	23	92	16q13	MT1A		Metallothionein 1A (functional)	156350	REa, A, REn	proximal to FRA16B		8(Mt1)
16.413	2	23	92	16q13	MT1B		Metallothionein 1B (functional)	156349	REn			
16.414	2	23	92	16q13	MT1E		Metallothionein 1E (functional)	156351	REn			
16.415	2	23	92	16q13	MT1F		Metallothionein 1F (functional)	156352	REn			
16.416	2	23	92	16q13	MT1G		Metallothionein 1G	156353	REn			
16.417	2	23	92	16q13	MT1H		Metallothionein 1H	156354	REn			
16.418	2	23	92	16q13	MT1I		Metallothionein 1I	156355	REn			
16.419	2	23	92	16q13	MT1J		Metallothionein 1J	156356	REn			
16.420	2	23	92	16q13	MT1K		Metallothionein 1K	156357	REn			
16.421	2	23	92	16q13	MT1L		Metallothionein 1L	156358	REn			
16.422	2	23	92	16q13	MT1X		Metallothionein 1X	156359	REn			
16.423	2	23	92	16q13	MT2A, MT2		Metallothionein 2A	156360	REa, A, REn	pseudogene MT2P1 on 4cen-q21		8(Mt2)
16.424	12	16	93	16q13	MT3, GIFB		Metallothionein 3 (growth inhibitory factor (neurotrophic))	139255	REa			
16.425	11	22	09	16p13.3	NME3, NM23H3		Nonmetastatic cells 3, protein expressed in	601817	Psh, A			
16.426	4	7	16	16q13	NUP93, NIC96, KIAA0095, NPHS12		Nucleoporin, 93kD	614351	R, REc		Nephrotic syndrome, type 12, 616892 (3)	
16.427	7	18	14	16q13	OGFOD1		2-oxoglutarate- and iron-dependent oxygenase domain-containing protein 1	615857	REc			
16.428	5	15	96	16q13	SLC12A3, NCCT, TSC		Solute carrier family 12 (sodium/potassium/chloride transporters), member 3	600968	Fd, A		Gitelman syndrome, 263800 (3)	
16.429	8	29	02	16q13	PLLP, PMLP, TM4SF11		Plasma membrane proteolipid (plasmolipin)	600340	R, A			
16.430	12	28	15	16q13	RSPRY1, KIAA1972, SEMDFA		RING finger- and SPRY domain-containing protein 11	616585	REc		Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3)	
16.431	8	3	12	16q21	TEPP		Testis-prostate-placenta-expressed protein	610264	REc			
16.432	7	6	17	16q21	USB1, C16orf57, PN		U6 small nuclear RNA biogenesis phosphodiesterase 1	613276	REc		Poikiloderma with neutropenia, 604173 (3)	
16.433	3	20	01	16q13-q21	ANMA		Anisomastia	605746	Ch		Anisomastia (2)	
16.434	2	7	01	16q21	KIFC3		Kinesin family member C3	604535	REa, R			
16.435	1	13	99	16q21	MMP15		Matrix metalloproteinase 15	602261	A			
16.436	9	15	17	16p13.3	MRPS34, MRPS12, COXPD32		Mitochondrial ribosomal protein S34	611994	REc		Combined oxidative phosphorylation deficiency 32, 617664 (3)	
16.437	5	23	94	16q21	POLR2C		Polymerase (RNA) II (DNA directed) polypeptide C, 33kD	180663	A			
16.438	07	23	18	16q12.2	CES1, SES1		Carboxylesterase 1 (monocyte/macrophage serine esterase 1)	114835	REa		Drug metabolism, altered, CES1-related, 618057 (3)	8(Ces1)
16.439	8	20	07	16q13-q22.1	EKD2		Episodic kinesigenic dyskinesia 2	611031	Fd	max lod at D16S503	Episodic kinesigenic dyskinesia 2 (2)	
16.440	6	2	16	16q21	ADGRG5, GPR114		Adhesion G protein-coupled receptor G5	616965	REc			
16.441	11	5	98	16q13	AMFR, GP78		Autocrine motility factor receptor	603243	A			
16.442	9	24	15	16q13	BBS2, RP74		Bardet-Biedl syndrome 2	606151	Fd, REc		Bardet-Biedl syndrome 2, 615981 (3); Retinitis pigmentosa 74, 616562 (3)	
16.443	2	18	10	16q21	BEAN, SCA31		Brain-expressed, associated with NEDD4	612051	REc		Spinocerebellar ataxia 31, 117210 (3)	
16.444	11	4	14	16q21	CCDC113		Coiled-coil domain-containing protein 113	616070	REc			
16.445	2	12	07	16q22.1	CES3, ES31		Carboxylesterase 3	605279	REc			
16.446	9	6	11	16q13	CETP, HDLCQ10		Cholesteryl ester transfer protein, plasma	118470	REa, A		Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein cholesterol level QTL 10], 143470 (3)	
16.447	4	6	18	16q21	CFAP20, BUG22, C16orf80, FSAP23		Cilia- and flagella-associated protein 20	617906	REc			
16.448	11	17	14	16q21	CIAPIN1		Cytokine-induced apoptosis inhibitor 1 (anamorsin)	608943	REc			
16.449	9	9	08	16q21	CNOT1, NOT1		CCR4-NOT transcription complex, subunit 1	604917	REc			
16.450	9	30	11	16q21	SLC38A7, SNAT7		Solute carrier family 38 (amino acid transporter), member 7	614236	REc			
16.451	11	30	06	16q21	GINS3, PSF3		GINS complex subunit 3	610610	R, REc			
16.452	4	26	90	16q21	GOT2		Glutamic-oxaloacetic transaminase-2, mitochondrial (EC 2.6.1.1)	138150	S, F, H	?pseudogenes on 12 and 1		8(Got2)
16.453	2	13	15	16q21	KATNB1, LIS6		Katanin, p80 subunit, B1	602703	REc		Lissencephaly 6, with microcephaly, 616212 (3)	
16.454	6	30	15	16q21	SETD6		SET domain-containing protein 6	616424	REc			
16.455	10	11	01	16q22.1	WWP2		WW domain-containing protein 2	602308	R			
16.456	4	30	09	16q22.2	DHX38, DDX38, PRP16		DEAH (Asp-Glu-Ala-His) box polypeptide 38 (PRP6, S. cerevisiae, homolog of)	605584	R			
16.457	11	20	15	16q21-q22	OPA8		Optic atrophy 8	616648	Fd	max lod at D16S752	Optic atrophy 8 (2)	
16.458	1	13	99	16q21	CDH8		Cadherin-8	603008	Psh			
16.459	5	9	18	16q21	CDH11, CAD11, ESWS		Cadherin-11 (OB-cadherin, osteoblast)	600023	H, Psh		Elsahy-Waters syndrome, 211380 (3)	8(cad11)
16.460	5	6	13	16q22.1	HSF4, CTM, CTRCT5		Heat-shock transcription factor 4	602438	A, Fd		Cataract 5, multiple types, 116800 (3)	
16.461	2	24	12	16q21	NDRG4, SMAP8, KIAA1180		NMYC downstream-regulated gene 4	614463	REc			
16.462	1	4	18	16q23.2	BCO1, BCMO1, BCDO		Beta-carotene oxygenase 1	605748	Psh, R	mutation identified in 1 HCVAD patient	?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	
16.463	10	27	89	16q22.1	CA7		Carbonic anhydrase VII	114770	REa, A			
16.464	11	29	12	16q22.1	NOL3, NOP, MYC, ARC, FCM		Nucleolar protein 3	605235	R		Myoclonus, familial cortical, 614937 (3)	
16.465	4	30	15	16q22.1	AARS, CMT2N, EIEE29		Alanyl-tRNA synthetase	601065	A, R		Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3); Epileptic encephalopathy, early infantile, 29, 616339 (3)	
16.466	4	20	04	16q22.1	AGRP, ART, AGRT		Agouti-related transcript, mouse, homolog of	602311	A		{Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)	
16.467	8	29	01	16q22	ANBC		Aneurysmal bone cysts	606179	Ch	t(16:17); ?defect at 17p13	Aneurysmal bone cysts (2)	
16.468	9	30	09	16q22	ATFB8		Atrial fibrillation, familial, 8	613055	Fd	associated with rs7193343	Atrial fibrillation, familial, 8 (2)	
16.469	6	13	02	16q22.1	ATP6V0D1		ATPase, H+ transporting, V0 subunit D1	607028	R, REc			
16.470	3	27	12	16q22	C16DELq22, DEL16q22		Chromosome 16q22 deletion syndrome	614541	Ch		Chromosome 16q22 deletion syndrome (4)	
16.471	3	27	12	16q22.1	CBFB, PEBP2B		Core-binding factor, beta subunit	121360	Ch	inv(16)(p13;q22); fuses to MYH11	Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	
16.472	9	28	00	16q23.1	CHST5		Carbohydrate sulfotransferase-5 (GlcNAc-6-O-sulfotransferase, intestinal)	604817	REc, R			
16.473	9	28	00	16q23.1	CHST6, MCDC1		Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)	605294	Fd, REc, R		Macular corneal dystrophy, 217800 (3)	
16.474	12	5	11	16q21	CMTM1, CKLFSF1		CKLF-like marvel transmembrane domain-containing 1	607884	REc			8(Cklfsf1)
16.475	12	5	11	16q21	CMTM2, CKLFSF2		CKLF-like marvel transmembrane domain-containing 2	607885	REc			8(Cklfsf2a/b)
16.476	12	5	11	16q22.1	CMTM3, CKLFSF3		CKLF-like marvel transmembrane domain-containing 3	607886	REc			8(Cklfsf3)
16.477	12	5	11	16q21-q22	CMTM4, CKLFSF4		CKLF-like marvel transmembrane domain-containing 4	607887	REc			8(Cklfsf4)
16.478	5	26	13	16q23.1	CNTNAP4, CASPR4, KIAA1763		Contactin-associated protein-like 4	610518	R, REc			
16.479	5	28	10	16q22.2	DHODH, URA1, POADS		Dihydroorotate dehydrogenase	126064	A		Miller syndrome, 263750 (3)	
16.480	4	29	02	16q22.1	FHOD1, FHOS		Formin homology 2 domain-containing 1	606881	R			
16.481	9	24	11	16q22.1	HSD11B2, HSD11K, AME		Hydroxysteroid (11-beta) dehydrogenase 2	614232	A		Apparent mineralocorticoid excess, 218030 (3)	
16.482	4	16	09	16q22.1	NAE1, APPBP1		NEDD8 activating enzyme E1 subunit 1	603385	A			
16.483	9	1	16	16q22	NAIC		North American Indian childhood cirrhosis	604901	Fd		North American Indian childhood cirrhosis (2)	
16.484	9	26	96	16q22.1	RRAD		Ras-related associated with diabetes	179503	Fd, A			
16.485	8	17	16	16q21	TK2, MTDPS2, PEOB3		Thymidine kinase, mitochondrial	188250	S, REc	mutation identified in 1 PEOB3 family	Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3); ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 (3)	
16.486	6	18	99	16q22.1	TRADD		TNRF1-associated death domain protein	603500	H			8(Tradd)
16.487	9	1	16	16q22.1	UTP4, CIRH1A, TEX292, KIAA1988		Utp4, S. cerevisiae, homolog of	607456	Fd, HZ			
16.488	3	24	06	16q22.1	VPS4A, VPS4		Vacuolar protein sorting 4, yeast, homolog of, A	609982	A, REc, H			8(Vps4a)
16.489	2	9	92	16q22.2	ZNF19, KOX12		Zinc finger protein-19 (KOX12)	194525	A	?16q23, 19q13		8(Zfp1)
16.490	11	4	93	16q22.2	ZNF23, KOX16		Zinc finger protein-32 (KOX16)	194527	A			8(Zfp4)
16.491	10	15	95	16q23.1	GLG1		Golgi apparatus protein 1	600753	A			8(Glg1)
16.492	6	8	15	16q23.2	MAF, CCA4, CTRCT21, AYGRP		v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog	177075	A		Cataract 21, multiple types, 610202 (3); Ayme-Gripp syndrome, 601088 (3)	
16.493	11	7	01	16q22.1	SNTB2, SNT2B2, SNTL		Syntrophin, beta-2	600027	REa, Psh, A			8(Sntb2)
16.494	3	8	91	16q24.1	COX4I1, COX4		Cytochrome c oxidase, subunit IV, isoform 1	123864	REa			
16.495	9	24	15	16q22.1	ACD, PTOP, PIP1, TINT1		Acd, mouse, homolog of	609377	R, REc	mutation has been identified in 1 DKCA7 and 1 DKCB7 family	?Dyskeratosis congenita, autosomal dominant 6, 616553 (3); ?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	8(Acd)
16.496	6	28	94	16q22.2	CALB2		Calbindin 2, 29kD (calretinin)	114051	REa			
16.497	10	09	18	16q22.1	CARMIL2, RLTPR, IMD58		Capping protein regulator and myosin 1 linker 2	610859	REc		Immunodeficiency 58, 618131 (3)	
16.498	9	21	17	16q22.1	CDH1, UVO, LCAM, ECAD, BCDS1		Cadherin-1 (E-cadherin; uvomorulin)	192090	REa, D, Ch	near LCAT	Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma, somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3); {Prostate cancer, susceptibility to}, 176807 (3); Blepharocheilodontic syndrome 1, 119580 (3)	8(Um)
16.499	1	23	09	16q22.1	CDH3, CDHP, PCAD, HJMD		Cadherin-3 (P-cadherin)	114021	H, Psh, Fd	in mouse tightly linked to ECAD	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	8(Pcad)
16.500	1	13	99	16q21	CDH5		Cadherin-5	601120	H, Psh			8(Cdh5)
16.501	1	13	05	16q22.1	CDH16		Cadherin-16	603118	A, R			8(Cdh16)
16.502	10	8	07	16q22.1	CENPT		Centromere protein T	611510	R, REc			
16.503	11	11	14	16q22.1	CES2		Carboxylesterase 2	605278	R, REc			
16.504	10	3	11	16q22.1	CHTF8, CTF8		Chromosome transmission fidelity factor 8, S. cerevisiae, homolog of	613202	REc			
16.505	9	28	15	16q22.1	CLEC18A		C-type lecting domain family 18, member A	616571	REc			
16.506	9	28	15	16q22.1	CLEC18C		C-type lectin domain family 18, member C	616573	REc			
16.507	10	12	10	16q22.1	COG4, COD1, CDG2J		Component of oligomeric golgi complex 4	606976	R		Congenital disorder of glycosylation, type IIj, 613489 (3)	
16.508	7	10	07	16q22.1	COG8, DOR1, CDG2H		Component of oligomeric golgi complex 8	606979	R, REc		Congenital disorder of glycosylation, type IIh, 611182 (3)	
16.509	2	23	09	16q22.1	CRCS9		Colorectal cancer, susceptibility to, 9	612590	Fd	associated with rs9929218	{Colorectal cancer, susceptibility to, 9} (2)	
16.510	11	5	13	16q22.1	CTCF, MRD21		CCCTC-binding factor	604167	A		Mental retardation, autosomal dominant 21, 615502 (3)	
16.511	11	4	93	16q22.1	CTRL		Chymotrypsin-like protease	118888	REn			
16.512	4	23	08	16q22.1	CYB5B, CYPB5M		Cytochrome b5, type B (outer mitochondrial membrane)	611964	REc			
16.513	3	10	03	16q22.1	DDX28, MDDX28		DEAD/H box 28	607618	REc			
16.514	3	1	06	16q22.1	DPEP2, MBD2		Dipeptidase 2	609925	R, REc			
16.515	3	1	06	16q22.1	DPEP3, MBD3		Dipeptidase 3	609926	REc			
16.516	12	28	08	16q22.1	DUS2L, DUS2		Dihydrouridine synthase 2-like	609707	R, REc			
16.517	10	2	95	16q22.1	E2F4		E2F transcription factor 4, p107/p130-binding	600659	A			
16.518	10	2	12	16q22.1	EDC4, RCD8, GE1, HEDL5		Enhancer of mRNA decapping 4	606030	REc, R			
16.519	9	10	09	16q22.1	ESRP2, RBM35B		Epithelial splicing regulatory protein 2	612960	REc			
16.520	9	8	11	16q22.1	EXOC3L1, EXOC3L		Exocyst complex component 3-like 1	614117	REc			8(Exoc3l1)
16.521	6	1	12	16q22.1	EXOSC6, MTR3		Exosome component 6	606490	REc			
16.522	8	31	12	16q22.1	FAM96B, MIP18		Family with sequence similarity 96, member B	614778	REc			
16.523	6	13	12	16q22.1	FBXL8, FBL8		F-box and leucine-rich repeat protein 8	609077	REc			
16.524	6	18	99	16q22.1	HAS3		Hyaluronan synthase 3	602428	Psh, REc			8(Has3)
16.525	7	22	11	16q22.2	HP		Haptoglobin	140100	Fc	just distal to fra16q22.1	[Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)	8(Hp)
16.526	1	12	89	16q22.2	HPR		Haptoglobin-related locus	140210	REa	2.2kb 3' to HP; multiple tandem genes in blacks		
16.527	5	25	13	16q13	NLRC5		NLR family, caspase recruitment domain-containing 5	613537	REc			
16.528	6	25	08	16q22.1	IL34, C16orf77		Interleukin 34	612081	REc			
16.529	5	29	02	16q22.1	LCAT		Lecithin-cholesterol acyltransferase	606967	F, LD, A, REa	very close to HP	Norum disease, 245900 (3); Fish-eye disease, 136120 (3)	8(Lcat)
16.530	5	16	05	16q22.1	LYPLA3, LLPL, ACS, LPLA2		Lysophospholipase 3	609362	R, REc			
16.531	11	4	93	16q22.1	MECL1, LMP10, PSMB10		Proteosome subunit MECL1	176847	REn	3.1kb from LCAT		8(Psmb10)
16.532	3	23	09	16q22.1	MIR140, MIRN140		Micro RNA 140	611894	REc			
16.533	1	20	11	16q22.1	MIR328, MIRN328		Micro RNA 328	613701	REc			
16.534	5	23	16	16q22.1	MTSS1L, ABBA1		Metastasis suppressor 1-like protein	616951	REc			
16.535	5	25	13	16q22.1	NFAT5, KIAA0827, NFATL1, TONEBP		Nuclear factor of activated T cells 5	604708	REc			
16.536	9	24	08	16q22.1	NQO1, DIA4, NMOR1		NAD(P)H dehydrogenase, quinone 1 (diaphorase-4)	125860	S, REa, Ch		{Benzene toxicity, susceptibility to} (3); {Leukemia, post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)	8(Nmor1)
16.537	12	10	13	16q22.1	PDP2, KIAA1348		Pyruvate dehydrogenase phosphatase catalytic subunit 2	615499	R, REc			
16.538	1	17	18	16q22.1	PDPR, KIAA1990		Pyruvate dehydrogenase phosphatase regulatory subunit	617835	REc			
16.539	4	24	18	16q22.1	PLEKHG4		Pleckstrin homology domain- and RhoGEF domain-containing protein G4	609526	REc			
16.540	10	18	16	16q22.1	PRMT7, KIAA1933, SBIDDS		Protein arginine N-methyltransferase 7	610087	REc		Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3)	
16.541	10	27	93	16q22.1	PSKH1		Putative serine kinase H1	177015	REn			
16.542	9	8	11	16q22.1	RANBP10, KIAA1464		Ran-binding protein 10	614031	REc			
16.543	10	13	97	16q22.1	SCA4		Spinocerebellar ataxia 4	600223	Fd		Spinocerebellar ataxia 4 (2)	
16.544	6	5	12	16q22.1	SF3B3, SF3B130, SAP130		Splicing factor 3B, subunit 3	605592	R, REc			
16.545	6	27	95	16q22.1	SLC9A5, NHE5		Solute carrier family 9 (sodium/hydrogen exchanger), member 5	600477	REa, A, Fd			
16.546	8	17	99	16q22.1	SLC12A4, KCC1		Solute carrier family 12 (potassium/chloride transporters), member 4	604119	REn			
16.547	2	2	17	16q22.1	TERB1, CCDC79		Telomere repeat-binding bouquet formation protein 1	617332	REc			
16.548	6	22	99	16q22.1	TERF2, TRF2		Telomeric repeat-binding factor-2	602027	Psh, R			8(Terf2)
16.549	9	30	13	16q22.1	THAP11, RONIN		THAP domain-containing protein 11	609119	REc			
16.550	6	2	16	16q22.1	TPPP3, p20		Tubulin polymerization-promoting protein family, member 3	616957	REc			
16.551	12	6	16	16q22.1	TSNAXIP1, TXI1		Translin-associated factor X-interacting protein 1	607720	REc			
16.552	8	1	16	16q22.1-q22.2	VAC14, TAX1BP2, TRX, SNDC		Vac14, S. cerevisiae, homolog of	604632	R, REc		Striatonigral degeneration, childhood-onset, 617054 (3)	
16.553	6	30	05	16q22.1	ZFP90, NK10, KIAA1954		Zinc finger protein 90, mouse, homolog of	609451	REc, H			8(Zfp90)
16.554	5	21	07	16q24.3	TRAPPC2L		Trafficking protein particle complex 2-like	610970	REc			
16.555	9	17	09	16q22.2	TAT		Tyrosine aminotransferase, soluble	613018	REa, A, H, D		Tyrosinemia, type II, 276600 (3)	8(Tat)
16.556	12	7	07	16q22.1-q23.1	OTSC4		Otosclerosis 4	611571	Fd	between D16S3107 and D16S3097	{Otosclerosis 4} (2)	
16.557	12	7	04	16q22.2	PKD1L3		Polycystin 1-like 3	607895	REc			8(Pkd1l3)
16.558	10	24	11	16q22.2	ATXN1L, BOAT1		Ataxin 1-like (brother of ataxin 1)	614301	REc			
16.559	2	4	15	16q22.2	CMTR2, MTR2, FTSJD1		CAP methyltransferase 2	616190	REc			
16.560	10	25	12	16q22.2	HYDIN, HYDIN1, CILD5		Hydin, mouse, homolog of	610812	REc, H, Fd	duplicated copy on 1q21.1	Ciliary dyskinesia, primary, 5, 608647 (3)	8(Hydin)
16.561	6	23	15	16q22.2	IST1, KIAA0174		Increased sodium tolerance 1, yeast, homolog of	616434	R, REc			
16.562	7	22	11	16q22.2	MARVELD3		Marvel domain-containing protein 3	614094	REc			
16.563	09	07	18	16q22.2	PMFBP1, STAP, SPGF31		Polyamine-modulated factor 1-binding protein 1	618085	REc, H		Spermatogenic failure 31, 618112 (3)	8(Pmfbp1)
16.564	10	25	17	16q22.2	TXNL4B, DLP, DIM2		Thioredoxin-like 4B	617722	REc			
16.565	6	18	01	16q23.1	ADAT1		Adenosine deaminase, tRNA-specific, 1	604230	R			
16.566	1	27	04	16q23.1	CFDP1, CP27, BCNT		Craniofacial development protein 1	608108	REc, Psh, A			
16.567	10	7	14	16q23.1	KARS, CMTRIB, DFNB89		Lysyl-tRNA synthetase	601421	Psh, A, R	mutation identified in 1 CMTRIB patient	?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3); Deafness, autosomal recessive 89, 613916 (3)	
16.568	9	24	15	16q23.1	CLEC18B		C-type lectin domain family 18, member B	616572	REc			
16.569	2	2	14	16q22.3	HCCAT5, HTA		Hepatocellular carcinoma-associated transcript 5	615613	REc			
16.570	8	21	07	16q22.2	PHLPPL, PHLPP2		PH domain and leucine-rich repeat protein phosphatase-like	611066	REc			
16.571	9	20	04	16q22.3-q23.1	KTCN2		Keratoconus 2	608932	Fd		Keratoconus 2 (2)	
16.572	2	28	03	16q23.1	GABARAPL2		GABA-A receptor-associated protein-like protein 2	607452	R			
16.573	1	22	15	16q22.2-q22.3	ZFHX3, ATBF1		Zinc finger homeobox 3	104155	A, D		{Prostate cancer, susceptibility to, somatic}, 176807 (3)	8(Atbf1)
16.574	11	11	13	16q23.1	ADAMTS18, MMCAT		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 18	607512	REc		Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	
16.575	9	18	00	16q22.2	AP1G1, ADTG, CLAPG1		Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)	603533	A, Psh			
16.576	5	4	09	16q23	BMND13		Bone mineral density quantitative trait locus 13	612727	Fd	associated with rs16945612	[Bone mineral density QTL 13] (2)	
16.577	11	3	14	16q21	CKLF, HSPC224		Chemokine-like factor	616074	R, REc			
16.578	8	27	15	16q23.1	CLEC3A, CLECSF1		C-type lectin domain family 3, member A	613588	A			
16.579	5	23	11	16q23.1	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35		Fatty acid 2-hydroxylase	611026	R, REc		Spastic paraplegia 35, autosomal recessive, 612319 (3)	8(Fa2h)
16.580	2	2	11	16q23	HSCR8		Hirschsprung disease, susceptibility to, 8	608462	LD		{Hirschsprung disease, susceptibility to, 8} (2)	
16.581	8	24	98	16q23.1	PSMD7, MOV34		Proteasome 25S subunit, non-ATPase, 7 (Moloney leukemia virus-34 proviral integration homolog)	157970	REa, A			8(Mov34)
16.582	5	25	00	16q23.1	BCAR1, CRKAS, CAS		Breast cancer antiestrogen resistance 1	602941	A, Psh			
16.583	4	8	13	16q23.1	MLKL		Mixed lineage kinase domain-like protein	615153	REc			
16.584	6	7	10	16q23.1	MON1B, SRG1, KIAA0872		Mon1, S. cerevisiae, homolog of, B	608954	REc			
16.585	11	29	17	16q23.1	RFWD3, FANCW		RING finger and WD repeat domains-containing protein 3	614151	REc	mutation identified in 1 FANCW patient	?Fanconi anemia, complementation group W, 617784 (3)	
16.586	6	24	10	16q23.1	TERF2IP, RAP1		Telomeric repeat binding factor 2, interacting protein	605061	R, REc			
16.587	7	21	14	16q23.1	TMEM231, JBTS20, MKS11		Transmembrane protein 231	614949	REc		Joubert syndrome 20, 614970 (3); Meckel syndrome 11, 615397 (3)	
16.588	4	20	17	16q23.1	WDR59, KIAA1923		WD repeat-containing protein 59	617418	REc			
16.589	12	5	16	16q23.1	ZFP1, ZNF475		Zinc finger protein 1, mouse, homolog of	617230	REc			
16.590	6	10	08	16q23.1	ZNRF1, NIN283		Zinc finger and ring finger protein 1	612060	REc			
16.591	07	19	18	16q23.2	ARLNC1, LINC02170		Androgen receptor-regulated long noncoding RNA 1	618053	REc			
16.592	7	20	12	16q23.2	ATMIN, ASCIZ, KIAA0431		ATM interactor	614693	R, REc			
16.593	10	8	07	16q23.2	CENPN		Centromere protein N	611509	REc			
16.594	3	13	15	16q23.2	MAFTRR, lincMAF4		MAF transcriptional regulator FNA, noncoding	616264	REc			
16.595	3	31	15	16q23.2	PKD1L2, PC1L2, KIAA1879		Polycystin 1-like 2	607894	REc, REn			8(Pkd1l2)
16.596	6	21	91	16q23.1	CTRB1		Chymotrypsinogen B1	118890	REa, H, D, Fd, Ch	HP-7cM-TAT-9cM-CTRB		8(Ctrb)
16.597	3	31	11	16q23.3	ADIPQTL5		Adiponectin, serum level of, quantitative trait locus 5	613836	Fd	associated with rs3865188	{Adiponectin, serum level of, QTL5] (2)	
16.598	2	21	06	16q23.2	DYNLRB2, DNCL2B		Dynein, light chain, roadblock-type 2	607168	REc			
16.599	3	25	14	16q23.3	HSBP1		Heat-shock factor-binding protein 1	604553	REc			
16.600	3	23	14	16q23.3	OSGIN1, OKL38		Oxidative stress-induced growth inhibitor 1	607975	REc			
16.601	12	30	14	16q23.3	SDR42E1		Short-chain dehydrogenase/reductase family 42E, member 1	616164	REc			
16.602	4	10	14	16q23.3	SLC38A8, FVH2		Solute carrier family 38 (amino acid transporter), member 8	615585	REc		Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	
16.603	2	25	16	16q23.1-q23.2	WWOX, FOR, SCAR12, EIEE28		WW domain-containing oxidoreductase	605131	REc, H, Ch, Fd		Esophageal squamous cell carcinoma, somatic, 133239 (3); Spinocerebellar ataxia, autosomal recessive 12, 614322 (3); Epileptic encephalopathy, early infantile, 28, 616211 (3)	8(Wox1, Fra8E1)
16.604	9	10	98	16q24.3	AFG3L1, AFG3		ATPase family gene 3, yeast, homolog of	603020	A, R			
16.605	10	30	07	16q24.2	BANP, SMAR1		BTG3-associated nuclear protein	611564	A			8(Banp)
16.606	6	15	99	16q24.3	CBFA2T3, MTGR2, MTG16		Core-binding factor, alpha subunit 2, translocated to, 3	603870	R, A			
16.607	10	1	17	16q24.3	CDK10, PISSLRE, ALSAS		Cyclin-dependent kinase 10	603464	RE		Al Kaissi syndrome, 617694 (3)	
16.608	2	13	09	16q23.2-q23.3	CMIP, KIAA1694, TCMIP		C-MAF-inducing protein	610112	R, REc			
16.609	7	9	90	16q24.2	CYBA		Cytochrome b-245, alpha polypeptide	608508	REa, A		Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)	
16.610	8	18	09	16q24.1	FOXF1, FKHL5, ACDMPV		Forkhead box F1	601089	A		Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	8(Foxf1)
16.611	4	27	18	16q23.2	GCSH, NKH		Glycine cleavage system H protein	238330	A	mutation identified in 1 NKH patient	?Glycine encephalopathy, 605899 (3)	
16.612	4	5	00	16q24.2	IL17C		Interleukin 17C	604628	R			
16.613	4	4	01	16q23.3-q24.1	MBTPS1, S1P		Membrane-bound transcription factor protease, site 1	603355	REa, A, R			
16.614	3	26	02	16q23.3	MLYCD, MCD		Malonyl-CoA decarboxylase	606761	R, Psh		Malonyl-CoA decarboxylase deficiency, 248360 (3)	
16.615	9	3	10	16q24	STQTL22		Stature quantitative trait locus 22	613547	Fd	linked to rs299956 and rs2076962	{Stature QTL 22} (2)	
16.616	2	1	01	16q24.1	TAF1C, TAFI110, SL1		TATA box-binding protein-associated factor 1C	604905	R, A			
16.617	4	21	10	16q24.1	USP10, KIAA0190		Ubiquitin-specific protein 10	609818	R, REc			
16.618	6	11	08	16q24.2	ZNF469, KIAA1858, BCS1		Zinc finger protein 469	612078	Fd, R, REc		Brittle cornea syndrome 1, 229200 (3)	
16.619	10	13	09	16q24.1	ATP2C2, SPCA2, KIAA0703		ATPase, Ca(2+)-transporting, type 2C, member 2	613082	R, REc			
16.620	2	1	11	16q24.1	COTL1, CLP		Coactosin-like protein 1	606748	R, Psh, REc	pseudogenes on 15, 17, and Y		
16.621	12	4	08	16q24.1	CRISPLD2		Cysteine-rich secretory protein, LCCL domain-containing, 2	612434	REc			
16.622	10	12	16	16q24.1	DNAAF1, LRRC50, ODA7, CILD13		Dynein, axonemal, assembly factor 1	613190	REc		Ciliary dyskinesia, primary, 13, 613193 (3)	
16.623	2	25	15	16q24.1	EMC8, NOC4		ER membrane protein complex subunit 8	604886	REc			
16.624	12	27	16	16q24.1	FAM92B		Family with sequence similarity 92, member B	617274	REc			
16.625	5	30	17	16q24.1	FENDRR, FOXF1AS1, TCONS_00024240		FOXF1 adjacent noncoding developmental regulatory RNA	614975	REc	partial overlap with FOXF1 promoter		
16.626	5	4	09	16q24.1	FOXL1, FKHL11, FREAC7, FKH6		Forkhead box L1	603252	REc			8(Foxl1)
16.627	11	2	00	16q23.2	GAN, GAN1		Gigaxonin	605379	Fd, LD, REc		Giant axonal neuropathy-1, 256850 (3)	
16.628	11	30	06	16q24.1	GINS2, PSF2		GINS complex subunit 2	610609	R, REc			
16.629	3	30	16	16q24.1	GSE1, KIAA0182		GSE1 coiled-coil protein	616886	REc			
16.630	4	23	03	16q24.1	HDLC3		High density lipoprotein cholesterol, low serum, 3	607687	Fd		{High density lipoprotein cholesterol, low serum, 3} (2)	
16.631	6	10	18	16q24.1	IRF8, ICSBP1, IMD32A, IMD32B		Interferon regulatory factor 8	601565	REc		Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3); Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3)	
16.632	3	10	03	16q24.1	KCNG4, KV6.3, KV6.4		Potassium channel, voltage-gated, subfamily G, member 4	607603	REc			
16.633	12	17	07	16q24.1	KIAA0513		KIAA0513 gene	611675	R, REc			
16.634	2	16	16	16q24.1	MTHFSD		Methenyltetrahydrofolate synthetase domain-containing protein	616820	REc			
16.635	10	25	12	16q23.3	PLCG2, FCAS3, APLAID		Phospholipase C, gamma 2	600220	Psh		Familial cold autoinflammatory syndrome 3, 614468 (3); Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	8(Plcg2)
16.636	1	14	13	16q24.1	TCONS00024492		Long noncoding RNA TCONS_00024492	614978	REc			
16.637	8	14	14	16q24.1	LINC01081, TCONS00024764		Long intergenic non-protein coding RNA 1081	614977	REc			
16.638	4	27	12	16q24.1	ZDHHC7, DHHC7		Zinc finger DHHC domain-containing protein 7	614604	REc			
16.639	7	11	95	16q23.3	HSD17B2, EDH17B2		Hydroxysteroid (17-beta) dehydrogenase 2	109685	A, Fd			
16.640	3	15	13	16q24.2	MAP1LC3B, LC3B		Microtubule-associated protein 1, light chain 3, beta	609604	R, REc			
16.641	1	13	99	16q23.3	CDH13, CDHH		Cadherin-13 (H-cadherin, heart)	601364	A			
16.642	11	23	16	16q24.2-q24.3	RNF166		RING finger protein 166	617178	REc			
16.643	10	1	11	16q24.3	ACSF3		Acyl-CoA synthetase family member 3	614245	REc		Combined malonic and methylmalonic aciduria, 614265 (3)	
16.644	9	21	11	16q24.3	ANKRD11, ANCO1, KBGS		Ankyrin repeat domain-containing protein 11	611192	REc		KBG syndrome, 148050 (3)	
16.645	9	21	12	16q24.3	APRT, APRTD		Adenine phosphoribosyltransferase	102600	S, D, REn	telomeric to GALNS, transcribed in same cen-tel direction	Adenine phosphoribosyltransferase deficiency, 614723 (3)	8(Aprt)
16.646	4	29	14	16q24.2	CA5A, CA5AD		Carbonic anhydrase VA (mitochondrial)	114761	Psh, A	pseudogene on 16p	Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	8(Car5)
16.647	2	17	09	16q24.3	CDH15, CDH14, CDH3, MRD3		Cadherin-15, M-cadherin (myotubule)	114019	REa, Psh	tightly linked to Aprt in mouse	Mental retardation, autosomal dominant 3, 612580 (3)	8(Cdh3)
16.648	3	15	11	16q24.3	CDT1		Chromatin licensing and DNA replication factor 1	605525	REc		Meier-Gorlin syndrome 4, 613804 (3)	
16.649	12	15	12	16q24.3	CHMP1A, PCOLN3, PRSM1, PCH8		CHMP family, member 1A	164010	Psh, REa		Pontocerebellar hypoplasia, type 8, 614961 (3)	
16.650	2	28	01	16q24.3	CPNE7		Copine VII	605689	D			
16.651	10	09	18	16q24.3	CTU2, C16orf84, NCS2, MFRG		Cytosolic thiouridylase, subunit 2	617057	REc		Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3)	
16.652	4	25	93	16q24.3	DPEP1, RDP, MDP, MBD1		Dipeptidase 1	179780	A, REa, Fd			
16.653	1	27	03	16q24.3	FANCA, FACA, FA1, FA, FAA		Fanconi anemia, complementation group A	607139	Fd, LD	linkage heterogeneity	Fanconi anemia, complementation group A, 227650 (3)	8(Fanca)
16.654	9	22	14	16q24.2	FBXO31, FBX31, FBXO14, FBX14, MRT45		F-box only protein 31	609102	REc	mutation identified in 1 MRT45 family	?Mental retardation, autosomal recessive 45, 615979 (3)	8(Fbxo31)
16.655	6	27	08	16q24.1	FOXC2, FKHL14, MFH1		Forkhead box C2	602402	A, Fd, Ch		Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	8(Mfh1)
16.656	9	18	08	16q24.3	GALNS, MPS4A		Galactosamine (N-acetyl)-6-sulfate sulfatase	612222	A, Psh, REn	centromeric to APRT	Mucopolysaccharidosis IVA, 253000 (3)	
16.657	1	11	16	16q24.3	GAS8, GAS11, CILD33		Growth arrest-specific 8	605178	REc		Ciliary dyskinesia, primary, 33, 616726 (3)	
16.658	8	17	17	16q24.3	GAS8-AS1, C16orf3, EID1		GAS8 antisense RNA 1	605179	REc			
16.659	1	24	09	16q24.3	IHPS5		Pyloric stenosis, infantile hypertrophic, 5	612525	Fd	between rs7197068 and rs750740	Pyloric stenosis, infantile hypertrophic, 5 (2)	
16.660	08	16	18	16q24.2	JPH3, JP3, HDL2		Junctophilin 3	605268	A	mutation identified in 1 HDL2 family	Huntington disease-like 2, 606438 (3)	
16.661	11	30	11	16q24.3	MC1R, SHEP2, CMM5		Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	A		[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3); [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced skin damage}, 266300 (3); {Albinism, oculocutaneous, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)	8(Mc1r)
16.662	11	18	15	16q24.2	MVD, MPD, POROK7		Mevalonate pyrophosphate decarboxylase	603236	REc, Fd		Porokeratosis 7, multiple types, 614714 (3)	
16.663	4	27	12	16q24.3	PGN, SPG7, CMAR, CAR		Paraplegin	602783	Fd, REc		Spastic paraplegia 7, autosomal recessive, 607259 (3)	
16.664	3	3	16	16q24.3	PIEZO1, FAM38A, MIB, DHS, LMPH3		PIEZO1 ion channel	611184	REc		Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3); Lymphedema, hereditary, III, 616843 (3)	
16.665	4	10	11	16q24.3	RPL13, BBC1, D16S44E		Ribosomal protein L13	113703	REc			
16.666	2	19	99	16q24.2	SLC7A5, D16S469E, MPE16		Solute carrier family 7, member 5	600182	REa			
16.667	5	5	09	16q24.2	SNAI3, SNAIL3, SMUC, ZFP293		SNAIL, Drosophila, homolog of, 3	612741	REc			
16.668	9	23	13	16q24.3	SPATA33, C16orf55		Spermatogenesis-associated protein 33	615409	REc			
16.669	10	7	08	16q24.3	TCF25, NULP1, KIAA1049		Transcription factor 25	612326	R, REc			
16.670	9	23	13	16q24.3	TUBB3, TUBB4, CFEOM3A, CDCBM1		Tubulin, beta-3	602661	REc		Fibrosis of extraocular muscles, congenital, 3A, 600638 (3); Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	
16.671	6	22	14	16q24.3	URAHP, URAH		Urate (hydroxyiso-) hydrolase, pseudogene	615805	REc			
16.672	10	13	00	16q24.1	WFDC1, PS20		WAP four-disulfide core domain-1, mouse, homolog of	605322	A			
16.673	2	16	04	16q24.3	ZFP276		Zinc finger protein 276	608460	REn			
16.674	2	28	03	16q24.2	ZFPM1, FOG, FOG1		Zinc finger protein, multitype 1 (friend of GATA1)	601950	REc			
16.675	8	27	01	16q22.1	DDX19, DBP5		DEAD/H box 19	605812	R			
16.676	9	30	02	16p12.2	EEF2K		Elongation factor 2 kinase	606968	R			
16.677	11	2	01	16q22.1	ELMO3		Engulfment and cell motility gene 3	606422	REc			
16.678	10	23	87	Chr.16	ESB3		Esterase-B3	133290	S			8(Es6)
16.679	6	14	95	Chr.16	GRLL1		Glucocorticoid receptor-like 1	138060	REb			
16.680	8	21	91	Chr.16	IFNR		Interferon production regulator	147573	REa, S			
16.681	1	27	03	16q23.1	LDHD		D-lactate dehydrogenase	607490	R			
16.682	10	23	87	Chr.16	LIPB		Lipase B, lysosomal acid	247980	S			
16.683	1	30	01	16q23.3	MPHOSPH6, MPP		M-phase phosphoprotein 6	605500	R			
16.684	8	30	01	16q13	MT4, MTIV		Metallothionein 4	606206	A			8(Mt4)
16.685	9	3	02	16q22.1	NFATC3		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 3	602698	R			
16.686	10	23	87	Chr.16	NHCP1		Nonhistone chromosomal protein-1	118870	S			
16.687	2	15	01	16q22.1	SLC7A6		Solute carrier family 7 (y+L-type amino acid transporter), member 6	605641	R			
16.688	9	25	01	16p13.3	SRRM2, SRM300, KIAA0324		Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD)	606032	R, REc			
16.689	9	2	09	1p36.13	TRNAG1, TRG1		tRNA glycine-1	189911	REa			
16.690	7	17	91	Chr.16	VDI, DIPI		Vesicular stomatitis virus defective interfering particle repressor	125260	S			
16.691	2	25	02	16p11.2	ZNF267, HZF2		Zinc finger protein-167	604752	R			
16.692	10	10	18	16q23.3	NECAB2		N-terminal EF-hand calcium-binding protein 2	618130	REc			
17.1	8	15	03	17p13.2	ASPA		Aspartoacylase (aminoacylase-2)	608034	A		Canavan disease, 271900 (3)	
17.2	9	10	14	17p13.2	ENO3, GSD13		Enolase-3, beta, muscle	131370	REa, A	mutation identified in 1 GSD13 patient	?Glycogen storage disease XIII, 612932 (3)	
17.3	1	24	09	17p13.2	GP1BA, BSS, BDPLT1, VWDP, BDPLT3		Glycoprotein Ib, platelet, alpha polypeptide	606672	A		Bernard-Soulier syndrome, type A1 (recessive), 231200 (3); {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand disease, platelet-type, 177820 (3)	
17.4	12	21	09	17p13.3	PLI, SERPINF2		Alpha-2-plasmin inhibitor	613168	Psh		Alpha-2-plasmin inhibitor deficiency, 262850 (3)	
17.5	10	12	90	17p13.2	ZFP3		Zinc finger protein-3	194480	REa	probably in cluster with ZNF29 proximal to TP53		11(Zfp3)
17.6	3	26	95	17p13.3	ABR		Active BCR-related gene	600365	A			
17.7	5	12	99	17p13.2	ALOX15		Arachidonate 15-lipoxygenase	152392	Psh			11(Alox15)
17.8	8	12	98	17p13.2	ATP2A3, SERCA3		ATPase, Ca(2+)-transporting, ubiquitous	601929	A			
17.9	1	23	96	17p13.3	BCPR		Breast cancer-related regulator of TP53	113721	D		Breast cancer (1)	
17.10	7	25	16	17p13.3	BHLHA9, BHLHF42, MSSD, CCSPD		Basic helix-loop-helix family, member A9	615416	REc	mutation identified in 1 CCSPD family	Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3); ?Camptosynpolydactyly, complex, 607539 (3)	
17.11	10	12	17	17p13.2	C1QBP, HABP1, COXPD33		Complement component C1q binding protein (hyaluronic acid-binding protein 1)	601269	A, Psh		Combined oxidative phosphorylation deficiency 33, 617713 (3)	
17.12	2	3	15	17p13.3	CLUH, CLU1, KIAA0664		Clustered mitochondria, D. discoideum, homolog of	616184	R, REc			
17.13	11	4	93	17p13.3	CRK		Avian sarcoma virus CT10 (v-crk) oncogene homolog	164762	A			
17.14	2	2	18	17p13.3	DDD3		Dowling-Degos disease 3	615674	Fd	max lod at D17S1529	Dowling-Degos disease 3 (2)	
17.15	1	12	07	17p13.3	DOC2B		Double C2-like domain-containing protein, beta	604568	REc			
17.16	4	21	16	17p13.3	DPH1, DPH2L1, OVCA1, DEDSSH		DPH1, S. cerevisiae, homolog of (ovarian cancer gene 1)	603527	REf		Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	
17.17	3	23	18	17p13.3	GEMIN4, NEDMCR		Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	606969	REc		Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3)	
17.18	4	4	17	17p13.3	INPP5K, SKIP, MDCCAID		Inositol polyphosphate-5-phosphatase K	607875	Psh, A		Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3)	
17.19	5	13	10	17p13.3	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3		Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome)	247200	Ch		Miller-Dieker lissencephaly syndrome (4)	
17.20	2	19	10	17p13.3	DUP17p13.3, C17DUPp13.3		Chromosome 17p13.3 duplication syndrome	613215	Ch	includes LIS1 and/or YWHAE	Chromosome 17p13.3 duplication syndrome (4)	
17.21	2	6	08	17p13.3	FAM57A, CT120		Family with sequence similarity 57, member A	611627	REc			
17.22	8	18	14	17p13.3	FAM101B, CFM1		Family with sequence similarity 101, member B	615928	REc			
17.23	6	16	99	17p13.1	GLP2R		Glucagon-like peptide 2 receptor	603659	A			
17.24	6	4	99	17p13.3	HIC1		Hypermethylated in cancer	603825	A, H			11(Hic1)
17.25	3	23	09	17p13.3	MIR22, MIRN22		Micro RNA 22	612077	REc			
17.26	3	23	09	17p13.3	MIR132, MIRN132		Micro RNA 132	610016	REc			
17.27	7	16	10	17p13.3	MIR212, MIRN212		Micro RNA 212	613487	REc			
17.28	9	18	98	17p13.3	MNT, ROX		MAX-binding protein	603039	REc			11(Mnt)
17.29	5	11	00	17p13.2	MYBBP1A, P160		MYB-binding protein 1A	604885	A, R			11(Mybbp1a)
17.30	7	22	09	17p13.3	NXN		Nucleoredoxin	612895	REc			11(Nxn)
17.31	7	2	18	17p13.3	OR1A1		Olfactory receptor, family 1, subfamily A, member 1	618046	REc			
17.32	7	2	18	17p13.3	OR1A2		Olfactory receptor, family 1, subfamily A, member 2	618047	REc			
17.33	8	24	98	17p13.3	OR1D2, OLFR1		Olfactory receptor, family 1, subfamily D, member 2	164342	A, Fd, REa	cluster of 16 genes in 350kb		
17.34	3	31	15	17p13.3	OVCA2		Ovarian cancer-associated gene 2	607896	REc			
17.35	7	16	17	17p13.2	P2RX1, P2X1		Purinergic receptor P2X, ligand-gated ion channel, 1	600845	A, H			11(P2rx1)
17.36	1	3	03	17p13.3	PAFAH1B1, LIS1		Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit	601545	Ch, RE, D		Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432 (3)	
17.37	12	22	15	17p13.2	PELP1, MNAR		Proline-, glutamic acid-, and leucine-rich protein 1	609455	REc			
17.38	9	10	12	17p13.2	PFN1, ALS18		Profilin-1	176610	REa, A, D		Amyotrophic lateral sclerosis 18, 614808 (3)	11(Pfn1)
17.39	9	7	10	17p13.3	PITPNA, PITPN		Phosphotidylinositol transfer protein, alpha	600174	Psh, A			11(Pitpn)
17.40	3	31	15	17p13.3	RILP		RAB-interacting lysosomal protein	607848	R, REc			11(Rilp)
17.41	2	28	03	17p13.3	PRPF8, PRPC8, RP13		Precursor mRNA-processing factor 8, S. cerevisiae, homolog of	607300	Fd, REc		Retinitis pigmentosa 13, 600059 (3)	
17.42	2	17	09	17p13.3	RNMTL1, HC90		RNA methyltransferase-like 1	612600	REc			
17.43	4	11	94	17p13.3	RPA1		Replication protein A1, 70kD	179835	Psh, R, A			
17.44	7	14	00	17p13.3	RPH3AL, NOC2		Rabphilin 3A-like	604881	REc			
17.45	5	24	13	17p13.3	RTN4RL1, NGRH2, NGR3		Reticulon 4 receptor-like 1	610461	REc			
17.46	3	13	08	17p13.3	SCARF1, SREC, KIAA0149		Scavenger receptor class F, member 1	607873	R, REc			
17.47	2	2	12	17p13.3	SERPINF1, PEDF, OI6		Serpin peptidase inhibitor, clade F, member 1	172860	REa, A, Psh	same region as RP13	Osteogenesis imperfecta, type VI, 613982 (3)	
17.48	9	24	11	17p13.3	SGSM2, KIAA0397		Small G protein signaling modulator 2	611418	REc, R			
17.49	10	20	99	17p13.2	SLC25A11, SLC20A4, OGC		Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11	604165	A			
17.50	3	8	07	17p13.3	SLC43A2, LAT4		Solute carrier family 43 (L-type amino acid transporter, member 2	610791	REc			
17.51	5	21	07	17p13.3	SMG6, EST1A, KIAA0732		SMG6, C. elegans, homolog of	610963	REc			
17.52	12	27	01	17p13.3	SRR		Serine racemase	606477	R			
17.53	9	16	13	17p13.3	TIMM22, TIM22		Translocase of inner mitochondrial membrane 22, yeast, homolog of	607251	R, REc			
17.54	1	8	01	17p13.2	TM4SF5		Transmembrane 4 superfamily, member 5	604657	REa, R			
17.55	12	14	98	17p13.1	TNFSF12, TWEAK, APO3L, DR3LG		Tumor necrosis factor ligand superfamily, member 12	602695	R			
17.56	5	24	13	17p13.3	TSR1, KIAA1401		TSR1, 20S r RNA accumulation, S. cerevisiae, homolog of	611214	REc, R			
17.57	9	2	08	17p13.3	TUSC5, LOST1		Tumor suppressor candidate 5	612211	REc			
17.58	6	22	14	17p13.3	VPS53, HCCS1, PCH2E		Vacuolar protein sorting 53, S. cerevisiae, homolog of	615850	REc		Pontocerebellar hypoplasia, type 2E, 615851 (3)	
17.59	7	9	18	17p13.3	WDR81, CAMRQ2, HYC3		WD repeat-containing protein 81	614218	REc		Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3); Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3)	11(Wdr81)
17.60	5	13	10	17p13.3	YWHAE, MDCR, MDS		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon isoform	605066	A, R, Ch, D			11(Ywhae)
17.61	12	18	14	17p13.3-p13.1	SHFLD3, DUP17p13.3, C17DUPp13.3		Split-hand/foot malformation with long bone deficiency 3	612576	Fd	max lod at or near D17S1533; contiguous gene duplication syndrome	Split-hand/foot malformation with long bone deficiency 3 (4)	
17.62	5	27	16	17p13.3-p12	MSPC		Palmoplantar carcinoma, multiple self-healing	616964	Fd	between rs8065368 and rs2322788	Palmoplantar carcinoma, multiple self-healing (2)	
17.63	2	25	15	17p13.2	ANKFY1, ANKHZN, KIAA1255		Ankyrin repeats- and FYVE domain-containing protein 1	607927	R, A, REc			
17.64	10	8	07	17p13.2	CAMTA2, KIAA0909		Calmodulin-binding transcription activator 2	611508	R, REc			
17.65	5	24	13	17p13.2	DERL2		DER1-like domain family, member 2	610304	REc			
17.66	1	1	12	17p13.2	DHX33		DEAH box polypeptide 33	614405	REc			
17.67	9	9	08	17p13.1	FBXO39, FBX39		F-box protein 39	609106	REc			11(Fbxo39)
17.68	10	9	08	17p13.2	GGT6		Gamma-glutamyltransferase 6	612341	REc			
17.69	1	12	11	17p13.1	HES7, SCDO4		Hairy/enhancer of split, Drosophila, homolog of, 7	608059	H, REc		Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	11(Hes7)
17.70	1	24	06	17p13.1	KCTD11, REn		Potassium channel tetramerization domain-containing protein 11	609848	REc, H			11(Kcntd11)
17.71	2	2	14	17p13.2	KIF1C, LTXS1, KIAA0706, SPAX2		Kinesin family member 1C	603060	REc		Spastic ataxia 2, autosomal recessive, 611302 (3)	
17.72	11	7	08	17p13.2	MED11		Mediator complex subunit 11	612383	REc			
17.73	2	2	16	17p13.2	MIS12		Mis12, S. pombe, homolog of	609178	R, REc			
17.74	10	28	15	17p13.2	NCBP3, C17orf85		Nuclear cap-binding protein 3	616624	REc			
17.75	8	8	17	17p13.2	PIMREG, RCS1, FAM64A		PICALM-interacting mitotic regulator	617611	REc			
17.76	9	16	17	17p13.2	PSMB6, LMPY		Proteasome subunit, beta-type, 6	600307	REc, A			
17.77	5	24	13	17p13.2	RNF167, RING105		RING finger protein 167	610431	R, REc			
17.78	1	1	12	17p13.2	SCIMP, C17orf87		SLP adaptor- and CSK-interacting membrane protein	614406	REc			
17.79	4	29	14	17p13.1	SLC16A11, MCT11		Solute carrier family 16, member 11	615765	REc			
17.80	1	31	13	17p13.2	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD		Solute carrier family 52, riboflavin transporter, member 1	607883	REc, R		Riboflavin deficiency, 615026 (3)	
17.81	8	19	13	17p13.2	SPAG7		Sperm-associated antigen 7	610056	REc			
17.82	9	15	17	17p13.2	SPATA22		Spermatogenesis-associated protein 22	617673	REc			
17.83	2	17	09	17p13.2	SPNS2		Spinster, Drosophila, homolog of, 2	612584	REc			
17.84	1	2	08	17p13.2	SPNS3		Spinster, Drosophila, homolog of, 3	611701	REc			11(Spns3)
17.85	4	20	11	17p13.2	UBE2G		Ubiquitin-conjugating enzyme E2G (UBC7, C. elegans, homolog of)	601569	R, REc	possible pseudogene on 1q42		
17.86	5	7	03	17p13.1	XAF1		XIAP-associated factor 1	606717	A			
17.87	7	7	14	17p13.2	ZMYND15, SPGF14		Zinc finger MYND-containing protein 15	614312	REc, H	mutation identified in 1 SPGF14 family	?Spermatogenic failure 14, 615842 (3)	11(Zmynd15)
17.88	7	9	15	17p13.2	ZNF232, ZSCAN11		Zinc finger protein 232	616463	Psh, REc			
17.89	11	19	11	17p13.2-p13.1	MRT33		Mental retardation, autosomal recessive 33	614341	Fd	between rs1367950 and rs1826925	Mental retardation, autosomal recessive 33 (2)	
17.90	4	3	09	17p13.2	AIPL1, LCA4		Arylhydrocarbon-interacting receptor protein-like 1	604392	Fd, REc, A, R	LCA1 due to GUCY2D mutation also on 17p13.1	Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa, juvenile, 604393 (3); Cone-rod dystrophy, 604393 (3)	
17.91	1	25	93	17p13.1	ALOX12		Arachidonate 12-lipoxygenase	152391	Psh	pseudogene also on chr.17		
17.92	1	18	13	17p13.1	ALOX12B, ARCI2		Archidonate 12-lipoxygenase, R type	603741	A, REc		Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	
17.93	5	25	13	17p13.1	ALOX15B		Arachidonate 15-lipoxygenase, second type	603697	REc			
17.94	1	18	13	17p13.1	ALOXE3, ARCI3		Arachidonate lipoxygenase 3	607206	Fd		Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	
17.95	3	9	04	17p13.1	ARGEF15, KIAA0915		Rho guanine nucleotide exchange factor 15	608504	R, REc			
17.96	11	2	04	17p13.1	BCL6B, BAZF		B-cell lymphoma 6B	608992	A			
17.97	10	23	15	17p13.1	BORCS6, C17orf59, LYSPERSIN		BLOC1-related complex, subunit 6	616599	REc			
17.98	11	23	16	17p13.1	C17orf49, BAP18		Chromosome 17 open reading frame 49	617215	REc			
17.99	6	3	14	17p13.1	CNTROB, LIP8		Centrosomal BRCA2-interacting protein	611425	REc			
17.100	5	8	12	17p13.1	CTC1, CRMCC, C17orf68, AAF132		Conserved telomere maintenance component 1	613129	REc		Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	11(Aaf132)
17.101	10	4	12	17p13.1	CTDNEP1, DULLARD		C-terminal domain nuclear envelope phosphatase 1	610684	REc			
17.102	9	9	10	17p13.1	CLEC10A, CLECSF14, MGL, HML, CD301		C-type lectin domain family 10, member A	605999	REc			
17.103	3	24	11	17p13.1	DEL17p13.1, C17DELp13.1		Chromosome 17p13.1 deletion syndrome	613776	Ch	contiguous gene deletion syndrome	Chromosome 17p13.1 deletion syndrome (4)	
17.104	12	30	14	17p13.1	DHRS7C, SDR32C2		Short-chain dehydrogenase reductase family, member 7C	616161	REc			
17.105	6	24	02	17p13.1	DLG4, PSD95, SAP90		Discs large, Drosophila, homolog of, 4	602887	R			
17.106	9	27	17	17p13.1	DVL2		Dishevelled 2	602151	REc, H			11(Dvl2)
17.107	3	7	13	17p13.1	ELP5, DERP6, C17orf81		Elongator acetyltransferase complex, subunit 5	615019	REc			
17.108	10	17	00	17p13.1	FXR2		Fragile X mental retardation, autosomal homolog-2	605339	REc			
17.109	10	1	17	17p13.1	GPS2		G protein pathway suppressor 2	601935	REc			
17.110	4	14	10	17p13.1	GABARAP		GABA-A receptor-associated protein	605125	REc			
17.111	10	09	18	17p13.1	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1		Guanylate cyclase 2D, membrane, retina-specific	600179	Psh, A, Fd	mutation identified in 1 CACD1 family	Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6, 601777 (3); ?Choroidal dystrophy, central areolar 1, 215500 (3)	
17.112	6	6	00	17p13.1	KCNAB3, KCNA3B		Potassium voltage-gated channel, shaker-related subfamily, beta member 3	604111	Psh, REn			
17.113	12	19	11	17p13.1	KDM6B, JMJD3, KIAA0346		Lysine-specific demethylase 6B	611577	REc			
17.114	9	22	16	17p13.1	KIAA0753, OFIP, OFD15		KIAA0753 gene	617112	REc	mutation identified in 1 OFD15 patient	?Orofaciodigital syndrome XV, 617127 (3)	
17.115	6	30	05	17p13.2	MINK1, MINK		Misshapen/nik-related kinase 1	609426	REc			
17.116	3	23	09	17p13.1	MIR195, MIRN195		Micro RNA 195	610718	REc			
17.117	3	7	14	17p13.1	MIR497		Micro RNA 497	615672	REc			
17.118	1	24	93	17p13.1	MYH1		Myosin, heavy polypeptide-1, skeletal muscle, adult	160730	REa, C	cluster = 6 genes in 500kb		11(Myh)
17.119	3	19	15	17p13.1	MYH2, MYPOP		Myosin, heavy polypeptide-2, skeletal muscle, adult	160740	REa, C		Proximal myopathy and ophthalmoplegia, 605637 (3)	
17.120	7	10	15	17p13.1	MYH3, DA2A, DA2B, DA8		Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	REa		Arthrogryposis, distal, type 2A, 193700 (3); Arthrogryposis, distal, type 2B, 601680 (3); Arthrogryposis, distal, type 8, 178110 (3)	
17.121	10	4	93	17p13.1	MYH4		Myosin, heavy polypeptide-4, skeletal muscle	160742	REa, REn			
17.122	2	24	15	17p13.1	MYH8, DA7		Myosin, heavy polypeptide-8, skeletal muscle, perinatal	160741	REa, REn, Fd		Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3)	
17.123	6	1	18	17p13.1	NAA38, LSMD1, MAK31		N-alpha-acetyltransferase 38, NatC auxiliary subunit	617990	REc			
17.124	7	17	14	17p13.1	NEURL4, KIAA1787		Neuralized E3 ubiquitin protein ligase 4	615865	REc			
17.125	10	2	12	17p13.1	NTN1, NTN1L		Netrin 1, mouse, homolog of	601614	A, REc			
17.126	7	3	06	17p13.1	ODF4, OPPO1		Outer dense fiber of sperm tails 4	610097	REc, H			11(Odf4)
17.127	5	3	13	17p13.1	PIK3R5, p101		Phosphatidylinositol 3-kinase, regulatory subunit 5	611317	R, REc		Ataxia-oculomotor apraxia 3, 615217 (3)	
17.128	9	27	17	17p13.1	PIK3R6, C17orf38		Phosphatidylinositol 3-kinase, regulatory subunit 6	611462	REc			
17.129	6	24	08	17p12	PIRT		Phosphoinositide-interacting regulator of transient receptor potential channels	612068	REc			
17.130	8	29	08	17p13.2-p13.1	PITPNM3, NIR1, CORD5		Phosphatidylinositol transfer protein, membrane-associated, 3	608921	R, A, Fd		Cone-rod dystrophy 5, 600977 (3)	
17.131	5	24	00	17p13.2	PLD2		Phospholipase D2	602384	A			11(Pld2)
17.132	3	10	03	17p13.1	PLSCR3		Phospholipid scramblase 3	607611	REc			
17.133	4	27	93	17p13.1	POLR2A, RPOL2		Polymerase (RNA) II (DNA directed) polypeptide A, 220kD	180660	REa, A, C			11(Rpo21)
17.134	2	25	15	17p13.1	RANGRF, MOG1		RAN guanine nucleotide release factor	607954	REc			
17.135	5	10	93	17p13.1	RCV1		Recoverin	179618	REa, A			11(Rcvrn)
17.136	8	30	16	17p13.1	RNASEK		Ribonuclease K	617098	REc			
17.137	10	13	09	17p13.1	SAT2, SSAT2		Spermidine/spermine N(1)-acetyltransferase 2	611463	REc			
17.138	7	9	09	17p13.1	SENP3		Sentrin-specific protease family, member 3	612844	REc			
17.139	3	12	07	17p13.1	SLC25A35		Solute carrier family 25, member 35	610818	REc			11(Slc25a35)
17.140	10	11	16	17p13.1	SNORD118, LCC		Small nucleolar RNA, C/D box, 118	616663	REc		Leukoencephalopathy, brain calcifications, and cysts, 614561 (3)	
17.141	8	28	17	17p13.1	SPDYE4		SPEEDY/RINGO cell cycle regulator family, member E4	617628	REc			5(Spdye4)
17.142	3	15	13	17p13.1	SPEM1, C17orf83		Spermatid maturation protein 1	615116	REc			
17.143	5	25	00	17p13.1	STK12, ARK2, AIK2, AIM1		Serine/threonine protein kinase 12	604970	A, R, H			11(Stk12)
17.144	11	2	04	17p13.1	TEKT1		Tektin 1	609002	REc			
17.145	12	15	17	17p13.1	TMEM88		Transmembrane protein 88	617813	REc			
17.146	12	15	17	17p13.1	TMEM95		Transmembrane protein 95	617814	REc			
17.147	7	13	17	17p13.1	TMEM107, MKS13, JBTS29		Transmembrane protein 107	616183	REc	mutation identified in 1 JBTS29	Meckel syndrome 13, 617562 (3); ?Joubert syndrome 29, 617562 (3); Orofaciodigital syndrome XVI, 617563 (3)	11(Tmem107)
17.148	11	11	14	17p13.1	TNFSF13, APRIL, TALL2		Tumor necrosis factor ligand superfamily, member 13	604472	REn			
17.149	9	16	03	17p13.1	TNK1		Tyrosine kinase, nonreceptor, 1	608076	Psh, A			
17.150	1	14	13	17p13.1	TP53, P53, LFS1 , BCC7		Tumor protein p53	191170	REa, A, D		Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3); Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer, 260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); {Basal cell carcinoma 7}, 614740 (3); {Glioma susceptibility 1}, 137800 (3)	11(Trp53)
17.151	4	26	11	17p13.1	TMEM102, CBAP		Transmembrane protein 102	613936	REc			
17.152	11	16	17	17p13.1	TMEM256, C17orf61		Transmembrane protein 256	617779	REc			
17.153	9	2	09	17p13.1	TRNAG2, TRG2		tRNA glycine-2	610407	A, Psh	at least 8 copies in this region		
17.154	10	24	14	17p13.1	TRNAK1, TRK1, TRK-TTT3-4		Transfer RNA lysine (TTT) 3-4	189918	REa, A			
17.155	9	2	09	17p13.1	TRNAL2, TRL2		tRNA leucine-2	189920	REa, A			
17.156	9	2	09	17p13.1	TRNAR1, TRR1		tRNA arginine-1	610406	A, Psh			
17.157	9	2	09	17p13.1	TRNAQ1, TRQ1		tRNA glutamine-1	189919	REa, A			
17.158	6	2	16	17p13.1	TXNDC17, TRP14, TXNL5		Thioredoxin domain-containing protein 17	616967	REc			
17.159	12	23	05	17p13.1	WDR16, WDRPUH		WD repeat-containing protein 16	609804	REc			
17.160	8	27	15	17p13.1	YBX2, MSY2, CSDA3, DBPC		Y box-binding protein 2	611447	Psh, REc			
17.161	9	22	08	17p13.1	ZBTB4, KIAA1538		Zinc finger and BTB domain-containing 4	612308	R, REc			
17.162	2	10	05	17p13.1	MPDU1, SL15, CDGIF		Mannose-P-dolichol utilization defect 1	604041	R		Congenital disorder of glycosylation, type If, 609180 (3)	
17.163	6	25	99	17p13.1	MYH13		Myosin, heavy polypeptide 13, skeletal muscle	603487	R, REc			11(Myh13)
17.164	3	16	99	17p13.1	EFNB3, EPLG8, LERK8, EFL6		Ephrin B3	602297	Psh			
17.165	9	12	95	17p11.2	NOS2B		Nitric oxide synthase 2B	600719	Psh			
17.166	9	12	95	17q11.2	NOS2C		Nitric oxide synthase 2C	600720	Psh			
17.167	9	26	05	17p13.1	ACADVL, VLCAD		Acyl-Coenzyme A dehydrogenase, very long chain	609575	REa, H		VLCAD deficiency, 201475 (3)	11(Acadvl)
17.168	11	27	94	17p13.2	ARRB2		Arrestin, beta 2	107941	A			
17.169	6	7	04	17p13	ASPG2		Asperger syndrome, susceptibility to, 2	608631	Ch	breakpoints between CHRNE and GP1BA	{Asperger syndrome susceptibility 2} (2)	
17.170	12	15	98	17p13.1	CD68		Macrophage antigen CD68 (macrosialin)	153634	A			11(Cd68)
17.171	5	29	98	17p13.1	CHD3		Chromodomain helicase DNA binding protein-3	602120	R			
17.172	7	22	13	17p13	CTRCT24, CTAA2		Cataract 24, anterior polar	601202	Fd		Cataract 24, anterior polar (2)	
17.173	2	28	03	17p13.2	CTNS		Cystinosin	606272	Fd, REc	?3 allelic forms	Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular nonnephropathic, 219750 (3); Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3); Cystinosis, atypical nephropathic, 219800 (3)	
17.174	11	27	00	17p13.2	CXCL16		CXC chemokine ligand-16	605398	Psh			11(Cxcl16)
17.175	2	21	06	17p13.1	DNAH2, DNAHC2		Dynein, axonemal, heavy chain-2	603333	REa, REc			11(Dnach2)
17.176	12	15	98	17p13.1	EIF4A1, DDX2A		Eukaryotic translation initiation factor 4A, isoform 1	602641	A			11(Eif4a1)
17.177	3	18	17	17p13.2	INCA1, HSD45		Inhibitor of CDK, cyclin A1-interacting protein 1	617374	REc			
17.178	8	1	14	17p13.2	ITGAE, CD103		Integrin, alpha-E	604682	RE			11(Itgae1)
17.179	1	24	93	17p13.1	MYH10		Myosin, heavy polypeptide-10, non-muscle	160776	REa, A			
17.180	12	27	01	17p13.3	MYO1C		Myosin IC	606538	Psh, R			
17.181	1	10	18	17p13.2	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK		NLR family, pyrin domain containing 1	606636	R, Fd		{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3); Palmoplantar carcinoma, multiple self-healing, 615225 (3); Autoinflammation with arthritis and dyskeratosis, 617388 (3)	
17.182	12	2	14	17p13	NDNC7		Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)	605779	Fd		Nail disorder, nonsyndromic congenital, 7 (2)	
17.183	5	20	99	17p13.2	NUP88		Nucleoporin, 88-kD	602552	A			
17.184	7	22	09	17p13.1	PHF23		PHD finger protein 23	612910	REc, A			
17.185	3	4	08	17p13.2	RABEP1, RABPT5		RAB GTPase-binding effector protein 1	603616	Ch	fused to PDGFRB in CMML		
17.186	1	11	17	17p13.2	RPAIN, RIP		RPA-interacting protein	617299	REc			
17.187	11	23	16	17p13.2	SHPK, CARKL		Sedoheptulokinase	605060	REn		[Sedoheptulokinase deficiency], 617213 (3)	
17.188	10	16	14	17p13.1	SLC2A4, GLUT4		Solute carrier family 2 (facilitated glucose transporter), member 4	138190	REa, A			
17.189	8	29	02	17p13.1	SOX15, SOX20		SRY (sex-determining region Y)-box 15	601297	A			
17.190	12	15	10	17p13	SXGQTL1		Sex hormone-binding globulin circulating level quantitative trait locus 1	613498	Fd	associated with rs1799941	[Sex hormone-binding globulin circulating level QTL 1] (2)	
17.191	7	28	15	17p13.2	TAX1BP3, TIP1		TAX1-binding protein 3	616484	REc			
17.192	5	21	07	17p13.1	TRAPPC1, MUM2, BET5		Trafficking protein particle complex, subunit 1	610969	R			
17.193	3	23	02	17p13.2	TRPV1, VR1		Transient receptor potential cation channel, subfamily V, member 1 (vanilloid receptor 1; capsaicin receptor)	602076	REc			11(Vr1)
17.194	6	3	15	17p13.2	TRPV3, OLMS, FNEPPK2		Transient receptor potential cation channel, subfamily V, member 3	607066	REc	mutation identified in 1 FNEPPK2 family	Olmsted syndrome, 614594 (3); ?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	11(Trpv3)
17.195	5	22	03	17p13.2	USP6, TRE2		Ubiquitin-specific protease 6	604334	A, REc			
17.196	7	1	11	17p13.1	WRAP53, TCAB1, WDR79, DKCB3		WD repeat-containing protein antisense to TP53	612661	REc		Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	
17.197	11	11	91	17p13.1	ASGR1		Asialoglycoprotein receptor-1	108360	H, REa			11(Asgr1)
17.198	4	30	15	17p13.2	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C		Cholinergic receptor, nicotinic, epsilon polypeptide	100725	Psh, REc		Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3); Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3); Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	
17.199	12	17	95	17p13.1	EIF5A		Eukaryotic translation initiation factor-5A	600187	A			
17.200	8	20	15	17p13.1	SCO1, SCOD1		SCO1 cytochrome c oxidase assembly protein	603644	REc, Fd		Mitochondrial complex IV deficiency, 220110 (3)	
17.201	6	21	91	17p13.1	SHBG, ABP		Sex hormone-binding globulin (androgen binding protein)	182205	A			11(Shbg)
17.202	8	11	14	17p13.1	SLC13A5, NACT, EIEE25		Solute carrier family 13 (sodium-dependent citrate transporter), member 5	608305	R, REc		Epileptic encephalopathy, early infantile, 25, 615905 (3)	
17.203	10	4	93	17p12	ZNF18, KOX11		Zinc finger protein-18 (KOX11)	194524	REa, A			
17.204	10	12	90	17p12	ZNF29		Zinc finger protein-29 (KOX26)	194535	REa, A	proximal to TP53		11(Zfp2)
17.205	1	22	01	17p12	AOMS2		Abdominal obesity-metabolic syndrome QTL2	605572	Fd	second QTL on 3q27	Abdominal obesity-metabolic syndrome (2)	
17.206	10	11	17	17p12	ARHGAP44, RICH2, KIAA0672		RHO GTPase-activating protein 44	617716	R, REc			
17.207	4	26	01	17p12	DNAH9, DNAH17L, DNEL1		Dynein, axonemal, heavy chain 9	603330	A			
17.208	12	17	07	17p11.2	FBXW10		F-box and WD40 domain protein 10	611679	REc			11(Fbxw10)
17.209	11	2	98	17p13.1	PER, RIGUI		Period, Drosophila, homolog of	602260	A			11(Per)
17.210	2	2	17	17p12	SHISA6		Shisa family, member 6	617327	REc			
17.211	6	6	00	17p13.1	STX8		Syntaxin 8	604203	REa, A			
17.212	3	31	09	17p12	TEKT3		Tektin 3	612683	REc			
17.213	6	23	15	17p12	TTC19, MC3DN2		Tetratricopeptide repeat domain 19	613814	REc		Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	
17.214	1	24	01	17p13.1	VAMP2, SYB2		Vesicle-associated membrane protein-2 (synaptobrevin-2)	185881	REa, A			11(Syb2)
17.215	3	30	12	17p12	ZSWIM7, SWS1		Zinc finger SWIM domain-containing protein 7	614535	REc			
17.216	3	26	95	17p12	ADORA2B		Adenosine A2b receptor	600446	A, Psh	incorrectly put on 10		
17.217	7	14	00	17p12	COX10		Cytochrome c oxidase, subunit X	602125	REc		Mitochondrial complex IV deficiency, 220110 (3); Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3)	
17.218	6	6	00	17p12	HS3ST3A1, 30ST3A1		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3A1	604057	REc			11(30st3a1)
17.219	6	6	00	17p12	HS3ST3B1, 30ST3B1		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3B1	604058	REc			11(30st3B)
17.220	12	20	96	17p11.2	LLGL1, DLG4		Lethal giant larvae, Drosophila, homolog of, 1	600966	REa, A			
17.221	5	4	12	17p11.2	PIGL, CHIME		Phosphatidylinositol glycan, class L	605947	R		CHIME syndrome, 280000 (3)	
17.222	6	25	99	17p11.2	PRPSAP2, PAP41		Phosphoribosylpyrophosphate synthetase-associated protein 2	603762	A			
17.223	09	06	18	17p11.2	TOP3A, MGRISCE2, PEOB5		Topoisomerase (DNA) III, alpha	601243	REa, A	mutation identified in 1 PEOB5 patient	Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3); ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5, 618098 (3)	
17.224	11	23	15	17p12-p11.2	YUHAL		Yuan-Harel-Lupski syndrome	616652	Ch	contiguous gene duplication syndrome	Yuan-Harel-Lupski syndrome (4)	
17.225	1	29	08	17p11.2	UBB		Ubiquitin B	191339	A, REc		Cleft palate, isolated, 119540 (2)	
17.226	4	30	15	17p13.1	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C		Cholinergic receptor, nicotinic, beta polypeptide-1, muscle	100710	H, REa, A	mutation identified in 1 CMS2C family	Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3); ?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	11(Acrb)
17.227	6	7	10	17p12-q11.2	DFNB85		Deafness, autosomal recessive 85	613392	Fd	between rs230884 and rs12603885	Deafness, autosomal recessive 85 (2)	
17.228	11	14	12	17p12-q21.2	ECTD6		Ectodermal dysplasia 6, hair/nail type	614928	Fd	between D17S839 and D17S1299	Ectodermal dysplasia 6, hair/nail type (2)	
17.229	3	27	95	17p11.2	ALDH3A1, ALDH3		Aldehyde dehydrogenase 3 family, member A1	100660	S, A			11(Ahd4)
17.230	8	9	05	17p11.2	ALDH3A2, ALDH10, SLS, FALDH		Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)	609523	Fd, LD		Sjogren-Larsson syndrome, 270200 (3)	
17.231	3	16	10	17p11.2	ALKBH5, ABH5		AlkB, E. coli, homolog of, 5	613303	REc			
17.232	8	16	17	17p11.2	ATPAF2, ATP12, MC5DN1		ATP synthase, mitochondrial F1 complex, assembly factor 2	608918	REc	mutation identified in 1 MC5DN1 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	11(Atpaf2)
17.233	9	24	16	17p11.2	B9D1, MKSR1, MKS9, JBTS27		B9 domain-containing protein 1	614144	REc	mutation identified in 1 MKS9 patient	?Meckel syndrome 9, 614209 (3); Joubert syndrome 27, 617120 (3)	
17.234	4	23	10	17p11.2	CENPV, P30		Centromere protein V	608139	R, REc			
17.235	1	8	01	17p11.2	COPS3, SGN3		COP9 signalosome, subunit 3	604665	REa, REc			
17.236	12	30	14	17p11.2	DHRS7B, SDR32C1		Short-chain dehydrogenase reductase family, member 7B	616160	REc			
17.237	3	6	01	17p11.2	DRG2		Developmentally regulated GTP-binding protein 2	602986	A, REa			
17.238	3	7	05	17p11.2	FLCN, BHD		Folliculin	607273	Fd, REc		Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)	
17.239	10	11	17	17p11.2	GID4, VID2, C17orf39		GID complex, subunit 4	617699	REc			
17.240	5	13	97	17p11.2	FLII		Flightless-I, Drosophila, homolog of	600362	A, REa			
17.241	2	2	04	17q11.2	GIT1		G protein-coupled receptor kinase-interacting protein 1	608434	REc, R			
17.242	11	21	02	17p11.2	IS2, AIS2		Scoliosis, idiopathic 2	607354	Fd	between D17S947 and D17S798	Scoliosis, idiopathic 2 (2)	
17.243	2	21	10	17p11.2	KCNJ18, KIR2.6, TTPP2		Potassium channel, inwardly rectifying, subfamily J, member 18	613236	REc		{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	
17.244	6	25	99	17p11.2	MAPK7, PRKM7, ERK5		Mitogen-activated protein kinase 7 (extracellular signal-regulated kinase 5)	602521	Psh			
17.245	3	22	06	17p11.2	MED9, MED25, FLJ10193		Mediator of RNA polymerase II transcription, subunit 9, S. cerevisiae, homolog of	609878	R, REc			
17.246	12	10	13	17p11.2	MEIF2, SMCR7, MID49		Mitochondrial elongation factor 2	615498	REc			
17.247	4	9	96	17p11.2	MFAP4		Microfibrillar-associated protein-4	600596	D			
17.248	10	12	10	17p11.2	MIR33B, MIRN33B		Micro RNA 33B	613486	REc			
17.249	8	17	09	17p11.2	MPRIP, MRIP, KIAA0864, RIP3, P116RIP		Myosin phosphatase Rho-interacting protein	612935	R, REc			
17.250	6	26	16	17p11.2	MTRNR2L1, HN1		MTRNR2-like 1	616985	REc			
17.251	3	16	04	17p12	MYOCD		Myocardin	606127	REc			
17.252	5	28	98	17p11.2	MYO15A, DFNB3		Myosin XVA	602666	Fd, REc		Deafness, autosomal recessive 3, 600316 (3)	11(sh2, Myo15)
17.253	6	21	01	17p11.2	NT5M, DNT2		Deoxyribonucleotidase, mitochondrial (5' nucleotidase, mitochondrial)	605292	REc, REn			
17.254	9	13	12	17p11.2	PEMT, PEMPT		Phosphatidylethanolamine N-methyltransferase	602391	REc			
17.255	1	31	17	17p12	PMP22, CMT1A, CMT1E, DSS, CIDP		Peripheral myelin protein-22	601097	Fd, D, A	mutation identified in 1 CIDP family	Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3); Roussy-Levy syndrome, 180800 (3); ?Neuropathy, inflammatory demyelinating, 139393 (3)	11(Tr)
17.256	12	17	12	17p11.2	PLD6, ZUC		Phospholipase D family, member 6	614960	REc			
17.257	8	1	14	17p11.2	PRG4, FLJ36000		p53-responsive gene 4	605160	REc			
17.258	4	17	07	17p11.2	PTLS		Potocki-Lupski syndrome	610883	Ch, REc	contiguous gene syndrome	Potocki-Lupski syndrome (4)	
17.259	3	25	03	17p11.2	RAI1, SMCR, SMS		Retinoic acid-induced gene 1	607642	REc, Ch		Smith-Magenis syndrome, 182290 (3)	
17.260	2	9	04	17p11.2	RASD1, DEXRAS1		Ras protein, dexamethasone-induced, 1	605550	REc, R			
17.261	9	8	17	17p11.2	RNF112, ZNF179, BFP		RING finger protein 112	601237	A			11(Bfp)
17.262	9	22	93	17p11.2	RNU3		RNA, U3 small nuclear	180710	D	deleted in Smith-Magenis syndrome		
17.263	7	8	96	17p12	SERK1, PRKMK4, MAPKK4, JNKK1		SAPK/ERK kinase-1	601335	Psh, A			11(Serk1)
17.264	7	13	93	17p11.2	SHMT1		Serine hydroxymethyltransferase (soluble)	182144	A, D	?role in Smith-Magenis syndrome		
17.265	7	9	09	17p11.2	SLC47A1, MATE1, FLJ10847		Solute carrier family 47, member 1	609832	REc			11(Mate1)
17.266	7	9	09	17p11.2	SLC47A2, MATE2, FLJ31196, MATE2K		Solute carrier family 47, member 2	609833	REc			11(Mate2)
17.267	8	17	16	17p11.2	SMCR8		Smith-Magenis syndrome chromosome region, candidate gene 8	617074	REc			
17.268	9	8	11	17p11.2	SPECC1, HCMOGT1, NSP		Sperm antigen with calponin homology and coiled-coil domains 1	608793	A			
17.269	1	10	96	17p11.2	SREBF1		Sterol regulatory element binding transcription factor 1	184756	REa, A			
17.270	12	15	10	17p11.2	TNFRSF13B, TACI, CVID2		Tumor necrosis factor receptor superfamily, member 13B	604907	REc		Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common variable, 2, 240500 (3)	
17.271	11	19	13	17p11.2	TOM1L2		TOM1-like 2	615519	REc			
17.272	2	25	15	17p12	TRIM16, EBBP		Tripartite motif-containing protein 16	609505	REa, A			
17.273	3	14	13	17p11.2	ULK2, KIAA0623, UNC51.2		UNC51-like kinase 2	608650	REc, R			11(Ulk2)
17.274	6	30	08	17p11.2	USP22, KIAA1064		Ubiquitin-specific protease 22	612116	R, REc			
17.275	3	10	00	17p11.2-p11.2	VWSM		Van der Woude syndrome modifier	604547	Fd			
17.276	5	3	04	17p11.2	KCNJ12, KCNJN1		Potassium inwardly-rectifying channel, subfamily J, member 12	602323	A			
17.277	4	2	09	17p11.2	AKAP10		A-kinase anchor protein 10	604694	R		{Cardiac conduction defect, susceptibility to}, 115080 (3)	
17.278	1	1	12	17q11.2	IFT20		Intraflagellar transport 20, chlamydomonas, homolog of	614394	REc			
17.279	11	4	98	17q11.2	CPD		Carboxypeptidase D	603102	Psh			11(Cpd)
17.280	10	8	99	17q11.2	SLC13A2, NADC1		Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2	604148	REa, A, R			
17.281	9	30	04	17p11	ADHD2		Attention deficit-hyperactivity disorder, susceptibility to, 2	608904	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
17.282	10	15	13	17p12	ELAC2, HPC2, COXPD17		elaC, E. coli, homolog 2	605367	Fd, R	at ~365cR	{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3); Combined oxidative phosphorylation deficiency 17, 615440 (3)	
17.283	1	2	91	17p13.1	ASGR2		Asialoglycoprotein receptor-2	108361	H			11(Asgr2)
17.284	4	12	92	17p13.1	ATP1B2, AMOG		ATPase, Na+K+ transporting, beta-2 polypeptide	182331	H, REa			11(Atp1b2)
17.285	1	26	97	17p	CACD1		Choroidal dystrophy, central areolar 1	215500	Fd		Choroidal dystrophy, central areolar 1 (2)	
17.286	10	14	98	17p13.1	GAS7		Growth arrest-specific 7	603127	REc, H			11(gas7)
17.287	11	4	13	17p13.1	RPL26, DBA11		Ribosomal protein L26	603704	Psh, R	mutation identified in 1 family	?Diamond-Blackfan anemia 11, 614900 (3)	
17.288	2	20	03	17q11.2	NOS2A, NOS2		Nitric oxide synthase 2A, inducible, hepatocytes	163730	REa, A, Psh, H	?cluster of 3 NOS2 genes	{Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance to}, 611162 (3)	11(Nos2)
17.289	9	15	89	17q11.2	ALDOC		Aldolase C, fructose-bisphosphatase	103870	REb, REa, A			
17.290	8	4	99	17q	HYT1		Hypertension, essential, susceptibility to, 1	603918	Fd	~18cM distal to ACE	{Hypertension, essential, susceptibility to, 1}, 145500 (2)	
17.291	10	20	99	17q25.1	RPL38		Ribosomal protein L38	604182	REa, R			
17.292	5	16	07	17q11	AUTS6		Autism, susceptibility to, 6	609378	Fd	max lod at D17S1800	{Autism susceptibility 6} (2)	
17.293	1	11	02	17q11	ERVE1, HERVE1		Endogenous retroviral sequence E, 1	606601	REc			
17.294	8	20	99	17q11.2	GOSR1, GOS28, GS28		Golgi snap receptor complex member 1	604026	R, A			
17.295	3	3	03	17q11.2	PPY2		Pancreatic polypeptide 2	606638	REa			
17.296	3	3	03	17q11.2	PYY2		Peptide YY, 2	606637	Psh, REa			
17.297	8	24	16	17q12	RAD51D, RAD51L3, BROVCA4		RAD51, S. cerevisiae, homolog of, D	602954	R, H		{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	11(Rad51d)
17.298	9	1	11	17q11.2	RNF135, MMFD		Ring finger protein 135	611358	REc		Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	
17.299	8	20	99	17q12	RPL23		Ribosomal protein L23	603662	REa, R			
17.300	3	26	95	17q12	RPL19		Ribosomal protein L19	180466	REa, A			
17.301	2	18	98	17q11.2	RPL23A		Ribosomal protein L23a	602326	A			
17.302	4	30	03	17q11.2	SARM, KIAA0524		Sterile alpha and heat/armadillo motifs-containing protein	607732	R, REc			
17.303	3	25	15	17q12	UNC45B, SMUNC45, CTRCT43		UNC45, C. elegans, homolog of, B	611220	REc, Fd	mutation identified in 1 CTRCT43 family	?Cataract 43, 616279 (3)	
17.304	8	7	92	17q11.2	VTN, VNT		Vitronectin (serum spreading factor, somatomedin B, complement S-protein)	193190	A			
17.305	8	24	98	17q11.2	FLOT2, M17S1, ECS1, ESA1		Flotillin 2 (epidermal surface antigen 1)	131560	Fd, REa, A, REn	~180kb centromeric to NF1		11(Esa1)
17.306	2	11	08	17q11.2	FOXN1, WHN		Forkhead box N1 (winged helix nude)	600838	R		T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	
17.307	12	27	01	17q11.2	MYO1D, KIAA0727		Myosin ID	606539	R, H			11(Myo1d)
17.308	6	28	02	17q12	STARD3, MLN64		Start domain-containing protein 3	607048	REa, A			
17.309	4	2	01	17q21.2	DANJC7, TTC2, TPR2		DnaJ, E. coli, homolog of, subfamily C, member 7 (tetratricopeptide repeat domain 2)	601964	REa			
17.310	5	8	96	17q23.3	CYB561		Cytochrome b-561	600019	REa			
17.311	8	1	08	17q25.1	ITGB4		Integrin, beta-4	147557	REa		Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa of hands and feet, 131800 (3)	
17.312	2	15	18	17q11.2	NEK8, JCK, NPHP9, RHPD2		Never in mitosis gene A-related kinase 8	609799	REc	mutations identified in 1 family with NPHP9	?Nephronophthisis 9, 613824 (3); Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	
17.313	4	18	07	17q11.2	RAB34, RAH		Ras-associated protein 34	610917	REc			
17.314	5	5	09	17q11.2	SLC46A1, HCP1, PCFT		Solute carrier family 46 (folate transporter), member 1	611672	REc		Folate malabsorption, hereditary, 229050 (3)	11(Slc46a1)
17.315	3	24	14	17q11.1	WSB1, SWIP1		WD repeat- and SOCS box-containing protein 1	610091	R, REc			
17.316	12	5	01	17q12	TAF15, TAF2N, RBP56		TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD	601574	REa, A, Psh	fusion gene with CSMF	Chondrosarcoma, extraskeletal myxoid, 612237 (1)	
17.317	5	23	13	17q11.2	CRYBA1, CRYB1, CTRCT10		Crystallin, beta A1	123610	REa, A, Fd	centromeric to NF1	Cataract 10, multiple types, 600881 (3)	11(Cryba1)
17.318	1	26	12	17q11.2	SLC6A4, HTT, OCD1		Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	182138	REa, A, Fd		{Anxiety-related personality traits}, 607834 (3); {Obsessive-compulsive disorder}, 164230 (3)	11(Htt)
17.319	7	17	14	17q11.2	ADAP2, CENTA2		ArfGAP with dual PH domains 2	608635	REc			
17.320	4	6	13	17q11.2	ANKRD13B		Ankyrin repeat domain-containing protein 13B	615124	REc			
17.321	1	12	12	17q11.2	ATAD5, C17orf41, FRAG1, FLJ12735		ATPase family, AAA domain containing 5	609534	A			11(Atad5)
17.322	7	26	16	17q11.2	BLMH, BMH		Bleomycin hydrolase	602403	REc			
17.323	2	5	07	17q11.2	CCL3L1, SCYA3L1, LD78		Chemokine, C-C motif, ligand 3-like 1	601395	REn	varies in copy number 1-10	{HIV/AIDS, susceptibility to}, 609423 (3)	
17.324	8	29	02	17q12	CCL8, SCYA8		Chemokine, C-C motif, ligand 8	602283	REc			
17.325	8	29	02	17q12	CCL13, SCYA13, NCC1		Chemokine, C-C motif, ligand 13	601391	REn			
17.326	8	29	02	17q12	CCL14, SCYA14, NCC2		Chemokine, C-C motif, ligand 14	601392	REn			
17.327	5	27	97	17q12	CCL15, SCYA15, NCC3, LKN1		Chemokine, C-C motif, ligand 15	601393	REn			
17.328	8	29	02	17q12	CCL16, SCYA16, NCC4		Chemokine, C-C motif, ligand 16	601394	REn			
17.329	8	29	02	17q12	CCL18, SCYA18, PARC, AMAC1, DCCK1		Chemokine, C-C motif, ligand 18	603757	REc	in 47kb, CCL18-CCL3-CCL4		
17.330	7	7	16	17q11.2	CDK5R1, p35		Cyclin-dependent kinase 5, regulatory subunit 1	603460	REc			11(Cdk5r)
17.331	10	11	12	17q11.2	CRLF3, CYTOR4, CRLM9, CREME9		Cytokine receptor-like factor 3	614853	REc			
17.332	1	21	11	17q11.2	DEL17q11.2, C17DELq11.2		Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)	613675	Ch		Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	
17.333	12	30	14	17q11.2	DHRS13, SDR7C5		Short-chain dehydrogenase reductase family, member 13	616157	REc			
17.334	7	11	17	17q11.2	ERAL1, ERAL1A, ERAL1B, PRLTS6		ERA G-protein-like 1	607435	Psh, H		Perrault syndrome 6, 617565 (3)	11(Eral1)
17.335	3	6	92	17q11.2	EVI2A, EVI2, EVDA		Ecotropic viral integration site 2A	158380	Fd, REa, RE	within the NF1 gene		11(Evi2)
17.336	3	4	92	17q11.2	EVI2B, EVDB		Ecotropic viral integration site 2B	158381	REn	within the NF1 gene		
17.337	6	22	14	17q11.2	JJAZ1, KIAA0160		JJAZ1 gene	606245	Ch, REn			
17.338	5	1	03	17q21.2	KRT24, FLJ20261		Keratin 24	607742	REc			
17.339	1	31	07	17q11.2	KSR, KSR1		Kinase suppressor of RAS	601132	REc			
17.340	4	18	05	17q11.2	LGALS9		Lectin, galactoside-binding, soluble, 9	601879	REc			
17.341	9	24	15	17q11.2	LRRC37B		Leucine-rich repeat-containing protein 37B	616558	A, REc			
17.342	5	12	09	17q12	LYZL6		Lysozyme-like 6	612751	REc			
17.343	3	23	09	17q11.2	MIR144, MIRN144		Micro RNA 144	612070	REc			
17.344	7	20	12	17q11.2	MIR193A		Micro RNA 193A	614733	REc			11(Mir193a)
17.345	3	23	09	17q11.2	MIR451, MIRN451		Micro RNA 451	612071	REc			
17.346	8	8	13	17q12	MMP28		Matrix metalloproteinase 28	608417	REc, Psh			
17.347	3	11	09	17q11.2	MPVQTL3		Mean platelet volume quantitative trait locus 3	612575	Fd	associated with rs2138852	[Mean platelet volume QTL3] (2)	
17.348	3	16	10	17q11.2	MYO18A, SPR210		Myosin XVIIIA	610067	REc			
17.349	8	20	14	17q11.2	NF1, VRNF, WSS, NFNS		Neurofibromin (neurofibromatosis, type I)	613113	Fd, EM, Ch, F		Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile myelomonocytic, 607785 (3); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan syndrome, 601321 (3); Watson syndrome, 193520 (3)	
17.350	5	18	99	17q21.1	NR1D1, THRAL, EAR1		Nuclear receptor 1, subfamily D, member 1 (thyroid hormone receptor, alpha-1-like)	602408	REn			
17.351	1	12	15	17q11.2	NSRP1, NSRP70, CCDC55		Nuclear speckle splicing regulatory protein 1	616173	REc			11(Nsrp1)
17.352	6	2	08	17q11.2	NUFIP2, KIAA1321, PIG1		Nuclear fragile X mental retardation protein-interacting protein 2	609356	R, REc			
17.353	8	13	91	17q11.2	OMG, OMGP		Oligodendrocyte-myelin glycoprotein	164345	REa, A	within the NF1 gene		
17.354	10	11	18	17q11.2	PIGS, GPIBD18		Phosphatidylinositol glycan, class S	610271	REc, R		Glycosylphosphatidylinositol biosynthesis defect 18, 618143 (3)	
17.355	9	9	08	17q11.2	POLDIP2, PDIP38		Polymerase delta-interacting protein 2	611519	R, REc			
17.356	6	23	99	17p11.2	PRKMK3, MAPKK3, MEK3		Protein kinase, mitogen-activated, kinase-3	602315	R			
17.357	3	18	17	17q11.2	PROCA1		Proline-rich cyclin A1-interacting protein	617376	REc			
17.358	9	25	12	17q11.2	PSMD11, S9		Proteasome 26S subunit, non-ATPase, 11	604449	REc			
17.359	4	23	08	17q11.2	RAB11FIP4, KIAA1821		RAB11 family-interacting protein 4	611999	REc			
17.360	7	22	09	17q12	RDM1		RAD52 motif-containing protein 1	612896	REc			
17.361	4	15	11	17q11.2	RHOT1, MIRO1, ARHT1		Ras homolog gene family, member T1	613888	REc			
17.362	8	6	98	17q11.2	SDF2		Stromal cell-derived factor-2	602934	A			
17.363	5	22	07	17q11.2	SEBOX, OG9		Skin-, embryo-, brain-, and oocyte-specific homeobox	610975	REc, H			11(Sebox)
17.364	12	1	15	17q11.2	SEZ6, BSRPC		Seizure-related 6, mouse, homolog of	616666	REc			
17.365	12	27	13	17q11.2	SPAG5, MAP126, ASTRIN		Sperm-associated antigen 5	615562	REc			
17.366	4	3	12	17q11.2	SSH2, KIAA1725		Slingshot, Drosophila, homolog of, 2	606779	R, REc			
17.367	8	27	15	17q21.2	STAT5B		Signal transducer and activator of transcription 5B	604260	A, Ch	fused with RARA in PML	Leukemia, acute promyelocytic, somatic, 102578 (3); Growth hormone insensitivity with immunodeficiency, 245590 (3)	
17.368	7	8	96	17q11.2	SUPT6H		Suppressor of Ty, S.cerevisiae, 6 homolog of	601333	Psh, A			11(Supt6h)
17.369	12	7	09	17q11.2	TAOK1, PSK2, TAO1, MARKK		TAO kinase 1	610266	REc			
17.370	6	19	15	17q11.2	TEFM, C17orf42		Transcription elongation factor, mitochondrial	616422	REc			
17.371	1	27	12	17q21.1	THRA, ERBA1, THRA1, CHNG6		Thyroid hormone receptor, alpha (oncogene ERBA1)	190120	REa, Ch		Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	11(Erba)
17.372	4	19	06	17q11.2	TIAF1, MYO18A, MYSPDZ, MAJN, SPR210, KIAA0216		TGFB1-induced antiapoptotic factor 1	609517	R, Psh, REc			
17.373	7	22	09	17q11.2	TMEM97, MAC30		Transmembrane protein 97	612912	Psh, REa, Ch			
17.374	10	1	17	17q11.2	TRAF4, MLN62, CART1		TNF receptor-associated factor 4	602464	REc			
17.375	3	10	16	17q11.2	TMEM98, NNO4		Transmembrane protein 98	615949	REc		Nanophthalmos 4, 615972 (3)	
17.376	2	29	16	17q11.2	TMEM199, VMA12, VPH2, C17orf32, CDG2P		Transmembrane protein 199	616815	REc		Congenital disorder of glycosylation, type IIp, 616829 (3)	
17.377	11	19	13	17q11.2	UNC119, HRG4, IMD13		Unc119, C. elegans, homolog of (human retinal gene 4)	604011	REa, A	mutation identified in 1 IMD13 family and CORD family	?Cone-rod dystrophy (3); ?Immunodeficiency 13, 615518 (3)	
17.378	6	18	99	17q11.2	ZNF207		Zinc finger protein-207	603428	A, REc	mapped by FISH to 6p21.3		
17.379	2	16	04	17q12	AATF, CHE1		Apoptosis-antagonizing transcription factor	608463	A			11(Aatf)
17.380	7	13	98	17q11-q12	ACCN1, BNC1, MDEG		Amiloride-sensitive cation channel 1, neuronal (degenerin)	601784	A			
17.381	9	18	00	17q12	AP2B1, CLAPB1, ADTB2		Adaptor-related protein complex 2, beta 1 subunit	601025	REa			
17.382	10	11	06	17q12	CCL2, SCYA2, MCP1, MCAF		Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)	158105	REa, A		{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
17.383	10	7	02	17q12	CCL5, SCYA5, D17S136E, TCP228		Chemokine, C-C motif, ligand 5	187011	REa, A		{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid progression of} (3)	
17.384	8	29	02	17q12	CCL7, SCYA7, MCP3		Chemokine, C-C motif, ligand 5	158106	A	close to ERBB2		
17.385	7	8	89	17q21.1	CSF3, GCSF		Colony-stimulating factor-3 (granulocyte)	138970	A, REa, REb, RE			11(Csfq)
17.386	10	15	97	17q12	LIG3		Ligase III, DNA, ATP-dependent	600940	Psh, A			
17.387	10	15	94	17q11.2-q24	MHS2		Malignant hyperthermia susceptibility 2	154275	Fd	?due to mutation in SCN4A	{Malignant hyperthermia susceptibility 2} (2)	
17.388	11	30	06	17q12	ARHGAP23, KIAA1501		RHO GTPase-activating protein 23	610590	R, REc			11(Arhgap23)
17.389	7	18	06	17q12	CCL3, SCYA3, MIP1A		Chemokine, C-C motif, ligand 3	182283	REa, REn	in 47kb, CCL18-CCL3-CCL4	{HIV infection, resistance to}, 609423 (2)	11(Mip1a)
17.390	2	2	04	17q12	CCL4, SCYA4, ACT2, MIP1B, AT744.1		Chemokine, C-C motif, ligand 4	182284	REa, A, REn			(Mip1b)
17.391	3	8	07	17q12	CCL4L, SCYA4L, LAG1		Chemokine, C-C motif, ligand 4-like	603782	Psh, REn			
17.392	3	8	07	17q12	CCL4L2		Chemokine, CC motif, ligand 4-like 2	610757	REc			
17.393	4	29	14	17q12	CCL23, SCYA23		Chemokine, C-C motif, ligand 23	602494	REn, REc			
17.394	1	30	07	17q12	CCT6B, CCTZ2		Chaperonin containing T-complex polypeptide 1, subunit 6B	610730	R, REc			
17.395	4	8	08	17q12	CISD3, MINER2		CDGSH iron sulfur domain protein 3	611933	R, REc			
17.396	3	30	12	17q12	DEL17q12, C17DELq12		Chromosome 17q12 deletion syndrome	614527	Ch		Chromosome 17q12 deletion syndrome (4)	
17.397	12	30	14	17q12	DHRS11, SDR24C1		Short-chain dehydrogenase reductase family, member 11	616159	REc			
17.398	3	30	12	17q12	DUP17q12, C17DUPq12		Chromosome 17q12 duplication syndrome	614526	Ch		Chromosome 17q12 duplication syndrome (4)	
17.399	12	6	17	17q12	EPOP, C17orf96		Elongin BC- and polycomb repressive complex 2-associated protein	617795	REc			
17.400	8	1	05	17q12	FBXO47		F-box only protein 47	609498	REc			
17.401	4	2	16	17q12	GAS2L2, GAR17		Growth arrest-specific 2-like 2	611398	REc			
17.402	1	31	13	17q12	GPR179, GPR158L, GPR158L1, CSNB1E		G protein-coupled receptor 179	614515	REc		Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	11(Gpr179)
17.403	4	23	08	17q12	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11		HNF1 homeobox B (transcription factor 2)	189907	REa		Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)	11(Hnf2)
17.404	1	21	09	17q12	HPC11		Prostate cancer, hereditary, 11	611955	Fd	associated with rs4430796 and rs7501939	{Prostate cancer, hereditary, 11} (2)	
17.405	2	25	98	17q21.2	KRT12		Keratin 12	601687	R, Fd, A		Meesmann corneal dystrophy, 122100 (3)	
17.406	12	2	10	17q12	LHX1, LIM1		LIM/homeodomain protein LHX1	601999	REc, A	previously mapped to 11p13-p12 by FISH		11(Lhx1)
17.407	6	27	17	17q12	LINC00672		Long intergenic noncoding RNA 672	617544	REc			
17.408	2	1	11	17q12	MED1, PPARBP, PBP, TRAP220		Mediator complex subunit 1 (peroxisome proliferator-activated receptor-binding protein)	604311	A			
17.409	12	15	17	17q12	MIEN1, C17orf37, RDX12		Migration and invasion enhancer 1	611802	REc			
17.410	09	06	18	17q12	MRM1		Mitochondrial ribosomal RNA methyltransferase 1	618099	REc			
17.411	3	18	17	17q12	MYO19, MYOHD1		Myosin XIX	617379	REc			
17.412	4	7	97	17q12	NEUROD2		Neurogenic differentiation 2	601725	A			11(Neurod2)
17.413	9	12	11	17q12	PBC5		Biliary cirrhosis, primary, 5	614221	Fd	associated with rs9303277	Biliary cirrhosis, primary, 5 (2)	
17.414	4	10	14	17q12	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4		Post-GPI attachment to proteins 3	611801	REc		Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	
17.415	10	25	12	17q12	PEX12, PBD3A		Peroxisome biogenesis factor 12	601758	H, REc		Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3); Peroxisome biogenesis disorder 3B, 266510 (3)	11(Pex12)
17.416	3	19	18	17q12	PIGW, HPMRS5		Phosphatidylinositol glycan, class W	610275	REc		Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3)	
17.417	2	25	15	17q12	PIP4K2B, PIP5P4KB, PIP5K2B		Phosphatidylinositol 5-phosphate 4-kinase, type II, beta	603261	R, REc			
17.418	10	24	14	17q12	PNMT, PENT		Phenylethanolamine N-methyltransferase	171190	REa, Fd, REc			
17.419	2	24	98	17q12	PSMB3		Proteasome subunit, beta type, 3	602176	A, REc	previously assigned to 2q35		
17.420	8	18	08	17q12	RASL10B, RRP17		Ras-like, family 10, member B	612128	REc			
17.421	11	28	05	17q12	RFFL		Ring finger and FYVE-like domain containing 1 (rififylin)	609735	R, REc			11(Rffl)
17.422	10	13	04	17q12	RNF110, ZNF144, MEL18		Ring finger protein 110 (zinc finger protein-144)	600346	A, H, REc	previously assigned to 12q22		10(Mel18)
17.423	12	17	12	17q12	SLFN5		Schlafen family, member 5	614952	REc			
17.424	11	30	12	17q12	SLFN11		Schlafen family, member 11	614953	REc			
17.425	12	17	12	17q12	SLFN12		Schlafen family, member 12	614955	REc			
17.426	12	17	12	17q12	SLFN12L		Schlafen family, member 12-like	614956	REc			
17.427	12	17	12	17q12	SLFN13		Schlafen family, member 13	614957	REc			
17.428	4	21	16	17q12	SLFN14, BDPLT20		Schlafen family, member 14	614958	REc		Bleeding disorder, platelet-type, 20, 616913 (3)	
17.429	2	24	17	17q12	SRCIN1, SNIP, KIAA1684		Src kinase signaling inhibitor 1	610786	REc			
17.430	5	12	09	17q11.2	SPACA3, LYZL3, SLLP1, LYC3, ALLP17		Sperm acrosome-associated 3	612749	REc			
17.431	5	12	03	17q12	TBC1D3, PRC17, TBC1D3A		TBC1D3 gene	607741	REc			
17.432	10	27	08	17q12	TBC1D3B, PRC17		TBC1 domain family, member 3B	610144	REc			
17.433	3	12	07	17q12	TBC1D3C		TBC1 domain family, member 3C	610806	REc			
17.434	09	27	18	17q12	TCAP, LGMDR7, CMH25		Telethonin	604488	Fd, REc		Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3); Cardiomyopathy, hypertrophic, 25, 607487 (3)	
17.435	1	12	17	17q12	TMEM132E		Transmembrane protein 132E	616178	REc			
17.436	6	12	17	17q12	ZNHIT3, TRIP3, PEHO		Zinc finger HIT domain-containing protein 3	604500	REc		PEHO syndrome, 260565 (3)	
17.437	10	5	10	17q21.31	ARL4D, ARF4L		ADP-ribosylation factor-like 4D	600732	REc, Psh			
17.438	2	21	14	17q21.2	COASY, NBIA6		Coenzyme A synthase	609855	REc		Neurodegeneration with brain iron accumulation 6, 615643 (3)	
17.439	3	4	94	17q21.2	IGFBP4		Insulin-like growth factor-binding protein-4	146733	A			
17.440	9	27	13	17q21.2	KRT9, EPPK		Keratin 9	607606	Fd, REa		Palmoplantar keratoderma, epidermolytic, 144200 (3)	
17.441	10	7	13	17q21.2	KRT14		Keratin 14	148066	REa		Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3); Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3); Dermatopathia pigmentosa reticularis, 125595 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	
17.442	4	10	14	17q21.2	KRT16, FNEPPK, PC1		Keratin 16	148067	REa, Fd	probably 17q21-q22	Pachyonychia congenita 1, 167200 (3); Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	
17.443	4	10	14	17q21.2	KRT17, PC2, PCHC1		Keratin 17	148069	REn, Fd	~5' to KRT16; probably 17q21-q22	Pachyonychia congenita 2, 167210 (3); Steatocystoma multiplex, 184500 (3)	
17.444	3	22	07	17q21.2	KRT20, CD20, KRT21		Keratin 20	608218	REn			
17.445	9	12	08	17q21.2	KRTAP1-1, KAP1.1, KAP1.7, KAP1.6		Keratin-associated protein 1-1	608819	REc			
17.446	9	12	08	17q21.2	KRTAP1-3, KAP1.3, KAP1.2, KAP1.9		Keratin-associated protein 1-3	608820	REc			
17.447	9	12	08	17q21.2	KRTAP1-4, KAP1.4		Keratin-associated protein 1-4	608821	REc			
17.448	9	12	08	17q21.2	KRTAP-15, KAP1.5		Keratin-associated protein 1-5	608822	REc			
17.449	2	18	08	17q21.2	TNS4, CTEN		Tensin 4	608385	REc			
17.450	3	12	07	17q12	TBC1D3D		TBC1 domain family, member 3D	610807	REc			
17.451	3	12	07	17q12	TBC1D3E		TBC1 domain family, member 3E	610808	REc			
17.452	3	12	07	17q12	TBC1D3F		TBC1 domain family, member 3F	610809	REc			
17.453	3	12	07	17q12	TBC1D3G		TBC1 domain family, member 3G	610810	REc			
17.454	3	12	07	17q12	TBC1D3H		TBC1 domain family, member 3H	610811	REc			
17.455	3	7	08	17q21.2	KRT31, KRTHA1, HA1		Keratin 31	601077	REc			
17.456	3	8	08	17q21.2	KRT32, KRTHA2, HA2		Keratin 32	602760	A			
17.457	3	8	08	17q21.2	KRT33A, KRTHA3A, HA3I		Keratin 33A	602761	REc			
17.458	3	8	08	17q21.2	KRT33B, KRTHA3A, HA3II		Keratin 33B	602762	REc			
17.459	3	7	08	17q21.2	KRT34, KRTHA4, HA4		Keratin 34	602763	REc			
17.460	3	7	08	17q21.2	KRT35, KRTHA5		Keratin 35	602764	REn			
17.461	3	7	08	17q21.2	KRT36, KRTHA6, HA6		Keratin 36	604540	REc			
17.462	3	7	08	17q21.2	KRT37, KRTHA7, HA7		Keratin 37	604541	REc			
17.463	3	7	08	17q21.2	KRT38,  KRTHA8, HA8		Keratin 38	604542	REc			
17.464	5	27	97	17q21.31	MPP2, DLG2		Membrane protein, palmitoylated-2 (MAGUK p55 subfamily member 2)	600723	RE			
17.465	5	27	97	17q21.31	MPP3, DLG3		Membrane protein, palmitoylated-3 (MAGUK p55 subfamily member 3)	601114	REc, A			
17.466	3	3	94	17q21.31	PPY		Pancreatic polypeptide	167780	REa, Fd, H, REn	in rat, close to GH		?11(Ppy)
17.467	1	31	01	17q21.31	PSME3, PA28G		Proteasome activator subunit 3	605129	REc, A			14(Psme3)
17.468	4	29	14	17q21.31	SOST, VBCH, CDD, SOST1		Sclerostin	605740	Fd, REc		Sclerosteosis 1, 269500 (3); Van Buchem disease, 239100 (3); Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	
17.469	4	26	10	17q12	TADA2L, TADA2A, ADA2A		Transcriptional adaptor 2A	602276	A			
17.470	9	2	96	17q12-q21	WT4		Wilms tumor-4	601363	Fd		Wilms tumor, type 4 (2)	
17.471	7	27	07	17q21.1	ZPBP2, ZPBPL		Zona pellucida-binding protein 2	608499	REc			
17.472	9	24	08	17q12	GGNBP2, DIF3, LCRG1, LZK1		Gametogenetin-binding protein 2	612275	REc			
17.473	2	14	01	17q21.2	RAMP2		Receptor activity-modifying protein 2	605154	R			11(Ramp2)
17.474	9	9	08	17q21.2	CCR7, CMKBR7, EBI1		Chemokine (C-C) receptor 7 (Epstein-Barr virus induced gene 1)	600242	REa, A			
17.475	2	16	04	17q21.1	MLN51, CASC3		MLN51 gene	606504	A			
17.476	09	27	18	17q21.33	SGCA, ADL, DAG2, LGMDR3		Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)	600119	Psh, A		Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3)	
17.477	10	15	95	17q21.31	CRHR1, CRHR		Corticotropin releasing hormone receptor 1	122561	Psh			
17.478	4	11	94	17q21.32	CDC27		Cell division cycle 27	116946	Psh, H	between ERBB2 and PRKCA		11(Cdc27)
17.479	5	23	11	17q12	ACACA, ACAC, ACC1, ACACAD		Acetyl-Coenzyme A carboxylase, alpha	200350	A	proximal to q21.33; others put at 17q12	Acetyl-CoA carboxylase deficiency, 613933 (1)	
17.480	3	16	99	17q21.31	AOC2, RAO		Amine oxidase, copper-containing, 2	602268	A			
17.481	6	25	99	17q21.31	AOC3, HPAO, VAP1		Amine oxidase, copper-containing 3	603735	TM			
17.482	11	20	06	17q21.31	ARHGAP27, CAMGAP1		RHO GTPase-activating protein 27	610591	REc			
17.483	2	29	08	17q21	ASRT6		Asthma-related traits, susceptibility to, 6	611403	Fd	strongly associated with rs7216389	{Asthma-related traits, susceptibility to, 6} (2)	
17.484	1	8	08	17q21.2	ATP6V0A1, ATP6N1A, VPP1		ATPase, H+ transporting, V0 subunit A1	192130	REa, REn			11(Atp6n1)
17.485	4	30	09	17q21	AUTS7		Autism, susceptibility to, 7	610676	Fd	max lod at D17S2180	{Autism susceptibility 7} (2)	
17.486	1	4	00	17q21.31	BECN1		Beclin 1	604378	REc, A			
17.487	3	9	18	17q21.31	BRCA1, PSCP, BROVCA1, PNCA4, FANCS		Breast cancer-1 gene	113705	Fd, REc		{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer, susceptibility to, 4}, 614320 (3); Fanconi anemia, complementation group S, 617883 (3)	11(Brca1)
17.488	11	20	13	17q12	CDK12, CRKRS, CRK7, KIAA0904		Cyclin-dependent kinase 12	615514	REc, R			11(Cdk12)
17.489	12	7	07	17q21.31	C1QL1, CRF, C1QRF		Complement component 1, q subcomponent-like 1	611586	A			
17.490	9	22	17	17q21.2	CAVIN1, PTRF		Caveolae-associated protein 1	603198	REc, H		Lipodystrophy, congenital generalized, type 4, 613327 (3)	11(Ptrf)
17.491	7	13	93	17q21.2	CNP, CNP1		2', 3' cyclic nucleotide 3' phosphohydrolase	123830	REa, A, Psh, Fd, REb	flanked by THRA1 and NGFR		11(Cnp)
17.492	3	27	15	17q21.2	CNTNAP1, CASPR, P190		Contactin-associated protein 1	602346	REc		Lethal congenital contracture syndrome 7, 616286 (3)	
17.493	9	14	95	17q21.31	ETV4		ETS variant gene-4 (E1A enhancer-binding protein, E1AF)	600711	REa, REc, A			
17.494	12	17	07	17q21.31	DBF4B, DRF1, ASKL1		DBF4, S. cerevisiae, homolog of, B	611661	REc			
17.495	1	14	97	17q21.31	DUSP3, VHR		Dual specificity phosphatase-3 (vaccinia virus phosphatase VH1-related)	600183	REn, RE			
17.496	2	24	97	17p13.1	FGF11, FHF3		Fibroblast growth factor-11	601514	REa, REl			11(Fhf3)
17.497	12	22	00	17q21.31	FMNL, C17orf1B		Formin-like	604656	A, R			
17.498	3	27	95	17q21.31	G6PC, G6PT		Glucose-6-phosphatase, catalytic	613742	REa, REn		Glycogen storage disease Ia, 232200 (3)	
17.499	6	7	11	17q21.31	G6PC3, UGRP, SCN4		Glucose-6-phosphatase, catalytic, 3	611045	REc		Neutropenia, severe congenital 4, autosomal recessive, 612541 (3); Dursun syndrome, 612541 (3)	
17.500	3	3	94	17q21.2	GAS, GAST		Gastrin	137250	REa			11(Gast)
17.501	1	8	01	17q21.31	GFAP, ALXDRD		Glial fibrillary acidic protein	137780	REa, A		Alexander disease, 203450 (3)	11(Gfap)
17.502	1	13	11	17q21.32	GNGT2		Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 2	139391	A			
17.503	7	1	11	17q21.32	GOSR2, GS27, EPM6		Golgi snap receptor complex member 2	604027	R, A		Epilepsy, progressive myoclonic 6, 614018 (3)	
17.504	10	13	09	17q21.1	GSDMA, GSDM1, GSDM		Gasdermin A	611218	REc, H			11(Gsdma1-3)
17.505	10	1	09	17q21.1	GSDMB, GSDML		Gasdermin B	611221	REc			
17.506	7	27	15	17q21.2	HCRT, OX, NRCLP1		Hypocretin	602358	R	mutation identified in 1 NRCLP1 patient	?Narcolepsy 1, 161400 (3)	
17.507	7	25	14	17q21.31	HDAC5		Histone deacetylase 5	605315	R, A			
17.508	1	8	97	17q21.31	IFI35		Interferon-induced protein-35	600735	REc			
17.509	8	10	07	17q12-q21	IKZF3, ZNFN1A3, AIOLOS		Ikaros family zinc finger 3	606221	A			
17.510	11	13	07	17q21.2	JUP, DP3, PDGB, ARVD12		Junction plakoglobin	173325	REa, Fd	incorrectly mapped to 7; close to BRCA1	Naxos disease, 601214 (3); Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	11(Jup, Pkgb)
17.511	5	12	09	17q21.2	KAT2A, GCN5L2, GCN5		K(lysine) acetyltransferase 2A	602301	A			11(Gcn5l2)
17.512	1	24	01	17q21.32	KPNB1		Karyopherin beta-1	602738	A			11(Kpnb1)
17.513	3	21	03	17q12	LASP1, MLN50		LIM and SH3 protein 1	602920	Ch, H	fused to MLL in AML		11(Lasp1)
17.514	9	14	00	17q21.31	MAP3K14, NIK, HSNIK		Mitogen-activated protein kinase kinase kinase-14	604655	A, R			
17.515	2	22	13	17q21.31	MEOX1, MOX1, KFS2		Mesenchyme homeo box 1 (Mox1, mouse, homolog of)	600147	RE		Klippel-Feil syndrome 2, 214300 (3)	
17.516	4	6	15	17q21.32	MIR10A		Micro RNA 10A	610173	REc			
17.517	3	2	98	17q12	MLLT6, AF17		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6	600328	Ch			
17.518	1	20	06	17q21.33	MYCBPAP, AMAP1		MYCBP-associated protein	609835	REc			
17.519	7	29	15	17q21.2	NAGLU, MPS3B, CMT2V		N-acetylglucosaminidase, alpha-	609701	REn	mutation identified in 1 CMT2V family	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3); ?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	
17.520	3	26	02	17q21.32	NPEPPS, PSA, MP100		Aminopeptidase, puromycin-sensitive	606793	A			11(Psa)
17.521	3	29	10	17q21.33	PHB		Prohibitin	176705	REa, A		{Breast cancer, susceptibility to}, 114480 (3)	
17.522	5	5	15	17q21.31	PYY		Peptide YY	600781	A	10kb from PPY		
17.523	8	3	12	17q21.31	RND2, ARHN, RHO7		Ras homolog gene family, member N (GTP-binding protein Rho7)	601555	REn			
17.524	6	30	16	17q21.2	STAT3, APRF, HIES, ADMIO1		Signal transducer and activator of transcription-3 (acute-phase response factor)	102582	A		Hyper-IgE recurrent infection syndrome, 147060 (3); Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	11(Stat3)
17.525	1	8	01	17q21.33	TOB1, TOB		Transducer of ERBB2, 1	605523	REc			
17.526	9	23	13	17q21.2	TUBG1, CDCBM4		Tubulin, gamma 1	191135	R		Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	
17.527	4	4	01	17q21.2	TUBG2		Tubulin, gamma 2	605785	R	pseudogene on chr. 7		
17.528	3	9	00	17q21.31	VAT1		Vesicle amine transport protein 1	604631	REn			
17.529	2	17	15	17q21.31-q21.32	WNT3, INT4, TETAMS		Wingless-type MMTV integration site family, member 3	165330	REa, S, A, H	mutation identified in 1 TETAMS1 family	?Tetra-amelia syndrome 1, 273395 (3)	11(Wnt4)
17.530	8	10	98	17q21.32	WNT15		Wingless-type MMTV integration site family, member 15	602864	REa, H, R			11(Wnt15)
17.531	4	29	97	17q12	CACNB1, CACNLB1, CCHLB1		Calcium channel, voltage-dependent, beta 1 subunit	114207	REa			
17.532	11	28	01	17q12	GRB7		Growth factor receptor-bound protein 7	601522	REc			11(Grb7)
17.533	7	26	12	17q21.32	HOXB1, HOX2I, HCFP3		Homeo box-B1	142968	RE		Facial paresis, hereditary congenital, 3, 614744 (3)	11(Hox2.9)
17.534	1	20	95	17q21.32	HOXB2, HOX2H		Homeo box-B2	142967	RE			11(Hox2.8)
17.535	1	20	95	17q21.32	HOXB3, HOX2G		Homeo box-B3	142966	RE			11(Hox2.7)
17.536	1	20	95	17q21.32	HOXB4, HOX2F		Homeo box-B4	142965	RE			11(Hox2.6)
17.537	1	20	95	17q21.32	HOXB5, HOX2A		Homeo box-B5	142960	REa, A, H, Fd, RE			11(Hox2.2)
17.538	1	20	95	17q21.32	HOXB6, HOX2B		Homeo box-B6	142961	RE			11(Hox2.2)
17.539	1	20	95	17q21.32	HOXB7, HOX2C		Homeo box-B7	142962	RE			11(Hox2.3)
17.540	1	20	95	17q21.32	HOXB8, HOX2D		Homeo box-B8	142963	RE			11(Hox2.4)
17.541	1	20	95	17q21.32	HOXB9, HOX2E		Homeo box-B9	142964	RE			11(Hox2.5)
17.542	8	20	07	17q21-q22	HPC9		Prostate cancer, hereditary, 9	610997	Fd	max LOD at D17S1820	{Prostate cancer, hereditary, 9} (2)	
17.543	12	21	10	17q21.2	KRT10, EHK, BCIE, BIE		Keratin 10	148080	REa, A, REn	in cluster of class I keratins	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)	
17.544	10	4	91	17q21.2	KRT15		Keratin 15	148030	H, REa, A, REn	tightly linked to Hox-2 in mouse		11(Krt1)
17.545	6	9	98	17q21.2	KRT19		Keratin 19	148020	REa	probably 17q21-q22		
17.546	3	23	09	17q21.32	MIR196A1, MIRN196A1		Micro RNA 196A1	608632	REc			
17.547	2	19	04	17q21-q22	MYP5		Myopia 5	608474	Fd	between D17S787 and D17S1811	Myopia 5 (2)	
17.548	6	6	89	17q21.33	NGFR, TNFRSF16		Nerve growth factor receptor	162010	REa, A, S, Fd, C	distal to APL breakpoint, q21; < 0.5mb from HOX2		11(Ngfr)
17.549	8	15	97	17q21.31	NSF		N-ethylmaleimide-sensitive factor	601633	Psh, A			11(Nsf)
17.550	8	18	08	17q21.31	RNU2-1, RNU2		RNA, U2 small nuclear, 1	180690	REa, A, C			
17.551	7	17	01	17q22	PCTP		Phosphatidylcholine transfer protein	606055	R			11(Pctp)
17.552	3	10	00	17q21-q22	PTLAH, FPAH		Patella aplasia or hypoplasia	168860	Fd		Patella aplasia or hypoplasia (2)	
17.553	10	15	95	17q21.31	SHCL1		SHC (Src homology 2 domain-containing) transforming protein-like 1	600739	A			
17.554	12	9	15	17q21.31	SLC4A1, AE1, EPB3, SPH4, SAO, CHC		Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	REa, RE, Fd, A		Ovalocytosis, SA type, 166900 (3); Spherocytosis, type 4, 612653 (3); [Malaria, resistance to], 611162 (3); Renal tubular acidosis, distal, AD, 179800 (3); Renal tubular acidosis, distal, AR, 611590 (3); [Blood group, Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3); Cryohydrocytosis, 185020 (3)	
17.555	2	2	16	17q23.2	TBX4, ICPPS		T-box 4	601719	REc		Ischiocoxopodopatellar syndrome, 147891 (3)	
17.556	5	26	05	17q21.2	TOP2A, TOP2		Topoisomerase (DNA) II, alpha, 170kD	126430	REa, A		DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	11(Top2a)
17.557	2	27	12	17q21.2	WNK4, PRKWNK4, PHA2B		WNK lysine deficient protein kinase 4	601844	Fd, REc		Pseudohypoaldosteronism, type IIB, 614491 (3)	
17.558	6	28	94	17q21.2	ACLY		ATP citrate lyase	108728	H, REa, R			?11(Atpcl)
17.559	12	22	08	17q12	DDX52, ROK1, HUSSY19		DEAD box polypeptide 52	612500	R			
17.560	5	27	05	17q12	ERBB2, NGL, NEU, HER2		Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	REa, A, R, Fd		Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic, 137800 (3); Gastric cancer, somatic, 613659 (3); Ovarian cancer, somatic, (3)	
17.561	7	1	97	17q21.31	FZD2		Frizzled, Drosophila, homolog of, 2	600667	A			11(Fzd2)
17.562	12	28	07	17q21.2	GJD3, GJC1, CX31.9		Gap junction protein, delta-3 (31.9kD)	607425	REc			
17.563	8	8	14	17q21.31	MAPT, MTBT1, DDPAC, MSTD		Microtubule-associated protein tau	157140	REb, A, R, Fd	see 6p21	Dementia, frontotemporal, with or without parkinsonism, 600274 (3); Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease, susceptibility to}, 168600 (3)	11(Mapt)
17.564	2	1	11	17q21.1	MED24, TRAP100, KIAA0130		Mediator complex subunit 24	607000	R, REc			
17.565	3	17	08	17q21.2	MLX, TCFL4		MAX-like protein X	602976	REc			
17.566	2	25	14	17q21.1	MSL1		Male-specific lethal 1, Drosophila, homolog of	614801	REc			
17.567	8	23	94	17q21.31	NBR1, M17S2		Neighbor of BRCA1 gene 1 (membrane component, chromosome 17, surface marker 2)	166945	A, REn			
17.568	11	11	14	17q21.2	NKIRAS2, KBRAS2		NFKB inhibitor-interacting Ras-like protein 2	604497	REc			
17.569	11	5	08	17q21.1	ORMDL3		ORM1-like protein 3	610075	REc			
17.570	11	30	06	17q12	PLXDC1, TEM7		Plexin domain containing 1	606826	R			
17.571	9	21	17	17q21.1	PSMD3, RPN3		Proteasome 26S subunit, non-ATPase, 3	617676	REc			
17.572	10	30	08	17q21.2	RARA		Retinoic acid receptor, alpha polypeptide	180240	A, Ch	fused with MYL in APL	Leukemia, acute promyelocytic, 612376 (1)	11(Rara)
17.573	7	17	02	17q21.31	STH		Saitohin	607067	REn	in intron 9 of TAU		
17.574	8	20	07	17q12	CCL11, SCYA11		Chemokine, C-C motif, ligand 11	601156	REa, A		{HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to}, 600807 (3)	
17.575	3	28	17	17q21.31	RPL27, DBA16		Ribosomal protein L27	607526	REa, R	mutation identified in 1 DBA16 patient	?Diamond-Blackfan anemia 16, 617408 (3)	
17.576	5	8	97	17q21.2	EZH1		Enhancer of zeste, Drosophila, homolog of, 1	601674	REn			11(Ezh1)
17.577	8	10	06	17q21.32	B4GALGT2, GALGT2, SD		Beta-1,4-N-acetyl-galactosaminyl transferase 2	111730	REc			11(B4galnt2)
17.578	7	28	15	17q21.2	CCR10, GPR2		Chemokine (C-C) receptor 10	600240	A, REc			11(Gpr2)
17.579	8	10	16	17q21.2	CDC6, CDC18L, MGORS5		Cell division cycle 6, S. cerevisiae, homolog of	602627	REc	mutation identified in 1 MGORS5 patient	?Meier-Gorlin syndrome 5, 613805 (3)	
17.580	4	30	09	17q21.2	DHX58, LGP2, D11LGP2		DEAH (Asp-Glu-Ala-His) box polypeptide 58	608588	REc			11(Lgp2)
17.581	8	12	15	17q21.2	FAM134C		Family with sequence similarity 134, member C	616498	REc			
17.582	6	13	12	17q12	FBXL20, FBL20, FBL2, SCR		F-box and leucine-rich repeat protein 20	609086	REc			11(Fbxl20)
17.583	2	13	15	17q21.2	FKBP10, FKBP65, OI11, BRKS1		FK506-binding protein 10	607063	R, REc, Fd, LD		Osteogenesis imperfecta, type XI, 610968 (3); Bruck syndrome 1, 259450 (3)	
17.584	3	9	00	17q21.32	HOXB13		Homeo box B13	604607	A			11(Hoxb13)
17.585	5	8	13	17q21.2	HSD17B1, EDH17B2		Estradiol 17-beta-dehydrogenase-1	109684	A, REa			
17.586	9	11	14	17q21.2	HSPB9		Heat-shock 27kD protein 9	608344	REc			
17.587	1	14	09	17q21.2	IBD22		Inflammatory bowel disease 22	612380	Fd	associated with rs744166	{Inflammatory bowel disease 22} (2)	
17.588	3	1	13	17q21.2	KLHL10, SPGF11		Kelch-like 10	608778	REc, H		Spermatogenic failure 11, 615081 (3)	11(Klhl10)
17.589	5	22	14	17q21.2	KRT13, WSN2		Keratin 13	148065	Psh, A, REn	in same PFGE fragment as KRT10, KRT15	White sponge nevus 2, 615785 (3)	
17.590	11	13	13	17q21.2	KRT23		Keratin 23	606194	REc			
17.591	1	15	16	17q21.2	KRT25, K25, KRT24IRS1, ARWH3		Keratin 25, type I	616646	REc, H		Woolly hair, autosomal recessive 3, 616760 (3)	11(Krt25)
17.592	12	4	15	17q21.2	KRT26, K25, K25B, K25IRS2		Keratin 26, type I	616675	REc, H			11(Krt26)
17.593	12	9	15	17q21.2	KRT28, K25D, K25IRS4		Keratin 28, type I	616677	REc			
17.594	12	4	15	17q21.2	KRT27, KRT25C, K25IRS3		Keratin 27, type I	616676	REc			11(Krt27)
17.595	12	9	15	17q21.2	KRT39		Keratin 38, type I	616678	REc, H			11(Krt39)
17.596	12	9	15	17q21.2	KRT40, KA36		Keratin 40, type I	616679	REc, H			11(Krt40)
17.597	5	7	03	17q21.32	OSBPL7, ORP7		Oxysterol-binding protein-like protein 7	606735	REc			
17.598	4	20	17	17q21.2	P3H4, SC65, LEPREL4		Proyly 3-hydroxylase 4	617419	REc			
17.599	11	3	11	17q21.2	PSMC3IP, TBPIP, GT198, HOP2, ODG3		PSMC3-interacting protein	608665	REc, R		Ovarian dysgenesis 3, 614324 (3)	
17.600	10	26	99	17q21.2	RAB5C, RABL		Ras-associated protein RAB5c	604037	REc, A			
17.601	5	11	16	17q21.2	SMARCE1, BAF57, CSS5		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	REc		{Meningioma, familial, susceptibility to}, 607174 (3); Coffin-Siris syndrome 5, 616938 (3)	
17.602	9	26	17	17q21.2	STAT5A, STAT5, MGF		Signal transducer and activator of transcription 5a	601511	REn, REc			11(Stat5a)
17.603	9	1	16	17q21.2	TTC25, CILD35		Tetratricopeptide repeat domain-containing protein 25	617095	REc		Ciliary dyskinesia, primary, 35, 617092 (3)	
17.604	12	23	05	17q21.2	WIRE, WICH		WASP-interacting protein-related protein	609692	R, REc			
17.605	10	30	08	17q21.2	HAP1, HLP, HAP2		Huntingtin-associated protein 1 (neuroan 1)	600947	H, A			11(Hap1)
17.606	12	11	98	17q21.31	ADAM11, MDC		A disintegrin and metalloproteinase domain 11	155120	REc			
17.607	4	17	07	17q21.33	EME1		Essential meiotic endonuclease 1, S. pombe, homolog of, 1	610885	REc			11(Eme1)
17.608	11	19	98	17q21.3	ERDA1		Expanded repeat domain, CAG/CTG, 1	603279	A	no apparent pathology		
17.609	12	4	03	17q21.32	IGF2BP1, IMP1, CRDBP, ZBP1		Insulin-like growth factor 2 mRNA-binding protein 1	608288	A			11(Crdbp)
17.610	3	15	10	17q21.33	LUC7L3, CROP, LUC7A		Luc7, S. cerevisiae, homolog of, 3	609434	R, REc			
17.611	2	26	08	17q21.32	MRPL10, MRPL8		Mitochondrial ribosomal protein L10	611825	R			
17.612	11	28	01	17q21.32	NESH		NESH protein	606363	Psh, R			
17.613	5	17	95	17q21.32	NFE2L1, NRF1		Nuclear factor, erythroid-derived 2-like 1	163260	A			11(Nfe2l1)
17.614	3	17	98	17q21.33	NME1, NM23		Non-metastatic cells 1, protein (NM23A) expressed in	156490	A, Fd, REa		Neuroblastoma, 256700 (3)	
17.615	5	27	93	17q21.33	NME2		Non-metastatic cells 2, protein (NM23) expressed in	156491	REa, A, REn			
17.616	09	04	18	17q21.31	PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3		Pleckstrin homology domain-containing protein, family M, member 1	611466	R, REc	mutation identified in 1 OPTB6 family	?Osteopetrosis, autosomal recessive 6, 611497 (3); Osteopetrosis, autosomal dominant 3, 618107 (3)	
17.617	2	21	07	17q21.32	PRAC1		Prostate, rectum, and colon gene	609819	REc			
17.618	3	19	08	17q21.31	RUNDC3A, RPIP8		RUN domain contain 3A	605448	REc			
17.619	7	19	12	17q21.33	RAC4, PPTC, HK1		Tachykinin 4	607833	REc			
17.620	12	17	12	17q21.32	SCRN2, SES2		Secernin 2	614966	REc			
17.621	4	17	06	17q21.32	TBX21, TBET		T-box 21	604895	REc, H		{Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and nasal polyps, 208550 (3)	11(Tbx21)
17.622	9	15	17	17q21.31	UBTF, UBF, CONDBA		Upstream binding transcription factor, RNA polymerase I	600673	A, R		Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3)	
17.623	4	17	07	17q21.2	VPS25, FAP20		Vacuolar protein sorting 25, S. cerevisiae, homolog of	610907	REc			
17.624	4	17	07	17q21.33	WFIKKN2, WFIKKNRP		WAP, fillistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 2	610895	REc			
17.625	7	11	14	17q21.33	DLX3, TDO, AI4		Distal-less homeo box-3	600525	REa, A, Fd		Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta, type IV, 104510 (3)	
17.626	2	4	16	17q21.33	DLX4, DLX7, DLX8, OFC15		Distal-less homeo box-4	601911	A	mutation identified in 1 OFC15 family	?Orofacial cleft 15, 616788 (3)	
17.627	3	20	94	17q21.32	GIP		Gastric inhibitory polypeptide	137240	REa, A			11(Gip)
17.628	2	28	08	17q21.33	MRPL27		Mitochondrial ribosomal protein L27	611837	R			
17.629	12	19	11	17q22	SRSF1, SFRS1, ASF, SF2, SRp30a		Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)	600812	REa, A			11(Sfrs1)
17.630	8	6	15	17q21.33	XYLT2, XT2, SOS		Xylosyltransferase 2	608125	R		{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Spondyloocular syndrome, 605822 (3)	
17.631	2	16	10	17q21.31	AARSD1		Alanyl-tRNA synthetase domain-containing 1	613212	REc			
17.632	1	31	13	17q21.31	ASB16		Ankyrin repeat- and SOCS box-containing protein 16	615056	REc			
17.633	6	13	12	17q21.31	CCDC103, SMH, PR46B, CILD17		Coiled-coil domain-containing protein 103	614677	REc		Ciliary dyskinesia, primary, 17, 614679 (3)	
17.634	5	24	13	17q21.31	CD300LG, TREM4, CLM9		CD300 antigen-like family, member G	610520	REc			
17.635	8	21	12	17q21.2	COA3, CCDC56		Cytochrome c oxidase assembly factor 3	614775	REc			
17.636	1	27	11	17q21.31	DUP17q21.31, C17DUPq21.31		Chromosome 17q21.31 duplication syndrome	613533	Ch	contiguous gene duplication syndrome	Chromosome 17q21.31 duplication syndrome (4)	
17.637	10	29	03	17q21.32	CDK5RAP3		CDK5 regulatory subunit-associated protein 3	608202	REc			
17.638	4	30	09	17q21.31	DHX8, DDX8, HRH1		DEAH (Asp-Glu-Ala-His) box polypeptide 8	600396	REc			
17.639	3	7	13	17q21.31	EFTUD2, KIAA0031, MFDGA		Elongation factor Tu GTP-binding domain-containing 2	603892	REa		Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	
17.640	12	19	11	17q21.31	GPATCH8, KIAA0553		G-patch domain-containing protein 8	614396	R, REc			16(Gpatch8)
17.641	12	5	03	17q21.31	IMP5		Intramembrane protease 5	608284	REc			
17.642	10	4	12	17q21.31	KANSL1, KIAA1267, MSL1V1, KDVS		KAT8 regulatory NSL complex subunit 1	612452	R, REc		Koolen-De Vries syndrome, 610443 (3)	
17.643	4	19	12	17q21.31	KIF18B		Kinesin family member 18B	614570	REc			
17.644	2	14	08	17q21.31	LSM12		LSM12, S. cerevisiae, homolog of	611793	REc			
17.645	5	2	16	17q21.31	MEIOC, C17orf104		Meiosis-specific protein with coiled-coil domain	616934	REc			11(Meioc)
17.646	3	5	08	17q12	MRPL45		Mitochondrial ribosomal protein L45	611850	REc	pseudogenes on 2 and 17		
17.647	12	21	03	17q21.31	NAGS		N-acetylglutamate synthase	608300	REc		N-acetylglutamate synthase deficiency, 237310 (3)	11(Nags)
17.648	9	17	08	17q21.31	NMT1, NMT		N-myristoyltransferase 1	160993	REc			
17.649	7	22	13	17q21.31	SLC25A39, CGI69		Solute carrier family 25, member 39	610820	REc, R			11(Slc25a39)
17.650	12	22	17	17q21.33	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1		Collagen I, alpha-1 polypeptide	120150	C, M, A, REa	fused with PDGFB in DFPB	Osteogenesis imperfecta, type I, 166200 (3); Osteogenesis imperfecta, type II, 166210 (3); Osteogenesis imperfecta, type III, 259420 (3); Caffey disease, 114000 (3); Osteogenesis imperfecta, type IV, 166220 (3); {Bone mineral density variation QTL, osteoporosis}, 166710 (3); Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3)	11(Col1a1)
17.651	4	17	13	17q21.31-q22	MRT35		Mental retardation, autosomal recessive 35	615162	Fd	between rs4792947 and rs11079258	Mental retardation, autosomal recessive 35 (2)	
17.652	9	24	15	17q21.31	LRRC37A		Leucine-rich repeat-containing protein 37A	616555	A, REc			
17.653	9	24	15	17q21.31-q21.32	LRRC37A2		Leucine-rich repeat-containing protein 37A2	616556	A, REc			
17.654	11	19	13	17q21.32	COPZ2		Coatomer protein complex, subunit zeta-2	615526	REc			
17.655	7	18	12	17q21.31	GRN, CLN11		Granulin	138945	REa, REc, REn		Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3); Aphasia, primary progressive, 607485 (3); Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	
17.656	3	23	14	17q21.31	HEXIM2		Hexamethylene bis acetamide-inducible protein 2	615695	REc			
17.657	7	25	18	17q21.32	HOXBAS1, HOXB3OS		Homeobox B cluster antisense RNA 1, noncoding	618066	REc			11(Hoxb3os)
17.658	5	6	13	17q21.31	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16		Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759	A, REb, REa, RE, F, LD	3' to GP3A; BAK platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune, BAK antigen related (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.659	5	6	13	17q21.32	ITGB3, GP3A, GT, BDPLT2, BDPLT16		Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470	REa, REb, A, RE, F, LD	in same 260kb fragment as GP2B; PL(A) platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.660	3	23	15	17q21.33	KAT7, MYST2, HBO1		K(lysine) acetyltransferase 7	609880	R, REc			
17.661	5	15	11	17q21.32	MIR152, MIRN152		Micro RNA 152	613788	REc			
17.662	12	27	16	17q21.32	MYL4		Myosin, light polypeptide-4, alkali, atrial, embryonic	160770	REa	mutation identified in 1 ATFB18 family	?Atrial fibrillation, familial, 18, 617280 (3)	11(Myla)
17.663	7	3	06	17q21.32	PNPO		Pyridoxamine 5'-phosphate oxidase	603287	REc, H		Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	11(Pnpo)
17.664	7	25	18	17q21.32	PRAC2, HOXBAS5		PRAC2 small nuclear protein	610787	REc			
17.665	1	30	12	17q21.32	SKAP1, SCAP1, SKAP55		SRC kinase-associated phosphoprotein 1, 55kD	604969	R, REc			
17.666	4	17	07	17q21.32	SNF8, VPS22, EAP30		SNF8, S. cerevisiae, homolog of	610904	R, REc			
17.667	12	10	12	17q21.32	SNX11		Sorting nexin 11	614906	REc			
17.668	9	27	17	17q21.32	SP2		Transcription factor Sp2	601801	REc			11(Sp2)
17.669	3	18	13	17q21.32	TBKBP1, PROSAPIP2, KIAA0775		TBK1-binding protein 1	608476	REc			
17.670	3	15	07	17q21.32	TTLL6		Tubulin tyrosine ligase-like family, member 6	610849	REc			
17.671	4	2	16	17q21.32	UBE2Z, USE1		Ubiquitin-conjugating enzyme E2Z	611362	REc			
17.672	5	23	13	17q21.32-q21.33	ZNF652, KIAA0924		Zinc finger protein 652	613907	R, REc			
17.673	6	10	08	17q21.33	ACSF2, FLJ20920		Acyl-CoA synthetase family member 2	610465	R, REc			
17.674	6	25	99	17q21.33	CHAD		Chondroadherin	602178	Psh, A			
17.675	1	27	04	17q21.33	HILS1		Spermatid-specific linker histone H1-like protein	608101	REc			11(Hils1)
17.676	12	21	12	17q21.33	ITGA3, CD49C, GAPB3, ILNEB		Integrin, alpha-3	605025	REc		Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	
17.677	10	11	12	17q21.33	LRRC59, p34		Leucine-rich repeat-containing protein 59	614854	REc			
17.678	11	3	14	17q21.33	NXPH3, NPH3		Neuroexophilin 3	604636	REc			
17.679	9	9	13	17q21.33	PDK2		Pyruvate dehydrogenase kinase, isoenzyme 2	602525	REc			
17.680	10	1	17	17q21.33	PPP1R9B, SPINO		Protein phosphatase 1, regulatory subunit 9B	603325	REc			
17.681	3	8	07	17q21.33	SLC35B1, UGTREL1		Solute carrier family 35, member B1	610790	R, REc			
17.682	4	18	02	17q21.33	SPAG9, SYD1, KIAA0516		Sperm-associated antigen 9	605430	R, REc			
17.683	5	16	11	17q21.33	SPATA20, SSP411		Spermatogenesis-associated protein 20	613939	REc			
17.684	12	19	12	17q21.33	SPOP		Speckle-type POZ protein	602650	REc, R			
17.685	7	15	09	17q21.33	UTP18		UTP18, S. cerevisiae, homolog of	612816	REc			
17.686	7	18	14	17q21-q22	CA10, CARPX		Carbonic anhydrase X	604642	REc			
17.687	2	28	01	17q21.33	ABCC3, CMOAT2, MRP3, MLP2		ATP-binding cassette, sub-family C, member 3	604323	R, A			
17.688	2	22	92	17q22	BCL5		B-cell CLL/lymphoma-5	151441	REa, A			
17.689	10	11	05	17q23.2	BRIP1, BACH1, FANCJ		BRCA1-associated C-terminal helicase 1	605882	REc, Fd	?or 17q23	Breast cancer, early-onset, 114480 (3); Fanconi anemia, complementation group J, 609054 (3)	
17.690	12	21	09	17q22	C17orf71, SMG8		Chromosome 17 open reading frame 71	613175	REc			
17.691	08	16	18	17q21.33	CACNA1G, SCA42, SCA42ND		Calcium channel, voltage-dependent, T type, alpha-1G subunit	604065	A, R, H		Spinocerebellar ataxia 42, 616795 (3); Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3)	11(Cacna1g)
17.692	8	20	99	17q22	COX11		Cytochrome c oxidase, subunit 11	603648	REa	pseudogene on 6p23-p22		
17.693	7	23	15	17q22	DGKE, NPHS7, AHUS7		Diacylglycerol kinase, epsilon, 64-kD	601440	A, R		Nephrotic syndrome, type 7, 615008 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	
17.694	8	21	00	17q22	HLF		Hepatic leukemia factor	142385	Ch, R			
17.695	4	8	13	17q22	KIF2B		Kinesin family member 2B	615142	REc			
17.696	3	7	14	17q22	MIR142		Micro RNA 142	615657	REc			
17.697	3	23	14	17q22	MIR301A, MIR301		Micro RNA 301A	615675	REc			
17.698	4	19	12	17q22	MMD, MMD1, PAQR11		Monocyte-to-macrophage differentiation-associated protein	604467	REc			
17.699	2	21	14	17q22	MSI2		Musashi, Drosophila, homolog of, 2	607897	A, REc			11(Msi2)
17.700	10	23	15	17q22	NOG, SYM1, SYNS1A		Noggin, mouse, homolog of	602991	A, R, Fd		Symphalangism, proximal, 1A, 185800 (3); Multiple synostoses syndrome 1, 186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumbs and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)	
17.701	11	30	06	17q25.1	PRCD, RP36		PRCD, Dog, homolog of	610598	REc		Retinitis pigmentosa 36, 610599 (3)	
17.702	7	8	10	17q22	RAD51C, FANCO, BROVCA3		RAD51, S. cerevisiae, homolog of, C	602774	REc		Fanconi anemia, complementation group O, 613390 (3); {Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	
17.703	8	18	14	17q22	PRR11		Proline-rich protein 11	615920	REc			
17.704	12	2	15	17q22	SKA2, FAM33A		Spindle- and kinetochore-associated complex, subunit 2	616674	REc			
17.705	2	25	15	17q22	STXBP4, SYNIP		Syntaxin-binding protein 4	610415	REc			
17.706	10	1	17	17q22	TEX14, SPGF23		Testis-expressed gene 14	605792	R, REc, H	mutation identified in 1 SPGF23 family	?Spermatogenic failure 23, 617707 (3)	11(Tex14)
17.707	4	30	15	17q22	TMEM100		Transmembrane protein 100	616334	REc			
17.708	7	11	12	17q22	TOM1L1		TOM1-like 1	604701	REc			
17.709	5	12	03	17q23.1-q23.2	USP32, USP10		Ubiquitin-specific protease 32	607740	REc			
17.710	9	24	08	17q22	VEZF1, ZNF161		Vascular endothelial zinc finger 1	606747	R			
17.711	9	30	02	17q23.2	APPBP2, PAT1		Amyloid beta precursor protein-binding protein 2	605324	R, REc			
17.712	1	12	95	17q22	COIL, CLN80		Coilin p80	600272	A			
17.713	2	1	11	17q23.2	MED13, THRAP1, TRAP240		Mediator complex subunit 13	603808	REa, REc			
17.714	4	24	08	17q22	MRPS23		Mitochondrial ribosomal protein S23	611985	R, REc			
17.715	5	19	17	17q23.2	PPM1D, WIP1, IDDGIP		Protein phosphatase, magnesium-dependent, 1, delta isoform	605100	A, REc	amplified in breast cancer	Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, 617450 (3); Breast cancer, somatic, 114480 (3)	
17.716	3	22	93	17q11.2	TNFAIP1		Tumor necrosis factor, alpha-induced protein-1 (endothelial)	191161	A			
17.717	11	26	01	17q22	TRIM37, MUL, KIAA0898		Tripartite motif-containing 37	605073	Fd, Ld, REn		Mulibrey nanism, 253250 (3)	
17.718	3	17	98	17q24.2	PRKCA, PKCA		Protein kinase C, alpha polypeptide	176960	REa, A, Fd	cen-COL1A1-PKCA-GH1	Pituitary tumor, invasive (3)	11(Pkca)
17.719	3	26	02	17q25.1	CMRF35, CMRF35A		CMRF35 antigen	606786	Psh, A			
17.720	7	18	91	17q23.3	CSH1, CSA, PL		Chorionic somatomammotropin hormone-1	150200	REa, A		[Placental lactogen deficiency] (1)	13(Pl1)
17.721	7	18	91	17q23.3	CSH2, CSB		Chorionic somatomammotropin B	118820	REa, A			13(Pl2)
17.722	6	25	99	17q23.3	CSHL1, CSL		Chorionic somatomammotropin hormone-like 1	603515	A			
17.723	7	14	09	17q23.3	GH1, GHN, IGHD1B		Growth hormone-1	139250	REa, A, Fd	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type IA, 262400 (3); Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)	11(Gh)
17.724	9	16	88	17q23.3	GH2, GHV		Growth hormone-2	139240	REa, A			
17.725	2	21	14	17q23.3	TACO1, CCDC44		Translational activator of mitochondrially encoded cytochrome c oxidase subunit I	612958	REc		Mitochondrial complex IV deficiency, 220110 (3)	
17.726	2	17	04	17q25.1	FOXJ1, FKHL13, HFH4		Forkhead box J1	602291	REc			
17.727	11	5	98	17q25.1	CDK3		Cyclin-dependent kinase 3	123828	Psh	distal to BRCA1		
17.728	7	25	16	17q23.3	ACE, DCP1, ACE1, MVCD3, ICH		Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	A, H, Fd		{Myocardial infarction, susceptibility to} (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3); {SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)	
17.729	5	19	06	17q23	BSZQTL		Bone size quantitative trait locus 1	609656	Fd		{Bone size QTL} (2)	
17.730	7	20	04	17q23.1	CA4, RP17		Carbonic anhydrase IV	114760	REa, A, Fd		Retinitis pigmentosa 17, 600852 (3)	
17.731	8	3	10	17q23.3	CD79B, IGB, B29, AGM6		CD79B antigen	147245	A		Agammaglobulinemia 6, 612692 (3)	
17.732	2	16	18	17q23.1	CLTC, MRD56		Clathrin, heavy polypeptide (Hc)	118955	REc, Ch	fusion gene with TFE3 in renal adenocarcinoma	Mental retardation, autosomal dominant 56, 617854 (3)	
17.733	5	22	14	17q23.1	LNCDC, LOC615638		Long noncoding RNA, dendritic cell	615772	REc			
17.734	9	23	16	17q22	MKS1, MKS, BBS13, JBTS28		MKS1 gene	609883	Fd, REc	frequent in Finland	Meckel syndrome 1, 249000 (3); Bardet-Biedl syndrome 13, 615990 (3); Joubert syndrome 28, 617121 (3)	
17.735	9	15	96	17q23.3	PECAM1		Platelet/endothelial cell adhesion molecule (CD31 antigen)	173445	Psh, A			6(Pecam1)
17.736	7	1	05	17q22	SEPT4, PNUTL2		Septin 4	603696	A, REc			11(Sept4)
17.737	2	19	97	17q23.2	TBX2		T-box 2	600747	A, H			11(Tbx2)
17.738	3	4	02	17q24.2	KPNA2, RCH1, QIP2		Karyopherin alpha-2	600685	REc			
17.739	7	17	06	17q23.3	POLG2, POLGB, PEOA4		Polymerase, DNA, gamma-2	604983	REc		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	
17.740	8	14	15	17q24.2	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1		Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	S, M, REa, RE, Fd	fused with RET to form PTC2	Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic, (3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)	11(Tse1)
17.741	1	27	04	17q24.1	RGS9, PERRS		Regulator of G protein signaling 9	604067	R, A		Bradyopsia, 608415 (3)	
17.742	5	30	17	17q23.3	SMARCD2, BAF60B, SGD2		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2	601736	Psh, R		Specific granule deficiency 2, 617475 (3)	
17.743	3	4	96	17q23.3	DDX5, HLR1, G17P1		DEAD/H box-5 (RNA helicase, 68kD)	180630	REa, REn	near BRCA1		
17.744	10	4	91	17q23.3	ICAM2		Intercellular adhesion molecule-2	146630	REa, C			
17.745	3	5	08	17q25.1	MRPL38		Mitochondrial ribosomal protein L38	611844	R, REc			
17.746	2	15	18	17q25.1	MRPS7, COXPD34		Mitochondrial ribosomal protein S7	611974	R, REc	mutation identified in 1 COXPD34 family	?Combined oxidative phosphorylation deficiency 34, 617872 (3)	
17.747	5	1	02	17q25.1	NT5C, UMPH2, DNT1		5', 3' nucleotidase, cytosolic	191720	REa			11(Umph2)
17.748	1	24	11	17q24.2	APOH		Apolipoprotein H (beta-2-glycoprotein I)	138700	Fd, REa			11(Apoh)
17.749	10	23	87	17q23-qter	PEPE		Peptidase E	170200	S			
17.750	8	18	15	17q22	EPX, EPXD		Eosinophil peroxidase	131399	REa, A		[Eosinophil peroxidase deficiency], 261500 (3)	
17.751	3	9	01	17q22	LPO		Lactoperoxidase	150205	REn			
17.752	5	5	09	17q23.1	MIR21, MIRN21		Micro RNA 21	611020	REc			
17.753	8	30	07	17q22	MPO		Myeloperoxidase	606989	REa, A, F, Ch, C, REc	translocated in t(15;17)(q22;q11.2)	Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease, susceptibility to}, 104300 (3); {Lung cancer, protection against, in smokers} (3)	11(Mpo)
17.754	3	13	15	17q23.1	PTRH2, BIT1, IMNEPD		Peptidyl-tRNA hydrolase 2	608625	R, REc		Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	
17.755	4	17	13	17q23.1	RNFT1		RING finger protein, transmembrane 1	615172	REc			11(Rnft1)
17.756	10	15	09	17q23.1	RPS6KB1, S6K1		Ribosomal protein S6 kinase, 70kD	608938	R, REc			
17.757	3	23	95	17q22	TRIM25, ZNF147, EFP		Tripartite motif-containing 25	600453	A, REc	300kb from MPO		11(Efp)
17.758	2	5	13	17q23.1	VMP1, TMEM49, EPG3		Vacuole membrane protein 1	611753	R, REc			
17.759	4	20	10	17q23.1-q23.2	DEL17q23.1q23.2, C17DELq23.1q23.2		Chromosome 17q23.1-q23.2 deletion syndrome	613355	Ch		Chromosome 17q23.1-q23.2 deletion syndrome (4)	
17.760	11	1	10	17q23.1-q23.2	DUP17q23.1q23.2, C17DUPq23.1q23.2		Chromosome 17q23.1-q23.2 duplication syndrome	613618	Ch	2.2 Mb contiguous gene duplication syndrome	Chromosome 17q23.1-q23.2 duplication syndrome (4)	
17.761	9	12	12	17q24.3	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9		Potassium channel, inwardly rectifying, subfamily J, member 2	600681	R, REc		Andersen syndrome, 170390 (3); Short QT syndrome 3, 609622 (3); Atrial fibrillation, familial, 9, 613980 (3)	11(Irk1)
17.762	4	30	15	17q23.3	SCN4A, HYPP, NAC1A, HOKPP2, CMS16		Sodium channel, voltage-gated, type IV, alpha polypeptide	603967	REa, Fd	21.5kb from GH1	Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, congenital, 16, 614198 (3); Hypokalemic periodic paralysis, type 2, 613345 (3)	
17.763	4	1	09	17q22	BZRAP1, PRAX1, RIMBP1, KIAA0612		Benzodiazapine receptor (peripheral)-associated protein 1	610764	R, A, REc, H			11(Bzrap1)
17.764	2	21	06	17q22	DYNLL2, DLC2		Dynein, light chain, LC8-type 2	608942	REc			
17.765	4	14	15	17q22	GDPD1, GDE4		Glycerophosphodiester phosphodiesterase domain-containing protein 1	616317	REc			
17.766	3	23	14	17q23.2	INTS2, INT2, KIAA1287		Integrator complex subunit 2	611346	REc			
17.767	6	7	10	17q23.2	MARCH10		Membrane-associated RING-CH finger protein 10	613337	REc			
17.768	9	24	08	17q23.2	MRC2, ENDO180, UPARAP, CD280		Mannose receptor, C-type, 2	612264	R, REc			
17.769	9	27	16	17q22	RNF43, RNF124, SSPCS		Ring finger protein 43	612482	REc		Sessile serrated polyposis cancer syndrome, 617108 (3)	
17.770	7	25	18	17q23.2	TLK2, MRD57		Tousled-like kinase 2	608439	A, REc		Mental retardation, autosomal dominant 57, 618050 (3)	
17.771	12	29	08	17q22	YPEL2		Yippee-like 2	609723	REc			11(Ypel2)
17.772	8	24	09	17q23.2-q25.1	BMIQ15		Body mass index quantitative trait locus 15	612967	Fd	associated with rs228883 and rs1005651	[Body mass index QTL 15] (2)	
17.773	4	20	10	17q23.3	DDX42, RHELP		DEAD (Asp-Glu-Ala-Asp) box polypeptide 42	613369	REc			
17.774	4	30	09	17q23.1	DHX40, DDX40		DEAH (Asp-Glu-Ala-His) box polypeptide 40	607570	REc			
17.775	12	10	13	17q23.3	ERN1, IRE1, IRE1A		Endoplasmic reticulum-to-nucleus signaling 1	604033	REc			
17.776	3	14	13	17q23.3	KCNH6, HERG2		Potassium channel, voltage-gated, subfamily H, member 6	608168	REc			
17.777	6	26	14	17q23.3	MAP3K3, MEKK3, MAPKKK3		Mitogen-activated kinase kinase kinase 3	602539	REc			
17.778	5	19	09	17q23.3	STRADA, STRAD, LYK5		STE20-related kinase adaptor alpha	608626	REc		Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	
17.779	1	31	13	17q23.2-q23.3	TANC2, KIAA1636		Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2	615047	REc			
17.780	5	12	09	17q23.3	TCAM1		Testicular cell adhesion molecule 1	612756	REc			11(Tcam1)
17.781	4	21	14	17q23.3-q24.1	SMURF2		SMAD-specific E3 ubiquitin protein ligase 2	605532	REc			
17.782	2	19	13	17q24.1	AXIN2, ODCRCS		Axis inhibitor 2 (conductin, mouse, homolog of)	604025	R, A		Oligodontia-colorectal cancer syndrome, 608615 (3); Colorectal cancer, somatic, 114500 (3)	
17.783	11	7	17	17q24.2	BPTF, FALZ, FAC1, NURF301, NEDDFL		Bromodomain PHD finger transcription factor	601819	A		Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3)	
17.784	4	29	97	17q24.2	CACNG1, CACNLG		Calcium channel, voltage-dependent, gamma-1 subunit	114209	A			
17.785	11	28	01	17q24.2	CACNG5		Calcium channel, voltage-dependent, gamma-5 subunit	606405	REc			
17.786	5	13	13	17q24	CTRCT7, CCA1		Cataract 7	115660	Fd		Cataract 7 (2)	
17.787	5	6	03	17q25.1	CMRF35H, CMRF35H9		CMRF35H antigen	606790	Psh, A			
17.788	11	29	99	17q25.1	GALK1		Galactokinase-1	604313	S, Ch, R, C, A		Galactokinase deficiency with cataracts, 230200 (3)	11(Glk)
17.789	6	23	15	17q24	SRXY10		46,XY sex reversal 10	616425	Ch	deletion of 32.5kb XYSR regulatory region upstream of SOX9	46XY sex reversal 10 (4)	
17.790	2	3	03	17q25.1	SSTR2		Somatostatin receptor-2	182452	REa			11(Sstr2)
17.791	12	12	00	17q25.1	CDC42EP4, BORG4		CDC42 effector protein 4 (binder of Rho GTPases 4)	605468	A			11(Borg4)
17.792	10	13	17	17q25.1	FDXR, ADXR, ANOA		Ferredoxin reductase (adrenodoxin reductase)	103270	REa, A		Auditory neuropathy and optic atrophy, 617717 (3)	
17.793	10	20	99	17q25.1	GRB2		Growth factor receptor-bound protein 2	108355	A, REa			11(Grb2)
17.794	10	22	96	17q25.1	PRPSAP1		Phosphoribosyl pyrophosphate synthetase-associated protein-1	601249	Psh, A			
17.795	2	24	97	17q23.3	PSMC5, TRIP1		Proteasome (prosome, macropain) 26S subunit, ATPase, 5	601681	Psh, A			
17.796	4	23	03	17q25.1	SANS, USH1G		Scaffold protein containing ankyrin repeats and SAM domain	607696	Fd	?allelic to DFNA20	Usher syndrome, type 1G, 606943 (3)	
17.797	5	22	07	17q25.1	TRIM47, GOA		Tripartite motif-containing protein 47	611041	A			
17.798	9	24	15	17q24.1	LRRC37A3		Leucine-rich repeat-containing protein 37A3	616557	A, REc			
17.799	12	23	08	17q24.3	ABCA5, KIAA1888		ATP-binding cassette, subfamily A, member 5	612503	Psh, R, REc			
17.800	12	22	08	17q24.2-q24.3	ABCA6		ATP-binding cassette, subfamily A, member 6	612504	REc			
17.801	12	22	08	17q24.2	ABCA8, KIAA0822		ATP-binding cassette, subfamily A, member 8	612505	R, REc			
17.802	12	24	08	17q24.2	ABCA9		ATP-binding cassette, subfamily A, member 9	612507	REc			
17.803	12	24	08	17q24.3	ABCA10		ATP-binding cassette, subfamily A, member 10	612508	REc			
17.804	4	17	13	17q24.2	AMZ2		Archaelysin family metallopeptidase 2	615169	REc			
17.805	10	14	18	17q24.2	ARSG, KIAA1001, USH4		Arylsulfatase G	610008	REc		Usher syndrome, type IV, 618144 (3)	
17.806	7	2	18	17q24.2	CACNG4		Calcium channel, voltage-dependent, gamma-4 subunit	606404	REc			
17.807	7	14	14	17q24.2	FAM20A, AIGFS, AI1G		Family with sequence similarity 20, member A	611062	R, REc		Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	
17.808	12	5	17	17q24.2	HELZ, KIAA0054, HUMORF5		Helicase with zinc finger domain	606699	R, REc			
17.809	8	19	13	17q24.2	NOL11		Nucleolar protein 11	615366	REc			
17.810	7	14	14	17q24.2	PITPNC1, RDGBB		Phosphatidylinositol transfer protein, cytoplasmic, 1	605134	REc			
17.811	6	12	17	17q24.2	PSMD12, P55, STISS		Proteasome 26S subunit, non-ATPase, 12	604450	REc		Stankiewicz-Isidor syndrome, 617516 (3)	
17.812	8	24	09	17q24.2-q24.3	HTGH, DEL17q24		Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)	135400	Ch		Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	
17.813	3	11	08	17q24.1	GNA13		Guanine nucleotide-binding protein, alpha-13	604406	R, REc			
17.814	8	17	16	17q24.3	LINC00673, HILNC75, SLNCR, LUCAIR1		Long intergenic noncoding RNA 673	617079	REc			
17.815	11	19	10	17q24.3	MAP2K6, PRKMK6, MKK6, MEK6, MAPKK6		Mitogen-activated protein kinase kinase 6	601254	REc			
17.816	3	30	18	17q24.3	TTPP3		Thyrotoxic periodic paralysis, susceptibility to, 3	614834	Fd	associated with rs312691	{Thyrotoxic periodic paralysis, susceptibility to, 3} (2)	
17.817	4	26	11	17q24.3-q25.1	SRXX2, DUP17q24.3		46XX sex reversal 2	278850	Ch	duplication or triplication of 68kb XXSR regulatory region upstream of SOX9	46XX sex reversal 2 (4)	
17.818	5	19	09	17q24.3-q25.1	PRBNS		Pierre Robin syndrome	261800	Fd	between D17S795 and D17S929	Pierre Robin syndrome (2)	
17.819	8	7	15	17q24.3-q25.1	SLC39A11, ZIP11, C17orf26		Solute carrier family 39 (zinc transporter), member 11	616508	REc			
17.820	5	24	13	17q25.3	C1QTNF1, GIP		C1q- and tumor necrosis factor-related protein 1	610365	REc			
17.821	6	23	15	17q24.3	SOX9, CMD1, SRA1		SRY (sex-determining region Y)-box 9	608160	Ch, REn		Campomelic dysplasia with autosomal sex reversal, 114290 (3); Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)	11(Ts, Sox9)
17.822	12	30	15	17q25.1	AANAT, SNAT		Arylalkylamine N-acetyltransferase	600950	Psh, A			11(Nat4)
17.823	4	6	00	17q25.3	API4		Apoptosis inhibitor 4	603352	A			
17.824	6	7	06	17q25.3	ASPSCR1, RCC17, ASPL, ASPS		Alveolar soft-part sarcoma chromosome region, candidate 1	606236	Ch	t(X;17)(p11.2;q25)	Alveolar soft-part sarcoma, 606243 (3)	
17.825	2	26	02	17q25.3	BAIAP2, IRSP53		BAI1-associated protein 2	605475	A			
17.826	1	22	16	17q25.3	CBX2, M33, SRXY5		Chromobox homolog 2, Drosophila polycomb class	602770	A	mutation identified in 1 SRXY5 patient	?46XY sex reversal 5, 613080 (3)	
17.827	2	11	98	17q25	CDR3		Cerebellar degeneration-related autoantigen-3	602197	H			11(Cdr3)
17.828	5	13	13	17q25.3	CSNK1D, ASPS, FASPS2		Casein kinase-1, delta	600864	A, Psh		Advanced sleep-phase syndrome, familial, 2, 615224 (3)	
17.829	10	1	10	17q25.1	CYGB, HGB, STAP		Cytoglobin	608759	REc			
17.830	9	30	09	17q25.3	CYTH1, D17S811E, SEC7		Cytohesin 1	182115	Psh, A			
17.831	8	19	13	17q25.3	DNAH17, DNEL2		Dynein, axonemal, heavy chain 17	610063	A, R			
17.832	12	3	08	17q25.1	DNAI2, CILD9		Dynein, axonemal, intermediate chain 2	605483	Psh, A		Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	
17.833	12	30	15	17q25	DSPS		Delayed sleep phase syndrome, susceptibility to	614163	Fd	associated with rs28936679 in AANAT	{Delayed sleep phase syndrome, susceptibility to} (2)	
17.834	1	5	11	17q25	EPR1		Effector cell protease receptor 1	603411	A			
17.835	4	14	10	17q25.3	TMC8, EVER2, EV2		Transmembrane channel-like 8	605829	Fd, REc	previously mapped to 2p24-p21	Epidermodysplasia verruciformis, 226400 (3)	
17.836	1	21	97	17q25.1	EVPL		Envoplakin	601590	REa, A			
17.837	1	12	95	17q25.3	FASN		Fatty acid synthase	600212	A			
17.838	12	18	07	17q25.3	FN3KRP		Fructosamine 3-kinase-related protein	611683	REc			
17.839	1	18	12	17q25.3	FOXK2, ILF1		Forkhead box K2 (interleukin enhancer-binding factor 1)	147685	REa, A			
17.840	6	25	03	17q25.3	FSCN2, RFSN, RP30		Fascin, sea urchin, homolog of, 2	607643	A, REc	within 200kb of ACTG1	Retinitis pigmentosa 30, 607921 (3)	
17.841	3	17	98	17q25.3	GCGR		Glucagon receptor	138033	A, Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
17.842	6	20	94	17q25.1	GRIN2C, NMDAR2C		Glutamate receptor, ionotropic, N-methyl D-aspartate 2C	138254	A			
17.843	2	16	96	17q25.1	H3F3B		H3 histone, family 3B (H3.3B)	601058	A			
17.844	2	7	01	17q25.3	HGS, HRS		Human growth factor-regulated tyrosine kinase substrate	604375	REa, A			
17.845	11	12	07	17q25.1	JMJD6, PSR		Jumonji domain containing 6 (phosphatidylserine receptor)	604914	REc			
17.846	5	29	01	17q24.3	KCNJ16, KIR5.1		Potassium channel, inwardly rectifying, subfamily J, member 16	605722	R			
17.847	7	12	95	17q25.3	LGALS3BP		Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein)	600626	A			11(Lgals3bp)
17.848	8	20	99	17q25.3	MAFG		v-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein G	602020	A			
17.849	4	7	15	17q25.3	P4HB, PROHB, CLCRP1		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide	176790	S, REa, A, C		Cole-Carpenter syndrome 1, 112240 (3)	
17.850	10	7	10	17q25.3	PDE6G, PDEG, RP57		Phosphodiesterase-6G, cGMP-specific, rod, gamma	180073	REa, A, Fd		Retinitis pigmentosa 57, 613582 (3)	11(Pdeg)
17.851	11	11	10	17q25.1	NUP85, PCNT1, PCNT		Nucleoporin 85kD	170285	REc			
17.852	5	22	14	17q25.1	RECQL5, RECQ5		DNA helicase, RecQ-like 5	603781	A			
17.853	10	20	99	17q25.3	RFNG		Radical fringe	602578	REa			11(Rfng)
17.854	2	25	11	17q25.3	RNF213, ALO17, KIAA1618, MYMY2		Ring finger protein 213	613768	Psh, REc, Fd		{Moyamoya disease 2, susceptibility to}, 607151 (3)	
17.855	7	20	06	17q25.3	SEPT9, MSF, MSF1, NAPB		Septin 9	604061	Ch, REa, Fd		Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1); Amyotrophy, hereditary neuralgic, 162100 (3)	
17.856	4	6	15	17q25.3	SLC26A11		Solute carrier family 26 (sulfate transporter), member 11	610117	REc, H			11(Slc26a11)
17.857	12	7	11	17q25.1	SRSF2, SFRS2, SC35		Serine/arginine-rich splicing factor 2	600813	H, REc			11(Sfrs2)
17.858	11	22	16	17q25.3	TBCD, PEBAT		Tubulin-specific chaperone D	604649	REc		Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3)	
17.859	9	22	93	17q25.3	TIMP2		Tissue inhibitor of metalloproteinase-2	188825	H, REa, A			11(Timp2)
17.860	4	14	10	17q25.3	TMC6, EVER1, EV1		Transmembrane channel-like 6	605828	Fd, REc		Epidermodysplasia verruciformis, 226400 (3)	
17.861	12	4	02	17q25.3	SYNGR2		Synaptogyrin 2	603926	A, REc	pseudogene on 15q11; near EV1, EV2, TK1		
17.862	8	25	17	17q25.1	WBP2, DFNB107		WW domain-binding protein 2	606962	A		Deafness, autosomal recessive 107, 617639 (3)	
17.863	6	25	99	17q25.3	MRPL12, RPML12		Ribosomal protein, mitochondrial, L12	602375	A			
17.864	4	20	11	17q25.1	ACOX1, ACOX, SCOX		Acyl-Coenzyme A oxidase 1, palmitoyl	609751	A, Psh		Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	
17.865	10	10	18	17q25.1	ATP5PD, APT5H		ATP synthase, peripheral stalk, subunit D	618121	REc			
17.866	9	24	15	17q25.1	CD300H		CD300H antigen	616560	REc			
17.867	4	10	15	17q25.1	CD300LD, CD300D		CD300 antigen-like family, member D	616301	REc			
17.868	1	22	07	17q25.1	CD300LB, TREM5, IREM3		CD300 antigen-like family, member B	610705	REc			11(Cd300lb)
17.869	8	29	08	17q25.1	CASKIN2, KIAA1139		CASK-interacting protein 2	612185	R, REc			
17.870	12	23	05	17q25.1	CD300E, CD300LE, IREM2, CLM2		CD300E antigen	609801	REc			
17.871	12	23	05	17q25.1	CD300LF, IGSF13, IREM1, CLM1		CD300 antigen-like family, member F	609807	REc			
17.872	1	14	11	17q25.1	COG1, LDLB, KIAA1381, CDG2G		Component of oligomeric golgi complex 1	606973	R, REc		Congenital disorder of glycosylation, type IIg, 611209 (3)	
17.873	9	14	05	17q25.1	EXOC1, EX070, KIAA1067		Exocyst complex component 7	608163	R, REc			
17.874	2	12	16	17q25.1	FGF1, ALB		FAS-binding factor 1	616807	REc			
17.875	6	13	12	17q25.1	GPR142, PGR2		G protein-coupled receptor 142	609046	REc			11(Gpr142)
17.876	11	27	17	17q25.1	HID1, 17orf28, DMC1		HID1 domain-containing protein 1	605752	REc			
17.877	3	10	11	17q25.1	ICT1, DS1		Immature colon carcinoma transcript 1	603000	REc			
17.878	7	26	10	17q25.1	KCTD2, KIAA0176		Potassium channel tetramerization domain-containing 2	613422	R, REc			
17.879	8	22	14	17q25.1	METTL23, C17orf95, MRT44		Methyltransferase-like 23	615262	REc		Mental retardation, autosomal recessive 44, 615942 (3)	
17.880	12	2	14	17q25.1-q25.3	NDNC9		Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)	614149	Fd	max lod at D17S1301	Nail disorder, nonsyndromic congenital, 9 (2)	
17.881	6	24	08	17q25.1	MIF4GD, SLIP1		MIF4G domain-containing protein	612072	REc			
17.882	3	14	06	17q25.1	RAB37		Pas-associated protein RAB37	609956	R, REc			
17.883	4	19	12	17q25.1	RHBDF2, IRHOM2, TOC		Rhomboid 5, Drosophila, homolog of, 2	614404	REc		Tylosis with esophageal cancer, 148500 (3)	
17.884	10	22	10	17q25.1	SAP30BP, HTRP, HCNGP, HTRG		SAP30-binding protein	610218	R, REc			
17.885	10	18	15	17q25.1	SDK2, KIAA1514		Sidekick, Drosophila, homolog of, 2	607217	REc			
17.886	9	23	08	17q25.1	SLC9A3R1, EBP50, NHERF1, NPHLOP2		Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1	604990	R, REc		Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	
17.887	4	6	01	17q25.1	SRP68		Signal recognition particle, 68kD	604858	R, A			
17.888	8	19	13	17q25.1	ST6GALNAC1, SIAT7A, STYI		ST6 alpha-N-aetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	610138	REc			
17.889	3	20	14	17q25.1	ST6GALNAC2, SIAT7B, SAITL1		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	610137	REc, Psh			
17.890	2	10	17	17q25.1	TEN1, C17orf106		TEN1, CST complex subunit	613130	REc			
17.891	2	13	15	17q25.1	TSEN54, SEN54, PCH2A, PCH4, PCH5		tRNA splicing endonuclease 54, S. cerevisiae, homolog of	608755	REc	mutation identified in 1 PCH5 patient	Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar hypoplasia type 4, 225753 (3); ?Pontocerebellar hypoplasia type 5, 610204 (3)	
17.892	9	16	12	17q25.1	TTYH2		Tweety, Drosophila, homolog of, 2	608855	REc			
17.893	8	31	17	17q25.1	UBE2O, KIAA1734		Ubiquitin-conjugating enzyme E2O	617649	REc			11(Ube2o)
17.894	9	3	04	17q25.1	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3		UNC13, C. elegans, homolog of, D	608897	Fd, REc		Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	
17.895	5	19	15	17q25.1	UNK, UNKEMPT, ZC3H5, KIAA1753		Unkempt family zinc finger protein	616375	REc			
17.896	5	20	99	17q25.3	NPTX1, NP1		Pentraxin I, neuronal	602367	A			11(Nptx1)
17.897	1	6	97	17q25.2-q25.3	SEC14L		SEC14, S. cerevisiae, like	601504	A			
17.898	5	7	01	17q25.1	GPRC5C, RAIG3		G protein-coupled receptor, family C, group 5, member C	605949	REc			
17.899	7	12	02	17q25.1	SPHK1		Sphingosine kinase	603730	REc			
17.900	1	2	91	17q25.3	CD7		CD7 antigen (p41)	186820	S, A			11(Cd7)
17.901	4	11	02	17q25.3	GAA		Glucosidase, acid alpha-	606800	S, A, D, C	distal to TK1	Glycogen storage disease II, 232300 (3)	
17.902	6	25	99	17q25.3	SECTM1, K12		Secreted and transmembrane 1	602602	REn			
17.903	3	8	96	17q25.3	TK1		Thymidine kinase-1	188300	S, Ch, R, C, Fd, A			11(Tk1)
17.904	10	31	00	17q25.3	AATK, AATYK		Apoptosis-associated tyrosine kinase	605276	REa, A			
17.905	4	19	12	17q25.3	ACTG1, DFNA20, DFNA26, BRWS2		Actin, gamma-1	102560	REa, A, Fd		Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter syndrome 2, 614583 (3)	
17.906	5	2	16	17q25.3	ALYREF, THOC4, ALY, BEF		ALY/REF export factor	604171	REc			
17.907	3	30	12	17q25.3	ANAPC11, APC11		Anaphase-promoting complex subunit 11	614534	REc			
17.908	8	1	14	17q25.3	ARHGDIA, GDIA1, NPHS8		Rho GDP dissociation inhibitor (GDI) alpha	601925	A, REa		Nephrotic syndrome, type 8, 615244 (3)	
17.909	10	12	09	17q25.3	ATOD4		Dermatitis, atopic, 4	605805	Fd	maximum lod at D17S1290	{Dermatitis, atopic, susceptibility to, 4} (2)	
17.910	2	1	11	17q25.3	AZI1, ZA1, KIAA1118		5-azacytidine-induced gene 1, mouse, homolog of	613479	R, REc			
17.911	8	31	17	17q25.3	BAHCC1, BAHD2, KIAA1447		BAH domain- and coiled-coil domain-containing protein 1	617646	Psh, REc			
17.912	8	2	13	17q25.3	B3GNTL1		Beat-1,3-N-acetylglucosaminyltransferase-like 1	615337	REc			
17.913	3	23	14	17q25.3	C17orf70, FAAP100		Chromosome 17 open reading frame 70	611301	REc			
17.914	10	13	17	17q25.3	CANT1, SCAN1, DBQD1, EDM7		Calcium-activated nucleotidase 1	613165	REc		Desbuquois dysplasia 1, 251450 (3); Epiphyseal dysplasia, multiple, 7, 617719 (3)	
17.915	12	1	14	17q25.3	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP		Caspase recruitment domain-containing protein 14	607211	Fd, REc		Psoriasis 2, 602723 (3); Pityriasis rubra pilaris, 173200 (3)	
17.916	11	11	14	17q25.3	CBX4, PC2		Chromobox homolog 4, Drosophila polycomb class	603079	REc			
17.917	3	18	17	17q25.3	CBX8, PC3		Chromobox homolog 8	617354	REc			
17.918	3	15	11	17q25.3	CCDC40, KIAA1640		Coiled-coil domain-containing protein 40	613799	REc		Ciliary dyskinesia, primary, 15, 613808 (3)	
17.919	10	5	11	17q25.3	CCDC137		Coiled-coil domain-containing protein 137	614271	REc			
17.920	4	17	07	17q25.3	CHMP6		CHMP family, member 6	610901	R, REc			
17.921	4	7	14	17q25.3	DCXR, P34H, PNTSU		Dicarbonyl/L-xylulose reductase	608347	R, REc		[Pentosuria], 260800 (3)	
17.922	3	11	14	17q25.3	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS		DEAD/H Box 48	608546	REc		Robin sequence with cleft mandible and limb anomalies, 268305 (3)	
17.923	6	26	16	17q25.3	ENPP7		Ectonucleotide pyrophosphatase/phosphodiesterase 7	616997	REc			
17.924	8	26	15	17q25.3	FAM195B, MCRIP1		Family with sequence similarity 194, member B	616514	REc			
17.925	8	8	13	17q25.3	FN3K		Fructosamine 3-kinase	608425	REc, A			
17.926	6	25	99	17q25.1	GALR2, GALNR2		Galanin receptor 2	603691	A			
17.927	10	7	02	17q25.3	GPR14, UTR2, UTR		G protein-coupled receptor-14 (urotensin II receptor)	600896	A			
17.928	2	12	07	17q25.3	GPS1		G protein pathway suppressor 1	601934	R, REc			
17.929	3	10	15	17q25.3	IS5		Scoliosis, idiopathic, susceptibility to, 5	612239	Fd	between D17S1806 and 17qter	{Scoliosis, idiopathic, susceptibility to, 5} (2)	
17.930	4	19	07	17q25.1	LGICZ1, ZAC, L2		Ligand-gated ion channel, zinc-activated, 1	610935	REc, REn			
17.931	2	25	15	17q25.3	METRNL		Meteorin-like protein	616241	REc			
17.932	12	4	08	17q25.2	MGAT5B		Alpha-1,6-mannosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase isozyme B	612441	REc			
17.933	7	1	11	17q25.3	MIR338, MIRN338		Micro RNA 338	614059	REc			
17.934	3	18	08	17q25.3	NAGLUEB, FLJ21865		N-acetylglucosaminidase, endo-beta	611898	R, REc			
17.935	1	24	06	17q25.3	NOTUM		Notum, Drosophila, homolog of	609847	REc			
17.936	2	25	15	17q25.3	NPB, PPL7		Neuropeptide B	607996	REc			
17.937	6	13	14	17q25.1	OTOP2		Otopetrin 2	607827	REc, H			11(Otop2)
17.938	6	13	14	17q25.1	OTOP3		Otopetrin 3	607828	REc, H			11(Otop3)
17.939	12	17	12	17q25.3	PGS1		Phosphatidylglycerophosphate synthase 1	614942	REc			
17.940	1	31	12	17q25.3	PYCR1, PRO3, ARCL2B, ARCL3B		Pyrroline-5-carboxylate reductase-1	179035	REa		Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	
17.941	2	1	01	17q25.3	RAC3		Ras-related C3 botulinum toxin substrate-3 (rho family, small GTP-binding protein Rac3)	602050	Psh, A			
17.942	6	26	16	17q25.3	RBFOX3, FOX3, NEUN, HRNBP3		RNA-binding protein FOX1, C. Elegans, homolog of, 3	616999	REc			
17.943	12	2	09	17q25.3	RPTOR, RAPTOR, KIAA1303		Regulatory-associated protein of MTOR	607130	REc			
17.944	2	2	11	17q25.3	SGSH, MPS3A, SFMD		N-sulfoglucosamine sulfohydrolase (sulfamidase)	605270	A		Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	11(Sgsh)
17.945	8	17	10	17q25.3	SIRT7, SIR2L7		Sirtuin 7 (Sir2, S. cerevisiae, homolog of, 7)	606212	REc			
17.946	3	26	02	17q25.3	SLC25A10, DIC		Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier)	606794	A			
17.947	2	13	12	17q25.1	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4		Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19	606521	A, Fd, REc		Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	
17.948	8	26	15	17q25.3	SLC38A10		Solute carrier family 38 (amino acid transporter), member 10	616525	REc			
17.949	10	8	09	17q25.3	SOCS3, SSI3, CIS3		Suppressor of cytokine signaling 3	604176	REc			
17.950	4	6	13	17q25.3	STRA13, CENPX, FAAP10, MHF2, D9		Stimulated by retinoic acid 13	615128	REc			
17.951	11	15	15	17q25.3	TBC1D16		TBC1 domain family, member 16	616637	REc			
17.952	2	13	14	17q25.3	TEX19		Testis-expressed gene 19	615647	REc			
17.953	1	31	07	17q25.3	TNRC6C, KIAA1582		Trinucleotide repeat-containing gene 6C	610741	R, REc			
17.954	1	27	09	17q25.3	USP36, KIAA1453		Ubiquitin-specific protease 36	612543	REa, REc			
17.955	5	17	18	17q25.3	WDR45B, WIPI3, WDR45L, NEDSBAS		WD repeat domain 45B	609226	REc		Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3)	
17.956	7	9	06	17q25.3	ZNF750, FLJ13841		Zinc finger protein 750	610226	REc, Fd		Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	
17.957	1	7	02	17q25.3	NPL4, KIAA1499		Npl4, S. cerevisiae, homolog of	606590	Psh, A			
17.958	5	26	98	17q22	AKAP1, AKAP149, SAKAP84		A-kinase anchor protein 1, 149kD	602449	TM			
17.959	4	30	03	17q12	AP1GBP1, SYNG		Adaptor-related protein complex 1 gamma subunit-binding protein 1	607291	R			
17.960	11	5	98	17q21.32	ATP5G1		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 1	603192	REc			
17.961	8	29	02	17q12	CCL1, SCYA1		Chemokine, C-C motif, ligand 1	182281	REa			
17.962	5	22	03	17p13.1	CENTB1, KIAA0050, ACAP1		Centaurin, beta-1	607763	Psh			
17.963	11	1	02	17q21.31	CLP1, HIS1		Cardiac lineage protein 1	607328	R			
17.964	12	11	02	17q12	DUSP14, MKP6		Dual-specificity phosphatase 14	606618	R			
17.965	10	7	02	17p11.2	EPN2, KIAA1065		Epsin 2	607263	R			
17.966	10	7	02	17q21.33	EPN3		Epsin 3	607264	REc			
17.967	4	10	90	Chr.17	G6PDL		Glucose-6-phosphate dehydrogenase-like	138110	REa, REb			
17.968	12	19	01	17q25.1	GGA3, KIAA0154		Golgi associated, gamma adaptin ear containing, ARF binding protein 3	606006	R			
17.969	6	25	99	17q22	MTMR4		Myotubularin-related protein 4	603559	R, REc			
17.970	12	27	01	17p13.1	NLGN2, KIAA1366		Neuroligin 2	606479	R			
17.971	2	3	03	17p13.1	NUDEL		Nude-like protein (endooligopeptidase A)	607538	R			
17.972	3	20	15	Chr.17	ODS1		Opioid dependence, susceptibility to, 1	610064	Fd		{Opioid dependence, susceptibility to, 1} (2)	
17.973	6	2	98	17p13.1	PFAS, FGARAT		phosphoribosylformylglycinamidine synthase (FGAR amidotransferase)	602133	REa, A			
17.974	3	23	02	17p11.2	TRPV2, VRL1		Transient receptor potential cation channel, subfamily V, member 2	606676	R			
17.975	11	21	02	17q23.1	TUBD1, TUBD		Tubulin, delta-1	607344	REc			
18.1	8	26	09	18p11.32	CETN1, CEN1		Centrin-1	603187	REa, REc			
18.2	6	14	94	18pter-p11.21	ERV1		Oncogene ERV1; endogenous retrovirus-1	131150	REa, A			
18.3	3	10	03	18p11.32	COLEC12, SRCL, CLP1		Collectin 12	607621	REc			
18.4	12	15	10	18p11.32	ENOSF1, RTS		Enolase superfamily member 1	607427	REn			
18.5	2	27	17	18p11.32	SMCHD1, KIAA0650, BAMS		Structural maintenance of chromosomes flexible hinge domain-containing protein 1	614982	REc		Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3); Bosma arhinia microphthalmia syndrome, 603457 (3)	17(Smchd1)
18.6	10	20	92	18p11.32	TYMS, TS, TMS		Thymidylate synthase	188350	S, A	<50 kb from YES1		
18.7	8	26	09	18p11.32	THOC1, HPR1		THO complex 1 (nuclear matrix protein p84)	606930	R, REc			
18.8	3	14	06	18p11.32-p11.31	DFNB46		Deafness, neurosensory, autosomal recessive 46	609647	Fd	between D18S59 and D18S391	Deafness, autosomal recessive 46 (2)	
18.9	11	30	06	18p11.31	ARHGAP28, KIAA1314		RHO GTPase-activating protein 28	610592	R, REc			
18.10	6	19	15	18p11.31	C18orf42		Chromosome 18 open reading frame 42	616427	REc			
18.11	7	14	14	18p11.31	DLGAP1, DAP1, DLGAP1A, DLGAP1B		Discs large-associated protein 1	605445	REc			
18.12	9	29	16	18p11.31	L3MBTL4		L3MBT-like 4	617135	REc			
18.13	9	20	14	18p11.31	LAMA1, PTBHS		Laminin, alpha-1	150320	A		Poretti-Boltshauser syndrome, 615960 (3)	17(Lama)
18.14	7	20	09	18p11.31	MYL12B, MRLC2		Myosin, light chain 12B, regulatory	609211	R, REc			
18.15	12	4	12	18p11.31	MYOM1, SKELEMIN		Myomesin 1	603508	Psh, A, REc			
18.16	11	12	98	18p11.31	MYP2		Myopia, high grade, autosomal dominant 1	160700	Fd		Myopia-2 (2)	
18.17	11	16	10	18p11.22	NDUFV2		NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kD	600532	REa, A	pseudogene on 19q13.3-qter	Mitochondrial complex I deficiency, 252010 (3)	
18.18	6	26	16	18p11.32	CLUL1		Clusterin-like protein 1	616990	R, REc			
18.19	11	13	12	18p11.3	POROK6, DSAP4		Porokeratosis 6	612353	Fd	between telomere and D18S391	Porokeratosis 6, multiple types (2)	
18.20	4	3	01	18p11.31	EPB41L3, DAL1		Erythrocyte membrane protein band 4.1-like 3	605331	REc			
18.21	11	18	11	18p11.3	MRT19		Mental retardation, autosomal recessive 19	614343	Fd	between rs4606805 and rs1787846	Mental retardation, autosomal recessive 19 (2)	
18.22	3	6	01	18p11.22	RAB31		Ras-associated protein RAB31	605694	REa, REc			
18.23	5	4	10	18p11.31	TGIF1, HPE4		TG-interacting factor 1	602630	Ch, A		Holoprosencephaly 4, 142946 (3)	
18.24	4	25	93	18p11.32	YES1		Oncogene YES-1	164880	REa, REn, A	<50 kb from TYMS		
18.25	2	12	07	18p11.3-p11.2	AA1		Alopecia areata 1	104000	Fd	max lod at D18S967	Alopecia areata 1 (2)	
18.26	7	13	93	18p11.21	PTPN2, PTPT		Protein tyrosine phosphatase, nonreceptor-type, 2	176887	REc, A			18(Ptpt)
18.27	9	27	02	18p11.22	TWSG1, TSG		Twisted gastrulation, Drosophila, homolog of	605049	R			17(Tsg)
18.28	12	18	08	18p11.23	PSORS10		Psoriasis susceptibility 10	612410	Fd	between D18S63 and D18S967	{Psoriasis susceptibility 10} (2)	
18.29	6	18	99	18p11.21	RNMT, MET		RNA guanine-7-methyltransferase	603514	A, R			
18.30	1	28	05	18p11.23-q12.2	ANIC		Anosmia, isolated congenital	107200	Fd	max lod at D18S1108	Anosmia, isolated congenital (2)	
18.31	11	30	06	18p11.22	ANKRD12, ANCO1, KIAA0874		Ankyrin repeat domain-containing protein 12	610616	R, REc			
18.32	12	30	14	18p11.22	GACAT2, MTCL1AS1		Gastric cancer-associated transcript 2, noncoding	616131	REc			
18.33	4	29	14	18p11.22	MTCL1, KIAA0802		Microtubule crosslinking factor 1	615766	REc, R			
18.34	4	29	14	18p11.22	NAPG		N-ethylmaleimide-sensitive factor attachment protein, gamma	603216	REc			
18.35	10	12	16	18p11.22-p11.21	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT		PIEZO-type mechanosensitive ion channel component 2	613629	REc	mutation identified in 1 MWKS patient	Arthrogryposis, distal, type 5, 108145 (3); Arthrogryposis, distal, type 3, 114300 (3); ?Marden-Walker syndrome, 248700 (3); Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3)	
18.36	8	26	09	18p11.22	PPP4R1, PP4R1		Protein phosphatase 4, regulatory subunit 1	604908	R, REc			
18.37	7	20	15	18p11.22	RAB12		Ras-associated protein RAB12	616448	REc			
18.38	11	29	17	18p11.22	TXNDC2, SPTRX1		Thioredoxin domain-containing protein 2	617790	REc			
18.39	8	26	09	18p11.22	VAPA, VAP33		Vesicle-associated membrane protein-associated protein A	605703	R, REc			
18.40	9	28	15	18p11.21	ANKRD30B		Ankyrin repeat domain-containing protein 30B	616565	REc			
18.41	6	19	15	18p11.21	CEP192, PPP1R62, KIAA1569		Centrosomal protein, 192kD	616426	Psh, REc			
18.42	2	14	12	18p11.21	CIDEA		Cell death-inducing DFFA-like effector A	604440	REc			
18.43	5	17	18	18p11.21	FAM210A, C18orf19		Family with sequence similarity 210, member A	617975	REc			
18.44	6	4	13	18p11.21	GNAL, DYT25		Guanine nucleotide-binding protein, alpha-subunit, olfactory type	139312	REc		Dystonia 25, 615073 (3)	18(Gnal)
18.45	9	11	15	18p11.21	PRELID3A, SLMO1, C18orf43		PRELI domain-containing protein 3A	616545	REc			
18.46	10	28	08	18p11.21	PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2		Proteasome (prosome, macropain) assembly chaperone 1	609702	R, REc			
18.47	4	14	05	18p11.21	SEH1L, SEH1, SEC13L		Seh1-like protein	609263	REc			
18.48	10	25	17	18p11.21	TUBB6, FPVEPD		Tubulin, beta-6	615103	REc	mutation identified in 1 FPVEPD family	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3)	
18.49	6	18	99	18p11.31	ZFP161, ZF5		Zinc finger protein-161	602126	Psh			17(Zfp161)
18.50	12	19	01	18p11.21	C18orf1		Chromosome 18 open reading frame 1	606571	REc			
18.51	9	30	02	18p11.2	DYX6, DYXQTL18		Dyslexia, susceptibility to, 6	606616	Fd		{Dyslexia, susceptibility to, 6} (2)	
18.52	8	9	05	18p11.2	FEB6		Febrile seizures, familial, 6	609253	Fd	max lod at D18S1158	Febrile seizures, familial, 6 (2)	
18.53	5	16	01	18p11.21	IMPA2		Myo-inositol monophosphatase 2	605922	REc			
18.54	12	4	02	18p11.21	MC2R		Melanocortin-2 receptor (ACTH receptor)	607397	A, Psh		Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	18(Mc2r)
18.55	5	17	95	18p11.21	MC5R		Melanocortin-5 receptor	600042	A			
18.56	3	20	08	18p11.21	MPPE1		Metallophosphoesterase 1	611900	REc			
18.57	11	4	93	18p11.23	PTPRM, PTPRL1, RPTPM		Protein tyrosine phosphatase, receptor type, mu polypeptide	176888	REa, A			
18.58	7	13	93	18p11.32	ADCYAP1		Adenylate cyclase activating polypeptide-1 (pituitary)	102980	A			
18.59	10	27	16	18p11.21	AFG3L2, SCA28, SPAX5		ATPase family gene 3-like 2	604581	R, Fd		Spinocerebellar ataxia 28, 610246 (3); Spastic ataxia 5, autosomal recessive, 614487 (3)	
18.60	7	16	14	18p11.22	APCDD1, HHS, HYPT1, HTS		Adenomatosis polyposis coli down-regulated 1	607479	REc		Hypotrichosis 1, 605389 (3)	
18.61	3	29	07	18p11.21	CHMP1B, C10orf2		CHMP family, member 1B	606486	REc			
18.62	1	16	03	18p11	DYT15		Dystonia-15, myoclonic	607488	Fd		Dystonia-15, myoclonic (2)	
18.63	10	28	08	18p11	IBD21		Inflammatory bowel disease 21	612354	Fd	associated with rs2542151	{Inflammatory bowel disease 21} (2)	
18.64	8	27	01	18p11.22	RALBP1, RLIP76		RALA-binding protein 1	605801	A			
18.65	1	24	09	18p	DEL18p, C18DELp		Chromosome 18p deletion syndrome	146390	Ch		Chromosome 18p deletion syndrome (4)	
18.66	5	26	98	18p	DYT7		Dystonia-7 (torsion dystonia, adult-onset, focal)	602124	Fd		Dystonia-7, torsion (2)	
18.67	1	15	09	18p11.31	LPIN2		Lipin 2	605519	REc		Majeed syndrome, 609628 (3)	17(Lpin2)
18.68	5	6	08	18p	MAFD1, BPAD, MD1		Major affective disorder 1	125480	Fd	?also 18q	{Major affective disorder 1} (2)	
18.69	12	15	98	18p	SCZD8		Schizophrenia susceptibility locus, chromosome 18-related	603206	Fd		{Schizophrenia}, 181500 (2)	
18.70	10	18	11	18p	TET18P		Tetrasomy 18p	614290	Ch		Tetrasomy 18p (4)	
18.71	2	28	03	18p11.32	USP14, TGT		Ubiquitin-specific protease 14	607274	R, REc			18(Usp14, ax)
18.72	11	16	08	18q	DEL18q		Chromosome 18q deletion syndrome	601808	DS		Chromosome 18q deletion syndrome (4)	
18.73	11	12	98	18q	OHDS		Orthostatic hypotensive disorder of Streeten	143850	Fd		Orthostatic hypotensive disorder of Streeten (2)	
18.74	8	20	99	18q21.1	RPL17		Ribosomal protein L17	603661	REa, R			
18.75	10	26	99	18q12.1	B4GALT6		Beta-1,4-galactosyltransferase 6	604017	TM			
18.76	3	13	03	18q11.2	NPC1, NPC		NPC1 gene	607623	Ch, H, Fd, M	some families not linked to 18; type D prob. allelic	Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease, type D, 257220 (3)	18(spm)
18.77	5	7	03	18q11.2	OSBPL1A, ORP1		Oxysterol-binding protein-like protein 1A	606730	R, REc			
18.78	4	5	11	18q12.3	SLC14A1, JK, UTE, UT1		Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)	613868	Fd, EM, A	previous suggestion of chr.7 or chr.2	[Blood group, Kidd], 111000 (3)	
18.79	8	29	08	18q11.2	ABHD3, LABH3		Abhydrolase domain-containing 3	612197	R, REc			
18.80	12	19	17	18q11.1-q11.2	GREB1L, C18orf6, KIAA1772, RHDA3		GREB1-like protein	617782	Psh, REc		Renal hypodysplasia/aplasia 3, 617805 (3)	
18.81	1	28	09	18q11.1	ROCK1		RHO-associated coiled-coil-containing protein kinase 1	601702	R, REc			
18.82	2	24	12	18q11.2	GATA6, AVSD5, ASD9, PACHD		GATA-binding protein-6	601656	A		Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9, 614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)	
18.83	8	11	98	18q12.1	CDH2, NCAD		Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020	REa, A			18(Ncad)
18.84	3	14	15	18q11.2	CHST9, GalNAc4ST2		Carbohydrate sulfotransferase 9	610191	REc			
18.85	12	28	08	18q11.2	ESCO1, ECO1, CTF, ESO1, EFO1, KIAA1911		Establishment of cohesion 1, S. cerevisiae, homolog of, 1	609674	REc			
18.86	5	6	03	18q11.2	HRH4, HH4R		Histamine receptor H4	606792	REc, R			
18.87	7	22	13	18q11.2	KCTD1, SENS		Potassium channel tetramerization domain-containing 1	613420	REc		Scalp-ear-nipple syndrome, 181270 (3)	
18.88	10	15	03	18q11.2	LAMA3, LOCS		Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)	600805	A		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)	
18.89	3	1	13	18q11.2	MIB1, MIB, DIP1, KIAA1323, LVNC7		Mindbomb, Drosophila, homolog of, 1	608677	REc, R		Left ventricular noncompaction 7, 615092 (3)	
18.90	5	24	13	18q11.2	MIR1-2		Micro RNA 1-2	610252	REc			
18.91	5	24	13	18q11.2	MIR133A1		Micro RNA 133A1	610254	REc			
18.92	8	31	17	18q11.2	PCAT18, LINC01092		Prostate cancer-associated transcript 18, noncoding	617647	REc			
18.93	1	19	18	18q11.2	PSMA8, PSMA7L		Proteasome subunit, alpha-type, 8	617841	REc			
18.94	2	21	12	18q11.2	RBBP8, RIM, SCKL2, JWDS		Retinoblastoma-binding protein 8	604124	A		Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3); Jawad syndrome, 251255 (3)	
18.95	10	31	17	18q11.2	RIOK3, SUDD		RIO kinase 3	603579	A, REc, Psh			
18.96	8	18	14	18q11.2	SNRPD1		Small nuclear ribonucleoprotein polypeptide D1	601063	REc			
18.97	6	26	01	18q11.2	SS18, SSXT, SYT		Synovial sarcoma translocation, chromosome 18	600192	Ch, RE	5' SYST/3' SSRC in t(X;18)	Sarcoma, synovial (1)	
18.98	7	7	14	18q11.2	TAF4B, TAF2C2, TAFII105, SPGF13		TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD	601689	R, REc	mutation identified in 1 SPGF13 family	?Spermatogenic failure 13, 615841 (3)	
18.99	11	1	13	18q11.2	TMEM241, C18orf45		Transmembrane protein 241	615430	REc			
18.100	5	22	07	18q11.2	ZNF521, EHZF, EVI3		Zinc finger protein 521	610974	REc			
18.101	12	13	96	18q11.2	AQP4, MIWC		Aquaporin-4	600308	A, Psh			18(Aqp4)
18.102	7	23	13	18q11.2	IMPACT		Impact RWD domain protein	615319	REc, H			18(Impact)
18.103	2	26	10	18q12.1	TTR, PALB		Transthyretin (prealbumin)	176300	REa, A		Amyloidosis, hereditary, transthyretin-related, 105210 (3); [Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)	18(Palb)
18.104	5	23	11	18q11.2-q12.2	APMR3		Alopecia-mental retardation syndrome 3	613930	Fd	between D18S866 and D18S811	Alopecia-mental retardation syndrome 3 (2)	
18.105	8	2	13	18q12.2	CELF4, BRUNOL4		CUGbp- and ELAV-like family, member 4	612679	REc			
18.106	7	16	14	18q12.1	DSG4, LAH, HYPT6		Desmoglein 4	607892	REn		Hypotrichosis 6, 607903 (3)	
18.107	1	8	16	18q12.1-q12.2	MAPRE2, EB2, RP1, CSCSC2		Microtubule-associated protein, RP/EB family, member 2	605789	R, A		Symmetric circumferential skin creases, congenital, 2, 616734 (3)	
18.108	7	18	12	18q12.2	RPRD1A, P15RS, FLJ10656		Regulation of nuclear pre-mRNA domain-containing protein 1A	610347	REc			
18.109	10	1	90	18q12.2	ZNF24		Zinc finger protein-24 (KOX17)	194534	REa, A			
18.110	10	4	05	18q12.2	ZNF396		Zinc finger protein-396	609600	REc			
18.111	10	4	05	18q12.2	ZNF397		Zinc finger protein-397	609601	REc			
18.112	5	1	02	18q12.2	ZNFEB, ZNF271		Epstein-Barr virus-induced zinc finger protein	604754	REc			
18.113	10	12	14	18q21.1	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22		ATP synthase, H+ transporting (ATPase, mitochondrial)	164360	S, REa, A	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3); ?Combined oxidative phosphorylation deficiency 22, 616045 (3)	
18.114	10	13	09	18q21.1	LOXHD1, DFNB77		Lipoxygenase homology domains-containing 1	613072	REc		Deafness, autosomal recessive 77, 613079 (3)	
18.115	5	29	97	18q21.1-q21.2	MAPK4, PRKM4, ERK3		Mitogen-activated protein kinase 4	176949	REa, A			
18.116	3	4	05	18q21.1	DYM, FLJ90130, DMC, SMC		Dymeclin	607461	REc, Fd		Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia, 607326 (3)	
18.117	11	10	13	18q12.1	ASXL3, KIAA1713, BRPS		Additional sex combs-like 3	615115	REc		Bainbridge-Ropers syndrome, 615485 (3)	
18.118	8	25	09	18q12.1	DSC1		Desmocollin-1	125643	REa, REc			
18.119	6	4	12	18q12.1	DSC2, DSC3, ARVD11		Desmocollin-2	125645	REa, Psh, H, REn, A		Arrhythmogenic right ventricular dysplasia 11, 610476 (3); Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	18(Dsc2)
18.120	10	04	14	18q12.1	DSC3, DSC4		Desmocollin-3	600271	A, Psh	mutation identified in 1 HYPTSV family	?Hypotrichosis and recurrent skin vesicles, 613102 (3)	
18.121	2	12	99	18q12.2	GALNT1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1	602273	A			
18.122	6	1	18	18q12.1	GAREM1		GRB2-associated regulator of MAPK1, subtype 1	617998	REc			
18.123	2	24	11	18q12.1	KLHL14, PRINTOR, KIAA1384		Kelch-like 14	613772	REc			
18.124	5	22	14	18q12.1	NOL4, NOLP		Nucleolar protein 4	603577	REc			
18.125	3	12	15	18q12.1	RNF125, TRAC1, TNORS		RING finger protein 125	610432	REc		Tenorio syndrome, 616260 (3)	
18.126	4	22	15	18q12.1	RNF138, NARF		RING finger protein 138	616319	REc			
18.127	12	30	14	18q12.1	SLC25A52, MCART2		Solute carrier family 25, member 52	616153	REc			
18.128	9	8	11	18q12.1	TRAPPC8, KIAA1012		Trafficking protein particle complex, subunit 8	614136	R, REc			
18.129	11	22	13	18q12.1	DSG1, PPKS1, SPPK1, EPKHE		Desmoglein-1	125670	REa, A, REn	pemphigus foliaceous antigen	Keratosis palmoplantaris striata I, AD, 148700 (3); Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	18(Dsg1)
18.130	7	17	09	18q12.1	DSG2, ARVD10, ARVC10, CMD1BB		Desmoglein-2	125671	Psh, REn		Arrhythmogenic right ventricular dysplasia 10, 610193 (3); Cardiomyopathy, dilated, 1BB, 612877 (3)	
18.131	5	26	94	18q12.1	DSG3		Desmoglein-3 (pemphigus vulgaris antigen)	169615	Psh, A, REn			18(Dsg3)
18.132	6	16	10	18q12.1	DTNA, D18S892E, DRP3, LVNC1		Dystobrevin, alpha (dystrophin-related protein 3)	601239	A		Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	
18.133	9	22	98	18q12.3	SLC14A2, UT2, UTR		Solute carrier family 14 (urea transporter), member 2	601611	A			
18.134	8	18	08	18q11.2	CABYR, FSP2		Calcium-binding tyrosine phosphorylation-regulated protein	612135	REc			18(Cabyr)
18.135	12	22	16	18q12.2	ELP2, STATIP1, MRT58		Elongator acetyltransferase complex, subunit 2	616054	REc		Mental retardation, autosomal recessive 58, 617270 (3)	
18.136	12	28	08	18q12.2	FHOD3, FHOS2, KIAA1695		Formin homology-2 domain-containing protein 3	609691	REc			
18.137	7	28	15	18q12.2	KIAA1328, HINDERIN		Hinderin	616480	REc			
18.138	3	31	09	18q12.2	MIR187, MIRN187		Micro RNA 187	612698	REc			
18.139	7	27	16	18q12.2	MOCOS, MCS, XAN2		Molybdenum cofactor sulfurase	613274	REc		Xanthinuria, type II, 603592 (3)	
18.140	3	27	95	18q12.1	MEP1B		Meprin A, beta	600389	REa			8(Mep1b)
18.141	9	28	00	18q12.2-q12.3	OPA4		Optic atrophy 4	605293	Fd		Optic atrophy 4 (2)	
18.142	9	27	17	18q12.3	PIK3C3		Phosphatidylinositol 3-kinase, class 3	602609	REc			
18.143	10	4	12	18q12.3	RIT2, RIN, ROC2		Ric-like protein without CAAX motif 2	609592	REc, R			
18.144	6	2	16	18q12.3	SETBP1, KIAA0437, SEB, MRD29		SET-binding protein 1	611060	R, A, ch	fused with NUP98 in ALL	Schinzel-Giedion midface retraction syndrome, 269150 (3); Mental retardation, autosomal dominant 29, 616078 (3)	
18.145	09	06	18	18q12.3	SIGLEC15		Sialic acid-binding immunoglobulin-like lectin 15	618105	REc			
18.146	2	14	01	18q12.3	SYT4		Synaptotagmin-4	600103	A			18(Syt4)
18.147	11	3	11	18q12.3	VUR6		Vesicoureteral reflux 6	614319	Fd	closest marker rs1054986	Vesicoureteral reflux 6 (2)	
18.148	3	1	13	18q12.3-q21.1	EPG5, KIAA1632, HEEW1, VICIS		Ectopic P-granules autophagy protein 5, C. elegans, homolog of	615068	REc, Psh		Vici syndrome, 242840 (3)	
18.149	12	7	12	18q21.31	ATP8B1, FIC1, BRIC, PFIC1, ICP1		ATPase, class I, type 8B, member 1	602397	Fd, LD		Cholestasis, progressive familial intrahepatic 1, 211600 (3); Cholestasis, benign recurrent intrahepatic, 243300 (3); Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	
18.150	12	2	05	18q21	ALS3		Amyotrophic lateral sclerosis 3	606640	Fd		Amyotrophic lateral sclerosis 3 (2)	
18.151	10	10	14	18q21.2	C18orf54, LAS2		Chromosome 18 open reading frame 54	613258	REc			18(C18orf54)
18.152	9	16	03	18q21.2	ELAC1, D29		Elac, E. coli, homolog of, 1	608079	REc			
18.153	10	23	87	18q21.32	GRP		Gastrin-releasing peptide	137260	REa, A	mammalian equivalent of bombesin		18(Grp)
18.154	12	9	98	18q21	IDDM6		Insulin-dependent diabetes mellitus-6	601941	Fd, LD		{Diabetes mellitus, insulin-dependent, 6} (2)	
18.155	8	24	98	18q21.1	MADH2, JV18, SMAD2		Mothers against decapentaplegic, Drosophila, homolog of, 2	601366	REn			
18.156	4	30	14	18q21.32	MALT1, MLT, IMD12		Mucosa-associated lymphoid tissue lymphoma translocation gene 1	604860	Ch	fused with API2 in MALT lymphoma	Immunodeficiency 12, 615468 (3)	
18.157	2	3	14	18q21.2	MBD2		Methyl-CpG-binding domain protein 2	603547	Psh, A			18(Mbd2)
18.158	3	20	15	18q21.2	ME2		Malic enzyme, mitochondrial	154270	REc	10cM distal to F13A; previously mapped to chr.6		7(Mod2)
18.159	3	23	09	18q21.31	MIR122A, MIRN122A		Micro RNA 122A	609582	REc			
18.160	8	27	08	18q21.2	MRO, B29		Maestro	608080	REc			
18.161	1	24	09	18q21.1	MYO5B, KIAA1119		Myosin VB	606540	REc, H		Microvillus inclusion disease, 251850 (3)	18(Myo5b)
18.162	11	22	16	18q21.31	NEDD4L, KIAA0439, RSP5, PVNH7		Ubiquitin protein ligase NEDD4-like	606384	R		Periventricular nodular heterotopia 7, 617201 (3)	
18.163	4	25	93	18q21	SSAV1		Simian sarcoma-associated virus-1/Gibbon ape leukemia virus	182090	REa, A			
18.164	9	10	07	18q22.1	DSEL, C18orf4, NCAG1		Dermatan sulfate epimerase-like	611125	REc			
18.165	6	28	02	18q21.2	STARD6		Start domain-containing protein 6	607051	REc			
18.166	10	13	15	18q21.1	ZBTB7C, APM1		Zinc finger- and BTB domain-containing protein 7C	616591	A			
18.167	7	19	12	18q21.1	ACAA2		Acetyl-CoA acyltransferase 2	604770	REc			
18.168	8	31	12	18q21.1	CCDC11, HTX6		Coiled-coil domain-containing protein 11	614759	REc		Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	
18.169	6	1	10	18q21.1	HAUS1, CCDC5, HEIC		HAUS augmin-like complex, subunit 1	608775	REc	pseudogenes on 5, 8, and X		
18.170	6	2	16	18q21.1	IER3IP1, MEDS		Immediate-early response 3-interacting protein 1	609382	REc		Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	
18.171	7	6	12	18q21.1	KATNAL2		Katanin, p60 subunit, A-like protein 2	614697	REc			
18.172	12	21	09	18q21.1	KIAA0427, CTIF		KIAA0427 gene	613178	R			
18.173	12	17	07	18q21.1	LIPG, EL, EDL		Lipase G, endothelial	603684	REc			
18.174	7	6	99	18q21.1	MBD1, PCM1		Methyl=CpG binding domain protein 1 (protein containing methyl-CpG binding domain 1)	156535	R			18(Mbd1)
18.175	10	24	00	18q21.2	POLI, RAD30B		Polymerase, DNA, iota	605252	REc, A			18(Rad30b)
18.176	10	12	14	18q21.1	PSTPIP2, MAYP		Proline/serine/threonine phosphatase-interacting protein 2	616046	REc			
18.177	2	25	14	18q21.1	SCARNA17		Small Cajal body-specific RNA 17	615645	REc			
18.178	8	26	09	18q21.1	SIAT8E		Sialyltransferase 8E	607162	R, REc			
18.179	12	2	15	18q21.1	SKA1, C18orf24		Spindle- and kinetochore-associated complex, subunit 1	616673	REc			
18.180	10	11	16	18q21.1	SKOR2, FUSSEL18, CORL2		SKI family transcriptional corepressor 2	617138	REc			
18.181	7	25	16	18q21.2	SMAD4, MADH4, DPC4, JIP, MYHRS		Mothers against decapentaplegic, Drosophila, homolog of, 4	600993	D, R		Pancreatic cancer, somatic, 260350 (3); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3); Polyposis, juvenile intestinal, 174900 (3)	
18.182	8	20	08	18q21.1	SMAD7, MADH7, CRCS3		Mothers against decapentaplegic, Drosophila, homolog of, 7	602932	REa, A		{Colorectal cancer, susceptibility to, 3}, 612229 (3)	
18.183	4	30	15	18q22.2	SOCS6, SSI4, STAT4, CIS4		Suppressor of cytokine signaling 6	605118	R, REc			
18.184	5	25	00	18q21.31	ONECUT2, OC2		One cut domain, family member 2	604894	R			
18.185	7	13	95	18q21.1-q21.3	CORD1, CRD1		Cone rod dystrophy 1, autosomal dominant	600624	Ch		Cone-rod retinal dystrophy-1 (2)	
18.186	8	26	09	18q21.31	NARS, ASNRS		Asparaginyl-tRNA synthetase	108410	REa, S, REc			
18.187	4	21	16	18q21.2	CCDC68		Coiled-coil domain-containing protein 68	616909	REc			
18.188	12	4	08	18q21.2	HYT8		Hypertension, essential, susceptibility to, 8	611014	Fd	associated with rs1941958 and rs1893379	{Hypertension, essential, susceptibility to, 8} (2)	
18.189	4	17	13	18q21.31	LINC-ROR		Long intergenic noncoding RNA, regulator of reprogramming	615173	REc			
18.190	12	4	08	18q21.2	MEX3C, RKHD2		Mex-3, C. elegans, homolog of, C	611005	REc			
18.191	7	29	15	18q21.2	TCF4, SEF2, ITF2, PTHS, FECD3		Transcription factor-4 (immunoglobulin transcription factor-2)	602272	Fd, R, Ch		Pitt-Hopkins syndrome, 610954 (3); Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	
18.192	10	10	05	18q21.33	BCL2		B-cell CLL/lymphoma-2	151430	Ch, RE, REn	most frequent hematologic malignancy t(14;18)(q32;q21)	Leukemia/lymphoma, B-cell, 2 (3)	1(Bcl2)
18.193	5	27	97	18q21.3	CNSN		Carnosinemia (carnosinase)	212200	Ch		Carnosinemia (2)	
18.194	7	6	17	18q21.2	DCC, MRMV1, HGPPS2		Deleted in colorectal carcinoma	120470	D, RE		Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3); Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3); Colorectal cancer, somatic, 114500 (3); Esophageal carcinoma, somatic, 133239 (3)	18(Dcc)
18.195	6	20	18	18q21.31	FECH, FCE, EPP1		Ferrochelatase	612386	A, REb		Protoporphyria, erythropoietic, 1, 177000 (3)	
18.196	6	13	17	18q21.33	KDSR, FVT1, EKVP4		3-ketodihydrosphingosine reductase	136440	RE	~10kb 5' to BCL2	Erythrokeratodermia variabilis et progressiva 4, 617526 (3)	
18.197	6	25	08	18q22.1	HMSD		Minor histocompatibility antigen, serpin domain-containing	612086	REc			
18.198	5	17	95	18q21.33	PI5, SERPINB5		Protease inhibitor 5 (maspin)	154790	REn, Psh	in cluster of serpins		
18.199	9	16	16	18q22.1	SERPINB8, PI8, CAP2, PSS5		Serpin family B, member 8	601697	Psh, REn		Peeling skin syndrome 5, 617115 (3)	
18.200	3	14	08	18q21.32	RAX, RX, MCOP3		Retina and anterior neural fold homeobox gene	601881	REc		Microphthalmia, isolated 3, 611038 (3)	
18.201	6	7	10	18q21.3-q22.1	SERPINB2, PAI2, PLANH2		Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (Plasminogen activator inhibitor, type II (arginine-serpin))	173390	REa, A, REn	600kb telomeric to BCL2		
18.202	3	23	14	18q21.33	SERPINB11		Serpin peptidase inhibitor, clade B (ovalbumin), member 11	615682	REc, H			1(Serpinb11)
18.203	2	25	14	18q21.33	SERPINB12		Serpin peptidase inhibitor, clade (ovalbumin), member 12	615662	REc			
18.204	11	27	00	18q21.33	SERPINB13, PI13, HURPIN		Protease inhibitor 13	604445	REc			
18.205	4	11	11	18q21.33	SERPINB3, SCCA1		Serpin peptidase inhibitor, clade B (ovalbumin), member 3 (squamous cell carcinoma antigen 1)	600517	REn, Psh, A			
18.206	3	21	02	18q21.33	SERPINB4, SCCA2		Serpin peptidase inhibitor, clade B (ovalbumin), member 4 (squamous cell carcinoma antigen 2)	600518	REn			
18.207	1	7	14	18q21.33	SERPINB7, MEGSIN, PPKN		Serpin peptidase inhibitor, clade B (ovalbumin), member 7	603357	REc		Palmoplantar keratoderma, Nagashima type, 615598 (3)	
18.208	11	5	97	18q22.1	SERPINB10, PI10		Protease inhibitor 10, ovalbumin type (bomapin)	602058	Psh, REn			
18.209	3	24	06	18q21.33	VPS4B, SKD1		Vacuolar protein sorting 4, yeast, homolog of, B	609983	R, A, REc, H			1(Vps4b)
18.210	9	29	10	18q21.31	WDR7, TRAG, KIAA0541		WD repeat-containing protein 7	613473	R, A, H, REc			18(Wdr7)
18.211	6	16	98	18q21.32	LMAN1, ERGIC53, F5F8D, MCFD1		Lectin, mannose-binding, 1	601567	A, Fd		Combined factor V and VIII deficiency, 227300 (3)	
18.212	7	20	12	18q21.31	TXNL1, TXNL		Thioredoxin-like 1	603049	REc			
18.213	9	30	14	18q21.32	CCBE1, KIAA1983, HKLLS1		Collagen and calcium-binding EGF domain-containing protein 1	612753	REc		Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	
18.214	3	31	15	18q21.32	PMAIP1, APR, NOXA		Phorbol-12-myristate-13-acetate-induced protein 1	604959	REc			
18.215	3	8	12	18q21.33	PHLPP1, SCOP, KIAA0606		PH domain and leucine-rich repeat protein phosphatase	609396	REc			
18.216	7	22	11	18q21.33	PIGN, MCAHS1		Phosphatidylinositol glycan, class N	606097	R, REc		Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	
18.217	6	1	18	18q21.33	RELCH, KIAA1468		RAB11 effector containing LIS1 homology domain, coiled-coil domains, and HEAT repeats	618001	REc			
18.218	8	26	15	18q21.33	RNF152		Ring finger protein 152	616512	REc			
18.219	1	20	09	18q22	DUP18pDEL18q, DUP18qDEL18p		Chromosome 18 pericentric inversion	609334	Ch		Chromosome 18 pericentric inversion (4)	
18.220	11	19	98	18q21.32	MC4R		Melanocortin-4 receptor	155541	A, R		Obesity, autosomal dominant, 601665 (3)	
18.221	4	1	01	18q22.1	CDH7		Cadherin-7	605806	Psh, A			
18.222	4	2	01	18q22.1	CDH19, CDH7		Cadherin 19	603016	Psh, A			
18.223	4	2	01	18q21.33	CDH20		Cadherin 20	605807	Psh, A			
18.224	7	23	03	18q22.3	NETO1, BCTL1		Neuropilin and tolloid like 1	607973	REc			
18.225	1	8	01	18q23	ZNF236		Zinc finger protein-236	604760	REa, A			
18.226	10	23	87	18q23	MBP		Myelin basic protein	159430	REa, A	defective in "shiverer," neurologic mutant in mouse		18(Mbp, shi)
18.227	5	25	17	18q22.1	LINC00305		Long intergenic noncoding RNA 305	617489	REc			
18.228	11	24	14	18q22.1	TMX3, TXNDC10, KIAA1830		Thioredoxin-related transmembrane protein 3	616102	REc			
18.229	6	30	15	18q21.33	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2		Tumor necrosis factor receptor superfamily, member 11A	603499	R, RE, Fd		Osteolysis, familial expansile, 174810 (3); {Paget disease of bone 2, early-onset}, 602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)	
18.230	11	14	12	18q22.1-q22.3	ECTD8		Ectodermal dysplasia 8, hair/tooth/nail type	602401	Fd	between D18S857 and D18S815	Ectodermal dysplasia 8, hair/tooth/nail type (2)	
18.231	3	29	16	18q22.2	RTTN, MSSP		Rotatin	610436	REc		Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	18(Rttn)
18.232	1	30	12	18q23	ATP9B		ATPase, class II, type 9B	614446	REc			
18.233	1	24	13	18q22.3	CBLN2		Cerebellin 2 precursor	600433	H, REc			18(Cbln1)
18.234	5	18	10	18q22.3	CNDP1, CN1		Carnosine dipeptidase 1	609064	R, REc			
18.235	1	31	01	18q22.2	DNAM1, CD226		DNAX accessory molecule 1	605397	A			
18.236	4	2	12	18q22.3	FAM69C		Family with sequence similarity 69, member C	614544	REc			
18.237	9	9	08	18q22.3	FBXO15, FBX15		F-box only protein 15	609093	REc			18(Fbxo15)
18.238	4	17	13	18q22.3	TIMM21, TIM21		Translocase of inner mitochondrial membrane 21, yeast, homolog of	615180	REc			
18.239	1	30	12	18q22.3	TSHZ1, TSH1, CAA		Teashirt zinc finger homeobox 1	614427	REc, Ch		Aural atresia, congenital, 607842 (3)	
18.240	7	17	14	18q22.3	ZNF407		Zinc finger protein 407	615894	REc			
18.241	4	20	17	18q23	ADNP2, KIAA0863		Activity-dependent neuroprotector homeobox 2	617422	REc			
18.242	5	31	05	18q23	CTDP1, FCP1, CCFDN		C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1	604927	Fd, REc		Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	
18.243	5	17	18	18q22.3	CYB5A, MCB5, METAG		Cytochrome b5	613218	Psh, REa, A	pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient	Methemoglobinemia and ambiguous genitalia, 250790 (3)	
18.244	12	18	98	18q23	GALR1, GALNR1, GALNR		Galanin receptor 1	600377	A, H, REc			18(Galnr)
18.245	5	17	95	18q23	NFATC1		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1	600489	REa, R			18(Nfatc)
18.246	11	2	04	18q23	PARD6G		partitioning-defective protein 6, C. elegans, homolog of	608976	R, REc			
18.247	10	23	87	18q22.3	PEPA		Peptidase A	169800	S, D			18(Pep1)
18.248	7	22	09	18q23	SALL3		Sal-like 3	605079	A			
18.249	1	8	15	18q23	TXNL4A, DIM1, BMKS		Thioredoxin-like 4A	611595	R, REc		Burn-McKeown syndrome, 608572 (3)	
18.250	3	15	13	18q23	ZNF516, KIAA0222		Zinc finger protein 516	615114	REc, R			
19.1	9	20	11	19pter-p13.1	FPH1, MUH, HPP		Hyperpigmentation, familial progressive, 1	614233	Fd		Hyperpigmentation, familial progressive, 1 (2)	
19.2	10	23	87	19pter-q13	CXB3S		Coxsackie virus B3 sensitivity	120050	S			
19.3	11	1	13	19p13.3	EEF2, EF2, SCA26		Eukaryotic translation elongation factor-2	130610	S	mutation identified in 1 family	?Spinocerebellar ataxia 26, 609306 (3)	
19.4	4	27	16	19p13.3	ABCA7, ABCX, AD9		ATP-binding cassette, subfamily A, member 7	605414	REc		{Alzheimer disease 9, susceptibility to}, 608907 (3)	
19.5	4	24	18	19p13.3	ABHD17A, FAM108A1		Abhydrolase domain-containing protein 17A	617942	REc			
19.6	12	15	10	19p13.3	ACER1		Alkaline ceraminidase 1	613491	REc			
19.7	12	6	11	19p13.3	ACSBG2, BGR		Acyl-CoA synthetase, bubblegum family, member 2	614363	REc			
19.8	8	1	13	19p13.3	ADAT3, TAD3, MRT36		Adenosine deaminase, tRNA-specific, 3	615302	REc		Mental retardation, autosomal recessive 36, 615286 (3)	
19.9	2	12	16	19p13.3-p13.2	ADGRE1, EMR1		Adhesion G protein-coupled receptor E1	600493	REa, A			17(Emr1)
19.10	2	12	16	19p13.2	ADGRE4P, EMR4, GPR127, EMR4P, FIRE		Adhesion G protein-coupled receptor E4, pseudogene	612305	REc			
19.11	6	30	15	19p13.12	ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821		Adhesion G protein-coupled receptor L1	616416	R, REc			
19.12	8	9	99	19p13.3	AES		Amino-terminal enhancer of split	600188	REa, A			
19.13	3	16	10	19p13.3	ALKBH7, ABH7		AlkB, E. coli, homolog of, 7	613305	REc			
19.14	7	10	14	19p13.2	ANGPTL4, PGAR, HFARP, FIAF, TGQTL		Angiopoietin-like 4	605910	R		Plasma triglyceride level QTL, low, 615881 (3)	
19.15	7	26	16	19p13.3	AP3D1, HPS10		Adaptor-related protein complex 3, delta-1 subunit	607246	REc, H	mutation identified in 1 HPS10 patient	?Hermansky-Pudlak syndrome 10, 617050 (3)	10(Ap3d1)
19.16	5	25	13	19p13.3	APBA3, X11L2, MINT3		Amyloid beta A4 precursor protein-binding, family A, member 3	604262	REc			
19.17	10	25	16	19p13.3	APC2, APCL, SOTOS3		APC2 gene	612034	A, H	mutation identified in 1 SOTOS3 family	?Sotos syndrome 3, 617169 (3)	10(Apc2)
19.18	11	22	10	19p13.3	DENND1C		DENN/MADD domain-containing protein 1C	613634	REc			
19.19	9	3	02	19p13.3	IS1, AIS		Adolescent idiopathic scoliosis	181800	Fd		Scoliosis, idiopathic 1 (2)	
19.20	10	26	03	19p13.3	ATCAY, CLAC, KIAA1872		Caytaxin	608179	REc, Fd, H		Ataxia, cerebellar, Cayman type, 601238 (3)	10(ji)
19.21	10	10	18	19p13.3	ATP5F1D, ATP5D, MC5DN5		ATP synthase F1 subunit delta	603150	REc		Mitochondrial complex V (ATP synthase) deficiency, 618120 (3)	
19.22	5	2	01	19p13.3	ATP8B3, ATPIK		ATPase, class I, type 8B, member 3	605866	REc			
19.23	10	26	92	19p13.3	AZU1, CAP37		Azurocidin-1 (cationic antimicrobial protein-37)	162815	A, REn	5\(rm-AZU1-8kb-PR3-3kb-ELAN-3'		
19.24	3	13	01	19p13.3	BSG		Basigin (blood group OK)	109480	A		[Blood group, OK], 111380 (3)	10(Bsg)
19.25	4	21	10	19p13.3	C2CD4C, NLF3, KIAA1957		C2 calcium-dependent domain containing 4C	610336	REc			
19.26	11	20	03	19p13.3	C19orf10, SF20, IL25		Stroma-derived growth factor 20	606746	REc			17(Il25)
19.27	11	23	15	19p13.3	C19orf70, MIC13, QIL1		Chromosome 19 open reading frame 70	616658	REc			
19.28	3	8	91	19p13.3	CAPS		Calcyphosine	114212	A			
19.29	5	24	17	19p13.3	CATSPERD, TMEM146		Cation channel, sperm-associated, auxiliary subunit delta	617490	REc			
19.30	12	5	11	19p13.2	CD209, CDSIGN		CD209 antigen	604672	R		{Dengue fever, protection against}, 614371 (3); {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
19.31	6	14	94	19p13.3	CDC34		Cell division cycle 34	116948	A			
19.32	4	26	11	19p13.3	CFD, ADN		Complement factor D	134350	REc		Complement factor D deficiency, 613912 (3)	
19.33	9	26	17	19p13.3	CHAF1A, CAF1B, CAF1P150		Chromatin assembly factor I, subunit A	601246	REc			
19.34	5	28	98	19p13.3	CIRBP		Cold-inducible RNA-binding protein	602649	A			
19.35	3	13	15	19p13.2	CLEC4G, LSECTIN		C-type lectin domain family 4, member G	616256	REc			
19.36	2	28	06	19p13.2	CLEC4M, CD209L, LSIGN, DCSIGNR		C-type lectin domain family 4, member M	605872	R		SARS infection, protection against (2)	
19.37	12	15	14	19p13.3	CLPP, PRLTS3, DFNB81		ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of	601119	REa, REc, Fd		Perrault syndrome 3, 614129 (3)	
19.38	2	1	11	19p13.3	CNN2		Calonin 2	602373	REc	previously assigned to 21q11.1		
19.39	11	28	05	19p13.3	CRB3		Crumbs, Drosophila, homolog of, 3	609737	R, REc			
19.40	4	23	08	19p13.3	CREB3L3, CREBH		cAMP responsive element-binding protein 3-like 3	611998	REc			
19.41	5	28	98	19p13.3	CSNK1G2		Casein kinase 1, gamma-2	602214	Psh, A			
19.42	3	31	15	19p13.3	DIRAS1, RIG		DIRAS family, GTP-binding Ras-like protein 1	607862	REc			
19.43	5	26	13	19p13.3	DOHH, HLRC1		Deoxyhypusine hydroxylase	611262	REc			
19.44	11	22	02	19p13.3	DOT1L, DOT1, KIAA1814		Dot1, yeast, homolog of	607375	R, REc			
19.45	11	10	98	19p13.3	DRIL1		Dead ringer, Drosophila, homolog-like 1	603265	A, REc			
19.46	8	27	01	19p13.3	EBI3		Epstein-Barr virus-induced gene 3	605816	A			
19.47	2	28	03	19p13.3	EFNA2, EPLG6, LERK6		Ephrin A2	602756	Psh, A			
19.48	6	7	11	19p13.3	ELANE, ELA2, SCN1		Elastase, neutrophil-expressed	130130	A, Fd, REc		Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	10(Ela2)
19.49	4	25	93	19p13.2	FCER2, FCE2, CD23, CLEC4J		Fc fragment of IgE, low affinity II, receptor for (CD23A)	151445	REa, A			
19.50	1	5	00	19p13.3	FEB2		Febrile seizures, familial, 2	602477	Fd		Febrile seizures, familial, 2 (2)	
19.51	8	27	15	19p13.3	FEM1A		Fem1, C. elegans, homolog of, A	613538	REc			17(Fem1a)
19.52	4	26	01	19p13.3	FGF22		Fibroblast growth factor 22	605831	REc			
19.53	3	18	07	19p13.3	FSD1, GLFND		Fibronectin type 3 and SPRY domains-containing protein 1	609828	REc			
19.54	9	17	03	19p13.3	FUT3, LE		Fucosyltransferase 3	111100	F, Psh, REn, Fd	cen-FUT5-23kb-FUT3-14kb-FUT6-ter	[Blood group, Lewis] (3)	
19.55	5	17	95	19p13.3	FUT5		Fucosyltransferase 5 (alpha (1,3) fucosyltransferase)	136835	A, REn	cen-FUT5-FUT3-FUT6-ter		
19.56	3	31	11	19p13.3	FUT6		Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)	136836	Psh, REn	in cluster with FUT3, FUT5	Fucosyltransferase 6 deficiency, 613852 (3)	
19.57	5	25	00	19p13.3	GADD45B, MYD118		Growth arrest- and DNA damage-inducible gene 45, beta	604948	R			
19.58	7	18	13	19p13.3	GAMT, CCDS2		Guanidinoacetate methyltransferase	601240	Psh, R		Cerebral creatine deficiency syndrome 2, 612736 (3)	10(Gamt)
19.59	7	26	11	19p13.3	GIPC3, DFNB15, DFNB72, DFNB95		GAIP C-terminus-interacting protein 3	608792	REc		Deafness, autosomal recessive 15, 601869 (3)	
19.60	1	11	16	19p13.3	GPX4, SMDS		Glutathione peroxidase-4 (phospholipid hydroperoxidase)	138322	REa, A		Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	
19.61	7	2	18	19p13.3	GRIN3B		Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	606651	REc			
19.62	11	22	94	19p13.3	GTF2F1, RAP74		General transcription factor IIF, polypeptide 1 (74kD subunit)	189968	A			
19.63	6	9	95	19p13.3	GZMM		Granzyme M (lymphocyte met-ase 1)	600311	H			10(Gzmm)
19.64	3	30	99	19p13.3	HCDH, FZR		CDH1/HCT1, S. cerevisiae, homolog of	603619	REc			
19.65	8	9	00	19p13.3	HCN2, BCNG2		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781	REc			
19.66	3	5	18	19p13.3	HDGFL2, HDGFRP2		Hepatoma-derived growth factor-like protein 2	617884	REc			
19.67	3	23	09	19p13.3	HMHA1, HLA-HA1, KIAA0223		Minor histocompatibility antigen HA-1	601155	R, REc			
19.68	1	8	01	19p13.3	HMG20B, BRAF35		High mobility group protein 20B	605535	REc			
19.69	11	3	06	19q13.32	IGFL1		IGF-like family member 1	610544	REc			7(Igfl1)
19.70	11	3	06	19q13.32	IGFL2		IGF-like family member 2	610545	REc			7(Igfl2)
19.71	11	3	06	19q13.32	IGFL3		IGF-like family member 3	610546	REc			7(Igfl3)
19.72	11	3	06	19q13.32	IGFL4		IGF-like family member 4	610547	REc			7(Igfl4)
19.73	7	20	12	19p13.3	KDM4B, JMJD2B, KIAA0876		Lysine-specific demethylase 4B	609765	R, REc			
19.74	7	19	12	19p13.3	JSRP1, JP45		Junctional sarcoplasmic reticulum protein 1	608743	REc			
19.75	4	20	06	19p13.3	KHSRP, KSRP, FUBP2, FBP2		KH-type splicing regulatory protein	603445	R, H			17(Khsrp)
19.76	8	24	09	19p13.3	KIR2DL5A, KIR2DL5		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A	605305	REc			
19.77	8	1	13	19p13.3	KISS1R, GPR54, HH8, CPPB1		KISS1 receptor	604161	REc, Fd	mutation identified in 1 CPPB1 patient	Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3); ?Precocious puberty, central, 1, 176400 (3)	
19.78	12	6	16	19p13.3	KLF16, BTEB4, DRRF		Kruppel-like factor 16	606139	REc, H			10(Klf16)
19.79	9	24	15	19p13.3	LMNB2, LMN2, EPM9		Lamin B2	150341	A	mutation identified in 1 EPM9 family	{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3); ?Epilepsy, progressive myoclonic, 9, 616540 (3)	
19.80	12	10	13	19p13.3	LRG1, LRG		Leucine-rich alpha-2-glycoprotein 1	611289	REc			11(Lrg1)
19.81	12	23	05	19p13.3	LRRN6B, LINGO3, LERN2		Leucine-rich repeat protein, neuronal, 6B	609792	R, REc			
19.82	8	24	09	19p13.3	LSM7		LSM7 protein	607287	R, REc			
19.83	9	21	11	19p13.2	ICAM4, CD242, LW		Intracellular adhesion molecule 4	614088	F, Fd, A, REc	close to C3, LU	[Blood group, Landsteiner-Wiener], 111250 (3)	
19.84	3	3	98	19p13.3	MACAM1		Mucosal addressin cell adhesion molecule-1	102670	Psh, A			
19.85	6	20	13	19p13.3	MAP2K2, PRKMK2, MEK2, MKK2, CFC4		Mitogen-activated protein kinase kinase 2	601263	A, REc	previously assigned to 7q32	Cardiofaciocutaneous syndrome 4, 615280 (3)	10(Mek2)
19.86	7	1	98	19p13.3	MATK, HYL, CTK		Megakaryocyte-associated tyrosine kinase	600038	A, REa, H			10(Matk)
19.87	7	8	99	19p13.3	MBD3		Methyl-CpG-binding domain protein 3	603573	REc			10(Mbd3)
19.88	6	19	97	19p13.3	MDRV		Muscular dystrophy with rimmed vacuoles	601846	Fd		Muscular dystrophy with rimmed vacuoles (2)	
19.89	2	25	15	19p13.2	MCEMP1		Mast cell-expressed membrane protein 1	609565	REc			
19.90	8	20	07	19p13.3	MEX3D, RKHD1, TINO, KIAA2031		Mex-3, C. elegans, homolog of, D	611009	REc			
19.91	10	26	17	19p13.3	MFSD12, PP3501		Major facilitator superfamily domain-containing protein 12	617745	REc			
19.92	8	24	09	19p13.3	MIDN		Midnolin, mouse, homolog of	606700	REc			
19.93	5	11	09	19p13.12	MIR181C, MIRN181C		Micro RNA 181C	612746	REc			
19.94	5	6	13	19p13.3	MIR1909		Micro RNA 1909	615201	REc			
19.95	6	26	13	19p13.3	MISP, C19orf21		Mitotic spindle-positioning protein	615289	REc			
19.96	5	28	02	19p13.3	MKNK2, MNK2, GPRK7		Mitogen-activated protein kinase-interacting serine/threonine kinase-2	605069	REc			
19.97	1	12	95	19p13.3	MLLT1, ENL		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 1	159556	Ch	fuses with ALL1		
19.98	3	11	08	19p13.3	MRPL54		Mitochondrial ribosomal protein L54	611858	R, REc			
19.99	4	30	09	19p13.3	NDUFA11		NADH-dehydrogenase 1 alpha subcomplex, 11	612638	REc		Mitochondrial complex I deficiency, 252010 (3)	
19.100	10	15	95	19p13.3	NFIC		Nuclear factor I/C (CCAAT-binding transcription factor)	600729	A	order: cen-NFIX-NFIC-tel		10(Nfic)
19.101	9	2	12	19p13.13	NFIX, NF1A, SOTOS2, MRSHSS		Nuclear factor I/X (CCAAT-binding transcription factor)	164005	A		Sotos syndrome 2, 614753 (3); Marshall-Smith syndrome, 602535 (3)	8(Nfix)
19.102	1	2	08	19p13.3	NRTN, NTN		Neurturin	602018	A			17(Nrtn)
19.103	8	28	97	19p13.3	OAZ1		Ornithine decarboxylase antizyme 1	601579	A			
19.104	11	11	14	19p13.3	PALM, KIAA0270		Paralemmin	608134	R, H, REc			10(Palm)
19.105	8	24	09	19p13.3	PCSK4		Proprotein convertase subtilisin/kexin type 4	600487	REa, REc			10(Pcsk4)
19.106	2	27	03	19p13.2	PEX11G		Peroxisome biogenesis factor 11G	607583	REc			
19.107	2	9	16	19p13.3	PIAS4, PIASY		Protein inhibitor of activated STAT4	605989	REc			
19.108	8	23	07	19p13.3	PIP5K1C, LCCS3		Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma	606102	R,		Lethal congenital contractural syndrome 3, 611369 (3)	
19.109	1	16	18	19p13.3	PLEKHJ1, GNRPX		Pleckstrin homology domain-containing protein, family J, member 1	617834	REc, H			10(Plekhj1)
19.110	1	21	10	19p13.3	PLIN3, M6PRBP1, TIP47		Perilipin 3	602702	REc			
19.111	3	3	10	19p13.3	PLIN4, KIAA1881		Perilipin 4	613247	R, REc			
19.112	3	3	10	19p13.3	PLIN5, LSDP5		Perilipin 5	613248	REc			17(Plin5)
19.113	10	26	17	19p13.3	PLPP2, PPAP2C		Phospholipid phosphatase 2	607126	REc			
19.114	1	9	17	19p13.3	PLPPR3, LPPR3, LPR3, PRG2		Phospholipid phosphatase-related protein 3	610391	REc			
19.115	3	19	15	19p13.2	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS		Patatin-like phospholipase domain-containing protein 6	603197	REc, A, Fd	mutation identified in 1 LMNS family	Spastic paraplegia 39, autosomal recessive, 612020 (3); Boucher-Neuhauser syndrome, 215470 (3); ?Laurence-Moon syndrome, 245800 (3); Oliver-McFarlane syndrome, 275400 (3)	8(Nte)
19.116	5	27	94	19p13.3	POLR2E		Polymerase (RNA) II (DNA directed) polypeptide E, 25kD	180664	A			
19.117	8	3	97	19p13.3	POLRMT, APOLMT		Polymerase (RNA) mitochondrial (DNA directed)	601778	Psh			
19.118	09	11	18	19p13.3	PRTN3, AGP7		Proteinase 3	177020	A, REn, Psh			10(Prtn3)
19.119	7	24	13	19p13.3	ONECUT3, OC3		One cut homeobox 3	611294	REc, R			10(Onecut3)
19.120	7	8	99	19p13.3	PSPN		Persephin	602921	Psh, R			
19.121	1	28	01	19p13.3	PTBP1, PTB, HNRNPI		Polypyrimidine tract-binding protein 1	600693	REc	pseudogene on chr. 14		
19.122	8	28	97	19p13.3	PTPRS		Protein tyrosine phosphatase, receptor type, sigma	601576	A, REc			17(Ptprs)
19.123	12	15	98	19p13.3	RANBP3		RAN-binding protein-3	603327	REc			
19.124	10	23	15	19p13.3	RAX2, RAXL1, QRX, CORD11, ARMD6		Retina and anterior neural fold homeobox 2	610362	R	mutation identified in 1 ARMD6 patient	?Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy 11, 610381 (3)	
19.125	1	20	17	19p13.3	REEP6, DP1L1, TB2L1, C19orf32, RP77		Receptor expression-enhancing protein 6	609346	R, REc, H		Retinitis pigmentosa 77, 617304 (3)	10(Dp1L1)
19.126	10	4	05	19p13.3	REXO1, REX1, ELOABP1, TCEB3BP1		RNA exonuclease 1, S. cerevisiae, homolog of	609614	R, REc			
19.127	4	18	02	19p13.12	RLN3, H3, RXN3		Relaxin 3	606855	REc			8(Rln3)
19.128	4	17	13	19p13.3	RNF126		RING finger protein 126	615177	REc			
19.129	3	1	18	19p13.3	RPL36		Ribosomal protein L36	617893	REc			
19.130	9	18	08	19p13.3	S1PR4, EDG6, S1P4		Sphingosine-1-phosphate receptor 4	603751	Psh			
19.131	8	29	03	19p13.3	SAFB2, KIAA0138		Scaffold attachment factor B2	608066	REc			
19.132	4	29	14	19p13.3	SBNO2, KIAA0963		Strawberry notch, Drosophila, homolog of, 2	615729	R, REc			
19.133	9	16	12	19p13.3	SEMA6B		Semaphorin 6B	608873	REc			
19.134	3	24	11	19p13.3	SCAMP4		Secretory carrier membrane protein 4	613764	REc			
19.135	7	7	13	19p13.3	SHC2, SHCB, SCK		SHC transforming protein 2	605217	REc			
19.136	2	25	15	19p13.3	SHD		SH2 domain-containing protein D	610481	REc, R			
19.137	3	1	01	19p13.3	SH3GL1, EEN		SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene)	601768	A, R, REa		Leukemia, acute myeloid, 601626 (1)	
19.138	8	30	01	19p13.3	SIRT6, SIR2L6		Sirtuin 6 (Sir2, S. cerevisiae, homolog of, 6)	606211	REc			
19.139	3	12	07	19p13.3	SLC25A41		Solute carrier family 25, member 41	610822	REc			17(Slc25a41)
19.140	10	13	09	19p13.3	SLC39A3, ZIP3		Solute carrier family 39, zinc transporter, member 3	612168	R, REc			
19.141	3	22	07	19p13.3	SNPPL2B, IMP4, KIAA1532		Signal peptide peptidase-like 2B	608239	R, REc			
19.142	3	31	15	19p13.3	STAP2, BKS		Signal-transducing adaptor protein 2	607881	REc			
19.143	4	12	13	19p13.3	STK11, PJS, LKB1		Serine/threonine protein kinase-11	602216	Fd, D, REc		Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant, somatic (3); Pancreatic cancer, 260350 (3); Testicular tumor, somatic, 273300 (3)	10(Stk11)
19.144	9	15	11	19p13.3	TBXA2R, BDPLT13		Thromboxane A2 receptor	188070	Psh, Fd, A, H		{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	10(Tbxa2r)
19.145	5	11	16	19p13.3	TCF3, E2A, AGM8		Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47)	147141	REa, A		Agammaglobulinemia 8, autosomal dominant, 616941 (3)	
19.146	2	25	15	19p13.3	THEG		Testicular haploid expressed gene, mouse, homolog of	609503	REc			
19.147	12	11	98	19p13.3	THOP1		Thimet oligopeptidase-1	601117	REa, A, REc			
19.148	3	14	18	19p13.3	TICAM1, TRIF, IIAE6		TIR domain-containing adaptor molecule 1	607601	REc		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3)	
19.149	12	4	02	19p13.3	TIMM13		Translocase of inner mitochondrial membrane 13, yeast, homolog of	607383	R			
19.150	5	23	13	19p13.3	TINCR		Terminal differentiation-induced noncoding RNA	615241	REc			17(Tincr)
19.151	3	31	09	19p13.3	TJP3, ZO3		Tight junction protein 3	612689	REc			
19.152	2	11	96	19p13.3	TLE2, ESG2		Transducin-like enhancer of split 2 (homolog of Drosophila E(spl))	601041	A			
19.153	2	12	16	19p13.3	TLE6, GRG6, PREMBL		Transducin-like enhancer of split 6	612399	REc		Preimplantation embryonic lethality, 616814 (3)	
19.154	11	16	17	19p13.3	TMEM259, C19orf6		Transmembrane protein 259 (membralin)	611011	REc			10(Orf61)
19.155	7	13	12	19p13.3	TMIGD2, IGPR1		Transmembrane and immunoglobulin domains-containing protein 2 `	614715	REc			
19.156	2	25	15	19p13.3	TMPRSS9		Transmembrane protease, serine 9	610477	REc, H			10(Tmprss9)
19.157	8	30	01	19p13.3	TNFSF9		Tumor necrosis factor ligand superfamily, member 9	606182	A			
19.158	1	18	02	19p13.3	TNFSF14, HVEML		Tumor necrosis factor ligand superfamily, member 14	604520	REc, A			
19.159	4	6	15	19p13.3	TRIP10, CIP4		Thyroid hormone receptor interactor 10	604504	R			
19.160	12	17	07	19p13.13	TRMT1, TRM1		tRNA methyltransferase 1, S. cerevisiae, homolog of	611669	REc			
19.161	7	22	13	19p13.3	TRNAG3		Transfer RNA glycine 3	615303	REc			
19.162	7	22	13	19p13.3	TRNAV32		Transfer RNA valine 32	615304	REc			
19.163	10	30	14	19p13.3	TUBB4A, DYT4, HLD6		Tubulin, beta-4A	602662	REc		Dystonia 4, torsion, autosomal dominant, 128101 (3); Leukodystrophy, hypomyelinating, 6, 612438 (3)	
19.164	10	27	08	19p13.3	UHRF1, ICBP90, NP95		Ubiquitin-like protein containing PHD and RING finger domains 1	607990	A			
19.165	10	9	09	19p13.11	UNC13A, KIAA1032		UNC13, C. elegans, homolog of, A	609894	R, REc			
19.166	11	15	05	19p13.3	UQCR		Ubiquinol-cytochrome c reductase, 6.4kD subunit	609711	R, REc			
19.167	11	23	16	19p13.3	VMAC		Vimentin-type intermediate filament-associated coiled-coil protein	617204	REc			
19.168	8	1	13	19p13.3	ZBTB7A, FBI1, LRF		Zinc finger and BTB domain containing 7A	605878	A			
19.169	6	10	08	19p13.3	ZNRF4, SPERIZIN		Zinc finger and ring finger protein 4	612063	Psh, H			17(Znrf4)
19.170	11	2	04	19p13.2	ADAMTS10, WMS1		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 10	608990	Fd, REc		Weill-Marchesani syndrome 1, recessive, 277600 (3)	
19.171	12	13	95	19p13.3	AMH, MIF		Anti-Mullerian hormone	600957	REa, A		Persistent Mullerian duct syndrome, type I, 261550 (3)	10(Amh)
19.172	3	15	92	19p13.3-p13.2	ATHS, ALP		Atherosclerosis susceptibility (lipoprotein associated)	108725	Fd	closely linked to LDLR; may be LDLR	{Atherosclerosis, susceptibility to} (2)	
19.173	3	10	11	19p13.3	C3, ARMD9, AHUS5		Complement component-3	120700	F, S, A, REa	LE ~7cM in males vs. C3 RFLP	C3 deficiency, 613779 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)	17(C3)
19.174	7	2	13	19p13.2	DNMT1, MCMT, HSN1E, ADCADN		DNA methyltransferase 1	126375	REa, A		Neuropathy, hereditary sensory, type IE, 614116 (3); Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	
19.175	3	23	93	19p13.2	EPOR		Erythropoietin receptor	133171	A, REa, H, Fd		[Erythrocytosis, familial, 1], 133100 (3)	9(Epor)
19.176	4	5	00	19p13.2	ICAM1		Intercellular adhesion molecule-1	147840	REa, H, A	close to Ldlr in mouse	{Malaria, cerebral, susceptibility to}, 611162 (3)	9(Icam1)
19.177	6	13	95	19p13.2	ICAM3, CDW50		Intercellular adhesion molecule-3	146631	A, Psh			
19.178	9	7	00	19p13.2	MCOLN1, ML4		Mucolipin 1	605248	Fd, REn		Mucolipidosis IV, 252650 (3)	
19.179	11	12	96	19p13.2	MYO1F		Myosin IF	601480	A			17(Myo1f)
19.180	5	15	00	19p13.2	HNRPM, HNRPM4, NAGR1		Heterogeneous nuclear ribonucleoprotein M	160994	A			
19.181	8	21	92	19p13.3	RFX2		Regulatory factor (trans-acting) 2 (influences HLA class II expression)	142765	A			
19.182	8	24	98	19p13.3	SAFB, HET		Scaffold attachment factor B	602895	REa, A			
19.183	3	29	00	19p13.3	SF3A2, SAP62, PRP11		Splicing factor 3a, subunit 2, 66kD	600796	REn			10(Sap62)
19.184	5	4	12	19p13.2	STXBP2, UNC18B, FHL5		Syntaxin binding protein 2	601717	A		Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	8(Stxbp2)
19.185	7	6	00	19p13.2	TIMM44		Translocase of inner mitochondrial membrane 44, yeast, homolog of	605058	A			
19.186	8	24	98	19p13.3	VAV1, VAV		Oncogene VAV1	164875	REa, A, RE	close to INSR		
19.187	9	28	96	19p13.11	ZNF14, KOX6		Zinc finger protein-14 (KOX 6)	194556	REc, A			
19.188	9	28	96	19p13.2	ZNF20, KOX13		Zinc finger protein-14 (KOX 6)	194557	REc, A			
19.189	6	11	11	19p13.2	ACP5, SPENCDI		Acid phosphatase 5, tartrate resistant	171640	REa, H, Psh	incorrectly assigned to 15 by A	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	9(Acp5)
19.190	7	1	05	19p13.2	ANGPTL6, AGF		Angiopoietin-like 6	609336	REc			
19.191	2	20	15	19p13.2	ANGPTL8, C19orf80, LIPASIN		Angiopoietin-like protein 8	616223	REc	within intron of DOCK6		9(C19orf80)
19.192	2	28	03	19p13.2	AP1M2, MU1B		Adaptor-related protein complex 1, mu-2 subunit	607309	A, H			9(Ap1m2)
19.193	4	7	17	19p13.2	ARHGEF18, KIAA0521, RP78		Rho guanine nucleotide exchange factor 18	616432	R, REc		Retinitis pigmentosa 78, 617433 (3)	
19.194	3	23	14	19p13.2	ATG4D, APG4D, AUTL4		Autophagy 4, S. cerevisiae, homolog of, D	611340	REc			
19.195	6	8	95	19p13.11	BST2		Bone marrow stromal cell antigen	600534	A			
19.196	2	12	16	19p13.2	C19orf66, RYDEN		Chromosome 19 open reading frame 66	616808	REc			
19.197	2	10	14	19p13.13	CALR, SSA		Sicca syndrome antigen A (autoantigen Ro; calreticulin)	109091	REa	distal to C3, near LDLR	Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)	8(Calr)
19.198	11	27	17	19p13.2	CAMSAP3, NEZHA, KIAA1543		Calmodulin-regulated spectrin-associated protein 3	612685	REc			
19.199	7	7	13	19p13.2	CARM1, PRMT4		Coactivator-associated arginine methyltransferase 1	603934	REc			
19.200	8	2	13	19p13.2	CERS4, LASS4, TRH1		Ceramide synthase 4	615334	REc			
19.201	10	9	14	19p13.2	CCDC151, CILD30		Coiled-coil domain-containing protein 151	615956	REc		Ciliary dyskinesia, primary, 30, 616037 (3)	
19.202	8	29	02	19p13.2	CCL25, SCYA25, TECK		Chemokine, C-C motif, ligand 25	602565	Psh, R, A			8(Teck)
19.203	1	20	17	19p13.2	CD320, 8D6, 8D6A, TCBLR		CD320 molecule	606475	R, REc		Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)	17(Cd320)
19.204	11	11	14	19p13.2	CDC37		Cell division cycle 37, S. cerevisiae, homolog of	605065	REc			
19.205	3	16	99	19p13.2	CNN1, SMCC		Calponin 1	600806	A, R, Psh			9(Cnn1)
19.206	8	9	01	19p13.2	COL5A3		Collagen, type V, alpha-3 polypeptide	120216	R			9(Col5a3)
19.207	9	22	08	19p13.2	CTXN1, CTXN		Cortexin 1	600135	REc			8(Ctxn)
19.208	9	30	99	19p13.12	CYP4F3, LTB4H		Cytochrome P450, subfamily IVF, polypeptide 3	601270	A			
19.209	3	12	01	19p13.12	DNAJB1, HSPF1		DnaJ, E. coli, homolog of, subfamily B, member 1 (heat-shock 40kD protein 1)	604572	A			
19.210	11	7	17	19p13.2	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5		Dynamin-2	602378	H, REc, Fd	1 LCCS5 family identified with mutation	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3); Centronuclear myopathy 1, 160150 (3); Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3); Lethal congenital contracture syndrome 5, 615368 (3)	9(Dnm2)
19.211	9	12	11	19p13.2	DOCK6, KIAA1395, AOS2		Dedicator of cytokinesis 6	614194	REc, R		Adams-Oliver syndrome 2, 614219 (3)	
19.212	10	3	07	19p13.2	EIF3G, EIF3S4		Eukaryotic translation initiation factor 3, subunit G	603913	REc			
19.213	2	8	99	19p13.2	ELAVL1, HUR		Embryonic lethal, abnormal vision, Drosophila, homolog-like 1	603466	A			
19.214	7	8	99	19p13.2	ELAVL3, HUC, PLE21		Embryonic lethal, abnormal vision, Drosophila, homolog-like 3	603458	A, H, R	centromeric to ELAVL1		9(HuC)
19.215	6	13	12	19p13.2	FBXL12, FBL12		F-box and leucine-rich repeat protein 12	609079	REc, REa			9(Fbxl12)
19.216	6	13	12	19p13.13	FBXW9, FBW9		F-box and WD40 domain protein 9	609074	REc			9(Fbxw9)
19.217	4	27	12	19p13.2	FDX1L, FDX2		Ferredoxin 1-like protein	614585	REc			
19.218	8	25	04	19p13.13	GCDH		Glutaryl-Coenzyme A dehydrogenase	608801	REa, A		Glutaricaciduria, type I, 231670 (3)	8(Gcdh)
19.219	3	14	13	19p13.13	MRI1, MRDI		Methylthioribose-1-phosphate isomerase, S. cerevisiae, homolog of	615105	REc			
19.220	4	10	14	19p13.2	PET100, C19orf79		PET100, S. cerevisiae, homolog of	614770	REc		Mitochondrial complex IV deficiency, 220110 (3)	
19.221	10	2	12	19p13.13	PRDX2, PRX2, TDPX1, PTX1, NKEFB		Peroxiredoxin 2	600538	REc	prev. mapped to chr.13		
19.222	7	8	02	19p13.2	RAD3D, GOV		Ras family, member RAB3D	604350	A			
19.223	5	25	00	19p13.2	ICAM5, TLCN, TLN		Intercellular adhesion molecule 5 (telencephalin)	601852	A			
19.224	9	14	12	19p13.11	INSL3		Insulin-like 3, Leydig cell	146738	A		Cryptorchidism, 219050 (3)	
19.225	12	29	06	19p13.2	INSR, HHF5		Insulin receptor	147670	REa, A, REb	1 gene for alpha and beta subunits	Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3); Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	8(Insr)
19.226	4	25	93	19p13.13	JUNB		jun B proto-oncogene	165161	A			8(Junb)
19.227	07	27	18	19p13.2	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16		KN motif- and ankyrin repeat domain-containing protein 2	614610	REc		Palmoplantar keratoderma and woolly hair, 616099 (3); Nephrotic syndrome, type 16, 617783 (3)	
19.228	5	4	12	19p13.2	KANK3		KN motif- and ankyrin repeat domain-containing protein 3	614611	REc			
19.229	1	16	07	19p13.2	KEAP1, KIAA0132		Kelch-like ECH-associated protein 1	606016	REa, REc			
19.230	2	24	12	19p13.2	LDLR, FHC, FH, LDLCQ2		Low density lipoprotein receptor	606945	F, REa, A	~20cM distal to C3	Hypercholesterolemia, familial, 143890 (3); LDL cholesterol level QTL2, 143890 (3)	9(Ldlr)
19.231	2	13	15	19p13.3	LONP1, PRSS15, LON, CODASS		lon peptidase 1, mitochondrial	605490	A		CODAS syndrome, 600373 (3)	
19.232	7	22	09	19p13.2	LRRC8E		Leucine-rich repeat-containing protein 8E	612891	REc			8(Lrrc8e)
19.233	6	26	14	19p13.2	MAP2K7, PRKMK7, MKK7, JNKK2, MAPKK7		Mitogen-activated protein kinase kinase 7	603014	REc			
19.234	6	7	10	19p13.2	MARCH2		Membrane-associated RING-CH finger protein 2	613332	REc			
19.235	9	24	08	19p13.13	MAST1, SAST, KIAA0973		Microtubule-associated serine/threonine kinase 1	612256	R, REc			
19.236	2	25	15	19p13.2	MBD3L1		Methyl-CpG binding domain protein 3-like 1	607963	R, REc			9(Mbd3l1)
19.237	2	25	15	19p13.2	MBD3L2		Methyl-CpG binding domain protein 3-like 2	607964	R, REc			9(Mbd3l2)
19.238	3	23	09	19p13.2	MIR199A1, MIRN199A1		Micro RNA 199A1	610719	REc			
19.239	2	26	08	19p13.2	MRPL4		Mitochondrial ribosomal protein L4	611823	R			
19.240	8	3	12	19p13.2	MUC16, CA125		Mucin 16	606154	REc			
19.241	12	3	98	19p13.2	NDUFA7		NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD, B14.5a)	602139	R	previously assigned to 20p13		
19.242	9	12	11	19p13.2	NRCLP6		Narcolepsy 6	614223	Fd	associated with rs2305795	Narcolepsy 6 (2)	
19.243	5	30	17	19p13.2	OLFM2, NOE2		Olfactomedin 2	617492	REc			
19.244	8	20	08	19p13.2	OR7D4, OR19B		Olfactory receptor, family 7, subfamily D, member 4	611538	REc			
19.245	4	20	11	19p13.2	PCOS1, PCO1, PCO		Polycystic ovary syndrome 1	184700	Fd	max lod at D19S884	Polycystic ovary syndrome 1 (2)	
19.246	8	21	98	19p13.2	PDE4A, DPDE2		Phosphodiesterase-4A, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E2)	600126	REa, A, REc			9(Pde4a)
19.247	5	25	00	19p13.11	PGLS		6-phosphogluconolactonase	604951	R			
19.248	3	25	03	19p13.11	PLVAP, PV1		Plasmalemma vesicle-associated protein	607647	REc, R, H			8(Plvap)
19.249	7	2	18	19p13.2	PRAM1		PML-RARA target gene encoding an adaptor molecule 1	606466	REc			
19.250	10	4	05	19p13.2	QTRT1, TGT		Queuine tRNA-ribosyltransferase 1	609615	REc			
19.251	12	15	17	19p13.2	RAB11B, NDAGSCW		Ras-associated protein RAB11B	604198	REc		Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3)	
19.252	1	12	95	19p13.13	RAD23A, HHR23A		RAD23, S. cerevisiae, homolog of, A	600061	A			8(Rad23a)
19.253	3	14	06	19p13.2	RAVER1, KIAA1978		Raver1, mouse, homolog of	609950	R, REc			
19.254	9	22	04	19p13.2	RETN, RSTN, FIZZ3		Resistin	605565	REc		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	
19.255	1	11	16	19p13.2	RGL3		Ral guanine nucleotide dissociation stimulator-like 3	616743	REc			
19.256	3	29	15	19p13.2	RPS28, DBA15		Ribosomal protein S28	603685	REa, R		Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	
19.257	3	16	16	19p13.2	S1PR2, EDG5, DFNB68		Sphingosine-1-phosphate receptor 2	605111	REc, Fd		Deafness, autosomal recessive 68, 610419 (3)	
19.258	9	18	08	19p13.2	S1PR5, EDG8		Sphingosine-1-phosphate receptor 5	605146	REc			
19.259	1	27	04	19p13.2	SITPEC, ECSIT		Signaling intermediate in toll pathway, evolutionarily conserved	608388	R, REc			
19.260	4	29	16	19p13.2	SMARCA4, BRG1, RTPS2, MRD16, CSS4		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254	REc		{Rhabdoid tumor predisposition syndrome 2}, 613325 (3); Coffin-Siris syndrome 4, 614609 (3)	
19.261	10	2	12	19p13.2	SNAPC2, SNAP45		Small nuclear RNA-activating protein complex, polypeptide 2	605076	REc			
19.262	7	14	14	19p13.2	SPC24, SPBC24		SPC24, NDC80 kinetochore complex component	609394	REc			
19.263	3	31	15	19p13.13	STX10, SYN10		Syntaxin 10	603765	REc			
19.264	3	30	12	19p13.2	SWSAP1, ZSWIM7AP1, C19orf39		SWIM-type zinc finger domain-containing protein 7-associated protein 1	614536	REc			
19.265	3	29	99	19p13.2	TCO		Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	Fd		Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)	
19.266	3	18	17	19p13.2	TIMM29, C19orf52		Translocase of inner mitochondrial membrane 29	617380	REc			
19.267	5	23	06	19p13.2	TMED1, IL1RL1LG		Transmembrane p24 trafficking protein 1 (interleukin-1 receptor-like 1 ligand)	605395	A			
19.268	2	24	11	19p13.2	TMEM205		Transmembrane protein 205	613771	REc			
19.269	9	12	14	19p13.2	TYK2, IMD35		Tyrosine kinase 2	176941	REa, A		Immunodeficiency 35, 611521 (3)	
19.270	4	16	02	19p13.2	UBL5, HUB1		Ubiquitin-like 5	606849	REc	pseudogene on 17p11.2		
19.271	3	15	07	19p13.2	XAB2		XPA-binding protein 2	610850	REc			
19.272	6	12	17	19p13.2	YIPF2		YIP1 domain family, member 2	617522	REc			
19.273	2	20	02	19p13.2	ZK1		Zinc finger protein ZK1	606697	A, R			
19.274	1	13	11	19p13.2	ZNF44, KOX7		Zinc finger protein-44 (KOX7)	194542	REc	previously assigned to 16p11		
19.275	1	13	11	19p13.2	ZNF69		Zinc finger protein-69 (Cos5)	194543	REc	previously assigned to 22q11.2		
19.276	8	24	09	19p13.2	ZNF266, HZF1		Zinc finger protein-266	604751	R, REc			
19.277	9	24	08	19p13.2	ZNF627		Zinc finger protein 627	612248	REc			
19.278	4	2	16	19p13.2	ZNF653, ZIP67		Zinc finger protein 653	611371	REc			
19.279	9	20	14	19p13.2	ZNF699, FLJ38144		Zinc finger protein 699	609571	REc			
19.280	12	16	11	19p13.2	ZGLP1, GLP1		Zinc finger GATA-like protein 1	611639	REc			
19.281	6	13	12	19p13.13	DAND5, CER2, CERL2, DANTE, COCO		DAN domain family, member 5	609068	REc			8(Crl2)
19.282	3	2	11	19p13.11	UPF1, RENT1, HUPF1		Upf1, yeast, homolog of	601430	REa			9(Rent1)
19.283	9	8	06	19p13.13	BEST2, VMD2L1		Bestrophin 2	607335	A			
19.284	6	19	00	19p13.2	ZNF136		Zinc finger protein-136	604078	A			
19.285	8	25	04	19p13.11	GDF15, PLAB, PDF, MIC1		Growth/differentiation factor-15 (bone morphogenetic protein, placental)	605312	A			
19.286	4	25	93	19p13.13	LYL1		Lymphoblastic leukemia derived sequence-1	151440	Ch, A		Leukemia, T-cell acute lymphoblastoid (2)	8(Lyl1)
19.287	7	25	18	19p13.11	NDUFA13, GRIM19		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 13	609435	A	mutation identified in 1 COX1D family	{Thyroid carcinoma, Hurthle cell}, 607464 (3); ?Mitochondrial complex I deficiency, 252010 (3)	
19.288	2	3	16	19p13.12	NOTCH3, CADASIL1, CASIL, IMF2, LMNS		Notch, Drosophila, homolog of, 3	600276	REa, A, Fd	mutation identified in 1 IMF2 family	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3); ?Myofibromatosis, infantile 2, 615293 (3); Lateral meningocele syndrome, 130720 (3)	17(Notch3)
19.289	2	28	03	19p13.2-p13.1	PAPA3		Polydactyly, postaxial, type A3	607324	Fd	between D19S1165 and D19S929	Polydactyly, postaxial, type A3 (2)	
19.290	7	22	16	19p13.2	PRKCSH, G19P1, PCLD1		Protein kinase C substrate 80K-H	177060	REb, Fd		Polycystic liver disease 1, 174050 (3)	
19.291	11	26	09	19p13.11	LRRC25, MAPA		Leucine rich repeat containing 25	607518	REc, R			
19.292	9	29	09	19p13.11	SLC5A5, NIS, TDH1		Solute carrier family 5 (sodium iodide symporter), member-5	601843	A		Thyroid dyshormonogenesis 1, 274400 (3)	
19.293	3	14	06	19p13.11	RAB8A, MEL		Ras-associated protein RAB8A (oncogene MEL)	165040	REa, Fd			
19.294	10	27	93	19p13.2-q13.3	LPSA, D19S381E		Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6)	164953	A		Liposarcoma (1)	
19.295	5	29	97	19p13.13	DNASE2, DNL		Deoxyribonuclease II, lysosomal	126350	S			
19.296	2	3	05	19p13.12	ASF1B		Anti-silencing function 1, S. cerevisiae, homolog of, B	609190	REc			
19.297	11	17	10	19p13.13	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13		Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome)	613638	Ch	contiguous gene syndrome	Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13 duplication syndrome (4)	
19.298	6	15	15	19p13.13	GADD45GIP1, PRG6, CRIF1		Growth arrest- and DNA damage-inducible DABB45G-interacting protein	605162	R, REc			
19.299	7	7	09	19p13.13	HOOK2, HK2		Hook, Drosophila, homolog of, 2	607824	REc			
19.300	8	24	09	19p13.12	MIR23A, MIRN23A		Micro RNA 23a	607962	REc			
19.301	3	28	17	19p13.13	NACC1, BTBD14B, NECFM		Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing	610672	R, REc		Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3)	
19.302	9	16	13	19p13.12	NANOS3, NOS3		Nanos, Drosophila, homolog of, 3	608229	REc			
19.303	10	15	07	19p13.13	RNASEH2A, RNHIA, AGS4		Ribonuclease H2, large subunit	606034	R, REc		Aicardi-Goutieres syndrome 4, 610333 (3)	
19.304	5	27	09	19p13.13	SYCE2, CESC1		Synaptonemal complex central element protein 2	611487	REc			
19.305	4	19	06	19p13.13	TNPO2, TRN2, KPNB2B		Transportin 2	603002	R			
19.306	3	8	16	19p13.13	WDR83, MORG1		WD repeat-containing protein 83	616850	REc			
19.307	2	12	14	19p13.13	KLF1, EKLF, INLU, HBFQTL6, CDAN4		Kruppel-like factor 1, erythroid	600599	A		Blood group--Lutheran inhibitor, 111150 (3); [Hereditary persistence of fetal hemoglobin], 613566 (3); Dyserythropoietic anemia, congenital, type IV, 613673 (3)	
19.308	2	25	15	19p13.12	AKAP8, AKAP95		A-kinase anchor protein 8	604692	REa, REc			
19.309	8	24	09	19p13.11	AP1M1, AP47, CLAPM2		Adaptor-related protein complex 1, mu 1 subunit	603535	REa			
19.310	7	21	15	19p13.11	CALR3, CRT2, CMH19		Calreticulin 3	611414	REc	mutation identified in 1 CMH19 patient	?Cardiomyopathy, hypertrophic, 19, 613875 (3)	
19.311	5	2	06	19p13.12	CC2D1A, MRT3		Coiled-coil and C2 domain-containing 1A	610055	REc, Fd		Mental retardation, autosomal recessive 3, 608443 (3)	
19.312	2	29	16	19p13.12	CLEC17A		C-type lectin domain family 17, member A	616838	REc			
19.313	11	11	14	19p13.12	CYP4F2		Cytochrome P450, family 4, subfamily F, polypeptide 2	604426	REc			
19.314	1	18	13	19p13.12	CYP4F22, ARCI5, LI3		Cytochrome P450, family 4, subfamily F, polypeptide 22	611495	REc		Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	
19.315	3	27	17	19p13.12	EPHX3, ABHD9		Epoxide hydrolase 3	617400	REc			
19.316	4	2	12	19p13.11	FAM32A, OTAG12		Family with sequence similarity 32, member A	614554	REc			8(Fam32a)
19.317	3	23	09	19p13.12	MIR24-2, MIRN24-2		Micro RNA 24-2	610724	REc			
19.318	3	23	09	19p13.12	MIR27, MIRN27A		Micro RNA 27A	612153	REc			
19.319	10	29	03	19p13.12	PGRPL		Peptidoglycan recognition protein, long	608199	REc			
19.320	8	24	15	19p13.12	RASAL3		Ras protein activator-like 3	616561	REc			
19.321	8	18	14	19p13.12	SLC1A6, EAAT4		Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6	600637	REc			
19.322	3	17	17	19p13.12	SYDE1		Synapse defective Rho GTPase, C. elegans, homolog of, 1	617377	REc			
19.323	6	2	11	19p13.12	TECR, GPSN2, TER, SC2, MRT14		Trans-2,3-enoyl-CoA reductase	610057	R, REc		Mental retardation, autosomal recessive 14, 614020 (3)	
19.324	5	30	17	19p13.12	UCA1, LINC00178, CUDR		Urothelial cancer-associated gene 1	617500	REc			
19.325	2	25	15	19p13.12	AKAP8L, HA95, NAKAP, HAP95		A-kinase anchor protein 8-like protein	609475	REa			
19.326	9	23	96	19p13.13	DHPS		Deoxyhypusine synthase	600944	REa, A			
19.327	6	15	99	19p13.12	NDUFB7		NADH-ubiquinone oxidoreductase 1 beta subcomplex, 7	603842	R			
19.328	1	8	01	19p12	ZNF254, ZNF91L		Zinc finger protein-254	604768	R			
19.329	3	24	06	19p13.11	BCNP1		B-cell novel protein 1	609967	R, REc			
19.330	10	23	15	19p13.11	BORCS8, MEF2BNB		BLOC1-related complex, subunit 8	616601	REc			
19.331	5	12	09	19p13.11	C10orf62, MERIT40, NBA1		Chromosome 19 open reading frame 62	612766	REc			
19.332	10	14	10	19p13.11	CILP2		Cartilage intermediate layer protein 2	612419	REc			
19.333	6	17	17	19p13.11	COLGALT1, GLT25D1		Collagen beta(1-0)galactosyltransferase 1	617531	REc			
19.334	8	24	09	19p13.11	COPE		Cotamer protein complex, subunit epsilon	606942	R, REc			
19.335	1	27	17	19p13.11	CPAMD8, KIAA1283, ASGD8		Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8	608841	REc		Anterior segment dysgenesis 8, 617319 (3)	
19.336	2	23	16	19p13.11	EPS15L1, EPS15R		EPS15-like protein 1	616826	REc			
19.337	9	7	10	19p13.11	FCHO1		FCH domain-only protein 1	613437	REc			
19.338	2	5	15	19p13.11	GTPBP3, MSS1, COXPD23		GTP-binding protein 3	608536	REc		Combined oxidative phosphorylation deficiency 23, 616198 (3)	
19.339	9	7	10	19p13.11	HAUS8, DGT4, HICE1		HAUS augmin-like complex, subunit 8	613434	REc			
19.340	7	9	06	19p13.11	HOMER3		Homer, homolog 3 (Drosophila)	604800	R, REc			
19.341	6	22	10	19p13.11	IFI30, GILT		Interferon-gamma-inducible protein 30	604664	REc			
19.342	4	17	13	19p13.11	KXD1, C10orf50		KXDL motif-containing protein 1	615178	REc			
19.343	9	16	16	19p13.11	LINC00663		Long intergenic noncoding RNA 663	617117	REc			
19.344	8	24	09	19p13.11	LSM4		LSM4 protein	607284	R, REc			
19.345	4	10	14	19p13.11	MAP1S, BPY2IP1, VCY2IP1, C19orf5		Microtubule-associated protein 1S	607573	R, REc			
19.346	9	24	08	19p13.11	MAST3, KIAA0561		Microtubule-associated serine/threonine kinase 3	612258	R, REc			
19.347	3	28	12	19p13.11	MAU2, SCC4, KIAA0892		MAU2 chromatid cohesion factor, C. elegans, homolog of	614560	REc			
19.348	8	24	09	19p13.11	MED26, CRSP7, CRSP70		Mediator complex subunit 26	605043	R, REc			
19.349	12	30	14	19p13.11	MPV17L2		MPV17-like protein 2	616133	REc			
19.350	7	12	13	19p13.11	NXNL1, RDCVF, TXNL6, LOC115861		Nucleoredoxin-like protein 1	608791	REc, H			8(Nxnl1)
19.351	1	4	16	19p13.11	NWD1		NACHT domain- and WD repeat-containing protein 1	616250	REc			
19.352	11	11	14	19p13.11	PBX4		Pre-B-cell leukemia transcription factor 4	608127	REc, A, H			8(Pbx4)
19.353	1	10	07	19p13.11	PGPEP1, PCP, PGP		Pyroglutamyl peptidase I	610694	REc			
19.354	11	10	17	19p13.11	SUGP1, SF4		SURP and G-patch domains-containing protein 1	607992	REc			
19.355	8	24	09	19p13.11	SIN3B, KIAA0700		Sin3, yeast, homolog of, B	607777	R, REc			
19.356	3	12	07	19p13.11	SLC25A42		Solute carrier family 25, member 42	610823	REc			8(Slc25a42)
19.357	11	10	17	19p13.11	SUGP2, SRFS14, KIAA0365		SURP and G-patch domains-containing protein 2	607993	R, REc			
19.358	11	6	00	19p13.12	TCCR, WSX1		T-cell cytokine receptor	605350	Psh, R			
19.359	11	24	08	19p13.11	TMEM16H, KIAA1623		Transmembrane protein 16H	610216	R, REc			
19.360	4	6	15	19p13.11	TMEM38A, TRICA		Transmembrane protein 38A	611235	REc			
19.361	1	23	07	19p13.11	TSSK6, SSTK, TSSK4		Testis-specific serine/threonine kinase 6	610712	REc			8(Tssk6)
19.362	2	11	16	19p13.12	ADGRE2, EMR2, VBU		Adhesion G protein-coupled receptor E2	606100	REc		Vibratory urticaria, 125630 (3)	
19.363	2	23	16	19p13.12	ADGRE5, CD97		Adhesion G protein-coupled receptor E5	601211	REa			
19.364	5	15	08	19p13.12	BRD4, CAP, HUNK1		Bromodomain-containing protein 4	608749	REc, A, H	fused with NUT		17(Brd4)
19.365	1	27	17	19p13.12	CASP14, ARCI12		Caspase 14, apoptosis-related cysteine protease	605848	REc		Ichthyosis, congenital, autosomal recessive 12, 617320 (3)	
19.366	7	4	95	19p13.11	COMP, EDM1, MED, PSACH		Cartilage oligomeric matrix protein	600310	REa, A, Fd		Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple, 1, 132400 (3)	
19.367	8	20	08	19p13.12	CYP4F8		Cytochrome P450, family 4, subfamily F, polypeptide 8	611545	REc			
19.368	10	13	09	19p13.12	CYP4F11		Cytochrome P450, family 4, subfamily F, polypeptide 11	611517	R, REc			
19.369	12	3	07	19p13.12	CYP4F12		Cytochrome P450, family 4, subfamily F, polypeptide 12	611485	REc			
19.370	4	23	96	19p13.11	ELL		ELL gene (11-19 lysine-rich leukemia gene)	600284	Ch, RE			
19.371	10	6	15	19p13.12	EMR3		EGF-like module-containing, mucin-like hormone receptor 3	606101	REc			
19.372	9	8	14	19p13.11	IL12RB1, IMD30		Interleukin-12 receptor, beta-1	601604	A		Immunodeficiency 30, 614891 (3)	
19.373	4	19	01	19p13.12	ILVBL, AHAS		IlvB-like (acetolactate synthase, bacterial, homolog of)	605770	REc			
19.374	12	17	07	19p13.11	ISYNA1, IPS		Myoinositol 1-phosphate synthase A1	611670	REc	pseudogene on 4p15		
19.375	5	4	12	19p13.11	JAK3, JAKL		Janus kinase 3 (Janus kinase, leukocyte)	600173	A, Psh		SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	
19.376	5	7	03	19p13.11	KLF2, LKLF		Kruppel-like factor 2	602016	R, REa, A			
19.377	3	5	08	19p13.11	MRPL34		Mitochondrial ribosomal protein L34	611840	R, REc			
19.378	12	7	05	19p13.11	MYO9B, MYR5, CELIAC4		Myosin IXB	602129	A, REc		{Celiac disease, susceptibility to, 4}, 609753 (3)	
19.379	8	24	09	19p13.11	NR2F6, ERBAL2, EAR2		Nuclear receptor subfamily 2, group F, member 6	132880	REb, REc			
19.380	12	14	99	19p13.11	PDE4C, DPDE1		Phosphodiesterase-4C, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E1)	600128	REa, A	between JUND (proximal) and RAB3A (distal)		8(Pde4c)
19.381	6	27	14	19p13.12	PRKACA		Protein kinase, cAMP-dependent, catalytic, alpha	601639	A		Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)	
19.382	6	13	95	19p13.12	PTGER1		Prostaglandin E receptor 1, EP1 subtype, 42kD	176802	A			
19.383	10	15	97	19p13.12	RFX1		Regulatory factor (trans-acting) 1 (influences HLA class II expression)	600006	A			
19.384	1	28	02	19p13.12	RGS19IP1, C19orf3, GIPC		Regulator of G-protein signaling 19 interacting protein 1	605072	R, A			
19.385	1	8	01	19p13.11	SLC27A1, FATP, FATP1		Solute carrier family 27, member 1	600691	A			
19.386	4	24	09	19p13.2	SLC44A2, CTL2		Solute carrier family 44, member 2	606106	REc			
19.387	12	4	02	19p13.11	SSBP4		Single-stranded DNA-binding protein 4	607391	REc			
19.388	9	29	96	19p13.12-p13.11	TPM4		Tropomyosin 4	600317	Psh, A			
19.389	2	23	08	19p13.11	USHBP1, MCC2		USH1C-binding protein 1	611810	R, REc			
19.390	2	23	08	19p13.12	ZNF333, KIAA1806		Zinc finger protein 333	611811	REc			
19.391	4	25	93	19p13.11	JUND		jun D proto-oncogene	165162	A			8(Jund)
19.392	4	25	93	19p13.11	RAB3A		RAS-associated protein RAB3A	179490	REb, A			
19.393	6	19	00	19p12	ZNF43		Zinc finger protein-43	603972	A			
19.394	3	20	94	19p13.11	UBA52		Ubiquitin A-52 residue ribosomal protein fusion product 1	191321	REa, A			
19.395	6	19	00	19p12	ZNF90		Zinc finger protein-90	603973	A			
19.396	6	19	00	19p12	ZNF91		Zinc finger protein-91	603971	A			
19.397	8	10	99	19p12	ZNF85		Zinc finger protein-85	603899	Psh, A			
19.398	6	19	00	19p12	ZNF93		Zinc finger protein-93	603975	A			
19.399	6	19	00	19p13.1-p12	ZNF94		Zinc finger protein-94	603976	REc			
19.400	6	6	00	19p12	ZNF100		Zinc finger protein-100	603982	A			
19.401	6	6	00	19p13.11	ZNF101		Zinc finger protein-101	603983	A			
19.402	6	6	00	19p13.1-p12	ZNF103		Zinc finger protein-103	603985	A			
19.403	6	6	00	19p13.1-p12	ZNF105		Zinc finger protein-105	603987	A			
19.404	6	6	00	19p13.1-p12	ZNF106		Zinc finger protein-106	603988	A			
19.405	6	6	00	19p13.1-p12	ZNF109		Zinc finger protein-109	603991	A			
19.406	6	6	00	19p13.1-p12	ZNF110		Zinc finger protein-110	603992	A			
19.407	6	6	00	19p13.1-p12	ZNF111		Zinc finger protein-111	603993	A			
19.408	6	6	00	19q13.31	ZNF112		Zinc finger protein-112	603994	A			
19.409	6	19	00	19p13.1-p12	ZNF113		Zinc finger protein-113	603995	A	?13q21		
19.410	6	19	00	19p13.1-p12	ZNF118		Zinc finger protein-118	603997	A	?13q21		
19.411	6	6	00	19p13.1-p12	ZNF119		Zinc finger protein-119	603998	A			
19.412	6	6	00	19p13.1-p12	ZNF120		Zinc finger protein-120	603999	A			
19.413	6	6	00	19p13.1-p12	ZNF122		Zinc finger protein-122	604000	A			
19.414	9	9	09	19p12	ZNF208, ZNF95		Zinc finger protein-208	603977	A			
19.415	9	2	09	19p12	ZNF737, ZNF102		Zinc finger protein-737	603984	A			
19.416	9	22	16	19p13.13	CACNA1A, CACNL1A4, SCA6, EIEE42		Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	A, Fd		Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type 2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3); Epileptic encephalopathy, early infantile, 42, 617106 (3)	8(tg, Cacl1a4)
19.417	11	9	95	19p13.2	CDKN2D		Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)	600927	A	possible tumor suppressor		
19.418	8	2	13	19p13.3	CELF5, BRUNOL5		CUGbp- and ELAV-like family, member 5	612680	REc			
19.419	10	27	08	19p13.11	CRTC1, MECT1, KIAA0616, FLJ14027		CREB-regulated transcription coactivator 1	607536	Ch	t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
19.420	10	17	00	19p13.3	FSTL3, FLRG		Follistatin-like 3	605343	REa, A			
19.421	8	13	13	19p13.3	GNA11, HHC2, HYPOC2		Guanine nucleotide-binding protein, Gq class, GNA11	139313	A, Fd		Hypocalciuric hypercalcemia, type II, 145981 (3); Hypocalcemia, autosomal dominant 2, 615361 (3)	10(Gna11)
19.422	9	27	95	19p13.3	GNA15, GNA16		Guanine nucleotide-binding protein (G protein) alpha 15 (Gq class)	139314	REa, A			10(Gna15)
19.423	2	21	02	19p13	IBD6		Inflammatory bowel disease 6	606674	Fd		{Inflammatory bowel disease 6} (2)	
19.424	5	6	03	19p13.2	ILF3, NF90, DRBP76, MPHOSPH4, NFAR		Interleukin enhancer-binding factor 3	603182	A			
19.425	10	24	03	19p13	MGR5		Migraine with or without aura, susceptibility to, 5	607508	Fd		{Migraine with or without aura, susceptibility to, 5} (2)	
19.426	6	15	99	19p13.3	NDUFS7, PSST		NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kD (NADH-coenzyme Q reductase)	601825	A		Leigh syndrome, 256000 (3)	
19.427	5	22	03	19p13.2	P2RY11		Purinergic receptor P2Y, G protein-coupled, 11	602697	REc	fuses with PPAN		
19.428	3	9	98	19p13.2	PIN1, DOD		Peptidyl-prolyl cis/trans isomerase, NIMA-interacting	601052	Psh, A			
19.429	7	18	14	19p13	PPNAD4		Pigmented nodular adrenocortical disease, primary, 4	615830	Ch	duplication of 294kb to 2.7Mb on 19p13	Pigmented nodular adrenocortical disease, primary, 4 (4)	
19.430	5	22	03	19p13.2	PPAN, SSF1		Peter pan, Drosophila, homolog of	607793	REc	fuses with P2RY11		
19.431	11	21	00	19p13	PSORS6		Psoriasis susceptibility 6	605364	Fd		{Psoriasis susceptibility 6} (2)	
19.432	8	25	05	19p13.13	RTBDN		Retbindin	609553	REc			
19.433	4	15	04	19p13.2	RDH8, PRRDH		Retinol dehydrogenase 8	608575	REc			
19.434	6	28	99	19p13.3	SGTA, SGT		Small glutamine-rich tetratricopeptide repeat-containing protein, alpha	603419	A			
19.435	12	11	98	19p13.3	TNFSF7, CD70, CD27L		Tumor necrosis factor ligand superfamily, member 7 (CD70 antigen)	602840	A			
19.436	6	4	13	19p13.3	UBXN6, UBXD1		UBX domain protein 6	611946	REc			
19.437	9	9	10	19p13.2	ZNF177		Zinc finger protein 177	601276	REc			
19.438	9	30	02	19p13.11	ZNF253		Zinc finger protein 253	606954	A			
19.439	4	6	11	19p13.2	ZNF317, KIAA1588		Zinc finger protein 317	613864	REc			
19.440	5	27	93	19q13.33	CD37		Leukocyte surface antigen CD37	151523	REa			
19.441	2	24	15	19p13.11	CERS1, LASS1, UOG1, EPM8		Ceramide synthase 1	606919	A	mutation identified in 1 EPM8 family	?Epilepsy, progressive myoclonic, 8, 616230 (3)	
19.442	11	10	14	19p13.11	CRLF1, CISS1		Cytokine-like factor 1	604237	TM, REc, Fd, Ch		Cold-induced sweating syndrome 1, 272430 (3)	
19.443	11	2	98	19p13.11	CSPG3, NCAN		Chondroitin sulfate proteoglycan 3 (neurocan)	600826	REc			
19.444	2	3	99	19p13.11	F2RL3, PAR4		Coagulation factor II, thrombin, receptor-like 3 (protease-activated receptor-4)	602779	A			
19.445	1	24	04	19p13.11	FKBP8, FKBP38		FK506-binding protein 8	604840	R, REc	pseudogene on 1q32		
19.446	4	24	18	19p13.11	GDF1, DTGA3, DORV, RAI, CHTD6		Growth/differentiation factor 1	602880	REc		Congenital heart defects, multiple types, 6, 613854 (3); Right atrial isomerism (Ivemark), 208530 (3)	
19.447	9	18	08	19p13.11	LPAR2, EDG4		Lysophosphatidic acid receptor 2	605110	REc			8(Edg4)
19.448	11	8	95	19p13.11	MEF2B		MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B)	600661	REn			?8(Mef2b)
19.449	11	30	06	19p13.12	PKN1, PRKCL1, PRK1, PAK1		Protein kinase N1	601032	R, A			8(Prkcl1)
19.450	11	2	98	19p13.11	RFXANK		Regulatory factor X, ankyrin repeat-containing	603200	REc		MHC class II deficiency, complementation group B, 209920 (3)	
19.451	12	27	01	19p13.11	TM6SF2, KIAA1926		Transmembrane 6 superfamily, member 2	606563	REc			
19.452	8	25	16	19p13.11	TMEM59L, BSMAP		Transmembrane protein 59-like	617096	REc, H			8(Tmem59l)
19.453	8	24	09	19p12	ZNF98		Zinc finger protein-98	603980	REc			
19.454	8	24	09	19p12	ZNF99		Zinc finger protein-99	603981	REc			
19.455	11	20	12	19p12	ZNF257		Zinc finger protein 257	606957	A			
19.456	11	1	05	19p13.11	GMIP		GEM-interacting protein	609694	REc			
19.457	11	30	94	19p	EXT3		Exostoses, multiple, 3	600209	Fd		Exostoses, multiple, type 3 (2)	
19.458	10	20	99	19p13.11	RPL18A		Ribosomal protein L18a	604178	REa, R			
19.459	2	7	01	19p13.3	RPS15, RIG		Ribosomal protein S15	180535	REa, R			
19.460	6	20	01	19p13.11	TMEM3, B3GNT3		Transmembrane protein 3 (beta-1,3-N-acetylglucosaminyltransferase 3)	605863	REc			
19.461	7	13	93	19p13.3	ZNF77		Zinc finger protein-77 (pT1)	194551	REa			
19.462	4	25	93	19p13.2	ZNF121, D19S204		Zinc finger protein-121 (clone ZHC32)	194628	REa, Fd			
19.463	8	9	05	19p13.13	MAN2B1, MANB		Mannosidase, alpha, class 2B, member 1	609458	S, Psh, REa		Mannosidosis, alpha-, types I and II, 248500 (3)	8(Man2b1)
19.464	2	21	10	19q13.11	PEPD		Peptidase D (prolidase)	613230	S, F, H, Fd	closely linked to APOC2	Prolidase deficiency, 170100 (3)	7(Pep4)
19.465	2	2	90	19q13.43	A1BG		Glycoprotein, alpha-1B	138670	F	order: C3-SE-LU-A1BG		
19.466	4	8	11	19q	BFIS1, BFIC1		Benign familial infantile seizures	601764	Fd		Seizures, benign familial infantile, 1 (2)	
19.467	3	29	07	19q13.43	CHMP2A, VPS2A, VPS2, BC2		CHMP family, member 2A	610893	R			
19.468	2	28	03	19q	HPCQTL19		Prostate cancer aggressiveness quantitative trait locus on chromosome 19	607592	Fd	D19S902	{Prostate cancer aggressiveness QTL}, 176807 (2)	
19.469	8	27	01	19q13.32	PUMA		p53-upregulated modulator of apoptosis	605854	R			
19.470	10	20	99	19q13.33	RPL18		Ribosomal protein L18	604179	REa, R			
19.471	7	13	92	19q13.33	RPS11		Ribosomal protein S11	180471	Psh			
19.472	2	7	01	19q13.2	RPS16		Ribosomal protein S16	603675	REa, R			
19.473	2	7	01	19q13.2	SIRT2, SIR2L, SIR2L2		Sirtuin, S. cerevisiae, homolog 2	604480	REc			
19.474	2	27	02	19q	SLI2		Specific language impairment QTL, 2	606712	Fd		Specific language impairment QTL, 2 (2)	
19.475	5	17	95	19q13.33	SYT3		Synaptotagmin-3	600327	REa, H			7(Syt3)
19.476	3	9	11	19q13.2	CXCL17, VCC1, DMC		Chemokine (C-X-C motif) ligand 17	611387	REc			
19.477	5	6	13	19q12	PLEKHF1, LAPF, PHAFIN1		Pleckstrin homolog domain-containing protein, family F, member 1	615200	REc			7(Plekhf1)
19.478	3	19	93	19q13.11	HPN		Hepsin	142440	REa			
19.479	11	20	13	19q12	C19orf12, NBIA4, SPG43		Chromosome 19 open reading frame 12	614297	REc	mutation identified in 1 SPG43 family	Neurodegeneration with brain iron accumulation 4, 614298 (3); ?Spastic paraplegia 43, autosomal recessive, 615043 (3)	
19.480	1	25	11	19q12	HSCR7		Hirschsprung disease, susceptibility to, 7	606875	Fd		{Hirschsprung disease, susceptibility to, 7} (2)	
19.481	1	14	13	19q13.2	MEGF8, EGFL4, CRPT2		Multiple epidermal growth factor-like domains 8	604267	R		Carpenter syndrome 2, 614976 (3)	
19.482	5	27	94	19q13.12	POLR2I		Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kD	180662	A			
19.483	8	24	09	19q12	RPP29, POP4		Ribonuclease P, 29kD subunit	606114	R, REc			
19.484	3	15	10	19q13.11	UBA2, SAE2		Ubiquitin-like modifier-activating enzyme 2	613295	REc			
19.485	7	4	95	19q12	UQCRFS1		Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	191327	REa, A, RE			
19.486	4	27	17	19q12	URI1, NNX3, RMP		Prefoldin-like chaperone URI1	603494	REc, A			
19.487	6	28	18	19q12	ZNF536, KIAA0390		Zinc finger protein 536	618037	REc			
19.488	6	3	14	19q13.2	DYRK1B, MIRK, AOMS3		Dual-specificity tyrosine phosphorylation-regulated kinase 1B	604556	R, REc		Abdominal obesity-metabolic syndrome 3, 615812 (3)	
19.489	10	12	14	19q13.2	ATP1A3, DYT12, RDP, AHC2, CAPOS		ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	REa, H, Fd		Dystonia-12, 128235 (3); Alternating hemiplegia of childhood 2, 614820 (3); CAPOS syndrome, 601338 (3)	7(Atpla3)
19.490	6	28	99	19q13.11	LRP3		Low density lipoprotein receptor related protein 3	603159	Psh, A			
19.491	7	9	09	19q13.12	SDHAF1		Succinate dehydrogenase complex assembly factor 1	612848	REc, Fd		Mitochondrial complex II deficiency, 252011 (3)	
19.492	9	30	09	19q13	AAA1, AAA		Aortic aneurysm, familial abdominal 1	100070	Fd	near D19S416	Aortic aneurysm, familial abdominal 1 (2)	
19.493	3	1	00	19q13.2	ACTN4, FSGS1, FSGS		Actinin, alpha-4	604638	Fd, REc		Glomerulosclerosis, focal segmental, 1, 603278 (3)	7(Actn4)
19.494	1	17	17	19q13.33	ACPT, AI1J		Acid phosphatase, testicular	606362	REc		Amelogenesis imperfecta, type IJ, 617297 (3)	
19.495	8	24	04	19q13	ANIB2		Aneurysm, intracranial berry, 2	608542	Fd	between D19S245 and D19S246	Aneurysm, intracranial berry, 2 (2)	
19.496	9	15	98	19q13.33	BCAT2, BCT2		Branched chain aminotransferase-2, mitochondrial	113530	S, H		?Hypervalinemia or hyperleucine-isoleucinemia (1)	7(Bcat2)
19.497	6	5	90	19q13.32	BCL3		B-cell CLL/lymphoma-3	109560	Ch, S, H		Leukemia/lymphoma, B-cell, 3 (2)	7(Bcl3)
19.498	2	3	06	19q13.32	BLOC1S3, BLOS3, HPS8		Biogenesis of lysosome-related organelles complex 1, subunit 3	609762	R, Fd		Hermansky-Pudlak syndrome 8, 614077 (3)	7(rp)
19.499	8	18	04	19q13.2	CAPN12		Calpain 12	608839	REc			7(Capn12)
19.500	7	23	13	19q13	CTRCT35, CATCN1		Cataract 35	609376	Fd	max lod at D19S416	Cataract 35, congenital nuclear (2)	
19.501	10	25	90	19q13.32	CKM, CKMM		Creatine kinase, muscle type	123310	REa, A			7(Ckmm)
19.502	6	19	15	19q13.12	CLIP3, CLIPR59		CAP-GLY domain-containing linker protein 3, 607382 (3)	607382	R			
19.503	1	31	08	19q13.2	CNFN		Cornifelin	611764	REc, H			7(Cnfn)
19.504	9	30	09	19q13.33	CYTH2, PSCD2, ARNO, PSCD2L		Cytohesin 2	602488	R			
19.505	3	30	00	19q13.2	DLL3, SCDO1		Delta, Drosophila, homolog of	602768	Fd, REc		Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	7(Dll3)
19.506	4	1	08	19q13	EA7		Episodic ataxia, type 7	611907	Fd	between rs1366444 and rs952108	Episodic ataxia, type 7 (2)	
19.507	9	12	95	19q13.2	ECH1		Enoyl Coenzyme A hydratase 1, peroxisomal	600696	REc, REa			
19.508	12	7	04	19q13.42	EPN1		Epsin 1	607262	REc			
19.509	6	30	05	19q13.33	FGF21		Fibroblast growth factor 21	609436	REc			
19.510	7	18	12	19q13.33	FUZ, NTD		Fuzzy, Drosophila, homolog of	610622	REc		Neural tube defects, 182940 (3)	
19.511	10	19	10	19q13.12	HAMP, LEAP1, HEPC, HFE2B		Hepcidin antimicrobial peptide	606464	REc, Fd	digenic form with HAMP and HFE mutations	Hemochromatosis, type 2B, 613313 (3)	7(Hepc1)
19.512	3	7	06	19q13.43	NALP5, MATER		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 5	609658	REc			
19.513	9	1	95	19q13	OFC3		Orofacial cleft-3	600757	Fd	?role of BCL3	Orofacial cleft-3 (2)	7(Cebpa)
19.514	10	29	03	19q13.32	PGRP, PGRPS		Peptidoglycan recognition protein	604963	REc			
19.515	8	11	91	19q13.31	PLAUR, URKR		Plasminogen activator, urokinase, receptor	173391	REa, Fd			
19.516	10	12	16	19q13.33	PRMT1, HRMT1L2, IR1B4		Protein arginine methyltransferase 1	602950	REa, A			7(Prmt1)
19.517	9	27	01	19q13.33	SLC17A7, BNPI, VGLUT1		Solute carrier family 17, (sodium-dependent inorganic phosphate cotransporter), member 7	605208	A			
19.518	8	1	12	19q13	UAQTL5		Uric acid concentration, serum, quantitative trait locus 5	614746	Fd	associated with rs150414818	[Uric acid concentration, serum, QTL5] (2)	
19.519	9	30	02	19q13.43	ZNF256		Zinc finger protein 256	606956	A			
19.520	12	2	92	19q13.12	ATP4A, ATP6A		ATPase, H+, K+ transporting, alpha	137216	A			7(Atp4a)
19.521	9	7	10	19q13.2	CATSPERG		Cation channel, sperm-associated, gamma	613452	REc			
19.522	3	31	15	19q12	CCNE1		Cyclin E1	123837	A, REc			7(Ccne)
19.523	7	13	93	19q13.12	CD22		CD22 antigen	107266	A			
19.524	12	30	14	19q13.11	CEBPA, CEBP		CCAAT/enhancer-binding protein (C/EBP), alpha	116897	REa, A	germline mutation identified in 1 AML family	?Leukemia, acute myeloid, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3)	
19.525	3	15	15	19q13.11	CHST8, GALNAC4ST1, PSS3		Carbohydrate sulfotransferase 8	610190	REc	mutation has been identified in 1 PSS3 family	?Peeling skin syndrome 3, 616265 (3)	
19.526	11	4	93	19q13.2	CLC		Charcot-Leyden crystal protein	153310	REa, A, RE			
19.527	11	7	16	19q13.2	COQ8B, ADCK4, NPHS9		Coenzyme Q8B	615567	REc		Nephrotic syndrome, type 9, 615573 (3)	
19.528	11	5	15	19q13.12	COX6B1		Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)	124089	A		Mitochondrial complex IV deficiency, 220110 (3)	
19.529	8	3	99	19q13.12	DAP10		DNAX-activation protein 10	604089	REn			
19.530	11	23	16	19q13.12	DMKN		Dermokine	617211	REc, H			7(Dmkn)
19.531	11	23	16	19q13.12	KDAP		Keratinocyte differentiation-associated protein	617212	REn, H			7(Krtdap)
19.532	11	23	16	19q13.2	ERF, PE2, CRS4, CHYTS		ETS2 repressor factor	611888	Psh, A, H		Craniosynostosis 4, 600775 (3); Chitayat syndrome, 617180 (3)	7(Erf)
19.533	5	16	05	19q13.12	ETV2, ETSRP71		ETS variant gene 2	609358	R, REc			
19.534	5	8	15	19q13.12	FFAR1, GPR40		Free fatty acid receptor 1	603820	REn			
19.535	5	8	15	19q13.12	FFAR3, GPR41		Free fatty acid receptor 3	603821	REn			
19.536	5	8	15	19q13.12	FFAR2, GPR43		Free fatty acid receptor 2	603823	REn			
19.537	5	23	00	19q13.12	FXYD1, PLM		FXYD domain-containing ion transport regulator 1 (phospholemman)	602359	A			
19.538	1	25	05	19q13.12	GAPDHS, GAPD2		Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	609169	REc	9.5 Mbp prox. to APOE		
19.539	9	9	10	19q13.11	GPI		Glucose phosphate isomerase; neuroleukin	172400	S, D, A		Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	7(Gpi1)
19.540	5	21	99	19q13.12	GPR42		G protein-coupled receptor-42	603822	REn			
19.541	5	2	01	19q13.2	KCNK6, TWIK2, TOSS		Potassium channel, subfamily K, member 6	603939	R			
19.542	1	9	17	19q13.12	KMT2B, MLL4, KIAA0304, DYT28		Lysine (K)-specific methyltransferase 2B	606834	R, REc, A		Dystonia 28, childhood-onset, 617284 (3)	
19.543	4	18	05	19q13.2	LGALS13, GAL13, PP13		Lectin, galactoside-binding, soluble, 13	608717	REc, R			
19.544	12	9	15	19q13.12	MAG, GMA, SPG75		Myelin-associated glycoprotein	159460	REa, REb, A		Spastic paraplegia 75, autosomal recessive, 616680 (3)	7(Mag)
19.545	5	22	03	19q13.12	KIRREL2, NEPH3, NLG1, FILTRIN		Kin or IRRE-like 2 (nephrin-like 3)	607762	REc			
19.546	2	9	00	19q13.2	NFKBIB, IKBB, TRIP9		Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, beta	604495	A			
19.547	10	25	10	19q13.12	NPHS1, NPHN		Nephrin	602716	Fd, REn		Nephrotic syndrome, type 1, 256300 (3)	
19.548	6	30	15	19q13.12	OVOL3		ovo-like 3	616442	REc			
19.549	10	2	98	19q13.2	PAFAH1B3		Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit	603074	R, A			
19.550	9	10	98	19q13.2	MRPS12, RPSM12		Ribosomal protein, mitochondrial, S12	603021	REa, R			
19.551	4	24	18	19q13.2	PLEKHG2, CLG, LDAMD		Pleckstrin homology domain- and RhoGEF domain-containing protein G2	611893	REc		Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	
19.552	3	22	07	19q13.2	PPP1R14A, CPI17		Protein phosphatase 1, regulatory subunit 14A	608153	R, REn			
19.553	12	4	17	19q13.12	PSENEN, PEN2, ACNINV2		Presenilin enhancer 2, C. elegans, homolog of	607632	R		Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3)	
19.554	2	28	03	19q13.2	RASGRP4		Ras guanyl nucleotide-releasing protein 4	607320	REc			
19.555	7	12	13	19q13.2	RYR1, MHS, CCO		Ryanodine receptor-1, skeletal	180901	A, Fd, H		{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3); King-Denborough syndrome, 145600 (3)	7(Ryr)
19.556	3	24	06	19q13.12	SBSN		Suprabasin	609969	REc, H			7(Sbsn)
19.557	2	22	18	19q13.33	CLEC11A, SCGF, LSLCL		C-type lectin domain family 11, member A	604713	A, REc, H			7(Scgf)
19.558	2	24	17	19q13.11	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52		Sodium channel, voltage-gated, type I, beta polypeptide	600235	A, Fd		Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3); Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3); Atrial fibrillation, familial, 13, 615377 (3); Epileptic encephalopathy, early infantile, 52, 617350 (3)	
19.559	8	18	08	19q13.2	SERTAD3, RBT1		SERTA domain-containing 3	612125	REc			
19.560	3	8	16	19q13.1-q13.2	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45		SIPA1-like protein 3	616655	R, REc	mutation identified in 1 CTRCT45 family	?Cataract 45, 616851 (3)	
19.561	4	21	10	19q13.11	SLC7A9, CSNU3		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9	604144	Fd, REc		Cystinuria, 220100 (3)	
19.562	2	12	99	19q13.2	SNRPA		Small nuclear ribonucleoprotein polypeptide A	182285	REa			
19.563	4	1	09	19q13.2	SPINT2, HAI2, DIAR3		Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2; bikunin, placental)	605124	Psh		Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	
19.564	12	23	05	19q13.2	TGFB1, DPD1, CED		Transforming growth factor, beta-1	190180	REa, A, Fd		Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung disease, modifier of}, 219700 (3)	7(Tgfb1)
19.565	7	15	99	19q13.33	TULP2		Tubby-like protein-2	602309	R			
19.566	12	11	02	19q13.12	TYROBP, PLOSL, DAP12		TYRO protein tyrosine kinase-binding protein	604142	REc, Fd, Ld		Nasu-Hakola disease, 221770 (3)	
19.567	3	17	08	19q13.12	UPK1A, UPIA		Uroplakin 1A	611557	REc			
19.568	7	11	17	19q13.12	USF2, FIP		Upstream transcription factor 2, c-fos interacting	600390	H, REc			7(Usf2)
19.569	1	17	07	19q13.12	ZBTB32, FAXF, TZFP, ROG		Zinc finger- and BTB domain-containing protein 32	605859	REc			
19.570	8	19	91	19q13.2	ZFP36, TTP		Zfp36, mouse, homolog of	190700	REa, A, H			7(Zfp36)
19.571	1	6	97	19q13.12	ZNF146, OZF		Zinc finger protein-146	601505	A			
19.572	11	14	11	19q13.2	AKT2, HIHGHH		Murine thymoma viral (v-akt) homolog-2	164731	A		Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	7(Akt2)
19.573	9	22	93	19q13.2	AXL		AXL transforming sequence (a receptor tyrosine kinase)	109135	A			
19.574	1	29	04	19q13.2	BCKDHA, MSUD1		Branched chain keto acid dehydrogenase E1, alpha polypeptide	608348	REa, REb, A		Maple syrup urine disease, type Ia, 248600 (3)	
19.575	2	9	15	19q13.2	LIPE, LHS, FPLD6		Lipase E, hormone-sensitive	151750	REa, A		Lipodystrophy, familial partial, type 6, 615980 (3)	7(Lipe)
19.576	1	31	13	19q13.2	LTBP4, LTBP4S, LTBP4L, ARCL1C		Latent transforming growth factor-beta-binding protein 4	604710	A		Cutis laxa, autosomal recessive, type IC, 613177 (3)	
19.577	9	24	08	19q13.31	LYPD3		LY6/PLAUR domain-containing protein 3	609484	A			
19.578	4	6	00	19q13.2	MAP3K10, MLK2, MST		Mitogen-activated protein kinase kinase kinase 10	600137	A			
19.579	7	30	14	19q13.2	PRX, CMT4F		Periaxin	605725	A, REc		Dejerine-Sottas disease, 145900 (3); Charcot-Marie-Tooth disease, type 4F, 614895 (3)	
19.580	6	28	99	19q13.2	SUPT5H, SPT5		Suppressor of Ty 5, S. cerevisiae, homolog of	602102	Psh, R, H			7(Supt5h)
19.581	1	12	07	19q13.2	MAP4K1, HPK1		Mitogen-activated protein kinase kinase kinase kinase 1	601983	R, REc			
19.582	11	23	16	19q13.11	DEL19q13.11p, C19DELq13.11p		Chromosome 19q13.11 deletion syndrome, proximal	617219	Ch		Chromosome 19q13.11 deletion syndrome, proximal (4)	
19.583	11	23	16	19q13.11	DEL19q13.11d, C19DELq13.11d		Chromosome 19q13.11 deletion syndrome, distal	613026	Ch	contiguous gene syndrome	Chromosome 19q13.11 deletion syndrome, distal (4)	
19.584	10	23	87	19q13.1-qter	E11S		Echo 11 sensitivity	129150	S			
19.585	4	17	07	19q13.11	C19orf40, FAAP24		Chromosome 19 open reading frame 40 (Fanconi anemia-associated protein, 24kD	610884	REc			
19.586	11	1	13	19q13.11	CEP89, CCDC123, CEP123, FLJ14640		Centrosomal protein, 89kD	615470	REc			
19.587	1	9	14	19q13.11	CEBPG, GPE1BP		CCAAT/enhancer-binding protein, gamma	138972	REc			
19.588	4	15	11	19q13.11	DPY19L3		DPY19-like 3	613894	REc			
19.589	1	9	13	19p13.11	GATAD2A		GATA zinc finger domain-containing protein 2A	614997	REc			
19.590	5	24	13	19q13.11	KCTD15		Potassium channel tetramerization domain-containing protein 15	615240	REc			
19.591	5	19	17	19q13.12	LGI4, AMCNMY		Leucine-rich gene, glioma-inactivated, 4	608303	REc		Arthrogryposis multiplex congenita, neurogenic, with myelin defect, 617468 (3)	7(Lgi4)
19.592	4	13	15	19q13.11	LSM14A, RAP55		LSM14A protein	610677	REc			
19.593	3	7	14	19q13.11	PDCD2L, MGC13096		Programmed cell death 2-like protein	615661	REc			
19.594	3	25	14	19q13.11	PDCD5, TFAR19		Programmed cell death 5	604583	REc			
19.595	2	7	07	19q13.11	RGS9BP, R9AP, RGS9, PERRS		Regulator of G protein signaling 9-binding protein	607814	R		Bradyopsia, 608415 (3)	
19.596	4	6	18	19q13.11	RHPN2		Rhophilin 2	617932	REc, H			7(Rhpn2)
19.597	2	22	13	19q13.11	SCGB2B2		Secretoglobin, family 2B, member 2	615063	REc			
19.598	2	25	15	19q13.11	SLC7A10, ASC1		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 10	607959	A, REc			
19.599	7	27	11	19q12	TSHZ3, KIAA1474		Teashirt zinc finger homeobox 3	614119	Psh, REc			
19.600	9	29	96	19q13.12	CKAP1		Cytoskeleton-associated protein 1	601303	A			
19.601	6	28	99	19q13.2	PSMC4, TBP7, S6		Proteasome 26S subunit, ATPase, 4	602707	A			
19.602	3	16	10	19q13.12	ALKBH6, ABH6		AlkB, E. coli, homolog of, 6	613304	REc			
19.603	12	10	12	19q13.12	ARHGAP33, TCGAP		Rho GTPase-activating protein 33	614902	REc			
19.604	8	24	09	19q13.12	CAPNS1, CAPN4		Calpain, small polypeptide	114170	REb, REc			
19.605	3	26	07	19q13.12	COX7A1, COX7AM		Cytochrome c oxidase, subunit VIIa, polypeptide-1, muscle	123995	REa, R, REc			
19.606	8	24	09	19q13.12	FXYD3, PLML, MAT8		FXYD domain-containing ion transport regulator 3	604996	R, REc			
19.607	3	26	07	19q13.12	FXYD5		FXYD domain-containing ion transport regulator 5	606669	R, REc			
19.608	8	24	09	19q13.12	FXYD7		FXYD domain-containing ion transport regulator 7	606684	R, REc			
19.609	9	7	10	19q13.12	HAUS5, DGT5, KIAA0841		HAUS augmin-like complex, subunit 5	613432	R, REc			
19.610	8	24	09	19q13.12	HKR1		GLI-Kruppel family member HKR1 (oncogene HKR1)	165250	REa, REc			
19.611	8	5	11	19q13.12	IGFLR1, TMEM149		IGF-like family receptor 1	614143	REc			
19.612	9	30	15	19q13.12	LSR		Lipolysis-stimulated lipoprotein receptor	616582	REc			
19.613	6	1	15	19q13.12	PRODH2, HYPDH		Proline dehydrogenase (oxidase) 2	616377	REc			
19.614	2	21	10	19q13.12	RBM42		RNA-binding motif protein 42	613232	REc			
19.615	11	22	13	19q13.12	SYNE4, NESP4, C19orf46, DFNB76		Spectrin repeat-containing nuclear envelope protein 4	615535	REc		Deafness, autosomal recessive 76, 615540 (3)	
19.616	1	20	09	19q13.12	THAP8		THAP domain-containing protein 8	612536	REc			
19.617	6	8	11	19q13.12	WDR62, C19orf14, MCPH2		WD repeat-containing protein 62	613583	REc, Fd		Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	
19.618	9	2	12	19q13.11	WTIP		WT1-interacting protein	614790	REc			
19.619	1	26	17	19q13.12	ZFP30, ZNF745, KIAA0961		Zinc finger protein 30, mouse, homolog of	617317	REc, H			7(Zfp30)
19.620	2	21	11	19q13.12	ZNF260, PEX1		Zinc finger protein 260	613749	REc, H			7(Zfp260)
19.621	11	23	16	19q13.12	ZNF420, APAK		Zinc finger protein 420	617216	REc			
19.622	10	5	11	19q13.12	ZNF565		Zinc finger protein 565	614275	REc			
19.623	7	11	17	19q13.12	ZNF568, ZFP568		Zinc finger protein 568	617566	REc			
19.624	5	16	11	19q13.12	ZNF569		Zinc finger protein 569	613904	REc			
19.625	3	29	00	19q13.2	ARHGEF1, LBCL2		Rho guanine nucleotide exchange factor, 115-kD	601855	R			
19.626	1	10	07	19q13.12	HSPB6, HSP20		Heat-shock 27kD protein 6	610695	REc			
19.627	2	11	13	19q13.2	IFNL1, IL29		Interferon, lambda 1	607403	REc			
19.628	2	11	13	19q13.2	IFNL2, IL28A		Interferon, lambda 2	607401	REc			
19.629	2	11	13	19q13.2	IFNL3, IL28B		Interferon, lambda 3	607402	REc		{Hepatitis C virus infection, response to therapy of}, 609532 (3)	
19.630	3	14	13	19q13.2	IFNL4		Interferon, lambda-4	615090	REc			
19.631	1	26	12	19q13.12	ZNF382, KS1		Zinc finger protein 382	609516	REc			
19.632	11	18	16	19q13.2	SELENOV, SELV		Selenoprotein V	607919	REc			
19.633	10	11	07	19q13.2	SPRED3		Sprouty-related EVH1 domain-containing protein 3	609293	REc			7(Spred3)
19.634	09	06	18	19q13.2	SPTBN4, QV, NEDHND, CMND		Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)	606214	R, A		Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3)	7(Spnb4)
19.635	5	13	11	19q13.12	ZNF540		Zinc finger protein 540	613903	REc			
19.636	1	1	96	19q13.2	BLVRB, BVRB, FLR		Biliverdin reductase B	600941	A			
19.637	12	18	08	19q13.2	DPF1, NEUD4		D4, zinc, and double PHD fingers family, member 1	601670	REa, REc			
19.638	2	1	00	19q13.2	NUMBL, NUMBR, NBL		Numb, Drosophila, homolog-like	604018	Fd			
19.639	10	25	16	19q13.33	GRIN2D, NMDAR2D, EIEE46		Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D	602717	R		Epileptic encephalopathy, early infantile, 46, 617162 (3)	
19.640	3	26	07	19q13.12	APLP1, APLP		Amyloid beta (A4) precursor-like protein-1	104775	REa			
19.641	10	16	95	19q13.32	APOC4		Apolipoprotein C-IV	600745	REn	555bp upstream of APOC2		
19.642	2	15	17	19q13.32	APOE, AD2, LPG, LDLCQ5		Apolipoprotein E	107741	F, REa, LD, A, Fd	possible 2nd locus for AD2 on chr.19	Hyperlipoproteinemia, type III, 617347 (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {?Macular degeneration, age-related}, 603075 (3); Lipoprotein glomerulopathy, 611771 (3); {Coronary artery disease, severe, susceptibility to}, 617347 (3)	7(Apoe)
19.643	4	25	93	19q13.32	APOC1		Apolipoprotein C-I	107710	REa, RE, A			
19.644	10	29	03	19q13.32	APOC2		Apolipoprotein C-II	608083	REa, F, LD, A, Fd		Hyperlipoproteinemia, type Ib, 207750 (3)	
19.645	12	22	16	19q13.2	ATP5SL		ATP5S-like protein	617262	REc			
19.646	11	15	17	19q13.2	B9D2, MKS10, JBTS34		B9 domain-containing protein 2	611951	REc	mutation identified in 1 MKS10 family	?Meckel syndrome 10, 614175 (3); Joubert syndrome 34, 614175 (3)	7(B9d2)
19.647	8	7	13	19q13.2	B3GNT8, BGALT15, B3GALT7		Beta-1,3-galactosyltransferase 8	615357	REc			7(B3gnt8)
19.648	6	27	17	19q13.31	CADM4, IGSF4C, TSLL2, NECL4, SYNCAM4		Cell adhesion molecule 4	609744	A, H			7(Igsf4c)
19.649	2	16	04	19q13.32	CBLC		CAS-BR-M murine ecotropic retroviral transforming sequence C	608453	Psh, R, A			
19.650	8	28	17	19q13.2	CCER2		Coiled-coil glutamate-rich protein 2	617634	REc			
19.651	1	6	00	19q13.2	CEACAM1, BGP		Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)	109770	H, REn	in CEA cluster		7(Bgp1)
19.652	1	6	00	19q13.2	CEACAM5, CEA		Carcinoembryonic antigen-related cell adhesion molecule 5	114890	REa, A, REc	proximal to PSG cluster in 1.1-1.2Mb segment		
19.653	1	6	00	19q13.2	CEACAM6, NCA		Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific crossreacting antigen)	163980	REa, A, REn	in CEA cluster		
19.654	5	22	14	19q13.2	CEACAM8, CD66B, CGM6		Carcinoembryonic antigen-related cell adhesion molecule 8	615747	REc			
19.655	8	2	17	19q13.2	CIC, KIAA0306, MRD45		Capicua, Drosophila, homolog of	612082	REc		Mental retardation, autosomal dominant 45, 617600 (3)	
19.656	8	26	03	19q13.2	CYP2A7		Cytochrome P450, subfamily IIA, polypeptide 7	608054	REc			
19.657	8	26	03	19q13.2	CYP2A13		Cytochrome P450, subfamily IIA, polypeptide 13	608055	REc			
19.658	9	26	17	19q13.2	CYP2G1		Cytochrome P450, subfamily IIG, polypeptide 1	601133	REc			
19.659	1	5	09	19q13.2	CYP2S1		Cytochrome P450, family 2, subfamily S, polypeptide 1	611529	REc			
19.660	8	17	16	19q13.2	DEDD2, FLAME3		Death effector domain-containing protein 2	617078	REc			
19.661	9	10	12	19q13.2	DMRTC2		Doublesex- and MAB3-related transcription factor C2	614806	REc			
19.662	2	24	17	19q13.2	EID2, CRI2		EP300-interacting inhibitor of differentiation 2	609773	REc, R			7(Cri2)
19.663	8	24	09	19q13.2	EGLN2, PHD1, HIFPH1		Egl9, C. elegans, homolog of, 2	606424	R, REc			
19.664	6	1	12	19q13.2	EXOSC5, RRP46		Exosome component 5	606492	REc			
19.665	9	29	10	19q13.2	FBL		Fibrillarin	134795	REc			
19.666	9	9	08	19q13.2	FBXO17, FBX17, FBX26, FBG4		F-box only protein 17	609094	REc			7(Fbxo17)
19.667	9	9	08	19q13.2	FBXO27, FBX27, FBG5		F-box only protein 27	609099	REc			7(Fbxo27)
19.668	6	28	17	19q13.2	FCGBP		Fc fragment of IgG-binding protein	617553	REc			
19.669	8	1	14	19q13.2	NCCRP1, FBXO50		Nonspecific cytotoxic cell receptor protein 1, zebrafish, homolog of	615901	REc			
19.670	2	4	00	19q13.2	GMFG		Glia maturation factor, gamma	604104	REn			
19.671	7	2	18	19q13.2	GSK3A		Glycogen synthase kinase 3-alpha	606784	Psh, A, REc			
19.672	11	11	14	19q13.2	HNRNPL, HNRPL		Heterogeneous nuclear riboprotein 1	603083	REc			
19.673	8	24	09	19q13.2	HNRNPUL1, HNRPUL1, E1BAP5		Heterogeneous nuclear ribonucleoprotein U-like 1	605800	R, REc			
19.674	6	18	18	19p13.11	HSH2D, ALX		Hemotopoietic SH2 domain-containing protein	608349	REc			
19.675	9	21	17	19q13.2	LGALS7B		Lectin, galactoside-binding, soluble, 7B	617139	REc			
19.676	7	15	09	19q13.2	LRFN1, SALM2, KIAA1484		Leucine-rich repeat and fibronectin type III domain-containing protein 1	612807	REc			
19.677	7	15	09	19q13.12	LRFN3, SALM4		Leucine-rich repeat and fibronectin type III domain-containing protein 3	612809	REc, H			7(Lrfn3)
19.678	12	20	01	19q13.32	MARK4, KIAA1860, MARKL1		Map/microtubule affinity-regulating kinase-4	606495	REc			
19.679	7	22	09	19q13.2	MED29, IXL		Mediator complex subunit 29	612914	REc			
19.680	10	4	02	19q13.31	NB1, PRV1, CD177, HNA2A		Neutrophil-specific antigen 1	162860	REc			
19.681	11	16	17	19q13.2	PLD3, HUK4, SCA46		Phospholipase D family, member 3	615698	REc	mutation identified in 1 SCA46 family	?Spinocerebellar ataxia 46, 617770 (3)	
19.682	8	24	09	19q13.2	POU2F2, OTF2, OCT2		POU domain, class 2, transcription factor 2	164176	REa, REc			7(Otf2)
19.683	1	6	00	19q13.2	PSG10, PSG12		Pregnancy-specific beta-1-glycoprotein-10	176399	A			
19.684	1	6	00	19q13.31	PSG11, PSG13, PSG14		Pregnancy-specific beta-1-glycoprotein-11	176401	A			
19.685	8	2	10	19q13.2	CD79A, IGA		CD79A antigen (immunoglobulin-associated alpha)	112205	Psh		Agammaglobulinemia 3, 613501 (3)	
19.686	5	8	07	19q13.2	CYP2A6, CYP2A3, CYP2A, P450C2A		Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720	REa, A, Fd, REn		Coumarin resistance, 122700 (3); {Nicotine addiction, protection from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)	7(Cyp2a)
19.687	4	2	12	19q13.2	CYP2B6, CYP2B, EFVM		Cytochrome P450, family 2, subfamily B, polypeptide 6	123930	REa, REn, Fd, Psh	same NotI fragment as CYP2A	Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	7(Cyp2b)
19.688	4	25	93	19q13.2	CYP2F1		Cytochrome P450, subfamily IIF, polypeptide 1	124070	Fd, REa, A, REn	CYP2A, CYP2B, CYP2F1 in 240kb		7(Cyp2f1)
19.689	10	3	07	19q13.2	EIF3K, PLAC24, EIF3S12		Eukaryotic translation initiation factor 3, subunit K	609596	REc			
19.690	3	24	06	19q13.2	GGN		Gametogenetin, mouse, homolog of	609966	R, REc			7(Ggn)
19.691	1	12	95	19q13.2	GRIK5		Glutamate receptor, ionotropic, kainate 5	600283	REa, A			7(Grik5)
19.692	3	24	06	19q13.32	HIF3A, IPAS		Hypoxia-inducible factor 3, alpha subunit	609976	REc			
19.693	1	4	08	19q13.2	HIPK4		Homeodomain-interacting protein kinase 4	611712	REc			
19.694	2	11	08	19q13.2	ITPKC		Inositol 1,4,5-trisphosphate 3-kinase C	606476	R, REc, Fd		{Kawasaki disease, susceptibility to}, 611775 (3)	
19.695	12	11	15	19q13.31	KCNN4, KCA4, SK4, DHS2		Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	602754	A		Dehydrated hereditary stomatocytosis 2, 616689 (3)	
19.696	4	18	05	19q13.2	LGALS4		Lectin, galactoside-binding, soluble, 4	602518	REc			
19.697	4	18	05	19q13.2	LGALS7		Lectin, galactoside-binding, soluble, 7 (galectin 7)	600615	REa, REc			
19.698	1	8	01	19q13.42	LILRA1, LIR6		Leukocyte immunoglobulin-like receptor, subfamily A, member 1	604810	R			
19.699	1	8	01	19q13.42	LILRB5, LIR8		Leukocyte immunoglobulin-like receptor, subfamily B, member 5	604814	R			
19.700	7	16	09	19q13.32	LU, AU, BCAM		B-cell adhesion molecule	612773	F, H	linked to SE	[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3)	7(lu)
19.701	6	28	17	19q13.32	NECTIN2, PVRL2, HVEB, PVRR2, PRR2		Nectin 2	600798	REc, A			
19.702	10	30	06	19q13.2	PAF1, PD2		PAF1 RNA polymerase II-associated factor, S. cerevisiae, homolog of	610506	Psh, REc			
19.703	8	24	09	19q13.2	PAK4		p21-activated kinase 4	605451	R, REc			
19.704	7	11	11	19q13.2	PAPL, FLJ16165		Purple acid phosphatase, long form	610490	REc			
19.705	10	7	02	19q13.2	PPL13		Placental protein 13-like protein	607260	REc			
19.706	8	20	07	19q13.33	PPP1R15A, GADD34		Protein phosphatase 1, regulatory subunit 15A	611048	A, REc			
19.707	8	24	09	19q13.2	PRA1		Prenylated RAB acceptor 1	604925	R, REc			
19.708	7	11	11	19q13.31	PRG1		p53-responsive gene 1	605157	REc			
19.709	3	1	01	19q13.2	PSG1, PSBG1, B1G1, SP1		Pregnancy-specific beta-1-glycoprotein-1	176390	REa, REc	distal to CEA		
19.710	4	25	93	19q13.31	PSG2, PSBG2		Pregnancy-specific beta-1-glycoprotein-2	176391	RE, A			
19.711	6	13	95	19q13.2	PSG3		Pregnancy-specific beta-1-glycoprotein-3	176392	A			
19.712	3	1	01	19q13.31	PSG4		Pregnancy-specific beta-1-glycoprotein-4	176393	REa, REc			
19.713	3	1	01	19q13.31	PSG5		Pregnancy-specific beta-1-glycoprotein-5	176394	REa, REc			
19.714	3	1	01	19q13.31	PSG6		Pregnancy-specific beta-1-glycoprotein-6	176395	REa, REc			
19.715	3	1	01	19q13.31	PSG7		Pregnancy-specific beta-1-glycoprotein-7	176396	REa, REc			
19.716	3	1	01	19q13.2	PSG8		Pregnancy-specific beta-1-glycoprotein-8	176397	REa, REc			
19.717	1	6	00	19q13.31	PSG9, PSG11		Pregnancy-specific beta-1-glycoprotein-9	176398	A			
19.718	1	23	18	19q13.2	PSMD8		Proteasome 26S subunit, non-ATPase, 8	617844	REc			
19.719	8	9	99	19q13.2	RPS19, DBA, DBA1		Ribosomal protein S19	603474	Ch, Fd, D, REc		Diamond-Blackfan anemia 1, 105650 (3)	
19.720	3	31	11	19q13.2	SARS2		Seryl-tRNA synthetase 2	612804	REc		Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	
19.721	1	25	18	19q13.2	SERTAD1, TRIPBR1		SERTA domain-containing protein 1	617850	REc			
19.722	2	2	17	19q13.2	SHKBP1, SB1		SH3KBP1-binding protein 1	617322	REc			
19.723	8	24	09	19q13.33	SPHK2		Sphingosine kinase 2	607092	R, REc			
19.724	1	11	07	19q13.2	TEC		Transient erythroblastopenia of childhood	227050	Fd		Transient erythroblastopenia of childhood (2)	
19.725	10	10	17	19q13.2	TIMM50, TIM50, MGCA9		Translocase of inner mitochondrial membrane 50, yeast, homolog of	607381	REc		3-methylglutaconic aciduria, type IX, 617698 (3)	
19.726	8	29	03	19q13.32	TOMM40, TOM40, PEREC1		Translocase of outer mitochondrial membrane 40, yeast, homolog of	608061	REc			
19.727	7	7	14	19q13.12	U2AF1L4, U2AF1RS3		U2 small nuclear RNA auxillary factor 1-like 4	601080	A			
19.728	8	27	17	19q13.31	XRCC1, SCAR26		X-ray-repair, complementing defective, repair in Chinese hamster cells-1	194360	S, A	mutation identified in 1 SCAR26 patient	?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3)	7(Xrcc1)
19.729	8	7	00	19q13.31	ZFP93, ANF270, HZF6		Zinc finger protein 93, mouse, homolog of	604749	REc			7(Zfp93)
19.730	2	7	07	19q13.31	ZNF45, ZNF13, KOX5		Zinc finger protein-45	194554	REc, A			
19.731	3	6	02	19q13.31	ZNF180		Zinc finger protein-180	606740	A			
19.732	3	6	02	19q13.11	ZNF181		Zinc finger protein-181	606741	A			
19.733	2	24	17	19q13.31	ZNF222		Zinc finger protein 222	617357	REc			
19.734	12	19	11	19q13.2	ZNF526, KIAA1951		Zinc finger protein 526	614387	REc			
19.735	2	12	13	19q13.32	AP2S1, CLAPS2, AP17, HHC3		Adaptor-related protein complex 2, sigma 1 subunit	602242	A		Hypocalciuric hypercalcemia, type III, 600740 (3)	
19.736	3	2	00	19q13.33	CA11, CARP2		Carbonic anhydrase XI	604644	A			
19.737	7	13	93	19q13.32	CALM3		Calmodulin-3	114183	REa, Psh, A			
19.738	4	27	12	19q13.32	CD3EAP, ASE1, PAF49		CD3-epsilon-associated protein	107325	REc			
19.739	11	3	00	19q13.32	DMPK, DM, DMK		Dystrophia myotonica-protein kinase	605377	F, Fd	distal to APOLP2; distal to CKM	Myotonic dystrophy 1, 160900 (3)	7(Dm15)
19.740	2	20	07	19q13.32	ERCC1, UV20, COFS4		Excision repair cross complementing rodent repair deficiency, complementation group-1	126380	S, RE, Fd, A	distal to CKM	Cerebrooculofacioskeletal syndrome 4, 610758 (3)	
19.741	6	2	15	19q13.32	ERCC2, EM9, XPD, COFS2, TTD1		Excision repair cross complementing rodent repair deficiency, complementation group-2	126340	S, RE, M	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy 1, photosensitive, 601675 (3); ?Cerebrooculofacioskeletal syndrome 2, 610756 (3)	7(Ercc2)
19.742	2	15	96	19q13.32	GPR4		G protein-coupled receptor-4	600551	A			
19.743	1	12	06	19q13.32	KLC3, KLC2L		Kinesin, light chain, 3	601334	REn			
19.744	5	16	18	19q13.33	LIG1		Ligase I, DNA, ATP-dependent	126391	REa, A			7(Lig1)
19.745	6	13	07	19q13.2-q13.3	MRT11		Mental retardation, autosomal recessive, 11	611097	Fd	between rs2109075 and rs8101149	Mental retardation, autosomal recessive, 11 (2)	
19.746	6	28	99	19q13.32	NPAS1, MOP5		Neuronal PAS domain protein 1	603346	Psh, R, H			7(Npas1)
19.747	9	9	11	19q13.32	OPA3, MGA3		OPA3 gene	606580	Fd, REc		3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy 3 with cataract, 165300 (3)	
19.748	5	2	11	19q13.31	PVR, PVS		Polio virus receptor	173850	S, A, REa			9(Pvs)
19.749	9	10	09	19q13.2	RAB4B		Ras-associated protein RAB4B	612945	R			
19.750	10	27	10	19q13.2-q13.3	TRNAU1, TRSP		Transfer RNA selenocysteine 1 (anticodon UCA)	165060	REa, A, Fd	pseudogene on 22		7(Trsp)
19.751	3	31	97	19q13.32	VASP		Vasodilator-stimulated phosphoprotein	601703	A			
19.752	4	17	14	19q13.32	CCDC8, 3M3		Coiled-coil domain-containing protein 8	614145	REc		3-M syndrome 3, 614205 (3)	
19.753	6	19	00	19q13.31	ZNF155		Zinc finger protein-155	604086	A			
19.754	6	4	99	19q13.2-q13.4	CFM1		Cystic fibrosis modifier-1	603855	Fd		{Meconium ileus in cystic fibrosis, susceptibility to} (2)	7(Cfm1)
19.755	9	18	02	19q13.32	FOXA3, HNF3G		Forkhead box A3 (hepatocyte nuclear factor-3, gamma)	602295	A			7(Hnf3g)
19.756	3	19	01	19q13.32	GRLF1, P190A		Glucocorticoid receptor DNA-binding factor 1	605277	REa, A, R			
19.757	9	15	96	19q13.33	NUCB1		Nucleobindin 1	601323	Psh, A			
19.758	8	22	14	19p13.11	PIK3R2, MPPH1		Phosphatidylinositol 3-kinase, regulatory subunit 2	603157	A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	
19.759	4	25	93	19q13.43	ZNF42, MZF1		Zinc finger protein-42 (myeloid-specific retinoic acid responsive)	194550	A, REb			
19.760	2	7	07	19q13.31	ZNF224, ZNF255, BMZF2, KOX22, ZNF27		Zinc finger protein-224	194555	REc, A			
19.761	9	18	00	19q13.33	AP2A1, CLAPA1, ADTAA		Adaptor-related protein complex 2, alpha 1 subunit	601026	REc	match to PAC AC006942		
19.762	6	3	02	19p13.13	ASNA1, ARSA1		arsA arsenite transporter, ATP-binding, E. coli, homolog of, 1	601913	Psh			8(Asna1)
19.763	8	24	09	19q13.33	ATF5, ATFX		Activating transcription factor 5	606398	R, REc			
19.764	3	12	07	19q13.33	BCL2L12		BCL2-like 12	610837	REc			
19.765	12	10	08	19q13.33	CARD8, TUCAN, KIAA0955, NDPP1		Caspase recruitment domain-containing protein 8	609051	REc			
19.766	2	8	13	19q13.33	CCDC114, CILD20		Coiled-coil domain-containing protein 114	615038	REc		Ciliary dyskinesia, primary, 20, 615067 (3)	
19.767	7	18	14	19q13.32	CLPTM1		Cleft lip and palate-associated transmembrane protein 1	604783	REc			
19.768	9	9	11	19q13.33	CRX, CORD2, CRD, LCA7		Cone-rod homeo box-containing gene	602225	Fd		Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital amaurosis 7, 613829 (3)	
19.769	8	30	07	19q13.32	DACT3		Dapper, antagonist of beta-catenin, 3	611112	R, REn			7(Dact3)
19.770	2	15	96	19q13.33	DBP		D site of albumin promoter binding protein	124097	REa, A, REc			7(Dbp)
19.771	3	20	06	19q13.32	DMWD, DMRN9		Dystrophia myotonica WD repeat-containing protein	609857	REc			
19.772	5	2	01	19q13.33	EHD2		EH domain-containing 2	605890	REc			
19.773	10	20	99	19q13.33	EMP3		Epithelial membrane protein 3	602335	A, REa, R			7(Emp3)
19.774	8	25	03	19q13.41	ETFB, MADD		Electron transfer flavoprotein, beta polypeptide	130410	REa, A		Glutaric acidemia IIB, 231680 (3)	7(Etfb)
19.775	9	9	08	19q13.32	FBXO46, FBX46		F-box only protein 46	609117	R, REc			7(Fbxo46)
19.776	9	23	96	19q13.33	FCGRT		Fc fragment of IgG, receptor, transporter, alpha	601437	A			
19.777	09	27	18	19q13.32	FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5		Fukutin-related protein	606596	R		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	
19.778	6	11	92	19q13.32	FOSB		Oncogene FOS-B	164772	REn			7(Fosb)
19.779	1	14	16	19q13.33	FUT1, H, HH		Fucosyltransferase-1 (Bombay phenotype)	211100	F, Fd	SE tightly linked	[Bombay phenotype], 616754 (3)	
19.780	1	24	09	19q13.33	FUT2, SE, B12QTL1		Fucosyltransferase-2 (secretor)	182100	F, Fd	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	{Norwalk virus infection, resistance to} (3); [Bombay phenotype] (3); {Vitamin B12 plasma level QTL1}, 612542 (3)	
19.781	7	8	10	19q13.32	GIPR, PGQTL2		Gastric inhibitory polypeptide receptor	137241	A, Fd		[Plasma glucose, 2-hour, QTL 2] (2)	
19.782	2	28	01	19q13.33	GLTSCR1		Glioma tumor suppressor candidate region gene 1	605690	D			
19.783	11	5	98	19q13.33	GPR32		G protein-coupled receptor-32	603195	A			
19.784	11	30	06	19q13.33	GRWD1, GRWD, KIAA1942		Glutamate-rich WD repeat-containing protein 1	610597	REc			
19.785	11	13	07	19q13.33	GYS1, GYS		Glycogen synthase	138570	REa, A		Glycogen storage disease 0, muscle, 611556 (3)	
19.786	1	25	91	19q13.33	HRC		Histidine-rich calcium-binding protein	142705	REa, A, H			
19.787	9	5	02	19q13.33	KCNA7		Potassium voltage-gated channel, shaker-related subfamily, member 7	176268	REa, A			7(Kcna7)
19.788	7	7	15	19q13.33	MED25, PTOV2, ARC92, CMT2B2, BVSYS		Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of	610197	Fd, REc	mutation identified in 1 CMT2B2 family	?Charcot-Marie-Tooth disease, type 2B2, 605589 (3); Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	
19.789	2	24	04	19q13.32-q13.33	NAPA, SNAPA		N-ethylmaleimide-sensitive factor attachment protein, alpha	603215	H, REc			7(hyh)
19.790	6	4	18	19q13.33	NOP53, GLTSCR2		NOP53 ribosome biogenesis factor	605691	D			
19.791	9	8	17	19q13.32	NOVA2, ANOVA		NOVA alternative splicing regulator 2	601991	REf			
19.792	5	17	95	19q13.33	NR1H2, UNR		Nuclear receptor subfamily 1, group H, member 2 (ubiquitously-expressed nuclear receptor)	600380	A			
19.793	10	3	09	19q13.33	NTF4 , NTF5, NT5, NT4, GLC1O		Neurotrophin-4 (neurotrophin-4/5)	162662	REa, A	3 genes, ? functional, also on 19	Glaucoma 1, open angle, 1O, 613100 (3)	7(Ntf5)
19.794	8	24	09	19q13.33	PLA2G4C		Phospholipase A2, group IVC	603602	REc			
19.795	4	10	96	19q13.32	PPP5C, PP5		Protein phosphatase-5, catalytic subunit	600658	Psh, A			
19.796	8	24	09	19q13.32	PRKD2, PKD2		Protein kinase D2	607074	R, REc			
19.797	6	13	95	19q13.32	PTGIR		Prostaglandin I2 (prostacyclin) receptor (IP)	600022	A, REa			7(Ptgir)
19.798	2	28	03	19q13.32	RSHL1		Radial spokehead-like 1	607548	REc			
19.799	3	29	12	19q13.32	RTN2, NSPL1, SPG12		Reticulon-2	603183	REc		Spastic paraplegia 12, autosomal dominant, 604805 (3)	
19.800	2	20	01	19q13.33	RUVBL2, TIP48, ECP51		RUVB, E. coli, homolog-like 2 (TATA box-binding protein-interacting protein)	604788	REn, R			7(Ruvbl2)
19.801	12	22	16	19q13.33	SCAF1		SR-related C-terminal domain-associated factor 1	617264	REc			
19.802	11	17	16	19q13.33	SELENOW, SEPW1		Selenoprotein W	603235	REc			
19.803	10	20	99	19q13.41	SIGLEC5, CD33L2, OBBP2		Sialic acid-binding Ig-like lectin 5	604200	A, REa, R			
19.804	2	7	01	19q13.41	SIGLEC6, CD33L, CD33L1, OBBP1		Sialic acid-binding immunoglobulin-like lectin 6	604405	A			
19.805	2	1	00	19q13.41	SIGLEC7, AIRM1		Sialic acid-binding immunoglobulin-like lectin 7	604410	REa, REn			
19.806	4	17	07	19q13.32	SIX5, DMAHP, BOR2		Sine oculis homeo box, Drosophila, homolog of, 5	600963	REn		Branchiootorenal syndrome 2, 610896 (3)	
19.807	4	28	17	19q13.33	SNRP70, U1RNP, RNPU1Z, RPU1		Small nuclear ribonucleoprotein, U1 subunit, 70kD	180740	REa, A			
19.808	6	4	99	19q13.32	SLC1A5, RDRC, M7V1, M7VS1		Solute carrier family 1 (neutral amino acid transporter), member 5 (receptor for RD114/simian type D retroviruses)	109190	A, Fd, R			
19.809	2	25	98	19q13.32	SPK		Symplekin	602388	REc			
19.810	8	18	99	19q13.33	SULT2A1, STD		Sulfotransferase family 2A, dehydroepiandrosterone-preferring, member 1 (DHEA sulfotransferase)	125263	A, Psh, Fd			
19.811	7	13	17	19q13.33	SULT2B1, ARCI14		Sulfotransferase family 2B, member 1	604125	A, Psh		Ichthyosis, congenital, autosomal recessive 14, 617571 (3)	
19.812	1	5	04	19q13.33	SYNGR4		Synaptogyrin 4	608373	REc			
19.813	6	28	99	19q13.33	TEAD2, TEF4		TEA domain family member 2	601729	A, R			
19.814	11	16	98	19p13.3	ZIPK		ZIP kinase	603289	Psh, R, A			
19.815	6	22	14	19q13.33	BAX		BCL2-associated X protein	600040	REa, A, REc		Colorectal cancer, somatic, 114500 (3); T-cell acute lymphoblastic leukemia, somatic, 613065 (3)	7(Bax)
19.816	9	16	16	19q13.32	C5AR1, C5R1, C5AR		Complement component 5a receptor 1	113995	REa, REc			
19.817	4	25	93	19q13.41	CD33		CD33 antigen (gp67)	159590	REa, A			
19.818	8	24	09	19q13.41	FPR2, FPRL1, FPRH1, LXA4R, HM63		Formyl peptide receptor 2	136538	REa, REc			
19.819	8	24	09	19q13.41	FPR3, FPRL2, FPRH2		Formyl peptide receptor 3	136539	REa, REc			
19.820	1	15	14	19q13.33	FTL, NBIA3, LFTD		Ferritin, light chain	134790	S, A, REa, REb		Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration with brain iron accumulation 3, 606159 (3); L-ferritin deficiency, dominant and recessive, 615604 (3)	7(Ftl1)
19.821	6	28	99	19q13.41	HAS1		Hyaluronan synthase 1	601463	Psh, REc, A			17(Has1)
19.822	12	28	08	19q13.33	IL4I1, FIG1		Interleukin 4-induced gene 1	609742	REn			
19.823	8	11	91	19q13.42	IL11		Interleukin-11	147681	A			
19.824	3	14	18	19q13.33	IRF3, IIAE7		Interferon regulatory factor 3	603734	Fd, REc		{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3)	
19.825	5	2	06	19q13.33	KCNC3, SCA13		Potassium voltage-gated channel, Shaw-related subfamily, member 3	176264	REa, A, Fd, H		Spinocerebellar ataxia 13, 605259 (3)	7(Kcnc3)
19.826	9	9	13	19q13.33	POLD1, CRCS10, MDPL		Polymerase (DNA directed), delta 1, catalytic subunit	174761	Psh, REa, A		{Colorectal cancer, susceptibility to, 10}, 612591 (3); Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	7(Pold1)
19.827	3	3	10	19q13.42	PPP1R12C, MBS85		Protein phosphatase 1, regulatory subunit 12C	613245	REc			
19.828	8	19	13	19q13.33	PTOV1, ACID2		Prostate tumor overexpressed gene 1	610195	A			
19.829	8	27	02	19q13.33	SIGLEC11		Sialic acid-binding immunoglobulin-like lectin 11	607157	REc	pseudogene 8kb upstream		
19.830	5	6	03	19q13.33	SPIB		SPIB transcription factor	606802	A			
19.831	10	15	94	19q13.41	ZNF83		Zinc finger protein-83	194558	A			
19.832	6	19	00	19q13.41	ZNF137		Zinc finger protein-137	604079	A			
19.833	3	27	95	19q13.41-q13.42	ZNF160		Zinc finger protein-160	600398	A			
19.834	11	6	01	19q13.41	ZNF320		Zinc finger protein 320	606427	REc			
19.835	6	20	01	19q13.42	ZNF331, ZNF463		Zinc finger protein-331	606043	A			
19.836	8	24	09	19q13.33	RRAS		Oncogene RRAS	165090	REa, REc			7(Rras)
19.837	5	2	16	19q13.31	C19orf61, SMG9, HBMS		Chromosome 19 open reading frame 61	613176	REc		Heart and brain malformation syndrome, 616920 (3)	
19.838	6	1	16	19q13.31-q13.32	CEACAM16, CEAL2, DFNA4B		Carcinoembryonic antigen-related cell adhesion molecule 16	614591	REc		Deafness, autosomal dominant 4B, 614614 (3)	
19.839	7	2	18	19q13.31	CEACAM19, CEAL1		Carcinoembryonic antigen related cell adhesion molecule 19	606691	REc			
19.840	3	23	09	19q13.31	TEX101, SGRG, TES101RP		Testis-expressed gene 101	612665	R, REc			
19.841	9	27	17	19q13.31	ZNF234, ZNF269, HZF4		Zinc finger protein 234	604750	REc			
19.842	9	2	08	19q13.33	BSPH1		Bovine seminal plasma protein-like 1	612213	REc			7(Bsph1)
19.843	10	23	87	19q13.33	CGB		Chorionic gonadotropin, beta polypeptide	118860	REa, H, A	at least 5 genes		7(Cgb)
19.844	10	17	13	19q13.32	DHX34, KIAA0134		DEAH box polypeptide 34	615475	REc, R			
19.845	5	30	17	19q13.32	EML2, EMAP2, ELP70		Echinoderm microtubule-associated protein-like 2	617494	REc			
19.846	2	10	04	19q13.31	ETHE1, HSCO, D83198		ETHE1 gene	608451	REc		Ethylmalonic encephalopathy, 602473 (3)	
19.847	4	27	16	19q13.32	EXOC3L2, XTP7		Exocyst complex component 3-like 2	616927	REc			7(Exoc3l2)
19.848	8	24	09	19q13.32	GEMIN7		GEM-associated protein 7	607419	R, REc			
19.849	7	23	13	19q13.32	IRF2BP1		Interferon regulatory factor 2-binding protein 1	615331	REc			
19.850	3	27	15	19q13.33	LHB, HH23		Luteinizing hormone, beta polypeptide	152780	RE	beta chains of FSH, TSH on 11p, 1p, respectively	Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	7(Lhb)
19.851	1	31	18	19q13.32	MYPOP		MYB-related transcription factor, partner of profilin	617861	REc			
19.852	9	23	13	19q13.32	NANOS2, NOS2		Nanos, Drosophila, homolog of, 2	608228	REc			
19.853	2	24	15	19q13.32	PPP1R13L, RAI, IASPP, NKIP1		Protein phosphatase 1, regulatory subunit 13-like	607463	REc			7(Ppp1r13l)
19.854	7	24	17	19q13.32	RELB, IREL, IMD53		v-rel avian reticuloendotheliosis viral oncogene homolog B	604758	REc	mutation identified in 1 IMD53 family	?Immunodeficiency 53, 617585 (3)	
19.855	3	15	10	19q13.32	SAE1, SUA1, AOS1		SUMO1-activating enzyme, subunit 1	613294	REc			
19.856	2	1	11	19q13.32	SLC8A2, NCX2		Solute carrier family 8, member 2 (sodium-calcium exchanger 2)	601901	REc			7(Slc8a2)
19.857	11	11	14	19q13.32	SNRPD2		Small nuclear ribonucleoprotein polypeptide D2	601061	REc			
19.858	8	21	12	19q13.32	STRN4, ZIN		Striatin, calmodulin-binding protein 4	614767	REc, A			
19.859	8	19	13	19q13.33	TPRX1		Tetrapeptide repeat homeobox 1	611166	REc			
19.860	8	19	13	19q13.32	TRAPPC6A		Trafficking protein particle complex, subunit 6A	610396	R, REc			7(Trappc6a)
19.861	6	7	10	19q13.33	TRPM4, PFHB1B		Transient receptor potential cation channel, subfamily M, member 4	606936	REc		Progressive familial heart block, type IB, 604559 (3)	
19.862	2	21	10	19q13.32	ZNF296, ZFP296, ZNF342		Zinc finger protein 296	613226	REc, R, H			7(Znf296)
19.863	1	8	97	19q13.2	MIA		Melanoma inhibitory activity	601340	A			
19.864	6	7	10	19q13.33	ALDH16A1		Aldehyde dehydrogenase 16 family, member A1	613358	REc			
19.865	9	10	14	19q13.33	CABP5, CABP3		Calcium-binding protein 5	607315	A			
19.866	09	19	18	19q13.33	CCDC155, KASH5		Coiled-coil domain-containing protein 155	618125	REc			
19.867	9	16	12	19q13.33	CGB1		Chorionic gonadotropin, beta polypeptide 1	608823	REc			
19.868	9	16	12	19q13.33	CGB7, CGB6		Chorionic gonadotropin, beta polypeptide 7	608826	REc			
19.869	3	28	15	19q13.33	CPT1C, SPG73		Carnitine palmitoyltransferase IC	608846	REc	mutation identified in 1 SPG73 family	?Spastic paraplegia 73, autosomal dominant, 616282 (3)	
19.870	7	25	16	19q13.41	CTU1, ATPBD3		Cytothiouridylase subunit 1	612694	REc			
19.871	7	2	18	19q13.33	DHDH, HUM2DD		Dimeric dihydrodiol dehydrogenase	606377	REc			
19.872	8	24	09	19q13.33	DKKL1, SGY1, SGY		Dickkopf-like 1	605418	REc			
19.873	6	13	12	19q13.33	ELSPBP1		Epididymal sperm binding protein 1	607443	REc			
19.874	2	25	15	19q13.33	EMC10, C19orf63, HSS1, HSM1		ER membrane protein complex subunit 10	614545	REc			
19.875	9	26	17	19q13.33	FLT3LG, FLG3L		FMS-related tyrosine kinase 3 ligand	600007	REc			
19.876	7	16	09	19q13.33	HSD17B14, DHRS10, RETSDR3		17-beta-hydroxysteroid dehydrogenase XIV	612832	REc			
19.877	4	10	14	19q13.33	IZUMO1, MGC34799		Izumo sperm-egg fusion protein 1	609278	REc			
19.878	7	23	13	19q13.33	JOSD2		Josephin domain-containing protein 2	615324	REc			
19.879	11	11	14	19q13.33	KDELR1, ERD2, HDEL		KDEL endoplasmic reticulum protein retention receptor 1	131235	REc			
19.880	10	7	08	19q13.33	LIN7B, VELI2, MALS2		Lin7, C. elegans, homolog of, B	612331	REc			
19.881	8	19	13	19q13.33	MAMSTR, MASTR		MEF2-activating SAP transcriptional regulator	610349	REc			
19.882	6	10	09	19q13.41	MIR125A, MIRN125A		Micro RNA 125A	611191	REc			
19.883	5	19	09	19q13.33	MIR150, MIRN150		Micro RNA 150	611114	REc			
19.884	8	24	09	19q13.33	MYBPC2, MYBPCF		Myosin-binding protein C, fast type	160793	REa, REc			
19.885	12	26	14	19q13.33	MYH14, KIAA2034, DFNA4A, PNMHH		Myosin, heavy chain 14, nonmuscle	608568	REc, Fd	mutation identified in 1 PNMHH family	Deafness, autosomal dominant 4A, 600652 (3); ?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	7(Myh14)
19.886	2	19	04	19q13.33	NAPA, NAP1, SNAPA		Napsin A	605631	REc			
19.887	1	15	16	19q13.33	NOSIP		Nitric oxide synthase-interacting protein	616759	REc			
19.888	8	21	07	19q13.33	NUP62, SNDI, IBSN		Nucleoporin, 62-kD	605815	R		Striatonigral degeneration, infantile, 271930 (3)	
19.889	10	13	09	19q13.33	PIH1D1, NOP17		PIH1 domain-containing protein 1	611480	R, REc			
19.890	8	24	09	19q13.33	PLEKHA4, PEPP1		Pleckstrin homology domain-containing protein, family A, member 4	607769	REc			
19.891	8	24	09	19q13.33	PPFIA3, LPNA3		Protein tyrosine phosphatase, receptor type, f polypeptide (liprin-alpha-3)	603144	R, REc			
19.892	11	17	15	19q13.33	PRR12, KIAA1205		Proline-rich protein 12	616633	R, REc			
19.893	11	11	14	19q13.33	PRRG2, PRGP2		Proline-rich gamma-carboxyglutamic acid protein 2	604429	REc			
19.894	3	23	18	19q13.33	PTH2, TIP39		Parathyroid hormone 2	608386	REc			
19.895	10	4	05	19q13.33	RASIP1, RAIN		Ras-interacting protein 1	609623	REc			
19.896	5	15	12	19q13.33	SHANK1, SSTRIP		SH3 and multiple ankyrin repeat domains 1	604999	REc			
19.897	5	24	13	19q13.33	SLC6A16, NT5		Solute carrier family 6 (neurotransmitter transporter), member 16	607972	REc, R			
19.898	3	2	06	19q13.33	SPACA4, SAMP14		Sperm acrosome-associated protein 4	609932	REc			7(Spaca4)
19.899	11	23	15	19q13.33	TBC1D17		TBC1 domain family, member 17	616659	REc			
19.900	8	24	09	19q13.33	ZNF114		Zinc finger protein-114	603996	REc			
19.901	4	6	18	19q13.33	ZNF473, ZFP100, KIAA1141		Zinc finger protein 473	617908	REc, H			7(Znf473)
19.902	3	23	06	19q13.42	MYADM		Myeloid-associated differentiation marker	609959	R			
19.903	2	15	01	19q13.41	SIGLEC8, SAF2, SIGLEC8L		Sialic acid-binding immunoglobulin-like lectin 8	605639	A			
19.904	7	7	09	19q13.42	BRSK1, KIAA1811		BR serine/threonine kinase 1	609235	REc			
19.905	9	16	16	19q13.32	C5AR2, GPF77, C5L2		Complement component 5a receptor 2	609949	REc, REn			
19.906	5	1	02	19q13.42	CACNG6		Calcium channel, voltage-dependent, gamma-6 subunit	606898	REc			
19.907	5	1	02	19q13.42	CACNG7		Calcium channel, voltage-dependent, gamma-7 subunit	606899	REc			
19.908	5	1	02	19q13.42	CACNG8		Calcium channel, voltage-dependent, gamma-8 subunit	606900	REc			
19.909	9	9	08	19q13.42	CNOT3, NOT3		CCR4-NOT transcription complex, subunit 3	604910	REc			
19.910	10	10	18	19q13.42	COX6B2, CT59		Cytochrome c oxidase, subunit 6B2	618127	REc, H			7(Cox6b2)
19.911	5	9	12	19q13.42	DNAAF3, PF22, DAB1, CILD2		Dynein, axonemal, assembly factor 3	614566	REc		Ciliary dyskinesia, primary, 2, 606763 (3)	
19.912	1	9	13	19q13.42	EPS8L1, EPS8R1		EPS8-like protein 1	614987	REc			7(Eps8l1)
19.913	7	12	92	19q13.42	FCAR		Fc fragment of IgA, receptor for	147045	REa, A			
19.914	8	24	09	19q13.41	FPR1		Formyl peptide receptor-1	136537	REa			
19.915	8	19	13	19q13.43	GALP, ALARIN		Galanin-like peptide (GALP precursor protein)	611178	REc			
19.916	9	15	11	19q13.42	GP6, GPIV, BDPLT11		Glycoprotein VI, platelet	605546	Fd, R, REc		Bleeding disorder, platelet-type, 11, 614201 (3)	7(Gp6)
19.917	4	23	08	19q13.4	HPC15		Prostate cancer, hereditary, 15	611959	Fd	associated with rs2735839	{Prostate cancer, hereditary, 15} (2)	
19.918	3	14	18	19q13.42	LILRA9, ILT11, CD85F, LIR9		Leukocyte immunoglobulin-like receptor, subfamily A, member 5	606047	REn			
19.919	5	12	00	19q13.42	KIR2DL1, NKAT1		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1	604936	REa, REc			
19.920	4	23	03	19q13.42	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1	604946	REa, REc		{AIDS, delayed/rapid progression to}, 609423 (3)	
19.921	5	12	00	19q13.42	KIR2DL3, NKAT2		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3	604938	REa, REc			
19.922	5	12	00	19q13.42	KIR2DL4, KIR103AS		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4	604945	REa, REc			
19.923	5	12	00	19q13.4	KIR2DS1		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1	604952	REc			
19.924	5	12	00	19q13.42	KIR2DS4, NKAT8		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4	604955	REa, REc			
19.925	5	12	00	19q13.42	KIR3DL2, NKAT4		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2	604947	REc			
19.926	8	24	09	19q13.4	KIR2DL2, NKAT6		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2	604937	REa, REc			
19.927	4	29	14	19q13.4	KIR2DL5B		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B	615727	REc, Psh			
19.928	8	24	09	19q13.4	KIR2DS2, NKAT5		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2	604953	R, REc			
19.929	8	24	09	19q13.4	KIR2DS3, NKAT7		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3	604954	R, REc			
19.930	3	31	15	19q13.4	KIR2DS5, NKAT9, CD158G		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5	604956	REc			
19.931	8	19	13	19q13.42	KIR3KL3, KIRC1, KIR3DL7, KIR44		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3	610095	REc			
19.932	9	20	14	19q13.33	KLK1, KLKR		Kallikrein 1	147910	REa, A, Fd	~10cM distal to APOC2	[Kallikrein, decreased urinary activity of], 615953 (3)	7(Kal)
19.933	11	30	06	19q13.33	KLK2		Kallikrein-related peptidase 2	147960	REa, RE	12kb from APS		
19.934	11	30	06	19q13.42	KIR3DP1, CD158C, KIRX, KIR48, KIR2DS6		Killer cell immunoglobulin-like receptor, three domains, pseudogene	610604	REc	functional in some individuals		
19.935	5	12	99	19q13.33	KLK3, APS, PSA		Kallikrein-related peptidase 3	176820	REa, RE, A	probably with cluster KLK1, KLK2		7(Aps)
19.936	8	4	09	19q13.41	KLK4, EMSP1, PRSS17, AI2A1		Kallikrein-related peptidase 4	603767	Psh, A		Amelogenesis imperfecta, type IIA1, 204700 (3)	
19.937	2	15	01	19q13.41	KLK5, SCTE, KLKL2		Kallikrein-related peptidase 5	605643	REc, REn			
19.938	2	15	01	19q13.41	KLK8, TADG14, PRSS19		Kallikrein-related peptidase 8	605644	REn			
19.939	11	30	06	19q13.41	KLK11, PRSS20, TLSP		Kallikrein-related peptidase 11	604434	REn			
19.940	11	30	06	19q13.41	KLK12, KLKL5		Kallikrein-related peptidase 12	605539	REn			
19.941	11	30	06	19q13.41	KLK13, KLKL4		Kallikrein-related peptidase 13	605505	REc			
19.942	11	30	06	19q13.41	KLK6, PRSS9, ZYME		Kallikrein-related peptidase 6	602652	Psh, A			
19.943	11	30	06	19q13.41	KLK9, KLKL3		Kallikrein-related peptidase 9	605504	REc, REn			
19.944	11	30	06	19q13.41	KLK14		Kallikrein-related peptidase 14	606135	REc			
19.945	11	30	06	19q13.41	KLK10, PRSSL1, NES1		Kallikrein-related peptidase 10	602673	A, REn			
19.946	11	30	06	19q13.33	KLK15		Kallikrein-related peptidase 15	610601	REc			
19.947	2	21	14	19q13.32	KPTN, 2E4, MRT41		Kaptin	615620	REc		Mental retardation, autosomal recessive 41, 615637 (3)	
19.948	12	15	98	19q13.42	LAIR1		Leukocyte-associated immunoglobulin-like receptor 1	602992	A			
19.949	8	21	00	19q13.42	LILRA2, LIR7, ILT1		Leukocyte immunoglobulin-like receptor, subfamily A, member 2	604812	R			
19.950	8	21	00	19q13.42	LILRB1, LIR1, ILT2, MIR7, CD85		Leukocyte immunoglobulin-like receptor, subfamily B, member 1	604811	R			
19.951	8	21	00	19q13.42	LILRB2, LIR2, ILT4, MIR10		Leukocyte immunoglobulin-like receptor, subfamily B, member 2	604815	R, A			
19.952	8	21	00	19q13.42	LILRB3, LIR3, ILT5, HL9		Leukocyte immunoglobulin-like receptor, subfamily B, member 3	604820	R			
19.953	8	21	00	19q13.42	LILRB4, LIR5, ILT3, HM18		Leukocyte immunoglobulin-like receptor, subfamily B, member 4	604821	R, A			
19.954	8	21	00	19q13.4	LILRA3, LIR4, ILT6, HM43		Leukocyte immunoglobulin-like receptor, subfamily A, member 3	604818	R			
19.955	8	6	13	19q13.41	LIM2, MP19, CTRCT19		Lens intrinsic protein 2, 19kD	154045	REc, REa, A	same cosmid as ETFB	Cataract 19, multiple types, 615277 (3)	7(Lim2)
19.956	11	22	16	19q13.42	MBOAT7, BB1, LENG4, MRT57		Membrane bound O-acyltransferase domain containing 7	606048	REc		Mental retardation, autosomal recessive 57, 617188 (3)	
19.957	7	7	09	19q13.4	MENOQ2		Menopause, natural, age at, QTL2	612884	Fd	associated with rs1172822, rs2384687, rs1551562, rs897798	{Menopause, natural, age at, QTL2} (2)	
19.958	5	16	05	19q13.42	NALP2, PAN1, PYPAF2		NACHT-, leucine-rich repeat-, and PYD-containing 2	609364	REc			
19.959	3	7	06	19q13.43	NALP4, PAN2, PYPAF4		NACHT domain-, leucine-rich repeat-c and PYD-containing protein 4	609645	REc			
19.960	11	14	14	19q13.42	NALP7, NOD12, PYPAF3, HYDM		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7	609661	Fd, REc		Hydatidiform mole, recurrent, 1, 231090 (3)	
19.961	3	7	06	19q13.43	NALP8, NOD16, PAN4		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 8	609659	REc			
19.962	4	17	13	19q13.42	NLRP12, NALP12, PYPAF7, RNO, FCAS2		NLR family, pyrin domain containing 12	609648	REc		Familial cold autoinflammatory syndrome 2, 611762 (3)	
19.963	3	7	06	19q13.42	NALP9, NOD6		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 9	609663	REc			
19.964	3	7	06	19q13.42-q13.43	NALP11, PYPAF7, NOD17		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 11	609664	REc			
19.965	3	7	06	19q13.43	NALP13, NOD14		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 13	609660	REc			
19.966	4	18	02	19q13.42	OSCAR		Osteoclast-associated receptor	606862	REc			7(Oscar)
19.967	8	5	97	19q13.43	PEG3		Paternally expressed gene 3	601483	REc			7(Peg3)
19.968	3	23	15	19q13.33	PNKP, PNK, MCSZ, EIEE10, AOA4		Polynucleotide kinase 3' phosphatase	605610	A		Microcephaly, seizures, and developmental delay, 613402 (3); Ataxia-oculomotor apraxia 4, 616267 (3)	
19.969	5	13	15	19q13.41	PPP2R1A, MRD36		Protein phosphatase 2, structural/regulatory subunit A, alpha	605983	REc		Mental retardation, autosomal dominant 36, 616362 (3)	
19.970	4	23	03	19q13.42	PRKCG, PKCC, PKCG, SCA14		Protein kinase C, gamma polypeptide	176980	REa, A, Fd		Spinocerebellar ataxia 14, 605361 (3)	7(Pkcc)
19.971	10	30	01	19q13.42	PRPF31, PRP31, RP11		Precursor RNA-processing factor 31, S. cerevisiae, homolog of	606419	REc		Retinitis pigmentosa 11, 600138 (3)	
19.972	4	15	98	19q13.42	PTPRH		Protein tyrosine phosphatase, receptor type, H	602510	A			
19.973	2	17	09	19q13.42	RFPL4A, RNF210		Ret finger protein-like 4A	612601	REc			7(Rfpl4a)
19.974	11	15	08	19q13.42	TSEN34, PCH2C, LENG5, SEN34		tRNA splicing endonuclease 34, S. cerevisiae, homolog of	608754	REc, Fd	mutation identified in 1 PCH2C patient	?Pontocerebellar hypoplasia type 2C, 612390 (3)	
19.975	6	19	00	19q13.43	ZNF132		Zinc finger protein-132	604074	A			
19.976	6	28	99	19q13.42	RPL28		Ribosomal protein L28	603638	RE, R			
19.977	6	28	99	19q13.43	RPS5		Ribosomal protein S5	603630	RE, R			
19.978	6	28	99	19q13.42	RPS9		Ribosomal protein S9	603631	RE, R			
19.979	2	15	01	19q13.41	SIGLEC9		Sialic acid-binding immunoglobulin-like lectin 9	605640	REc			
19.980	6	8	09	19q13.41	SIGLEC10		Sialic acid-binding immunoglobulin-like lectin 10	606091	REc			
19.981	9	21	11	19q13.41	SIGLEC12, SIGLECL1, S2V, SLG		Sialic acid-binding immunoglobulin-like lectin 12	606094	REc			
19.982	2	11	16	19q13.42	TARM1		T cell-interacting activating receptor on myeloid cells 1	616802	REc			
19.983	2	20	08	19q13.42	TNNI3, CMH7, CMD2A, RCM1, CMD1FF		Troponin-I, cardiac	191044	REa, R	mutation identified in 1 CMD2A family	Cardiomyopathy, hypertrophic, 7, 613690 (3); Cardiomyopathy, familial restrictive, 1, 115210 (3); ?Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)	7(Tnni3)
19.984	8	2	13	19q13.42	TNNT1, ANM, NEM5		Troponin-T1, skeletal, slow	191041	REa, Psh, A		Nemaline myopathy 5, Amish type, 605355 (3)	
19.985	9	27	17	19q13.43	TRIM28, KAP1, TIF1B		Tripartite motif-containing protein 28	601742	REc, A			
19.986	4	4	01	19q13.42	TTYH1		Tweety, Drosophila, homolog of, 1	605784	A, R			
19.987	3	14	03	19q13.43	VN1R1, V1RL1		Vomeronasal 1 receptor 1	605234	R			
19.988	2	12	16	19q13.42	VSTM1, SIRL1		V-SET and transmembrane domains-containing protein 1	616804	REc			
19.989	9	2	10	19q13.43	ZNF71		Zinc finger protein-71 (Cos26)	194545	REc	previously assigned to 22q11.2		
19.990	6	19	00	19q13.43	ZNF134		Zinc finger protein-134	604076	A			
19.991	6	19	00	19q13.43	ZNF135		Zinc finger protein-135	604077				
19.992	6	19	00	19q13.43	ZNF154		Zinc finger protein-154	604085	A			
19.993	10	4	99	19q13.41	ZNF175, OTK18		Zinc finger protein-175	601139	A			
19.994	8	24	09	19q13.43	ZNF264		Zinc finger protein-264	604668	R, REc			
19.995	5	10	04	19q13.43	ZNF272, HZF8, ZNF460		Zinc finger protein-272	604755	REc			
19.996	8	24	09	19q13.43	ZNF274		Zinc finger protein-274	605467	R, REa, REc			
19.997	5	10	04	19q13.12	ZNF461, GIOT1		Zinc finger protein-461	608640	REc			
19.998	12	29	06	19q13.42	ZNF628, ZEC		Zinc finger protein 628	610671	REc			
19.999	8	20	07	19q13.43	ZNF667, MIPU1		Zinc finger protein 667	611024	REc			
19.1000	6	12	97	19q13.43	ZNFC25		Zinc finger protein-C2H2-25	601856	Psh, REc			
19.1001	2	11	16	19q13.43	ZFP28		Zinc finger protein 28	616798	REc			
19.1002	4	20	11	19q13.4-qter	AAVS1		Adeno-associated virus integration site-1	102699	REa, A			
19.1003	11	25	13	19q13.41	LKL7, PRSS6, SCCE		Kallikrein-related peptidase 7	604438	REc			
19.1004	8	19	13	19q13.41	MIRLET7E, LET7E		Micro RNA Let7e	611250	REc			
19.1005	3	29	12	19q13.41	MIR99B		Micro RNA 99B	614510	REc			
19.1006	4	6	15	19q13.42	MIR371A		Micro RNA 371A	612043	REc			
19.1007	3	23	09	19q13.42	MIR372, MIRN372		Micro RNA 372	612044	REc			
19.1008	3	23	09	19q13.42	MIR373, MIRN373		Micro RNA 373	611954	REc			
19.1009	10	10	18	19q13.41	SIGLEC14		Sialic acid-binding immunoglobulin-like lectin 14	618132	REc			
19.1010	10	26	17	19q13.41	VSIG10L		V-set and immunoglobulin domains-containing protein 10-like	617740	REc			
19.1011	9	27	17	19q13.41	ZNF350, ZBRK1		Zinc finger protein 350	605422	REc			
19.1012	3	1	16	19q13.41	ZNF468		Zinc finger protein 468	616841	REc			
19.1013	5	16	11	19q13.41	ZNF480		Zinc finger protein 480	613910	REc			
19.1014	12	26	13	19q13.41	ZNF528, KIAA1827		Zinc finger protein 528	615580	REc			
19.1015	3	20	08	19q13.41	ZNF649		Zinc finger protein 649	611903	R, REc			
19.1016	9	29	10	19q13.42	CCDC106		Coiled-coil domain-containing protein 106	613478	REc			
19.1017	7	14	14	19q13.42	CDC42EP5, CEP5, BORG3		CDC42 effector protein 5	609171	REc			
19.1018	8	19	13	19q13.42	DPRX		Divergent-paired related homeobox	611165	REc	many pseudogenes		
19.1019	7	14	14	19q13.42	FIZ1, FLJ14768		FLT3-interacting zinc finger protein 1	609133	REc			
19.1020	8	17	09	19q13.42	HSPBP1		Heat-shock 70kD protein-binding protein 1	612939	REc			
19.1021	8	17	09	19q13.42	ISOC2		Isochorismatase domain-containing 2	612928	REc			
19.1022	9	28	15	19q13.42	LENG8, KIAA1932		Leukocyte receptor cluster gene 8	616575	R, REc			
19.1023	12	30	14	19q13.42	LIAR2, CD306		Leukocyte-associated immunoglobulin-like receptor 2	602993	REc			
19.1024	11	11	14	19q13.42	LILRA4, ILT7		Leukocyte immunoglobulin-like receptor, subfamily A, member 4	607517	R, REc			
19.1025	9	24	11	19q13.42	MIR519D, MIRN519D		Micro RNA 519D	614247	REc			
19.1026	8	18	14	19q13.42	MIR520C		Micro RNA 520C	615908	REc			
19.1027	3	25	15	19q13.42	MIR520G		Micro RNA 520G	616272	REc			
19.1028	9	2	12	19q13.42	MIR520H		Micro RNA 520H	614755	REc			
19.1029	8	24	09	19q13.42	NCR1, LY94, NKP46		Natural cytotoxicity triggering receptor 1 (lymphocyte antigen 94, mouse, homolog of)	604530	REa, REc			
19.1030	5	25	13	19q13.42	NDUFA3		NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 3	603832	REc			
19.1031	3	29	07	19q13.42	SAPS1, PP6R1, KIAA1115		SAPS domain family, member 1	610875	R, REc			
19.1032	2	2	17	19q13.42	SHISA7		Shisa family, member 7	617328	REc			
19.1033	12	29	09	19q13.42	SUV420H2		Suppressor of variegation 4-20, Drosophila, homolog of, 2	613198	REc			
19.1034	2	1	11	19q13.42	SYT5		Synaptotagmin-5	600782	REc			7(Syt5)
19.1035	11	23	16	19q13.42	TMC4		Transmembrane channel-like protein 4	617181	REc			7(Tmc4)
19.1036	12	22	17	19q13.42	TMEM86B		Transmembrane protein 86B	617806	REc			
19.1037	1	9	17	19q13.42	TMEM150B, DRAM3, TTN2, TMEM224		Transmembrane protein 150B	617291	REc			
19.1038	7	18	14	19q13.42	U2AF2, U2AF65		U2 small nuclear RNA auxiliary factor 2	191318	REc			
19.1039	3	1	07	19q13.42	UBE2S, EPF5, E2EPF		Ubiquitin-conjugating enzyme E2S	610309	REc, R			
19.1040	3	5	18	19q13.42	ZNF580		Zinc finger protein 580	617888	REc			
19.1041	7	7	16	19q13.43	AURKC, STK13, AIE2, SPGF5		Aurora kinase C	603495	RE, A, R		Spermatogenic failure 5, 243060 (3)	
19.1042	8	19	13	19q13.43	DUXA		Double homeobox A	611168	REc	many pseudogenes		
19.1043	8	24	09	19q13.43	SLC27A5, FATP5, VLACSR, VLCSH2		Solute carrier family 27 (fatty acid transporter), member 5	603314	R, REc			
19.1044	6	13	12	19q13.43	UBE2M, UBC12		Ubiquitin-conjugating enzyme E2M	603173	REc			
19.1045	1	13	11	19q13.43	ZNF8		Zinc finger protein-8	194532	REc	previously assigned to 20q13		
19.1046	3	28	11	19q13.43	ZNF304		Zinc finger protein 304	613840	REc			
19.1047	5	11	17	19q13.43	ZNF324, ZF5128		Zinc finger protein 324	617477	REc			
19.1048	3	28	17	19q13.43	ZNF419		Zinc finger protein 419	617410	REc			
19.1049	8	24	09	19q13.43	ZNF444, EZF2		Zinc finger protein 444	607874	R, REc			
19.1050	3	8	16	19q13.43	ZNF543		Zinc finger protein 543	616847	REc			
19.1051	1	7	14	19q13.43	ZNF582		Zinc finger protein 582	615600	REc			
19.1052	5	16	11	19q13.43	ZNF606, ZNF328, KIAA1852		Zinc finger protein 606	613905	REc			
19.1053	7	26	10	19q13.43	ZSCAN4, ZNF494		Zinc finger- and SCAN domain-containing protein 4	613419	REc, H			7(Zscan4)
19.1054	8	24	09	19q13.43	ZSCAN22, HKR2		Zinc finger- and SCAN domain-containing protein 22	165260	REa			
19.1055	6	19	00	Chr.19	ZNF97		Zinc finger protein-97	603979	REc			
20.1	5	13	93	20p12.3	CHGB, SCG1		Chromogranin B (secretogranin B)	118920	REa, A, H			2(Scg1)
20.2	10	28	99	20p13	PRND, DPL		Prion gene complex, downstream (doppel)	604263	REc			2(Prnd)
20.3	11	27	13	20p13	PRNP, PRIP, KURU, CJD		Prion protein (p27-30)	176640	REa, REb, A	pter-PRNP-SCG1-BMP2A-PAX1-cen	Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease, 137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3); {Kuru, susceptibility to}, 245300 (3); Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	2(Prnp)
20.4	10	8	08	20pter-p11.2	BMIQ6		Body mass index quantitative trait locus 6	608559	Fd	near D20S482 and D20S851	[Body mass index QTL6] (2)	
20.5	9	3	02	20p13	ADAM33		A disintegrin and metalloproteinase domain 33	607114	REc			
20.6	8	26	09	20p13	ADRA1D, ADRA1A		Adrenergic, alpha-1D-, receptor	104219	A	incorrectly assigned to 5q		11(Adra1a)
20.7	4	23	04	20p13	ALS7		Amyotrophic lateral sclerosis 7	608031	Fd	max lod at D20S103	Amyotrophic lateral sclerosis 7 (2)	
20.8	6	28	99	20p13	ANGPT4, ANG4		Angiopoietin 4	603705	A	no ANGT3 in human		2(Angpt3)
20.9	9	18	12	20p13	AP5S1, C20orf29		Adaptor-related protein complex 5, sigma-1 subunit	614824	REc			
20.10	8	14	00	20p13	ATRN, MGCA		Attractin (mahogany, mouse, homolog of)	603130	REc			2(Atrn)
20.11	4	25	93	20p13	AVP, AVRP, VP		Arginine vasopressin (neurophysin II, antidiuretic hormone)	192340	REa, RE, Fd	distal 20p	Diabetes insipidus, neurohypophyseal, 125700 (3)	2(Avp)
20.12	12	29	06	20p13	C20orf28, CLAMP, SPEF1		Sperm flagellar protein 1	610674	REc			2(Spef1)
20.13	8	5	11	20p13	C20orf194		Chromosome 20 open reading frame 194	614146	REc			
20.14	11	4	93	20p13	CDC25B		Cell division cycle 25B	116949	REa, A, Psh			
20.15	6	15	99	20p12.3	CDS2		CDP-diacylglycerol synthase 2	603549	R, A, H			2(Cds2)
20.16	1	12	95	20p13	CENPB		Centromeric protein B	117140	REa, A			
20.17	8	10	16	20p13	CSNK2A1, CK2A1, OCNDS		Casein kinase-2, alpha-1 polypeptide	115440	REa, A	pseudogene on 11p15	Okur-Chung neurodevelopmental syndrome, 617062 (3)	
20.18	1	10	18	20p13	DDRGK1, UFBP1, C20orf116, SEMDSH		DDRGK domain-containing protein 1	616177	REc		Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3)	
20.19	3	22	06	20p13	EBF4, KIAA1442		Early B-cell factor 4	609935	R, REc			
20.20	3	23	14	20p13	FAM110A, C20orf55		Family with sequence similarity 110, member A	611393	REc			
20.21	10	5	11	20p13	FASTKD5		Fast kinase domain-containing protein 5	614272	REc			
20.22	4	25	93	20p13	FKBP1A, FKBP12		FK506-binding protein-1A, 12kD	186945	Psh, A			
20.23	2	18	98	20p13	GNRH2		Gonadotropin-releasing hormone-2	602352	A			
20.24	1	16	07	20p13	HSPA12B		Heat-shock 70kD protein 12B	610702	REc			2(Hspa12b)
20.25	5	4	12	20p13	IDH3B, RP46		Isocitrate dehydrogenase 3, beta subunit	604526	R, A		Retinitis pigmentosa 46, 612572 (3)	
20.26	7	17	03	20p12.3	KIND1, URP1, C20orf42		Kindlin 1	607900	REc, Fd		Kindler syndrome, 173650 (3)	
20.27	10	12	09	20p13	MAVS, VISA, IPS1, CARDIF, KIAA1271		Mitochondrial antiviral signaling protein	609676	R, REc			
20.28	12	21	09	20p13	MIR103-2, MIRN103-2		Micro RNA 103-2	613188	REc			
20.29	8	9	11	20p13	MIR1292, MIRN1292		Micro RNA 1292	614155	REc			
20.30	4	24	08	20p13	MRPS26, MRPS13		Mitochondrial ribosomal protein S26	611988	R, REc			
20.31	9	6	11	20p13	NOP56, SCA36		Nop56, S. cerevisiae, homolog of	614154	REc		Spinocerebellar ataxia 36, 614153 (3)	
20.32	12	29	06	20p13	NRSN2		Neurensin 2	610666	REc			
20.33	4	25	93	20p13	OXT		Oxytocin-neurophysin I	167050	RE, Fd, A	12kb from ARVP		2(Oxt)
20.34	12	21	10	20p13	PDYN, SCA23		Prodynorphin	131340	REa, A, Fd		Spinocerebellar ataxia 23, 610245 (3)	
20.35	9	28	12	20p12.3	PROKR2, PKR2, GPR73L1, HH3		Prokineticin receptor 2	607123	REc		Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	
20.36	7	11	11	20p13	PROSAPIP1, KIAA0552		Proline-rich synapse-associated protein-interacting protein 1	610484	R, REc			
20.37	1	31	18	20p13	PSMF1, PI31		Proteasome inhibitor subunit 1	617858	REc			
20.38	8	17	92	20p13	PTPRA, PTPA, PTPRL2, LRP		Protein tyrosine phosphatase, receptor type, alpha polypeptide	176884	REa, A			2(Ptpa)
20.39	2	4	15	20p13	RBCK1, HOIL1, PGBM1, PBMEI		RANBP-type and C3HC4-type zinc finger-containing 1	610924	R, REc		Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	
20.40	8	8	08	20p13	RLS5		Restless legs syndrome, susceptibility to, 5	611242	Fd	max lod at D20S849	{Restless legs syndrome 5} (2)	
20.41	6	25	07	20p13	RSPO4, CRISTIN4		R-spondin family, member 4	610573	REc		Anonychia congenita, 206800 (3)	2(Rspo4)
20.42	2	24	17	20p13	SDCBP2, SITAC, ST2, SITAC18		Syndecan-binding protein 2	617358	REc			
20.43	2	15	06	20p13	SIRPG, SIRPB2		Signal regulatory protein, gamma	605466	Psh, R			
20.44	1	28	16	20p13	SIGLEC1, SN, CD169		Sialic acid-binding immunoglobulin-like lectin 1 (sialoadhesin)	600751	REa, A			2(Sn)
20.45	3	12	15	20p13	SNRPB, CCMS		Small nuclear ribonucleoprotein polypeptides B and B1	182282	REc		Cerebrocostomandibular syndrome, 117650 (3)	
20.46	8	29	02	20p13	SOX12, SOX22		SRY (sex-determining region Y)-box 12	601947	A			
20.47	7	13	98	20p13	SHPS1		SHP substrate-1	602461	A			2(Shps1)
20.48	1	20	06	20p11.23	SLC24A3, NCKX3		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3	609839	REc			
20.49	5	10	17	20p13	SLC52A3, C20orf54, RFT2, BVVLS1		Solute carrier family 52, riboflavin transporter, member 3	613350	REc	mutation identified in 1 FZLD family	Brown-Vialetto-Van Laere syndrome 1, 211530 (3); ?Fazio-Londe disease, 211500 (3)	
20.50	7	18	14	20p13	SMOX, SMO, PAO1, C20orf16, PAOH		Spermine oxidase	615854	REc			
20.51	12	7	07	20p13	SNPH		Syntaphilin	604942	R, REc			
20.52	7	27	17	20p13	SRXN1, SRX		Sulfiredoxin 1	617583	REc			
20.53	5	16	05	20p13	STK35, CLIK1		Serine/threonine kinase 35	609370	REn			
20.54	2	25	14	20p13	TBC1D20, C20orf140, WARBM4		TBC1 domain family, member 20	611663	REc		Warburg micro syndrome 4, 615663 (3)	
20.55	2	18	96	20p13	TCF15		Transcription factor-15 (basic helix-loop-helix)	601010	A			2(Meso1)
20.56	2	26	02	20p13	TMC2		Transmembrane channel-like protein 2	606707	REc			
20.57	7	11	16	20p13-p12	TMEM230, C20orf30		Transmembrane protein 230	617019	REc			
20.58	3	31	15	20p13	TRIB3, NIPK, SINK, C20orf97, SKIP3		Tribbles, Drosophila, homolog of, 3	607898	R, REc			
20.59	11	19	15	20p13	VPS16		Vacuolar protein sorting 18, yeast, homolog of	608550	REc			
20.60	10	5	10	20p12.3	CRLS1, GCD10, C20orf155		Cardiolipin synthase 1	608188	REc			
20.61	3	19	15	20p12.3	MCM8, POF10		Minichromosome maintenance complement component 8	608187	REc	mutation identified in 1 POF10 family	?Premature ovarian failure 10, 612885 (3)	
20.62	3	9	10	20p13	PANK2, NBIA1, PKAN, HARP		Pantothenate kinase 2	606157	LD, Fd		Neurodegeneration with brain iron accumulation 1, 234200 (3); HARP syndrome, 607236 (3)	
20.63	7	22	11	20p13	TGM6, TG6, TGY, SCA35		Transglutaminase 6	613900	REc		Spinocerebellar ataxia 35, 613908 (3)	2(Tgm6)
20.64	12	24	08	20p13	RNF24, G1L		Ring finger protein 24	612489	REc			
20.65	3	30	16	20p13	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4		Solute carrier family 4 (sodium borate cotransporter), member 11	610206	REc, Fd		Corneal endothelial dystrophy, autosomal recessive, 217700 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	
20.66	8	26	09	20p13	SLC23A2, SVCT2		Solute carrier family 23 (nucleobase transporters), member 2 (sodium-dependent vitamin C transporter 2)	603791	R, REc			
20.67	1	22	08	20p12.3	BMND7		Bone mineral density QTL 7	611738	Fd	most significant association with haplotype C	{Osteoporosis}, 166710 (2)	
20.68	2	23	09	20p12.3	CRCS11		Colorectal cancer, susceptibility to, 11	612592	Fd	associated with rs961253	{Colorectal cancer, susceptibility to, 11} (2)	
20.69	7	27	11	20p12.3	GPCPD1, GDE5, KIAA1434		Glycerophosphocholine phosphodiesterase GDE1, S. cerevisiae, homolog of	614124	REc			
20.70	6	25	18	20p12.3	SHLD1, RINN3, C20orf196		Shield complex, subunit 1	618028	REc			
20.71	1	21	16	20p12.3	TMX4		Thioredoxin-related transmembrane protein 4	616766	REc			
20.72	9	10	07	20p12.1	SPTLC3, SPTLC2L		Serine palmitoyltransferase, long-chain base subunit 3	611120	REc			
20.73	12	27	13	20p12.2	BTBD3, KIAA0952		BTB/POZ domain-containing protein 3	615566	REc			
20.74	6	1	12	20p12.2	LAMP5, BADLAMP		Lysosome-associated membrane protein 5	614641	REc			
20.75	9	20	14	20p12.2	SLX4IP, C20orf94		SLX4-interacting protein	615958	REc			
20.76	9	11	08	20p12.1	DSTN, ADF		Destrin	609114	R, REc			
20.77	6	22	14	20p12.1	ISM1, ISM		Isthmin 1, angiogenesis inhibitor	615793	REc			2(Ism1)
20.78	12	17	12	20p12.1	NDUFAF5, C20orf7		NADH dehydrogenase (ubiquinone) complex I, assembly factor T	612360	REc		Mitochondrial complex 1 deficiency, 252010 (3)	
20.79	10	18	11	20p12.1	SEL1L2		Suppressor of Lin12-like 2	614289	REc			
20.80	5	25	13	20p12.1	SNRPB2		Small nuclear ribonucleoprotein polypeptide B-double prime	603520	REc			
20.81	3	22	07	20p12.1	TASP1, C20orf13		Threonine aspartase 1	608270	REc			
20.82	5	9	17	20p12.1	BFSP1, CP115, CTRCT33		Beaded filament structural protein-1 (filensin)	603307	A		Cataract 33, multiple types, 611391 (3)	
20.83	2	16	18	20p12.3	BMP2, BMP2A, BDA2, SSFSC		Bone morphogenetic protein-2	112261	H, REa, A		{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly, type A2, 112600 (3); Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 617877 (3)	2(Bmp2a)
20.84	8	29	05	20p12	GLC1K, JOAG3		Glaucoma 1K, primary open angle, juvenile-onset	608696	Fd	between D20S189 and D20S104	Glaucoma 1K, primary open angle, juvenile-onset (2)	
20.85	2	1	01	20p12.3	HAO1, GOX1		Hydroxyacid oxidase 1	605023	R, REc			
20.86	5	22	18	20p12.2	JAG1, AGS1, AHD, DCHE		Jagged 1	601920	Ch, D, Fd, A, REc	mutation identified in 1 DCHE family	Alagille syndrome 1, 118450 (3); Tetralogy of Fallot, 187500 (3); ?Deafness, congenital heart defects, and posterior embryotoxon, 617992 (3)	
20.87	2	23	08	20p12.1	MACROD2, C2orf133		Macro domain-containing 2	611567	REc			
20.88	10	16	14	20p12.2	MKKS, HMCS, KMS, MKS, BBS6		McKusick-Kaufman syndrome gene	604896	Fd		McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6, 605231 (3)	
20.89	6	28	17	20p12.3	PCNA, ATLD2		Proliferating cell nuclear antigen	176740	REa, A	pseudogenes on X and 6; mutation identified in one ATLD2 family	?Ataxia-telangiectasia-like disorder 2, 615919 (3)	
20.90	2	11	11	20p12.3	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12		Phospholipase C, beta-1	607120	A, Psh		Epileptic encephalopathy, early infantile, 12, 613722 (3)	
20.91	6	4	12	20p12.3-p12.2	PLCB4, ARCND2		Phospholipase C, beta 4	600810	Psh, A		Auriculocondylar syndrome 2, 614669 (3)	
20.92	5	31	06	20p12	SLEB7		Systemic lupus erythematosus, susceptibility to, 7	610065	Fd		{Systemic lupus erythematosus, susceptibility to, 7} (2)	
20.93	8	27	01	20p11.21	NXT1, MTR2		NTF2-related export protein 1	605811	REc			
20.94	5	19	98	20p12.1	RRBP1, ES130		Ribosome binding protein-1	601418	A			
20.95	1	9	13	20p11.23	LINC00237		Long intergenic noncoding RNA 237	614992	A			
20.96	5	30	17	20p11.23	KAT14, CRP2BP, CSRP2BP, ATAC2		Lysine acetyltransferase 14	617501	REc			
20.97	5	22	14	20p11.23	KIZ, KIZUNA, C20orf19, RP69		Kizuna centrosomal protein	615757	REc		Retinitis pigmentosa 69, 615780 (3)	
20.98	2	21	13	20p11.23	MGME1, C20orf72, MTDPS11		Mitochondrial genome maintenance exonuclease 1	615076	REc		Mitochondrial DNA depletion syndrome 11, 615084 (3)	
20.99	3	30	16	20p11.23	OVOL2, ZNF339, PPCD1		ovo-like 2	616441	RE, H, REc		Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	2(Ovol2)
20.100	8	21	12	20p11.23	PET117		PET117, S. cerevisiae, homolog of	614771	REc			
20.101	4	26	17	20p11.23	POLR3F, RPC39, RPC6		Polymerase III, RNA, subunit F	617455	REc			
20.102	12	1	11	20p11.21	ACSS1, ACECS1		Acyl-CoA synthetase short-chain family, member 1	614355	REc			
20.103	12	18	08	20p11.22	AGA3		Alopecia, androgenetic, 3	612421	Fd	associated with rs1160312	Alopecia, androgenetic, 3 (2)	
20.104	10	12	09	20p11.23	RIN2, MACS		RAS and RAB interactor 2	610222	R, REc		Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	
20.105	5	21	07	20p11.23	CRNKL1, CRN		Crooked neck pre-mRNA splicing factor-like 1	610952	REc, A			
20.106	4	15	98	20p11.21	CST1		Cystatin SN	123855	A			
20.107	4	15	98	20p11.21	CST2		Cystatin SA	123856	REa, A			
20.108	6	26	16	20p11.21	CST3, ARMD11		Cystatin C	604312	REa, A	proximal to 20p11.2	Cerebral amyloid angiopathy, 105150 (3); {Macular degeneration, age-related, 11}, 611953 (3)	2(Cst3)
20.109	4	15	98	20p11.21	CST4		Cystatin S	123857	A			
20.110	1	27	11	20p11.21	ABHD12, PHARC		Abhydrolase domain-containing protein 12	613599	REc, Fd		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	
20.111	8	8	13	20p11.21	C1QR1, CD93, C1QR		Complement component 1, q subcomponent, receptor 1	120577	REc			
20.112	3	31	97	20p11.21	CST5		Cystatin D	123858	A			
20.113	11	11	14	20p11.21	CST7, CMAP		Cystatin 7	603253	A, H			2(Cst7)
20.114	11	28	05	20p11.21	CST11, CST8L		Cystatin 11	609731	REc			
20.115	1	16	18	20p11.21	GINS1, PSF1, KIAA0186, IMD55		GINS complex subunit 1	610608	R, REc		Immunodeficiency 55, 617827 (3)	
20.116	9	14	17	20p11.21	GZF1, ZNF336, JLSM		GDNF-inducible zinc finger protein 1	613842	REc		Joint laxity, short stature, and myopia, 617662 (3)	2(Gzf1)
20.117	8	19	13	20p11.21	NAPB, SNAPB		N-ethylmaleimide-sensitive factor attachment protein, beta	611270	REc, R			
20.118	10	25	11	20p11.21	SYNDIG1, TMEM90B		Synapse differentiation-induced gene 1	614311	REc			
20.119	7	17	14	20p11.21	APMAP, C20orf3, BSCV		Adipocyte plasma membrane-associated protein	615884	REc			
20.120	9	4	15	20p11.21	CST9, CLM		Cystatin 9	616543	REc			
20.121	9	2	15	20p11.21	CST9L		Cystatin 9-like	616536	R			
20.122	8	9	99	20p11.23	INSM1, IA1		Insulinoma-associated 1	600010	A			
20.123	3	6	07	20p11.23	NAT5, NAT3		N-acetyltransferase 5	610833	REc, R			
20.124	12	5	13	20p11.22	PAX1, OFC2		Paired box homeotic gene-1	167411	A, Psh, REa	mutation identified in 1 family	?Otofaciocervical syndrome 2, 615560 (3)	2(Pax1)
20.125	5	14	95	20p11.21	SSTR4		Somatostatin receptor-4	182454	A, Psh			2(Sstr4)
20.126	9	29	96	20p12.1	PCSK2, NEC2, PC2		Proprotein convertase subtilisin/kexin type 2	162151	A, R			2(Nec2)
20.127	2	20	01	20p11.23	RBBP9, BOG		Retinoma-binding protein 9	602908	A			2(Rbbp9)
20.128	07	28	18	20p11.23	SEC23B, CDAN2, HEMPAS, CWS7		Sec23, S. cerevisiae, homolog of, B	610512	R, REc, Fd	mutation identified in 1 CWS7 family	Dyserythropoietic anemia, congenital, type II, 224100 (3); ?Cowden syndrome 7, 616858 (3)	
20.129	4	30	15	20p12.2	SNAP25, CMS18		Synaptosomal-associated protein, 25kD	600322	R	mutation identified in 1 CMS18 patient	?Myasthenic syndrome, congenital, 18, 616330 (3)	2(Snap)
20.130	3	1	12	20p11.21	THBD, THRM, AHUS6, THPH12		Thrombomodulin	188040	REb, A, R		Thrombophilia due to thrombomodulin defect, 614486 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	2(Thbd)
20.131	3	30	16	20p11.21	VSX1, RINX, KTCN1, CAASDS		Visual system homeo box gene 1, zebrafish, homolog of	605020	R, Fd	mutation identified in 1 CAASDS family	Keratoconus 1, 148300 (3); ?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	
20.132	6	19	00	20p11.23	ZNF133		Zinc finger protein-133	604075	A			
20.133	4	24	96	20p11.21	PYGB		Phosphorylase, glycogen, brain	138550	REa, REb, A			2(Pygb)
20.134	8	18	04	20p11.22	XRN2		Exoribonuclease 2	608851	R			
20.135	11	25	08	20p11.2-q13.12	DYT17		Dystonia-17, primary torsion	612406	Fd	between D20S472 and D20S911	Dystonia-17, primary torsion (2)	
20.136	10	9	08	20p11.21	GGTLC1, GGTL6, GGTLA4		Gamma-glutamyltransferase, light chain 1	612338	REc			
20.137	5	22	07	20p11.23	DTD1, C20orf88		D-tyrosyl-tRNA deacylase 1, S. cerevisiae, homolog of	610996	REc			
20.138	6	11	13	20p12.1	FLRT3, HH21		Fibronectin-like domain-containing leucine-rich transmembrane protein-3	604808	REc		Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	
20.139	9	18	02	20p11.21	FOXA2, HNF3B		Forkhead box A2 (hepatic nuclear factor-3, beta)	600288	H, A			2(Hnf3b)
20.140	2	16	07	20p11.21	NANP, HDHD4		N-acetylneuraminic acid phosphatase	610763	REc			
20.141	2	11	08	20p11.22	NKX2-2, NKX2B		NK2, homeobox 2	604612	A			
20.142	2	11	08	20p11.22	NKX2-4, NKX2D		NK2 homeobox 4	607808	R, H			2(Nkx2d)
20.143	7	11	01	20p12.1	OTOR		Otoraplin	606067	A, REc			2(Otor)
20.144	8	26	09	20p11.23	SNX5		Sorting nexin 5	605937	R, REc			
20.145	11	20	15	20p13	ITPA, EIEE35		Inosine triphosphatase-A	147520	S		[Inosine triphosphatase deficiency], 613850 (3); Epileptic encephalopathy, early infantile, 35, 616647 (3)	2(Itp)
20.146	4	10	97	20q11.22	MAP1ALC3, MAP1BLC3		Microtubule-associated proteins 1A and 1B, light chain 3	601242	REa			
20.147	2	21	11	20q11.22	AHCY, SAHH		S-adenosylhomocysteine hydrolase	180960	S, F	~13cM from ADA	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	
20.148	7	25	16	20p	AD8		Alzheimer disease 8	607116	Fd	?related to CST3	Alzheimer disease 8 (2)	
20.149	10	12	09	20p	ATOD3		Dermatitis, atopic, 3	605804	Fd	max lod at D20S115	{Dermatitis, atopic, susceptibility to, 3} (2)	
20.150	12	11	02	20p13	P47		p47, rat, homolog of	606610	REc			
20.151	1	8	01	20q12	LPIN3		Lipin 3	605520	REc			2(Lpin3)
20.152	4	30	15	20q13.33	OSBPL2, ORP2, KIAA0772, DNFA67		Oxysterol-binding protein-like protein 2	606731	R, REc		Deafness, autosomal dominant 67, 616340 (3)	
20.153	6	26	01	20q13.12	PKIG		Protein kinase, cAMP-dependent catalytic, inhibitor gamma	604932	R			
20.154	6	1	12	20q11.21	BPIFA1, PLUNC, SPLUNC1		BPI fold-containing protein, family A, member 1	607412	H, REc			2(Plunc)
20.155	6	1	12	20q11.21	BPIFB2, BPIL1		BPI fold-containing protein, family B, member 2	614108	Psh, R, REc			
20.156	6	1	12	20q11.21	BPIFB6, BPIL3		BPI fold-containing protein, family B, member 6	614110	Psh, R, REc			
20.157	3	25	03	20q11.21	DEFB118, C20orf63, ESC42		Defensin, beta, 118	607650	REc			
20.158	1	15	96	20q11.21	ID1		Inhibitor of DNA binding 1, dominant negative	600349	REa, A			
20.159	12	19	01	20q11.22	NCOA6, ASC2, RAP250, NRC, PRIP		Nuclear receptor coactivator 6	605299	R, A			
20.160	3	8	07	20q11.21	PDRG1, PDRG, C20orf126		P53 and DNA damage-regulated 1	610789	REc			2(Pdrg1)
20.161	10	23	87	20q11.21	HCK		Hemopoietic cell kinase	142370	REb, A			
20.162	7	18	06	20q11-q13	HYT5		Hypertension, essential, susceptibility to, 5	610261	Fd		{Hypertension, essential, susceptibility to, 5}, 145500 (2)	
20.163	1	19	07	20q11-q13	SCAR6, CLA3		Spinocerebellar ataxia, autosomal recessive 6	608029	Fd	between D20S471 and D20S119	Spinocerebellar ataxia, autosomal recessive 6 (2)	
20.164	11	5	14	20q11.21	DEFB119, DEFB120, DEFB20		Defensin, beta, 119	615997	REc, H			2(Defb19)
20.165	11	5	14	20q11.21	DEFB121, DEFB21		Defensin, beta, 121	616075	REc, H			2(Defb21)
20.166	11	5	14	20q11.21	DEFB122, DEFB22		Defensin, beta, 122, pseudogene	616077	REc			2(Defb22)
20.167	11	4	15	20q11.21	DEFB123, DEFB23		Defensin, beta, 123	616076	REc, H			2(Defb23)
20.168	7	20	12	20q11.21	FOXS1, FKHL18, FREAC10		Forkhead box S1	602939	REa, A			
20.169	8	27	01	20q11.21	MAPRE1, EB1		Microtubule-associated protein, RP/EB family, member 1	603108	A, REc			
20.170	5	26	13	20q11.22-q11.23	PHF20, GLEA2, HCA58		PHD finger protein 20	610335	REc, Psh			
20.171	11	30	11	20q11.22	ASIP, AGTIL, SHEP9		Agouti, mouse, signaling protein	600201	Psh, A		[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	2(a)
20.172	5	11	01	20q11.21	C20orf1, P100		Proliferation-associated nuclear protein, 100kD	605917	A			
20.173	4	4	05	20q11.21-q11.22	CBFA2T2, MTGR1, EHT		Core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (ETO homolog on chromosome 20)	603672	Psh, A			
20.174	8	26	09	20q11.21	CDK5RAP1		CDK5 regulatory subunit-associated protein 1	608200	R, REc			
20.175	12	28	08	20q11.22	CEP2, CEP250, CNAP1		Centrosomal protein 2	609689	R			
20.176	9	24	08	20q11.2	CMM7		Melanoma, cutaneous malignant, susceptibility to, 7	612263	Fd	between rs910873 and rs1885120	{Melanoma, cutaneous malignant, 7} (2)	
20.177	11	29	99	20q11.21	DNMT3B, ICF1		DNA methyltransferase 3B	602900	A, Fd		Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	
20.178	7	1	98	20q11.22	E2F1		E2F transcription factor-1	189971	A			
20.179	10	3	07	20q11.22	EIF6, EIF3A, ITGB4BP		Eukaryotic translation initiation factor 6	602912	A			
20.180	9	28	00	20p11.21	ENTPD6, CD39L2		Ectonucleoside triphosphate diphosphohydrolase 6	603160	R, Psh			
20.181	8	20	15	20q11.22	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B		Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	H, Fd	mutation identified in 1 AMDHT family	?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3); Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Du Pan syndrome, 228900 (3); Brachydactyly, type A2, 112600 (3); Symphalangism, proximal, 1B, 615298 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis-5}, 612400 (3); Brachydactyly, type A1, C, 615072 (3)	2(bp)
20.182	10	9	08	20q11.22	GGT7, GGTL3, GGTL5, GGT4		Gamma-glutamyltransferase 7	612342	REc			
20.183	8	24	98	20q11.23	GHRH, GHRF		Growth hormone releasing hormone (somatocrinin)	139190	REa, REb, Ch, Fd, A		?Isolated growth hormone deficiency due to defect in GHRF (1); Gigantism due to GHRF hypersecretion (1)	
20.184	7	1	05	20q11.22	GSS, GSHS		Glutathione synthetase	601002	REa, A		Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3); Glutathione synthetase deficiency, 266130 (3)	
20.185	5	11	00	20q11.22	MMP25		Matrix metalloproteinase 24	604871	A			
20.186	11	27	00	20q11.22	PROCR, EPCR, CCCA, CCD41		Protein C receptor	600646	R, A			2(Procr)
20.187	5	27	94	20q11.23	RBL1, CP107		Retinoblastoma-like 1 (p107)	116957	A			2(Rbl1)
20.188	8	18	17	20q11.22	RBM12, KIAA0765, SCZD19		RNA-binding motif protein 12	607179	A		{Schizophrenia 19, susceptibility to}, 617629 (3)	
20.189	1	4	16	20q11.23	SAMHD1, AGS5, DCIP, CHBL2		SAM domain- and HD domain-containing protein 1	606754	REc	mutation identified in 1 CHBL2 family	Aicardi-Goutieres syndrome 5, 612952 (3); ?Chilblain lupus 2, 614415 (3)	
20.190	9	21	15	20q11.21	SNTA1, SNT1, TACIP1, LQT12		Syntrophin, alpha-1	601017	REa, Psh, A		Long QT syndrome 12, 612955 (3)	2(Snta1)
20.191	11	22	16	20q11.21	SUN5, TSARG4, SPAG4L, SPGF16		Sad1 and Unc84 domain-containing protein 5	613942	REc		Spermatogenic failure 16, 617187 (3)	
20.192	12	8	98	20q11.22	SPAG4		Sperm-associated antigen-4	603038	A			
20.193	6	27	17	20q11.22	TP53INP2, PIGU, DOR, C20orf110		Tumor protein p53-inducible nuclear protein 2	617549	REc			
20.194	12	2	09	20q11.23	BLCAP, BC10		Bladder cancer-associated protein	613110	REc			
20.195	8	20	08	20q11.23	CTNNBL1, NAP		Catenin, beta-like, 1	611537	REc			2(Ctnnbl1)
20.196	3	5	14	20q11.23	EPB41L1, MRD11		Erythrocyte membrane protein band 4.1-like 1	602879	R, Psh	mutation identified in 1 patient	?Mental retardation, autosomal dominant 11, 614257 (3)	
20.197	3	31	09	20q11.2-q12	MLRL, MTS		Myeloid leukemia-related locus (myeloid tumor suppressor)	601308	Ch			
20.198	10	15	98	20q11.23	NNAT		Neuronatin	603106	Psh, A			2(Nnat)
20.199	2	28	03	20q11.23	TGIF2		Transforming growth factor-beta-induced factor 2	607294	A			
20.200	1	12	95	20q11.23	TGM2		Transglutaminase-2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)	190196	A, Psh			
20.201	7	22	16	20q12	MAFB, KRML, MCTO, DURS3		v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B	608968	REc		Multicentric carpotarsal osteolysis syndrome, 166300 (3); Duane retraction syndrome 3, 617041 (3)	
20.202	10	12	09	20q13.12	MMP9, CLG4B, MANDP2		Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)	120361	REa, Fd, H, A		Metaphyseal anadysplasia 2, 613073 (3)	2(Clg4b)
20.203	11	4	14	20q13.12	ZNF335, NIF1, NIF2, MCPH10		Zinc finger protein 335	610827	REc	mutation identified in 1 MCPH10 family	?Microcephaly 10, primary, autosomal recessive, 615095 (3)	
20.204	10	25	11	20q11.21	ASXL1, KIAA0978, BOPS, MDS		Additional sex combs-like 1	612990	A, REc		Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome, somatic, 614286 (3)	
20.205	3	17	03	20q11.21	BASE		Breast cancer- and salivary gland-expressed gene	607627	REc			
20.206	3	1	10	20q11.21	BCL2L1, BCLX, BCLXL, BCLXS		BCL2-like 1	600039	REc			
20.207	4	10	14	20q11.21	BPIFBP3, RYA3		BPI fold-containing protein, family B, member 3	615717	REc			2(Bpifbp3)
20.208	4	10	14	20q11.21	BPIFB4, RY2G5		BPI fold-containing protein, family B, member 4	615718	REc			2(Bpifb4)
20.209	12	22	15	20q11.21	COMMD7		COMM domain-containing protein 7	616703	REc			
20.210	5	4	09	20q11.21	COX4I2		Cytochrome c oxidase, subunit IV, isoform 2	607976	REc		Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	
20.211	7	23	13	20q11.22	CHMP4B, SNF7, CTPP3, CTRCT31		CHMP family, member 4B	610897	REc, Fd		Cataract 31, multiple types, 605387 (3)	
20.212	1	29	16	20q11.21	DUSP15, VHY		Dual-specificity phosphatase 15	616776	REn, REc			
20.213	8	26	09	20q11.21	HM13, SPP		Minor histocompatibility 13 (signal peptide peptidase)	607106	R, REc			
20.214	8	26	09	20q11.21	KIF3B, KIAA0359		Kinesin family member 3B	603754	R, REc			
20.215	8	3	12	20q11.21	PLAGL2		Pleomorphic adenoma gene-like 2	604866	REc			
20.216	7	23	13	20q11.21	POFUT1, OFUCT1, KIAA0180, DDD2		Protein O-fucosyltransferase 1	607491	REc		Dowling-Degos disease 2, 615327 (3)	
20.217	6	2	16	20q11.21	REM1, GES		RRAD- and GEM-like GTPase 1	610388	REc, R			
20.218	10	25	17	20q11.21	TM9SF4, KIAA0255		Transmembrane 9 superfamily, member 4	617727	R, REc			
20.219	9	19	00	20q11.23	NDRG3		N-myc downstream-regulated gene 3	605273	REc, R			
20.220	5	13	08	20q11.22	ACSS2, ACS		Acetyl-CoA synthetase short-chain family member 2	605832	R, REc			
20.221	5	25	13	20q11.22	CPNE1, CPN1		Copine I	604205	REc			
20.222	5	24	13	20q11.22	EDEM2		Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2	610302	REc			
20.223	6	2	16	20q11.22	ERGIC3, C2orf47		Endoplasmic reticulum-golgi intermediate compartment protein 3	616971	REc			
20.224	1	27	11	20q11.22	MIR499, MIRN499		Micro RNA 499	613614	REc			2(Mir499)
20.225	3	1	06	20q11.22	MYH7B, MYH14, KIAA1512		Myosin, heavy chain 7B, cardiac muscle, beta	609928	R, REc			
20.226	12	17	08	20q11.22	NECAB3, EFCBP3, NIP1, APBA2BP, XB51, STIP3		N-terminal EF-hand calcium-binding protein 3	612478	REc			
20.227	3	5	18	20q11.22	NFS1, NIFS		Nitrogen fixation gene 1	603485	R, REc			
20.228	4	27	16	20q11.22	PIGU, CDC91L1		Phosphatidylinositol glycan anchor biosynthesis class U protein	608528	REc, REn			
20.229	6	2	15	20q11.22	PXMP4, PMP24		Peroxisomal membrane protein 4	616397	REc			
20.230	10	2	12	20q11.22	RBM39, CAPER, RNPC2		RNA binding motif protein 39	604739	REc, R			
20.231	2	17	09	20q11.22	STQTL14		Stature quantitative trait locus 14	612228	Fd	associated with rs6060373	{Stature QTL 14} (2)	
20.232	2	17	09	20q11.22	UQCC, CBP3, BFZB, C20orf44		Ubiquinol-cytochrome C reductase complex chaperone	611797	REc			
20.233	9	20	14	20q11.22	ITCH, AIP4, NAPP1, ADMFD		Itchy, mouse, homolog of	606409	A, R		Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	2(Itch)
20.234	2	25	10	20q11.23	PPP1R16B, TIMAP, KIAA0823		Protein phosphatase 1, regulatory subunit 16B	613275	REc			
20.235	2	24	17	20q11.23	AAR2, C20orf4		Aar2 splicing factor, S. cerevisiae, homolog of	617365	REc			
20.236	2	13	13	20q11.23	ADIG, SMAF1		Adipogenin	611396	REc			2(Smaf1)
20.237	2	4	15	20q11.23	DLGAP4, SAPAP4, KIAA0964		Discs LARGE-associated protein 4	616191	REc	noncoding RNAs transcribed from intron 1 are expressed in all tissues		
20.238	2	2	16	20q11.23	DSN1, C20orf172		DSN1 homolog, MIS12 kinetochore complex component	609175	REc			
20.239	7	15	16	20q12	LINC01370, HILNC25		Long intergenic noncoding RNA 1370	617038	REc			
20.240	2	21	06	20q11.23	MYL9, MLC2		Myosin light chain 9, regulatory	609905	R, REc			
20.241	7	14	16	20q11.23	NORAD, LINC00657		Noncoding RNA activated by DNA damage	617037	REc			
20.242	7	18	12	20q11.23	RPRD1B, CREPT		Regulation of nuclear pre-mRNA domain-containing protein 1B	614694	REc			
20.243	5	24	13	20q11.23	SCAND1, RAZ1, SDP1		SCAN domain-containing 1	610416	REc			
20.244	8	26	09	20q11.23	SLA2, SLAP2		SRC-like adaptor 2	606577	R, REc			
20.245	6	30	15	20q11.23	SLC32A1, VGAT, VIAAT		Solute carrier family 32 (GABA vesicular transporter), member 1	616440	REc			
20.246	2	2	04	20q11.22	TRPC4AP, TRUSS		TRPC4-associated protein	608430	R, REc			2(Trpc4ap)
20.247	1	18	12	20q11.23	TTI1, KIAA0406		TELO2-interacting protein 1	614425	R, REc			
20.248	9	2	15	20q11.23	VSTM2L, C20orf102		V-SET and transmembrane domains-containing protein 2-like	616537	REc			
20.249	12	3	14	20q12	CHD6, CHD5, RIGB		Chromodomain helicase DNA-binding protein 6	616114	REc			
20.250	4	25	93	20q11.23	BPI		Bactericidal/permeability-increasing protein	109195	REa, A			
20.251	4	25	93	20q11.23	LBP		Lipopolysaccharide-binding protein	151990	REa, A			
20.252	2	23	17	20q11-q13	MBCS		Mulchandani-Bhoj-Conlin syndrome	617352	Ch	maternal uniparental disomy of imprinted region	Mulchandani-Bhoj-Conlin syndrome, 617352 (3)	
20.253	9	18	08	20q13.12	DBNDD2, HSMNP1		Dysbindin domain-containing 2	611453	A			
20.254	4	11	11	20q13.12	JPH2, JP2, CMH17		Junctophilin 2	605267	A		Cardiomyopathy, hypertrophic, 17, 613873 (3)	
20.255	11	12	10	20q13.12	L3MBTL, L3MBTL1, KIAA0681		L3MBT-like	608802	Psh, R			
20.256	2	1	00	20q13.12	NCOA3, AIB1, TNRC14		Nuclear receptor coactivator 3 (amplified in breast cancer-1)	601937	Pcm			
20.257	12	23	16	20p13	TGM3, UHS2		Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)	600238	Psh, A	mutation identified in 1 UHS2 patient	?Uncombable hair syndrome 2, 617251 (3)	
20.258	11	21	02	20q13.12	KCNK15, TASK5		Potassium channel, subfamily K, member 15	607368	REc			
20.259	5	27	94	20q13.12	PI3		Protease inhibitor 3, skin derived (SKALP)	182257	REa, A			
20.260	12	19	96	20q13.12	SDC4		Syndecan 4 (amphiglycan, ryudocan)	600017	A, H			2(Sdc4)
20.261	10	4	05	20q12	ZHX3, KIAA0395		Zinc finger and homeodomain protein-3	609598	R, REc			
20.262	5	30	16	20q11.23	SRC, ASV, SRC1, THC6		Protooncogene SRC, Rous sarcoma	190090	REa, A, REb	mutation identified in 1 THC6 family	Colon cancer, advanced, somatic, 114500 (3); ?Thrombocytopenia 6, 616937 (3)	2(Src)
20.263	3	29	99	20q13.12	WISP2		Wnt-1 inducible signaling pathway protein 2	603399	R			
20.264	10	13	14	20q13.12	HNF4A, TCF14, MODY1, FRTS4		Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281	Fd, A		MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	2(Hnf4a)
20.265	3	1	00	20q12-q13.1	NIDDM3		Noninsulin-dependent diabetes mellitus 3	603694	Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	
20.266	7	12	94	20q12	PLCG1, PLC1		Phospholipase C, gamma 1 (formerly subtype 148)	172420	REa, A, Fd			
20.267	12	17	07	20q13.12	PLTP, HDLCQ9		Phospholipid transfer protein	172425	REa, A		[High density lipoprotein cholesterol level QTL 9] (3)	2(Pltp)
20.268	12	11	13	20q12-q13	PTPRT, KIAA0283		Protein-tyrosine phosphatase, receptor-type, T	608712	REc, H			2(Ptprt)
20.269	12	10	91	20q11.23	RPN2		Ribophorin II	180490	REa, A			2(Rpn2)
20.270	7	13	93	20q13.12	SEMG1, SEMG		Semenogelin	182140	A, REn			
20.271	7	13	93	20q13.12	SEMG2		Semenogelin II	182141	REn			
20.272	12	22	15	20q13.12	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14		Solute carrier family 12, (potassium-chloride transporter) member 5	606726	R, A		Epileptic encephalopathy, early infantile, 34, 616645 (3); {Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	5(Slc12a5)
20.273	10	24	01	20q13.12	SLC13A3, NADC3		Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3	606411	A			
20.274	5	16	11	20q13.12	SPINT3		Serin protease inhibitor, Kunitz-type, 3	613941	REc			
20.275	5	26	05	20q12	TOP1		Topoisomerase (DNA) I	126420	REa, A	pseudogenes on chr.1 and 22	DNA topoisomerase I, camptothecin-resistant (3)	2(Top1)
20.276	3	22	06	20q13.12	WFDC12, WAP2, SWAM2		Wap 4-disulfide core domain 12	609872	REc			
20.277	5	28	09	20q11.22	DYNLRB1, DNCL2A, DNLC2A		Dynein, light chain, roadblock type, 1	607167	R			
20.278	6	1	98	20q13.12	TNNC2		Troponin C2, fast	191039	Psh, R			
20.279	5	6	11	20q12-q13.12	PSMNSW		Parasomnia, sleepwalking type	613938	Fd	between 55.6 and 61.4 cM	Parasomnia, sleepwalking type (2)	
20.280	7	1	11	20q13.12	CD40, TNFRSF5		CD40 antigen	109535	A, D		Immunodeficiency with hyper-IgM, type 3, 606843 (3)	2(Cd40)
20.281	1	12	05	20q13.12	WFDC5, PRG5, WAP1		WAP 4-disulfide core domain 5	605161	REc			
20.282	9	30	10	20q13.33	BHLHE23, BHLHB4		Basic helix-loop-helix family, member E23	609331	A, REa, H			2(Bhlhb4)
20.283	6	3	98	20q13.13	CSE1L, CAS		Chromosome segregation-1, yeast, homolog of, like	601342	A			
20.284	9	10	09	20q13.32	CTSZ		Cathepsin Z	603169	A, REc			
20.285	6	3	15	20q13.33	EEF1A2, EIEE33, MRD38		Eukaryotic translation elongation factor-1, alpha-2	602959	H, A		Mental retardation, autosomal dominant 38, 616393 (3); Epileptic encephalopathy, early infantile, 33, 616409 (3)	2(wst, Eef1a2)
20.286	9	16	16	20q13.12	ELMO2, CED12, VMPI		Engulfment and cell motility gene 2	606421	REc		Vascular malformation, primary intraosseous, 606893 (3)	
20.287	9	7	04	20q13	GEVQ2		Gene expression, variation in, quantitative trait locus on chromosome 20	608878	Fd		{Gene expression, variation in, QTL} (2)	
20.288	8	15	06	20q13	HPC3		Prostate cancer, hereditary, 3	608656	Fd		{Prostate cancer, susceptibility to, 3}, 176807 (2)	
20.289	2	12	09	20q13	IBD24		Inflammatory bowel disease 24	612566	Fd	associated with rs2315008 and rs4809330	{Inflammatory bowel disease 24} (2)	
20.290	5	21	99	20q13.13	KCNG1, KH2		Potassium voltage-gated channel, subfamily G, member 1	603788	A			
20.291	6	15	99	20q13.33	NTSR1		Neurotensin receptor	162651	A			2(Ntsr1)
20.292	3	7	13	20q13.31	PMEPA1, TMEPAI		Prostate transmembrane protein, androgen-induced	606564	REc			
20.293	8	24	09	20q13	PSORS12		Psoriasis susceptibility 12	612950	Fd	associated with rs495337	{Psoriasis susceptibility 12} (2)	
20.294	12	24	08	20q13.13	RNF114, ZNF313		Ring finger protein 114	612451	REc			
20.295	5	31	06	20q13	SLEB8		Systemic lupus erythematosus, susceptibility to, 8	610066	Fd		{Systemic lupus erythematosus, susceptibility to, 8} (2)	
20.296	8	20	01	20q13.32	TH1L, TH1		TH1, Drosophila, homolog of	605297	REn			
20.297	1	12	99	20q13.33	TNFRSF6B, DCR3		Tumor necrosis factor receptor superfamily, member 6b (decoy receptor 3)	603361	R, Fd			
20.298	3	17	06	20q13.12	ACOT8, PTE1		Acyl-CoA thioesterase 8	608123	R, REc			2(Acot8)
20.299	3	1	06	20q13.12	CDH22		Cadherin 22	609920	R, REc			
20.300	9	12	92	20q13.13	CEBPB, TCF5		CCAAT/enhancer-binding protein (C/EBP), beta (transcription factor-5)	189965	REa, A			2(Cebpb)
20.301	11	23	09	20q13.12	CTSA, PPGB, GSL, NGBE, GLB2		Cathepsin A (protective protein for beta-galactosidase)	613111	S, A, Fd		Galactosialidosis, 256540 (3)	2(Ppgb)
20.302	2	3	97	20q13.12	EYA2		Eyes absent, Drosophila, homolog of, 2	601654	A, R			2(Eya2)
20.303	9	23	96	20q13.12	MYBL2, BMYB		v-myb avian myeloblastosis viral oncogene homolog-like 2	601415	A			2(Mybl2)
20.304	2	19	15	20q13.12	NCOA5, CIA		Nuclear receptor coactivator 5	616825	REc			
20.305	5	2	06	20q13.12	SLC2A10, GLUT10, ATS		Solute carrier family 2 (facilitated glucose transporter), member 10	606145	REc, Fd		Arterial tortuosity syndrome, 208050 (3)	
20.306	10	22	99	20q13.13	SNAI1		Snail 1, Drosophila, homolog of	604238	A, R	pseudogene on 2q34		
20.307	3	31	15	20q13.13	STAU1, STAU		Staufen, Drosophila, homolog of, 1	601716	A, REa			
20.308	9	28	96	20q13.12	YWHAB		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide	601289	A			
20.309	11	29	99	20q13.13	B4GALT5		Beta-1,4-galactosyltransferase 5	604016	Psh, TM	previously mapped to chr.11		
20.310	2	7	01	20q13.12	MATN4		Matrilin 4	603897	A			
20.311	1	7	09	20q13.13	PTPN1, PTP1B		Protein tyrosine phosphatase, nonreceptor-type, 1	176885	REa, A, H	20pter-q12 by REa	{Insulin resistance, susceptibility to}, 125853 (3)	2(Ptpn1)
20.312	8	26	09	20q13.13	SPATA2, KIAA0757		Spermatogenesis-associated protein 2	607662	R, REc			
20.313	8	26	09	20q13.31	BMP7		Bone morphogenetic protein-7 (osteogenic protein-1)	112267	REa, H			2(Bmp7)
20.314	11	21	06	20q13.12	SERINC3, TDE1		Serine incorporator 3	607165	A			
20.315	5	31	05	20q13.12	ADA		Adenosine deaminase	608958	S, D, REa, F, A, Fd		Severe combined immunodeficiency due to ADA deficiency, 102700 (3); Adenosine deaminase deficiency, partial, 102700 (3)	2(Ada)
20.316	10	14	09	20q13.11	GRD2		Graves disease, susceptibility to, 2	603388	Fd		{Graves disease, susceptibility to, 2} (2)	
20.317	12	19	11	20q13.11	SRSF6, SFRS6, SRp55		Splicing factor, serine/arginine-rich, 6	601944	R, REc			
20.318	12	20	02	20q13.13	PTGIS, CYP8A1, PGIS, CYP8		Prostaglandin I2 synthase	601699	A		Hypertension, essential, 145500 (3)	
20.319	4	2	16	20q13.12	DNTTIP1, TDIF1, C20orf167		Deoxynucleotidyltransferase, terminal, interacting protein 1	611388	REc			
20.320	6	9	08	20q13.12	FIT2, C20orf142		Fat-inducing transcript 2	612029	R, REc			
20.321	8	30	16	20q13.12	IFT52		Intraflagellar transport 52, Chlamydomonas, homolog of	617094	REc		Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3)	
20.322	7	20	12	20q13.12	KCNS1, KV9.1		Potassium channel, voltage-gated, delayed-rectifier, subfamily S, member 1	602905	REc			
20.323	1	21	16	20q13.12	PIGT, NDAP, PNH2, MCAHS3		Phosphatidylinositol glycan, class T	610272	REc, R	mutation identified in 1 PNH2 family	?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	
20.324	11	24	14	20q13.12	RBPJL, RBPL, SUHL		RBPJ-like protein	616104	A, REc			
20.325	8	8	13	20q13.12	SLPI, HUSI		Secretory leukocyte protease inhibitor	107285	REc			2(Slpi)
20.326	5	19	06	20q13.12	SULF2, KIAA1247		Sulfatase 2	610013	REc			2(Sulf2)
20.327	9	9	09	20q13.12	SYS1		Sys1 golgi-localized integral membrane protein, S. cerevisiae, homolog of	612979	REc			
20.328	10	12	14	20q13.12	TOMM34, TOM34		Translocase of outer mitochondrial membrane 34, yeast, homolog of	616049	REc			
20.329	8	19	13	20q13.12	TOX2, GCX1, C20orf100		TOX high mobility group box family member 2	611163	REc			
20.330	10	31	17	20q13.12	TP53RK, PRPK, GAMOS4		TP53-regulating kinase	608679	A, Psh, REc		Galloway-Mowat syndrome 4, 617730 (3)	
20.331	3	5	18	20q13.12	TP53TG5		TP53 target gene 5	617316	REc			
20.332	10	31	08	20q13.12	UBE2C, UBCH10		Ubiquitin-conjugating enzyme E2C	605574	R, REc			
20.333	6	27	17	20q13.12	WFDC2, HE4, WAP5		WAP 4-disulfide core domain 2	617548	REc			
20.334	4	10	14	20q13.12	ZMYND8, PRKCBP1		Zinc finger MYND domain-containing protein 8	615713	REc, R			
20.335	7	17	14	20q13.13	ADNP, ADNP1, KIAA0784, HVDAS, MRD28		Activity-dependent neuroprotector homeobox	611386	REc, A		Helsmoortel-van der Aa syndrome, 615873 (3)	
20.336	8	17	09	20q13.13	ARFGEF2, BIG2, PVNH2		ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited	605371	REa, Fd		Periventricular heterotopia with microcephaly, 608097 (3)	
20.337	11	15	08	20q13.13	BCAS4		Breast carcinoma amplified sequence 4	607471	REc			
20.338	10	28	15	20q13.13	DDX27, RHLP		DEAD box polypeptide 27	616621	REc			
20.339	8	25	04	20q13.13	DPM1, MPDS, CDGIE		Dolichyl-phosphate mannosyltransferase 1, catalytic subunit	603503	REc, Fd		Congenital disorder of glycosylation, type Ie, 608799 (3)	
20.340	11	2	04	20q13.13	PARD6B		Partitioning-defective protein 6, C. elegans, homolog of, beta	608975	R, REc			
20.341	5	13	02	20q13.13	PREX1, KIAA1415		Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1	606905	REc			
20.342	5	4	09	20q13.13	SLC9A8, NHE8, KIAA0939		Solute carrier family 9 (sodium/hydrogen exchanger), member 8	612730	REc			
20.343	4	17	07	20q13.2	SALL4, HSAL4		sal-like 4	607343	REc, Fd		Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)	
20.344	10	15	98	20q13.2	BCAS1, NABC1		Breast carcinoma amplified sequence	602968	REc			
20.345	1	24	13	20q13.2	CBLN4		Precerebellin 4	615029	REc			
20.346	5	25	13	20q13.2-q13.3	CSTF1		Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD	600369	REc			
20.347	2	28	03	20q13.31	CTCFL, BORIS		CCCTC-binding factor-like protein	607022	A			
20.348	12	13	03	20q13.2	DOK5		Docking protein 5	608334	REc			
20.349	9	26	17	20q13.32	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3		GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	REa, H, A, Fd		Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome, somatic, mosaic 174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Pituitary adenoma 3, multiple types, somatic, 617686 (3); Pseudopseudohypoparathyroidism, 612463 (3); ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	2(Gnas)
20.350	4	27	12	20q13.32	GNASAS1, GNASAS, SANG, NESPAS		GNAS antisense RNA 1	610540	REc		Pseudohypoparathyroidism, type IB, 603233 (3)	
20.351	10	24	14	20q13.13	KCNB1, EIEE26		Potassium voltage-gated channel, Shab-related subfamily, member 1	600397	A, Fd		Epileptic encephalopathy, early infantile, 26, 616056 (3)	2(Kcnb1)
20.352	7	22	09	20q13.2	MC3R, BMIQ9		Melanocortin-3 receptor	155540	A		{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3); {Mycobacterium tuberculosis, protection against}, 607948 (3)	2(Mc3r)
20.353	7	9	06	20q13.2	PFDN4, C1		Prefoldin 4	604898	R			
20.354	8	26	09	20q13.12	SGK2		Serum/glucocorticoid-regulated kinase 2	607589	R, REc			
20.355	6	13	12	20q13.12	SPINLW1, EPPIN, WAP7		Serine protease inhibitor-like protein with Kunitz and WAP domains 1	609031	REc			2(Spinlw1)
20.356	10	17	12	20q13.12	STK4, MST1, KRS2, TIIAC		Serine/threonine protein kinase 4	604965	R, REc		T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	
20.357	1	26	97	20q13.31	TFAP2C		Transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma)	601602	A			2(Tfap2c)
20.358	4	6	15	20q13.13	TMEM189, KUA		Transmembrane protein 189	610994	REc			
20.359	7	27	11	20q13.2	TSHZ2		Teashirt zinc finger homeobox 2	614118	REc			
20.360	11	4	98	20q13.13	UBE2V1, UEV1		Ubiquitin-conjugating enzyme E2 variant 1	602995	A			
20.361	09	07	18	20q13.2	ZFP64, ZNF338		Zinc finger protein 64	618111	REc			
20.362	5	5	99	20q13.2	ZNF217		Zinc finger protein-217	602967	REn			
20.363	4	17	06	20q13.2	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK		Aurora kinase A	603072	H, REc		{Colon cancer, susceptibility to}, 114500 (3)	
20.364	7	19	04	20q13.33	CHRNA4, ENFL1		Cholinergic receptor, nicotinic, alpha polypeptide-4	118504	REa, REn, A		Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine addiction, susceptibility to}, 188890 (3)	2(Acra4)
20.365	6	2	16	20q13.2	CYP24A1, CYP24, HCINF1		Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)	126065	A, REa		Hypercalcemia, infantile, 1, 143880 (3)	2(Cyp24)
20.366	7	19	06	20q13.2-q13.3	DFNB65		Deafness, autosomal recessive 65	610248	Fd	max lod at D20S840	Deafness, autosomal recessive 65 (2)	
20.367	1	25	11	20q13.32	EDN3, WS4B, HSCR4		Endothelin-3	131242	REa, A		Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)	2(Edn3)
20.368	3	15	92	20q13.2-q13.3	EEGV1, EEGL		Electroencephalographic variant pattern 1	130180	Fd			
20.369	3	30	18	20q13.33	GATA5, CHTD5		GATA-binding protein 5	611496	REc, H		Congenital heart defects, multiple types, 5, 617912 (3)	2(Gata5)
20.370	10	19	97	20q13.33	LAMA5		Laminin, alpha-5	601033	A			2(Lama5)
20.371	2	14	97	20q13.2	NFATC2, NFATP		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2	600490	REa, A			2(Nfatp)
20.372	7	14	00	20q13.31	SPO11		Spo11, S. cerevisiae, homolog of	605114	A			2(Spo11)
20.373	6	15	99	20q13.33	TPD52L2		Tumor protein D52-like 2	603747	A			
20.374	10	7	14	20q13.32	ATP5E, MC5DN3		ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	606153	R	pseudogene on 4q25; mutation identified in 1 MC5DN3 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	
20.375	3	19	01	20q13.33	BIRC7, MLIAP, KIAP, LIVIN		Baculoviral IAP repeat-containing protein 7	605737	R, A			
20.376	7	1	02	20q13.33	CDH4		Cadherin 4	603006	R			
20.377	6	3	02	20q13.33	COL9A3, EDM3, IDD		Collagen IX, alpha-3 polypeptide	120270	Fd, A, R		Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)	
20.378	9	14	95	20q13.33	GPR8		G protein-coupled receptor-8	600731	A	related sequence on 14		
20.379	2	11	11	20q13.33	KCNQ2, EBN1, EIEE7, BFNS1		Potassium voltage-gated channel, KQT-like subfamily, member 2	602235	REc, Fd		Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3); Epileptic encephalopathy, early infantile, 7, 613720 (3)	
20.380	12	23	05	20q13.33	LIME1, LIME		LCK-interacting transmembrane adaptor 1	609809	REc, R			
20.381	8	26	09	20q13.32	MIR296, MIRN296		Micro RNA 296	610945	REc			
20.382	12	17	01	20q11.21	MYLK2, MLCK		Myosin light chain kinase 2	606566	REc		Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	
20.383	11	1	09	20q13.33	MYT1, PLPB1		Myelin transcription factor 1	600379	REc, H			2(Myt1)
20.384	8	23	01	20q13.33	PPP1R3D, PPP1R6		Protein phosphatase 1, regulatory subunit 3D	603326	R			
20.385	7	11	11	20q13.33	PRIC285, PDIP1, KIAA1769		Peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285kD subunit	611265	R, REc			
20.386	3	14	13	20q13.33	PTK6, BRK		Protein-tyrosine kinase 6	602004	A			
20.387	9	10	09	20q13.32	RAB22A		Ras-associated protein RAB22A	612966	R			
20.388	11	11	14	20q13.33	RGS19, GAIP		Regulator of G protein signaling 19	605071	REc, H			2(Rgs19)
20.389	2	23	08	20q13.12	RIMS4		Protein regulating synaptic membrane exocytosis 4	611601	REc			2(Rims4)
20.390	2	7	01	20q13.33	RPS21		Ribosomal protein S21	180477	REa, R			
20.391	6	1	15	20q13.33	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3		Regulator of telomere elongation helicase 1	608833	REc, H		Dyskeratosis congenita, autosomal recessive 5, 615190 (3); Dyskeratosis congenita, autosomal dominant 4, 615190 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	2(Rtel)
20.392	11	3	14	20q13.33	SLC17A9, C20orf59, POROK8		Solute carrier family 17, member 9	612107	REc		Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	
20.393	1	11	07	20q13.33	SS18L1, KIAA0693, CREST		SS18-like gene 1	606472	R, A			
20.394	1	27	04	20q13.33	STMN3, SCLIP		Stathmin-like 3	608362	REc			
20.395	5	2	06	20q13.32	VAPB, VAPC, ALS8		Vesicle-associated membrane protein-associated protein B	605704	R, Fd		Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	
20.396	12	22	08	20q13.31	RBM38, RNPC1		RNA-binding motif protein 38	612428	REc			
20.397	10	11	17	20q13.31	PCK1, PCKDC		Phosphoenolpyruvate carboxykinase-1 (soluble)	614168	REa, A, Fd	mutation identified in 1 PCKDC family	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3)	2(Pck1)
20.398	12	2	09	20q13.32	TUBB1		Tubulin, beta-1	612901	REc		Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	
20.399	8	23	02	20q13.31	ZBP1, C20orf183, DLM1		Z-DNA binding protein 1 (tumor stroma and activated macrophage protein DLM1)	606750	REc			
20.400	4	20	11	20q13.31-q13.33	MTBS3		Mycobacterium tuberculosis, susceptibility to, 3	612929	Fd	associated with rs3827103	{Mycobacterium tuberculosis, susceptibility to, 3} (2)	
20.401	12	10	12	20q13.32	MIR298		Micro RNA 298	614914	REc			
20.402	7	16	12	20q13.32-q13.33	PHACTR3, SCAPININ		Phosphatase and actin regulator 3	608725	REc			
20.403	12	10	08	20q13.32	STX16, SYN16		Syntaxin 16	603666	REn, REc		Pseudohypoparathyroidism, type IB, 603233 (3)	
20.404	1	4	18	20q13.33	ADRM1, ARM1, RPN13		Adhesion-regulating molecule 1	610650	R, REc			
20.405	1	27	04	20q13.33	ARFGAP1		ADP-ribosylation factor GTPase-activating protein 1	608377	REc			
20.406	2	24	12	20q13.33	ARFRP1, ARP		ADP-ribosylation factor-related protein 1	604699	REc			
20.407	9	22	17	20q13.33	CDH26		Cadherin 26	617685	REc			
20.408	11	4	05	20q13.33	DATF1, DIO1		Death-associated transcription factor 1	604140	REc			
20.409	1	5	12	20q13.33	DNAJC5, DNAJC5A, CSP, CLN4B		DNAJ/HSP40 homolog, subfamily C, member 5	611203	REc		Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	
20.410	10	11	17	20q13.33	GID8, C20orf11, TWA1		GID complex, subunit 8	611625	R, REc			
20.411	4	13	10	20q13.33	GLM6		Glioma susceptibility 6	613031	Fd	associated with rs6010620	{Glioma susceptibility 6} (2)	
20.412	8	26	09	20q13.33	GMEB2, KIAA1269		Glucocorticoid modulatory element-binding protein 2	607451	R, REc			
20.413	4	18	07	20q13.33	GTPBP5, OBGH1		GTP-binding protein 5	610919	R, REc			
20.414	1	6	09	20q13.33	HAR1A, HAR1F		Highly accelerated region gene 1A	610556	REc			
20.415	1	6	09	20q13.33	HAR1B, HAR1R		Highly accelerated region gene 1B	610557	REc			
20.416	3	25	14	20q13.33	HRH3, GPCR97		Histamine receptor H3	604525	REc			
20.417	5	24	13	20q13.33	MIR1-1		Micro RNA 1-1	609326	REc			
20.418	5	24	13	20q13.33	MIR133A2		Micro RNA 133A2	610255	REc			2(Mir133a2)
20.419	8	18	15	20q13.33	MRGBP, C20orf20		MRG/MORF4L-binding protein	611157	R, REc			
20.420	7	16	09	20q13.33	NKAIN4		Na+/K+ transporting ATPase-interacting 4	612873	REc			2(Nkain4)
20.421	7	2	18	20q13.33	OGFR		Opioid growth factor receptor	606459	REc, A			
20.422	9	27	17	20q13.33	OPRL1, NOP		Opioid receptor-like 1	602548	REc			
20.423	5	20	11	20q13.33	PRPF6, PRP6, ANT1, TOM, C20orf14		Precursor mRNA-processing factor 6, S. cerevisiae, homolog of	613979	REc		Retinitis pigmentosa 60, 613983 (3)	
20.424	8	26	09	20q13.33	PSMA7		Proteasome subunit, alpha-type, 7	606607	R, REc			
20.425	12	4	08	20q13.33	SLCO4A1, OATPE, OATP4A1		Solute carrier organic anion transporter family, member 4A1	612436	R, REc			
20.426	6	2	15	20q13.33	SOX18, HLTS, HLTRS		SOX18, mouse, homolog of	601618	REa, R		Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3); Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	2(Sox18, ragged)
20.427	12	5	17	20q13.33	SRMS, C20orf148		Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites	617797	REc			2(Srms)
20.428	2	7	01	20q13.33	SYCP2, SCP2		Synaptonemal complex protein 2	604105	A			
20.429	8	26	09	20q13.33	TAF4, TAF2C1, TAFII130, TAF2C		TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD	601796	R, REc			
20.430	3	26	07	20q13.33	UCKL1, UCK1L, URKL1		Uridine/cytidine kinase-like 1	610866	REc			
20.431	8	26	15	20q13.33	YTHDF1		YTH N6-methyladenosine RNA-binding protein 1	616529	REc			
20.432	7	20	12	20q13.33	ZBTB46, BZEL		Zinc finger- and BTB domain-containing protein 46	614639	REc			
20.433	3	5	18	20q13.33	ZNF512B, KIAA1196		Zinc finger protein 512B	617886	R, REc			
20.434	10	23	87	Chr.20	HTL, LEUT, HLT		Leucine transport, high	151310	S			
21.1	8	24	09	21p13-q11	AUTS12		Autism, susceptibility to, 12	610838	Fd	max lod at D21S1437	{Autism susceptibility 12} (2)	
21.2	4	26	90	21p12	RNR4		Ribosomal RNA-4	180453	A			
21.3	11	16	17	21p11.2	BAGE1, BAGE		BAGE family, member 1	605167	REc	previously assigned to chr.13		
21.4	11	16	17	21p11.2	BAGE2		BAGE family, member 2	617776	REc			
21.5	11	16	17	21p11.2	BAGE3		BAGE family, member 3	617777	REc			
21.6	2	27	01	21p11.2	TPTE		Transmembrane phosphatase with tensin homology	604336	REc, A			
21.7	12	21	98	21q11.2-q21.1	NRIP1, RIP140		Nuclear receptor interacting protein 1 (receptor interacting protein 140)	602490	A, REc			
21.8	3	5	96	21q11.2	STCH		Stress 70 protein chaperone, microsome-associated, p60	601100	A			
21.9	9	16	12	21q11.2	ABCC13		ATP-binding cassette, subfamily C, member 13	608835	REc			
21.10	10	27	99	21q21.1	CXADR, CAR		Coxsackie virus and adenovirus receptor	602621	Psh, A	pseudogenes on chr.15 and chr.18		
21.11	3	31	05	21q11.2	LIPI, LPDL, PRED5		Lipase I	609252	REc		{Hypertriglyceridemia, susceptibility to}, 145750 (3)	16(Lipi)
21.12	12	15	04	21q11.2	NRCLP3		Narcolepsy 3	609039	Fd	max lod at D21S1245	Narcolepsy 3 (2)	
21.13	6	7	10	21q11.2	POTED, ANKRD21, POTE		POTE ankyrin domain family, member D	607549	REc, A			
21.14	4	12	18	21q11.2	RBM11		RNA-binding motif protein 11	617937	REc			
21.15	7	24	03	21q11.2	SAMSN1, HACS1		SAM domain, SH3 domain, and nuclear localization signals 1	607978	REc			
21.16	3	26	96	21q11.2	TAM, MST		Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	159595	Ch		Leukemia, transient, of Down syndrome (2)	
21.17	3	5	08	21q21.3	MRPL39, MRPL5		Mitochondrial ribosomal protein L39	611845	R, REc			
21.18	2	27	01	21q21.1	BTG3, ANA, TOB5		B-cell translocation gene 3	605674	A			
21.19	4	17	12	21q21.3	APP, AAA, CVAP, AD1		Amyloid beta (A4) precursor protein	104760	REa, A, Fd, RE	proximal to SOD; very distal q21 or boundary with q22	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)	16(App)
21.20	4	1	15	21q21.1	CHODL		Chondrolectin	607247	A			
21.21	11	6	00	21q21.1	NCAM2		Cell adhesion molecule, neural, 2	602040	Psh			
21.22	10	04	18	21q21.1	TMPRSS15, PRSS7, ENTK		Transmembrane protease, serine 15	606635	A		Enterokinase deficiency, 226200 (3)	
21.23	6	13	07	21q21.3	TAK1L, C21orf7		TAK1-like	611110	REc			
21.24	5	29	98	21q21	USH1E		Usher syndrome-1E, autosomal recessive, severe	602097	Fd		Usher syndrome, type 1E (2)	
21.25	2	1	01	21q21.3	ADAMTS5, ADAMTS11		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 5 (aggrecanase 2)	605007	REa, R			16(Adamts5)
21.26	10	17	95	21q21.3	GABPA, E4TF1A		GA-binding protein transcription factor, alpha subunit, 60kD	600609	A, REn, Psh, REc			
21.27	12	6	16	21q21.1	MIR99A		Micro RNA 99A	614509	REc			
21.28	9	20	14	21q21.1	MIR99AHG, MONC, LINC00478		MIR99A-LET7C cluster host gene, noncoding	615964	REc			
21.29	3	23	09	21q21.1	MIR125B2, MIRN125B2		Micro RNA 125B-2	610105	REc			
21.30	3	23	09	21q21.1	MIRLET7C, MIRNLET7C, LET7C		Micro RNA Let7c	612144	REc			
21.31	1	29	01	21q21.3	ADAMTS1, METH1		A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 1	605174	REc			
21.32	4	29	02	21q21.3	JAM2, VEJAM		Junctional adhesion molecule 2	606870	REc			
21.33	2	1	11	21q21.3	ATP5J, ATP5		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6	603152	REc			9(Atp5j)
21.34	11	29	17	21q21.3	CCT8, KIAA0002		Chaperonin containing T-complex polypeptide 1, subunit 8	617786	Psh, REc			
21.35	6	27	16	21q21.3	CLDN17		Claudin 17	617005	REn			
21.36	10	12	14	21q21.3	CYYR1		Cysteine/tyrosine-rich protein 1	616020	R, REc, H			16(Cyyr1)
21.37	10	12	14	21q21.3	CYYR1AS1, CYYR1-AS1		CYRR1 antisense RNA 1	616021	REc			
21.38	3	23	09	21q21.3	MIR155, BIC, MIRN155		Micro RNA 155	609337	REc			
21.39	4	2	12	21q21.3	N6AMT1		N6 adenine-specific DNA methyltransferase 1, putative	614553	REc			
21.40	12	10	13	21q21.3	USP16, UBPM		Ubiquitin-specific protease 16	604735	REc			
21.41	4	24	08	21q22.11	MRPS6		Mitochondrial ribosomal protein S6	611973	R, REc			
21.42	5	28	13	21q22.3	FAM3B		Family with sequence similarity 3, member B	608617	REc			16(Fam3b)
21.43	8	20	08	21q22	FEB7		Febrile seizures, familial, 7	611515	Fd	max lod at D21S1910	Febrile seizures, familial, 7 (2)	
21.44	3	1	94	21q21.3	GRIK1, GLUR5		Glutamate receptor, ionotropic, kainate 1	138245	REc, REa, A, Fd			16(Glur5)
21.45	12	27	01	21q22.11	HUNK		Hormonally upregulated NEU-associated kinase	606532	H			16(Hunk)
21.46	9	28	11	21q22.3	RRP1B, KIAA0179, NNP1L		Ribosomal RNA-processing protein 1, S. cerevisiae, homolog of, B	610654	Psh, REc			
21.47	3	27	95	21q22.11	SLC5A3		Solute carrier family 5 (inositol transporter), member 3	600444	A	?role in Down syndrome		
21.48	6	24	05	21q22	TUKLS		Tukel syndrome	609428	Fd	max lod at D21S1259	Tukel syndrome (2)	
21.49	11	28	01	21q21.3	BACH1		BTB and CNC homology 1	602751	REc			
21.50	1	12	11	21q22.11	CRFB4, IBD25		Cytokine receptor, family II, member 4	123889	Fd, REn	35kb distal to IFNAR; D21S58	{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	16(Crfb4)
21.51	6	18	99	21q22.11	CRYZL1		Crystallin, zeta-like 1	603920	A			
21.52	8	4	17	21q22.11	DONSON, C21orf60, MISSLA, MIMIS		Downstream neighbor of SON	611428	REc, H		Microcephaly-micromelia syndrome, 251230 (3); Microcephaly, short stature, and limb abnormalities, 617604 (3)	
21.53	11	29	11	21q22.13	DYRK1A, MNBH, MNB, MRD7		Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of)	600855	REn, H, REc	?triplicate state responsible for mental defect in Down syndrome	Mental retardation, autosomal dominant 7, 614104 (3)	16(mmb)
21.54	6	3	94	21q22.11	GART, PRGS, PGFT		Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase)	138440	S, H, REa	multifunctional protein: Ade(-)C, Ade(-)G, GART		16(Prgs)
21.55	2	20	03	21q22.13	HLCS, HCS		Holocarboxylase synthetase	609018	Psh, A		Holocarboxylase synthetase deficiency, 253270 (3)	16(Hlcs)
21.56	8	24	98	21q22.11	IFNAR1		Interferon, alpha, beta and omega, receptor 1	107450	S, D, A, REn			16(Ifrc)
21.57	12	2	15	21q22.11	IFNAR2, IMD45		Interferon, alpha, beta, and omega, receptor 2	602376	REa, REc	mutation identified in 1 IMD45 family	{Hepatitis B virus, susceptibility to}, 610424 (3); ?Immunodeficiency 45, 616669 (3)	
21.58	1	14	11	21q22.11	KCNE2, MIRP1, LQT6, ATFB4		Potassium voltage-gated channel, Isk-related family, member 2	603796	RE		Long QT syndrome 6, 613693 (3); Atrial fibrillation, familial, 4, 611493 (3)	
21.59	3	30	15	21q22.13	KCNJ6, GIRK2, KCNJ7, KPLBS		Potassium inwardly-rectifying channel, subfamily J, member 6	600877	A		Keppen-Lubinsky syndrome, 614098 (3)	16(Kcnj6)
21.60	2	10	05	21q22.11	MRAP, FALP, C21orf61, GCCD2, FGD2		Melanocortin 2 receptor accessory protein	609196	REc, Fd		Glucocorticoid deficiency 2, 607398 (3)	
21.61	1	23	18	21q21.3	RWDD2B, C21orf6		RWD domain-containing protein 2B	617843	REc			
21.62	9	21	12	21q22.11	SOD1, ALS1		Superoxide dismutase-1, soluble	147450	S, D, Fd	mid q22.1	Amyotrophic lateral sclerosis 1, 105400 (3)	16(Sod1)
21.63	1	27	04	21q22.11	TCP10L		T-complex protein 10-like	608365	REc			
21.64	2	15	96	21q22.11	TIAM1		T-cell lymphoma invasion and metastasis 1	600687	REc, H			16(Tiam1)
21.65	9	16	12	21q22.11	URB1, NPA1, C21orf108, KIAA0539		URB1 ribosome biogenesis 1 homolog (S. cerevisiae)	608865	REc, R			
21.66	12	13	95	21q22.11	ATP5O		ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein)	600828	REa, A			
21.67	9	8	14	21q22.11	IFNGR2, IFNGT1, IFGR2, IMD28		Interferon gamma receptor-2 (interferon gamma transducer 1)	147569	S, A		Immunodeficiency 28, mycobacteriosis, 614889 (3)	16(Ifgr2)
21.68	11	19	98	21q22.11	ITSN1, SH3D1A, SH3P17		Intersectin 1 (SH3 domain protein-1A)	602442	REc			
21.69	1	14	11	21q22.12	KCNE1, JLNS, LQT5, JLNS2		Potassium voltage-gated channel, Isk-related subfamily, member 1	176261	REa, A, Psh, Fd		Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome 5, 613695 (3)	
21.70	8	1	17	21q22.13	PIGP, DSCR5, EIEE55		Phosphatidylinositol glycan, class P	605938	REc	mutation identified one EIEE55 family	?Epileptic encephalopathy, early infantile, 55, 617599 (3)	16(Dscr5)
21.71	9	24	08	21q22.12	RCAN1, DSCR1, MCIP1, CSP1		Regulator of calcineurin 1	602917	REc			16(Rcan1)
21.72	11	23	16	21q22.11	SON, TOKIMS		SON DNA-binding protein	182465	Psh		ZTTK syndrome, 617140 (3)	
21.73	11	11	13	21q22.11	C21orf59, CILD26		Chromosome 21 open reading frame 59	615494	REc		Ciliary dyskinesia, primary, 26, 615500 (3)	
21.74	5	26	13	21q22.11	CLDN8		Claudin 8	611231	REc			
21.75	12	21	09	21q22.11	KRTAP11-1, HACL1		Keratin-associated protein 11-1	600064	REc, H			16(Krtap11-1)
21.76	11	13	13	21q22.11	KRTAP13-1		Keratin-associated protein 13-1	608718	REc			
21.77	9	29	10	21q21.3	LTN1, RNF160, KIAA0714		Listerin E3 ubiquitin protein ligase 1	613083	R, REc			16(Rnf160)
21.78	10	09	18	21q22.11	MIS18A		Mis18 kinetochore protein A	618137	REc			
21.79	9	20	14	21q22.11	OLIG1		Oligodendrocyte lineage transcription factor 1	606385	REc			
21.80	3	11	08	21q22.11	OLIG2, PRKCBP2		Oligodendrocyte lineage transcription factor 2	606386	R, REc			
21.81	8	28	17	21q22.11	PAXBP1, GCFC1, C21orf66		PAX3- and PAX7-binding protein 1	617621	REc			
21.82	9	30	14	21q22.11	SCAF4, KIAA1172		SR-related C-terminal domain-associated factor 4	616023	R, REc			
21.83	3	1	18	21q22.11	TMEM50B, C21orf4		Transmembrane protein 50B	617894	REc			
21.84	8	24	98	21q22.12	CBR1		Carbonyl reductase 1	114830	REa, Fd, A			16(Cbr1)
21.85	7	22	13	21q22.12	CLIC6, CLIC1L		Chloride intracellular channel 6	615321	REc			
21.86	11	24	14	21q22.12	MIR802		Micro RNA 802	616090	REc			
21.87	3	24	14	21q22.12	MORC3, NXP2		MORC family CW-type zinc finger 3	610078	Psh, REc			
21.88	10	11	05	21q22.13	MAFD3, BPEO		Major affective disorder 3	609633	Fd	max lod at D21S1252	{Major affective disorder 3, early onset} (2)	
21.89	3	22	06	21q22.13-qter	BMND6		Bone mineral density QTL 6	609876	Fd	max lod at D21S1446	[Bone mineral density QTL 6] (2)	
21.90	9	12	96	21q22.12-q22.13	CAF1A		Chromatin assembly factor I, p60 subunit	601245	REn, Psh			
21.91	2	6	01	21q22.12	CBR3		Carbonyl reductase 3	603608	REc			
21.92	8	25	09	21q22.12	DOPEY2, 21orf5, KIAA0933		Dopey family member 2	604803	REc			
21.93	5	11	00	21q22.13	DSCR4, DSCRB		Down syndrome critical region gene 4	604829	REc			
21.94	3	22	06	21q22.13	DSCR6, RIPPLY3		Down syndrome critical region gene 6	609892	REc			
21.95	6	7	10	21q22.13	DSCR8, MMA1		Down syndrome critical region gene 8	613396	REc			
21.96	12	29	06	21q22.2	JAM4		Junctional adhesion molecule 4	610638	R, REc			
21.97	3	20	98	21q22.1-q22.2	KCNJ15		Potassium inwardly-rectifying channel, subfamily J, member 15	602106	REf			
21.98	7	31	97	21q22.13	SIM2		Single-minded, Drosophila, homolog of, 2	600892	REc			
21.99	3	9	17	21q22.11	SYNJ1, PARK20, EIEE53		Synaptojanin 1	604297	A		Parkinson disease 20, early-onset, 615530 (3); Epileptic encephalopathy, early infantile, 53, 617389 (3)	16(Synj1)
21.100	1	13	99	21q22.13	TTC3, TPRD		Tetratricopeptide repeat domain 3	602259	REc			
21.101	12	22	17	21q22.2	BRWD1, WRD9, C21orf107		Bromodomain and WD repeat domain-containing protein 1	617824	REc, H			16(Brwd1)
21.102	1	15	08	21q22.2	C21orf24		Chromosome 21 open reading frame 24	611723	REc			
21.103	4	17	98	21q22.2	DSCAM		Down syndrome cell adhesion molecule	602523	REc			
21.104	3	28	90	21q22.3	S100B		S100 calcium-binding protein, beta (neural)	176990	REa, A			10(S100b)
21.105	10	29	99	21q22.3	ABCG1, ABC8, WHITE1		ATP-binding cassette, subfamily G, member 1 (white, Drosophila, homolog of)	603076	A			17(Abc8)
21.106	2	25	98	21q22.3	ADARB1, RED1		Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of)	601218	Psh, REc			
21.107	9	2	12	21q22.3	AGPAT3, LPAAT3		1-acylglycerol-3-phosphate O-acyltransferase 3	614794	REc			
21.108	3	11	09	21q22.3	AIRE, APECED, APS1		Autoimmune regulator	607358	Fd		Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	
21.109	5	23	00	21q22.2	B3GALT5, GLCT5		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5	604066	REc			
21.110	2	20	01	21q22.2-q22.3	BACE2, ALP56, DRAP		Beta-site amyloid beta A4 precursor protein-cleaving enzyme 2 (Down syndrome region aspartic protease)	605668	REc, A			
21.111	8	2	17	21q22.3	C2CD2, TMEM24L, C21orf25		C2 calcium-dependent domain-containing protein 2	617581	REc			
21.112	12	19	08	21q22.3	C21orf56		Chromosome 21 open reading frame 56	612412	REc			
21.113	6	7	10	21q22.3	CBS		Cystathionine beta-synthase	613381	S, D, A, Fd	subtelomeric	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3); Thrombosis, hyperhomocysteinemic, 236200 (3)	17(Cbs)
21.114	7	19	18	21q22.3	CFAP410, C21orf2, SMDAX, RDMS		Cilia and flagella-associated protein 410	603191	REn		Spondylometaphyseal dysplasia, axial, 602271 (3); Retinal dystrophy with macular staphyloma, 617547 (3)	
21.115	7	1	11	21q22.13	CLDN14, DFNB29		Claudin 14	605608	REc, Fd		Deafness, autosomal recessive 29, 614035 (3)	
21.116	7	20	15	21q22.3	COL6A1, BTHLM1, UCHMD1		Collagen VI, alpha-1 polypeptide	120220	REa, A, REn, Fd		Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3)	10(Col6a1)
21.117	7	20	15	21q22.3	COL6A2, BTHLM1, UCMD1		Collagen VI, alpha-2 polypeptide	120240	REa, A, REn, Fd	mutation identified in 1 MYSCL family	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); ?Myosclerosis, congenital, 255600 (3)	10(Col6a2)
21.118	5	28	08	21q22.3	COL18A1, KNO1		Collagen XVIII, alpha-1 polypeptide	120328	A, Fd		Knobloch syndrome, type 1, 267750 (3)	10(Col18a1)
21.119	5	24	13	21q22.3	CRYAA, CRYA1, CTRCT9		Crystallin, alpha A	123580	REa, A, RE, Fd		Cataract 9, multiple types, 604219 (3)	17(Crya1)
21.120	12	7	11	21q22.3	CSTB, STFB, EPM1, PME, EPM1A, ULD		Cystatin B (stefin B)	601145	REn		Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	
21.121	9	16	96	21q22.3	DCR, DSCR		Down syndrome chromosome region	190685	Ch	many genes are involved in this phenotype	Down syndrome (4)	
21.122	8	29	07	21q22.3	DIP2, KIAA0184		Disco-interacting protein 2, Drosophila, homolog of	607711	REc	previously mapped to Chr.2		10(Dip2)
21.123	1	7	02	21q22.3	DNMT3L		DNA methyltransferase 3-like protein	606588	REc			
21.124	2	1	01	21q22.13	DSCR3, DSCRA		Down syndrome critical region gene 3	605298	REn			
21.125	10	15	94	21q22.2	ERG		Erythroblastosis virus E26, avian, (v-ets) oncogene related	165080	REa, Fd, A	fused with EWS in Ewing sarcoma, with FUS in leukemia		
21.126	3	18	91	21q22.2	ETS2		Oncogene ETS-2	164740	REa, A, Fd	proximal q22.3		16(Ets2)
21.127	8	22	03	21q22.3	FTCD		Formiminotransferase cyclodeminase	606806	R		Glutamate formiminotransferase deficiency, 229100 (3)	10(Ftcd)
21.128	09	06	18	21q22.3	GATD3A, ES1, HES1, GT335, C21orf33		Glutamine amidotransferase-like class 1 domain-containing protein 3A	601659	REc			
21.129	8	28	02	21q22.2	HMGN1, HMG14		High-mobility group nucleosomal binding protein 1	163920	REa, Fd, A			
21.130	4	9	96	21q22.3	HPE1		Holoprosencephaly-1, alobar	236100	Ch, REa		Holoprosencephaly 1 (2)	
21.131	10	19	97	21q22.3	HRMT1L1, PRMT2		HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1	601961	REa, REc			
21.132	2	6	01	21q22.3	HSF2BP		Heat-shock transcription factor 2-binding protein	604554	REc			
21.133	8	25	09	21q22.3	ICOSLG, B7H2, GL50, B7RP1		Inducible T-cell co-stimulator ligand	605717	R, REc			
21.134	7	11	16	21q22.3	LINC00163, NCRNA00163, NLC1A		Long intergenic nonprotein coding RNA 163	610259	Fd, REc			
21.135	10	08	18	21q22.3	MCM3AP, MAP80, GANP, PNRIID		Minichromosome maintenance 3-associated protein, 80-kD	603294	R, A		Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3)	
21.136	2	6	01	21q22.3	PDXK, PNK, PKH		Pyridoxal kinase	179020	REc			
21.137	5	24	13	21q22.3	POFUT2, C21Orf80, KIAA0958		Protein O-fucosyltransferase 2	610249	R, REc			
21.138	1	23	96	21q22.3	ITGB2, CD18, LCAMB, LAD		Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)	600065	S, A, Fd	common subunit for CR3, LFA1, and P150,95	Leukocyte adhesion deficiency, 116920 (3)	7(Ly15)
21.139	8	11	17	21q22.3	LRRC3, C21orf102, C21orf30		Leucine-rich repeat-containing protein 3	617620	REc			
21.140	8	7	15	21q22.3	LSS, OSC, CTRCT44		Lanosterol synthase	600909	REa, REc		Cataract 44, 616509 (3)	
21.141	3	18	91	21q22.3	MX1, MX, IFI78		Myxovirus (influenza) resistance-1 (interferon induced protein p78)	147150	REa, D, Fd			16(Mx1)
21.142	8	25	09	21q22.3	MX2		Myxovirus (influenza) resistance-2	147890	REa, REc			16(Mx2)
21.143	8	20	98	21q22.3	NDUFV3		NADH-ubiquinone oxidoreductase flavoprotein 3, 10kD	602184	A, REc			
21.144	3	16	05	21q22.3	PCBP3		Poly(rC)-binding protein 3	608502	REc			10(Pcbp3)
21.145	11	11	10	21q22.3	PCNT, PCNT2, KEN, SCKL4, MOPD2		Pericentrin	605925	Psh, A, Fd		Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	
21.146	8	15	97	21q22.2	PCP4		Purkinje cell protein 4	601629	REc, Psh, A			16(Pcp4)
21.147	6	18	99	21q22.3	PDE9A, HSPDE9A2		Phosphodiesterase 9A	602973	Psh, REc			
21.148	3	18	91	21q22.3	PFKL		Phosphofructokinase, liver type	171860	S, D, Fd		Hemolytic anemia due to phosphofructokinase deficiency (1)	17(Pfkl)
21.149	11	23	16	21q22.3	PICSAR, LINC00162, NLC1C		p38-inhibited cutaneous squamous cell carcinoma-associated long intergenic noncoding RNA	617191	REc			
21.150	6	18	99	21q22.3	PKNOX1		PBX/knotted 1 homeo box 1	602100	Psh, Fd, A			17(Pknox1)
21.151	2	24	11	21q22.2	PLAC4		Placenta-specific gene 4	613770	REc			
21.152	9	18	17	21q22.3	PRDM15, ZNF298		PR domain-containing protein 15	617692	REc			
21.153	9	24	08	21q22.2	PSMG1, DSCR2, C21LRP		Proteasome (prosome, macropain) assembly chaperone 1	605296	REn			
21.154	8	8	00	21q22.3	PTTG1IP, C21orf1, C21orf3, PBF		Pituitary tumor-transforming gene 1 protein-interacting protein	603784	A, TM			
21.155	1	26	97	21q22.3	PWP2H, PWP2		PWP2 periodic tryptophan protein, yeast, homolog of	601475	RE			
21.156	10	14	18	21q22.3	RIPK4, NKRD3, DIK, PPS2, CHANDS		Receptor-interacting serine-threonine kinase 4	605706	REc		Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3); CHAND syndrome, 214350 (3)	
21.157	11	1	13	21q22.3	RSPH1, TSGA2, TSA2, CILD24		Radial spoke head 1, Chlamydomonas, homolog of	609314	R		Ciliary dyskinesia, primary, 24, 615481 (3)	17(Tsa2)
21.158	8	23	09	21q22.12	RUNX1, CBFA2, AML1		Runt-related transcription factor 1 (aml1 oncogene)	151385	Ch, Fd		Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	
21.159	1	19	98	21q22.2	SH3GBR		SH3 domain binding glutamic acid-rich protein	602230	REc			
21.160	10	17	95	21q22.3	SLC19A1, FOLT		Solute carrier family 19 (folate transporter), member 1	600424	REa, A			
21.161	9	16	03	21q22.3	SLC37A1, G3PP		Solute carrier family 37 (glycerol-3-phosphate transporter), member 1	608094	REc			
21.162	4	30	15	21q22.3	SIK1, SNF1LK, MSK, EIEE30		Salt-inducible kinase 1	605705	REc		Epileptic encephalopathy, early infantile, 30, 616341 (3)	
21.163	8	25	04	21q22.3	SUMO3, SMT3H1		Small ubiquitin-like modifier 3	602231	REc			
21.164	10	15	96	21q22.3	TFF1, BCEI		Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in)	113710	REa, A, Fd			
21.165	8	24	98	21q22.3	TFF2, SML1		Trefoil factor 2 (spasmolytic protein-1)	182590	A, REn, REa	within 230kb of BCEI		
21.166	4	9	96	21q22.3	TFF3, ITF		Trefoil factor 3 (intestinal)	600633	Psh, A, REn			17(Tff3)
21.167	2	25	98	21q22.3	TMEM1, EHOC1		Transmembrane protein 1	602103	REc	near PWP2H		
21.168	6	9	98	21q22.3	TMPRSS2		Transmembrane protease, serine 2	602060	Psh, REc			
21.169	1	9	13	21q22.3	TMPRSS3, ECHOS1, DFNB8, DFNB10		Transmembrane protease, serine 3	605511	Fd, REc		Deafness, autosomal recessive 8/10, 601072 (3)	
21.170	6	18	99	21q22.3	TRPM2, TRPC7, KNP3		Transient receptor potential cation channel, subfamily M, member 2	603749	REf			
21.171	3	9	18	21q22.3	TSPEAR, C21orf29, DFNB98		Thrombospondin-type laminin G domain and EAR repeats	612920	REc, Fd	mutation identified in 1 DFNB98 family	?Deafness, autosomal recessive 98, 614861 (3)	
21.172	9	28	96	21q22.3	U2AF1		U2(RNU2) small nuclear RNA auxillary factor 1	191317	A, REa			
21.173	10	26	98	21q22.3	UBE2G2, UBC7		Ubiquitin-conjugating enzyme E2G 2	603124	Psh			
21.174	3	16	01	21q22.3	UBASH3A		Ubiquitin-associated and SH3 domain-containing protein A	605736	REc			
21.175	4	6	11	21q22.3	UMODL1		Uromodulin-like 1	613859	REc			
21.176	5	25	01	21q22.3	WDR4		WD repeat-containing protein 4	605924	REf			
21.177	5	5	99	21q22.2	WRB, CHD5		Tryptophan-rich basic protein	602915	REc, REn			
21.178	8	26	15	21q22.3	ZBTB21, ZNF295, KIAA1227		Zinc finger- and BTB domain-containing protein 21	616485	REc			
21.179	10	23	87	Chr.21	BAS		Beta-adrenergic stimulation, response to	109670	D			
21.180	10	23	87	Chr.21	HTOR		5-hydroxytryptamine oxygenase regulator	143460	D			
21.181	4	26	17	21q22.3	YBEY, C21orf57		YBEY metallopeptidase	617461	REc			
22.1	4	26	90	22p12	RNR5		Ribosomal RNA-5	180454	A			
22.2	8	20	92	22q11.1	ZNF72		Zinc finger protein-72 (Cos8)	194546	REa			
22.3	8	20	92	22p11.2	ZNF73		Zinc finger protein-73 (Cos12)	194547	REa			
22.4	3	13	07	22q12.2	UCRC		Ubiquinol-cytochrome C reductase complex, 7.2kD subunit	610843	R, REc			
22.5	10	20	99	22q13.1	RPL3		Ribosomal protein L3	604163	REa, R			
22.6	10	30	03	22q11	ACF		Asymmetric crying facies (Cayler cardiofacial syndrome)	125520	Fd		Cayler cardiofacial syndrome (2)	
22.7	11	27	94	22q12.1	ADRBK2, BARK2, GRK3		Adrenergic, beta, receptor kinase-2	109636	A			
22.8	6	29	99	22q11.21	ARVCF		Armadillo repeat gene deleted in VCFS	602269	A, REc	?role in VCFS		
22.9	10	23	87	22q11	CECR, CES		Cat eye syndrome	115470	Ch, A, D	partial tetrasomy of 22q11	Cat eye syndrome (4)	
22.10	10	26	98	22q11.21	CRKL		v-crk avian sarcoma virus CT10 oncogene homolog-like	602007	A			
22.11	8	24	98	22q11.21	DGCR6		DiGeorge syndrome critical region 6	601279	REn			
22.12	12	2	08	22q11.21	DGCR6L		DiGeorge syndrome critical region gene 6-like	609459	REc, REn			
22.13	8	15	96	22q11.21	DVL, DVL1		Dishevelled, Drosophila, homolog-like	601225	Ch, REc			
22.14	3	1	12	22q11.21	HCF2, HC2, SERPIND1, THPH10		Heparin cofactor II	142360	REb, REa	proximal to BCR	Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	
22.15	8	24	98	22q11.21	HIRA, TUPLE1		Histone cell cycle regulation defective, S. cerevisiae, homolog of, A (Tup-like enhancer of split 1)	600237	A	?role in CATCH22		16(Tuple1)
22.16	4	5	05	22q13.2	NAGA		Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170	S, Ch	proximal to Ph1 break	Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3); Schindler disease, type III, 609241 (3)	
22.17	9	16	03	22q11.21	P2RXL1, P2XM, P2X6		Purinergic receptor P2X-like 1	608077	A			
22.18	5	31	05	22q11.21	RTN4R, NOGOR		NOGO receptor (reticulon 4 receptor)	605566	REc		{Schizophrenia, susceptibility to}, 181500 (3)	
22.19	3	15	11	22q11.21	SCARF2, SREC2, VDEGS		Scavenger receptor class F, member 2	613619	REc		Van den Ende-Gupta syndrome, 600920 (3)	16(Scarf2)
22.20	5	6	13	22q11.21	SLC25A1, SLC20A3, CTP, D2L2AD		Solute carrier family 25 (mitochondrial citrate transporter), member 1	190315	REc, Psh, A		Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	
22.21	2	2	18	22q11.23	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	Ch, REc		Rhabdoid tumors, somatic, 609322 (3); {Rhabdoid tumor predisposition syndrome 1}, 609322 (3); Coffin-Siris syndrome 3, 614608 (3); {Schwannomatosis-1, susceptibility to}, 162091 (3)	
22.22	6	29	99	22q11.22	TOP3B		Topoisomerase, DNA, III, beta	603582	REc			
22.23	7	26	17	22q11.21	TUBA8, TUBAL2, CDCBM8		Tubulin, alpha 8	605742	R		Cortical dysplasia, complex, with other brain malformations 8, 613180 (3)	
22.24	2	1	01	22q11.23	VPREB3		Pre-B-lymphocyte gene 3	605017	A			10(Vpreb3)
22.25	11	21	03	22q12.1	HSC20, HSCB, JAC1		HSC20, E. coli, homolog of	608142	REc			
22.26	2	9	92	22q11-q12	LRE1, L1.2		Line-1.2 retrotransposable element	151626	REa, A			
22.27	9	17	09	22q13.2	XRCC6, G22P1, TLAA, Ku70		X-ray repair, complementing defecting, in chinese hamster, 6	152690	REa, F	tight linkage to CYP2D		15(Ku70)
22.28	6	7	10	22q11.1	POTEH, POTE22, ACTBL1		POTE ankyrin domain family, member H	608913	REc, A			
22.29	12	17	07	22q11.1	XKR3, XTES, XRG3		X Kell blood group precursor-related family, member 3	611674	REc			
22.30	9	24	15	22q11.21	LZTR1, SWNTS2, NS10		Leucine-zipper-like regulator-1	600574	RE		{Schwannomatosis-2, susceptibility to}, 615670 (3); Noonan syndrome 10, 616564 (3)	
22.31	12	7	98	22q11.21	GGT2		Gamma-glutamyltransferase-2	137181	REn		[Gamma-glutamyltransferase, familial high serum] (2)	
22.32	8	28	97	22q11.23	ADORA2A		Adenosine A2a receptor	102776	REa, REl, Psh, A	incorrectly assigned to 11q		
22.33	3	27	17	22q11.21	ATP6V1E1, ATP6E, ARCL2C		ATPase, H+ transporting, V1 subunit E1	108746	REa, REc		Cutis laxa, autosomal recessive, type IIC, 617402 (3)	6(Atp6e)
22.34	12	3	98	22q11.21	BID		BH3-interacting domain death agonist	601997	Psh, D			6(Bid)
22.35	4	14	10	22q11.23	CABIN1, CAIN		Calcineurin-binding protein 1	604251	REc			
22.36	11	16	08	22q11.2	DEL22q11.2, C22DELq11.2		Chromosome 22q11.2 deletion syndrome, distal	611867	Ch		Chromosome 22q11.2 deletion syndrome, distal (4)	
22.37	1	20	09	22q11.2	DUP22q11.2		Chromosome 22q11.2 microduplication syndrome	608363	Ch	contiguous gene microduplication syndrome	Chromosome 22q11.2 microduplication syndrome (4)	
22.38	1	20	11	22q11.2	DER22t8-22		Supernumerary der(22)t(8;22) syndrome	613700	Ch		Supernumerary der(22)t(8-22) syndrome (4)	
22.39	1	20	11	22q11.2	DER22t11-22		Emanuel syndrome (supernumerary der(22)t(11;22) syndrome)	609029	Ch		Emanuel syndrome (4)	
22.40	8	10	16	22q11.21	CDC45L, CDC45L2, MGORS7		Cell division cycle 45, S. Cerevisiae, homolog-like	603465	D, A, REc		Meier-Gorlin syndrome 7, 617063 (3)	
22.41	8	14	14	22q11.1	CECR1, PAN, SNEDS		Cat eye syndrome chromosome region, candidate 1	607575	REc	mutation identified in 1 SNEDS family	Polyarteritis nodosa, childhood-onset, 615688 (3); ?Sneddon syndrome, 182410 (3)	
22.42	2	26	03	22q11.1-q11.2	CECR2, KIAA1740		Cat eye syndrome chromosome region, candidate 2	607576	REc			6(Cecr2)
22.43	2	3	99	22q11.21	CLDN5, TMVCF, AWAL		Claudin-5 (transmembrane protein deleted in velocardiofacial syndrome)	602101	REc			16(Tmvcf)
22.44	12	19	05	22q11.21	COMT		Catechol-O-methyltransferase	116790	S, D, A, REn		{Schizophrenia, susceptibility to}, 181500 (3); {Panic disorder, susceptibility to}, 167870 (3)	16(Comt)
22.45	5	12	99	22q11.21	CLTCL1, CLTD		Clathrin, heavy polypeptide-like 1	601273	RE			11(Cltd)
22.46	8	3	99	22q11.23	DDT		D-dopachrome tautomerase	602750	Fd, A			10(Ddt)
22.47	2	18	98	22q11.21	DGCR2, IDD		DiGeorge critical region gene 2 (integral membrane protein deleted in DiGeorge syndrome)	600594	Ch			16(Idd)
22.48	6	28	18	22q11.21	DGCR5, LINC00037		Digeorge syndrome critical region gene 5	618040	REc			
22.49	5	2	07	22q11.21	DGCR8		DiGeorge syndrome critical region gene 8	609030	REc, Ch			16(Dgcr8)
22.50	9	27	17	22q11.21	ESS2, DGSI, DGCR14		Ess2 splicing factor, Xenopus, homolog of	601755	REc			16(Dgsi)
22.51	8	25	09	22q12.2	EIF4ENIF1		Eukaryotic translation initiation factor 4E nuclear import factor 1	607445	R, REc			
22.52	6	18	18	22q11.23	GGT1, GGT, GGTD		Gamma-glutamyltransferase 1	612346	REc	mutation identified in 1 GGTD family	?Glutathioninuria, 231950 (3)	
22.53	10	9	08	22q11.23	GGT5		Gamma-glutamyltransferase 5	137168	REc			
22.54	10	9	08	22q11.22	GGTLC2, GGTL4		Gamma-glutamyltransferase, light chain 2	612339	REc			
22.55	10	9	08	22q11.21	GGTLC3		Gamma-glutamyltransferase, light chain 3	612340	REc			
22.56	9	13	92	22q11.22-q11.23	GNAZ		Guanine nucleotide-binding protein (G protein), alpha z polypeptide	139160	REa, A			10(Gnaz)
22.57	2	21	07	22q11.21	GNB1L, WDR14		Guanine nucleotide-binding protein, beta-1-like	610778	REc			16(Gnb1l)
22.58	9	21	11	22q11.21	GP1BB, BS, BDPLT1		Glycoprotein Ib, platelet, beta polypeptide	138720	REa, D		Bernard-Soulier syndrome, type B, 231200 (3); Giant platelet disorder, isolated, 231200 (3)	16(Gp1bb)
22.59	5	4	00	22q11.2	GSTT1		Glutathione S-transferase, theta-1	600436	A			
22.60	3	27	95	22q11.23	GSTT2		Glutathione S-transferase theta-2	600437	REa, A			
22.61	5	7	03	22q11.21	HIC2, HRG22, KIAA1020		Hypermethylated in cancer 2	607712	REc			
22.62	4	15	08	22q11.2	IGLV@		Immunoglobulin lambda light chain variable gene cluster	147240	REa, A	many genes		
22.63	4	15	08	22q11.2	IGLJ@		Immunoglobulin lambda light chain joining gene cluster	147230	REa, A	nine J-C duplexes		
22.64	12	7	98	22q11.22	IGLC1, IGLC		Constant region of lambda light chains	147220	REa, A	several genes		16(Igl1)
22.65	9	13	99	22q11.22	MAPK1, PRKM1, ERK2		Mitogen-activated protein kinase 1	176948	REa, A, H			16(Prkm1)
22.66	1	27	11	22q11.21	MED15, PCQAP, TIG1, ARC105		Mediator complex subunit 15	607372	Ch			16(Pcqap)
22.67	3	30	04	22q11.23	MIF		Macrophage migration inhibitory factor	153620	REa, A	previously assigned to chr.19	{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	10(Mif)
22.68	7	13	94	22q11.23	MMP11, STMY3		Matrix metalloproteinase 11 (stromelysin 3)	185261	REa, A			
22.69	6	13	18	22q12.3	MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS		Myosin, heavy polypeptide-9, nonmuscle	160775	REa, A		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3); Deafness, autosomal dominant 17, 603622 (3)	
22.70	5	24	13	22q11.23	PIWIL3		PIWI-like 3	610314	REc			
22.71	5	31	05	22q11.21	PRODH, PRODH2, SCZD4		Proline dehydrogenase (proline oxidase)	606810	D, A		Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility to, 4}, 600850 (3)	
22.72	2	20	01	22q11.23	RAB36		Ras family, member 36	605662	REc			
22.73	9	2	08	22q11.23	RGL4, RGR		Ral guanine nucleotide dissociation stimulator-like 4	612214	REc			
22.74	3	30	16	22q11.22-q11.23	RSPH14, RTDR1		Radial spoke head 14, Chlamydomonas, homolog of	605663	REc			
22.75	2	28	03	22q11.21	SDF2L1		Stromal cell-derived factor 2-like 1	607551	REc			
22.76	11	1	05	22q11.21	SEPT5, PNUTL1, CDCREL		Septin 5	602724	REn, Ch	just 5' of GP1BB		
22.77	8	19	13	22q11.23	SLC2A11, GLUT11		Solute carrier family 2 (facilitated glucose transporter), member 11	610367	REc			
22.78	5	12	99	22q11.21	SLC7A4, CAT4		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 4	603752	A, REc			
22.79	4	7	05	22q11.21	SLC25A18, GC2		Solute carrier family 25 (mitochondrial carrier, glutamate), member 18	609303	REc			
22.80	9	19	05	22q11.21	SNAP29, CEDNIK		Synaptosomal-associated protein, 29kD	604202	R, REc		Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	
22.81	3	25	16	22q11.21	TANGO2, C22orf25, MECRCN		Transport and golgi organization 2, Drosophila, homolog of	616830	REc		Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	
22.82	4	21	97	22q11.21	UFD1L		Ubiquitin fusion degradation 1-like	601754	REc, D, A	?role in CATCH22		
22.83	2	8	13	22q11.21	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR		T-box 1	602054	REa, D, Ch		Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome, 188400 (3); Velocardiofacial syndrome, 192430 (3); Tetralogy of Fallot, 187500 (3)	16(Tbx1)
22.84	12	22	17	22q11.21	TXNRD2, TRXR2, SELZ, GCCD5		Thioredoxin reductase 2	606448	REc	mutation identified in 1 GCCD5 family	?Glucocorticoid deficiency 5, 617825 (3)	16(Txnrd2)
22.85	12	21	09	22q11.23	UPB1, BUP1		Beta-ureidopropionase	606673	A		Beta-ureidopropionase deficiency, 613161 (3)	
22.86	3	27	17	22q11.21	USP18, UBP43, ISG43, PTORCH2		Ubiquitin-specific protease 18	607057	A		Pseudo-TORCH syndrome 2, 617397 (3)	6(Usp18)
22.87	12	13	00	22q11.22	VPREB1, IGI, VPREB		Pre-B lymphocyte gene 1	605141	REa			
22.88	9	16	03	22q11.21-q11.22	YPEL1		Yippee-like 1	608082	A, REc	pseudogene on 9p24.3		16(Ypel1)
22.89	8	20	92	22q11.23	ZNF70		Zinc finger protein-70 (Cos17)	194544	REa			
22.90	8	20	92	22q11.21	ZNF74		Zinc finger protein-74 (Cos52)	194548	REa			
22.91	8	6	13	22q12.1	CRYBB1, CATCN3, CTRCT17		Crystallin, beta B1	600929	REc		Cataract 17, multiple types, 611544 (3)	5(Crybb1)
22.92	5	3	13	22q11.23	CRYBB2, CRYB2, CTRCT3, CCA2		Crystallin, beta-B2	123620	REa, A	2nd CRYB2 gene in same region	Cataract 3, multiple types, 601547 (3)	5(Crybb2)
22.93	12	27	16	22q11.23	CRYBB3, CRYB3, CATCN2, CTRCT22		Crystallin, beta-B3	123630	RE		Cataract 22, 609741 (3)	5(Crybb3)
22.94	2	11	02	22q12.1	HPS4		HPS gene 4	606682	REc		Hermansky-Pudlak syndrome 4, 614073 (3)	5(le)
22.95	2	9	92	22q12.3	IL2RB		Interleukin-2 receptor, beta polypeptide	146710	REa, A, Fd, H			15(Il2rb)
22.96	10	23	87	22q12.3	MB		Myoglobin	160000	REa, Fd			
22.97	7	22	13	22q12.1	CRYBA4, CTRCT23		Crystallin, beta polypeptide A4	123631	REa, Fd		Cataract 23, 610425 (3)	
22.98	2	7	01	22q11.21	UBE2L3, UBCH7		Ubiquitin-conjugating enzyme E2L 3	603721	REa, A	pseudogenes on 12q12 and 19q13.1-q13.2		
22.99	8	25	09	22q12.2	INPP5J, PIB5PA, PIPP		Inositol polyphosphate-5-phosphatase J	606481	R, REc			
22.100	12	18	07	22q12.2	PLA2G3, SPLA2III		Phospholipase A2, group III	611651	REc			
22.101	6	29	99	22q12.3	MPST		Mercaptopyruvate sulfurtransferase	602496	REc			
22.102	7	8	10	22q12.2	TCN2, TC2		Transcobalamin II	613441	F, S, D	linked to P1	Transcobalamin II deficiency, 275350 (3)	11(Tcn2)
22.103	6	29	99	22q12.3	TST, RDS		Thiosulfate sulfurtransferase (Rhodanese)	180370	REc			
22.104	1	11	17	22q11.21	AIFM3, AIFL		Apoptosis-inducing factor, mitochondria-associated, 3	617298	REc			
22.105	8	27	15	22q11.23	BCR, CML, PHL, ALL		Breakpoint cluster region	151410	Ch, RE	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	Leukemia, chronic myeloid, somatic, 608232 (3); Leukemia, acute lymphocytic, somatic, 613065 (3)	10(Bcr)
22.106	5	24	13	22q11.21	GSC2, GSCL		Goosecoid homeobox 2	601845	REc			
22.107	8	10	10	22q11.23	IGLL1, IGO, IGL5, VPREB2, AGM2		Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide)	146770	REa, Ch	between BCR2 and BCR4; distal to IGLC	Agammaglobulinemia 2, 613500 (3)	
22.108	6	22	18	22q11.21	KLHL22		Kelch-like 22	618020	REc			
22.109	10	28	08	22q11.21	MICAL3, KIAA1364		Microtubule-associated monooxygenase, calponin and LIM domains-containing 3	608882	R, REc			
22.110	12	27	13	22q11.21	MIR185		Micro RNA 185	615576	REc	within first intron of C22orf25		
22.111	2	5	15	22q11.21	MIR648		Micro RNA 648	616205	REc	in intron 1 of MICAL3		
22.112	8	3	12	22q11.21	MRPL40, NLVCF, MRPL22		Mitochondrial ribosomal protein L40	605089	REc			16(Nlvcf)
22.113	10	25	12	22q11.21	PEX26, PBD7A, PBD7B		Peroxisome biogenesis factor 26	608666	REc		Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3); Peroxisome biogenesis disorder 7B, 614873 (3)	
22.114	9	2	15	22q11.21	PI4KA, PIK4CA, PMGYCHA		Phosphatidylinositol 4-kinase, catalytic, alpha	600286	REc		Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	
22.115	2	28	03	22q11.21	PPIL2, CYP60		Peptidyl-prolyl isomerase-like 2	607588	R			
22.116	8	8	13	22q11.21	RANBP1, HTF9A		RAN-binding protein 1	601180	REc			
22.117	4	1	09	22q11.21	RIMBP3, RIMBP3A, KIAA1666		RIMS-binding protein 3	612699	REc, H			16(Rimbp3)
22.118	4	1	09	22q11.21	RIMBP3B		RIMS-binding protein 3B	612700	REc, H			16(Rimbp3)
22.119	4	1	09	22q11.21	RIMBP3C		RIMS-binding protein 3C	612701	REc, H			16(Rimbp3)
22.120	4	23	09	22q11.21	TRMT2A, HTF9C		tRNA methyltransferase 2, S. cerevisiae, homolog of, A	611151	REc			
22.121	1	22	07	22q11.21	TSSK2, STK22B		Testis-specific serine/threonine kinase 2	610710	REc			16(Tssk2)
22.122	3	22	06	22q11.21	ZDHHC8, ZNF378, KIAA1292		Zinc finger DHHC domain-containing protein 8	608784	R, REc			
22.123	1	21	11	22q11.21	MIR130B, MIRN130B		Micro RNA 130B	613682	REc			
22.124	11	21	03	22q11.21-q12.1	DFNB40		Deafness, autosomal recessive 40	608264	Fd		Deafness, autosomal recessive 40 (2)	
22.125	9	9	13	22q11.22	MIR650		Micro RNA 650	615379	REc			
22.126	8	25	09	22q11.22	PRAME, MAPE, OIP4		Preferentially expressed antigen in melanoma	606021	R, REc			
22.127	12	19	16	22q11.1	IL17RA, IL17R, IMD51		Interleukin 17 receptor A	605461	R		Immunodeficiency 51, 613953 (3)	6(Il17r)
22.128	2	5	15	22q11.23	CHCHD10, FTDALS2, SMAJ, IMMD		Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903	REc	mutation identified in 1 IMMD family	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3); ?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3); Spinal muscular atrophy, Jokela type, 615048 (3)	
22.129	5	24	13	22q11.23	DERL3		DER1-like domain family, member 3	610305	REc, R			
22.130	9	28	17	22q11.23	SNRPD3		Small nuclear ribonucleoprotein polypeptide D3	601062	REc			
22.131	3	16	15	22q11.23	SPECC1L, KIAA0376, OBLFC1, GBBB2		Sperm antigen with calponin homology and coiled-coil domains 1-like	614140	R, REc	mutation identified in 1 OBLFC1 patient	?Facial clefting, oblique, 1, 600251 (3); Opitz GBBB syndrome, type II, 145410 (3)	
22.132	7	18	14	22q11.23	SUSD2		Sushi domain-containing protein 2	615825	REc			
22.133	9	18	00	22q12.2	AP1B1, ADTB1, BAM22, CLAPB2		Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta)	600157	D			
22.134	11	23	09	22q12	BRV2		Vertigo, benign recurrent, 2	613106	Fd		Vertigo, benign recurrent, 2 (2)	
22.135	9	2	08	22q12.2	EWSR1, EWS		Ewing sarcoma breakpoint region-1	133450	Ch	t(11;22)(q24;q12); t(21;22)(q22;q12)	Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)	
22.136	7	11	07	22q12.2	GAS2L1, GAR22		Growth arrest-specific 2 like 1	602128	REc			
22.137	1	28	13	22q12.3	HMOX1, HMOX1D		Heme oxygenase 1	141250	Psh, A		Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	
22.138	2	14	13	22q12	KAZA1		Kala-azar (visceral leishmaniasis), susceptibility to, 1	608207	Fd		{Kala-azar, susceptibility to, 1} (2)	
22.139	6	16	99	22q13.1	MFNG		Manic fringe	602577	REa, R, A			15(Mfng)
22.140	6	29	99	22q12.2	MTMR3		Myotubularin-related protein 3	603558	R, Psh, A, REc			
22.141	11	5	98	22q12.2	NIPSNAP1		4-nitrophenylphosphatase domain and nonneuronal SNAP25-like 1	603249	REn			
22.142	5	7	03	22q12.2	OSBP2, ORP4, KIAA1664		Oxysterol-binding protein 2	606729	REc			
22.143	5	19	09	22q12.2	PISD, PSD, PSSC		Phosphatidylserine decarboxylase	612770	REc			
22.144	8	18	08	22q12.2	RASL10A, RRP22		Ras-like, family 10, member A	602220	REc			
22.145	7	16	09	22q12.2	SEC14L3, TAP2		Sec14-like 3	612824	REc			
22.146	7	16	09	22q12.2	SEC14L4, TAP3		Sec14-like 4	612825	REc			
22.147	5	9	07	22q12	SQTL2		Smoking as a quantitative trait locus 2	611004	Fd	max lod at D22S315	{Smoking as a quantitative trait locus 2} (2)	
22.148	5	5	09	22q12.2	THOC5, FMIP		THO complex 5	612733	REc, REn			
22.149	10	30	08	22q12.1	XBP1, XBP2		X-box-binding protein-1	194355	REa	pseudogene on chr.5	{Major affective disorder-7, susceptibility to}, 612371 (3)	
22.150	9	28	96	22q12.3	YWHAH, YWHA1		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22	113508	REb, A			
22.151	4	4	05	22q12.2	ZNF278, PATZ, MAZR		Zinc finger protein-278	605165	REc, R			
22.152	5	8	03	22q13.1	CBY, C22orf2, HS508I15A		Chibby	607757	R			
22.153	6	22	05	22q12-q13	CDAGS		Craniosynostosis, anal anomalies, and porokeratosis syndrome	603116	Fd		CDAGS syndrome (2)	
22.154	10	22	95	22q13.1	CSNK1E		Casein kinase-1, epsilon	600863	A			
22.155	3	31	09	22q12.3	FBXO7, FBX7, FBX, PKPS, PARK15		F-box only protein 7	605648	REc		Parkinson disease 15, autosomal recessive, 260300 (3)	10(Fbxo7)
22.156	2	28	03	22q13.1	GCAT, KBL		Glycine C-acetyltransferase	607422	REc			
22.157	3	15	10	22q12-q13	HCHGQ3		Hematocrit/hemoglobin quantitative trait locus 3	613284	Fd	associated with rs855791	[Hematocrit/hemoglobin quantitative trait locus 3] (2)	
22.158	6	8	01	22q12.2	RFPL1		RET finger protein-like 1	605968	REc			
22.159	7	2	01	22q12.2	RFPL1S		Ret finger protein-like 1, antisense	605972	REc			
22.160	6	8	01	22q12.3	RFPL2		RET finger protein-like 2	605969	REc			
22.161	6	8	01	22q12.3	RFPL3		RET finger protein-like 3	605970	REc			
22.162	7	2	01	22q12.3	RFPL3S		Ret finger protein-like 3, antisense	605971	REc			
22.163	5	10	11	22q13.1	SUN2, UNC84B, KIAA0668		SAD1 and UNC84 domain-containing protein 2	613569	REc, R			
22.164	5	30	08	22q12.3	TMPRSS6, IRIDA		Transmembrane protease, serine 6 (matriptase 2)	609862	REn, Fd		Iron-refractory iron deficiency anemia, 206200 (3)	
22.165	6	19	02	22q13.1	TOMM22, TOM22		Translocase of outer mitochondrial membrane 22, yeast, homolog of	607046	REc			
22.166	1	2	03	22q13.1	GTPBP1, GP1		GTP-binding protein 1	602245	R, REc			15(Gtpbp1)
22.167	4	25	93	22q13.1	LGALS1		Lectin, galactose-binding, soluble, 1	150570	A			15(Lgals1)
22.168	3	15	05	22q13.31	PPARA, PPAR		Peroxisome proliferator-activated receptor-alpha	170998	REa, Fd		{Hyperapobetalipoproteinemia, susceptibility to} (3)	
22.169	3	18	91	22q12.3	PVALB		Parvalbumin	168890	REa, D, H	?role in DiGeorge syndrome		15(Pva)
22.170	11	2	04	22q13.1	APOBEC3F		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3F	608993	REc, A			
22.171	5	22	03	22q13.1	APOBEC3G, MDS019, CEM15, FLJ12740		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G	607113	A, REc			
22.172	2	1	01	22q13.1	GRAP2, GRID		GRB2-related adaptor protein 2	604518	REc			
22.173	8	27	01	22q12.2	PES1, PES		Pescadillo, zebrafish, homolog of, 1	605819	REc			11(Pes1)
22.174	8	4	09	22q12.1	CHEK2, RAD53, CHK2, CDS1, LFS2		Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)	604373	REc		Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility to} (3)	
22.175	3	18	17	22q12.1	KREMEN1, KRM1, ECTD13		Kringle domain-containing transmembrane protein 1	609898	R, REc		Ectodermal dysplasia 13, hair/tooth type, 617392 (3)	
22.176	11	2	11	22q12.1	MIAT, C22orf35		MIAT gene	611082	REc		{Myocardial infarction, susceptibility to}, 608446 (3)	
22.177	9	21	15	22q12.1	MYO18B, KFS4		Myosin XVIIIB	607295	REc		Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	
22.178	8	25	09	22q12.1	PITPNB		Phosphatidylinositol transfer protein, beta	606876	R, REc			
22.179	9	30	02	22q12.1	SEZ6L		Seizure-related 6-like	607021	Ch, REc			
22.180	1	27	11	22q12.1	SRRD		SRR1 domain-containing protein	602254	REc			
22.181	5	11	09	22q12.1	TFIP11, TIP39, NTR1		Tuftelin-interacting protein 11	612747	REc			5(Tfip11)
22.182	10	14	98	22q12.1	TPST2		Tyrosylprotein phosphotransferase 2	603126	REc			
22.183	3	14	13	22q12.1	TTC28, TPRBK, KIAA1043		Tetratricopeptide repeat domain-containing protein 28	615098	REc			
22.184	6	10	08	22q12.1	ZNRF3, KIAA1133		Zinc finger and ring finger protein 3	612062	REc			
22.185	11	21	02	22q12.1-q12.2	ITS		Insulinoma tumor suppressor gene locus	606960	LOH		Insulinoma (1)	
22.186	9	28	93	22q12.2	LIF, HILDA		Leukemia inhibitory factor (cholinergic differentiation factor)	159540	REa, A, RE	distal to ES		11(Lif)
22.187	9	28	93	22q12.2	OSM		Oncostatin M	165095	REa, REn	10kb from LIF		
22.188	1	12	95	22q12.3	TIMP3, SFD		Tissue inhibitor of metalloproteinase-3	188826	REa, A, Fd		Sorsby fundus dystrophy, 136900 (3)	
22.189	3	3	03	22q12.2	SEC14L2, TAP, KIAA1186		Sec14-like 2	607558	R, REc			
22.190	4	25	06	22q12.2	TBC1D10A, EPI64		TBC1 domain family, member 10A	610020	REc			
22.191	9	8	11	22q12.2	ASCC2, p100		Activating signal cointegrator 1 complex, subunit 2	614216	REc			
22.192	2	7	07	22q12.2	GAL3ST1, CST		Galactose-3-O-sulfotransferase 1	602300	R, REc			
22.193	7	14	16	22q12.2	GATSL3, CASTOR1		GATS protein-like 3	617034	REc			
22.194	5	25	13	22q12.2	LIMK2		LIM domain kinase 2	601988	REc			
22.195	12	17	15	22q12.2	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z		MORC family CW-type zinc finger protein 2	616661	R, REc		Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	
22.196	5	24	13	22q12.2	MTFP1		Mitochondrial fission process 1	610235	REc			
22.197	4	27	16	22q12.2	NEFH, CMT2CC		Neurofilament, heavy polypeptide	162230	A, RE, D	mutation identified in 1 family with ALS susceptibility	?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	11(Nfh)
22.198	1	17	18	22q12.2	NF2		Merlin	607379	RE, F, Ch, D, Fd	loss of heterozygosity	Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related, somatic, 607174 (3); Schwannomatosis, somatic, 162091 (3)	11(Nf2)
22.199	8	25	09	22q12.2	SF3A1, SF3A120, SAP114, PRP21		Splicing factor 3A, subunit 1	605595	REa, REc			
22.200	5	12	09	22q12.2	SFI1, KIAA0542		SFI1, yeast, homolog of	612765	R, REc			
22.201	11	18	16	22q12.2	SELENOM, SELM, SEPM		Selenoprotein M	610918	REc			
22.202	1	15	13	22q12.2	TUG1		Taurine-upregulated gene 1, noncoding	614971	REc			
22.203	9	22	16	22q12.2-q12.3	DEPDC5, KIAA0645, FFEVF1		DEP domain-containing protein 5	614191	Psh, REc, Fd		Epilepsy, familial focal, with variable foci 1, 604364 (3)	
22.204	12	5	11	22q12.3	CSF2RB, SMDP5		Colony-stimulating factor-2 receptor, beta, low-affinity	138981	Psh, A		Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	
22.205	6	29	99	22q13.1	GALR3		Galanin receptor 3	603692	REc, A			
22.206	4	27	00	22q13.1	MAFF		v-MAF avian musculoaponeurotic fibrosarcoma oncogene family, protein F	604877	REc			
22.207	10	25	10	22q12.3	APOL1, FSGS4		Apolipoprotein L1	603743	R, REc		{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	
22.208	12	11	02	22q12.3	APOL2		Apolipoprotein L2	607252	R, REc		{Schizophrenia}, 181500 (1)	
22.209	12	11	02	22q12.3	APOL3		Apolipoprotein L3	607253	R, REc			
22.210	12	11	02	22q12.3	APOL4		Apolipoprotein L4	607254	R, REc		{Schizophrenia}, 181500 (1)	
22.211	12	11	02	22q12.3	APOL5		Apolipoprotein L5	607255	R, REc			
22.212	12	11	02	22q12.3	APOL6		Apolipoprotein L6	607256	R, REc			
22.213	12	10	12	22q12.3	C1QTNF6, CTFP6		C1q- and tumor necrosis factor-related protein 6	614910	REc			
22.214	3	24	11	22q12.3	FOXRED2, ERFAD		FAD-dependent oxidoreductase domain-containing protein 2	613777	REc			
22.215	2	29	08	22q12.3	HPC6		Prostate cancer, hereditary, 6	609558	Fd	between D22S1265 and D22S277	{Prostate cancer, susceptibility to}, 176807 (2)	
22.216	7	17	14	22q12.3	IFT27, RABL4, BBS19		Intraflagellar transport 27, Chlamydomonas, homolog of	615870	REc	mutation identified in 1 BBS19 family	?Bardet-Biedl syndrome 19, 615996 (3)	
22.217	6	2	08	22q12.3	ISX, RAXLX		Intestine-specific homeobox	612019	REc			
22.218	6	1	16	22q12.3	KCTD17		Potassium channel tetramerization domain-containing protein 17	616386	REc		Dystonia 26, myoclonic, 616398 (3)	
22.219	6	10	09	22q12.3	RASD2, RHES, TEM2		RASD family, member 2	612842	REc			
22.220	7	17	14	22q12.3	RTCB, C22orf28, HSPC117		RNA 2-prime, 3-prime cyclic phosphate and 5-prime-OH ligase	613901	REc			
22.221	5	28	99	22q12.2	SMTN		Smoothelin	602127	A, R			11(Smtn)
22.222	8	20	98	22q12.3	SYN3		Synapsin III	602705	REn	?relation to schizophrenia		
22.223	2	12	16	22q12.3	TXN2, TRX2, MTRX, COXPD29		Thioredoxin 2	609063	REc	mutation identified in 1 COXPD29 patient	?Combined oxidative phosphorylation deficiency 29, 616811 (3)	
22.224	9	30	09	22q13.1	CYTH4, PSCD4, CYT4		Cytohesin 4	606514	REc			
22.225	11	10	10	22q12.3	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6		Acetylglucosaminyltransferase-like protein	603590	D, REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	8(Large)
22.226	1	20	11	22q12.3-q13.1	MDNS		Mammary-digital-nail syndrome	613689	Fd	max lod at D22S277, D22S1142, D22S683, D22S283	Mammary-digital-nail syndrome (2)	
22.227	11	11	13	22q13.1	PDGFB, SIS, IBGC5		Platelet-derived growth factor, beta polypeptide (oncogene SIS)	190040	REa, Fd	fused with COL1A1 in DFSP	Meningioma, SIS-related, 607174 (3); Dermatofibrosarcoma protuberans, 607907 (3); Basal ganglia calcification, idiopathic, 5, 615483 (3)	15(Pdgfb)
22.228	3	22	06	22q13.1	PICK1, PRKCABP		Protein interacting with C kinase 1	605926	REc			
22.229	10	27	03	22q13.1	RAC2		Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP-binding protein Rac2)	602049	A		Neutrophil immunodeficiency syndrome, 608203 (3)	
22.230	2	25	15	22q13.1	SLC16A8, MCT3		Solute carrier family 16 (monocarboxylic acid transporter), member 8	610409	REc, R			
22.231	3	16	99	22q12.1	MN1, MGCR		Meningioma chromosome region	156100	Fd, Ch	fused with TEL in AML	Meningioma, 607174 (3)	
22.232	8	23	02	22q13.1	APOBEC3A, PHRBN		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (phorbolin 1)	607109	A, REc			
22.233	8	23	02	22q13.1	APOBEC3B, PHRBNL		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B	607110	A, REc			
22.234	5	22	03	22q13.1	APOBEC3C		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3C	607750	REn, A			
22.235	8	30	07	22q13.31	ATXN10, SCA10		Ataxin 10	611150	Fd	ATTCTn repeat in intron 9	Spinocerebellar ataxia 10, 603516 (3)	
22.236	6	1	12	22q12.3	BPIFC, BPIL2		BPI fold-containing protein, family C	614109	Psh, R, REc			
22.237	2	22	00	22q13.33	BRL		BR140-like gene	604589	A			
22.238	5	24	13	22q13.31	CERK, KIAA1646		Ceramide kinase	610307	REc			
22.239	7	22	11	22q13.33	CHKB, CHKL, CKEKB, EKB, MDCMC		Choline kinase, beta	612395	REc		Muscular dystrophy, congenital, megaconial type, 602541 (3)	
22.240	10	13	09	22q13.33	CPT1B		Carnitine palmitoyltransferase I, muscle	601987	A, REn			
22.241	11	20	13	22q13	DUP22q13, C22DUPq13		Chromosome 22q13 duplication syndrome	615538	Ch		Chromosome 22q13 duplication syndrome, 615538 (4)	
22.242	2	19	13	22q13.2	EP300, RSTS2		E1A-binding protein, 300kD	602700	A		Rubinstein-Taybi syndrome 2, 613684 (3); Colorectal cancer, somatic, 114500 (3)	
22.243	5	26	13	22q13.33	IL17REL		Interleukin 17 receptor E-like	613414	REc			
22.244	5	22	03	22q13.33	MAPK8IP2, JIP2, IB2		Mitogen-activated protein kinase 8-interacting protein 2	607755	REc			
22.245	3	26	07	22q13	MENAQ1		Menarche, age at, QTL 1	610873	Fd	max lod at UT7136	{Menarche, age at, QTL} (2)	
22.246	3	23	09	22q13.31	MIRLET7B, LET7B, MIRNLET7B		Micro RNA Let7B	611249	R, REn			
22.247	6	28	01	22q13.1-q13.2	MKL1, AMKL, MAL		Megakaryoblastic leukemia 1 gene	606078	Ch	fusion with RBM15	Megakaryoblastic leukemia, acute (3)	
22.248	6	7	10	22q13	NAFLD1		Fatty liver disease, nonalcoholic, susceptibility to, 1	613282	Fd	associated with rs738409	{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)	
22.249	12	4	08	22q13	NRCLP4		Narcolepsy 4	612417	Fd	associated with rs5770917	{Narcolepsy 4} (2)	
22.250	11	2	14	22q13.33	PANX2, PX2		Pannexin 2	608421	REc			
22.251	3	9	10	22q13.31	PNPLA3, ADPN		Patatin-like phospholipase domain-containing protein 3	609567	REc			
22.252	8	21	07	22q13.1	RNU86		RNA, U86 small nucleolar	611069	REc			
22.253	8	26	15	22q13.33	SCO2, CEMCOX1, MYP6		SCO2 cytochrome c oxidase assembly protein	604272	REc, Fd		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3); Myopia 6, 608908 (3)	
22.254	1	22	08	22q13.2	SCUBE1		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 1	611746	REc, H			15(Scube1)
22.255	3	26	02	22q13.2	SLC25A17, PMP34		Solute carrier family 25 (mitochondrial carrier), member 17 (peroxisomal membrane protein, 34kD)	606795	REc			
22.256	8	21	07	22q13.1	SNORD43, RNU43		Small nucleolar RNA, C/D box, 43	611068	REc			
22.257	8	21	07	22q13.1	SNORD83A, RNU83A		Small nucleolar RNA, C/D box, 83A	611070	REc			
22.258	8	21	07	22q13.1	SNORD83B, RNU83B		Small nucleolar RNA, C/D box, 83B	611071	REc			
22.259	3	16	10	22q13.1	SOX10, WS4, WS4C, PCWH		SRY (sex-determining region Y)-box-10	602229	REn	megacolon and spotting in mice	Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)	15(Sox10, Dom)
22.260	1	10	96	22q13.2	SREBF2		Sterol regulatory element binding transcription factor 2	600481	REa, A			
22.261	3	3	03	22q13.2	ST13, P48, HOP		Suppression of tumorigenicity 13	606796	A			
22.262	2	7	01	22q13.1	SYNGR1		Synaptogyrin 1	603925	REc			
22.263	11	17	94	22q13.2	TEF		Thyrotroph embryonic factor	188595	A			15(Tef)
22.264	10	28	11	22q13.31	TRMU, MTO2		tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase	610230	REc		{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure, transient infantile, 613070 (3)	15(Trmu)
22.265	6	9	98	22q13.31	WNT7B		Wingless-type MMTV integration site family, member-7B	601967	A			
22.266	11	8	03	22q13.1	ADSL		Adenylosuccinate lyase	608222	S, REa, A	ade(-)I; bifunctional	Adenylosuccinase deficiency, 103050 (3)	15(Adsl)
22.267	4	29	10	22q13.1	ANKRD54, LIAR		Ankyrin repeat domain-containing protein 54	613383	REc, H			15(Ankrd54)
22.268	5	22	07	22q13.1	APOBEC3H, ARP10		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H	610976	REc, REn			
22.269	2	10	09	22q13.1	ATF4, CREB2, TAXREB67		Activating transcription factor 4	604064	R, REc			
22.270	6	20	17	22q13.1	BAIAP2L2, PINKBAR		Bai1-associated protein 2-like 2	617536	REc			
22.271	3	22	07	22q13.1	CACNA1I, KIAA1120		Calcium channel, voltage-dependent, T type, alpha-1I subunit	608230	REc			
22.272	3	8	17	22q12.3	CACNG2, MRD10		Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)	602911	REc	mutation identified one MRD10 patient	?Mental retardation, autosomal dominant 10, 614256 (3)	15(Cacng2)
22.273	8	25	09	22q13.1	CARD10, CARMA3, BIMP1		Caspase recruitment domain-containing protein 10	607209	R, REc			
22.274	4	20	17	22q13.1	CBX6		Chromobox homolog 6	617438	REc			
22.275	2	16	04	22q13.1	CBX7		Chromobox homolog 7	608457	R, REc			
22.276	8	25	09	22q13.1	CDC42EP1, MSE55, BORG5, CEP1		CDC42 effector protein 1	606084	R, REc			
22.277	1	20	09	22q13.2	CYP2D6, CPD6, P450DB1		Cytochrome P450, subfamily IID, polypeptide 6	124030	F, Fd, Psh, A		{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902 (3)	15(Cyp2d)
22.278	11	11	14	22q13.1	DMC1, LIM15		Disrupted meiotic cDNA 1, yeast, homolog of	602721	REc			
22.279	11	3	14	22q13.1	DNAL4, MRMV3		Dynein, axonemal, light chain 4	610565	REc	mutation identified in 1 MRMV3 family	?Mirror movements 3, 616059 (3)	15(Dnal4)
22.280	2	19	04	22q13.1	DDX17, RH70, P72		DEAD/H box-17	608469	R, REc			
22.281	10	3	07	22q12.3	EIF3D, EIF3S7		Eukaryotic translation initiation factor 3, subunit D	603915	REc			
22.282	8	25	98	22q13.1	H1F0, H1FV		H1 histone family, member 0	142708	Psh, A			
22.283	5	18	95	22q13.1	KCNJ4, HIR		Potassium inwardly-rectifying channel, subfamily J, member 4	600504	Psh, A			
22.284	2	21	03	22q12.3	HMGXB4, HMG2L1		HMG box domain-containing 4	604702	REc			
22.285	7	23	13	22q13.1	JOSD1, KIAA0063		Josephin domain-containing protein 1	615323	REc, Psh			
22.286	4	18	05	22q13.1	LGALS2		Lectin, galactoside-binding, soluble, 2	150571	A, REc		{Myocardial infarction, susceptibility to}, 608446 (3)	
22.287	7	11	17	22q12.3	MCM5, CDC46, MGORS8		Minichromosome maintenance, S. cerevisiae, homolog of, 5	602696	A	mutation identified in 1 MGORS8 patient	?Meier-Gorlin syndrome 8, 617564 (3)	
22.288	12	10	13	22q13.1	MEIF1, SMCR7L, MID51		Mitochondrial elongation factor 1	615497	REc			
22.289	3	9	00	22q13.1	MGAT3, GNT3		Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase	604621	A			
22.290	8	27	15	22q13.1	MIR659		Micro RNA 659	613556	REc			
22.291	5	27	16	22q12.3	NCF4, P40PHOX, CGD3		Neutrophil cytosolic factor-4	601488	Psh, A	mutation identified in 1 CGD3 patient	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	
22.292	10	14	18	22q13.2	NDUFA6		NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6	602138	R		Mitochondrial complex I deficiency, 252010 (3)	
22.293	3	9	10	22q13.1	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14		Phospholipase A2, group VI	603604	REc, Fd		Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration with brain iron accumulation 2B, 610217 (3); Parkinson disease 14, autosomal recessive, 612953 (3)	
22.294	5	19	97	22q13.2	PMM1		Phosphomannomutase 1	601786	REa, A			
22.295	2	7	01	22q13.1	POLR2F		Polymerase II, RNA, subunit F	604414	REc			
22.296	7	18	16	22q12.3	RBFOX2, RBM9, FOX2, RTA		RNA binding protein, fox-1 homolog 2	612149	R, REc			
22.297	6	30	06	22q13.1	RPS19BP1, S19BP, MGC52010		Ribosomal protein S19 binding protein 1	610225	REc, H			15(Rps19bp1)
22.298	5	24	13	22q13.1	SGSM3, RUTBC3, MAP, RUSC3		Small G protein signaling modulator 3	610440	R, REc			
22.299	2	24	17	22q13.1	SH3BP1, ARHGAP43, BGIN		SH3 domain-binding protein 1	617368	REc			
22.300	4	16	02	22q12.3	SLC5A1, SGLT1		Solute carrier family 5 (sodium/glucose transporter), member 1	182380	REa		Glucose/galactose malabsorption, 606824 (3)	
22.301	4	25	93	22q13.1	SSTR3		Somatostatin receptor-3	182453	REa			15(Sstr3)
22.302	1	11	16	22q13.1	TAB1, MAP3K7IP1		Tak1 (MAP3K7) binding protein 1	602615	R, REc			
22.303	1	31	07	22q13.1	TNRC6B, KIAA1093		Trinucleotide repeat-containing gene 6B	610740	R, REc			
22.304	11	19	13	22q12.3	TOM1		Target of MYB1, chicken, homolog of	604700	REn			8(Tom1)
22.305	1	11	06	22q13.1	TRIOBP, KIAA1662		Trio- and F-actin-binding protein	609761	REc, Fd		Deafness, autosomal recessive 28, 609823 (3)	
22.306	3	15	07	22q13.2	TTLL1, KIAA0173		tubulin tyrosine ligase-like protein 1	608955	REc			
22.307	12	15	10	22q13.2	TNFRSF13C, BAFFR, CVID4		Tumor necrosis factor receptor superfamily, member 13C	606269	REc		Immunodeficiency, common variable, 4, 613494 (3)	15(Baffr)
22.308	12	4	02	22q13.2	TOB2, KIAA1663		Transducer of erbb2, 2	607396	A			
22.309	2	8	13	22q13.2	A4GALT, P1PK		Alpha 1,4-galactosyltransferase	607922	REc		[Blood group, P1Pk system, p phenotype], 111400 (3); [Blood group, P1Pk system, P(2) phenotype], 111400 (3); NOR polyagglutination syndrome, 111400 (3)	
22.310	11	10	15	22q13.2	ACO2, ICRD, OPA9		Aconitase, mitochondrial	100850	S, Ch, REc	distal to Ph1 break; mutation identified in 1 OPA9 family	Infantile cerebellar-retinal degeneration, 614559 (3); ?Optic atrophy 9, 616289 (3)	
22.311	12	4	08	22q13.2	ARFGAP3		ADP-ribosylation factor GTPase-activating protein 3	612439	R, REc			
22.312	2	25	15	22q13.2	CHADL		Chondroadherin-like	616236	REc			
22.313	9	22	17	22q13.2	CSDC2, PIPPIN		Cold-shock domain-containing protein C2	617689	REc			
22.314	7	20	12	22q13.2	DESI1, PPPDE2		Desumoylating isopeptidase 1	614637	REc			
22.315	3	23	14	22q13.2	DNAJB7, DJ5, HSC3		DNAJ/HSP40 homolog, subfamily B, member 7	611336	REc			
22.316	9	30	11	22q13.2	FAM109B, SES2, IPIP27B		Family with sequence similarity 109, member B	614240	REc			
22.317	3	23	09	22q13.2	MIR33A, MIRN33A		Micro RNA 33A	612156	REc			
22.318	1	29	07	22q13.2	NFAM1, CNAIP		NFAT activating protein with ITAM motif 1	608740	REc			
22.319	2	1	11	22q13.2	NHP2L1		Non-histone chromosome protein 2, S. cerevisiae, like 1	601304	REc	previously assigned to 12q24.3 by FISH		
22.320	12	10	13	22q13.2	PACSIN2		Protein kinase C and casein kinase substrate in neurons 2	604960	REc			
22.321	1	24	18	22q13.2	PHF5A, SF3B7, SF3B14B		PHD finger protein 5A	617846	REc, H			15(Phf5a)
22.322	10	13	09	22q13.2	POLDIP3, SKAR, PDIP46		Polymerase delta-interacting protein 3	611520	R, REc			
22.323	9	27	17	22q13.2	RANGAP1		GTPase-activating protein, RAN, 1	602362	REc			
22.324	3	30	12	22q13.2	RBX1, ROC1		RING-box 1	603814	REc			
22.325	12	7	03	22q13.2	SEPT3, SEP3		Septin 3	608314	REc			
22.326	9	9	13	22q13.2	SERHL		Serine hydrolase-like	607979	REc			
22.327	2	2	17	22q13.2	SHISA8		Shisa family, member 8	617329	REc			
22.328	1	7	14	22q13.2	SMDT1, EMRE, C22orf32		Single-pass membrane protein with aspartate-rich tail 1	615588	REc			
22.329	5	22	07	22q13.2	WBP2NL, PAWP		WWBP2 N-terminal-like protein	610981	REc			
22.330	3	9	04	22q13.2	BIK, NBK		Bcl2-interacting killer	603392	A			
22.331	3	10	00	22q13.31	CELSR1		Cadherin EGF LAG seven-pass G-type receptor 1	604523	A			15(Celsr1)
22.332	7	15	14	22q13.31	FBLN1		Fibulin 1	135820	A		Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4)	15(Fbln1)
22.333	2	28	08	22q13.2	L3MBTL2, L3MBT		L3MBT-like 2	611865	REc			15(L3mbtl2)
22.334	6	29	99	22q13.33	MAPK12, SAPK3, ERK3		Mitogen-activated protein kinase 12 (Stress-activated protein kinase-3)	602399	A			
22.335	6	7	10	22q13.2	MCHR1, GPR24, SLC1		Melanin-concentrating hormone receptor 1	601751	A, R			
22.336	1	9	01	22q13.31	NUP50, NPAP60L, NPAP60		Nucleoporin, 50 kD	604646	H, REc			15(Npap60)
22.337	5	4	00	22q13.31	PKDREJ		Polycystic kidney disease and sea urchin REJ homolog-like	604670	R			
22.338	11	27	00	22q13.33	RABL2B		RAB-like 2B	605413	REc			
22.339	3	28	12	22q13.33	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15		SH3 and multiple ankyrin repeat domains 3	606230	A		Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15}, 613950 (3)	
22.340	11	4	98	22q13.2	TCF20, SPBP, AR1		Transcription factor 20	603107	A, Psh			
22.341	6	30	05	22q13.31	ARHGAP8, BPGAP1		GTPase-activating protein, RHO, 8	609405	REc, H			15(Arhgap8)
22.342	8	25	09	22q13.1	GGA1		Golgi associated, gamma adaptin ear containing, ARF binding protein 1	606004	R, REc			
22.343	1	20	11	22q13.31	GRAMD4, KIAA0767, DIP		Gram domain-containing protein 4	613691	REc			
22.344	2	24	12	22q13.2	MCAT		Malonyl CoA:ACP acyltransferase, mitochondrial	614479	REc			
22.345	3	23	09	22q13.31	MIRLET7A3, LET7A3, MIRNLET7A3		Micro RNA let7a3	612143	REc			
22.346	3	16	10	22q13.2	MPPED1, C22orf1, 239AB		Metallophosphoesterase domain-containing protein 1	602112	REc			
22.347	12	29	06	22q13.2	PANE1, C22orf18		Proliferation-associated nuclear element 1	610152	REc			
22.348	10	29	09	22q13.31	PARVB		Parvin, beta	608121	REc			
22.349	10	29	09	22q13.31	PARVG		Parvin, gamma	608122	REc			
22.350	1	4	16	22q13.31	PHF21B, PHF4, BHC80L		PHD finger protein 21B	616727	REc			
22.351	2	23	08	22q13.31	PNPLA5, GS2L		Patatin-like phospholipase domain-containing 5	611589	R, REc			
22.352	6	30	05	22q13.31	PRR5, PP610		Proline-rich protein 5	609406	REc, H			15(Prr5)
22.353	6	10	08	22q13.31	SAMM50, SAM50		Sorting and assembly machinery component 50, S. cerevisiae, homolog of	612058	R, REc			
22.354	10	11	16	22q13.31	SULT4A1, BRSTL1		Sulfotransferase family 4A, member 1	608359	R, REc			
22.355	3	29	16	22q13.31	TBC1D22A, C22orf4		TBC1 domain family, member 22A	616879	REc			
22.356	7	9	10	22q13.2	TSPO, BZRP, PBR, PBS, BPBS		Translocator protein, 18kD (benzodiazepine receptor, peripheral type)	109610	A			15(Bzrp)
22.357	4	14	12	22q13.31	UPK3A, UPK3, UPIII		Uroplakin 3A	611559	REc			
22.358	11	22	99	22q13.33	PLXNB2, MM1		Plexin B2	604293	REc, R			
22.359	9	8	10	22q13.2	XPNPEP3, APP3, NPHPL1		X-prolyl aminopeptidase 3	613553	REc		Nephronophthisis-like nephropathy 1, 613159 (3)	
22.360	2	27	03	22q13.33	ARSA		Arylsulfatase A	607574	S, D		Metachromatic leukodystrophy, 250100 (3)	15(As2)
22.361	2	21	10	22q13.2	CYB5R3, DIA1, B5R		Cytochrome b5 reductase 3	613213	S, REa		Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II, 250800 (3)	15(Dia1)
22.362	5	30	17	22q13.32	FAM19A5, TAFA5		Family with sequence similarity 19, member A5, CC motif chemokine-like	617499	REc			
22.363	12	21	10	22q13.33	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1		Thymidine phosphorylase	131222	REa, A, Fd		Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	
22.364	4	20	11	22q13.33	ACR		Acrosin	102480	REa, Ch, REc		?Male infertility due to acrosin deficiency (2)	15(Acr)
22.365	2	19	07	22q13.33	ALG12, CDG1G		Dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6- mannosyltransferase	607144	R, Ch		Congenital disorder of glycosylation, type Ig, 607143 (3)	
22.366	7	2	18	22q13.33	MIOX, ALDRL6		Myoinositol oxygenase	606774	REc			
22.367	2	19	07	22q13.33	MLC1, LVM, VL		MLC1 gene	605908	Fd, REc, Ch		Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	
22.368	5	24	13	22q13.33	NCAPH2, CAPH2		Non-SMC condensin II complex subunit H2	611230	REc, R			15(Ncaph2)
22.369	8	25	09	22q13.33	MOV10L1		Mov10-like 1	605794	R, REc			
22.370	5	26	13	22q13.33	PIM3		Oncogene PIM3	610580	REc, R			
22.371	3	29	07	22q13.33	SAPS2, PP6R2, KIAA0685		SAPS domain family, member 2	610877	R, REc			
22.372	7	1	13	22q13.33	SBF1, MTMR5, CMT4B3		SET-binding factor 1 (myotubularin-related protein 5)	603560	RE, R, REc		Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	
22.373	11	17	16	22q13.33	SELENOO, SELO		Selenoprotein O	607917	REc			
22.374	6	22	14	22q13.33	SYCE3		Synaptonemal complex central element protein 3	615775	REc			
22.375	1	12	15	22q13.33	TUBGCP6, GCP6, KIAA1669, MCCRP1		Tubulin-gamma complex-associated protein 6	610053	REc		Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	
22.376	1	24	09	22q13.33	ZBED4, KIAA0637		Zinc finger BED domain-containing protein 4	612552	R, REc			
22.377	6	16	89	Chr.22	MSK41		Antigen MSK41 identified by monoclonal antibody E3	107260	S			
23.1	7	9	90	Xpter-p22.32	ARSC2		Arylsulfatase C, f form	301780	D	probably close to STS = ARSC1, or s form		
23.2	4	25	93	Xp22.33	ASMT, HIOMT		Acetylserotonin methyltransferase	300015	REa, Fd	pseudoautosomal		
23.3	12	3	98	Xp22.33	ASMTLX, ASTML		Acetylserotonin methyltransferase-like	300162	REc			
23.4	2	14	03	Xp22.33	CD99, MIC2, MIC2X		CD99 antigen (MIC2 (monoclonal antibody 12E7))	313470	S, A, D	distal to STS		
23.5	4	30	98	Xp22.33	SHOX, GCFX, SS, PHOG		Short stature homeo box	312865	Fd, D, REc	pseudoautosomal; ?gene causing short stature in Turner syndrome	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
23.6	12	31	99	Xpter-p22.32	HDPA		Hodgkin disease, susceptibility, pseudoautosomal	300221	Fd		{Hodgkin disease susceptibility, pseudoautosomal} (2)	
23.7	10	23	87	Xpter-p22.32	XG		Xg blood group	314700	F, D	nonlyonizing; spans pseudoautosomal boundary; XGPY on Yq11.21	[Blood group, XG system] (3)	
23.8	8	30	11	Xp22.33	GTPBP6, PGPL		GTP-binding protein 6	300124	Psh, A, REc			
23.9	4	6	15	Xp22.33	MXRA5		Matrix remodeling-associated protein 5	300938	REc			
23.10	1	21	11	Xp22.32-p22.31	NLGN4, KIAA1260, AUTSX2, ASPGX2		Neuroligin 4	300427	R		{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)	
23.11	7	1	16	Xp22.33	PLCXD1		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1	300974	REc	in pseudoautosomal region		
23.12	5	28	13	Xp22.33	PPP2R3B, PR48		Protein phosphatase 2, regulatory subunit B-double prime, beta	300339	REc			
23.13	10	23	00	Xp22.33	VSPA		Visuospatial/perceptual abilities	313000	D		Turner syndrome-associated neurocognitive phenotype (2); [Visuospatial/perceptual abilities] (2)	
23.14	1	6	09	Xp22.33	ZBED1, ALTE, KIAA0785, TRAMP		Zinc finger BED domain-containing protein 1	300178	REc			
23.15	9	14	12	Xp22.33	XG, PBDX		XG glycoprotein	300879	REc			
23.16	2	16	04	Xp22.31	FAM9A		Family with sequence similarity 9, member A	300477	REc	pseudogene on Xq28, Yp11.31, 1p36.12, 8p11.1		
23.17	12	19	11	Xp22.33	AKAP17A, SFRS17A, DXYS155E, XE7		A kinase (PRKA) anchor protein 17A	312095	REn	nonlyonizing		
23.18	12	5	11	Xp22.33	CSF2RA, SMDP4		Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage	306250	A	order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	19(Csf2ra)
23.19	2	16	04	Xp22.31	FAM9B		Family with sequence similarity 9, member B	300478	REc			
23.20	11	7	08	Xp22.31	HDHD1A, DXF68S1E, GS1		Haloacid dehalogenase-like hydrolase domain-containing 1A	306480	REn	escapes X-inactivation; 100kb telomeric to STS		
23.21	3	6	00	Xp22.33	SLC25A6, ANT3		Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver)	300151	Pcm, REc, REn	1st intron ~1.3Mb from Xqter; nonlyonized		
23.22	4	30	09	Xp22.31	STS, ARSC1, ARSC, SSDD, XLI		Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)	300747	F, S, D	nonlyonizing	Ichthyosis, X-linked, 308100 (3)	X,Y(Sts)
23.23	10	12	90	Xp22.32	XGR		XG/MIC2 regulator	314705	F	?between XG and MIC2		
23.24	11	30	06	Xp22.2	ASB11		Ankyrin repeat- and SOCS box-containing protein 11	300626	REc			
23.25	7	9	09	Xp22.2	FANCB, FAAP95, FAAP90, FLJ34064		Fanconi anemia, complementation group B gene	300515	REn		Fanconi anemia, complementation group B, 300514 (3)	
23.26	2	16	04	Xp22.2	FAM9C		Family with sequence similarity 9, member C	300479	REc			
23.27	11	23	98	Xp22.2	FIGF, VEGFD		c-fos induced growth factor (vascular endothelial growth factor D)	300091	Psh			
23.28	8	30	16	Xp22.31	VCS3B, VCXC		Variably charged, X chromosome, 3B	300981	REc			
23.29	2	18	98	Xp22.2	ARHGAP6		Rho GTPase-activating protein-6	300118	REc			
23.30	3	28	03	Xp22.33	ARSE, CDPX1, CDPXR		Arylsulfatase E	300180	D, Fd	CDPX1 in contiguous gene syndrome with STS	Chondrodysplasia punctata, X-linked recessive, 302950 (3)	
23.31	2	14	97	Xp22.33	ARSD		Arylsulfatase D	300002	REn			
23.32	2	14	97	Xp22.33	ARSF		Arylsulfatase F	300003	REn, REc			
23.33	5	19	06	Xp22.33	ARSH		Arylsulfatase H	300586	REc			
23.34	8	10	16	Xp22.2	CLCN4, MRX49, MRX15		Chloride channel-4	302910	RE		Mental retardation, X-linked 49/15, 300114 (3)	
23.35	8	30	01	Xp22.33	CRLF2, CRL2		Cytokine receptor-like factor 2	300357	A	pseudoautosomal		
23.36	10	23	97	Xp22.31	DXS1283E		GS2 gene	300102	REn			
23.37	10	19	99	Xp22.3	EMWX		Episodic muscle weakness, X-linked	300211	Fd		Episodic muscle weakness, X-linked (2)	
23.38	6	7	10	Xp22.2	GPR143, OA1, NYS6		G protein-coupled receptor 143	300808	F, Fd	linked to XG	Ocular albinism, type I, Nettleship-Falls type, 300500 (3); Nystagmus 6, congenital, X-linked, 300814 (3)	X(Oa1)
23.39	2	7	01	Xp22.33	GYG2, GN2		Glycogenin 2	300198	A			
23.40	10	4	93	Xp22.33	IL3RA		Interleukin-3 receptor, alpha subunit	308385	REa, A, REn	same 190kb segment as CSF2RA		14(Il3ra)
23.41	9	28	12	Xp22.31	KAL1, KMS, ADMLX, HH1		Kallmann syndrome-1 sequence (anosmin-1)	300836	F, Fd, D, REa, REn	with ichthyosis in probable microdeletion syndrome	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	
23.42	9	10	09	Xp22.3	LECD		Corneal dystrophy, Lisch epithelial	300778	Fd	max lod between DXYS233 and DXYS228X	Corneal dystrophy, Lisch epithelial (2)	
23.43	7	18	06	Xp22.2	MSL3L1		Male-specific lethal 3-like 1	300609	REc			
23.44	3	26	03	Xp22.3	MRX2		Mental retardation, X-linked, 2	300428	Fd		Mental retardation, X-linked 2 (2)	
23.45	12	16	93	Xp22.3	OASD		Ocular albinism and sensorineural deafness	300650	Fd	?allelic to OA1	Ocular albinism with sensorineural deafness (2)	
23.46	7	28	11	Xp22.33	P2RY8, P2Y8		Pyrimidinergic receptor P2Y, G protein-coupled, 8	300525	REc			
23.47	8	5	97	Xp22.33	PRKX		Protein kinase, X-linked	300083	REc			
23.48	4	18	07	Xp22.2	SHROOM2, APXL		Shroom family member 2	300103	REn			X(Apxl)
23.49	5	24	02	Xp22.3-p22.2	TBL1X, TBL1		Transducin-beta-like 1, X-linked	300196	A			X(Tbl1)
23.50	4	14	05	Xp22.31	VCX, VCXB1, VCX10R		Variably charged, X chromosome	300229	REc			
23.51	4	14	05	Xp22.31	VCX2, VCX2R, VCXB		Variably charged, X chromosome, 2	300532	R			
23.52	4	14	05	Xp22.31	VCX3A, VCX8R, VCXA		Variably charged, X chromosome, 3A	300533	R			
23.53	11	5	14	Xp22.2	OFD1, CXorf5, SGBS2, JBTS10, RP23		OFD1 protein	300170	Fd, REc	mutation identified in 1 RP23 family	Orofaciodigital syndrome I, 311200 (3); Simpson-Golabi-Behmel syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3); ?Retinitis pigmentosa 23, 300424 (3)	
23.54	12	4	90	Xp22.2	PRPS2		Phosphoribosyl pyrophosphate synthetase-2	311860	REa, A	between STS and ZFX		
23.55	6	24	10	Xp22.2	TLR7		Toll-like receptor 7	300365	REc	centromeric to TLR8		
23.56	6	24	10	Xp22.2	TLR8		Toll-like receptor 8	300366	REc	16kb telomeric to TLR7		
23.57	7	11	14	Xp22.2	AMELX, AMG, AIH1, AMGX, AI1E		Amelogenin	300391	REa, A, Fd	also Y	Amelogenesis imperfecta, type 1E, 301200 (3)	X(Amel)
23.58	9	28	93	Xp22.2	GRPR		Gastrin-releasing peptide receptor	305670	Psh			
23.59	7	22	16	Xp22.1-p21.3	POLA1		Polymerase, DNA, alpha-1	312040	S, Fd		Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3)	X(Pola)
23.60	1	31	13	Xp22.2	ASB9		Ankyrin repeat- and SOCS box-containing protein 9	300890	REc			
23.61	4	29	14	Xp22.2	ATXN3L		Ataxin 3-like	300920	REc			
23.62	7	11	17	Xq26.2	FIRRE, LINC01200		Functional intergenic repeating RNA element	300999	REc, H			X(Firre)
23.63	10	23	97	Xp22.2	BMX		BMX non-receptor tyrosine kinase	300101	A			
23.64	1	10	92	Xp22.2	CMTX2		Charcot-Marie-Tooth disease, X-linked recessive, 2	302801	Fd		Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)	
23.65	9	26	16	Xp22.2	FRMPD4, PRESO, KIAA0316, MRX104		FERM and PDZ domains-containing protein 4	300838	R, REc		Mental retardation, X-linked 104, 300983 (3)	
23.66	9	29	15	Xp22.2	GEMIN8, FAM51A1		GEM-associated protein 8	300962	REc			
23.67	11	13	07	Xp22.2	HBFQTL3, FCP1, FCPX, FCP		Fetal hemoglobin quantitative trait locus 3	305435	F, Fd		Fetal hemoglobin quantitative trait locus 3 (2)	
23.68	9	28	96	Xp22.2	GPM6B, M6B		Glycoprotein M6B	300051	A			
23.69	5	26	13	Xp22.2	INE2		Inactivation escape 2	300165	A			
23.70	3	25	15	Xp22.2	MRX73		Mental retardation, X-linked 73	300355	Fd	between DXS8019 and DXS365	Mental retardation, X-linked 73 (2)	
23.71	9	20	14	Xp22.2	PIR		Pirin	300931	REc			
23.72	12	5	00	Xp22.2	RAB9		RAS-associated protein RAB9	300284	R			
23.73	1	13	11	Xp22.2	RBBP7		Retinoblastoma-binding protein 7	300825	REc			
23.74	5	27	93	Xp22.11	ZFX		Zinc finger protein, X-linked	314980	Ch, REa, Fd	nonlyonizing		X(Zfx)
23.75	1	18	18	Xp22.11	EIF2S3, EIF2G, MEHMO, MRXSBRK		Eukaryotic translation initiation factor 2, subunit 3	300161	A, H		MEHMO syndrome, 300148 (3)	
23.76	11	3	14	Xp22.12	PDHA1, PHE1A, PDHAD		Pyruvate dehydrogenase, E1-alpha polypeptide-1	300502	REa, A, Fd		Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	X(Pdha1)
23.77	2	1	11	Xp22.11	PHEX, HYP, HPDR1, LXHR		Phosphate regulating endopeptidase homolog, X-linked	300550	Fd		Hypophosphatemic rickets, X-linked dominant, 307800 (3)	X(Phex, Gy)
23.78	10	1	09	Xp22.13	PHKA2, PHK, XLG, PYKL, GSD9A		Phosphorylase kinase, liver, alpha-2 subunit	300798	Fd, REa, A		Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage disease, type IXa2, 306000 (3)	
23.79	6	9	98	Xp22.13	PPEF1		Protein phosphatase, EF hand calcium-binding domain 1	300109	REc			
23.80	7	1	11	Xp22.12	RPS6KA3, RSK2, MRX19		Ribosomal protein S6 kinase, 90kD, polypeptide 3	300075	Fd, RE		Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked 19, 300844 (3)	
23.81	3	31	11	Xp22.13	RS1, XLRS1		Retinoschisin	300839	F, Fd	25cM from XG	Retinoschisis, 312700 (3)	
23.82	2	7	01	Xp22.13	SCML1		Sex comb on midleg, Drosophila, homolog-like 1	300227	REn			
23.83	3	14	07	Xp22.2	TRAPPC2, SEDL, SEDT		Trafficking protein particle complex 2 (sedlin)	300202	Fd		Spondyloepiphyseal dysplasia tarda, 313400 (3)	
23.84	5	28	13	Xp22.12	YY2, ZNF631		Transcription factor YY2	300570	REc			
23.85	10	24	11	Xp21.3	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32		Aristaless-related homeobox, X-linked	300382	REc, Fd		Epileptic encephalopathy, early infantile, 1, 308350 (3); Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510 (3); Hydranencephaly with abnormal genitalia, 300215 (3)	
23.86	7	23	13	Xp22.2-p22.1	NHS, CXN, CTRCT40		NHS gene	300457	Fd, REc		Nance-Horan syndrome, 302350 (3); Cataract 40, X-linked, 302200 (3)	?X(Xcat)
23.87	10	15	98	Xp22.13-p21.1	MEHMO		MEHMO syndrome (Mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity)	300148	Fd		MEHMO syndrome (2)	
23.88	12	8	17	Xp22.12	CNKSR2, CNK2, KIAA0902, MRXSHG		connector enhancer of KSR 2	300724	R, REc	conflicting assignment to chr.1	Mental retardation, X-linked, syndromic, Houge type, 301008 (3)	
23.89	12	15	10	Xp22.12	MAP3K15, ASK3		Mitogen-activated protein kinase kinase kinase 15	300820	REc			
23.90	8	19	18	Xp22.12	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19		Membrane-bound transcription factor protease, site 2	300294	A, REc	mutation identified in 1 OLMSX family	IFAP syndrome with or without BRESHECK syndrome, 308205 (3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3); ?Olmsted syndrome, X-linked, 300918 (3); Osteogenesis imperfecta, type XIX, 301014 (3)	
23.91	10	23	11	Xp22.11	ACOT9, MTACT48		Acyl-CoA thioesterase 9	300862	REc			X(Acot9)
23.92	4	2	15	Xp22.11	PCYT1B		Phosphate cytidylyltransferase 1, choline, beta isoform	300948	REc			
23.93	8	19	13	Xp22.11	PDK3, CMTX6		Pyruvate dehydrogenase kinase, isoenzyme 3	300906	REc	1 family identified with mutation	?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	
23.94	8	18	14	Xp22.11	PRDX4, AOE372		Peroxiredoxin 4	300927	REc			
23.95	10	13	15	Xp22.11	PTCHD1, AUTSX4		Patched domain-containing protein 1	300828	REc		{Autism, susceptibility to, X-linked 4}, 300830 (3)	
23.96	12	17	08	Xp22.11	APOO, MYO25, FAM121B		Apolipoprotein O	300753	REc			
23.97	5	28	13	Xp22.2	CXorf15, FIAT		Chromosome X open reading frame 15	300677	REc			
23.98	3	9	00	Xp22.2	CA5B		Carbonic anhydrase VB, mitochondrial	300230	A			X(Car5b)
23.99	9	22	16	Xp22.11	KLHL15, KIAA1677		Kelch-like 15	300980	Psh, REc		Mental retardation, X-linked 103, 300982 (3)	
23.100	6	3	14	Xp22.2	PIGA, PNH1, MCAHS2		Phosphatidylinositol glycan, class A	311770	A	pseudogene on chr.12	Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	X(Piga)
23.101	10	13	15	Xp22.11	SAT1, SSAT		Spermidine/spermine N1-acetyltransferase 1	313020	Psh, A, D			
23.102	7	1	11	Xp22.12	SMPX, DFNX4		Small muscle protein, X-linked	300226	A, R, REc, Fd		Deafness, X-linked 4, 300066 (3)	
23.103	5	6	04	Xp22.11	SMS, SRS, MRSR		Spermine synthase	300105	REn, Fd		Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	X(Sms)
23.104	4	10	97	Xp22.2	ZRSR2, U2AF1RS2		Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2	300028	A			X(U2af1rs2)
23.105	3	13	06	Xp21.3-p21.2	IL1RAPL1, IL1R8, MRX21, MRX34		Il-1 receptor accessory protein-like 1	300206	F, Fd, D, REc		Mental retardation, X-linked 21/34, 300143 (3)	
23.106	12	11	02	Xp22.12	SH3KBP1, CIN85		SH3-domain kinase-binding protein 1	300374	A			
23.107	10	12	90	Xp22.2	GLRA2		Glycine receptor, alpha-2 polypeptide	305990	REa, Fd			X(Glra2)
23.108	2	23	17	Xp11.23	ZNF81		Zinc finger protein-81 (HFZ20)	314998	REa			
23.109	2	2	14	Xp11.3	ZNF41		Zinc finger protein-41	314995	REa			
23.110	5	16	01	Xp22.2	ACE2, ACEH		Angiotensin I converting enzyme 2	300335	REc			
23.111	12	18	89	Xp22	AGMX2, XLA2, IMD6		Agammaglobulinemia, X-linked 2 (with growth hormone deficiency)	300310	Fd		Agammaglobulinemia, X-linked 2 (2)	X(Xid)
23.112	10	8	88	Xp22	AIC		Aicardi syndrome	304050	X/A, Ch	?in p22.31 with FDH as contiguous gene syndrome	Aicardi syndrome (2)	
23.113	5	29	12	Xp22	ANIB5		Aneurysm, intracranial berry, 5	300870	Fd		Aneurysm, intracranial berry, 5 (2)	
23.114	7	17	14	Xp22.2	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS		Adaptor-related protein complex 1, sigma-2 subunit	300629	REc, Fd		Mental retardation, X-linked syndromic 5, 304340 (3)	
23.115	7	14	15	Xp22.13	CDKL5, STK9, ISSX, EIEE2		Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9)	300203	Fd, Ch		Epileptic encephalopathy, early infantile, 2, 300672 (3)	X(Stk9)
23.116	5	7	03	Xp22.2	CTPS2		Cytidine 5-prime triphosphate synthetase 2	300380	REc			
23.117	2	1	01	Xp22.2	EGFL6		Epidermal growth factor-like 6	300239	REa, REc			
23.118	5	13	15	Xp22.2	HCCS, MCOPS7, LSDMCA1		Holocytochrome c synthase (cytochrome c heme-lyase)	300056	REc		Linear skin defects with multiple congenital anomalies 1, 309801 (3)	
23.119	12	30	03	Xp21.3	MAGEB5		Melanoma antigen, family B, 5	300466	REc			
23.120	12	30	03	Xp21.3	MAGEB6		Melanoma antigen, family B, 6	300467	REc			
23.121	9	26	16	Xp22.2	MID1, OGS1, BBBG1, FXY, OSX		Midline-1	300552	Fd, Ch	type II defect on chr.22	Opitz GBBB syndrome, type I, 300000 (3)	X(Mid1)
23.122	10	18	00	Xp22	MNG2		Multinodular goiter-2	300273	Fd		Goiter, multinodular, 2 (2)	
23.123	11	29	99	Xp22.13	RAI2		Retinoic acid-induced 2	300217	REc			
23.124	2	7	01	Xp22.13	SCML2		Sex comb on midleg, Drosophila, homolog-like 2	300208	A			
23.125	12	29	06	Xp22.2	TMEM27, NX17		Transmembrane protein 27 (collectrin)	300631	REc			
23.126	08	20	18	Xp22.13	ADGRG2, GPR64, HE6, CBAVDX		Adhesion G protein-coupled receptor G2	300572	A, H		Congenital bilateral absence of vas deferens, X-linked, 300985 (3)	X(Gpr64)
23.127	3	19	09	Xp21.2	MAGEB1, MAGEL1, DAM10		Melanoma antigen, family B, 1	300097	RE			X(Smage1/2)
23.128	3	19	09	Xp21.2	MAGEB2, DAM6		Melanoma antigen, family B, 2	300098	REc			
23.129	10	26	98	Xp21.2	MAGEB3		Melanoma antigen, family B, 3	300152	REc			
23.130	10	26	98	Xp21.2	MAGEB4		Melanoma antigen, family B, 4	300153	REc			
23.131	3	19	09	Xp21.3	MAGEB10		Melanoma antigen, family B, 10	300761	REc			
23.132	3	19	09	Xp21.1	MAGEB16		Melanoma antigen, family B, 16	300762	REc			
23.133	3	19	09	Xp22.2	MAGEB17		Melanoma antigen, family B, 17	300763	REc			
23.134	3	26	07	Xp21.3	MENOQ1		Menopause, natural, age at, QTL 1	300488	Fd		{Menopause, natural, age at, QTL1} (2)	
23.135	2	28	03	Xq21.31	TGIF2LX, TGIFLX		Transforming growth factor-beta-induced factor 2-like, X-linked	300411	REc			
23.136	6	12	17	Xp21.2	NR0B1, DAX1, AHC, AHX, SRXY2		Nuclear receptor subfamily 0, group B, member 1	300473	D, Fd	distal to GK	Adrenal hypoplasia, congenital, 300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)	X(Ahch)
23.137	2	24	04	Xp21.2	GK		Glycerol kinase	300474	D, Fd	2Mb distal to DMD; pseudogene on 4q32	Glycerol kinase deficiency, 307030 (3)	X(Gyk)
23.138	1	25	93	Xp21.3-p21.2	RP6		Retinitis pigmentosa-6, X-linked recessive	312612	Fd		?Retinitis pigmentosa, X-linked recessive, 6 (2)	
23.139	3	18	08	Xp21.2	DFNX3, DFN4		Deafness, X-linked 3	300030	Fd	?same as DMD	Deafness, X-linked 3 (2)	
23.140	3	14	02	Xp21.2-p21.1	DMD, BMD, CMD3B		Dystrophin	300377	X/A, Fd, D	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy, 300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)	X(Dmd)
23.141	3	23	14	Xp21.2	FTHL17		Ferritin heavy polypeptide-like 17	300308	R, REc			
23.142	1	11	16	Xp21.2	TAB3		Tak1 (MAP3K7) binding protein 3	300480	REc			
23.143	5	23	11	Xp21.1	XK, MCLDS		Kell blood group precursor	314850	F, D	~500kb distal to CGD	McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	
23.144	2	5	99	Xp11.3	USP11, UHX1		Ubiquitin-specific protease-11 (ubiquitin carboxyl-terminal hydrolase)	300050	REa, REc			
23.145	8	25	98	Xp21.2-q21.1	XS, LUXS		Lutheran suppressor, X-linked	309050	Fd			
23.146	9	8	14	Xp21.1-p11.4	CYBB, CGD, AMCBX2, IMD34		Cytochrome b-245, beta polypeptide	300481	F, D	proximal to DMD	Chronic granulomatous disease, X-linked, 306400 (3); Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	X(Cybb)
23.147	12	4	03	Xp11.4	OTC		Ornithine transcarbamylase	300461	L, REa, A, D	proximal to DMD, CGD	Ornithine transcarbamylase deficiency, 311250 (3)	X(spf; Otc)
23.148	12	31	99	Xp11.4	SRPX, ETX1		Sushi-repeat-containing protein, X chromosome	300187	Fd, D	probably between OTC and CGD		
23.149	10	5	11	Xp21.1-p11.23	MRXS17		Mental retardation, X-linked, syndromic 17	300858	Fd	between rs2748314 and rs5906782	Mental retardation, X-linked, syndromic 17 (2)	
23.150	9	9	10	Xp21	DELXp21, CXDELp21		Chromosome Xp21 deletion syndrome	300679	Ch	contiguous gene deletion syndrome	Chromosome Xp21 deletion syndrome (4)	
23.151	3	6	01	Xp11.4	TCTE1L		T complex-associated testis-expressed 1-like	300302	REc			
23.152	3	19	17	Xp11.4	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS		ATPase, H+ transporting, lysosomal, accessory protein 2	300556	REc, Fd	mutation identified in 1 XPDS family	Mental retardation, X-linked, syndromic, Hedera type, 300423 (3); ?Parkinsonism with spasticity, X-linked, 300911 (3)	
23.153	3	30	04	Xp11.4	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2		BCL6 corepressor	300485	R, REc, Fd		Microphthalmia, syndromic 2, 300166 (3)	
23.154	3	28	12	Xp11.4	CASK, MICPCH, FGS4, CMG, MRXSNA		Calcium/calmodulin-dependent serine protein kinase	300172	R, Fd		Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)	
23.155	1	31	13	Xp11.4	NYX, CSNB1A, NBM1		Nyctalopin	300278	Fd, REc		Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	
23.156	9	18	00	Xp11.4	GPR34		G protein-coupled receptor 34	300241	A, REc			
23.157	10	29	08	Xp11.4	GPR82		G protein-coupled receptor 82	300748	REc			
23.158	9	28	15	Xp11.4	MID1IP1, MIG12		MID1-interacting protein 1	300961	REc			
23.159	8	25	14	Xp11.3	NDP, ND, EVR2		Norrin	300658	Fd, D		Norrie disease, 310600 (3); Exudative vitreoretinopathy 2, X-linked, 305390 (3)	X(Ndp)
23.160	6	7	10	Xp11.4	NYS5		Nystagmus 5, congenital, X-linked	300589	Fd	max lod at DXS993	Nystagmus 5, congenital, X-linked (2)	
23.161	3	5	13	Xp11.4	RPGR, RP3, CRD, RP15, COD1, CORDX1		Retinitis pigmentosa GTPase regulator	312610	D, Fd		Retinitis pigmentosa 3, 300029 (3); Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3); Cone-rod dystrophy, X-linked, 1, 304020 (3)	
23.162	2	28	08	Xp21.1	TMEM47, BCMP1		Transmembrane protein 47	300698	R			
23.163	3	1	16	Xp11.4	USP9X, DFFRX, MRX99, MRXS99F		Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)	300072	REa, REc		Mental retardation, X-linked 99, 300919 (3); Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	
23.164	3	25	02	Xp11.23	PFC, PFD		Properdin P factor, complement	300383	Fd, REa, A		Properdin deficiency, X-linked, 312060 (3)	X(Pfc)
23.165	9	9	11	Xp11.4-p11.21	OPA2		Optic atrophy, X-linked	311050	Fd		Optic atrophy 2, X-linked (2)	
23.166	3	21	94	Xp11.3	ARAF1, RAFA1, PKS2		Oncogene ARAF1	311010	REa, A, Fd			X(Araf)
23.167	8	10	99	Xp11.4	MED14, CRSP2, CXorf4, TRAP170, EXLM1		Mediator complex subunit 14	300182	A			
23.168	8	24	04	Xp11.3-p11.2	SYN1		Synapsin I	313440	A, Fd, REn	5kb from PFC	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	X(Syn1)
23.169	2	28	06	Xp11.3	CHST7, C6ST2		Carbohydrate sulfotransferase 7	300375	REc			
23.170	9	24	15	Xp11.3	CXorf36, DIA1R		Chromosome X open reading frame 36	300959	REc			
23.171	2	18	09	Xp11.3	DELXp11.3, CXDELp11.3		Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa)	300578	Ch		Chromosome Xp11.3 deletion syndrome (4)	
23.172	5	28	13	Xp11.3	DUSP21, LMWDSP21		Dual-specificity phosphatase 21	300678	REc			
23.173	9	9	10	Xp11.3	EFHC2		EF-hand domain (C-terminal)-containing protein 2	300817	REc			
23.174	7	20	12	Xp11.3	FUNDC1		FUN14 domain-containing protein 1	300871	REc			
23.175	3	23	09	Xp11.3	MIR221, MIRN221		Micro RNA 221	300568	REc	near MIRN222		
23.176	3	23	09	Xp11.3	MIR222, MIRN222		Micro RNA 222	300569	REc	near MIRN221		
23.177	2	2	14	Xp11.3	MRX89		Mental retardation, X-linked 89	300848	Ch	t(X;7)(p11.3;q11.21)	Mental retardation, X-linked 89 (2)	
23.178	1	24	14	Xp11.3	MRX92		Mental retardation, X-linked 92	300851	Fd	previously associated with ZNF674	Mental retardation, X-linked 92 (2)	
23.179	12	6	15	Xp11.3	NDUFB11, LSDMCA3		NADH-dehydrogenase 1 beta subcomplex, 11	300403	R, REc	mutation identified in 1 COX I deficient patient	Linear skin defects with multiple congenital anomalies 3, 300952 (3); ?Mitochondrial complex I deficiency, 252010 (3)	
23.180	6	27	02	Xp11.23	PCSK1N, PROSAAS		Proprotein convertase, subtilisin/kexin-type, 1, inhibitor of	300399	R			
23.181	2	28	06	Xp11.3	SLC9A7, NHE7		Solute carrier family 9 (sodium/hydrogen exchanger), member 7	300368	R			
23.182	8	16	99	Xp11.23	ZNF21		Zinc finger protein-12	314993	REc			
23.183	3	23	06	Xp11.3	ZNF673, FLJ20344		Zinc finger protein 673	300585	REc			
23.184	4	17	13	Xp11.3	CDK16, PCTK1, PCTAIRE1		Cyclin-dependent kinase 16	311550	A, REn			
23.185	9	4	15	Xp11.4	DDX3X, DDX3, DBX, MRX102		DEAD/H box-3, X-linked	300160	A		Mental retardation, X-linked 102, 300958 (3)	
23.186	12	18	07	Xp11.23	TBC1D25, OATL1		TBC1 domain family, member 25	311240	REa, A, Fd			
23.187	8	21	91	Xp11.3	TIMP1, TIMP, EPA		Erythroid-potentiating activity (tissue inhibitor of metalloproteinases)	305370	REa, A	in intron of SYN1		X(Timp)
23.188	2	24	17	Xp11.3-p11.21	MRX45		Mental retardation, X-linked 45	300498	Fd		Mental retardation,X-linked 45 (2)	
23.189	6	29	99	Xp11.3-p11.21	MRX50		Mental retardation, X-linked nonspecific, type 50	300115	Fd		Mental retardation, X-linked 50 (2)	
23.190	2	25	08	Xp11.3-q12	AGSPX		Angioma serptiginosum, X-linked	300652	Fd	between DXS8026 and DXS106	Angio serpiginosum (2)	
23.191	9	22	96	Xp11.3-q13.3	MRX14		Mental retardation, X-linked-14	300062	Fd		Mental retardation, X-linked 14 (2)	
23.192	11	9	11	Xp11.3-q22	MRXS7		Mental retardation, X-linked, syndromic 7	300218	Fd		Mental retardation, X-linked syndromic 7 (2)	
23.193	9	30	04	Xp11.3-q22.3	MRX84		Mental retardation, X-linked 84	300505	Fd	29 other MRX loci in same region	Mental retardation, X-linked 84 (2)	
23.194	1	31	13	Xp11.23	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2		Calcium channel, voltage-dependent, alpha-1F subunit	300110	REn, Fd		Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)	
23.195	11	24	15	Xp11.23	CCDC22, RTSC2		Coiled-coil domain-containing protein 22	300859	REc		Ritscher-Schinzel syndrome 2, 300963 (3)	
23.196	3	27	15	Xp11.23	CCDC120		Coiled-coil domain-containing protein 120	300947	REc			
23.197	2	1	07	Xp11.23	FTSJ1, JM23, SPB1, MRX44, MRX9		FTSJ homolog 1	300499	REc		Mental retardation, X-linked 9/44, 309549 (3)	
23.198	9	2	08	Xp11.23	GAGE1		G antigen 1	300594	Psh, A, REc			
23.199	9	2	08	Xp11.23	GAGE2A		G antigen 2A	300720	REc			
23.200	9	2	08	Xp11.23	GAGE2B		G antigen 2B	300726	REc			
23.201	9	2	08	Xp11.23	GAGE2C, GAGE2		G antigen 2C	300595	Psh, A, REc			
23.202	9	2	08	Xp11.23	GAGE2D		G antigen 2D	300735	REc			
23.203	9	2	08	Xp11.23	GAGE2E		G antigen 2E	300736	REc			
23.204	5	28	13	Xp11.23	GAGE3		G antigen 3	300596	REc			
23.205	5	28	13	Xp11.23	GAGE4		G antigen 4	300597	REc			
23.206	6	1	12	Xp11.23	GAGE5		G antigen 5	300598	REc			
23.207	6	1	12	Xp11.23	GAGE6		G antigen 6	300599	REc			
23.208	3	13	08	Xp11.23	GAGE7		G antigen 7	300601	REc			
23.209	9	2	08	Xp11.23	GAGE7B		G antigen 7B	300637	Psh, A, REc			
23.210	9	2	08	Xp11.23	GAGE10		G antigen 10	300737	REc			
23.211	9	2	08	Xp11.23	GAGE12C		G antigen 12C	300727	REc			
23.212	9	2	08	Xp11.23	GAGE12D		G antigen 12D	300728	REc			
23.213	9	2	08	Xp11.23	GAGE12E		G antigen 12E	300729	REc			
23.214	9	2	08	Xp11.23	GAGE12F		G antigen 12F	300730	REc			
23.215	9	2	08	Xp11.23	GAGE12G		G antigen 12G	300731	REc			
23.216	9	2	08	Xp11.23	GAGE12H		G antigen 12H	300732	REc			
23.217	9	2	08	Xp11.23	GAGE12J		G antigen 12J	300733	REc			
23.218	9	2	08	Xp11.23	GAGE13		G antigen 13	300734	REc			
23.219	7	20	12	Xp11.23	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP		GATA-binding protein-1 (globin transcription factor-1)	305371	REa, A		Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	X(Gf1)
23.220	8	28	17	Xp11.23	GPKOW, GPATCH5		G-patch domain and KO@ motifs	301003	REc			
23.221	2	17	15	Xp11.23	GRIPAP1, GRASP1, KIAA1167		GRIP1-associated protein 1	300408	R, REc			
23.222	2	17	15	Xp11.23	HDAC6, CPBHM		Histone deacetylase 6	300272	R, A	mutation identified in 1 CPBHM family	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	
23.223	5	26	13	Xp11.3	INE1		Inactivation escape 1	300164	A			
23.224	6	1	12	Xp11.23	KCND1		Potassium voltage-gated channel, SHAL-related subfamily, member 1	300281	R, REc			
23.225	2	7	01	Xp11.22	MAGED1		Melanoma antigen, family D, 1	300224	R			
23.226	7	26	16	Xp11.3	MAOA, BRNRS		Monoamine oxidase A	309850	Fd, REa, D, A, REn	NDP, MAOA, MAOB closely linked	Brunner syndrome, 300615 (3); {Antisocial behavior}, 300615 (3)	X(Maoa)
23.227	4	10	90	Xp11.3	MAOB		Monoamine oxidase B	309860	REa, D, A, REn			X(Maob)
23.228	4	17	13	Xp11.23	MIR502		Micro RNA 502	300893	REc			
23.229	3	13	08	Xp11.22	NUDT10, DIPP3A, APS2		Nucleoside diphosphate-linked moiety X motif 10	300527	REc			
23.230	3	13	08	Xp11.22	NUDT11, DIPP3B, APS1		Nucleoside diphosphate-linked moiety X motif 11	300528	REc			
23.231	6	5	08	Xp11.23	OTUD5, DUBA		OTU domain-containing protein 5	300713	REc			
23.232	9	4	08	Xp11.23	GAGEB1, PAGE1		P antigen family, member 1	300288	REc, Psh			
23.233	9	4	08	Xp11.23	PAGE4, GAGEC1		P antigen family, member 4	300287	REa, R			
23.234	5	26	13	Xp11.3	PHF16, JADE3, KIAA0215		PHD finger protein 16	300618	REc			X(Phf16)
23.235	8	31	07	Xp11.23	PORCN, PORC, DHOF, FODH		Porcupine, Drosophila, homolog of	300651	REc		Focal dermal hypoplasia, 305600 (3)	
23.236	4	6	11	Xp11.23	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8		Polyglutamine-binding protein 1	300463	REc, R, Fd		Renpenning syndrome, 309500 (3)	
23.237	3	31	11	Xp11.23	PRAF2, JM4		PRA1 domain family, member 2	300840	REc			
23.238	11	1	13	Xp11.23	PRICKLE3, LMO6		Prickle, Drosophila, homolog of, 3	300111	REc			
23.239	2	19	96	Xp11.23	RBM3		RNA binding motif protein 3	300027	REc, REn			
23.240	7	8	10	Xp11.3	RBM10, DXS8237E, KIAA0122, TARPS		RNA-binding motif protein 10	300080	REc		TARP syndrome, 311900 (3)	
23.241	6	18	10	Xp11.3	RP2		Retinitis pigmentosa-2, X-linked recessive	300757	Fd		Retinitis pigmentosa 2, 312600 (3)	
23.242	8	22	07	Xp11.23	SLC38A5, SN2		Solute carrier family 38 (amino acid transporter), member 5	300649	REc			
23.243	3	13	08	Xp11.23	SPACA5, LOC389852		Sperm acrosome associated 5	300593	REc			
23.244	5	28	13	Xp11.23	SSX1, SSRC		Synovial sarcoma, X breakpoint 1	312820	Ch, RE, A, REc	fused with SYT in synovial sarcoma	?Sarcoma, synovial, 300813 (3)	
23.245	5	28	13	Xp11.23	SSX3		Synovial sarcoma, X breakpoint 3	300325	Psh, REc			
23.246	5	28	13	Xp11.23	SSX4		Synovial sarcoma, X breakpoint 4	300326	Ch, RE, REc			
23.247	5	28	13	Xp11.23	SSX6		Synovial sarcoma, X breakpoint 6	300541	REc			
23.248	5	26	13	Xp11.23	SSX9		Sarcoma, synovial, X breakpoint 9	300544	REc			
23.249	5	28	13	Xp11.23	SSX5		Synovial sarcoma, X breakpoint 5	300327	REc			
23.250	2	1	01	Xp11.23	SUV39H1		Suppressor of variegation 3-9, Drosophila, homolog of, 1	300254	REc			
23.251	2	24	12	Xp11.3	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1		Ubiquitin-like modifier-activating enzyme 1	314370	A, S, Ch, REa, Fd	escapes inactivation	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	
23.252	6	1	12	Xp11.23	UXT		Ubiquitously expressed transcript	300234	REc			
23.253	11	2	04	Xp11.23	WDR13		WD repeat-containing protein 13	300512	A, REc			
23.254	4	17	13	Xp11.23	WDR45, WIPI4, NBIA5		WD repeat-containing protein 45	300526	REc	?pseudogene on 4q31.3	Neurodegeneration with brain iron accumulation 5, 300894 (3)	
23.255	10	12	10	Xp11.23	ZNF630		Zinc finger protein 630	300819	REc			
23.256	10	12	09	Xp11.23-p11.22	DUPXp11.23p11.22, CXDUPp11.23p11.22		Chromosome Xp11.23-p11.22 duplication syndrome	300801	Ch		Chromosome Xp11.23-p11.22 duplication syndrome (4)	
23.257	9	24	15	Xp11.23	EBP, CDPX2, CPXD, CPX, MEND		Emopamil-binding protein	300205	Fd, R, H		Chondrodysplasia punctata, X-linked dominant, 302960 (3); MEND syndrome, 300960 (3)	X(Bpa)
23.258	9	30	99	Xp11.23	PLP2		Proteolipid protein 2	300112	REc			
23.259	8	6	13	Xp11.23	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M		Solute carrier family 35 (UDP-galactose transporter), member 2	314375	A		Congenital disorder of glycosylation, type IIm, 300896 (3)	
23.260	10	8	09	Xp11.23	SYP, MRXSYP		Synaptophysin	313475	RE, REa, F, Fd		Mental retardation, X-linked 96, 300802 (3)	X(Syp)
23.261	11	13	17	Xp11.23	WAS, IMD2, THC1, SCNX		Wiskott-Aldrich syndrome gene	300392	Fd, X/A	t(18;X)(q11.2;p11.2); distal to TIMP	Wiskott-Aldrich syndrome, 301000 (3); Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia, X-linked, intermittent, 313900 (3)	X(Wasp, ?sf)
23.262	2	28	03	Xp11.22	GSPT2, GST2, ERF3B		G1- to S-phase transition 2	300418	R			
23.263	9	26	11	Xp11.21	UBQLN2, PLIC2, CHAP1, ALS15		Ubiquilin 2	300264	R		Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	
23.264	1	27	04	Xp11.23	FOXP3, IPEX, AIID, XPID, PIDX		Forkhead box P3 (scurfin)	300292	Fd, REc		Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)	X(sf, Foxp3)
23.265	3	22	07	Xp11.22	CCNB3		Cyclin B3	300456	A, REc			
23.266	8	31	07	Xp11.23	CLCN5, CLCK2, NPHL2, DENTS, NPHL1		Chloride channel-5	300008	RE		Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3); Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	X(Clcn5)
23.267	3	9	11	Xp11.22	DGKK		Diacylglycerol kinase, kappa, 142kD	300837	REc			
23.268	8	22	14	Xp11.22	DUPXp11.22, MRX17, MRX31		Xp11.22 microduplication syndrome	300705	Ch	minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10	Xp11.22 microduplication syndrome (4)	
23.269	7	18	12	Xp11.22	GNL3L		Guanine nucleotide binding protein-like 3-like protein	300873	REc			
23.270	2	2	14	Xp11.22	GPR173, SREB3		G protein-coupled receptor 173	300253	R, REc			
23.271	4	23	08	Xp11.22	HPCX2		Prostate cancer, hereditary, X-linked 2	300704	Fd	associated with rs5945572	{Prostate cancer, hereditary, X-linked 2} (2)	
23.272	9	12	11	Xp11.22	HYSP4		Hypospadias 4, X-linked, susceptibility to	300856	Fd	associated with rs1934179 and rs7063116	{Hypospadias 4, X-linked, susceptibility to} (2)	
23.273	5	11	16	Xp11.22	IQSEC2, KIAA0522, MRX1, MRX78		IQ motif- and Sec7 domain-containing protein 2	300522	R, REc, H		Mental retardation, X-linked 1/78, 309530 (3)	X(Iqsec2)
23.274	12	21	09	Xp11.22	MIR98, MIRN98		Micro RNA 98	300810	REc			
23.275	3	23	09	Xp11.22	MIRLET7F2, LET7F2, MIRNLET7F2		Micro RNA Let7f2	300721	REc			
23.276	5	28	13	Xp11.22	SSX2		Sarcoma, synovial, X breakpoint 2	300192	Ch, RE		?Sarcoma, synovial, 300813 (3)	
23.277	5	29	13	Xp11.22	SSX7		Sarcoma, synovial, X breakpoint 7	300542	REc			
23.278	5	28	13	Xp11.22	SSX8		Sarcoma, synovial, X breakpoint 8	300543	REc			
23.279	9	20	11	Xp11.23	TFE3, RCCX1		Transcription factor for IgH enhancer	314310	REa, Fd	fuses with PRCC in RCCP	Renal cell carcinoma, papillary, 1, 300854 (3)	X(Tfe3)
23.280	3	25	15	Xp11.22	TSR2, WGG1, DBA14		TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of	300945	REc	mutation identified in 1 DBA14 family	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	
23.281	9	22	08	Xp11.22	XAGE1A		X antigen family, member 1A	300742	REc			
23.282	9	22	08	Xp11.22	XAGE1B		X antigen family, member 1B	300743	REc			
23.283	9	22	08	Xp11.22	XAGE1C		X antigen family, member 1C	300744	REc			
23.284	9	22	08	Xp11.22	XAGE1E		X antigen family, member 1E	300745	REc			
23.285	5	26	13	Xp11.22	XAGE2, GAGED3		X antigen family, member 2	300416	REc			
23.286	9	8	08	Xp11.22	XAGE3, PLAC6		X antigen family, member 3	300740	REc			
23.287	10	24	11	Xp11.22	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ		Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C)	314690	REa, REn, A	escapes inactivation	Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	X(Smcx)
23.288	2	9	17	Xp11.22	SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2		Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)	300040	REn	escapes lyonization	Cornelia de Lange syndrome 2, 300590 (3)	X(Sb1.8)
23.289	6	10	98	Xp11.21	TRO		Trophinin	300132	A			
23.290	3	17	16	Xp11.21	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1		Aminolevulinate, delta-, synthase-2	301300	Ch, REa, A, Fd		Anemia, sideroblastic, 1, 300751 (3); Protoporphyria, erythropoietic, X-linked, 300752 (3)	X(Alas)
23.291	5	12	09	Xp11.21	APEX2, APE2, XTH2, APEXL2		APEX nuclease (apurinic/apyrimidinic endonuclease) 2	300773	REc			
23.292	5	26	13	Xp11.21	DSF34		DXF34 gene	300621	REc			X(Dxf34)
23.293	10	27	11	Xp11.22	FGD1, FGDY, AAS, MRXS16		FYVE, RhoGEF, and PH domain-containing protein 1	300546	X/A, Fd		Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked syndromic 16, 305400 (3)	X(Fgdy)
23.294	4	10	15	Xp11.21	FOXR2, FOXN6		Forkhead box R2	300949	REc, H			X(Foxn6)
23.295	5	28	13	Xp11.21	MAGEH1, MAGEH		Melanoma antigen, family H, 1	300548	REc			
23.296	9	4	08	Xp11.21	PAGE2, GAGEC2		P antigen family, member 2	300738	REc			
23.297	9	4	08	Xp11.21	PAGE3, GAGEC1		P antigen family, member 3	300739	REc			
23.298	12	22	17	Xp11.21	PAGE5, CT16, GAGEE1		P antigen family, member 5	301009	REc			
23.299	4	27	00	Xp11.21	PFKFB1, PFRX		Fructose-2,6-bisphosphatase	311790	REa, A, REc	?Xq27-q25; ?Xcen-q13		
23.300	8	29	08	Xp11.21	RRAGB, RAGB		Ras-related GTP-binding protein B	300725	R, REc			
23.301	5	26	13	Xp11.21	SNORA11		Small nucleolar RNA, H/ACA box, 11	300662	REc	in intron 1 of MAGED2		
23.302	5	26	13	Xp11.21	SPIN2		Spindlin family, member 2	300517	REc			
23.303	1	8	01	Xp11.21	ZXDA		Zinc finger-encoding gene, X-linked, duplicated, A	300235	REa, REc			
23.304	1	8	01	Xp11.21	ZXDB		Zinc finger-encoding gene, X-linked, duplicated, B	300236	REa, REc			
23.305	8	25	04	Xp11.21-q22.3	MRX52		Mental retardation, X-linked 52	300504	Fd	max lod at DXS559	Mental retardation, X-linked 52 (2)	
23.306	10	1	99	Xp11.22	AKAP4, AKAP82, HI, FSC1		A-kinase anchor protein 4, 82kD	300185	A			
23.307	8	31	06	Xp11.22	BMP15, GDF9B, ODG2, POF4		Bone morphogenetic protein 15	300247	A		Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4, 300510 (3)	X(Bmp15)
23.308	9	22	08	Xp11.22	FAM120C, CXorf17		Family with sequence similarity 120, member C	300741	REc			
23.309	5	10	17	Xp11.22	HSD17B10, HADH2, ERAB, MRXS10, HSD10MD		17-beta-hydroxysteroid dehydrogenase X	300256	REc, Fd		HSD10 mitochondrial disease, 300438 (3)	
23.310	9	12	92	Xp11.23	ELK1		ELK1, member of ETS oncogene family	311040	REa, A	distal to OATL1		X(Elk1)
23.311	7	2	03	Xp11.23	HRAS2, HRASP		v-Ha-ras harvey rat sarcoma viral oncogene homolog 2	300437	REc			
23.312	6	5	08	Xp11.22	HUWE1, UREB1, KIAA0312, LASU1		HECT, UBA, and WWE domains-containing protein 1	300697	REc, R		Mental retardation, X-linked syndromic, Turner type, 300706 (3)	X(Huwe1)
23.313	1	26	12	Xp11.3	KDM6A, UTX, KABUK2		Lysine (K)-specific demethylase 6A	300128	REa, A	UTY also in mouse and man; escapes inactivation	Kabuki syndrome 2, 300867 (3)	X(Utx)
23.314	5	19	16	Xp11.21	MAGED2, MAGED, BARTS5		Melanoma antigen, family D, 2	300470	REc, A		Bartter syndrome, type 5, antenatal, transient, 300971 (3)	
23.315	4	17	06	Xp11.22	PHF8, ZNF422, KIAA1111, MRXSSD		PHD finger protein 8	300560	Fd, REc		Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	
23.316	4	20	17	Xp11.22	SHROOM4, KIAA1202, SDSX		Shroom family member 4	300579	Fd, Ch, REc		Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	
23.317	7	6	00	Xp11.23	TIMM17B, TIM17B		Translocase of inner mitochondrial membrane 17, yeast, homolog of, B	300249	A			
23.318	9	2	08	Xp11.22	TSPYL2, CDA1, DENTT, CINAP		TSPY-like 2	300564	R, REc			
23.319	5	26	05	Xp11.22	WNK3, PRKWNK3, KIAA1566		WNK lysine deficient protein kinase 3	300358	R, REc			
23.320	9	26	16	Xp11.23	USP27X, USP22L, MRX105		Ubiquitin-specific protease 27, X-linked	300975	REc		Mental retardation, X-linked 105, 300984 (3)	
23.321	2	15	96	Xp11.3	ZNF157		Zinc finger protein-157 (HZF22)	300024	REc			
23.322	10	22	99	Xp11.3	RGN, SMP30		Regucalcin	300212	Psh			
23.323	5	12	03	Xp11.2-q12	MRX81		Mental retardation, X-linked 81	300433	Fd	between DXS1039 and DXS1216	Mental retardation, X-linked 81 (2)	
23.324	2	24	17	Xp11.21	NBDY, LINC01420, NOBODY		Negative regulator of P-body association	300992	REc			
23.325	3	13	08	Xp11.21	FAAH2		Fatty acid amide hydrolase 2	300654	REc			
23.326	10	14	09	Xp11	GRDX, GD3		Graves disease, susceptibility to, X-linked	300351	Fd		{Graves disease, susceptibility to, X-linked} (2)	
23.327	6	29	98	Xp11	IDDMX		Diabetes mellitus, insulin-dependent, X-linked, susceptibility to	300136	Fd	only with DR3	{Diabetes mellitus, insulin-dependent, X-linked} (2)	
23.328	12	28	05	Xp11	LOAS		Leber optic atrophy, susceptibility to	308905	Fd		{Leber optic atrophy, susceptibility to} (2)	
23.329	3	11	08	Xp11.22	MAGED4, MAGEE1, KIAA1859		Melanoma antigen, family D, 4	300702	R			
23.330	3	19	09	Xp11.22	MAGED4B		Melanoma antigen, family D, 4B	300765	REc			
23.331	2	17	06	Xp11	MRXS12		Mental retardation, X-linked, syndromic 12	309545	Fd		?Mental retardation, X-linked, syndromic 12 (2)	
23.332	5	26	13	Xp11.22	SPANXN5		SPANX family, member N5	300668	REc			
23.333	1	24	14	Xp11.3	ZNF674		Zinc finger protein 674	300573	REc			
23.334	4	16	96	Xp11-q21	MRX20		Mental retardation, X-linked-20	300047	Fd		Mental retardation, X-linked 20 (2)	
23.335	1	10	93	Xp11-q21	PRS, MRXS2		Prieto syndrome (mental retardation, X-linked, syndromic 2, with dysmorphism and cerebral atrophy)	309610	Fd		Prieto syndrome (2)	
23.336	12	1	94	Xp22.2	CALB3, CABP9K		Calbindin 3 (vitamin D-dependent calcium-binding protein)	302020	REa			
23.337	12	22	17	Xq13.1	ARR3, MYP26		Arrestin 3, retinal	301770	REa		Myopia 26, X-linked, female-limited, 301010 (3)	
23.338	8	5	97	Xq	CGF1		Cognitive function-1, social	300082	Ch	imprinted locus	[Social cognition] (2)	
23.339	3	28	90	Xq	DXS435E, A11		A-11 gene	300010	REc			
23.340	11	29	11	Xq	MGR2		Migraine, familial typical, susceptibility to, 2	300125	Fd		{Migraine, familial typical, susceptibility to, 2} (2)	
23.341	8	15	13	Xq	MTBSX		Mycobacterium tuberculosis, susceptibility to, X-linked	300259	Fd		{Mycobacterium tuberculosis, susceptibility, X-linked} (2)	
23.342	11	8	03	Xp11.4	TSPAN7, TM4SF2, MXS1, A15, MRX58		Tetraspanin 7	300096	REa, Ch, A		Mental retardation, X-linked 58, 300210 (3)	
23.343	5	15	08	Xq11-q12	AGA2		Alopecia, androgenetic, 2	300710	Fd	associated with rs6152	Alopecia, androgenetic, 2 (2)	
23.344	2	23	09	Xq12	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1		Androgen receptor (dihydrotestosterone receptor)	313700	S, Fd, REa, A		Androgen insensitivity, 300068 (3); Spinal and bulbar muscular atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to}, 176807 (3); Hypospadias 1, X-linked, 300633 (3)	X(Tfm)
23.345	8	9	99	Xq12	HEPH		Hephaestin	300167	R, H, Psh, REc			X(Heph)
23.346	9	23	13	Xq11.2	AMER1, FAM123B, WTX, OSCS		APC membrane recruitment protein 1	300647	REc		Osteopathia striata with cranial sclerosis, 300373 (3)	
23.347	1	31	13	Xq11.2	ASB12		Ankyrin repeat- and SOCS box-containing protein 12	300891	REc			
23.348	12	22	00	Xq11.2	SPG16		Spastic paraplegia 16, X-linked, complicated	300266	Fd		Spastic paraplegia 16, X-linked, complicated (2)	
23.349	7	1	13	Xq11.2	ZC4H2, KIAA1166, WRWF		Zinc finger C4H2 domain-containing protein	300897	REc, R		Wieacker-Wolff syndrome, 314580 (3)	
23.350	12	15	16	Xq12	MSN, IMD50		Moesin	309845	REa, A		Immunodeficiency 50, 300988 (3)	X(Msn)
23.351	2	28	08	Xq12	EDAR2, XEDAR, EDAA2R		Ectodysplasin A2 receptor	300276	REc			
23.352	6	23	04	Xq13.1	EFNB1, EPLG2, CFNS, CFND		eph-related receptor tyrosine kinase ligand 2 (ephrin B1)	300035	REa, A, REc, H, Ch, Fd	?CFNS also on Xp22	Craniofrontonasal dysplasia, 304110 (3)	X(Eplg2)
23.353	3	2	06	Xq13.1	INGX, ING2		Inhibitor of growth, X-linked	300452	REc			
23.354	8	10	16	Xq12	LAS1L, WTS		Las1-like ribosome biogenesis factor	300964	REc		Wilson-Turner syndrome, 309585 (3)	
23.355	3	23	09	Xq12	MIR223, MIRN223		Micro RNA 223	300694	REc			
23.356	3	24	06	Xq12	OPHN1, MRX60		Oligophrenin-1	300127	Ch, A		Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	
23.357	8	30	01	Xq12	Z39IG		Immunoglobulin superfamily protein Z39IG	300353	REc			
23.358	1	9	13	Xq11-q12	ZC3H12B, MCPIP2		Zinc finger CCCH domain-containing protein 12B	300889	REc			
23.359	6	7	10	Xq21.1	ATP7A, MNK, MK, OHS, SMAX3		ATPase, Cu++ transporting, alpha polypeptide	300011	Fc, X/A, H	probably Xq13.2-q13.3, ~150kb prox. to PGK1	Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3); Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	X(Mnk)
23.360	5	16	01	Xq13.1	ITGB1BP2		Integrin, beta-1, binding protein of, 2	300332	A			X(Itgb1bp2)
23.361	2	6	07	Xp11.4-p11.2	GAGE8		G antigen 8	300638	Psh, A			
23.362	12	17	12	Xq13.1	EDA, ED1, ECTD1, HED1, STHAGX1		Ectodysplasin A	300451	X/A, H, Fd		Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3); Tooth agenesis, selective, X-linked 1, 313500 (3)	X(Ta)
23.363	6	12	17	Xq12-q13	YIPF6		YIP1 domain family, member 6	300996	REc			
23.364	5	13	13	Xq21.1	TBX22, CPX, ABERS		T-box 22	300307	REc, Fd	1 ABERS family identified with mutation	Cleft palate with ankyloglossia, 303400 (3); ?Abruzzo-Erickson syndrome, 302905 (3)	
23.365	10	10	02	Xp22.3	FGS3		FG syndrome 3	300406	Fd		FG syndrome 3 (2)	
23.366	12	11	03	Xq12-q21.3	MRX77		Mental retardation, X-linked 77	300454	Fd		Mental retardation, X-linked 77 (2)	
23.367	6	9	08	Xq12-q21.31	MRXS9		Mental retardation, X-linked, syndromic 9	300709	Fd	between DXS1111 and DXS1197	Mental retardation, X-linked, syndromic 9 (2)	
23.368	12	7	07	Xq21.1	ATRX, XH2, XNP, SHS, SFM1, MRXHF1		ATR-X gene (helicase 2; X-linked nuclear protein)	300032	RE, Fd		Alpha-thalassemia/mental retardation syndrome, 301040 (3); Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	X(Xh2)
23.369	2	26	10	Xq21.1	BRWD3, MRX93		Bromodomain-and WD repeat-containing protein 3	300553	REc		Mental retardation, X-linked 93, 300659 (3)	
23.370	3	1	06	Xq13.1	CXCR3, GPR9, CD182		Chemokine, C-X-C motif, receptor 3 (G protein-coupled receptor-9)	300574	A, REc, R	previously assigned to chr.8		
23.371	9	10	12	Xq13.1	DMRTC1		Doublesex- and MAB3-related transcription factor C1	300878	REc			
23.372	8	10	16	Xq13.1	HDAC8, MRXS6, CDLS5		Histone deacetylase 8	300269	A, R, Fd		Cornelia de Lange syndrome 5, 300882 (3)	
23.373	5	18	95	Xq13.1	IL2RG, SCIDX1, SCIDX, IMD4		Interleukin-2 receptor, gamma	308380	Fd	linked to DXS159	Severe combined immunodeficiency, X-linked, 300400 (3); Combined immunodeficiency, X-linked, moderate, 312863 (3)	X(Il2rg)
23.374	5	13	13	Xq13.1	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX		Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of	300188	REc, Fd		Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3); Ohdo syndrome, X-linked, 300895 (3)	X(Opa1)
23.375	12	16	05	Xq13.1	NLGN3, ASPGX1, AUTSX1		Neuroligin 3	300336	REc		{Autism susceptibility, X-linked 1}, 300425 (3); {Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	
23.376	12	11	02	Xq21.1	NSBP1		Nucleosomal binding protein 1	300385	R			X(Nsbp1)
23.377	6	28	17	Xq13.1	OGT, MRX106		O-linked N-acetylglucosamine transferase	300255	A, R		Mental retardation, X-linked 106, 300997 (3)	X(Ogt)
23.378	10	15	97	Xq13.1	P2RY4, NRU, P2Y4		Pyrimidinergic receptor P2Y, G-protein coupled, 4	300038	A			
23.379	7	2	07	Xq21.1	PGK1, PGKA		Phosphoglycerate kinase-1	311800	S, R, REb, Fd	?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6	Phosphoglycerate kinase 1 deficiency, 300653 (3)	X(Pgk1)
23.380	5	15	07	Xq13.1	PHKA1		Phosphorylase kinase, muscle, alpha polypeptide	311870	REa, A, REn	?proximal and close to PGKA;	Muscle glycogenosis, 300559 (3)	X(Phka)
23.381	2	1	01	Xq13.1	PIN4, PAR14, EPVH		Peptidyl-prolyl cis/trans isomerase, nima-interacting, 4	300252	REc			
23.382	1	11	16	Xq13.1	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33		TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD	313650	S, H	SVA retrotransposon insertion	Dystonia-Parkinsonism, X-linked, 314250 (3); Mental retardation, X-linked, syndromic 33, 300966 (3)	X(Ccg1)
23.383	8	29	02	Xq21.1	CYSLTR1, CYSLT1		Cysteinyl leukotriene receptor 1	300201	REa, R			
23.384	10	14	18	Xq13.2	RNF12, RLIM, TOKAS		Putative RING zinc finger protein NY-REN-43 antigen	300379	A		Tonne-Kalscheuer syndrome, 300978 (3)	X(Rnf12)
23.385	4	24	08	Xq21.1	LPAR4, LPA4, P2RY9, P2Y9, GPR23		Lysophosphatidic acid receptor 4	300086	A			
23.386	10	25	11	Xq13-q22	MCS, MRXS4		Miles-Carpenter syndrome (mental retardation, X-linked, syndromic 4, with congenital contractures and low fingertip arches)	309605	Fd	linked to DXYS1	Miles-Carpenter syndrome (2)	
23.387	12	27	01	Xq13.1	ACRC		Acidic repeat-containing gene	300369	REc			
23.388	7	18	14	Xq13.1	AWAT1, DGA2		Acyl-CoA wax alcohol acyltransferase 1	300924	REc			
23.389	7	18	14	Xq13.1	DGAT2L6, DC3		Diacylglycerol O-acyltransferase 2-like 6	300926	REc			
23.390	7	18	14	Xq13.1	AWAT2, DC4, MFAT		Acyl-CoA wax alcohol acyltransferase 2	300925	REc			X(Awat2)
23.391	8	10	11	Xq13.1	DLG3, NEDLG, SAP102, MRX90		Discs large, Drosophila, homolog of, 3	300189	A, R		Mental retardation, X-linked 90, 300850 (3)	
23.392	1	17	08	Xq13.1	ERCC6L, PICH		ERCC6-like	300687	REc			
23.393	4	17	13	Xq13.1	FOXO4, MLLT7, AFX1		Forkhead box O4	300033	Ch			
23.394	8	1	16	Xq13.1	GDPD2, GDE3		Glycerophosphodiester phosphodiesterase domain-containing protein 2	300940	REc			
23.395	10	27	93	Xq13.1	GJB1, CX32, CMTX1		Gap junction protein, beta-1, 32kD (connexin 32)	304040	REa, Fd		Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	X(Gjb1)
23.396	8	11	14	Xq13.1	KIF4A, KIF4, MRX100		Kinesin family member 4A	300521	A	mutation identified in 1 MRX100 family	?Mental retardation, X-linked 100, 300923 (3)	
23.397	3	19	09	Xq13.3	MAGEE1, DAMAGE, KIAA1587		Melanoma antigen, family E, 1	300759	REc			
23.398	3	19	09	Xq13.3	MAGEE2		Melanoma antigen, family E, 2	300760	REc			
23.399	1	13	99	Xq13.1	MSG1		Melanocyte-specific gene 1	300149	Psh			X(msg1)
23.400	2	19	16	Xq13.1	NONO, NRB54, MRXS34		Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)	300084	A	2Mb proximal to PHKA1	Mental retardation, X-linked, syndromic 34, 300967 (3)	
23.401	6	5	08	Xq13.1	OTUD6A, DUBA2		OTU domain-containing protein 6A	300714	REc			
23.402	1	5	07	Xq13.1	PDZD11, AIPP1, PISP		PDZ domain-containing 11	300632	REc			
23.403	6	19	12	Xq13.1	PJA1		Praja 1	300420	REc			
23.404	4	4	00	Xq13.1	RPS4X, CCG2, SCAR		Ribosomal protein S4, X-linked	312760	A, REa, REn	cen-RPS4X-PHKA1-XIST-qter in 2.6Mb		X(Rps4x)
23.405	5	28	13	Xq13.1	SLC7A3, CAT3		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3	300443	REc, R			
23.406	12	10	12	Xq13.1	SNX12		Sorting nexin 12	300883	REc			
23.407	1	28	08	Xq13.1	STARD8, DLC3, STARTGAP3, KIAA0189		START domain-containing protein 8	300689	R, REc			
23.408	6	18	15	Xq13.1	TEX11, SPGFX2		Testis-expressed gene 11	300311	R, REc		Spermatogenic failure, X-linked, 2, 309120 (3)	
23.409	10	12	99	Xq13.1	ZMYM3, ZNF261, DXS6673E		Zinc finger, MYM-type 3	300061	REc			
23.410	2	2	14	Xq21.1	MAGT1, IAP, XMEN		Magnesium transporter 1	300715	REc, H		Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	X(Magt1)
23.411	10	29	99	Xq13.3	ABCB7, ABC7, ASAT		ATP-binding cassette-7	300135	A		Anemia, sideroblastic, with ataxia, 301310 (3)	X(Abc7)
23.412	2	3	04	Xq13.1	IGBP1		Immunoglobulin-binding protein 1	300139	A		Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	
23.413	5	19	06	Xq13.1-q22.1	CFTDX		Myopathy, congenital, with fiber-type disproportion, X-linked	300580	Fd	between DXS8019 and DXS99	Myopathy, congenital, with fiber-type disproportion, X-linked (2)	
23.414	12	24	08	Xq21.1	TAF9B, TAF9L, TAFII31L		TAF9B RNA polymerase II, TATA box-binding protein-associated factor, 31kD	300754	R, REc			
23.415	9	14	95	Xq13.2	CDX4		Caudal type homeo box transcription factor 4	300025	REn			X(Cdx4)
23.416	6	22	14	Xq13.2	CHIC1, BRX		Cystein-rich hydrophobic domain protein 1	300922	REc			
23.417	11	24	14	Xq13.2	FTX, LINC00182		FTX transcript, XIST regulator, noncoding	300936	REc			X(Ftx)
23.418	10	25	11	Xq13.2	MRXSAB		Abidi X-linked mental retardation syndrome	300262	Fd		Mental retardation, X-linked syndromic, Abidi type (2)	
23.419	6	1	12	Xq13.2	NAP1L2, BPX		Nucleosome assembly protein 1-like 2	300026	REc			
23.420	2	8	11	Xq13.2	NCRNA00183, JPX, ENOX		Noncoding RNA 183	300832	REc			
23.421	9	13	17	Xq13.3	NEXMIF, KIAA2022, MRX98		Neurite extension and migration factor	300524	Ch	inv(X)(q13;p22)	Mental retardation, X-linked 98, 300912 (3)	
23.422	6	21	05	Xq13.2	SLC16A2, DXS128, XPCT		Solute carrier family 16 (monocarboxylic acid transporters), member 2	300095	RE		Allan-Herndon-Dudley syndrome, 300523 (3)	
23.423	3	29	99	Xq13.2	TSIX		X-inactivation-specific transcript-antisense	300181	REn			
23.424	3	17	98	Xq13.2	XIC, XCE, XIST, SXI1		X chromosome controlling element (X-inactivation center)	314670	Ch, S, A	q13-q21; metaphase bend, or fold, at q13.3-q21.1	X-inactivation, familial skewed, 300087 (3)	X(Xce)
23.425	8	26	15	Xq13.3	BRAFP1		BRAF pseudogene 1	300956	REc			10(Brafrs1)
23.426	4	15	11	Xq21.1	PGAM4, PGAM3		Phosphoglycerate mutase family member 4	300567	REn			
23.427	5	21	99	Xq21.1	SH3BGR		SH3-binding domain glutamic acid-rich protein-like	300190	A			
23.428	5	26	13	Xq13.3	UPRT		Uracil phosphoribosyltransferase, S. cerevisiae, homolog of	300656	REc			
23.429	2	21	06	Xq13.3	ZDHHC15, MRX91		Zinc finger DHHC domain-containing protein 15	300576	REc, Ch	disruption of ZDHHC15 identified in 1 patient	?Mental retardation, X-linked 91, 300577 (3)	
23.430	3	8	00	Xq21.1	ITM2A, E25A		Integral membrane protein 2A	300222	A			X(Itm2a)
23.431	5	18	12	Xq21	DELXq21, CXDELq21		Chromosome Xq21 deletion syndrome	303110	Ch	at least CHM and POU3F4 deleted	Choroideremia, deafness, and mental retardation (4)	
23.432	7	17	06	Xq21.1	FLJ22792, POF1B, POF2B		FLJ22792 gene	300603	REc, Ch	mutation identified in 1 POF2B family	?Premature ovarian failure 2B, 300604 (3)	
23.433	3	6	01	Xq21.1	RPS6KA6, RSK4		Ribosomal protein S6 kinase, 90kD, 6	300303	REc			
23.434	7	17	01	Xq21.33	EPAG		Early lymphoid activation gene	300347	A, REa			
23.435	4	10	15	Xq21-q25	PARK12		Parkinson disease-12	300557	Fd	max lod with DXS1106, DXS8055, DXS1001	{Parkinson disease 12} (2)	
23.436	3	24	09	Xq21.1	CYLC1		Cylicin 1	300768	REc			
23.437	5	13	15	Xq21.1	COX7B, LSDMCA2		Cytochrome c oxidase, subunit VIIb	300885	REc		Linear skin defects with multiple congenital anomalies 2, 300887 (3)	
23.438	7	11	16	Xq21.1	FAM46D		Family with sequence similarity 46, member D	300976	REc			
23.439	10	15	13	Xq21.1	FGF16, MF4		Fibroblast growth factor 16	300827	REc	previously mapped to 8q21.3	Metacarpal 4-5 fusion, 309630 (3)	
23.440	8	2	13	Xq21.1	GPR174, GPCR17		G protein-coupled receptor 174	300903	REc			X(Gpr174)
23.441	5	30	17	Xq21.1	HDX, CXorf43		Highly divergent homeobox	300994	REc			
23.442	5	28	13	Xq21.1	P2RY10, P2Y10		Purinergic receptor P2Y, G protein-coupled, 10	300529	REc			
23.443	3	18	08	Xq21.1	POU3F4, DFN3, DFNX2		POU domain, class 3, transcription factor 4	300039	Fd, D, H, REn		Deafness, X-linked 2, 304400 (3)	X(Pou3f4)
23.444	10	29	11	Xq21.1	ZNF711, ZNF6, CMPX1, MRX97		Zinc finger protein-711	314990	REa, A		Mental retardation, X-linked 97, 300803 (3)	
23.445	7	28	15	Xq21.1	APOOL, FAM121A, Cxorf33		Apolipoprotein O-like	300955	REc			
23.446	5	1	02	Xq21.2	CHM, TCD		Rab escort protein 1	300390	Fd, LD, D, A, Ch, X/A		Choroideremia, 303100 (3)	X(rep1)
23.447	2	26	09	Xq21.3	AD16		Alzheimer disease 16	300756	Fd	associated with rs5984894	{Alzheimer disease 16} (2)	
23.448	5	26	13	Xq21.2	DACH2		Dachshund, Drosophila, homolog of, 2	300608	REc			X(Dach2)
23.449	5	28	13	Xq21.31	KLHL4		Kelch-like 4	300348	REc			
23.450	4	30	03	Xq21.31	PABPC5, PABP5		Polyadenylate-binding protein, cytoplasmic, 5	300407	REa			
23.451	7	26	02	Xq21.31	PCDH11X, PCDH11, PCDHX		Protocadherin 11, X-linked	300246	REc			
23.452	12	24	08	Xq22.1	BTK, AGMX1, IMD1, XLA, AT		Bruton agammaglobulinemia tyrosine kinase	300300	H, Fd, A		Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	X(xid, Btp)
23.453	6	29	99	Xq21.32	NAP1L3		Nucleosome assembly protein 1-like 3	300117	Psh			
23.454	6	29	99	Xp22.2	TMSB4X, TMSB4, TB4X, PTMB4		Thymosin, beta-4, X chromosome	300159	Psh			X(Tmsb4x)
23.455	8	27	01	Xq22.1	NXF3		Nuclear RNA export factor 3	300316	REc			
23.456	3	23	09	Xq21.33	RPA4		Replication protein A4	300767	REc			
23.457	7	31	08	Xq22.1	SYTL4		Synaptotagmin-like 4	300723	REc			
23.458	3	14	06	Xq22.1	ARMCX1, ALEX1		Armadillo repeat containing, X-linked 1	300362	R			
23.459	3	14	06	Xq22.1	ARMCX2, ALEX2, KIAA0512		Armadillo repeat containing, X-linked 2	300363	R			
23.460	3	14	06	Xq22.1	ARMCX3, ALEX3		Armadillo repeat containing, X-linked 3	300364	REc			
23.461	10	28	11	Xq21.33-q23	MRXSCS		Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	Fd	max lod at DXS1120	Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)	
23.462	10	16	14	Xq22.1	SRPX2, SRPUL, RESDX		SUSHI repeat-containing protein, X-linked, 2	300642	A, REc	mutation identified in 1 RESDX family	?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	
23.463	5	28	13	Xq22.3	ATG4A, APG4A, AUTL2		Autophagy 4, S. cerevisiae, homolog of, A	300663	REc			
23.464	2	6	08	Xq22.2	BEX2		Brain-expressed X-linked gene 2	300691	R			
23.465	5	9	17	Xq21.33	DIAPH2, DIA, POF2A		Diaphanous, Drosophila, homolog of, 2	300108	REc, A	mutation identified in 1 POF2A family	?Premature ovarian failure 2A, 300511 (3)	
23.466	7	8	96	Xq22.1	DRP2		Dystrophin-related protein 2	300052	REc			
23.467	10	21	96	Xq22.1	FSHPRH1, LRPR1		FSH primary response, rat, homolog of, 1	300065	REn, REc			
23.468	3	10	02	Xq22.1	GPRASP1, GASP, KIAA0443		G protein-coupled receptor-associated sorting protein 1	300417	REc	conflicting assignment to chr.9		
23.469	3	28	07	Xq22.1	GLA		Galactosidase, alpha	300644	S, R, A, Fd		Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)	X(Ags)
23.470	5	29	98	Xq22-q23	GUCY2F, GUC2F		Guanylate cyclase 2F	300041	A			X(Gucy2f)
23.471	6	16	17	Xq22.1	HNRNPH2, NRPH2, MRXSB		Heterogeneous nuclear ribonucleoprotein H2	300610	A, REc	second signal at 6q25.3-q26, pseudogene?	Mental retardation, X-linked, syndromic, Bain type, 300986 (3)	
23.472	11	4	00	Xq22.3	IL1RAPL2		Interleukin 1 receptor accessory protein-like 2	300277	REc			
23.473	6	9	08	Xq23	KKLC1, CXorf61		Kita-Kyushu lung cancer antigen 1	300625	REc			
23.474	8	12	14	Xq22.3	MID2, MRX101		Midline 2	300204	REc	mutation identified in 1 MRX101 family	?Mental retardation, X-linked 101, 300928 (3)	X(Mid2)
23.475	6	6	03	Xq22.2	MORFL2, MRGX, KIAA0026		Mortality factor 4-like 2	300409	A			
23.476	01	03	00	Xq22.1	NOX1, MOX1, NOH1		NADPH oxidase 1	300225	REc			
23.477	2	24	10	Xq22.1	PCDH19, KIAA1313, EFMR, EIEE9		Protocadherin 19	300460	R, REc, Fd		Epileptic encephalopathy, early infantile, 9, 300088 (3)	
23.478	1	29	13	Xq22.2	PLP1, PMD, HLD1, SPG2		Proteolipid protein 1	300401	REa, A, Ch, R, Fd		Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia 2, X-linked, 312920 (3)	X(Plp(jp))
23.479	4	25	08	Xq22.1	TNMD, TEM, CHM1L		Tenomodulin	300459	REc			
23.480	1	20	06	Xq22.1	TSPAN6, TM4SF6		Tetraspanin 6	300191	A			
23.481	4	21	16	Xq22.1	TIMM8A, DFN1, DDP, MTS, DDP1		Translocase of inner mitochondrial membrane 8, yeast, homolog of, A	300356	Fd, REn		Mohr-Tranebjaerg syndrome, 304700 (3)	
23.482	7	8	89	Xq22.3	MYCL2		MYCL-related processed gene	310310	REa	pseudogene on Xq27.3		
23.483	4	26	06	Xq24	MCTS1, MCT1		Malignant T-cell amplified sequence 1	300587	A			
23.484	5	22	03	Xq24	PGRMC1		Progesterone receptor membrane component 1	300435	Psh			
23.485	2	26	10	Xq22.3	PRPS1, CMTX5, DFNX1, DFN2		Phosphoribosyl pyrophosphate synthetase-1	311850	S, R, REa, A, Fd		Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1, 304500 (3)	
23.486	7	11	14	Xq22-q28	AI1E2, AIH3		Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2	301201	Fd		?Amelogenesis imperfecta, type IE, X-linked 2 (2)	
23.487	2	11	11	Xq11.1	ARHGEF9, PEM2, KIAA0424, EIEE8		Rho guanine nucleotide exchange factor 9	300429	REc		Epileptic encephalopathy, early infantile, 8, 300607 (3)	
23.488	2	6	08	Xq22.1	BEX5, NGFRAP1L1		BEX family member 5	300693	REc			
23.489	4	29	14	Xq22.1	BHLHB9, P60TRP, KIAA1701		Basic helix-loop-helix domain-containing protein, class B, 9	300921	REc			
23.490	11	1	13	Xq22.1	CSTF64		Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD	300907	REc			
23.491	8	17	16	Xq22.1	GPRASP2, GASP2		G protein-coupled receptor-associated sorting protein 2	300969	REc			
23.492	11	19	13	Xq22.1	NXF5		Nuclear RNA export factor 5	300319	REc			
23.493	6	26	13	Xq22.1	RPL36A, RPL44		Ribosomal protein L36A	300902	REc, R			
23.494	4	04	00	Xq22.2	TCEAL1, P21, SIIR		Transcription elongation factor A-like 1	300237	A, REc			
23.495	11	25	14	Xq22.1	TMSB15A, TMSB15, TMSNB		Thymosin, beta-15A	300939	REc			
23.496	12	17	07	Xq22.1	XKRX, XPLAC, XKR2, XRG2		X Kell blood group precursor-related, X-linked	300684	REc			
23.497	11	16	17	Xq22.1	ZMAT1, KIAA1789		Zinc finger, matrin-type 1	301007	REc			
23.498	2	6	08	Xq22.1	BEX1		Brain-expressed X-linked gene 1	300690	REc, H			X(Bex1)
23.499	5	10	04	Xq22.2	ESX1L, ESXR1		ESX1-like protein	300154	REc, H			X(Esx1)
23.500	8	27	01	Xq22.1	NXF4		Nuclear RNA export factor 4	300318	REc			
23.501	12	8	00	Xq22.2	RAB9B, RAB9L		RAS-associated protein RAB9B	300285	R			
23.502	5	5	09	Xq22.2	TCEAL7		Transcription elongation factor A-like 7	300771	REc			
23.503	5	26	13	Xq22.3	VSIG1, GPA34		V-set and immunoglobulin domains-containing protein 1	300620	REc			
23.504	4	10	12	Xq23	CHRDL1, VOPT, MGC1		Chordin-like 1	300350	REc, Fd		Megalocornea 1, X-linked 309300 (3)	
23.505	10	10	01	Xq22.2	NGFRAP1, BEX3, NADE, DXS6984E		Nerve growth factor receptor (TNFRSF16) associated protein 1	300361	REc			
23.506	2	6	08	Xq22.1	BEX4		BEX family member 4	300692	REc			X(Bex4)
23.507	5	26	13	Xq22.2	H2BFWT		H2B histone family, member W, testis-specific	300507	REc			
23.508	10	12	14	Xq22.1	RAB40AL, RLGP, MRXSMP		Ras-associated protein, RAB40A-like	300405	REc			
23.509	12	30	14	Xq22.2	SLC25A53		Solute carrier family 25, member 53	300941	REc			
23.510	9	16	16	Xq22.3	TBG, TBGQTL		Thyroxine-binding globulin	314200	REa, A		[Thyroxine-binding globulin QTL], 300932 (3)	
23.511	2	20	07	Xq22.3	TSC22D3, DSIPI, GILZ		TSC22 domain family, member 3	300506	A			
23.512	1	23	18	Xq22.2	TMSB15B		Thymosin, beta-15B	301011	REc	opposite strand relative to TMSB15A		
23.513	4	26	01	Xq22.2-q26	MRX53		Mental retardation, X-linked-53	300324	Fd		Mental retardation, X-linked 53 (2)	
23.514	9	18	08	Xq23	ACSL4, FACL4, ACS4, MRX63		Acyl-CoA synthetase long-chain family member 4	300157	A, REc, Fd		Mental retardation, X-linked 63, 300387 (3)	
23.515	7	16	10	Xq22.3	AMMEC, DELXq22.3, CXDELq22.3		Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)	300194	Ch	contiguous gene deletion syndrome	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	
23.516	1	27	17	Xq23	AMMECR1, MFHIEN		Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1	300195	Ch		Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3)	
23.517	4	4	00	Xq22.3	COL4A5, ATS, ASLN		Collagen IV, alpha-5 polypeptide	303630	REa, A, Fd	diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6	Alport syndrome, 301050 (3)	X(Col4a5)
23.518	2	2	14	Xq22.3	COL4A6, DELXq22.3, CXDELq22.3, DFNX6		Collagen IV, alpha-6 polypeptide	303631	REn, A	mutation identified in 1 DFNX6 family	?Deafness, X-linked 6, 300914 (3)	
23.519	3	14	06	Xq22.3	FGS5		FG syndrome 5	300581	Ch		FG syndrome 5 (2)	
23.520	10	11	17	Xq22.3	FRMPD3, KIAA1817		FERM- and PDZ domain-containing protein 3	301005	Psh, REc			
23.521	8	7	13	Xq22.3	IRS4		Insulin receptor substrate 4	300904	REc			
23.522	4	17	01	Xq23	KCNE1L		Potassium voltage-gated channel, Isk-related family, member 1-like	300328	REc			
23.523	4	21	16	Xq22.3	MORC4, ZCW4, ZCWCC2		MORC family CW-type zinc finger protein 4	300970	REc			
23.524	8	17	09	Xq22.3	NRK, NESK		NIK-related kinase	300791	REc, H			X(Nrk)
23.525	2	9	17	Xq22.3	PIH1D3, CILD36		PIH1 domain-containing protein 3	300933	REc		Ciliary dyskinesia, primary, 36, X-linked, 300991 (3)	
23.526	9	24	12	Xq22.3	PSMD10, p28		Proteasome 26S subunit, non-ATPase, 10	300880	REc			
23.527	3	22	06	Xq22.3	RIPPLY1		Ripply1, zebrafish, homolog of	300575	R, REc			
23.528	5	15	11	Xq22.3	RNF128, GRAIL		Ring finger protein 128	300439	R, REc			
23.529	5	28	13	Xq22.3	CLDN2		Claudin 2	300520	REc			
23.530	8	25	98	Xq23	DCX, DBCN, LISX		Doublecortin	300121	REc, Fd, X/A		Lissencephaly, X-linked, 300067 (3); Subcortical laminal heterotopia, X-linked, 300067 (3)	X(Dcx)
23.531	1	24	14	Xq23	AGTR2		Angiotensin receptor 2	300034	REa, A			X(Agtr2)
23.532	11	29	16	Xq23	ALG13, GLT28D1, CDG1S, EIEE36		Alg13, S. cerevisiae, homolog of	300776	REc	mutation identified in 1 CDG1S male patient	Epileptic encephalopathy, early infantile, 36, 300884 (3); ?Congenital disorder of glycosylation, type Is, 300884 (3)	
23.533	1	7	13	Xq24	C1GALT1C1, COSMC, C1GALT2, TNPS		C1GALT1-specific chaperone 1	300611	REc		Tn polyagglutination syndrome, somatic, 300622 (3)	
23.534	5	26	13	Xq23	CAPN6		Calpain 6	300146	R			
23.535	1	24	11	Xq24	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15		Cullin-4B	300304	REc, F		Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	
23.536	7	11	17	Xq23	DANT1		DXZ4-associated noncoding transcript 1, proximal	301001	REc, H			X(Dant1)
23.537	8	31	17	Xq23	DANT2		DXZ4-associated noncoding transcript 2, distal	301004	REc			
23.538	5	15	08	Xq23	IHPS4		Pyloric stenosis, infantile hypertrophic, 4	300711	Fd	max lod at rs3027802	Pyloric stenosis, infantile hypertrophic, 4 (2)	
23.539	12	28	08	Xq23	LHFPL1		LHFP-like protein 1	300566	REc			
23.540	5	28	13	Xq23	LUZP4		Leucine zipper protein 4	300616	REc			
23.541	3	23	09	Xq23	MIR448, MIRN448		Micro RNA 448	300686	R			
23.542	8	27	01	Xq23	NXT2		NTF2-related export protein 2	300320	REc			
23.543	5	23	11	Xq23	PAK3, MRX30, MRX47		p21-activated kinase-3	300142	Fd, REc		Mental retardation, X-linked 30/47, 300558 (3)	
23.544	11	11	13	Xq23	PLS3, BMND18		Plastin 3	300131	Psh, REc		Bone mineral density QTL18, osteoporosis, 300910 (3)	
23.545	12	22	15	Xq23	RGAG1, MAR9, KIAA1318		Retrotransposon GAG domain-containing protein 1	300965	REc, H			X(Rgag1)
23.546	5	7	01	Xq23	TRPC5, TRP5		Transient receptor potential channel 5	300334	REc			
23.547	6	26	13	Xq23	XACT		Active X chromosome-coating transcript, noncoding	300901	REc			
23.548	9	2	08	Xq24	ZBTB33, KAISO		Zinc finger- and BTB domain-containing protein 33	300329	REc			X(Kaiso)
23.549	1	27	04	Xq23-q24	MRX23		Mental retardation, X-linked-23	300046	Fd	other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80	Mental retardation, X-linked 23 (2)	
23.550	10	8	08	Xq23	SLC6A14, OBX, BMIQ11		Solute carrier family 6 (neurotransmitter transporter), member 14	300444	REc, Fd		{Obesity, susceptibility to, BMIQ11}, 300306 (3)	
23.551	12	4	03	Xq23-q26	CHDS3		Coronary heart disease, susceptibility to, 3	300464	Fd		{Coronary heart disease, susceptibility to, 3} (2)	
23.552	10	28	10	Xq23-q27.2	MYP13		Myopia 13	300613	Fd	between DXS1210 and DXS1227	Myopia 13 (2)	
23.553	3	7	05	Xq24	AKAP14, AKAP28		A-kinase anchor protein 14	300462	REc			
23.554	7	20	09	Xq24	CT47A1		Cancer/testis antigen family 45, member A1	300780	REc			
23.555	7	20	09	Xq24	CT47A2		Cancer/testis antigen family 47, member A2	300781	REc			
23.556	7	20	09	Xq24	CT47A3		Cancer/testis antigen family 47, member A3	300782	REc			
23.557	7	20	09	Xq24	CT47A4		Cancer/testis antigen family 47, member A4	300783	REc			
23.558	7	20	09	Xq24	CT47A5		Cancer/testis antigen family 47, member A5	300784	REc			
23.559	7	20	09	Xq24	CT47A6		Cancer/testis antigen family 47, member A6	300785	REc			
23.560	7	20	09	Xq24	CT47A7		Cancer/testis antigen family 47, member A7	300786	REc			
23.561	7	20	09	Xq24	CT47A8		Cancer/testis antigen family 47, member A8	300787	REc			
23.562	7	20	09	Xq24	CT47A9		Cancer/testis antigen family 47, member A9	300788	REc			
23.563	7	20	09	Xq24	CT47A10		Cancer/testis antigen family 47, member A10	300789	REc			
23.564	5	18	09	Xq24	CT47A11, LOC255313		Cancer/testis antigen family 47, member A11	300592	REc			
23.565	7	20	09	Xq24	CT47B1, CT47A13		Cancer/testis antigen family 47, member B1	300790	REc			
23.566	4	30	18	Xq24	CXorf56, MRX107		Chromosome X open reading frame 56	301012	REc	mutation identified in 1 MRX107 family	?Mental retardation, X-linked 107, 301013 (3)	
23.567	5	26	13	Xq24	DOCK11, ACG, ZIZ2		Dedicator of cytokinesis 11	300681	REc			
23.568	5	18	95	Xq23	HTR2C		5-hydroxytryptamine (serotonin) receptor-2C	312861	REa, A, H, Fd	formerly HTR1C		X(Htr2c)
23.569	8	25	98	Xq23	IL13RA2		Interleukin-13 receptor, alpha-2	300130	A			
23.570	6	12	17	Xq24	KIAA1210		Kiaa1210 gene	300995	REc, H			X(Kiaa1210)
23.571	5	26	13	Xq24	KLHL13, KIAA1309		Kelch-like 13	300655	REc			
23.572	7	28	11	Xq24	LAMP2, LAMPB, LGP110		Lysosome-associated membrane protein-2	309060	A, D		Danon disease, 300257 (3)	X(Lamp2)
23.573	3	25	15	Xq24	MRX88		Mental retardation, X-linked 88	300852	Ch		Mental retardation, X-linked 88 (2)	
23.574	9	27	01	Xq24	MRSS		Mental retardation, X-linked, with short stature	300360	Fd		Mental retardation, X-linked, with short stature (2)	
23.575	11	13	07	Xq24	NDUFA1, MWFE		NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kD	300078	A		Mitochondrial complex I deficiency, 252010 (3)	
23.576	7	13	09	Xq24	NKAP		NFKB-activating protein	300766	R, REc			
23.577	7	20	09	Xq24	NKRF, NRF		NFKB-repressing factor	300440	R, REc			
23.578	5	4	12	Xq24	RHOXF1, OTEX, PEPP1		RHOX homeobox family, member 1	300446	REc			X(Pem)
23.579	5	4	12	Xq24	RHOXF2, PEPP2		RHOX homeobox family, member 2	300447	REc			X(Pem)
23.580	6	30	16	Xq24	RHOXF1P1		RHOX homeobox family member 1, pseudogene 1	300973	REc			
23.581	6	18	15	Xq24	RNF113A, ZNF183, TTD5		RING finger protein 113A	300951	REc	mutation identified in 1 TTD5 family	?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	
23.582	5	29	13	Xq24	RPL39		Ribosomal protein L39	300899	REc, Psh, R			
23.583	5	12	00	Xq26.1	SLC25A14, BMCP1		Solute carrier family 25 (mitochondrial carrier), member 14	300242	REc			X(Slc25a14)
23.584	3	12	07	Xq24	SLC25A43		Solute carrier family 25, member 43	300641	REc			X(Slc25a43)
23.585	9	1	16	Xq24	UBE2A, RAD6A, MRXSN, MRXS30		Ubiquitin-conjugating enzyme E2A (RAD6 homolog)	312180	A, REa		Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	
23.586	3	5	08	Xq24	ZCCHC12, SIZN1		Zinc finger CCHC domain-containing protein 12	300701	REc			
23.587	2	10	05	Xq24-q25	MRX82		Mental retardation, X-linked 82	300518	Fd	between DXS6805 and DXS7346	Mental retardation, X-linked 82 (2)	
23.588	10	4	02	Xq24-q25	RRDX		Radial ray deficiency	300378	Fd		Radial ray deficiency (2)	
23.589	11	15	08	Xq24-q25	SPG34		Spastic paraplegia 34, X-linked	300750	Fd	max lod at DXS8057	Spastic paraplegia 34, X-linked (2)	
23.590	2	17	09	Xq24-q25	STQTL6		Stature quantitative trait locus 6	300591	Fd	max lod at DXS8067	{Stature QTL 6} (2)	
23.591	4	20	11	Xq24-q26	ADFN, ALDS		Albinism-deafness syndrome	300700	Fd	~8cM proximal to F9	Albinism-deafness syndrome (2)	
23.592	3	6	00	Xq24	SLC25A5, ANT2, T3		Solute carrier family 25 (mitochondrial carrier), member 5 (adenine nucleotide translocator-2, fibroblast)	300150	REa			
23.593	10	17	95	Xq24-q27	BZX		Bazex syndrome	301845	Fd		Bazex syndrome (2)	
23.594	2	23	08	Xq24	SEPT6, SEP2, KIAA0128		Septin 6	300683	REc, Psh			
23.595	5	24	00	Xq24-q27.1	PTOS2, PTOSX		Ptosis, hereditary congenital 2	300245	Fd		Ptosis, hereditary congenital 2 (2)	
23.596	9	11	02	Xq24-qter	CND		Corneal dermoids	304730	Fd		Dermoids of cornea (2)	
23.597	7	18	06	Xq25	ACTRT1, ARPT1		Actin-related protein T1	300487	REc			
23.598	1	22	08	Xq26.1	BCORL1		BCL6 corepressor-like 1	300688	REc			
23.599	4	17	07	Xq26.1	ENOX2		ECTO-NOX disulfide-thiol exchanger 2	300282	R, REc			
23.600	9	16	16	Xq25	DUPXq25		Xq25 duplication syndrome	300979	Ch		Xq25 duplication syndrome (4)	
23.601	8	1	16	Xq24	GLUD2		Glutamate dehydrogenase-2	300144	A, REn		{Parkinson disease, age of onset, modifier}, 168600 (3)	
23.602	1	14	13	Xq26.1	IGSF1, IGDC1, CHTE		Immunoglobulin superfamily, member 1	300137	REn		Hypothyroidism, central, and testicular enlargement, 300888 (3)	
23.603	6	7	04	Xq25	SH2D1A, LYP, IMD5, XLP, XLPD1		SH2 domain protein 1A	300490	Fd, D	1cM from DXS42; no recombination with DXS37	Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	X(Sh2d1a)
23.604	11	22	10	Xq25	STAG2, SA2		Stromal antigen 2	300826	REc			
23.605	2	5	15	Xq25	TENM1, ODZ1, TNM1		Teneurin transmembrane protein 1	300588	REc			
23.606	9	8	15	Xq25	THOC2, THO2, MRX12, MRX35		THO complex 2 (Tho2, yeast, homolog of)	300395	R, REc		Mental retardation, X-linked 12/35, 300957 (3)	
23.607	7	16	09	Xq25	XECD		Corneal dystrophy, endothelial, X-linked	300779	Fd	between DXS8057 and DXS1047	Corneal dystrophy, endothelial, X-linked (2)	
23.608	1	7	11	Xq25	XIAP, BIRC4, API3, XLP2		Inhibitor of apoptosis, X-linked	300079	A		Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	X(Api3)
23.609	11	22	13	Xq26.1	XPNPEP2, AEACEI		X-prolyl aminopeptidase 2 (aminopeptidase P)	300145	REa, A		{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	
23.610	4	1	08	Xq25	GRIA3, GLUR3, MRX94		Glutamate receptor, ionotropic, AMPA 3	305915	Psh, A, Ch		Mental retardation, X-linked 94, 300699 (3)	X(Glur3)
23.611	3	29	99	Xq25-q26	SXI2		X inactivation, familial skewed, 2	300179	Fd		X inactivation, familial skewed, 2 (2)	
23.612	10	11	07	Xq24	UPF3B, RENT3B, MRXS14		UPF3 regulator of nonsense transcripts, yeast, homolog of, B	300298	REc		Mental retardation, X-linked, syndromic 14, 300676 (3)	
23.613	8	25	98	Xq25-q26.1	THAS, TAS		Thoracoabdominal syndrome	313850	Fd		Thoracoabdominal syndrome (2)	
23.614	3	1	01	Xq26.1	APLN		Apelin	300297	REc			
23.615	6	5	09	Xq25-q27	LKMCD		Leukoencephalopathy with metaphyseal chondrodysplasia	300660	Fd	between DXS8093 and DXS1232	Leukoencephalopathy with metaphyseal chondrodysplasia (2)	
23.616	4	23	08	Xq25-q27.1	SCAX5		Spinocerebellar ataxia, X-linked 5	300703	Fd	between DXS1047 and DXS1227	Spinocerebellar ataxia, X-linked 5 (2)	
23.617	5	15	18	Xq26.3	ARHGEF6, MRX46, COOL2		Rho guanine nucleotide exchange factor-6	300267	Ch, Fd	mutation identified in 1 MRX46 family	?Mental retardation, X-linked 46, 300436 (3)	
23.618	4	16	03	Xq26	CMTX3		Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	Fd	between DXS984 and DXS8106	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)	
23.619	10	28	99	Xq26.3	CXX1		CAAX box protein 1	300213	REc			
23.620	7	13	09	Xq26.1	ELF4, MEF		E74-like factor 4	300775	A			
23.621	10	4	02	Xq26.2	GPC3, SDYS, SGBS1		Glypican 3	300037	A		Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor, somatic, 194070 (3)	
23.622	2	5	99	Xq26.2	GPC4		Glypican 4	300168	A	centromeric to GPC3		
23.623	7	14	93	Xq26	GUST		Gustavson mental retardation syndrome (with microcephaly, optic atrophy, deafness)	309555	Fd		Gustavson syndrome (2)	
23.624	2	7	01	Xq27.2	MAGEC1		Melanoma antigen, family C, 1	300223	R, A			
23.625	7	11	11	Xq26.2	MASK, MST4		MST3- and SOK1-related kinase	300547	A, REc			
23.626	3	14	03	Xq26.2	MBNL3, MBXL		Muscleblind-like protein 3	300413	REn			
23.627	1	23	02	Xq26	MRX42		Mental retardation, X-linked nonspecific, 42	300372	Fd	?pericentromeric region	Mental retardation, X-linked 42 (2)	
23.628	1	23	01	Xq26.3	PLAC1		Placenta-specific gene 1	300296	REc			X(Plac1)
23.629	11	25	15	Xq26.3	RBMX, MRXS11		RNA-binding motif protein, X chromosome	300199	REc, Fd	mutation identified in 1 MRXS11 family	?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	X(Rbmx)
23.630	10	16	94	Xq26	SHFM2, SHFD2		Split hand/foot malformation, type (ectrodactyly) 2	313350	Fd		Split hand/foot malformation 2 (2)	
23.631	4	8	02	Xq26.3	TNFSF5, CD40LG, HIGM1, IGM		Tumor necrosis factor ligand superfamily, member 5	300386	Fd, A, Psh	Between DSX144E and DSX300	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	X(CD40l)
23.632	2	22	10	Xq26.3	ZNF75D, ZNF75		Zinc finger protein-75D	314997	REa, A	1Mb distal to HPRT		
23.633	6	2	08	Xq26-q27	CFSS		Craniofacioskeletal syndrome	300712	Fd		?Craniofacioskeletal syndrome (2)	
23.634	6	8	89	Xq26-q27	HPT, HPTX, HYPX		Hypoparathyroidism	307700	Fd	?mutations in SOX3	Hypoparathyroidism, X-linked (2)	
23.635	11	2	98	Xq26-q27	RP24		Retinitis pigmentosa-24	300155	Fd		Retinitis pigmentosa 24 (2)	
23.636	6	29	99	Xq26.3	BRS3		Bombesin-like receptor 3	300107	Psh			
23.637	9	8	17	Xq26-qter	INDX		Immunoneurologic syndrome X-linked, of Woods, Black, and Norbury	300076	Fd		Woods-Black-Norbury syndrome (2)	
23.638	12	1	15	Xq26.1	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5		Apoptosis-inducing factor, mitochondrion-associated, 1	300169	REc, Fd		Combined oxidative phosphorylation deficiency 6, 300816 (3); Cowchock syndrome, 310490 (3); Deafness, X-linked 5, 300614 (3)	
23.639	11	24	14	Xq26.1	ARHGAP36		Rho GTPase-activating protein 36	300937	REc			
23.640	5	26	13	Xq26.1	GPR119, GPCR2		G protein-coupled receptor 119	300513	REc			X(Gpr119)
23.641	1	21	09	Xq26.1	OCRL, LOCR, OCRL1, NPHL2		Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene)	300535	X/A, Fd		Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)	
23.642	5	28	13	Xq26.1	SASH3, HACS2, CXorf9, SLY		SAM and SH3 domain containing 3	300441	REc			
23.643	8	19	98	Xq25-q26	SMARCA1, SNF2L1		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	300012	RE			
23.644	5	28	13	Xq26.1	UTP14A		Utp14, S. cerevisiae, homolog of, A	300508	REc			X(Utp14a)
23.645	12	2	09	Xq26.1	ZDHHC9, DHHC9, MRXSZ		Zinc finger DHHC domain-containing protein 9	300646	R, REc		Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	
23.646	3	24	06	Xq26.3	VGLL1, VGL1, TDU		Vestigial-like 1	300583	REc			
23.647	11	19	11	Xq26.2	FRMD7, NYS1, XIPAN		FERM domain-containing 7	300628	REc		Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	
23.648	9	26	17	Xq26.2-q26.3	HPRT1, HPRT		Hypoxanthine phosphoribosyltransferase 1	308000	S, M, C, R, REa, Fd		Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)	X(Hprt)
23.649	6	30	05	Xq26.2	HS6ST2		Heparan sulfate 6-O-sulfotransferase 2	300545	R, REc			
23.650	3	23	09	Xq26.2	MIR19B2, MIRN19B2		Micro RNA 19B2	300722	REc			
23.651	4	13	15	Xq26.2	MIR20B		Micro RNA 20B	300950	REc			
23.652	9	9	09	Xq26.2	MIR106A, MIRN106A		Micro RNA 106A	300792	REc			
23.653	10	10	18	Xq26.2	RAP2C		Ras-related protein 2C	301016	REc			
23.654	5	11	09	Xq26.2	TFDP3, HCA661, CT30, DP4		Transcription factor DP family, member 3	300772	REc			
23.655	4	25	05	Xq26.2	USP26		Ubiquitin-specific protease 26	300309	R, REc			
23.656	5	4	12	Xq26.3	ZIC3, HTX1, HTX, VACTERLX		Zic family, member 3	300265	Fd, REc		Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)	
23.657	4	30	09	Xq26.3	CT45A1, CT45		Cancer/testis antigen family 45, member A1	300648	REc			
23.658	9	2	09	Xq26.3	CT45A2, CT45.2		Cancer/testis antigen family 45, member A2	300793	REn			
23.659	9	2	09	Xq26.3	CT45A3, CT45.3		Cancer/testis antigen family 45, member A3	300794	REn			
23.660	9	2	09	Xq26.3	CT45A4, CT45.4		Cancer/testis antigen family 45, member A4	300795	REn			
23.661	9	2	09	Xq26.3	CT45A5, CT45.5		Cancer/testis antigen family 45, member A5	300796	REn			
23.662	9	2	09	Xq26.3	CT45A6, CT45.6		Cancer/testis antigen family 45, member A6	300797	REn			
23.663	2	4	15	Xq26.3	CXDUPq26.3, DUPXq26.3, XLAG		Chromosome Xq26.3 duplication syndrome	300942	Ch		Chromosome Xq26.3 duplication syndrome (4)	
23.664	5	28	13	Xq26.3	MOSPD1		Motile sperm domain-containing protein 1	300674	REc			X(Mospd1)
23.665	6	16	99	Xq26.2	PHF6, BFLS		PHD finger protein 6	300414	Fd, REc		Borjeson-Forssman-Lehmann syndrome, 301900 (3)	
23.666	6	16	99	Xq26.3-q27.1	FGF13, FGF2		Fibroblast growth factor-13	300070	REa, H, REc, Ch			X(Fhf2)
23.667	9	26	17	Xq26.3	GPR101, PAGH2, PITA2		G protein-coupled receptor 101	300393	REc		Pituitary adenoma 2, GH-secreting, 300943 (3)	
23.668	5	28	13	Xq26.3	HTATSF1, TATSF1		HIV-1 TAT stimulatory factor 1	300346	REc, R			
23.669	9	20	14	Xq26.3	MAP7D3, MDP3		MAP7 domain-containing protein 3	300930	REc			
23.670	3	23	09	Xq26.3	MIR424, MIRN424, MIR322		Micro RNA 424	300682	REc			
23.671	12	19	11	Xq26.3	MIR503		Micro RNA 503	300865	REc			
23.672	5	6	08	Xq26.3	SLC9A6, NHE6		Solute carrier family 9 (sodium/hydrogen exchanger), member 6	300231	R		Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	
23.673	6	2	08	Xq27.1	SOX3, MRGH		SRY (sex determining region Y)-box 3	313430	REa, H, Fd	P mutant in BFLS	Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)	X(Sox3)
23.674	3	24	11	Xq26.3	SRXX3		46XX sex reversal 3	300833	Ch	due to deletion/duplication/rearrangement upstream of SOX3	46XX sex reversal 3 (4)	
23.675	11	30	06	Xq26.3	ZNF449, ZSCAN19		Zinc finger protein 449	300627	REc			
23.676	4	30	01	Xq27.2	SPANXC, CTP11		Sperm protein associated with the nucleus, X chromosome, family member C	300330	REa, REc			
23.677	5	26	13	Xq27.1	ATP11C, ATPIQ, ATPIG, HACXL		ATPase, class VI, type 11C	300516	REc	mutation identified in 1 HACXL patient	?Hemolytic anemia, congenital, X-linked, 301015 (3)	
23.678	5	18	05	Xq27	BMND4		Bone mineral density QTL 4	300536	Fd		[Bone mineral density QTL 4] (2)	
23.679	5	7	01	Xq28	CNGA2, CNG2, OCNC1		Cyclic nucleotide-gated channel, alpha-2	300338	REc			
23.680	8	5	97	Xq27	COD2		Cone dystrophy-2, X-linked	300085	Fd		Cone dystrophy, progressive X-linked, 2 (2)	
23.681	6	19	15	Xq28	CXorf40A, EOLA1		Chromosome X open reading frame 40A	300954	REc			
23.682	4	27	12	Xq27.3	FMR1AS1, ASFMR1		FMR1 antisense RNA 1	300805	REc			
23.683	8	27	02	Xq27.1	LDOC1		Leucine zipper downregulated in cancer 1	300402	A			
23.684	12	30	03	Xq27.2	MAGEC3		Melanoma antigen, family C, 3	300469	REc			
23.685	3	19	09	Xq27.2	MAGEC2, MAGEE1, CT10, HCA587		Melanoma antigen, family C, 2	300468	REa, A, R			
23.686	1	25	91	Xq27.1	MCF2, DBL		Oncogene MCF2 (oncogene DBL)	311030	REa, A, RE, D	~60kb telomeric to F9; 5' replacement by chr.15 segment		X(Mcf2)
23.687	10	11	17	Xq27.3	SLITRK2, KIAA1854, CXorf1, CXorf2		SLIT- and NTRK-like family, member 2	300561	REc, H			X(Slitrk2)
23.688	12	28	08	Xq27.3	SLITRK4		SLIT- and NTRK-like family, member 4	300562	REc, H			X(Slitrk4)
23.689	5	26	13	Xq27.3	SPANXN1		SPANX family, member N1	300664	REc			X(Spanxn)
23.690	5	28	13	Xq27.3	SPANXN2		SPANX family, member N2	300665	REc			
23.691	5	26	13	Xq27.3	SPANXN3		SPANX family, member N3	300666	REc			
23.692	5	28	13	Xq27.3	SPANXN4		SPANX family, member N4	300667	REc			
23.693	2	1	00	Xq27	TGCT1		Testicular germ cell tumor 1	300228	Fd		Testicular germ cell tumor (2)	
23.694	7	25	06	Xq27-q28	MCOPS4, ANOP1		Microphthalmia, syndromic 4	301590	F		?Microphthalmia, syndromic 4 (2)	
23.695	9	29	98	Xq27-q28	HPCX1		Prostate cancer, hereditary, X-linked 1	300147	Fd	between D3S2390 and bG82i1.0	{Prostate cancer, hereditary, X-linked 1} (2)	
23.696	5	28	13	Xq27.1	CIRS7, CDR1AS		Circular RNA sponge for MIR7	300898	REc			
23.697	9	21	11	Xq27.1	HTC2, HCG, CGH, CXINSq27.1		Hypertrichosis, congenital generalized	307150	Fd	palindrome-mediated interchromosomal insertion at Xq27.1	Hypertrichosis, congenital generalized (4)	
23.698	3	19	01	Xq27.2	SPANXA1, SPANX		Sperm protein associated with the nucleus, X chromosome, family member A1	300305	REa, A			
23.699	5	26	13	Xq27.2	SPANXD		SPANX family, member D	300670	REc			
23.700	5	26	13	Xq27.2	SPANXE		SPANX family, member E	300671	REc			
23.701	7	7	98	Xq27.1	CDR1, CDR62A		Cerebellar degeneration-related protein-1, 34kD	302650	REa, A, Fd	between HPRT and F9		X(Cdr)
23.702	3	1	12	Xq27.1	F9, HEMB, THPH8		Coagulation factor IX (plasma thromboplastic component)	300746	REa, A, Fd, D, X/A, RE	distal to HPRT; proximal part of Xq27	Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3); Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)	X(Cf9)
23.703	5	26	13	Xq27.1	SPANXB1, SPANXB		SPANX family, member B1	300669	REc			
23.704	10	31	17	Xq26.3	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU		Four-and-a-half LIM domains 1	300163	Psh, A, R	mutation identified in 1 FCMSU family	Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy, X-linked, with postural muscle atrophy, 300696 (3); Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3); Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3); ?Uruguay faciocardiomusculoskeletal syndrome, 300280 (3)	
23.705	4	30	09	Xq27.2-q28	BPP, PMGX, CBPS		Polymicrogyria, bilateral perisylvian	300388	Fd	possible genetic heterogeneity	Polymicrogyria, bilateral perisylvian (2)	
23.706	12	23	05	Xq27.2	SPANXA2		Sperm protein associated with the nucleus, X chromosome, family member A2	300493	REn			
23.707	10	21	04	Xq27.3	DYX9		Dyslexia, susceptibility to, 9	300509	Fd	max lod at DXS8043	{Dyslexia, susceptibility to, 9} (2)	
23.708	9	19	11	Xq27.3	FMR1, FRAXA, POF1		FMR1 gene	309550	Ch, F, Fd, RE	8-8.7Mb from telomere	Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome, 300623 (3); Premature ovarian failure 1, 311360 (3)	X(Fmr1)
23.709	9	2	12	Xq27.3	MIR506		Micro RNA 506	300877	REc			
23.710	9	2	12	Xq27.3	MIR508		Micro RNA 508	300874	REc			
23.711	9	2	12	Xq27.3	MIR509-1		Micro RNA 509-2	300875	REc			
23.712	9	2	12	Xq27.3	MIR509-3		Micro RNA 509-3	300876	REc			
23.713	12	19	11	Xq27.3	MIR510		Micro RNA 510	300866	REc			
23.714	3	28	12	Xq27.3-q28	DUPXq27.3q28, CXDUPq27.3q28		Chromosome Xq27.3-q28 duplication syndrome	300869	Ch		Chromosome Xq27.3-q28 duplication syndrome (4)	
23.715	8	3	95	Xq27.3-qter	EBM		Epidermolysis bullosa, macular type	302000	Fd			
23.716	6	21	13	Xq28	ABCD1, ALD, AMN		ATP-binding cassette, subfamily D, member 1	300371	F, Fd, D	about 650kb from GCP/RCP	Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, adult, 300100 (3)	X(Ald)
23.717	11	11	09	Xq28	AFF2, FMR2, FRAXE, MRX2		AF4/FMR2 family, member 2 (fragile site, X-linked, E)	300806	Ch, REn		Mental retardation, X-linked, FRAXE type, 309548 (3)	
23.718	11	1	13	Xq28	BCAP31, BAP31, DXS1357E, DDCH		B-cell receptor-associated protein 31	300398	REa		Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	X(Bap31)
23.719	4	26	11	Xq28	BED		Bornholm eye disease	300843	Fd	linked to F8	Bornholm eye disease (2)	
23.720	2	14	13	Xq28	ATP2B3, PMCA3, SCAX1		ATPase, Ca++ transporting, plasma membrane, 3	300014	REa, A, Fd	mutation identified in 1 family	?Spinocerebellar ataxia, X-linked 1, 302500 (3)	
23.721	6	26	16	Xq28	ATP6AP1, ATP6IP1, ATP6S1, VATPS1		ATPase, H+ transporting, lysosomal, accessory protein 1	300197	REc		Immunodeficiency 47, 300972 (3)	
23.722	10	4	05	Xq28	AVPR2, DIR, DI1, ADHR		Arginine vasopressin receptor-2	300538	Fd, S, REa, Psh		Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	
23.723	12	15	16	Xq28	BGN, SEMDX, MRLS		Biglycan	301870	REa, A	proximal Xq28	Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3); Meester-Loeys syndrome, 300989 (3)	X(Bgn)
23.724	6	26	11	Xq28	BRCC3, BRCC36		BRCA1/BRCA2-containing complex, subunit 3	300617	Psh			
23.725	9	8	11	Xq28	CD99L2, CD99B		CD99 antigen-like 2	300846	REc			X(Cd99l2)
23.726	5	18	95	Xq28	CETN2, CALT		Centrin, EF-hand protein, 2 (caltractin)	300006	A			
23.727	2	4	15	Xq28	CLIC2, XAP121, MRXS32		Chloride intracellular channel 2	300138	REc	mutation identified in 1 MRXS32 family	?Mental retardation, X-linked, syndromic 32, 300886 (3)	
23.728	3	23	15	Xq28	CSAG1, CSAGE		CSAG family, member 1 `	300944	REc			
23.729	5	26	13	Xq28	CTAG1A, LAGE2A		Cancer/testis antigen 1A	300657	REc			
23.730	11	5	98	Xq28	CTAG1B, CTAG1		Cancer/testis antigen 1B	300156	REa, A			
23.731	5	28	13	Xq28	CTAG2, LAGE1, CAMEL		Cancer/testis antigen 2	300396	Psh, A			
23.732	3	29	10	Xq28	DUPXq28, CXq28		Chromosome Xq28 duplication syndrome	300815	Ch		Chromosome Xq28 duplication syndrome (4)	
23.733	9	19	13	Xq28	DKC1, DKCX		Dyskerin	300126	Fd, REc		Dyskeratosis congenita, X-linked, 305000 (3)	X(Dkc1)
23.734	5	19	97	Xq28	DNASE1L1, DNL1L		Deoxyribonuclease I-like 1	300081	RE	between QM and DXS1010E		
23.735	5	28	13	Xq28	DUSP9, MKP4		Dual-specificity phosphatase 9	300134	Psh, REc			
23.736	3	22	93	Xq28	DXS522E, F8B		DNA segment, single copy, expressed probes, intron 22 probe, F8B	305424	RE			
23.737	4	4	02	Xq28	EMD, EDMD, STA		Emerin	300384	F, Fd, H, REn	in distal Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	
23.738	9	13	92	Xq28	F8A, DXS522E, HAP40		Factor VIII associated gene 1	305423	RE	3 copies, 1 in intron 22 of F8C		X(F8a)
23.739	9	28	00	Xq28	F8, F8C, HEMA		Coagulation factor VIII, procoagulant component	300841	F, Fd, REa, A, RE	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	Hemophilia A, 306700 (3)	X(Cf8)
23.740	5	28	13	Xq28	FAM3A		Family with sequence similarity 3, member A	300492	REc			
23.741	11	22	09	Xq28	FAM11A, FRAXF		Family with sequence similarity 11, member A	300031	REc			
23.742	6	18	12	Xq28	FAM50A, DXS9928E, HXC26		Family with sequence similarity 50, member A	300453	REc			
23.743	4	23	08	Xq28	FAM58A, STAR		Family with sequence similarity 58, member A	300708	REc		STAR syndrome, 300707 (3)	
23.744	6	19	12	Xq28	FATE1		Fetal and adult testis-expressed gene 1	300450	REc			
23.745	3	5	18	Xq28	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2		Filamin A, alpha (actin-binding protein-280)	300017	REa, A, REn	mutation identified in 1 FGS2 patient	Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome, type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3); Frontometaphyseal dysplasia 1, 305620 (3); ?FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3); Congenital short bowel syndrome, 300048 (3)	X(Fln1)
23.746	01	9	18	Xq28	G6PD, G6PD1		Glucose-6-phosphate dehydrogenase	305900	F, S, REb, RE		Hemolytic anemia, G6PD deficient (favism), 300908 (3); {Resistance to malaria due to G6PD deficiency}, 611162 (3)	X(G6pd)
23.747	5	28	13	Xq28	GAB3		GRB2-associated binding protein 3	300482	REc, R			
23.748	12	29	89	Xq28	GABRA3		Gamma-aminobutyric acid (GABA) A receptor, alpha-3	305660	H, REa, A, RE	4Mb from telomere		X(Gabra3)
23.749	6	9	98	Xq28	GABRE		Gamma-aminobutyric acid (GABA) A receptor, epsilon	300093	REn			
23.750	8	30	01	Xq28	GABRQ		Gamma-aminobutyric acid receptor, theta	300349	REc			
23.751	9	8	11	Xq28	GDI1, RABGD1A, MRX41, MRX48		GDP dissociation inhibitor 1	300104	REn		Mental retardation, X-linked 41, 300849 (3)	
23.752	6	7	10	Xq28	HAUS7, UCHL5IP, UIP1		HAUS augmin-like complex, subunit 7	300540	REc			
23.753	5	14	95	Xq28	HMS1, GAY1		Homosexuality, male	306995	Fd		[?Homosexuality, male] (2)	
23.754	2	7	01	Xq28	GPR50		G protein-coupled receptor 50	300207	R			X(Gpr50)
23.755	2	8	13	Xq28	H2AFB, H2ABBD		H2A histone family, member B	300445	REc			
23.756	11	1	13	Xq28	HCFC1, HCF1, MRX3		Host cell factor C1 (VP16-accessory protein)	300019	REn, REa, A, Fd	50kb distal to V2R	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	X(Hcfc1)
23.757	7	17	14	Xq28	HMGB3, HMG4, HMG2A, MCOPS13		High-mobility group box 3 (high mobility group protein 4)	300193	REc, Fd	mutation identified in 1 MCOPS13 family	?Microphthalmia, syndromic 13, 300915 (3)	
23.758	4	21	99	Xq28	IDH3G		Isocitrate dehydrogenase 3 (NAD+), gamma	300089	REc			
23.759	2	9	11	Xq28	IDS, MPS2, SIDS		Iduronate 2-sulfatase (Hunter syndrome)	300823	X/A, Fd, F, RE	telomeric IDS2 source of inversion in IDS	Mucopolysaccharidosis II, 309900 (3)	X(Ids)
23.760	5	19	15	Xq28	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33		Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)	300248	Fd, REn		Incontinentia pigmenti, 308300 (3); Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency, isolated, 300584 (3); Immunodeficiency 33, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	X(Ikbkg)
23.761	11	6	95	Xq28	IL9R		Interleukin-9 receptor	300007	A, REc	in PAR2 pseudoautosomal region		
23.762	2	1	01	Xq28	IRAK1		Interleukin 1 receptor-associated kinase 1	300283	R			X(Irak1)
23.763	1	29	13	Xq28	L1CAM, CAML1, HSAS1, MASA, SPG1		L1 cell adhesion molecule	308840	A, RE, H, Fd	between RCP/GCP cluster and G6PD	Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome, 303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)	X(L1cam)
23.764	10	31	17	Xq28	LAGE3, ITBA2, GAMOS2		L antigen family member 3	300060	RE		Galloway-Mowat syndrome 2, X-linked, 301006 (3)	
23.765	3	14	13	Xq28	LINC00850, KUCG1		Long intergenic noncoding RNA 850	300892	REc			
23.766	5	6	08	Xq28	MAFD2, MDX		Major affective disorder 2	309200	F	linkage to G6PD,CB in non-Ashkenazi Jews	{?Major affective disorder 2} (2)	
23.767	2	5	96	Xq28	MAGE1		Melanoma antigen 1 (directs expression of antigen MZ2-E)	300016	REa, A	cluster of 12 genes		
23.768	6	29	99	Xq28	MAGEA2, MAGE2		Melanoma antigen, family A, 2	300173	RE, REn			
23.769	5	26	13	Xq28	MAGEA2B		Melanoma antigen, family A, 2B	300549	REc			
23.770	6	29	99	Xq28	MAGEA3, MAGE3		Melanoma antigen, family A, 3	300174	RE, REn			
23.771	6	29	99	Xq28	MAGEA4, MAGE4A, MAGE4B		Melanoma antigen, family A, 4	300175	RE, REn			
23.772	7	17	01	Xq28	MAGEA5, MAGE5		Melanoma antigen, family A, 5	300340	REa, REc			X(Mage5)
23.773	7	17	01	Xq28	MAGEA8, MAGE8		Melanoma antigen, family A, 8	300341	REa, REc			X(Mage8)
23.774	7	17	01	Xq28	MAGEA9, MAGE9		Melanoma antigen, family A, 9	300342	REa, REc			
23.775	3	19	09	Xq28	MAGEA9B		Melanoma antigen, family A, 9B	300764	REc			
23.776	7	17	01	Xq28	MAGEA10, MAGE10		Melanoma antigen, family A, 10	300343	REa, REc			
23.777	7	17	01	Xq28	MAGEA11, MAGE11		Melanoma antigen, family A, 11	300344	REc, REa			
23.778	6	29	99	Xq28	MAGEA6, MAGE6		Melanoma antigen, family A, 6	300176	RE, REn			
23.779	6	29	99	Xq28	MAGEA12, MAGE12		Melanoma antigen, family A, 12	300177	RE, REn			
23.780	2	23	09	Xq28	MAMLD1, CXorf6, F18, HYSP2		Mastermind-like domain containing 1	300120	REc, D	near MTM1 in microdeletion	Hypospadias 2, X-linked, 300758 (3)	
23.781	7	14	15	Xq28	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13		Methyl-CpG-binding protein-2	300005	H, REc, Ch, Fd, A	70kb centromeric of RCP/GCP	Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic 13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked 3}, 300496 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3); Rett syndrome, atypical, 312750 (3)	X(Mecp2)
23.782	12	21	09	Xq28	MIR105-1, MIRN105-1		Micro RNA 105-1	300811	REc			
23.783	12	21	09	Xq28	MIR105-2, MIRN105-2		Micro RNA 105-2	300812	REc			
23.784	9	20	14	Xq28	MIR718		Micro RNA 718	300929	REc			
23.785	4	1	09	Xq28	MIR224, MIRN224		Micro RNA 224	300769	REc			
23.786	10	21	92	Xq28	MPP1, PEMP, EMP55		Membrane protein, palmitoylated-1, 55kD	305360	REa, REn	~30kb 3' and centromeric to F8		X(Emp55)
23.787	10	23	87	Xq28	MRSD, CHRS		Mental retardation-skeletal dysplasia	309620	Fd		Mental retardation-skeletal dysplasia (2)	
23.788	9	19	00	Xq28	MRXSA		Armfield X-linked mental retardation syndrome	300261	Fd		Mental retardation syndrome, X-linked, Armfield type (2)	
23.789	6	15	99	Xq28	MTCP1		Mature T-cell proliferation 1	300116	Ch, A			
23.790	12	20	02	Xq28	MTM1, MTMX		Myotubularin	300415	Fd, REc	close to F8	Myotubular myopathy, X-linked, 310400 (3)	
23.791	3	29	99	Xq28	MTMR1		Myotubularin-related protein-1	300171	REc			
23.792	6	28	11	Xq28	MYMY4, CXDELq38		Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism	300845	Ch	contiguous gene deletion syndrome (3.4kb)	Moyamoya disease 4 (4)	
23.793	11	12	98	Xq28	MYP1		Myopia 1, X-linked	310460	Fd		Myopia-1 (2)	
23.794	12	10	15	Xq28	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1		N-alpha-acetyltransferase 10, NatA catalytic subunit	300013	RE, Fd	mutation identified in 1 MCOPS1 family	Ogden syndrome, 300855 (3); ?Microphthalmia, syndromic 1, 309800 (3)	
23.795	2	11	11	Xq28	NSDHL		NAD(P)H steroid dehydrogenase-like protein	300275	REc		CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)	X(Nsdhl)
23.796	9	13	10	Xq28	OPN1C		OPN1LW and OPN1MW genes, controller of	300824	REc			
23.797	9	13	10	Xq28	OPN1LW, RCP, CBP, CBBM		Red cone pigment (opsin 1, long-wave-sensitive)	300822	F, RE, A, Fd	5' to CBD	Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.798	8	30	10	Xq28	OPN1MW, GCP, CBD, CBBM		Green cone pigment (opsin 1, medium-wave-sensitive)	300821	F, RE, A, Fd	linked to G6PD; multiple genes	Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.799	3	28	17	Xq28	PASD1, CT64, OXTES1		PAS domain-containing repressor 1	300993	REc			
23.800	1	11	07	Xq28	PDZD4, PDZK4, PDZRN4L, KIAA1444, LU1		PDZ domain-containing 4	300634	R, REc, H			X(Pdzd4)
23.801	11	29	99	Xq28	PLXNB3, PLXN6		Plexin B3	300214	REn			
23.802	10	9	07	Xq28	PNCK, CAMK1B, BSTK3		Pregnancy-upregulated, nonubiquitous, CAM kinase	300680	H, REn			X(Pnck)
23.803	5	26	13	Xq28	PNMA3, MA3		Paraneoplastic MA antigen 3	300675	REc			
23.804	3	7	14	Xq28	PNMA5, KIAA1934		Paraneoplastic MA antigen family, member 5	300916	REc			
23.805	3	7	14	Xq28	PNMA6A, PNMA6		Paraneoplastic MA antigen family, member 6A	300917	REc			
23.806	1	2	08	Xq28	PRRG3, PRGP3, TMG3		Proline-rich gamma-carboxyglutamic acid protein 3	300685	REc			
23.807	1	21	15	Xq28	RAB39B, MRX72, WSMN		Ras-associated protein RAB39B	300774	Fd, REc	mutation identified in 1 WSMN family	Mental retardation, X-linked 72, 300271 (3); ?Waisman syndrome, 311510 (3)	
23.808	6	14	94	Xq28	RENBP		Renin-binding protein	312420	REn, Psh			
23.809	2	15	96	Xq28	RGC1		Rho-GAP hematopoietic protein C1	300023	RE			
23.810	7	19	06	Xq28	RP34		Retinitis pigmentosa 34	300605	Fd		Retinitis pigmentosa 34 (2)	
23.811	7	6	17	Xq28	RPL10, DXS648, QM, AUTSX5, MRXS35		Ribosomal protein L10	312173	S, RE		{Autism, susceptibility to, X-linked 5}, 300847 (3); Mental retardation, X-linked, syndromic, 35, 300998 (3)	
23.812	12	4	03	Xq26.3	SAGE		Sarcoma antigen	300359	R			
23.813	2	15	96	Xq28	SEX		Sex chromosome X transmembrane protein of HGF receptor family 3	300022	RE			
23.814	7	18	13	Xq28	SLC6A8, CRTR, CCDS1		Solute carrier family 6 (neurotransmitter transporter, creatine), member 8	300036	REa, Psh, A	distal to G6PD	Cerebral creatine deficiency syndrome 1, 300352 (3)	X(Slc6a8)
23.815	3	16	10	Xq28	SLC10A3, P3		Solute carrier family 10 (sodium/bile acid cotransporter family) member 3 (protein p3)	312090	RE, H	order: G6PD-3'-(7kb)-5'-P3-3'-(0.5kb)-5'-GDX		X(P3)
23.816	2	2	10	Xq28	SLEB15		Systemic lupus erythematosus, susceptibility to, 15	300809	Fd	associated with rs17435	{Systemic lupus erythematosus, susceptibility to, 15} (2)	
23.817	5	25	09	Xq28	SPRY3		Sprouty, Drosophila, homolog of, 3	300531	REc	in pseudoautosomal region PAR2		
23.818	7	27	17	Xq28	SRPK3, STK23, MSSK1		Protein kinase, serine/arginine-specific, 3	301002	REc, H			X(Srpk3)
23.819	11	29	16	Xq28	SSR4, TRAPD, CDG1Y		Signal sequence receptor, delta	300090	REc		Congenital disorder of glycosylation, type Iy, 300934 (3)	
23.820	7	17	12	Xq28	TAZ, EFE2, BTHS, CMD3A, LVNCX		Tafazzin	300394	Fd		Barth syndrome, 302060 (3)	
23.821	8	13	14	Xq28	TEX28		Testis-expressed gene on Xq28	300092	REn			
23.822	8	25	98	Xq28	TKCR, TKC		Torticollis, keloids, cryptorchidism and renal dysplasia	314300	X/A	distal to G6PD	Goeminne TKCR syndrome (2)	
23.823	10	15	98	Xq28	TKTL1, TKT2, TKR		Transketolase-like 1	300044	REf	between GCP and FLN1		
23.824	5	4	12	Xq28	TMEM187, CXorf12, DXS9878E, ITBA1 gene		Transmembrane protein 187	300059	RE			
23.825	4	21	16	Xq28	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6		Epsilon-trimethyllysine hydroxylase	300777	REc		{Autism, susceptibility to, X-linked 6}, 300872 (3)	
23.826	9	10	07	Xq28	UBL4A, GDX, UBL4, DX254E		Ubiquitin-like 4A	312070	RE, H	40kb 3' to G6PD		X(Gdx)
23.827	12	11	02	Xq28	TREX2		3-prime repair exonuclease 2	300370	REc			
23.828	10	12	09	Xq28	VAMP7, SYBL1, TIVAMP		Vesicle-associated membrane protein 7	300053	D			
23.829	7	13	98	Xq28	VBP1		Von Hippel-Lindau binding protein-1	300133	REc			X(Vbp1)
23.830	9	11	15	Xq28	VMA21, XMEA		Vma21, S. cerevisiae, homolog of	300913	REc		Myopathy, X-linked, with excessive autophagy, 310440 (3)	
23.831	10	23	87	Xq28	XM		Xm	314900	F	linked to DCB, PCB		
23.832	3	3	03	Xq28	ZNF185		Zinc finger protein 185	300381	REc			
23.833	2	28	03	Xq23	AMOT, KIAA1071		Angiomotin	300410	Psh			
23.834	11	3	11	Chr.X	CCCSX		Cerebral-cerebellar-coloboma syndrome, X-linked	300864	Fd		Cerebral-cerebellar-coloboma syndrome, X-linked (2)	
23.835	2	3	04	Chr.X	CVMRF		Cubitus valgus with mental retardation and unusual facies	300471	Fd		Cubitus valgus with mental retardation and unusual facies (2)	
23.836	6	27	08	Chr.X	DFCTRPS		Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	Fd		Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)	
23.837	2	7	01	Xp22.12	EIF1A, EIF4C, EIF1AX		Eukaryotic translation initiation factor 1A	300186	REa			
23.838	3	9	12	Chr.X	THCYTX		Thrombocythemia, X-linked	300331	Fd		Thrombocythemia, X-linked (2)	
23.839	12	13	00	Xp11.22	GAGED2, XAGE1		G antigen, family D, 2	300289	REa			
23.840	8	25	98	Xq24	IL13RA1		Interleukin-13 receptor, alpha-1	300119	Psh			
23.841	1	30	01	Xp11.21	KLF8, ZNF741, BKLF3		Kruppel-like factor 8	300286	R			
23.842	7	26	06	Chr.X	MCOPCB1		Microphthalmia, isolated, with coloboma 1	300345	Fd		Microphthalmia with coloboma 1 (2)	
23.843	2	2	14	Chr.X	MRX95		Mental retardation, X-linked 95	300716	Fd		Mental retardation, X-linked 95 (2)	
23.844	3	25	15	Chr.X	MRXSBWB		Brooks-Wisniewski-Brown syndrome	300612	Fd		Brooks-Wisniewski-Brown syndrome (2)	
23.845	3	25	15	Chr.X	MRXSMP		Mental retardation, X-linked, syndromic, Martin-Probst type	300519	Fd		Mental retardation, X-linked, syndromic, Martin-Probst type (2)	
23.846	8	27	01	Xq22.1	NXF2		Nuclear RNA export factor 2	300315	REc, R			
23.847	2	1	01	Xp11.23	PIM2		Oncogene PIM2	300295	R			
23.848	5	7	01	Xq26.1	RAB33A		Ras-associated protein RAB33A	300333	REc			
23.849	8	27	01	Xp22.2	REPS2, POB1		RALBP1-associated EPS domain-containing protein 2	300317	R			
23.850	12	5	01	Xq22.1	TAF7L, TAF2Q		TAF7-like RNA polymerase II, TATA box-binding protein-associated factor, 50kD	300314	R			
23.851	3	29	01	Xq22.3	TEX13A		Testis-expressed gene 13A	300312	R			
23.852	3	29	01	Xq22.3	TEX13B		Testis-expressed gene 13B	300313	R			
24.1	12	19	11	Yp11.2	AKAP17A, SFRS17A, XE7Y		A kinase (PRKA) anchor protein 17A	465000	REn	see 300015 locus		
24.2	10	4	93	Yp11.2	ASMTY		Acetylserotonin methyltransferase (Y chromosome)	402500	REa, Fd	pseudoautosomal		
24.3	3	23	04	Yp11.2	ASMTLY		Acetylserotonin methyltransferase-like, Y-linked	400011	REc			
24.4	10	4	93	Yp11.2	MIC2Y		Antigen identified by monoclonal 12E7, Y homolog	450000	S, A, D, Fd	pseudoautosomal		
24.5	11	16	09	Yp11.2	SHOXY		Short stature homeo box, Y-linked	400020	Ch, A	pseudoautosomal	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
24.6	10	13	93	Yp11.2	TSPY1, TSPY		Testis-specific protein, Y-linked, 1	480100	RE			
24.7	7	1	16	Yp11.32	PLCXD1Y		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1	400046	REc	in pseudoautosomal region		
24.8	9	5	01	Yp11.2	CRLF2Y		Cytokine receptor-like factor 2, Y-linked	400023	A	pseudoautosomal		
24.9	10	4	93	Yp11.2	IL3RA, IL3RY, IL3RAY		Interleukin-3 receptor (Y chromosome)	430000	REa, A, REn	308385 = X homolog; pseudoautosomal		
24.10	10	28	08	Yp11.2	RPS4Y1		Ribosomal protein S4, Y-linked, 1	470000	REn			
24.11	8	20	09	Yp11.2	SRY, TDF, TDY, SRXX1, SRXY1		Sex-determining region Y (testis determining factor)	480000	Ch, Fd		46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)	Yp(Tdy, Sry)
24.12	1	13	95	Yp11.2	ZFY		Zinc finger protein, Y-linked	490000	REn, A			
24.13	7	10	02	Yp11.2	PCDH11Y, PCDH22, PCDHY		Protocadherin 22	400022	REc			
24.14	8	5	97	Yp11.2	PRKY		Protein kinase, Y-linked	400008	A			
24.15	3	23	04	Yp11.2	TBL1Y		Transducin-beta-like 1, Y-linked	400033	REc			
24.16	2	28	03	Yp11.2	TGIF2LY, TGIFLY		Transforming growth factor-beta-induced factor 2-like, Y-linked	400025	REc			
24.17	10	4	93	Yp11.2	AMELY, AMGL		Amelogenin (Y chromosome)	410000	D	301200 = X homolog		
24.18	10	4	93	Yp11.2	CSF2RY		Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome)	425000	A	306250 = X homolog; distal to MIC2Y		
24.19	3	23	04	Yp11	XGR		XG regulator	489500	REc	in pseudoautosomal region		
24.20	10	4	93	Yp11.2	ANT3Y		Adenine nucleotide translocator-3 (Y chromosome)	403000	REc, REn	300151 = X homolog; proximal to CSF2RY		
24.21	7	8	99	Yq11.223	BPY2		Basic protein on Y chromosome, 2	400013	RE			
24.22	3	23	04	Yq	HEY		Hairy ears, Y-linked	425500	Fd		?Hairy ears, Y-linked (2)	
24.23	5	14	96	Yq11.223	DAZ		Deleted in azoospermia	400003	D	?same as AZF	?Sertoli-cell-only syndrome (1)	17(dazla)
24.24	3	16	09	Yq11.221	DDX3Y, DBY		DEAD/H box-3, Y-linked	400010	D			
24.25	11	3	11	Yq11	DELYq11, CYDELq11, SPGFY1		Chromosome Yq11 interstitial deletion syndrome	400042	Ch	contiguous gene deletion syndrome	Spermatogenic failure, Y-linked, 1 (4)	
24.26	8	19	09	Yq11.223	KDM5D, JARID1D, SMCY, HYA		Lysine-specific demethylase 5D	426000	D, REc	encodes H-Y epitope in mouse		Yp(Smcy)
24.27	7	9	99	Yq11.223	RBMY1A1, RBM1, YRRM1, RBM2		RNA binding motif protein, Y chromosome, family 1, member A1	400006	REc			Y(Rbmy)
24.28	8	11	98	Yq11.221	UTY		Ubiquitously transcribed TPR gene on Y chromosome	400009	REn			
24.29	3	23	04	Yq11.223	DAZ2		Deleted in azoospermia 2	400026	REc			
24.30	3	23	04	Yq11.23	DAZ3		Deleted in azoospermia 3	400027	REc			
24.31	3	23	04	Yq11.222-q11.223	CYorf15A		Chromosome Y open reading frame 15A	400031	REc			
24.32	3	23	04	Yq11.222	HSFY		Heat shock transcription factor, Y-linked	400029	REc			
24.33	3	23	04	Yq11.223	RPS4Y2		Ribosomal protein S4, Y-linked	400030	REc			
24.34	3	23	04	Yq11.2	CYorf15B		Chromosome Y open reading frame 15B	400032	REc			
24.35	3	23	04	Yq11.221	NLGN4Y, KIAA0951		Neuroligin 4, Y-linked	400028	REc			
24.36	11	2	04	Yq11.223	PRY2		PTPBL-related gene on Y, 2	400041	REc			
24.37	11	3	11	Yq11.221	USP9Y, DFFRY, SPGFY2		Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)	400005	REa, REc		Spermatogenic failure, Y-linked, 2, 415000 (3)	
24.38	8	19	09	Yq11.222	CDY2		Chromodomain protein, Y chromosome, 2	400018	REc			
24.39	8	24	09	Yq11.221	TMSB4Y		Thymosin, beta-4, Y chromosome	400017	REc			
24.40	8	24	09	Yq11.221	VCY, BPY1		Variably charged, Y chromosome	400012	REc			
24.41	8	24	09	Yq11.222	XKRY		XK-related protein on Y chromosome	400015	REc			
24.42	8	19	09	Yq11.223	EIF1AY		Eukaryotic translation initiation factor 1A, Y isoform	400014	REc			
24.43	8	24	09	Yq11.223	PRY		PTPN13-like, Y-linked	400019	Psh			
24.44	5	28	13	Yq11.223	TTTY4		Testis-specific transcript, Y-linked, 4	400037	REc			
24.45	5	28	13	Yq11.223	TTTY5		Testis-specific transcript, Y-linked, 5	400038	REc			
24.46	5	28	13	Yq11.223	TTTY6		Testis-specific transcript, Y-linked, 6	400039	REc			
24.47	5	28	13	Yq11.223	TTY17		Testis-specific transcript, Y-linked, 17	400040	REc			
24.48	8	19	09	Yq11.23	CDY1, CDY		Chromodomain protein, Y chromosome	400016	REc			Y(Cdy1)
24.49	11	10	17	Yq11.23	CSPG4P1Y, CSPG4LY		Chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked	400034	REc			
24.50	5	28	13	Yq11.23	GOLGA2LY		Golgi autoantigen, golgin subfamily A, 2-like, Y-linked	400035	REc			
24.51	5	28	13	Yq11.23	TTTY3		Testis-specific transcript, Y-linked, 3	400036	REc			
24.52	8	25	98	Yq12	GCY, TSY, STA		Growth control, Y-chromosome influenced	475000	Ch, D			
24.53	3	20	08	Chr.Y	DFNY1		Deafness, Y-linked 1	400043	Fd		Deafness, Y-linked 1 (1)	
24.54	2	8	01	Chr.Y	RPY		Retinitis pigmentosa, Y-linked	400004	Fd		Retinitis pigmentosa, Y-linked (2)	
#
#
#
#
# Native OMIM data only in this file.  A version of this map integrated
# with NCBI genomic coordinates, HGNC symbols, and more is genemap2.txt
#
# Confidence Codes :
# ------------------
#
# Confidence code are deprecated, however the column is retain so as not
# to break existing workflows.
#
#
# Mapping Method Codes :
# ----------------------
#
# The methods for mapping genes are symbolized as follows:
#
# A = in situ DNA-RNA or DNA-DNA annealing (`hybridization'); e.g.,
# ribosomal RNA genes to acrocentric chromosomes;
# kappa light chain genes to chromosome 2.
#
# AAS = deductions from the amino acid sequence of proteins; e.g., linkage of
# delta and beta hemoglobin loci from study of hemoglobin Lepore.
# (Includes deductions of hybrid protein
# structure by monoclonal antibodies; e.g., close linkage of MN and SS from
# study of Lepore-like MNSs blood group antigen.)
# Also includes examples of hybrid genes as in one form of hypertrophic
# cardiomyopathy and in apolipoprotein (Detroit).
#
# C = chromosome mediated gene transfer (CMGT); e.g., cotransfer of galactokinase
# and thymidine kinase.
# (In conjunction with this approach fluorescence-activated flow sorting
# can be used for transfer of specific chromosomes.)
#
# Ch = chromosomal change associated with particular phenotype and not proved to
# represent linkage (Fc), deletion (D), or virus effect (V);  e.g., loss of
# 13q14 band in some cases of retinoblastoma.
# (`Fragile sites,' observed in cultured cells with or without
# folate-deficient medium or BrdU treatment, fall into this class of method;
# e.g., fragile site at Xq27.3 in one form of X-linked mental retardation.
# Fragile sites have been used as markers in family linkage studies; e.g.,
# FS16q22 and haptoglobin.)
#
# D = deletion or dosage mapping (concurrence of chromosomal deletion and
# phenotypic evidence of hemizygosity), trisomy mapping (presence of three
# alleles in the case of a highly
# polymorphic locus), or gene dosage effects (correlation of trisomic state of
# part or all of a chromosome with 50% more gene product).
# Includes "loss of heterozygosity" (loss of alleles) in malignancies.
# Examples:  glutathione reductase to chromosome 8.
# Includes DNA dosage; e.g., fibrinogen loci to 4q2.
# Dosage mapping also includes coamplification in tumor cells.
#
# EM = exclusion mapping, i.e., narrowing the possible location of loci by
# exclusion of parts of the map by deletion mapping, extended to include
# negative lod scores from families with marker chromosomes and negative lod
# scores with other assigned loci; e.g., support for assignment of MNSs to 4q.
#
# F = linkage study in families; e.g., linkage of ABO blood group and
# nail-patella syndrome.
# (When a chromosomal heteromorphism or rearrangement is one trait, Fc
# is used; e.g., Duffy blood group locus on chromosome 1.
# When 1 or both of the linked loci are identified by a DNA polymorphism,
# Fd is used; e.g., Huntington disease on chromosome 4.  F = L in
# the HGM workshops.)
#
# H = based on presumed homology; e.g., proposed assignment of TF to 3q.
# Includes Ohno's law of evolutionary conservatism of X chromosome in mammals.
# Mainly heuristic or confirmatory.
#
# HS = DNA/cDNA molecular hybridization in solution (`Cot analysis'); e.g.,
# assignment of Hb beta to chromosome 11 in derivative hybrid cells.
#
# L = lyonization; e.g., OTC to X chromosome.  (L = family linkage study in the
# HGM workshops.)
#
# LD = linkage disequilibrium; e.g., beta and delta globin genes (HBB, HBD).
#
# M = Microcell mediated gene transfer (MMGT); e.g., a collagen gene (COL1A1) to
# chromosome l7.
#
# OT = ovarian teratoma (centromere mapping); e.g., PGM3 and centromere of
# chromosome 6.
#
# Pcm = PCR of microdissected chromosome segments (see REl).
#
# Psh = PCR of somatic cell hybrid DNA.
#
# R = irradiation of cells followed by `rescue' through fusion with
# nonirradiated (nonhuman) cells (Goss-Harris method of radiation-induced gene
# segregation); e.g., order of genes on  Xq.
# (Also called cotransference. The complement of cotransference = recombination.)
#
# RE = Restriction endonuclease techniques; e.g., fine structure map of the
# beta-globin cluster (HBBC) on 11p; physical linkage of 3 fibrinogen genes
# (on 4q) and APOA1 and APOC3 (on 11p).
#
# REa = combined with somatic cell hybridization; e.g., NAG (HBBC) to 11p.
#
# REb = combined with chromosome sorting; e.g., insulin to 11p.
# Includes Lebo's adaptation (dual laser chromosome sorting and spot blot DNA
# analysis); e.g., MGP to 11q.  (For this method, using flow sorted
# chromosomes, W is the symbol adopted by the HGM workshops.)
#
# REc = hybridization of cDNA to genomic fragment (by YAC, PFGE,
# microdissection, etc.), e.g., A11 on Xq.
#
# REf = isolation of gene from genomic DNA; includes 'exon trapping'
#
# REl = isolation of gene from chromosome-specific genomic
# library (see Pcm).
#
# REn = neighbor analysis in restriction fragments, e.g., in PFGE.
#
# S = `segregation' (cosegregation) of human cellular traits and human
# chromosomes (or segments of chromosomes) in particular clones from interspecies
# somatic cell hybrids; e.g., thymidine kinase to chromosome 17.
# When with restriction enzyme, REa; with hybridization in solution, HS.
#
# T = TACT = telomere-associated chromosome fragmentation; e.g.,
# interferon-inducible protein 6-16.
#
# V = induction of microscopically evident chromosomal change by a virus; e.g.,
# adenovirus 12 changes on chromosomes 1 and 17.
#
# X/A = X-autosome translocation in female with X-linked recessive disorder;
# e.g., assignment of Duchenne muscular dystrophy to Xp21.
#
#
# Phenotypes :
# ------------
#
# Each Phenotype is followed by its MIM number, if different from
# that of the locus, preceded by a comma
# Phenotype mapping key in parentheses follows the phenotype MIM
# number (explanation below).
# Allelic disorders are separated by a semi-colon following the
# phenotype mapping key.
#
#
# Phenotype Mapping Key - Appears in parentheses after a disorder :
# -----------------------------------------------------------------
#
# 1 - The disorder is placed on the map based on its association with
# a gene, but the underlying defect is not known.
# 2 - The disorder has been placed on the map by linkage; no mutation
# has been found.
# 3 - The molecular basis for the disorder is known; a mutation has
# been found in the gene.
# 4 - A contiguous gene deletion or duplication syndrome, multiple
# genes are deleted or duplicated causing the phenotype.
#
